[
  {
    "id": 2,
    "user_query": "Is the protein Papilin secreted?",
    "vicuna-7b_response": "Papilin is a protein that is found in various organisms, including humans. The exact function of Papilin is not fully understood, but it is believed to play a role in cellular signaling and communication.\nThere is limited information available on whether Papilin is secreted or not. However, it is known that Papilin is expressed in various tissues and cell types, including the brain, heart, and testis. It is also found in the extracellular matrix, which is the matrix of extracellular macromolecules that surrounds cells and gives tissues their structure.\nIn summary, while there is limited information available on whether Papilin is secreted or not, it is expressed in various tissues and cell types and can be found in the extracellular matrix. Further research is needed to fully understand the function of Papilin and its role in cellular signaling and communication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Papilin is a protein that is found in various organisms, including humans.\n2. The exact function of Papilin is not fully understood.\n3. Papilin is believed to play a role in cellular signaling and communication.\n4. Papilin is expressed in various tissues and cell types, including the brain, heart, and testis.\n5. Papilin is found in the extracellular matrix.",
    "vicuna-7b_fact": [
      "Papilin is a protein that is found in various organisms, including humans.",
      "The exact function of Papilin is not fully understood.",
      "Papilin is believed to play a role in cellular signaling and communication.",
      "Papilin is expressed in various tissues and cell types, including the brain, heart, and testis.",
      "Papilin is found in the extracellular matrix."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 8,
    "user_query": "Has Denosumab (Prolia) been approved by FDA?",
    "vicuna-7b_response": "Yes, Denosumab (Prolia) has been approved by the FDA. Denosumab is a monoclonal antibody that is used to treat osteoporosis in postmenopausal women and to prevent skeletal complications in patients with multiple myeloma. It is also used to treat certain types of bone cancer.\nDenosumab works by inhibiting the activity of a protein called RANK ligand, which is involved in the formation and maintenance of bone. By inhibiting RANK ligand, denosumab increases bone density and reduces the risk of fractures.\nThe FDA approved Denosumab under the brand name Prolia in 2010 for the treatment of osteoporosis in postmenopausal women and in 2010 for the prevention of skeletal complications in patients with multiple myeloma. In 2017, the FDA also approved Denosumab for the treatment of certain types of bone cancer.\nIt is important to note that Denosumab is not approved for all types of bone cancer and its use should be determined by a healthcare professional based on the individual patient's medical history and other factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Denosumab (Prolia) has been approved by the FDA.\n2. Denosumab is a monoclonal antibody that is used to treat osteoporosis in postmenopausal women and to prevent skeletal complications in patients with multiple myeloma.\n3. The FDA approved Denosumab under the brand name Prolia in 2010 for the treatment of osteoporosis in postmenopausal women and prevention of skeletal complications in patients with multiple myeloma.\n4. In 2017, the FDA approved Denosumab for the treatment of certain types of bone cancer.\n5. Denosumab is not approved for all types of bone cancer.",
    "vicuna-7b_fact": [
      "Denosumab (Prolia) has been approved by the FDA.",
      "Denosumab is a monoclonal antibody that is used to treat osteoporosis in postmenopausal women and to prevent skeletal complications in patients with multiple myeloma.",
      "The FDA approved Denosumab under the brand name Prolia in 2010 for the treatment of osteoporosis in postmenopausal women and prevention of skeletal complications in patients with multiple myeloma.",
      "In 2017, the FDA approved Denosumab for the treatment of certain types of bone cancer.",
      "Denosumab is not approved for all types of bone cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-7b_response": "Acrokeratosis paraneoplastica is a condition characterized by the development of thick, rough, and often discolored patches of skin on the fingers, toes, and sometimes the soles of the feet. These patches are caused by the body's immune system reacting to a cancerous or precancerous growth in the body.\nOne possible name synonym for Acrokeratosis paraneoplastica is \"hand-foot syndrome.\" This name is sometimes used to describe the condition when it is limited to the hands and feet, and does not involve other parts of the body.\nAnother possible name synonym for Acrokeratosis paraneoplastica is \"pachyonychia hystrix.\" This name refers to the thick, rough texture of the skin patches that are characteristic of the condition.\nIt's important to note that while these names may be used to describe similar conditions, they may not always be used interchangeably with Acrokeratosis paraneoplastica. It's always best to consult with a medical professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Acrokeratosis paraneoplastica is characterized by the development of thick, rough, and often discolored patches of skin on fingers, toes, and sometimes the soles of the feet.\n2. These skin patches in Acrokeratosis paraneoplastica are caused by the body's immune system reacting to a cancerous or precancerous growth.\n3. \"Hand-foot syndrome\" is sometimes used as a synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.\n4. \"Pachyonychia hystrix\" is another possible synonym for Acrokeratosis paraneoplastica, referring to the characteristic skin texture.\n5. The names \"hand-foot syndrome\" and \"pachyonychia hystrix\" may not always be used interchangeably with Acrokeratosis paraneoplastica.",
    "vicuna-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by the development of thick, rough, and often discolored patches of skin on fingers, toes, and sometimes the soles of the feet.",
      "These skin patches in Acrokeratosis paraneoplastica are caused by the body's immune system reacting to a cancerous or precancerous growth.",
      "\"Hand-foot syndrome\" is sometimes used as a synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.",
      "\"Pachyonychia hystrix\" is another possible synonym for Acrokeratosis paraneoplastica, referring to the characteristic skin texture.",
      "The names \"hand-foot syndrome\" and \"pachyonychia hystrix\" may not always be used interchangeably with Acrokeratosis paraneoplastica."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: \"Hand-foot syndrome\" is not a synonym for Acrokeratosis paraneoplastica. It refers to a distinct condition, often linked with certain chemotherapy drugs, causing redness, swelling and pain in hands and feet.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 11,
    "user_query": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?",
    "vicuna-7b_response": "The Vaughan-Williams classification is a system used to classify anti-arrhythmic drugs based on their mechanism of action. The classification was proposed by William Vaughan-Williams in 1960 and is still widely used today.\nAccording to the Vaughan-Williams classification, anti-arrhythmic drugs can be classified into the following classes:\n1. Class I: These drugs prolong the duration of the action potential and slow the rate of depolarization. Examples of drugs in this class include quinidine and disopyramide.\n2. Class II: These drugs prolong the duration of the action potential and slow the rate of depolarization. They also prolong the duration of the refractory period and reduce the rate of automaticity. Examples of drugs in this class include procainamide and moricizine.\n3. Class III: These drugs prolong the duration of the action potential and slow the rate of depolarization. They also prolong the duration of the refractory period and reduce the rate of automaticity. They also inhibit the release of acetylcholine from the nerve terminals. Examples of drugs in this class include flecainide and propafenone.\n4. Class IV: These drugs prolong the duration of the action potential and slow the rate of depolarization. They also prolong the duration of the refractory period and reduce the rate of automaticity. They also inhibit the release of acetylcholine from the nerve terminals. They also have a negative inotropic effect. Examples of drugs in this class include encainide and terfenadine.\n5. Class V: These drugs prolong the duration of the action potential and slow the rate of depolarization. They also prolong the duration of the refractory period and reduce the rate of automaticity. They also inhibit the release of acetylcholine from the nerve terminals. They also have a negative inotropic effect. They also have a negative chronotropic effect. Examples of drugs in this class include ibutilide.\nIt's important to note that this classification is not exhaustive and some drugs may fit into more than one class. Also, the classification is based on the mechanism of action of the drugs and not on",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Vaughan-Williams classification was proposed by William Vaughan-Williams in 1960.\n2. This classification divides anti-arrhythmic drugs into several classes based on their mechanism of action.\n3. According to this classification, Class I drugs prolong the duration of the action potential and slow the rate of depolarization with quinidine and disopyramide being examples.\n4. Class V drugs according to this classification, in addition to sharing qualities with Classes I-IV, also have a negative chronotropic effect with an example being ibutilide.\n5. The Vaughan-Williams classification system is not exhaustive and some drugs may fit into more than one class.",
    "vicuna-7b_fact": [
      "The Vaughan-Williams classification was proposed by William Vaughan-Williams in 1960.",
      "This classification divides anti-arrhythmic drugs into several classes based on their mechanism of action.",
      "According to this classification, Class I drugs prolong the duration of the action potential and slow the rate of depolarization with quinidine and disopyramide being examples.",
      "Class V drugs according to this classification, in addition to sharing qualities with Classes I-IV, also have a negative chronotropic effect with an example being ibutilide.",
      "The Vaughan-Williams classification system is not exhaustive and some drugs may fit into more than one class."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: According to the Vaughan-Williams classification, Class I drugs block the sodium channel, thereby slowing the rate of rapid depolarization, with quinidine and disopyramide being examples.\n4. FALSE [correction]: Class V in the Vaughan-Williams classification doesn't share qualities with Classes I-IV, but it's rather marked by drugs that don't fit into those four classes. Adenosine and digoxin are examples, not ibutilide.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 12,
    "user_query": "Which are the different isoforms of the mammalian Notch receptor?",
    "vicuna-7b_response": "The Notch receptor is a transmembrane protein that plays a crucial role in cell-cell communication and development in mammals. There are four different isoforms of the Notch receptor, each with unique characteristics and functions.\nThe four isoforms of the Notch receptor are:\n1. Notch1: This isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival. It is also involved in the development of T cells, B cells, and mast cells.\n2. Notch2: This isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival. It is also involved in the development of T cells and B cells.\n3. Notch3: This isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival. It is also involved in the development of T cells and B cells.\n4. Notch4: This isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival. It is also involved in the development of T cells and B cells.\nOverall, the Notch receptor isoforms play important roles in cellular signaling and development, and their dysregulation has been implicated in various diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Notch receptor is a transmembrane protein that plays a crucial role in cell-cell communication and development in mammals.\n2. There are four different isoforms of the Notch receptor.\n3. Notch1, Notch2, Notch3, and Notch4 are the four isoforms of the Notch receptor.\n4. Each Notch receptor isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival. \n5. Dysregulation of the Notch receptor isoforms has been implicated in various diseases, including cancer.",
    "vicuna-7b_fact": [
      "The Notch receptor is a transmembrane protein that plays a crucial role in cell-cell communication and development in mammals.",
      "There are four different isoforms of the Notch receptor.",
      "Notch1, Notch2, Notch3, and Notch4 are the four isoforms of the Notch receptor.",
      "Each Notch receptor isoform is expressed in most tissues and plays a role in cell proliferation, differentiation, and survival.",
      "Dysregulation of the Notch receptor isoforms has been implicated in various diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 15,
    "user_query": "Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?",
    "vicuna-7b_response": "Trastuzumab (Herceptin) is a monoclonal antibody that is primarily used in the treatment of breast cancer. It is not typically used in the treatment of prostate cancer.\nTrastuzumab is a type of targeted therapy that works by binding to the HER2/neu protein, which is overexpressed in some types of breast cancer. By binding to this protein, Trastuzumab can help to block the growth and spread of cancer cells.\nProstate cancer, on the other hand, is a type of cancer that affects the prostate gland, which is a small gland located below the bladder in men. Prostate cancer typically grows slowly and may not cause any symptoms in the early stages. Treatment options for prostate cancer typically include surgery, radiation therapy, and hormone therapy.\nWhile Trastuzumab may not be a viable treatment option for prostate cancer, there are other monoclonal antibodies that are being studied for the treatment of various types of cancer, including prostate cancer. It is important to note, however, that these treatments are still in the research and development stage and may not be widely available for use in the treatment of prostate cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Trastuzumab (Herceptin) is a monoclonal antibody primarily used in the treatment of breast cancer.\n2. Trastuzumab works by binding to the HER2/neu protein, which blocks the growth and spread of cancer cells.\n3. Prostate cancer affects the prostate gland in men.\n4. Treatment options for prostate cancer typically include surgery, radiation therapy, and hormone therapy.\n5. Other monoclonal antibodies are being researched for the treatment of various types of cancer, including prostate cancer.",
    "vicuna-7b_fact": [
      "Trastuzumab (Herceptin) is a monoclonal antibody primarily used in the treatment of breast cancer.",
      "Trastuzumab works by binding to the HER2/neu protein, which blocks the growth and spread of cancer cells.",
      "Prostate cancer affects the prostate gland in men.",
      "Treatment options for prostate cancer typically include surgery, radiation therapy, and hormone therapy.",
      "Other monoclonal antibodies are being researched for the treatment of various types of cancer, including prostate cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 22,
    "user_query": "Are transcription and splicing connected?",
    "vicuna-7b_response": "Yes, transcription and splicing are connected processes in the central dogma of molecular biology.\nTranscription is the process by which the information in a DNA molecule is used to synthesize a complementary RNA molecule, called messenger RNA (mRNA). This process occurs in the nucleus of a cell and is initiated by the enzyme RNA polymerase.\nSplicing is the process by which the mRNA molecule is edited to remove non-coding sequences called introns and join together the remaining coding sequences, called exons. This process occurs in the cytoplasm of a cell and is carried out by the enzyme spliceosome.\nThe transcription and splicing processes are connected in that the mRNA molecule produced by transcription is the starting point for splicing. The spliceosome uses the mRNA molecule as a template to edit the introns out of the mRNA and join the exons together to form a functional mRNA molecule.\nIn summary, transcription and splicing are two connected processes in the central dogma of molecular biology that work together to produce a functional mRNA molecule that can be used to synthesize proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcription is the process by which a DNA molecule's information is used to create a complementary RNA molecule.\n2. The enzyme RNA polymerase initiates the transcription process in the nucleus of a cell.\n3. Splicing is the process where a mRNA molecule is edited to remove non-coding intron sequences and join together coding exon sequences.\n4. The enzyme spliceosome conducts the process of splicing in the cytoplasm of a cell.\n5. Transcription and splicing are two connected processes that work together to make a functional mRNA molecule.",
    "vicuna-7b_fact": [
      "Transcription is the process by which a DNA molecule's information is used to create a complementary RNA molecule.",
      "The enzyme RNA polymerase initiates the transcription process in the nucleus of a cell.",
      "Splicing is the process where a mRNA molecule is edited to remove non-coding intron sequences and join together coding exon sequences.",
      "The enzyme spliceosome conducts the process of splicing in the cytoplasm of a cell.",
      "Transcription and splicing are two connected processes that work together to make a functional mRNA molecule."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The enzyme spliceosome conducts the process of splicing in the nucleus of a cell.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 23,
    "user_query": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?",
    "vicuna-7b_response": "Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disorder that affects the muscles, specifically the voluntary muscles that control movement. The mode of inheritance of FSHD is autosomal dominant, which means that a person with FSHD has a 50% chance of passing the gene on to their children.\nFSHD is caused by a mutation in the DUX4 gene, which is located on chromosome 4. The mutation results in the production of an abnormal protein that causes muscle degeneration and weakness. The gene is dominant, which means that a person with one copy of the mutated gene (called a carrier) has a 50% chance of passing the gene on to their children.\nIn most cases, the symptoms of FSHD appear in early childhood, with progressive muscle weakness and atrophy affecting the face, shoulder blades, and upper arms (hence the name \"facioscapulohumeral\" muscular dystrophy). The muscles affected by FSHD are those that are responsible for movement, including those in the arms, legs, and face.\nThere is no cure for FSHD, but treatments are available to help manage the symptoms and improve quality of life. Physical therapy, assistive devices, and medications can help to alleviate muscle stiffness and improve mobility. In some cases, surgery may be necessary to correct deformities caused by muscle weakness.\nIn summary, the mode of inheritance of FSHD is autosomal dominant, and the disorder is caused by a mutation in the DUX4 gene. A person with one copy of the mutated gene is a carrier, and has a 50% chance of passing the gene on to their children.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disorder that affects the muscles.\n2. FSHD is caused by a mutation in the DUX4 gene, which is located on chromosome 4.\n3. In most cases, the symptoms of FSHD appear in early childhood, with progressive muscle weakness and atrophy affecting the face, shoulder blades, and upper arms.\n4. There is no cure for FSHD, but treatments are available to help manage the symptoms and improve quality of life.\n5. A person with one copy of the mutated gene is a carrier and has a 50% chance of passing the gene on to their children.",
    "vicuna-7b_fact": [
      "Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disorder that affects the muscles.",
      "FSHD is caused by a mutation in the DUX4 gene, which is located on chromosome 4.",
      "In most cases, the symptoms of FSHD appear in early childhood, with progressive muscle weakness and atrophy affecting the face, shoulder blades, and upper arms.",
      "There is no cure for FSHD, but treatments are available to help manage the symptoms and improve quality of life.",
      "A person with one copy of the mutated gene is a carrier and has a 50% chance of passing the gene on to their children."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In most cases, the symptoms of FSHD appear in early adulthood, not childhood, with progressive muscle weakness and atrophy affecting the face, shoulder blades, and upper arms.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 25,
    "user_query": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?",
    "vicuna-7b_response": "The ryanodine receptor (RyR) is a type of intracellular Ca2+ release channel that plays a crucial role in regulating intracellular Ca2+ levels in muscle and non-muscle cells. The RyR quaternary macromolecular complex is composed of four subunits: RyR1, RyR2, RyR3, and phospholemman (PLM).\nRyR1 and RyR2 are the major subunits that form the functional channel for Ca2+ release. RyR3 is a regulatory subunit that modulates the activity of the channel by controlling its open probability and Ca2+ affinity. PLM is a regulatory subunit that interacts with RyR3 and modulates its activity.\nIn addition to these subunits, other proteins can also interact with the RyR complex and play a role in its regulation and function. For example, the protein calsequestrin is a major Ca2+ buffer in muscle cells and interacts with the RyR complex to regulate Ca2+ release. The protein triadin is a scaffolding protein that interacts with RyR1 and RyR2 and plays a role in the assembly and function of the RyR complex.\nOverall, the formation of the RyR quaternary macromolecular complex involves the interaction of several key subunits, including RyR1, RyR2, RyR3, and PLM, as well as other regulatory and accessory proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ryanodine receptor (RyR) is a type of intracellular Ca2+ release channel.\n2. The RyR quaternary macromolecular complex is composed of RyR1, RyR2, RyR3, and phospholemman (PLM).\n3. RyR1 and RyR2 are the major subunits that form the functional channel for Ca2+ release, while RyR3 modulates the activity of the channel.\n4. Phospholemman (PLM) is a regulatory subunit that interacts with RyR3 and modulates its activity.\n5. The proteins calsequestrin and triadin interact with the RyR complex to regulate Ca2+ release and aid in the assembly and function of the complex.",
    "vicuna-7b_fact": [
      "The ryanodine receptor (RyR) is a type of intracellular Ca2+ release channel.",
      "The RyR quaternary macromolecular complex is composed of RyR1, RyR2, RyR3, and phospholemman (PLM).",
      "RyR1 and RyR2 are the major subunits that form the functional channel for Ca2+ release, while RyR3 modulates the activity of the channel.",
      "Phospholemman (PLM) is a regulatory subunit that interacts with RyR3 and modulates its activity.",
      "The proteins calsequestrin and triadin interact with the RyR complex to regulate Ca2+ release and aid in the assembly and function of the complex."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: Phospholemman (PLM) is not typically associated with the ryanodine receptor complex. It is FK506-binding protein (FKBP) that is known to interact with the receptor and modulate its function.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 26,
    "user_query": "What kind of chromatography is HILIC?",
    "vicuna-7b_response": "HILIC (hydrophilic interaction liquid chromatography) is a type of chromatography that is used to separate and analyze compounds based on their hydrophilic interactions with a stationary phase.\nHILIC is a reversed-phase chromatography, which means that it uses a hydrophobic stationary phase and a hydrophilic mobile phase. The hydrophobic stationary phase interacts with the hydrophobic groups of the compounds, while the hydrophilic mobile phase interacts with the hydrophilic groups of the compounds.\nHILIC is particularly useful for separating and analyzing polar and hydrophilic compounds, such as peptides, proteins, and nucleic acids. It is also used for the analysis of lipids, carbohydrates, and other polar compounds.\nHILIC can be used in a variety of applications, including the analysis of metabolites, the identification of impurities in pharmaceuticals, and the characterization of proteins and other biomolecules.\nIn summary, HILIC is a type of chromatography that is used to separate and analyze compounds based on their hydrophilic interactions with a stationary phase. It is particularly useful for separating and analyzing polar and hydrophilic compounds, and it is used in a variety of applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. HILIC (hydrophilic interaction liquid chromatography) is a type of chromatography used to separate and analyze compounds based on their hydrophilic interactions with a stationary phase.\n2. HILIC is a reversed-phase chromatography. \n3. In HILIC, a hydrophobic stationary phase interacts with the hydrophobic groups of the compounds, while a hydrophilic mobile phase interacts with the hydrophilic groups of the compounds.\n4. HILIC is particularly useful for separating and analyzing polar and hydrophilic compounds.\n5. HILIC is used in a variety of applications, including the analysis of metabolites, the identification of impurities in pharmaceuticals, and the characterization of proteins and other biomolecules.",
    "vicuna-7b_fact": [
      "HILIC (hydrophilic interaction liquid chromatography) is a type of chromatography used to separate and analyze compounds based on their hydrophilic interactions with a stationary phase.",
      "HILIC is a reversed-phase chromatography.",
      "In HILIC, a hydrophobic stationary phase interacts with the hydrophobic groups of the compounds, while a hydrophilic mobile phase interacts with the hydrophilic groups of the compounds.",
      "HILIC is particularly useful for separating and analyzing polar and hydrophilic compounds.",
      "HILIC is used in a variety of applications, including the analysis of metabolites, the identification of impurities in pharmaceuticals, and the characterization of proteins and other biomolecules."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: HILIC is not a reversed-phase chromatography; it is a form of normal-phase chromatography.\n3. FALSE [correction]: In HILIC, a hydrophilic stationary phase interacts with the hydrophilic groups of the compounds, while a hydrophobic mobile phase interacts with the hydrophobic groups of the compounds.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 27,
    "user_query": "What is the effect of TRH on myocardial contractility?",
    "vicuna-7b_response": "TRH (Thyrotropin-Releasing Hormone) is a hormone that is produced by the hypothalamus and stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland. TSH, in turn, stimulates the production and release of thyroid hormones (T4 and T3) from the thyroid gland.\nThe effect of TRH on myocardial contractility is not well understood. However, TRH has been shown to have a positive effect on heart function in some studies. For example, one study found that TRH administration improved left ventricular function in patients with heart failure. Another study found that TRH administration increased cardiac output and reduced systemic blood pressure in patients with heart failure.\nIt is important to note that these findings are not consistent across all studies, and more research is needed to fully understand the effects of TRH on myocardial contractility. Additionally, TRH is not currently approved for the treatment of heart failure, and its use in this context should be approached with caution.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TRH (Thyrotropin-Releasing Hormone) is a hormone produced by the hypothalamus.\n2. TRH stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.\n3. TSH stimulates the production and release of thyroid hormones (T4 and T3) from the thyroid gland.\n4. One study found that TRH administration improved left ventricular function in patients with heart failure.\n5. TRH is not currently approved for the treatment of heart failure.",
    "vicuna-7b_fact": [
      "TRH (Thyrotropin-Releasing Hormone) is a hormone produced by the hypothalamus.",
      "TRH stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.",
      "TSH stimulates the production and release of thyroid hormones (T4 and T3) from the thyroid gland.",
      "One study found that TRH administration improved left ventricular function in patients with heart failure.",
      "TRH is not currently approved for the treatment of heart failure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 28,
    "user_query": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
    "vicuna-7b_response": "Yes, the complete genome of the bacteria of the genus Arthrobacter is available. Arthrobacter is a gram-positive, aerobic bacterium that is commonly found in soil and the rhizosphere of plants. It is known for its ability to degrade a wide range of organic compounds, including lignocellulose, and has potential applications in bioremediation and biotechnology.\nThe complete genome of Arthrobacter sp. strain SC-1 was sequenced in 2008 as part of the DOE Joint Genome Institute's Genomic Encyclopedia of Bacteria and Archaea (GEBA) project. The genome consists of a single circular chromosome that is approximately 4.5 megabases in size. It contains 3,888 protein-coding genes, as well as a variety of other functional elements such as ribosomal RNA genes, transfer RNA genes, and regulatory sequences.\nThe genome of Arthrobacter sp. strain SC-1 has been annotated and is publicly available through the National Center for Biotechnology Information's (NCBI) GenBank database under the accession number CP001108. The annotation provides information on the function of each gene, as well as information on the metabolic pathways and other biological processes that are encoded in the genome. This information can be useful for a variety of applications, including proteomic analyses and other types of functional genomic studies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The complete genome of the bacteria of the genus Arthrobacter is available.\n2. Arthrobacter is a gram-positive, aerobic bacterium that is commonly found in soil and the rhizosphere of plants.\n3. The complete genome of Arthrobacter sp. strain SC-1 was sequenced in 2008 as part of the DOE Joint Genome Institute's Genomic Encyclopedia of Bacteria and Archaea (GEBA) project.\n4. The genome of Arthrobacter sp. strain SC-1 consists of a single circular chromosome that is approximately 4.5 megabases in size and contains 3,888 protein-coding genes, as well as a variety of other functional elements.\n5. The genome of Arthrobacter sp. strain SC-1 is publicly available through the National Center for Biotechnology Information's (NCBI) GenBank database under the accession number CP001108.",
    "vicuna-7b_fact": [
      "The complete genome of the bacteria of the genus Arthrobacter is available.",
      "Arthrobacter is a gram-positive, aerobic bacterium that is commonly found in soil and the rhizosphere of plants.",
      "The complete genome of Arthrobacter sp. strain SC-1 was sequenced in 2008 as part of the DOE Joint Genome Institute's Genomic Encyclopedia of Bacteria and Archaea (GEBA) project.",
      "The genome of Arthrobacter sp. strain SC-1 consists of a single circular chromosome that is approximately 4.5 megabases in size and contains 3,888 protein-coding genes, as well as a variety of other functional elements.",
      "The genome of Arthrobacter sp. strain SC-1 is publicly available through the National Center for Biotechnology Information's (NCBI) GenBank database under the accession number CP001108."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 29,
    "user_query": "What is the structural fold of bromodomain proteins?",
    "vicuna-7b_response": "The structural fold of bromodomain proteins is a unique fold that is characterized by the presence of a bromodomain, which is a protein module that recognizes acetylated lysine residues in histone and non-histone proteins. Bromodomain proteins are involved in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions.\nThe bromodomain fold is composed of two domains: the bromodomain and the chromodomain. The bromodomain is responsible for recognizing acetylated lysine residues, while the chromodomain is involved in binding to chromatin. The bromodomain fold is found in a variety of proteins, including transcriptional regulators, chromatin-associated proteins, and proteins involved in the regulation of cellular signaling pathways.\nThe bromodomain fold is characterized by the presence of a conserved structural motif called the bromodomain fold signature, which includes a conserved cysteine residue that is involved in the formation of a disulfide bond. This disulfide bond is essential for the stability and function of the bromodomain fold.\nOverall, the structural fold of bromodomain proteins is a unique fold that is characterized by the presence of a bromodomain, which is involved in the recognition of acetylated lysine residues in histone and non-histone proteins. The bromodomain fold is found in a variety of proteins and is characterized by the presence of the bromodomain fold signature, which includes a conserved cysteine residue that is involved in the formation of a disulfide bond.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The structural fold of bromodomain proteins is characterized by the presence of a bromodomain.\n2. Bromodomain proteins recognize acetylated lysine residues in histone and non-histone proteins. \n3. The bromodomain fold is composed of two domains: the bromodomain and the chromodomain.\n4. The bromodomain fold is characterized by a conserved structural motif called the bromodomain fold signature, which includes a conserved cysteine residue involved in the formation of a disulfide bond.\n5. Bromodomain proteins are involved in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions.",
    "vicuna-7b_fact": [
      "The structural fold of bromodomain proteins is characterized by the presence of a bromodomain.",
      "Bromodomain proteins recognize acetylated lysine residues in histone and non-histone proteins.",
      "The bromodomain fold is composed of two domains: the bromodomain and the chromodomain.",
      "The bromodomain fold is characterized by a conserved structural motif called the bromodomain fold signature, which includes a conserved cysteine residue involved in the formation of a disulfide bond.",
      "Bromodomain proteins are involved in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The bromodomain fold is not composed of two domains: the bromodomain and the chromodomain. Rather, it is characterized by a bundle of four alpha-helices.\n4. FALSE [correction]: The bromodomain fold is characterized by a conserved structural motif, but it does not include a conserved cysteine residue involved in the formation of a disulfide bond. It formation is generally stabilized by as many as four alpha-helices.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 32,
    "user_query": "Which MAP kinase phosphorylates the transcription factor c-jun?",
    "vicuna-7b_response": "The MAP kinase that phosphorylates the transcription factor c-jun is the Jun N-terminal kinase (JNK). JNK is a member of the MAP kinase family and plays a role in the regulation of cell growth, differentiation, and apoptosis. It is activated in response to a variety of stimuli, including inflammation, UV radiation, and oxidative stress, and phosphorylates a number of transcription factors, including c-jun. Phosphorylation of c-jun by JNK leads to its activation and translocation to the nucleus, where it can bind to DNA and regulate the expression of target genes involved in cell proliferation and survival.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The MAP kinase that phosphorylates the transcription factor c-jun is the Jun N-terminal kinase (JNK).\n2. JNK is a member of the MAP kinase family.\n3. JNK plays a role in the regulation of cell growth, differentiation, and apoptosis.\n4. JNK is activated in response to a variety of stimuli, including inflammation, UV radiation, and oxidative stress.\n5. Phosphorylation of c-jun by JNK leads to its activation and translocation to the nucleus, where it can bind to DNA and regulate the expression of target genes.",
    "vicuna-7b_fact": [
      "The MAP kinase that phosphorylates the transcription factor c-jun is the Jun N-terminal kinase (JNK).",
      "JNK is a member of the MAP kinase family.",
      "JNK plays a role in the regulation of cell growth, differentiation, and apoptosis.",
      "JNK is activated in response to a variety of stimuli, including inflammation, UV radiation, and oxidative stress.",
      "Phosphorylation of c-jun by JNK leads to its activation and translocation to the nucleus, where it can bind to DNA and regulate the expression of target genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 36,
    "user_query": "Which fusion protein is involved in the development of Ewing sarcoma?",
    "vicuna-7b_response": "Ewing sarcoma is a type of bone cancer that is caused by a genetic mutation in the chromosome 22. The specific fusion protein involved in the development of Ewing sarcoma is the EWS-FLI1 fusion protein.\nEWS-FLI1 is a transcription factor that plays a crucial role in the development and progression of Ewing sarcoma. The fusion protein is formed by the combination of the Ewing's sarcoma breakpoint region 1 (EWS) gene and the FLI1 gene. The EWS-FLI1 fusion protein has a unique property of being able to bind to specific DNA sequences, which allows it to regulate the expression of genes involved in cell proliferation, differentiation, and survival.\nThe EWS-FLI1 fusion protein is overexpressed in Ewing sarcoma cells, which leads to the uncontrolled proliferation and survival of these cells. This overexpression of the fusion protein is thought to be responsible for the development and progression of Ewing sarcoma.\nIn summary, the EWS-FLI1 fusion protein is the specific fusion protein involved in the development of Ewing sarcoma.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ewing sarcoma is a type of bone cancer caused by a genetic mutation in chromosome 22.\n2. The EWS-FLI1 fusion protein is involved in the development of Ewing sarcoma.\n3. EWS-FLI1 fusion protein is a transcription factor that plays a crucial role in developing Ewing sarcoma.\n4. The fusion protein is formed by the combination of the EWS gene and the FLI1 gene.\n5. This fusion protein is overexpressed in Ewing sarcoma cells leading to uncontrolled proliferation and survival of these cells.",
    "vicuna-7b_fact": [
      "Ewing sarcoma is a type of bone cancer caused by a genetic mutation in chromosome 22.",
      "The EWS-FLI1 fusion protein is involved in the development of Ewing sarcoma.",
      "EWS-FLI1 fusion protein is a transcription factor that plays a crucial role in developing Ewing sarcoma.",
      "The fusion protein is formed by the combination of the EWS gene and the FLI1 gene.",
      "This fusion protein is overexpressed in Ewing sarcoma cells leading to uncontrolled proliferation and survival of these cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Ewing sarcoma is a cancer that occurs primarily in the bone or soft tissue, and it is thought to arise from certain cells in bone marrow. Genetic mutations, especially translocations, may play a role, but it is not definitively caused by a mutation in chromosome 22 only.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 40,
    "user_query": "Treatment of which disease was investigated in the MR CLEAN study?",
    "vicuna-7b_response": "The MR CLEAN study, which stands for \"Multicenter Randomized Clinical Evaluation of Ischemic Lesions,\" investigated the treatment of acute ischemic stroke. Acute ischemic stroke is a type of stroke that occurs when there is a blockage or clot in a blood vessel that supplies blood to the brain. The MR CLEAN study was a large, multicenter clinical trial that aimed to evaluate the effectiveness of a treatment called thrombolytic therapy for acute ischemic stroke. Thrombolytic therapy involves the use of drugs to dissolve the clot and restore blood flow to the brain. The results of the MR CLEAN study were published in the New England Journal of Medicine in 2015 and showed that thrombolytic therapy was effective in improving outcomes for patients with acute ischemic stroke.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The MR CLEAN study stands for \"Multicenter Randomized Clinical Evaluation of Ischemic Lesions.\"\n2. The MR CLEAN study investigated the treatment of acute ischemic stroke.\n3. Acute ischemic stroke occurs when there is a blockade or clot in a blood vessel that supplies blood to the brain.\n4. Thrombolytic therapy, which involves the use of drugs to dissolve the clot and restore blood flow to the brain, was the treatment evaluated in the MR CLEAN study.\n5. The results of the MR CLEAN study were published in the New England Journal of Medicine in 2015.",
    "vicuna-7b_fact": [
      "The MR CLEAN study stands for \"Multicenter Randomized Clinical Evaluation of Ischemic Lesions.\"",
      "The MR CLEAN study investigated the treatment of acute ischemic stroke.",
      "Acute ischemic stroke occurs when there is a blockade or clot in a blood vessel that supplies blood to the brain.",
      "Thrombolytic therapy, which involves the use of drugs to dissolve the clot and restore blood flow to the brain, was the treatment evaluated in the MR CLEAN study.",
      "The results of the MR CLEAN study were published in the New England Journal of Medicine in 2015."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The MR CLEAN study stands for \"Multicenter Randomized Clinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands.\"\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Endovascular treatment, which involves mechanically removing the clot, was the treatment evaluated in the MR CLEAN study.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 44,
    "user_query": "Does BNP increase after intensive exercise in athletes?",
    "vicuna-7b_response": "Yes, it is common for BNP (brain natriuretic peptide) to increase after intensive exercise in athletes. BNP is a hormone produced by the heart that helps regulate blood pressure and fluid balance. During intense exercise, the heart works harder to pump blood and oxygen to the muscles, which can cause an increase in BNP levels.\nIn athletes, increased BNP levels can be a sign of heart health and adaptation to exercise. However, high levels of BNP can also indicate heart failure or other cardiac conditions, so it is important for athletes to monitor their BNP levels and consult with a healthcare provider if they have concerns.\nIt is worth noting that BNP levels can be affected by a variety of factors, including age, sex, and medications, so it is important to consider these factors when interpreting BNP levels. Additionally, BNP levels can be affected by other factors such as stress, illness, and hormonal changes, so it is important to consider these factors when evaluating BNP levels in athletes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BNP (brain natriuretic peptide) often increases after intensive exercise in athletes.\n2. BNP is a hormone produced by the heart that helps regulate blood pressure and fluid balance.\n3. Increased BNP levels in athletes can be a sign of heart health and adaptation to exercise.\n4. High levels of BNP can indicate heart failure or other cardiac conditions.\n5. BNP levels can be affected by age, sex, medications, stress, illness, and hormonal changes.",
    "vicuna-7b_fact": [
      "BNP (brain natriuretic peptide) often increases after intensive exercise in athletes.",
      "BNP is a hormone produced by the heart that helps regulate blood pressure and fluid balance.",
      "Increased BNP levels in athletes can be a sign of heart health and adaptation to exercise.",
      "High levels of BNP can indicate heart failure or other cardiac conditions.",
      "BNP levels can be affected by age, sex, medications, stress, illness, and hormonal changes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Increased BNP levels in athletes can be a sign of physical stress to the heart rather than an indicator of heart health.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-7b_response": "Weaver syndrome and Sotos syndrome are two distinct genetic disorders that have some similarities but also have distinct characteristics.\nWeaver syndrome, also known as Weaver-Wintle syndrome, is a rare genetic disorder that is characterized by a combination of physical and developmental abnormalities. The main features of Weaver syndrome include:\n* Short stature\n* Broad chest and wide-set shoulders\n* Wide nasal bridge\n* Low-set and posteriorly rotated ears\n* Abnormalities of the hands and feet, such as webbing between the fingers and toes\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\nSotos syndrome, also known as cytomegalic inclusion disease, is a genetic disorder that is characterized by a combination of physical and developmental abnormalities. The main features of Sotos syndrome include:\n* Large head size (macrocephaly)\n* Abnormal facial features, such as a flat face, full cheeks, and a wide forehead\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\n* Macrocephaly\n* Abnormalities of the hands and feet\n* Delayed bone maturation\nWhile both Weaver syndrome and Sotos syndrome have some similarities in terms of physical and developmental abnormalities, they are distinct disorders with different genetic causes and underlying mechanisms. Weaver syndrome is caused by mutations in the PHF8 gene, while Sotos syndrome is caused by mutations in the SOX18 gene.\nIn summary, while Weaver syndrome and Sotos syndrome share some similarities in terms of physical and developmental abnormalities, they are distinct disorders with different genetic causes and underlying mechanisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Weaver syndrome and Sotos syndrome are two distinct genetic disorders.\n2. Weaver syndrome, also known as Weaver-Wintle syndrome, is characterized by physical and developmental abnormalities such as short stature, broad chest and wide-set shoulders, and low-set and posteriorly rotated ears.\n3. Sotos syndrome, also known as cytomegalic inclusion disease, is a genetic disorder characterized by a combination of physical and developmental abnormalities like large head size and abnormal facial features.\n4. Weaver syndrome is caused by mutations in the PHF8 gene.\n5. Sotos syndrome is caused by mutations in the SOX18 gene.",
    "vicuna-7b_fact": [
      "Weaver syndrome and Sotos syndrome are two distinct genetic disorders.",
      "Weaver syndrome, also known as Weaver-Wintle syndrome, is characterized by physical and developmental abnormalities such as short stature, broad chest and wide-set shoulders, and low-set and posteriorly rotated ears.",
      "Sotos syndrome, also known as cytomegalic inclusion disease, is a genetic disorder characterized by a combination of physical and developmental abnormalities like large head size and abnormal facial features.",
      "Weaver syndrome is caused by mutations in the PHF8 gene.",
      "Sotos syndrome is caused by mutations in the SOX18 gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Weaver syndrome, also known as Weaver-Smith syndrome, is characterized by physical and developmental abnormalities such as rapid growth, large size, and distinctive facial features, not short stature, broad chest, and wide-set shoulders.\n3. FALSE [correction]: Sotos syndrome, also known as cerebral gigantism, is a genetic disorder characterized by a combination of physical and developmental abnormalities like large head size and abnormal facial features.\n4. FALSE [correction]: Weaver syndrome is caused by mutations in the EZH2 gene.\n5. FALSE [correction]: Sotos syndrome is caused by mutations in the NSD1 gene.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 49,
    "user_query": "Are ultraconserved elements often transcribed?",
    "vicuna-7b_response": "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species, meaning that they are found in similar forms in different organisms. UCEs are typically not transcribed into RNA, as they do not contain any known protein-coding genes or other functional elements.\nHowever, it is possible that UCEs may play a role in regulating gene expression or other cellular processes, although the exact function of UCEs is not yet fully understood. Some studies have suggested that UCEs may be involved in the regulation of gene expression through their interaction with other regulatory elements, such as enhancers or silencers.\nOverall, while UCEs are not typically transcribed, they may still play a role in regulating gene expression or other cellular processes. Further research is needed to fully understand the function of UCEs in different organisms and contexts.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.\n2. UCEs typically do not contain any known protein-coding genes or other functional elements.\n3. Ultraconserved elements are typically not transcribed into RNA.\n4. Ultraconserved elements may be involved in the regulation of gene expression.\n5. The exact function of UCEs is not yet fully understood.",
    "vicuna-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.",
      "UCEs typically do not contain any known protein-coding genes or other functional elements.",
      "Ultraconserved elements are typically not transcribed into RNA.",
      "Ultraconserved elements may be involved in the regulation of gene expression.",
      "The exact function of UCEs is not yet fully understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ultraconserved elements are typically transcribed into RNA.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 54,
    "user_query": "Which DNA sequences are more prone for the formation of R-loops?",
    "vicuna-7b_response": "R-loops are formed when a single-stranded region of DNA is wrapped around a double-stranded region, creating a structure that can interfere with the normal functioning of the cell's genetic machinery. The likelihood of R-loop formation depends on the sequence of nucleotides in the single-stranded region.\nIn general, R-loops are more likely to form in regions of DNA that contain stretches of A-T base pairs, as these base pairs are less stable than the complementary C-G base pairs and are more prone to forming R-loops. Additionally, R-loops are more likely to form in regions of DNA that contain repeated sequences, as these sequences are more likely to form stretches of single-stranded DNA.\nIt is also worth noting that R-loops are more likely to form in regions of DNA that are transcribed or translated, as these regions are more likely to be in close proximity to the cell's ribosomes and other translation and transcription machinery.\nOverall, the likelihood of R-loop formation depends on a combination of factors, including the sequence of nucleotides in the single-stranded region, the presence of repeated sequences, and the proximity of the region to the cell's translation and transcription machinery.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. R-loops are formed when a single-stranded region of DNA is wrapped around a double-stranded region.\n2. The formation of R-loops can interfere with the normal functioning of a cell's genetic machinery. \n3. R-loops are more likely to form in regions of DNA that contain stretches of A-T base pairs.\n4. They are also more likely to form in regions of DNA that contain repeated sequences.\n5. R-loops  are also more likely to form in regions of DNA that are transcribed or translated.",
    "vicuna-7b_fact": [
      "R-loops are formed when a single-stranded region of DNA is wrapped around a double-stranded region.",
      "The formation of R-loops can interfere with the normal functioning of a cell's genetic machinery.",
      "R-loops are more likely to form in regions of DNA that contain stretches of A-T base pairs.",
      "They are also more likely to form in regions of DNA that contain repeated sequences.",
      "R-loops  are also more likely to form in regions of DNA that are transcribed or translated."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: R-loops are formed when RNA strand invades the double helix of DNA, displacing one of the DNA strands. \n2. TRUE\n3. FALSE [correction]: R-loops are more likely to form in regions of DNA that contain G-C rich sequences, not A-T base pairs.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 55,
    "user_query": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?",
    "vicuna-7b_response": "The mutation of the tumor suppressor gene, CDKN2A, is implicated in the familial isolated pituitary adenoma. CDKN2A gene encodes for the cyclin-dependent kinase inhibitor p16, which plays a role in regulating cell growth and division. Mutations in the CDKN2A gene have been found to be associated with the development of pituitary adenomas, particularly in families with a history of multiple cases of pituitary adenomas.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The mutation of the CDKN2A gene is implicated in the familial isolated pituitary adenoma.\n2. CDKN2A gene is a tumor suppressor gene.\n3. The CDKN2A gene encodes for the cyclin-dependent kinase inhibitor p16.\n4. The cyclin-dependent kinase inhibitor p16 plays a role in regulating cell growth and division.\n5. Mutations in the CDKN2A gene have been associated with the development of pituitary adenomas particularly in families with multiple cases.",
    "vicuna-7b_fact": [
      "The mutation of the CDKN2A gene is implicated in the familial isolated pituitary adenoma.",
      "CDKN2A gene is a tumor suppressor gene.",
      "The CDKN2A gene encodes for the cyclin-dependent kinase inhibitor p16.",
      "The cyclin-dependent kinase inhibitor p16 plays a role in regulating cell growth and division.",
      "Mutations in the CDKN2A gene have been associated with the development of pituitary adenomas particularly in families with multiple cases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 56,
    "user_query": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?",
    "vicuna-7b_response": "Mutations in the troponin C gene have been found to cause hypertrophic cardiomyopathy in some individuals. This gene provides instructions for making a protein that is a component of the troponin complex, which is responsible for regulating the contraction and relaxation of muscles, including the heart muscle.\nThere are several types of mutations in the troponin C gene that have been associated with hypertrophic cardiomyopathy. These include:\n1. Missense mutations: These are mutations that change a single amino acid in the troponin C protein. Some missense mutations have been shown to cause hypertrophic cardiomyopathy by disrupting the normal function of the troponin complex.\n2. Splice site mutations: These are mutations that affect the way the troponin C gene is spliced, or joined together, during the process of gene expression. Splice site mutations can disrupt the normal production of the troponin C protein and may lead to the development of hypertrophic cardiomyopathy.\n3. Deletion mutations: These are mutations that involve the deletion of a section of the troponin C gene. Deletion mutations can disrupt the production of the troponin C protein and may lead to the development of hypertrophic cardiomyopathy.\n4. Insertion mutations: These are mutations that involve the insertion of a section of DNA into the troponin C gene. Insertion mutations can disrupt the normal function of the troponin C protein and may lead to the development of hypertrophic cardiomyopathy.\nIt is important to note that not all mutations in the troponin C gene will cause hypertrophic cardiomyopathy. The specific type and location of the mutation, as well as the overall genetic background of the individual, can all play a role in determining whether a mutation will cause disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Troponin C gene provides instructions for making a protein that is a component of the troponin complex, which regulates the contraction and relaxation of muscles, including the heart muscle.\n2. Missense mutations in the troponin C gene, which change a single amino acid in the troponin C protein, have been found to cause hypertrophic cardiomyopathy.\n3. Splice site mutations in the troponin C gene that affect the gene splicing process can lead to the development of hypertrophic cardiomyopathy.\n4. Deletion mutations in the troponin C gene, which involve the deletion of a section of the gene, have been associated with the development of hypertrophic cardiomyopathy.\n5. Insertion mutations in the troponin C gene, which involve the insertion of a section of DNA into the gene, have been linked to the development of hypertrophic cardiomyopathy.",
    "vicuna-7b_fact": [
      "Troponin C gene provides instructions for making a protein that is a component of the troponin complex, which regulates the contraction and relaxation of muscles, including the heart muscle.",
      "Missense mutations in the troponin C gene, which change a single amino acid in the troponin C protein, have been found to cause hypertrophic cardiomyopathy.",
      "Splice site mutations in the troponin C gene that affect the gene splicing process can lead to the development of hypertrophic cardiomyopathy.",
      "Deletion mutations in the troponin C gene, which involve the deletion of a section of the gene, have been associated with the development of hypertrophic cardiomyopathy.",
      "Insertion mutations in the troponin C gene, which involve the insertion of a section of DNA into the gene, have been linked to the development of hypertrophic cardiomyopathy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 58,
    "user_query": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?",
    "vicuna-7b_response": "Constitutive heterochromatin is a type of chromatin structure that is characterized by the presence of specific post-translational histone modifications. These modifications include:\n1. Histone H3 lysine 9 (H3K9) methylation: This modification is typically associated with constitutive heterochromatin, as it helps to repress gene expression by recruiting histone-modifying enzymes and silencing proteins.\n2. Histone H3 lysine 27 (H3K27) trimethylation: This modification is also commonly found in constitutive heterochromatin, as it helps to repress transcription by recruiting histone-modifying enzymes and silencing proteins.\n3. Histone H4 lysine 20 (H4K20) trimethylation: This modification is found in constitutive heterochromatin and is thought to play a role in the formation of higher-order chromatin structures, which can help to repress gene expression.\n4. Histone H3 lysine 36 (H3K36) trimethylation: This modification is found in constitutive heterochromatin and is thought to play a role in the formation of higher-order chromatin structures, which can help to repress gene expression.\nIt's worth noting that these modifications are not exclusive to constitutive heterochromatin, and they can also be found in other types of chromatin structures such as facultative heterochromatin and euchromatin.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Constitutive heterochromatin is characterized by specific post-translational histone modifications.\n2. Histone H3 lysine 9 (H3K9) methylation is a modification typically associated with constitutive heterochromatin.\n3. Histone H3 lysine 27 (H3K27) trimethylation is commonly found in constitutive heterochromatin.\n4. Histone H4 lysine 20 (H4K20) trimethylation is found in constitutive heterochromatin.\n5. Histone H3 lysine 36 (H3K36) trimethylation modification is found in constitutive heterochromatin.",
    "vicuna-7b_fact": [
      "Constitutive heterochromatin is characterized by specific post-translational histone modifications.",
      "Histone H3 lysine 9 (H3K9) methylation is a modification typically associated with constitutive heterochromatin.",
      "Histone H3 lysine 27 (H3K27) trimethylation is commonly found in constitutive heterochromatin.",
      "Histone H4 lysine 20 (H4K20) trimethylation is found in constitutive heterochromatin.",
      "Histone H3 lysine 36 (H3K36) trimethylation modification is found in constitutive heterochromatin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Histone H3 lysine 27 (H3K27) trimethylation is commonly found in facultative heterochromatin, not constitutive heterochromatin.\n4. TRUE\n5. FALSE [correction]: Histone H3 lysine 36 (H3K36) trimethylation modification is typically associated with actively transcribed genes, not with constitutive heterochromatin.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 63,
    "user_query": "Are long non coding RNAs as conserved in sequence as protein coding genes?",
    "vicuna-7b_response": "Long non-coding RNAs (lncRNAs) are a class of non-protein coding RNAs that are typically longer than 200 nucleotides in length. While lncRNAs are not as well conserved in sequence as protein-coding genes, they are still highly conserved across different organisms and species.\nThe degree of conservation of lncRNAs can vary depending on the specific lncRNA and the organism in question. Some lncRNAs are highly conserved across multiple species, while others may have a more limited degree of conservation.\nOne reason for the limited conservation of lncRNAs is that they are not subject to the same selective pressures as protein-coding genes. While protein-coding genes are essential for the proper functioning of cells and organisms, lncRNAs are generally not required for the basic functioning of cells and can therefore be more variable in their sequence.\nHowever, despite their lower degree of conservation, lncRNAs are still important for many cellular processes and have been shown to play a variety of roles in regulating gene expression, cellular development, and other processes. As such, lncRNAs are an active area of research and have been the subject of many studies aimed at understanding their functions and potential therapeutic applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNAs (lncRNAs) are typically longer than 200 nucleotides in length. \n2. lncRNAs are not as well conserved in sequence as protein-coding genes.\n3. The degree of conservation of lncRNAs can vary depending on the specific lncRNA and the organism in question.\n4. lncRNAs are generally not required for the basic functioning of cells.\n5. lncRNAs are important for many cellular processes such as regulating gene expression and cellular development.",
    "vicuna-7b_fact": [
      "Long non-coding RNAs (lncRNAs) are typically longer than 200 nucleotides in length.",
      "lncRNAs are not as well conserved in sequence as protein-coding genes.",
      "The degree of conservation of lncRNAs can vary depending on the specific lncRNA and the organism in question.",
      "lncRNAs are generally not required for the basic functioning of cells.",
      "lncRNAs are important for many cellular processes such as regulating gene expression and cellular development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some lncRNAs are essential for the basic functioning of cells, though many are not.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 65,
    "user_query": "What is clathrin?",
    "vicuna-7b_response": "Clathrin is a protein complex that plays a crucial role in the endocytosis process, which is the mechanism by which cells take in extracellular matter. It is composed of three subunits: clathrin, adaptin, and AP-2.\nClathrin is responsible for forming the clathrin coat, which surrounds and encloses extracellular matter, such as proteins, lipids, and small molecules. The clathrin coat then undergoes endocytosis, which involves the fusion of the clathrin-coated vesicle with the cell membrane and the internalization of the extracellular matter into the cell.\nAdaptin is a protein that helps to assemble the clathrin coat and is involved in the transport of the clathrin-coated vesicle to the cell membrane. AP-2 is another protein that helps to assemble the clathrin coat and is involved in the sorting of the extracellular matter that is taken up by the cell.\nClathrin is an essential protein complex that plays a critical role in many cellular processes, including the transport of proteins and lipids across the cell membrane, the formation of synapses, and the regulation of cell signaling.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Clathrin is a protein complex involved in the endocytosis process.\n2. The clathrin protein complex is composed of three subunits: clathrin, adaptin, and AP-2.\n3. Clathrin is responsible for forming the clathrin coat, which envelops extracellular matter for endocytosis.\n4. Adaptin is a protein that helps assemble the clathrin coat and helps transport the clathrin-coated vesicle to the cell membrane.\n5. Clathrin plays a role in several cellular processes, including protein and lipid transport across the cell membrane, formation of synapses, and regulation of cell signaling.",
    "vicuna-7b_fact": [
      "Clathrin is a protein complex involved in the endocytosis process.",
      "The clathrin protein complex is composed of three subunits: clathrin, adaptin, and AP-2.",
      "Clathrin is responsible for forming the clathrin coat, which envelops extracellular matter for endocytosis.",
      "Adaptin is a protein that helps assemble the clathrin coat and helps transport the clathrin-coated vesicle to the cell membrane.",
      "Clathrin plays a role in several cellular processes, including protein and lipid transport across the cell membrane, formation of synapses, and regulation of cell signaling."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The clathrin protein complex is composed of three heavy chains and three light chains. \n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 66,
    "user_query": "What are the main results of PRKAR1A Knockdown?",
    "vicuna-7b_response": "PRKAR1A (Protein Kinase, AMP-Activated, Regulatory Subunit 1 alpha) is a protein kinase that plays a crucial role in regulating cellular energy homeostasis. Knockdown of PRKAR1A has been shown to have various effects on cellular metabolism and physiology.\nOne of the main results of PRKAR1A knockdown is an increase in cellular energy demand, leading to increased glucose uptake and glycolysis. This is due to the inhibition of the AMP-activated protein kinase (AMPK), which is a key regulator of cellular energy homeostasis.\nAnother effect of PRKAR1A knockdown is the activation of the mammalian target of rapamycin (mTOR) pathway, which promotes cell growth and proliferation. This can lead to increased cellular proliferation and survival, as well as enhanced angiogenesis and tissue regeneration.\nPRKAR1A knockdown has also been shown to have anti-inflammatory effects, by reducing the production of pro-inflammatory cytokines and chemokines. This can lead to reduced oxidative stress and inflammation, which can have beneficial effects on various diseases, such as cancer, diabetes, and neurodegenerative disorders.\nOverall, PRKAR1A knockdown can have both beneficial and detrimental effects on cellular metabolism and physiology, depending on the context in which it is studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PRKAR1A (Protein Kinase, AMP-Activated, Regulatory Subunit 1 alpha) is a protein kinase that plays a crucial role in regulating cellular energy homeostasis.\n2. Knockdown of PRKAR1A leads to an increase in cellular energy demand, increased glucose uptake and glycolysis.\n3. A result of PRKAR1A knockdown is the activation of the mammalian target of rapamycin (mTOR) pathway, promoting cell growth and proliferation.\n4. PRKAR1A knockdown has been shown to have anti-inflammatory effects, reducing the production of pro-inflammatory cytokines and chemokines.\n5. The effects of PRKAR1A knockdown can have both beneficial and detrimental effects on cellular metabolism and physiology.",
    "vicuna-7b_fact": [
      "PRKAR1A (Protein Kinase, AMP-Activated, Regulatory Subunit 1 alpha) is a protein kinase that plays a crucial role in regulating cellular energy homeostasis.",
      "Knockdown of PRKAR1A leads to an increase in cellular energy demand, increased glucose uptake and glycolysis.",
      "A result of PRKAR1A knockdown is the activation of the mammalian target of rapamycin (mTOR) pathway, promoting cell growth and proliferation.",
      "PRKAR1A knockdown has been shown to have anti-inflammatory effects, reducing the production of pro-inflammatory cytokines and chemokines.",
      "The effects of PRKAR1A knockdown can have both beneficial and detrimental effects on cellular metabolism and physiology."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 72,
    "user_query": "Are transcribed ultraconserved regions involved in cancer?",
    "vicuna-7b_response": "Yes, transcribed ultraconserved regions (UCRs) have been implicated in cancer. UCRs are regions of DNA that are highly conserved across different species, including humans, and are believed to be important for the regulation of gene expression.\nResearch has shown that UCRs can play a role in the development and progression of cancer by regulating the expression of genes that are involved in cell growth, differentiation, and apoptosis (programmed cell death). For example, UCRs have been shown to regulate the expression of genes involved in cell cycle progression, such as CDKN1A (p21), which is a tumor suppressor gene that helps to prevent cells from entering the cell cycle.\nAdditionally, UCRs have been shown to be involved in the regulation of epigenetic modifications, such as DNA methylation and histone modifications, which can also play a role in the development and progression of cancer.\nOverall, while more research is needed to fully understand the role of UCRs in cancer, it is clear that they play an important role in the regulation of gene expression and cellular processes that are involved in the development and progression of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcribed ultraconserved regions (UCRs) have been implicated in cancer.\n2. UCRs are regions of DNA that are highly conserved across different species, including humans.\n3. UCRs play a role in the development and progression of cancer by regulating the expression of genes that are involved in cell growth, differentiation, and apoptosis (programmed cell death).\n4. UCRs have been shown to regulate the expression of genes involved in cell cycle progression, such as CDKN1A (p21), a tumor suppressor gene.\n5. UCRs are involved in the regulation of epigenetic modifications, such as DNA methylation and histone modifications, which can play a role in the development and progression of cancer.",
    "vicuna-7b_fact": [
      "Transcribed ultraconserved regions (UCRs) have been implicated in cancer.",
      "UCRs are regions of DNA that are highly conserved across different species, including humans.",
      "UCRs play a role in the development and progression of cancer by regulating the expression of genes that are involved in cell growth, differentiation, and apoptosis (programmed cell death).",
      "UCRs have been shown to regulate the expression of genes involved in cell cycle progression, such as CDKN1A (p21), a tumor suppressor gene.",
      "UCRs are involved in the regulation of epigenetic modifications, such as DNA methylation and histone modifications, which can play a role in the development and progression of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 75,
    "user_query": "List side effects of SGLT2 inhibitors?",
    "vicuna-7b_response": "SGLT2 inhibitors are a type of medication used to treat type 2 diabetes. While they can be effective in helping to control blood sugar levels, they can also cause side effects. Some common side effects of SGLT2 inhibitors include:\n1. Urinary tract infections (UTIs): SGLT2 inhibitors can cause an increase in the amount of urine produced, which can lead to a higher risk of UTIs.\n2. Dehydration: SGLT2 inhibitors can cause the body to lose more water than usual, which can lead to dehydration.\n3. Fatigue: Some people taking SGLT2 inhibitors may experience fatigue or weakness.\n4. Nausea: Some people may experience nausea when taking SGLT2 inhibitors.\n5. Diarrhea: SGLT2 inhibitors can cause diarrhea, which may be severe in some cases.\n6. Skin rash: Some people may experience a skin rash while taking SGLT2 inhibitors.\n7. Fever: In rare cases, SGLT2 inhibitors may cause a fever.\nIt's important to note that these are not all the possible side effects of SGLT2 inhibitors, and that everyone's experience may be different. If you experience any side effects while taking SGLT2 inhibitors, it's important to talk to your doctor or healthcare provider. They can help you manage any side effects and determine if the medication is right for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SGLT2 inhibitors are a type of medication used to treat type 2 diabetes.\n2. SGLT2 inhibitors can cause an increase in the amount of urine produced, potentially leading to urinary tract infections.\n3. Dehydration can be a side effect of SGLT2 inhibitors due to the body potentially losing more water than usual.\n4. Some people taking SGLT2 inhibitors may experience fatigue or weakness. \n5. Nausea, diarrhea, skin rash, and fever are potential side effects of using SGLT2 inhibitors.",
    "vicuna-7b_fact": [
      "SGLT2 inhibitors are a type of medication used to treat type 2 diabetes.",
      "SGLT2 inhibitors can cause an increase in the amount of urine produced, potentially leading to urinary tract infections.",
      "Dehydration can be a side effect of SGLT2 inhibitors due to the body potentially losing more water than usual.",
      "Some people taking SGLT2 inhibitors may experience fatigue or weakness.",
      "Nausea, diarrhea, skin rash, and fever are potential side effects of using SGLT2 inhibitors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-7b_response": "The JASPAR database is a repository of protein-protein interaction data that is widely used in bioinformatics research. Here is a list of the releases of the JASPAR database:\n1. JASPAR 2019: This is the latest release of the JASPAR database, which was released in 2019. It includes 83 datasets of protein-protein interactions, covering a wide range of organisms and functional categories.\n2. JASPAR 2016: This release of the JASPAR database was released in 2016 and includes 74 datasets of protein-protein interactions.\n3. JASPAR 2014: This release of the JASPAR database was released in 2014 and includes 66 datasets of protein-protein interactions.\n4. JASPAR 2012: This release of the JASPAR database was released in 2012 and includes 59 datasets of protein-protein interactions.\n5. JASPAR 2010: This release of the JASPAR database was released in 2010 and includes 52 datasets of protein-protein interactions.\nIt's worth noting that the JASPAR database is updated regularly, and new releases are made available periodically. Researchers can access the latest version of the JASPAR database through the official website of the JASPAR consortium (<https://jaspar.genereg.net/>).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The JASPAR database is a repository of protein-protein interaction data.\n2. The JASPAR 2019 database was released in 2019 and includes 83 datasets of protein-protein interactions.\n3. The JASPAR 2016 database was released in 2016 and includes 74 datasets of protein-protein interactions.\n4. The JASPAR 2014 database was released in 2014 and includes 66 datasets of protein-protein interactions.\n5. The JASPAR 2012 database was released in 2012 and includes 59 datasets of protein-protein interactions.",
    "vicuna-7b_fact": [
      "The JASPAR database is a repository of protein-protein interaction data.",
      "The JASPAR 2019 database was released in 2019 and includes 83 datasets of protein-protein interactions.",
      "The JASPAR 2016 database was released in 2016 and includes 74 datasets of protein-protein interactions.",
      "The JASPAR 2014 database was released in 2014 and includes 66 datasets of protein-protein interactions.",
      "The JASPAR 2012 database was released in 2012 and includes 59 datasets of protein-protein interactions."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The JASPAR database is a repository of transcription factor binding profiles.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 83,
    "user_query": "Which gene is required for the efficient function of clopidogrel?",
    "vicuna-7b_response": "Clopidogrel is a medication used to prevent blood clots and is often used in patients with cardiovascular disease or those at risk for stroke. The gene that is required for the efficient function of clopidogrel is the CYP2C19 gene.\nThe CYP2C19 gene encodes for an enzyme that metabolizes clopidogrel, which is responsible for its effectiveness. The activity of this enzyme can vary greatly between individuals, and this can affect the efficacy of clopidogrel. Some individuals may have reduced activity of the CYP2C19 enzyme, which can lead to reduced metabolism of clopidogrel and a lower response to the medication.\nIn summary, the CYP2C19 gene is required for the efficient function of clopidogrel, as it is responsible for metabolizing the medication and determining its effectiveness.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Clopidogrel is a medication used to prevent blood clots. \n2. The CYP2C19 gene is required for the efficient function of clopidogrel.\n3. The CYP2C19 gene encodes for an enzyme that metabolizes clopidogrel. \n4. The activity of the CYP2C19 enzyme can vary greatly between individuals. \n5. Some individuals may have reduced activity of the CYP2C19 enzyme, leading to reduced metabolism of clopidogrel and a lower response to the medication.",
    "vicuna-7b_fact": [
      "Clopidogrel is a medication used to prevent blood clots.",
      "The CYP2C19 gene is required for the efficient function of clopidogrel.",
      "The CYP2C19 gene encodes for an enzyme that metabolizes clopidogrel.",
      "The activity of the CYP2C19 enzyme can vary greatly between individuals.",
      "Some individuals may have reduced activity of the CYP2C19 enzyme, leading to reduced metabolism of clopidogrel and a lower response to the medication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 86,
    "user_query": "Which antibiotics target peptidoglycan biosynthesis?",
    "vicuna-7b_response": "Peptidoglycan is a key component of the bacterial cell wall, and several antibiotics target the biosynthesis of this molecule. Here are some examples of antibiotics that target peptidoglycan biosynthesis:\n1. Penicillins: Penicillins are a group of antibiotics that target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation. Penicillins include penicillin G, ampicillin, and amoxicillin.\n2. Cephalosporins: Cephalosporins are a group of antibiotics that target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation. Cephalosporins include cephalothin, cefazolin, and cefuroxime.\n3. Aminoglycosides: Aminoglycosides are a group of antibiotics that target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation. Aminoglycosides include streptomycin, neomycin, and gentamicin.\n4. Carbapenems: Carbapenems are a group of antibiotics that target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation. Carbapenems include imipenem, meropenem, and ertapenem.\nOverall, these antibiotics target peptidoglycan biosynthesis by inhibiting the activity of enzymes involved in its formation, leading to the death of bacteria.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Peptidoglycan is a key component of the bacterial cell wall.\n2. Certain antibiotics target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation.\n3. Penicillins, such as penicillin G, ampicillin, and amoxicillin, are antibiotics that target peptidoglycan biosynthesis.\n4. Cephalosporins, including cephalothin, cefazolin, and cefuroxime, are antibiotics that target peptidoglycan biosynthesis.\n5. Carbapenems, such as imipenem, meropenem, and ertapenem, are also antibiotics that target peptidoglycan biosynthesis.",
    "vicuna-7b_fact": [
      "Peptidoglycan is a key component of the bacterial cell wall.",
      "Certain antibiotics target the biosynthesis of peptidoglycan by inhibiting the activity of enzymes involved in its formation.",
      "Penicillins, such as penicillin G, ampicillin, and amoxicillin, are antibiotics that target peptidoglycan biosynthesis.",
      "Cephalosporins, including cephalothin, cefazolin, and cefuroxime, are antibiotics that target peptidoglycan biosynthesis.",
      "Carbapenems, such as imipenem, meropenem, and ertapenem, are also antibiotics that target peptidoglycan biosynthesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 92,
    "user_query": "What is the mode of action of everolimus?",
    "vicuna-7b_response": "Everolimus is a macrolide antibiotic that works by inhibiting the activity of the mTOR (mechanistic target of rapamycin) protein. mTOR is a key regulator of cell growth and proliferation, and its inhibition by everolimus leads to the suppression of cell division and the induction of cell cycle arrest.\nEverolimus is used in the treatment of various medical conditions, including cancer, kidney transplant rejection, and autoimmune diseases. It is typically administered orally as a tablet or solution.\nIn cancer treatment, everolimus is used to inhibit the growth and proliferation of cancer cells by targeting the mTOR pathway, which is often hyperactive in cancer cells. By inhibiting the mTOR pathway, everolimus can slow down the growth of cancer cells and prevent them from dividing and spreading.\nIn kidney transplantation, everolimus is used to prevent the rejection of transplanted kidneys by inhibiting the activation of T-cells, which are a key component of the immune system. By suppressing the activation of T-cells, everolimus can prevent the immune system from attacking the transplanted kidney.\nIn autoimmune diseases, everolimus is used to suppress the immune system and reduce the activity of immune cells that cause inflammation and damage to tissues. By suppressing the immune system, everolimus can reduce the symptoms of autoimmune diseases such as lupus and rheumatoid arthritis.\nOverall, everolimus works by inhibiting the activity of the mTOR protein, which is a key regulator of cell growth and proliferation. By targeting the mTOR pathway, everolimus can inhibit the growth and proliferation of cancer cells, prevent the rejection of transplanted organs, and reduce the activity of immune cells in autoimmune diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Everolimus is a macrolide antibiotic.\n2. Everolimus works by inhibiting the activity of mTOR protein. \n3. Everolimus is used in the treatment of various medical conditions including cancer, kidney transplant rejection, and autoimmune diseases.\n4. In cancer treatment, everolimus inhibits the growth and proliferation of cancer cells by targeting the mTOR pathway.\n5. In kidney transplantation, everolimus inhibits the activation of T-cells to prevent the rejection of transplanted kidneys.",
    "vicuna-7b_fact": [
      "Everolimus is a macrolide antibiotic.",
      "Everolimus works by inhibiting the activity of mTOR protein.",
      "Everolimus is used in the treatment of various medical conditions including cancer, kidney transplant rejection, and autoimmune diseases.",
      "In cancer treatment, everolimus inhibits the growth and proliferation of cancer cells by targeting the mTOR pathway.",
      "In kidney transplantation, everolimus inhibits the activation of T-cells to prevent the rejection of transplanted kidneys."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Everolimus is not a macrolide antibiotic, but a derivative of Rapamycin and a mTOR inhibitor.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 97,
    "user_query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "vicuna-7b_response": "Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by an abnormal thickening of the heart muscle. This thickening can lead to a decrease in the heart's pumping function and can cause the heart to become enlarged. HCM is a genetic disorder that can be inherited, and it is the most common cause of sudden cardiac death in young athletes. Symptoms of HCM can include chest pain, shortness of breath, and fatigue, and it is often diagnosed through a combination of physical examination, electrocardiogram (ECG), and echocardiogram. Treatment for HCM typically includes medications to control blood pressure and heart rate, and in some cases, surgery may be necessary to implant a pacemaker or defibrillator.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by an abnormal thickening of the heart muscle.\n2. The thickening of the heart muscle in HCM can lead to a decrease in the heart's pumping function.\n3. Hypertrophic cardiomyopathy (HCM) is a genetic disorder that can be inherited.\n4. Hypertrophic cardiomyopathy (HCM) is often diagnosed through a combination of physical examination, electrocardiogram (ECG), and echocardiogram.\n5. Treatment for HCM typically includes medications to control blood pressure and heart rate, and in some cases, surgery may be necessary to implant a pacemaker or defibrillator.",
    "vicuna-7b_fact": [
      "Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by an abnormal thickening of the heart muscle.",
      "The thickening of the heart muscle in HCM can lead to a decrease in the heart's pumping function.",
      "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that can be inherited.",
      "Hypertrophic cardiomyopathy (HCM) is often diagnosed through a combination of physical examination, electrocardiogram (ECG), and echocardiogram.",
      "Treatment for HCM typically includes medications to control blood pressure and heart rate, and in some cases, surgery may be necessary to implant a pacemaker or defibrillator."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-7b_response": "The viral KP4 protein is a viral protein that plays a critical role in the replication of certain viruses. The KP4 protein is found in the Kobuvirus family of viruses, which includes the Kobuvirus genus of baculoviruses.\nThe KP4 protein is a small, non-structural protein that is produced during the replication of the virus. It is thought to play a role in the regulation of viral RNA synthesis and the translation of viral RNA into proteins.\nIn addition to its role in viral replication, the KP4 protein has also been shown to play a role in the immune response to viral infection. It has been shown to inhibit the activity of the interferon signaling pathway, which is a key component of the host's antiviral response.\nOverall, the function of the KP4 protein is to help the virus replicate and evade the host's immune response.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The viral KP4 protein plays a critical role in the replication of certain viruses.\n2. The KP4 protein is found in the Kobuvirus family of viruses, which includes the Kobuvirus genus of baculoviruses.\n3. The KP4 protein is a non-structural protein and is produced during the replication of the virus.\n4. The KP4 protein is thought to play a role in the regulation of viral RNA synthesis and the translation of viral RNA into proteins.\n5. The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway.",
    "vicuna-7b_fact": [
      "The viral KP4 protein plays a critical role in the replication of certain viruses.",
      "The KP4 protein is found in the Kobuvirus family of viruses, which includes the Kobuvirus genus of baculoviruses.",
      "The KP4 protein is a non-structural protein and is produced during the replication of the virus.",
      "The KP4 protein is thought to play a role in the regulation of viral RNA synthesis and the translation of viral RNA into proteins.",
      "The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The KP4 protein is not found in the Kobuvirus family of viruses but is produced by some species of fungi to inhibit the growth of other fungi.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 101,
    "user_query": "What is the principle of the PAR-CLIP methodology?",
    "vicuna-7b_response": "The PAR-CLIP (Probabilistic Automated Reasoning for CLIP) methodology is a machine learning approach that combines the power of deep learning with the principles of probabilistic graphical models to generate natural language descriptions of visual scenes.\nThe PAR-CLIP methodology is based on the idea that visual scenes can be represented as a graphical model, where each node in the graph represents a visual feature, such as an object or a part of an object, and each edge in the graph represents a relationship between two features. The methodology uses a deep neural network to learn the structure of the graphical model and the probabilities of the relationships between the features.\nThe PAR-CLIP methodology is a generative model, which means that it can generate natural language descriptions of visual scenes by sampling from the learned graphical model. The generated descriptions are typically in the form of a natural language caption, which describes the visual scene in a human-readable way.\nThe PAR-CLIP methodology has been shown to be effective in generating natural language descriptions of visual scenes, and it has been used in a variety of applications, such as image captioning, video description, and visual question answering.\nIn summary, the principle of the PAR-CLIP methodology is to use deep learning and probabilistic graphical models to generate natural language descriptions of visual scenes. The methodology is based on the idea that visual scenes can be represented as a graphical model, and it uses a deep neural network to learn the structure of the graphical model and the probabilities of the relationships between the features. The generated descriptions are typically in the form of a natural language caption, which describes the visual scene in a human-readable way.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The PAR-CLIP (Probabilistic Automated Reasoning for CLIP) method is a machine learning approach that uses deep learning and probabilistic graphical models.\n2. The PAR-CLIP methodology uses a deep neural network to learn the structure of the graphical model and the probabilities of the relationships between the features.\n3. Visual scenes can be represented as a graphical model in the PAR-CLIP methodology.\n4. The PAR-CLIP methodology has been used in applications such as image captioning, video description, and visual question answering.\n5. The methodology generates descriptions in the form of a natural language caption which describes the visual scene in a human-readable way.",
    "vicuna-7b_fact": [
      "The PAR-CLIP (Probabilistic Automated Reasoning for CLIP) method is a machine learning approach that uses deep learning and probabilistic graphical models.",
      "The PAR-CLIP methodology uses a deep neural network to learn the structure of the graphical model and the probabilities of the relationships between the features.",
      "Visual scenes can be represented as a graphical model in the PAR-CLIP methodology.",
      "The PAR-CLIP methodology has been used in applications such as image captioning, video description, and visual question answering.",
      "The methodology generates descriptions in the form of a natural language caption which describes the visual scene in a human-readable way."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) is a method used to study RNA-protein interactions.\n2. FALSE [correction]: The PAR-CLIP methodology does not involve a deep neural network or probabilistic graphical models. It is a biochemical method used in molecular biology.\n3. FALSE [correction]: Visual scenes cannot be represented as a graphical model in the PAR-CLIP methodology, as PAR-CLIP is a biochemical technique, not a computational method.\n4. FALSE [correction]: The PAR-CLIP methodology has not been used in applications such as image captioning, video description, and visual question answering, as it is a research tool used in biology, not in visual scene understanding or image processing.\n5. FALSE [correction]: The methodology does not generate descriptions in the form of a natural language caption. PAR-CLIP is a method used to study RNA-protein interactions in a biological context.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 106,
    "user_query": "Which package is available for analysing genomic interactions in R/Bioconductor?",
    "vicuna-7b_response": "There are several packages available in R/Bioconductor for analyzing genomic interactions. Some of the most commonly used packages include:\n1. Cluster: This package is used for clustering genes based on their expression levels or other genomic features.\n2. edgeR: This package is used for counting and summarizing counts of high-throughput sequencing experiments.\n3. limma: This package is used for analyzing microarray and RNA-seq data, including normalization, statistical tests, and model selection.\n4. voom: This package is used for normalizing and visualizing RNA-seq data.\n5. DESeq2: This package is used for comparing count data from different samples or conditions.\n6. GSEA: This package is used for identifying genes that are differentially expressed between two groups of samples.\n7. GROMACS: This package is used for simulating and analyzing molecular dynamics and protein-protein interactions.\n8. HOMER: This package is used for simulating and analyzing gene regulatory networks.\nThese are just a few examples of the many packages available in R/Bioconductor for analyzing genomic interactions. The choice of package will depend on the specific type of data and analysis that you are performing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Cluster package in R/Bioconductor is used for clustering genes based on their expression levels or other genomic features.\n2. The edgeR package in R/Bioconductor is used for counting and summarizing counts of high-throughput sequencing experiments.\n3. The limma package in R/Bioconductor is used for analyzing microarray and RNA-seq data, including normalization, statistical tests, and model selection.\n4. The DESeq2 package in R/Bioconductor is used for comparing count data from different samples or conditions.\n5. The GROMACS package in R/Bioconductor is used for simulating and analyzing molecular dynamics and protein-protein interactions.",
    "vicuna-7b_fact": [
      "The Cluster package in R/Bioconductor is used for clustering genes based on their expression levels or other genomic features.",
      "The edgeR package in R/Bioconductor is used for counting and summarizing counts of high-throughput sequencing experiments.",
      "The limma package in R/Bioconductor is used for analyzing microarray and RNA-seq data, including normalization, statistical tests, and model selection.",
      "The DESeq2 package in R/Bioconductor is used for comparing count data from different samples or conditions.",
      "The GROMACS package in R/Bioconductor is used for simulating and analyzing molecular dynamics and protein-protein interactions."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The GROMACS is not a package in R/Bioconductor. It is actually a standalone software used for simulating and analyzing molecular dynamics and protein-protein interactions.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 107,
    "user_query": "How many clinical trials for off-label drugs in neonates are cited in the literature.",
    "vicuna-7b_response": "I'm sorry, but I am not able to browse the internet or access specific literature. However, I can provide you with some general information about clinical trials for off-label drugs in neonates.\nOff-label use of drugs refers to the use of a medication for a condition or patient population that has not been approved by the Food and Drug Administration (FDA). Off-label use is legal and common, but it is important to note that the safety and efficacy of the medication have not been fully established in this context.\nClinical trials are a key component of the process for evaluating the safety and efficacy of medications, including those used off-label. Clinical trials for off-label drugs in neonates may be conducted to establish safety and efficacy in this patient population, or to compare the safety and efficacy of an off-label drug to that of an approved drug for the same indication.\nIt is difficult to provide an exact number of clinical trials for off-label drugs in neonates, as this information may vary depending on the specific drug and indication, as well as the location and time period in question. However, it is important to note that clinical trials are an important tool for evaluating the safety and efficacy of medications, including those used off-label in neonates.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Off-label use of drugs refers to the use of a medication for a condition or patient population that has not been approved by the FDA.\n2. Off-label use is legal and is commonly practiced.\n3. Clinical trials are pivotal in evaluating the safety and efficacy of medications, including off-label drugs.\n4. Clinical trials for off-label drugs in neonates have been conducted to establish safety and efficacy or to compare to an approved drug for the same indication.\n5. The exact number of clinical trials for off-label drugs in neonates may vary depending on the specific drug and indication, location, and time period.",
    "vicuna-7b_fact": [
      "Off-label use of drugs refers to the use of a medication for a condition or patient population that has not been approved by the FDA.",
      "Off-label use is legal and is commonly practiced.",
      "Clinical trials are pivotal in evaluating the safety and efficacy of medications, including off-label drugs.",
      "Clinical trials for off-label drugs in neonates have been conducted to establish safety and efficacy or to compare to an approved drug for the same indication.",
      "The exact number of clinical trials for off-label drugs in neonates may vary depending on the specific drug and indication, location, and time period."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 112,
    "user_query": "What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?",
    "vicuna-7b_response": "Affinity purification is a technique used to isolate specific proteins from a mixture of proteins. In the case of isolating soluble lysosomal proteins, one type of affinity purification that could be used is based on the interaction between the protein of interest and a ligand that specifically binds to it.\nFor example, if the protein of interest is a lysosomal enzyme, such as an acid hydrolase, a ligand that specifically binds to the enzyme could be used to purify the enzyme from the mixture. This could be done by first immobilizing the ligand on a solid support, such as a bead or a column, and then mixing the mixture with the immobilized ligand. The enzyme would bind to the ligand, and could then be easily separated from the rest of the mixture using, for example, centrifugation or filtration.\nAnother example of affinity purification that could be used to isolate soluble lysosomal proteins is based on the interaction between the protein of interest and a ligand that specifically binds to it, but this time the ligand is a antibody. In this case, the protein of interest is immunoprecipitated by the antibody, and then the antibody-protein complex can be easily separated from the rest of the mixture using, for example, centrifugation or filtration.\nIt's important to note that the choice of the affinity purification method will depend on the specific protein of interest and the available ligands. Additionally, it's important to validate the purification method by checking the purity and the activity of the purified protein.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Affinity purification is a technique used to isolate specific proteins from a mixture of proteins.\n2. Soluble lysosomal protein can be isolated by an affinity purification method that uses a ligand which specifically binds to the protein of interest.\n3. In the affinity purification method, the ligand can be immobilized on a solid support and mixed with the protein mixture to bind with the protein of interest.\n4. A different affinity purification method for isolating soluble lysosomal proteins utilises an antibody to immunoprecipitate the protein of interest.\n5. The choice of the affinity purification method depends on the specific protein of interest and the available ligands, and requires validation by checking the purity and activity of the purified protein.",
    "vicuna-7b_fact": [
      "Affinity purification is a technique used to isolate specific proteins from a mixture of proteins.",
      "Soluble lysosomal protein can be isolated by an affinity purification method that uses a ligand which specifically binds to the protein of interest.",
      "In the affinity purification method, the ligand can be immobilized on a solid support and mixed with the protein mixture to bind with the protein of interest.",
      "A different affinity purification method for isolating soluble lysosomal proteins utilises an antibody to immunoprecipitate the protein of interest.",
      "The choice of the affinity purification method depends on the specific protein of interest and the available ligands, and requires validation by checking the purity and activity of the purified protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 113,
    "user_query": "Which are the genes thought to be regulated by EWS/FLI?",
    "vicuna-7b_response": "EWS/FLI is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types. EWS/FLI is a fusion protein that results from the fusion of the Ewing's sarcoma breakpoint 1 (EWS) gene with the FLI1 (forkhead box L1) gene.\nSeveral studies have identified genes that are thought to be regulated by EWS/FLI. For example, a study published in the journal \"Cancer Research\" in 2011 identified a set of genes that were upregulated in Ewing's sarcoma cells upon EWS/FLI overexpression. These genes included the following:\n* CCNB1: A gene that encodes for cyclin B1, a protein that regulates the progression of the cell cycle.\n* CDK6: A gene that encodes for cyclin-dependent kinase 6, a protein that regulates the progression of the cell cycle.\n* EZH2: A gene that encodes for enhancer of zeste homolog 2, a protein that plays a role in the regulation of gene expression through the methylation of histone H3 lysine 27.\n* GADD45A: A gene that encodes for growth arrest and DNA damage 45A, a protein that plays a role in the regulation of cell cycle progression and DNA damage response.\n* HSP90AA1: A gene that encodes for heat shock protein 90 kDa alpha subunit 1, a protein that plays a role in the regulation of protein folding and stability.\n* ITGB4: A gene that encodes for integrin beta 4, a protein that plays a role in cell adhesion and migration.\n* MAP2K4: A gene that encodes for mitogen-activated protein kinase 4, a protein that plays a role in the regulation of cell proliferation and differentiation.\n* MAPK8: A gene that encodes for mitogen-activated protein kinase 8, a protein that plays a role in the regulation of cell proliferation and differentiation.\n* NFKBIA: A gene that encodes for inhibitor of kappa B alpha, a protein that",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. EWS/FLI is a fusion protein that results from the fusion of the EWS gene with the FLI1 gene.\n2. EWS/FLI is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types.\n3. A study published in the journal \"Cancer Research\" in 2011 identified a set of genes that were upregulated in Ewing's sarcoma cells upon EWS/FLI overexpression.\n4. The CCNB1 gene, which is thought to be regulated by EWS/FLI, encodes for cyclin B1 that regulates the cell cycle progression.\n5. The ITGB4 gene, thought to be under EWS/FLI regulation, encodes for integrin beta 4, a protein that plays a role in cell adhesion and migration.",
    "vicuna-7b_fact": [
      "EWS/FLI is a fusion protein that results from the fusion of the EWS gene with the FLI1 gene.",
      "EWS/FLI is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types.",
      "A study published in the journal \"Cancer Research\" in 2011 identified a set of genes that were upregulated in Ewing's sarcoma cells upon EWS/FLI overexpression.",
      "The CCNB1 gene, which is thought to be regulated by EWS/FLI, encodes for cyclin B1 that regulates the cell cycle progression.",
      "The ITGB4 gene, thought to be under EWS/FLI regulation, encodes for integrin beta 4, a protein that plays a role in cell adhesion and migration."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 115,
    "user_query": "Which pathological conditions are caused by mutations in the CYLD gene?",
    "vicuna-7b_response": "The CYLD gene encodes a protein called c-Cbl, which is a ubiquitin ligase that plays a role in regulating cell growth and survival. Mutations in the CYLD gene have been associated with several pathological conditions, including:\n1. Fanconi anemia: Fanconi anemia is a genetic disorder that affects the bone marrow and leads to a high risk of developing cancer. CYLD mutations have been identified in some cases of fanconi anemia.\n2. Familial adenomatous polyposis (FAP): FAP is a genetic condition that causes the growth of many polyps in the colon. CYLD mutations have been identified in some cases of FAP.\n3. Cowden syndrome: Cowden syndrome is a genetic condition that is characterized by the growth of benign tumors on the thyroid gland, as well as other tumors in the breast, thyroid, and brain. CYLD mutations have been identified in some cases of Cowden syndrome.\n4. Bannayan-Riley-Ruvalcaba syndrome: Bannayan-Riley-Ruvalcaba syndrome is a rare genetic condition that is characterized by the growth of many benign tumors on the gastrointestinal tract, as well as other tumors in the breast, thyroid, and brain. CYLD mutations have been identified in some cases of Bannayan-Riley-Ruvalcaba syndrome.\nOverall, mutations in the CYLD gene have been associated with a range of genetic conditions that affect cell growth and survival, and can increase the risk of developing cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The CYLD gene encodes a protein called c-Cbl, which is a ubiquitin ligase that plays a role in regulating cell growth and survival.\n2. Mutations in the CYLD gene have been associated with Fanconi anemia, a genetic disorder that affects the bone marrow and leads to a high risk of developing cancer.\n3. Familial adenomatous polyposis (FAP), a genetic condition that causes the growth of many polyps in the colon, has been associated with mutations in the CYLD gene.\n4. Cowden syndrome, a genetic condition characterized by the growth of benign tumors on the thyroid gland, among other tumors, has been linked to mutations in the CYLD gene.\n5. Bannayan-Riley-Ruvalcaba syndrome, a rare genetic condition characterized by the growth of many benign tumors on the gastrointestinal tract, among other tumors, has been linked to mutations in the CYLD gene.",
    "vicuna-7b_fact": [
      "The CYLD gene encodes a protein called c-Cbl, which is a ubiquitin ligase that plays a role in regulating cell growth and survival.",
      "Mutations in the CYLD gene have been associated with Fanconi anemia, a genetic disorder that affects the bone marrow and leads to a high risk of developing cancer.",
      "Familial adenomatous polyposis (FAP), a genetic condition that causes the growth of many polyps in the colon, has been associated with mutations in the CYLD gene.",
      "Cowden syndrome, a genetic condition characterized by the growth of benign tumors on the thyroid gland, among other tumors, has been linked to mutations in the CYLD gene.",
      "Bannayan-Riley-Ruvalcaba syndrome, a rare genetic condition characterized by the growth of many benign tumors on the gastrointestinal tract, among other tumors, has been linked to mutations in the CYLD gene."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The CYLD gene does not encode a protein called c-Cbl. It encodes a protein CYLD lysine 63 deubiquitinase, which is a deubiquitination enzyme that regulates signaling pathways.\n2. FALSE [correction]: Mutations in the CYLD gene have not been associated with Fanconi anemia. This condition is generally caused by mutations in other genes (like FANCA, FANCC, etc.).\n3. FALSE [correction]: Familial adenomatous polyposis (FAP) is not associated with mutations in the CYLD gene, but with mutations in the APC gene.\n4. FALSE [correction]: Cowden syndrome has not been linked to mutations in the CYLD gene but is associated with mutations in the PTEN gene.\n5. FALSE [correction]: Bannayan-Riley-Ruvalcaba syndrome has not been linked to mutations in the CYLD gene. It is often caused by mutations in the PTEN gene.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 121,
    "user_query": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).",
    "vicuna-7b_response": "Charcot-Marie-Tooth disease type 1A (CMT1A) is a genetic disorder that affects the peripheral nerves and is characterized by progressive muscle weakness and sensory loss. CMT1A is caused by mutations in the PMP22 gene, which is located on chromosome Xq26.3.\nThe PMP22 gene encodes for a protein called periaxin, which is involved in the maintenance and myelination of peripheral nerve fibers. Mutations in the PMP22 gene can lead to the production of non-functional or misfolded proteins, which can cause the death of nerve cells and lead to the symptoms of CMT1A.\nThere are several types of mutations that have been identified in the PMP22 gene, including missense mutations, nonsense mutations, deletions, and insertions. Some of the most common mutations that have been found in CMT1A patients include:\n* G1177V: This is a missense mutation that results in the substitution of valine for glycine at position 1177 in the PMP22 gene.\n* 1298+1G>A: This is a missense mutation that results in the substitution of glutamic acid for aspartic acid at position 1298 in the PMP22 gene.\n* 2289+1G>A: This is a missense mutation that results in the substitution of glutamic acid for aspartic acid at position 2289 in the PMP22 gene.\n* 2457+1G>A: This is a missense mutation that results in the substitution of glutamic acid for aspartic acid at position 2457 in the PMP22 gene.\nIt is important to note that not all mutations in the PMP22 gene will result in CMT1A. Additionally, some patients with CMT1A may have mutations in other genes that are involved in the maintenance and myelination of peripheral nerve fibers.\nIn summary, the PMP22 gene is the main gene responsible for CMT1A, and mutations in this",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Charcot-Marie-Tooth disease type 1A (CMT1A) is characterized by progressive muscle weakness and sensory loss.\n2. CMT1A is caused by mutations in the PMP22 gene, which is located on chromosome Xq26.3.\n3. The PMP22 gene encodes for a protein called periaxin, which is involved in the maintenance and myelination of peripheral nerve fibers.\n4. There are several types of mutations in the PMP22 gene that can cause CMT1A, including missense mutations, nonsense mutations, deletions, and insertions.\n5. Not all mutations in the PMP22 gene will result in CMT1A, and some patients with CMT1A may have mutations in other genes that are involved in the maintenance and myelination of peripheral nerve fibers.",
    "vicuna-7b_fact": [
      "Charcot-Marie-Tooth disease type 1A (CMT1A) is characterized by progressive muscle weakness and sensory loss.",
      "CMT1A is caused by mutations in the PMP22 gene, which is located on chromosome Xq26.3.",
      "The PMP22 gene encodes for a protein called periaxin, which is involved in the maintenance and myelination of peripheral nerve fibers.",
      "There are several types of mutations in the PMP22 gene that can cause CMT1A, including missense mutations, nonsense mutations, deletions, and insertions.",
      "Not all mutations in the PMP22 gene will result in CMT1A, and some patients with CMT1A may have mutations in other genes that are involved in the maintenance and myelination of peripheral nerve fibers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: CMT1A is caused by duplication of the PMP22 gene which is located on chromosome 17p11.2.\n3. FALSE [correction]: PMP22 gene encodes for a protein called Peripheral Myelin Protein 22, which is involved in the formation and maintenance of compact myelin in the peripheral nervous system.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 123,
    "user_query": "Which genes have been associated with Cerebral Cavernous Malformation?",
    "vicuna-7b_response": "Cerebral cavernous malformation (CCM) is a rare neurological disorder characterized by the formation of blood-filled cysts in the brain. The genetic basis of CCM is complex and multifactorial, with both inherited and sporadic forms of the disorder. Several genes have been associated with CCM, including:\n1. CCM1 (also known as CCM2): This gene has been identified as the cause of hereditary CCM, which accounts for about 50% of all cases. Mutations in the CCM1 gene can lead to the formation of abnormal blood vessels in the brain, which can result in the development of CCM.\n2. CCM2 (also known as CCM3): This gene has also been implicated in the development of hereditary CCM. Mutations in the CCM2 gene can cause similar abnormalities in blood vessel formation as those seen in CCM1.\n3. PDCD10: This gene has been associated with sporadic CCM, which accounts for the majority of cases. Mutations in the PDCD10 gene have been shown to disrupt the normal function of immune cells, which may contribute to the development of CCM.\n4. KDR (also known as VEGFR2): This gene has been associated with both hereditary and sporadic forms of CCM. Mutations in the KDR gene can lead to the formation of abnormal blood vessels in the brain, which can result in the development of CCM.\n5. NOTCH2: This gene has been associated with sporadic CCM. Mutations in the NOTCH2 gene can disrupt the normal function of immune cells, which may contribute to the development of CCM.\nIn summary, several genes have been associated with Cerebral Cavernous Malformation, including CCM1, CCM2, PDCD10, KDR, and NOTCH2. Mutations in these genes can lead to the formation of abnormal blood vessels in the brain, which can result in the development of CCM.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cerebral cavernous malformation (CCM) is a rare neurological disorder characterized by the formation of blood-filled cysts in the brain.\n2. Several genes have been associated with CCM, including CCM1, CCM2, PDCD10, KDR, and NOTCH2.\n3. CCM1 gene has been identified as the cause of hereditary CCM, which accounts for about 50% of all cases.\n4. PDCD10 gene has been associated with sporadic CCM, which accounts for the majority of cases.\n5. KDR gene has been associated with both hereditary and sporadic forms of CCM.",
    "vicuna-7b_fact": [
      "Cerebral cavernous malformation (CCM) is a rare neurological disorder characterized by the formation of blood-filled cysts in the brain.",
      "Several genes have been associated with CCM, including CCM1, CCM2, PDCD10, KDR, and NOTCH2.",
      "CCM1 gene has been identified as the cause of hereditary CCM, which accounts for about 50% of all cases.",
      "PDCD10 gene has been associated with sporadic CCM, which accounts for the majority of cases.",
      "KDR gene has been associated with both hereditary and sporadic forms of CCM."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Several genes have been associated with CCM, including CCM1, CCM2, and PDCD10.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-7b_response": "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog that has been used in experimental and clinical studies. It is structurally similar to L-thyronine, the natural form of thyroid hormone, but with an iodine atom replaced by a hydrogen atom and an additional iodine atom attached to the carbon atom that is two positions away from the iodine atom in L-thyronine.\nDITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hyperthyroidism, hypothyroidism, and thyroid cancer. It has been shown to have a similar effect on the body as L-thyronine, but with a longer half-life and a more consistent release of hormones into the bloodstream.\nIn clinical studies, DITPA has been administered to patients through oral or intravenous routes. The safety and efficacy of DITPA have been evaluated in several clinical trials, and the results have been promising. However, more research is needed to fully understand the potential benefits and risks of DITPA as a treatment for thyroid-related conditions.\nOverall, DITPA is a thyroid hormone analog that has been studied in experimental and clinical settings. It has shown promise as a potential treatment for thyroid-related conditions, but more research is needed to fully understand its safety and efficacy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog.\n2. DITPA is used in experimental and clinical studies.\n3. DITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hyperthyroidism, hypothyroidism, and thyroid cancer.\n4. DITPA has been shown to have a similar effect on the body as L-thyronine, but with a longer half-life and a more consistent release of hormones into the bloodstream.\n5. DITPA has been administered to patients through oral or intravenous routes in clinical studies.",
    "vicuna-7b_fact": [
      "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog.",
      "DITPA is used in experimental and clinical studies.",
      "DITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hyperthyroidism, hypothyroidism, and thyroid cancer.",
      "DITPA has been shown to have a similar effect on the body as L-thyronine, but with a longer half-life and a more consistent release of hormones into the bloodstream.",
      "DITPA has been administered to patients through oral or intravenous routes in clinical studies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 130,
    "user_query": "What is needed for MMP proteins to be functional?",
    "vicuna-7b_response": "MMP (Major Matrix Proteins) are a family of zinc-dependent endopeptidases that play a crucial role in the degradation of extracellular matrix (ECM) proteins. MMPs are expressed in various tissues and cells, including fibroblasts, endothelial cells, and smooth muscle cells. They are involved in a variety of physiological and pathological processes, such as embryonic development, wound healing, and cancer progression.\nFor MMPs to be functional, they require several cofactors and substrates. These include:\n1. Zinc: MMPs require zinc ions for their activity. Zinc ions bind to the active site of the enzyme and are essential for the cleavage of peptide bonds.\n2. Serine proteases: MMPs require serine proteases as their activators. Serine proteases cleave the peptide bonds in the ECM proteins, releasing the protein fragments that are then degraded by MMPs.\n3. Inhibitors: MMPs are regulated by various inhibitors, such as TIMPs (Tissue Inhibitors of Metalloproteinases), which bind to MMPs and inhibit their activity.\n4. Substrates: MMPs require specific substrates for their activity. The substrates are cleaved by MMPs, releasing the protein fragments that are then degraded by other proteases.\nIn summary, for MMPs to be functional, they require zinc ions, serine proteases, inhibitors, and specific substrates. The interaction between these cofactors and substrates is crucial for the proper functioning of MMPs in various physiological and pathological processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MMPs are a family of zinc-dependent endopeptidases involved in the degradation of extracellular matrix proteins.\n2. MMPs are expressed in various tissues and cells, including fibroblasts, endothelial cells, and smooth muscle cells.\n3. MMPs require zinc ions for their activity, serving a critical role in the cleavage of peptide bonds.\n4. MMPs are regulated by various inhibitors, such as TIMPs.\n5. For MMPs to be functional, they require zinc ions, serine proteases, inhibitors, and specific substrates.",
    "vicuna-7b_fact": [
      "MMPs are a family of zinc-dependent endopeptidases involved in the degradation of extracellular matrix proteins.",
      "MMPs are expressed in various tissues and cells, including fibroblasts, endothelial cells, and smooth muscle cells.",
      "MMPs require zinc ions for their activity, serving a critical role in the cleavage of peptide bonds.",
      "MMPs are regulated by various inhibitors, such as TIMPs.",
      "For MMPs to be functional, they require zinc ions, serine proteases, inhibitors, and specific substrates."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: MMPs are functional with the presence of zinc ions and specific substrates. Serine proteases and inhibitors are not required for MMPs to function.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 133,
    "user_query": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?",
    "vicuna-7b_response": "The most well-known bacterium responsible for botulism is Clostridium botulinum. Botulism is a serious illness caused by the toxins produced by this bacterium. It can cause a variety of symptoms, including muscle weakness, difficulty swallowing, and paralysis. The toxins produced by C. botulinum are some of the most toxic substances known, and can be fatal in high doses.\nC. botulinum is a gram-positive, anaerobic bacterium that can grow in a variety of environments, including soil, water, and the gastrointestinal tracts of animals and humans. It is commonly found in improperly canned or preserved foods, such as sausages, that have not been properly sterilized.\nIt's important to note that there are several different strains of C. botulinum, and some of them are more dangerous than others. For example, strain A is the most dangerous and is responsible for most cases of botulism. Strains B and E are less dangerous, but can still cause serious illness.\nIn conclusion, Clostridium botulinum is the most well-known bacterium responsible for botulism, a serious illness caused by the toxins produced by this bacterium. It can cause a variety of symptoms, including muscle weakness, difficulty swallowing, and paralysis. The toxins produced by C. botulinum are some of the most toxic substances known, and can be fatal in high doses. It's important to properly can or preserve foods to prevent the growth of C. botulinum.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The bacterium responsible for botulism is Clostridium botulinum.\n2. Botulism is a serious illness caused by the toxins produced by Clostridium botulinum.\n3. The toxins produced by Clostridium botulinum are some of the most toxic substances known.\n4. Clostridium botulinum is a gram-positive, anaerobic bacterium that can grow in environments like soil, water, and the gastrointestinal tracts of animals and humans.\n5. There are several different strains of Clostridium botulinum, some more dangerous than others, such as the strain A.",
    "vicuna-7b_fact": [
      "The bacterium responsible for botulism is Clostridium botulinum.",
      "Botulism is a serious illness caused by the toxins produced by Clostridium botulinum.",
      "The toxins produced by Clostridium botulinum are some of the most toxic substances known.",
      "Clostridium botulinum is a gram-positive, anaerobic bacterium that can grow in environments like soil, water, and the gastrointestinal tracts of animals and humans.",
      "There are several different strains of Clostridium botulinum, some more dangerous than others, such as the strain A."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 138,
    "user_query": "Which are the plant DNA (cytosine-5) methyltransferase families?",
    "vicuna-7b_response": "There are several plant DNA (cytosine-5) methyltransferase families, including:\n1. CMT3 family: This family includes plant-specific methyltransferases that methylate CpG residues in the promoter regions of genes, leading to transcriptional repression.\n2. CMT4 family: This family includes methyltransferases that methylate CpG residues in the 5' region of transposable elements, such as retrotransposons and transposons.\n3. CMT5 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n4. CMT6 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n5. CMT7 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n6. CMT8 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n7. CMT9 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n8. CMT10 family: This family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\nIt's important to note that this list is not exhaustive and new families of plant DNA (cytosine-5) methyltransferases may be discovered in the future.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are several plant DNA (cytosine-5) methyltransferase families.\n2. The CMT3 family includes plant-specific methyltransferases that methylate CpG residues in the promoter regions of genes.\n3. The CMT4 family includes methyltransferases that methylate CpG residues in the 5' region of transposable elements.\n4. The CMT5 family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.\n5. New families of plant DNA (cytosine-5) methyltransferases may be discovered in the future.",
    "vicuna-7b_fact": [
      "There are several plant DNA (cytosine-5) methyltransferase families.",
      "The CMT3 family includes plant-specific methyltransferases that methylate CpG residues in the promoter regions of genes.",
      "The CMT4 family includes methyltransferases that methylate CpG residues in the 5' region of transposable elements.",
      "The CMT5 family includes methyltransferases that methylate CpG residues in the 5' region of genes, leading to transcriptional repression.",
      "New families of plant DNA (cytosine-5) methyltransferases may be discovered in the future."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 139,
    "user_query": "Where is the histone variant CENPA preferentially localized?",
    "vicuna-7b_response": "CENPA (centromere protein A) is a histone variant that is primarily localized to the centromere region of chromosomes. The centromere is the region of the chromosome where the chromosome fibers (also called microtubules) attach, allowing for proper chromosome segregation during cell division.\nCENPA is a key component of the kinetochore, the structure that forms on the centromere and serves as the attachment point for microtubules. The kinetochore is responsible for ensuring that the correct chromosomes are separated during cell division, and CENPA plays a crucial role in this process by helping to assemble and stabilize the kinetochore.\nIn addition to its role in the centromere, CENPA has also been shown to be involved in other cellular processes, such as transcription regulation and DNA repair. However, its primary localization is to the centromere region of chromosomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CENPA is a histone variant. \n2. CENPA is primarily localized to the centromere region of chromosomes.\n3. The centromere is the region of the chromosome where the chromosome fibers attach.\n4. CENPA is a key component of the kinetochore, which forms on the centromere.\n5. CENPA has been shown to be involved in transcription regulation and DNA repair.",
    "vicuna-7b_fact": [
      "CENPA is a histone variant.",
      "CENPA is primarily localized to the centromere region of chromosomes.",
      "The centromere is the region of the chromosome where the chromosome fibers attach.",
      "CENPA is a key component of the kinetochore, which forms on the centromere.",
      "CENPA has been shown to be involved in transcription regulation and DNA repair."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CENPA does not directly participate in transcription regulation and DNA repair; instead, it plays a role in chromosome segregation during cell division.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 140,
    "user_query": "In which proteins is the chromodomain present?",
    "vicuna-7b_response": "Chromodomain is a protein domain that is present in a number of chromatin-associated proteins. These proteins play a role in regulating the accessibility of DNA to the proteins that read and interpret the genetic code.\nSome examples of proteins that contain a chromodomain include:\n* Chromodomain-helicase-DNA binding proteins (CHDs)\n* Trithorax-related proteins (TRX)\n* MLL (mixed lineage leukemia) proteins\n* KMT (lysine-specific methyltransferase) proteins\n* Coactivator proteins\nThese proteins are involved in a variety of cellular processes, including transcriptional regulation, DNA replication, and DNA repair. The chromodomain is responsible for recognizing and binding to specific sequences of DNA, and it plays a role in recruiting other proteins to specific regions of the genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chromodomain is a protein domain that is present in a number of chromatin-associated proteins.\n2. Chromodomain-helicase-DNA binding proteins (CHDs), Trithorax-related proteins (TRX), MLL (mixed lineage leukemia) proteins, KMT (lysine-specific methyltransferase) proteins, and Coactivator proteins are examples of proteins that contain a chromodomain.\n3. These proteins play a role in regulating the accessibility of DNA to proteins that read and interpret the genetic code.\n4. The proteins containing chromodomain are involved in transcriptional regulation, DNA replication, and DNA repair.\n5. The chromodomain is responsible for recognizing and binding to specific sequences of DNA, and it plays a role in recruiting other proteins to specific regions of the genome.",
    "vicuna-7b_fact": [
      "Chromodomain is a protein domain that is present in a number of chromatin-associated proteins.",
      "Chromodomain-helicase-DNA binding proteins (CHDs), Trithorax-related proteins (TRX), MLL (mixed lineage leukemia) proteins, KMT (lysine-specific methyltransferase) proteins, and Coactivator proteins are examples of proteins that contain a chromodomain.",
      "These proteins play a role in regulating the accessibility of DNA to proteins that read and interpret the genetic code.",
      "The proteins containing chromodomain are involved in transcriptional regulation, DNA replication, and DNA repair.",
      "The chromodomain is responsible for recognizing and binding to specific sequences of DNA, and it plays a role in recruiting other proteins to specific regions of the genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The chromodomain is responsible for recognizing and binding to specific modifications on histones, not sequences of DNA. It plays a role in recruiting other proteins to specific regions of the genome.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 142,
    "user_query": "Is amiodarone a class I anti-arrhythmic drug?",
    "vicuna-7b_response": "Yes, amiodarone is a class I anti-arrhythmic drug. It is used to treat various types of irregular heartbeats, including atrial fibrillation and ventricular tachycardia. It works by slowing the conduction of electrical impulses in the heart, which helps to restore a normal heart rhythm. Amiodarone is also used to prevent recurrence of atrial fibrillation after cardioversion.\nIt is important to note that amiodarone can have serious side effects, including thyroid problems, liver damage, and lung problems. It is also not recommended for people with certain medical conditions, such as lung disease or a history of lung disease. It is important to consult with a healthcare professional before taking amiodarone, as it is a powerful medication that requires close monitoring.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Amiodarone is a class I anti-arrhythmic drug.\n2. Amiodarone is used to treat various types of irregular heartbeats, including atrial fibrillation and ventricular tachycardia.\n3. The drug functions by slowing the conduction of electrical impulses in the heart.\n4. It is used to prevent recurrence of atrial fibrillation after cardioversion.\n5. Amiodarone can have serious side effects, including thyroid problems, liver damage, and lung problems.",
    "vicuna-7b_fact": [
      "Amiodarone is a class I anti-arrhythmic drug.",
      "Amiodarone is used to treat various types of irregular heartbeats, including atrial fibrillation and ventricular tachycardia.",
      "The drug functions by slowing the conduction of electrical impulses in the heart.",
      "It is used to prevent recurrence of atrial fibrillation after cardioversion.",
      "Amiodarone can have serious side effects, including thyroid problems, liver damage, and lung problems."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Amiodarone is a class III anti-arrhythmic drug.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-7b_response": "COUGER is a tool that stands for \"COmputer-based UGer Reasoning\". It is a software application that is used to analyze and evaluate the reasoning skills of individuals. COUGER is commonly used in the field of psychology and education to assess cognitive abilities such as problem-solving, critical thinking, and decision-making.\nThe COUGER tool typically consists of a series of tasks that are designed to test specific cognitive skills. For example, one task might involve a person being presented with a series of shapes and being asked to identify the shape that is different from the others. Another task might involve a person being presented with a series of statements and being asked to determine which statement is the most logical conclusion based on the other statements.\nThe results of the COUGER tool are typically used to help diagnose cognitive disorders, such as attention deficit hyperactivity disorder (ADHD), and to help identify areas where an individual may need additional support or training.\nIt's important to note that COUGER is just one of many tools that can be used to assess cognitive abilities, and that the results of any one tool should be interpreted in the context of the individual's overall cognitive profile.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. COUGER stands for \"COmputer-based UGer Reasoning\".\n2. COUGER is software that is used to analyze and evaluate the reasoning skills of individuals.\n3. This tool is commonly used in the fields of psychology and education.\n4. The tasks within the COUGER tool are designed to test specific cognitive skills.\n5. The results from the COUGER tool are often used to help diagnose cognitive disorders like attention deficit hyperactivity disorder (ADHD).",
    "vicuna-7b_fact": [
      "COUGER stands for \"COmputer-based UGer Reasoning\".",
      "COUGER is software that is used to analyze and evaluate the reasoning skills of individuals.",
      "This tool is commonly used in the fields of psychology and education.",
      "The tasks within the COUGER tool are designed to test specific cognitive skills.",
      "The results from the COUGER tool are often used to help diagnose cognitive disorders like attention deficit hyperactivity disorder (ADHD)."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-7b_response": "Yes, there are drugs available for the treatment of Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks. The most common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\nThe treatment for TBE typically involves supportive care, such as rest and fluids, to help manage symptoms. Antiviral medications, such as ribavirin and oseltamivir, may also be used to help reduce the severity of the illness and shorten the duration of symptoms.\nIt is important to note that the most effective way to prevent TBE is to avoid being bitten by infected ticks. This can be done by using tick repellents, wearing protective clothing, and conducting regular tick checks after spending time outdoors in tick-endemic areas.\nIn addition, vaccination is also an effective way to prevent TBE. There are two types of TBE vaccines available: inactivated vaccine and live attenuated vaccine. The inactivated vaccine is given as a single dose, while the live attenuated vaccine is given in two doses.\nIt is recommended that individuals who live in or travel to areas where TBE is common consult with their healthcare provider to determine the most appropriate preventive measures and treatment options for TBE.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are drugs available for the treatment of Tick-borne Encephalitis (TBE).\n2. The most common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\n3. Antiviral medications such as ribavirin and oseltamivir can be used to treat TBE.\n4. Measures such as using tick repellents, wearing protective clothing, and conducting regular tick checks can help prevent TBE.\n5. Two types of TBE vaccines are available: inactivated vaccine and live attenuated vaccine.",
    "vicuna-7b_fact": [
      "There are drugs available for the treatment of Tick-borne Encephalitis (TBE).",
      "The most common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.",
      "Antiviral medications such as ribavirin and oseltamivir can be used to treat TBE.",
      "Measures such as using tick repellents, wearing protective clothing, and conducting regular tick checks can help prevent TBE.",
      "Two types of TBE vaccines are available: inactivated vaccine and live attenuated vaccine."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: While there are vaccines available for the prevention of Tick-borne Encephalitis (TBE), there are no specific antiviral treatments for the condition itself.\n2. FALSE [correction]: The most common symptoms of TBE are flu-like and include fever, headache, muscle and joint pain, but a skin rash is not a typical symptom.\n3. FALSE [correction]: There are no specific antiviral medications such as ribavirin and oseltamivir for the treatment of TBE. Treatment is supportive, aiming to relieve symptoms.\n4. TRUE\n5. FALSE [correction]: There are no live attenuated TBE vaccines- only inactivated vaccines are available for TBE.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 146,
    "user_query": "Is SLC22A3 expressed in the brain?",
    "vicuna-7b_response": "SLC22A3, also known as solute carrier family 22 member 3, is a protein that is expressed in various tissues throughout the body, including the brain.\nSLC22A3 is a solute carrier protein that is responsible for transporting various substances across cell membranes. It is primarily expressed in the liver, kidney, and intestine, where it plays a role in the uptake and transport of various substances, including glucose, amino acids, and organic acids.\nHowever, SLC22A3 is also expressed in the brain, where it may play a role in the transport of various substances across the blood-brain barrier. The blood-brain barrier is a specialized network of blood vessels and cells that separates the brain from the bloodstream and protects the brain from harmful substances in the blood.\nWhile the exact function of SLC22A3 in the brain is not fully understood, studies have suggested that it may be involved in the transport of various substances across the blood-brain barrier, including glucose, amino acids, and other substances.\nOverall, SLC22A3 is expressed in the brain and may play a role in the transport of various substances across the blood-brain barrier. However, further research is needed to fully understand the function of SLC22A3 in the brain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SLC22A3, also known as solute carrier family 22 member 3, is a protein that is expressed in various tissues throughout the body, including the brain.\n2. SLC22A3 is responsible for transporting various substances across cell membranes.\n3. SLC22A3 is primarily expressed in the liver, kidney, and intestine.\n4. SLC22A3 is expressed in the brain, where it may play a role in the transport of various substances across the blood-brain barrier.\n5. The blood-brain barrier is a specialized network of blood vessels and cells that separates the brain from the bloodstream and protects the brain from harmful substances in the blood.",
    "vicuna-7b_fact": [
      "SLC22A3, also known as solute carrier family 22 member 3, is a protein that is expressed in various tissues throughout the body, including the brain.",
      "SLC22A3 is responsible for transporting various substances across cell membranes.",
      "SLC22A3 is primarily expressed in the liver, kidney, and intestine.",
      "SLC22A3 is expressed in the brain, where it may play a role in the transport of various substances across the blood-brain barrier.",
      "The blood-brain barrier is a specialized network of blood vessels and cells that separates the brain from the bloodstream and protects the brain from harmful substances in the blood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: SLC22A3 is not primarily expressed in the brain, it has a low expression in the brain. It is primarily expressed in organs like liver, kidney, and intestine.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-7b_response": "There are several genome browser databases that allow users to annotate DNA shape information. Some of the most popular ones include:\n1. UCSC Genome Browser: This is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape information. Users can view and annotate DNA shape data using a variety of tools and resources provided by the UCSC Genome Browser.\n2. Ensembl Genome Browser: Ensembl is another popular genome browser that provides access to a wide range of genomic data, including DNA shape information. Users can view and annotate DNA shape data using the Ensembl Genome Browser, and can also use the browser to perform a variety of genetic analyses.\n3. Genome Analysis Toolkit (GATK): GATK is a suite of tools for genetic analysis that includes a genome browser called the Variant Analysis Tool (VAT). The VAT allows users to view and annotate DNA shape information, as well as other types of genomic data.\n4. Integrative Genomics Viewer (IGV): IGV is a genome browser that is specifically designed for working with large genomic datasets. It includes a variety of tools for viewing and analyzing DNA shape information, as well as other types of genomic data.\nOverall, there are many genome browser databases available that allow users to annotate DNA shape information. The choice of which one to use will depend on the specific needs and goals of the user.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UCSC Genome Browser is a free, online genome browser that provides access to genomic data, including DNA shape information.\n2. The Ensembl Genome Browser provides access to a wide range of genomic data, including DNA shape information.\n3. Genome Analysis Toolkit (GATK) includes a genome browser called the Variant Analysis Tool (VAT) that allows users to view and annotate DNA shape information.\n4. Integrative Genomics Viewer (IGV) is a genome browser designed for working with large genomic datasets and includes tools for viewing and analyzing DNA shape information.\n5. There are multiple genome browser databases available that allow users to annotate DNA shape information.",
    "vicuna-7b_fact": [
      "The UCSC Genome Browser is a free, online genome browser that provides access to genomic data, including DNA shape information.",
      "The Ensembl Genome Browser provides access to a wide range of genomic data, including DNA shape information.",
      "Genome Analysis Toolkit (GATK) includes a genome browser called the Variant Analysis Tool (VAT) that allows users to view and annotate DNA shape information.",
      "Integrative Genomics Viewer (IGV) is a genome browser designed for working with large genomic datasets and includes tools for viewing and analyzing DNA shape information.",
      "There are multiple genome browser databases available that allow users to annotate DNA shape information."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Genome Analysis Toolkit (GATK) is a software package for analysis of high-throughput sequencing data, not a genome browser. The Variant Analysis Tool (VAT) mentioned doesn't exist in GATK.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 153,
    "user_query": "What is the relationship between TailorX and Oncotype?",
    "vicuna-7b_response": "TailorX and Oncotype are both companies that provide genetic testing services for cancer patients.\nTailorX is a genetic testing company that offers a range of tests for cancer patients, including tests for breast, colon, and ovarian cancer. The company's tests are designed to help doctors determine the most effective treatment plan for each patient based on their unique genetic profile.\nOncotype, on the other hand, is a genetic testing company that specializes in breast cancer testing. The company's test, called the Oncotype DX Breast Recurrence Score test, measures the activity of genes in breast cancer tumors to predict the risk of recurrence and the likelihood of benefit from chemotherapy.\nWhile both TailorX and Oncotype offer genetic testing services for cancer patients, they focus on different types of cancer and offer different types of tests. TailorX offers a range of tests for different types of cancer, while Oncotype specializes in breast cancer testing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TailorX and Oncotype are genetic testing companies.\n2. TailorX offers a range of tests for cancer patients, including tests for breast, colon, and ovarian cancer.\n3. Oncotype specializes in breast cancer testing.\n4. Oncotype's test, called the Oncotype DX Breast Recurrence Score test, measures the activity of genes in breast cancer tumors to predict the risk of recurrence and the likelihood of benefit from chemotherapy.\n5. Both TailorX and Oncotype offer genetic testing services for cancer patients.",
    "vicuna-7b_fact": [
      "TailorX and Oncotype are genetic testing companies.",
      "TailorX offers a range of tests for cancer patients, including tests for breast, colon, and ovarian cancer.",
      "Oncotype specializes in breast cancer testing.",
      "Oncotype's test, called the Oncotype DX Breast Recurrence Score test, measures the activity of genes in breast cancer tumors to predict the risk of recurrence and the likelihood of benefit from chemotherapy.",
      "Both TailorX and Oncotype offer genetic testing services for cancer patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 154,
    "user_query": "Does strenuous physical activity affect thyroid hormone metabolism?",
    "vicuna-7b_response": "Yes, strenuous physical activity can affect thyroid hormone metabolism. The thyroid gland plays a crucial role in regulating metabolism in the body, and physical activity can affect its function.\nWhen you engage in physical activity, your body releases hormones such as adrenaline and cortisol, which can stimulate the thyroid gland to produce more thyroid hormones. This can lead to an increase in your body's metabolic rate, which can help you burn more calories and lose weight.\nHowever, if you engage in strenuous physical activity for an extended period of time, your body may not be able to keep up with the increased demand for thyroid hormones. This can lead to a condition called overtraining syndrome, which can cause your thyroid gland to become underactive and reduce your metabolic rate.\nIt's important to note that the effects of physical activity on thyroid hormone metabolism can vary depending on several factors, such as your age, sex, and overall health. If you have a thyroid disorder or are taking medication for thyroid problems, it's important to consult with your healthcare provider before starting a new exercise program.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The thyroid gland plays a crucial role in regulating metabolism in the body.\n2. Physical activity can affect the function of the thyroid gland.\n3. Physical activity can stimulate the thyroid gland to produce more thyroid hormones which can increase the metabolic rate.\n4. Extended periods of strenuous physical activity can lead to overtraining syndrome, causing the thyroid gland to become underactive and reduce the metabolic rate.\n5. The effects of physical activity on thyroid hormone metabolism can vary depending on age, sex, and overall health.",
    "vicuna-7b_fact": [
      "The thyroid gland plays a crucial role in regulating metabolism in the body.",
      "Physical activity can affect the function of the thyroid gland.",
      "Physical activity can stimulate the thyroid gland to produce more thyroid hormones which can increase the metabolic rate.",
      "Extended periods of strenuous physical activity can lead to overtraining syndrome, causing the thyroid gland to become underactive and reduce the metabolic rate.",
      "The effects of physical activity on thyroid hormone metabolism can vary depending on age, sex, and overall health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 155,
    "user_query": "Which is the main function of \"RNA sponges\"?",
    "vicuna-7b_response": "RNA sponges, also known as RNA binding proteins, are proteins that bind to RNA molecules and regulate their function. The main function of RNA sponges is to protect RNA molecules from degradation, to transport RNA molecules to different cellular compartments, and to regulate RNA stability and translation.\nRNA sponges can bind to RNA molecules through various mechanisms, such as Watson-Crick base pairing, Hoogsteen base pairing, or hydrogen bonding. Once bound, RNA sponges can regulate RNA stability by protecting RNA molecules from degradation by RNA-degrading enzymes, or by promoting the degradation of specific RNA molecules.\nRNA sponges can also regulate RNA translation by blocking the interaction between RNA and ribosomes, or by promoting the interaction between RNA and ribosomes. This can lead to the translation of specific RNA molecules or the inhibition of the translation of other RNA molecules.\nIn summary, the main function of RNA sponges is to regulate RNA stability and translation by binding to RNA molecules and modulating their interactions with other cellular components.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA sponges, also known as RNA binding proteins, bind to RNA molecules and regulate their function.\n2. The main function of RNA sponges is to protect RNA molecules from degradation, transport them to different cellular compartments, and regulate RNA stability and translation.\n3. RNA sponges can bind to RNA molecules through various mechanisms, including Watson-Crick base pairing, Hoogsteen base pairing, or hydrogen bonding.\n4. RNA sponges can regulate RNA stability by protecting RNA molecules from degradation by RNA-degrading enzymes.\n5. RNA sponges can regulate RNA translation by blocking or promoting the interaction between RNA and ribosomes.",
    "vicuna-7b_fact": [
      "RNA sponges, also known as RNA binding proteins, bind to RNA molecules and regulate their function.",
      "The main function of RNA sponges is to protect RNA molecules from degradation, transport them to different cellular compartments, and regulate RNA stability and translation.",
      "RNA sponges can bind to RNA molecules through various mechanisms, including Watson-Crick base pairing, Hoogsteen base pairing, or hydrogen bonding.",
      "RNA sponges can regulate RNA stability by protecting RNA molecules from degradation by RNA-degrading enzymes.",
      "RNA sponges can regulate RNA translation by blocking or promoting the interaction between RNA and ribosomes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: RNA sponges are not also known as RNA binding proteins. They are non-coding RNAs that bind and sequester other RNA molecules, while RNA binding proteins are proteins that bind to RNA.\n2. FALSE [correction]: This description pertains to the function of RNA binding proteins, not RNA sponges. RNA sponges primarily function to sequester and inhibit the function of other RNA molecules by binding to them.\n3. FALSE [correction]: RNA sponges bind to RNA molecules mainly through base complementarity, not through Watson-Crick base pairing, Hoogsteen base pairing, or hydrogen bonding.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 157,
    "user_query": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?",
    "vicuna-7b_response": "Mutations in the phospholamban (PLN) gene have been found to be associated with cardiomyopathy in some patients. Cardiomyopathy is a group of diseases that affect the heart muscle and can lead to heart failure.\nThere are several types of cardiomyopathies, and some of them are inherited in a dominant or recessive manner. In these cases, mutations in genes such as PLN can cause the disease.\nMutations in the PLN gene have been found to cause a form of dominant cardiomyopathy known as hypertrophic cardiomyopathy (HCM). HCM is characterized by thickening of the heart muscle, which can lead to heart failure.\nIn addition to HCM, mutations in the PLN gene have also been found to cause a form of recessive cardiomyopathy known as dilated cardiomyopathy (DCM). DCM is characterized by a weakened heart muscle and enlargement of the heart.\nOther mutations in the PLN gene have been found to be associated with other types of cardiomyopathies, such as restrictive cardiomyopathy and arrhythmogenic right ventricular dysplasia (ARVD).\nIt is important to note that not all mutations in the PLN gene will result in cardiomyopathy. The specific effects of a mutation depend on the location and nature of the mutation. Therefore, genetic testing is necessary to determine if a mutation in the PLN gene is associated with cardiomyopathy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mutations in the phospholamban (PLN) gene have been found to be associated with cardiomyopathy in some patients.\n2. Mutations in the PLN gene have been found to cause a form of dominant cardiomyopathy known as hypertrophic cardiomyopathy (HCM).\n3. HCM is characterized by thickening of the heart muscle, which can lead to heart failure.\n4. Mutations in the PLN gene have also been found to cause a form of recessive cardiomyopathy known as dilated cardiomyopathy (DCM).\n5. Genetic testing is necessary to determine if a mutation in the PLN gene is associated with cardiomyopathy.",
    "vicuna-7b_fact": [
      "Mutations in the phospholamban (PLN) gene have been found to be associated with cardiomyopathy in some patients.",
      "Mutations in the PLN gene have been found to cause a form of dominant cardiomyopathy known as hypertrophic cardiomyopathy (HCM).",
      "HCM is characterized by thickening of the heart muscle, which can lead to heart failure.",
      "Mutations in the PLN gene have also been found to cause a form of recessive cardiomyopathy known as dilated cardiomyopathy (DCM).",
      "Genetic testing is necessary to determine if a mutation in the PLN gene is associated with cardiomyopathy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 160,
    "user_query": "Is there any software for automated analysis of FISH images?",
    "vicuna-7b_response": "Yes, there are several software programs available for automated analysis of fluorescence in situ hybridization (FISH) images. Some of the most popular options include:\n1. CellProfiler: This is an open-source software program that is widely used for automated image analysis in cell biology research. It can be used to analyze FISH images and detect and quantify cellular features such as nuclei, chromosomes, and fluorescent signals.\n2. ImageJ: This is a free, open-source software program that can be used for a wide range of image analysis tasks, including FISH image analysis. It can be used to detect and quantify fluorescent signals, as well as to measure distances and angles between cells and chromosomes.\n3. AQUA: This is a commercial software program that is specifically designed for automated analysis of FISH images. It can be used to detect and quantify fluorescent signals, as well as to measure distances and angles between cells and chromosomes.\n4. Aria: This is another commercial software program that is designed for automated analysis of FISH images. It can be used to detect and quantify fluorescent signals, as well as to measure distances and angles between cells and chromosomes.\nIt's worth noting that the choice of software program will depend on the specific requirements of the research question and the available resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is software available for automated analysis of fluorescence in situ hybridization (FISH) images.\n2. CellProfiler is an open-source software program used for automated image analysis in cell biology research.\n3. ImageJ is a free, open-source software program that can be used for a wide range of image analysis tasks, including FISH image analysis.\n4. AQUA is a commercial software program specifically designed for automated analysis of FISH images.\n5. Aria is a commercial software program designed for automated analysis of FISH images.",
    "vicuna-7b_fact": [
      "There is software available for automated analysis of fluorescence in situ hybridization (FISH) images.",
      "CellProfiler is an open-source software program used for automated image analysis in cell biology research.",
      "ImageJ is a free, open-source software program that can be used for a wide range of image analysis tasks, including FISH image analysis.",
      "AQUA is a commercial software program specifically designed for automated analysis of FISH images.",
      "Aria is a commercial software program designed for automated analysis of FISH images."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 165,
    "user_query": "List markers for autophagy.",
    "vicuna-7b_response": "Autophagy is a process by which cells break down and recycle their own components. There are several markers that can be used to identify autophagy in cells. Here are some of the most commonly used markers:\n1. LC3 (microtubule-associated protein 1 light chain 3): LC3 is a marker protein that is recruited to autophagosomes, the membrane-bound structures that enclose the material to be degraded by autophagy. The accumulation of LC3-II (the cleaved form of LC3) in the cytoplasm of cells is an indicator of autophagy.\n2. Beclin 1: Beclin 1 is a protein that is involved in the initiation of autophagy. It is recruited to the site of autophagosome formation and plays a role in the formation of the autophagosome membrane.\n3. Atg8 (autophagy-related gene 8): Atg8 is a family of proteins that are involved in the formation of autophagosomes. There are several isoforms of Atg8, including Atg8a, Atg8b, and Atg8c. The accumulation of Atg8-positive structures in the cytoplasm of cells is an indicator of autophagy.\n4. p62/SQSTM1: p62/SQSTM1 is a protein that is involved in the clearance of damaged organelles and protein aggregates. It can also be recruited to autophagosomes and is thought to play a role in the degradation of cytoplasmic components by autophagy.\n5. GABARAP (Golgi apparatus-associated beta-propeller protein): GABARAP is a protein that is involved in the formation of the autophagosome membrane. It is recruited to the site of autophagosome formation and plays a role in the fusion of the autophagosome with lysosomes.\nThese markers can be used to identify and study autophagy in cells, and they can also be used to monitor the effects of drugs or other interventions on autophagy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process by which cells break down and recycle their own components.\n2. LC3 is a marker protein that is recruited to autophagosomes, indicating autophagy.\n3. Beclin 1 is a protein involved in the initiation of autophagy and plays a role in the formation of the autophagosome membrane.\n4. Atg8 is a family of proteins involved in the formation of autophagosomes and its accumulation in the cytoplasm of cells is an indicator of autophagy.\n5. p62/SQSTM1 is a protein involved in the clearance of damaged organelles and protein aggregates and plays a role in the degradation of cytoplasmic components by autophagy.\n6. GABARAP is a protein involved in the formation of the autophagosome membrane and plays a role in the fusion of the autophagosome with lysosomes.",
    "vicuna-7b_fact": [
      "Autophagy is a process by which cells break down and recycle their own components.",
      "LC3 is a marker protein that is recruited to autophagosomes, indicating autophagy.",
      "Beclin 1 is a protein involved in the initiation of autophagy and plays a role in the formation of the autophagosome membrane.",
      "Atg8 is a family of proteins involved in the formation of autophagosomes and its accumulation in the cytoplasm of cells is an indicator of autophagy.",
      "p62/SQSTM1 is a protein involved in the clearance of damaged organelles and protein aggregates and plays a role in the degradation of cytoplasmic components by autophagy.",
      "GABARAP is a protein involved in the formation of the autophagosome membrane and plays a role in the fusion of the autophagosome with lysosomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 169,
    "user_query": "Are there any specific antidotes for rivaroxaban?",
    "vicuna-7b_response": "Yes, there are specific antidotes for rivaroxaban, a blood thinner medication used to prevent blood clots. The most commonly used antidote for rivaroxaban is prothrombin complex concentrate (PCC). PCC is a blood product that contains clotting factors and is used to reverse the blood-thinning effects of rivaroxaban.\nIt is important to note that the use of PCC to reverse the effects of rivaroxaban should only be done in a healthcare setting, such as a hospital or emergency room, as it requires close monitoring and dosing. Additionally, the use of PCC should only be done by a healthcare professional who is trained in the use of this medication.\nIt is also important to note that the use of PCC to reverse the effects of rivaroxaban is not a substitute for following the recommended dosing and administration instructions for rivaroxaban. If you have any questions or concerns about the use of rivaroxaban, it is important to speak with your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Rivaroxaban is a blood thinner medication used to prevent blood clots.\n2. Prothrombin complex concentrate (PCC) is a commonly used antidote for rivaroxaban.\n3. PCC is a blood product that contains clotting factors and is used to reverse the blood-thinning effects of rivaroxaban.\n4. The use of PCC to reverse the effects of rivaroxaban should only be done in a healthcare setting.\n5. The use of PCC for rivaroxaban should be performed by a healthcare professional trained in the use of this medication.",
    "vicuna-7b_fact": [
      "Rivaroxaban is a blood thinner medication used to prevent blood clots.",
      "Prothrombin complex concentrate (PCC) is a commonly used antidote for rivaroxaban.",
      "PCC is a blood product that contains clotting factors and is used to reverse the blood-thinning effects of rivaroxaban.",
      "The use of PCC to reverse the effects of rivaroxaban should only be done in a healthcare setting.",
      "The use of PCC for rivaroxaban should be performed by a healthcare professional trained in the use of this medication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Prothrombin complex concentrate (PCC) may be used in emergencies to reverse the effect of rivaroxaban, but it is not the commonly used antidote. Andexanet alfa is a FDA-approved specific reversal agent for rivaroxaban.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 171,
    "user_query": "What is the function of 6SRNA in bacteria?",
    "vicuna-7b_response": "The 6S ribosomal RNA (rRNA) is a component of the small subunit of the bacterial ribosome, which is responsible for catalyzing the peptide bond formation between amino acids during protein synthesis. The 6S rRNA is involved in the formation of the peptidyl transferase center, which is the active site of the ribosome where the peptide bond is formed.\nIn bacteria, the 6S rRNA is essential for the growth and survival of the organism. The 6S rRNA is also involved in the regulation of gene expression, as it can interact with various proteins to regulate the activity of the ribosome.\nOverall, the function of the 6S rRNA in bacteria is to play a crucial role in the process of protein synthesis, which is essential for the growth and survival of the organism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 6S ribosomal RNA is a component of the small subunit of the bacterial ribosome.\n2. The 6S rRNA in bacteria is involved in catalyzing the peptide bond formation during protein synthesis.\n3. The 6S rRNA is involved in the formation of the peptidyl transferase center, which is the active site of the ribosome where the peptide bond is formed.\n4. In bacteria, the 6S rRNA is essential for the growth and survival of the organism.\n5. The 6S rRNA can interact with various proteins to regulate the activity of the ribosome in bacteria.",
    "vicuna-7b_fact": [
      "The 6S ribosomal RNA is a component of the small subunit of the bacterial ribosome.",
      "The 6S rRNA in bacteria is involved in catalyzing the peptide bond formation during protein synthesis.",
      "The 6S rRNA is involved in the formation of the peptidyl transferase center, which is the active site of the ribosome where the peptide bond is formed.",
      "In bacteria, the 6S rRNA is essential for the growth and survival of the organism.",
      "The 6S rRNA can interact with various proteins to regulate the activity of the ribosome in bacteria."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The 16S ribosomal RNA is a component of the small subunit of the bacterial ribosome, not the 6S rRNA. \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 172,
    "user_query": "Is cytisine superior to nicotine replacement therapy for smoking cessation?",
    "vicuna-7b_response": "Cytisine and nicotine replacement therapy (NRT) are both medications that can be used to help people quit smoking. However, there is limited evidence to support the superiority of cytisine over NRT for smoking cessation.\nCytisine is a plant-based medication that works on the same receptors in the brain as nicotine, but with a lower affinity for these receptors. This means that cytisine may be less addictive than nicotine and may be less likely to cause withdrawal symptoms when people stop taking it.\nNicotine replacement therapy (NRT) is a group of medications that can be used to help people quit smoking by providing a steady supply of nicotine to the body. There are several different forms of NRT available, including gum, patches, lozenges, and inhalers.\nBoth cytisine and NRT have been shown to be effective in helping people quit smoking. However, the evidence for the superiority of cytisine over NRT is limited. Some studies have suggested that cytisine may be more effective than NRT for smoking cessation, but other studies have found no significant differences between the two medications.\nIt is important to note that both cytisine and NRT can have side effects, and it is important to talk to your healthcare provider about the risks and benefits of these medications before starting treatment. Your healthcare provider can help you determine the best treatment option for you based on your individual needs and preferences.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cytisine and nicotine replacement therapy (NRT) are both medications that can be used to help people quit smoking.\n2. Cytisine is a plant-based medication that works on the same receptors in the brain as nicotine, but with a lower affinity for these receptors.\n3. Nicotine replacement therapy (NRT) is a group of medications that provide a steady supply of nicotine to the body with different forms including gum, patches, lozenges, and inhalers.\n4. Both cytisine and NRT have been shown to be effective in helping people quit smoking.\n5. The evidence for the superiority of cytisine over NRT for smoking cessation is limited.",
    "vicuna-7b_fact": [
      "Cytisine and nicotine replacement therapy (NRT) are both medications that can be used to help people quit smoking.",
      "Cytisine is a plant-based medication that works on the same receptors in the brain as nicotine, but with a lower affinity for these receptors.",
      "Nicotine replacement therapy (NRT) is a group of medications that provide a steady supply of nicotine to the body with different forms including gum, patches, lozenges, and inhalers.",
      "Both cytisine and NRT have been shown to be effective in helping people quit smoking.",
      "The evidence for the superiority of cytisine over NRT for smoking cessation is limited."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 173,
    "user_query": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?",
    "vicuna-7b_response": "Cadasil syndrome, also known as hereditary spastic paraplegia, is a rare genetic disorder characterized by progressive spastic paraplegia, seizures, and dementia. The disorder is caused by mutations in the PRNP gene, which codes for the prion protein. The most common mutation associated with Cadasil syndrome is the G2019S mutation, which results in the substitution of serine for asparagine at position 2019 in the prion protein. This mutation is found in about 70% of cases of Cadasil syndrome. Other mutations in the PRNP gene have also been associated with the disorder, including the G1888R mutation, which results in the substitution of arginine for glutamine at position 1888, and the G1282R mutation, which results in the substitution of arginine for glutamine at position 1282.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cadasil syndrome, also known as hereditary spastic paraplegia, is a rare genetic disorder.\n2. Cadasil syndrome is characterized by progressive spastic paraplegia, seizures, and dementia.\n3. This disorder is caused by mutations in the PRNP gene, which codes for the prion protein.\n4. The most common mutation associated with Cadasil syndrome is the G2019S mutation, which results in the substitution of serine for asparagine at position 2019 in the prion protein.\n5. Other mutations in the PRNP gene have also been associated with the disorder, including the G1888R mutation and the G1282R mutation.",
    "vicuna-7b_fact": [
      "Cadasil syndrome, also known as hereditary spastic paraplegia, is a rare genetic disorder.",
      "Cadasil syndrome is characterized by progressive spastic paraplegia, seizures, and dementia.",
      "This disorder is caused by mutations in the PRNP gene, which codes for the prion protein.",
      "The most common mutation associated with Cadasil syndrome is the G2019S mutation, which results in the substitution of serine for asparagine at position 2019 in the prion protein.",
      "Other mutations in the PRNP gene have also been associated with the disorder, including the G1888R mutation and the G1282R mutation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cadasil syndrome, also known as Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy, is a rare genetic disorder.\n2. TRUE\n3. FALSE [correction]: This disorder is caused by mutations in the NOTCH3 gene, which codes for the Notch 3 receptor protein.\n4. FALSE [correction]: The most common mutation associated with Cadasil syndrome is located on chromosome 19 in the NOTCH3 gene, not in the PRNP gene.\n5. FALSE [correction]: Different mutations in the NOTCH3 gene have been associated with the disorder, but not the PRNP gene. There's no specific mention of the G1888R mutation and the G1282R mutation with Cadasil syndrome.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-7b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Wolf-Hirschhorn syndrome: This is a genetic disorder that is caused by a deletion on chromosome 4, which includes the EZH2 gene. It is characterized by growth retardation, intellectual disability, and distinctive facial features.\n2. Dandy-Walker syndrome: This is a congenital brain malformation that is characterized by a cyst in the cerebellum and a large ventricle in the brain. Mutations in the EZH2 gene have been found to be associated with this condition.\n3. Microcephaly: Microcephaly is a condition characterized by a small head size and intellectual disability. Mutations in the EZH2 gene have been found to be associated with this condition.\n4. Renal cell carcinoma: EZH2 has been found to be overexpressed in some cases of renal cell carcinoma, a type of kidney cancer.\n5. Prostate cancer: EZH2 has been found to be overexpressed in some cases of prostate cancer.\nIt's important to note that these are just a few examples of the syndromes associated with mutations in the EZH2 gene, and that the specific symptoms and severity of the condition can vary depending on the specific mutation and the individual affected.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Wolf-Hirschhorn syndrome is linked with the mutation of the EZH2 gene.\n2. Dandy-Walker syndrome has been associated with mutations in the EZH2 gene.\n3. Microcephaly is linked to the mutation in the EZH2 gene.\n4. EZH2 gene has been found to be overexpressed in some cases of renal cell carcinoma.\n5. EZH2 gene has been found to be overexpressed in some cases of prostate cancer.",
    "vicuna-7b_fact": [
      "Wolf-Hirschhorn syndrome is linked with the mutation of the EZH2 gene.",
      "Dandy-Walker syndrome has been associated with mutations in the EZH2 gene.",
      "Microcephaly is linked to the mutation in the EZH2 gene.",
      "EZH2 gene has been found to be overexpressed in some cases of renal cell carcinoma.",
      "EZH2 gene has been found to be overexpressed in some cases of prostate cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Wolf-Hirschhorn syndrome is linked with the deletion in the short arm of chromosome 4, not a mutation in the EZH2 gene.\n2. FALSE [correction]: Dandy-Walker syndrome is linked with mutations in different genes, but the EZH2 gene is not cited among them.\n3. FALSE [correction]: Microcephaly is linked to mutations in various genes, however EZH2 isn't typically associated directly with this condition.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 175,
    "user_query": "Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?",
    "vicuna-7b_response": "There are several databases that exist for experimentally determined topologies of α-helical transmembrane proteins. Here are a few examples:\n1. The Protein Data Bank (PDB) is a comprehensive database of experimentally determined three-dimensional structures of proteins. The PDB includes a number of structures of α-helical transmembrane proteins, which can be searched using various criteria such as topology and function.\n2. The Transmembrane Protein Topology Database (TMPTDB) is a database that provides information on the topology of transmembrane proteins, including α-helical transmembrane proteins. The TMPTDB includes information on the number and orientation of transmembrane helices, as well as other features such as the presence of signal peptides and cytoplasmic domains.\n3. The Protein Structure Initiative (PSI) is a research program that aimed to determine the structures of a large number of proteins, including many transmembrane proteins. The PSI database includes a number of structures of α-helical transmembrane proteins that were determined as part of the program.\n4. The Structural Classification of Proteins (SCOP) database is a database that classifies proteins based on their structural features. The SCOP database includes a number of α-helical transmembrane proteins in its classification, which can be searched using various criteria such as topology and function.\nThese are just a few examples of databases that exist for experimentally determined topologies of α-helical transmembrane proteins. There may be other databases that are specific to certain research areas or organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Protein Data Bank is a database of experimentally determined three-dimensional structures of proteins, including α-helical transmembrane proteins.\n2. The Transmembrane Protein Topology Database provides information on the topology of transmembrane proteins, including α-helical transmembrane proteins.\n3. The Protein Structure Initiative (PSI) was a research program that aimed to determine the structures of a large number of proteins, including transmembrane proteins.\n4. α-helical transmembrane proteins structures determined as part of the PSI program are included in the PSI database.\n5. The Structural Classification of Proteins (SCOP) database classifies proteins based on their structural features.",
    "vicuna-7b_fact": [
      "The Protein Data Bank is a database of experimentally determined three-dimensional structures of proteins, including α-helical transmembrane proteins.",
      "The Transmembrane Protein Topology Database provides information on the topology of transmembrane proteins, including α-helical transmembrane proteins.",
      "The Protein Structure Initiative (PSI) was a research program that aimed to determine the structures of a large number of proteins, including transmembrane proteins.",
      "α-helical transmembrane proteins structures determined as part of the PSI program are included in the PSI database.",
      "The Structural Classification of Proteins (SCOP) database classifies proteins based on their structural features."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: α-helical transmembrane proteins structures determined as part of the PSI program are included in the Protein Data Bank.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 178,
    "user_query": "How is oprozomib administered?",
    "vicuna-7b_response": "Oprozomib, also known as Ponatinib, is a medication used to treat certain types of blood cancers, such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is typically administered orally, in the form of a tablet or capsule, and the dosage and frequency of administration will depend on the individual patient and their specific medical condition.\nOprozomib is usually taken once daily, with or without food. It is important to take oprozomib at the same time every day to maintain a consistent level of the medication in your body. If you miss a dose of oprozomib, it is recommended to take it as soon as you remember. However, if it is almost time for your next dose, it is best to skip the missed dose and continue with your regular dosing schedule.\nIt is important to follow the dosing instructions provided by your healthcare provider and to talk to your healthcare provider if you have any questions or concerns about how to take oprozomib. Your healthcare provider may also recommend certain laboratory tests to monitor the effectiveness and side effects of oprozomib treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oprozomib, also known as Ponatinib, is used to treat certain types of blood cancers, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).\n2. Oprozomib is typically administered orally, in the form of a tablet or capsule.\n3. The dosage and frequency of Oprozomib administration depend on the individual patient and their specific medical condition.\n4. Oprozomib is usually taken once daily, with or without food.\n5. Healthcare providers may recommend certain laboratory tests to monitor the effectiveness and side effects of oprozomib treatment.",
    "vicuna-7b_fact": [
      "Oprozomib, also known as Ponatinib, is used to treat certain types of blood cancers, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).",
      "Oprozomib is typically administered orally, in the form of a tablet or capsule.",
      "The dosage and frequency of Oprozomib administration depend on the individual patient and their specific medical condition.",
      "Oprozomib is usually taken once daily, with or without food.",
      "Healthcare providers may recommend certain laboratory tests to monitor the effectiveness and side effects of oprozomib treatment."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Oprozomib is not the same as Ponatinib. Both are used to treat certain types of blood cancers, but they are different drugs.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 182,
    "user_query": "Does thyroid hormone regulate calcium transient in the myocardium?",
    "vicuna-7b_response": "Yes, thyroid hormone can regulate calcium transients in the myocardium. Thyroid hormone plays an important role in the regulation of metabolism in the body, including the heart. One of the ways it does this is by affecting the levels of calcium in the myocardial cells.\nCalcium is an essential ion for proper muscle contraction and heart function. The concentration of calcium inside the myocardial cells is tightly regulated, with a delicate balance between influx and efflux. The influx of calcium ions into the myocardial cells is primarily regulated by the L-type calcium channels, which are activated by the influx of thyroid hormone.\nIncreased levels of thyroid hormone can increase the activity of these channels, leading to an increase in the influx of calcium ions into the myocardial cells. This increase in calcium can lead to increased contractility of the heart and improved cardiac function.\nOn the other hand, decreased levels of thyroid hormone can lead to decreased activity of the L-type calcium channels, resulting in a decrease in the influx of calcium ions into the myocardial cells. This decrease in calcium can lead to decreased contractility of the heart and impaired cardiac function.\nIn summary, thyroid hormone plays a crucial role in regulating calcium transients in the myocardium by affecting the activity of the L-type calcium channels. The balance of thyroid hormone levels is important for maintaining proper heart function and overall cardiac health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thyroid hormone can regulate calcium transients in the myocardium.\n2. Thyroid hormone plays an important role in the regulation of metabolism in the body, including the heart.\n3. Calcium is an essential ion for muscle contraction and heart function.\n4. The concentration of calcium inside the myocardial cells is regulated by the L-type calcium channels, which are activated by the influx of thyroid hormone.\n5. The balance of thyroid hormone levels is important for maintaining proper heart function and overall cardiac health.",
    "vicuna-7b_fact": [
      "Thyroid hormone can regulate calcium transients in the myocardium.",
      "Thyroid hormone plays an important role in the regulation of metabolism in the body, including the heart.",
      "Calcium is an essential ion for muscle contraction and heart function.",
      "The concentration of calcium inside the myocardial cells is regulated by the L-type calcium channels, which are activated by the influx of thyroid hormone.",
      "The balance of thyroid hormone levels is important for maintaining proper heart function and overall cardiac health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The concentration of calcium inside the myocardial cells is regulated by the L-type calcium channels, which are activated by the influx of calcium ions, not thyroid hormone.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 185,
    "user_query": "The protein NONO forms heterodimers. With which proteins?",
    "vicuna-7b_response": "NONO (Nuclear Orphan Receptor Nuclear Translocator) is a protein that plays a role in various cellular processes, including cell proliferation, differentiation, and apoptosis. NONO can form heterodimers with other proteins, including:\n1. PPAR-gamma: NONO can form a heterodimer with the peroxisome proliferator-activated receptor gamma (PPAR-gamma) to regulate the expression of genes involved in adipogenesis and glucose metabolism.\n2. RXR alpha: NONO can form a heterodimer with the retinoid X receptor alpha (RXR alpha) to regulate the expression of genes involved in cell differentiation and development.\n3. VDR: NONO can form a heterodimer with the vitamin D receptor (VDR) to regulate the expression of genes involved in calcium homeostasis and bone metabolism.\n4. HSP90: NONO can form a heterodimer with the heat shock protein 90 (HSP90) to regulate the stability and activity of other proteins involved in various cellular processes.\nOverall, NONO can form heterodimers with a variety of proteins to regulate the expression of genes involved in different cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NONO (Nuclear Orphan Receptor Nuclear Translocator) is a protein that plays a role in cell proliferation, differentiation, and apoptosis.\n2. NONO can form a heterodimer with PPAR-gamma to regulate the expression of genes related to adipogenesis and glucose metabolism.\n3. NONO can form a heterodimer with the retinoid X receptor alpha (RXR alpha) and alter the expression of genes involved in cell differentiation and development.\n4. The protein NONO can form a heterodimer with the vitamin D receptor (VDR) to regulate the expression of genes involved in calcium homeostasis and bone metabolism.\n5. NONO can form a heterodimer with the heat shock protein 90 (HSP90) to regulate the stability and activity of other proteins.",
    "vicuna-7b_fact": [
      "NONO (Nuclear Orphan Receptor Nuclear Translocator) is a protein that plays a role in cell proliferation, differentiation, and apoptosis.",
      "NONO can form a heterodimer with PPAR-gamma to regulate the expression of genes related to adipogenesis and glucose metabolism.",
      "NONO can form a heterodimer with the retinoid X receptor alpha (RXR alpha) and alter the expression of genes involved in cell differentiation and development.",
      "The protein NONO can form a heterodimer with the vitamin D receptor (VDR) to regulate the expression of genes involved in calcium homeostasis and bone metabolism.",
      "NONO can form a heterodimer with the heat shock protein 90 (HSP90) to regulate the stability and activity of other proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 188,
    "user_query": "Is there any link between CTF4 and CTF18 during sister chromatid cohesion?",
    "vicuna-7b_response": "Yes, there is a link between CTF4 and CTF18 during sister chromatid cohesion. CTF4, also known as the minichromosome maintenance (MCM) complex subunit, is a key component of the cohesin complex, which is responsible for holding sister chromatids together during cell division. CTF18, on the other hand, is a component of the condensin complex, which is responsible for condensing and segregating chromosomes during cell division.\nDuring the S phase of the cell cycle, CTF4 and CTF18 work together to form a complex that helps to maintain sister chromatid cohesion. This complex is thought to be involved in the recruitment of cohesin to the chromosomes, as well as in the regulation of cohesin activity.\nIn addition to its role in sister chromatid cohesion, CTF4 is also involved in the regulation of other cellular processes, such as transcription and DNA replication. CTF18, on the other hand, is primarily involved in the regulation of chromosome condensation and segregation during cell division.\nOverall, the link between CTF4 and CTF18 during sister chromatid cohesion is an important aspect of the cell's ability to properly segregate its genetic material during cell division.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CTF4, also known as the minichromosome maintenance (MCM) complex subunit, is a key component of the cohesin complex which holds sister chromatids together during cell division.\n2. CTF18 is a component of the condensin complex, which is responsible for condensing and segregating chromosomes during cell division.\n3. During the S phase of the cell cycle, CTF4 and CTF18 work together to form a complex that helps to maintain sister chromatid cohesion.\n4. In addition to its role in sister chromatid cohesion, CTF4 is also involved in the regulation of transcription and DNA replication.\n5. CTF18 is primarily involved in the regulation of chromosome condensation and segregation during cell division.",
    "vicuna-7b_fact": [
      "CTF4, also known as the minichromosome maintenance (MCM) complex subunit, is a key component of the cohesin complex which holds sister chromatids together during cell division.",
      "CTF18 is a component of the condensin complex, which is responsible for condensing and segregating chromosomes during cell division.",
      "During the S phase of the cell cycle, CTF4 and CTF18 work together to form a complex that helps to maintain sister chromatid cohesion.",
      "In addition to its role in sister chromatid cohesion, CTF4 is also involved in the regulation of transcription and DNA replication.",
      "CTF18 is primarily involved in the regulation of chromosome condensation and segregation during cell division."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CTF4, also known as the minichromosome maintenance (MCM) complex subunit, is involved in DNA replication, but it is not a key component of the cohesin complex.\n2. FALSE [correction]: CTF18 is a component of the RFC(CTF18) complex, not the condensin complex, which is responsible for sister chromatid cohesion and DNA replication during cell division.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-7b_response": "Certainly! Here is a list of human proteins that are known to undergo a dimer-to-tetramer transition:\n1. Cytochrome c\n2. Cytochrome b\n3. Cytochrome c oxidase\n4. Hemoglobin\n5. Myoglobin\n6. Thioredoxin\n7. Glutaredoxin\n8. Peroxiredoxin\n9. Thioredoxin reductase\n10. DnaK\n11. DnaJ\n12. GrpE\n13. Hsp70\n14. Hsp90\n15. Hsp100\n16. Hsp110\n17. Hsp70-like protein\n18. Hsp60\n19. Hsp40\n20. Hsp27\nIt's worth noting that this is not an exhaustive list, and there may be other human proteins that undergo a dimer-to-tetramer transition. Additionally, the dimer-to-tetramer transition is a common phenomenon in many proteins, not just those found in humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cytochrome c is a human protein that is known to undergo a dimer-to-tetramer transition.\n2. Hemoglobin is a human protein that is subject to a dimer-to-tetramer transition.\n3. Thioredoxin is a human protein that is known to undergo a dimer-to-tetramer transition.\n4. DnaK is a human protein that undergoes a dimer-to-tetramer transition.\n5. The dimer-to-tetramer transition is a common phenomenon in many proteins, not just those found in humans.",
    "vicuna-7b_fact": [
      "Cytochrome c is a human protein that is known to undergo a dimer-to-tetramer transition.",
      "Hemoglobin is a human protein that is subject to a dimer-to-tetramer transition.",
      "Thioredoxin is a human protein that is known to undergo a dimer-to-tetramer transition.",
      "DnaK is a human protein that undergoes a dimer-to-tetramer transition.",
      "The dimer-to-tetramer transition is a common phenomenon in many proteins, not just those found in humans."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cytochrome c is a human protein, but it is not known to undergo a dimer-to-tetramer transition.\n2. TRUE\n3. FALSE [correction]: Thioredoxin is a human protein, but it is not known to undergo a dimer-to-tetramer transition.\n4. FALSE [correction]: DnaK is a human protein, but it is not known to undergo a dimer-to-tetramer transition.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 197,
    "user_query": "Which gene strand is targeted by transcription-coupled repair (TCR)?",
    "vicuna-7b_response": "Transcription-coupled repair (TCR) is a mechanism that repairs DNA damage that occurs during transcription. TCR is activated when a lesion is encountered on the template strand of a gene that is being transcribed. The lesion can be a base pair mismatch, a base pair insertion or deletion, or a double-stranded break.\nOnce TCR is activated, the repair machinery moves along the template strand of the gene, repairing the lesion as it goes. The repair machinery includes the transcription machinery, which is responsible for synthesizing the new strand. The repair machinery also includes the transcription-translation elongation factor (ETF), which is responsible for elongating the RNA polymerase along the template strand.\nThe repair machinery moves along the template strand, repairing the lesion as it goes. Once the repair is complete, the transcription machinery can continue transcribing the gene, and the RNA polymerase can move on to the next nucleotide.\nIn summary, TCR targets the template strand of a gene that is being transcribed. The repair machinery moves along the template strand, repairing the lesion as it goes, and the transcription machinery continues transcribing the gene once the repair is complete.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcription-coupled repair (TCR) is a mechanism that repairs DNA damage occurring during transcription.\n2. TCR activates when a lesion is found on the template strand of a gene being transcribed.\n3. The lesion that TCR targets can be a base pair mismatch, a base pair insertion or deletion, or a double-stranded break.\n4. The repair machinery of TCR, which includes the transcription machinery and the transcription-translation elongation factor (ETF), moves along the template strand and repairs the lesion.\n5. Once the repair is complete, the transcription machinery can continue transcribing the gene.",
    "vicuna-7b_fact": [
      "Transcription-coupled repair (TCR) is a mechanism that repairs DNA damage occurring during transcription.",
      "TCR activates when a lesion is found on the template strand of a gene being transcribed.",
      "The lesion that TCR targets can be a base pair mismatch, a base pair insertion or deletion, or a double-stranded break.",
      "The repair machinery of TCR, which includes the transcription machinery and the transcription-translation elongation factor (ETF), moves along the template strand and repairs the lesion.",
      "Once the repair is complete, the transcription machinery can continue transcribing the gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The lesion that TCR targets can be a variety of damages, but not a base pair mismatch, insertion or deletion, or a double-stranded break. TCR is especially important for lesions that block progression of the RNA polymerase.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 199,
    "user_query": "Which is the branch site consensus sequence in U12-dependent introns?",
    "vicuna-7b_response": "The branch site consensus sequence in U12-dependent introns is AGGWG.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The branch site consensus sequence in U12-dependent introns is AGGWG.",
    "vicuna-7b_fact": [
      "The branch site consensus sequence in U12-dependent introns is AGGWG."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 201,
    "user_query": "What is the suggested therapy for Mycobacterium avium infection?",
    "vicuna-7b_response": "Mycobacterium avium is a type of slow-growing Mycobacterium that can cause various types of infections, including lung infections, skin infections, and other types of infections. The recommended therapy for Mycobacterium avium infection depends on the type and severity of the infection, as well as the patient's overall health.\nFor lung infections caused by Mycobacterium avium, the recommended therapy is typically a combination of antibiotics and other medications. The most commonly used antibiotics for treating Mycobacterium avium lung infections include:\n* Rifampin\n* Ethambutol\n* Streptomycin\n* Ciprofloxacin\n* Azithromycin\nThe duration of treatment for Mycobacterium avium lung infections can vary from several weeks to several months, depending on the severity of the infection and the response to treatment.\nFor skin infections caused by Mycobacterium avium, the recommended therapy is typically a topical antibiotic cream or ointment. The most commonly used topical antibiotics for treating Mycobacterium avium skin infections include:\n* Erythromycin\n* Clindamycin\n* Doxycycline\nThe duration of treatment for Mycobacterium avium skin infections can vary from several days to several weeks, depending on the severity of the infection and the response to treatment.\nIt is important to note that Mycobacterium avium infections can be difficult to treat, and the most effective therapy may vary from person to person. It is important to consult with a healthcare provider for the most appropriate treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mycobacterium avium is a type of slow-growing Mycobacterium.\n2. Mycobacterium avium can cause various types of infections, including lung and skin infections.\n3. The recommended therapy for Mycobacterium avium lung infections is typically a combination of antibiotics and other medications, such as Rifampin, Ethambutol, Streptomycin, Ciprofloxacin, and Azithromycin.\n4. The duration of treatment for Mycobacterium avium lung infections can vary from several weeks to several months, depending on the severity of the infection and the response to treatment.\n5. The recommended therapy for skin infections caused by Mycobacterium avium is typically a topical antibiotic cream or ointment, such as Erythromycin, Clindamycin, and Doxycycline.",
    "vicuna-7b_fact": [
      "Mycobacterium avium is a type of slow-growing Mycobacterium.",
      "Mycobacterium avium can cause various types of infections, including lung and skin infections.",
      "The recommended therapy for Mycobacterium avium lung infections is typically a combination of antibiotics and other medications, such as Rifampin, Ethambutol, Streptomycin, Ciprofloxacin, and Azithromycin.",
      "The duration of treatment for Mycobacterium avium lung infections can vary from several weeks to several months, depending on the severity of the infection and the response to treatment.",
      "The recommended therapy for skin infections caused by Mycobacterium avium is typically a topical antibiotic cream or ointment, such as Erythromycin, Clindamycin, and Doxycycline."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-7b_response": "Phospholamban (PLN) is an important protein that plays a role in regulating the contraction of muscles in the heart. PLN has been found to interact with a number of other proteins, including anti-apoptotic proteins. One such protein that has been found to interact with PLN and is also an anti-apoptotic protein is Bcl-2.\nBcl-2 is a well-known anti-apoptotic protein that plays a critical role in preventing cell death. It has been shown to interact with PLN and to play a role in regulating the contraction of muscles in the heart. In fact, PLN has been shown to interact with a number of anti-apoptotic proteins, including Bcl-2, Bcl-xL, and Mcl-1, which are all important for maintaining the survival of heart muscle cells.\nOverall, the interaction between PLN and anti-apoptotic proteins like Bcl-2 is an important area of research, as it may provide new insights into the mechanisms that regulate heart muscle cell survival and function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phospholamban (PLN) is a protein that plays a role in regulating the contraction of muscles in the heart.\n2. Phospholamban (PLN) interacts with a number of other proteins, including anti-apoptotic proteins.\n3. Bcl-2 is a protein that interacts with Phospholamban (PLN) and is an anti-apoptotic protein.\n4. Bcl-2 plays a critical role in preventing cell death.\n5. Phospholamban (PLN) interacts with anti-apoptotic proteins, including Bcl-2, Bcl-xL, and Mcl-1, which are all important for maintaining the survival of heart muscle cells.",
    "vicuna-7b_fact": [
      "Phospholamban (PLN) is a protein that plays a role in regulating the contraction of muscles in the heart.",
      "Phospholamban (PLN) interacts with a number of other proteins, including anti-apoptotic proteins.",
      "Bcl-2 is a protein that interacts with Phospholamban (PLN) and is an anti-apoptotic protein.",
      "Bcl-2 plays a critical role in preventing cell death.",
      "Phospholamban (PLN) interacts with anti-apoptotic proteins, including Bcl-2, Bcl-xL, and Mcl-1, which are all important for maintaining the survival of heart muscle cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 213,
    "user_query": "Is protein M3/6 a dual specificity phosphatase?",
    "vicuna-7b_response": "Protein M3/6 is a protein that is known to be a dual specificity phosphatase.\nDual specificity phosphatases (DSPs) are a type of phosphatase enzyme that can dephosphorylate both tyrosine and serine/threonine residues on proteins. They have two distinct phosphatase sites, one that recognizes tyrosine residues and another that recognizes serine/threonine residues. This allows them to remove phosphate groups from a wide range of substrates, making them versatile and important for regulating various cellular processes.\nProtein M3/6 is a known DSP, and it has been shown to play a role in regulating cellular processes such as cell division and the immune response. It is a member of the M3/6 family of DSPs, which are characterized by a unique domain structure that includes a DSP catalytic domain and a regulatory domain that is responsible for targeting the protein to specific subcellular locations.\nOverall, protein M3/6 is a dual specificity phosphatase that plays an important role in regulating cellular processes and is a member of the M3/6 family of DSPs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Protein M3/6 is a dual specificity phosphatase (DSP).\n2. DSPs can dephosphorylate both tyrosine and serine/threonine residues on proteins. \n3. Dual specificity phosphatases have two distinct phosphatase sites, one for tyrosine residues and another for serine/threonine residues.\n4. Protein M3/6 plays a role in regulating cellular processes such as cell division and the immune response.\n5. Protein M3/6 is a member of the M3/6 family of DSPs, characterized by a unique domain structure that includes a DSP catalytic domain and a regulatory domain.",
    "vicuna-7b_fact": [
      "Protein M3/6 is a dual specificity phosphatase (DSP).",
      "DSPs can dephosphorylate both tyrosine and serine/threonine residues on proteins.",
      "Dual specificity phosphatases have two distinct phosphatase sites, one for tyrosine residues and another for serine/threonine residues.",
      "Protein M3/6 plays a role in regulating cellular processes such as cell division and the immune response.",
      "Protein M3/6 is a member of the M3/6 family of DSPs, characterized by a unique domain structure that includes a DSP catalytic domain and a regulatory domain."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Dual specificity phosphatases do not have two distinct phosphatase sites, but instead can dephosphorylate both tyrosine and serine/threonine residues on proteins.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-7b_response": "Yes, there is evidence to suggest that vitamin D supplementation may help to reduce the incidence of falls in older people. Several clinical trials have investigated the effects of vitamin D supplementation on falls in older adults, with some studies finding that vitamin D supplementation may reduce the risk of falls.\nFor example, a meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults. The study, published in the Journal of Clinical Endocrinology and Metabolism, found that vitamin D supplementation was associated with a 19% reduction in the risk of falls.\nAnother study, published in the Journal of Bone and Mineral Research, found that vitamin D supplementation may also improve balance and reduce the risk of falls in older adults. The study found that vitamin D supplementation improved balance and reduced the risk of falls in older adults with vitamin D deficiency.\nIt is important to note that while vitamin D supplementation may have some benefits in reducing the risk of falls in older people, it is not a guarantee of preventing falls. Other factors, such as age, gender, and underlying health conditions, can also play a role in falls. It is always best to consult with a healthcare professional before starting any new supplement regimen.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is evidence that vitamin D supplementation may reduce the incidence of falls in older people.\n2. Several clinical trials have investigated the effects of vitamin D supplementation on falls in older adults.\n3. A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.\n4. Another study found that vitamin D supplementation improved balance and reduced the risk of falls in older adults with a vitamin D deficiency.\n5. It is important to consult with a healthcare professional before starting any new supplement regimen.",
    "vicuna-7b_fact": [
      "There is evidence that vitamin D supplementation may reduce the incidence of falls in older people.",
      "Several clinical trials have investigated the effects of vitamin D supplementation on falls in older adults.",
      "A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.",
      "Another study found that vitamin D supplementation improved balance and reduced the risk of falls in older adults with a vitamin D deficiency.",
      "It is important to consult with a healthcare professional before starting any new supplement regimen."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 221,
    "user_query": "What is the generic name of Gliolan?",
    "vicuna-7b_response": "Gliolan is the generic name for a class of drugs called Glial Cell Line-Derived Neurotrophic Factor (GDNF) modulators. GDNF is a protein that is naturally produced by glial cells in the brain and has been shown to promote the survival and differentiation of certain types of neurons. Gliolan drugs are designed to mimic the effects of GDNF and have been studied as potential treatments for a variety of neurological conditions, including Parkinson's disease, Huntington's disease, and chronic pain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gliolan is the generic name for a class of drugs known as Glial Cell Line-Derived Neurotrophic Factor (GDNF) modulators.\n2. GDNF is a protein that is naturally produced by glial cells in the brain.\n3. GDNF promotes the survival and differentiation of certain types of neurons.\n4. Gliolan drugs are designed to mimic the effects of GDNF.\n5. Gliolan drugs have been studied as potential treatments for a variety of neurological conditions, including Parkinson's disease, Huntington's disease, and chronic pain.",
    "vicuna-7b_fact": [
      "Gliolan is the generic name for a class of drugs known as Glial Cell Line-Derived Neurotrophic Factor (GDNF) modulators.",
      "GDNF is a protein that is naturally produced by glial cells in the brain.",
      "GDNF promotes the survival and differentiation of certain types of neurons.",
      "Gliolan drugs are designed to mimic the effects of GDNF.",
      "Gliolan drugs have been studied as potential treatments for a variety of neurological conditions, including Parkinson's disease, Huntington's disease, and chronic pain."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Gliolan is a brand-name drug used to help visualize malignant tissue during surgery for glioma, a type of brain tumor. It is not a class of drugs known as Glial Cell Line-Derived Neurotrophic Factor (GDNF) modulators.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Gliolan is used to help visualize malignant tissue during brain tumor surgery, not as a treatment for Parkinson's disease, Huntington's disease, and chronic pain. However, GDNF has been studied as potential treatments for these conditions.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-7b_response": "Yes, there is an association between JARID2 and miR-155 in Th17 cells.\nJARID2, which stands for JmjC domain-containing protein that regulates inflammatory disease, has been shown to play a role in the regulation of Th17 cells. JARID2 has been shown to negatively regulate the transcription of the miR-155 gene, which is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function.\nIn addition, miR-155 has been shown to negatively regulate the expression of JARID2 in Th17 cells. This suggests that the JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.\nOverall, the association between JARID2 and miR-155 in Th17 cells suggests that these two molecules may play important roles in the regulation of Th17 cell differentiation and function. Further research is needed to fully understand the role of JARID2 and miR-155 in Th17 cells and their potential as therapeutic targets for inflammatory diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease.\n2. JARID2 has been shown to negatively regulate the transcription of the miR-155 gene.\n3. miR-155 is a microRNA involved in the regulation of Th17 cell differentiation and function.\n4. miR-155 has been shown to negatively regulate the expression of JARID2 in Th17 cells.\n5. The JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.",
    "vicuna-7b_fact": [
      "JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease.",
      "JARID2 has been shown to negatively regulate the transcription of the miR-155 gene.",
      "miR-155 is a microRNA involved in the regulation of Th17 cell differentiation and function.",
      "miR-155 has been shown to negatively regulate the expression of JARID2 in Th17 cells.",
      "The JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. FALSE [correction]: miR-155 has been shown to positively regulate the expression of JARID2 in Th17 cells.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-7b_response": "The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact": [
      "The human HOXD cluster contains 13 genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 229,
    "user_query": "Which are the human glutamate transporters?",
    "vicuna-7b_response": "There are several human glutamate transporters, including:\n1. Sodium-dependent glutamate transporter (Na+-dependent glutamate transporter, excitatory amino acid transporter 1, EAAT1)\n2. Cation-dependent glutamate transporter (C-type glutamate transporter, CXMT)\n3. Cation-independent glutamate transporter (A-type glutamate transporter, GLT-1)\n4. Glutamate transporter 3 (GLT-3)\n5. Glutamate transporter 4 (GLT-4)\n6. Glutamate transporter 5 (GLT-5)\n7. Glutamate transporter 6 (GLT-6)\n8. Glutamate transporter 7 (GLT-7)\n9. Glutamate transporter 8 (GLT-8)\n10. Glutamate transporter 9 (GLT-9)\nThese transporters play important roles in regulating glutamate levels in the brain and are involved in various neurological disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sodium-dependent glutamate transporter is a type of human glutamate transporter.\n2. Cation-dependent glutamate transporter is a type of human glutamate transporter.\n3. Cation-independent glutamate transporter is a type of human glutamate transporter.\n4. Glutamate transporter 3 is a type of human glutamate transporter.\n5. These transporters play important roles in regulating glutamate levels in the brain and are involved in various neurological disorders.",
    "vicuna-7b_fact": [
      "Sodium-dependent glutamate transporter is a type of human glutamate transporter.",
      "Cation-dependent glutamate transporter is a type of human glutamate transporter.",
      "Cation-independent glutamate transporter is a type of human glutamate transporter.",
      "Glutamate transporter 3 is a type of human glutamate transporter.",
      "These transporters play important roles in regulating glutamate levels in the brain and are involved in various neurological disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no categorization of human glutamate transporters as 'Cation-dependent glutamate transporter'.\n3. FALSE [correction]: There is no categorization of human glutamate transporters as 'Cation-independent glutamate transporter'.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 235,
    "user_query": "What is the causative agent of the \"Panama disease\" affecting bananas?",
    "vicuna-7b_response": "The causative agent of the \"Panama disease\" affecting bananas is a fungus called Fusarium oxysporum f. sp. cubense (Foc). It is also known as the \"Panama strain\" of the fungus. Foc is a soil-borne fungus that can infect a wide range of plants, including bananas, and can cause serious damage to the plant. The disease is also known as \"Panama disease\" because it was first detected in Panama in the 1910s and has since become a major threat to banana production worldwide. The disease is spread through the soil and can infect both planting material and mature plants. It can cause yellowing and browning of the leaves, stunted growth, and ultimately death of the plant. The disease is considered one of the most destructive diseases of bananas and is a major concern for the banana industry.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The causative agent of the \"Panama disease\" affecting bananas is a fungus called Fusarium oxysporum f. sp. cubense (Foc).\n2. \"Panama disease\" is also known as the \"Panama strain\" of the fungus.\n3. The Panama disease was first detected in Panama in the 1910s.\n4. Fusarium oxysporum f. sp. cubense can infect a wide range of plants and can cause serious damage to the plant.\n5. The Panama disease is considered one of the most destructive diseases of bananas and is a major concern for the banana industry.",
    "vicuna-7b_fact": [
      "The causative agent of the \"Panama disease\" affecting bananas is a fungus called Fusarium oxysporum f. sp. cubense (Foc).",
      "\"Panama disease\" is also known as the \"Panama strain\" of the fungus.",
      "The Panama disease was first detected in Panama in the 1910s.",
      "Fusarium oxysporum f. sp. cubense can infect a wide range of plants and can cause serious damage to the plant.",
      "The Panama disease is considered one of the most destructive diseases of bananas and is a major concern for the banana industry."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: \"Panama disease\" is not a strain of the fungus. It is a disease caused by a specific strain of the Fusarium oxysporum f.sp. cubense (Foc) called Tropical Race 4 (TR4).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 237,
    "user_query": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?",
    "vicuna-7b_response": "The Mercedes Benz syndrome is a rare cranial base syndrome characterized by the synostosis (fusion) of certain cranial structures. The specific cranial structures that are characteristic of the Mercedes Benz syndrome include:\n1. Fusion of the basilar invagination with the petrous portion of the temporal bone\n2. Fusion of the sphenoidal strut with the clivus\n3. Fusion of the pterygoid plates\n4. Fusion of the occipital condyles\nThese fusions can result in a variety of neurological symptoms, including hearing loss, tinnitus, and facial weakness. The syndrome is named after the distinctive imaging appearance of the fused cranial structures, which resemble the hood of a Mercedes Benz.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Mercedes Benz syndrome is a rare cranial base syndrome.\n2. This syndrome is characterized by the fusion of certain cranial structures.\n3. Specific cranial structures included are the basilar invagination with the petrous portion of the temporal bone, the sphenoidal strut with the clivus, the pterygoid plates, and the occipital condyles.\n4. These fusions can cause a variety of neurological symptoms, including hearing loss, tinnitus, and facial weakness.\n5. The syndrome is named after the distinctive imaging appearance of the fused cranial structures, which resemble the hood of a Mercedes Benz.",
    "vicuna-7b_fact": [
      "The Mercedes Benz syndrome is a rare cranial base syndrome.",
      "This syndrome is characterized by the fusion of certain cranial structures.",
      "Specific cranial structures included are the basilar invagination with the petrous portion of the temporal bone, the sphenoidal strut with the clivus, the pterygoid plates, and the occipital condyles.",
      "These fusions can cause a variety of neurological symptoms, including hearing loss, tinnitus, and facial weakness.",
      "The syndrome is named after the distinctive imaging appearance of the fused cranial structures, which resemble the hood of a Mercedes Benz."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: There is no such term as Mercedes Benz syndrome in medical terminology.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: Mercedes Benz isn't used as a name for a medical syndrome due to fused cranial structures.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 242,
    "user_query": "What is a mitochondrial nucleoid?",
    "vicuna-7b_response": "A mitochondrial nucleoid is a region within the mitochondria of eukaryotic cells that contains DNA. Mitochondria are organelles that are responsible for generating energy for the cell through a process called cellular respiration. They have their own DNA, which is separate from the DNA found in the cell nucleus. The mitochondrial DNA (mtDNA) is circular and has a relatively small genome, containing only 37 genes. The mtDNA is organized into a nucleoid, which is a region of the mitochondrion that contains the mtDNA. The nucleoid is surrounded by a double membrane, and the mtDNA is wound around proteins called histones, which help to compact the DNA. The nucleoid is important for the proper functioning of the mitochondria, as the mtDNA is responsible for coding for the enzymes and other proteins that are necessary for cellular respiration.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A mitochondrial nucleoid is a region within the mitochondria of eukaryotic cells that contains DNA.\n2. Mitochondria are responsible for generating energy for the cell through cellular respiration.\n3. The mitochondrial DNA is separate from the DNA found in the cell nucleus.\n4. The mitochondrial DNA (mtDNA) is circular and contains only 37 genes.\n5. The mtDNA codes for the enzymes and other proteins necessary for cellular respiration.",
    "vicuna-7b_fact": [
      "A mitochondrial nucleoid is a region within the mitochondria of eukaryotic cells that contains DNA.",
      "Mitochondria are responsible for generating energy for the cell through cellular respiration.",
      "The mitochondrial DNA is separate from the DNA found in the cell nucleus.",
      "The mitochondrial DNA (mtDNA) is circular and contains only 37 genes.",
      "The mtDNA codes for the enzymes and other proteins necessary for cellular respiration."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 247,
    "user_query": "What is the effect of ivabradine in heart failure with preserved ejection fraction?",
    "vicuna-7b_response": "Ivabradine is a medication that is used to treat heart failure with preserved ejection fraction (HFpEF). It works by slowing the heart rate, which can help to reduce the workload on the heart and improve symptoms of heart failure.\nStudies have shown that ivabradine can improve symptoms of heart failure, such as shortness of breath and fatigue, and can also improve exercise capacity and quality of life in patients with HFpEF. Additionally, ivabradine has been shown to reduce the risk of hospitalization for heart failure and the risk of death from heart failure.\nIt is important to note that ivabradine is not appropriate for all patients with heart failure, and it should only be used in patients with HFpEF who have a resting heart rate greater than 75 bpm. Additionally, ivabradine should not be used in patients with certain types of heart rhythms or other conditions that may be worsened by a slowed heart rate.\nOverall, ivabradine can be an effective treatment for heart failure with preserved ejection fraction, and can help to improve symptoms and reduce the risk of hospitalization and death in these patients.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ivabradine is used to treat heart failure with preserved ejection fraction (HFpEF).\n2. Ivabradine works by slowing the heart rate, which can help to reduce the workload on the heart.\n3. Ivabradine has been shown to reduce the risk of hospitalization for heart failure.\n4. Ivabradine has also been shown to reduce the risk of death from heart failure.\n5. Ivabradine should only be used in patients with HFpEF who have a resting heart rate greater than 75 bpm.",
    "vicuna-7b_fact": [
      "Ivabradine is used to treat heart failure with preserved ejection fraction (HFpEF).",
      "Ivabradine works by slowing the heart rate, which can help to reduce the workload on the heart.",
      "Ivabradine has been shown to reduce the risk of hospitalization for heart failure.",
      "Ivabradine has also been shown to reduce the risk of death from heart failure.",
      "Ivabradine should only be used in patients with HFpEF who have a resting heart rate greater than 75 bpm."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Ivabradine is approved for treatment of stable heart failure with reduced ejection fraction (HFrEF) who have a resting heart rate greater than 70 bpm.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Ivabradine should only be used in patients with HFrEF who have a resting heart rate greater than 70 bpm.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 248,
    "user_query": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?",
    "vicuna-7b_response": "Low T3 syndrome is a condition in which the levels of triiodothyronine (T3), a hormone produced by the thyroid gland, are low. Renal insufficiency is a condition in which the kidneys are not functioning properly.\nThere is limited research on the prognostic value of low T3 syndrome in patients with renal insufficiency. Some studies have suggested that low T3 syndrome may be associated with an increased risk of mortality and cardiovascular events in patients with chronic kidney disease (CKD), but the evidence is not consistent and more research is needed to confirm these findings.\nIn general, low T3 syndrome can be a sign of an underlying thyroid disorder, and it is important to diagnose and treat the underlying cause of low T3 syndrome in order to prevent complications. In patients with renal insufficiency, managing underlying thyroid disorders and other comorbidities is important for improving outcomes.\nIt is important to note that low T3 syndrome can be caused by a variety of factors, including medication use, infection, and certain medical conditions. Therefore, it is important to consider other potential causes of low T3 syndrome in patients with renal insufficiency and to perform appropriate diagnostic tests to determine the underlying cause.\nIn summary, while there is limited research on the prognostic value of low T3 syndrome in patients with renal insufficiency, it is important to consider low T3 syndrome as a potential sign of an underlying thyroid disorder and to manage the underlying cause in order to prevent complications. Further research is needed to better understand the role of low T3 syndrome as a prognostic marker in patients with renal insufficiency.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Low T3 syndrome is a condition in which the levels of triiodothyronine (T3), a hormone produced by the thyroid gland, are low.\n2. Renal insufficiency is a condition in which the kidneys are not functioning properly.\n3. Some studies have suggested that low T3 syndrome may be associated with an increased risk of mortality and cardiovascular events in patients with chronic kidney disease (CKD).\n4. Low T3 syndrome can be a sign of an underlying thyroid disorder.\n5. Low T3 syndrome can be caused by a variety of factors, including medication use, infection, and certain medical conditions.",
    "vicuna-7b_fact": [
      "Low T3 syndrome is a condition in which the levels of triiodothyronine (T3), a hormone produced by the thyroid gland, are low.",
      "Renal insufficiency is a condition in which the kidneys are not functioning properly.",
      "Some studies have suggested that low T3 syndrome may be associated with an increased risk of mortality and cardiovascular events in patients with chronic kidney disease (CKD).",
      "Low T3 syndrome can be a sign of an underlying thyroid disorder.",
      "Low T3 syndrome can be caused by a variety of factors, including medication use, infection, and certain medical conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 254,
    "user_query": "Which is the relation between sweating and anaerobic threshold?",
    "vicuna-7b_response": "Sweating and anaerobic threshold are related in that sweating is a sign of increased metabolic activity, which can occur during high-intensity exercise that pushes the body to its anaerobic threshold.\nAnaerobic threshold, also known as lactate threshold, is the point during exercise at which the body begins to produce lactic acid in large quantities. This occurs when the demand for oxygen exceeds the supply, and the body switches from aerobic to anaerobic metabolism. Sweating is a sign of increased metabolic activity, as the body works to cool down and maintain homeostasis during exercise.\nAs exercise intensity increases and approaches the anaerobic threshold, the body's demand for oxygen increases, and the heart rate and breathing rate increase to meet this demand. This can lead to increased sweating as the body works to dissipate heat and maintain a stable internal environment.\nIn summary, sweating is a sign of increased metabolic activity during high-intensity exercise that pushes the body to its anaerobic threshold. The body's demand for oxygen increases, leading to increased heart rate and breathing rate, and sweating as a means of dissipating heat and maintaining homeostasis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sweating is a sign of increased metabolic activity which can occur during high-intensity exercise.\n2. Anaerobic threshold is also known as lactate threshold.\n3. Anaerobic threshold is the point during exercise where the body begins to produce lactic acid in large quantities.\n4. This state occurs when the demand for oxygen exceeds the supply, and the body switches from aerobic to anaerobic metabolism.\n5. As exercise intensity approaches the anaerobic threshold, the heart rate and breathing rate increase to meet the higher oxygen demand.",
    "vicuna-7b_fact": [
      "Sweating is a sign of increased metabolic activity which can occur during high-intensity exercise.",
      "Anaerobic threshold is also known as lactate threshold.",
      "Anaerobic threshold is the point during exercise where the body begins to produce lactic acid in large quantities.",
      "This state occurs when the demand for oxygen exceeds the supply, and the body switches from aerobic to anaerobic metabolism.",
      "As exercise intensity approaches the anaerobic threshold, the heart rate and breathing rate increase to meet the higher oxygen demand."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 256,
    "user_query": "What is the mode of action of bedaquiline?",
    "vicuna-7b_response": "Bedaquiline is an antibiotic drug that belongs to the class of medications called dideoxyinosine derivatives. It works by inhibiting the growth of Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB).\nBedaquiline acts by binding to the dihydrofolate reductase enzyme in the bacterial cell membrane, which is essential for the synthesis of the bacterial cell wall. By inhibiting this enzyme, bedaquiline prevents the formation of the bacterial cell wall, leading to the death of the bacteria.\nBedaquiline is used in the treatment of multidrug-resistant TB (MDR-TB) and extremely drug-resistant TB (XDR-TB), which are difficult-to-treat forms of TB that are resistant to several first-line TB drugs. It is usually used in combination with other TB drugs in a regimen known as \"directly observed therapy\" (DOT), where the patient is observed by a healthcare provider to ensure that they are taking their medication as prescribed.\nIt's important to note that bedaquiline should only be used under the supervision of a healthcare provider, as it can have side effects and interactions with other medications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bedaquiline is an antibiotic drug that belongs to the class of medications called dideoxyinosine derivatives.\n2. Bedaquiline works by inhibiting the growth of Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB).\n3. Bedaquiline binds to the dihydrofolate reductase enzyme in the bacterial cell membrane, which is essential for the synthesis of the bacterial cell wall.\n4. Bedaquiline is used in the treatment of multidrug-resistant TB (MDR-TB) and extremely drug-resistant TB (XDR-TB).\n5. Bedaquiline is usually used in combination with other TB drugs in a regimen known as \"directly observed therapy\" (DOT).",
    "vicuna-7b_fact": [
      "Bedaquiline is an antibiotic drug that belongs to the class of medications called dideoxyinosine derivatives.",
      "Bedaquiline works by inhibiting the growth of Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB).",
      "Bedaquiline binds to the dihydrofolate reductase enzyme in the bacterial cell membrane, which is essential for the synthesis of the bacterial cell wall.",
      "Bedaquiline is used in the treatment of multidrug-resistant TB (MDR-TB) and extremely drug-resistant TB (XDR-TB).",
      "Bedaquiline is usually used in combination with other TB drugs in a regimen known as \"directly observed therapy\" (DOT)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Bedaquiline is an antibiotic drug that belongs to the class of medications called diarylquinolines, not dideoxyinosine derivatives.\n2. TRUE\n3. FALSE [correction]: Bedaquiline inhibits the proton pump for ATP synthase, an enzyme essential for the energy supply to the Mycobacterium tuberculosis bacteria, not the dihydrofolate reductase enzyme. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 259,
    "user_query": "Is oxidative stress affected by FOXO expression?",
    "vicuna-7b_response": "FOXO is a transcription factor that plays a role in regulating cellular metabolism, including oxidative stress. In general, FOXO expression can affect oxidative stress by regulating the expression of genes involved in the antioxidant defense system.\nFOXO proteins are known to regulate the expression of genes involved in the antioxidant defense system, such as those encoding for enzymes like superoxide dismutase (SOD) and catalase (CAT), which help to detoxify reactive oxygen species (ROS). Additionally, FOXO proteins can also regulate the expression of genes involved in the synthesis of antioxidant molecules, such as glutathione (GSH) and vitamin E.\nIn summary, FOXO expression can affect oxidative stress by regulating the expression of genes involved in the antioxidant defense system, which can help to reduce oxidative damage and protect cells from oxidative stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. FOXO is a transcription factor that plays a role in regulating cellular metabolism, including oxidative stress.\n2. FOXO expression can regulate the expression of genes involved in the antioxidant defense system.\n3. FOXO proteins regulate the expression of enzymes like superoxide dismutase (SOD) and catalase (CAT).\n4. FOXO proteins can regulate the expression of genes involved in the synthesis of antioxidant molecules, such as glutathione (GSH) and vitamin E.\n5. The regulation of antioxidant defenses by FOXO can help to reduce oxidative damage and protect cells from oxidative stress.",
    "vicuna-7b_fact": [
      "FOXO is a transcription factor that plays a role in regulating cellular metabolism, including oxidative stress.",
      "FOXO expression can regulate the expression of genes involved in the antioxidant defense system.",
      "FOXO proteins regulate the expression of enzymes like superoxide dismutase (SOD) and catalase (CAT).",
      "FOXO proteins can regulate the expression of genes involved in the synthesis of antioxidant molecules, such as glutathione (GSH) and vitamin E.",
      "The regulation of antioxidant defenses by FOXO can help to reduce oxidative damage and protect cells from oxidative stress."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 260,
    "user_query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "vicuna-7b_response": "The LINX system is a minimally invasive surgical treatment option for gastroesophageal reflux disease (GERD). It is a laparoscopic implant procedure that involves the placement of a small, flexible band of magnetized beads around the lower esophageal sphincter (LES), the muscle that separates the esophagus and stomach.\nThe LINX system works by preventing the reflux of stomach contents into the esophagus by tightening the LES when pressure is applied. The magnetized beads are connected to a small titanium ring that is placed around the LES. When the beads are pulled in the direction of the stomach, they tighten the ring, which in turn tightens the LES. This helps to keep the stomach contents from flowing back into the esophagus.\nThe LINX system is designed to be adjustable, which means that it can be adjusted to fit the individual patient's needs. The system is made of materials that are safe for use in the body and are designed to be biocompatible.\nThe LINX system is typically a minimally invasive procedure that is performed laparoscopically, which means that it involves smaller incisions and less tissue damage compared to traditional surgical procedures. This can result in less pain, less scarring, and a faster recovery time for the patient.\nOverall, the LINX system is a novel and effective treatment option for patients with GERD who are looking for a minimally invasive surgical solution. It works by tightening the LES to prevent the reflux of stomach contents into the esophagus, which can help to improve symptoms of GERD and quality of life for patients.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The LINX system is a minimally invasive surgical treatment option for gastroesophageal reflux disease (GERD).\n2. The LINX system operates by preventing the backflow of stomach contents into the esophagus by tightening the lower esophageal sphincter (LES) when pressure is applied.\n3. The LINX system is adjustable and can be tailored to fit individual patients' needs.\n4. The LINX system is typically performed laparoscopically, which involves smaller incisions and less tissue damage compared to traditional surgical procedures.\n5. The LINX system can improve symptoms of GERD and quality of life for patients.",
    "vicuna-7b_fact": [
      "The LINX system is a minimally invasive surgical treatment option for gastroesophageal reflux disease (GERD).",
      "The LINX system operates by preventing the backflow of stomach contents into the esophagus by tightening the lower esophageal sphincter (LES) when pressure is applied.",
      "The LINX system is adjustable and can be tailored to fit individual patients' needs.",
      "The LINX system is typically performed laparoscopically, which involves smaller incisions and less tissue damage compared to traditional surgical procedures.",
      "The LINX system can improve symptoms of GERD and quality of life for patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 262,
    "user_query": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.",
    "vicuna-7b_response": "The Dyke-Davidoff-Masson (DDM) syndrome is a rare genetic disorder that is characterized by a range of physical and developmental abnormalities. The characteristic feature of the DDM syndrome is the presence of a small head (microcephaly) and intellectual disability.\nAdditionally, individuals with DDM syndrome may have other physical features such as low-set and malformed ears, abnormalities of the eyes (such as strabismus or crossed eyes), and a broad nasal bridge. They may also have delayed development and difficulty with feeding and swallowing.\nThe DDM syndrome is caused by a mutation in the PHF8 gene, which is located on the X chromosome. The mutation leads to the loss of function of the PHF8 protein, which is involved in the development of the brain and other organs.\nThe DDM syndrome is inherited in an X-linked recessive pattern, which means that the mutation occurs on the X chromosome and affects primarily males, who have only one X chromosome. Females who inherit the mutation on one of their X chromosomes (due to a carrier father or a carrier mother) may be affected, but the severity of the symptoms can vary.\nIt is important to note that the DDM syndrome is a rare disorder and that the symptoms and severity can vary from one individual to another.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dyke-Davidoff-Masson (DDM) syndrome is a genetic disorder characterized by physical and developmental abnormalities.\n2. Individuals with DDM syndrome may have microcephaly and intellectual disability.\n3. DDM syndrome may present other physical features such as low-set and malformed ears, eye abnormalities, a broad nasal bridge, delayed development, and difficulty with feeding and swallowing.\n4. The DDM syndrome is caused by a mutation in the PHF8 gene, which is responsible for the development of the brain and other organs.\n5. The DDM syndrome is inherited in an X-linked recessive pattern.",
    "vicuna-7b_fact": [
      "Dyke-Davidoff-Masson (DDM) syndrome is a genetic disorder characterized by physical and developmental abnormalities.",
      "Individuals with DDM syndrome may have microcephaly and intellectual disability.",
      "DDM syndrome may present other physical features such as low-set and malformed ears, eye abnormalities, a broad nasal bridge, delayed development, and difficulty with feeding and swallowing.",
      "The DDM syndrome is caused by a mutation in the PHF8 gene, which is responsible for the development of the brain and other organs.",
      "The DDM syndrome is inherited in an X-linked recessive pattern."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Dyke-Davidoff-Masson syndrome is a condition that results from brain damage due to a variety of causes, rather than a genetic disorder. \n2. TRUE\n3. FALSE [correction]: While DDM syndrome can involve physical and developmental abnormalities, it does not typically include features such as low-set and malformed ears, eye abnormalities, or a broad nasal bridge. The primary characteristics usually involve loss of brain tissue (cerebral hemiatrophy), seizures, and learning disabilities. \n4. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not caused by a mutation in the PHF8 gene. It occurs due to loss or damage to one half of the brain, often resulting from injury, infection, or inadequate blood flow. \n5. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not inherited as it is not a genetic disorder. It generally occurs due to brain damage.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 263,
    "user_query": "Which gene is involved in the development of Barth syndrome?",
    "vicuna-7b_response": "Barth syndrome is a rare genetic disorder caused by mutations in the TAF1 gene. The TAF1 gene provides instructions for making a protein called transcriptional adaptor factor 1, which is involved in the development of the body's cells. The TAF1 protein helps to regulate the activity of other genes, including those involved in the development of the heart and other organs.\nMutations in the TAF1 gene can cause a range of symptoms, including heart problems, growth delays, and immune system abnormalities. The severity of the symptoms can vary depending on the specific mutation and the presence of other genetic factors.\nThere is currently no cure for Barth syndrome, but treatments are available to help manage the symptoms and improve quality of life. These treatments may include medications to manage heart problems, growth hormone therapy to promote growth, and other supportive care.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Barth syndrome is a genetic disorder caused by mutations in the TAF1 gene.\n2. The TAF1 gene provides instructions for making a protein called transcriptional adaptor factor 1, which is involved in cell development.\n3. The TAF1 protein helps to regulate the activity of other genes, including those involved in the development of the heart and other organs.\n4. Mutations in the TAF1 gene can cause a range of symptoms, including heart problems, growth delays, and immune system abnormalities.\n5. There is currently no cure for Barth syndrome, but treatments are available to help manage the symptoms and improve quality of life.",
    "vicuna-7b_fact": [
      "Barth syndrome is a genetic disorder caused by mutations in the TAF1 gene.",
      "The TAF1 gene provides instructions for making a protein called transcriptional adaptor factor 1, which is involved in cell development.",
      "The TAF1 protein helps to regulate the activity of other genes, including those involved in the development of the heart and other organs.",
      "Mutations in the TAF1 gene can cause a range of symptoms, including heart problems, growth delays, and immune system abnormalities.",
      "There is currently no cure for Barth syndrome, but treatments are available to help manage the symptoms and improve quality of life."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Barth syndrome is a genetic disorder caused by mutations in the TAZ gene, not the TAF1 gene.\n2. FALSE [correction]: The TAF1 gene provides instructions for making a protein involved in gene expression, not cellular development. \n3. UNKNOWN\n4. FALSE [correction]: Mutations in the TAZ gene, not TAF1, can cause a range of symptoms, including heart problems, growth delays, and immune system abnormalities in Barth syndrome.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-7b_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that plays a role in various cellular processes, including cell division, mitosis, and the regulation of gene expression. Phosphorylation of specific residues on substrate proteins by CK1 is an important mechanism for its regulation and function. Here are some of the phosphorylation consensus motifs for CK1:\n1. S/T-X-X-X-R: This motif is found in many substrates of CK1 and is recognized by the CK1 catalytic subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n2. S/T-X-X-X-X-R: This motif is similar to the first one, but includes an additional phosphate group.\n3. S/T-X-X-X-X-X-R: This motif is also found in many substrates of CK1 and is recognized by the CK1 regulatory subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n4. S/T-X-X-X-X-X-X-R: This motif is similar to the third one, but includes an additional phosphate group.\nIt's important to note that these are not the only consensus motifs recognized by CK1, and different substrates may have different motifs recognized by the kinase. Additionally, the specific residues that are phosphorylated by CK1 can vary depending on the substrate and the cellular context in which CK1 is acting.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Casein Kinase 1 (CK1) is a serine/threonine protein kinase.\n2. CK1 plays a role in cell division, mitosis, and the regulation of gene expression.\n3. CK1 phosphorylates specific residues on substrate proteins.\n4. Some of the phosphorylation consensus motifs for CK1 include: S/T-X-X-X-R, S/T-X-X-X-X-R, S/T-X-X-X-X-X-R, and S/T-X-X-X-X-X-X-R.\n5. The specific residues that are phosphorylated by CK1 can vary depending on the substrate and the cellular context in which CK1 is acting.",
    "vicuna-7b_fact": [
      "Casein Kinase 1 (CK1) is a serine/threonine protein kinase.",
      "CK1 plays a role in cell division, mitosis, and the regulation of gene expression.",
      "CK1 phosphorylates specific residues on substrate proteins.",
      "Some of the phosphorylation consensus motifs for CK1 include: S/T-X-X-X-R, S/T-X-X-X-X-R, S/T-X-X-X-X-X-R, and S/T-X-X-X-X-X-X-R.",
      "The specific residues that are phosphorylated by CK1 can vary depending on the substrate and the cellular context in which CK1 is acting."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 273,
    "user_query": "What is the Barr body?",
    "vicuna-7b_response": "The Barr body is a structure found in the cytoplasm of certain cells, particularly in the red blood cells of mammals. It is named after the German physician and histologist, Theodor Barr, who first described it in the late 19th century.\nThe Barr body is composed of a group of specialized organelles called nucleoli, which are involved in the production of ribosomes, the small structures inside cells that are responsible for protein synthesis. The nucleoli in the Barr body are larger and more complex than those found in other parts of the cell, and they contain a higher concentration of ribosomal RNA.\nThe Barr body is typically found in the cytoplasm of erythrocytes (red blood cells) and is not present in other types of cells. It is thought to play a role in the development and differentiation of erythrocytes, as well as in the regulation of ribosomal RNA synthesis.\nOverall, the Barr body is an important structure in the study of cell biology and has implications for our understanding of the development and function of certain types of cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Barr body is a structure found in the cytoplasm of certain cells, particularly in the red blood cells of mammals. \n2. The Barr body is named after the German physician and histologist, Theodor Barr, who first described it in the late 19th century.\n3. The Barr body is composed of a group of specialized organelles called nucleoli, involved in the production of ribosomes. \n4. Nucleoli in the Barr body are larger and more complex than those found in other parts of the cell, and they contain a higher concentration of ribosomal RNA.\n5. The Barr body is thought to play a role in the development and differentiation of erythrocytes, as well as in the regulation of ribosomal RNA synthesis.",
    "vicuna-7b_fact": [
      "The Barr body is a structure found in the cytoplasm of certain cells, particularly in the red blood cells of mammals.",
      "The Barr body is named after the German physician and histologist, Theodor Barr, who first described it in the late 19th century.",
      "The Barr body is composed of a group of specialized organelles called nucleoli, involved in the production of ribosomes.",
      "Nucleoli in the Barr body are larger and more complex than those found in other parts of the cell, and they contain a higher concentration of ribosomal RNA.",
      "The Barr body is thought to play a role in the development and differentiation of erythrocytes, as well as in the regulation of ribosomal RNA synthesis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Barr body is not a structure found in the cytoplasm, but rather, it is an inactivated X chromosome in the nuclei of female somatic cells.\n2. FALSE [correction]: The Barr body is named after Murray Barr, a Canadian physician, who co-discovered it with E.G. Bertram in the mid 20th century.\n3. FALSE [correction]: The Barr body is not composed of nucleoli. It's an inactivated X chromosome and does not participate directly in ribosome production.\n4. FALSE [correction]: As the Barr body is an inactivated X chromosome and not composed of nucleoli, they do not contain a higher concentration of ribosomal RNA.\n5. FALSE [correction]: The Barr Body doesn't play a direct role in the development and differentiation of erythrocytes or in the regulation of ribosomal RNA synthesis. Instead, it helps ensure dosage compensation between the sexes in mammals, by inactivating one X chromosome in female cells.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 275,
    "user_query": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?",
    "vicuna-7b_response": "Shotgun lipidomics is a mass spectrometry-based approach that involves the direct infusion of a lipid sample into a mass spectrometer. The term \"shotgun\" refers to the fact that the sample is not separated prior to analysis, but rather analyzed directly. This approach allows for the simultaneous analysis of a wide range of lipids, including both hydrophobic and hydrophilic lipids, and has become a popular method for studying lipid metabolism and lipid-related diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Shotgun lipidomics is a mass spectrometry-based approach.\n2. In shotgun lipidomics, a lipid sample is directly infused into a mass spectrometer.\n3. The term \"shotgun\" refers to the fact that the sample is not separated prior to analysis.\n4. Shotgun lipidomics allows for the simultaneous analysis of a wide range of lipids, including both hydrophobic and hydrophilic lipids.\n5. Shotgun lipidomics has become a popular method for studying lipid metabolism and lipid-related diseases.",
    "vicuna-7b_fact": [
      "Shotgun lipidomics is a mass spectrometry-based approach.",
      "In shotgun lipidomics, a lipid sample is directly infused into a mass spectrometer.",
      "The term \"shotgun\" refers to the fact that the sample is not separated prior to analysis.",
      "Shotgun lipidomics allows for the simultaneous analysis of a wide range of lipids, including both hydrophobic and hydrophilic lipids.",
      "Shotgun lipidomics has become a popular method for studying lipid metabolism and lipid-related diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 283,
    "user_query": "List functions that are evaluated with the Full Outline of Unresponsiveness score?",
    "vicuna-7b_response": "The Full Outline of Unresponsiveness (FOU) score is a measure of the degree of unresponsiveness in a patient. It is a standardized score that is used to assess the level of consciousness in a patient and is calculated based on the patient's response to stimuli. The FOU score is based on the patient's ability to follow commands, respond to pain, and show reflexes.\nThe following are some of the functions that are evaluated with the FOU score:\n1. Level of consciousness: The FOU score is used to assess the level of consciousness in a patient. The score ranges from 3 to 15, with higher scores indicating a higher level of consciousness.\n2. Pupillary response: The FOU score also evaluates the patient's pupillary response to light. A normal pupillary response is a constriction of the pupil in response to light.\n3. Response to pain: The FOU score evaluates the patient's response to pain by assessing their ability to withdraw their limb from a source of pain.\n4. Reflexes: The FOU score evaluates the patient's reflexes by assessing their ability to respond to stimuli such as touch, sound, and sight.\n5. Verbal response: The FOU score evaluates the patient's verbal response to commands, such as their ability to follow simple commands.\n6. Motor response: The FOU score evaluates the patient's motor response to commands, such as their ability to perform simple movements.\nIt is important to note that the FOU score is not a diagnostic tool and should not be used to diagnose a specific condition. It is used as a tool to assess the level of consciousness in a patient and to guide further evaluation and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Full Outline of Unresponsiveness (FOU) score is a measure of the degree of unresponsiveness in a patient.\n2. The FOU score is used to assess the level of consciousness in a patient and ranges from 3 to 15.\n3. The FOU score evaluates the patient's pupillary response to light.\n4. The FOU score assesses the patient's ability to withdraw their limb from a source of pain.\n5. The FOU score evaluates the patient's ability to respond to stimuli such as touch, sound, and sight.\n",
    "vicuna-7b_fact": [
      "The Full Outline of Unresponsiveness (FOU) score is a measure of the degree of unresponsiveness in a patient.",
      "The FOU score is used to assess the level of consciousness in a patient and ranges from 3 to 15.",
      "The FOU score evaluates the patient's pupillary response to light.",
      "The FOU score assesses the patient's ability to withdraw their limb from a source of pain.",
      "The FOU score evaluates the patient's ability to respond to stimuli such as touch, sound, and sight."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in a patient and ranges from 3 to 15, not the FOU score.\n3. FALSE [correction]: The Glasgow Coma Scale (GCS), not the FOU score, evaluates the patient's pupillary response to light.\n4. FALSE [correction]: The Glasgow Coma Scale (GCS), not the FOU score, assesses the patient's ability to withdraw their limb from a source of pain.\n5. FALSE [correction]: The Glasgow Coma Scale (GCS), not the FOU score, evaluates the patient's ability to respond to stimuli such as touch, sound, and sight.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 285,
    "user_query": "Is ospemifene effective for treatment of dyspareunia?",
    "vicuna-7b_response": "Ospemifene is a medication that is commonly used to treat symptoms of vulvar and vaginal atrophy, including dyspareunia, in postmenopausal women.\nDyspareunia is a common symptom of vulvar and vaginal atrophy, which is a condition that occurs due to a decrease in estrogen levels after menopause. Ospemifene works by increasing the levels of estrogen in the body, which helps to alleviate the symptoms of vulvar and vaginal atrophy, including dyspareunia.\nStudies have shown that ospemifene is effective in treating dyspareunia caused by vulvar and vaginal atrophy. A study published in the Journal of Women's Health Physical Therapy found that ospemifene was effective in improving sexual function and reducing symptoms of dyspareunia in postmenopausal women.\nIt is important to note that ospemifene is not approved for the treatment of dyspareunia in premenopausal women. It is also not recommended for women with a history of breast cancer or other specific medical conditions.\nIn conclusion, ospemifene is an effective medication for the treatment of dyspareunia caused by vulvar and vaginal atrophy in postmenopausal women. However, it is important to consult with a healthcare provider before starting treatment with ospemifene to determine if it is the right treatment option for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ospemifene is a medication used to treat symptoms of vulvar and vaginal atrophy, including dyspareunia, in postmenopausal women.\n2. Dyspareunia is a common symptom of vulvar and vaginal atrophy which occurs due to a decrease in estrogen levels after menopause.\n3. A study published in the Journal of Women's Health Physical Therapy found that ospemifene was effective in improving sexual function and reducing symptoms of dyspareunia in postmenopausal women.\n4. Ospemifene is not approved for the treatment of dyspareunia in premenopausal women.\n5. Ospemifene is not recommended for women with a history of breast cancer or other specific medical conditions.",
    "vicuna-7b_fact": [
      "Ospemifene is a medication used to treat symptoms of vulvar and vaginal atrophy, including dyspareunia, in postmenopausal women.",
      "Dyspareunia is a common symptom of vulvar and vaginal atrophy which occurs due to a decrease in estrogen levels after menopause.",
      "A study published in the Journal of Women's Health Physical Therapy found that ospemifene was effective in improving sexual function and reducing symptoms of dyspareunia in postmenopausal women.",
      "Ospemifene is not approved for the treatment of dyspareunia in premenopausal women.",
      "Ospemifene is not recommended for women with a history of breast cancer or other specific medical conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 287,
    "user_query": "What is the biological role of expansins in fungi?",
    "vicuna-7b_response": "Expansins are a family of proteins that are found in many organisms, including fungi. In fungi, expansins play a crucial role in the growth and development of the organism.\nExpansins are responsible for the expansion of the cell wall, which is the rigid structure that surrounds and supports the cell. They do this by breaking down the bonds between the polymers that make up the cell wall, allowing it to expand and grow.\nIn fungi, expansins are particularly important for the growth of hyphae, which are long, branching structures that make up the mycelium, the vegetative part of the fungus. Hyphae are constantly growing and branching, and expansins are necessary for the expansion of the cell wall as the hyphae grow.\nExpansins also play a role in the response of fungi to environmental stress. For example, when a fungus is exposed to dry conditions, expansins can help to maintain the integrity of the cell wall by preventing it from breaking down too quickly.\nOverall, expansins are an important family of proteins in fungi, playing a crucial role in the growth, development, and response of the organism to its environment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Expansins are a family of proteins found in many organisms, including fungi.\n2. In fungi, expansins are responsible for the expansion of the cell wall.\n3. Expansins break down the bonds between the polymers that make up the cell wall, allowing it to expand and grow.\n4. Expansins are particularly important for the growth of hyphae in fungi, which are long, branching structures that make up the mycelium.\n5. Expansins can help to maintain the integrity of the fungal cell wall when exposed to dry conditions.",
    "vicuna-7b_fact": [
      "Expansins are a family of proteins found in many organisms, including fungi.",
      "In fungi, expansins are responsible for the expansion of the cell wall.",
      "Expansins break down the bonds between the polymers that make up the cell wall, allowing it to expand and grow.",
      "Expansins are particularly important for the growth of hyphae in fungi, which are long, branching structures that make up the mycelium.",
      "Expansins can help to maintain the integrity of the fungal cell wall when exposed to dry conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 301,
    "user_query": "Which oncogenes are able to induce cellular senescence?",
    "vicuna-7b_response": "Oncogenes are genes that have the potential to cause cancer when they are mutated or overexpressed. Some oncogenes are able to induce cellular senescence, which is a mechanism by which cells stop dividing and undergo cellular aging in response to stress or DNA damage.\nOne example of an oncogene that can induce cellular senescence is the Myc oncogene. Myc is a transcription factor that plays a crucial role in regulating cell growth and division. When Myc is overexpressed or mutated, it can cause cells to enter into a state of cellular senescence, which can prevent the growth and proliferation of tumors.\nAnother example of an oncogene that can induce cellular senescence is the Ras oncogene. Ras is a small GTPase protein that plays a key role in signaling pathways that regulate cell growth and division. When Ras is mutated or overexpressed, it can cause cells to enter into a state of cellular senescence, which can prevent the growth and proliferation of tumors.\nOther oncogenes that have been shown to induce cellular senescence include the Bcl-2 oncogene, the Akt oncogene, and the EGFR oncogene.\nIt's important to note that while oncogenes can induce cellular senescence, this is not the only mechanism by which oncogenes can cause cancer. Oncogenes can also cause cancer by promoting cell division and proliferation, or by inhibiting programmed cell death (apoptosis).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oncogenes are genes that can potentially cause cancer when mutated or overexpressed.\n2. Some oncogenes, like the Myc and Ras oncogenes, can induce cellular senescence.\n3. Cellular senescence is a state where cells stop dividing and undergo cellular aging due to stress or DNA damage.\n4. The Bcl-2, Akt, and EGFR oncogenes have also been shown to induce cellular senescence.\n5. Besides inducing cellular senescence, oncogenes can also cause cancer by promoting cell division and proliferation, or by inhibiting programmed cell death (apoptosis).",
    "vicuna-7b_fact": [
      "Oncogenes are genes that can potentially cause cancer when mutated or overexpressed.",
      "Some oncogenes, like the Myc and Ras oncogenes, can induce cellular senescence.",
      "Cellular senescence is a state where cells stop dividing and undergo cellular aging due to stress or DNA damage.",
      "The Bcl-2, Akt, and EGFR oncogenes have also been shown to induce cellular senescence.",
      "Besides inducing cellular senescence, oncogenes can also cause cancer by promoting cell division and proliferation, or by inhibiting programmed cell death (apoptosis)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-7b_response": "The ASPH gene, also known as the GATase gene, encodes for the aspartate beta-hydroxylase enzyme. This enzyme is involved in the metabolism of l-aspartate, a non-essential amino acid, and is responsible for the first step in the metabolism of aspartate in the urea cycle.\nThere are two main isoforms of the ASPH enzyme, which are produced by alternative splicing of the ASPH gene:\n1. Aspartate beta-hydroxylase (E1) isoform: This isoform is responsible for the first step in the metabolism of aspartate, which is the conversion of l-aspartate to aspartate.\n2. Aspartate beta-hydroxylase (E2) isoform: This isoform is responsible for the conversion of aspartate to N-acetylaspartate.\nBoth of these isoforms are expressed in the liver, kidney, and brain, and are involved in the metabolism of l-aspartate. The E1 isoform is responsible for the majority of the aspartate metabolism in the body, while the E2 isoform is responsible for the conversion of aspartate to N-acetylaspartate, which is then further metabolized in the urea cycle.\nIt is important to note that there are other genes that are involved in the metabolism of aspartate, such as the GAD genes (glutamate decarboxylase) and the GLA genes (glutamate-oxaloacetate transaminase), which are also involved in the urea cycle.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.\n2. The aspartate beta-hydroxylase enzyme plays a role in the metabolism of l-aspartate, a non-essential amino acid.\n3. There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.\n4. Both the E1 and E2 isoforms of the ASPH enzyme are expressed in the liver, kidney, and brain.\n5. The E1 isoform is responsible for the majority of the aspartate metabolism in the body, while the E2 isoform is responsible for the conversion of aspartate to N-acetylaspartate.",
    "vicuna-7b_fact": [
      "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.",
      "The aspartate beta-hydroxylase enzyme plays a role in the metabolism of l-aspartate, a non-essential amino acid.",
      "There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.",
      "Both the E1 and E2 isoforms of the ASPH enzyme are expressed in the liver, kidney, and brain.",
      "The E1 isoform is responsible for the majority of the aspartate metabolism in the body, while the E2 isoform is responsible for the conversion of aspartate to N-acetylaspartate."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 310,
    "user_query": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"",
    "vicuna-7b_response": "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the chi-squared test. The chi-squared test is a statistical test that compares the observed frequencies of a categorical variable with the expected frequencies under a null hypothesis. In the context of genomic signatures, the observed frequencies are the relative abundances of different dinucleotides in a sample, and the expected frequencies are the frequencies that would be expected if the sample were drawn from a null hypothesis population. The chi-squared test calculates a test statistic that measures the difference between the observed and expected frequencies, and then compares this value to a critical value to determine whether the null hypothesis can be rejected. If the test statistic is greater than the critical value, then the null hypothesis can be rejected, indicating that the observed frequencies are significantly different from the expected frequencies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the chi-squared test.\n2. The chi-squared test is a statistical test that compares the observed frequencies of a categorical variable with the expected frequencies under a null hypothesis.\n3. In the context of genomic signatures, the observed frequencies are the relative abundances of different dinucleotides in a sample.\n4. The expected frequencies are the frequencies that would be expected if the sample were drawn from a null hypothesis population.\n5. If the test statistic of a chi-squared test is greater than the critical value, the null hypothesis can be rejected.",
    "vicuna-7b_fact": [
      "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the chi-squared test.",
      "The chi-squared test is a statistical test that compares the observed frequencies of a categorical variable with the expected frequencies under a null hypothesis.",
      "In the context of genomic signatures, the observed frequencies are the relative abundances of different dinucleotides in a sample.",
      "The expected frequencies are the frequencies that would be expected if the sample were drawn from a null hypothesis population.",
      "If the test statistic of a chi-squared test is greater than the critical value, the null hypothesis can be rejected."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 312,
    "user_query": "Why do we use \"N-terminal proteomics\"?",
    "vicuna-7b_response": "N-terminal proteomics refers to the study of proteins based on their N-terminal amino acid residues. This approach is used to identify and quantify proteins in a sample, as well as to determine their post-translational modifications and localization within a cell or organism.\nThe N-terminus of a protein is the end that is attached to the ribosome during translation, and it contains important information about the protein's function and structure. By analyzing the N-terminal amino acids of a protein, researchers can gain insights into the protein's origin, processing, and modification.\nN-terminal proteomics can be used in a variety of applications, such as identifying proteins in complex samples, studying protein evolution and function, and understanding the regulation of protein expression. It can also be used to detect and quantify proteins that are modified or cleaved, which can provide valuable information about their biological roles and functions.\nOverall, N-terminal proteomics is a powerful tool for understanding the complexity of protein biology and has many potential applications in fields such as biomedicine, agriculture, and environmental science.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. N-terminal proteomics refers to the study of proteins based on their N-terminal amino acid residues.\n2. The N-terminus of a protein is the end that is attached to the ribosome during translation.\n3. N-terminal proteomics can be used to identify and quantify proteins in a sample, as well as to determine their post-translational modifications and localization within a cell or organism.\n4. N-terminal proteomics can be used in a variety of applications like studying protein evolution and function, and understanding the regulation of protein expression.\n5. N-terminal proteomics has potential applications in fields such as biomedicine, agriculture, and environmental science.",
    "vicuna-7b_fact": [
      "N-terminal proteomics refers to the study of proteins based on their N-terminal amino acid residues.",
      "The N-terminus of a protein is the end that is attached to the ribosome during translation.",
      "N-terminal proteomics can be used to identify and quantify proteins in a sample, as well as to determine their post-translational modifications and localization within a cell or organism.",
      "N-terminal proteomics can be used in a variety of applications like studying protein evolution and function, and understanding the regulation of protein expression.",
      "N-terminal proteomics has potential applications in fields such as biomedicine, agriculture, and environmental science."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The N-terminus of a protein is the end that is released from the ribosome during translation.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 317,
    "user_query": "Have mutations in the Polycomb group been found in human diseases?",
    "vicuna-7b_response": "Yes, mutations in the Polycomb group (Pcg) genes have been found to be associated with various human diseases. The Pcg genes are a family of genes that play a crucial role in the regulation of gene expression during development and in the maintenance of cell identity.\nMutations in Pcg genes have been linked to a variety of human diseases, including cancer, developmental disorders, and genetic disorders. For example, mutations in the Pcg gene BMI1 have been found to be associated with the development of acute myeloid leukemia (AML), a type of blood cancer. Similarly, mutations in the Pcg gene EZH2 have been linked to the development of prostate cancer and other types of cancer.\nIn addition to cancer, mutations in Pcg genes have also been found to be associated with developmental disorders such as Angelman syndrome and Prader-Willi syndrome. These disorders are characterized by developmental delays, intellectual disability, and other symptoms.\nOverall, mutations in Pcg genes have been found to be associated with a wide range of human diseases, highlighting the important role that these genes play in regulating cellular processes and maintaining health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mutations in the Polycomb group (Pcg) genes have been linked to various human diseases.\n2. Pcg genes play a crucial role in the regulation of gene expression during development and in the maintenance of cell identity.\n3. Mutations in the Pcg gene BMI1 have been found to be associated with the development of acute myeloid leukemia.\n4. Mutations in the Pcg gene EZH2 have been linked to the development of prostate cancer and other types of cancer.\n5. Mutations in Pcg genes have also been associated with developmental disorders such as Angelman syndrome and Prader-Willi syndrome.",
    "vicuna-7b_fact": [
      "Mutations in the Polycomb group (Pcg) genes have been linked to various human diseases.",
      "Pcg genes play a crucial role in the regulation of gene expression during development and in the maintenance of cell identity.",
      "Mutations in the Pcg gene BMI1 have been found to be associated with the development of acute myeloid leukemia.",
      "Mutations in the Pcg gene EZH2 have been linked to the development of prostate cancer and other types of cancer.",
      "Mutations in Pcg genes have also been associated with developmental disorders such as Angelman syndrome and Prader-Willi syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in genes on chromosome 15 have been associated with developmental disorders such as Angelman syndrome and Prader-Willi syndrome, not Pcg genes.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 318,
    "user_query": "Describe the mechanism of action of drisapersen",
    "vicuna-7b_response": "Drisapersen is a medication that is used to treat a genetic disorder called Duchenne muscular dystrophy (DMD). DMD is a rare, inherited disorder that affects muscle strength and function. It is caused by a deficiency of dystrophin, a protein that is essential for maintaining the structure and function of muscles.\nDrisapersen works by targeting the underlying cause of DMD by restoring the production of dystrophin. It does this by inhibiting the activity of an enzyme called exon-skipping, which is responsible for skipping over certain genetic errors that cause the production of a non-functional dystrophin protein. By inhibiting exon-skipping, drisapersen allows for the production of a functional dystrophin protein, which helps to maintain the structure and function of muscles.\nIn addition to its mechanism of action, drisapersen is also unique in that it is the first medication to target the underlying cause of DMD. It has been shown to improve muscle function and delay the progression of the disease in patients with DMD.\nOverall, drisapersen is a promising treatment for DMD that works by restoring the production of dystrophin and targeting the underlying cause of the disorder.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Drisapersen is a medication used to treat the genetic disorder Duchenne muscular dystrophy (DMD).\n2. Duchenne muscular dystrophy (DMD) is an inherited disorder that affects muscle strength and function due to a deficiency of the protein dystrophin.\n3. Drisapersen works by restoring the production of dystrophin, maintaining the structure and function of muscles.\n4. Drisapersen inhibits the activity of an enzyme called exon-skipping, which skips over certain genetic errors causing non-functional dystrophin protein production.\n5. Drisapersen is the first medication to target the underlying cause of DMD.",
    "vicuna-7b_fact": [
      "Drisapersen is a medication used to treat the genetic disorder Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy (DMD) is an inherited disorder that affects muscle strength and function due to a deficiency of the protein dystrophin.",
      "Drisapersen works by restoring the production of dystrophin, maintaining the structure and function of muscles.",
      "Drisapersen inhibits the activity of an enzyme called exon-skipping, which skips over certain genetic errors causing non-functional dystrophin protein production.",
      "Drisapersen is the first medication to target the underlying cause of DMD."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 325,
    "user_query": "How does ranolazine affect calcium handling in the heart",
    "vicuna-7b_response": "Ranolazine is a medication that is primarily used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. Ranolazine works by blocking the late sodium current in the heart, which helps to reduce the amount of calcium that enters the heart cells during each beat. This reduction in calcium influx can help to reduce the workload on the heart and improve blood flow to the heart muscle.\nIn addition to its use in angina, ranolazine has also been studied for its potential effects on the heart in other contexts. For example, some studies have suggested that ranolazine may have anti-fibrotic effects, which could potentially help to reduce the scarring and thickening of heart tissue that can occur following a heart attack. Ranolazine has also been studied for its potential effects on atrial fibrillation, a common heart rhythm disorder.\nOverall, while more research is needed to fully understand the effects of ranolazine on calcium handling in the heart, the available evidence suggests that ranolazine may have beneficial effects on heart function and blood flow. However, as with any medication, it is important to consult with a healthcare professional before starting ranolazine or any other medication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ranolazine is a medication primarily used to treat angina.\n2. Angina is a condition characterized by chest pain due to reduced blood flow to the heart muscle.\n3. Ranolazine works by blocking the late sodium current in the heart, this reduces the amount of calcium that enters the heart cells during each beat.\n4. Ranolazine has been studied for its potential anti-fibrotic effects and possible impact on atrial fibrillation.\n5. It is important to consult with a healthcare professional before starting ranolazine or any other medication.",
    "vicuna-7b_fact": [
      "Ranolazine is a medication primarily used to treat angina.",
      "Angina is a condition characterized by chest pain due to reduced blood flow to the heart muscle.",
      "Ranolazine works by blocking the late sodium current in the heart, this reduces the amount of calcium that enters the heart cells during each beat.",
      "Ranolazine has been studied for its potential anti-fibrotic effects and possible impact on atrial fibrillation.",
      "It is important to consult with a healthcare professional before starting ranolazine or any other medication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 326,
    "user_query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "vicuna-7b_response": "The Reverse Warburg effect and the conventional Warburg effect are two distinct phenomena that describe different aspects of cellular metabolism.\nThe conventional Warburg effect, also known as the aerobic glycolysis, describes the metabolic pathway that occurs in most cells when they are exposed to oxygen. In this pathway, glucose is converted into pyruvate through a series of reactions that generate ATP and other energy-rich molecules. The conventional Warburg effect is characterized by the preferential use of glucose as a primary energy source, with the production of lactate as a byproduct.\nThe Reverse Warburg effect, on the other hand, describes a metabolic pathway that occurs in some cancer cells when they are deprived of oxygen. In this pathway, the cells rely on the anaerobic breakdown of glucose to generate energy and other metabolites, rather than relying on oxygen-dependent metabolism. The Reverse Warburg effect is characterized by the production of lactate as a primary energy source, with the production of other metabolites as a byproduct.\nThe primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the availability of oxygen. In the conventional Warburg effect, oxygen is available and is used as the primary source of energy, while in the Reverse Warburg effect, oxygen is not available and the cells rely on anaerobic metabolism. Additionally, the Reverse Warburg effect is often associated with the aggressive behavior of cancer cells, as it allows them to survive and proliferate in the absence of oxygen.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The conventional Warburg effect describes the metabolic pathway that occurs in most cells when exposed to oxygen.\n2. The conventional Warburg effect brings about the conversion of glucose into pyruvate, generating ATP and other energy-rich molecules.\n3. The Reverse Warburg effect describes a metabolic pathway that occurs in some cancer cells when they are deprived of oxygen.\n4. The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the availability of oxygen.\n5. The Reverse Warburg effect is often associated with the aggressive behavior of cancer cells.",
    "vicuna-7b_fact": [
      "The conventional Warburg effect describes the metabolic pathway that occurs in most cells when exposed to oxygen.",
      "The conventional Warburg effect brings about the conversion of glucose into pyruvate, generating ATP and other energy-rich molecules.",
      "The Reverse Warburg effect describes a metabolic pathway that occurs in some cancer cells when they are deprived of oxygen.",
      "The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the availability of oxygen.",
      "The Reverse Warburg effect is often associated with the aggressive behavior of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The conventional Warburg effect describes the metabolic pathway that occurs in most cancer cells, even when enough oxygen is present for normal cellular functions.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 327,
    "user_query": "What is the role of per genes in circadian rhythm control?",
    "vicuna-7b_response": "Per genes play a crucial role in the regulation of circadian rhythm, which is the internal biological clock that controls the daily fluctuation of physiological processes in living organisms. The circadian rhythm is regulated by a complex network of genes, proteins, and signaling pathways, and Per genes are one of the key components of this network.\nPer genes are members of the PER (short for \"period\") family of genes, which encode a group of proteins that play a central role in the regulation of circadian rhythm. The PER proteins are produced in the cytoplasm of cells and are transported to the nucleus, where they bind to the DNA and regulate the expression of other genes involved in the circadian rhythm.\nThe PER proteins are involved in the negative feedback loop that regulates the circadian rhythm. The loop is activated when the PER proteins bind to the DNA and repress the transcription of the genes involved in the circadian rhythm. As the day progresses, the PER proteins are degraded by the proteasome, which allows the transcription of the genes involved in the circadian rhythm to be activated. This leads to an increase in the production of the PER proteins, which in turn represses the transcription of the genes involved in the circadian rhythm, and the cycle repeats.\nIn summary, Per genes play a crucial role in the regulation of circadian rhythm by participating in the negative feedback loop that regulates the expression of genes involved in the circadian rhythm. The PER proteins produced by the Per genes bind to the DNA and regulate the transcription of other genes involved in the circadian rhythm, which helps to maintain the daily fluctuation of physiological processes in living organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Per genes regulate the circadian rhythm, the internal biological clock that controls the daily fluctuation of physiological processes in organisms.\n2. Per genes are part of the PER family of genes that encode a group of proteins central to the regulation of circadian rhythm.\n3. The PER proteins are produced in the cytoplasm of cells and are transported to the nucleus, where they bind to the DNA and regulate the expression of other genes involved in the circadian rhythm.\n4. PER proteins are involved in the negative feedback loop that influences the circadian rhythm.\n5. The cycle involving PER proteins' binding, repression, and degradation regulates the expression of genes involved in the circadian rhythm.",
    "vicuna-7b_fact": [
      "Per genes regulate the circadian rhythm, the internal biological clock that controls the daily fluctuation of physiological processes in organisms.",
      "Per genes are part of the PER family of genes that encode a group of proteins central to the regulation of circadian rhythm.",
      "The PER proteins are produced in the cytoplasm of cells and are transported to the nucleus, where they bind to the DNA and regulate the expression of other genes involved in the circadian rhythm.",
      "PER proteins are involved in the negative feedback loop that influences the circadian rhythm.",
      "The cycle involving PER proteins' binding, repression, and degradation regulates the expression of genes involved in the circadian rhythm."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-7b_response": "Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014 for the treatment of type 2 diabetes. It is marketed under the brand name Jardiance and is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Empagliflozin works by helping the kidneys remove sugar from the body, which can help lower blood sugar levels in people with type 2 diabetes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Empagliflozin was approved by the US Food and Drug Administration in 2014.\n2. The medication is used for the treatment of type 2 diabetes.\n3. Empagliflozin is marketed under the brand name Jardiance.\n4. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n5. Empagliflozin works by helping the kidneys remove sugar from the body.",
    "vicuna-7b_fact": [
      "Empagliflozin was approved by the US Food and Drug Administration in 2014.",
      "The medication is used for the treatment of type 2 diabetes.",
      "Empagliflozin is marketed under the brand name Jardiance.",
      "Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Empagliflozin works by helping the kidneys remove sugar from the body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 331,
    "user_query": "Which R/bioconductor package is used for integrative genomics visualizations?",
    "vicuna-7b_response": "The R/bioconductor package used for integrative genomics visualizations is called \"Integrative Genomics Viewer\" (IGV).",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The \"Integrative Genomics Viewer\" (IGV) is an R/bioconductor package used for integrative genomics visualizations.",
    "vicuna-7b_fact": [
      "The \"Integrative Genomics Viewer\" (IGV) is an R/bioconductor package used for integrative genomics visualizations."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The \"Integrative Genomics Viewer\" (IGV) is a high-performance visualization tool for interactive exploration of large, integrated genomic datasets. It is not specifically an R/bioconductor package.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 333,
    "user_query": "How many genes are imprinted in the human genome?",
    "vicuna-7b_response": "Imprinting is a process by which a specific region of the genome is differentially methylated on one of the two copies of the genome, resulting in the silencing of the corresponding gene. Imprinting is a form of genomic imprinting, which is a type of epigenetic regulation that occurs when a specific region of the genome is differentially methylated on one of the two copies of the genome, resulting in the silencing of the corresponding gene.\nImprinting is a process that occurs in the human genome, and it is involved in the regulation of gene expression during development. Imprinted genes are genes that are imprinted, which means that they are expressed from only one of the two copies of the genome. Imprinted genes are typically found on chromosomes 11 and 14, and they are involved in the regulation of various developmental processes, such as fetal growth and organ development.\nThere are several types of imprinted genes, including maternally imprinted genes, which are expressed from the maternal copy of the genome, and paternally imprinted genes, which are expressed from the paternal copy of the genome. Imprinted genes can also be monoallelic, meaning that they are expressed from only one copy of the genome, or biallelic, meaning that they are expressed from both copies of the genome.\nIn summary, imprinting is a process that occurs in the human genome, and it is involved in the regulation of gene expression during development. Imprinted genes are genes that are imprinted, which means that they are expressed from only one of the two copies of the genome. Imprinted genes are typically found on chromosomes 11 and 14, and they are involved in the regulation of various developmental processes, such as fetal growth and organ development.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Imprinting is a process by which a specific region of the genome is differentially methylated on one of the two copies of the genome, causing the silencing of the corresponding gene.\n2. Imprinting is a form of genomic imprinting, which is a type of epigenetic regulation.\n3. Imprinted genes are expressed from only one of the two copies of the genome.\n4. Imprinted genes are typically found on chromosomes 11 and 14, and are involved in the regulation of various developmental processes, such as fetal growth and organ development.\n5. There are maternally imprinted genes, expressed from the maternal copy of the genome, and paternally imprinted genes, expressed from the paternal copy of the genome.",
    "vicuna-7b_fact": [
      "Imprinting is a process by which a specific region of the genome is differentially methylated on one of the two copies of the genome, causing the silencing of the corresponding gene.",
      "Imprinting is a form of genomic imprinting, which is a type of epigenetic regulation.",
      "Imprinted genes are expressed from only one of the two copies of the genome.",
      "Imprinted genes are typically found on chromosomes 11 and 14, and are involved in the regulation of various developmental processes, such as fetal growth and organ development.",
      "There are maternally imprinted genes, expressed from the maternal copy of the genome, and paternally imprinted genes, expressed from the paternal copy of the genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Imprinted genes are not necessarily limited to chromosomes 11 and 14, they can be found in various chromosomes.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 336,
    "user_query": "In which cells are A-type lamins expressed?",
    "vicuna-7b_response": "A-type lamins are expressed in the cytoplasm and in the nuclear lamina, a structure that surrounds the nucleus and is composed of intermediate filaments. The A-type lamins are a family of proteins that include lamin A, B, C, and D. Lamin A is the most abundant form of lamin and is expressed in most cell types, while lamin B is expressed in some cell types, such as muscle cells. Lamin C is expressed in testis and placenta, and lamin D is expressed in testis and fetal brain. The expression of lamins can be regulated by various factors, such as cell type, differentiation, and stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A-type lamins are expressed in the cytoplasm and in the nuclear lamina.\n2. The A-type lamins are a family of proteins that include lamin A, B, C, and D.\n3. Lamin A is the most abundant form of lamin and is expressed in most cell types.\n4. Lamin B is expressed in some cell types, such as muscle cells.\n5. Lamin C is expressed in testis and placenta, and lamin D is expressed in testis and fetal brain.",
    "vicuna-7b_fact": [
      "A-type lamins are expressed in the cytoplasm and in the nuclear lamina.",
      "The A-type lamins are a family of proteins that include lamin A, B, C, and D.",
      "Lamin A is the most abundant form of lamin and is expressed in most cell types.",
      "Lamin B is expressed in some cell types, such as muscle cells.",
      "Lamin C is expressed in testis and placenta, and lamin D is expressed in testis and fetal brain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The A-type lamins are a family of proteins that include lamin A and lamin C.\n3. FALSE [correction]: Lamin B is the most abundant form of lamin and is expressed in most cell types.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 338,
    "user_query": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?",
    "vicuna-7b_response": "In prokaryotic organisms, gene silencing can be achieved through a process called \"messenger RNA (mRNA) degradation.\"\nWhen a specific mRNA molecule is recognized as \"unwanted\" or \"unnecessary\" by the cell, it can be degraded by the cell's machinery. This process is similar to RNAi in eukaryotic organisms, in that it involves the degradation of specific mRNA molecules. However, the mechanism by which this process occurs is different from RNAi, as it does not involve the use of small RNA molecules.\nIn summary, the analogous process of gene silencing in prokaryotic organisms is mRNA degradation, which involves the degradation of specific mRNA molecules by the cell's machinery.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms.\n2. In prokaryotic organisms, gene silencing can be achieved through a process called \"messenger RNA (mRNA) degradation.\"\n3. When a specific mRNA molecule is recognized as \"unwanted\" or \"unnecessary\" by the cell, it can be degraded by the cell's machinery.\n4. The process of mRNA degradation in prokaryotes is similar to RNAi in eukaryotic organisms, as it involves the degradation of specific mRNA molecules.\n5. The mechanism by which mRNA degradation occurs in prokaryotes is different from RNAi, as it does not involve the use of small RNA molecules.",
    "vicuna-7b_fact": [
      "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms.",
      "In prokaryotic organisms, gene silencing can be achieved through a process called \"messenger RNA (mRNA) degradation.\"",
      "When a specific mRNA molecule is recognized as \"unwanted\" or \"unnecessary\" by the cell, it can be degraded by the cell's machinery.",
      "The process of mRNA degradation in prokaryotes is similar to RNAi in eukaryotic organisms, as it involves the degradation of specific mRNA molecules.",
      "The mechanism by which mRNA degradation occurs in prokaryotes is different from RNAi, as it does not involve the use of small RNA molecules."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The process of mRNA degradation in prokaryotes is not similar to RNAi in eukaryotic organisms, while both involve the degradation of specific mRNA molecules, the mechanisms by which they achieve this are different.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 339,
    "user_query": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?",
    "vicuna-7b_response": "Mutational biases are introduced between certain types of DNA bases due to directional mutation pressure. These bases include Adenine (A) and Guanine (G), which are the two purine bases, and Thymine (T) and Cytosine (C), which are the two pyrimidine bases.\nDirectional mutation pressure, also known as positive selection, acts on certain traits and genes that are beneficial for the survival and reproduction of an organism. This pressure favors the accumulation of beneficial mutations in the population, which can lead to the fixation of certain alleles.\nIn the case of the DNA bases, the directional mutation pressure can lead to a bias towards the accumulation of certain mutations in one direction, depending on the specific base pair and the effect of the mutation on the function of the gene. For example, in the A-T base pair, a mutation in the A base can lead to a change in the stability of the base pair and can cause a change in the function of the gene. On the other hand, a mutation in the T base has a less significant effect on the stability of the base pair and is less likely to be selected for.\nIn summary, mutational biases are introduced between certain types of DNA bases due to directional mutation pressure, with A-T base pair being an example of such bias.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Directional mutation pressure introduces mutational biases between DNA bases including Adenine (A), Guanine (G), Thymine (T), and Cytosine (C).\n2. Adenine (A) and Guanine (G) are purine bases.\n3. Thymine (T) and Cytosine (C) are pyrimidine bases.\n4. Directional mutation pressure or positive selection acts on certain traits and genes beneficial for an organism's survival and reproduction.\n5. In the A-T base pair, a mutation in the A base can lead to a change in the stability of the base pair and can cause a change in the function of the gene.",
    "vicuna-7b_fact": [
      "Directional mutation pressure introduces mutational biases between DNA bases including Adenine (A), Guanine (G), Thymine (T), and Cytosine (C).",
      "Adenine (A) and Guanine (G) are purine bases.",
      "Thymine (T) and Cytosine (C) are pyrimidine bases.",
      "Directional mutation pressure or positive selection acts on certain traits and genes beneficial for an organism's survival and reproduction.",
      "In the A-T base pair, a mutation in the A base can lead to a change in the stability of the base pair and can cause a change in the function of the gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While it is true that directional mutation pressure can influence the frequency of certain traits and genes, it is actually natural selection, not directional mutation pressure, which specifically acts on traits and genes beneficial for an organism's survival and reproduction.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 340,
    "user_query": "Is it feasible to determine the complete proteome of yeast?",
    "vicuna-7b_response": "Yes, it is feasible to determine the complete proteome of yeast. The proteome of a organism refers to all the proteins produced by that organism. The complete proteome of yeast can be determined by using a combination of techniques such as mass spectrometry, protein microarrays, and bioinformatics.\nOne of the most common methods used to determine the proteome of an organism is mass spectrometry. This technique involves separating proteins by their mass and then identifying them by their mass-to-charge ratio. This method is particularly useful for identifying proteins that are present in low abundance.\nAnother method that can be used to determine the proteome of an organism is protein microarrays. This technique involves labeling a large number of proteins with different fluorescent tags and then using a microarray to detect the presence of these proteins in a sample. This method is useful for identifying proteins that are present in high abundance.\nBioinformatics can also be used to help determine the proteome of an organism. This involves using computer algorithms to analyze large amounts of data, such as gene expression data, to identify the proteins that are produced by an organism.\nIn conclusion, the complete proteome of yeast can be determined by using a combination of techniques such as mass spectrometry, protein microarrays, and bioinformatics.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The proteome of an organism refers to all the proteins produced by that organism.\n2. Mass spectrometry is one of the methods used to determine the proteome of an organism.\n3. Mass spectrometry technique involves separating proteins by their mass and then identifying them by their mass-to-charge ratio.\n4. Protein microarrays can be used to determine the proteome of an organism.\n5. Bioinformatics can be used to help determine the proteome of an organism.",
    "vicuna-7b_fact": [
      "The proteome of an organism refers to all the proteins produced by that organism.",
      "Mass spectrometry is one of the methods used to determine the proteome of an organism.",
      "Mass spectrometry technique involves separating proteins by their mass and then identifying them by their mass-to-charge ratio.",
      "Protein microarrays can be used to determine the proteome of an organism.",
      "Bioinformatics can be used to help determine the proteome of an organism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 346,
    "user_query": "Which is the most common cause of sudden cardiac death in young athletes?",
    "vicuna-7b_response": "Sudden cardiac death (SCD) is a tragic and unpredictable event that can occur in young athletes, particularly those who participate in sports that involve strenuous physical activity and high-intensity exercise. While there are several potential causes of SCD in young athletes, the most common cause is hypertrophic cardiomyopathy (HCM).\nHypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and can cause thickening and stiffening of the heart walls. This can lead to reduced blood flow to the heart and make it harder for the heart to pump blood effectively. As a result, HCM can increase the risk of SCD, particularly during physical activity.\nOther potential causes of SCD in young athletes include coronary artery disease, commotio cordis (a sudden, intense shock to the chest that can cause cardiac arrest), and certain medications or substances that can affect the heart's electrical activity.\nIt's important for young athletes and their families to be aware of the potential risks of SCD and to take steps to reduce their risk, such as getting regular medical check-ups and screenings, avoiding substances that can affect the heart, and following safety guidelines and rules for their sport.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sudden cardiac death (SCD) is unpredictable and can occur in young athletes, particularly those participating in high-intensity sports.\n2. The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy (HCM).\n3. Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle causing thickening and stiffening of the heart walls.\n4. Other potential causes of SCD in young athletes include coronary artery disease, commotio cordis, and certain medications or substances that can affect the heart's electrical activity.\n5. Young athletes and their families can reduce the risk of SCD by getting regular medical check-ups and screenings, avoiding substances affecting the heart, and following safety guidelines for their sport.",
    "vicuna-7b_fact": [
      "Sudden cardiac death (SCD) is unpredictable and can occur in young athletes, particularly those participating in high-intensity sports.",
      "The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy (HCM).",
      "Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle causing thickening and stiffening of the heart walls.",
      "Other potential causes of SCD in young athletes include coronary artery disease, commotio cordis, and certain medications or substances that can affect the heart's electrical activity.",
      "Young athletes and their families can reduce the risk of SCD by getting regular medical check-ups and screenings, avoiding substances affecting the heart, and following safety guidelines for their sport."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 347,
    "user_query": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?",
    "vicuna-7b_response": "The Menzerath-Altmann law, also known as the \"word length law,\" states that the average length of words in a language tends to increase as the language becomes more complex. This law has been observed in many natural languages, and has been used to study the evolution of language.\nIn the context of genomes, the Menzerath-Altmann law could potentially be applied to the length of genes or other functional units within a genome. However, the application of the Menzerath-Altmann law to genomes is not as straightforward as it is in natural languages, due to the complex nature of genetic information and the various factors that influence the length of genes.\nOne potential approach to proving the Menzerath-Altmann law mathematically in genomes would be to use statistical methods to analyze the data. For example, one could compare the average length of genes in different species or strains of a given organism, and look for a pattern that suggests a correlation between complexity and gene length.\nHowever, it is important to note that the Menzerath-Altmann law is a generalization that may not hold true in all cases. There may be factors specific to genomes that could influence the length of genes and prevent the law from being applied in a straightforward manner. Therefore, any attempt to prove the Menzerath-Altmann law mathematically in genomes would need to take these factors into account and be carefully designed to avoid potential biases or limitations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Menzerath-Altmann law, also known as the \"word length law,\" states that the average length of words in a language tends to increase as the language becomes more complex.\n2. The Menzerath-Altmann law has been observed in many natural languages.\n3. The application of the Menzerath-Altmann law to genomes is not as straightforward as it is in natural languages, due to the complex nature of genetic information.\n4. One approach to proving the Menzerath-Altmann law mathematically in genomes is to use statistical methods to analyze data.\n5. The Menzerath-Altmann law is a generalization that may not hold true in all cases.",
    "vicuna-7b_fact": [
      "The Menzerath-Altmann law, also known as the \"word length law,\" states that the average length of words in a language tends to increase as the language becomes more complex.",
      "The Menzerath-Altmann law has been observed in many natural languages.",
      "The application of the Menzerath-Altmann law to genomes is not as straightforward as it is in natural languages, due to the complex nature of genetic information.",
      "One approach to proving the Menzerath-Altmann law mathematically in genomes is to use statistical methods to analyze data.",
      "The Menzerath-Altmann law is a generalization that may not hold true in all cases."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Menzerath-Altmann law, also known as the \"word length law,\" states that the larger the whole, the smaller its constituent parts tend to be. In terms of language, this means the longer a phrase or sentence, the shorter the words in it tend to be on average.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis can result in various negative effects on plant growth and development. Lon1 is a member of the Lon family of proteases, which are enzymes that break down other proteins. In Arabidopsis, Lon1 has been shown to play a role in the degradation of certain proteins involved in stress responses, such as those involved in the heat shock response.\nWhen Lon1 is lost in Arabidopsis, the degradation of these proteins is impaired, leading to an accumulation of these proteins in the cell. This can result in the inhibition of stress responses, leading to increased sensitivity to environmental stressors such as heat, drought, and salt. Additionally, the accumulation of these proteins can also lead to the inhibition of other cellular processes, such as protein synthesis and metabolism, which can further impair plant growth and development.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, making it more susceptible to environmental stressors and impairing its overall health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lon1 is a member of the Lon family of proteases in the plant Arabidopsis.\n2. Lon1 plays a role in the degradation of certain proteins involved in stress responses in Arabidopsis.\n3. When Lon1 is lost in Arabidopsis, the degradation of stress response proteins is impaired.\n4. Loss of Lon1 in Arabidopsis can lead to an accumulation of these undegraded proteins, inhibiting stress responses and increasing plant sensitivity to environmental stressors.\n5. The accumulation of undegraded proteins due to Lon1 loss can inhibit processes like protein synthesis and metabolism, impairing plant growth and development.",
    "vicuna-7b_fact": [
      "Lon1 is a member of the Lon family of proteases in the plant Arabidopsis.",
      "Lon1 plays a role in the degradation of certain proteins involved in stress responses in Arabidopsis.",
      "When Lon1 is lost in Arabidopsis, the degradation of stress response proteins is impaired.",
      "Loss of Lon1 in Arabidopsis can lead to an accumulation of these undegraded proteins, inhibiting stress responses and increasing plant sensitivity to environmental stressors.",
      "The accumulation of undegraded proteins due to Lon1 loss can inhibit processes like protein synthesis and metabolism, impairing plant growth and development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 352,
    "user_query": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?",
    "vicuna-7b_response": "Yes, there have been studies that have investigated the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's disease, Prion's disease, and Cadasil syndrome.\nDown syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21. Studies have shown that individuals with Down syndrome have an increased risk of developing Alzheimer's disease and other forms of dementia, and that this may be related to abnormal functioning of the Notch pathway.\nPick's disease is a progressive neurodegenerative disorder that affects the brain and is characterized by the accumulation of abnormal clumps of a protein called tau. Studies have suggested that mutations in the Notch pathway may contribute to the development of Pick's disease.\nPrion's disease, also known as transmissible spongiform encephalopathy, is a degenerative brain disorder that is caused by the accumulation of abnormal prion protein. Studies have shown that mutations in the Notch pathway may contribute to the development of Prion's disease.\nCadasil syndrome, also known as familial diffuse leucoencephalopathy with spheroids, is a rare genetic disorder that is characterized by the progressive degeneration of the brain. Studies have suggested that mutations in the Notch pathway may contribute to the development of Cadasil syndrome.\nIn summary, Notch mutations have been implicated in the development of several neurodegenerative diseases, including Down syndrome, Pick's disease, Prion's disease, and Cadasil syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Studies have investigated the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's disease, Prion's disease, and Cadasil syndrome.\n2. Down syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21.\n3. Individuals with Down syndrome have an increased risk of developing Alzheimer's disease and other forms of dementia, possibly related to abnormal functioning of the Notch pathway.\n4. Studies suggest that mutations in the Notch pathway may contribute to the development of Pick's disease and Prion's disease.\n5. Cadasil syndrome, a progressive degeneration of the brain, might develop due to mutations in the Notch pathway.",
    "vicuna-7b_fact": [
      "Studies have investigated the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's disease, Prion's disease, and Cadasil syndrome.",
      "Down syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21.",
      "Individuals with Down syndrome have an increased risk of developing Alzheimer's disease and other forms of dementia, possibly related to abnormal functioning of the Notch pathway.",
      "Studies suggest that mutations in the Notch pathway may contribute to the development of Pick's disease and Prion's disease.",
      "Cadasil syndrome, a progressive degeneration of the brain, might develop due to mutations in the Notch pathway."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 353,
    "user_query": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?",
    "vicuna-7b_response": "Yes, there are functional differences between the Mfd protein and its human Cocaine syndrome protein B (CSB) homolog.\nMfd is a protein that is involved in the repair of DNA damage caused by alkylating agents, such as cisplatin. It is a member of the MutL homolog 1 (MLH1) family of proteins, which are involved in the mismatch repair pathway of DNA repair. Mfd is expressed in a wide range of tissues, including the testis, ovary, and small intestine.\nCSB is a protein that is homologous to Mfd, and is also involved in the repair of DNA damage caused by alkylating agents. However, CSB is primarily expressed in the testis and is involved in the mismatch repair pathway of DNA repair.\nOne of the main functional differences between Mfd and CSB is their expression patterns. Mfd is expressed in a wide range of tissues, while CSB is primarily expressed in the testis. Additionally, Mfd is involved in the mismatch repair pathway of DNA repair, while CSB is involved in the mismatch repair pathway of DNA repair.\nAnother functional difference between Mfd and CSB is their role in DNA repair. Mfd is involved in the repair of DNA damage caused by alkylating agents, while CSB is involved in the repair of DNA damage caused by alkylating agents.\nIn summary, Mfd and CSB are homologous proteins that are involved in the repair of DNA damage caused by alkylating agents, but they have different expression patterns and roles in DNA repair.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mfd is a protein involved in the repair of DNA damage caused by alkylating agents, such as cisplatin.\n2. Mfd is a member of the MutL homolog 1 (MLH1) family of proteins.\n3. Mfd is expressed in a wide range of tissues including the testis, ovary and small intestine.\n4. CSB is a protein homologous to Mfd and is also involved in the repair of DNA damage caused by alkylating agents.\n5. CSB is primarily expressed in the testis.",
    "vicuna-7b_fact": [
      "Mfd is a protein involved in the repair of DNA damage caused by alkylating agents, such as cisplatin.",
      "Mfd is a member of the MutL homolog 1 (MLH1) family of proteins.",
      "Mfd is expressed in a wide range of tissues including the testis, ovary and small intestine.",
      "CSB is a protein homologous to Mfd and is also involved in the repair of DNA damage caused by alkylating agents.",
      "CSB is primarily expressed in the testis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mfd is not a member of the MutL homolog 1 (MLH1) family of proteins.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 354,
    "user_query": "What is membrane scission?",
    "vicuna-7b_response": "Membrane scission is a process in which the lipid bilayer of a cell membrane is broken, resulting in the formation of two separate membranes. This process can occur naturally, for example during cell division, or it can be induced artificially, for example in the study of membrane transport or the creation of liposomes. Membrane scission is typically achieved through the use of physical or chemical means, such as the application of pressure, temperature, or chemical agents. The outcome of membrane scission can be either the formation of two separate membranes or the creation of a pore in the membrane.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Membrane scission is a process in which the lipid bilayer of a cell membrane is broken, resulting in the formation of two separate membranes.\n2. Membrane scission can occur naturally during cell division.\n3. Membrane scission can be artificially induced for example, in membrane transport studies or liposome creation.\n4. Physical or chemical means, such as the application of pressure, temperature, or chemical agents are typically used to achieve membrane scission.\n5. The outcome of membrane scission can be either the formation of two separate membranes or the creation of a pore in the membrane.",
    "vicuna-7b_fact": [
      "Membrane scission is a process in which the lipid bilayer of a cell membrane is broken, resulting in the formation of two separate membranes.",
      "Membrane scission can occur naturally during cell division.",
      "Membrane scission can be artificially induced for example, in membrane transport studies or liposome creation.",
      "Physical or chemical means, such as the application of pressure, temperature, or chemical agents are typically used to achieve membrane scission.",
      "The outcome of membrane scission can be either the formation of two separate membranes or the creation of a pore in the membrane."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 356,
    "user_query": "Is the yeast Μac1 transcription factor induced upon copper deficiency?",
    "vicuna-7b_response": "The Mac1 transcription factor is a key regulator of copper homeostasis in yeast. When copper levels in the cell are low, the Mac1 transcription factor is induced, leading to the upregulation of genes involved in copper uptake and homeostasis. This response helps the yeast cell to maintain copper balance and prevent copper toxicity. Therefore, the answer to your question is yes, the Mac1 transcription factor is induced upon copper deficiency in yeast.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Mac1 transcription factor is a key regulator of copper homeostasis in yeast.\n2. When copper levels in the cell are low, the Mac1 transcription factor is induced.\n3. The induction of the Mac1 transcription factor leads to the upregulation of genes involved in copper uptake and homeostasis.\n4. The Mac1 transcription factor helps the yeast cell to maintain copper balance and prevent copper toxicity.\n5. The Mac1 transcription factor is induced upon copper deficiency in yeast.",
    "vicuna-7b_fact": [
      "The Mac1 transcription factor is a key regulator of copper homeostasis in yeast.",
      "When copper levels in the cell are low, the Mac1 transcription factor is induced.",
      "The induction of the Mac1 transcription factor leads to the upregulation of genes involved in copper uptake and homeostasis.",
      "The Mac1 transcription factor helps the yeast cell to maintain copper balance and prevent copper toxicity.",
      "The Mac1 transcription factor is induced upon copper deficiency in yeast."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 357,
    "user_query": "What is the mechanism of DNA replication termination in vertebrates?",
    "vicuna-7b_response": "DNA replication is the process by which a cell makes an exact copy of its DNA. In vertebrates, DNA replication occurs in the nucleus of the cell and is initiated at specific regions called origins of replication. The process of DNA replication is continuous, meaning that it occurs in both directions along the DNA molecule.\nDNA replication termination in vertebrates is the process by which the replication of DNA is stopped at specific points along the DNA molecule. This is important because if replication were to continue indefinitely, it could lead to the formation of double-stranded breaks in the DNA molecule, which could be harmful to the cell.\nThere are several mechanisms that are used to terminate DNA replication in vertebrates. One mechanism is the use of specialized proteins called replicative helicases, which unwind the double helix of DNA and separate the two strands. Once the strands are separated, the replication process is terminated.\nAnother mechanism is the use of proteins called replicative polymerases, which are responsible for synthesizing new DNA strands during replication. These polymerases are able to recognize specific sequences of nucleotides on the DNA molecule and use them as a template to synthesize new strands. Once the new strands are synthesized, the replication process is terminated.\nIn addition to these mechanisms, there are also proteins called replication inhibitors that are able to recognize specific regions of the DNA molecule and prevent replication from occurring at those regions. These inhibitors are able to recognize specific sequences of nucleotides on the DNA molecule and use them as a template to inhibit replication.\nOverall, the mechanism of DNA replication termination in vertebrates is complex and involves the use of a variety of proteins and enzymes. These proteins and enzymes are able to recognize specific sequences of nucleotides on the DNA molecule and use them as a template to terminate replication and prevent the formation of double-stranded breaks in the DNA molecule.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNA replication is the process by which a cell makes an exact copy of its DNA.\n2. In vertebrates, DNA replication occurs in the nucleus of the cell and is initiated at specific regions called origins of replication.\n3. DNA replication termination in vertebrates is the process by which the replication of DNA is stopped at specific points along the DNA molecule.\n4. One mechanism of DNA replication termination in vertebrates is the use of specialized proteins called replicative helicases, which unwind the double helix of DNA and separate the two strands.\n5. Another mechanism is the use of proteins called replicative polymerases, these are responsible for synthesizing new DNA strands during replication.\n6. There are proteins called replication inhibitors that are able to recognize specific regions of the DNA molecule and prevent replication from occurring at those regions.",
    "vicuna-7b_fact": [
      "DNA replication is the process by which a cell makes an exact copy of its DNA.",
      "In vertebrates, DNA replication occurs in the nucleus of the cell and is initiated at specific regions called origins of replication.",
      "DNA replication termination in vertebrates is the process by which the replication of DNA is stopped at specific points along the DNA molecule.",
      "One mechanism of DNA replication termination in vertebrates is the use of specialized proteins called replicative helicases, which unwind the double helix of DNA and separate the two strands.",
      "Another mechanism is the use of proteins called replicative polymerases, these are responsible for synthesizing new DNA strands during replication.",
      "There are proteins called replication inhibitors that are able to recognize specific regions of the DNA molecule and prevent replication from occurring at those regions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: One mechanism of DNA replication termination in vertebrates is the use of specialized proteins called termination proteins which block the action of the replication fork.\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 360,
    "user_query": "Have thyronamines  effects on fat tissue?",
    "vicuna-7b_response": "Thyronamines (TA) are a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may have effects on fat tissue, but more research is needed to fully understand their role in the body.\nTA is a group of hormones that are structurally similar to thyroid hormones, but they are not as well studied as thyroid hormones. Some studies have suggested that TA may",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thyronamines (TA) are a group of hormones that are structurally similar to thyroid hormones.\n2. TA are not as well studied as thyroid hormones.\n3. Some studies have suggested that TA may have effects on fat tissue.\n4. More research is needed to fully understand the role of TA in the body.",
    "vicuna-7b_fact": [
      "Thyronamines (TA) are a group of hormones that are structurally similar to thyroid hormones.",
      "TA are not as well studied as thyroid hormones.",
      "Some studies have suggested that TA may have effects on fat tissue.",
      "More research is needed to fully understand the role of TA in the body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 361,
    "user_query": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?",
    "vicuna-7b_response": "There are several anti-CD52 monoclonal antibodies that have been studied for the treatment of multiple sclerosis (MS), including:\n1. Ocrelizumab: This is a humanized monoclonal antibody that binds to CD20, a protein found on the surface of B cells. Ocrelizumab has been approved for the treatment of relapsing-remitting MS and primary progressive MS.\n2. Ofatumumab: This is another humanized monoclonal antibody that binds to CD20. Ofatumumab has been studied for the treatment of relapsing-remitting MS, but it has not been approved for use yet.\n3. BCD-121: This is a mouse monoclonal antibody that binds to CD52, a protein found on the surface of T cells. BCD-121 has been studied for the treatment of MS, but it has not been approved for use yet.\n4. Hu5F9-G4: This is a mouse monoclonal antibody that binds to CD52. Hu5F9-G4 has been studied for the treatment of MS, but it has not been approved for use yet.\nIt's important to note that these are just a few examples of anti-CD52 monoclonal antibodies that have been studied for the treatment of MS, and more research is needed to determine the safety and efficacy of these treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ocrelizumab is a humanized monoclonal antibody that binds to CD20, a protein found on the surface of B cells.\n2. Ocrelizumab has been approved for the treatment of relapsing-remitting MS and primary progressive MS.\n3. Ofatumumab is another humanized monoclonal antibody that binds to CD20.\n4. BCD-121 and Hu5F9-G4 are mouse monoclonal antibodies that bind to CD52, a protein found on the surface of T cells.\n5. BCD-121 and Hu5F9-G4 have been studied for the treatment of MS, but they have not been approved for use yet.",
    "vicuna-7b_fact": [
      "Ocrelizumab is a humanized monoclonal antibody that binds to CD20, a protein found on the surface of B cells.",
      "Ocrelizumab has been approved for the treatment of relapsing-remitting MS and primary progressive MS.",
      "Ofatumumab is another humanized monoclonal antibody that binds to CD20.",
      "BCD-121 and Hu5F9-G4 are mouse monoclonal antibodies that bind to CD52, a protein found on the surface of T cells.",
      "BCD-121 and Hu5F9-G4 have been studied for the treatment of MS, but they have not been approved for use yet."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 369,
    "user_query": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?",
    "vicuna-7b_response": "Pharmacological treatment of subclinical hypothyroidism can be effective in reducing cardiovascular events in certain individuals. Specifically, studies have shown that treatment of subclinical hypothyroidism can reduce the risk of cardiovascular events in individuals with an elevated serum cholesterol level, hypertension, or a personal or family history of coronary artery disease. Additionally, some studies have found that treatment of subclinical hypothyroidism can improve lipid profiles and reduce inflammation, both of which are known risk factors for cardiovascular disease.\nIt is important to note that not all individuals with subclinical hypothyroidism will benefit from pharmacological treatment, and the decision to initiate treatment should be based on a careful consideration of an individual's overall health status and the potential risks and benefits of treatment. Additionally, treatment should always be initiated and monitored under the supervision of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pharmacological treatment of subclinical hypothyroidism can be effective in reducing cardiovascular events.\n2. Treatment of subclinical hypothyroidism can reduce risk of cardiovascular events in individuals with elevated serum cholesterol level, hypertension, or a personal/family history of coronary artery disease according to some studies.\n3. Some studies have found that treatment of subclinical hypothyroidism can improve lipid profiles and reduce inflammation.\n4. Not all individuals with subclinical hypothyroidism will benefit from pharmacological treatment.\n5. Treatment for subclinical hypothyroidism should always be initiated and monitored under the supervision of a healthcare professional.",
    "vicuna-7b_fact": [
      "Pharmacological treatment of subclinical hypothyroidism can be effective in reducing cardiovascular events.",
      "Treatment of subclinical hypothyroidism can reduce risk of cardiovascular events in individuals with elevated serum cholesterol level, hypertension, or a personal/family history of coronary artery disease according to some studies.",
      "Some studies have found that treatment of subclinical hypothyroidism can improve lipid profiles and reduce inflammation.",
      "Not all individuals with subclinical hypothyroidism will benefit from pharmacological treatment.",
      "Treatment for subclinical hypothyroidism should always be initiated and monitored under the supervision of a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 372,
    "user_query": "What is known about the association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring?",
    "vicuna-7b_response": "The association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and the risk for autism in offspring is a topic of ongoing research and debate.\nStudies have suggested that SSRI use during pregnancy may be associated with an increased risk for autism spectrum disorder (ASD) in offspring. For example, a study published in the Journal of the American Academy of Child and Adolescent Psychiatry in 2011 found that children born to mothers who took SSRIs during pregnancy were more likely to have autism spectrum disorder than children born to mothers who did not take SSRIs.\nHowever, other studies have found no association between SSRI use during pregnancy and the risk for autism. For example, a study published in the Journal of the American Medical Association in 2015 found that SSRI use during pregnancy was not associated with an increased risk for autism spectrum disorder.\nIt is important to note that the evidence regarding the association between SSRI use during pregnancy and the risk for autism is still evolving, and more research is needed to fully understand the potential risks and benefits of SSRI use during pregnancy.\nIn summary, while some studies have suggested that SSRI use during pregnancy may be associated with an increased risk for autism in offspring, the evidence is still inconclusive, and more research is needed to fully understand the potential risks and benefits of SSRI use during pregnancy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and the risk for autism in offspring is a topic of ongoing research and debate.\n2. A study published in the Journal of the American Academy of Child and Adolescent Psychiatry in 2011 found that children born to mothers who took SSRIs during pregnancy were more likely to have autism spectrum disorder.\n3. A study published in the Journal of the American Medical Association in 2015 found that SSRI use during pregnancy was not associated with an increased risk for autism spectrum disorder.\n4. The evidence regarding the association between SSRI use during pregnancy and the risk for autism is still evolving.\n5. More research is needed to fully understand the potential risks and benefits of SSRI use during pregnancy.",
    "vicuna-7b_fact": [
      "The association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and the risk for autism in offspring is a topic of ongoing research and debate.",
      "A study published in the Journal of the American Academy of Child and Adolescent Psychiatry in 2011 found that children born to mothers who took SSRIs during pregnancy were more likely to have autism spectrum disorder.",
      "A study published in the Journal of the American Medical Association in 2015 found that SSRI use during pregnancy was not associated with an increased risk for autism spectrum disorder.",
      "The evidence regarding the association between SSRI use during pregnancy and the risk for autism is still evolving.",
      "More research is needed to fully understand the potential risks and benefits of SSRI use during pregnancy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 374,
    "user_query": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?",
    "vicuna-7b_response": "Desmin is a protein that is primarily found in skeletal muscle and is a component of the intermediate filament (IF) network. While desmin has been implicated in the development and progression of certain cardiac diseases, there is limited evidence to suggest that it plays a role in dilated cardiomyopathy (DCM).\nDCM is a type of heart disease characterized by an enlarged and weakened heart muscle. It is thought to be caused by a variety of factors, including genetics, environmental factors, and lifestyle choices. While desmin has been shown to play a role in the development of other types of cardiomyopathies, such as hypertrophic cardiomyopathy (HCM), its role in DCM is less clear.\nSome studies have suggested that desmin may be involved in the development of DCM, as abnormalities in the IF network have been observed in the hearts of individuals with this condition. However, these findings are still preliminary and more research is needed to fully understand the role of desmin in DCM.\nOverall, while desmin is an important protein in the development and function of skeletal muscle, its role in DCM is still not well understood and further research is needed to fully elucidate its role in this disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Desmin is a protein that is primarily found in skeletal muscle.\n2. Desmin is a component of the intermediate filament (IF) network.\n3. Dilated cardiomyopathy (DCM) is a type of heart disease characterized by an enlarged and weakened heart muscle.\n4. Desmin has been shown to play a role in the development of hypertrophic cardiomyopathy (HCM).\n5. Abnormalities in the IF network have been observed in the hearts of individuals with DCM.",
    "vicuna-7b_fact": [
      "Desmin is a protein that is primarily found in skeletal muscle.",
      "Desmin is a component of the intermediate filament (IF) network.",
      "Dilated cardiomyopathy (DCM) is a type of heart disease characterized by an enlarged and weakened heart muscle.",
      "Desmin has been shown to play a role in the development of hypertrophic cardiomyopathy (HCM).",
      "Abnormalities in the IF network have been observed in the hearts of individuals with DCM."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Desmin has been shown to play a role in the development of dilated cardiomyopathy (DCM), not hypertrophic cardiomyopathy (HCM).\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 376,
    "user_query": "List human diseases involving genomic imprinting.",
    "vicuna-7b_response": "Genomic imprinting is a process by which a parent's DNA is expressed differently depending on whether it is inherited from the mother or father. This can lead to certain diseases that are caused by imprinting disorders. Here are some examples of human diseases that involve genomic imprinting:\n1. Prader-Willi syndrome: This is a genetic disorder that occurs when a child's genes are imprinted from the father instead of the mother. It is characterized by low muscle tone, poor feeding, and a constant feeling of hunger.\n2. Angelman syndrome: This is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father. It is characterized by developmental delays, seizures, and a happy demeanor.\n3. Beckwith-Wiedemann syndrome: This is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father. It is characterized by an overgrowth of certain body parts, such as the tongue, and an increased risk of developing certain cancers.\n4. Silver-Russell syndrome: This is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father. It is characterized by short stature, low muscle tone, and an underdeveloped brain.\n5. Birt-Hogg-Dubé syndrome: This is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father. It is characterized by skin tumors, lung problems, and an increased risk of developing certain cancers.\nThese are just a few examples of human diseases that involve genomic imprinting. It is important to note that imprinting disorders can have a wide range of symptoms and can affect many different parts of the body. If you have concerns about a potential imprinting disorder, it is important to speak with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Genomic imprinting is a process by which a parent's DNA is expressed differently depending on whether it is inherited from the mother or father.\n2. Prader-Willi syndrome is a genetic disorder that occurs when a child's genes are imprinted from the father instead of the mother.\n3. Angelman syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father.\n4. Beckwith-Wiedemann syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father.\n5. Silver-Russell syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father.",
    "vicuna-7b_fact": [
      "Genomic imprinting is a process by which a parent's DNA is expressed differently depending on whether it is inherited from the mother or father.",
      "Prader-Willi syndrome is a genetic disorder that occurs when a child's genes are imprinted from the father instead of the mother.",
      "Angelman syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father.",
      "Beckwith-Wiedemann syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father.",
      "Silver-Russell syndrome is a genetic disorder that occurs when a child's genes are imprinted from the mother instead of the father."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Prader-Willi syndrome is a genetic disorder that occurs when a certain gene is not inherited from the father as it ought to be.\n3. TRUE\n4. FALSE [correction]: Beckwith-Wiedemann syndrome is a genetic disorder that is typically associated with abnormalities in genetic imprinting but it's not necessarily related to the gene inheritance from the mother.\n5. FALSE [correction]: The exact cause of Silver-Russell syndrome is not known. However, it can sometimes be associated with a loss of genetic information on a certain gene inherited from one's father.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 378,
    "user_query": "Which deficiency is the cause of restless leg syndrome?",
    "vicuna-7b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, often accompanied by unpleasant sensations in the legs. The exact cause of RLS is not fully understood, but it is believed to be related to a deficiency of a neurotransmitter called dopamine.\nDopamine is a chemical messenger that plays an important role in regulating movement and mood. In people with RLS, it is thought that there may be a problem with the normal functioning of the dopamine system in the brain, which can lead to the symptoms of RLS.\nThere are several potential causes of dopamine deficiency, including genetic factors, certain medical conditions, and certain medications. In some cases, RLS may be associated with other conditions such as iron deficiency, kidney disease, and diabetes.\nIt is important to note that RLS is a distinct condition from Parkinson's disease, which is a neurological disorder characterized by a combination of symptoms including tremors, stiffness, and difficulty with movement. While RLS and Parkinson's disease share some similarities, they are distinct conditions with different causes and treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs.\n2. Restless leg syndrome is believed to be related to a deficiency of a neurotransmitter called dopamine.\n3. Dopamine is a chemical messenger that plays an important role in regulating movement and mood.\n4. Potential causes of dopamine deficiency include genetic factors, certain medical conditions, and certain medications.\n5. Restless leg syndrome is a distinct condition from Parkinson's disease, which is a neurological disorder characterized by a combination of symptoms including tremors, stiffness, and difficulty with movement.",
    "vicuna-7b_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs.",
      "Restless leg syndrome is believed to be related to a deficiency of a neurotransmitter called dopamine.",
      "Dopamine is a chemical messenger that plays an important role in regulating movement and mood.",
      "Potential causes of dopamine deficiency include genetic factors, certain medical conditions, and certain medications.",
      "Restless leg syndrome is a distinct condition from Parkinson's disease, which is a neurological disorder characterized by a combination of symptoms including tremors, stiffness, and difficulty with movement."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 379,
    "user_query": "What histone modification is recognized by the bromodomain?",
    "vicuna-7b_response": "Bromodomain is a protein module that recognizes acetylated lysine residues on histone tails. It is a histone-interacting domain that recognizes acetylated lysine residues on histone tails and plays a role in regulating gene expression. The bromodomain is found in a variety of proteins, including transcriptional regulators, chromatin-modifying enzymes, and epigenetic readers. The bromodomain is a common target for drugs that modulate gene expression and has been implicated in a variety of diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bromodomain is a protein module that recognizes acetylated lysine residues on histone tails.\n2. The bromodomain plays a role in regulating gene expression. \n3. The bromodomain is found in a variety of proteins, including transcriptional regulators, chromatin-modifying enzymes, and epigenetic readers.\n4. The bromodomain is a common target for drugs that modulate gene expression.\n5. The bromodomain has been implicated in a variety of diseases, including cancer.",
    "vicuna-7b_fact": [
      "Bromodomain is a protein module that recognizes acetylated lysine residues on histone tails.",
      "The bromodomain plays a role in regulating gene expression.",
      "The bromodomain is found in a variety of proteins, including transcriptional regulators, chromatin-modifying enzymes, and epigenetic readers.",
      "The bromodomain is a common target for drugs that modulate gene expression.",
      "The bromodomain has been implicated in a variety of diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 387,
    "user_query": "What is the methodological principle of ChIA-PET?",
    "vicuna-7b_response": "ChIA-PET stands for Chemical Imaging by Protein Electron Tomography. It is a method used to study the three-dimensional structure of proteins and other biological macromolecules in a native, unperturbed state.\nThe methodology of ChIA-PET involves the use of a transmission electron microscope (TEM) to image the sample. The sample is first embedded in a polymer matrix, which is then thinly sectioned and mounted on a grid. The grid is then placed in the TEM, and a series of images are taken at different angles. These images are then combined to form a 3D reconstruction of the sample.\nThe advantage of ChIA-PET is that it allows for the visualization of the three-dimensional structure of proteins in their native state, without the need for crystallization or other manipulation. This makes it a valuable tool for studying the structure and function of proteins in their native environment.\nIn summary, ChIA-PET is a method that uses a transmission electron microscope to image biological macromolecules in a native, unperturbed state, allowing for the visualization of their three-dimensional structure.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ChIA-PET stands for Chemical Imaging by Protein Electron Tomography.\n2. ChIA-PET is a method used to study the three-dimensional structure of proteins and other biological macromolecules.\n3. It involves the use of a transmission electron microscope (TEM).\n4. The sample is first embedded in a polymer matrix, which is then thinly sectioned and mounted on a grid.\n5. This method allows for the visualization of the three-dimensional structure of proteins in their native state, without the need for crystallization or other manipulation.",
    "vicuna-7b_fact": [
      "ChIA-PET stands for Chemical Imaging by Protein Electron Tomography.",
      "ChIA-PET is a method used to study the three-dimensional structure of proteins and other biological macromolecules.",
      "It involves the use of a transmission electron microscope (TEM).",
      "The sample is first embedded in a polymer matrix, which is then thinly sectioned and mounted on a grid.",
      "This method allows for the visualization of the three-dimensional structure of proteins in their native state, without the need for crystallization or other manipulation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ChIA-PET stands for Chromatin Interaction Analysis by Paired-End Tag Sequencing.\n2. FALSE [correction]: ChIA-PET is a method used to study the three-dimensional structure of chromatin interactions.\n3. FALSE [correction]: It does not involve the use of a transmission electron microscope (TEM).\n4. FALSE [correction]: The sample preparation in ChIA-PET does not involve embedding in a polymer matrix, sectioning or mounting on a grid.\n5. FALSE [correction]: This method allows for the visualization of the three-dimensional structure of chromatin and any potential interactions between proteins, but does not visualize proteins in their native state without manipulation.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 390,
    "user_query": "Does PU.1 (SPI1) affect NF-kB binding?",
    "vicuna-7b_response": "PU.1 (SPI1) is a transcription factor that plays a role in the regulation of gene expression in various cell types. It has been shown to affect the binding of the nuclear factor kappa B (NF-kB) transcription factor to DNA.\nPU.1 is a member of the PU.1 family of transcription factors, which are involved in the regulation of cell growth, differentiation, and apoptosis. PU.1 has been shown to bind to the promoter regions of genes involved in these processes, and to regulate their expression.\nIn addition, PU.1 has been shown to interact with NF-kB and to affect its activity. For example, PU.1 has been shown to inhibit the transcriptional activity of NF-kB by competing with other transcription factors for binding to NF-kB. This can result in a decrease in the expression of genes involved in inflammation and immune response.\nIn summary, PU.1 (SPI1) affects NF-kB binding by interacting with NF-kB and competing with other transcription factors for binding to NF-kB, which can result in a decrease in the expression of genes involved in inflammation and immune response.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PU.1 (SPI1) is a transcription factor that plays a role in the regulation of gene expression in various cell types.\n2. PU.1 has been shown to affect the nuclear factor kappa B (NF-kB) transcription factor's binding to DNA.\n3. PU.1 is a member of the PU.1 family of transcription factors, which are involved in the regulation of cell growth, differentiation, and apoptosis.\n4. PU.1 has been shown to bind to the promoter regions of genes involved in processes of cell growth, differentiation, and apoptosis, and to regulate their expression.\n5. PU.1 affects NF-kB binding by interacting with NF-kB and competing with other transcription factors, which can result in a decrease in the expression of genes involved in inflammation and immune response.",
    "vicuna-7b_fact": [
      "PU.1 (SPI1) is a transcription factor that plays a role in the regulation of gene expression in various cell types.",
      "PU.1 has been shown to affect the nuclear factor kappa B (NF-kB) transcription factor's binding to DNA.",
      "PU.1 is a member of the PU.1 family of transcription factors, which are involved in the regulation of cell growth, differentiation, and apoptosis.",
      "PU.1 has been shown to bind to the promoter regions of genes involved in processes of cell growth, differentiation, and apoptosis, and to regulate their expression.",
      "PU.1 affects NF-kB binding by interacting with NF-kB and competing with other transcription factors, which can result in a decrease in the expression of genes involved in inflammation and immune response."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: PU.1 is a member of the ETS family of transcription factors, which are involved in the regulation of cell growth, differentiation, and apoptosis.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 391,
    "user_query": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?",
    "vicuna-7b_response": "The second parity rule (PR2) is a mathematical concept that deals with the distribution of elements in a set. It states that if a set has two elements, and one of them is in the majority, then the other element must be in the minority.\nIn the context of mitochondrial genomes, it is not possible to determine whether the majority of mitochondrial genomes abide by the second parity rule, as the number of mitochondrial genomes in a set is not specified. Additionally, the concept of \"majority\" and \"minority\" does not apply to mitochondrial genomes, as they are not elements in a set.\nIt is important to note that the second parity rule is a mathematical concept and it does not have any relation to the mitochondrial genomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The second parity rule (PR2) is a mathematical concept that deals with the distribution of elements in a set.\n2. The second parity rule states that if a set has two elements, and one of them is in the majority, then the other element must be in the minority.\n3. The concept of \"majority\" and \"minority\" doesn't apply to mitochondrial genomes as they are not elements in a set.\n4. It is not possible to determine whether the majority of mitochondrial genomes abide by the second parity rule.\n5. The second parity rule does not have any relation to the mitochondrial genomes.",
    "vicuna-7b_fact": [
      "The second parity rule (PR2) is a mathematical concept that deals with the distribution of elements in a set.",
      "The second parity rule states that if a set has two elements, and one of them is in the majority, then the other element must be in the minority.",
      "The concept of \"majority\" and \"minority\" doesn't apply to mitochondrial genomes as they are not elements in a set.",
      "It is not possible to determine whether the majority of mitochondrial genomes abide by the second parity rule.",
      "The second parity rule does not have any relation to the mitochondrial genomes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: The concept of \"majority\" and \"minority\" can apply to mitochondrial genomes when treated as elements in a set.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 396,
    "user_query": "Which hormone abnormalities are common in Williams syndrome ?",
    "vicuna-7b_response": "Williams syndrome is a rare genetic disorder that is characterized by a range of physical and cognitive abnormalities. One of the most notable features of Williams syndrome is the presence of cardiovascular abnormalities, including a narrowed aortic valve and an elongated heart shape.\nIn addition to cardiovascular abnormalities, individuals with Williams syndrome often have abnormalities in their endocrine system, specifically in the production of hormones. Some of the common hormone abnormalities in Williams syndrome include:\n1. Growth hormone deficiency: Individuals with Williams syndrome often have growth hormone deficiency, which can lead to short stature and delayed puberty.\n2. Thyroid hormone abnormalities: Individuals with Williams syndrome may have an overactive or underactive thyroid gland, which can lead to hyperthyroidism or hypothyroidism.\n3. Adrenal gland abnormalities: Individuals with Williams syndrome may have abnormalities in the production of adrenal hormones, including aldosterone and cortisol.\n4. Calcium regulation abnormalities: Individuals with Williams syndrome may have abnormalities in the regulation of calcium levels in the body, which can lead to hypocalcemia.\nIt is important to note that the specific hormone abnormalities that an individual with Williams syndrome may have can vary widely, and may not be present in all individuals. Additionally, some of the hormone abnormalities associated with Williams syndrome may not be apparent until later in life. If you have concerns about your own hormone levels or those of a loved one with Williams syndrome, it is important to speak with a healthcare provider who is familiar with the disorder.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Williams syndrome is a rare genetic disorder characterized by physical and cognitive abnormalities.\n2. Individuals with Williams syndrome often have abnormalities with their endocrine system, specifically in the production of hormones.\n3. Growth hormone deficiency, which can lead to short stature and delayed puberty, is common in individuals with Williams syndrome.\n4. Individuals with Williams syndrome may have thyroid hormone abnormalities, leading to either hyperthyroidism or hypothyroidism.\n5. People with Williams syndrome may have abnormalities in the production of adrenal hormones, including aldosterone and cortisol.\n6. Calcium regulation abnormalities, which can lead to hypocalcemia, may occur in individuals with Williams syndrome.",
    "vicuna-7b_fact": [
      "Williams syndrome is a rare genetic disorder characterized by physical and cognitive abnormalities.",
      "Individuals with Williams syndrome often have abnormalities with their endocrine system, specifically in the production of hormones.",
      "Growth hormone deficiency, which can lead to short stature and delayed puberty, is common in individuals with Williams syndrome.",
      "Individuals with Williams syndrome may have thyroid hormone abnormalities, leading to either hyperthyroidism or hypothyroidism.",
      "People with Williams syndrome may have abnormalities in the production of adrenal hormones, including aldosterone and cortisol.",
      "Calcium regulation abnormalities, which can lead to hypocalcemia, may occur in individuals with Williams syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 398,
    "user_query": "Albumin depletion is a common first step for proteomic analysis of CSF fluid. What is the advantage and disadvantage of this procedure?",
    "vicuna-7b_response": "Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid (CSF) fluid because albumin is a large protein that can interfere with the detection of smaller proteins of interest. The advantage of albumin depletion is that it allows for the separation of the proteins of interest from the albumin, which can improve the sensitivity and specificity of the analysis. The disadvantage is that it can also remove some of the proteins of interest, which can affect the accuracy of the analysis. Additionally, albumin depletion can also affect the stability of the proteins, which can also affect the results of the analysis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid (CSF).\n2. Albumin is a large protein that can interfere with the detection of smaller proteins.\n3. The advantage of albumin depletion is that it allows for the separation of the proteins of interest from the albumin.\n4. Albumin depletion can improve the sensitivity and specificity of the proteomic analysis.\n5. Albumin depletion can also affect the stability of the proteins and the accuracy of the analysis.",
    "vicuna-7b_fact": [
      "Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid (CSF).",
      "Albumin is a large protein that can interfere with the detection of smaller proteins.",
      "The advantage of albumin depletion is that it allows for the separation of the proteins of interest from the albumin.",
      "Albumin depletion can improve the sensitivity and specificity of the proteomic analysis.",
      "Albumin depletion can also affect the stability of the proteins and the accuracy of the analysis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 401,
    "user_query": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?",
    "vicuna-7b_response": "The phosphorylation of alpha-synuclein at Ser129 is a key event in the pathogenesis of Parkinson's disease. Studies have shown that the accumulation of phosphorylated alpha-synuclein in Lewy bodies is a hallmark of the disease. The phosphorylation of alpha-synuclein at Ser129 is mediated by protein kinase A (PKA) and protein kinase C (PKC), which are activated by various stimuli, including dopamine. The phosphorylation of alpha-synuclein at Ser129 leads to its aggregation and formation of Lewy bodies, which are the characteristic neurodegenerative lesions found in Parkinson's disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alpha-synuclein is phosphorylated at Ser129 in Lewy bodies.\n2. The phosphorylation of alpha-synuclein at Ser129 is a key event in the pathogenesis of Parkinson's disease.\n3. The accumulation of phosphorylated alpha-synuclein in Lewy bodies is a hallmark of Parkinson's disease.\n4. The phosphorylation of alpha-synuclein at Ser129 is mediated by protein kinase A (PKA) and protein kinase C (PKC).\n5. The phosphorylation of alpha-synuclein at Ser129 leads to its aggregation and formation of Lewy bodies, which are characteristic neurodegenerative lesions found in Parkinson's Disease.",
    "vicuna-7b_fact": [
      "Alpha-synuclein is phosphorylated at Ser129 in Lewy bodies.",
      "The phosphorylation of alpha-synuclein at Ser129 is a key event in the pathogenesis of Parkinson's disease.",
      "The accumulation of phosphorylated alpha-synuclein in Lewy bodies is a hallmark of Parkinson's disease.",
      "The phosphorylation of alpha-synuclein at Ser129 is mediated by protein kinase A (PKA) and protein kinase C (PKC).",
      "The phosphorylation of alpha-synuclein at Ser129 leads to its aggregation and formation of Lewy bodies, which are characteristic neurodegenerative lesions found in Parkinson's Disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 403,
    "user_query": "What is known about thalidomide therapy and survival of glioblastoma patients?",
    "vicuna-7b_response": "Thalidomide is a drug that has been studied for its potential to treat various types of cancer, including glioblastoma. Glioblastoma is a type of brain cancer that is often difficult to treat and has a poor prognosis.\nThere have been several studies that have investigated the use of thalidomide in the treatment of glioblastoma. These studies have shown that thalidomide can cause tumor shrinkage and improve survival in some patients. However, the majority of studies have been small and have had limited follow-up periods, so more research is needed to fully understand the effectiveness of thalidomide in the treatment of glioblastoma.\nIt is important to note that thalidomide is not currently approved by the FDA for the treatment of glioblastoma, and its use in this context is considered investigational. Patients who are interested in trying thalidomide as a treatment for their glioblastoma should discuss this with their oncologist and consider enrolling in a clinical trial.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thalidomide is a drug that has been studied for its potential to treat various types of cancer, including glioblastoma.\n2. Glioblastoma is a type of brain cancer that is often difficult to treat and has a poor prognosis.\n3. There have been studies investigating the use of thalidomide in the treatment of glioblastoma.\n4. Current knowledge suggests thalidomide can cause tumor shrinkage and improve survival in some glioblastoma patients.\n5. Thalidomide is not currently approved by the FDA for the treatment of glioblastoma.",
    "vicuna-7b_fact": [
      "Thalidomide is a drug that has been studied for its potential to treat various types of cancer, including glioblastoma.",
      "Glioblastoma is a type of brain cancer that is often difficult to treat and has a poor prognosis.",
      "There have been studies investigating the use of thalidomide in the treatment of glioblastoma.",
      "Current knowledge suggests thalidomide can cause tumor shrinkage and improve survival in some glioblastoma patients.",
      "Thalidomide is not currently approved by the FDA for the treatment of glioblastoma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 404,
    "user_query": "Is endostatin a proangiogenic factor?",
    "vicuna-7b_response": "Endostatin is a protein that is produced by cells in the bone and is thought to play a role in regulating blood vessel growth, or angiogenesis. While endostatin has been shown to inhibit the growth of new blood vessels in some contexts, it is not considered a proangiogenic factor.\nIn fact, endostatin is a potent inhibitor of angiogenesis, which is the process by which new blood vessels form. It does this by binding to and inhibiting the activity of various proteins involved in blood vessel growth, including vascular endothelial growth factor (VEGF).\nOverall, while endostatin may have some potential as a therapeutic agent for certain conditions, it is not generally considered a proangiogenic factor.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Endostatin is a protein that is produced by cells in the bone.\n2. Endostatin plays a role in regulating blood vessel growth, or angiogenesis.\n3. Endostatin has been shown to inhibit the growth of new blood vessels in some contexts.\n4. Endostatin is a potent inhibitor of angiogenesis.\n5. Endostatin inhibits the activity of proteins involved in blood vessel growth, including vascular endothelial growth factor (VEGF).",
    "vicuna-7b_fact": [
      "Endostatin is a protein that is produced by cells in the bone.",
      "Endostatin plays a role in regulating blood vessel growth, or angiogenesis.",
      "Endostatin has been shown to inhibit the growth of new blood vessels in some contexts.",
      "Endostatin is a potent inhibitor of angiogenesis.",
      "Endostatin inhibits the activity of proteins involved in blood vessel growth, including vascular endothelial growth factor (VEGF)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Endostatin is a protein that is produced by cells in a wide variety of tissues, not just in the bone.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 407,
    "user_query": "List the off-label use of SSRIs",
    "vicuna-7b_response": "SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant medications that are commonly used to treat depression and anxiety disorders. While SSRIs are FDA-approved for these conditions, they may also be used off-label for other conditions. Here are some examples of off-label uses for SSRIs:\n1. Obsessive-compulsive disorder (OCD): SSRIs have been shown to be effective in treating OCD, although they are not FDA-approved for this use.\n2. Panic disorder: SSRIs may be used off-label to treat panic disorder, which is characterized by severe panic attacks.\n3. Social anxiety disorder: SSRIs may be used off-label to treat social anxiety disorder, which is characterized by excessive fear of social or performance situations.\n4. Post-traumatic stress disorder (PTSD): SSRIs may be used off-label to treat PTSD, which is a condition that develops in response to a traumatic event.\n5. Attention-deficit/hyperactivity disorder (ADHD): Some studies have suggested that SSRIs may be effective in treating ADHD, although they are not FDA-approved for this use.\n6. Eating disorders: SSRIs may be used off-label to treat eating disorders such as anorexia nervosa and bulimia nervosa.\nIt's important to note that while SSRIs may be effective in treating some of these conditions, they may not be appropriate for everyone, and their use should be carefully considered on a case-by-case basis. It's always best to consult with a healthcare professional before taking any medication, including SSRIs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SSRIs are a class of antidepressant medications used to treat depression and anxiety disorders.\n2. Obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and eating disorders are off-label uses for SSRIs.\n3. SSRIs are not FDA-approved for treating obsessive-compulsive disorder (OCD) or attention-deficit/hyperactivity disorder (ADHD).\n4. The use of SSRIs should be carefully considered on a case-by-case basis.\n5. Before taking any medication, including SSRIs, it's recommended to consult with a healthcare professional.",
    "vicuna-7b_fact": [
      "SSRIs are a class of antidepressant medications used to treat depression and anxiety disorders.",
      "Obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and eating disorders are off-label uses for SSRIs.",
      "SSRIs are not FDA-approved for treating obsessive-compulsive disorder (OCD) or attention-deficit/hyperactivity disorder (ADHD).",
      "The use of SSRIs should be carefully considered on a case-by-case basis.",
      "Before taking any medication, including SSRIs, it's recommended to consult with a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD) are some of the disorders that SSRIs are used to treat, but not attention-deficit/hyperactivity disorder (ADHD) or eating disorders.\n3. FALSE [correction]: SSRIs are FDA-approved for treating obsessive-compulsive disorder (OCD), but not for attention-deficit/hyperactivity disorder (ADHD).\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 408,
    "user_query": "Which is the definition of pyknons in DNA?",
    "vicuna-7b_response": "Pyknons are regions of DNA that are rich in guanine and cytosine base pairs and are thought to play a role in regulating gene expression. Pyknons are typically found in the promoter regions of genes and are involved in the recruitment of transcription factors, which are proteins that bind to specific DNA sequences and regulate the transcription of genes. Pyknons are also thought to play a role in the regulation of chromatin structure, which is the complex of DNA, RNA, and proteins that make up the chromosomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pyknons are regions of DNA that are rich in guanine and cytosine base pairs.\n2. Pyknons are thought to play a role in regulating gene expression.\n3. Pyknons are typically found in the promoter regions of genes.\n4. Pyknons are involved in the recruitment of transcription factors.\n5. Pyknons are thought to play a role in the regulation of chromatin structure.",
    "vicuna-7b_fact": [
      "Pyknons are regions of DNA that are rich in guanine and cytosine base pairs.",
      "Pyknons are thought to play a role in regulating gene expression.",
      "Pyknons are typically found in the promoter regions of genes.",
      "Pyknons are involved in the recruitment of transcription factors.",
      "Pyknons are thought to play a role in the regulation of chromatin structure."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-7b_response": "Yes, a linker histone does exist in the yeast genome.\nLinker histones are a type of histone that plays a crucial role in the regulation of chromatin structure and gene expression. In the yeast genome, there are several types of linker histones, including H1, H5, and H7.\nH1 is the most abundant linker histone in eukaryotic cells, including yeast. It is responsible for maintaining the structure of chromatin and facilitating the interaction between DNA and other proteins. In yeast, H1 is encoded by the HOP1 gene and is essential for cell viability.\nH5 and H7 are less abundant linker histones in yeast, but they also play important roles in chromatin structure and gene expression. H5 is involved in the regulation of transcription and is required for proper development in yeast. H7 is involved in the regulation of DNA replication and is required for the proper segregation of chromosomes during cell division.\nOverall, linker histones are important components of the chromatin structure in yeast and play a crucial role in regulating gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A linker histone exists in the yeast genome.\n2. Linker histones play a critical role in the regulation of chromatin structure and gene expression.\n3. In the yeast genome, the types of linker histones include H1, H5, and H7.\n4. The H1 histone is the most abundant linker histone in eukaryotic cells, including yeast, and it is encoded by the HOP1 gene.\n5. H5 and H7 histones in yeast play important roles in chromatin structure and gene expression, with H5 involved in the regulation of transcription and H7 in the regulation of DNA replication.",
    "vicuna-7b_fact": [
      "A linker histone exists in the yeast genome.",
      "Linker histones play a critical role in the regulation of chromatin structure and gene expression.",
      "In the yeast genome, the types of linker histones include H1, H5, and H7.",
      "The H1 histone is the most abundant linker histone in eukaryotic cells, including yeast, and it is encoded by the HOP1 gene.",
      "H5 and H7 histones in yeast play important roles in chromatin structure and gene expression, with H5 involved in the regulation of transcription and H7 in the regulation of DNA replication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The yeast genome does not contain typical linker histones like H1, H5, and H7.\n4. FALSE [correction]: The H1 histone is the most abundant linker histone in some eukaryotic cells, but yeast notably lacks an H1 histone equivalent.\n5. FALSE [correction]: Yeast does not have H5 and H7 histones. These types of histones are not known to exist in yeast and their roles in regulation of transcription and DNA replication in yeast are not established.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 410,
    "user_query": "What is the role of deadenylases in the cell?",
    "vicuna-7b_response": "Deadenylases are enzymes that play a crucial role in the regulation of gene expression in eukaryotic cells. They are responsible for removing the poly(A) tail from the 3' end of mRNA molecules, which is a crucial step in the process of mRNA degradation.\nThe poly(A) tail is a long chain of adenine nucleotides that is added to the 3' end of mRNA molecules by the enzyme poly(A) polymerase. This tail serves as a recognition site for the exonucleases that degrade mRNA molecules. When the poly(A) tail is removed by deadenylases, the mRNA molecules are no longer recognized by these exonucleases and are therefore protected from degradation.\nIn addition to their role in mRNA degradation, deadenylases also play a role in the regulation of gene expression by controlling the stability of mRNA molecules. By removing the poly(A) tail from mRNA molecules, deadenylases can increase the stability of these molecules and allow them to persist in the cell for longer periods of time. This can lead to an increase in the expression of certain genes and can have a significant impact on the overall gene expression profile of the cell.\nOverall, deadenylases play a crucial role in the regulation of gene expression in eukaryotic cells by controlling the stability and degradation of mRNA molecules.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Deadenylases are enzymes that play a key part in the regulation of gene expression in eukaryotic cells.\n2. Deadenylases are responsible for removing the poly(A) tail from the 3' end of mRNA molecules.\n3. The process of removing the poly(A) tail from mRNA molecules is a crucial step in mRNA degradation.\n4. The poly(A) tail serves as a recognition site for exonucleases that degrade mRNA molecules.\n5. Deadenylases also play a role in the stability and regulation of mRNA molecules, which can affect gene expression.",
    "vicuna-7b_fact": [
      "Deadenylases are enzymes that play a key part in the regulation of gene expression in eukaryotic cells.",
      "Deadenylases are responsible for removing the poly(A) tail from the 3' end of mRNA molecules.",
      "The process of removing the poly(A) tail from mRNA molecules is a crucial step in mRNA degradation.",
      "The poly(A) tail serves as a recognition site for exonucleases that degrade mRNA molecules.",
      "Deadenylases also play a role in the stability and regulation of mRNA molecules, which can affect gene expression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 412,
    "user_query": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?",
    "vicuna-7b_response": "A long interspersed nuclear element (LINE) is a type of transposable element that is found in the genome of many eukaryotes, including humans. LINE elements are typically around 3-5 kilobases (kb) in length.\nTransposable elements are sequences of DNA that can move or \"jump\" from one location in the genome to another. LINE elements are one type of transposable element, and they make up a significant portion of the human genome.\nIt's worth noting that the length of LINE elements can vary somewhat from one individual to another, and there may be some variation in the size of LINE elements within a single genome as well. However, the typical length of a LINE element is around 3-5 kb.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A long interspersed nuclear element (LINE) is a type of transposable element.\n2. LINE elements are found in the genome of many eukaryotes, including humans.\n3. LINE elements are typically around 3-5 kilobases (kb) in length.\n4. Transposable elements are sequences of DNA that can move from one location in the genome to another.\n5. LINE elements make up a significant portion of the human genome.",
    "vicuna-7b_fact": [
      "A long interspersed nuclear element (LINE) is a type of transposable element.",
      "LINE elements are found in the genome of many eukaryotes, including humans.",
      "LINE elements are typically around 3-5 kilobases (kb) in length.",
      "Transposable elements are sequences of DNA that can move from one location in the genome to another.",
      "LINE elements make up a significant portion of the human genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: LINE elements are typically around 6-8 kilobases (kb) in length.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 414,
    "user_query": "List receptors of the drug Cilengitide",
    "vicuna-7b_response": "Cilengitide is a drug that is used to treat various types of cancer. It works by binding to a specific receptor on cancer cells called the integrin alpha v beta 3. This binding inhibits the growth and spread of cancer cells.\nIn addition to the integrin alpha v beta 3, Cilengitide also binds to other receptors on cancer cells, including:\n* EGFR (epidermal growth factor receptor)\n* VEGFR (vascular endothelial growth factor receptor)\n* HER2 (human epidermal growth factor receptor 2)\nThese additional binding sites may contribute to the anti-cancer effects of Cilengitide, by inhibiting the growth and survival of cancer cells in different ways.\nIt's important to note that Cilengitide is not a cure for cancer, but it can be used in combination with other treatments to help slow the growth and spread of cancer. It is typically given as an infusion into a vein, and the dosage and frequency of treatment will depend on the specific type of cancer being treated and the individual patient's response to the drug.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cilengitide is a drug used to treat various types of cancer.\n2. Cilengitide works by binding to a specific receptor on cancer cells called the integrin alpha v beta 3.\n3. Cilengitide binds to other receptors on cancer cells, including EGFR (epidermal growth factor receptor), VEGFR (vascular endothelial growth factor receptor), and HER2 (human epidermal growth factor receptor 2).\n4. Cilengitide is typically given as an infusion into a vein.\n5. The dosage and frequency of treatment with Cilengitide will depend on the specific type of cancer being treated and the individual patient's response to the drug.",
    "vicuna-7b_fact": [
      "Cilengitide is a drug used to treat various types of cancer.",
      "Cilengitide works by binding to a specific receptor on cancer cells called the integrin alpha v beta 3.",
      "Cilengitide binds to other receptors on cancer cells, including EGFR (epidermal growth factor receptor), VEGFR (vascular endothelial growth factor receptor), and HER2 (human epidermal growth factor receptor 2).",
      "Cilengitide is typically given as an infusion into a vein.",
      "The dosage and frequency of treatment with Cilengitide will depend on the specific type of cancer being treated and the individual patient's response to the drug."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Cilengitide does not bind to EGFR, VEGFR, or HER2. It selectively binds to integrins, specifically alpha v beta 3 and alpha v beta 5. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 415,
    "user_query": "Can protein coding exons originate from ALU sequences?",
    "vicuna-7b_response": "Yes, it is possible for protein coding exons to originate from ALU sequences.\nThe process of gene expression involves the transcription of DNA into RNA, followed by the translation of RNA into proteins. During this process, the DNA is first transcribed into messenger RNA (mRNA), which is then translated into proteins by ribosomes.\nProtein coding exons are the regions of the DNA that contain the instructions for making proteins. These exons are typically composed of DNA sequences that are specific to protein coding regions, such as the codons that specify the amino acids that make up the protein.\nHowever, it is also possible for exons to originate from non-coding sequences, such as those found in Alu sequences. Alu sequences are short, non-coding repetitive DNA sequences that make up a large portion of the human genome. They are thought to have originated from mobile genetic elements, such as retroviruses, and have been incorporated into the genome through a process called \"Alu-mediated gene duplication.\"\nIn some cases, it is possible for exons to originate from Alu sequences. This can occur through a process called \"Alu-mediated exonization,\" where an Alu sequence is inserted into the genome and then becomes a part of the gene. This process is thought to be relatively rare, but it has been observed in some cases.\nOverall, while it is possible for protein coding exons to originate from Alu sequences, this is a relatively rare occurrence and is not a common mechanism for the origin of exons.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. The process of gene expression involves the transcription of DNA into RNA, followed by the translation of RNA into proteins.\n2. Protein coding exons are the regions of the DNA that contain the instructions for making proteins.\n3. Exons can originate from non-coding sequences, such as Alu sequences.\n4. Alu sequences are short, non-coding repetitive DNA sequences that make up a large portion of the human genome.\n5. It is possible for exons to originate from Alu sequences through a process called \"Alu-mediated exonization.\"",
    "vicuna-7b_fact": [
      "The process of gene expression involves the transcription of DNA into RNA, followed by the translation of RNA into proteins.",
      "Protein coding exons are the regions of the DNA that contain the instructions for making proteins.",
      "Exons can originate from non-coding sequences, such as Alu sequences.",
      "Alu sequences are short, non-coding repetitive DNA sequences that make up a large portion of the human genome.",
      "It is possible for exons to originate from Alu sequences through a process called \"Alu-mediated exonization.\""
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-7b_response": "Yes, there is evidence that tomato juice may help lower cholesterol levels.\nResearch has shown that consuming tomato juice or tomato products, such as tomato sauce or ketchup, may help lower cholesterol levels due to the high levels of lycopene in them. Lycopene is an antioxidant that has been shown to help reduce inflammation in the body, which can contribute to lower cholesterol levels.\nAdditionally, tomato juice contains other nutrients that may also help lower cholesterol levels, such as potassium and vitamin C.\nIt's important to note that while tomato juice may be beneficial in helping to lower cholesterol levels, it should not be used as a sole treatment for high cholesterol. It's always best to consult with a healthcare professional before making any changes to your diet or taking any supplements.\nIn conclusion, there is evidence that tomato juice may help lower cholesterol levels due to its high levels of lycopene and other nutrients. However, it should not be used as a sole treatment and it's always best to consult with a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Research has found that consuming tomato juice or tomato products may help lower cholesterol levels. \n2. Lycopene, an antioxidant found at high levels in tomato products, has been shown to help reduce inflammation in the body, which can lower cholesterol levels. \n3. Tomato juice contains nutrients like potassium and vitamin C which may also help lower cholesterol levels. \n4. Tomato juice should not be used as a sole treatment for high cholesterol.\n5. It is recommended to consult with a healthcare professional before making any changes to your diet or taking any supplements.",
    "vicuna-7b_fact": [
      "Research has found that consuming tomato juice or tomato products may help lower cholesterol levels.",
      "Lycopene, an antioxidant found at high levels in tomato products, has been shown to help reduce inflammation in the body, which can lower cholesterol levels.",
      "Tomato juice contains nutrients like potassium and vitamin C which may also help lower cholesterol levels.",
      "Tomato juice should not be used as a sole treatment for high cholesterol.",
      "It is recommended to consult with a healthcare professional before making any changes to your diet or taking any supplements."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 423,
    "user_query": "What is the mode of inheritance of nemaline myopathy?",
    "vicuna-7b_response": "Nemaline myopathy is an inherited muscle disorder that is caused by mutations in the nemaline myopathy protein (NMTP) gene. The mode of inheritance of nemaline myopathy is autosomal recessive.\nThis means that a person must inherit two copies of the gene, one from each parent, to develop the disorder. If a person only has one copy of the gene, they are a carrier of the disorder but usually do not show any symptoms.\nThe NMTP gene provides instructions for making a protein that is important for the structure and function of muscle fibers. Mutations in the NMTP gene can cause the production of a defective or non-functional protein, which can lead to the muscle fibers becoming thick and rigid, resulting in the symptoms of nemaline myopathy.\nIt is important to note that there are different types of nemaline myopathy, and the mode of inheritance may vary depending on the specific type. Some types of nemaline myopathy may be inherited in an autosomal dominant manner, while others may be inherited in an X-linked recessive manner.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nemaline myopathy is an inherited muscle disorder caused by mutations in the nemaline myopathy protein (NMTP) gene.\n2. The mode of inheritance of nemaline myopathy is usually autosomal recessive.\n3. A person must inherit two copies of the NMTP gene to develop nemaline myopathy.\n4. The NMTP gene provides instructions for creating a protein that affects the structure and function of muscle fibers.\n5. There are different types of nemaline myopathy and the mode of inheritance can vary depending on the specific type.",
    "vicuna-7b_fact": [
      "Nemaline myopathy is an inherited muscle disorder caused by mutations in the nemaline myopathy protein (NMTP) gene.",
      "The mode of inheritance of nemaline myopathy is usually autosomal recessive.",
      "A person must inherit two copies of the NMTP gene to develop nemaline myopathy.",
      "The NMTP gene provides instructions for creating a protein that affects the structure and function of muscle fibers.",
      "There are different types of nemaline myopathy and the mode of inheritance can vary depending on the specific type."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Nemaline myopathy is an inherited muscle disorder caused by mutations in multiple genes, not specifically the \"nemaline myopathy protein (NMTP)\" gene.\n2. TRUE\n3. FALSE [correction]: A person must inherit mutated copies of a specific gene (not the NMTP gene), from both parents to develop nemaline myopathy in case of autosomal recessive inheritance.\n4. FALSE [correction]: There is no specific \"NMTP\" gene. Nemaline myopathy is caused by mutations in different genes which provide instructions for creating proteins involved in muscle contraction.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 432,
    "user_query": "Is it possible to detect survivin protein expression in normal human adult tissues?",
    "vicuna-7b_response": "Yes, it is possible to detect survivin protein expression in normal human adult tissues. Survivin is a protein that is expressed in a variety of tissues, including normal adult tissues.\nSurvivin is a member of the inhibitor of apoptosis (IAP) family of proteins, which plays a role in the regulation of cell death. It is expressed in a wide range of tissues, including the heart, lung, kidney, liver, and pancreas, among others.\nThere are several methods that can be used to detect survivin protein expression in normal human adult tissues, including immunohistochemistry (IHC), Western blotting, and RNA sequencing.\nFor example, IHC can be used to detect survivin protein expression in tissue sections using antibodies that specifically bind to the survivin protein. This method can be used to detect survivin protein expression in a variety of normal adult tissues, including the heart, lung, kidney, liver, and pancreas.\nWestern blotting can also be used to detect survivin protein expression in tissue lysates. This method can be used to detect survivin protein expression in a variety of normal adult tissues, including the heart, lung, kidney, liver, and pancreas.\nRNA sequencing can also be used to detect survivin protein expression in normal human adult tissues. This method can be used to detect survivin mRNA expression in a variety of tissues, including the heart, lung, kidney, liver, and pancreas.\nOverall, survivin protein expression is widely distributed in normal human adult tissues, and there are several methods that can be used to detect it.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Survivin is a protein that is expressed in a variety of tissues, including normal adult tissues.\n2. Survivin is a member of the inhibitor of apoptosis (IAP) family of proteins.\n3. Survivin plays a role in the regulation of cell death.\n4. Methods to detect survivin protein expression include immunohistochemistry (IHC), Western blotting, and RNA sequencing.\n5. The survivin protein is expressed in tissues including the heart, lung, kidney, liver, and pancreas.",
    "vicuna-7b_fact": [
      "Survivin is a protein that is expressed in a variety of tissues, including normal adult tissues.",
      "Survivin is a member of the inhibitor of apoptosis (IAP) family of proteins.",
      "Survivin plays a role in the regulation of cell death.",
      "Methods to detect survivin protein expression include immunohistochemistry (IHC), Western blotting, and RNA sequencing.",
      "The survivin protein is expressed in tissues including the heart, lung, kidney, liver, and pancreas."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 433,
    "user_query": "List symptoms of Meigs' Syndrome.",
    "vicuna-7b_response": "Meigs' Syndrome is a rare genetic disorder characterized by the presence of an extra rib (rib 12) and a variety of other physical abnormalities. Some of the symptoms of Meigs' Syndrome include:\n1. Presence of an extra rib (rib 12)\n2. Short stature\n3. Flat face\n4. Low-set ears\n5. Narrow chest\n6. Abnormalities of the breast development\n7. Abnormalities of the genitals and urinary tract\n8. Delayed puberty\n9. Increased risk of certain types of cancer (such as breast and ovarian cancer)\nIt's important to note that not all individuals with Meigs' Syndrome will experience all of these symptoms, and some may experience additional symptoms not listed here. If you are concerned about your symptoms, it is important to speak with a healthcare provider for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Meigs' Syndrome is a rare genetic disorder.\n2. Presence of an extra rib is one of the symptoms of Meigs' Syndrome.\n3. Short stature, flat face, and low-set ears are some of the physical symptoms of Meigs' Syndrome.\n4. People with Meigs' Syndrome may have abnormalities of the genitals and urinary tract.\n5. Meigs' Syndrome can increase the risk of certain types of cancer, such as breast and ovarian cancer.",
    "vicuna-7b_fact": [
      "Meigs' Syndrome is a rare genetic disorder.",
      "Presence of an extra rib is one of the symptoms of Meigs' Syndrome.",
      "Short stature, flat face, and low-set ears are some of the physical symptoms of Meigs' Syndrome.",
      "People with Meigs' Syndrome may have abnormalities of the genitals and urinary tract.",
      "Meigs' Syndrome can increase the risk of certain types of cancer, such as breast and ovarian cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Meigs' Syndrome is a rare condition characterized by ovarian fibroma, ascites, and pleural effusion.\n2. FALSE [correction]: Presence of an extra rib is not a symptom of Meigs' Syndrome. \n3. FALSE [correction]: These physical symptoms are not associated with Meigs' Syndrome.\n4. FALSE [correction]: There is no evidence to suggest that abnormalities of the genitals and urinary tract are typically seen in individuals with Meigs' Syndrome.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 435,
    "user_query": "What is the molecular function of psoralen photobinding on DNA?",
    "vicuna-7b_response": "Psoralen is a naturally occurring compound found in certain plants and animals. It is also synthetically produced for use in various medical and scientific applications. Psoralen photobinding to DNA refers to the process by which psoralen molecules bind to specific regions of DNA through a process called intercalation.\nIntercalation is a process where a molecule inserts itself between the base pairs of DNA, disrupting the normal structure of the DNA double helix. Psoralen molecules can bind to DNA through intercalation, particularly to the guanine base pair, which is the target site for psoralen binding.\nOnce bound to DNA, psoralen molecules can undergo various chemical reactions, such as crosslinking, which can alter the structure and stability of the DNA molecule. This can have a variety of effects on the cell, including inhibiting DNA replication and repair, which can lead to cell death.\nPsoralen photobinding to DNA has various medical and scientific applications, including the treatment of psoriasis and other skin conditions, as well as the study of DNA structure and function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Psoralen is a naturally occurring compound found in certain plants and animals.\n2. Psoralen can also be synthetically produced for use in various medical and scientific applications.\n3. Psoralen molecules bind to specific regions of DNA through a process called intercalation.\n4. Psoralen molecules can alter the structure and stability of the DNA molecule, which can lead to cell death.\n5. Psoralen photobinding to DNA is used in the treatment of psoriasis and other skin conditions, as well as in the study of DNA structure and function.",
    "vicuna-7b_fact": [
      "Psoralen is a naturally occurring compound found in certain plants and animals.",
      "Psoralen can also be synthetically produced for use in various medical and scientific applications.",
      "Psoralen molecules bind to specific regions of DNA through a process called intercalation.",
      "Psoralen molecules can alter the structure and stability of the DNA molecule, which can lead to cell death.",
      "Psoralen photobinding to DNA is used in the treatment of psoriasis and other skin conditions, as well as in the study of DNA structure and function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Psoralen molecules bind to DNA through a process called cross-linking, not intercalation.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 440,
    "user_query": "Which are the main causes of fetal echogenic bowel?",
    "vicuna-7b_response": "Fetal echogenic bowel is a condition in which the bowel appears bright and clear on an ultrasound, rather than being hidden by the abdominal wall like it should be. There are several possible causes of fetal echogenic bowel, including:\n1. Increased amniotic fluid: Increased levels of amniotic fluid can cause the bowel to appear more visible on ultrasound.\n2. Maternal diabetes: Women with diabetes are at a higher risk of having a baby with fetal echogenic bowel.\n3. Maternal obesity: Women who are obese are at a higher risk of having a baby with fetal echogenic bowel.\n4. Genetic factors: There is a genetic component to fetal echogenic bowel, and some cases may be caused by inherited conditions.\n5. Other medical conditions: Certain medical conditions, such as hypothyroidism, can increase the risk of fetal echogenic bowel.\nIt's important to note that in most cases, fetal echogenic bowel is not a cause for concern and the baby will be healthy. However, if you have fetal echogenic bowel and are concerned about your baby's health, it's important to discuss your concerns with your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fetal echogenic bowel is a condition in which the bowel appears bright and clear on an ultrasound.\n2. Increased levels of amniotic fluid can cause the bowel to appear more visible on ultrasound.\n3. Women with diabetes are at a higher risk of having a baby with fetal echogenic bowel.\n4. Obese women are at a higher risk of having a baby with fetal echogenic bowel.\n5. Certain medical conditions, such as hypothyroidism, can increase the risk of fetal echogenic bowel.",
    "vicuna-7b_fact": [
      "Fetal echogenic bowel is a condition in which the bowel appears bright and clear on an ultrasound.",
      "Increased levels of amniotic fluid can cause the bowel to appear more visible on ultrasound.",
      "Women with diabetes are at a higher risk of having a baby with fetal echogenic bowel.",
      "Obese women are at a higher risk of having a baby with fetal echogenic bowel.",
      "Certain medical conditions, such as hypothyroidism, can increase the risk of fetal echogenic bowel."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: There is no direct correlation between women with diabetes and increased risk of having a baby with fetal echogenic bowel. However, it indicates that the mother or baby may have other conditions that require monitoring or treatment.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 442,
    "user_query": "Which is the enzymatic activity of the myotubularin family of proteins?",
    "vicuna-7b_response": "Myotubularin is a member of the RCC1-like family of proteins, which are characterized by the presence of a RCC1-like zinc finger motif and a myotubularin-like domain. Myotubularin is a protein that is primarily expressed in skeletal muscle and is involved in the regulation of muscle development and differentiation.\nThe enzymatic activity of myotubularin is not well understood, as it is not a classical enzyme. However, it has been suggested that myotubularin may play a role in the regulation of intracellular signaling pathways, possibly through its interaction with other proteins.\nIn summary, myotubularin is a protein that is not an enzyme in the classical sense, but it may play a role in the regulation of intracellular signaling pathways through its interaction with other proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Myotubularin is a member of the RCC1-like family of proteins.\n2. The RCC1-like family of proteins are characterized by the presence of a RCC1-like zinc finger motif and a myotubularin-like domain.\n3. Myotubularin is primarily expressed in skeletal muscle.\n4. Myotubularin is involved in the regulation of muscle development and differentiation.\n5. It's suggested that myotubularin may play a role in the regulation of intracellular signaling pathways through its interaction with other proteins.",
    "vicuna-7b_fact": [
      "Myotubularin is a member of the RCC1-like family of proteins.",
      "The RCC1-like family of proteins are characterized by the presence of a RCC1-like zinc finger motif and a myotubularin-like domain.",
      "Myotubularin is primarily expressed in skeletal muscle.",
      "Myotubularin is involved in the regulation of muscle development and differentiation.",
      "It's suggested that myotubularin may play a role in the regulation of intracellular signaling pathways through its interaction with other proteins."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Myotubularin is a member of the protein tyrosine phosphatase (PTP) family, not the RCC1-like family of proteins.\n2. FALSE [correction]: The myotubularin family of proteins is characterized by a phosphoinositide phosphatase domain and a coiled-coil domain.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 445,
    "user_query": "Is there any relationship between histone ubiquitylation and splicing?",
    "vicuna-7b_response": "Yes, there is a relationship between histone ubiquitylation and splicing.\nHistone ubiquitylation is a post-translational modification that involves the addition of ubiquitin molecules to histone proteins. This modification can affect the stability, localization, and function of histones, and it has been implicated in a variety of cellular processes, including transcription, DNA repair, and chromosome segregation.\nSplicing is the process by which introns are removed from RNA transcripts and the remaining exons are joined together to form a mature RNA molecule. This process is essential for generating functional RNAs from genomic DNA, and it is regulated by a variety of proteins, including splicing factors and ubiquitin-modified histones.\nIn particular, ubiquitylation of histone H2A and H2B has been implicated in the regulation of splicing. For example, ubiquitylation of histone H2A has been shown to promote the recruitment of splicing factors to specific regions of the genome, while ubiquitylation of histone H2B has been shown to regulate the accessibility of splicing factors to their target sites.\nOverall, the relationship between histone ubiquitylation and splicing is complex and multifaceted, and it is still an active area of research.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone ubiquitylation is a post-translational modification that involves the addition of ubiquitin molecules to histone proteins.\n2. Histone ubiquitylation can affect the stability, localization, and function of histones, and has been implicated in processes including transcription, DNA repair, and chromosome segregation.\n3. Splicing is the process by which introns are removed from RNA transcripts and the remaining exons are joined together to form a mature RNA molecule.\n4. Ubiquitylation of histone H2A and H2B has been implicated in the regulation of splicing.\n5. Ubiquitylation of histone H2A has been shown to promote the recruitment of splicing factors to specific regions of the genome, while ubiquitylation of histone H2B regulates the accessibility of splicing factors to their target sites.",
    "vicuna-7b_fact": [
      "Histone ubiquitylation is a post-translational modification that involves the addition of ubiquitin molecules to histone proteins.",
      "Histone ubiquitylation can affect the stability, localization, and function of histones, and has been implicated in processes including transcription, DNA repair, and chromosome segregation.",
      "Splicing is the process by which introns are removed from RNA transcripts and the remaining exons are joined together to form a mature RNA molecule.",
      "Ubiquitylation of histone H2A and H2B has been implicated in the regulation of splicing.",
      "Ubiquitylation of histone H2A has been shown to promote the recruitment of splicing factors to specific regions of the genome, while ubiquitylation of histone H2B regulates the accessibility of splicing factors to their target sites."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 448,
    "user_query": "What are the advantages of the top down mass spectrometric analysis of histones?",
    "vicuna-7b_response": "Top-down mass spectrometry is a powerful technique for analyzing histones and other proteins. One of the main advantages of top-down mass spectrometry is that it allows for the direct analysis of intact proteins, without the need for protein digestion or other pre-processing steps. This means that the native conformation of the protein can be preserved, which can be important for understanding the function of the protein.\nAnother advantage of top-down mass spectrometry is that it can provide high-resolution mass information, which can be used to identify and quantitate different post-translational modifications (PTMs) on the histone protein. This can be useful for understanding the role of PTMs in regulating histone function and for identifying potential drug targets.\nIn addition, top-down mass spectrometry can be used to study the dynamics of histone proteins in solution, which can be important for understanding their behavior in the cell. This can be done by monitoring the migration of the protein in a mass spectrometer as a function of time, which can provide information about the rate of exchange between different states or conformations of the protein.\nOverall, top-down mass spectrometry is a powerful tool for studying histones and other proteins, and it has many advantages over other techniques, such as bottom-up mass spectrometry.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Top-down mass spectrometry allows for the direct analysis of intact proteins, without the need for protein digestion or other pre-processing steps.\n2. The technique can preserve the native conformation of the protein, which can be important for understanding the function of the protein.\n3. Top-down mass spectrometry can provide high-resolution mass information, which can be used to identify and quantitate different post-translational modifications on the histone protein.\n4. The technique can be used to study the dynamics of histone proteins in solution.\n5. Top-down mass spectrometry can provide information about the rate of exchange between different states or conformations of the protein.",
    "vicuna-7b_fact": [
      "Top-down mass spectrometry allows for the direct analysis of intact proteins, without the need for protein digestion or other pre-processing steps.",
      "The technique can preserve the native conformation of the protein, which can be important for understanding the function of the protein.",
      "Top-down mass spectrometry can provide high-resolution mass information, which can be used to identify and quantitate different post-translational modifications on the histone protein.",
      "The technique can be used to study the dynamics of histone proteins in solution.",
      "Top-down mass spectrometry can provide information about the rate of exchange between different states or conformations of the protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 451,
    "user_query": "What is the indication of Daonil (Glibenclamide)?",
    "vicuna-7b_response": "Daonil (Glibenclamide) is an oral anti-diabetic medication that belongs to a class of drugs called sulfonylureas. It is used to control high blood sugar levels in patients with type 2 diabetes.\nThe main indication for Daonil is to improve blood sugar control in patients who are unable to achieve adequate glycemic control with diet and exercise alone. Daonil works by stimulating the release of insulin from the pancreas, which helps to lower blood sugar levels.\nDaonil is usually taken once daily, with or without food. The dosage may vary depending on the individual patient and their response to the medication. It is important to follow the dosage instructions provided by your healthcare provider and to regularly monitor your blood sugar levels to ensure that the medication is working effectively.\nIt is important to note that Daonil is not suitable for everyone with diabetes, and it may not be effective in controlling blood sugar levels in some patients. Therefore, it is important to consult with your healthcare provider to determine if Daonil is an appropriate treatment option for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Daonil (Glibenclamide) is an oral anti-diabetic medication.\n2. Daonil belongs to a class of drugs called sulfonylureas.\n3. Daonil is used to control high blood sugar levels in patients with type 2 diabetes.\n4. Daonil improves blood sugar control in patients who are not able to achieve adequate glycemic control with just diet and exercise.\n5. Daonil works by stimulating the release of insulin from the pancreas.",
    "vicuna-7b_fact": [
      "Daonil (Glibenclamide) is an oral anti-diabetic medication.",
      "Daonil belongs to a class of drugs called sulfonylureas.",
      "Daonil is used to control high blood sugar levels in patients with type 2 diabetes.",
      "Daonil improves blood sugar control in patients who are not able to achieve adequate glycemic control with just diet and exercise.",
      "Daonil works by stimulating the release of insulin from the pancreas."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 452,
    "user_query": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?",
    "vicuna-7b_response": "The most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is the signal peptide.\nThe signal peptide is a short sequence of amino acids that is typically found at the N-terminus of a protein and is responsible for directing the protein into the secretory pathway. Once the protein reaches the Golgi apparatus, the signal peptide is cleaved off, leaving the mature protein behind to be transported to its final destination.\nIn addition to the signal peptide, there are other peptide sequences that can also be involved in the retrieval of ER lumenal proteins from the Golgi apparatus, such as sorting signals and chaperone-mediated signals. However, the signal peptide is the most common and most important peptide sequence for this process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The signal peptide is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus.\n2. The signal peptide is a short sequence of amino acids. \n3. The signal peptide is typically found at the N-terminus of a protein.\n4. The signal peptide is responsible for directing the protein into the secretory pathway.\n5. There are other peptide sequences, such as sorting signals and chaperone-mediated signals, that can be involved in the retrieval of ER lumenal proteins from the Golgi apparatus.",
    "vicuna-7b_fact": [
      "The signal peptide is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus.",
      "The signal peptide is a short sequence of amino acids.",
      "The signal peptide is typically found at the N-terminus of a protein.",
      "The signal peptide is responsible for directing the protein into the secretory pathway.",
      "There are other peptide sequences, such as sorting signals and chaperone-mediated signals, that can be involved in the retrieval of ER lumenal proteins from the Golgi apparatus."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The KDEL or KKXX motif, not the signal peptide, is most typically responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 454,
    "user_query": "List the main proteases used for sample digestion in proteomics.",
    "vicuna-7b_response": "In proteomics, proteases are enzymes that are used to break down proteins into smaller peptides or amino acids. There are several main proteases that are commonly used for sample digestion in proteomics. Here are some of the most commonly used proteases:\n1. Trypsin: Trypsin is a protease that is commonly used for protein digestion in proteomics. It is a serine protease that cleaves peptides at the carboxyl side of lysine and arginine residues. Trypsin is often used as the first protease in a proteomic sample digestion protocol, as it is highly specific for lysine and arginine residues and can cleave peptides at the C-terminus of these residues.\n2. Chymotrypsin: Chymotrypsin is another protease that is commonly used for protein digestion in proteomics. It is a serine protease that cleaves peptides at the carboxyl side of aspartic and glutamic acid residues. Chymotrypsin is often used as a second protease in a proteomic sample digestion protocol, as it can cleave peptides at the C-terminus of aspartic and glutamic acid residues.\n3. Glucoamylase: Glucoamylase is an amylolytic enzyme that is commonly used for protein digestion in proteomics. It is an endo-amylase that cleaves starch into glucose, and it can also cleave peptides at the C-terminus of asparagine residues. Glucoamylase is often used as a third protease in a proteomic sample digestion protocol, as it can cleave peptides at the C-terminus of asparagine residues.\n4. Aspartyl protease: Aspartyl protease is a protease that is commonly used for protein digestion in proteomics. It is a serine protease that cleaves peptides at the carboxyl side of aspartic acid residues. Aspartyl protease is often used as a fourth protease in a proteomic sample digestion protocol, as it can cleave peptides at the C-terminus of aspartic acid residues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Proteases are enzymes that are used to break down proteins into smaller peptides or amino acids in proteomics.\n2. Trypsin is a serine protease that cleaves peptides at the carboxyl side of lysine and arginine residues.\n3. Chymotrypsin is a serine protease that cleaves peptides at the carboxyl side of aspartic and glutamic acid residues.\n4. Glucoamylase is an amylolytic enzyme that cleaves starch into glucose, and it can also cleave peptides at the C-terminus of asparagine residues.\n5. Aspartyl protease is a serine protease that cleaves peptides at the carboxyl side of aspartic acid residues.",
    "vicuna-7b_fact": [
      "Proteases are enzymes that are used to break down proteins into smaller peptides or amino acids in proteomics.",
      "Trypsin is a serine protease that cleaves peptides at the carboxyl side of lysine and arginine residues.",
      "Chymotrypsin is a serine protease that cleaves peptides at the carboxyl side of aspartic and glutamic acid residues.",
      "Glucoamylase is an amylolytic enzyme that cleaves starch into glucose, and it can also cleave peptides at the C-terminus of asparagine residues.",
      "Aspartyl protease is a serine protease that cleaves peptides at the carboxyl side of aspartic acid residues."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chymotrypsin is a serine protease that cleaves peptides at the carboxyl side of tryptophan, tyrosine, and phenylalanine residues.\n4. FALSE [correction]: Glucoamylase is an amylolytic enzyme that cleaves starch into glucose, but it does not cleave peptides at the C-terminus of asparagine residues.\n5. FALSE [correction]: Aspartyl protease is not a serine protease. It is a class of enzymes that cleave peptides at the carboxyl side of aspartic acid residues but it uses aspartic acid residue in its active site, not serine.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 456,
    "user_query": "What is the association between Generalized anxiety disorder and mortality risk?",
    "vicuna-7b_response": "Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry about a variety of events and activities. It is estimated that approximately 7.2% of adults in the United States have GAD, and it is more common in women than in men.\nThere is evidence to suggest that individuals with GAD may have an increased risk of mortality compared to those without the disorder. Studies have found that individuals with GAD have a higher risk of death from all causes, including cardiovascular disease, cancer, and other causes.\nOne possible explanation for this association is that individuals with GAD may engage in behaviors that increase their risk of mortality, such as smoking, lack of exercise, and poor diet. Additionally, individuals with GAD may have other health conditions that increase their risk of mortality, such as depression or substance abuse.\nIt is important to note that the relationship between GAD and mortality risk is complex and may be influenced by a variety of factors. Further research is needed to better understand the association between GAD and mortality risk, and to identify the underlying mechanisms that may contribute to this association.\nIn summary, there is evidence to suggest that individuals with GAD may have an increased risk of mortality compared to those without the disorder. This association may be influenced by a variety of factors, including behaviors and health conditions. Further research is needed to better understand the relationship between GAD and mortality risk.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry about a variety of events and activities.\n2. Approximately 7.2% of adults in the United States have Generalized anxiety disorder (GAD).\n3. Generalized anxiety disorder (GAD) is more common in women than in men.\n4. Studies have found that individuals with GAD have a higher risk of death from all causes, including cardiovascular disease, cancer, and other causes.\n5. Individuals with GAD may engage in behaviors that increase their risk of mortality, such as smoking, lack of exercise, and poor diet.",
    "vicuna-7b_fact": [
      "Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry about a variety of events and activities.",
      "Approximately 7.2% of adults in the United States have Generalized anxiety disorder (GAD).",
      "Generalized anxiety disorder (GAD) is more common in women than in men.",
      "Studies have found that individuals with GAD have a higher risk of death from all causes, including cardiovascular disease, cancer, and other causes.",
      "Individuals with GAD may engage in behaviors that increase their risk of mortality, such as smoking, lack of exercise, and poor diet."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Approximately 3.1% of adults in the United States have Generalized anxiety disorder (GAD).\n3. TRUE\n4. FALSE [correction]: Studies have found that individuals with GAD have higher risk of comorbid physical health conditions, but not specifically higher risk of death.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 457,
    "user_query": "Which molecule is targeted by a monoclonal antibody Mepolizumab?",
    "vicuna-7b_response": "Mepolizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha chain. This receptor is expressed on the surface of eosinophils, a type of white blood cell that plays a role in allergic and inflammatory responses. By binding to the IL-5 receptor alpha chain, mepolizumab can reduce the number of eosinophils in the blood and tissues, thereby reducing inflammation and improving symptoms in patients with certain chronic inflammatory diseases, such as severe asthma and eosinophilic esophagitis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mepolizumab is a monoclonal antibody.\n2. Mepolizumab targets the interleukin-5 (IL-5) receptor alpha chain.\n3. The IL-5 receptor alpha chain is expressed on the surface of eosinophils.\n4. Mepolizumab has the ability to reduce the number of eosinophils in the blood and tissues.\n5. Mepolizumab is used in the treatment of certain chronic inflammatory diseases, such as severe asthma and eosinophilic esophagitis.",
    "vicuna-7b_fact": [
      "Mepolizumab is a monoclonal antibody.",
      "Mepolizumab targets the interleukin-5 (IL-5) receptor alpha chain.",
      "The IL-5 receptor alpha chain is expressed on the surface of eosinophils.",
      "Mepolizumab has the ability to reduce the number of eosinophils in the blood and tissues.",
      "Mepolizumab is used in the treatment of certain chronic inflammatory diseases, such as severe asthma and eosinophilic esophagitis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mepolizumab targets the interleukin-5 (IL-5), not its receptor.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 461,
    "user_query": "Which genes are affected in ROMANO-WARD syndrome?",
    "vicuna-7b_response": "ROMANO-WARD syndrome is a rare genetic disorder caused by mutations in the PEX7 gene. The PEX7 gene provides instructions for making a protein that helps transport a substance called peroxisomal protein import 1 (PPI1) into peroxisomes, which are small organelles found in cells.\nMutations in the PEX7 gene can lead to the accumulation of PPI1 in the endoplasmic reticulum (ER), which can cause the ER to become enlarged and disorganized, leading to a range of symptoms. These symptoms can include developmental delays, intellectual disability, and a distinctive facial appearance, including a broad forehead, low-set ears, and a small jaw.\nIn addition to these symptoms, individuals with ROMANO-WARD syndrome may also have other health issues, such as seizures, vision problems, and hearing loss. The severity of the symptoms can vary widely among individuals, and some people with ROMANO-WARD syndrome may have only a few of the characteristic symptoms.\nThere is currently no cure for ROMANO-WARD syndrome, and treatment is focused on managing the symptoms and improving quality of life. This may include medications to control seizures, therapy to improve communication and other skills, and support services to help individuals with ROMANO-WARD syndrome and their families.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ROMANO-WARD syndrome is a genetic disorder caused by mutations in the PEX7 gene.\n2. The PEX7 gene in ROMANO-WARD syndrome is responsible for making a protein that transports PPI1 into peroxisomes.\n3. Mutations in the PEX7 gene can lead to accumulation of PPI1 in the endoplasmic reticulum.\n4. ROMANO-WARD syndrome can cause many symptoms, including developmental delays, intellectual disability, a distinctive facial appearance, seizures, vision problems, and hearing loss.\n5. Currently, there is no cure for ROMANO-WARD syndrome and the treatment is focused on managing the symptoms and improving quality of life.",
    "vicuna-7b_fact": [
      "ROMANO-WARD syndrome is a genetic disorder caused by mutations in the PEX7 gene.",
      "The PEX7 gene in ROMANO-WARD syndrome is responsible for making a protein that transports PPI1 into peroxisomes.",
      "Mutations in the PEX7 gene can lead to accumulation of PPI1 in the endoplasmic reticulum.",
      "ROMANO-WARD syndrome can cause many symptoms, including developmental delays, intellectual disability, a distinctive facial appearance, seizures, vision problems, and hearing loss.",
      "Currently, there is no cure for ROMANO-WARD syndrome and the treatment is focused on managing the symptoms and improving quality of life."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Romano-Ward syndrome is a genetic disorder caused by mutations in the KCNQ1, KCNH2 or SCN5A gene.\n2. FALSE [correction]: The PEX7 gene is not associated with Romano-Ward syndrome.\n3. FALSE [correction]: Mutations in the PEX7 gene are not related to Romano-Ward syndrome.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 462,
    "user_query": "Does melanoma  occur in people of African origin ?",
    "vicuna-7b_response": "Yes, melanoma can occur in people of African origin. Melanoma is a type of skin cancer that can develop in any part of the skin, including the skin of people of African descent. The risk of developing melanoma is higher in people with light skin, but it can occur in people of any skin color.\nMelanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more common in people with light skin, but it can occur in people of any skin color. Melanoma is more",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Melanoma can occur in people of African origin.\n2. Melanoma is a type of skin cancer that can develop in any part of the skin.\n3. The risk of developing melanoma is higher in people with light skin.\n4. Melanoma is more common in people with light skin.\n5. Melanoma can occur in people of any skin color.",
    "vicuna-7b_fact": [
      "Melanoma can occur in people of African origin.",
      "Melanoma is a type of skin cancer that can develop in any part of the skin.",
      "The risk of developing melanoma is higher in people with light skin.",
      "Melanoma is more common in people with light skin.",
      "Melanoma can occur in people of any skin color."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 463,
    "user_query": "What is the effect of resveratrol on mTOR activity?",
    "vicuna-7b_response": "Resveratrol is a polyphenolic compound found in various plant-based foods, such as grapes, berries, and peanuts. It has been shown to have a variety of health benefits, including anti-inflammatory, antioxidant, and anti-cancer effects.\nOne of the key molecular targets of resveratrol is the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway is a key regulator of cell growth and metabolism, and it is often activated in response to various stimuli, such as growth factors, nutrients, and stress.\nResveratrol has been shown to inhibit the mTOR pathway by binding to and inhibiting the activity of the mTOR kinase, which is a key enzyme in the pathway. This inhibition of the mTOR pathway has been shown to have a variety of effects on cellular metabolism and growth, including:\n* Inhibition of protein synthesis and cell growth\n* Induction of autophagy (cellular self-digestion)\n* Modulation of energy metabolism\n* Regulation of cellular stress response\nOverall, the effects of resveratrol on the mTOR pathway suggest that it may have potential as a therapeutic agent for a variety of diseases, including cancer, metabolic disorders, and neurodegenerative diseases, by targeting the mTOR pathway and its downstream effects on cellular metabolism and growth.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Resveratrol is a polyphenolic compound found in various plant-based foods, such as grapes, berries, and peanuts.\n2. Resveratrol has been shown to have health benefits, including anti-inflammatory, antioxidant, and anti-cancer effects.\n3. One of the key molecular targets of resveratrol is the mammalian target of rapamycin (mTOR) pathway.\n4. Resveratrol inhibits the mTOR pathway by binding to and inhibiting the activity of the mTOR kinase.\n5. The inhibition of the mTOR pathway by resveratrol can have effects on cellular metabolism and growth, including inhibition of protein synthesis and cell growth, induction of autophagy, modulation of energy metabolism, and regulation of cellular stress response.",
    "vicuna-7b_fact": [
      "Resveratrol is a polyphenolic compound found in various plant-based foods, such as grapes, berries, and peanuts.",
      "Resveratrol has been shown to have health benefits, including anti-inflammatory, antioxidant, and anti-cancer effects.",
      "One of the key molecular targets of resveratrol is the mammalian target of rapamycin (mTOR) pathway.",
      "Resveratrol inhibits the mTOR pathway by binding to and inhibiting the activity of the mTOR kinase.",
      "The inhibition of the mTOR pathway by resveratrol can have effects on cellular metabolism and growth, including inhibition of protein synthesis and cell growth, induction of autophagy, modulation of energy metabolism, and regulation of cellular stress response."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 464,
    "user_query": "Are people with blood group O protected against severe Malaria?",
    "vicuna-7b_response": "People with blood group O are not protected against severe malaria. Malaria is a parasitic infection that is spread through the bites of infected mosquitoes. It can cause a range of symptoms, from mild flu-like symptoms to severe and life-threatening complications, such as anemia, seizures, and coma.\nWhile blood group O is one of the most common blood types, it does not provide any protection against malaria. Malaria can affect people of all blood types, including those with blood group O.\nHowever, there are some factors that can affect the risk of developing severe malaria. For example, people who live in areas where malaria is common, those who have a weakened immune system, and pregnant women are at higher risk of developing severe malaria.\nTo prevent malaria, it is important to take measures such as using insect repellent, wearing protective clothing, and sleeping in a mosquito-proofed room. In addition, taking antimalarial medication, such as chloroquine or primaquine, can also help to reduce the risk of developing malaria.\nIf you have concerns about malaria or any other health issue, it is important to speak with a healthcare professional. They can provide you with personalized advice and recommendations based on your individual circumstances.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Malaria is a parasitic infection that spreads through the bites of infected mosquitoes.\n2. Blood group O does not provide any protection against malaria.\n3. Malaria can affect people of all blood types, including those with blood group O.\n4. People who live in areas where malaria is common, those who have a weakened immune system, and pregnant women are at a higher risk of developing severe malaria.\n5. Using insect repellent, wearing protective clothing, and sleeping in a mosquito-proofed room are some recommended measures to prevent malaria.",
    "vicuna-7b_fact": [
      "Malaria is a parasitic infection that spreads through the bites of infected mosquitoes.",
      "Blood group O does not provide any protection against malaria.",
      "Malaria can affect people of all blood types, including those with blood group O.",
      "People who live in areas where malaria is common, those who have a weakened immune system, and pregnant women are at a higher risk of developing severe malaria.",
      "Using insect repellent, wearing protective clothing, and sleeping in a mosquito-proofed room are some recommended measures to prevent malaria."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Some studies suggest that people with blood group O may be less susceptible to severe forms of malaria.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 467,
    "user_query": "What is the mechanism of action of solanezumab?",
    "vicuna-7b_response": "Solanezumab is a monoclonal antibody that is used to treat Alzheimer's disease. It works by binding to and clearing beta-amyloid protein, which is a hallmark of the disease. Beta-amyloid protein is a toxic substance that accumulates in the brains of people with Alzheimer's and is believed to play a role in the development of the disease. By removing beta-amyloid protein, solanezumab may help to slow the progression of Alzheimer's and improve cognitive function. Additionally, solanezumab may also help to reduce the formation of new beta-amyloid plaques in the brain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Solanezumab is a monoclonal antibody used to treat Alzheimer's disease.\n2. Solanezumab works by binding to and clearing beta-amyloid protein.\n3. Beta-amyloid protein is a substance that accumulates in the brains of people with Alzheimer's.\n4. The removal of beta-amyloid protein by solanezumab may slow the progression of Alzheimer's and improve cognitive function.\n5. Solanezumab may help to reduce the formation of new beta-amyloid plaques in the brain.",
    "vicuna-7b_fact": [
      "Solanezumab is a monoclonal antibody used to treat Alzheimer's disease.",
      "Solanezumab works by binding to and clearing beta-amyloid protein.",
      "Beta-amyloid protein is a substance that accumulates in the brains of people with Alzheimer's.",
      "The removal of beta-amyloid protein by solanezumab may slow the progression of Alzheimer's and improve cognitive function.",
      "Solanezumab may help to reduce the formation of new beta-amyloid plaques in the brain."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Solanezumab is a monoclonal antibody that is being studied for the treatment of Alzheimer's disease, but it is not yet approved for this use.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Solanezumab does not reduce the formation of new beta-amyloid plaques, it works by binding to and helping to clear existing plaques.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 469,
    "user_query": "What is the treatment of neuropathic pain in children?",
    "vicuna-7b_response": "Neuropathic pain in children can be challenging to treat due to the complexity of the condition and the fact that children may not be able to communicate their symptoms effectively. However, there are several treatment options available for managing neuropathic pain in children.\nThe first line of treatment for neuropathic pain in children is usually non-pharmacological interventions such as physical therapy, occupational therapy, and cognitive-behavioral therapy. These interventions can help to reduce pain and improve function.\nIf non-pharmacological interventions are not effective, medications may be used to manage neuropathic pain in children. The most commonly used medications for neuropathic pain in children are anticonvulsants, which are effective in reducing pain and inflammation. Other medications that may be used include opioids, tricyclic antidepressants, and topical creams.\nIn some cases, surgery may be necessary to manage neuropathic pain in children. This may include nerve blocks, nerve decompression, or spinal cord stimulation.\nIt is important to note that the treatment of neuropathic pain in children should be individualized and tailored to the specific needs of the child. The treatment plan should be developed in collaboration with the child's healthcare team, which may include a pediatric neurologist, a pediatric pain specialist, and other healthcare professionals.\nIn summary, the treatment of neuropathic pain in children typically involves a combination of non-pharmacological interventions and medications, with surgery being considered in some cases. The treatment plan should be individualized and tailored to the specific needs of the child.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neuropathic pain in children can be managed with non-pharmacological interventions such as physical therapy, occupational therapy, and cognitive-behavioral therapy.\n2. If non-pharmacological interventions are not effective, medications may be used to manage neuropathic pain in children.\n3. The most commonly used medications for neuropathic pain in children are anticonvulsants.\n4. Other medications that may be used for neuropathic pain in children include opioids, tricyclic antidepressants, and topical creams.\n5. In some cases, surgery may be necessary to manage neuropathic pain in children.",
    "vicuna-7b_fact": [
      "Neuropathic pain in children can be managed with non-pharmacological interventions such as physical therapy, occupational therapy, and cognitive-behavioral therapy.",
      "If non-pharmacological interventions are not effective, medications may be used to manage neuropathic pain in children.",
      "The most commonly used medications for neuropathic pain in children are anticonvulsants.",
      "Other medications that may be used for neuropathic pain in children include opioids, tricyclic antidepressants, and topical creams.",
      "In some cases, surgery may be necessary to manage neuropathic pain in children."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 470,
    "user_query": "Which phenomenon is known as the \"calcium paradox\" in the isolated perfused heart?",
    "vicuna-7b_response": "The \"calcium paradox\" in the isolated perfused heart refers to the observation that, despite the presence of high levels of extracellular calcium ions (Ca2+), cardiac muscle cells in the heart do not contract. This phenomenon is paradoxical because high levels of extracellular Ca2+ are known to stimulate muscle contraction in other cells.\nThe paradox is resolved by understanding that the heart is an exception to the general rule. In the heart, the level of intracellular Ca2+ is regulated by the sarcoplasmic reticulum (SR), which is a specialized organelle that is responsible for storing and releasing calcium ions in response to changes in the concentration of Ca2+ in the extracellular space. In the heart, the SR is closely coupled to the plasma membrane, allowing it to respond quickly to changes in the concentration of Ca2+ in the extracellular space.\nWhen the heart is isolated and perfused with a solution that maintains a high level of extracellular Ca2+, the SR becomes saturated with calcium ions, and the level of intracellular Ca2+ remains low. This prevents the muscle cells from contracting, even though the extracellular space is saturated with calcium ions.\nIn summary, the \"calcium paradox\" in the isolated perfused heart refers to the observation that, despite the presence of high levels of extracellular calcium ions, cardiac muscle cells in the heart do not contract. This phenomenon is resolved by understanding that the heart is an exception to the general rule, and that the level of intracellular Ca2+ is regulated by the sarcoplasmic reticulum in the heart.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"calcium paradox\" in the isolated perfused heart refers to the situation where cardiac muscles do not contract despite the presence of high levels of extracellular calcium ions.\n2. High levels of extracellular Ca2+ are generally known to stimulate muscle contraction in cells.\n3. Intracellular Ca2+ levels in the heart are regulated by the sarcoplasmic reticulum.\n4. The sarcoplasmic reticulum is responsible for storing and releasing calcium ions in response to changes in the concentration of Ca2+ in the extracellular space.\n5. When the heart is isolated and perfused with a solution that maintains a high level of extracellular Ca2+, the level of intracellular Ca2+ remains low. This prevents the muscle cells from contracting.",
    "vicuna-7b_fact": [
      "The \"calcium paradox\" in the isolated perfused heart refers to the situation where cardiac muscles do not contract despite the presence of high levels of extracellular calcium ions.",
      "High levels of extracellular Ca2+ are generally known to stimulate muscle contraction in cells.",
      "Intracellular Ca2+ levels in the heart are regulated by the sarcoplasmic reticulum.",
      "The sarcoplasmic reticulum is responsible for storing and releasing calcium ions in response to changes in the concentration of Ca2+ in the extracellular space.",
      "When the heart is isolated and perfused with a solution that maintains a high level of extracellular Ca2+, the level of intracellular Ca2+ remains low. This prevents the muscle cells from contracting."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-7b_response": "Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that play important roles in regulating mRNA stability.\nHsp70 is a highly conserved protein that functions as a chaperone, helping to fold and stabilize proteins. It also plays a role in regulating the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation by RNA-degrading enzymes. In addition, Hsp70 can also help to stabilize mRNAs by promoting the formation of RNA-protein complexes.\nHsp110 is another type of HSP that is involved in the regulation of mRNA stability. It has been shown to bind to unstable RNA molecules and promote their degradation by RNA-degrading enzymes. Hsp110 can also interact with RNA-binding proteins and help to regulate the stability of specific mRNAs.\nOverall, Hsp70 and Hsp110 play important roles in regulating mRNA stability by binding to unstable RNA molecules and promoting their degradation or stabilization, respectively. These proteins are important for maintaining the proper balance of gene expression and ensuring that cells respond appropriately to stress conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that regulate mRNA stability.\n2. Hsp70 functions as a chaperone, helping to fold and stabilize proteins.\n3. Hsp70 regulates the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation.\n4. Hsp110 is involved in the regulation of mRNA stability.\n5. Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes.",
    "vicuna-7b_fact": [
      "Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that regulate mRNA stability.",
      "Hsp70 functions as a chaperone, helping to fold and stabilize proteins.",
      "Hsp70 regulates the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation.",
      "Hsp110 is involved in the regulation of mRNA stability.",
      "Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Hsp70 and Hsp110 are types of heat shock proteins (HSPs) that mainly assist with protein folding, not regulation of mRNA stability.\n2. TRUE\n3. FALSE [correction]: Hsp70 does not regulate the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation. Instead, it assists with protein folding.\n4. FALSE [correction]: Hsp110, like Hsp70, is involved in protein folding, not in the regulation of mRNA stability.\n5. FALSE [correction]: Hsp110 does not bind to unstable RNA molecules to promote their degradation by RNA-degrading enzymes. Rather, it aids in protein folding and stabilizing.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 477,
    "user_query": "What is FINDbase?",
    "vicuna-7b_response": "FINDbase is a software platform that provides a suite of tools for managing and analyzing data. It is designed to help businesses and organizations of all sizes collect, store, and analyze data from a variety of sources, including databases, spreadsheets, and other data sources.\nFINDbase offers a range of features that make it easy to manage and analyze data, including data integration, data visualization, and data reporting. It also provides tools for data cleansing and data transformation, which can help ensure that data is accurate and consistent.\nOne of the key benefits of FINDbase is its flexibility. It can be used to manage data from a wide range of sources, including relational databases, flat files, and cloud-based data sources. It also supports a variety of data formats, including CSV, Excel, and SQL.\nIn addition to its data management and analysis capabilities, FINDbase also offers a range of security features to help protect sensitive data. It supports user authentication and access control, as well as data encryption and data backup and recovery.\nOverall, FINDbase is a powerful and flexible software platform that can help businesses and organizations of all sizes manage and analyze their data more effectively.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. FINDbase is a software platform that provides tools for managing and analyzing data.\n2. FINDbase offers features such as data integration, data visualization, data reporting, data cleansing, and data transformation.\n3. FINDbase can be used for managing data from a variety of sources including databases, spreadsheets, flat files, and cloud-based data sources.\n4. FINDbase supports various data formats, including CSV, Excel, and SQL.\n5. FINDbase offers security features such as user authentication and access control, data encryption, and data backup and recovery.",
    "vicuna-7b_fact": [
      "FINDbase is a software platform that provides tools for managing and analyzing data.",
      "FINDbase offers features such as data integration, data visualization, data reporting, data cleansing, and data transformation.",
      "FINDbase can be used for managing data from a variety of sources including databases, spreadsheets, flat files, and cloud-based data sources.",
      "FINDbase supports various data formats, including CSV, Excel, and SQL.",
      "FINDbase offers security features such as user authentication and access control, data encryption, and data backup and recovery."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: FINDbase is a database that collects and documents frequencies of causative mutations leading to inherited disorders worldwide.\n2. FALSE [correction]: FINDbase does not directly offer data integration, data visualization, data reporting, data cleansing, or data transformation features but provides mutation frequency data for researchers.\n3. FALSE [correction]: FINDbase is used for collecting data regarding genetic disorders and their frequency, it does not manage data from a variety of sources like databases, spreadsheets, flat files, and cloud-based data sources.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-7b_response": "Skeletal muscle contains several types of deiodinases, including type 1 (D1), type 2 (D2), and type 3 (D3) deiodinases.\nType 1 deiodinase (D1) is also known as the thyroid hormone deiodinase, and it is responsible for converting T4 to T3 in the periphery. D1 is primarily expressed in the thyroid gland, but it is also found in skeletal muscle, heart, and other tissues. In skeletal muscle, D1 plays a crucial role in regulating muscle metabolism and energy expenditure.\nType 2 deiodinase (D2) is also known as the peripheral deiodinase, and it is responsible for converting T4 to T3 in the periphery. D2 is primarily expressed in the liver, but it is also found in skeletal muscle, adipose tissue, and other tissues. In skeletal muscle, D2 plays a role in regulating glucose metabolism and insulin sensitivity.\nType 3 deiodinase (D3) is also known as the gut-derived deiodinase, and it is responsible for converting T4 to T3 in the gut. D3 is primarily expressed in the gut, but it is also found in other tissues such as the liver and skeletal muscle. In skeletal muscle, D3 plays a role in regulating muscle growth and development.\nIn summary, skeletal muscle contains D1, D2, and D3 deiodinases, which play important roles in regulating muscle metabolism, glucose metabolism, and muscle growth and development.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Skeletal muscle contains several types of deiodinases, including type 1, type 2, and type 3.\n2. Type 1 deiodinase (D1) is responsible for converting T4 to T3 in the periphery and it is also found in skeletal muscle.\n3. Type 2 deiodinase (D2) is also responsible for converting T4 to T3 in the periphery and it is also found in skeletal muscle.\n4. Type 3 deiodinase (D3) is responsible for converting T4 to T3 in the gut and it is also found in skeletal muscle.\n5. These deiodinases play important roles in regulating muscle metabolism, glucose metabolism, and muscle growth and development.",
    "vicuna-7b_fact": [
      "Skeletal muscle contains several types of deiodinases, including type 1, type 2, and type 3.",
      "Type 1 deiodinase (D1) is responsible for converting T4 to T3 in the periphery and it is also found in skeletal muscle.",
      "Type 2 deiodinase (D2) is also responsible for converting T4 to T3 in the periphery and it is also found in skeletal muscle.",
      "Type 3 deiodinase (D3) is responsible for converting T4 to T3 in the gut and it is also found in skeletal muscle.",
      "These deiodinases play important roles in regulating muscle metabolism, glucose metabolism, and muscle growth and development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Type 3 deiodinase (D3) is responsible for converting T4 into reverse T3, an inactive form, and it is found in placenta, fetal tissues and central nervous system, not typically in skeletal muscle.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 483,
    "user_query": "Which is the molecular weight of the protein angiogenin?",
    "vicuna-7b_response": "Angiogenin is a protein that has a molecular weight of approximately 27 kDa.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The protein angiogenin has a molecular weight of approximately 27 kDa.",
    "vicuna-7b_fact": [
      "The protein angiogenin has a molecular weight of approximately 27 kDa."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 484,
    "user_query": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.",
    "vicuna-7b_response": "Sure, here are some SGLT2 inhibitors that have been FDA approved for the treatment of type 2 diabetes mellitus:\n1. Canagliflozin (Invokana, Janssen Pharmaceuticals)\n2. Dapagliflozin (Farxiga, Bristol-Myers Squibb and AstraZeneca)\n3. Empagliflozin (Jardiance, Boehringer Ingelheim and Eli Lilly)\n4. Ertugliflozin (Steglatro, Merck & Co., Inc.)\n5. Sitagliptin (Januvia, Merck & Co., Inc.)\n6. Saxagliptin (Onglyza, AstraZeneca)\n7. Vildagliptin (Galvus, Novo Nordisk)\nThese SGLT2 inhibitors work by inhibiting the reabsorption of glucose in the kidneys, leading to lower blood glucose levels. They are often used as an add-on therapy to other diabetes medications, such as metformin or sulfonylureas. It's important to note that these medications should be used under the guidance of a healthcare provider, as they can have potential side effects and interactions with other medications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Canagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.\n2. Dapagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.\n3. Empagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.\n4. Ertugliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.\n5. SGLT2 inhibitors work by inhibiting the reabsorption of glucose in the kidneys, leading to lower blood glucose levels.",
    "vicuna-7b_fact": [
      "Canagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.",
      "Dapagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.",
      "Empagliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.",
      "Ertugliflozin is an FDA-approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus.",
      "SGLT2 inhibitors work by inhibiting the reabsorption of glucose in the kidneys, leading to lower blood glucose levels."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 486,
    "user_query": "Why does the prodrug amifostine (ethyol) create hypoxia?",
    "vicuna-7b_response": "Amifostine (ethyol) is a prodrug that is used as an antioxidant and to protect against radiation-induced damage. It is not directly associated with creating hypoxia.\nHowever, it is important to note that amifostine is a prodrug, which means it is a compound that is converted into another compound in the body. In the case of amifostine, it is converted into a compound called ethyol, which is a water-soluble derivative of the antioxidant glutathione.\nEthyol has been shown to have several effects in the body, including the ability to protect against oxidative stress and inflammation. However, it is not directly associated with creating hypoxia.\nHypoxia, or low oxygen levels in the body, can be caused by a variety of factors, including decreased blood flow, increased oxygen demand, and impaired oxygen transport. It is important to note that amifostine is not associated with any of these factors, and it is not directly linked to the creation of hypoxia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Amifostine (ethyol) is used as an antioxidant and to protect against radiation-induced damage.\n2. A prodrug is a compound that is converted into another compound in the body.\n3. Amifostine is converted into a compound called ethyol.\n4. Ethyol is a water-soluble derivative of the antioxidant glutathione.\n5. Hypoxia, or low oxygen levels in the body, can be caused by decreased blood flow, increased oxygen demand, and impaired oxygen transport.",
    "vicuna-7b_fact": [
      "Amifostine (ethyol) is used as an antioxidant and to protect against radiation-induced damage.",
      "A prodrug is a compound that is converted into another compound in the body.",
      "Amifostine is converted into a compound called ethyol.",
      "Ethyol is a water-soluble derivative of the antioxidant glutathione.",
      "Hypoxia, or low oxygen levels in the body, can be caused by decreased blood flow, increased oxygen demand, and impaired oxygen transport."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Amifostine is converted into an active metabolite called WR-1065 in the body.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 493,
    "user_query": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?",
    "vicuna-7b_response": "Goldberg-Shprintzen syndrome is a rare genetic disorder caused by mutations in the GNAS gene. The main features of this condition include short stature, low blood calcium levels, and a wide range of facial and skeletal abnormalities. One of the additional features of Goldberg-Shprintzen syndrome is a congenital heart defect, specifically a ventricular septal defect. This is a hole in the dividing wall between the two lower chambers of the heart, which can cause symptoms such as shortness of breath, fatigue, and poor growth. Other possible features of Goldberg-Shprintzen syndrome can include hearing loss, kidney abnormalities, and intellectual disability.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Goldberg-Shprintzen syndrome is a rare genetic disorder caused by mutations in the GNAS gene.\n2. Main features of Goldberg-Shprintzen syndrome include short stature, low blood calcium levels, and a wide range of facial and skeletal abnormalities.\n3. The syndrome can include a congenital heart defect known as a ventricular septal defect.\n4. A ventricular septal defect is a hole in the dividing wall between the two lower chambers of the heart.\n5. Other possible features of Goldberg-Shprintzen syndrome can include hearing loss, kidney abnormalities, and intellectual disability.",
    "vicuna-7b_fact": [
      "Goldberg-Shprintzen syndrome is a rare genetic disorder caused by mutations in the GNAS gene.",
      "Main features of Goldberg-Shprintzen syndrome include short stature, low blood calcium levels, and a wide range of facial and skeletal abnormalities.",
      "The syndrome can include a congenital heart defect known as a ventricular septal defect.",
      "A ventricular septal defect is a hole in the dividing wall between the two lower chambers of the heart.",
      "Other possible features of Goldberg-Shprintzen syndrome can include hearing loss, kidney abnormalities, and intellectual disability."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Goldberg-Shprintzen syndrome is a rare genetic disorder caused by mutations in the KIAA1279 gene, not the GNAS gene.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 496,
    "user_query": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?",
    "vicuna-7b_response": "Parkinson's disease is a disease of the central nervous system that is characterized by the presence of Lewy bodies. Lewy bodies are abnormal clumps of a protein called alpha-synuclein that are found in the brain cells of people with Parkinson's disease. The presence of Lewy bodies is one of the key diagnostic criteria for Parkinson's disease. Other symptoms of Parkinson's disease include tremors, stiffness, and difficulty with movement and coordination. Parkinson's disease is a progressive disorder, which means that it gets worse over time. There is currently no cure for Parkinson's disease, but there are medications and other treatments that can help manage the symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Parkinson's disease is characterized by the presence of Lewy bodies in the central nervous system.\n2. Lewy bodies are abnormal clumps of alpha-synuclein found in the brain cells.\n3. The presence of Lewy bodies is a key diagnostic criterion for Parkinson's disease.\n4. Symptoms of Parkinson's disease include tremors, stiffness, and difficulty with movement and coordination.\n5. Currently, there is no cure for Parkinson's disease.",
    "vicuna-7b_fact": [
      "Parkinson's disease is characterized by the presence of Lewy bodies in the central nervous system.",
      "Lewy bodies are abnormal clumps of alpha-synuclein found in the brain cells.",
      "The presence of Lewy bodies is a key diagnostic criterion for Parkinson's disease.",
      "Symptoms of Parkinson's disease include tremors, stiffness, and difficulty with movement and coordination.",
      "Currently, there is no cure for Parkinson's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The presence of Lewy bodies alone is not a key diagnostic criterion for Parkinson's disease. The diagnosis is typically based on the clinical symptoms.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 501,
    "user_query": "Is Kanzaki disease associated with deficiency in alpha-N-acetylgalactosaminidase?",
    "vicuna-7b_response": "Kanzaki disease is a rare genetic disorder that affects the body's ability to produce a protein called alpha-N-acetylgalactosaminidase (alpha-Na-Gal). This enzyme is responsible for breaking down a type of sugar called galactose, which is found in many foods.\nPeople with Kanzaki disease are missing or have low levels of alpha-Na-Gal, which can cause a buildup of galactose in the body. This buildup can lead to a range of symptoms, including jaundice, anemia, and developmental delays.\nThere is no specific treatment for Kanzaki disease, and the condition is usually diagnosed at birth or soon after. However, people with Kanzaki disease can lead relatively normal lives with proper medical care and management of their symptoms.\nIn summary, Kanzaki disease is associated with a deficiency in alpha-N-acetylgalactosaminidase, which is responsible for breaking down galactose in the body. The condition can lead to a range of symptoms and is usually diagnosed at birth or soon after.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Kanzaki disease is a genetic disorder that affects the body's ability to produce a protein called alpha-N-acetylgalactosaminidase (alpha-Na-Gal).\n2. Alpha-N-acetylgalactosaminidase is responsible for breaking down a type of sugar called galactose.\n3. People with Kanzaki disease may have a buildup of galactose in the body due to low levels or lack of alpha-Na-Gal. \n4. The buildup of galactose in individuals with Kanzaki disease can lead to symptoms such as jaundice, anemia, and developmental delays.\n5. Kanzaki disease is usually diagnosed at birth or soon after.",
    "vicuna-7b_fact": [
      "Kanzaki disease is a genetic disorder that affects the body's ability to produce a protein called alpha-N-acetylgalactosaminidase (alpha-Na-Gal).",
      "Alpha-N-acetylgalactosaminidase is responsible for breaking down a type of sugar called galactose.",
      "People with Kanzaki disease may have a buildup of galactose in the body due to low levels or lack of alpha-Na-Gal.",
      "The buildup of galactose in individuals with Kanzaki disease can lead to symptoms such as jaundice, anemia, and developmental delays.",
      "Kanzaki disease is usually diagnosed at birth or soon after."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Alpha-N-acetylgalactosaminidase is an enzyme that helps break down complex molecules called glycoproteins and glycolipids, not specifically galactose.\n3. FALSE [correction]: People with Kanzaki disease may have a buildup of a certain compound in the body due to low levels or lack of alpha-Na-Gal, but this compound is not galactose.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 512,
    "user_query": "Is vemurafenib effective for hairy-cell leukemia?",
    "vicuna-7b_response": "Vemurafenib is a medication that is primarily used to treat certain types of skin cancer, such as melanoma. It is not typically used to treat hairy-cell leukemia.\nHairy-cell leukemia is a type of cancer that affects the blood cells. It is a relatively rare form of leukemia, and it is typically treated with chemotherapy. There are a number of different chemotherapy drugs that are used to treat hairy-cell leukemia, and the specific treatment plan will depend on the individual patient and the severity of their condition.\nIt is important to note that vemurafenib is not approved for the treatment of hairy-cell leukemia. If you have been diagnosed with hairy-cell leukemia and are considering treatment with vemurafenib, it is important to speak with your healthcare provider about the risks and benefits of this medication. They can provide you with more information about the treatment options that are available for your specific condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vemurafenib is primarily used to treat certain types of skin cancer, such as melanoma.\n2. Vemurafenib is not typically used to treat hairy-cell leukemia.\n3. Hairy-cell leukemia is a type of cancer that affects the blood cells.\n4. This type of leukemia is typically treated with chemotherapy.\n5. Vemurafenib is not approved for the treatment of hairy-cell leukemia.",
    "vicuna-7b_fact": [
      "Vemurafenib is primarily used to treat certain types of skin cancer, such as melanoma.",
      "Vemurafenib is not typically used to treat hairy-cell leukemia.",
      "Hairy-cell leukemia is a type of cancer that affects the blood cells.",
      "This type of leukemia is typically treated with chemotherapy.",
      "Vemurafenib is not approved for the treatment of hairy-cell leukemia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 513,
    "user_query": "Which are the inhibitors of histone methyltransferases?",
    "vicuna-7b_response": "Inhibitors of histone methyltransferases (HMTs) are compounds that prevent or reduce the activity of these enzymes. Some of the most common inhibitors of HMTs include:\n1. Trichostatin A (TSA): TSA is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\n2. Romidepsin: Romidepsin is a histone deacetylase inhibitor that also inhibits HMTs, including G9a and Kmt2b.\n3. MS-27-275: MS-27-275 is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\n4. Tubastatin A: Tubastatin A is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\n5. Chromatin-associated protein 1 (CHRAC1): CHRAC1 is a protein that binds to and inhibits the activity of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\nIt's important to note that the specific inhibitors used will depend on the specific HMT being targeted and the research question being studied. Additionally, some of these inhibitors may have off-target effects, so it's important to carefully evaluate their specific effects and potential side effects before using them in experiments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Inhibitors of histone methyltransferases (HMTs) are compounds that prevent or reduce the activity of these enzymes.\n2. Trichostatin A (TSA) is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\n3. Romidepsin is a histone deacetylase inhibitor that also inhibits HMTs, including G9a and Kmt2b.\n4. MS-27-275 is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.\n5. CHRAC1 is a protein that binds to and inhibits the activity of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.",
    "vicuna-7b_fact": [
      "Inhibitors of histone methyltransferases (HMTs) are compounds that prevent or reduce the activity of these enzymes.",
      "Trichostatin A (TSA) is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.",
      "Romidepsin is a histone deacetylase inhibitor that also inhibits HMTs, including G9a and Kmt2b.",
      "MS-27-275 is a potent and selective inhibitor of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b.",
      "CHRAC1 is a protein that binds to and inhibits the activity of HMTs, including H3K4 methyltransferases such as G9a and Kmt2b."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Trichostatin A (TSA) is a potent inhibitor of histone deacetylases, not HMTs.\n3. FALSE [correction]: Romidepsin is a histone deacetylase inhibitor, not an HMT inhibitor.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 517,
    "user_query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "vicuna-7b_response": "The JAK (Janus kinase) inhibitor that is approved for treatment of rheumatoid arthritis is tofacitinib.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. Tofacitinib is a JAK (Janus kinase) inhibitor that is approved for the treatment of rheumatoid arthritis.",
    "vicuna-7b_fact": [
      "Tofacitinib is a JAK (Janus kinase) inhibitor that is approved for the treatment of rheumatoid arthritis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 519,
    "user_query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "vicuna-7b_response": "There are several newly identified DNA nucleases that have shown promise in treating thalassemia. One such nuclease is zinc finger nucleases (ZFNs), which are artificial enzymes that can be used to make precise cuts in DNA. ZFNs have been used to treat a form of thalassemia called beta-thalassemia, and have been shown to be effective in reducing the amount of abnormal hemoglobin produced by the disease.\nAnother nuclease that has been studied for the treatment of thalassemia is transcription activator-like effector nucleases (TALENs). TALENs are also artificial enzymes that can be used to make precise cuts in DNA, and have been shown to be effective in treating beta-thalassemia in animal models.\nIn addition to ZFNs and TALENs, another nuclease that has been studied for the treatment of thalassemia is CRISPR-Cas9. CRISPR-Cas9 is a natural defense mechanism found in bacteria and other organisms, and can be used to make precise cuts in DNA. CRISPR-Cas9 has been used to treat beta-thalassemia in animal models, and has shown promise as a potential treatment for the disease.\nOverall, these nucleases have shown promise in treating thalassemia, and further research is needed to determine their effectiveness in humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The zinc finger nucleases (ZFNs) are artificial enzymes that can be used to make precise cuts in DNA.\n2. ZFNs have been used to treat a form of thalassemia called beta-thalassemia.\n3. Transcription activator-like effector nucleases (TALENs) can also be used to make precise cuts in DNA.\n4. TALENs has demonstrated effectiveness in treating beta-thalassemia in animal models.\n5. CRISPR-Cas9, a natural defense mechanism found in bacteria, has been used to treat beta-thalassemia in animal models.",
    "vicuna-7b_fact": [
      "The zinc finger nucleases (ZFNs) are artificial enzymes that can be used to make precise cuts in DNA.",
      "ZFNs have been used to treat a form of thalassemia called beta-thalassemia.",
      "Transcription activator-like effector nucleases (TALENs) can also be used to make precise cuts in DNA.",
      "TALENs has demonstrated effectiveness in treating beta-thalassemia in animal models.",
      "CRISPR-Cas9, a natural defense mechanism found in bacteria, has been used to treat beta-thalassemia in animal models."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 524,
    "user_query": "Is the protein β1-integrin recycled?",
    "vicuna-7b_response": "Yes, the protein β1-integrin is recycled.\nβ1-Integrin is a type of integrin, which are transmembrane proteins that play a key role in cell adhesion and signaling. Integrins are composed of an α-subunit and a β-subunit, and the β-subunit is responsible for interacting with extracellular matrix (ECM) ligands.\nOnce the β-subunit has bound to its ECM ligand, it is internalized through endocytosis. The internalized β-subunit is then transported to the lysosome, where it is degraded by proteases. This process allows for the recycling of the β-subunit, so that it can be reused for future adhesion and signaling events.\nIn summary, the protein β1-integrin is recycled through a process of internalization, transport to the lysosome, and degradation by proteases. This allows for the reuse of the β-subunit for future adhesion and signaling events.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. β1-Integrin is a type of integrin.\n2. Integrins are transmembrane proteins that play a key role in cell adhesion and signaling.\n3. Integrins are composed of an α-subunit and a β-subunit, and the β-subunit is responsible for interacting with extracellular matrix (ECM) ligands.\n4. After binding to its ECM ligand, the β-subunit is internalized through endocytosis and transported to the lysosome to be degraded by proteases.\n5. The recycling process of the β1-integrin protein allows for the reuse of the β-subunit for future adhesion and signaling events.",
    "vicuna-7b_fact": [
      "β1-Integrin is a type of integrin.",
      "Integrins are transmembrane proteins that play a key role in cell adhesion and signaling.",
      "Integrins are composed of an α-subunit and a β-subunit, and the β-subunit is responsible for interacting with extracellular matrix (ECM) ligands.",
      "After binding to its ECM ligand, the β-subunit is internalized through endocytosis and transported to the lysosome to be degraded by proteases.",
      "The recycling process of the β1-integrin protein allows for the reuse of the β-subunit for future adhesion and signaling events."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: After the β1-Integrin binds to its ligand, it does not get transported to the lysosome for degradation but gets recycled back to the plasma membrane.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 526,
    "user_query": "Which signaling pathway is activating the dishevelled proteins?",
    "vicuna-7b_response": "The dishevelled proteins are activated through the planar cell polarity (PCP) signaling pathway. The PCP pathway is a cell signaling pathway that plays a crucial role in the development of many organisms, including animals and plants. It is involved in the regulation of cell polarity, which is the orientation of cellular structures such as microtubules and cytoskeleton.\nThe PCP pathway is activated through the interaction of the dishevelled proteins with their ligands, such as Vangl2 and Par3. These interactions lead to the phosphorylation of dishevelled proteins, which in turn activates downstream signaling pathways, such as the Wnt/beta-catenin pathway.\nThe activation of the PCP pathway by dishevelled proteins is crucial for the proper development of many organisms. For example, in the Drosophila melanogaster model organism, the PCP pathway is involved in the formation of the tracheal system, which is a network of tubes that allows for gas exchange in the fly's body.\nIn summary, the dishevelled proteins are activated through the PCP signaling pathway, which is involved in the regulation of cell polarity and the proper development of many organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The dishevelled proteins are activated through the planar cell polarity (PCP) signaling pathway.\n2. The PCP pathway plays a crucial role in the development of many organisms, including animals and plants.\n3. The PCP pathway is activated through the interaction of the dishevelled proteins with their ligands, such as Vangl2 and Par3.\n4. The activation of the PCP pathway by dishevelled proteins is crucial for the proper development of many organisms.\n5. In the Drosophila melanogaster model organism, the PCP pathway is involved in the formation of the tracheal system.",
    "vicuna-7b_fact": [
      "The dishevelled proteins are activated through the planar cell polarity (PCP) signaling pathway.",
      "The PCP pathway plays a crucial role in the development of many organisms, including animals and plants.",
      "The PCP pathway is activated through the interaction of the dishevelled proteins with their ligands, such as Vangl2 and Par3.",
      "The activation of the PCP pathway by dishevelled proteins is crucial for the proper development of many organisms.",
      "In the Drosophila melanogaster model organism, the PCP pathway is involved in the formation of the tracheal system."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 533,
    "user_query": "Can a peptide aptamer be used as protein inhibitor?",
    "vicuna-7b_response": "Yes, a peptide aptamer can be used as a protein inhibitor. An aptamer is a small RNA molecule that binds to a specific target with high affinity and specificity, and peptide aptamers are aptamers that are linked to a peptide sequence. Peptide aptamers have been shown to be effective in inhibiting the activity of proteins, and they have potential applications in a variety of fields, including medicine and biotechnology.\nOne way that a peptide aptamer can be used as a protein inhibitor is by binding to a specific epitope on the protein surface and blocking its activity. This can be achieved by designing the peptide aptamer to bind to a specific region of the protein that is involved in its function. Once bound, the peptide aptamer can prevent the protein from interacting with its target, thereby inhibiting its activity.\nIn addition to blocking activity, peptide aptamers can also be used to modulate protein function by altering its conformation or stability. This can be achieved by designing the peptide aptamer to bind to a specific region of the protein that is involved in its structure or stability. By altering the protein's conformation or stability, the peptide aptamer can modulate its activity, leading to a change in its function.\nOverall, peptide aptamers have the potential to be used as protein inhibitors, and they have been shown to be effective in a variety of applications. However, the development of peptide aptamers as protein inhibitors requires careful design and optimization to ensure that they bind specifically and effectively to their target proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A peptide aptamer can be used as a protein inhibitor.\n2. An aptamer is a small RNA molecule that binds to a specific target with high affinity and specificity.\n3. Peptide aptamers are aptamers that are linked to a peptide sequence.\n4. Peptide aptamers have been shown to be effective in inhibiting the activity of proteins.\n5. They have potential applications in a variety of fields, including medicine and biotechnology.",
    "vicuna-7b_fact": [
      "A peptide aptamer can be used as a protein inhibitor.",
      "An aptamer is a small RNA molecule that binds to a specific target with high affinity and specificity.",
      "Peptide aptamers are aptamers that are linked to a peptide sequence.",
      "Peptide aptamers have been shown to be effective in inhibiting the activity of proteins.",
      "They have potential applications in a variety of fields, including medicine and biotechnology."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Peptide aptamers are small proteins that bind to a specific target with high affinity and specificity, not aptamers linked to a peptide. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-7b_response": "Caspases are a family of enzymes that play a crucial role in the process of programmed cell death, also known as apoptosis. There are several inflammatory caspases that have been identified, including:\n1. Caspase-1: also known as interleukin-1β-converting enzyme (ICE), is activated in response to bacterial infections and plays a role in the inflammatory response.\n2. Caspase-4: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n3. Caspase-5: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n4. Caspase-6: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n5. Caspase-7: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n6. Caspase-8: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n7. Caspase-9: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n8. Caspase-11: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\nIt's important to note that this list is not exhaustive and there are other caspases that have been identified as inflammatory caspases. Additionally, the role of caspases in inflammation is complex and not fully understood, and further research is needed to fully understand the function of these proteins in the immune response.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Caspases are a family of enzymes that play a role in the process of programmed cell death, known as apoptosis.\n2. Caspase-1, also known as interleukin-1β-converting enzyme (ICE), is activated in response to bacterial infections and plays a role in the inflammatory response.\n3. Caspase-4 is activated in response to viral infections and plays a role in the regulation of the immune response.\n4. Caspase-5 is activated in response to viral infections and plays a role in the regulation of the immune response.\n5. The role of caspases in inflammation is complex and not fully understood, with further research needed to fully understand the function of these proteins.",
    "vicuna-7b_fact": [
      "Caspases are a family of enzymes that play a role in the process of programmed cell death, known as apoptosis.",
      "Caspase-1, also known as interleukin-1β-converting enzyme (ICE), is activated in response to bacterial infections and plays a role in the inflammatory response.",
      "Caspase-4 is activated in response to viral infections and plays a role in the regulation of the immune response.",
      "Caspase-5 is activated in response to viral infections and plays a role in the regulation of the immune response.",
      "The role of caspases in inflammation is complex and not fully understood, with further research needed to fully understand the function of these proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 541,
    "user_query": "List available databases containing information about conserved noncoding elements.",
    "vicuna-7b_response": "There are several databases available that contain information about conserved noncoding elements (CNEs). Here are some of the most well-known ones:\n1. ENCODE (Encyclopedia of DNA Elements): This is a large-scale project that aims to identify and characterize all of the functional elements in the human genome. ENCODE has generated a wealth of data on CNEs, including their locations, sizes, and functional annotations.\n2. Roadmap Epigenomics Consortium: This is a large-scale effort to map the epigenome, which is the set of chemical modifications that turn genes on or off. The Roadmap Epigenomics Consortium has generated data on the distribution of CNEs across the human genome, as well as information on their functional roles.\n3. FANTOM5 (Fly Annotation Project for Transcriptional Omics by Massive-scale sequencing): This is a project that aims to identify and characterize all of the functional elements in the fly genome. FANTOM5 has generated data on CNEs in the fly genome, including their locations, sizes, and functional annotations.\n4. ENCODE Drosophila: This is a subset of the ENCODE data that is specific to the fly genome. It contains data on CNEs in the fly genome, including their locations, sizes, and functional annotations.\n5. ENCODE Mouse: This is a subset of the ENCODE data that is specific to the mouse genome. It contains data on CNEs in the mouse genome, including their locations, sizes, and functional annotations.\n6. ENCODE Human: This is the main database for the ENCODE project, which contains data on CNEs in the human genome, including their locations, sizes, and functional annotations.\nThese databases provide a wealth of information on CNEs, and they can be used to study the functional roles of these elements in various organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ENCODE (Encyclopedia of DNA Elements) is a database that contains information about conserved noncoding elements in the human genome, including their locations, sizes, and functional annotations.\n2. The Roadmap Epigenomics Consortium is a database that provides data on the distribution of conserved noncoding elements across the human genome, as well as information on their functional roles.\n3. FANTOM5 (Fly Annotation Project for Transcriptional Omics by Massive-scale sequencing) is a database that offers data on conserved noncoding elements in the fly genome.\n4. ENCODE Drosophila is a subset of the ENCODE database that is specific to the fly genome.\n5. ENCODE Mouse is a subset of the ENCODE database that is specific to the mouse genome.",
    "vicuna-7b_fact": [
      "ENCODE (Encyclopedia of DNA Elements) is a database that contains information about conserved noncoding elements in the human genome, including their locations, sizes, and functional annotations.",
      "The Roadmap Epigenomics Consortium is a database that provides data on the distribution of conserved noncoding elements across the human genome, as well as information on their functional roles.",
      "FANTOM5 (Fly Annotation Project for Transcriptional Omics by Massive-scale sequencing) is a database that offers data on conserved noncoding elements in the fly genome.",
      "ENCODE Drosophila is a subset of the ENCODE database that is specific to the fly genome.",
      "ENCODE Mouse is a subset of the ENCODE database that is specific to the mouse genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: FANTOM5 (Functional Annotation Of The Mammalian Genome) is a database that offers data on the functional roles of mammalian genomic regions.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 546,
    "user_query": "What disease in Loxapine prominently used for?",
    "vicuna-7b_response": "Loxapine is an antipsychotic medication that is primarily used to treat symptoms of psychosis, such as delusions, hallucinations, and disordered thinking. It is also used to treat symptoms of mania and depression in patients with bipolar disorder. Loxapine is not typically used to treat other medical conditions or diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Loxapine is an antipsychotic medication.\n2. Loxapine is used to treat symptoms of psychosis, including delusions, hallucinations, and disordered thinking.\n3. Loxapine is used to treat symptoms of mania and depression in patients with bipolar disorder.\n4. Loxapine is not typically used to treat other medical conditions or diseases.",
    "vicuna-7b_fact": [
      "Loxapine is an antipsychotic medication.",
      "Loxapine is used to treat symptoms of psychosis, including delusions, hallucinations, and disordered thinking.",
      "Loxapine is used to treat symptoms of mania and depression in patients with bipolar disorder.",
      "Loxapine is not typically used to treat other medical conditions or diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Loxapine is used to treat symptoms of schizophrenia and does not specifically treat the symptoms of mania and depression in patients with bipolar disorder.\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 548,
    "user_query": "Which antibodies cause Riedel thyroiditis?",
    "vicuna-7b_response": "Riedel thyroiditis is an autoimmune disorder that affects the thyroid gland. It is caused by the production of antibodies that attack the thyroid gland, leading to inflammation and destruction of the thyroid tissue.\nThere are several antibodies that have been associated with Riedel thyroiditis, including:\n1. Thyroid peroxidase (TPO) antibodies: These antibodies are the most common cause of Riedel thyroiditis. They are produced by the body's immune system and attack the thyroid gland, leading to inflammation and destruction of the thyroid tissue.\n2. Thyroglobulin (Tg) antibodies: These antibodies are less common than TPO antibodies, but they can also cause Riedel thyroiditis. They are produced by the body's immune system and attack the thyroid gland, leading to inflammation and destruction of the thyroid tissue.\n3. Thyroid stimulating hormone (TSH) receptor antibodies: These antibodies can also cause Riedel thyroiditis. They are produced by the body's immune system and attack the thyroid gland, leading to inflammation and destruction of the thyroid tissue.\nIt is important to note that not everyone with Riedel thyroiditis will have elevated levels of these antibodies. However, having elevated levels of these antibodies can indicate an increased risk of developing Riedel thyroiditis.\nIf you have been diagnosed with Riedel thyroiditis and have elevated levels of TPO, Tg, or TSH receptor antibodies, it is important to work with your healthcare provider to manage your condition and prevent complications. This may include medications to suppress your immune system, dietary changes, and regular monitoring of your thyroid function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Riedel thyroiditis is an autoimmune disorder that affects the thyroid gland.\n2. Riedel thyroiditis is caused by the production of antibodies that attack the thyroid gland.\n3. Thyroid peroxidase (TPO) antibodies are the most common cause of Riedel thyroiditis.\n4. Thyroglobulin (Tg) antibodies can cause Riedel thyroiditis.\n5. Thyroid stimulating hormone (TSH) receptor antibodies can also cause Riedel thyroiditis.",
    "vicuna-7b_fact": [
      "Riedel thyroiditis is an autoimmune disorder that affects the thyroid gland.",
      "Riedel thyroiditis is caused by the production of antibodies that attack the thyroid gland.",
      "Thyroid peroxidase (TPO) antibodies are the most common cause of Riedel thyroiditis.",
      "Thyroglobulin (Tg) antibodies can cause Riedel thyroiditis.",
      "Thyroid stimulating hormone (TSH) receptor antibodies can also cause Riedel thyroiditis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The exact cause of Riedel thyroiditis is unknown but it is not typically associated with the production of antibodies that attack the thyroid gland.\n3. FALSE [correction]: Thyroid peroxidase (TPO) antibodies are not the cause of Riedel thyroiditis.\n4. FALSE [correction]: Thyroglobulin (Tg) antibodies do not cause Riedel thyroiditis.\n5. FALSE [correction]: Thyroid stimulating hormone (TSH) receptor antibodies do not cause Riedel thyroiditis.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 551,
    "user_query": "Which receptors are bound by Tasimelteon?",
    "vicuna-7b_response": "Tasimelteon is a melatonin receptor agonist that binds to and activates the MT1 and MT2 melatonin receptors. These receptors are G protein-coupled receptors that are primarily found in the suprachiasmatic nucleus (SCN) of the brain, which is the primary circadian clock. Activation of the MT1 and MT2 receptors by tasimelteon can help to regulate the sleep-wake cycle and improve sleep quality.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tasimelteon is a melatonin receptor agonist.\n2. Tasimelteon binds to and activates the MT1 and MT2 melatonin receptors.\n3. MT1 and MT2 melatonin receptors are G protein-coupled receptors. \n4. These receptors are primarily found in the suprachiasmatic nucleus (SCN) of the brain.\n5. Activation of the MT1 and MT2 receptors by tasimelteon can help regulate the sleep-wake cycle and improve sleep quality.",
    "vicuna-7b_fact": [
      "Tasimelteon is a melatonin receptor agonist.",
      "Tasimelteon binds to and activates the MT1 and MT2 melatonin receptors.",
      "MT1 and MT2 melatonin receptors are G protein-coupled receptors.",
      "These receptors are primarily found in the suprachiasmatic nucleus (SCN) of the brain.",
      "Activation of the MT1 and MT2 receptors by tasimelteon can help regulate the sleep-wake cycle and improve sleep quality."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 552,
    "user_query": "Is zyxin a focal adhesion protein?",
    "vicuna-7b_response": "Yes, Zyxin is a focal adhesion protein. Focal adhesions are structures that form at the interface between the extracellular matrix and the plasma membrane of a cell. They are responsible for anchoring the cell to the extracellular matrix and for transmitting mechanical forces to the cell. Zyxin is a component of focal adhesions and plays a role in regulating their stability and function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Zyxin is a focal adhesion protein.\n2. Focal adhesions form at the interface between the extracellular matrix and the plasma membrane of a cell.\n3. Focal adhesions are responsible for anchoring the cell to the extracellular matrix.\n4. Focal adhesions transmit mechanical forces to the cell.\n5. Zyxin plays a role in regulating the stability and function of focal adhesions.",
    "vicuna-7b_fact": [
      "Zyxin is a focal adhesion protein.",
      "Focal adhesions form at the interface between the extracellular matrix and the plasma membrane of a cell.",
      "Focal adhesions are responsible for anchoring the cell to the extracellular matrix.",
      "Focal adhesions transmit mechanical forces to the cell.",
      "Zyxin plays a role in regulating the stability and function of focal adhesions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 556,
    "user_query": "Which RNA polymerase is used for the replication of viroids?",
    "vicuna-7b_response": "RNA polymerase is an enzyme that synthesizes RNA molecules from DNA templates. There are several types of RNA polymerases, each with a specific function and specificity for the type of RNA molecule it synthesizes.\nViroids are small, single-stranded RNA molecules that are not surrounded by a protein coat and are not able to replicate on their own. Instead, they rely on the replication machinery of the host cell to replicate their RNA.\nIt is not known which specific type of RNA polymerase is used for the replication of viroids. However, it is known that viroids use the host cell's RNA polymerase to synthesize new copies of their RNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA polymerase is an enzyme that synthesizes RNA molecules from DNA templates.\n2. There are several types of RNA polymerases, each with a specific function and specificity for the type of RNA molecule it synthesizes.\n3. Viroids are small, single-stranded RNA molecules that are not surrounded by a protein coat.\n4. Viroids are not able to replicate on their own and rely on the replication machinery of the host cell to replicate their RNA.\n5. Viroids use the host cell's RNA polymerase to synthesize new copies of their RNA.",
    "vicuna-7b_fact": [
      "RNA polymerase is an enzyme that synthesizes RNA molecules from DNA templates.",
      "There are several types of RNA polymerases, each with a specific function and specificity for the type of RNA molecule it synthesizes.",
      "Viroids are small, single-stranded RNA molecules that are not surrounded by a protein coat.",
      "Viroids are not able to replicate on their own and rely on the replication machinery of the host cell to replicate their RNA.",
      "Viroids use the host cell's RNA polymerase to synthesize new copies of their RNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 559,
    "user_query": "What is known about Vancomycin dosing in neonates?",
    "vicuna-7b_response": "Vancomycin is a commonly used antibiotic in the treatment of serious infections caused by Gram-positive bacteria. However, the dosing of vancomycin in neonates is not well established and can vary depending on several factors such as the patient's weight, age, and the type of infection.\nIn neonates, vancomycin is usually dosed based on body weight, with the recommended dosage ranging from 6 to 15 mg/kg/day administered in 2-3 divided doses. However, the optimal dosing regimen for neonates has not been well established, and the dosage may need to be adjusted based on factors such as the severity of the infection, the patient's renal function, and the susceptibility of the causative organism.\nIt is important to note that neonates are at a higher risk of developing nephrotoxicity and ototoxicity due to vancomycin, and therefore, close monitoring of renal and auditory function is necessary during treatment. Additionally, the use of vancomycin in neonates should be reserved for situations where alternative antibiotics are not effective or appropriate.\nIn summary, while there is limited information available on vancomycin dosing in neonates, the recommended dosage ranges from 6 to 15 mg/kg/day administered in 2-3 divided doses, with dosing adjustments based on factors such as the severity of the infection, renal function, and the susceptibility of the causative organism. Close monitoring of renal and auditory function is necessary during treatment, and vancomycin should be reserved for situations where alternative antibiotics are not effective or appropriate in neonates.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vancomycin is used in the treatment of serious infections caused by Gram-positive bacteria.\n2. Vancomycin dosing in neonates usually depends on the patient's weight, age, and the type of infection.\n3. In neonates, the recommended dosage of vancomycin ranges from 6 to 15 mg/kg/day administered in 2-3 divided doses.\n4. Neonates are at a higher risk of developing nephrotoxicity and ototoxicity due to vancomycin.\n5. The use of vancomycin in neonates should be reserved for situations where alternative antibiotics are not effective or appropriate.",
    "vicuna-7b_fact": [
      "Vancomycin is used in the treatment of serious infections caused by Gram-positive bacteria.",
      "Vancomycin dosing in neonates usually depends on the patient's weight, age, and the type of infection.",
      "In neonates, the recommended dosage of vancomycin ranges from 6 to 15 mg/kg/day administered in 2-3 divided doses.",
      "Neonates are at a higher risk of developing nephrotoxicity and ototoxicity due to vancomycin.",
      "The use of vancomycin in neonates should be reserved for situations where alternative antibiotics are not effective or appropriate."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 562,
    "user_query": "Which antiepileptic drug is most strongly associated with spina bifida?",
    "vicuna-7b_response": "The antiepileptic drug most strongly associated with spina bifida is valproic acid. Valproic acid is an antiepileptic drug that is commonly used to treat various types of seizures. It is also known to increase the risk of spina bifida in developing fetuses when taken during pregnancy. The risk of spina bifida is highest during the first trimester of pregnancy, and the risk decreases as the pregnancy progresses. It is important for women who are taking valproic acid and who are planning to become pregnant to discuss the risks and benefits of continuing the medication with their healthcare provider. Other antiepileptic drugs that have been associated with an increased risk of spina bifida include carbamazepine and lamotrigine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Valproic acid is an antiepileptic drug that is used to treat various types of seizures.\n2. The drug is associated with an increased risk of spina bifida in developing fetuses when taken during pregnancy.\n3. The risk of spina bifida is highest during the first trimester of pregnancy, and it decreases as the pregnancy progresses.\n4. Other antiepileptic drugs associated with an increased risk of spina bifida include carbamazepine and lamotrigine.\n5. Women taking valproic acid and planning to become pregnant need to discuss the risks and benefits of continuing the medication with their healthcare provider.",
    "vicuna-7b_fact": [
      "Valproic acid is an antiepileptic drug that is used to treat various types of seizures.",
      "The drug is associated with an increased risk of spina bifida in developing fetuses when taken during pregnancy.",
      "The risk of spina bifida is highest during the first trimester of pregnancy, and it decreases as the pregnancy progresses.",
      "Other antiepileptic drugs associated with an increased risk of spina bifida include carbamazepine and lamotrigine.",
      "Women taking valproic acid and planning to become pregnant need to discuss the risks and benefits of continuing the medication with their healthcare provider."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Other antiepileptic drugs associated with an increased risk of birth defects include carbamazepine and lamotrigine, but not specifically spina bifida.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 564,
    "user_query": "The drug JTV519 is derivative of which group of chemical compounds?",
    "vicuna-7b_response": "JTV519 is a derivative of the chemical compound known as JTV-803. JTV-803 is a small molecule inhibitor of the protein kinase C (PKC) family, which is a group of enzymes that play a role in various cellular processes, including signal transduction, gene expression, and cell growth and differentiation. JTV519 is a specific inhibitor of PKC theta, a member of the PKC family that has been implicated in the development of various diseases, including cancer. JTV519 has shown promise as a potential therapeutic agent for the treatment of various cancers, including breast, ovarian, and prostate cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. JTV519 is a derivative of the chemical compound known as JTV-803.\n2. JTV-803 is a small molecule inhibitor of the protein kinase C (PKC) family.\n3. The protein kinase C (PKC) family plays a role in various cellular processes, including signal transduction, gene expression, and cell growth and differentiation.\n4. JTV519 is a specific inhibitor of PKC theta.\n5. PKC theta has been implicated in the development of various diseases, including cancer.",
    "vicuna-7b_fact": [
      "JTV519 is a derivative of the chemical compound known as JTV-803.",
      "JTV-803 is a small molecule inhibitor of the protein kinase C (PKC) family.",
      "The protein kinase C (PKC) family plays a role in various cellular processes, including signal transduction, gene expression, and cell growth and differentiation.",
      "JTV519 is a specific inhibitor of PKC theta.",
      "PKC theta has been implicated in the development of various diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 566,
    "user_query": "Oxantel is used for periodontitis treatment. How does it work?",
    "vicuna-7b_response": "Oxantel is an anthelmintic drug that is used to treat various types of parasitic infections, including periodontitis. Periodontitis is a chronic inflammatory disease that affects the gums and the supporting structures of the teeth. It is caused by the bacteria that accumulate in the mouth and lead to the formation of plaque, which can cause inflammation and damage to the gums and the bone that support the teeth.\nOxantel works by targeting the parasites that cause periodontitis. It enters the parasites' bodies and disrupts their metabolism, leading to their death. This helps to reduce the number of bacteria in the mouth and reduce the inflammation that is associated with periodontitis.\nOxantel can be administered orally or topically, depending on the type of parasitic infection being treated. It is usually given in the form of a pill or a liquid, and the dosage will depend on the severity of the infection and the individual's weight and medical history.\nIt is important to note that while oxantel can be effective in treating periodontitis, it is not a cure for the condition. It is usually used in combination with other treatments, such as scaling and root planing, to help manage the symptoms and prevent the spread of the infection.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oxantel is an anthelmintic drug that is used to treat various types of parasitic infections, including periodontitis.\n2. Periodontitis is a chronic inflammatory disease that affects the gums and the supporting structures of the teeth.\n3. Oxantel works by targeting the parasites that cause periodontitis.\n4. Oxantel can be administered orally or topically, depending on the type of parasitic infection being treated.\n5. Oxantel is usually used in combination with other treatments, such as scaling and root planing, to help manage the symptoms and prevent the spread of the infection.",
    "vicuna-7b_fact": [
      "Oxantel is an anthelmintic drug that is used to treat various types of parasitic infections, including periodontitis.",
      "Periodontitis is a chronic inflammatory disease that affects the gums and the supporting structures of the teeth.",
      "Oxantel works by targeting the parasites that cause periodontitis.",
      "Oxantel can be administered orally or topically, depending on the type of parasitic infection being treated.",
      "Oxantel is usually used in combination with other treatments, such as scaling and root planing, to help manage the symptoms and prevent the spread of the infection."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Oxantel is an anthelmintic drug used to treat certain parasitic infections, but it is not used for periodontitis.\n2. TRUE\n3. FALSE [correction]: Oxantel works by targeting certain types of parasites. However, periodontitis is not caused by parasites, but by bacteria.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 568,
    "user_query": "What is the function of the protein encoded by the gene PABPC4?",
    "vicuna-7b_response": "PABPC4 is a protein that is encoded by a gene of the same name. The function of PABPC4 is to play a role in the post-transcriptional modification of RNA. Specifically, PABPC4 is involved in the process of polyadenylation, which is the addition of a string of adenine nucleotides to the end of an RNA molecule. This process is important for the regulation of gene expression, as it helps to ensure that the correct amount of RNA is produced for a particular gene. PABPC4 is expressed in a wide variety of tissues and has been implicated in a number of cellular processes, including cell proliferation, differentiation, and apoptosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PABPC4 is a protein that is encoded by a gene of the same name.\n2. The function of PABPC4 is to play a role in the post-transcriptional modification of RNA.\n3. PABPC4 is involved in the process of polyadenylation, which is the addition of a string of adenine nucleotides to the end of an RNA molecule.\n4. This process of polyadenylation is important for the regulation of gene expression.\n5. PABPC4 is implicated in a number of cellular processes, including cell proliferation, differentiation, and apoptosis.",
    "vicuna-7b_fact": [
      "PABPC4 is a protein that is encoded by a gene of the same name.",
      "The function of PABPC4 is to play a role in the post-transcriptional modification of RNA.",
      "PABPC4 is involved in the process of polyadenylation, which is the addition of a string of adenine nucleotides to the end of an RNA molecule.",
      "This process of polyadenylation is important for the regulation of gene expression.",
      "PABPC4 is implicated in a number of cellular processes, including cell proliferation, differentiation, and apoptosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 570,
    "user_query": "What is the mode of inheritance of Romano Ward long QT syndrome?",
    "vicuna-7b_response": "Romano-Ward long QT syndrome is an inherited disorder that affects the heart's electrical activity. It is inherited in an autosomal dominant manner, which means that having one copy of the gene mutation that causes the disorder in a person's DNA is enough to cause the disorder. This means that if a person has Romano-Ward long QT syndrome, their parents each carry one copy of the mutated gene. There is a 50% chance that any children of a person with Romano-Ward long QT syndrome will also have the disorder, as they will inherit one copy of the mutated gene from their parent with the disorder.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Romano-Ward long QT syndrome is an inherited genetic disorder that affects the heart's electrical activity.\n2. The disorder is inherited in an autosomal dominant manner.\n3. A single copy of the gene mutation that causes Romano-Ward long QT syndrome is enough to cause the disorder.\n4. Parents of a person with Romano-Ward long QT syndrome each carry one copy of the mutated gene.\n5. There is a 50% chance any children of a person with Romano-Ward long QT syndrome will also have the disorder.",
    "vicuna-7b_fact": [
      "Romano-Ward long QT syndrome is an inherited genetic disorder that affects the heart's electrical activity.",
      "The disorder is inherited in an autosomal dominant manner.",
      "A single copy of the gene mutation that causes Romano-Ward long QT syndrome is enough to cause the disorder.",
      "Parents of a person with Romano-Ward long QT syndrome each carry one copy of the mutated gene.",
      "There is a 50% chance any children of a person with Romano-Ward long QT syndrome will also have the disorder."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Not all parents of a person with Romano-Ward long QT syndrome carry a copy of the mutated gene, it could be a new mutation.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 571,
    "user_query": "Which histone modifications have been associated to alternative splicing?",
    "vicuna-7b_response": "Histone modifications have been implicated in alternative splicing, a process by which cells generate multiple RNA transcripts from a single gene. Some of the histone modifications that have been associated with alternative splicing include:\n1. H3K4me3: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon inclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the androgen receptor.\n2. H3K27me3: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon exclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the tumor suppressor protein p53.\n3. H3K36me3: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon inclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the androgen receptor.\n4. H4K16ac: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon inclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the androgen receptor.\n5. H3K27ac: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon inclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the androgen receptor.\n6. H3K4me2: This mark has been shown to be involved in the regulation of alternative splicing in various organisms, including humans. It has been found to be associated with exon inclusion and has been shown to be involved in the regulation of alternative splicing in the gene encoding the androgen receptor.\n7. H3K4me1: This mark has been shown to be involved in the",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone modifications have been implicated in alternative splicing.\n2. The H3K4me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon inclusion.\n3. The H3K27me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon exclusion.\n4. The H3K36me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon inclusion.\n5. The H4K16ac mark has been found to be involved in the regulation of alternative splicing and is associated with exon inclusion.",
    "vicuna-7b_fact": [
      "Histone modifications have been implicated in alternative splicing.",
      "The H3K4me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon inclusion.",
      "The H3K27me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon exclusion.",
      "The H3K36me3 mark has been shown to be involved in the regulation of alternative splicing and is associated with exon inclusion.",
      "The H4K16ac mark has been found to be involved in the regulation of alternative splicing and is associated with exon inclusion."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 575,
    "user_query": "What is the mechanism of action of decitabine?",
    "vicuna-7b_response": "Decitabine is a chemotherapy drug that is used to treat various types of cancer, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The mechanism of action of decitabine is complex and involves several steps.\nDecitabine works by inhibiting the activity of DNA polymerase, an enzyme that is responsible for synthesizing new DNA strands during the replication of cells. When DNA polymerase is inhibited, it causes the replication of DNA to slow down or stop, which ultimately leads to the death of cancer cells.\nDecitabine also causes the breakdown of the telomeres, which are the protective caps on the ends of chromosomes. This breakdown leads to the activation of a cellular pathway called the DNA damage response, which triggers the cell to undergo programmed cell death, or apoptosis.\nIn addition to its direct effects on cancer cells, decitabine also has indirect effects on the immune system. It has been shown to stimulate the production of immune cells, such as T cells and natural killer cells, which can help to fight cancer.\nOverall, the mechanism of action of decitabine involves inhibition of DNA synthesis, telomere breakdown, and activation of the DNA damage response, leading to the death of cancer cells and stimulation of the immune system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Decitabine is a chemotherapy drug that is used to treat various types of cancer, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).\n2. Decitabine works by inhibiting the activity of DNA polymerase, an enzyme responsible for synthesizing new DNA strands during cell replication.\n3. When DNA polymerase is inhibited, it slows down or stops the replication of DNA, which leads to the death of cancer cells.\n4. Decitabine causes the breakdown of the telomeres, which are the protective caps on the ends of chromosomes and this triggers the cell to undergo programmed cell death, or apoptosis.\n5. Decitabine has been shown to stimulate the production of immune cells, such as T cells and natural killer cells, which can help to fight cancer.",
    "vicuna-7b_fact": [
      "Decitabine is a chemotherapy drug that is used to treat various types of cancer, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).",
      "Decitabine works by inhibiting the activity of DNA polymerase, an enzyme responsible for synthesizing new DNA strands during cell replication.",
      "When DNA polymerase is inhibited, it slows down or stops the replication of DNA, which leads to the death of cancer cells.",
      "Decitabine causes the breakdown of the telomeres, which are the protective caps on the ends of chromosomes and this triggers the cell to undergo programmed cell death, or apoptosis.",
      "Decitabine has been shown to stimulate the production of immune cells, such as T cells and natural killer cells, which can help to fight cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Decitabine works by inhibiting DNA methylation, not DNA polymerase.\n3. FALSE [correction]: As a DNA methylation inhibitor, Decitabine doesn't halt DNA replication. It reforms the way cells differentiate and mature, leading potentially to slowed disease progression.\n4. FALSE [correction]: Decitabine doesn't cause breakdown of telomeres, but it inhibits DNA methylation, which can reactivate silenced genes and influence cell behavior.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 576,
    "user_query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "vicuna-7b_response": "Mitchell-Riley syndrome is a rare genetic disorder caused by mutations in the GJB2 gene. The GJB2 gene provides instructions for making a protein called connexin 26, which is a component of gap junctions, which are structures that allow cells to communicate with each other. Mutations in the GJB2 gene can affect the function of connexin 26 and disrupt the normal function of gap junctions, leading to the symptoms of Mitchell-Riley syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mitchell-Riley syndrome is a rare genetic disorder.\n2. This syndrome is caused by mutations in the GJB2 gene.\n3. The GJB2 gene provides instructions for making a protein called connexin 26.\n4. Connexin 26 is a component of gap junctions, which allow cells to communicate with each other.\n5. Mutations in the GJB2 gene can affect the function of connexin 26 and disrupt the normal function of gap junctions.",
    "vicuna-7b_fact": [
      "Mitchell-Riley syndrome is a rare genetic disorder.",
      "This syndrome is caused by mutations in the GJB2 gene.",
      "The GJB2 gene provides instructions for making a protein called connexin 26.",
      "Connexin 26 is a component of gap junctions, which allow cells to communicate with each other.",
      "Mutations in the GJB2 gene can affect the function of connexin 26 and disrupt the normal function of gap junctions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mitchell-Riley syndrome is caused by mutations in the RFX6 gene, not the GJB2 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-7b_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B.\nThe aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process, including the formation of chromosomes during cell division. It is involved in the phosphorylation of several proteins, including histone H3, which is necessary for the proper assembly of the mitotic spindle and the maintenance of chromosome stability.\nThe polycomb protein ring1B is a member of the polycomb group (PcG) of proteins, which are involved in the regulation of gene expression during development. Ring1B is a histone-modifying protein that is involved in the repression of gene expression by modifying histone H2A and H3. It is also involved in the regulation of the mitotic process, and has been shown to interact with aurora B kinase.\nRecent studies have shown that aurora B kinase and ring1B interact and that this interaction is important for the proper regulation of the mitotic process. The interaction between these two proteins may be important for the proper assembly of the mitotic spindle and the maintenance of chromosome stability during cell division.\nIn summary, there is a link between the aurora B kinase and the polycomb protein ring1B, and this interaction is important for the proper regulation of the mitotic process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process.\n2. Aurora B kinase is involved in the phosphorylation of several proteins, including histone H3.\n3. The polycomb protein ring1B is a member of the polycomb group (PcG) of proteins, which are involved in the regulation of gene expression during development.\n4. Ring1B is a histone-modifying protein that modifies histone H2A and H3, it is also involved in the regulation of the mitotic process.\n5. Recent studies have shown that aurora B kinase and ring1B interact and that this interaction is important for the proper regulation of the mitotic process.",
    "vicuna-7b_fact": [
      "Aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process.",
      "Aurora B kinase is involved in the phosphorylation of several proteins, including histone H3.",
      "The polycomb protein ring1B is a member of the polycomb group (PcG) of proteins, which are involved in the regulation of gene expression during development.",
      "Ring1B is a histone-modifying protein that modifies histone H2A and H3, it is also involved in the regulation of the mitotic process.",
      "Recent studies have shown that aurora B kinase and ring1B interact and that this interaction is important for the proper regulation of the mitotic process."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 582,
    "user_query": "Name five programs for transcript quantification from RNASeq experiments",
    "vicuna-7b_response": "1. Cufflinks\n2. Tophat2\n3. Cutadapt\n4. STAR\n5. HISAT2",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cufflinks is a program for transcript quantification from RNASeq experiments.\n2. Tophat2 is a program for transcript quantification from RNASeq experiments.\n3. Cutadapt is a program for transcript quantification from RNASeq experiments.\n4. STAR is a program for transcript quantification from RNASeq experiments.\n5. HISAT2 is a program for transcript quantification from RNASeq experiments.",
    "vicuna-7b_fact": [
      "Cufflinks is a program for transcript quantification from RNASeq experiments.",
      "Tophat2 is a program for transcript quantification from RNASeq experiments.",
      "Cutadapt is a program for transcript quantification from RNASeq experiments.",
      "STAR is a program for transcript quantification from RNASeq experiments.",
      "HISAT2 is a program for transcript quantification from RNASeq experiments."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tophat2 is a program for aligning sequencing reads to a genome.\n3. FALSE [correction]: Cutadapt is a program for removing adapter sequences, primers, poly-A tails and other types of unwanted sequence contamination from high-throughput sequencing reads.\n4. FALSE [correction]: STAR is a program for aligning short sequencing reads to the reference genome.\n5. FALSE [correction]: HISAT2 is a program for aligning RNA sequencing reads to a genome.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 587,
    "user_query": "List variants of the MC1R gene.",
    "vicuna-7b_response": "The MC1R gene, also known as the \"red hair gene,\" encodes for a protein that is involved in the production of melanin, which is responsible for the color of hair, skin, and eyes. Variants of the MC1R gene can affect the production of melanin and can result in a range of hair and skin colors, including red hair, blonde hair, brown hair, and black hair.\nThere are several variants of the MC1R gene that have been identified, including:\n1. R151C: This variant results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of red hair and fair skin.\n2. D294H: This variant also results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of red hair and fair skin.\n3. C164Y: This variant results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of blonde hair and fair skin.\n4. S164W: This variant also results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of blonde hair and fair skin.\n5. R167H: This variant results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of red hair and fair skin.\n6. G167A: This variant also results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of red hair and fair skin.\n7. E270K: This variant results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of blonde hair and fair skin.\n8. V370A: This variant also results in a change in the amino acid sequence of the MC1R protein, leading to reduced production of melanin and a greater likelihood of blonde hair and fair skin.\nIt's important to note that these variants can",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The MC1R gene, also referred to as the \"red hair gene,\" encodes for a protein involved in the production of melanin.\n2. Variants of the MC1R gene can affect the production of melanin, resulting in different hair and skin colors.\n3. The R151C variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of red hair and fair skin.\n4. The D294H variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of red hair and fair skin.\n5. The S164W variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of blonde hair and fair skin.",
    "vicuna-7b_fact": [
      "The MC1R gene, also referred to as the \"red hair gene,\" encodes for a protein involved in the production of melanin.",
      "Variants of the MC1R gene can affect the production of melanin, resulting in different hair and skin colors.",
      "The R151C variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of red hair and fair skin.",
      "The D294H variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of red hair and fair skin.",
      "The S164W variant of the MC1R gene can lead to reduced production of melanin and a greater likelihood of blonde hair and fair skin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 589,
    "user_query": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?",
    "vicuna-7b_response": "The BSCL2 gene encodes for the brain-specific class ligand 2 protein, which is involved in the regulation of synaptic plasticity and neural development. Heterozygous mutations in the BSCL2 gene have been associated with a variety of phenotypes, including:\n1. Intellectual disability: Heterozygous mutations in the BSCL2 gene have been linked to intellectual disability, which is characterized by significant impairments in cognitive and adaptive skills.\n2. Epilepsy: Individuals with heterozygous mutations in the BSCL2 gene may be at an increased risk for developing epilepsy, a neurological disorder characterized by recurrent seizures.\n3. Autism spectrum disorder: Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with autism spectrum disorder, a neurodevelopmental disorder characterized by social impairments, communication difficulties, and repetitive behaviors.\n4. Attention deficit hyperactivity disorder: Heterozygous mutations in the BSCL2 gene have been linked to attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity.\n5. Schizophrenia: Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with an increased risk of developing schizophrenia, a serious mental disorder characterized by symptoms such as hallucinations, delusions, and disorganized thinking.\nIt's important to note that these associations are not yet fully understood and further research is needed to confirm these findings. Additionally, it's important to note that not all individuals with heterozygous mutations in the BSCL2 gene will develop these phenotypes, and that other factors such as environmental and genetic interactions may also play a role in the development of these disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The BSCL2 gene encodes for the brain-specific class ligand 2 protein, involved in the regulation of synaptic plasticity and neural development.\n2. Heterozygous mutations in the BSCL2 gene have been associated with intellectual disability, a condition characterized by significant impairments in cognitive and adaptive skills.\n3. Individuals with heterozygous mutations in the BSCL2 gene may be at an increased risk for developing epilepsy, a neurological disorder characterized by recurrent seizures.\n4. Some studies suggest that heterozygous mutations in the BSCL2 gene may be associated with autism spectrum disorder, a neurodevelopmental disorder.\n5. Heterozygous mutations in the BSCL2 gene have been linked to attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity.",
    "vicuna-7b_fact": [
      "The BSCL2 gene encodes for the brain-specific class ligand 2 protein, involved in the regulation of synaptic plasticity and neural development.",
      "Heterozygous mutations in the BSCL2 gene have been associated with intellectual disability, a condition characterized by significant impairments in cognitive and adaptive skills.",
      "Individuals with heterozygous mutations in the BSCL2 gene may be at an increased risk for developing epilepsy, a neurological disorder characterized by recurrent seizures.",
      "Some studies suggest that heterozygous mutations in the BSCL2 gene may be associated with autism spectrum disorder, a neurodevelopmental disorder.",
      "Heterozygous mutations in the BSCL2 gene have been linked to attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE \n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 592,
    "user_query": "What is the genomic structure of the FAA (FANCA) gene?",
    "vicuna-7b_response": "The FAA (FANCA) gene is located on the long (q) arm of chromosome 1 at position 13.3 and spans approximately 200 kilobases (kb) in length. The gene contains 20 exons and is composed of 19 introns and one untranslated region (UTR). The FAA gene is composed of 18 coding exons, which encode for the Fanconi anemia (FA) protein, and two non-coding introns. The FAA gene is transcribed from a single promoter located 5' to the first exon and is regulated by a complex network of transcription factors and cofactors. The gene is expressed in a wide range of tissues, including the bone marrow, testis, and placenta, and is involved in the development and function of various organs and systems. The FAA gene is also involved in the DNA damage response pathway, which is responsible for repairing DNA damage caused by various agents, such as UV radiation, alkylating agents, and topoisomerase inhibitors. The FAA gene is a key player in the development of various types of cancer, and mutations in the gene have been associated with a variety of hematological and solid tumors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The FAA (FANCA) gene is located on the long (q) arm of chromosome 1 at position 13.3.\n2. The FAA gene spans approximately 200 kilobases (kb) in length.\n3. The FAA gene contains 20 exons, 19 introns, and one untranslated region (UTR).\n4. The FAA gene encodes for the Fanconi anemia (FA) protein.\n5. The FAA gene is involved in the DNA damage response pathway, which is responsible for repairing DNA damage.",
    "vicuna-7b_fact": [
      "The FAA (FANCA) gene is located on the long (q) arm of chromosome 1 at position 13.3.",
      "The FAA gene spans approximately 200 kilobases (kb) in length.",
      "The FAA gene contains 20 exons, 19 introns, and one untranslated region (UTR).",
      "The FAA gene encodes for the Fanconi anemia (FA) protein.",
      "The FAA gene is involved in the DNA damage response pathway, which is responsible for repairing DNA damage."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The FANCA gene, not FAA, is located on the long (q) arm of chromosome 16 at position 24.3.\n2. FALSE [correction]: The FANCA gene spans approximately 43 kilobases (kb) in length.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 593,
    "user_query": "What is Snord116?",
    "vicuna-7b_response": "Snord116 is a character in the popular video game Minecraft. He is a member of the Minecraft community known as the \"Spleef\" community, which is known for its competitive Spleef events. Snord116 is known for his expertise in Spleef and is considered one of the best Spleefers in the community. He is also known for his humorous and entertaining commentary during Spleef events.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Snord116 is a character in the video game Minecraft.\n2. Snord116 is a member of the \"Spleef\" community in Minecraft.\n3. The \"Spleef\" community is known for its competitive Spleef events.\n4. Snord116 is known for his expertise in Spleef.\n5. Snord116 is considered one of the best Spleefers in the community.",
    "vicuna-7b_fact": [
      "Snord116 is a character in the video game Minecraft.",
      "Snord116 is a member of the \"Spleef\" community in Minecraft.",
      "The \"Spleef\" community is known for its competitive Spleef events.",
      "Snord116 is known for his expertise in Spleef.",
      "Snord116 is considered one of the best Spleefers in the community."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 594,
    "user_query": "What is the functional role of the protein Drp1?",
    "vicuna-7b_response": "DRP1, also known as Mitochondrial Dynamics-related Protein 1, is a protein that plays a critical role in mitochondrial dynamics and cellular homeostasis.\nDRP1 is a key regulator of mitochondrial fission, which is the process of dividing a mitochondrion into two smaller mitochondria. This process is important for maintaining mitochondrial number and function, as well as for removing damaged mitochondria.\nDRP1 also plays a role in mitochondrial fusion, which is the process of combining two mitochondria into one. This process is important for maintaining mitochondrial network structure and ensuring efficient energy production.\nIn addition to its role in mitochondrial dynamics, DRP1 has also been implicated in a variety of cellular processes, including cell cycle progression, apoptosis, and autophagy.\nOverall, DRP1 is an essential protein that plays a critical role in maintaining mitochondrial health and function, as well as in regulating cellular homeostasis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DRP1, also known as Mitochondrial Dynamics-related Protein 1, is a protein that plays a role in mitochondrial dynamics and cellular homeostasis.\n2. DRP1 is a key regulator of mitochondrial fission, the process of dividing a mitochondrion into two smaller mitochondria.\n3. DRP1 plays a role in mitochondrial fusion, which is the process of combining two mitochondria into one.\n4. DRP1 has been implicated in a variety of cellular processes, including cell cycle progression, apoptosis, and autophagy.\n5. DRP1 plays a role in maintaining mitochondrial health and function, as well as in regulating cellular homeostasis.",
    "vicuna-7b_fact": [
      "DRP1, also known as Mitochondrial Dynamics-related Protein 1, is a protein that plays a role in mitochondrial dynamics and cellular homeostasis.",
      "DRP1 is a key regulator of mitochondrial fission, the process of dividing a mitochondrion into two smaller mitochondria.",
      "DRP1 plays a role in mitochondrial fusion, which is the process of combining two mitochondria into one.",
      "DRP1 has been implicated in a variety of cellular processes, including cell cycle progression, apoptosis, and autophagy.",
      "DRP1 plays a role in maintaining mitochondrial health and function, as well as in regulating cellular homeostasis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DRP1 does not play a role in mitochondrial fusion, it plays a role in mitochondrial fission, which is the process of dividing a mitochondrion into two smaller mitochondria.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 595,
    "user_query": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
    "vicuna-7b_response": "Fanconi anemia (FA) is a rare genetic disorder characterized by a wide range of symptoms, including bone marrow failure, developmental delays, and an increased risk of cancer. Fanconi anemia complementation group D1 (FANCD1) is a protein that plays a critical role in the FA pathway.\nThe genetic cause of FANCD1-associated FA is a mutation in the FANCD1 gene. This mutation results in the production of a non-functional FANCD1 protein, which leads to the accumulation of DNA damage in cells and the subsequent development of FA.\nThere are several types of FANCD1-associated FA, and the specific genetic cause of each type can vary. For example, some people with FANCD1-associated FA have a mutation in the FANCD1 gene itself, while others may have a mutation in a different gene that is involved in the FA pathway.\nIn summary, the genetic cause of FANCD1-associated FA is a mutation in the FANCD1 gene that results in the production of a non-functional FANCD1 protein. This mutation leads to the accumulation of DNA damage in cells and the subsequent development of FA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fanconi anemia (FA) is a rare genetic disorder characterized by symptoms such as bone marrow failure, developmental delays, and an increased risk of cancer.\n2. Fanconi anemia complementation group D1 (FANCD1) is a protein that plays a critical role in the FA pathway.\n3. The genetic cause of FANCD1-associated FA is a mutation in the FANCD1 gene.\n4. This mutation results in the production of a non-functional FANCD1 protein, which leads to the accumulation of DNA damage in cells and the subsequent development of FA.\n5. Some people with FANCD1-associated FA have a mutation in the FANCD1 gene, while others may have a mutation in a different gene involved in the FA pathway.",
    "vicuna-7b_fact": [
      "Fanconi anemia (FA) is a rare genetic disorder characterized by symptoms such as bone marrow failure, developmental delays, and an increased risk of cancer.",
      "Fanconi anemia complementation group D1 (FANCD1) is a protein that plays a critical role in the FA pathway.",
      "The genetic cause of FANCD1-associated FA is a mutation in the FANCD1 gene.",
      "This mutation results in the production of a non-functional FANCD1 protein, which leads to the accumulation of DNA damage in cells and the subsequent development of FA.",
      "Some people with FANCD1-associated FA have a mutation in the FANCD1 gene, while others may have a mutation in a different gene involved in the FA pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 596,
    "user_query": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?",
    "vicuna-7b_response": "Mutations in the Calsequestrin 2 (CASQ2) gene can cause a group of rare genetic disorders known as hereditary cardiac arrhythmia syndromes. These disorders are characterized by abnormal heart rhythms, or arrhythmias, which can lead to serious complications such as heart failure and sudden death.\nThe specific diseases caused by mutations in the CASQ2 gene include:\n1. Catecholaminergic polymorphic ventricular tachycardia (CPVT)\n2. Andersen-Tawil syndrome (ATS)\n3. Early-onset dilated cardiomyopathy with atrial septal aneurysm and intraventricular conduction delay (ESC-Dilated)\n4. Late-onset dilated cardiomyopathy with atrial septal aneurysm and intraventricular conduction delay (ESC-Dilated 2)\n5. Hypertrophic cardiomyopathy with catecholaminergic polymorphic ventricular tachycardia (HCM-CPVT)\nIt is important to note that these are just a few examples of the diseases that can be caused by mutations in the CASQ2 gene. Other genetic disorders that can be caused by mutations in this gene include arrhythmogenic right ventricular dysplasia (ARVD), atrial fibrillation, and atrial flutter.\nIf you have a family history of any of these conditions or if you have symptoms such as palpitations, shortness of breath, or fainting, it is important to speak with a healthcare provider who can evaluate your risk and recommend appropriate testing and management.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mutations in the Calsequestrin 2 (CASQ2) gene can cause hereditary cardiac arrhythmia syndromes.\n2. Hereditary cardiac arrhythmia syndromes are characterized by abnormal heart rhythms.\n3. The specific diseases caused by mutations in the CASQ2 gene include Catecholaminergic polymorphic ventricular tachycardia (CPVT).\n4. Andersen-Tawil syndrome (ATS) can be caused by a mutation in the CASQ2 gene.\n5. Other genetic disorders that can be caused by mutations in the CASQ2 gene include arrhythmogenic right ventricular dysplasia (ARVD), atrial fibrillation, and atrial flutter.",
    "vicuna-7b_fact": [
      "Mutations in the Calsequestrin 2 (CASQ2) gene can cause hereditary cardiac arrhythmia syndromes.",
      "Hereditary cardiac arrhythmia syndromes are characterized by abnormal heart rhythms.",
      "The specific diseases caused by mutations in the CASQ2 gene include Catecholaminergic polymorphic ventricular tachycardia (CPVT).",
      "Andersen-Tawil syndrome (ATS) can be caused by a mutation in the CASQ2 gene.",
      "Other genetic disorders that can be caused by mutations in the CASQ2 gene include arrhythmogenic right ventricular dysplasia (ARVD), atrial fibrillation, and atrial flutter."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Andersen-Tawil syndrome (ATS) is usually caused by a mutation in the KCNJ2 gene not the CASQ2 gene.\n5. FALSE [correction]: Arrhythmogenic right ventricular dysplasia (ARVD), atrial fibrillation, and atrial flutter are not typically associated with mutations in the CASQ2 gene. ARVD is most often associated with mutations in genes that encode components of cardiac desmosomes. Atrial fibrillation and flutter have a variety of genetic and non-genetic causes.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\" which are composed of specific nucleotides that are recognized by the spliceosome, the complex of proteins that catalyzes the splicing of RNA.\nThe splice consensus sequences at the donor site are:\n* 5'GT-AG-3' (guanine and thymine followed by adenine and guanine)\n* 5'AGT-3' (adenine, guanine, and thymine followed by adenine and guanine)\n* 5'GGT-3' (guanine, thymine, and cytosine followed by adenine and guanine)\n* 5'GGT-AG-3' (guanine, thymine, and cytosine followed by adenine and guanine)\nThe splice consensus sequences at the acceptor site are:\n* 3'CTG-5' (cytosine, thymine, and guanine followed by adenine and cytosine)\n* 3'CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine)\n* 3'CGG-CTG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\n* 3'CGG-CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\nIt's important to note that these are the most frequent motifs, but not all of them are present in all the species, and some species have additional motifs that are recognized by the spliceosome.\nIt's also important to note that the splice consensus sequences are not absolute and can be modified by various factors such as the presence of introns, the length of the intron, the presence of other elements in the vicinity of the splice site, and the presence of certain proteins that bind to the R",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\".\n2. The splice consensus sequences are composed of specific nucleotides that are recognized by the spliceosome.\n3. Each consensus sequence at the donor site is 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.\n4. Each consensus sequence at the acceptor site is 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.\n5. The splice consensus sequences are not absolute and can be modified by various factors such as the presence of introns, the length of the intron, the presence of other elements in the vicinity of the splice site, and the presence of certain proteins that bind to the RNA.",
    "vicuna-7b_fact": [
      "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\".",
      "The splice consensus sequences are composed of specific nucleotides that are recognized by the spliceosome.",
      "Each consensus sequence at the donor site is 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.",
      "Each consensus sequence at the acceptor site is 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.",
      "The splice consensus sequences are not absolute and can be modified by various factors such as the presence of introns, the length of the intron, the presence of other elements in the vicinity of the splice site, and the presence of certain proteins that bind to the RNA."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The most frequent canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\".\n2. TRUE\n3. FALSE [correction]: The consensus sequence at the donor site is typically 5'GT...AG3' (G/GU at the beginning of intron and AG at the end).\n4. FALSE [correction]: The consensus sequence at the acceptor site is typically 3'AG...GU5' (AG at the end of the intron and G/GU at the beginning of the next exon).\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 602,
    "user_query": "Which are the Atg8 homologs in human?",
    "vicuna-7b_response": "There are several Atg8 homologs in human, including:\n1. Vps35: This protein is also known as autophagy-related protein 35 (Atg35) and is involved in the early stages of autophagy.\n2. Atg8: This protein is also known as microtubule-associated protein 1 light chain 3-II (MAP1LC3B) and is involved in the late stages of autophagy.\n3. Atg12: This protein is also known as autophagy-related protein 12 (Atg12) and is involved in the formation of autophagosomes.\n4. Atg16L: This protein is also known as autophagy-related protein 16-like (Atg16L) and is involved in the formation of autophagosomes.\n5. Atg2: This protein is also known as autophagy-related protein 2 (Atg2) and is involved in the formation of autophagosomes.\n6. Atg14: This protein is also known as autophagy-related protein 14 (Atg14) and is involved in the formation of autophagosomes.\nThese proteins play important roles in the autophagy pathway, which is a cellular process that helps to clear damaged organelles and proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vps35, also known as autophagy-related protein 35 (Atg35), is a human homolog of Atg8.\n2. Atg8, also known as microtubule-associated protein 1 light chain 3-II (MAP1LC3B), is a human homolog of Atg8.\n3. Atg12, also known as autophagy-related protein 12 (Atg12), is a human homolog of Atg8.\n4. Atg16L, also known as autophagy-related protein 16-like (Atg16L), is a human homolog of Atg8.\n5. Atg2, also known as autophagy-related protein 2 (Atg2), is a human homolog of Atg8.\n6. Atg14, also known as autophagy-related protein 14 (Atg14), is a human homolog of Atg8.",
    "vicuna-7b_fact": [
      "Vps35, also known as autophagy-related protein 35 (Atg35), is a human homolog of Atg8.",
      "Atg8, also known as microtubule-associated protein 1 light chain 3-II (MAP1LC3B), is a human homolog of Atg8.",
      "Atg12, also known as autophagy-related protein 12 (Atg12), is a human homolog of Atg8.",
      "Atg16L, also known as autophagy-related protein 16-like (Atg16L), is a human homolog of Atg8.",
      "Atg2, also known as autophagy-related protein 2 (Atg2), is a human homolog of Atg8.",
      "Atg14, also known as autophagy-related protein 14 (Atg14), is a human homolog of Atg8."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Vps35, also known as Vacuolar Protein Sorting 35, is not a human homolog of Atg8.\n2. TRUE\n3. FALSE [correction]: Atg12, also known as autophagy-related protein 12 (Atg12), is not a human homolog of Atg8.\n4. FALSE [correction]: Atg16L, also known as autophagy-related protein 16-like (Atg16L), is not a human homolog of Atg8.\n5. FALSE [correction]: Atg2, also known as autophagy-related protein 2 (Atg2), is not a human homolog of Atg8.\n6. FALSE [correction]: Atg14, also known as autophagy-related protein 14 (Atg14), is not a human homolog of Atg8.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 606,
    "user_query": "Which is the molecular mechanism underlying K-ras alterations in carcinomas?",
    "vicuna-7b_response": "K-ras is a proto-oncogene that is mutated in a significant number of human cancers. The molecular mechanism underlying K-ras alterations in carcinomas involves the activation of downstream signaling pathways that promote cell proliferation, survival, and angiogenesis.\nThe K-ras gene encodes a small GTPase protein that is involved in the regulation of cell growth and differentiation. Mutations in the K-ras gene can lead to the production of a constitutively active form of the protein, which can activate downstream signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K) pathway.\nThe MAPK pathway is involved in the regulation of cell proliferation, differentiation, and survival, and it is activated by a variety of growth factors and oncogenes. The activation of the MAPK pathway by K-ras leads to the phosphorylation and activation of downstream targets such as the extracellular signal-regulated kinase (ERK) and the p38 MAPK. This results in the activation of transcription factors that regulate the expression of genes involved in cell proliferation and survival.\nThe PI3K pathway is involved in the regulation of cell survival, proliferation, and angiogenesis. The activation of the PI3K pathway by K-ras leads to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3), which serves as a lipid second messenger that activates downstream targets such as the protein kinase B (Akt) and the mammalian target of rapamycin (mTOR). This results in the activation of genes involved in cell survival and the promotion of angiogenesis.\nOverall, the activation of downstream signaling pathways by K-ras mutations leads to the promotion of cell proliferation, survival, and angiogenesis, which are key events in the development of carcinomas.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. K-ras is a proto-oncogene that is frequently mutated in human cancers.\n2. The K-ras gene encodes a small GTPase protein that regulates cell growth and differentiation.\n3. Mutations in the K-ras gene can lead to the production of a constitutively active form of the protein that activates downstream signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K) pathway.\n4. The mitogen-activated protein kinase (MAPK) pathway is involved in the regulation of cell proliferation, differentiation, and survival.\n5. The phosphatidylinositol 3-kinase (PI3K) pathway is involved in the regulation of cell survival, proliferation, and angiogenesis.",
    "vicuna-7b_fact": [
      "K-ras is a proto-oncogene that is frequently mutated in human cancers.",
      "The K-ras gene encodes a small GTPase protein that regulates cell growth and differentiation.",
      "Mutations in the K-ras gene can lead to the production of a constitutively active form of the protein that activates downstream signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K) pathway.",
      "The mitogen-activated protein kinase (MAPK) pathway is involved in the regulation of cell proliferation, differentiation, and survival.",
      "The phosphatidylinositol 3-kinase (PI3K) pathway is involved in the regulation of cell survival, proliferation, and angiogenesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 607,
    "user_query": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?",
    "vicuna-7b_response": "Yes, microRNA-30 (miR-30) has been shown to play a role in post-ischemic cardiac remodeling.\nmiR-30 is a microRNA that has been shown to be upregulated in response to myocardial infarction (heart attack) and other forms of cardiac injury. It has been shown to play a role in the regulation of cell proliferation and apoptosis (programmed cell death) in the heart.\nSeveral studies have shown that miR-30 is involved in the post-ischemic remodeling of the heart. For example, one study published in the journal Circulation Research found that miR-30 was upregulated in the hearts of mice following myocardial infarction and that it played a role in the regulation of cardiac fibrosis (scarring) and remodeling. Another study published in the journal Aging Cell found that miR-30 was downregulated in the hearts of older mice and that it played a role in the regulation of cellular senescence (cell aging) and cardiac function.\nOverall, the evidence suggests that miR-30 is involved in the post-ischemic remodeling of the heart and may play a role in the regulation of cardiac fibrosis, cellular senescence, and other processes that contribute to the remodeling of the heart following cardiac injury.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MicroRNA-30 (miR-30) plays a role in post-ischemic cardiac remodeling.\n2. MiR-30 is a microRNA that has been shown to be upregulated in response to myocardial infarction and other forms of cardiac injury.\n3. MiR-30 plays a role in the regulation of cell proliferation and apoptosis in the heart.\n4. One study published in the Journal Circulation Research found that miR-30 was upregulated in the hearts of mice following myocardial infarction and that it played a role in the regulation of cardiac fibrosis and remodeling.\n5. Another study published in the journal Aging Cell found that miR-30 was downregulated in the hearts of older mice and that it played a role in the regulation of cellular senescence and cardiac function.",
    "vicuna-7b_fact": [
      "MicroRNA-30 (miR-30) plays a role in post-ischemic cardiac remodeling.",
      "MiR-30 is a microRNA that has been shown to be upregulated in response to myocardial infarction and other forms of cardiac injury.",
      "MiR-30 plays a role in the regulation of cell proliferation and apoptosis in the heart.",
      "One study published in the Journal Circulation Research found that miR-30 was upregulated in the hearts of mice following myocardial infarction and that it played a role in the regulation of cardiac fibrosis and remodeling.",
      "Another study published in the journal Aging Cell found that miR-30 was downregulated in the hearts of older mice and that it played a role in the regulation of cellular senescence and cardiac function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 613,
    "user_query": "How is myotonic dystrophy inherited?",
    "vicuna-7b_response": "Myotonic dystrophy is a genetic disorder that is inherited in an autosomal dominant manner. This means that a person with the disorder has a 50% chance of passing the gene on to each of their children.\nThe disorder is caused by a mutation in the DMPK gene, which is located on chromosome 19. This mutation results in the production of an abnormal RNA molecule that causes the muscles to become progressively weaker over time.\nThere are three types of myotonic dystrophy, each with varying degrees of severity. Type 1 is the mildest form, while type 2 is the most severe. Type 3 is a milder form that tends to occur later in life.\nMyotonic dystrophy is diagnosed through a combination of physical examination, genetic testing, and muscle biopsy. Treatment options for the disorder are limited, but medications can help to manage some of the symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Myotonic dystrophy is a genetic disorder that is inherited in an autosomal dominant manner.\n2. The disorder is caused by a mutation in the DMPK gene, which is located on chromosome 19.\n3. There are three types of myotonic dystrophy, each with varying degrees of severity.\n4. Myotonic dystrophy is diagnosed through a combination of physical examination, genetic testing, and muscle biopsy.\n5. Treatment options for myotonic dystrophy are limited, but medications can help to manage some of the symptoms.",
    "vicuna-7b_fact": [
      "Myotonic dystrophy is a genetic disorder that is inherited in an autosomal dominant manner.",
      "The disorder is caused by a mutation in the DMPK gene, which is located on chromosome 19.",
      "There are three types of myotonic dystrophy, each with varying degrees of severity.",
      "Myotonic dystrophy is diagnosed through a combination of physical examination, genetic testing, and muscle biopsy.",
      "Treatment options for myotonic dystrophy are limited, but medications can help to manage some of the symptoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There are two types of myotonic dystrophy, each with varying degrees of severity.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 615,
    "user_query": "Which are the mammalian orthologs of Drosophila Yki?",
    "vicuna-7b_response": "Yki, also known as Yes-associated protein kinase, is a protein kinase that plays a crucial role in the regulation of cell proliferation and differentiation in the fruit fly Drosophila melanogaster. In mammals, there are several protein kinases that have been shown to have similar functions to Yki, including:\n1. AKT1 (also known as protein kinase B), which is involved in regulating cell growth and survival.\n2. PKB/Akt2, which is similar to AKT1 and also plays a role in cell proliferation and survival.\n3. PKB/Akt3, which is similar to AKT1 and PKB/Akt2 and is involved in regulating cell growth and survival.\n4. PKB/Akt4, which is similar to AKT1, PKB/Akt2, and PKB/Akt3 and is involved in regulating cell growth and survival.\n5. PKB/Akt5, which is similar to AKT1, PKB/Akt2, PKB/Akt3, and PKB/Akt4 and is involved in regulating cell growth and survival.\nThese are some of the mammalian orthologs of Drosophila Yki, and they play important roles in regulating cell proliferation and differentiation in mammalian cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Yes-associated protein kinase (Yki) plays a key role in the regulation of cell proliferation and differentiation in the fruit fly Drosophila melanogaster.\n2. AKT1, also known as protein kinase B, is a mammalian ortholog of Drosophila Yki that is involved in cell growth and survival.\n3. PKB/Akt2 is another ortholog that functions similarly to Yki in regulating cell proliferation and survival.\n4. PKB/Akt3 and PKB/Akt4 are also orthologs of Drosophila Yki and play a part in regulating cell growth and survival.\n5. PKB/Akt5, similar to AKT1, PKB/Akt2, PKB/Akt3, and PKB/Akt4, is involved in regulating cell growth and survival in mammalian cells.",
    "vicuna-7b_fact": [
      "Yes-associated protein kinase (Yki) plays a key role in the regulation of cell proliferation and differentiation in the fruit fly Drosophila melanogaster.",
      "AKT1, also known as protein kinase B, is a mammalian ortholog of Drosophila Yki that is involved in cell growth and survival.",
      "PKB/Akt2 is another ortholog that functions similarly to Yki in regulating cell proliferation and survival.",
      "PKB/Akt3 and PKB/Akt4 are also orthologs of Drosophila Yki and play a part in regulating cell growth and survival.",
      "PKB/Akt5, similar to AKT1, PKB/Akt2, PKB/Akt3, and PKB/Akt4, is involved in regulating cell growth and survival in mammalian cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: AKT1, also known as protein kinase B, is not a mammalian ortholog of Drosophila Yki. It is involved in cell growth and survival in its own right.\n3. TRUE\n4. FALSE [correction]: PKB/Akt3 is an ortholog of Drosophila Akt1, not Yki. There is no known PKB/Akt4.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 618,
    "user_query": "Does molindone affect body weight?",
    "vicuna-7b_response": "Molindone is a medication that is primarily used to treat psychiatric disorders such as schizophrenia and bipolar disorder. While molindone can affect body weight, the extent of its effect is generally not significant.\nMolindone works by blocking the action of dopamine, a neurotransmitter that is involved in regulating movement, emotion, and motivation. This can help to reduce the symptoms of psychiatric disorders such as hallucinations, delusions, and agitation.\nSome studies have suggested that molindone may cause weight gain, particularly in the first few months of treatment. However, the overall effect on body weight is generally not significant and may depend on various factors such as the individual's baseline weight, other medications being taken, and the duration of treatment.\nIt is important to note that weight gain can be a side effect of many medications, including some antipsychotics like molindone. If you are taking molindone and are concerned about your weight, it is important to discuss your concerns with your healthcare provider. They can help you monitor your weight and adjust your treatment plan as needed to minimize any potential side effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Molindone is used primarily to treat psychiatric disorders such as schizophrenia and bipolar disorder.\n2. Molindone works by blocking the actions of dopamine, a neurotransmitter that helps regulate movement, emotion, and motivation.\n3. Studies suggest that molindone may cause weight gain, especially in the first few months of treatment.\n4. The overall effect of molindone on body weight is generally not significant.\n5. Weight gain can be a side effect of many medications, including some antipsychotics like molindone.",
    "vicuna-7b_fact": [
      "Molindone is used primarily to treat psychiatric disorders such as schizophrenia and bipolar disorder.",
      "Molindone works by blocking the actions of dopamine, a neurotransmitter that helps regulate movement, emotion, and motivation.",
      "Studies suggest that molindone may cause weight gain, especially in the first few months of treatment.",
      "The overall effect of molindone on body weight is generally not significant.",
      "Weight gain can be a side effect of many medications, including some antipsychotics like molindone."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 622,
    "user_query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "vicuna-7b_response": "Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures. There are several types of dystonia, and the treatment options vary depending on the type and severity of the dystonia.\nOne type of neurostimulation that is used for the treatment of dystonia is deep brain stimulation (DBS) of the globus pallidus interna (GPi). The GPi is a nucleus located in the basal ganglia, which is a group of brain structures involved in movement control. DBS of the GPi is used to treat dystonia that is refractory to other treatments, such as medications and botulinum toxin injections.\nDuring the DBS procedure, a neurosurgeon implants a small electrode into the GPi, and then uses a programmable pulse generator to deliver electrical stimulation to the GPi. The stimulation is adjusted over time to find the optimal settings for the individual patient.\nIt is important to note that DBS of the GPi is not appropriate for all patients with dystonia, and the decision to undergo the procedure should be made on an individual basis, after careful consideration of the potential benefits and risks.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures.\n2. Deep brain stimulation (DBS) of the globus pallidus interna (GPi) is used to treat dystonia.\n3. The globus pallidus interna (GPi) is a nucleus located in the basal ganglia which helps control movement.\n4. During the DBS procedure, an electrode is implanted into the GPi for electrical stimulation.\n5. DBS of the GPi is not suitable for all patients with dystonia and a decision on its use should be made after considering the potential benefits and risks.",
    "vicuna-7b_fact": [
      "Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures.",
      "Deep brain stimulation (DBS) of the globus pallidus interna (GPi) is used to treat dystonia.",
      "The globus pallidus interna (GPi) is a nucleus located in the basal ganglia which helps control movement.",
      "During the DBS procedure, an electrode is implanted into the GPi for electrical stimulation.",
      "DBS of the GPi is not suitable for all patients with dystonia and a decision on its use should be made after considering the potential benefits and risks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 625,
    "user_query": "Where is the angiogenin binding element  located?",
    "vicuna-7b_response": "The angiogenin binding element (ABE) is a specific DNA sequence that binds to the angiogenin protein. The ABE is located in the promoter region of the gene that encodes for angiogenin, which is a protein that plays a role in the development of new blood vessels.\nThe promoter region is the region of the gene that controls the transcription of the gene into messenger RNA (mRNA), which is then translated into protein. The ABE is located in the promoter region and is responsible for recruiting the transcriptional machinery to the gene, which leads to the production of angiogenin.\nThe ABE is a specific sequence of nucleotides that is recognized by the angiogenin protein through its DNA-binding domain. The ABE is located in the promoter region of the angiogenin gene and is responsible for the regulation of angiogenin expression.\nIn summary, the angiogenin binding element (ABE) is located in the promoter region of the angiogenin gene, and it is a specific DNA sequence that binds to the angiogenin protein. The ABE is responsible for the regulation of angiogenin expression and is essential for the development of new blood vessels.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The angiogenin binding element (ABE) is a specific DNA sequence that binds to the angiogenin protein.\n2. The ABE is located in the promoter region of the gene that encodes for angiogenin.\n3. The promoter region controls the transcription of the gene into messenger RNA (mRNA).\n4. The ABE is responsible for recruiting the transcriptional machinery to the gene, leading to the production of angiogenin.\n5. Angiogenin protein plays a role in the development of new blood vessels.",
    "vicuna-7b_fact": [
      "The angiogenin binding element (ABE) is a specific DNA sequence that binds to the angiogenin protein.",
      "The ABE is located in the promoter region of the gene that encodes for angiogenin.",
      "The promoter region controls the transcription of the gene into messenger RNA (mRNA).",
      "The ABE is responsible for recruiting the transcriptional machinery to the gene, leading to the production of angiogenin.",
      "Angiogenin protein plays a role in the development of new blood vessels."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 626,
    "user_query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "vicuna-7b_response": "NF-κB (nuclear factor kappa B) is a transcription factor that plays a crucial role in regulating the immune response and inflammation. Cytoplasmic sequestration of NF-κB refers to the process by which NF-κB is prevented from entering the nucleus and activating its target genes.\nThere are several proteins that have been shown to cause cytoplasmic sequestration of NF-κB, including:\n1. IκB proteins: IκB proteins are a family of proteins that bind to and inhibit the activity of NF-κB. When activated, certain signaling pathways can lead to the degradation of IκB proteins, allowing NF-κB to enter the nucleus and activate its target genes.\n2. TGF-β (transforming growth factor-β): TGF-β is a cytokine that can inhibit NF-κB activation by binding to its receptor and preventing the activation of NF-κB signaling pathways.\n3. A20: A20 is a protein that has been shown to inhibit NF-κB activation by binding to and inhibiting the activity of the IKK (IκB kinase) complex, which is responsible for phosphorylating and degrading IκB proteins.\n4. HDAC (histone deacetylase) inhibitors: HDAC inhibitors are a class of drugs that have been shown to activate NF-κB by increasing the acetylation of histone proteins, which allows NF-κB to bind to its target DNA sequences and activate its target genes.\nOverall, these proteins play a crucial role in regulating NF-κB activity and preventing its excessive activation, which is important for maintaining proper immune function and preventing inflammation-related diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NF-κB is a transcription factor that plays a crucial role in regulating the immune response and inflammation.\n2. IκB proteins bind to and inhibit the activity of NF-κB.\n3. TGF-β is a cytokine that can inhibit NF-κB activation by binding to its receptor and preventing the activation of NF-κB signaling pathways.\n4. A20 is a protein that inhibits NF-κB activation by binding to and inhibiting the activity of the IKK complex.\n5. HDAC inhibitors are a class of drugs that can activate NF-κB by increasing the acetylation of histone proteins.",
    "vicuna-7b_fact": [
      "NF-κB is a transcription factor that plays a crucial role in regulating the immune response and inflammation.",
      "IκB proteins bind to and inhibit the activity of NF-κB.",
      "TGF-β is a cytokine that can inhibit NF-κB activation by binding to its receptor and preventing the activation of NF-κB signaling pathways.",
      "A20 is a protein that inhibits NF-κB activation by binding to and inhibiting the activity of the IKK complex.",
      "HDAC inhibitors are a class of drugs that can activate NF-κB by increasing the acetylation of histone proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: HDAC inhibitors are a class of drugs that can inhibit NF-κB by increasing the acetylation of histone proteins.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 627,
    "user_query": "What is the mode of inheritance of Marchesani syndrome?",
    "vicuna-7b_response": "Marchesani syndrome is an inherited disorder that is caused by a mutation in the EIF2B5 gene. This gene provides instructions for making a protein that is involved in the production of energy in cells. The mutation that causes Marchesani syndrome results in the production of a non-functional protein, which leads to the accumulation of harmful substances in the cells and the development of the symptoms of the disorder.\nMarchesani syndrome is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. The disorder is relatively rare, and it is estimated that about 1 in 50,000 people have Marchesani syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Marchesani syndrome is an inherited disorder.\n2. The disorder is caused by a mutation in the EIF2B5 gene.\n3. The mutated gene creates a non-functional protein, leading to the accumulation of harmful substances in cells and development of symptoms.\n4. Marchesani syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the disorder.\n5. It is estimated that about 1 in 50,000 people have Marchesani syndrome.",
    "vicuna-7b_fact": [
      "Marchesani syndrome is an inherited disorder.",
      "The disorder is caused by a mutation in the EIF2B5 gene.",
      "The mutated gene creates a non-functional protein, leading to the accumulation of harmful substances in cells and development of symptoms.",
      "Marchesani syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the disorder.",
      "It is estimated that about 1 in 50,000 people have Marchesani syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Marchesani Syndrome is caused by mutations in the ADAMTS10 or FBN1 genes.\n3. FALSE [correction]: The mutation often results in structurally abnormal or deficient proteins that negatively affect the microfibrils, a component of the body's connective tissues.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-7b_response": "The event that results in the acetylation of S6K1 is the interaction between S6K1 and p300/CBP coactivators.\nS6K1 is a serine/threonine kinase that plays a crucial role in regulating cell growth and metabolism. It is activated by the phosphorylation of its T-loop by AKT, which is activated by PI3K signaling. However, S6K1 activity can also be regulated by post-translational modifications, such as acetylation.\nThe interaction between S6K1 and p300/CBP coactivators is a key event in the regulation of S6K1 activity. p300/CBP are transcriptional coactivators that play a role in the regulation of gene expression. They interact with S6K1 and acetylate its lysine residues, leading to the inhibition of its kinase activity and the repression of its target genes.\nIn summary, the acetylation of S6K1 is regulated by the interaction between S6K1 and p300/CBP coactivators, which leads to the inhibition of its kinase activity and the repression of its target genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The event that results in the acetylation of S6K1 is the interaction between S6K1 and p300/CBP coactivators.\n2. S6K1 is a serine/threonine kinase that plays a crucial role in regulating cell growth and metabolism.\n3. S6K1 is activated by the phosphorylation of its T-loop by AKT, which is activated by PI3K signaling.\n4. p300/CBP coactivators play a role in the regulation of gene expression.\n5. The interaction between S6K1 and p300/CBP coactivators leads to the inhibition of S6K1's kinase activity and the repression of its target genes.",
    "vicuna-7b_fact": [
      "The event that results in the acetylation of S6K1 is the interaction between S6K1 and p300/CBP coactivators.",
      "S6K1 is a serine/threonine kinase that plays a crucial role in regulating cell growth and metabolism.",
      "S6K1 is activated by the phosphorylation of its T-loop by AKT, which is activated by PI3K signaling.",
      "p300/CBP coactivators play a role in the regulation of gene expression.",
      "The interaction between S6K1 and p300/CBP coactivators leads to the inhibition of S6K1's kinase activity and the repression of its target genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The interaction between S6K1 and p300/CBP coactivators leads to the acetylation, not the inhibition, of S6K1's kinase activity and not necessarily the repression of its target genes.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 630,
    "user_query": "List angiocrine factors",
    "vicuna-7b_response": "Angiocrine factors are a type of signaling molecule that are produced by endothelial cells, which are cells that line the blood vessels. These factors are involved in the regulation of various physiological processes, including blood flow, blood pressure, and the development of blood vessels. Some examples of angiocrine factors include:\n1. Angiopoietins: Angiopoietins are a family of proteins that are produced by endothelial cells and play a role in the development and maintenance of blood vessels. There are two main types of angiopoietins, angiopoietin-1 and angiopoietin-2, and they work together to regulate the growth and differentiation of blood vessels.\n2. Vascular endothelial growth factor (VEGF): VEGF is a protein that is produced by endothelial cells and plays a key role in the development and maintenance of blood vessels. It stimulates the growth of new blood vessels and promotes the survival of existing blood vessels.\n3. Platelet-derived growth factor (PDGF): PDGF is a protein that is produced by platelets, which are blood cells that help to clot blood. It is also produced by endothelial cells and plays a role in the growth and differentiation of blood vessels.\n4. Hepatocyte growth factor (HGF): HGF is a protein that is produced by various cells in the body, including endothelial cells. It plays a role in the development and maintenance of blood vessels and also promotes the growth and survival of certain types of cells, including cancer cells.\n5. Angiotensin-converting enzyme (ACE): ACE is an enzyme that is produced by endothelial cells and plays a role in the regulation of blood pressure. It helps to convert a substance called angiotensin I into a more potent vasoconstrictor called angiotensin II, which increases blood pressure.\nOverall, angiocrine factors are an important class of signaling molecules that play a crucial role in the regulation of various physiological processes, including blood flow, blood pressure, and the development of blood vessels.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Angiocrine factors are signaling molecules produced by endothelial cells.\n2. Angiocrine factors contribute to the regulation of physiological processes like blood flow, blood pressure, and the development of blood vessels.\n3. Angiopoietins, which include angiopoietin-1 and angiopoietin-2, play a role in the growth and differentiation of blood vessels.\n4. Vascular endothelial growth factor stimulates the growth of new blood vessels and promotes the survival of existing blood vessels.\n5. Hepatocyte growth factor promotes the growth and survival of certain types of cells, including cancer cells, and plays a role in the development and maintenance of blood vessels.",
    "vicuna-7b_fact": [
      "Angiocrine factors are signaling molecules produced by endothelial cells.",
      "Angiocrine factors contribute to the regulation of physiological processes like blood flow, blood pressure, and the development of blood vessels.",
      "Angiopoietins, which include angiopoietin-1 and angiopoietin-2, play a role in the growth and differentiation of blood vessels.",
      "Vascular endothelial growth factor stimulates the growth of new blood vessels and promotes the survival of existing blood vessels.",
      "Hepatocyte growth factor promotes the growth and survival of certain types of cells, including cancer cells, and plays a role in the development and maintenance of blood vessels."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 631,
    "user_query": "What is protein carbamylation?",
    "vicuna-7b_response": "Protein carbamylation is a post-translational modification that involves the addition of a carbamate group to a protein. This modification is typically found in proteins involved in cellular signaling and can affect their function and stability.\nThe process of protein carbamylation involves the transfer of a carbamate group from a carbamate donor molecule, such as ornithine carbamoyl transferase (OCT), to a protein. This transfer results in the formation of a carbamate linkage between the protein and the carbamate donor molecule.\nProtein carbamylation has been implicated in a variety of cellular processes, including cell growth and differentiation, cell cycle progression, and cell death. It has also been shown to play a role in the development of certain diseases, such as cancer and neurodegenerative disorders.\nOverall, protein carbamylation is an important post-translational modification that can affect the function and stability of proteins involved in cellular signaling. Further research is needed to fully understand the role of protein carbamylation in various cellular processes and its potential as a therapeutic target for the treatment of diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Protein carbamylation is a post-translational modification that involves the addition of a carbamate group to a protein.\n2. This process affects the function and stability of proteins involved in cellular signaling.\n3. The process of protein carbamylation involves the transfer of a carbamate group from a carbamate donor molecule, such as ornithine carbamoyl transferase (OCT), to a protein.\n4. Protein carbamylation plays a role in various cellular processes, including cell growth and differentiation, cell cycle progression, and cell death.\n5. Protein carbamylation has been implicated in the development of certain diseases, such as cancer and neurodegenerative disorders.",
    "vicuna-7b_fact": [
      "Protein carbamylation is a post-translational modification that involves the addition of a carbamate group to a protein.",
      "This process affects the function and stability of proteins involved in cellular signaling.",
      "The process of protein carbamylation involves the transfer of a carbamate group from a carbamate donor molecule, such as ornithine carbamoyl transferase (OCT), to a protein.",
      "Protein carbamylation plays a role in various cellular processes, including cell growth and differentiation, cell cycle progression, and cell death.",
      "Protein carbamylation has been implicated in the development of certain diseases, such as cancer and neurodegenerative disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The process of protein carbamylation involves the binding (not transfer) of a carbamate group derived from isocyanic acid to the protein. The exact molecules involved could vary and doesn't necessarily involve Ornithine Carbamoyl Transferase (OCT).\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-7b_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by a mutation in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel, which is responsible for regulating the flow of calcium ions into cells.\nThe mutation in the CACNA1A gene that causes EA6 results in a loss of function of the alpha-1A subunit, which leads to an imbalance of calcium ions in the cells of the nervous system. This imbalance can cause a variety of symptoms, including episodic ataxia, which is characterized by sudden, recurrent episodes of poor coordination and balance.\nOther symptoms of EA6 can include vertigo, dizziness, nausea, and difficulty speaking. The severity of the symptoms can vary widely among individuals, and some people with EA6 may experience only a few episodes of ataxia throughout their lives, while others may have frequent and severe episodes.\nEpisodic ataxia type 6 is inherited in an autosomal dominant pattern, which means that a person with the disorder has a 50% chance of passing the mutated gene on to each of their children. However, not everyone with the mutated gene will develop the disorder, and the age of onset and the severity of the symptoms can vary widely among affected individuals.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Episodic ataxia type 6 (EA6) is a genetic disorder caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel.\n3. The mutation in the CACNA1A gene that causes EA6 results in a loss of function of the alpha-1A subunit.\n4. Symptoms of EA6 can include episodic ataxia, vertigo, dizziness, nausea, and difficulty speaking.\n5. Episodic ataxia type 6 is inherited in an autosomal dominant pattern, meaning a person with the disorder has a 50% chance of passing the mutated gene on to each of their children.",
    "vicuna-7b_fact": [
      "Episodic ataxia type 6 (EA6) is a genetic disorder caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel.",
      "The mutation in the CACNA1A gene that causes EA6 results in a loss of function of the alpha-1A subunit.",
      "Symptoms of EA6 can include episodic ataxia, vertigo, dizziness, nausea, and difficulty speaking.",
      "Episodic ataxia type 6 is inherited in an autosomal dominant pattern, meaning a person with the disorder has a 50% chance of passing the mutated gene on to each of their children."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 633,
    "user_query": "What is the main role of Ctf4 in dna replication?",
    "vicuna-7b_response": "Ctf4 is a protein that plays a crucial role in the initiation of DNA replication in eukaryotes. It is a component of the replicative helicase, which is responsible for unwinding and separating the two strands of DNA during replication.\nCtf4 is recruited to the origin of replication by the origin recognition complex (ORC), which is a protein complex that binds to specific DNA sequences to initiate the replication process. Once Ctf4 is recruited to the origin, it forms a complex with other helicase subunits, including DnaA, to create the replicative helicase.\nThe replicative helicase then unwinds the DNA double helix and separates the two strands, creating a replication fork. This process is essential for the accurate replication of DNA and is required for the maintenance of the genome.\nIn summary, Ctf4 is a key component of the replicative helicase that is responsible for unwinding and separating the two strands of DNA during the initiation of DNA replication. It is recruited to the origin of replication by the origin recognition complex and forms a complex with other helicase subunits to create the replicative helicase.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ctf4 is a protein that plays a role in the initiation of DNA replication in eukaryotes.\n2. Ctf4 is a component of the replicative helicase, which unwinds and separates the two strands of DNA during replication.\n3. The origin recognition complex (ORC) recruits Ctf4 to the origin of replication.\n4. Ctf4 forms a complex with other helicase subunits, including DnaA, to create the replicative helicase.\n5. The replicative helicase unwinds the DNA double helix and separates the two strands, creating a replication fork.",
    "vicuna-7b_fact": [
      "Ctf4 is a protein that plays a role in the initiation of DNA replication in eukaryotes.",
      "Ctf4 is a component of the replicative helicase, which unwinds and separates the two strands of DNA during replication.",
      "The origin recognition complex (ORC) recruits Ctf4 to the origin of replication.",
      "Ctf4 forms a complex with other helicase subunits, including DnaA, to create the replicative helicase.",
      "The replicative helicase unwinds the DNA double helix and separates the two strands, creating a replication fork."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ctf4 is not known to form a complex with DnaA. Instead, Ctf4 is known to interact with components of the MCM helicase complex in eukaryotes, not with DnaA which is a component of the bacterial replication machinery.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 634,
    "user_query": "Could Arimidex (anastrozole) cause hot flashes?",
    "vicuna-7b_response": "Yes, Arimidex (anastrozole) can cause hot flashes as a side effect. Hot flashes are a common symptom of menopause, which is a natural part of aging for women. However, hot flashes can also be a side effect of certain medications, including Arimidex, which is used to treat breast cancer in postmenopausal women.\nHot flashes are characterized by a feeling of warmth or redness in the face, neck, and upper body, which can be accompanied by sweating, flushing, and sometimes a rapid heartbeat. Hot flashes can be bothersome and disruptive to daily life, but they are usually not serious and tend to resolve on their own over time.\nIf you are taking Arimidex and experiencing hot flashes, it is important to talk to your healthcare provider about your symptoms. They may be able to recommend ways to manage your hot flashes or adjust your treatment plan if necessary. In some cases, your healthcare provider may recommend a different medication or treatment option to help manage your hot flashes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Arimidex (anastrozole) can cause hot flashes as a side effect.\n2. Hot flashes are a common symptom of menopause.\n3. Hot flashes can also be a side effect of certain medications, including Arimidex.\n4. Arimidex is used to treat breast cancer in postmenopausal women.\n5. Hot flashes can be characterized by warmth or redness in the face, neck, and upper body, and can be accompanied by sweating and sometimes a rapid heartbeat.",
    "vicuna-7b_fact": [
      "Arimidex (anastrozole) can cause hot flashes as a side effect.",
      "Hot flashes are a common symptom of menopause.",
      "Hot flashes can also be a side effect of certain medications, including Arimidex.",
      "Arimidex is used to treat breast cancer in postmenopausal women.",
      "Hot flashes can be characterized by warmth or redness in the face, neck, and upper body, and can be accompanied by sweating and sometimes a rapid heartbeat."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 635,
    "user_query": "What is the role of Inn1 in cytokinesis?",
    "vicuna-7b_response": "Inn1, also known as INCENP, is a key protein involved in the regulation of cytokinesis, the process by which a cell divides into two daughter cells.\nInn1 is a component of the spindle assembly checkpoint, a quality control mechanism that ensures the proper alignment and attachment of microtubules to the kinetochores, the protein complexes on the chromosomes. The spindle assembly checkpoint monitors the attachment of microtubules to kinetochores and prevents anaphase onset until all kinetochores are properly attached.\nInn1 also plays a role in the regulation of the mitotic spindle, the structure that forms during cell division and is responsible for separating the chromosomes. Inn1 interacts with the mitotic kinesin Eg5, which is involved in the movement of microtubules and the separation of the chromosomes during anaphase.\nInn1 is also involved in the recruitment of the anaphase-promoting complex/cyclosome (APC/C) to the kinetochores, which is necessary for the degradation of the kinetochore protein BubR1 and the progression of anaphase.\nOverall, Inn1 plays a crucial role in the regulation of cytokinesis by participating in the spindle assembly checkpoint and the regulation of the mitotic spindle, and by promoting the degradation of key kinetochore proteins during anaphase.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Inn1, also known as INCENP, is a protein involved in the regulation of cytokinesis, a process by which a cell divides into two daughter cells.\n2. Inn1 is a component of the spindle assembly checkpoint, ensuring the proper alignment and attachment of microtubules to kinetochores.\n3. Inn1 plays a role in the regulation of the mitotic spindle, the structure that separates the chromosomes during cell division.\n4. Inn1 interacts with the mitotic kinesin Eg5, which is involved in the movement of microtubules and the separation of chromosomes.\n5. Inn1 is involved in the recruitment of the anaphase-promoting complex/cyclosome to the kinetochores, which is necessary for the degradation of the kinetochore protein BubR1 and the progression of anaphase.",
    "vicuna-7b_fact": [
      "Inn1, also known as INCENP, is a protein involved in the regulation of cytokinesis, a process by which a cell divides into two daughter cells.",
      "Inn1 is a component of the spindle assembly checkpoint, ensuring the proper alignment and attachment of microtubules to kinetochores.",
      "Inn1 plays a role in the regulation of the mitotic spindle, the structure that separates the chromosomes during cell division.",
      "Inn1 interacts with the mitotic kinesin Eg5, which is involved in the movement of microtubules and the separation of chromosomes.",
      "Inn1 is involved in the recruitment of the anaphase-promoting complex/cyclosome to the kinetochores, which is necessary for the degradation of the kinetochore protein BubR1 and the progression of anaphase."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 636,
    "user_query": "Which hormone deficiency is implicated in the Costello syndrome ?",
    "vicuna-7b_response": "The Costello syndrome is a rare genetic disorder caused by mutations in the HRAS gene. The HRAS gene provides instructions for making a protein called H-Ras, which is a component of a signaling pathway that plays a role in cell growth and division. The mutations in the HRAS gene that cause the Costello syndrome result in the production of an abnormal form of H-Ras that is unable to properly regulate cell growth and division.\nOne of the symptoms of the Costello syndrome is a deficiency of growth hormone, which is a hormone produced by the pituitary gland that plays a crucial role in growth and development. However, it is important to note that the Costello syndrome is a genetic disorder, and the hormone deficiency is a result of the genetic mutation, rather than a direct cause of the syndrome.\nIn summary, the Costello syndrome is caused by mutations in the HRAS gene, which result in the production of an abnormal form of H-Ras that is unable to properly regulate cell growth and division. One of the symptoms of the Costello syndrome is a deficiency of growth hormone, which is a hormone produced by the pituitary gland that plays a crucial role in growth and development.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Costello syndrome is a genetic disorder caused by mutations in the HRAS gene.\n2. The HRAS gene provides instructions for making a protein named H-Ras that regulates cell growth and division.\n3. Mutations in the HRAS gene result in the production of an abnormal form of H-Ras protein.\n4. One of the symptoms of the Costello syndrome is a deficiency of growth hormone.\n5. Growth hormone is produced by the pituitary gland and plays a role in growth and development.",
    "vicuna-7b_fact": [
      "The Costello syndrome is a genetic disorder caused by mutations in the HRAS gene.",
      "The HRAS gene provides instructions for making a protein named H-Ras that regulates cell growth and division.",
      "Mutations in the HRAS gene result in the production of an abnormal form of H-Ras protein.",
      "One of the symptoms of the Costello syndrome is a deficiency of growth hormone.",
      "Growth hormone is produced by the pituitary gland and plays a role in growth and development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: One of the symptoms of Costello syndrome is accelerated growth and large body size.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 640,
    "user_query": "Which is the most common CFTR mutation in Caucasians?",
    "vicuna-7b_response": "The most common CFTR mutation in Caucasians is the F508del mutation. This mutation results in a loss of function of the CFTR protein, which is responsible for transporting salt and water in and out of the cells in the lungs, pancreas, and other organs. Individuals with this mutation typically have a more severe form of cystic fibrosis, which is a genetic disease that affects the respiratory and digestive systems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The most common CFTR mutation in Caucasians is the F508del mutation.\n2. The F508del mutation results in a loss of function of the CFTR protein.\n3. The CFTR protein is responsible for transporting salt and water in and out of certain cells.\n4. Individuals with the F508del mutation typically have a more severe form of cystic fibrosis.\n5. Cystic fibrosis is a genetic disease that affects the respiratory and digestive systems.",
    "vicuna-7b_fact": [
      "The most common CFTR mutation in Caucasians is the F508del mutation.",
      "The F508del mutation results in a loss of function of the CFTR protein.",
      "The CFTR protein is responsible for transporting salt and water in and out of certain cells.",
      "Individuals with the F508del mutation typically have a more severe form of cystic fibrosis.",
      "Cystic fibrosis is a genetic disease that affects the respiratory and digestive systems."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 641,
    "user_query": "Which CDK targets control cytokinesis?",
    "vicuna-7b_response": "Cytokinesis is the process by which a cell divides into two daughter cells. The CDK (Cyclin-Dependent Kinase) family of proteins play a crucial role in regulating the progression of the cell cycle, including cytokinesis.\nThere are several CDKs that have been shown to play a role in controlling cytokinesis, including:\n1. CDK1 (also known as CDC2) - This CDK is activated at the start of mitosis and is responsible for promoting the progression of the cell cycle from G1 phase to S phase. It also plays a role in regulating the timing of cytokinesis.\n2. CDK2 - This CDK is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase. It also plays a role in regulating the timing of cytokinesis.\n3. CDK4 - This CDK is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase. It also plays a role in regulating the timing of cytokinesis.\n4. CDK6 - This CDK is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase. It also plays a role in regulating the timing of cytokinesis.\n5. CDK2AP1 - This CDK is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase. It also plays a role in regulating the timing of cytokinesis.\nThese are just a few examples of CDKs that have been shown to play a role in controlling cytokinesis. The specific CDKs that are involved in regulating cytokinesis can vary depending on the type of cell and the stage of the cell cycle.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cytokinesis is the process by which a cell divides into two daughter cells.\n2. The Cyclin-Dependent Kinase (CDK) family of proteins play a role in regulating the progression of the cell cycle, including cytokinesis.\n3. CDK1, also known as CDC2, is activated at the start of mitosis and is responsible for promoting the progression of the cell cycle from G1 phase to S phase.\n4. CDK2 is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase.\n5. CDK4 and CDK6 also manage progression from the G1 phase to the S phase of the cell cycle and they're activated in the late G1 phase.\n6. CDK2AP1, just like the other CDKs listed, is activated in the late G1 phase and pushes the cell cycle from G1 phase to S phase.",
    "vicuna-7b_fact": [
      "Cytokinesis is the process by which a cell divides into two daughter cells.",
      "The Cyclin-Dependent Kinase (CDK) family of proteins play a role in regulating the progression of the cell cycle, including cytokinesis.",
      "CDK1, also known as CDC2, is activated at the start of mitosis and is responsible for promoting the progression of the cell cycle from G1 phase to S phase.",
      "CDK2 is activated in late G1 phase and promotes the progression of the cell cycle from G1 phase to S phase.",
      "CDK4 and CDK6 also manage progression from the G1 phase to the S phase of the cell cycle and they're activated in the late G1 phase.",
      "CDK2AP1, just like the other CDKs listed, is activated in the late G1 phase and pushes the cell cycle from G1 phase to S phase."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CDK1, also known as CDC2, is activated at the start of mitosis and is responsible for promoting the progression of the cell cycle from G2 phase to M phase.\n4. TRUE\n5. TRUE\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 643,
    "user_query": "In what type(s) of plant organelles we can detect prolamellar bodies?",
    "vicuna-7b_response": "Prolamellar bodies are found in the rough endoplasmic reticulum (RER) of plants. The RER is a type of organelle in plants and some protists that is responsible for the modification and transport of proteins and lipids.\nProlamellar bodies are specialized structures within the RER that are involved in the processing and modification of proteins. They are composed of protein and lipid components and are thought to play a role in the folding and maturation of proteins.\nIn addition to the RER, prolamellar bodies have also been observed in the plastids of some plant species. Plastids are organelles that are responsible for the synthesis of pigments and other molecules in plants.\nOverall, prolamellar bodies are found in the RER of plants and in some plastids, and they are involved in the processing and modification of proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prolamellar bodies are found in the rough endoplasmic reticulum (RER) of plants.\n2. The RER is a type of organelle in plants and some protists that is responsible for the modification and transport of proteins and lipids.\n3. Prolamellar bodies are specialized structures within the RER that are involved in the processing and modification of proteins.\n4. Prolamellar bodies have also been observed in the plastids of some plant species.\n5. Plastids are organelles that are responsible for the synthesis of pigments and other molecules in plants.",
    "vicuna-7b_fact": [
      "Prolamellar bodies are found in the rough endoplasmic reticulum (RER) of plants.",
      "The RER is a type of organelle in plants and some protists that is responsible for the modification and transport of proteins and lipids.",
      "Prolamellar bodies are specialized structures within the RER that are involved in the processing and modification of proteins.",
      "Prolamellar bodies have also been observed in the plastids of some plant species.",
      "Plastids are organelles that are responsible for the synthesis of pigments and other molecules in plants."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Prolamellar bodies are found in the chloroplasts of plants, not in the rough endoplasmic reticulum (RER).\n2. TRUE\n3. FALSE [correction]: Prolamellar bodies are not involved in the processing and modification of proteins. Instead, they are involved in the initial formation of the chloroplast lamellar system, which plays a vital role in photosynthesis.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-7b_response": "Chromomethylases are enzymes that add a methyl group to a DNA base, resulting in the formation of a methylated base. These enzymes are commonly found in bacteria and plants, but they are not present in animal genomes.\nIn animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs). DNMTs add a methyl group to cytosine residues in the DNA, resulting in the formation of 5-methylcytosine. This process is important for regulating gene expression and maintaining the stability of the genome.\nWhile chromomethylases are not present in animal genomes, they have been found in some viruses, such as bacteriophages and retroviruses. These viruses use chromomethylases to add methyl groups to the DNA of their host cells, allowing them to establish long-term infections and evade the host's immune system.\nIn summary, chromomethylases are not present in animal genomes, but they have been found in some viruses. In animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chromomethylases are enzymes that add a methyl group to a DNA base.\n2. Chromomethylases are commonly found in bacteria and plants.\n3. Chromomethylases are not present in animal genomes.\n4. In animal genomes, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs).\n5. Chromomethylases have been found in some viruses, such as bacteriophages and retroviruses.",
    "vicuna-7b_fact": [
      "Chromomethylases are enzymes that add a methyl group to a DNA base.",
      "Chromomethylases are commonly found in bacteria and plants.",
      "Chromomethylases are not present in animal genomes.",
      "In animal genomes, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs).",
      "Chromomethylases have been found in some viruses, such as bacteriophages and retroviruses."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Chromomethylases have not been found in viruses, such bacteriophages and retroviruses.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 647,
    "user_query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "vicuna-7b_response": "Charcot-Marie-Tooth disease (CMT) is a group of inherited neuropathies characterized by progressive degeneration of the peripheral nerves. There are several types of CMT, and the most common form is autosomal dominant CMT (AD-CMT), which is caused by mutations in one of several genes.\nThe genes that have been identified as causing AD-CMT include:\n1. GDAP1: mutations in this gene have been identified in a small percentage of AD-CMT cases.\n2. PMP22: mutations in this gene are the most common cause of AD-CMT and account for about 70% of cases.\n3. MPZ: mutations in this gene can also cause AD-CMT.\n4. GJB1: mutations in this gene, which encodes for the protein connexin32, can cause AD-CMT.\n5. CX32: mutations in this gene can also cause AD-CMT.\n6. MFN2: mutations in this gene have been identified in a small percentage of AD-CMT cases.\nIt's important to note that there are other genes that have been associated with CMT, and not all cases of AD-CMT have a identified genetic cause.\nIt's also important to note that genetic testing is available for these genes, and if a person has a family history of CMT, genetic testing can be done to determine if they are at risk of developing the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The most common form of Charcot-Marie-Tooth disease is autosomal dominant CMT.\n2. Mutations in the GDAP1 gene have been identified in a small percentage of AD-CMT cases.\n3. Around 70% of AD-CMT cases are caused by mutations in the PMP22 gene.\n4. Mutations in the genes MPZ, GJB1, CX32, and MFN2 can cause AD-CMT.\n5. Not all cases of AD-CMT have a identified genetic cause.\n6. Genetic testing is available for these genes.",
    "vicuna-7b_fact": [
      "The most common form of Charcot-Marie-Tooth disease is autosomal dominant CMT.",
      "Mutations in the GDAP1 gene have been identified in a small percentage of AD-CMT cases.",
      "Around 70% of AD-CMT cases are caused by mutations in the PMP22 gene.",
      "Mutations in the genes MPZ, GJB1, CX32, and MFN2 can cause AD-CMT.",
      "Not all cases of AD-CMT have a identified genetic cause.",
      "Genetic testing is available for these genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 648,
    "user_query": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?",
    "vicuna-7b_response": "The interferon-beta (IFN-b) enhanceosome is a complex that is formed by the recruitment of transcription factors (TFs) to the promoter region of genes that are induced by IFN-b. The formation of the IFN-b enhanceosome is important for the regulation of the expression of genes that are involved in the immune response to viral infections.\nThe following TFs have been shown to participate in the formation of the IFN-b enhanceosome:\n1. IRF-1: Interferon regulatory factor 1 (IRF-1) is a key TF that is involved in the formation of the IFN-b enhanceosome. IRF-1 binds to the IFN-b promoter and recruits other TFs to the promoter region, leading to the activation of gene expression.\n2. STAT1: Signal transducer and activator of transcription 1 (STAT1) is a TF that is involved in the IFN-b signaling pathway. STAT1 is recruited to the IFN-b promoter by IRF-1 and other TFs, and it plays a role in the activation of gene expression.\n3. NF-κB: Nuclear factor kappa B (NF-κB) is a TF that is involved in the regulation of the immune response to viral infections. NF-κB is recruited to the IFN-b promoter by IRF-1 and other TFs, and it plays a role in the activation of gene expression.\n4. ATF-2: Activating transcription factor 2 (ATF-2) is a TF that is involved in the regulation of the immune response to viral infections. ATF-2 is recruited to the IFN-b promoter by IRF-1 and other TFs, and it plays a role in the activation of gene expression.\n5. C/EBPβ: C/EBPβ is a TF that is involved in the regulation of the immune response to viral infections. C/EBPβ is recruited to the IFN-b promoter by IRF-1 and other TFs, and",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The interferon-beta enhanceosome is formed by the recruitment of transcription factors to the promoter region of genes induced by IFN-b.\n2. The formation of the IFN-b enhanceosome is significant for the regulation of the expression of genes involved in the immune response to viral infections.\n3. Interferon regulatory factor 1 (IRF-1) is a transcription factor involved in the formation of the IFN-b enhanceosome.\n4. Signal transducer and activator of transcription 1 (STAT1) is a transcription factor involved in the IFN-b signaling pathway.\n5. Nuclear factor kappa B (NF-κB), activating transcription factor 2 (ATF-2), and C/EBPβ are transcription factors that participate in the formation of the IFN-b enhanceosome.\n",
    "vicuna-7b_fact": [
      "The interferon-beta enhanceosome is formed by the recruitment of transcription factors to the promoter region of genes induced by IFN-b.",
      "The formation of the IFN-b enhanceosome is significant for the regulation of the expression of genes involved in the immune response to viral infections.",
      "Interferon regulatory factor 1 (IRF-1) is a transcription factor involved in the formation of the IFN-b enhanceosome.",
      "Signal transducer and activator of transcription 1 (STAT1) is a transcription factor involved in the IFN-b signaling pathway.",
      "Nuclear factor kappa B (NF-κB), activating transcription factor 2 (ATF-2), and C/EBPβ are transcription factors that participate in the formation of the IFN-b enhanceosome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-7b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Here are some of the most popular ones:\n1. ChIPS: This package provides tools for ChIP-seq data analysis, including the identification of TFBSs.\n2. DRIMMER: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n3. MEME: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\n4. PITA: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n5. TESS: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n6. TRANSFAC: This package provides a database of TFBSs and can be used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n7. MotifSampler: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\nThese are just a few examples of the many packages available for TFBS analysis in R/Bioconductor. The choice of package will depend on the specific needs of the analysis and the type of data available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The package ChIPS in R/Bioconductor offers tools for ChIP-seq data analysis, including the identification of TFBSs.\n2. The package DRIMMER in R/Bioconductor is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n3. The MEME package in R/Bioconductor is used for the discovery of motifs in DNA sequences, including TFBSs.\n4. The PITA package in R/Bioconductor is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n5. The TRANSFAC package in R/Bioconductor provides a database of TFBSs and can be used for the identification of TFBSs from ChIP-seq or ChIP-chip data.",
    "vicuna-7b_fact": [
      "The package ChIPS in R/Bioconductor offers tools for ChIP-seq data analysis, including the identification of TFBSs.",
      "The package DRIMMER in R/Bioconductor is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.",
      "The MEME package in R/Bioconductor is used for the discovery of motifs in DNA sequences, including TFBSs.",
      "The PITA package in R/Bioconductor is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.",
      "The TRANSFAC package in R/Bioconductor provides a database of TFBSs and can be used for the identification of TFBSs from ChIP-seq or ChIP-chip data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 651,
    "user_query": "Simpson grading is used to describe resection of which brain tumor?",
    "vicuna-7b_response": "Simpson grading is used to describe the degree of differentiation of a brain tumor. It is a system used to classify the appearance of a tumor under a microscope, based on the degree to which it resembles normal brain tissue. The system is based on three grades: grade I, II, and III. Grade I tumors are well-differentiated and resemble normal brain tissue, while grade III tumors are poorly differentiated and have a high likelihood of being malignant. The Simpson grading system is used to help determine the prognosis and treatment options for a brain tumor.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Simpson grading is used to describe the degree of differentiation of a brain tumor.\n2. Simpson grading system includes grade I, II, and III.\n3. Grade I tumors in the Simpson grading system are well-differentiated and resemble normal brain tissue.\n4. Grade III tumors in the Simpson grading system are poorly differentiated and have a high likelihood of being malignant.\n5. The Simpson grading system is used to help determine the prognosis and treatment options for a brain tumor.",
    "vicuna-7b_fact": [
      "Simpson grading is used to describe the degree of differentiation of a brain tumor.",
      "Simpson grading system includes grade I, II, and III.",
      "Grade I tumors in the Simpson grading system are well-differentiated and resemble normal brain tissue.",
      "Grade III tumors in the Simpson grading system are poorly differentiated and have a high likelihood of being malignant.",
      "The Simpson grading system is used to help determine the prognosis and treatment options for a brain tumor."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Simpson grading system is used to report the extent of resection in a meningioma brain tumor not the degree of differentiation.\n2. FALSE [correction]: Simpson grading system includes five grades from I to V.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 653,
    "user_query": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?",
    "vicuna-7b_response": "Delayed enhancement (DE) is a technique used in cardiac magnetic resonance (CMR) imaging to detect myocardial damage or scar tissue in the heart. It is commonly used to evaluate patients with ischemic dilated cardiomyopathy, which is a type of heart disease caused by reduced blood flow to the heart muscle. However, the use of DE in patients with non-ischemic dilated cardiomyopathy is less well established.\nNon-ischemic dilated cardiomyopathy is a type of heart disease that occurs when the heart muscle becomes enlarged and weakened for an unknown reason. It is different from ischemic dilated cardiomyopathy, which is caused by reduced blood flow to the heart muscle due to narrowed or blocked coronary arteries.\nThere is limited research on the use of DE in patients with non-ischemic dilated cardiomyopathy. Some studies have suggested that DE may be useful in detecting myocardial damage or scar tissue in these patients, but more research is needed to confirm these findings.\nIn summary, while there is limited information available on the use of DE in patients with non-ischemic dilated cardiomyopathy, it is possible that this technique may be useful in detecting myocardial damage or scar tissue in these patients. However, further research is needed to confirm these findings and establish the role of DE in the evaluation of non-ischemic dilated cardiomyopathy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Delayed enhancement is a technique used in cardiac magnetic resonance imaging to detect myocardial damage or scar tissue in the heart.\n2. This technique is commonly used to evaluate patients with ischemic dilated cardiomyopathy, a type of heart disease caused by reduced blood flow to the heart muscle.\n3. Non-ischemic dilated cardiomyopathy is a type of heart disease that occurs when the heart muscle becomes enlarged and weakened for an unknown reason.\n4. Non-ischemic dilated cardiomyopathy differs from ischemic dilated cardiomyopathy which is caused by narrowed or blocked coronary arteries.\n5. There is limited research on the use of delayed enhancement in patients with non-ischemic dilated cardiomyopathy.",
    "vicuna-7b_fact": [
      "Delayed enhancement is a technique used in cardiac magnetic resonance imaging to detect myocardial damage or scar tissue in the heart.",
      "This technique is commonly used to evaluate patients with ischemic dilated cardiomyopathy, a type of heart disease caused by reduced blood flow to the heart muscle.",
      "Non-ischemic dilated cardiomyopathy is a type of heart disease that occurs when the heart muscle becomes enlarged and weakened for an unknown reason.",
      "Non-ischemic dilated cardiomyopathy differs from ischemic dilated cardiomyopathy which is caused by narrowed or blocked coronary arteries.",
      "There is limited research on the use of delayed enhancement in patients with non-ischemic dilated cardiomyopathy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 654,
    "user_query": "Which enzyme is inhibited by Varespladib?",
    "vicuna-7b_response": "Varespladib is a drug that inhibits the enzyme called \"protein kinase C\" (PKC). Protein kinase C is an enzyme that plays a role in various cellular processes, including inflammation, blood clotting, and cell proliferation. By inhibiting PKC, varespladib may have anti-inflammatory and anti-thrombotic effects, and may be useful in the treatment of certain medical conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Varespladib is a drug that inhibits the enzyme \"protein kinase C\" (PKC).\n2. Protein kinase C is an enzyme that plays a role in various cellular processes.\n3. The cellular processes include inflammation, blood clotting, and cell proliferation.\n4. Varespladib may have anti-inflammatory and anti-thrombotic effects due to its inhibition of PKC. \n5. Varespladib may be useful in the treatment of certain medical conditions.",
    "vicuna-7b_fact": [
      "Varespladib is a drug that inhibits the enzyme \"protein kinase C\" (PKC).",
      "Protein kinase C is an enzyme that plays a role in various cellular processes.",
      "The cellular processes include inflammation, blood clotting, and cell proliferation.",
      "Varespladib may have anti-inflammatory and anti-thrombotic effects due to its inhibition of PKC.",
      "Varespladib may be useful in the treatment of certain medical conditions."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Varespladib inhibits the enzyme phospholipase A2 (PLA2), not protein kinase C (PKC).\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Varespladib may have anti-inflammatory and anti-thrombotic effects due to its inhibition of PLA2, not PKC.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 660,
    "user_query": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?",
    "vicuna-7b_response": "The autophagy pathway triggered by the KFERQ motif of cytosolic proteins is called the KFERQ-mediated autophagy.\nAutophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components through the formation of autophagosomes. Autophagosomes then fuse with lysosomes, where the contents are degraded, leading to the recycling of cellular components and the removal of damaged or unnecessary ones.\nThe KFERQ motif is a sequence of amino acids that is found in cytosolic proteins and is recognized by the autophagy protein ATG12. When ATG12 binds to the KFERQ motif, it triggers the formation of an autophagosome, leading to the degradation of the cytosolic protein.\nKFERQ-mediated autophagy is an important process in the regulation of cellular homeostasis and has been implicated in various cellular processes, including cell survival, differentiation, and metabolism. Dysregulation of KFERQ-mediated autophagy has been linked to various diseases, including cancer, neurodegenerative disorders, and infections.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The KFERQ motif of cytosolic proteins triggers the KFERQ-mediated autophagy pathway.\n2. Autophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components through the formation of autophagosomes.\n3. Autophagosomes fuse with lysosomes where the contents are degraded.\n4. The KFERQ motif is a sequence of amino acids found in cytosolic proteins and is recognized by the autophagy protein ATG12. \n5. Dysregulation of KFERQ-mediated autophagy has been linked to various diseases, including cancer, neurodegenerative disorders, and infections.",
    "vicuna-7b_fact": [
      "The KFERQ motif of cytosolic proteins triggers the KFERQ-mediated autophagy pathway.",
      "Autophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components through the formation of autophagosomes.",
      "Autophagosomes fuse with lysosomes where the contents are degraded.",
      "The KFERQ motif is a sequence of amino acids found in cytosolic proteins and is recognized by the autophagy protein ATG12.",
      "Dysregulation of KFERQ-mediated autophagy has been linked to various diseases, including cancer, neurodegenerative disorders, and infections."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The KFERQ motif is a sequence of amino acids found in cytosolic proteins and is recognized by the autophagy protein HSC70.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 665,
    "user_query": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?",
    "vicuna-7b_response": "Yes, overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae). Sirtuins are a family of NAD+-dependent deacetylases that regulate a variety of cellular processes, including metabolism, stress response, and aging.\nSeveral studies have shown that overexpression of sirtuins in budding yeast can extend lifespan and delay the onset of aging-related phenotypes. For example, a study published in the journal Aging Cell in 2012 found that overexpression of the sirtuin SIR2 in budding yeast extended lifespan by up to 50%. The study suggested that sirtuins may play a role in regulating the metabolic and stress response pathways that are known to be important for lifespan extension in yeast.\nOther studies have also shown that overexpression of sirtuins can extend lifespan in other model organisms, including mice and roundworms. These findings suggest that sirtuins may be important regulators of aging and lifespan in a variety of organisms.\nHowever, it is important to note that the mechanisms by which sirtuins extend lifespan are still not fully understood, and further research is needed to fully elucidate the role of sirtuins in aging and lifespan extension.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae).\n2. Sirtuins are a family of NAD+-dependent deacetylases that regulate a variety of cellular processes.\n3. A study found that overexpression of the sirtuin SIR2 in budding yeast extended lifespan by up to 50%.\n4. Overexpression of sirtuins can extend lifespan in other model organisms, including mice and roundworms.\n5. The mechanisms by which sirtuins extend lifespan are not fully understood.",
    "vicuna-7b_fact": [
      "Overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae).",
      "Sirtuins are a family of NAD+-dependent deacetylases that regulate a variety of cellular processes.",
      "A study found that overexpression of the sirtuin SIR2 in budding yeast extended lifespan by up to 50%.",
      "Overexpression of sirtuins can extend lifespan in other model organisms, including mice and roundworms.",
      "The mechanisms by which sirtuins extend lifespan are not fully understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 669,
    "user_query": "How does phospholamban affect the biological activity of the calcium ATPase SERCA?",
    "vicuna-7b_response": "Phospholamban is a protein that plays a critical role in regulating the activity of the calcium ATPase sarcoendoplasmic reticulum calcium- ATPase type 2 (SERCA2) in the heart. SERCA2 is responsible for pumping calcium ions (Ca2+) out of the sarcoplasmic reticulum (SR) and into the cytoplasm, where it can be used to activate proteins involved in muscle contraction.\nPhospholamban is a phosphoprotein that binds to SERCA2 and inhibits its activity by preventing the release of Ca2+ from the SR. This is important because too much Ca2+ in the SR can lead to muscle contraction and potentially fatal arrhythmias. By inhibiting SERCA2, phospholamban helps to regulate the level of Ca2+ in the SR and maintain normal muscle function.\nIn summary, phospholamban is an important regulator of SERCA2 activity in the heart, and its dysfunction can lead to a variety of cardiac disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phospholamban is a protein that regulates the activity of the calcium ATPase SERCA2 in the heart.\n2. The calcium ATPase sarcoendoplasmic reticulum calcium-ATPase type 2 (SERCA2) is responsible for pumping calcium ions (Ca2+) out of the sarcoplasmic reticulum and into the cytoplasm.\n3. Phospholamban binds to SERCA2 and inhibits its activity by preventing the release of Ca2+ from the sarcoplasmic reticulum.\n4. Too much Ca2+ in the sarcoplasmic reticulum can lead to muscle contraction and potentially fatal arrhythmias.\n5. Dysfunction of phospholamban can lead to a variety of cardiac disorders.",
    "vicuna-7b_fact": [
      "Phospholamban is a protein that regulates the activity of the calcium ATPase SERCA2 in the heart.",
      "The calcium ATPase sarcoendoplasmic reticulum calcium-ATPase type 2 (SERCA2) is responsible for pumping calcium ions (Ca2+) out of the sarcoplasmic reticulum and into the cytoplasm.",
      "Phospholamban binds to SERCA2 and inhibits its activity by preventing the release of Ca2+ from the sarcoplasmic reticulum.",
      "Too much Ca2+ in the sarcoplasmic reticulum can lead to muscle contraction and potentially fatal arrhythmias.",
      "Dysfunction of phospholamban can lead to a variety of cardiac disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The calcium ATPase sarcoendoplasmic reticulum calcium-ATPase type 2 (SERCA2) is responsible for pumping calcium ions (Ca2+) into the sarcoplasmic reticulum from the cytoplasm.\n3. TRUE\n4. FALSE [correction]: Too much Ca2+ in the cytoplasm, not the sarcoplasmic reticulum, can lead to muscle contraction and potentially fatal arrhythmias.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 670,
    "user_query": "List the components of mTOR Complex 2 (mTORC2).",
    "vicuna-7b_response": "mTOR Complex 2 (mTORC2) is a complex that regulates cell growth, metabolism, and survival. The components of mTORC2 are:\n1. mTOR (mechanistic target of rapamycin)\n2. Regulatory subunit of mTOR (Raptor)\n3. mLST8 (mTOR-like protein, sterile 21-kDa)\n4. mTOR-associated protein (RAM)\n5. Tuberous sclerosis complex 2 (TSC2)\n6. Rheb GTPase\nmTORC2 is activated by the activation of the small GTPase Rheb, which promotes the recruitment of the other components of the complex. Once assembled, mTORC2 regulates cell growth and metabolism by activating downstream targets such as the serine/threonine kinase Akt/PKB (also known as protein kinase B).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. mTOR Complex 2 (mTORC2) is a complex that regulates cell growth, metabolism, and survival.\n2. The mTOR (mechanistic target of rapamycin) is a component of mTORC2.\n3. Regulatory subunit of mTOR (Raptor) is part of mTORC2.\n4. mLST8 (mTOR-like protein, sterile 21-kDa) is a part of mTORC2.\n5. mTOR-associated protein (RAM) is a component of mTORC2.\nNote: As there is a high probability of confusion, it should be noted that the response has more than 5 facts, but due to the integrated context, it is hard to extract only 5.",
    "vicuna-7b_fact": [
      "mTOR Complex 2 (mTORC2) is a complex that regulates cell growth, metabolism, and survival.",
      "The mTOR (mechanistic target of rapamycin) is a component of mTORC2.",
      "Regulatory subunit of mTOR (Raptor) is part of mTORC2.",
      "mLST8 (mTOR-like protein, sterile 21-kDa) is a part of mTORC2.",
      "mTOR-associated protein (RAM) is a component of mTORC2.",
      "te: As there is a high probability of confusion, it should be noted that the response has more than 5 facts, but due to the integrated context, it is hard to extract only 5."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Regulatory subunit of mTOR (Raptor) is part of mTOR Complex 1 (mTORC1), not mTORC2.\n4. TRUE\n5. FALSE [correction]: mTOR-associated protein (RAM) does not appear to be a recognized component of either mTORC1 or mTORC2.\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 675,
    "user_query": "Which multiple kinase inhibitors are used in cancer therapy?",
    "vicuna-7b_response": "Multiple kinase inhibitors are used in cancer therapy to target specific proteins that are involved in the growth and proliferation of cancer cells. Some examples of kinase inhibitors used in cancer therapy include:\n1. Imatinib (Gleevec) for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST)\n2. Sunitinib (Sutent) for kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumors\n3. Sorafenib (Nexavar) for kidney cancer, liver cancer, and thyroid cancer\n4. Vemurafenib (Zelboraf) for melanoma\n5. Lapatinib (Tykerb) for breast cancer\n6. Pazopanib (Votrient) for kidney cancer, liver cancer, and soft tissue sarcoma\n7. Axitinib (Inlyta) for kidney cancer\n8. Neratinib (Nerlynx) for breast cancer\nThese are just a few examples of the many kinase inhibitors that are used in cancer therapy. The choice of which kinase inhibitor to use depends on the specific type of cancer, the patient's individual characteristics, and other factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Imatinib is a kinase inhibitor used in the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.\n2. Sunitinib is used for kidney cancer and gastrointestinal stromal tumors.\n3. Sorafenib is used in the treatment of kidney cancer, liver cancer, and thyroid cancer.\n4. Vemurafenib is a kinase inhibitor used for treating melanoma.\n5. Lapatinib is used in breast cancer treatment.",
    "vicuna-7b_fact": [
      "Imatinib is a kinase inhibitor used in the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.",
      "Sunitinib is used for kidney cancer and gastrointestinal stromal tumors.",
      "Sorafenib is used in the treatment of kidney cancer, liver cancer, and thyroid cancer.",
      "Vemurafenib is a kinase inhibitor used for treating melanoma.",
      "Lapatinib is used in breast cancer treatment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 678,
    "user_query": "List types of avoided words in bacterial genomes",
    "vicuna-7b_response": "Avoided words in bacterial genomes can be classified into several categories, including:\n1. Antibiotic resistance genes: These genes can make bacteria resistant to antibiotics, which can lead to the development of drug-resistant strains of bacteria.\n2. Virulence genes: These genes are involved in the ability of bacteria to cause disease in humans or animals.\n3. Toxin-encoding genes: These genes encode toxins that can cause disease or damage to host cells.\n4. Pathogenicity islands: These are regions of bacterial genomes that contain genes that are involved in pathogenicity, such as those that encode virulence factors or antibiotic resistance.\n5. Mobile genetic elements: These are genetic elements that can move around the bacterial genome, often inserting themselves into other genes and disrupting their function.\n6. Genes involved in DNA repair: These genes are involved in the repair of DNA damage, which can be caused by antibiotics or other environmental stressors.\n7. Genes involved in metabolism: These genes are involved in the metabolic processes of the bacteria, such as the synthesis of amino acids or the breakdown of sugars.\n8. Genes involved in transcriptional regulation: These genes are involved in the regulation of gene expression, which can affect the expression of other genes in the genome.\nIt is important to note that the presence of these types of genes in a bacterial genome does not necessarily mean that the bacteria is harmful or pathogenic. However, the presence of certain types of genes can increase the likelihood of bacteria causing disease or becoming resistant to antibiotics.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Antibiotic resistance genes in bacterial genomes can make bacteria resistant to antibiotics leading to drug-resistant strains.\n2. Virulence genes are involved in the ability of bacteria to cause disease in humans or animals.\n3. Toxin-encoding genes encode toxins that can cause disease or damage to host cells.\n4. Pathogenicity islands in bacterial genomes contain genes involved in pathogenicity.\n5. Mobile genetic elements are genetic elements that can move around the bacterial genome, often inserting themselves into other genes and disrupting their function.",
    "vicuna-7b_fact": [
      "Antibiotic resistance genes in bacterial genomes can make bacteria resistant to antibiotics leading to drug-resistant strains.",
      "Virulence genes are involved in the ability of bacteria to cause disease in humans or animals.",
      "Toxin-encoding genes encode toxins that can cause disease or damage to host cells.",
      "Pathogenicity islands in bacterial genomes contain genes involved in pathogenicity.",
      "Mobile genetic elements are genetic elements that can move around the bacterial genome, often inserting themselves into other genes and disrupting their function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 681,
    "user_query": "Which is the physiological target for LeuRS translational quality control?",
    "vicuna-7b_response": "LeuRS is a tRNA ligase enzyme that is responsible for the formation of aminoacyl-tRNA from amino acids and tRNA. The physiological target for LeuRS translational quality control is the amino acid Leu (L-Leucine).\nLeuRS plays a crucial role in the accuracy of protein synthesis by ensuring that the correct amino acid is attached to the correct tRNA molecule. It does this by catalyzing the formation of aminoacyl-tRNA from the corresponding amino acid and tRNA.\nLeuRS is a highly conserved enzyme and is found in all organisms from bacteria to humans. It is essential for the survival of cells and is involved in a variety of cellular processes, including protein synthesis, cell growth, and cell division.\nIn order to ensure the accuracy of protein synthesis, LeuRS has evolved mechanisms to detect and correct errors in the formation of aminoacyl-tRNA. These mechanisms include proofreading and editing, which allow the enzyme to recognize and correct incorrect amino acid-tRNA pairs.\nOverall, the physiological target for LeuRS translational quality control is the amino acid Leu, and the enzyme plays a crucial role in ensuring the accuracy of protein synthesis by detecting and correcting errors in the formation of aminoacyl-tRNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LeuRS is a tRNA ligase enzyme responsible for the formation of aminoacyl-tRNA from amino acids and tRNA.\n2. The physiological target for LeuRS translational quality control is the amino acid Leu (L-Leucine).\n3. LeuRS is crucial to the accuracy of protein synthesis, ensuring the correct amino acid is attached to the correct tRNA molecule.\n4. LeuRS is a highly conserved enzyme found in organisms from bacteria to humans.\n5. LeuRS has evolved mechanisms to detect and correct errors in the formation of aminoacyl-tRNA, including proofreading and editing.",
    "vicuna-7b_fact": [
      "LeuRS is a tRNA ligase enzyme responsible for the formation of aminoacyl-tRNA from amino acids and tRNA.",
      "The physiological target for LeuRS translational quality control is the amino acid Leu (L-Leucine).",
      "LeuRS is crucial to the accuracy of protein synthesis, ensuring the correct amino acid is attached to the correct tRNA molecule.",
      "LeuRS is a highly conserved enzyme found in organisms from bacteria to humans.",
      "LeuRS has evolved mechanisms to detect and correct errors in the formation of aminoacyl-tRNA, including proofreading and editing."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 685,
    "user_query": "Which is the target of the drug Denosumab?",
    "vicuna-7b_response": "Denosumab is a drug that is primarily used to treat conditions related to bone health, such as osteoporosis and cancer-induced bone loss. The drug works by targeting a protein called RANKL, which is involved in the regulation of bone density and the formation of new bone tissue. By inhibiting the activity of RANKL, denosumab helps to increase bone density, reduce the risk of fractures, and slow down the progression of bone loss in patients with conditions such as osteoporosis and cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Denosumab is a drug used to treat conditions related to bone health.\n2. Conditions that Denosumab treats include osteoporosis and cancer-induced bone loss.\n3. The drug works by targeting a protein called RANKL.\n4. RANKL is involved in the regulation of bone density and the formation of new bone tissue.\n5. Denosumab inhibits the activity of RANKL, helping to increase bone density, reduce the risk of fractures, and slow the progression of bone loss in patients with conditions such as osteoporosis and cancer.",
    "vicuna-7b_fact": [
      "Denosumab is a drug used to treat conditions related to bone health.",
      "Conditions that Denosumab treats include osteoporosis and cancer-induced bone loss.",
      "The drug works by targeting a protein called RANKL.",
      "RANKL is involved in the regulation of bone density and the formation of new bone tissue.",
      "Denosumab inhibits the activity of RANKL, helping to increase bone density, reduce the risk of fractures, and slow the progression of bone loss in patients with conditions such as osteoporosis and cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 693,
    "user_query": "Which gene test can be used for the X-linked myotubular myopathy?",
    "vicuna-7b_response": "X-linked myotubular myopathy (MTM) is a genetic disorder caused by mutations in the X-linked muscle-specific creatine kinase gene (CKXM). A gene test that can be used for X-linked myotubular myopathy is a genetic test that can detect mutations in the CKXM gene.\nThere are several genetic tests that can be used to diagnose X-linked myotubular myopathy, including:\n1. Sequencing of the CKXM gene: This test can detect mutations in the CKXM gene that are responsible for X-linked myotubular myopathy.\n2. Multiplex ligation-dependent probe amplification (MLPA): This test can detect deletions or duplications in the CKXM gene that are responsible for X-linked myotubular myopathy.\n3. Array-based comparative genomic hybridization (CGH): This test can detect deletions or duplications in the CKXM gene that are responsible for X-linked myotubular myopathy.\nIt is important to note that genetic testing should only be performed by a qualified healthcare professional, and the results should be interpreted in the context of the individual's symptoms and medical history.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. X-linked myotubular myopathy (MTM) is a genetic disorder caused by mutations in the X-linked muscle-specific creatine kinase gene (CKXM).\n2. A gene test can be used to detect mutations in the CKXM gene linked to myotubular myopathy.\n3. Sequencing of the CKXM gene is one genetic test that can detect mutations in the CKXM gene causing X-linked myotubular myopathy.\n4. Multiplex ligation-dependent probe amplification (MLPA) can detect deletions or duplications in the CKXM gene responsible for X-linked myotubular myopathy.\n5. Array-based comparative genomic hybridization (CGH) can detect deletions or duplications in the CKXM gene that cause X-linked myotubular myopathy.",
    "vicuna-7b_fact": [
      "X-linked myotubular myopathy (MTM) is a genetic disorder caused by mutations in the X-linked muscle-specific creatine kinase gene (CKXM).",
      "A gene test can be used to detect mutations in the CKXM gene linked to myotubular myopathy.",
      "Sequencing of the CKXM gene is one genetic test that can detect mutations in the CKXM gene causing X-linked myotubular myopathy.",
      "Multiplex ligation-dependent probe amplification (MLPA) can detect deletions or duplications in the CKXM gene responsible for X-linked myotubular myopathy.",
      "Array-based comparative genomic hybridization (CGH) can detect deletions or duplications in the CKXM gene that cause X-linked myotubular myopathy."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: X-linked myotubular myopathy (MTM) is a genetic disorder caused by mutations in the MTM1 gene, not the CKXM gene.\n2. FALSE [correction]: A gene test can be used to detect mutations in the MTM1 gene linked to myotubular myopathy.\n3. FALSE [correction]: Sequencing of the MTM1 gene is one genetic test that can detect mutations in the gene causing X-linked myotubular myopathy.\n4. FALSE [correction]: Multiplex ligation-dependent probe amplification (MLPA) can detect deletions or duplications in the MTM1 gene responsible for X-linked myotubular myopathy.\n5. FALSE [correction]: Array-based comparative genomic hybridization (CGH) can detect deletions or duplications in the MTM1 gene that cause X-linked myotubular myopathy.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 695,
    "user_query": "What is the association between adiponectin and migraine?",
    "vicuna-7b_response": "Adiponectin is a hormone produced by fat cells that has been shown to have a role in regulating metabolism and inflammation. There is some evidence to suggest that adiponectin may also be involved in the development of migraines.\nStudies have shown that people with migraines tend to have lower levels of adiponectin in their blood compared to people without migraines. Additionally, some studies have found that increasing adiponectin levels through medication or other means may help to reduce the frequency and severity of migraines.\nHowever, more research is needed to fully understand the relationship between adiponectin and migraines, and it is not yet clear whether increasing adiponectin levels is a safe or effective treatment for migraines.\nIn summary, there is some evidence to suggest that adiponectin may be involved in the development of migraines, and that increasing adiponectin levels may help to reduce the frequency and severity of migraines. However, more research is needed to fully understand this association.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Adiponectin is a hormone produced by fat cells.\n2. Adiponectin has a role in regulating metabolism and inflammation.\n3. Some studies suggest that people with migraines tend to have lower levels of adiponectin in their blood compared to people without migraines.\n4. There is evidence that increasing adiponectin levels may help reduce the frequency and severity of migraines.\n5. The relationship between adiponectin levels and migraines still requires more research for full understanding.",
    "vicuna-7b_fact": [
      "Adiponectin is a hormone produced by fat cells.",
      "Adiponectin has a role in regulating metabolism and inflammation.",
      "Some studies suggest that people with migraines tend to have lower levels of adiponectin in their blood compared to people without migraines.",
      "There is evidence that increasing adiponectin levels may help reduce the frequency and severity of migraines.",
      "The relationship between adiponectin levels and migraines still requires more research for full understanding."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 703,
    "user_query": "Is there an association between FGFR3 mutation and plagiocephaly?",
    "vicuna-7b_response": "Yes, there is an association between FGFR3 mutation and plagiocephaly.\nPlagiocephaly is a condition in which the skull is asymmetrically shaped, typically resulting in an abnormal flattening on one side of the head. FGFR3 mutation is a genetic disorder that affects the development of bones and cartilage, including the skull.\nStudies have shown that individuals with FGFR3 mutation are at an increased risk of developing plagiocephaly. This is thought to be due to the abnormal development of the skull and facial bones that occurs as a result of the FGFR3 mutation.\nIt is important to note that not all individuals with FGFR3 mutation will develop plagiocephaly, and not all cases of plagiocephaly are caused by FGFR3 mutation. However, in individuals with FGFR3 mutation, early detection and treatment of plagiocephaly can help to prevent or reduce the severity of the condition.\nIn summary, there is an association between FGFR3 mutation and plagiocephaly, and individuals with FGFR3 mutation are at an increased risk of developing this condition. Early detection and treatment of plagiocephaly in individuals with FGFR3 mutation can help to prevent or reduce the severity of the condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Plagiocephaly is a condition in which the skull is asymmetrically shaped, usually flat on one side.\n2. FGFR3 mutation is a genetic disorder that influences the development of bones and cartilage, including the skull.\n3. Individuals with the FGFR3 mutation have a greater chance of developing plagiocephaly.\n4. Not all individuals with an FGFR3 mutation will develop plagiocephaly.\n5. Early detection and treatment of plagiocephaly in individuals with FGFR3 mutations can reduce the severity of the condition.",
    "vicuna-7b_fact": [
      "Plagiocephaly is a condition in which the skull is asymmetrically shaped, usually flat on one side.",
      "FGFR3 mutation is a genetic disorder that influences the development of bones and cartilage, including the skull.",
      "Individuals with the FGFR3 mutation have a greater chance of developing plagiocephaly.",
      "Not all individuals with an FGFR3 mutation will develop plagiocephaly.",
      "Early detection and treatment of plagiocephaly in individuals with FGFR3 mutations can reduce the severity of the condition."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 708,
    "user_query": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?",
    "vicuna-7b_response": "The enzymes involved in the addition of 7-methylguanosine in mRNA are called methylguanine DNA methyltransferases (MGMT). MGMT is an enzyme that is responsible for adding a methyl group to the 7-position of guanine in DNA. It is also capable of adding a methyl group to the 7-position of guanosine in RNA. MGMT is an important enzyme in the regulation of gene expression, and it plays a role in the development of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The enzymes involved in the addition of 7-methylguanosine in mRNA are called methylguanine DNA methyltransferases (MGMT).\n2. MGMT is an enzyme that adds a methyl group to the 7-position of guanine in DNA.\n3. MGMT is also capable of adding a methyl group to the 7-position of guanosine in RNA.\n4. MGMT is an important enzyme in the regulation of gene expression.\n5. MGMT plays a role in the development of cancer.",
    "vicuna-7b_fact": [
      "The enzymes involved in the addition of 7-methylguanosine in mRNA are called methylguanine DNA methyltransferases (MGMT).",
      "MGMT is an enzyme that adds a methyl group to the 7-position of guanine in DNA.",
      "MGMT is also capable of adding a methyl group to the 7-position of guanosine in RNA.",
      "MGMT is an important enzyme in the regulation of gene expression.",
      "MGMT plays a role in the development of cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The enzyme that adds a methyl group to the 7-position of guanosine in mRNA is called mRNA guanine-7 methyltransferase, not MGMT.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 709,
    "user_query": "What is HOCOMOCO?",
    "vicuna-7b_response": "HOCOMOCO is a concept in computer science that refers to the hierarchical organization of data in a network. It is a way of organizing data in a tree-like structure, where each node in the tree represents a different level of abstraction or granularity.\nIn a HOCOMOCO structure, the top-level nodes represent the most general concepts or categories, and the lower-level nodes represent more specific or detailed concepts or objects. For example, in a HOCOMOCO structure for a library, the top-level nodes might represent different types of books, such as fiction or non-fiction, while the lower-level nodes might represent specific genres of fiction, such as mystery or romance.\nHOCOMOCO is often used in data modeling and database design, as it can help to organize and structure data in a way that is easy to understand and navigate. It can also be used in other areas of computer science, such as software design and natural language processing, to help organize and structure complex systems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. HOCOMOCO is a concept in computer science related to the hierarchical organization of data in a network.\n2. In a HOCOMOCO structure, each node in the tree represents a different level of abstraction or granularity.\n3. HOCOMOCO is used in data modeling and database design to structure data in a way that is easy to understand and navigate.\n4. HOCOMOCO can also be applied to areas of computer science such as software design and natural language processing.\n5. In a HOCOMOCO structure for a library, the top-level nodes might represent different types of books, and the lower-level nodes might categorize these books more specifically into genres.",
    "vicuna-7b_fact": [
      "HOCOMOCO is a concept in computer science related to the hierarchical organization of data in a network.",
      "In a HOCOMOCO structure, each node in the tree represents a different level of abstraction or granularity.",
      "HOCOMOCO is used in data modeling and database design to structure data in a way that is easy to understand and navigate.",
      "HOCOMOCO can also be applied to areas of computer science such as software design and natural language processing.",
      "In a HOCOMOCO structure for a library, the top-level nodes might represent different types of books, and the lower-level nodes might categorize these books more specifically into genres."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: HOCOMOCO is not a concept in computer science related to the hierarchical organization of data in a network.\n2. FALSE [correction]: The statement does not hold true as HOCOMOCO is not a recognized concept or structure in computer science.\n3. FALSE [correction]: HOCOMOCO is not associated with data modelling and database design.\n4. FALSE [correction]: HOCOMOCO cannot be applied to areas of computer science such as software design and natural language processing because it doesn't exist in this context.\n5. FALSE [correction]: Given that HOCOMOCO is not a recognized or existing concept in database or library structure, this statement is not true.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 713,
    "user_query": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?",
    "vicuna-7b_response": "Coronary artery bypass graft (CABG) surgery can cause changes in the thyroid profile metabolism. The alteration in the thyroid profile metabolism after CABG surgery is usually temporary and returns to normal within a few weeks.\nThe thyroid gland is responsible for producing hormones that regulate metabolism. CABG surgery can cause changes in the levels of these hormones, leading to an alteration in the thyroid profile metabolism.\nOne of the most common changes in the thyroid profile metabolism after CABG surgery is an increase in the levels of thyroid hormones. This increase in thyroid hormones can lead to an increase in heart rate and blood pressure, which can be dangerous for patients with pre-existing heart conditions.\nAnother change that can occur in the thyroid profile metabolism after CABG surgery is a decrease in the levels of thyroid hormones. This decrease in thyroid hormones can lead to an increase in cholesterol levels and an increase in the risk of heart disease.\nIt is important to note that the alteration in the thyroid profile metabolism after CABG surgery is usually temporary and returns to normal within a few weeks. However, in some cases, the alteration in the thyroid profile metabolism can be permanent, especially if the patient has pre-existing thyroid disorders.\nIn conclusion, CABG surgery can cause changes in the thyroid profile metabolism, which can lead to an increase in heart rate and blood pressure, an increase in cholesterol levels, and an increase in the risk of heart disease. The alteration in the thyroid profile metabolism is usually temporary and returns to normal within a few weeks, but in some cases, it can be permanent.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Coronary artery bypass graft (CABG) surgery can cause changes in the thyroid profile metabolism.\n2. The thyroid gland produces hormones that regulate metabolism.\n3. One of the common changes post-CABG surgery is an increase in the levels of thyroid hormones.\n4. Another possible change after CABG surgery is a decrease in the levels of thyroid hormones, which can potentially increase cholesterol levels and the risk of heart disease.\n5. The disruption in the thyroid profile metabolism due to CABG surgery is usually temporary but can sometimes be permanent, especially in cases where the patient has pre-existing thyroid disorders.",
    "vicuna-7b_fact": [
      "Coronary artery bypass graft (CABG) surgery can cause changes in the thyroid profile metabolism.",
      "The thyroid gland produces hormones that regulate metabolism.",
      "One of the common changes post-CABG surgery is an increase in the levels of thyroid hormones.",
      "Another possible change after CABG surgery is a decrease in the levels of thyroid hormones, which can potentially increase cholesterol levels and the risk of heart disease.",
      "The disruption in the thyroid profile metabolism due to CABG surgery is usually temporary but can sometimes be permanent, especially in cases where the patient has pre-existing thyroid disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 715,
    "user_query": "What does the SAGA complex acronym stands for?",
    "vicuna-7b_response": "The SAGA complex stands for \"Spt-associated gene A (SGA) and Gcn5-related acetyltransferase (GAT)\". The SAGA complex is a multi-subunit complex that plays a crucial role in the regulation of gene expression in eukaryotes, particularly in the regulation of chromatin structure and transcription. The complex is composed of several subunits, including Spt-20, Spt-21, Spt-26, Spt-27, Spt-28, Spt-29, Spt-30, Spt-31, Spt-32, Spt-33, Spt-34, Spt-35, Spt-36, Spt-37, Spt-38, Spt-39, Spt-40, Spt-41, Spt-42, Spt-43, Spt-44, Spt-45, Spt-46, Spt-47, Spt-48, Spt-49, Spt-50, Spt-51, Spt-52, Spt-53, Spt-54, Spt-55, Spt-56, Spt-57, Spt-58, Spt-59, Spt-60, Spt-61, Spt-62, Spt-63, Spt-64, Spt-65, Spt-66, Spt-67, Spt-68, Spt-69, Spt-70, Spt-71, Spt-72, Spt-73, Spt-74, Spt-75, Spt-76, Spt-77, Spt-78, Spt-79, Spt-80, Spt-81, Spt-82, Spt-83, Spt-84, Spt-85, Spt-86, Spt-87, Spt-88, Spt-89, Spt-90, Spt-91, Spt-92, Spt-93, S",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAGA complex stands for \"Spt-associated gene A (SGA) and Gcn5-related acetyltransferase (GAT)\".\n2. The SAGA complex plays a crucial role in the regulation of gene expression in eukaryotes.\n3. The SAGA complex is involved particularly in the regulation of chromatin structure and transcription.\n4. The SAGA complex is composed of several subunits.\n5. Some of the subunits that SAGA complex is composed of includes: Spt-20, Spt-21, Spt-26, Spt-27, Spt-28, Spt-29, Spt-30, Spt-31, Spt-32, Spt-33, Spt-34, and others.",
    "vicuna-7b_fact": [
      "SAGA complex stands for \"Spt-associated gene A (SGA) and Gcn5-related acetyltransferase (GAT)\".",
      "The SAGA complex plays a crucial role in the regulation of gene expression in eukaryotes.",
      "The SAGA complex is involved particularly in the regulation of chromatin structure and transcription.",
      "The SAGA complex is composed of several subunits.",
      "Some of the subunits that SAGA complex is composed of includes: Spt-20, Spt-21, Spt-26, Spt-27, Spt-28, Spt-29, Spt-30, Spt-31, Spt-32, Spt-33, Spt-34, and others."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 716,
    "user_query": "What is the result of the interaction between TSC1 and PLK1?",
    "vicuna-7b_response": "The TSC1 gene encodes a protein called tuberous sclerosis complex 1 (TSC1), which plays a role in regulating cell growth and division. The PLK1 gene encodes a protein called polo-like kinase 1 (PLK1), which is involved in the regulation of cell division.\nThe interaction between TSC1 and PLK1 has been shown to play a role in the regulation of cell division. Specifically, TSC1 has been shown to inhibit the activity of PLK1, which is necessary for the proper progression of the cell cycle. In the absence of TSC1, PLK1 activity is increased, leading to an accumulation of cells in the G2 phase of the cell cycle and an increased risk of cell division errors, such as chromosomal abnormalities.\nIn summary, the interaction between TSC1 and PLK1 is important for the regulation of cell division and the prevention of cell division errors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TSC1 gene encodes a protein called tuberous sclerosis complex 1 (TSC1).\n2. TSC1 plays a role in regulating cell growth and division.\n3. The PLK1 gene encodes a protein called polo-like kinase 1 (PLK1), which is involved in the regulation of cell division.\n4. The interaction between TSC1 and PLK1 plays a role in the regulation of cell division.\n5. In the absence of TSC1, PLK1 activity is increased, leading to an accumulation of cells in the G2 phase of the cell cycle, and an increased risk of cell division errors.",
    "vicuna-7b_fact": [
      "The TSC1 gene encodes a protein called tuberous sclerosis complex 1 (TSC1).",
      "TSC1 plays a role in regulating cell growth and division.",
      "The PLK1 gene encodes a protein called polo-like kinase 1 (PLK1), which is involved in the regulation of cell division.",
      "The interaction between TSC1 and PLK1 plays a role in the regulation of cell division.",
      "In the absence of TSC1, PLK1 activity is increased, leading to an accumulation of cells in the G2 phase of the cell cycle, and an increased risk of cell division errors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 717,
    "user_query": "What are the characteristics of the \"Universal Proteomics Standard 2\" (UPS2)?",
    "vicuna-7b_response": "The Universal Proteomics Standard 2 (UPS2) is a widely used standard for protein quantitation and characterization in proteomics experiments. Some of the key characteristics of UPS2 are:\n1. Robustness: UPS2 is designed to be robust and stable, making it suitable for use in a wide range of experimental conditions.\n2. Sensitivity: UPS2 is highly sensitive, allowing for the detection of low-abundance proteins and peptides.\n3. Quantitation: UPS2 is used for quantitative analysis of proteins, allowing for the accurate measurement of protein abundance in a sample.\n4. Multiple reaction monitoring (MRM) mode: UPS2 is optimized for MRM mode, which allows for the selective detection of specific peptides or proteins in a complex mixture.\n5. Dynamic range: UPS2 has a wide dynamic range, making it suitable for the analysis of samples with a wide range of protein abundance.\n6. Compatibility: UPS2 is compatible with a wide range of mass spectrometers and proteomics instruments, allowing for its use in a variety of experimental setups.\n7. Standardization: UPS2 is a standardized protocol, which allows for the comparison of results across different laboratories and experiments.\n8. Flexibility: UPS2 is flexible and can be adapted to different experimental needs, such as different sample types, experimental designs, and instrumentation.\nOverall, UPS2 is a widely used and well-established standard for protein quantitation and characterization in proteomics experiments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Universal Proteomics Standard 2 (UPS2) is widely used for protein quantitation and characterization in proteomics experiments.\n2. UPS2 is designed to be robust and stable.\n3. UPS2 is highly sensitive and allows for the detection of low-abundance proteins and peptides.\n4. UPS2 is used for quantitative analysis of proteins.\n5. UPS2 is optimized for Multiple Reaction Monitoring (MRM) mode.\n6. UPS2 has a wide dynamic range for the analysis of samples with a wide range of protein abundance.\n7. UPS2 is compatible with a wide range of mass spectrometers and proteomics instruments.\n8. UPS2 is a standardized protocol that allows for the comparison of results across different laboratories and experiments.\n9. UPS2 is flexible and can be adapted to different experimental needs.",
    "vicuna-7b_fact": [
      "The Universal Proteomics Standard 2 (UPS2) is widely used for protein quantitation and characterization in proteomics experiments.",
      "UPS2 is designed to be robust and stable.",
      "UPS2 is highly sensitive and allows for the detection of low-abundance proteins and peptides.",
      "UPS2 is used for quantitative analysis of proteins.",
      "UPS2 is optimized for Multiple Reaction Monitoring (MRM) mode.",
      "UPS2 has a wide dynamic range for the analysis of samples with a wide range of protein abundance.",
      "UPS2 is compatible with a wide range of mass spectrometers and proteomics instruments.",
      "UPS2 is a standardized protocol that allows for the comparison of results across different laboratories and experiments.",
      "UPS2 is flexible and can be adapted to different experimental needs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n6. UNKNOWN\n7. TRUE\n8. UNKNOWN\n9. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 719,
    "user_query": "Which are the smallest known subviral pathogens of plants?",
    "vicuna-7b_response": "Subviral pathogens of plants are a type of plant virus that are too small to be seen with the naked eye. They are typically smaller than 100 nanometers in size and are not considered true viruses because they lack a viral genome. Instead, they are composed of a single protein or RNA molecule.\nOne example of a subviral pathogen of plants is the viroid. Viroids are small, single-stranded RNA molecules that infect plants and can cause a range of diseases, including stunting, chlorosis, and necrosis. They are much smaller than plant viruses, with some viroids measuring only a few nucleotides in length.\nAnother example of a subviral pathogen of plants is the satRNA. SatRNAs are small, single-stranded RNA molecules that can infect plants and cause a range of diseases, including stunting, chlorosis, and necrosis. They are typically smaller than 50 nucleotides in length.\nIt's worth noting that the classification of subviral pathogens is still a topic of debate in the scientific community, and some researchers consider them to be a type of virus rather than a distinct entity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Subviral pathogens of plants are typically smaller than 100 nanometers in size.\n2. Subviral pathogens are not considered true viruses as they lack a viral genome.\n3. Viroids are a type of subviral pathogen of plants composed of small, single-stranded RNA molecules.\n4. Another type of subviral pathogen of plants is the satRNA, typically smaller than 50 nucleotides in length.\n5. The classification of subviral pathogens is a topic of debate in the scientific community.",
    "vicuna-7b_fact": [
      "Subviral pathogens of plants are typically smaller than 100 nanometers in size.",
      "Subviral pathogens are not considered true viruses as they lack a viral genome.",
      "Viroids are a type of subviral pathogen of plants composed of small, single-stranded RNA molecules.",
      "Another type of subviral pathogen of plants is the satRNA, typically smaller than 50 nucleotides in length.",
      "The classification of subviral pathogens is a topic of debate in the scientific community."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Another type of subviral pathogen of plants is the satRNA, typically smaller than 500 nucleotides in length.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 720,
    "user_query": "What causes Katayama Fever?",
    "vicuna-7b_response": "Katayama Fever, also known as Culture-Induced Fever, is caused by a bacterial infection with the species Klebsiella pneumoniae. It is commonly found in hospitals and other healthcare settings, where it can be spread through contaminated equipment, surfaces, and hands.\nThe bacteria can enter the body through cuts or abrasions, or through the respiratory tract. Once inside, it can cause a range of symptoms, including fever, chills, and muscle aches. In severe cases, it can lead to pneumonia, sepsis, and even death.\nKatayama Fever is more common in people who have weakened immune systems, such as those with cancer, HIV/AIDS, or other chronic illnesses. It is also more common in people who have undergone surgery or other medical procedures, as well as in those who have recently been in a hospital or other healthcare setting.\nPrevention measures include washing hands frequently, using personal protective equipment such as masks and gloves, and keeping surfaces and equipment clean and disinfected. Treatment typically involves antibiotics, and in severe cases, hospitalization may be necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Katayama Fever, also known as Culture-Induced Fever, is caused by a bacterial infection with the species Klebsiella pneumoniae.\n2. The bacteria Klebsiella pneumoniae can enter the body through cuts or abrasions, or through the respiratory tract.\n3. Katayama Fever is more common in people who have weakened immune systems, for example those with cancer, HIV/AIDS, or other chronic illnesses.\n4. Katayama Fever is also more common in individuals who have undergone surgery or other medical procedures, and those who have recently been in a hospital or other healthcare setting.\n5. Treatment for Katayama Fever typically involves antibiotics, and severe cases may require hospitalization.",
    "vicuna-7b_fact": [
      "Katayama Fever, also known as Culture-Induced Fever, is caused by a bacterial infection with the species Klebsiella pneumoniae.",
      "The bacteria Klebsiella pneumoniae can enter the body through cuts or abrasions, or through the respiratory tract.",
      "Katayama Fever is more common in people who have weakened immune systems, for example those with cancer, HIV/AIDS, or other chronic illnesses.",
      "Katayama Fever is also more common in individuals who have undergone surgery or other medical procedures, and those who have recently been in a hospital or other healthcare setting.",
      "Treatment for Katayama Fever typically involves antibiotics, and severe cases may require hospitalization."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Katayama Fever, also known as Acute Schistosomiasis, is caused by infection with a parasitic worm from the Schistosoma species, not Klebsiella pneumoniae.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-7b_response": "Certainly! Here is a list of clinical trials for the prevention of sarcopenia:\n1. Sarcopenia Prevention with Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n2. Sarcopenia Prevention with Resistance Exercise (SPRE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance exercise in preventing sarcopenia in older adults.\n3. Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance exercise in preventing sarcopenia in older adults.\n4. Sarcopenia Prevention with Progressive Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance training in preventing sarcopenia in older adults.\n5. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n6. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance training and nutrition intervention in preventing sarcopenia in older adults.\n7. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n8. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n2. The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial that aims to determine the effectiveness of resistance exercise in preventing sarcopenia in older adults.\n3. The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance exercise in preventing sarcopenia in older adults.\n4. The Sarcopenia Prevention with Progressive Resistance Training (SPRT) Trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance training in preventing sarcopenia in older adults.\n5. The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.",
    "vicuna-7b_fact": [
      "The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial that aims to determine the effectiveness of resistance exercise in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance exercise in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Progressive Resistance Training (SPRT) Trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance training in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-7b_response": "There are several databases that focus on molecular recognition features in membrane proteins. Here are a few examples:\n1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins. It includes information on molecular recognition features such as ligand binding sites, ion channels, and transporters.\n2. The Membrane Protein Structure Prediction (MPSP) database is a database that contains information on the structure prediction of membrane proteins. It includes information on the methods used to predict the structure of membrane proteins, as well as information on the molecular recognition features that were predicted.\n3. The Membrane Protein Classification (MPC) database is a database that contains information on the classification of membrane proteins. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\n4. The Membrane Protein Structure Annotation (MPSA) database is a database that contains information on the annotation of membrane protein structures. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\nThese are just a few examples of databases that focus on molecular recognition features in membrane proteins. There are many other databases that may also be relevant, depending on the specific research question or interest.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.\n2. The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.\n3. The Membrane Protein Classification (MPC) database contains information on the classification of membrane proteins.\n4. The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures.\n5. These databases contain information on molecular recognition features such as ligand binding sites, ion channels, and transporters.",
    "vicuna-7b_fact": [
      "The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.",
      "The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.",
      "The Membrane Protein Classification (MPC) database contains information on the classification of membrane proteins.",
      "The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures.",
      "These databases contain information on molecular recognition features such as ligand binding sites, ion channels, and transporters."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 731,
    "user_query": "What kind of bonds are connecting keratin molecules?",
    "vicuna-7b_response": "Keratin molecules are composed of long chains of amino acids and are found in the skin, hair, nails, and other tissues of the body. The bonds that connect keratin molecules are called covalent bonds, which are formed by the sharing of electrons between the atoms of the molecule.\nThe covalent bonds in keratin molecules are primarily formed by the condensation reaction, in which water is removed from the reaction mixture. This reaction results in the formation of a long chain of amino acids, which are held together by covalent bonds.\nThe covalent bonds in keratin molecules are also responsible for the rigidity and strength of the protein. The hydrogen bonds that form between the amino acid side chains also contribute to the stability of the keratin molecule.\nOverall, the combination of covalent bonds and hydrogen bonds in keratin molecules gives them the necessary strength and rigidity to perform their functions in the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Keratin molecules are composed of long chains of amino acids.\n2. Covalent bonds connect keratin molecules.\n3. Covalent bonds are formed by the sharing of electrons between the atoms.\n4. The covalent bonds in keratin molecules are formed by the condensation reaction, which removes water from the reaction mixture.\n5. Hydrogen bonds also form in keratin molecules between the amino acid side chains, contributing to the stability of the keratin molecule.",
    "vicuna-7b_fact": [
      "Keratin molecules are composed of long chains of amino acids.",
      "Covalent bonds connect keratin molecules.",
      "Covalent bonds are formed by the sharing of electrons between the atoms.",
      "The covalent bonds in keratin molecules are formed by the condensation reaction, which removes water from the reaction mixture.",
      "Hydrogen bonds also form in keratin molecules between the amino acid side chains, contributing to the stability of the keratin molecule."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The peptide bonds in keratin molecules are formed by the condensation reaction, which removes water from the reaction mixture.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 734,
    "user_query": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?",
    "vicuna-7b_response": "Fanconi anemia is a rare genetic disorder that affects the bone marrow and leads to a higher risk of developing certain types of cancer, including acute myelogenous leukemia (AML).\nAML is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid growth of abnormal white blood cells, which can interfere with the production of normal blood cells.\nThe risk of developing AML in individuals with Fanconi anemia is higher than in the general population. Studies have shown that up to 80% of individuals with Fanconi anemia will develop some type of cancer, with AML being the most common.\nThe risk of developing AML in individuals with Fanconi anemia is related to the specific genetic mutation that caused the disorder. Some mutations are associated with a higher risk of AML than others.\nIt is important for individuals with Fanconi anemia to have regular check-ups and cancer screenings to detect any signs of cancer early, when it is more treatable. Treatment for AML in individuals with Fanconi anemia may include chemotherapy, radiation therapy, and bone marrow transplantation.\nIn summary, the risk of developing acute myelogenous leukemia in Fanconi anemia is higher than in the general population, and it is important for individuals with Fanconi anemia to be aware of the signs and symptoms of AML and to seek medical attention if they develop any of these symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fanconi anemia is a rare genetic disorder that affects the bone marrow and increases the risk of developing certain types of cancer, including acute myelogenous leukemia (AML).\n2. AML is a type of cancer that affects the blood and bone marrow and is often associated with the rapid growth of abnormal white blood cells.\n3. The risk of individuals with Fanconi anemia developing AML is higher than in the general population.\n4. The risk of developing AML in individuals with Fanconi anemia is directly related to the specific genetic mutation that caused the disorder.\n5. Treatment for AML in individuals with Fanconi anemia may include chemotherapy, radiation therapy, and bone marrow transplantation.",
    "vicuna-7b_fact": [
      "Fanconi anemia is a rare genetic disorder that affects the bone marrow and increases the risk of developing certain types of cancer, including acute myelogenous leukemia (AML).",
      "AML is a type of cancer that affects the blood and bone marrow and is often associated with the rapid growth of abnormal white blood cells.",
      "The risk of individuals with Fanconi anemia developing AML is higher than in the general population.",
      "The risk of developing AML in individuals with Fanconi anemia is directly related to the specific genetic mutation that caused the disorder.",
      "Treatment for AML in individuals with Fanconi anemia may include chemotherapy, radiation therapy, and bone marrow transplantation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 735,
    "user_query": "How many different mutations have been associated with Muenke syndrome?",
    "vicuna-7b_response": "Muenke syndrome is a rare genetic disorder caused by mutations in the MKKS gene. The MKKS gene provides instructions for making a protein called the MKS1 kinase, which is involved in regulating cell division. Mutations in the MKKS gene can lead to the development of Muenke syndrome, which is characterized by a range of physical and developmental abnormalities.\nThere have been several reported cases of Muenke syndrome caused by different mutations in the MKKS gene. Some of the most common mutations associated with Muenke syndrome include:\n* 1625G>A: This mutation results in the substitution of the amino acid glutamine for arginine at position 541 in the MKS1 protein.\n* 1625G>C: This mutation results in the substitution of the amino acid glutamine for cysteine at position 541 in the MKS1 protein.\n* 1625G>T: This mutation results in the substitution of the amino acid glutamine for threonine at position 541 in the MKS1 protein.\n* 1625G>A;1625G>C;1625G>T: This triplet mutation results in the substitution of the amino acid glutamine for arginine, cysteine, or threonine at position 541 in the MKS1 protein.\nThese are just a few examples of the many different mutations that have been associated with Muenke syndrome. It is important to note that each mutation can have different effects on the function of the MKS1 protein and can lead to different symptoms and severity of the disorder.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Muenke syndrome is a rare genetic disorder caused by mutations in the MKKS gene.\n2. The MKKS gene provides instructions for making a protein called the MKS1 kinase.\n3. The MKS1 kinase is involved in regulating cell division.\n4. There have been several reported cases of Muenke syndrome caused by different mutations in the MKKS gene.\n5. Each mutation can have different effects on the function of the MKS1 protein and can lead to different symptoms and severity of the disorder.",
    "vicuna-7b_fact": [
      "Muenke syndrome is a rare genetic disorder caused by mutations in the MKKS gene.",
      "The MKKS gene provides instructions for making a protein called the MKS1 kinase.",
      "The MKS1 kinase is involved in regulating cell division.",
      "There have been several reported cases of Muenke syndrome caused by different mutations in the MKKS gene.",
      "Each mutation can have different effects on the function of the MKS1 protein and can lead to different symptoms and severity of the disorder."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Muenke syndrome is a rare genetic disorder caused by mutations in the FGFR3 gene.\n2. FALSE [correction]: The MKKS gene provides instructions for making a protein that is involved in the assembly of the cilium, a structure that protrudes from the surface of cells.\n3. FALSE [correction]: The protein coded by the MKKS gene is not known as MKS1 kinase, and it does not directly regulate cell division.\n4. FALSE [correction]: There have been several reported cases of Muenke syndrome caused by different mutations in the FGFR3 gene, not the MKKS gene.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 737,
    "user_query": "Which genes have been proposed as potential candidates for gene therapy of heart failure?",
    "vicuna-7b_response": "There are several genes that have been proposed as potential candidates for gene therapy of heart failure. One such gene is BMP2, which encodes a bone morphogenetic protein that has been shown to improve cardiac function in animal models of heart failure. Another gene that has been studied for its potential use in gene therapy of heart failure is ANF, which encodes the hormone atrial natriuretic factor, which plays a role in regulating blood pressure and cardiac function. Additionally, the gene for the enzyme phosphodiesterase 5B (PDE5B) has been proposed as a potential target for gene therapy, as inhibition of this enzyme has been shown to improve cardiac function in animal models of heart failure. Finally, the gene for the protein troponin I (TNNI3) has also been proposed as a potential target for gene therapy, as mutations in this gene have been linked to heart failure.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BMP2 is a gene that has been proposed as a potential candidate for gene therapy of heart failure.\n2. BMP2 encodes a bone morphogenetic protein that has been shown to improve cardiac function in animal models of heart failure.\n3. ANF, which encodes the hormone atrial natriuretic factor, has been studied as a possible gene for therapy of heart failure.\n4. The gene for the enzyme phosphodiesterase 5B (PDE5B) has been proposed for heart failure gene therapy.\n5. The gene for the protein troponin I (TNNI3) has been proposed as a potential target for gene therapy, with mutations in this gene linked to heart failure.",
    "vicuna-7b_fact": [
      "BMP2 is a gene that has been proposed as a potential candidate for gene therapy of heart failure.",
      "BMP2 encodes a bone morphogenetic protein that has been shown to improve cardiac function in animal models of heart failure.",
      "ANF, which encodes the hormone atrial natriuretic factor, has been studied as a possible gene for therapy of heart failure.",
      "The gene for the enzyme phosphodiesterase 5B (PDE5B) has been proposed for heart failure gene therapy.",
      "The gene for the protein troponin I (TNNI3) has been proposed as a potential target for gene therapy, with mutations in this gene linked to heart failure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 738,
    "user_query": "DX-88 is investigational name of which drug?",
    "vicuna-7b_response": "DX-88 is the investigational name of a drug called Daprodustat. Daprodustat is an oral, small molecule inhibitor of the erythropoietin receptor that is being developed for the treatment of anemia in patients with chronic kidney disease (CKD) and in patients with beta-thalassemia. It is being developed by Daiichi Sankyo and is currently in various stages of clinical trials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DX-88 is the investigational name for the drug Daprodustat.\n2. Daprodustat is an oral, small molecule inhibitor of the erythropoietin receptor.\n3. Daprodustat is being developed for the treatment of anemia in patients with chronic kidney disease (CKD) and beta-thalassemia.\n4. The drug is being developed by Daiichi Sankyo.\n5. Daprodustat is in various stages of clinical trials.",
    "vicuna-7b_fact": [
      "DX-88 is the investigational name for the drug Daprodustat.",
      "Daprodustat is an oral, small molecule inhibitor of the erythropoietin receptor.",
      "Daprodustat is being developed for the treatment of anemia in patients with chronic kidney disease (CKD) and beta-thalassemia.",
      "The drug is being developed by Daiichi Sankyo.",
      "Daprodustat is in various stages of clinical trials."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Daprodustat is an oral, small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH).\n3. TRUE\n4. FALSE [correction]: The drug is being developed by GlaxoSmithKline.\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 740,
    "user_query": "Which genes have been found to be associated with restless leg syndrome",
    "vicuna-7b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, often accompanied by unpleasant sensations in the legs. The exact cause of RLS is not fully understood, but it is thought to be related to abnormal functioning of the brain's dopamine system.\nSeveral genetic studies have identified genetic variants that may be associated with an increased risk of developing RLS. One of the most well-known genetic risk factors for RLS is a variant on chromosome 12, which has been found to be associated with an increased risk of developing the condition. Other genetic variants that have been associated with RLS include variants on chromosomes 6, 17, and 20.\nIn addition to genetic factors, there are also environmental and lifestyle factors that may contribute to the development of RLS. These include smoking, alcohol consumption, and certain medications.\nIt is important to note that while genetic factors may increase the risk of developing RLS, not everyone with a genetic predisposition will develop the condition. Additionally, RLS can also occur in people without any known genetic risk factors. If you are experiencing symptoms of RLS, it is important to speak with a healthcare professional for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, often accompanied by unpleasant sensations in the legs.\n2. Genetic studies have identified genetic variants that may be associated with an increased risk of developing RLS.\n3. A variant on chromosome 12 has been found to be associated with an increased risk of developing Restless leg syndrome.\n4. Other genetic variants have been associated with RLS, including variants on chromosomes 6, 17, and 20.\n5. Environmental and lifestyle factors, such as smoking, alcohol consumption, and certain medications, may contribute to the development of RLS.",
    "vicuna-7b_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, often accompanied by unpleasant sensations in the legs.",
      "Genetic studies have identified genetic variants that may be associated with an increased risk of developing RLS.",
      "A variant on chromosome 12 has been found to be associated with an increased risk of developing Restless leg syndrome.",
      "Other genetic variants have been associated with RLS, including variants on chromosomes 6, 17, and 20.",
      "Environmental and lifestyle factors, such as smoking, alcohol consumption, and certain medications, may contribute to the development of RLS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 743,
    "user_query": "Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?",
    "vicuna-7b_response": "The Sleeping Beauty (SB) and piggyBac transposons are both transposable elements that have been widely used in genetic engineering and functional genomics studies. Both transposons have been shown to have high transposition efficiency in various organisms, including mammalian cells.\nThe Sleeping Beauty transposon is a transposon that is derived from the mariner transposon and has been modified to have a higher transposition efficiency in mammalian cells. The SB transposon can integrate into the genome at a variety of sites, including non-coding regions, introns, and exons, and can generate a variety of insertion mutations. The SB transposon has been used in a number of gene therapy studies, including the treatment of X-linked severe combined immunodeficiency (X-SCID) and the generation of gene knockout mice.\nThe piggyBac transposon is another transposon that has been widely used in genetic engineering and functional genomics studies. The piggyBac transposon can integrate into the genome at a variety of sites and can generate a variety of insertion mutations. The piggyBac transposon has been used in a number of gene therapy studies, including the treatment of X-linked retinitis pigmentosa and the generation of gene knockout mice.\nIn summary, both the Sleeping Beauty and piggyBac transposons have high transposition efficiency and have been widely used in genetic engineering and functional genomics studies. The choice of transposon will depend on the specific research question and the organism being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Sleeping Beauty (SB) and piggyBac transposons are both transposable elements used in genetic engineering and functional genomics studies.\n2. The Sleeping Beauty transposon is derived from the mariner transposon and has been modified for higher transposition efficiency in mammalian cells.\n3. The SB transposon can integrate into the genome at a variety of sites.\n4. The piggyBac transposon can also integrate into a variety of sites in the genome.\n5. Both the Sleeping Beauty and piggyBac transposons have been used in gene therapy studies, including the treatment of X-linked severe combined immunodeficiency (X-SCID), X-linked retinitis pigmentosa and the generation of gene knockout mice.",
    "vicuna-7b_fact": [
      "The Sleeping Beauty (SB) and piggyBac transposons are both transposable elements used in genetic engineering and functional genomics studies.",
      "The Sleeping Beauty transposon is derived from the mariner transposon and has been modified for higher transposition efficiency in mammalian cells.",
      "The SB transposon can integrate into the genome at a variety of sites.",
      "The piggyBac transposon can also integrate into a variety of sites in the genome.",
      "Both the Sleeping Beauty and piggyBac transposons have been used in gene therapy studies, including the treatment of X-linked severe combined immunodeficiency (X-SCID), X-linked retinitis pigmentosa and the generation of gene knockout mice."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Sleeping Beauty transposon is derived from the Tc1/mariner superfamily of transposons and has been synthesized for higher transposition efficiency in mammalian cells.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 744,
    "user_query": "Where does TORC1 sequester during heat stress?",
    "vicuna-7b_response": "TORC1 (Target of Rapamycin Complex 1) is a complex that regulates cell growth and metabolism in response to environmental cues. During heat stress, TORC1 is sequestered in the endoplasmic reticulum (ER) in response to the increase in cellular stress. This sequestration helps to prevent TORC1 from activating downstream targets that could lead to further stress and damage to the cell. The sequestration of TORC1 in the ER also helps to maintain the proper balance of amino acids and other nutrients in the cell, which is important for cell survival during heat stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TORC1 is a complex that regulates cell growth and metabolism in response to environmental cues.\n2. During heat stress, TORC1 is sequestered in the endoplasmic reticulum.\n3. The sequestration of TORC1 in the endoplasmic reticulum helps to prevent it from activating downstream targets.\n4. The sequestration aids in maintaining the proper balance of amino acids and other nutrients in the cell.\n5. This balance is important for cell survival during heat stress.",
    "vicuna-7b_fact": [
      "TORC1 is a complex that regulates cell growth and metabolism in response to environmental cues.",
      "During heat stress, TORC1 is sequestered in the endoplasmic reticulum.",
      "The sequestration of TORC1 in the endoplasmic reticulum helps to prevent it from activating downstream targets.",
      "The sequestration aids in maintaining the proper balance of amino acids and other nutrients in the cell.",
      "This balance is important for cell survival during heat stress."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. It is a medication that is primarily metabolized by the liver, but a small portion of the drug is also metabolized by the kidneys. The kidneys play an important role in the elimination of rivaroxaban from the body.\nRivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots from forming in the body. It is commonly used to prevent blood clots from forming in people who have atrial fibrillation, a type of irregular heartbeat that increases the risk of blood clots.\nThe medication is taken orally and is typically taken once daily. It is important to note that the kidneys play a role in the elimination of rivaroxaban from the body, so kidney function should be considered when prescribing the medication.\nIn summary, rivaroxaban is metabolized in the kidneys, and the kidneys play an important role in the elimination of the drug from the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Rivaroxaban is metabolized in the kidneys.\n2. The drug is primarily metabolized by the liver.\n3. Rivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots.\n4. The medication is commonly used to prevent blood clots from forming in people who have atrial fibrillation.\n5. The medication is taken orally and is typically taken once daily.",
    "vicuna-7b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "The drug is primarily metabolized by the liver.",
      "Rivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots.",
      "The medication is commonly used to prevent blood clots from forming in people who have atrial fibrillation.",
      "The medication is taken orally and is typically taken once daily."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Rivaroxaban is excreted by the kidneys, but not metabolized in them.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 746,
    "user_query": "What are the side effects of Nalmefene?",
    "vicuna-7b_response": "Nalmefene is a medication used to treat alcohol use disorder (AUD). It works by blocking the effects of alcohol on the brain and reducing the desire to drink.\nCommon side effects of nalmefene include:\n* Nausea\n* Vomiting\n* Constipation\n* Dizziness\n* Headache\n* Fatigue\n* Insomnia\n* Decreased appetite\n* Diarrhea\n* Abdominal pain\n* Upper respiratory tract infection\n* Sinusitis\n* Nasopharyngitis (inflammation of the nasopharynx)\n* Back pain\n* Muscle spasms\n* Abnormal dreams\n* Depression\n* Suicidal thoughts\nIt is important to note that these side effects are not experienced by all users and that the severity of the side effects can vary from person to person. If you experience any severe or persistent side effects, it is important to speak with your healthcare provider.\nIt is also important to note that nalmefene should not be used in combination with other medications that also block the effects of alcohol, such as disulfiram (Antabuse) or acamprosate (Campral), as this can lead to dangerous interactions.\nIt is important to consult with a healthcare provider before starting nalmefene treatment to discuss the potential benefits and risks of the medication and to determine the best course of treatment for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nalmefene is used to treat alcohol use disorder (AUD).\n2. Nalmefene works by blocking the effects of alcohol on the brain and reducing the desire to drink.\n3. Nalmefene may have side effects like nausea, vomiting, constipation, dizziness, headache, fatigue, insomnia, decreased appetite, abdominal pain, chest infection, sinusitis and more.\n4. Not all users experience these side effects and their severity can vary from person to person.\n5. Nalmefene should not be used in combination with other medications that block the effects of alcohol, such as disulfiram (Antabuse) or acamprosate (Campral).",
    "vicuna-7b_fact": [
      "Nalmefene is used to treat alcohol use disorder (AUD).",
      "Nalmefene works by blocking the effects of alcohol on the brain and reducing the desire to drink.",
      "Nalmefene may have side effects like nausea, vomiting, constipation, dizziness, headache, fatigue, insomnia, decreased appetite, abdominal pain, chest infection, sinusitis and more.",
      "Not all users experience these side effects and their severity can vary from person to person.",
      "Nalmefene should not be used in combination with other medications that block the effects of alcohol, such as disulfiram (Antabuse) or acamprosate (Campral)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 756,
    "user_query": "Which is the E3 ubiquitin ligase of Hsp90?",
    "vicuna-7b_response": "The E3 ubiquitin ligase of Hsp90 is called HSP90-CDK4/6 inhibitor alpha.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The E3 ubiquitin ligase of Hsp90 is HSP90-CDK4/6 inhibitor alpha.",
    "vicuna-7b_fact": [
      "The E3 ubiquitin ligase of Hsp90 is HSP90-CDK4/6 inhibitor alpha."
    ],
    "vicuna-7b_judge_raw": "UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 757,
    "user_query": "Which are the major phycobiliproteins present in cyanobacteria?",
    "vicuna-7b_response": "Cyanobacteria are photosynthetic bacteria that contain a range of phycobiliproteins, which are pigments that absorb light and convert it into energy. Some of the major phycobiliproteins present in cyanobacteria include:\n1. Phycocyanin: This is the most abundant phycobiliprotein in cyanobacteria and is responsible for the blue color of cyanobacteria. It is found in the chloroplasts of cyanobacteria and is involved in light harvesting.\n2. Phycoerythrin: This phycobiliprotein is responsible for the red color of cyanobacteria and is found in the cytoplasm of cyanobacteria. It is involved in light harvesting and energy transfer.\n3. Phycobilisomes: These are complexes of phycobiliproteins that are found in the chloroplasts of cyanobacteria. They are involved in the organization of photosynthetic pigments and the transfer of energy.\n4. C-phycocyanin: This phycobiliprotein is found in the chloroplasts of some cyanobacteria and is responsible for the orange-red color of cyanobacteria. It is involved in light harvesting and energy transfer.\n5. Allophycocyanin: This phycobiliprotein is found in some cyanobacteria and is responsible for the yellow-green color of cyanobacteria. It is involved in light harvesting and energy transfer.\nOverall, these phycobiliproteins play a crucial role in the photosynthesis process of cyanobacteria, allowing them to convert light energy into chemical energy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cyanobacteria are photosynthetic bacteria that contain a range of phycobiliproteins.\n2. Phycocyanin, a major phycobiliprotein in cyanobacteria, is responsible for the blue color of cyanobacteria.\n3. Phycoerythrin is a phycobiliprotein in cyanobacteria responsible for their red color.\n4. Cyanobacteria contain phycobilisomes, which are complexes of phycobiliproteins.\n5. C-phycocyanin and Allophycocyanin are phycobiliproteins found in some cyanobacteria and are responsible for the orange-red and yellow-green colors respectively.\n6. Phycobiliproteins in cyanobacteria convert light energy into chemical energy through photosynthesis.",
    "vicuna-7b_fact": [
      "Cyanobacteria are photosynthetic bacteria that contain a range of phycobiliproteins.",
      "Phycocyanin, a major phycobiliprotein in cyanobacteria, is responsible for the blue color of cyanobacteria.",
      "Phycoerythrin is a phycobiliprotein in cyanobacteria responsible for their red color.",
      "Cyanobacteria contain phycobilisomes, which are complexes of phycobiliproteins.",
      "C-phycocyanin and Allophycocyanin are phycobiliproteins found in some cyanobacteria and are responsible for the orange-red and yellow-green colors respectively.",
      "Phycobiliproteins in cyanobacteria convert light energy into chemical energy through photosynthesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: C-phycocyanin and Allophycocyanin are phycobiliproteins found in some cyanobacteria and are responsible for the blue and yellow-green colors respectively.\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 759,
    "user_query": "In which kingdom do microsporidia belong, according to their current classification scheme?",
    "vicuna-7b_response": "Microsporidia are a type of protist that belong to the kingdom Protista. They are classified within the Eumycota phylum, which includes fungi. However, unlike other fungi, microsporidia are not classified as part of the kingdom Fungi, but rather as part of the kingdom Chromista.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Microsporidia are a type of protist.\n2. Microsporidia belong to the kingdom Protista.\n3. Microsporidia are classified within the Eumycota phylum.\n4. Eumycota phylum includes fungi.\n5. Microsporidia are part of the kingdom Chromista.",
    "vicuna-7b_fact": [
      "Microsporidia are a type of protist.",
      "Microsporidia belong to the kingdom Protista.",
      "Microsporidia are classified within the Eumycota phylum.",
      "Eumycota phylum includes fungi.",
      "Microsporidia are part of the kingdom Chromista."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Microsporidia are classified within the Fungi kingdom, not the Eumycota phylum.\n4. TRUE\n5. FALSE [correction]: Microsporidia are not part of the kingdom Chromista, they are part of the kingdom Protista.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-7b_response": "TRalpha2 is a transcription factor that plays a crucial role in the regulation of gene expression in various tissues, including the heart. TRalpha2 is a member of the thyroid hormone receptor (TR) family, which is a group of nuclear receptors that regulate the expression of genes involved in metabolism, development, and other processes.\nIn the heart, TRalpha2 has been shown to play a role in the regulation of gene expression related to cardiac function and development. Studies have shown that TRalpha2 is expressed in the heart and regulates the expression of genes involved in cardiac growth and development, as well as the regulation of contractility and electrical activity of the heart.\nSome of the genes that have been shown to be regulated by TRalpha2 in the heart include:\n* Myh7: Myosin heavy chain 7 (Myh7) is a gene that encodes for a protein that is involved in the development and function of skeletal muscle, including the heart. TRalpha2 has been shown to regulate the expression of Myh7 in the heart.\n* Nkx2.5: Nkx2.5 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Nkx2.5 in the heart.\n* Tbx20: Tbx20 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Tbx20 in the heart.\n* Gata4: Gata4 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Gata4 in the heart.\n* Mef2c: Mef2c is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Mef2c in the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRalpha2 in the heart. TRalpha2 plays a crucial role",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TRalpha2 is a transcription factor that plays a crucial role in the regulation of gene expression in various tissues including the heart.\n2. TRalpha2 is a part of the thyroid hormone receptor (TR) family which regulates the expression of genes involved in metabolism, development, and other processes.\n3. TRalpha2 is expressed in the heart and regulates the expression of genes.\n4. TRalpha2 regulates the expression of the gene Myh7 in the heart.\n5. TRalpha2 regulates the expression of the genes Nkx2.5, Tbx20, Gata4, and Mef2c in the heart.",
    "vicuna-7b_fact": [
      "TRalpha2 is a transcription factor that plays a crucial role in the regulation of gene expression in various tissues including the heart.",
      "TRalpha2 is a part of the thyroid hormone receptor (TR) family which regulates the expression of genes involved in metabolism, development, and other processes.",
      "TRalpha2 is expressed in the heart and regulates the expression of genes.",
      "TRalpha2 regulates the expression of the gene Myh7 in the heart.",
      "TRalpha2 regulates the expression of the genes Nkx2.5, Tbx20, Gata4, and Mef2c in the heart."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 767,
    "user_query": "Is tubulin acetylation involved in cell motility?",
    "vicuna-7b_response": "Yes, tubulin acetylation is involved in cell motility. Tubulin is a protein that makes up microtubules, which are dynamic cytoskeletal structures that play a crucial role in cell motility. Tubulin acetylation is a post-translational modification that affects the stability and dynamics of microtubules.\nStudies have shown that changes in tubulin acetylation levels can affect cell motility. For example, inhibition of tubulin acetylation has been shown to decrease cell motility, while increased levels of tubulin acetylation have been shown to increase cell motility. Additionally, some studies have suggested that changes in tubulin acetylation levels can be regulated by various signaling pathways, such as the Wnt signaling pathway, which plays a role in cell motility and migration.\nOverall, tubulin acetylation is an important regulator of cell motility, and changes in tubulin acetylation levels can have significant effects on cell behavior and migration.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tubulin acetylation is involved in cell motility.\n2. Tubulin is a protein that makes up microtubules.\n3. Microtubules are dynamic cytoskeletal structures that play a crucial role in cell motility.\n4. Changes in tubulin acetylation levels can affect cell motility.\n5. The Wnt signaling pathway can regulate changes in tubulin acetylation levels and plays a role in cell motility and migration.",
    "vicuna-7b_fact": [
      "Tubulin acetylation is involved in cell motility.",
      "Tubulin is a protein that makes up microtubules.",
      "Microtubules are dynamic cytoskeletal structures that play a crucial role in cell motility.",
      "Changes in tubulin acetylation levels can affect cell motility.",
      "The Wnt signaling pathway can regulate changes in tubulin acetylation levels and plays a role in cell motility and migration."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 768,
    "user_query": "List available genetic multicolor cell labeling techiniques in Drosophila",
    "vicuna-7b_response": "There are several genetic multicolor cell labeling techniques available in Drosophila that can be used to label different cell types in the fly. Here are some of the most commonly used techniques:\n1. GAL4/UAS-based system: This is a widely used technique for cell labeling in Drosophila. It involves the expression of a reporter gene (such as green fluorescent protein, or GFP) under the control of the GAL4 transcription factor. The GAL4 protein can be targeted to specific cell types by using tissue-specific or cell-specific promoters to drive the expression of the GAL4 protein. This allows researchers to label specific cell types in the fly.\n2. tTA/tetO-based system: This is another popular cell labeling technique in Drosophila. It involves the expression of a reporter gene (such as red fluorescent protein, or mRFP) under the control of the tetracycline transcriptional repressor (tTA) and the tetracycline-responsive element (tetO). The tetO promoter drives the expression of tTA in the presence of tetracycline, which can be used to induce the expression of the reporter gene in specific cells.\n3. FLP/FRT-based system: This technique involves the use of the FLP and FRT sites, which are recombination-based systems. The FLP protein can be used to create a double-stranded break at a specific site in the genome, which can be used to induce the expression of a reporter gene in specific cells. The FRT site can be used to target the expression of the FLP protein to specific cells.\n4. TALEN/CRISPR-based system: This technique involves the use of transcription activator-like effector nucleases (TALENs) or clustered regularly interspaced short palindromic repeats (CRISPR) to induce double-stranded breaks in the genome. This can be used to knock out or modify specific genes in specific cells, allowing researchers to label cells that express the desired gene.\nThese are just a few examples of the many genetic multicolor cell labeling techniques available in Drosophila. The choice of technique will depend on",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The GAL4/UAS-based system is a commonly used genetic multicolor cell labeling technique in Drosophila.\n2. The tTA/tetO-based system is another popular cell labeling technique in Drosophila.\n3. The FLP/FRT-based system is a genetic multicolor cell labeling technique that uses recombination-based systems in Drosophila.\n4. The TALEN/CRISPR-based system is a technique that uses transcription activator-like effector nucleases or clustered regularly interspaced short palindromic repeats to induce double-stranded breaks in the genome in Drosophila.\n5. There are many genetic multicolor cell labeling techniques available in Drosophila.",
    "vicuna-7b_fact": [
      "The GAL4/UAS-based system is a commonly used genetic multicolor cell labeling technique in Drosophila.",
      "The tTA/tetO-based system is another popular cell labeling technique in Drosophila.",
      "The FLP/FRT-based system is a genetic multicolor cell labeling technique that uses recombination-based systems in Drosophila.",
      "The TALEN/CRISPR-based system is a technique that uses transcription activator-like effector nucleases or clustered regularly interspaced short palindromic repeats to induce double-stranded breaks in the genome in Drosophila.",
      "There are many genetic multicolor cell labeling techniques available in Drosophila."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 769,
    "user_query": "Which growth factors are known to be involved in the induction of EMT?",
    "vicuna-7b_response": "EMT, or epithelial-to-mesenchymal transition, is a process by which epithelial cells undergo a transformation into mesenchymal cells. This process is involved in the development and tissue repair, but it can also play a role in the progression of various diseases, such as cancer.\nThere are several growth factors that have been shown to be involved in the induction of EMT:\n1. TGF-β (transforming growth factor-β) is a cytokine that plays a key role in the regulation of EMT. It binds to specific receptors on the surface of cells and activates intracellular signaling pathways that promote the expression of genes involved in EMT.\n2. Wnt signaling pathway is a cell signaling pathway that plays a role in the regulation of EMT. It is activated by the binding of Wnt proteins to their receptors, leading to the activation of beta-catenin, a transcription factor that regulates the expression of genes involved in EMT.\n3. BMPs (bone morphogenetic proteins) are a family of growth factors that play a role in the regulation of EMT. They bind to specific receptors on the surface of cells and activate intracellular signaling pathways that promote the expression of genes involved in EMT.\n4. HGF (hepatocyte growth factor) is a growth factor that plays a role in the regulation of EMT. It binds to specific receptors on the surface of cells and activates intracellular signaling pathways that promote the expression of genes involved in EMT.\n5. PDGF (platelet-derived growth factor) is a growth factor that plays a role in the regulation of EMT. It binds to specific receptors on the surface of cells and activates intracellular signaling pathways that promote the expression of genes involved in EMT.\nThese growth factors can act alone or in combination with other signaling pathways to induce EMT. Understanding the mechanisms involved in EMT is important for the development of new therapies for diseases where EMT plays a role, such as cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. EMT, or epithelial-to-mesenchymal transition, is a process by which epithelial cells transform into mesenchymal cells.\n2. TGF-β (transforming growth factor-β) is a cytokine that plays a key role in the regulation of EMT.\n3. The Wnt signaling pathway plays a role in the regulation of EMT through the activation of beta-catenin.\n4. BMPs (bone morphogenetic proteins) are a family of growth factors that regulate EMT.\n5. HGF (hepatocyte growth factor) is a growth factor that plays a role in the regulation of EMT.\n6. PDGF (platelet-derived growth factor) is a growth factor that plays a role in the regulation of EMT.",
    "vicuna-7b_fact": [
      "EMT, or epithelial-to-mesenchymal transition, is a process by which epithelial cells transform into mesenchymal cells.",
      "TGF-β (transforming growth factor-β) is a cytokine that plays a key role in the regulation of EMT.",
      "The Wnt signaling pathway plays a role in the regulation of EMT through the activation of beta-catenin.",
      "BMPs (bone morphogenetic proteins) are a family of growth factors that regulate EMT.",
      "HGF (hepatocyte growth factor) is a growth factor that plays a role in the regulation of EMT.",
      "PDGF (platelet-derived growth factor) is a growth factor that plays a role in the regulation of EMT."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 774,
    "user_query": "Which histone modification discriminates between active and poised enhancers?",
    "vicuna-7b_response": "The histone modification that is most commonly used to discriminate between active and poised enhancers is histone H3 lysine 4 trimethylation (H3K4me3).\nH3K4me3 is a mark that is associated with active gene expression, and it is found at the promoters and bodies of actively transcribed genes. In contrast, poised enhancers are characterized by the presence of H3K4me1 and H3K27ac, which are associated with the ability of the enhancer to become active in response to specific signals.\nOther histone modifications, such as H3K27me3 and H3K9ac, are also used to distinguish between active and poised enhancers. For example, H3K27me3 is associated with repression and is found at the promoters of silenced genes, while H3K9ac is associated with transcriptional activation and is found at the bodies of actively transcribed genes.\nOverall, the presence of H3K4me3 at the body of an enhancer is a strong indication that it is poised and ready to become active in response to specific signals.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Histone H3 lysine 4 trimethylation (H3K4me3) is the histone modification most commonly used to discriminate between active and poised enhancers.\n2. H3K4me3 is a mark that is associated with active gene expression. \n3. H3K4me1 and H3K27ac are associated with the ability of the enhancer to become active in response to specific signals, and characterize poised enhancers.\n4. H3K27me3 is associated with repression and is found at the promoters of silenced genes.\n5. H3K9ac is associated with transcriptional activation and is found at the bodies of actively transcribed genes.",
    "vicuna-7b_fact": [
      "Histone H3 lysine 4 trimethylation (H3K4me3) is the histone modification most commonly used to discriminate between active and poised enhancers.",
      "H3K4me3 is a mark that is associated with active gene expression.",
      "H3K4me1 and H3K27ac are associated with the ability of the enhancer to become active in response to specific signals, and characterize poised enhancers.",
      "H3K27me3 is associated with repression and is found at the promoters of silenced genes.",
      "H3K9ac is associated with transcriptional activation and is found at the bodies of actively transcribed genes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Histone H3 lysine 27 acetylation (H3K27ac) and Histone H3 lysine 4 monomethylation (H3K4me1) are commonly used to discriminate between active and poised enhancers, not H3K4me3.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 776,
    "user_query": "What is the inheritance pattern of Li–Fraumeni syndrome?",
    "vicuna-7b_response": "Li–Fraumeni syndrome is a rare genetic disorder that is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors. The inheritance pattern of Li–Fraumeni syndrome is typically autosomal dominant, which means that a person has a 50% chance of inheriting the gene from an affected parent. However, it is important to note that not all cases of Li–Fraumeni syndrome are inherited, and some cases may be caused by a spontaneous mutation in the gene. Additionally, the age of onset and the specific types of cancer that a person with Li–Fraumeni syndrome is at risk of developing can vary widely depending on the specific genetic changes that are present.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Li–Fraumeni syndrome is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors.\n2. The inheritance pattern of Li–Fraumeni syndrome is typically autosomal dominant.\n3. In autosomal dominant inheritance, a person has a 50% chance of inheriting the gene from an affected parent.\n4. Some cases of Li–Fraumeni syndrome may be caused by a spontaneous mutation in the gene.\n5. The age of onset and the specific types of cancer that a person with Li–Fraumeni syndrome is at risk of developing can vary widely depending on specific genetic changes.",
    "vicuna-7b_fact": [
      "Li–Fraumeni syndrome is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors.",
      "The inheritance pattern of Li–Fraumeni syndrome is typically autosomal dominant.",
      "In autosomal dominant inheritance, a person has a 50% chance of inheriting the gene from an affected parent.",
      "Some cases of Li–Fraumeni syndrome may be caused by a spontaneous mutation in the gene.",
      "The age of onset and the specific types of cancer that a person with Li–Fraumeni syndrome is at risk of developing can vary widely depending on specific genetic changes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 781,
    "user_query": "Which are the synonyms of prostate-specific antigen?",
    "vicuna-7b_response": "Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. It is also known as the prostate-specific antigen (PSA) or the prostate-specific glycoprotein (PSGP). PSA is used as a tumor marker for prostate cancer, as an elevated level of PSA in the blood may indicate the presence of prostate cancer. However, it is important to note that an elevated PSA level can also be caused by other conditions, such as benign prostatic hyperplasia (BPH) or infection, and further testing is needed to determine the cause.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland.\n2. Prostate-specific antigen is also known as prostate-specific glycoprotein (PSGP).\n3. The term PSA is used as a tumor marker for prostate cancer.\n4. An elevated level of PSA in the blood may indicate the presence of prostate cancer.\n5. An elevated PSA level can also be caused by other conditions such as benign prostatic hyperplasia (BPH) or infection.",
    "vicuna-7b_fact": [
      "Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland.",
      "Prostate-specific antigen is also known as prostate-specific glycoprotein (PSGP).",
      "The term PSA is used as a tumor marker for prostate cancer.",
      "An elevated level of PSA in the blood may indicate the presence of prostate cancer.",
      "An elevated PSA level can also be caused by other conditions such as benign prostatic hyperplasia (BPH) or infection."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Prostate-specific antigen is not known as prostate-specific glycoprotein (PSGP).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 783,
    "user_query": "What is the function of circular RNA?",
    "vicuna-7b_response": "Circular RNA (circRNA) is a type of non-coding RNA that plays a crucial role in various cellular processes. The main function of circRNA is to regulate gene expression by modulating the stability and localization of messenger RNA (mRNA) molecules.\ncircRNA is formed when a portion of a longer RNA molecule is circularized through the action of enzymes called reverse transcriptases and RNA ligases. This circularization process allows circRNA to form a stable, self-looped structure that can interact with other RNA molecules and proteins.\nOne of the key functions of circRNA is to act as a scaffold for the formation of RNA-protein complexes. These complexes can regulate the translation of mRNA molecules, leading to changes in gene expression. Additionally, circRNA can also function as a sponge for miRNAs, small non-coding RNAs that regulate gene expression by binding to mRNA molecules and promoting their degradation.\nOverall, circRNA plays a critical role in regulating gene expression and cellular processes, and its dysregulation has been implicated in various diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Circular RNA (circRNA) is a type of non-coding RNA.\n2. circRNA regulates gene expression by modulating the stability and localization of messenger RNA (mRNA) molecules.\n3. circRNA is formed when a portion of a longer RNA molecule is circularized through the action of enzymes called reverse transcriptases and RNA ligases.\n4. One function of circRNA is to act as a scaffold for the formation of RNA-protein complexes.\n5. Dysregulation of circRNA has been implicated in various diseases, including cancer.",
    "vicuna-7b_fact": [
      "Circular RNA (circRNA) is a type of non-coding RNA.",
      "circRNA regulates gene expression by modulating the stability and localization of messenger RNA (mRNA) molecules.",
      "circRNA is formed when a portion of a longer RNA molecule is circularized through the action of enzymes called reverse transcriptases and RNA ligases.",
      "One function of circRNA is to act as a scaffold for the formation of RNA-protein complexes.",
      "Dysregulation of circRNA has been implicated in various diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: circRNA is formed when a spliceosome induces a covalently closed circular structure, not through the action of reverse transcriptases and RNA ligases.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-7b_response": "There are several biomedical question answering systems available, including:\n1. BioASQ: A system for answering biomedical questions using a machine learning approach.\n2. Biocreative: A system for generating biomedical text from unstructured data, including questions and answers.\n3. Biomedical Question Answering Challenge (Bio-QA): A competition aimed at developing and evaluating biomedical question answering systems.\n4. Clinical Question Answering (CRAQ): A system for answering clinical questions using a knowledge base and natural language processing.\n5. MedQA: A system for answering clinical questions using a machine learning approach.\n6. PubMedQA: A system for answering biomedical questions using the PubMed database.\n7. Question Answering Challenge (QAC): A competition aimed at developing and evaluating question answering systems in general.\nThese are just a few examples, and there may be other biomedical question answering systems available as well.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BioASQ is a biomedical question answering system that uses a machine learning approach.\n2. Biocreative is a system for generating biomedical text from unstructured data.\n3. Biomedical Question Answering Challenge (Bio-QA) is a competition aimed at developing and evaluating biomedical question answering systems.\n4. Clinical Question Answering (CRAQ) is a system for answering clinical questions using a knowledge base and natural language processing.\n5. MedQA is a system for answering clinical questions using a machine learning approach.\n6. PubMedQA is a system for answering biomedical questions using the PubMed database.\n7. Question Answering Challenge (QAC) is a competition aimed at developing and evaluating question answering systems in general.",
    "vicuna-7b_fact": [
      "BioASQ is a biomedical question answering system that uses a machine learning approach.",
      "Biocreative is a system for generating biomedical text from unstructured data.",
      "Biomedical Question Answering Challenge (Bio-QA) is a competition aimed at developing and evaluating biomedical question answering systems.",
      "Clinical Question Answering (CRAQ) is a system for answering clinical questions using a knowledge base and natural language processing.",
      "MedQA is a system for answering clinical questions using a machine learning approach.",
      "PubMedQA is a system for answering biomedical questions using the PubMed database.",
      "Question Answering Challenge (QAC) is a competition aimed at developing and evaluating question answering systems in general."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n6. TRUE\n7. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-7b_response": "The transcription factor that activates the betalain pathway is known as the Beta-carotene-15,15'-oxygenase (BCO) transcription factor. BCO is a transcription factor that is responsible for activating the genes involved in the betalain pathway, which is responsible for the synthesis of betalains in plants.\nThe betalain pathway is a complex pathway that involves several enzymes and genes. The BCO transcription factor is responsible for activating the genes involved in the pathway, which are located on the long arm of chromosome 4 in the genome of Solanum tuberosum, the species that is commonly used as a source of potatoes.\nThe BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family, which is a family of transcription factors that play important roles in the regulation of gene expression in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.\nIn summary, the BCO transcription factor is the transcription factor that activates the betalain pathway in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.\n2. BCO is responsible for activating the genes involved in the betalain pathway in plants.\n3. The genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.\n4. The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.\n5. The activity of the BCO transcription factor is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact": [
      "The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.",
      "BCO is responsible for activating the genes involved in the betalain pathway in plants.",
      "The genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.",
      "The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.",
      "The activity of the BCO transcription factor is required for the synthesis of betalains in plants."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 796,
    "user_query": "Which is the most well-accepted method for Down syndrome non-invasive prenatal diagnosis?",
    "vicuna-7b_response": "Non-invasive prenatal diagnosis (NIPD) for Down syndrome is a method that uses cell-free fetal DNA (cffDNA) in the maternal blood to detect chromosomal abnormalities, including Down syndrome. The most well-accepted method for Down syndrome NIPD is the non-invasive prenatal test (NIPT) that analyzes the maternal blood for the presence of specific chromosomal aneuploidies, including Down syndrome.\nNIPT is a highly accurate test that can detect Down syndrome with a high sensitivity and specificity. The test analyzes the maternal blood for the presence of cell-free fetal DNA (cffDNA) which is shed into the maternal circulation during early pregnancy. The cffDNA is then analyzed for specific chromosomal aneuploidies, including Down syndrome.\nNIPT is a non-invasive test that does not require a invasive procedure such as amniocentesis, and it is considered a safe and reliable method for prenatal testing. It is also a more convenient option for pregnant women as it can be performed as early as 10 weeks of gestation, and it does not carry the risk of miscarriage associated with amniocentesis.\nIt is important to note that NIPT is not a replacement for traditional prenatal testing methods such as ultrasound and blood tests, but it can be used in conjunction with these tests to provide more information about the fetus.\nIn summary, the most well-accepted method for Down syndrome non-invasive prenatal diagnosis is the non-invasive prenatal test (NIPT) that analyzes the maternal blood for the presence of specific chromosomal aneuploidies, including Down syndrome. It is a highly accurate test that is considered a safe and reliable method for prenatal testing, and it can be performed as early as 10 weeks of gestation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Non-invasive prenatal diagnosis (NIPD) for Down syndrome is a method that uses cell-free fetal DNA (cffDNA) in the maternal blood to detect chromosomal abnormalities, including Down syndrome.\n2. The most well-accepted method for Down syndrome NIPD is the non-invasive prenatal test (NIPT) that analyzes the maternal blood for the presence of specific chromosomal aneuploidies, including Down syndrome.\n3. NIPT can detect Down syndrome with a high sensitivity and specificity, and it can be performed as early as 10 weeks of gestation.\n4. NIPT does not require an invasive procedure such as amniocentesis, and it does not carry the risk of miscarriage associated with amniocentesis.\n5. NIPT is used in conjunction with traditional prenatal testing methods such as ultrasound and blood tests, and it is not a replacement for these methods.",
    "vicuna-7b_fact": [
      "Non-invasive prenatal diagnosis (NIPD) for Down syndrome is a method that uses cell-free fetal DNA (cffDNA) in the maternal blood to detect chromosomal abnormalities, including Down syndrome.",
      "The most well-accepted method for Down syndrome NIPD is the non-invasive prenatal test (NIPT) that analyzes the maternal blood for the presence of specific chromosomal aneuploidies, including Down syndrome.",
      "NIPT can detect Down syndrome with a high sensitivity and specificity, and it can be performed as early as 10 weeks of gestation.",
      "NIPT does not require an invasive procedure such as amniocentesis, and it does not carry the risk of miscarriage associated with amniocentesis.",
      "NIPT is used in conjunction with traditional prenatal testing methods such as ultrasound and blood tests, and it is not a replacement for these methods."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 799,
    "user_query": "What is the average diameter of intermediate filaments?",
    "vicuna-7b_response": "Intermediate filaments are a type of cytoskeletal protein found in the cytoplasm of most eukaryotic cells. They are composed of a linear array of three or more polypeptide chains that are cross-linked by disulfide bonds. The average diameter of intermediate filaments is approximately 5-6 nm.\nIntermediate filaments are responsible for providing mechanical support to the cell and are involved in cellular processes such as cell division, cell movement, and cell shape maintenance. They are also involved in the formation of the extracellular matrix and play a role in tissue repair and regeneration.\nThere are three types of intermediate filaments: desmin, vimentin, and neurofilament. Desmin is found in muscle cells, vimentin is found in non-muscle cells, and neurofilament is found in neurons. Each type of intermediate filament has a unique sequence of amino acids and a distinct pattern of cross-linking, which contributes to their unique properties and functions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intermediate filaments are a type of cytoskeletal protein found in the cytoplasm of most eukaryotic cells.\n2. Intermediate filaments are composed of a linear array of three or more polypeptide chains that are cross-linked by disulfide bonds.\n3. The average diameter of intermediate filaments is approximately 5-6 nm.\n4. There are three types of intermediate filaments: desmin, vimentin, and neurofilament.\n5. Each type of intermediate filament (desmin, vimentin, and neurofilament) has a unique sequence of amino acids and a distinct pattern of cross-linking.",
    "vicuna-7b_fact": [
      "Intermediate filaments are a type of cytoskeletal protein found in the cytoplasm of most eukaryotic cells.",
      "Intermediate filaments are composed of a linear array of three or more polypeptide chains that are cross-linked by disulfide bonds.",
      "The average diameter of intermediate filaments is approximately 5-6 nm.",
      "There are three types of intermediate filaments: desmin, vimentin, and neurofilament.",
      "Each type of intermediate filament (desmin, vimentin, and neurofilament) has a unique sequence of amino acids and a distinct pattern of cross-linking."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Intermediate filaments are composed of fibrous proteins wound together like the threads of a rope.\n3. TRUE\n4. FALSE [correction]: There are more than three types of intermediate filaments, including desmin, vimentin, neurofilament, and lamins among others.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 805,
    "user_query": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?",
    "vicuna-7b_response": "The intermediate filament protein that can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone is nestin.\nNestin is a type III intermediate filament protein that is expressed in a variety of cell types, including neuronal precursor cells of the subventricular zone. It is a marker of neural stem cells and progenitor cells, and it is involved in the maintenance and differentiation of these cells.\nNestin is expressed in the subventricular zone of the developing and adult brain, where it is found in the neural stem cells and progenitor cells that give rise to new neurons. It is also expressed in other regions of the brain, including the hippocampus and cerebellum.\nIn addition to its expression in the subventricular zone, nestin is also expressed in other cell types, including cardiomyocytes, smooth muscle cells, and epithelial cells. Therefore, it is not a specific marker of neuronal precursor cells, but it is a useful marker for identifying neural stem cells and progenitor cells in the subventricular zone.\nOverall, nestin is a useful marker for identifying and studying the properties of neuronal precursor cells in the subventricular zone, and it has been used in a variety of research studies to investigate the cellular and molecular mechanisms that regulate the development and maintenance of the nervous system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nestin is an intermediate filament protein that can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone.\n2. Nestin is a marker of neural stem cells and progenitor cells.\n3. Nestin is involved in the maintenance and differentiation of neural stem cells and progenitor cells.\n4. Nestin is expressed in the subventricular zone of the developing and adult brain.\n5. Besides its expression in the subventricular zone, nestin is also expressed in other cell types, including cardiomyocytes, smooth muscle cells, and epithelial cells.",
    "vicuna-7b_fact": [
      "Nestin is an intermediate filament protein that can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone.",
      "Nestin is a marker of neural stem cells and progenitor cells.",
      "Nestin is involved in the maintenance and differentiation of neural stem cells and progenitor cells.",
      "Nestin is expressed in the subventricular zone of the developing and adult brain.",
      "Besides its expression in the subventricular zone, nestin is also expressed in other cell types, including cardiomyocytes, smooth muscle cells, and epithelial cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 806,
    "user_query": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?",
    "vicuna-7b_response": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is called DNMT3A (DNA (cytosine-5-)-methyltransferase 3A).\nDNMT3A is a type of enzyme called a DNA methyltransferase, which is responsible for adding a methyl group to the cytosine base of DNA. This process is important for maintaining the integrity of DNA and regulating gene expression.\nDNMT3A is particularly involved in the maintenance of DNA methylation at the 5-position of cytosine in CpG dinucleotides, which are sequences of DNA that contain a cytosine base paired with a guanine base and a \"paucity\" of guanine bases on either side. CpG dinucleotides are often found in the promoter regions of genes, where they play a role in regulating gene expression.\nDNMT3A is a key enzyme in the maintenance of DNA methylation and is involved in a variety of cellular processes, including embryonic development, cell differentiation, and tumor suppression. Dysregulation of DNMT3A has been implicated in a number of diseases, including cancer, and is a target of cancer therapies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNMT3A (DNA (cytosine-5-)-methyltransferase 3A) is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation.\n2. DNMT3A is a DNA methyltransferase, responsible for adding a methyl group to the cytosine base of DNA.\n3. DNMT3A maintains DNA methylation at the 5-position of cytosine in CpG dinucleotides.\n4. CpG dinucleotides are sequences of DNA that contain a cytosine base paired with a guanine base.\n5. Dysregulation of DNMT3A has been implicated in a number of diseases, including cancer, and is a target of cancer therapies.",
    "vicuna-7b_fact": [
      "DNMT3A (DNA (cytosine-5-)-methyltransferase 3A) is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation.",
      "DNMT3A is a DNA methyltransferase, responsible for adding a methyl group to the cytosine base of DNA.",
      "DNMT3A maintains DNA methylation at the 5-position of cytosine in CpG dinucleotides.",
      "CpG dinucleotides are sequences of DNA that contain a cytosine base paired with a guanine base.",
      "Dysregulation of DNMT3A has been implicated in a number of diseases, including cancer, and is a target of cancer therapies."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: DNMT1 (DNA (cytosine-5-)-methyltransferase 1), not DNMT3A, is the enzyme mainly involved in the maintenance of DNA (cytosine-5-)-methylation.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CpG dinucleotides are sequences of DNA where a cytosine base is adjacent to a guanine base.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 807,
    "user_query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "vicuna-7b_response": "Transcapillary albumin escape refers to the movement of albumin from the blood vessels into the interstitial space, which is the space between the cells in the tissue. In diabetic patients, there is evidence to suggest that transcapillary albumin escape is altered.\nDiabetes is a condition characterized by high blood sugar levels, which can damage the small blood vessels in the body. This damage can lead to changes in the permeability of the blood vessels, allowing larger molecules like albumin to escape from the blood vessels into the interstitial space.\nStudies have shown that albumin levels are increased in the interstitial space of the kidneys in diabetic patients, indicating that transcapillary albumin escape is altered in these patients. Additionally, diabetes is also associated with an increased risk of kidney disease, which is characterized by damage to the glomeruli, the structures in the kidney that filter the blood and remove waste products. This damage can lead to changes in the permeability of the glomeruli, allowing albumin to escape from the blood into the urine, further supporting the idea that transcapillary albumin escape is altered in diabetic patients.\nOverall, the evidence suggests that transcapillary albumin escape is altered in diabetic patients, which may contribute to the development and progression of kidney disease in these patients.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcapillary albumin escape refers to the movement of albumin from the blood vessels into the interstitial space.\n2. Diabetes is a condition characterized by high blood sugar levels.\n3. High blood sugar levels can damage the small blood vessels in the body.\n4. Studies have shown that albumin levels are increased in the interstitial space of the kidneys in diabetic patients.\n5. Diabetes is associated with an increased risk of kidney disease.",
    "vicuna-7b_fact": [
      "Transcapillary albumin escape refers to the movement of albumin from the blood vessels into the interstitial space.",
      "Diabetes is a condition characterized by high blood sugar levels.",
      "High blood sugar levels can damage the small blood vessels in the body.",
      "Studies have shown that albumin levels are increased in the interstitial space of the kidneys in diabetic patients.",
      "Diabetes is associated with an increased risk of kidney disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 812,
    "user_query": "Which cell type has the protein Chromogranin A as marker?",
    "vicuna-7b_response": "Chromogranin A is a protein that is commonly used as a marker for cells of the neuroendocrine system, which includes cells that are involved in the regulation of hormone secretion and the nervous system.\nChromogranin A is found in a variety of cell types, including neuroendocrine cells, such as those found in the pancreas, where it is involved in the secretion of hormones such as insulin and glucagon. It is also found in cells of the sympathetic nervous system, such as those found in the adrenal medulla, and in cells of the paraganglia, which are found in various locations throughout the body.\nIn addition to its role as a marker for neuroendocrine cells, Chromogranin A has also been used as a marker for certain types of cancer, such as small cell lung cancer and neuroendocrine tumors.\nOverall, Chromogranin A is a protein that is expressed in a variety of cell types, including those of the neuroendocrine system, and it has been used as a marker for these cells as well as for certain types of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chromogranin A is a protein that is used as a marker for cells of the neuroendocrine system.\n2. Neuroendocrine system cells regulate hormone secretion and the nervous system.\n3. Chromogranin A is found in neuroendocrine cells in the pancreas.\n4. Chromogranin A is also found in cells of the sympathetic nervous system and in cells of the paraganglia.\n5. Chromogranin A has been used as a marker for certain types of cancer, such as small cell lung cancer and neuroendocrine tumors.",
    "vicuna-7b_fact": [
      "Chromogranin A is a protein that is used as a marker for cells of the neuroendocrine system.",
      "Neuroendocrine system cells regulate hormone secretion and the nervous system.",
      "Chromogranin A is found in neuroendocrine cells in the pancreas.",
      "Chromogranin A is also found in cells of the sympathetic nervous system and in cells of the paraganglia.",
      "Chromogranin A has been used as a marker for certain types of cancer, such as small cell lung cancer and neuroendocrine tumors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 813,
    "user_query": "Does a selective sweep increase genetic variation?",
    "vicuna-7b_response": "A selective sweep is a genetic phenomenon that occurs when a beneficial mutation becomes fixed in a population due to positive selection. The term \"sweep\" refers to the rapid spread of the mutation throughout the population.\nThe effect of a selective sweep on genetic variation depends on the size of the sweep and the population structure. If the sweep is large and affects a large portion of the population, it can lead to a reduction in genetic variation. This is because the beneficial mutation becomes fixed in the population, and any variation that is not associated with the sweep is lost.\nHowever, if the selective sweep is small and affects only a small portion of the population, it may have little effect on genetic variation. Additionally, if the population is large and diverse, the effect of the selective sweep on genetic variation may be minimal.\nIt's worth noting that selective sweeps can also lead to an increase in genetic variation if they create new genetic diversity by introducing new alleles into the population. This can happen if the beneficial mutation creates a new functional allele that is different from the original one.\nIn summary, the effect of a selective sweep on genetic variation depends on the size and population structure of the sweep, as well as the type of variation being considered.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A selective sweep is a genetic phenomenon that occurs when a beneficial mutation becomes fixed in a population due to positive selection.\n2. If a selective sweep is large and affects a large portion of the population, it can lead to a reduction in genetic variation.\n3. If the selective sweep is small and affects only a small portion of the population, it may have little effect on genetic variation.\n4. Selective sweeps can also lead to an increase in genetic variation if they create new genetic diversity by introducing new alleles into the population.\n5. The effect of a selective sweep on genetic variation depends on the size and population structure of the sweep, as well as the type of variation being considered.",
    "vicuna-7b_fact": [
      "A selective sweep is a genetic phenomenon that occurs when a beneficial mutation becomes fixed in a population due to positive selection.",
      "If a selective sweep is large and affects a large portion of the population, it can lead to a reduction in genetic variation.",
      "If the selective sweep is small and affects only a small portion of the population, it may have little effect on genetic variation.",
      "Selective sweeps can also lead to an increase in genetic variation if they create new genetic diversity by introducing new alleles into the population.",
      "The effect of a selective sweep on genetic variation depends on the size and population structure of the sweep, as well as the type of variation being considered."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Selective sweeps do not lead to an increase in genetic variation by introducing new alleles into the population. Instead, they lead to a decrease in genetic variation because they cause a particular allele to become more common at the expense of other alleles.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 814,
    "user_query": "Which disease phenotypes are associated to PRPS1 mutations?",
    "vicuna-7b_response": "PRPS1 mutations are associated with a group of rare genetic disorders known as porphyria cutanea tarda (PCT). PCT is a chronic, inherited disorder characterized by skin symptoms such as blistering, scarring, and skin discoloration, as well as symptoms related to liver function such as abdominal pain, nausea, and fatigue.\nPRPS1 mutations can also be associated with other porphyrias, such as variegate porphyria (VP), hereditary coproporphyria (HCP), and acute intermittent porphyria (AIP). These disorders are all caused by defects in the heme biosynthesis pathway and result in the accumulation of toxic substances called porphyrins in the body.\nIn addition to skin and liver symptoms, individuals with PCT and other porphyrias may also experience symptoms such as abdominal pain, nausea, vomiting, and fatigue. The severity of symptoms can vary widely among individuals, and some may experience more severe symptoms than others.\nIt is important to note that not all individuals with PRPS1 mutations will develop symptoms of PCT or other porphyrias. The likelihood of developing symptoms depends on the specific mutation and other genetic and environmental factors.\nIf you have concerns about your risk of developing PCT or other porphyrias based on your PRPS1 mutation, it is important to speak with a healthcare provider who can provide guidance and recommend appropriate testing and management.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PRPS1 mutations are associated with a group of rare genetic disorders known as porphyria cutanea tarda (PCT).\n2. PCT is a chronic, inherited disorder characterized by skin symptoms such as blistering, scarring, and skin discoloration, as well as symptoms related to liver function.\n3. PRPS1 mutations can also be associated with other porphyrias, such as variegate porphyria (VP), hereditary coproporphyria (HCP), and acute intermittent porphyria (AIP).\n4. These disorders are all caused by defects in the heme biosynthesis pathway and result in the accumulation of toxic substances called porphyrins in the body.\n5. Not all individuals with PRPS1 mutations will develop symptoms of PCT or other porphyrias, with the likelihood deriving from the specific mutation and other genetic and environmental factors.",
    "vicuna-7b_fact": [
      "PRPS1 mutations are associated with a group of rare genetic disorders known as porphyria cutanea tarda (PCT).",
      "PCT is a chronic, inherited disorder characterized by skin symptoms such as blistering, scarring, and skin discoloration, as well as symptoms related to liver function.",
      "PRPS1 mutations can also be associated with other porphyrias, such as variegate porphyria (VP), hereditary coproporphyria (HCP), and acute intermittent porphyria (AIP).",
      "These disorders are all caused by defects in the heme biosynthesis pathway and result in the accumulation of toxic substances called porphyrins in the body.",
      "Not all individuals with PRPS1 mutations will develop symptoms of PCT or other porphyrias, with the likelihood deriving from the specific mutation and other genetic and environmental factors."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: PRPS1 mutations are associated with a group of rare genetic disorders known as Arts syndrome, Charcot-Marie-Tooth disease-5, and nonsyndromic sensorineural deafness.\n2. TRUE\n3. FALSE [correction]: PRPS1 mutations are not typically associated with other porphyrias such as variegate porphyria (VP), hereditary coproporphyria (HCP), and acute intermittent porphyria (AIP).\n4. TRUE\n5. FALSE [correction]: Not all individuals with PRPS1 mutations will develop symptoms of the disorders associated with PRPS1 gene, with the likelihood deriving from the specific mutation and other genetic and environmental factors.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 815,
    "user_query": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?",
    "vicuna-7b_response": "The use of antioxidant supplements in patients at risk for coronary artery disease (CAD) is a topic of ongoing debate and research. While some studies have suggested that antioxidant supplements may have potential benefits in reducing the risk of CAD, other studies have found no such benefits or have even suggested that antioxidant supplements may be harmful in some cases.\nIn general, antioxidants are substances that can help protect cells from damage caused by free radicals, which are unstable molecules that can damage cells and contribute to the development of diseases such as CAD. Some antioxidants, such as vitamins C and E, are found naturally in foods, while others are available as dietary supplements.\nThere are several factors to consider when evaluating the potential benefits and risks of antioxidant supplements in patients at risk for CAD. These include the type of antioxidant being used, the dosage being taken, the individual's age, sex, and health status, and the presence of any underlying medical conditions or medications.\nSome studies have suggested that certain antioxidants, such as vitamin C and E, may have potential benefits in reducing the risk of CAD. For example, a study published in the Journal of the American College of Cardiology found that higher intakes of vitamin C and E were associated with a lower risk of CAD in a group of middle-aged and older adults.\nHowever, other studies have found no such benefits or have suggested that antioxidant supplements may be harmful in some cases. For example, a study published in the Journal of the American Medical Association found that high doses of vitamin E may increase the risk of death in patients with heart disease.\nOverall, the evidence regarding the use of antioxidant supplements in patients at risk for CAD is mixed and more research is needed to fully understand the potential benefits and risks of these supplements. It is important for individuals to speak with their healthcare provider before starting to take any antioxidant supplements, as they may have potential interactions with other medications or medical conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Antioxidants are substances that can help protect cells from damage caused by free radicals.\n2. Some antioxidants, such as vitamins C and E, are found naturally in foods, while others are available as dietary supplements.\n3. A study published in the Journal of the American College of Cardiology found that higher intakes of vitamin C and E were associated with a lower risk of CAD in a group of middle-aged and older adults.\n4. A study published in the Journal of the American Medical Association found that high doses of vitamin E may increase the risk of death in patients with heart disease.\n5. The use, type, dosage of antioxidant, and the individual's age, sex, and health status affect the effects of antioxidants on CAD.",
    "vicuna-7b_fact": [
      "Antioxidants are substances that can help protect cells from damage caused by free radicals.",
      "Some antioxidants, such as vitamins C and E, are found naturally in foods, while others are available as dietary supplements.",
      "A study published in the Journal of the American College of Cardiology found that higher intakes of vitamin C and E were associated with a lower risk of CAD in a group of middle-aged and older adults.",
      "A study published in the Journal of the American Medical Association found that high doses of vitamin E may increase the risk of death in patients with heart disease.",
      "The use, type, dosage of antioxidant, and the individual's age, sex, and health status affect the effects of antioxidants on CAD."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 821,
    "user_query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "vicuna-7b_response": "Yes, K-63 linked ubiquitination is often associated with proteasomal degradation.\nK-63 linked ubiquitin chains are a type of ubiquitin modification that is typically found on lysine residues at position 63 of the ubiquitin protein. These chains are often added to proteins by ubiquitin-conjugating enzymes (E2s) and are recognized by the 26S proteasome, which is responsible for degrading ubiquitinated proteins through a process called proteolysis.\nIn general, the presence of K-63 linked ubiquitin chains on a protein indicates that the protein is targeted for degradation by the proteasome. This is because the proteasome recognizes the ubiquitin chains and recognizes them as a signal for degradation.\nTherefore, K-63 linked ubiquitination is often associated with proteasomal degradation, as the proteasome recognizes these chains as a signal for degradation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. K-63 linked ubiquitination is often associated with proteasomal degradation.\n2. K-63 linked ubiquitin chains are a type of ubiquitin modification typically found on lysine residues at position 63 of the ubiquitin protein.\n3. These chains are often added to proteins by ubiquitin-conjugating enzymes (E2s).\n4. They are recognized by the 26S proteasome, which is responsible for degrading ubiquitinated proteins through a process called proteolysis.\n5. The presence of K-63 linked ubiquitin chains on a protein usually means that the protein is targeted for degradation by the proteasome.",
    "vicuna-7b_fact": [
      "K-63 linked ubiquitination is often associated with proteasomal degradation.",
      "K-63 linked ubiquitin chains are a type of ubiquitin modification typically found on lysine residues at position 63 of the ubiquitin protein.",
      "These chains are often added to proteins by ubiquitin-conjugating enzymes (E2s).",
      "They are recognized by the 26S proteasome, which is responsible for degrading ubiquitinated proteins through a process called proteolysis.",
      "The presence of K-63 linked ubiquitin chains on a protein usually means that the protein is targeted for degradation by the proteasome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: K-63 linked ubiquitination is not typically associated with proteasomal degradation, but instead with other cellular processes like signal transduction and DNA repair.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While the 26S proteasome does recognize ubiquitinated proteins for degradation, it is typically the K-48 linked ubiquitin chains, not K-63 linked chains, that are indicative of this process.\n5. FALSE [correction]: The presence of K-63 linked ubiquitin chains on a protein does not usually mean that the protein is targeted for degradation by the proteasome. This is more often indicative of other processes, like signaling.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 822,
    "user_query": "Could transcription factors act as cell-cell signalling molecules?",
    "vicuna-7b_response": "Yes, transcription factors can act as cell-cell signaling molecules. Transcription factors are proteins that bind to specific DNA sequences and regulate the transcription of genes into RNA. They can also interact with other proteins and modify their activity, leading to changes in gene expression.\nIn addition to their role in regulating gene expression, transcription factors can also act as cell-cell signaling molecules. This occurs through their ability to bind to specific DNA sequences in the genome of neighboring cells, leading to changes in gene expression and ultimately affecting cell behavior.\nFor example, the transcription factor Nodal has been shown to act as a cell-cell signaling molecule in the development of the mouse embryo. Nodal is expressed in the primitive streak, a region of the embryo that gives rise to the gut and other organs. Nodal binds to specific DNA sequences in the genome of neighboring cells, leading to the activation of genes involved in cell-cell signaling and the formation of a signaling gradient that guides the development of the embryo.\nIn summary, transcription factors can act as cell-cell signaling molecules by binding to specific DNA sequences in the genome of neighboring cells and altering gene expression. This can lead to changes in cell behavior and ultimately affect the development and function of tissues and organs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcription factors are proteins that bind to specific DNA sequences and regulate the transcription of genes into RNA.\n2. Transcription factors can interact with other proteins and modify their activity.\n3. Transcription factors can also act as cell-cell signaling molecules through their ability to bind to specific DNA sequences in the genome of neighboring cells.\n4. The transcription factor Nodal has been shown to act as a cell-cell signaling molecule in the development of the mouse embryo.\n5. Nodal is expressed in the primitive streak, a region of the embryo that gives rise to the gut and other organs.",
    "vicuna-7b_fact": [
      "Transcription factors are proteins that bind to specific DNA sequences and regulate the transcription of genes into RNA.",
      "Transcription factors can interact with other proteins and modify their activity.",
      "Transcription factors can also act as cell-cell signaling molecules through their ability to bind to specific DNA sequences in the genome of neighboring cells.",
      "The transcription factor Nodal has been shown to act as a cell-cell signaling molecule in the development of the mouse embryo.",
      "Nodal is expressed in the primitive streak, a region of the embryo that gives rise to the gut and other organs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Transcription factors do not act as cell-cell signaling molecules through their ability to bind to specific DNA sequences in the genome of neighboring cells. They regulate gene transcription within the same cell where they are located.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 828,
    "user_query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "vicuna-7b_response": "Yes, muscle LIM protein (MLP) is involved in cardiomyopathies. MLP is a protein that plays a role in the development and maintenance of the heart muscle. Mutations in the MLP gene have been linked to several types of cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and restrictive cardiomyopathy.\nIn hypertrophic cardiomyopathy, the heart muscle becomes thick and stiff, leading to abnormal heart function and increased risk of heart failure. Mutations in the MLP gene have been found to cause this type of cardiomyopathy.\nIn dilated cardiomyopathy, the heart muscle becomes weak and enlarged, leading to decreased heart function and increased risk of heart failure. Mutations in the MLP gene have also been found to cause this type of cardiomyopathy.\nIn restrictive cardiomyopathy, the heart muscle becomes stiff and less flexible, leading to decreased heart function and increased risk of heart failure. Mutations in the MLP gene have been found to cause this type of cardiomyopathy as well.\nOverall, MLP plays an important role in the development and maintenance of the heart muscle, and mutations in the MLP gene can lead to several types of cardiomyopathies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Muscle LIM protein (MLP) is involved in cardiomyopathies.\n2. MLP plays a role in the development and maintenance of the heart muscle.\n3. Mutations in the MLP gene have been linked to multiple types of cardiomyopathies, including hypertrophic, dilated, and restrictive cardiomyopathy.\n4. Hypertrophic cardiomyopathy causes the heart muscle to thicken and stiffen, leading to abnormal heart function and an increased risk of heart failure.\n5. Mutations in the MLP gene can cause hypertrophic, dilated, and restrictive cardiomyopathy.",
    "vicuna-7b_fact": [
      "Muscle LIM protein (MLP) is involved in cardiomyopathies.",
      "MLP plays a role in the development and maintenance of the heart muscle.",
      "Mutations in the MLP gene have been linked to multiple types of cardiomyopathies, including hypertrophic, dilated, and restrictive cardiomyopathy.",
      "Hypertrophic cardiomyopathy causes the heart muscle to thicken and stiffen, leading to abnormal heart function and an increased risk of heart failure.",
      "Mutations in the MLP gene can cause hypertrophic, dilated, and restrictive cardiomyopathy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 834,
    "user_query": "What is Tn-seq?",
    "vicuna-7b_response": "Tn-seq (Transposon-based Sequence Analysis) is a technique used to analyze the transcriptional activity of genes in a cell or organism. It involves the use of transposable elements, such as transposons, to insert random DNA sequences into the genome of a cell or organism. These transposable elements can then be used to track the expression of genes in the cell or organism by measuring the activity of the inserted DNA sequences.\nTn-seq works by introducing a transposable element, such as a transposon, into the genome of a cell or organism. The transposable element is typically introduced into the genome using a viral vector or other method. Once introduced, the transposable element can move around the genome and insert itself into different locations.\nTo analyze the transcriptional activity of genes using Tn-seq, the transposable elements are then used to track the activity of genes in the cell or organism. This is done by measuring the activity of the inserted DNA sequences, which can be used as markers for the expression of genes. The activity of the inserted DNA sequences can be measured using a variety of techniques, such as PCR or sequencing.\nTn-seq has several advantages over other techniques for analyzing transcriptional activity, such as RNA sequencing. For example, Tn-seq is less expensive and time-consuming than RNA sequencing, and it can be used to analyze the transcriptional activity of genes in a variety of cell types and organisms. Additionally, Tn-seq can be used to analyze the transcriptional activity of genes in real-time, which is not possible with RNA sequencing.\nOverall, Tn-seq is a powerful technique for analyzing the transcriptional activity of genes in a cell or organism, and it has many applications in fields such as biology, medicine, and agriculture.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tn-seq stands for Transposon-based Sequence Analysis and is used to analyze the transcriptional activity of genes in a cell or organism.\n2. Tn-seq involves using transposable elements to insert random DNA sequences into a cell's genome.\n3. The activity of the inserted DNA sequences in Tn-seq is measured using techniques such as PCR or sequencing.\n4. Tn-seq is less expensive and time-consuming than RNA sequencing.\n5. Tn-seq can be used to analyze the transcriptional activity of genes in real-time.",
    "vicuna-7b_fact": [
      "Tn-seq stands for Transposon-based Sequence Analysis and is used to analyze the transcriptional activity of genes in a cell or organism.",
      "Tn-seq involves using transposable elements to insert random DNA sequences into a cell's genome.",
      "The activity of the inserted DNA sequences in Tn-seq is measured using techniques such as PCR or sequencing.",
      "Tn-seq is less expensive and time-consuming than RNA sequencing.",
      "Tn-seq can be used to analyze the transcriptional activity of genes in real-time."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Tn-seq stands for Transposon sequencing and is used to identify essential genes in a cell or organism.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Tn-seq does not provide real-time analysis of gene activity. It provides a snapshot of gene essentiality at the time of sampling.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 836,
    "user_query": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?",
    "vicuna-7b_response": "Yes, there is a functional association between the flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.\nThe flaviviridae family of viruses includes several important human pathogens such as yellow fever, dengue, and Zika viruses. These viruses have a single-stranded RNA genome and use a positive-sense RNA-dependent RNA polymerase (RdRp) to synthesize new RNA copies of the genome. The RdRp enzyme is responsible for synthesizing the viral RNA strand from the positive-sense RNA template.\nIn addition to the RdRp, flaviviridae viruses also contain a helicase enzyme that is responsible for unwinding the double-stranded RNA intermediate produced by the RdRp. The helicase enzyme is thought to be responsible for moving the RNA polymerase along the negative-strand template, allowing the RdRp to synthesize new RNA copies of the genome.\nTherefore, the RdRp and helicase enzymes work together during flaviviridae virus replication to synthesize new RNA copies of the genome. The RdRp synthesizes the positive-sense RNA template, and the helicase unwinds the double-stranded RNA intermediate and moves the RdRp along the negative-strand template.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is a functional association between the flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.\n2. The flaviviridae family of viruses includes human pathogens such as yellow fever, dengue, and Zika viruses.\n3. These viruses have a single-stranded RNA genome and use a positive-sense RNA-dependent RNA polymerase (RdRp) to synthesize new RNA copies of the genome.\n4. Flaviviridae viruses also contain a helicase enzyme that is responsible for unwinding the double-stranded RNA intermediate produced by the RdRp.\n5. The RdRp and helicase enzymes work together during flaviviridae virus replication to synthesize new RNA copies of the genome.",
    "vicuna-7b_fact": [
      "There is a functional association between the flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.",
      "The flaviviridae family of viruses includes human pathogens such as yellow fever, dengue, and Zika viruses.",
      "These viruses have a single-stranded RNA genome and use a positive-sense RNA-dependent RNA polymerase (RdRp) to synthesize new RNA copies of the genome.",
      "Flaviviridae viruses also contain a helicase enzyme that is responsible for unwinding the double-stranded RNA intermediate produced by the RdRp.",
      "The RdRp and helicase enzymes work together during flaviviridae virus replication to synthesize new RNA copies of the genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 838,
    "user_query": "Which is the prevalence of cystic fibrosis in the human population?",
    "vicuna-7b_response": "Cystic fibrosis is a genetic disorder that affects the respiratory and digestive systems of the human body. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which leads to the production of abnormal mucus that clogs the lungs and digestive system.\nThe prevalence of cystic fibrosis varies depending on the population and geographic location. In the United States, for example, the prevalence of cystic fibrosis is about 1 in 2,500 live births, or about 30,000 people affected. In Europe, the prevalence is about 1 in 2,500 live births as well.\nHowever, the prevalence of cystic fibrosis can be higher in certain populations. For example, in the Ashkenazi Jewish population, the prevalence is about 1 in 27,000 live births. In the Irish population, the prevalence is about 1 in 19,000 live births.\nIt's important to note that the prevalence of cystic fibrosis is increasing due to advances in medical technology, such as prenatal testing and screening, which have led to earlier detection and diagnosis of the disease.\nOverall, the prevalence of cystic fibrosis varies depending on the population and geographic location, but it is a serious genetic disorder that affects thousands of people worldwide.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cystic fibrosis is a genetic disorder that affects the respiratory and digestive systems.\n2. The cystic fibrosis disorder is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.\n3. In the United States and Europe, the prevalence of cystic fibrosis is about 1 in 2,500 live births.\n4. In the Ashkenazi Jewish population, the prevalence of cystic fibrosis is about 1 in 27,000 live births.\n5. In the Irish population, the prevalence of cystic fibrosis is about 1 in 19,000 live births.",
    "vicuna-7b_fact": [
      "Cystic fibrosis is a genetic disorder that affects the respiratory and digestive systems.",
      "The cystic fibrosis disorder is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.",
      "In the United States and Europe, the prevalence of cystic fibrosis is about 1 in 2,500 live births.",
      "In the Ashkenazi Jewish population, the prevalence of cystic fibrosis is about 1 in 27,000 live births.",
      "In the Irish population, the prevalence of cystic fibrosis is about 1 in 19,000 live births."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the Ashkenazi Jewish population, the prevalence of cystic fibrosis is about 1 in 3,300 live births.\n5. FALSE [correction]: In the Irish population, the prevalence of cystic fibrosis is about 1 in 2,500 live births.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 844,
    "user_query": "Is there a genome-wide technique for the detection of R-loop formation?",
    "vicuna-7b_response": "Yes, there are several genome-wide techniques for the detection of R-loop formation.\nOne of the most commonly used techniques is Chromatin Immunoprecipitation (ChIP) followed by sequencing (ChIP-seq). This technique allows researchers to identify the regions of the genome where a particular protein is bound, including R-loops. By using antibodies specific to the R-loop-forming protein, such as the RPA or HMGB1, researchers can detect R-loops throughout the genome.\nAnother technique is Hi-C, which allows researchers to map the three-dimensional structure of the genome. This technique can detect R-loops by identifying regions of the genome that are in close proximity to each other, indicating the presence of an R-loop.\nAdditionally, R-loop-specific probes can be used in DNA microarray analysis to detect R-loop formation. This technique allows researchers to measure the amount of R-loop formation in a sample by comparing the expression of genes that are associated with R-loops to those that are not.\nOverall, these genome-wide techniques allow researchers to detect R-loop formation in a genome-wide manner, providing valuable insights into the role of R-loops in gene regulation and genome stability.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chromatin Immunoprecipitation (ChIP) followed by sequencing (ChIP-seq) is a commonly used genome-wide technique for the detection of R-loop formation.\n2. ChIP-seq allows researchers to identify the regions of the genome where a particular protein is bound, including R-loops.\n3. Hi-C technique allows researchers to map the three-dimensional structure of the genome and can detect R-loops by identifying regions of the genome that are in close proximity.\n4. R-loop-specific probes can be used in DNA microarray analysis to detect R-loop formation.\n5. These genome-wide techniques allow researchers to detect R-loop formation in a genome-wide manner.",
    "vicuna-7b_fact": [
      "Chromatin Immunoprecipitation (ChIP) followed by sequencing (ChIP-seq) is a commonly used genome-wide technique for the detection of R-loop formation.",
      "ChIP-seq allows researchers to identify the regions of the genome where a particular protein is bound, including R-loops.",
      "Hi-C technique allows researchers to map the three-dimensional structure of the genome and can detect R-loops by identifying regions of the genome that are in close proximity.",
      "R-loop-specific probes can be used in DNA microarray analysis to detect R-loop formation.",
      "These genome-wide techniques allow researchers to detect R-loop formation in a genome-wide manner."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Chromatin Immunoprecipitation (ChIP) followed by sequencing (ChIP-seq) is a commonly used genome-wide technique for identifying DNA regions bound by a specific protein, not the detection of R-loop formation.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 847,
    "user_query": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?",
    "vicuna-7b_response": "Transcription-associated mutagenesis (TAM) is a type of mutagenesis that occurs during transcription and is caused by errors in the transcription process. TAM can result in the creation of mutations in the DNA sequence that is being transcribed. These mutations can affect the function of the gene and can lead to changes in gene expression levels.\nIn general, TAM is thought to be more likely to occur in genes that are transcribed at high levels or under conditions of high stress, as these genes are more likely to experience errors in the transcription process. However, the exact relationship between TAM and gene expression levels is complex and depends on a variety of factors, including the type of mutation that is created, the location of the mutation in the gene, and the presence of other mutations or alterations in the gene.\nOverall, while TAM is related to gene expression levels in that it can affect the function of the gene and lead to changes in gene expression, the relationship between TAM and gene expression is complex and depends on a variety of factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transcription-associated mutagenesis (TAM) is a type of mutagenesis that occurs during transcription.\n2. TAM is caused by errors in the transcription process.\n3. TAM can result in mutations in the DNA sequence that is being transcribed.\n4. These mutations can affect the function of the gene and lead to changes in gene expression levels.\n5. TAM is more likely to occur in genes that are transcribed at high levels or under conditions of high stress.",
    "vicuna-7b_fact": [
      "Transcription-associated mutagenesis (TAM) is a type of mutagenesis that occurs during transcription.",
      "TAM is caused by errors in the transcription process.",
      "TAM can result in mutations in the DNA sequence that is being transcribed.",
      "These mutations can affect the function of the gene and lead to changes in gene expression levels.",
      "TAM is more likely to occur in genes that are transcribed at high levels or under conditions of high stress."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 848,
    "user_query": "Is there a pharmacogenetic test for trastuzumab?",
    "vicuna-7b_response": "Yes, there is a pharmacogenetic test for trastuzumab. Trastuzumab is a monoclonal antibody drug used to treat breast cancer and other types of cancer. The test is called the HER2 gene test and it helps to determine how well a patient will respond to trastuzumab treatment.\nThe HER2 gene test looks for changes in the HER2 gene, which can affect the production of the HER2 protein. The HER2 protein is involved in the growth and division of cancer cells. Trastuzumab works by binding to the HER2 protein and blocking its activity, which can help to slow or stop the growth of cancer cells.\nThe HER2 gene test is typically done on a sample of breast cancer tissue. The test can determine whether the cancer cells have too much of the HER2 protein, which is known as HER2-positive breast cancer. Patients with HER2-positive breast cancer are more likely to benefit from trastuzumab treatment.\nThe HER2 gene test can also be used to monitor the effectiveness of trastuzumab treatment. If the test shows that the cancer cells are producing less HER2 protein after treatment, it may indicate that the treatment is working.\nIt's important to note that the HER2 gene test is not a diagnostic test for breast cancer. A diagnosis of breast cancer is made through a combination of clinical examination, imaging tests, and biopsy. The HER2 gene test is used to help guide treatment decisions for patients with breast cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is a pharmacogenetic test for Trastuzumab.\n2. Trastuzumab is a drug used to treat breast cancer and other types of cancer.\n3. The HER2 gene test helps to determine how well a patient will respond to trastuzumab treatment.\n4. The HER2 gene test can also be used to monitor the effectiveness of trastuzumab treatment.\n5. The HER2 gene test is not a diagnostic test for breast cancer.",
    "vicuna-7b_fact": [
      "There is a pharmacogenetic test for Trastuzumab.",
      "Trastuzumab is a drug used to treat breast cancer and other types of cancer.",
      "The HER2 gene test helps to determine how well a patient will respond to trastuzumab treatment.",
      "The HER2 gene test can also be used to monitor the effectiveness of trastuzumab treatment.",
      "The HER2 gene test is not a diagnostic test for breast cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The HER2 gene test can be used to determine if a breast cancer patient's cells produce too much HER2 protein, which can indicate the patient may respond to trastuzumab treatment. However, it is not generally used to monitor the effectiveness of trastuzumab treatment.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 849,
    "user_query": "Which calcium channels does ethosuximide target?",
    "vicuna-7b_response": "Ethosuximide is a medication that is primarily used to treat seizures in people with epilepsy. It works by blocking certain types of calcium channels in the brain, specifically the high-voltage-activated calcium channels (HVA calcium channels). These channels are responsible for allowing calcium ions to enter the cells of the brain, which can trigger seizures. By blocking these channels, ethosuximide helps to reduce the frequency and severity of seizures in people with epilepsy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ethosuximide is primarily used to treat seizures in people with epilepsy.\n2. Ethosuximide works by blocking high-voltage-activated (HVA) calcium channels in the brain.\n3. High-voltage-activated calcium channels allow calcium ions to enter the cells of the brain.\n4. The entry of calcium ions into the brain cells can trigger seizures.\n5. By blocking HVA calcium channels, ethosuximide can reduce the frequency and severity of seizures in people with epilepsy.",
    "vicuna-7b_fact": [
      "Ethosuximide is primarily used to treat seizures in people with epilepsy.",
      "Ethosuximide works by blocking high-voltage-activated (HVA) calcium channels in the brain.",
      "High-voltage-activated calcium channels allow calcium ions to enter the cells of the brain.",
      "The entry of calcium ions into the brain cells can trigger seizures.",
      "By blocking HVA calcium channels, ethosuximide can reduce the frequency and severity of seizures in people with epilepsy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 850,
    "user_query": "What is the sedimentation coefficient of the mammalian mitoribosome?",
    "vicuna-7b_response": "The sedimentation coefficient of the mammalian mitoribosome is a measure of its sedimentation behavior in a centrifugation experiment. The sedimentation coefficient is a value that describes the size and shape of a particle and is used to determine the molecular weight of a protein.\nThe sedimentation coefficient of the mammalian mitoribosome is typically measured using the sedimentation velocity analytical technique. This technique involves centrifuging a sample of the mitoribosome in a solution and measuring the velocity at which the mitoribosome sediments in the centrifuge tube.\nThe sedimentation coefficient of the mammalian mitoribosome is typically measured in Svedberg units (S). The sedimentation coefficient of the mitoribosome is typically in the range of 7-10 S.\nIt's important to note that the sedimentation coefficient of the mitoribosome is not a fixed value and can vary depending on the species of the mammal, the conditions of the experiment and the method used to measure it.\nIn summary, the sedimentation coefficient of the mammalian mitoribosome is a measure of its sedimentation behavior in a centrifugation experiment, typically measured using the sedimentation velocity analytical technique, and typically in the range of 7-10 S.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The sedimentation coefficient of the mammalian mitoribosome is a measure of its sedimentation behavior in a centrifugation experiment.\n2. The sedimentation coefficient describes the size and shape of a particle and is used to determine the molecular weight of a protein.\n3. The sedimentation coefficient of the mammalian mitoribosome is typically measured using the sedimentation velocity analytical technique.\n4. The sedimentation coefficient of the mammalian mitoribosome is usually in the range of 7-10 Svedberg units (S).\n5. The sedimentation coefficient of the mitoribosome is not a fixed value and can vary depending on the species of the mammal, the conditions of the experiment, and the method used to measure it.",
    "vicuna-7b_fact": [
      "The sedimentation coefficient of the mammalian mitoribosome is a measure of its sedimentation behavior in a centrifugation experiment.",
      "The sedimentation coefficient describes the size and shape of a particle and is used to determine the molecular weight of a protein.",
      "The sedimentation coefficient of the mammalian mitoribosome is typically measured using the sedimentation velocity analytical technique.",
      "The sedimentation coefficient of the mammalian mitoribosome is usually in the range of 7-10 Svedberg units (S).",
      "The sedimentation coefficient of the mitoribosome is not a fixed value and can vary depending on the species of the mammal, the conditions of the experiment, and the method used to measure it."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The sedimentation coefficient of the mammalian mitoribosome is usually in the range of 55-80 Svedberg units (S).\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 852,
    "user_query": "Which proteins act as histone-like molecules in prokaryotes?",
    "vicuna-7b_response": "In prokaryotes, several proteins can act as histone-like molecules and are involved in the regulation of gene expression. These proteins are called histone-like proteins or histone-like DNA-binding proteins. Some examples of histone-like proteins in prokaryotes include:\n1. H-NS (Histone-like protein NusG) in Escherichia coli\n2. HU (Histone-like protein UmuD) in Bacillus subtilis\n3. HM (Histone-like protein Mcm1) in Mycoplasma genitalium\n4. HU (Histone-like protein U) in Streptococcus pneumoniae\n5. H-NS (Histone-like protein NusG) in Helicobacter pylori\n6. H-NS (Histone-like protein NusG) in Staphylococcus aureus\nThese histone-like proteins are involved in the regulation of gene expression by binding to DNA and modulating the accessibility of the DNA to transcriptional factors. They play a crucial role in the regulation of gene expression at the level of chromatin structure and can affect the transcriptional activity of genes by altering the accessibility of the DNA to the transcriptional machinery.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In prokaryotes, several proteins can act as histone-like molecules.\n2. These proteins are called histone-like proteins or histone-like DNA-binding proteins.\n3. Some examples of histone-like proteins in prokaryotes include H-NS in Escherichia coli, HU in Bacillus subtilis and in Streptococcus pneumoniae, HM in Mycoplasma genitalium, H-NS in Helicobacter pylori, and H-NS in Staphylococcus aureus.\n4. Histone-like proteins are involved in the regulation of gene expression by binding to DNA and modulating the accessibility of the DNA to transcriptional factors.\n5. They can affect the transcriptional activity of genes by altering the accessibility of the DNA to the transcriptional machinery.",
    "vicuna-7b_fact": [
      "In prokaryotes, several proteins can act as histone-like molecules.",
      "These proteins are called histone-like proteins or histone-like DNA-binding proteins.",
      "Some examples of histone-like proteins in prokaryotes include H-NS in Escherichia coli, HU in Bacillus subtilis and in Streptococcus pneumoniae, HM in Mycoplasma genitalium, H-NS in Helicobacter pylori, and H-NS in Staphylococcus aureus.",
      "Histone-like proteins are involved in the regulation of gene expression by binding to DNA and modulating the accessibility of the DNA to transcriptional factors.",
      "They can affect the transcriptional activity of genes by altering the accessibility of the DNA to the transcriptional machinery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 860,
    "user_query": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?",
    "vicuna-7b_response": "Yes, hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia (FA). FA is a rare genetic disorder that affects the body's ability to repair damaged DNA. This leads to a high risk of developing cancer, particularly of the blood and bone marrow.\nOne of the key features of FA is the presence of a specific pattern of genetic mutations in the genes that are responsible for repairing DNA damage. These mutations can lead to a reduced ability to repair DNA crosslinks, which are damage caused by certain chemicals, including crosslinking agents.\nPatients with FA are also more sensitive to the toxic effects of these agents, which can cause a range of symptoms, including skin rashes, fever, and anemia. This sensitivity is thought to be due to the reduced ability of FA cells to repair DNA damage, which makes them more susceptible to the toxic effects of crosslinking agents.\nOverall, hypersensitivity to DNA crosslinking agents is a key feature of Fanconi anemia, and is one of the ways in which the disorder contributes to an increased risk of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia (FA).\n2. FA is a rare genetic disorder that affects the body's ability to repair damaged DNA.\n3. This disorder can cause a high risk of developing cancer, particularly of the blood and bone marrow.\n4. Fanconi anemia is characterized by a specific pattern of genetic mutations in the genes responsible for repairing DNA damage.\n5. Patients with Fanconi anemia are more sensitive to the toxic effects of crosslinking agents.",
    "vicuna-7b_fact": [
      "Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia (FA).",
      "FA is a rare genetic disorder that affects the body's ability to repair damaged DNA.",
      "This disorder can cause a high risk of developing cancer, particularly of the blood and bone marrow.",
      "Fanconi anemia is characterized by a specific pattern of genetic mutations in the genes responsible for repairing DNA damage.",
      "Patients with Fanconi anemia are more sensitive to the toxic effects of crosslinking agents."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 869,
    "user_query": "What is the pyroptotic pathway?",
    "vicuna-7b_response": "The pyroptotic pathway is a type of cell death that occurs in response to infection by certain bacteria, such as Staphylococcus aureus and Streptococcus pyogenes. It is characterized by the rapid production of reactive oxygen species (ROS) and the subsequent destruction of the infected cell.\nThe pyroptotic pathway is triggered when the bacterial cell wall is recognized as foreign by the host cell's immune system. This triggers a cascade of events that leads to the activation of the inflammasome, a complex composed of proteins that are involved in the regulation of inflammation. The inflammasome activates the caspase-1 enzyme, which leads to the activation of the interleukin-1β (IL-1β) and IL-18 cytokines. These cytokines then trigger the production of ROS by the host cell, leading to the destruction of the infected cell.\nThe pyroptotic pathway is distinct from the apoptotic pathway, which is a more traditional form of cell death that occurs in response to a variety of stimuli, including genetic mutations, oxidative stress, and starvation. Apoptosis is characterized by the gradual breakdown of the infected cell, with the eventual release of the contents of the cell into the surrounding environment.\nOverall, the pyroptotic pathway is an important mechanism for the host cell to defend against infection by bacteria that are resistant to other forms of cell death. However, the excessive production of ROS can also lead to tissue damage and inflammation, which can contribute to the development of sepsis and other severe infections.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The pyroptotic pathway is a form of cell death triggered by infection from certain bacteria.\n2. The pyroptotic pathway is characterized by the rapid production of reactive oxygen species and the subsequent destruction of infected cells.\n3. It is activated when the bacterial cell wall is recognized by the host cell's immune system, triggering a series of events including activation of the inflammasome and caspase-1 enzyme.\n4. The pyroptotic pathway is distinct from the apoptotic pathway, another form of cell death that responds to different stimuli.\n5. The excessive production of ROS in the pyroptotic pathway can lead to tissue damage and inflammation, contributing to the development of sepsis and other severe infections.",
    "vicuna-7b_fact": [
      "The pyroptotic pathway is a form of cell death triggered by infection from certain bacteria.",
      "The pyroptotic pathway is characterized by the rapid production of reactive oxygen species and the subsequent destruction of infected cells.",
      "It is activated when the bacterial cell wall is recognized by the host cell's immune system, triggering a series of events including activation of the inflammasome and caspase-1 enzyme.",
      "The pyroptotic pathway is distinct from the apoptotic pathway, another form of cell death that responds to different stimuli.",
      "The excessive production of ROS in the pyroptotic pathway can lead to tissue damage and inflammation, contributing to the development of sepsis and other severe infections."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The pyroptotic pathway is characterized by cellular swelling, membrane rupture and release of proinflammatory contents (This excludes the rapid production of reactive oxygen species and the subsequent destruction of infected cells which is a characteristic of other forms of cell death).\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While excessive ROS production can lead to tissue damage and inflammation, this is not unique to the pyroptotic pathway. Pyroptosis itself, however, can contribute to the development of sepsis and other severe infections due to the release of proinflammatory contents.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 871,
    "user_query": "What are the known families of deadenylases?",
    "vicuna-7b_response": "Deadenylases are enzymes that remove the poly(A) tail from the 3' end of RNA molecules. There are several known families of deadenylases, including:\n1. CCR4-NOT deadenylases: These are the most well-known family of deadenylases and are found in all eukaryotes. They play a crucial role in the regulation of gene expression by controlling the stability of mRNAs.\n2. DExH/D deadenylases: These deadenylases are found in bacteria and are involved in the regulation of gene expression at the post-transcriptional level.\n3. Hda1/Hda2 deadenylases: These deadenylases are found in yeast and play a role in the regulation of gene expression at the transcriptional level.\n4. Rrp6 deadenylases: These deadenylases are found in plants and are involved in the regulation of gene expression at the post-transcriptional level.\n5. RNase III: This enzyme is found in all organisms and removes the 3' end of RNA molecules, including the poly(A) tail.\nOverall, deadenylases play a crucial role in the regulation of gene expression by controlling the stability of mRNAs and are found in a variety of organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Deadenylases are enzymes that remove the poly(A) tail from the 3' end of RNA molecules.\n2. CCR4-NOT deadenylases are the most well-known family of deadenylases and are found in all eukaryotes.\n3. DExH/D deadenylases are found in bacteria and are involved in the regulation of gene expression at the post-transcriptional level.\n4. Hda1/Hda2 deadenylases are found in yeast and play a role in the regulation of gene expression at the transcriptional level.\n5. RNase III is an enzyme found in all organisms that removes the 3' end of RNA molecules, including the poly(A) tail.",
    "vicuna-7b_fact": [
      "Deadenylases are enzymes that remove the poly(A) tail from the 3' end of RNA molecules.",
      "CCR4-NOT deadenylases are the most well-known family of deadenylases and are found in all eukaryotes.",
      "DExH/D deadenylases are found in bacteria and are involved in the regulation of gene expression at the post-transcriptional level.",
      "Hda1/Hda2 deadenylases are found in yeast and play a role in the regulation of gene expression at the transcriptional level.",
      "RNase III is an enzyme found in all organisms that removes the 3' end of RNA molecules, including the poly(A) tail."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: RNase III is an enzyme that cleaves double-stranded RNA, not specifically the poly(A) tail.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 872,
    "user_query": "Which translocation is harbored in the Askin tumor cells?",
    "vicuna-7b_response": "The Askin tumor cells harbor a specific translocation called the t(17;22)(q21;q12), also known as the \"Philadelphia chromosome\". This translocation results from a reciprocal translocation between chromosomes 17 and 22, which fuses the BCR gene on chromosome 22 to the ABL1 gene on chromosome 17. The resulting fusion gene, BCR-ABL1, encodes a chimeric protein with both tyrosine kinase domains and is constitutively active, leading to the uncontrolled proliferation of tumor cells. This translocation is a hallmark of chronic myeloid leukemia (CML) and is also found in other hematological malignancies such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute lymphoblastic leukemia (ALL).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The translocation t(17;22)(q21;q12), also known as the \"Philadelphia chromosome\", is harbored in Askin tumor cells.\n2. This translocation fuses the BCR gene on chromosome 22 to the ABL1 gene on chromosome 17.\n3. The resulting BCR-ABL1 fusion gene encodes a chimeric protein with both tyrosine kinase domains.\n4. This translocation is constitutively active, leading to the uncontrolled proliferation of tumor cells.\n5. This translocation is a hallmark of chronic myeloid leukemia (CML) and is also found in other hematological malignancies such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute lymphoblastic leukemia (ALL).",
    "vicuna-7b_fact": [
      "The translocation t(17;22)(q21;q12), also known as the \"Philadelphia chromosome\", is harbored in Askin tumor cells.",
      "This translocation fuses the BCR gene on chromosome 22 to the ABL1 gene on chromosome 17.",
      "The resulting BCR-ABL1 fusion gene encodes a chimeric protein with both tyrosine kinase domains.",
      "This translocation is constitutively active, leading to the uncontrolled proliferation of tumor cells.",
      "This translocation is a hallmark of chronic myeloid leukemia (CML) and is also found in other hematological malignancies such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute lymphoblastic leukemia (ALL)."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 875,
    "user_query": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?",
    "vicuna-7b_response": "The R/bioconductor package that utilizes the Hilbert curve to visualize genomic data is called \"ggplot2\".\nThe Hilbert curve is a mathematical function that is used to flatten a 2D space into a 1D space, while preserving the relative distances between points. This property makes it useful for visualizing high-dimensional data in a 2D plot, such as genomic data.\nThe \"ggplot2\" package is a widely used R package for data visualization, particularly in the bioinformatics field. It provides a variety of functions for creating visualizations, including scatter plots, heatmaps, and bar charts. The package also includes a function called \"ggplotly\", which can be used to create interactive plots that can be shared on the web.\nIn summary, the \"ggplot2\" package is a popular R/bioconductor package that utilizes the Hilbert curve to visualize genomic data.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The R/bioconductor package \"ggplot2\" utilizes the Hilbert curve to visualize genomic data.\n2. The Hilbert curve is a mathematical function that flattens a 2D space into a 1D space.\n3. The Hilbert curve preserves the relative distances between points.\n4. The \"ggplot2\" package is widely used for data visualization in the bioinformatics field.\n5. \"ggplot2\" offers a function called \"ggplotly\", which can be used to create interactive web plots.",
    "vicuna-7b_fact": [
      "The R/bioconductor package \"ggplot2\" utilizes the Hilbert curve to visualize genomic data.",
      "The Hilbert curve is a mathematical function that flattens a 2D space into a 1D space.",
      "The Hilbert curve preserves the relative distances between points.",
      "The \"ggplot2\" package is widely used for data visualization in the bioinformatics field.",
      "\"ggplot2\" offers a function called \"ggplotly\", which can be used to create interactive web plots."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The R/bioconductor package that utilizes the Hilbert curve to visualize genomic data is \"ggbio\", not \"ggplot2\".\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The function \"ggplotly\" is not offered by \"ggplot2\". It is a function from the \"plotly\" package that converts \"ggplot2\" objects to interactive web plots.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 876,
    "user_query": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
    "vicuna-7b_response": "Yes, non-invasive prenatal testing (NIPT) can detect fetal aneuploidy. NIPT is a type of prenatal testing that analyzes a sample of a pregnant woman's blood to detect genetic abnormalities in the fetus. NIPT can detect a wide range of genetic abnormalities, including Down syndrome, and it is considered a highly accurate test for detecting fetal aneuploidy.\nNIPT is typically performed after the 10th week of pregnancy and is offered as an alternative to traditional prenatal testing methods such as ultrasound and amniocentesis. NIPT is a non-invasive test, meaning it does not involve inserting a needle into the uterus, and it is considered a safe and effective way to detect fetal aneuploidy.\nIt's important to note that NIPT is not 100% accurate and there is a small chance that it may produce a false positive or false negative result. Therefore, it is important for women to discuss the risks and benefits of NIPT with their healthcare provider before deciding whether to undergo the test.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Non-invasive prenatal testing (NIPT) can detect fetal aneuploidy.\n2. NIPT is a type of prenatal testing that analyzes a sample of a pregnant woman's blood to detect genetic abnormalities in the fetus. \n3. NIPT can be used to detect a wide range of genetic abnormalities, including Down syndrome.\n4. NIPT is typically performed after the 10th week of pregnancy and is an alternative to traditional prenatal testing methods.\n5. NIPT is not 100% accurate and there is a small chance it may produce a false positive or false negative result.",
    "vicuna-7b_fact": [
      "Non-invasive prenatal testing (NIPT) can detect fetal aneuploidy.",
      "NIPT is a type of prenatal testing that analyzes a sample of a pregnant woman's blood to detect genetic abnormalities in the fetus.",
      "NIPT can be used to detect a wide range of genetic abnormalities, including Down syndrome.",
      "NIPT is typically performed after the 10th week of pregnancy and is an alternative to traditional prenatal testing methods.",
      "NIPT is not 100% accurate and there is a small chance it may produce a false positive or false negative result."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 877,
    "user_query": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?",
    "vicuna-7b_response": "There are several packages in R/bioconductor that can be used for performing overlap analysis of genomic regions. Some of the most commonly used packages include:\n1. bedtools: This package provides a set of tools for working with bed files, which are text files that contain genomic data. The package includes functions for performing overlap analysis, such as finding the intersection and union of two bed files.\n2. bedpost: This package is a bedtools plugin that provides additional functionality for working with bed files. It includes functions for performing overlap analysis, such as finding the intersection and union of two bed files.\n3. GenomicRanges: This package provides a set of functions for working with genomic regions, including functions for finding the intersection and union of two genomic regions.\n4. overlap: This package provides a set of functions for performing overlap analysis of genomic regions. It can be used to find the intersection and union of two genomic regions, as well as to calculate the size of the overlap between two regions.\n5. overlapSets: This package provides a set of functions for performing overlap analysis of genomic regions. It can be used to find the intersection and union of two genomic regions, as well as to calculate the size of the overlap between two regions.\nThese are just a few examples of the packages that can be used for performing overlap analysis of genomic regions in R/bioconductor. The best package to use will depend on the specific requirements of the analysis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. bedtools is a package in R/bioconductor used for performing overlap analysis of genomic regions.\n2. bedpost is a plugin for bedtools that provides additional functionality for working with bed files.\n3. GenomicRanges is a package in R/bioconductor that provides functions for working with genomic regions, including functions for finding the intersection and union of two genomic regions.\n4. overlap is a package in R/bioconductor used for performing overlap analysis of genomic regions.\n5. overlapSets is a package in R/bioconductor that provides functions for performing overlap analysis of genomic regions, including functions for finding the intersection and union of two genomic regions, as well as to calculate the size of the overlap between two regions.",
    "vicuna-7b_fact": [
      "bedtools is a package in R/bioconductor used for performing overlap analysis of genomic regions.",
      "bedpost is a plugin for bedtools that provides additional functionality for working with bed files.",
      "GenomicRanges is a package in R/bioconductor that provides functions for working with genomic regions, including functions for finding the intersection and union of two genomic regions.",
      "overlap is a package in R/bioconductor used for performing overlap analysis of genomic regions.",
      "overlapSets is a package in R/bioconductor that provides functions for performing overlap analysis of genomic regions, including functions for finding the intersection and union of two genomic regions, as well as to calculate the size of the overlap between two regions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: 'overlap' is not a package in R/bioconductor for performing overlap analysis of genomic regions. 'GenomicRanges' and 'IRanges' packages can be used for this kind of analysis.\n5. FALSE [correction]: 'overlapSets' is not a package in R/bioconductor. Functions for overlapping, intersecting, set differences can be found in packages such as 'GenomicRanges' and 'IRanges'.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 878,
    "user_query": "Is dichlorphenamide effective for periodic paralysis?",
    "vicuna-7b_response": "Dichlorphenamide is a medication that is primarily used to treat symptoms of idiopathic generalized periodic paralysis (IGPP), which is a rare genetic disorder characterized by episodes of muscle weakness and paralysis. The effectiveness of dichlorphenamide for treating IGPP has been supported by several clinical studies.\nIn a randomized controlled trial published in the journal Neurology in 2015, researchers evaluated the efficacy and safety of dichlorphenamide in patients with IGPP. The study found that dichlorphenamide significantly reduced the frequency and severity of muscle weakness and paralysis episodes compared to placebo.\nAnother study published in the journal Neurology in 2018 found that dichlorphenamide was effective in reducing muscle weakness and paralysis episodes in patients with IGPP. The study also found that the medication was well-tolerated by patients.\nIt's important to note that while dichlorphenamide has been shown to be effective in treating IGPP, it may not be effective in treating other types of periodic paralysis. It's always best to consult with a healthcare professional to determine the most appropriate treatment for your specific condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dichlorphenamide is a medication used for treating idiopathic generalized periodic paralysis (IGPP).\n2. The effectiveness of dichlorphenamide for treating IGPP is supported by several clinical studies.\n3. A study published in the Journal Neurology in 2015 found that dichlorphenamide significantly reduced the frequency and severity of muscle weakness and paralysis episodes compared to placebo.\n4. Another study published in the journal Neurology in 2018 found that dichlorphenamide was effective in reducing muscle weakness and paralysis episodes in patients with IGPP.\n5. Dichlorphenamide may not be effective in treating other types of periodic paralysis.",
    "vicuna-7b_fact": [
      "Dichlorphenamide is a medication used for treating idiopathic generalized periodic paralysis (IGPP).",
      "The effectiveness of dichlorphenamide for treating IGPP is supported by several clinical studies.",
      "A study published in the Journal Neurology in 2015 found that dichlorphenamide significantly reduced the frequency and severity of muscle weakness and paralysis episodes compared to placebo.",
      "Another study published in the journal Neurology in 2018 found that dichlorphenamide was effective in reducing muscle weakness and paralysis episodes in patients with IGPP.",
      "Dichlorphenamide may not be effective in treating other types of periodic paralysis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 881,
    "user_query": "Which pathway is activated by ficolin-3?",
    "vicuna-7b_response": "Ficolin-3 is a pattern recognition molecule that recognizes specific carbohydrate structures on pathogens and activates the immune response. The pathway activated by ficolin-3 is the lectin pathway of the complement system.\nThe lectin pathway is activated when a pattern recognition molecule, such as ficolin-3, recognizes a carbohydrate structure on a pathogen. This recognition triggers a cascade of events that leads to the activation of the complement component C1q, followed by the activation of the complement component C4 and C2. The activated C4 and C2 proteins cleave each other, releasing the C4b and C2a fragments. These fragments bind to the surface of the pathogen, leading to the formation of the C3bBb complex.\nThe C3bBb complex is a key component of the lectin pathway and plays a critical role in the recognition and destruction of pathogens. It binds to the surface of the pathogen, leading to the activation of the complement component C3, which cleaves into C3a and C3b. C3b binds to the surface of the pathogen, forming the C3bBbC3b complex. This complex is highly effective at opsonizing pathogens, making them more susceptible to phagocytosis by immune cells.\nIn summary, ficolin-3 activates the lectin pathway of the complement system by recognizing carbohydrate structures on pathogens, leading to the activation of the C4 and C2 proteins, the formation of the C3bBb complex, and the opsonization of pathogens for phagocytosis by immune cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ficolin-3 is a pattern recognition molecule that recognizes specific carbohydrate structures on pathogens and activates the immune response.\n2. The pathway activated by ficolin-3 is the lectin pathway of the complement system.\n3. This recognition triggers a cascade of events that leads to the activation of the complement components C1q, C4, and C2.\n4. The activated C4 and C2 proteins cleave each other, releasing the C4b and C2a fragments, leading to the formation of the C3bBb complex.\n5. The C3bBb complex is a key component of the lectin pathway and plays a critical role in the recognition and destruction of pathogens.",
    "vicuna-7b_fact": [
      "Ficolin-3 is a pattern recognition molecule that recognizes specific carbohydrate structures on pathogens and activates the immune response.",
      "The pathway activated by ficolin-3 is the lectin pathway of the complement system.",
      "This recognition triggers a cascade of events that leads to the activation of the complement components C1q, C4, and C2.",
      "The activated C4 and C2 proteins cleave each other, releasing the C4b and C2a fragments, leading to the formation of the C3bBb complex.",
      "The C3bBb complex is a key component of the lectin pathway and plays a critical role in the recognition and destruction of pathogens."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: This recognition triggers a cascade of events that leads to the activation of the complement components MASP-2, C4, and C2.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-7b_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses. Some of the preferred technologies include:\n1. Ion exchange chromatography: This technique involves the use of an ion exchange resin to separate charged molecules, including phosphorylated peptides.\n2. TiO2 beads: These beads are coated with a layer of titanium dioxide, which can selectively bind to phosphorylated peptides.\n3. Phosphopeptide enrichment columns: These columns contain a resin that is specifically designed to bind to phosphorylated peptides, allowing for their enrichment from a larger sample.\n4. Phospho-specific antibodies: Antibodies that are specific to phosphorylated peptides can be used to capture and enrich them from a sample.\n5. Phospho-specific affinity beads: These beads are coated with a ligand that specifically binds to phosphorylated peptides, allowing for their enrichment from a sample.\nIt is important to note that the choice of technology will depend on the specific requirements of the experiment, such as the size of the sample, the sensitivity of detection, and the specificity of the enrichment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.\n2. TiO2 beads can selectively bind to phosphorylated peptides and are used in phosphoproteomic analyses.\n3. Phosphopeptide enrichment columns are designed to bind phosphorylated peptides for their enrichment from larger samples.\n4. Phospho-specific antibodies are used to capture and enrich phosphorylated peptides from a sample.\n5. Phospho-specific affinity beads allow for the enrichment of phosphorylated peptides from a sample.",
    "vicuna-7b_fact": [
      "Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.",
      "TiO2 beads can selectively bind to phosphorylated peptides and are used in phosphoproteomic analyses.",
      "Phosphopeptide enrichment columns are designed to bind phosphorylated peptides for their enrichment from larger samples.",
      "Phospho-specific antibodies are used to capture and enrich phosphorylated peptides from a sample.",
      "Phospho-specific affinity beads allow for the enrichment of phosphorylated peptides from a sample."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 885,
    "user_query": "Does  thyroid hormone receptor beta1 affect insulin secretion?",
    "vicuna-7b_response": "Yes, thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion. TRβ1 is a nuclear receptor that plays a role in regulating metabolism and glucose homeostasis. It has been shown to be involved in the regulation of insulin secretion from pancreatic beta cells in response to changes in blood glucose levels.\nIncreased levels of TRβ1 have been shown to enhance insulin secretion in response to glucose, while decreased levels of TRβ1 have been associated with impaired insulin secretion and increased risk of type 2 diabetes. TRβ1 also plays a role in the regulation of glucose uptake in muscle and adipose tissue, which can further affect insulin secretion and glucose homeostasis.\nOverall, TRβ1 is an important regulator of insulin secretion and glucose homeostasis, and its dysregulation can contribute to the development of type 2 diabetes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion.\n2. TRβ1 is a nuclear receptor that regulates metabolism and glucose homeostasis.\n3. Increased levels of TRβ1 can enhance insulin secretion in response to glucose.\n4. Decreased levels of TRβ1 are associated with impaired insulin secretion and an increased risk of type 2 diabetes.\n5. TRβ1 plays a role in the regulation of glucose uptake in muscle and adipose tissue.",
    "vicuna-7b_fact": [
      "Thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion.",
      "TRβ1 is a nuclear receptor that regulates metabolism and glucose homeostasis.",
      "Increased levels of TRβ1 can enhance insulin secretion in response to glucose.",
      "Decreased levels of TRβ1 are associated with impaired insulin secretion and an increased risk of type 2 diabetes.",
      "TRβ1 plays a role in the regulation of glucose uptake in muscle and adipose tissue."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 893,
    "user_query": "What is commotio cordis?",
    "vicuna-7b_response": "Commotio cordis is a rare and sudden death of a young person due to a direct blow to the chest, usually from a blunt object such as a ball or a bat. The term \"commotio cordis\" is derived from Latin and means \"agitation of the heart.\"\nThe sudden impact of the blow causes a temporary disruption of the normal electrical activity of the heart, leading to a condition known as \"sudden death.\" Commotio cordis is a medical emergency that requires immediate medical attention.\nThe condition is most commonly seen in young athletes who participate in sports that involve balls or bats, such as baseball, hockey, and lacrosse. However, it can also occur in other settings, such as during a car accident or a violent encounter.\nThe risk of commotio cordis can be reduced by wearing protective gear, such as a helmet or a face mask, and by following safety guidelines and rules of the sport.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Commotio cordis is a rare and sudden death of a young person due to a direct blow to the chest.\n2. The term \"commotio cordis\" is derived from Latin and means \"agitation of the heart.\"\n3. Commotio cordis is a medical emergency that requires immediate medical attention.\n4. The condition is most commonly seen in young athletes who participate in sports that involve balls or bats, such as baseball, hockey, and lacrosse.\n5. The risk of commotio cordis can be reduced by wearing protective gear and by following safety guidelines and rules of the sport.",
    "vicuna-7b_fact": [
      "Commotio cordis is a rare and sudden death of a young person due to a direct blow to the chest.",
      "The term \"commotio cordis\" is derived from Latin and means \"agitation of the heart.\"",
      "Commotio cordis is a medical emergency that requires immediate medical attention.",
      "The condition is most commonly seen in young athletes who participate in sports that involve balls or bats, such as baseball, hockey, and lacrosse.",
      "The risk of commotio cordis can be reduced by wearing protective gear and by following safety guidelines and rules of the sport."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 894,
    "user_query": "What is the cause of Phthiriasis Palpebrarum?",
    "vicuna-7b_response": "Phthiriasis palpebrarum, also known as eye lice or pediculosis capitis, is caused by the parasitic insect Phthirus pubis. This insect is a small, wingless mite that lives on the skin and hair of the scalp, particularly in the eyebrows and eyelashes. It is a common problem in children and can be transmitted through direct contact with an infected person or through shared personal items such as hats, brushes, or combs.\nThe mites feed on the oils and sweat on the skin, causing irritation and itching. The itching can lead to scratching, which can cause further irritation and inflammation. In severe cases, the infection can lead to redness, swelling, and even scarring of the eyelids.\nTreatment for Phthiriasis palpebrarum typically involves the use of medicated shampoos or creams to kill the mites and soothe the skin. In some cases, medicated lotions or creams may be applied directly to the affected area. It is important to follow the instructions provided by a healthcare professional carefully to ensure effective treatment and prevent recurrence of the infection.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phthiriasis palpebrarum is caused by the parasitic insect Phthirus pubis.\n2. Phthirus pubis is a small, wingless mite that lives on the skin and hair of the scalp, specifically the eyebrows and eyelashes.\n3. Phthiriasis palpebrarum can be transmitted through direct contact with an infected person or through shared personal items like hats, brushes, or combs.\n4. The mites feed on the oils and sweat on the skin, causing irritation and itching.\n5. Treatment for Phthiriasis palpebrarum usually involves the use of medicated shampoos or creams.",
    "vicuna-7b_fact": [
      "Phthiriasis palpebrarum is caused by the parasitic insect Phthirus pubis.",
      "Phthirus pubis is a small, wingless mite that lives on the skin and hair of the scalp, specifically the eyebrows and eyelashes.",
      "Phthiriasis palpebrarum can be transmitted through direct contact with an infected person or through shared personal items like hats, brushes, or combs.",
      "The mites feed on the oils and sweat on the skin, causing irritation and itching.",
      "Treatment for Phthiriasis palpebrarum usually involves the use of medicated shampoos or creams."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Phthirus pubis, also known as the pubic louse, is a small, wingless insect that lives on the body hair, specifically the pubic hair. It is not a mite.\n3. TRUE\n4. FALSE [correction]: The lice feed on human blood, not oils and sweat, causing irritation and itching.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 896,
    "user_query": "How are CpG island shores defined?",
    "vicuna-7b_response": "CpG island shores are defined as regions of DNA that are rich in CpG dinucleotides (where the cytosine is followed by a guanine) and are located near the edge of a CpG island. CpG islands are regions of DNA that are enriched in CpG dinucleotides and are often found in the promoter regions of genes.\nCpG island shores are important because they are involved in the regulation of gene expression. The presence of CpG island shores near the promoter region of a gene can increase the accessibility of the promoter to transcription factors, which can enhance the expression of the gene. Additionally, CpG island shores can also be involved in the regulation of DNA methylation, which can further impact gene expression.\nCpG island shores are typically defined using computational methods that analyze the DNA sequence of a genome. These methods look for regions of DNA that are rich in CpG dinucleotides and are located near the edge of a CpG island. The exact definition of a CpG island shore can vary depending on the specific computational method used.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CpG island shores are regions of DNA that are rich in CpG dinucleotides and are located near the edge of a CpG island.\n2. CpG islands, which are often found in the promoter regions of genes, are areas of DNA enriched in CpG dinucleotides.\n3. CpG island shores are involved in the regulation of gene expression.\n4. CpG island shores can increase the accessibility of the promoter to transcription factors, potentially enhancing the expression of the gene.\n5. The definition of CpG island shores can vary depending on the computational method used to analyze the DNA sequence of a genome.",
    "vicuna-7b_fact": [
      "CpG island shores are regions of DNA that are rich in CpG dinucleotides and are located near the edge of a CpG island.",
      "CpG islands, which are often found in the promoter regions of genes, are areas of DNA enriched in CpG dinucleotides.",
      "CpG island shores are involved in the regulation of gene expression.",
      "CpG island shores can increase the accessibility of the promoter to transcription factors, potentially enhancing the expression of the gene.",
      "The definition of CpG island shores can vary depending on the computational method used to analyze the DNA sequence of a genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 899,
    "user_query": "What is the role of edaravone in traumatic brain injury?",
    "vicuna-7b_response": "Edaravone is a medication that has been studied for its potential to improve outcomes in patients with traumatic brain injury (TBI). TBI is a type of injury that occurs when the brain is damaged due to a blow or jolt to the head or other traumatic event.\nThe role of edaravone in TBI is still being studied, but it has been shown to have some potential benefits. One study found that edaravone may help to reduce brain damage and improve outcomes in patients with TBI. Another study found that edaravone may help to reduce the risk of death and improve cognitive function in patients with TBI.\nIt is important to note that more research is needed to fully understand the role of edaravone in TBI. Additionally, edaravone is not currently approved by the FDA for the treatment of TBI, and its use in this context is considered experimental.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Edaravone is a medication that has been studied for its potential to improve outcomes in patients with traumatic brain injury (TBI).\n2. TBI is an injury that occurs when the brain is damaged due to a blow or jolt to the head or other traumatic event.\n3. The role of edaravone in TBI is still being studied.\n4. Edaravone is not currently approved by the FDA for the treatment of TBI.\n5. The use of edaravone in the context of TBI is considered experimental.",
    "vicuna-7b_fact": [
      "Edaravone is a medication that has been studied for its potential to improve outcomes in patients with traumatic brain injury (TBI).",
      "TBI is an injury that occurs when the brain is damaged due to a blow or jolt to the head or other traumatic event.",
      "The role of edaravone in TBI is still being studied.",
      "Edaravone is not currently approved by the FDA for the treatment of TBI.",
      "The use of edaravone in the context of TBI is considered experimental."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 900,
    "user_query": "Are there plasma membrane receptors for thyroid hormones?",
    "vicuna-7b_response": "Yes, there are plasma membrane receptors for thyroid hormones. Thyroid hormones are small signaling molecules that play important roles in regulating metabolism in the body. They bind to specific receptors on the surface of cells, which then trigger intracellular signaling pathways that regulate the expression of genes involved in metabolism.\nThe two main types of thyroid hormone receptors are the thyroid hormone receptor alpha (TR alpha) and the thyroid hormone receptor beta (TR beta). These receptors are expressed in a variety of tissues throughout the body, including the brain, heart, muscles, and liver.\nWhen thyroid hormones bind to their receptors, they can regulate the metabolic rate of the cell by activating a variety of downstream signaling pathways. For example, TR alpha can activate the transcription factor nuclear receptor corepressor (NCoR) and the coactivator steroid receptor coactivator-1 (SRC-1), which in turn can regulate the expression of genes involved in metabolism.\nOverall, the plasma membrane receptors for thyroid hormones play a crucial role in regulating metabolism in the body and are essential for maintaining proper cellular function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are plasma membrane receptors for thyroid hormones.\n2. Thyroid hormones play important roles in regulating metabolism in the body.\n3. The two main types of thyroid hormone receptors are the thyroid hormone receptor alpha (TR alpha) and the thyroid hormone receptor beta (TR beta).\n4. These receptors are expressed in a variety of tissues throughout the body, including the brain, heart, muscles, and liver.\n5. TR alpha can activate the transcription factor nuclear receptor corepressor (NCoR) and the coactivator steroid receptor coactivator-1 (SRC-1), which in turn can regulate the expression of genes involved in metabolism.",
    "vicuna-7b_fact": [
      "There are plasma membrane receptors for thyroid hormones.",
      "Thyroid hormones play important roles in regulating metabolism in the body.",
      "The two main types of thyroid hormone receptors are the thyroid hormone receptor alpha (TR alpha) and the thyroid hormone receptor beta (TR beta).",
      "These receptors are expressed in a variety of tissues throughout the body, including the brain, heart, muscles, and liver.",
      "TR alpha can activate the transcription factor nuclear receptor corepressor (NCoR) and the coactivator steroid receptor coactivator-1 (SRC-1), which in turn can regulate the expression of genes involved in metabolism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "vicuna-7b_response": "The Palmini classification is a system used to rate the severity of various medical conditions. It is not a specific disorder, but rather a way of categorizing and comparing the severity of different conditions. The Palmini classification is typically used in the field of neurology to assess the severity of conditions such as stroke, traumatic brain injury, and other neurological disorders.\nThe Palmini classification is based on the degree of motor and sensory impairment, as well as the presence of other symptoms such as language and cognitive impairment. The classification is divided into five levels, ranging from level 1 (mild impairment) to level 5 (severe impairment).\nIt is important to note that the Palmini classification is not a diagnostic tool and should not be used to diagnose a specific condition. If you have concerns about a medical condition, it is important to speak with a qualified healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Palmini classification is a system used to classify and compare the severity of different medical conditions.\n2. The Palmini classification is typically used in the field of neurology.\n3. The Palmini classification is not a singular disorder.\n4. The Palmini classification rates conditions based on degree of motor and sensory impairment, and the presence of other symptoms such as language and cognitive impairment.\n5. The classification is divided into five levels, from level 1 (mild impairment) to level 5 (severe impairment).",
    "vicuna-7b_fact": [
      "The Palmini classification is a system used to classify and compare the severity of different medical conditions.",
      "The Palmini classification is typically used in the field of neurology.",
      "The Palmini classification is not a singular disorder.",
      "The Palmini classification rates conditions based on degree of motor and sensory impairment, and the presence of other symptoms such as language and cognitive impairment.",
      "The classification is divided into five levels, from level 1 (mild impairment) to level 5 (severe impairment)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 904,
    "user_query": "Are there any desmins present in plants?",
    "vicuna-7b_response": "Yes, there are several types of dismutases present in plants. Dismutases are enzymes that catalyze the breakage of molecular bonds in substrates, leading to the formation of two or more new substances.\nIn plants, there are several types of dismutases, including:\n1. Superoxide dismutase (SOD): This enzyme catalyzes the breakage of superoxide anions into hydrogen peroxide and oxygen. SOD is present in all plant cells and is involved in the detoxification of reactive oxygen species (ROS).\n2. Catalase: This enzyme catalyzes the breakage of hydrogen peroxide into water and oxygen. Catalase is present in all plant cells and is involved in the detoxification of hydrogen peroxide.\n3. Ascorbate peroxidase (APX): This enzyme catalyzes the breakage of hydrogen peroxide into water and ascorbate. APX is present in the cell walls of plants and is involved in the detoxification of hydrogen peroxide.\n4. Dehydroascorbate reductase (DHAR): This enzyme catalyzes the reduction of ascorbate to ascorbate peroxide. DHAR is present in the cell walls of plants and is involved in the detoxification of hydrogen peroxide.\nOverall, dismutases play an important role in the detoxification of reactive oxygen species in plants, helping to protect the plant from damage caused by these harmful molecules.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dismutases are enzymes that catalyze the breakage of molecular bonds in substrates.\n2. There are several types of dismutases present in plants, including superoxide dismutase, catalase, ascorbate peroxidase, and dehydroascorbate reductase.\n3. Superoxide dismutase in plants catalyzes the breakage of superoxide anions into hydrogen peroxide and oxygen.\n4. Catalase in plants catalyzes the breakage of hydrogen peroxide into water and oxygen.\n5. Ascorbate peroxidase and dehydroascorbate reductase in plants are involved in the detoxification of hydrogen peroxide.",
    "vicuna-7b_fact": [
      "Dismutases are enzymes that catalyze the breakage of molecular bonds in substrates.",
      "There are several types of dismutases present in plants, including superoxide dismutase, catalase, ascorbate peroxidase, and dehydroascorbate reductase.",
      "Superoxide dismutase in plants catalyzes the breakage of superoxide anions into hydrogen peroxide and oxygen.",
      "Catalase in plants catalyzes the breakage of hydrogen peroxide into water and oxygen.",
      "Ascorbate peroxidase and dehydroascorbate reductase in plants are involved in the detoxification of hydrogen peroxide."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Dismutases are enzymes that catalyze the disproportionation of specific molecules, not the breakage of molecular bonds.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-7b_response": "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by a variety of factors, including viruses.\nViruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis. These viruses can cause direct damage to the thyroid gland or trigger an immune response that leads to inflammation.\nThe symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism (too much thyroid hormone) and hypothyroidism (too little thyroid hormone). Therefore, it can be difficult to definitively diagnose subacute thyroiditis without further testing.\nTreatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms, as well as hormone replacement therapy if the thyroid gland is damaged. In some cases, surgery may be necessary to remove part or all of the thyroid gland.\nIt is important to note that while viruses can play a role in the development of subacute thyroiditis, other factors such as autoimmune disorders, infections, and medications can also cause this condition. Therefore, a thorough evaluation by a healthcare professional is necessary to determine the underlying cause of subacute thyroiditis and develop an appropriate treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Subacute thyroiditis is an inflammatory condition of the thyroid gland caused by various factors, including viruses.\n2. Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.\n3. The symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism and hypothyroidism. \n4. Treatment for subacute thyroiditis can involve medications, hormone replacement therapy, and in some cases, surgery.\n5. Other factors such as autoimmune disorders, infections, and medications can also cause subacute thyroiditis.",
    "vicuna-7b_fact": [
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland caused by various factors, including viruses.",
      "Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.",
      "The symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism and hypothyroidism.",
      "Treatment for subacute thyroiditis can involve medications, hormone replacement therapy, and in some cases, surgery.",
      "Other factors such as autoimmune disorders, infections, and medications can also cause subacute thyroiditis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 910,
    "user_query": "Which is the receptor for substrates of Chaperone Mediated Autophagy?",
    "vicuna-7b_response": "The receptor for substrates of Chaperone-Mediated Autophagy (CMA) is the Atg8-containing vesicle, also known as the autophagosome.\nAutophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components through the formation of autophagosomes. CMA is a specific type of autophagy that relies on the action of the autophagy-related (ATG) proteins, such as Atg8, to form the autophagosomes.\nThe Atg8-containing vesicle is the receptor for substrates of CMA because it is responsible for recognizing and engulfing the cellular components that are targeted for degradation by autophagy. The autophagosome then fuses with lysosomes, where the contents of the autophagosome are degraded by hydrolases, resulting in the breakdown of the targeted cellular components.\nIn summary, the Atg8-containing vesicle is the receptor for substrates of CMA, and it plays a crucial role in the recognition and degradation of cellular components by autophagy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The receptor for substrates of Chaperone-Mediated Autophagy (CMA) is the Atg8-containing vesicle, also known as the autophagosome.\n2. Autophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components.\n3. Chaperone-Mediated Autophagy is a specific type of autophagy that relies on the action of the autophagy-related (ATG) proteins, such as Atg8.\n4. The autophagosome fuses with lysosomes, where the contents of the autophagosome are degraded by hydrolases.\n5. The Atg8-containing vesicle plays a crucial role in the recognition and degradation of cellular components by autophagy.",
    "vicuna-7b_fact": [
      "The receptor for substrates of Chaperone-Mediated Autophagy (CMA) is the Atg8-containing vesicle, also known as the autophagosome.",
      "Autophagy is a cellular process that involves the degradation of damaged organelles, proteins, and other cellular components.",
      "Chaperone-Mediated Autophagy is a specific type of autophagy that relies on the action of the autophagy-related (ATG) proteins, such as Atg8.",
      "The autophagosome fuses with lysosomes, where the contents of the autophagosome are degraded by hydrolases.",
      "The Atg8-containing vesicle plays a crucial role in the recognition and degradation of cellular components by autophagy."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The receptor for substrates of Chaperone-Mediated Autophagy (CMA) is the LAMP2A, not the Atg8-containing vesicle.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 913,
    "user_query": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?",
    "vicuna-7b_response": "There have been several clinical trials that have directly compared microsurgical clipping with endovascular coiling for the treatment of ruptured brain aneurysms. Here are a few examples:\n1. The International Subarachnoid Aneurysm Trial (ISAT): This was a multicenter, randomized controlled trial that compared the outcomes of patients treated with endovascular coiling versus microsurgical clipping for ruptured intracranial aneurysms. The trial enrolled over 2,000 patients from 100 centers in 14 countries and was published in the New England Journal of Medicine in 2006. The results showed that endovascular coiling was associated with fewer deaths and disabilities at 6 months and 1 year compared to microsurgical clipping.\n2. The International Cooperative Study on the Timing of Operative Intervention in Subarachnoid Hemorrhage (TOAST): This was a multicenter, randomized controlled trial that compared the outcomes of patients treated with endovascular coiling versus microsurgical clipping for ruptured intracranial aneurysms. The trial enrolled over 1,000 patients from 40 centers in 5 countries and was published in the New England Journal of Medicine in 1995. The results showed that both endovascular coiling and microsurgical clipping were associated with similar rates of good neurological outcomes at 6 months and 1 year.\n3. The International Study of Unruptured Intracranial Aneurysms (ISUIA): This was a multicenter, observational study that compared the outcomes of patients with unruptured intracranial aneurysms who were treated with endovascular coiling versus microsurgical clipping. The study enrolled over 20,000 patients from 100 centers in 14 countries and was published in the New England Journal of Medicine in 2015. The results showed that both endovascular coiling and microsurgical clipping were associated with similar rates of aneurysm rupture and death over a 5-year period.\nOverall, these studies suggest that both microsurgical cli",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The International Subarachnoid Aneurysm Trial (ISAT) was a multicenter, randomized controlled trial that compared endovascular coiling and microsurgical clipping for ruptured intracranial aneurysms.\n2. ISAT enrolled over 2,000 patients from 100 centers in 14 countries and was published in 2006 in the New England Journal of Medicine.\n3. The International Cooperative Study on the Timing of Operative Intervention in Subarachnoid Hemorrhage (TOAST) was a multicenter, randomized controlled trial that compared endovascular coiling and microsurgical clipping for ruptured intracranial aneurysms.\n4. TOAST enrolled over 1,000 patients from 40 centers in 5 countries and was published in 1995 in the New England Journal of Medicine.\n5. The International Study of Unruptured Intracranial Aneurysms (ISUIA) was a multicenter, observational study that compared the outcomes of patients with unruptured intracranial aneurysms who were treated with endovascular coiling versus microsurgical clipping.",
    "vicuna-7b_fact": [
      "The International Subarachnoid Aneurysm Trial (ISAT) was a multicenter, randomized controlled trial that compared endovascular coiling and microsurgical clipping for ruptured intracranial aneurysms.",
      "ISAT enrolled over 2,000 patients from 100 centers in 14 countries and was published in 2006 in the New England Journal of Medicine.",
      "The International Cooperative Study on the Timing of Operative Intervention in Subarachnoid Hemorrhage (TOAST) was a multicenter, randomized controlled trial that compared endovascular coiling and microsurgical clipping for ruptured intracranial aneurysms.",
      "TOAST enrolled over 1,000 patients from 40 centers in 5 countries and was published in 1995 in the New England Journal of Medicine.",
      "The International Study of Unruptured Intracranial Aneurysms (ISUIA) was a multicenter, observational study that compared the outcomes of patients with unruptured intracranial aneurysms who were treated with endovascular coiling versus microsurgical clipping."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: ISAT enrolled 2,143 patients from 43 centers in Europe, North America, Australia and Asia and was published in 2002 in the Lancet.\n3. FALSE [correction]: The International Cooperative Study on the Timing of Aneurysm Surgery was not a controlled trial comparing endovascular coiling and microsurgical clipping. It evaluated the timing of surgery, and its second part studied predictors of outcome of surgical interventions for aneurysmal Subarachnoid Hemorrhage.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 919,
    "user_query": "Which are the mutational hotspots of the human KRAS oncogene?",
    "vicuna-7b_response": "The KRAS oncogene is a well-known oncogene that is commonly mutated in various types of cancer, including colorectal, lung, and pancreatic cancer. The KRAS gene is located on chromosome 12 at position 22.1 and contains 22 exons. The mutational hotspots of the KRAS oncogene are primarily found in exon 2 and exon 3.\nExon 2 mutations are the most common type of KRAS mutations and are found in approximately 90% of KRAS-mutated cancers. These mutations typically result in the substitution of glutamic acid with another amino acid, such as aspartic acid or a stop codon. Exon 3 mutations are less common and typically result in the substitution of aspartic acid with another amino acid.\nIn addition to exon 2 and exon 3 mutations, other mutations in the KRAS gene have been identified, including mutations in exon 1 and exon 4. These mutations can also lead to the activation of the KRAS oncogene and contribute to the development of cancer.\nOverall, the mutational hotspots of the KRAS oncogene are primarily found in exon 2 and exon 3, and exon 2 mutations are the most common type of KRAS mutations found in cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The KRAS oncogene is commonly mutated in various types of cancer, including colorectal, lung, and pancreatic cancer.\n2. The KRAS gene is located on chromosome 12 at position 22.1 and contains 22 exons.\n3. The mutational hotspots of the KRAS oncogene are primarily found in exon 2 and exon 3.\n4. Exon 2 mutations are found in approximately 90% of KRAS-mutated cancers and typically result in the substitution of glutamic acid with another amino acid.\n5. In addition to exon 2 and exon 3 mutations, other mutations in the KRAS gene have been identified, including mutations in exon 1 and exon 4.",
    "vicuna-7b_fact": [
      "The KRAS oncogene is commonly mutated in various types of cancer, including colorectal, lung, and pancreatic cancer.",
      "The KRAS gene is located on chromosome 12 at position 22.1 and contains 22 exons.",
      "The mutational hotspots of the KRAS oncogene are primarily found in exon 2 and exon 3.",
      "Exon 2 mutations are found in approximately 90% of KRAS-mutated cancers and typically result in the substitution of glutamic acid with another amino acid.",
      "In addition to exon 2 and exon 3 mutations, other mutations in the KRAS gene have been identified, including mutations in exon 1 and exon 4."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Exon 2 mutations are found in approximately 90% of KRAS-mutated cancers and typically result in the substitution of glycine with another amino acid.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 921,
    "user_query": "What is the mechanism of action of ocrelizumab for treatment of multiple sclerosis?",
    "vicuna-7b_response": "Ocrelizumab is a monoclonal antibody that binds to CD20 protein, which is expressed on the surface of B cells. The binding of ocrelizumab to CD20 protein induces cell death (apoptosis) and reduces the number of B cells in the brain and spinal cord, which are thought to play a role in the pathogenesis of multiple sclerosis (MS).\nOcrelizumab has been shown to reduce the frequency of relapses, improve disability progression, and reduce the accumulation of brain lesions in patients with relapsing-remitting MS (RRMS) and primary progressive MS (PPMS). The exact mechanism of action of ocrelizumab in MS is not fully understood, but it is thought to work by inhibiting the activation and proliferation of autoreactive B cells, which are involved in the immune response in MS.\nIn addition, ocrelizumab has been shown to reduce the levels of interleukin-6 (IL-6), a pro-inflammatory cytokine that is involved in the pathogenesis of MS, and to increase the levels of IL-4, a anti-inflammatory cytokine that can inhibit the activation of T cells and B cells.\nOverall, the mechanism of action of ocrelizumab in the treatment of MS is complex and involves multiple immunological and cellular pathways.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ocrelizumab is a monoclonal antibody that binds to CD20 protein.\n2. The CD20 protein is expressed on the surface of B cells.\n3. Ocrelizumab induces cell death (apoptosis) and reduces the number of B cells in the brain and spinal cord.\n4. Ocrelizumab has been shown to reduce the frequency of relapses, improve disability progression, and reduce the accumulation of brain lesions in patients with relapsing-remitting MS (RRMS) and primary progressive MS (PPMS).\n5. Ocrelizumab has been shown to reduce the levels of interleukin-6 (IL-6) and increase the levels of IL-4.",
    "vicuna-7b_fact": [
      "Ocrelizumab is a monoclonal antibody that binds to CD20 protein.",
      "The CD20 protein is expressed on the surface of B cells.",
      "Ocrelizumab induces cell death (apoptosis) and reduces the number of B cells in the brain and spinal cord.",
      "Ocrelizumab has been shown to reduce the frequency of relapses, improve disability progression, and reduce the accumulation of brain lesions in patients with relapsing-remitting MS (RRMS) and primary progressive MS (PPMS).",
      "Ocrelizumab has been shown to reduce the levels of interleukin-6 (IL-6) and increase the levels of IL-4."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 933,
    "user_query": "Are patients with marfan syndrome at increased risk of arrhythmias?",
    "vicuna-7b_response": "Yes, patients with Marfan syndrome are at increased risk of developing arrhythmias. Marfan syndrome is a genetic disorder that affects the connective tissue in the body, including the heart. The disorder can cause the heart's chambers to enlarge and stretch, which can lead to an irregular heartbeat (arrhythmia).\nArrhythmias are common in patients with Marfan syndrome and can range from mild to severe. Some arrhythmias may not cause any symptoms, while others can cause palpitations, dizziness, or fainting. In severe cases, arrhythmias can lead to heart failure or stroke.\nTo manage the risk of arrhythmias, patients with Marfan syndrome may need to take medications to help regulate their heart rhythm and prevent sudden cardiac arrest. They may also need to avoid certain activities that can put strain on the heart, such as strenuous exercise or heavy lifting.\nIt is important for patients with Marfan syndrome to work closely with their healthcare provider to monitor their heart health and manage any arrhythmias that may develop. Regular check-ups and testing, including electrocardiograms (ECGs) and echocardiograms, can help detect any potential problems early and prevent serious complications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Patients with Marfan syndrome are at increased risk of developing arrhythmias.\n2. Marfan syndrome is a genetic disorder that affects the connective tissue in the body, including the heart.\n3. To manage the risk of arrhythmias, patients with Marfan syndrome may need to take medications to help regulate their heart rhythm and prevent sudden cardiac arrest.\n4. Patients with Marfan syndrome may need to avoid strenuous exercise or heavy lifting.\n5. Regular check-ups and testing, including electrocardiograms (ECGs) and echocardiograms, can help detect any potential problems early and prevent serious complications in patients with Marfan syndrome.",
    "vicuna-7b_fact": [
      "Patients with Marfan syndrome are at increased risk of developing arrhythmias.",
      "Marfan syndrome is a genetic disorder that affects the connective tissue in the body, including the heart.",
      "To manage the risk of arrhythmias, patients with Marfan syndrome may need to take medications to help regulate their heart rhythm and prevent sudden cardiac arrest.",
      "Patients with Marfan syndrome may need to avoid strenuous exercise or heavy lifting.",
      "Regular check-ups and testing, including electrocardiograms (ECGs) and echocardiograms, can help detect any potential problems early and prevent serious complications in patients with Marfan syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 935,
    "user_query": "List Kartagener Syndrome Triad.",
    "vicuna-7b_response": "Kartagener Syndrome, also known as Kartagener's Disease, is a rare genetic disorder characterized by a triad of symptoms:\n1. Bronchiectasis: a condition in which the airways become damaged and widened, leading to chronic cough and mucus production.\n2. Primary ciliary dyskinesia (PCD): a condition in which the cilia, the tiny hair-like structures in the respiratory tract, do not function properly, leading to respiratory infections and chronic lung disease.\n3. Nasal polyps: benign growths that develop in the nasal passages and can cause blockage of the nasal airways.\nKartagener Syndrome is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the gene (one from each parent) to develop the condition. It is estimated to affect approximately 1 in 25,000 people worldwide.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Kartagener Syndrome, or Kartagener's Disease, is a genetic disorder.\n2. The triad of symptoms characterizing Kartagener Syndrome includes bronchiectasis, primary ciliary dyskinesia (PCD), and nasal polyps.\n3. Bronchiectasis is characterized by the damage and widening of airways, leading to chronic cough and mucus production.\n4. Primary ciliary dyskinesia (PCD) is a condition where the cilia in the respiratory tract do not function properly, which can lead to respiratory infections and chronic lung disease.\n5. Kartagener Syndrome is inherited through an autosomal recessive pattern, requiring two copies of the gene (one from each parent) to develop the condition.",
    "vicuna-7b_fact": [
      "Kartagener Syndrome, or Kartagener's Disease, is a genetic disorder.",
      "The triad of symptoms characterizing Kartagener Syndrome includes bronchiectasis, primary ciliary dyskinesia (PCD), and nasal polyps.",
      "Bronchiectasis is characterized by the damage and widening of airways, leading to chronic cough and mucus production.",
      "Primary ciliary dyskinesia (PCD) is a condition where the cilia in the respiratory tract do not function properly, which can lead to respiratory infections and chronic lung disease.",
      "Kartagener Syndrome is inherited through an autosomal recessive pattern, requiring two copies of the gene (one from each parent) to develop the condition."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The triad of symptoms characterizing Kartagener Syndrome includes bronchiectasis, primary ciliary dyskinesia (PCD), and situs inversus.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 936,
    "user_query": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "vicuna-7b_response": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is a type of cancer called Fragile X-associated tremor/ataxia syndrome (FXTAS).\nDUX4 is a gene that encodes a protein called DUX4, which is involved in the development and progression of cancer. Ectopic expression of DUX4 has been observed in certain types of cancer, including prostate cancer and breast cancer. However, the most well-known association of DUX4 with a disease is FXTAS.\nFXTAS is a rare disorder that affects older men and is characterized by a combination of symptoms including tremors, balance problems, and cognitive decline. The disorder is caused by the ectopic expression of DUX4 in certain brain cells, which leads to the accumulation of abnormal proteins and the disruption of normal cellular processes.\nWhile FXTAS is a rare disorder, it is important to note that the ectopic expression of DUX4 has also been observed in other types of cancer, including prostate cancer and breast cancer. Further research is needed to fully understand the role of DUX4 in cancer and to develop effective treatments for cancer patients with ectopic DUX4 expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The protein encoded by the gene DUX4 is associated with Fragile X-associated tremor/ataxia syndrome (FXTAS), a type of cancer.\n2. The gene DUX4 encodes a protein that is involved in the development and progression of cancer.\n3. Ectopic expression of DUX4 has been observed in certain types of cancer, including prostate and breast cancer.\n4. FXTAS is a disorder that affects older men with symptoms including tremors, balance problems, and cognitive decline.\n5. FXTAS is caused by the ectopic expression of DUX4 in certain brain cells.",
    "vicuna-7b_fact": [
      "The protein encoded by the gene DUX4 is associated with Fragile X-associated tremor/ataxia syndrome (FXTAS), a type of cancer.",
      "The gene DUX4 encodes a protein that is involved in the development and progression of cancer.",
      "Ectopic expression of DUX4 has been observed in certain types of cancer, including prostate and breast cancer.",
      "FXTAS is a disorder that affects older men with symptoms including tremors, balance problems, and cognitive decline.",
      "FXTAS is caused by the ectopic expression of DUX4 in certain brain cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The protein encoded by the gene DUX4 is associated with facioscapulohumeral muscular dystrophy, not Fragile X-associated tremor/ataxia syndrome (FXTAS), a type of cancer.\n2. FALSE [correction]: The gene DUX4 encodes a protein that is involved in muscle development, not directly in cancer progression.\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: FXTAS is caused by a mutation in the FMR1 gene, not by the ectopic expression of DUX4.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 938,
    "user_query": "Which are the main functions of the APOBEC3 family of proteins?",
    "vicuna-7b_response": "The APOBEC3 family of proteins is a group of cytidine deaminases that play important roles in the immune system of higher organisms. The main functions of APOBEC3 proteins are:\n1. Antiviral defense: APOBEC3 proteins are able to deaminate (change) cytosine to uracil in the DNA of viruses, which can lead to mutations and viral replication failure. This is an important mechanism of the immune system to prevent viral infections.\n2. Cancer suppression: APOBEC3 proteins are also expressed in normal cells, and they can act as tumor suppressors by deaminating cytosine in the DNA of cancer cells, leading to mutations and cell death.\n3. Neurodegeneration: APOBEC3 proteins have been implicated in the pathogenesis of certain neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n4. Immune regulation: APOBEC3 proteins can also regulate the immune response by deaminating cytosine in the DNA of immune cells, leading to changes in gene expression and immune function.\nOverall, the APOBEC3 family of proteins plays important roles in the immune system, cancer suppression, and neurodegeneration.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The APOBEC3 family of proteins is a group of cytidine deaminases that play important roles in the immune system of higher organisms.\n2. APOBEC3 proteins can deaminate cytosine to uracil in the DNA of viruses, potentially leading to viral replication failure.\n3. APOBEC3 proteins can also act as tumor suppressors, causing mutations and cell death in cancer cells by deaminating cytosine in DNA.\n4. APOBEC3 proteins have been implicated in the pathogenesis of certain neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n5. APOBEC3 proteins can regulate the immune response by deaminating cytosine in the DNA of immune cells, leading to changes in gene expression and immune function.",
    "vicuna-7b_fact": [
      "The APOBEC3 family of proteins is a group of cytidine deaminases that play important roles in the immune system of higher organisms.",
      "APOBEC3 proteins can deaminate cytosine to uracil in the DNA of viruses, potentially leading to viral replication failure.",
      "APOBEC3 proteins can also act as tumor suppressors, causing mutations and cell death in cancer cells by deaminating cytosine in DNA.",
      "APOBEC3 proteins have been implicated in the pathogenesis of certain neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",
      "APOBEC3 proteins can regulate the immune response by deaminating cytosine in the DNA of immune cells, leading to changes in gene expression and immune function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: While APOBEC3 proteins can cause mutations by deaminating cytosine in DNA, there is currently no evidence to suggest that they directly regulate the immune response by changing gene expression and immune function in immune cells.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 939,
    "user_query": "Which histone modifications are associated with constitutive heterochromatin?",
    "vicuna-7b_response": "Constitutive heterochromatin refers to heterochromatin that is present in all cells and tissues, regardless of the stage of the cell cycle. Histone modifications play a crucial role in the formation and maintenance of heterochromatin. Some of the histone modifications associated with constitutive heterochromatin include:\n1. Histone H3 lysine 9 (H3K9) trimethylation: This modification is associated with the formation of constitutive heterochromatin. Trimethylated H3K9 is found at the 5' end of constitutive heterochromatin and is thought to be involved in the recruitment of chromatin-modifying enzymes.\n2. Histone H4 lysine 16 (H4K16) trimethylation: This modification is associated with the formation of constitutive heterochromatin. Trimethylated H4K16 is found at the 3' end of constitutive heterochromatin and is thought to be involved in the formation of a compact chromatin structure.\n3. Histone H3 lysine 27 (H3K27) trimethylation: This modification is associated with the formation of constitutive heterochromatin. Trimethylated H3K27 is found at the 5' end of constitutive heterochromatin and is thought to be involved in the repression of gene expression.\n4. Histone H3 lysine 79 (H3K79) methylation: This modification is associated with the formation of constitutive heterochromatin. Methylated H3K79 is found at the 5' end of constitutive heterochromatin and is thought to be involved in the repression of gene expression.\nThese histone modifications are associated with the formation of constitutive heterochromatin, which is present in all cells and tissues, regardless of the stage of the cell cycle.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Constitutive heterochromatin is present in all cells and tissues, regardless of the stage of the cell cycle.\n2. Histone modifications play a crucial role in the formation and maintenance of heterochromatin.\n3. Histone H3 lysine 9 (H3K9) trimethylation is associated with the formation of constitutive heterochromatin.\n4. Histone H4 lysine 16 (H4K16) trimethylation is associated with the formation of constitutive heterochromatin.\n5. Histone H3 lysine 27 (H3K27) trimethylation is associated with the formation of constitutive heterochromatin.",
    "vicuna-7b_fact": [
      "Constitutive heterochromatin is present in all cells and tissues, regardless of the stage of the cell cycle.",
      "Histone modifications play a crucial role in the formation and maintenance of heterochromatin.",
      "Histone H3 lysine 9 (H3K9) trimethylation is associated with the formation of constitutive heterochromatin.",
      "Histone H4 lysine 16 (H4K16) trimethylation is associated with the formation of constitutive heterochromatin.",
      "Histone H3 lysine 27 (H3K27) trimethylation is associated with the formation of constitutive heterochromatin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Histone H4 lysine 16 (H4K16) acetylation, not trimethylation, is associated with the loosening of chromatin structure, not the formation of constitutive heterochromatin.\n5. FALSE [correction]: Histone H3 lysine 27 (H3K27) trimethylation is associated with the formation of facultative heterochromatin, not constitutive heterochromatin.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 940,
    "user_query": "What is the main application of SWATH-MS in proteomics?",
    "vicuna-7b_response": "SWATH-MS (Surface Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) is a powerful analytical technique that is widely used in proteomics research. The main application of SWATH-MS in proteomics is to quantitatively and comprehensively analyze proteins in complex samples, such as cells, tissues, or biological fluids.\nSWATH-MS allows for the simultaneous analysis of multiple proteins in a single sample, providing a more comprehensive view of the proteome than traditional bottom-up proteomics methods. It also allows for the accurate quantitation of proteins, even in the presence of abundant proteins or proteins with similar masses, which is not possible with traditional proteomics methods.\nIn addition, SWATH-MS can be used to study protein modifications, such as phosphorylation or ubiquitination, which are important for understanding protein function and regulation. It can also be used to study protein-protein interactions, which are critical for understanding cellular processes and disease mechanisms.\nOverall, SWATH-MS is a powerful tool for proteomics research, providing a comprehensive and accurate view of the proteome, and enabling the study of protein modifications and interactions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SWATH-MS is used in proteomics research.\n2. The main application of SWATH-MS in proteomics is to quantitatively and comprehensively analyze proteins in complex samples.\n3. SWATH-MS allows for the simultaneous analysis of multiple proteins in a single sample.\n4. SWATH-MS can be used to study protein modifications such as phosphorylation or ubiquitination.\n5. SWATH-MS can also be used to study protein-protein interactions.",
    "vicuna-7b_fact": [
      "SWATH-MS is used in proteomics research.",
      "The main application of SWATH-MS in proteomics is to quantitatively and comprehensively analyze proteins in complex samples.",
      "SWATH-MS allows for the simultaneous analysis of multiple proteins in a single sample.",
      "SWATH-MS can be used to study protein modifications such as phosphorylation or ubiquitination.",
      "SWATH-MS can also be used to study protein-protein interactions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While SWATH-MS can provide quantitative information about proteins, it does not directly facilitate the study of protein-protein interactions. Techniques like Co-Immunoprecipitation, Yeast 2 Hybrid, etc. are used to study protein-protein interactions.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 949,
    "user_query": "Do R-loops tend to form at sites of DNA replication?",
    "vicuna-7b_response": "Yes, R-loops tend to form at sites of DNA replication. R-loops, or replication origin recognition complex (ORC) protein-DNA complexes, are formed at the sites of DNA replication to help recruit the replicative helicase and initiate the replication process.\nDuring the S phase of the cell cycle, the replication machinery moves along the DNA molecule, synthesizing new DNA strands in the 5' to 3' direction. As the replication machinery approaches a replication origin, it encounters the R-loop, which is formed by the interaction of ORC proteins with the DNA template strand.\nThe R-loop helps to stabilize the replication fork and recruit the replicative helicase, which is responsible for unwinding the DNA double helix and synthesizing new DNA strands. The R-loop also helps to prevent the replication machinery from moving too far ahead of the replication origin, which could lead to the formation of double-stranded breaks in the DNA molecule.\nIn summary, R-loops are an important component of the replication machinery and play a crucial role in the initiation and progression of DNA replication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. R-loops tend to form at sites of DNA replication.\n2. R-loops are formed by the interaction of ORC proteins with the DNA template strand.\n3. The R-loop helps to stabilize the replication fork and recruit the replicative helicase.\n4. The replicative helicase is responsible for unwinding the DNA double helix and synthesizing new DNA strands.\n5. The R-loop helps to prevent the replication machinery from moving too far ahead of the replication origin.",
    "vicuna-7b_fact": [
      "R-loops tend to form at sites of DNA replication.",
      "R-loops are formed by the interaction of ORC proteins with the DNA template strand.",
      "The R-loop helps to stabilize the replication fork and recruit the replicative helicase.",
      "The replicative helicase is responsible for unwinding the DNA double helix and synthesizing new DNA strands.",
      "The R-loop helps to prevent the replication machinery from moving too far ahead of the replication origin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: R-loops are formed by the hybridization of RNA with the DNA template strand, not by the interaction of ORC proteins with the DNA template strand.\n3. FALSE [correction]: The R-loop can actually destabilize the replication fork and hinder replication rather than help to stabilize the replication fork and recruit the replicative helicase.\n4. TRUE\n5. FALSE [correction]: The R-loop does not help to prevent the replication machinery from moving too far ahead of the replication origin; instead, it can cause genomic instability if not properly resolved.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 951,
    "user_query": "What are the structures formed when keratin molecules come together?",
    "vicuna-7b_response": "Keratin molecules are long, fibrous proteins that make up the structural components of hair, nails, and skin. When keratin molecules come together, they form structures called keratin fibers.\nKeratin fibers are composed of multiple layers of keratin molecules that are arranged in a specific way to create a strong, rigid structure. The layers of keratin molecules are held together by hydrogen bonds, which give the fibers their strength and rigidity.\nThe structure of keratin fibers can vary depending on the type of tissue they are found in. For example, hair keratin fibers are thicker and more rigid than keratin fibers found in skin or nails.\nOverall, keratin fibers are an important component of the skin, hair, and nails, providing structure and support to these tissues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Keratin molecules are long, fibrous proteins that make up the structural components of hair, nails, and skin.\n2. When keratin molecules come together, they form structures called keratin fibers.\n3. Keratin fibers are composed of multiple layers of keratin molecules arranged in a specific structure, held together by hydrogen bonds.\n4. The structure of keratin fibers can vary depending on the type of tissue they are found in.\n5. Keratin fibers provide structure and support to the skin, hair, and nails.",
    "vicuna-7b_fact": [
      "Keratin molecules are long, fibrous proteins that make up the structural components of hair, nails, and skin.",
      "When keratin molecules come together, they form structures called keratin fibers.",
      "Keratin fibers are composed of multiple layers of keratin molecules arranged in a specific structure, held together by hydrogen bonds.",
      "The structure of keratin fibers can vary depending on the type of tissue they are found in.",
      "Keratin fibers provide structure and support to the skin, hair, and nails."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 953,
    "user_query": "Which are the main features of CREST and other ALS-linked proteins?",
    "vicuna-7b_response": "CREST (Corticospinal and Reticulospinal Tracts) is a group of proteins that are involved in the development and function of the nervous system. Some of the main features of CREST and other ALS-linked proteins include:\n1. Motor neuron degeneration: CREST proteins are involved in the development and function of motor neurons, which are the nerve cells that control muscle movement. Mutations in CREST proteins have been linked to the development of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects motor neurons.\n2. Protein structure and function: CREST proteins are involved in the structure and function of the cytoskeleton, which is a network of protein fibers that provide support and guidance for cells. Mutations in CREST proteins can disrupt the normal function of the cytoskeleton and lead to cellular dysfunction and death.\n3. Signal transduction: CREST proteins are involved in the transmission of signals between cells, which is important for the proper function of the nervous system. Mutations in CREST proteins can disrupt signal transduction and lead to cellular dysfunction and death.\n4. Cellular trafficking: CREST proteins are involved in the transport of proteins and other molecules within cells. Mutations in CREST proteins can disrupt cellular trafficking and lead to cellular dysfunction and death.\nOverall, CREST proteins play important roles in the development and function of the nervous system, and mutations in these proteins have been linked to the development of ALS and other neurodegenerative diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CREST proteins are involved in the development and function of the nervous system.\n2. Mutations in CREST proteins have been linked to the development of Amyotrophic Lateral Sclerosis (ALS).\n3. CREST proteins are involved in the structure and function of the cytoskeleton.\n4. CREST proteins are involved in the transmission of signals between cells.\n5. CREST proteins are involved in the transport of proteins and other molecules within cells.",
    "vicuna-7b_fact": [
      "CREST proteins are involved in the development and function of the nervous system.",
      "Mutations in CREST proteins have been linked to the development of Amyotrophic Lateral Sclerosis (ALS).",
      "CREST proteins are involved in the structure and function of the cytoskeleton.",
      "CREST proteins are involved in the transmission of signals between cells.",
      "CREST proteins are involved in the transport of proteins and other molecules within cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CREST proteins are not directly involved in the structure and function of the cytoskeleton, but they might influence it indirectly.\n4. FALSE [correction]: CREST proteins are not involved in the transmission of signals between cells; they are associated with the regulation of gene expression.\n5. FALSE [correction]: CREST proteins are not involved in the transport of proteins and other molecules within cells; they are mainly associated with chromatin remodeling.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 955,
    "user_query": "What is the relationship between nucleosomes and exons?",
    "vicuna-7b_response": "Nucleosomes and exons are both important components of chromatin, the complex of DNA and proteins that makes up the chromosomes in the nucleus of a cell.\nNucleosomes are composed of histone proteins that wrap around the DNA molecule to compact it into a smaller space. This compacted form of chromatin is more stable and easier to work with by the cell's machinery. The position of the nucleosomes along the DNA molecule is important because it determines the accessibility of the DNA to the cell's machinery, such as the enzymes that read the DNA sequence to make RNA.\nExons are the stretches of DNA that are transcribed into mRNA, the molecule that carries the genetic information from the nucleus to the cytoplasm of the cell, where it can be translated into proteins. The exons are separated by introns, which are stretches of DNA that are not included in the final mRNA molecule. The process of splicing, in which the introns are removed and the exons are joined together, takes place in the nucleus.\nSo, the relationship between nucleosomes and exons is that nucleosomes are involved in compacting the DNA into chromatin, and the position of the nucleosomes determines the accessibility of the DNA to the cell's machinery, while exons are the stretches of DNA that are transcribed into mRNA and are separated by introns.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nucleosomes and exons are components of chromatin.\n2. Nucleosomes are composed of histone proteins that wrap around the DNA molecule to compact it.\n3. The position of the nucleosomes along the DNA molecule determines the accessibility of the DNA to the cell's machinery.\n4. Exons are the stretches of DNA that are transcribed into mRNA.\n5. Introns are stretches of DNA that are not included in the final mRNA molecule.",
    "vicuna-7b_fact": [
      "Nucleosomes and exons are components of chromatin.",
      "Nucleosomes are composed of histone proteins that wrap around the DNA molecule to compact it.",
      "The position of the nucleosomes along the DNA molecule determines the accessibility of the DNA to the cell's machinery.",
      "Exons are the stretches of DNA that are transcribed into mRNA.",
      "Introns are stretches of DNA that are not included in the final mRNA molecule."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Nucleosomes are components of chromatin, but exons are parts of genes, not chromatin. \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 956,
    "user_query": "List programs suitable for pharmacophore modelling",
    "vicuna-7b_response": "Pharmacophore modeling is a computational method used to identify the structural features of a molecule that are responsible for its biological activity. Here are some programs that can be used for pharmacophore modeling:\n1. LigandScout: This is a pharmacophore modeling software that uses a combination of machine learning algorithms and statistical methods to identify pharmacophores. It can also be used to predict the binding affinity of a molecule.\n2. PharmFarm: This is a pharmacophore modeling software that uses a combination of machine learning algorithms and statistical methods to identify pharmacophores. It can also be used to predict the binding affinity of a molecule.\n3. Pharmacophore Elucidation System (PES): This is a pharmacophore modeling software that uses a combination of machine learning algorithms and statistical methods to identify pharmacophores. It can also be used to predict the binding affinity of a molecule.\n4. LigandScout Pro: This is an advanced version of LigandScout that includes additional features such as advanced clustering algorithms, advanced statistical methods, and advanced machine learning algorithms.\n5. Pharmacophore Elucidation System (PES) Pro: This is an advanced version of PES that includes additional features such as advanced clustering algorithms, advanced statistical methods, and advanced machine learning algorithms.\n6. Pharmacophore Elucidation System (PES) Enterprise: This is a commercial version of PES that includes additional features such as advanced clustering algorithms, advanced statistical methods, and advanced machine learning algorithms. It also includes advanced reporting and visualization tools.\nThese are some of the popular programs used for pharmacophore modeling. However, it is important to note that the choice of software depends on the specific requirements of the user and the available resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pharmacophore modeling is a computational method used to identify the structural features of a molecule that are responsible for its biological activity.\n2. LigandScout is a software program that can be used for pharmacophore modeling.\n3. PharmFarm is a software program for pharmacophore modeling, and it uses machine learning algorithms and statistical methods to identify pharmacophores.\n4. Pharmacophore Elucidation System (PES) is a software program that can be used for pharmacophore modeling.\n5. LigandScout Pro is an advanced version of LigandScout with additional features.\n6. Pharmacophore Elucidation System (PES) Pro and PES Enterprise are advanced versions of PES with additional features.",
    "vicuna-7b_fact": [
      "Pharmacophore modeling is a computational method used to identify the structural features of a molecule that are responsible for its biological activity.",
      "LigandScout is a software program that can be used for pharmacophore modeling.",
      "PharmFarm is a software program for pharmacophore modeling, and it uses machine learning algorithms and statistical methods to identify pharmacophores.",
      "Pharmacophore Elucidation System (PES) is a software program that can be used for pharmacophore modeling.",
      "LigandScout Pro is an advanced version of LigandScout with additional features.",
      "Pharmacophore Elucidation System (PES) Pro and PES Enterprise are advanced versions of PES with additional features."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 959,
    "user_query": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?",
    "vicuna-7b_response": "Circulating tumour DNA (ctDNA) is a type of DNA that is present in the bloodstream of cancer patients. ctDNA can be used as a biomarker for the early detection and monitoring of cancer. There are several methods for ctDNA detection, including:\n1. Polymerase chain reaction (PCR): PCR is a method that amplifies specific DNA sequences. It is commonly used to detect ctDNA in the bloodstream.\n2. Next-generation sequencing (NGS): NGS is a technique that allows for the analysis of large amounts of DNA sequencing data. It is often used to detect ctDNA in the bloodstream.\n3. Digital PCR (dPCR): dPCR is a method that allows for the precise quantification of DNA molecules. It is commonly used to detect ctDNA in the bloodstream.\n4. Droplet digital PCR (ddPCR): ddPCR is a method that allows for the precise quantification of DNA molecules. It is commonly used to detect ctDNA in the bloodstream.\n5. Massively parallel sequencing (MPS): MPS is a technique that allows for the analysis of large amounts of DNA sequencing data. It is often used to detect ctDNA in the bloodstream.\nThese are some of the most common methods for ctDNA detection. The choice of method will depend on the specific application and the type of cancer being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ctDNA can be detected in the bloodstream of cancer patients.\n2. Polymerase chain reaction (PCR), a method that amplifies specific DNA sequences, is commonly used to detect ctDNA.\n3. Next-generation sequencing (NGS), a technique that analyzes large amounts of DNA sequencing data, is often used to detect ctDNA.\n4. Digital PCR (dPCR), a method that allows for the precise quantification of DNA molecules, is used to detect ctDNA.\n5. Massively parallel sequencing (MPS), a technique that allows for the analysis of large amounts of DNA sequencing data, is used to detect ctDNA.",
    "vicuna-7b_fact": [
      "ctDNA can be detected in the bloodstream of cancer patients.",
      "Polymerase chain reaction (PCR), a method that amplifies specific DNA sequences, is commonly used to detect ctDNA.",
      "Next-generation sequencing (NGS), a technique that analyzes large amounts of DNA sequencing data, is often used to detect ctDNA.",
      "Digital PCR (dPCR), a method that allows for the precise quantification of DNA molecules, is used to detect ctDNA.",
      "Massively parallel sequencing (MPS), a technique that allows for the analysis of large amounts of DNA sequencing data, is used to detect ctDNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 960,
    "user_query": "Which gene is associated with Muenke syndrome?",
    "vicuna-7b_response": "Muenke syndrome is a genetic disorder caused by mutations in the PAX6 gene. The PAX6 gene provides instructions for making a protein that is involved in the development of the eye and the brain. Mutations in the PAX6 gene can cause Muenke syndrome by disrupting the normal function of the protein and leading to vision problems and other abnormalities.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Muenke syndrome is a genetic disorder.\n2. Muenke syndrome is caused by mutations in the PAX6 gene.\n3. The PAX6 gene provides instructions for making a protein.\n4. This protein is involved in the development of the eye and the brain.\n5. Mutations in the PAX6 gene can lead to vision problems and other abnormalities.",
    "vicuna-7b_fact": [
      "Muenke syndrome is a genetic disorder.",
      "Muenke syndrome is caused by mutations in the PAX6 gene.",
      "The PAX6 gene provides instructions for making a protein.",
      "This protein is involved in the development of the eye and the brain.",
      "Mutations in the PAX6 gene can lead to vision problems and other abnormalities."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Muenke syndrome is caused by mutations in the FGFR3 gene, not the PAX6 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-7b_response": "STAT3 (signal transducer and activator of transcription 3) is a transcription factor that plays a role in various cellular processes, including cell growth, differentiation, and survival. It has been shown to be involved in the regulation of autophagy, a process of cellular self-digestion that is important for maintaining cellular homeostasis.\nEIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) is a kinase that plays a role in the regulation of cellular metabolism and autophagy. It has been shown to be involved in the suppression of autophagy in response to various stimuli, such as nutrient availability and stress.\nThere is evidence to suggest that STAT3 may be involved in the EIF2AK2-dependent suppression of autophagy. For example, studies have shown that STAT3 can interact with and phosphorylate EIF2AK2, which may play a role in the regulation of autophagy. Additionally, STAT3 has been shown to be involved in the regulation of the expression of genes that are involved in the suppression of autophagy, such as the inhibitor of apoptosis protein (IAP) family member 2 (XIAP).\nOverall, while the exact role of STAT3 in the EIF2AK2-dependent suppression of autophagy is not fully understood, there is evidence to suggest that it may play a role in this process. Further research is needed to fully elucidate the relationship between STAT3 and EIF2AK2 in the regulation of autophagy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. STAT3 is a transcription factor that plays a role in various cellular processes, including cell growth, differentiation, and survival.\n2. STAT3 is involved in the regulation of autophagy, a process of cellular self-digestion.\n3. EIF2AK2 is a kinase that plays a role in the regulation of cellular metabolism and autophagy.\n4. There is evidence to suggest that STAT3 may be involved in the EIF2AK2-dependent suppression of autophagy.\n5. Studies indicate that STAT3 can interact with and phosphorylate EIF2AK2.",
    "vicuna-7b_fact": [
      "STAT3 is a transcription factor that plays a role in various cellular processes, including cell growth, differentiation, and survival.",
      "STAT3 is involved in the regulation of autophagy, a process of cellular self-digestion.",
      "EIF2AK2 is a kinase that plays a role in the regulation of cellular metabolism and autophagy.",
      "There is evidence to suggest that STAT3 may be involved in the EIF2AK2-dependent suppression of autophagy.",
      "Studies indicate that STAT3 can interact with and phosphorylate EIF2AK2."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 965,
    "user_query": "What are the Topological Domains (TADs)?",
    "vicuna-7b_response": "Topological domains (TADs) are a concept in mathematics and theoretical computer science that refers to a set of points in a topological space that are \"close\" to each other in a certain sense. In other words, a topological domain is a set of points in a topological space that can be connected to each other by a continuous path.\nIn the context of theoretical computer science, TADs are used to model the behavior of algorithms and the complexity of computational problems. Specifically, a TAD is a set of points in a topological space that can be reached from each other by a sequence of operations that are allowed by a particular algorithm or problem.\nFor example, consider the problem of finding the shortest path between two points in a graph. In this case, the topological domain of the problem would be the set of all possible paths between the two points, since any path that connects the two points can be used to find the shortest path.\nIn summary, topological domains are a way of modeling the behavior of algorithms and the complexity of computational problems in a topological space. They are used to study the properties of algorithms and the complexity of computational problems, and to understand how different algorithms and problems are related to each other.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Topological domains (TADs) are a concept in mathematics and theoretical computer science.\n2. TADs refer to a set of points in a topological space that can be connected to each other by a continuous path.\n3. In theoretical computer science, TADs are used to model the behavior of algorithms and the complexity of computational problems.\n4. A TAD is a set of points in a topological space that can be reached from each other by a sequence of operations allowed by an algorithm or problem.\n5. Topological domains are used to study the properties of algorithms and the complexity of computational problems.",
    "vicuna-7b_fact": [
      "Topological domains (TADs) are a concept in mathematics and theoretical computer science.",
      "TADs refer to a set of points in a topological space that can be connected to each other by a continuous path.",
      "In theoretical computer science, TADs are used to model the behavior of algorithms and the complexity of computational problems.",
      "A TAD is a set of points in a topological space that can be reached from each other by a sequence of operations allowed by an algorithm or problem.",
      "Topological domains are used to study the properties of algorithms and the complexity of computational problems."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Topological domains (TADs) are a concept in genomics, not mathematics or theoretical computer science.\n2. FALSE [correction]: TADs refer to a self-interacting genomic region, meaning that DNA sequences within a TAD physically interact with each other more frequently than with sequences outside the TAD.\n3. FALSE [correction]: In genomics, not theoretical computer science, TADs are used to model the spatial organization of the genome.\n4. FALSE [correction]: A TAD is a self-interacting genomic region, DNA sequences within a TAD physically interact with each other more frequently than with sequences outside the TAD; it does not relate to a sequence of operations in an algorithm or problem.\n5. FALSE [correction]: Topological domains are used to study the spatial organization of the genome and their role in gene regulation, not the properties of algorithms and complexity of computational problems.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 966,
    "user_query": "What is the vibrational theory of olfaction?",
    "vicuna-7b_response": "The vibrational theory of olfaction is a model that proposes that odors are caused by the vibrational modes of molecules. This theory suggests that the sense of smell is triggered by the vibrational motion of molecules in the air, which is detected by specialized receptors in the nose.\nAccording to this theory, the molecules in a substance have a specific set of vibrational modes that are responsible for its odor. These vibrational modes are what give the substance its unique smell. When the molecules in the air are in a state that matches one of these vibrational modes, the receptors in the nose are triggered and the sense of smell is perceived.\nThe vibrational theory of olfaction is supported by research that has shown that the odor of a substance can be altered by changing the vibrational modes of its molecules. For example, research has shown that the odor of a substance can be changed by adding or removing a hydrogen atom, which can alter the vibrational modes of the molecules.\nOverall, the vibrational theory of olfaction is a useful model for understanding how the sense of smell works and how odors are perceived. It provides a framework for understanding how the chemical properties of substances can give rise to their unique odors, and it has been used to explain a wide range of olfactory phenomena.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The vibrational theory of olfaction is a model that proposes that odors are caused by the vibrational modes of molecules.\n2. The theory suggests that the vibrational motion of molecules in the air is detected by specialized receptors in the nose.\n3. The molecules in a substance have a specific set of vibrational modes that are responsible for its odor, according to the theory.\n4. Research has shown that the odor of a substance can be changed by altering the vibrational modes of its molecules, as per the vibrational theory of olfaction.\n5. This theory provides a framework for understanding how the chemical properties of substances can give rise to their unique odors.",
    "vicuna-7b_fact": [
      "The vibrational theory of olfaction is a model that proposes that odors are caused by the vibrational modes of molecules.",
      "The theory suggests that the vibrational motion of molecules in the air is detected by specialized receptors in the nose.",
      "The molecules in a substance have a specific set of vibrational modes that are responsible for its odor, according to the theory.",
      "Research has shown that the odor of a substance can be changed by altering the vibrational modes of its molecules, as per the vibrational theory of olfaction.",
      "This theory provides a framework for understanding how the chemical properties of substances can give rise to their unique odors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 971,
    "user_query": "Which deiodinases are best known to be present in brain?",
    "vicuna-7b_response": "The best known deiodinases present in the brain are type 2 (D2) and type 3 (D3) deiodinases. These enzymes play important roles in regulating the levels of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) in the brain.\nType 2 deiodinase (D2) is primarily found in the brain and is responsible for converting the inactive form of T4 (tetraiodothyronine, T4) into the active form of T3. D2 is also involved in the regulation of the levels of the hormone calcitonin.\nType 3 deiodinase (D3) is also found in the brain and is responsible for converting T4 into T3. However, D3 is less active than D2 and is thought to play a less important role in regulating thyroid hormone levels in the brain.\nOther deiodinases, such as type 1 (D1) and type 4 (D4), are also present in the brain, but their functions are less well understood.\nOverall, D2 and D3 are the best known deiodinases present in the brain and play important roles in regulating thyroid hormone levels in this tissue.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Type 2 (D2) and type 3 (D3) deiodinases are known to be present in the brain.\n2. D2 and D3 deiodinases regulate the levels of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) in the brain.\n3. Type 2 deiodinase (D2) converts the inactive form of T4 into the active form of T3 and is also involved in the regulation of the hormone calcitonin.\n4. Type 3 deiodinase (D3) also converts T4 into T3 but is less active than D2.\n5. Other deiodinases, such as type 1 (D1) and type 4 (D4), are also present in the brain, but their functions are less understood.",
    "vicuna-7b_fact": [
      "Type 2 (D2) and type 3 (D3) deiodinases are known to be present in the brain.",
      "D2 and D3 deiodinases regulate the levels of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) in the brain.",
      "Type 2 deiodinase (D2) converts the inactive form of T4 into the active form of T3 and is also involved in the regulation of the hormone calcitonin.",
      "Type 3 deiodinase (D3) also converts T4 into T3 but is less active than D2.",
      "Other deiodinases, such as type 1 (D1) and type 4 (D4), are also present in the brain, but their functions are less understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Type 2 deiodinase (D2) converts the inactive form of T4 into the active form of T3 but is not involved in the regulation of the hormone calcitonin.\n4. FALSE [correction]: Type 3 deiodinase (D3) converts T4 into reverse T3 which is biologically inactive, not into the active form of T3.\n5. FALSE [correction]: Only three types of deiodinases (D1, D2 and D3) are known, and there is no type 4 deiodinase (D4).",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-7b_response": "Theatre is a software tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting genomic data. It is designed to help researchers and clinicians to identify genetic variants that are associated with disease, and to understand the functional impact of these variants on gene expression and protein function.\nTheatre provides a user-friendly interface that allows users to easily navigate and analyze large-scale genomic data sets. It includes a range of tools for data visualization, variant annotation, and functional analysis, which can be used to identify and prioritize genetic variants for further study.\nOne of the key features of Theatre is its ability to integrate data from a variety of sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data. This allows users to analyze data from multiple angles and to gain a more comprehensive understanding of the genetic and functional changes that occur in disease.\nIn addition, Theatre includes a range of tools for functional analysis, such as gene set enrichment analysis and pathway analysis, which can be used to identify genes and pathways that are associated with disease. This information can be used to develop new diagnostic tools and therapeutic strategies.\nOverall, Theatre is a powerful tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting large-scale genomic data sets. It is widely used by researchers and clinicians in the fields of genomics, genetics, and personalized medicine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Theatre is a software tool for genomic analysis.\n2. Theatre is designed to help researchers and clinicians identify genetic variants associated with disease and understand their functional impact.\n3. Theatre's features include data visualization, variant annotation, and functional analysis tools.\n4. Theatre can integrate data from various sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data.\n5. Theatre is used by researchers and clinicians in the fields of genomics, genetics, and personalized medicine.",
    "vicuna-7b_fact": [
      "Theatre is a software tool for genomic analysis.",
      "Theatre is designed to help researchers and clinicians identify genetic variants associated with disease and understand their functional impact.",
      "Theatre's features include data visualization, variant annotation, and functional analysis tools.",
      "Theatre can integrate data from various sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data.",
      "Theatre is used by researchers and clinicians in the fields of genomics, genetics, and personalized medicine."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Theatre is not known as a software tool for genomic analysis.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 974,
    "user_query": "How are CRM (cis-regulatory modules) defined?",
    "vicuna-7b_response": "CRMs, or cis-regulatory modules, are regions of DNA that control the expression of genes. They are typically located near the start of a gene and consist of a sequence of nucleotides that bind to transcription factors, which are proteins that regulate gene expression.\nThere are several ways in which CRMs can be defined. One common method is to use computational approaches, such as motif discovery algorithms, to identify regions of DNA that are likely to be bound by transcription factors. These regions are then defined as CRMs.\nAnother way to define CRMs is to use experimental approaches, such as chromatin immunoprecipitation (ChIP) or DNA microarray analysis. In these methods, researchers can identify the proteins that bind to a specific region of DNA and determine the regulatory regions that are associated with those proteins.\nOnce a CRM is identified, researchers can use a variety of techniques to study its function, including mutagenesis, overexpression, and RNA interference. These techniques can be used to determine the role of the CRM in regulating gene expression and to identify the specific transcription factors that bind to the CRM.\nOverall, the definition and identification of CRMs is a complex and multifaceted process that involves both computational and experimental approaches.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cis-regulatory modules (CRMs) are regions of DNA that control the expression of genes.\n2. CRMs are typically located near the start of a gene and consist of a sequence of nucleotides that bind to transcription factors.\n3. One method to define CRMs is to use computational approaches like motif discovery algorithms to identify regions of DNA likely to be bound by transcription factors.\n4. Another way to define CRMs is by using experimental approaches such as chromatin immunoprecipitation (ChIP) or DNA microarray analysis.\n5. Once a CRM is identified, mutagenesis, overexpression, and RNA interference can be used to study its function and to identify the specific transcription factors that bind to the CRM.",
    "vicuna-7b_fact": [
      "Cis-regulatory modules (CRMs) are regions of DNA that control the expression of genes.",
      "CRMs are typically located near the start of a gene and consist of a sequence of nucleotides that bind to transcription factors.",
      "One method to define CRMs is to use computational approaches like motif discovery algorithms to identify regions of DNA likely to be bound by transcription factors.",
      "Another way to define CRMs is by using experimental approaches such as chromatin immunoprecipitation (ChIP) or DNA microarray analysis.",
      "Once a CRM is identified, mutagenesis, overexpression, and RNA interference can be used to study its function and to identify the specific transcription factors that bind to the CRM."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 978,
    "user_query": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?",
    "vicuna-7b_response": "Treslin/TICRR is a protein that interacts with various factors throughout the cell cycle of human cells. One such factor is the cyclin-dependent kinase inhibitor p21, which interacts with Treslin/TICRR to regulate the G1 phase of the cell cycle.\nDuring the G1 phase, p21 acts as a negative regulator of cyclin-dependent kinases (CDKs), which are enzymes that promote cell division. p21 binds to and inhibits the activity of CDKs, preventing them from phosphorylating and activating the cyclin proteins that are required for cell division.\nTreslin/TICRR, on the other hand, promotes the degradation of p21, allowing the activity of CDKs to increase and allowing the cell to progress through the G1 phase and into the S phase of the cell cycle.\nIn addition to its interaction with p21, Treslin/TICRR has also been shown to interact with other factors, such as the retinoblastoma protein (pRb) and the tumor suppressor protein p53, to regulate cell cycle progression and prevent the development of cancer.\nOverall, Treslin/TICRR plays a crucial role in regulating the cell cycle of human cells by interacting with various factors, including p21, pRb, and p53, to promote cell division and prevent the development of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Treslin/TICRR is a protein that interacts with various factors throughout the cell cycle of human cells.\n2. One of those factors is the cyclin-dependent kinase inhibitor p21, which interacts with Treslin/TICRR to regulate the G1 phase of the cell cycle.\n3. p21 binds to and inhibits the activity of cyclin-dependent kinases (CDKs), preventing them from activating the cyclin proteins required for cell division.\n4. Treslin/TICRR promotes the degradation of p21, allowing the activity of CDKs to increase and the cell to progress through the G1 phase.\n5. Treslin/TICRR also interacts with retinoblastoma protein (pRb) and the tumor suppressor protein p53 to regulate cell cycle progression and prevent the development of cancer.",
    "vicuna-7b_fact": [
      "Treslin/TICRR is a protein that interacts with various factors throughout the cell cycle of human cells.",
      "One of those factors is the cyclin-dependent kinase inhibitor p21, which interacts with Treslin/TICRR to regulate the G1 phase of the cell cycle.",
      "p21 binds to and inhibits the activity of cyclin-dependent kinases (CDKs), preventing them from activating the cyclin proteins required for cell division.",
      "Treslin/TICRR promotes the degradation of p21, allowing the activity of CDKs to increase and the cell to progress through the G1 phase.",
      "Treslin/TICRR also interacts with retinoblastoma protein (pRb) and the tumor suppressor protein p53 to regulate cell cycle progression and prevent the development of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 981,
    "user_query": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
    "vicuna-7b_response": "When managing patients with suspected acute opioid overdose, naloxone is the medication of choice. Naloxone is an opioid antagonist that can quickly reverse the effects of an opioid overdose by blocking the opioid receptors in the brain. It is administered via intramuscular or intravenous injection and can be lifesaving in these situations.\nIt is important to note that naloxone should only be administered by trained healthcare professionals, as it can cause withdrawal symptoms in patients who are physically dependent on opioids. Additionally, it is important to seek emergency medical assistance immediately after administering naloxone, as further treatment may be necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. When managing patients with suspected acute opioid overdose, naloxone is the medication of choice.\n2. Naloxone is an opioid antagonist that can quickly reverse the effects of an opioid overdose by blocking the opioid receptors in the brain.\n3. Naloxone is administered via intramuscular or intravenous injection.\n4. Naloxone can cause withdrawal symptoms in patients who are physically dependent on opioids.\n5. It is important to seek emergency medical assistance immediately after administering naloxone, as further treatment may be necessary.",
    "vicuna-7b_fact": [
      "When managing patients with suspected acute opioid overdose, naloxone is the medication of choice.",
      "Naloxone is an opioid antagonist that can quickly reverse the effects of an opioid overdose by blocking the opioid receptors in the brain.",
      "Naloxone is administered via intramuscular or intravenous injection.",
      "Naloxone can cause withdrawal symptoms in patients who are physically dependent on opioids.",
      "It is important to seek emergency medical assistance immediately after administering naloxone, as further treatment may be necessary."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 982,
    "user_query": "In which nuclear compartments is heterochromatin located?",
    "vicuna-7b_response": "Heterochromatin is a type of chromatin that is characterized by its condensed and heterogeneous distribution in the nucleus. It is found in several nuclear compartments, including:\n1. Nucleolar organizer regions (NORs): These regions are found in the nucleolus and are involved in the formation of ribosomal RNA.\n2. Telomeres: These regions are found at the ends of chromosomes and are involved in the protection of chromosomes from degradation.\n3. Perichromatin fibrils (PCFs): These regions are found between the chromatin fibers and are involved in the compaction of chromatin.\n4. Nucleolar satellite regions (NSRs): These regions are found outside the nucleolus and are involved in the regulation of ribosomal RNA synthesis.\nOverall, heterochromatin is found in various regions of the nucleus and plays important roles in the regulation of gene expression and chromosome stability.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Heterochromatin is a type of chromatin found in various regions of the nucleus.\n2. Nucleolar organizer regions (NORs), a type of heterochromatin, are found in the nucleolus and are involved in the formation of ribosomal RNA.\n3. Telomeres, a type of heterochromatin, are found at the ends of chromosomes and are involved in the protection of chromosomes from degradation.\n4. Perichromatin fibrils (PCFs), a type of heterochromatin, are found between the chromatin fibers and are involved in the compaction of chromatin.\n5. Nucleolar satellite regions (NSRs), a type of heterochromatin, are found outside the nucleolus and are involved in the regulation of ribosomal RNA synthesis.",
    "vicuna-7b_fact": [
      "Heterochromatin is a type of chromatin found in various regions of the nucleus.",
      "Nucleolar organizer regions (NORs), a type of heterochromatin, are found in the nucleolus and are involved in the formation of ribosomal RNA.",
      "Telomeres, a type of heterochromatin, are found at the ends of chromosomes and are involved in the protection of chromosomes from degradation.",
      "Perichromatin fibrils (PCFs), a type of heterochromatin, are found between the chromatin fibers and are involved in the compaction of chromatin.",
      "Nucleolar satellite regions (NSRs), a type of heterochromatin, are found outside the nucleolus and are involved in the regulation of ribosomal RNA synthesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Perichromatin fibrils (PCFs) are not a type of heterochromatin. They are part of the euchromatin and are involved in the early stages of RNA processing.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 984,
    "user_query": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
    "vicuna-7b_response": "Global genome nucleotide excision repair (GG-NER) is a DNA repair mechanism that is used by bacteria to repair DNA damage caused by various types of lesions, including nucleotide excision repair (NER) lesions. GG-NER is a complex process that involves the action of several enzymes.\nIn bacteria, the enzymes involved in GG-NER include:\n1. Helicases: These enzymes unwind the DNA molecule and separate the damaged region from the undamaged DNA.\n2. Endonucleases: These enzymes cut the DNA molecule at the site of the lesion, creating a gap in the DNA strand.\n3. Exonucleases: These enzymes remove nucleotides from the 5' and 3' ends of the DNA strand, gradually filling in the gap created by the endonucleases.\n4. Ligases: These enzymes join the ends of the DNA strand together, sealing the gap created by the endonucleases.\n5. Polymerases: These enzymes synthesize new DNA molecules to fill in the gap created by the endonucleases, allowing the DNA molecule to be repaired.\nOverall, the enzymes involved in GG-NER work together to repair DNA damage caused by nucleotide excision repair lesions in bacteria.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Global genome nucleotide excision repair (GG-NER) is a DNA repair mechanism used by bacteria for DNA damage repair.\n2. Helicases, which unwind the DNA molecule and separate the damaged region from the undamaged DNA, are involved in GG-NER in bacteria.\n3. Endonucleases, which cut the DNA molecule at the site of the lesion, are also part of the GG-NER process in bacteria.\n4. Exonucleases, which remove nucleotides from the 5' and 3' ends of the DNA strand, are enzymes used in GG-NER in bacteria.\n5. Ligases and Polymerases, which join the ends of the DNA strand together and synthesize new DNA molecules respectively, are also included in the enzymes used in bacterial GG-NER.",
    "vicuna-7b_fact": [
      "Global genome nucleotide excision repair (GG-NER) is a DNA repair mechanism used by bacteria for DNA damage repair.",
      "Helicases, which unwind the DNA molecule and separate the damaged region from the undamaged DNA, are involved in GG-NER in bacteria.",
      "Endonucleases, which cut the DNA molecule at the site of the lesion, are also part of the GG-NER process in bacteria.",
      "Exonucleases, which remove nucleotides from the 5' and 3' ends of the DNA strand, are enzymes used in GG-NER in bacteria.",
      "Ligases and Polymerases, which join the ends of the DNA strand together and synthesize new DNA molecules respectively, are also included in the enzymes used in bacterial GG-NER."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Global genome nucleotide excision repair (GG-NER) is a DNA repair mechanism used by all living organisms, not only bacteria.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Exonucleases, which remove nucleotides from the damaged DNA strand, are enzymes used in GG-NER in bacteria.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 988,
    "user_query": "In which genomic regions are Alu enriched?",
    "vicuna-7b_response": "Alu elements are a class of mobile DNA elements that are enriched in the human genome. They are present in approximately 17% of the human genome and are found in all human chromosomes. Alu elements are known to be enriched in certain genomic regions, such as:\n1. L1 repeat regions: Alu elements are often found in close proximity to L1 repeat regions, which are another class of mobile DNA elements.\n2. Non-coding regions: Alu elements are often found in non-coding regions of the genome, such as intergenic regions and introns.\n3. Gene deserts: Alu elements are also found in gene deserts, which are regions of the genome that are devoid of protein-coding genes.\n4. Chromosome ends: Alu elements are enriched at the ends of chromosomes, particularly at the telomeres, which are the repetitive DNA sequences that protect the ends of chromosomes from degradation.\n5. Heterochromatin: Alu elements are also found in heterochromatin, which is a type of chromatin that is characterized by a high degree of condensation and a low level of transcription.\nIt is important to note that Alu elements are not only enriched in certain genomic regions, but they also have a significant impact on the human genome. They are known to cause genetic instability, and they can also disrupt the expression of nearby genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alu elements belong to a class of mobile DNA elements enriched in the human genome.\n2. Alu elements constitute approximately 17% of the human genome.\n3. Alu elements are not only present but also enriched in L1 repeat regions, non-coding regions, gene deserts, chromosome ends, and heterochromatin.\n4. Alu elements can cause genetic instability and disrupt the expression of nearby genes.\n5. Alu elements are found in all human chromosomes.",
    "vicuna-7b_fact": [
      "Alu elements belong to a class of mobile DNA elements enriched in the human genome.",
      "Alu elements constitute approximately 17% of the human genome.",
      "Alu elements are not only present but also enriched in L1 repeat regions, non-coding regions, gene deserts, chromosome ends, and heterochromatin.",
      "Alu elements can cause genetic instability and disrupt the expression of nearby genes.",
      "Alu elements are found in all human chromosomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Alu elements constitute approximately 11% of the human genome.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 993,
    "user_query": "Are there clinical trials using stem cells for the treatment of cardiac disease?",
    "vicuna-7b_response": "Yes, there are clinical trials using stem cells for the treatment of cardiac disease. Stem cells are a type of cell that has the ability to develop into many different types of cells in the body, including cells that form the heart. Researchers are exploring the use of stem cells to repair damaged heart tissue and potentially treat heart disease.\nThere have been several clinical trials that have used stem cells to treat heart disease. For example, in one trial, researchers used stem cells to create new heart muscle cells in patients with heart failure. Another trial used stem cells to repair damaged heart tissue in patients who had suffered a heart attack.\nWhile the results of these trials are promising, it is important to note that more research is needed to fully understand the potential of stem cells for the treatment of cardiac disease. Additionally, it is important to note that stem cell therapies are still in the experimental stage and are not yet widely available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are clinical trials using stem cells for the treatment of cardiac disease.\n2. Stem cells are a type of cell that has the ability to develop into many different types of cells in the body, including cells that form the heart.\n3. There have been clinical trials where stem cells were used to create new heart muscle cells in patients with heart failure.\n4. Another trial used stem cells to repair damaged heart tissue in patients who had suffered a heart attack.\n5. Stem cell therapies for the treatment of cardiac disease are still in the experimental stage and are not widely available.",
    "vicuna-7b_fact": [
      "There are clinical trials using stem cells for the treatment of cardiac disease.",
      "Stem cells are a type of cell that has the ability to develop into many different types of cells in the body, including cells that form the heart.",
      "There have been clinical trials where stem cells were used to create new heart muscle cells in patients with heart failure.",
      "Another trial used stem cells to repair damaged heart tissue in patients who had suffered a heart attack.",
      "Stem cell therapies for the treatment of cardiac disease are still in the experimental stage and are not widely available."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 996,
    "user_query": "Has Revlimid been approved by the US Food and Drug Administration?",
    "vicuna-7b_response": "Yes, Revlimid (also known as lenalidomide) has been approved by the US Food and Drug Administration (FDA) for the treatment of several conditions, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.\nRevlimid is a prescription medication that is taken orally as a capsule or solution. It works by blocking the action of a protein called \"proteasome,\" which helps to break down abnormal cells in the body. By blocking proteasome, Revlimid can help to slow the growth and proliferation of cancer cells.\nRevlimid has been shown to be effective in clinical trials for the treatment of multiple myeloma, a type of blood cancer that affects the bone marrow. It is typically used in combination with other medications, such as dexamethasone, for the treatment of multiple myeloma.\nRevlimid has also been approved by the FDA for the treatment of MDS, a type of blood disorder in which the bone marrow does not produce enough healthy blood cells. Revlimid is typically used in combination with other medications for the treatment of MDS.\nIn addition, Revlimid has been approved by the FDA for the treatment of mantle cell lymphoma, a type of blood cancer that affects the immune system. It is typically used in combination with other medications, such as rituximab, for the treatment of mantle cell lymphoma.\nIt is important to note that Revlimid may cause side effects, such as diarrhea, nausea, and fatigue. It is important to talk to your healthcare provider about any side effects you may experience while taking Revlimid.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Revlimid, also known as lenalidomide, has been approved by the US Food and Drug Administration (FDA).\n2. Revlimid is approved by the FDA for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.\n3. Revlimid is an oral prescription medication that works by blocking the action of a protein called \"proteasome.\"\n4. Revlimid has shown effectiveness in clinical trials for the treatment of multiple myeloma.\n5. Revlimid can cause side effects, such as diarrhea, nausea, and fatigue.",
    "vicuna-7b_fact": [
      "Revlimid, also known as lenalidomide, has been approved by the US Food and Drug Administration (FDA).",
      "Revlimid is approved by the FDA for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.",
      "Revlimid is an oral prescription medication that works by blocking the action of a protein called \"proteasome.\"",
      "Revlimid has shown effectiveness in clinical trials for the treatment of multiple myeloma.",
      "Revlimid can cause side effects, such as diarrhea, nausea, and fatigue."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Revlimid is an oral prescription medication that works by modulating the immune system and directly affecting cancer cells.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-7b_response": "The Smith-Waterman algorithm is a widely used algorithm for the alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on several factors, including the length of the sequences being aligned, the gap penalty and extension penalty used, and the algorithm's parameters.\nIn general, the execution time of the Smith-Waterman algorithm is O(n^2), where n is the length of the sequences being aligned. This is because the algorithm performs a sliding window search, where it compares each position in one sequence with every position in the other sequence.\nHowever, the actual execution time can be much faster than O(n^2) in practice, depending on the specific implementation and the parameters used. For example, if the gap penalty is set to zero and the extension penalty is set to a large value, the algorithm can be very fast, as it will not allow for any gaps or extensions in the alignment.\nIn summary, the execution time of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), but it can be much faster in practice, depending on the specific implementation and parameters used.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Smith-Waterman algorithm is used for the alignment of two sequences.\n2. The execution time of the Smith-Waterman algorithm is influenced by several factors, including the length of the sequences, the gap penalty and extension penalty used, and the algorithm's parameters.\n3. In general, the execution time of the Smith-Waterman algorithm is O(n^2), where n is the length of the sequences being aligned.\n4. The actual execution time of the Smith-Waterman algorithm can be faster than O(n^2) depending on the specific implementation and parameters used.\n5. If the gap penalty is set to zero and the extension penalty is set to a large value, the Smith-Waterman algorithm becomes fast as it doesn't allow for any gaps or extensions in the alignment.",
    "vicuna-7b_fact": [
      "The Smith-Waterman algorithm is used for the alignment of two sequences.",
      "The execution time of the Smith-Waterman algorithm is influenced by several factors, including the length of the sequences, the gap penalty and extension penalty used, and the algorithm's parameters.",
      "In general, the execution time of the Smith-Waterman algorithm is O(n^2), where n is the length of the sequences being aligned.",
      "The actual execution time of the Smith-Waterman algorithm can be faster than O(n^2) depending on the specific implementation and parameters used.",
      "If the gap penalty is set to zero and the extension penalty is set to a large value, the Smith-Waterman algorithm becomes fast as it doesn't allow for any gaps or extensions in the alignment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1003,
    "user_query": "What is Piebaldism?",
    "vicuna-7b_response": "Piebaldism is a rare genetic disorder characterized by the presence of white and black hairs in the same hair follicle. This results in a patchy, mottled appearance of the hair, with areas of white and black hair intermingled. Piebaldism is caused by a mutation in the KIT gene, which is responsible for the development of melanin, the pigment that gives hair its color.\nPiebaldism is a congenital disorder, meaning that it is present at birth. The severity of the condition can vary, with some individuals having only a few patches of white hair, while others may have a more extensive white and black hair pattern.\nPiebaldism is a relatively rare condition, affecting approximately 1 in every 10,000 individuals. It is more common in people of Southeast Asian and Northern European descent.\nThere is no cure for Piebaldism, and treatment is focused on managing the appearance of the condition. This may include using hair dyes or other cosmetic treatments to cover up the patchy hair pattern. In some cases, surgical hair transplantation may be considered to fill in areas of white hair.\nIt's important to note that Piebaldism is not the same as poliosis, which is a condition characterized by the absence of pigment in the hair. Poliosis can also cause a patchy appearance of the hair, but it is caused by a different genetic mutation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Piebaldism is a rare genetic disorder characterized by white and black hairs intermingling in the same hair follicle.\n2. Piebaldism is caused by a mutation in the KIT gene.\n3. The condition is present at birth and its severity can vary between individuals.\n4. Piebaldism affects approximately 1 in every 10,000 individuals and is more common in people of Southeast Asian and Northern European descent.\n5. Piebaldism is not the same as poliosis, a condition also causing a patchy appearance of the hair but caused by a different genetic mutation.",
    "vicuna-7b_fact": [
      "Piebaldism is a rare genetic disorder characterized by white and black hairs intermingling in the same hair follicle.",
      "Piebaldism is caused by a mutation in the KIT gene.",
      "The condition is present at birth and its severity can vary between individuals.",
      "Piebaldism affects approximately 1 in every 10,000 individuals and is more common in people of Southeast Asian and Northern European descent.",
      "Piebaldism is not the same as poliosis, a condition also causing a patchy appearance of the hair but caused by a different genetic mutation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Piebaldism is a rare genetic disorder characterized by the absence of cells called melanocytes in certain parts of the skin and hair, leading to patches of skin and hair that are white.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-7b_response": "FLVCR1 is a member of the SLC22A1 family.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. FLVCR1 is a member of the SLC22A1 family.",
    "vicuna-7b_fact": [
      "FLVCR1 is a member of the SLC22A1 family."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: FLVCR1 is a member of the SLC49A1 family.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 1008,
    "user_query": "Which inherited disorder is known to be caused by mutations in the NEMO gene?",
    "vicuna-7b_response": "The inherited disorder known to be caused by mutations in the NEMO gene is called X-linked agammaglobulinemia (XLA).\nXLA is a genetic disorder characterized by a lack of immunoglobulin A (IgA) production, which is an essential component of the immune system. This disorder is caused by mutations in the NEMO gene, which is located on the X chromosome and is responsible for regulating the immune system.\nMutations in the NEMO gene can lead to a reduction in the production of immunoglobulin A, which can result in a weakened immune system and an increased susceptibility to infections. XLA is inherited in an X-linked recessive pattern, meaning that males are more severely affected than females, as they only have one X chromosome.\nXLA is a rare disorder, and treatment options are limited. However, with proper medical care, individuals with XLA can lead healthy and fulfilling lives.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. X-linked agammaglobulinemia (XLA) is an inherited disorder caused by mutations in the NEMO gene.\n2. XLA is characterized by a lack of immunoglobulin A (IgA) production.\n3. The NEMO gene, located on the X chromosome, regulates the immune system.\n4. Mutations in the NEMO gene can lead to a reduction in the production of IgA and a weakened immune system.\n5. XLA is inherited in an X-linked recessive pattern, meaning that males are more severely affected than females.",
    "vicuna-7b_fact": [
      "X-linked agammaglobulinemia (XLA) is an inherited disorder caused by mutations in the NEMO gene.",
      "XLA is characterized by a lack of immunoglobulin A (IgA) production.",
      "The NEMO gene, located on the X chromosome, regulates the immune system.",
      "Mutations in the NEMO gene can lead to a reduction in the production of IgA and a weakened immune system.",
      "XLA is inherited in an X-linked recessive pattern, meaning that males are more severely affected than females."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: X-linked agammaglobulinemia (XLA) is an inherited disorder caused by mutations in the BTK (Bruton's tyrosine kinase) gene, not the NEMO gene.\n2. TRUE\n3. FALSE [correction]: The NEMO gene, located on the X chromosome, plays a crucial role in the NF-kappaB signaling pathway, which is important in the immune system. However, it is not the gene associated with XLA.\n4. FALSE [correction]: Mutations in the BTK gene can lead to a reduction in the production of all types of immunoglobulins (not only IgA), resulting in a weakened immune system.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1009,
    "user_query": "What is ISMARA?",
    "vicuna-7b_response": "ISMARA is an acronym that stands for \"Intelligent Systems for MArine Renewable Energy\". It is a research field that focuses on the development of intelligent systems and technologies for the efficient and sustainable use of marine renewable energy resources, such as ocean waves, tidal currents, and ocean thermal energy.\nThe main goal of ISMARA is to harness the vast energy potential of the ocean to generate electricity, heat, and other forms of energy, while minimizing the environmental impact of these systems. To achieve this goal, ISMARA researchers use a variety of techniques, including machine learning, artificial intelligence, and control theory, to develop intelligent systems that can optimize the performance of marine renewable energy systems and ensure their safe and efficient operation.\nISMARA is a rapidly growing field that has the potential to play a key role in the transition to a more sustainable and renewable energy system. It is an interdisciplinary field that involves researchers from a variety of backgrounds, including engineering, computer science, physics, and environmental science.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ISMARA is an acronym that stands for \"Intelligent Systems for MArine Renewable Energy\".\n2. ISMARA is a research field that focuses on utilizing marine renewable energy resources, like ocean waves, tidal currents, and ocean thermal energy.\n3. The main goal of ISMARA is to generate electricity, heat, and other forms of energy from the ocean while minimizing the environmental impact of these systems.\n4. Machine learning, artificial intelligence, and control theory are used in ISMARA research to optimize the performance of marine renewable energy systems.\n5. ISMARA is an interdisciplinary field that involves engineering, computer science, physics, and environmental science.",
    "vicuna-7b_fact": [
      "ISMARA is an acronym that stands for \"Intelligent Systems for MArine Renewable Energy\".",
      "ISMARA is a research field that focuses on utilizing marine renewable energy resources, like ocean waves, tidal currents, and ocean thermal energy.",
      "The main goal of ISMARA is to generate electricity, heat, and other forms of energy from the ocean while minimizing the environmental impact of these systems.",
      "Machine learning, artificial intelligence, and control theory are used in ISMARA research to optimize the performance of marine renewable energy systems.",
      "ISMARA is an interdisciplinary field that involves engineering, computer science, physics, and environmental science."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1014,
    "user_query": "What histone variants play a role in the DNA damage reponse?",
    "vicuna-7b_response": "Histone variants play a crucial role in the DNA damage response (DDR) by regulating the accessibility of DNA to repair machinery and modulating the expression of genes involved in the DDR.\nHistone variants are post-transcriptional modifications of histone proteins that are involved in regulating chromatin structure and gene expression. There are several types of histone variants, including histone H2A.X, histone H3.3, and histone H4.1.\nHistone H2A.X is a histone variant that is phosphorylated at serine 139 in response to DNA damage. This phosphorylation event recruits the repair machinery to the site of DNA damage, allowing for the repair of DNA lesions. Additionally, histone H2A.X has been shown to play a role in the recruitment of transcription factors to the site of DNA damage, leading to the activation of genes involved in the DDR.\nHistone H3.3 is a histone variant that is involved in the regulation of chromatin structure and gene expression. In response to DNA damage, histone H3.3 is acetylated, leading to the relaxation of chromatin structure and the accessibility of DNA to repair machinery. This allows for the repair of DNA lesions and the restoration of chromatin structure.\nHistone H4.1 is a histone variant that is involved in the regulation of chromatin structure and gene expression. In response to DNA damage, histone H4.1 is acetylated, leading to the relaxation of chromatin structure and the accessibility of DNA to repair machinery. Additionally, histone H4.1 has been shown to play a role in the recruitment of transcription factors to the site of DNA damage, leading to the activation of genes involved in the DDR.\nIn summary, histone variants play a crucial role in the DNA damage response by regulating the accessibility of DNA to repair machinery and modulating the expression of genes involved in the DDR. Histone H2A.X, histone H3.3, and histone H4.1 are just a few examples of histone variants that are involved in the DDR.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone variants play a crucial role in the DNA damage response (DDR).\n2. Histone variants are post-transcriptional modifications of histone proteins that are involved in regulating chromatin structure and gene expression.\n3. Histone H2A.X, histone H3.3, and histone H4.1 are examples of histone variants.\n4. Histone H2A.X is phosphorylated at serine 139 in response to DNA damage and this recruits repair machinery to the site of DNA damage.\n5. In response to DNA damage, histone H3.3 and histone H4.1 are acetylated, leading to the relaxation of chromatin structure and the accessibility of DNA to repair machinery.",
    "vicuna-7b_fact": [
      "Histone variants play a crucial role in the DNA damage response (DDR).",
      "Histone variants are post-transcriptional modifications of histone proteins that are involved in regulating chromatin structure and gene expression.",
      "Histone H2A.X, histone H3.3, and histone H4.1 are examples of histone variants.",
      "Histone H2A.X is phosphorylated at serine 139 in response to DNA damage and this recruits repair machinery to the site of DNA damage.",
      "In response to DNA damage, histone H3.3 and histone H4.1 are acetylated, leading to the relaxation of chromatin structure and the accessibility of DNA to repair machinery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Histone variants are alternative versions of histone proteins, not post-transcriptional modifications. They play a role in regulating chromatin structure and gene expression.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Histone H3.3 and histone H4.1 are not typically described as being acetylated in response to DNA damage. Instead, another histone variant, histone H2A.X, is commonly noted as being modified (specifically, phosphorylated) in the DNA damage response process.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1019,
    "user_query": "Which disease has been associated to a disruptive ALX1 protein?",
    "vicuna-7b_response": "The ALX1 protein is associated with the development of a disruptive disease called Alstrom syndrome. Alstrom syndrome is a rare genetic disorder that affects multiple organ systems, including the eyes, kidneys, and heart. The disease is caused by mutations in the ALX1 gene, which codes for the ALX1 protein.\nThe ALX1 protein is involved in the development and maintenance of several tissues, including the retina, pancreas, and adipose tissue. In Alstrom syndrome, mutations in the ALX1 gene lead to the production of a non-functional ALX1 protein, which disrupts normal tissue development and function.\nThe symptoms of Alstrom syndrome vary from person to person, but they typically include vision loss, diabetes, and heart problems. The disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated ALX1 gene (one from each parent) to develop the disease.\nThere is no cure for Alstrom syndrome, and treatment is focused on managing the symptoms and preventing complications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ALX1 protein is associated with the development of Alstrom syndrome.\n2. Alstrom syndrome is a rare genetic disorder that affects multiple organ systems, including the eyes, kidneys, and heart.\n3. Alstrom syndrome is caused by mutations in the ALX1 gene.\n4. Symptoms of Alstrom syndrome typically include vision loss, diabetes, and heart problems.\n5. The disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated ALX1 gene to develop the disease.",
    "vicuna-7b_fact": [
      "The ALX1 protein is associated with the development of Alstrom syndrome.",
      "Alstrom syndrome is a rare genetic disorder that affects multiple organ systems, including the eyes, kidneys, and heart.",
      "Alstrom syndrome is caused by mutations in the ALX1 gene.",
      "Symptoms of Alstrom syndrome typically include vision loss, diabetes, and heart problems.",
      "The disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated ALX1 gene to develop the disease."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The ALMS1 protein is associated with the development of Alstrom syndrome.\n2. TRUE\n3. FALSE [correction]: Alstrom syndrome is caused by mutations in the ALMS1 gene.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1022,
    "user_query": "In which yeast chromosome does the rDNA cluster reside?",
    "vicuna-7b_response": "The rDNA cluster, also known as the ribosomal DNA (rDNA) locus, resides on chromosome 5 in yeast.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The ribosomal DNA (rDNA) locus, also known as the rDNA cluster, is located on chromosome 5 in yeast.",
    "vicuna-7b_fact": [
      "The ribosomal DNA (rDNA) locus, also known as the rDNA cluster, is located on chromosome 5 in yeast."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 1023,
    "user_query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "vicuna-7b_response": "Exon skipping is a mechanism used to treat Duchenne muscular dystrophy (DMD) by targeting specific exons in the dystrophin gene. The dystrophin gene contains 79 exons, and mutations in this gene cause DMD. Exon skipping involves the use of small RNA molecules, such as antisense oligonucleotides, to target specific exons and skip over them during mRNA processing. This results in the production of a shorter, functional dystrophin protein that can still perform its functions in the muscle cells.\nThe process of exon skipping involves the use of a small RNA molecule that binds to the exon and blocks its inclusion in the mRNA. This causes the exon to be skipped over during mRNA processing, resulting in the production of a shorter, functional dystrophin protein. The small RNA molecule can be delivered to the muscle cells through various methods, such as intravenous injection or gene therapy.\nExon skipping is a promising treatment for DMD because it targets the specific mutation causing the disease and can result in the production of a functional dystrophin protein. However, the efficacy of exon skipping can vary depending on the specific mutation and the method of delivery. Further research is needed to optimize the use of exon skipping as a treatment for DMD.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Exon skipping is a mechanism used to treat Duchenne muscular dystrophy by targeting specific exons in the dystrophin gene.\n2. The dystrophin gene contains 79 exons, with mutations in this gene causing Duchenne muscular dystrophy.\n3. Exon skipping involves the use of small RNA molecules, such as antisense oligonucleotides, to skip over target exons during mRNA processing.\n4. The process results in a shorter, functional dystrophin protein.\n5. The efficacy of exon skipping can vary depending on the specific mutation and the method of delivery.",
    "vicuna-7b_fact": [
      "Exon skipping is a mechanism used to treat Duchenne muscular dystrophy by targeting specific exons in the dystrophin gene.",
      "The dystrophin gene contains 79 exons, with mutations in this gene causing Duchenne muscular dystrophy.",
      "Exon skipping involves the use of small RNA molecules, such as antisense oligonucleotides, to skip over target exons during mRNA processing.",
      "The process results in a shorter, functional dystrophin protein.",
      "The efficacy of exon skipping can vary depending on the specific mutation and the method of delivery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1028,
    "user_query": "What is the link between Dax1 and Esrrb?",
    "vicuna-7b_response": "Dax1 and Esrrb are two genes that are known to be involved in the development and function of certain types of neurons in the brain.\nDax1, also known as D-type dopamine receptor 1, is a protein that is expressed in the brain and other tissues. It is a G protein-coupled receptor that binds to the neurotransmitter dopamine and plays a role in the regulation of dopamine signaling. Dax1 has been implicated in the development and function of certain types of neurons in the brain, including dopaminergic neurons, which are involved in the regulation of movement and reward.\nEsrrb, also known as estrogen-related receptor beta, is a protein that is expressed in the brain and other tissues. It is a nuclear receptor that binds to steroid hormones, including estrogen, and plays a role in the regulation of gene expression. Esrrb has been implicated in the development and function of certain types of neurons in the brain, including GABAergic neurons, which are involved in the regulation of excitatory and inhibitory neurotransmission.\nWhile the exact link between Dax1 and Esrrb is not fully understood, it is thought that both genes may play a role in the development and function of certain types of neurons in the brain, and that disruptions in the regulation of these genes may contribute to the development of certain neurological disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dax1 and Esrrb are genes that are involved in the development and function of certain types of neurons in the brain.\n2. Dax1, also known as D-type dopamine receptor 1, is a protein expressed in the brain and other tissues.\n3. Dax1 is a G protein-coupled receptor that binds to the neurotransmitter dopamine.\n4. Esrrb, also known as estrogen-related receptor beta, is a protein that is expressed in the brain and other tissues.\n5. Esrrb is a nuclear receptor that binds to steroid hormones, including estrogen.",
    "vicuna-7b_fact": [
      "Dax1 and Esrrb are genes that are involved in the development and function of certain types of neurons in the brain.",
      "Dax1, also known as D-type dopamine receptor 1, is a protein expressed in the brain and other tissues.",
      "Dax1 is a G protein-coupled receptor that binds to the neurotransmitter dopamine.",
      "Esrrb, also known as estrogen-related receptor beta, is a protein that is expressed in the brain and other tissues.",
      "Esrrb is a nuclear receptor that binds to steroid hormones, including estrogen."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Dax1, also known as the dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1, not D-type dopamine receptor 1, is a protein involved in the development of certain types of neurons in the brain.\n3. FALSE [correction]: Dax1 is not a G protein-coupled receptor that binds to the neurotransmitter dopamine. Dax1 is a transcription factor that is involved in the development of the adrenal gland and the reproductive system.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1030,
    "user_query": "Are DNA helicases involved in progeroid syndromes?",
    "vicuna-7b_response": "Yes, DNA helicases are involved in progeroid syndromes.\nProgeroid syndromes are a group of rare genetic disorders that are characterized by premature aging of the skin, hair, and other tissues. These disorders are caused by mutations in genes that encode proteins involved in DNA replication, repair, and maintenance.\nOne of the key proteins involved in these processes is the DNA helicase, which is responsible for untwisting and separating the two strands of DNA during replication and repair. Several progeroid syndromes are caused by mutations in helicase genes, including the WDR5 gene, which encodes a helicase component of the SWI/SNF chromatin-remodeling complex.\nMutations in helicase genes can lead to reduced helicase activity, which can disrupt DNA replication and repair, leading to the accumulation of DNA damage and the premature aging of cells. This is why helicases are involved in progeroid syndromes.\nIn summary, DNA helicases are involved in progeroid syndromes by playing a crucial role in DNA replication, repair, and maintenance. Mutations in helicase genes can lead to reduced helicase activity and the accumulation of DNA damage, which can cause premature aging of cells and lead to the development of progeroid syndromes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Progeroid syndromes are a group of rare genetic disorders characterized by premature aging of the skin, hair, and other tissues.\n2. These disorders are caused by mutations in genes that encode proteins involved in DNA replication, repair, and maintenance.\n3. DNA helicase, which is responsible for untwisting and separating the two strands of DNA during replication and repair, is one of the key proteins involved in these processes.\n4. Several progeroid syndromes are caused by mutations in helicase genes, including the WDR5 gene.\n5. Mutations in helicase genes can lead to reduced helicase activity, which can disrupt DNA replication and repair, leading to the accumulation of DNA damage and the premature aging of cells.",
    "vicuna-7b_fact": [
      "Progeroid syndromes are a group of rare genetic disorders characterized by premature aging of the skin, hair, and other tissues.",
      "These disorders are caused by mutations in genes that encode proteins involved in DNA replication, repair, and maintenance.",
      "DNA helicase, which is responsible for untwisting and separating the two strands of DNA during replication and repair, is one of the key proteins involved in these processes.",
      "Several progeroid syndromes are caused by mutations in helicase genes, including the WDR5 gene.",
      "Mutations in helicase genes can lead to reduced helicase activity, which can disrupt DNA replication and repair, leading to the accumulation of DNA damage and the premature aging of cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Several progeroid syndromes are caused by mutations in helicase genes, for instance in the LMNA, WRN, and BLM genes, rather than the WDR5 gene.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1034,
    "user_query": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?",
    "vicuna-7b_response": "Hsp90 is a molecular chaperone that plays a crucial role in the folding, assembly, and stability of a variety of client proteins, including many that are involved in cell signaling, protein trafficking, and protein degradation. Hsp90 inhibition has been shown to cause the upregulation of several heat shock proteins (Hsps), including Hsp70, Hsp27, and Hsp22.\nHsp70 is a ubiquitous Hsp that is involved in the folding and assembly of client proteins, and its upregulation in response to Hsp90 inhibition has been observed in a variety of cell types and model organisms. Hsp27 is another ubiquitous Hsp that is involved in the regulation of cellular stress responses, and its upregulation in response to Hsp90 inhibition has also been observed in several cell types. Hsp22 is a small, cytosolic Hsp that is involved in the protection of cells against oxidative stress and other forms of cellular damage, and its upregulation in response to Hsp90 inhibition has been observed in several cell types.\nOverall, the upregulation of Hsp70, Hsp27, and Hsp22 in response to Hsp90 inhibition is a well-established phenomenon, and these Hsps are all potential targets for the development of Hsp90 inhibitors as therapeutic agents.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hsp90 is a molecular chaperone that plays a crucial role in the folding, assembly, and stability of a variety of client proteins.\n2. Hsp70, Hsp27, and Hsp22 are upregulated during Hsp90 inhibition.\n3. Hsp70 is involved in the folding and assembly of client proteins.\n4. Hsp27 is involved in the regulation of cellular stress responses.\n5. Hsp22 is a small, cytosolic Hsp that is involved in the protection of cells against oxidative stress and other forms of cellular damage.",
    "vicuna-7b_fact": [
      "Hsp90 is a molecular chaperone that plays a crucial role in the folding, assembly, and stability of a variety of client proteins.",
      "Hsp70, Hsp27, and Hsp22 are upregulated during Hsp90 inhibition.",
      "Hsp70 is involved in the folding and assembly of client proteins.",
      "Hsp27 is involved in the regulation of cellular stress responses.",
      "Hsp22 is a small, cytosolic Hsp that is involved in the protection of cells against oxidative stress and other forms of cellular damage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1036,
    "user_query": "What is the name for anorexia in gymnasts?",
    "vicuna-7b_response": "Anorexia in gymnasts is commonly referred to as \"gymnastics anorexia\" or \"competitive anorexia.\" It is a serious eating disorder that can have severe health consequences, including malnutrition, osteoporosis, and heart problems. Gymnasts who engage in this behavior often have an intense fear of gaining weight and may go to extreme lengths to control their weight, such as skipping meals, vomiting, and using laxatives. It is important for gymnasts and their coaches to be aware of the risks associated with gymnastics anorexia and to prioritize the health and well-being of the gymnast.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Anorexia in gymnasts is commonly referred to as \"gymnastics anorexia\" or \"competitive anorexia.\"\n2. Gymnastics anorexia is a serious eating disorder.\n3. The disorder can potentially result in severe health problems including malnutrition, osteoporosis, and heart problems.\n4. Gymnasts with this disorder often fear gaining weight and engage in extreme behaviors to control their weight.\n5. These behaviors can include skipping meals, vomiting, and using laxatives.",
    "vicuna-7b_fact": [
      "Anorexia in gymnasts is commonly referred to as \"gymnastics anorexia\" or \"competitive anorexia.\"",
      "Gymnastics anorexia is a serious eating disorder.",
      "The disorder can potentially result in severe health problems including malnutrition, osteoporosis, and heart problems.",
      "Gymnasts with this disorder often fear gaining weight and engage in extreme behaviors to control their weight.",
      "These behaviors can include skipping meals, vomiting, and using laxatives."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1038,
    "user_query": "What are the indications for alteplase?",
    "vicuna-7b_response": "Alteplase is a medication that is used to treat acute ischemic stroke. It is given as an intravenous (IV) injection and works by dissolving blood clots in the brain, which can help to restore blood flow and reduce the damage caused by the stroke.\nIndications for alteplase include:\n* Acute ischemic stroke (a type of stroke caused by a blood clot in the brain)\n* Symptoms have started within 4.5 hours of the onset of the stroke\n* The patient is able to receive the injection within 4.5 hours of the onset of the stroke\n* The patient has not had a previous stroke or transient ischemic attack (TIA) within the past 3 months\n* The patient is not pregnant or breastfeeding\nIt is important to note that alteplase should only be given under the supervision of a healthcare professional, and the decision to administer the medication should be based on a careful evaluation of the patient's individual risk factors and medical history.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alteplase is used to treat acute ischemic stroke.\n2. Alteplase is administered as an intravenous (IV) injection.\n3. The drug works by dissolving blood clots in the brain to restore blood flow and reduce stroke damage.\n4. Alteplase can be given if symptoms have started within 4.5 hours of the onset of stroke.\n5. The patient has to be able to receive the injection within 4.5 hours of the onset of the stroke.",
    "vicuna-7b_fact": [
      "Alteplase is used to treat acute ischemic stroke.",
      "Alteplase is administered as an intravenous (IV) injection.",
      "The drug works by dissolving blood clots in the brain to restore blood flow and reduce stroke damage.",
      "Alteplase can be given if symptoms have started within 4.5 hours of the onset of stroke.",
      "The patient has to be able to receive the injection within 4.5 hours of the onset of the stroke."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1039,
    "user_query": "List scaffold proteins of the ERK signaling pathway.",
    "vicuna-7b_response": "The ERK signaling pathway is a key signaling pathway in the regulation of cellular processes such as proliferation, differentiation, and survival. The pathway is activated by the binding of growth factors to their receptors, leading to the activation of the receptor tyrosine kinases (RTKs) such as the epidermal growth factor receptor (EGFR). The activated RTKs phosphorylate and activate the ERK1 and ERK2 kinases, which then phosphorylate and activate downstream targets such as the transcription factors Elk-1 and SAPK/JNK.\nScaffold proteins play a critical role in the regulation of the ERK signaling pathway by serving as platforms for the assembly and activation of signaling complexes. Some of the scaffold proteins that have been identified in the ERK signaling pathway include:\n1. Grb2: Grb2 is a adaptor protein that binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n2. Shc: Shc is a adaptor protein that binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n3. SHC: SHC is a adaptor protein that binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n4. Gab1: Gab1 is a adaptor protein that binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n5. PLC-gamma: PLC-gamma is a enzyme that generates the second messenger molecule diacylglycerol (DAG) from phosphatidylinositol triphosphate (PIP3) which then activates the ERK kinases through the binding of DAG to the pleckstrin homology (PH) domain of the ERK kinases.\n6. Vav: Vav is a guanine nucleotide exchange factor (GEF) that activates the small GTPase Rac1, which in turn activates the ERK kinases by promoting their translocation to the plasma membrane.\n7.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ERK signaling pathway is a key signaling pathway in the regulation of cellular processes such as proliferation, differentiation, and survival. \n2. Scaffold proteins play a critical role in the regulation of the ERK signaling pathway by serving as platforms for the assembly and activation of signaling complexes.\n3. The scaffold protein Grb2 binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n4. The scaffold protein SHC binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.\n5. PLC-gamma, a scaffold protein in the ERK signaling pathway, generates the second messenger molecule diacylglycerol (DAG) from phosphatidylinositol triphosphate (PIP3) which then activates the ERK kinases.",
    "vicuna-7b_fact": [
      "The ERK signaling pathway is a key signaling pathway in the regulation of cellular processes such as proliferation, differentiation, and survival.",
      "Scaffold proteins play a critical role in the regulation of the ERK signaling pathway by serving as platforms for the assembly and activation of signaling complexes.",
      "The scaffold protein Grb2 binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.",
      "The scaffold protein SHC binds to the activated RTKs and recruits the ERK kinases to the plasma membrane.",
      "PLC-gamma, a scaffold protein in the ERK signaling pathway, generates the second messenger molecule diacylglycerol (DAG) from phosphatidylinositol triphosphate (PIP3) which then activates the ERK kinases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The adaptor protein Grb2 binds to the activated RTKs and helps to recruit proteins like SOS and RAF, not the ERK kinases, to the plasma membrane.\n4. FALSE [correction]: The adaptor protein SHC binds to the activated RTKs and helps to recruit proteins like Grb2, not the ERK kinases, to the plasma membrane.\n5. FALSE [correction]: PLC-gamma is not a scaffold protein in the ERK signaling pathway. Instead, it is an enzyme that generates the second messenger molecules diacylglycerol (DAG) and inositol trisphosphate (IP3) from phosphatidylinositol bisphosphate (PIP2). It does not directly activate ERK kinases.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1041,
    "user_query": "Which classes of endogenous retroelements are known to date?",
    "vicuna-7b_response": "Endogenous retroelements are retrotransposons that are integrated into the host genome and can produce RNA transcripts. There are two main classes of endogenous retroelements: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).\nLINEs are the longest retrotransposons, with lengths ranging from several hundred to several thousand base pairs. They are characterized by the presence of long terminal repeats (LTRs) at their ends, which contain the reverse transcription and integration machinery. LINEs can produce RNA transcripts that are processed into small RNAs, such as microRNAs (miRNAs) and small RNA viruses (svRNAs), which can regulate gene expression.\nSINEs are shorter retrotransposons, with lengths ranging from several hundred to several thousand base pairs. They are characterized by the absence of LTRs at their ends and are thought to integrate randomly into the genome. SINEs do not produce RNA transcripts and do not appear to have a significant impact on gene expression.\nOther classes of endogenous retroelements include long interspersed nuclear elements-1 (LINE-1) and Alu elements. LINE-1 is the most abundant retrotransposon in the human genome and is thought to have played a significant role in the evolution of the human genome. Alu elements are short, non-LTR retrotransposons that are found in many mammalian genomes.\nOverall, there are many different classes of endogenous retroelements, each with its own unique characteristics and functions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Endogenous retroelements are retrotransposons that are integrated into the host genome and can produce RNA transcripts.\n2. There are two main classes of endogenous retroelements: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).\n3. LINEs are the longest retrotransposons, with lengths ranging from several hundred to several thousand base pairs and they can produce RNA transcripts.\n4. SINEs are shorter retrotransposons, with lengths ranging from several hundred to several thousand base pairs, and they do not produce RNA transcripts.\n5. Other classes of endogenous retroelements include long interspersed nuclear elements-1 (LINE-1) and Alu elements with LINE-1 being the most abundant retrotransposon in the human genome.",
    "vicuna-7b_fact": [
      "Endogenous retroelements are retrotransposons that are integrated into the host genome and can produce RNA transcripts.",
      "There are two main classes of endogenous retroelements: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).",
      "LINEs are the longest retrotransposons, with lengths ranging from several hundred to several thousand base pairs and they can produce RNA transcripts.",
      "SINEs are shorter retrotransposons, with lengths ranging from several hundred to several thousand base pairs, and they do not produce RNA transcripts.",
      "Other classes of endogenous retroelements include long interspersed nuclear elements-1 (LINE-1) and Alu elements with LINE-1 being the most abundant retrotransposon in the human genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: SINEs are shorter retrotransposons, with lengths generally less than 500 base pairs, and they do not produce RNA transcripts by themselves but depend on LINEs for transcription.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types. It has been shown to interact with a wide range of proteins, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\nOne approach to identifying GATA-1 interacting partners is through the use of biotinylation tagging. This method involves introducing a biotinylated version of GATA-1 into cells, which allows for the capture of proteins that interact with GATA-1.\nSeveral studies have used biotinylation tagging to identify GATA-1 interacting partners. Here are some examples:\n1. A study published in the journal Molecular Cell in 2007 used biotinylation tagging to identify GATA-1 interacting partners in hematopoietic cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of gene expression, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\n2. A study published in the journal Blood in 2011 used biotinylation tagging to identify GATA-1 interacting partners in erythroid cells. The study found that GATA-1 interacted with a number of proteins involved in erythroid differentiation, including erythropoietin, transferrin receptor, and glycophorin A.\n3. A study published in the journal Cell Death and Differentiation in 2013 used biotinylation tagging to identify GATA-1 interacting partners in pancreatic ductal adenocarcinoma cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of cell proliferation and survival, including cyclin D1, survivin, and c-Myc.\nOverall, these studies have identified a number of GATA-1 interacting partners using the biotinylation tagging approach. These interactions are likely to play important roles in the regulation of gene expression and cellular processes in various cell types.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GATA-1 is a transcription factor that is crucial in the regulation of gene expression in various cell types.\n2. Biotinylation tagging is a method used to identify proteins that interact with GATA-1.\n3. A Molecular Cell 2007 study identified GATA-1 interacting partners involved in gene regulation in hematopoietic cells through biotinylation tagging.\n4. A Blood 2011 study found that GATA-1 interacted with proteins involved in erythroid differentiation, including erythropoietin, transferrin receptor, and glycophorin A.\n5. A Cell Death and Differentiation 2013 study showed that GATA-1 interacted with proteins involved in the regulation of cell proliferation and survival in pancreatic ductal adenocarcinoma cells.",
    "vicuna-7b_fact": [
      "GATA-1 is a transcription factor that is crucial in the regulation of gene expression in various cell types.",
      "Biotinylation tagging is a method used to identify proteins that interact with GATA-1.",
      "A Molecular Cell 2007 study identified GATA-1 interacting partners involved in gene regulation in hematopoietic cells through biotinylation tagging.",
      "A Blood 2011 study found that GATA-1 interacted with proteins involved in erythroid differentiation, including erythropoietin, transferrin receptor, and glycophorin A.",
      "A Cell Death and Differentiation 2013 study showed that GATA-1 interacted with proteins involved in the regulation of cell proliferation and survival in pancreatic ductal adenocarcinoma cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1053,
    "user_query": "Which proteins are the different members of the NF-kappaB family of transcription factors?",
    "vicuna-7b_response": "The NF-kappaB family of transcription factors is a group of related proteins that play important roles in regulating the immune response and inflammation. The different members of the NF-kappaB family include:\n1. NF-kappaB p65 (also known as RelA)\n2. NF-kappaB p50\n3. NF-kappaB p52 (also known as RELB)\n4. NF-kappaB p105 (also known as RELB)\n5. NF-kappaB p100 (also known as RELB)\n6. NF-kappaB p52 (also known as RELB)\n7. NF-kappaB p52 (also known as RELB)\n8. NF-kappaB p52 (also known as RELB)\n9. NF-kappaB p52 (also known as RELB)\n10. NF-kappaB p52 (also known as RELB)\nEach member of the NF-kappaB family has a specific function and regulates the expression of different genes. For example, NF-kappaB p65 is involved in the regulation of immune response and inflammation, while NF-kappaB p50 is involved in the regulation of cell growth and differentiation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The NF-kappaB family of transcription factors plays important roles in regulating the immune response and inflammation.\n2. Different members of the NF-kappaB family include NF-kappaB p65 (RelA), NF-kappaB p50, NF-kappaB p52 (RELB), NF-kappaB p105 (RELB), and NF-kappaB p100 (RELB).\n3. Each member of the NF-kappaB family has a specific function and regulates the expression of different genes.\n4. NF-kappaB p65 is involved in the regulation of immune response and inflammation.\n5. NF-kappaB p50 is involved in the regulation of cell growth and differentiation.",
    "vicuna-7b_fact": [
      "The NF-kappaB family of transcription factors plays important roles in regulating the immune response and inflammation.",
      "Different members of the NF-kappaB family include NF-kappaB p65 (RelA), NF-kappaB p50, NF-kappaB p52 (RELB), NF-kappaB p105 (RELB), and NF-kappaB p100 (RELB).",
      "Each member of the NF-kappaB family has a specific function and regulates the expression of different genes.",
      "NF-kappaB p65 is involved in the regulation of immune response and inflammation.",
      "NF-kappaB p50 is involved in the regulation of cell growth and differentiation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Different members of the NF-kappaB family include NF-kappaB p65 (RelA), NF-kappaB p50, NF-kappaB p52, NF-kappaB p105, and NF-kappaB p100.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1061,
    "user_query": "Which proteins have been identified as RET ligands?",
    "vicuna-7b_response": "RET (Ret receptor tyrosine kinase) is a receptor tyrosine kinase that plays a role in the development and function of the nervous system, as well as in the regulation of cell growth and differentiation. RET ligands are molecules that bind to and activate the RET receptor.\nSeveral proteins have been identified as RET ligands, including:\n1. GDNF (Glial cell line-derived neurotrophic factor): GDNF is a protein that is produced by glial cells and is a potent activator of the RET receptor. GDNF has been shown to promote the survival and differentiation of neurons and has been studied as a potential therapeutic agent for a variety of neurological disorders.\n2. CNP (Calcitonin gene-related peptide): CNP is a peptide that is produced by neuroendocrine cells and is a potent activator of the RET receptor. CNP has been shown to promote the survival and differentiation of neurons and has been studied as a potential therapeutic agent for a variety of neurological disorders.\n3. PACAP (Pituitary adenylate cyclase-activating polypeptide): PACAP is a peptide that is produced by neuroendocrine cells and is a potent activator of the RET receptor. PACAP has been shown to promote the survival and differentiation of neurons and has been studied as a potential therapeutic agent for a variety of neurological disorders.\n4. GDNF-related protein (GDNF-R1): GDNF-related protein (GDNF-R1) is a protein that is structurally related to GDNF and is a potent activator of the RET receptor. GDNF-R1 has been shown to promote the survival and differentiation of neurons and has been studied as a potential therapeutic agent for a variety of neurological disorders.\n5. Neurturin (NRTN): Neurturin is a protein that is structurally related to GDNF and is a potent activator of the RET receptor. Neurturin has been shown to promote the survival",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RET (Ret receptor tyrosine kinase) is a receptor tyrosine kinase that plays a role in the development and function of the nervous system, as well as in the regulation of cell growth and differentiation.\n2. GDNF (Glial cell line-derived neurotrophic factor) has been identified as a RET ligand.\n3. CNP (Calcitonin gene-related peptide) has been identified as a RET ligand.\n4. PACAP (Pituitary adenylate cyclase-activating polypeptide) has been identified as a RET ligand.\n5. GDNF-related protein (GDNF-R1) and Neurturin (NRTN) have been identified as RET ligands.",
    "vicuna-7b_fact": [
      "RET (Ret receptor tyrosine kinase) is a receptor tyrosine kinase that plays a role in the development and function of the nervous system, as well as in the regulation of cell growth and differentiation.",
      "GDNF (Glial cell line-derived neurotrophic factor) has been identified as a RET ligand.",
      "CNP (Calcitonin gene-related peptide) has been identified as a RET ligand.",
      "PACAP (Pituitary adenylate cyclase-activating polypeptide) has been identified as a RET ligand.",
      "GDNF-related protein (GDNF-R1) and Neurturin (NRTN) have been identified as RET ligands."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CNP (Calcitonin gene-related peptide) has not been identified as a RET ligand.\n4. FALSE [correction]: PACAP (Pituitary adenylate cyclase-activating polypeptide) has not been identified as a RET ligand.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1066,
    "user_query": "List all articles on network meta-analysis for smoking cessation",
    "vicuna-7b_response": "Network meta-analysis (NMA) is a statistical method used to compare the effectiveness of different interventions or treatments, such as smoking cessation methods. Here are some articles on NMA for smoking cessation:\n1. \"Network meta-analysis of smoking cessation treatments: an updated review\" by J.A. Schmid et al. published in the journal Cochrane Database of Systematic Reviews in 2019.\n2. \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis\" by J. Zhu et al. published in the journal BMC Medicine in 2018.\n3. \"Network meta-analysis of smoking cessation treatments: a systematic review and network meta-analysis of randomized controlled trials\" by J.A. Schmid et al. published in the journal Clinical Pharmacology and Therapeutics in 2017.\n4. \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis of observational studies\" by J. Zhu et al. published in the journal Nicotine & Tobacco Research in 2018.\n5. \"Network meta-analysis of smoking cessation treatments: a systematic review and network meta-analysis of randomized controlled trials and observational studies\" by J.A. Schmid et al. published in the journal Drug and Alcohol Dependence in 2016.\nThese articles provide a comprehensive overview of the effectiveness of different smoking cessation treatments and interventions, as well as the limitations and challenges of NMA in this field.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Network meta-analysis (NMA) is a statistical method used to compare the effectiveness of different interventions or treatments.\n2. An article titled \"Network meta-analysis of smoking cessation treatments: an updated review\" by J.A. Schmid et al. was published in the journal Cochrane Database of Systematic Reviews in 2019.\n3. An article titled \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis\" by J. Zhu et al. was published in the journal BMC Medicine in 2018.\n4. An article titled \"Network meta-analysis of smoking cessation treatments: a systematic review and network meta-analysis of randomized controlled trials\" by J.A. Schmid et al. was published in the journal Clinical Pharmacology and Therapeutics in 2017.\n5. An article titled \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis of observational studies\" by J. Zhu et al. was published in the journal Nicotine & Tobacco Research in 2018.",
    "vicuna-7b_fact": [
      "Network meta-analysis (NMA) is a statistical method used to compare the effectiveness of different interventions or treatments.",
      "An article titled \"Network meta-analysis of smoking cessation treatments: an updated review\" by J.A. Schmid et al. was published in the journal Cochrane Database of Systematic Reviews in 2019.",
      "An article titled \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis\" by J. Zhu et al. was published in the journal BMC Medicine in 2018.",
      "An article titled \"Network meta-analysis of smoking cessation treatments: a systematic review and network meta-analysis of randomized controlled trials\" by J.A. Schmid et al. was published in the journal Clinical Pharmacology and Therapeutics in 2017.",
      "An article titled \"Network meta-analysis of smoking cessation interventions: a systematic review and network meta-analysis of observational studies\" by J. Zhu et al. was published in the journal Nicotine & Tobacco Research in 2018."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1068,
    "user_query": "Which clotting factor is inhibited by betrixaban?",
    "vicuna-7b_response": "Betrixaban is a direct oral anticoagulant that inhibits the activity of factor Xa, which is involved in the coagulation cascade. It is used to prevent venous thromboembolism (VTE) in patients who have undergone total knee or hip replacement surgery. Betrixaban works by binding to and inhibiting the activity of factor Xa, which is involved in the formation of blood clots. By inhibiting factor Xa, betrixaban reduces the risk of VTE, which can be life-threatening.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Betrixaban is a direct oral anticoagulant.\n2. Betrixaban inhibits the activity of factor Xa.\n3. Factor Xa is involved in the coagulation cascade.\n4. Betrixaban is used to prevent venous thromboembolism (VTE) in patients who have undergone total knee or hip replacement surgery.\n5. By inhibiting factor Xa, betrixaban reduces the risk of VTE.",
    "vicuna-7b_fact": [
      "Betrixaban is a direct oral anticoagulant.",
      "Betrixaban inhibits the activity of factor Xa.",
      "Factor Xa is involved in the coagulation cascade.",
      "Betrixaban is used to prevent venous thromboembolism (VTE) in patients who have undergone total knee or hip replacement surgery.",
      "By inhibiting factor Xa, betrixaban reduces the risk of VTE."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Betrixaban is used to prevent venous thromboembolism (VTE) in patients hospitalized for an acute medical illness.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1071,
    "user_query": "Are there any specific antidotes for dabigatran?",
    "vicuna-7b_response": "Yes, there are specific antidotes for dabigatran. The most commonly used antidote for dabigatran is prothrombin complex concentrate (PCC). PCC contains activated prothrombin, which can convert dabigatran to a form that can be removed from the blood by the kidneys.\nAnother antidote for dabigatran is recombinant factor VIIa (rFVIIa). rFVIIa is a synthetic version of a naturally occurring protein in the body that helps to restore the body's ability to clot blood.\nIt is important to note that both PCC and rFVIIa have risks and potential side effects, and their use should be carefully considered on a case-by-case basis. It is also important to seek medical attention immediately if you suspect that you or someone else has taken an excessive amount of dabigatran.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There exist specific antidotes for dabigatran.\n2. The most commonly used antidote for dabigatran is prothrombin complex concentrate (PCC).\n3. Prothrombin complex concentrate contains activated prothrombin, which can convert dabigatran to a form that can be removed from the blood by the kidneys.\n4. Another antidote for dabigatran is recombinant factor VIIa (rFVIIa).\n5. Both PCC and rFVIIa have risks and potential side effects.",
    "vicuna-7b_fact": [
      "There exist specific antidotes for dabigatran.",
      "The most commonly used antidote for dabigatran is prothrombin complex concentrate (PCC).",
      "Prothrombin complex concentrate contains activated prothrombin, which can convert dabigatran to a form that can be removed from the blood by the kidneys.",
      "Another antidote for dabigatran is recombinant factor VIIa (rFVIIa).",
      "Both PCC and rFVIIa have risks and potential side effects."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The specific antidote for dabigatran is idarucizumab, not prothrombin complex concentrate (PCC).\n3. FALSE [correction]: Prothrombin complex concentrate is used to promote blood coagulation and doesn’t convert dabigatran to any form. It contains Vitamin K-dependent factors and is used for reversal of anticoagulation in cases of severe bleeding or prior to emergency surgery.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-7b_response": "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1. The interaction between TAF10 and GATA1 can affect gene expression and play a role in the regulation of cellular processes.\nThe specific outcome of TAF10 interacting with GATA1 depends on the context in which they interact. In some cases, the interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes. In other cases, the interaction may inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes.\nThe exact outcome of TAF10 and GATA1 interaction will depend on the specific genes they are regulating, the cellular context, and other factors. However, it is clear that the interaction between TAF10 and GATA1 can have a significant impact on gene expression and cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.\n2. The interaction between TAF10 and GATA1 can affect gene expression.\n3. The interaction between TAF10 and GATA1 plays a role in the regulation of cellular processes.\n4. In some cases, the interaction between TAF10 and GATA1 may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.\n5. In certain situations, the interaction between TAF10 and GATA1 may inhibit the transcriptional activity of GATA1, resulting in decreased expression of target genes.",
    "vicuna-7b_fact": [
      "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.",
      "The interaction between TAF10 and GATA1 can affect gene expression.",
      "The interaction between TAF10 and GATA1 plays a role in the regulation of cellular processes.",
      "In some cases, the interaction between TAF10 and GATA1 may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.",
      "In certain situations, the interaction between TAF10 and GATA1 may inhibit the transcriptional activity of GATA1, resulting in decreased expression of target genes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1073,
    "user_query": "How does TNF affect thyroid hormone receptors?",
    "vicuna-7b_response": "TNF (Tumor Necrosis Factor) is a cytokine that plays a key role in the immune response and inflammation. TNF has been shown to affect the expression and activity of thyroid hormone receptors (TRs) in various cell types, including thyroid cells.\nTRs are nuclear receptors that play a crucial role in the regulation of thyroid hormone homeostasis. TRs are expressed in the thyroid gland, where they regulate the expression of genes involved in the synthesis and secretion of thyroid hormones. TRs are also expressed in other tissues, where they regulate the expression of genes involved in the metabolism and utilization of thyroid hormones.\nStudies have shown that TNF can affect the expression and activity of TRs in thyroid cells. For example, TNF has been shown to decrease the expression of TRs in thyroid cells in vitro and in vivo. This decrease in TR expression can lead to decreased synthesis and secretion of thyroid hormones, which can result in hypothyroidism.\nIn addition, TNF has been shown to affect the activity of TRs by altering their DNA-binding ability and their ability to regulate gene expression. TNF has also been shown to increase the production of reactive oxygen species (ROS) in thyroid cells, which can further damage TRs and impair their function.\nIn conclusion, TNF can affect the expression and activity of thyroid hormone receptors in thyroid cells, leading to decreased synthesis and secretion of thyroid hormones and potentially contributing to the development of hypothyroidism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TNF (Tumor Necrosis Factor) is a cytokine that plays a key role in the immune response and inflammation.\n2. Studies have shown that TNF can affect the expression and activity of TRs in thyroid cells.\n3. TNF has been shown to decrease the expression of TRs in thyroid cells in vitro and in vivo.\n4. TNF can also affect the activity of TRs by altering their DNA-binding ability and their ability to regulate gene expression.\n5. TNF can increase the production of reactive oxygen species (ROS) in thyroid cells.",
    "vicuna-7b_fact": [
      "TNF (Tumor Necrosis Factor) is a cytokine that plays a key role in the immune response and inflammation.",
      "Studies have shown that TNF can affect the expression and activity of TRs in thyroid cells.",
      "TNF has been shown to decrease the expression of TRs in thyroid cells in vitro and in vivo.",
      "TNF can also affect the activity of TRs by altering their DNA-binding ability and their ability to regulate gene expression.",
      "TNF can increase the production of reactive oxygen species (ROS) in thyroid cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1078,
    "user_query": "What is the action of molindone?",
    "vicuna-7b_response": "Molindone is an atypical antipsychotic medication that is used to treat schizophrenia and other psychiatric conditions. It works by blocking the action of dopamine in the brain, which helps to reduce symptoms of psychosis such as hallucinations and delusions.\nMolindone is typically taken orally, in the form of a tablet or a solution, once or twice daily. The exact dosage will depend on the individual and the condition being treated, and should be determined by a healthcare professional.\nIt is important to note that molindone can cause side effects, such as dizziness, drowsiness, and restlessness. It may also cause changes in appetite, weight, and blood sugar levels. It is important to discuss any side effects with a healthcare professional and to follow their instructions for taking the medication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Molindone is an atypical antipsychotic medication used to treat schizophrenia and other psychiatric conditions.\n2. Molindone works by blocking the action of dopamine in the brain.\n3. Molindone is typically taken orally, in the form of a tablet or a solution, once or twice daily.\n4. The dosage of molindone is determined by a healthcare professional based on individual factors and the condition being treated.\n5. Molindone can cause side effects such as dizziness, drowsiness, restlessness, changes in appetite, weight, and blood sugar levels.",
    "vicuna-7b_fact": [
      "Molindone is an atypical antipsychotic medication used to treat schizophrenia and other psychiatric conditions.",
      "Molindone works by blocking the action of dopamine in the brain.",
      "Molindone is typically taken orally, in the form of a tablet or a solution, once or twice daily.",
      "The dosage of molindone is determined by a healthcare professional based on individual factors and the condition being treated.",
      "Molindone can cause side effects such as dizziness, drowsiness, restlessness, changes in appetite, weight, and blood sugar levels."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Molindone is a typical antipsychotic medication used to treat conditions like schizophrenia.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-7b_response": "Yes, there are several decision support systems for chronic pain management. These systems are designed to help healthcare providers make informed decisions about the treatment of chronic pain.\nOne example of a decision support system for chronic pain management is the Clinical Decision Support (CDS) system. CDS systems are computerized tools that provide healthcare providers with patient-specific information and recommendations to support clinical decision-making. CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.\nAnother example is the Pain Management Decision Support System (PMDSS). PMDSS is a web-based tool that provides healthcare providers with patient-specific information and recommendations for the management of chronic pain. The system uses a patient-specific algorithm to generate recommendations based on the patient's medical history, medications, and other relevant factors.\nIn addition, some electronic health record (EHR) systems have built-in decision support systems for chronic pain management. These systems can provide healthcare providers with patient information and recommendations based on the patient's medical history and other relevant factors.\nOverall, decision support systems for chronic pain management can help healthcare providers make informed decisions about the treatment of chronic pain, and can improve the quality of care for patients with chronic pain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are decision support systems for chronic pain management.\n2. The Clinical Decision Support (CDS) system is a type of decision support system for chronic pain management.\n3. CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.\n4. The Pain Management Decision Support System (PMDSS) is a web-based tool for managing chronic pain.\n5. Some electronic health record (EHR) systems have built-in decision support systems for chronic pain management.",
    "vicuna-7b_fact": [
      "There are decision support systems for chronic pain management.",
      "The Clinical Decision Support (CDS) system is a type of decision support system for chronic pain management.",
      "CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.",
      "The Pain Management Decision Support System (PMDSS) is a web-based tool for managing chronic pain.",
      "Some electronic health record (EHR) systems have built-in decision support systems for chronic pain management."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1084,
    "user_query": "Which is the methyl donor of histone methyltransferases?",
    "vicuna-7b_response": "The methyl donor of histone methyltransferases is S-adenosylmethionine (SAM).\nHistone methyltransferases are enzymes that add a methyl group to the amino-terminal side chain of histone proteins. SAM is the primary methyl donor for these enzymes, and it is converted to S-adenosylhomocysteine (SAH) by the enzyme S-adenosylmethionine synthetase before being donated to the methyltransferase.\nThe addition of a methyl group to histone proteins can have a significant impact on their structure and function. For example, it can alter the interaction of histone proteins with DNA, leading to changes in chromatin structure and gene expression.\nOverall, the role of SAM as the methyl donor for histone methyltransferases is crucial for regulating chromatin structure and gene expression, and dysregulation of this process has been implicated in a variety of diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The methyl donor of histone methyltransferases is S-adenosylmethionine (SAM).\n2. Histone methyltransferases are enzymes that add a methyl group to the amino-terminal side chain of histone proteins.\n3. SAM is converted to S-adenosylhomocysteine (SAH) by the enzyme S-adenosylmethionine synthetase.\n4. The addition of a methyl group can alter the interaction of histone proteins with DNA, leading to changes in chromatin structure and gene expression.\n5. Dysregulation of the process of methyl group addition has been implicated in a variety of diseases, including cancer.",
    "vicuna-7b_fact": [
      "The methyl donor of histone methyltransferases is S-adenosylmethionine (SAM).",
      "Histone methyltransferases are enzymes that add a methyl group to the amino-terminal side chain of histone proteins.",
      "SAM is converted to S-adenosylhomocysteine (SAH) by the enzyme S-adenosylmethionine synthetase.",
      "The addition of a methyl group can alter the interaction of histone proteins with DNA, leading to changes in chromatin structure and gene expression.",
      "Dysregulation of the process of methyl group addition has been implicated in a variety of diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: SAM is converted to S-adenosylhomocysteine (SAH) by the action of methyltransferases, not S-adenosylmethionine synthetase.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1085,
    "user_query": "How are human accelerated regions (HAR) defined?",
    "vicuna-7b_response": "Human accelerated regions (HARs) are defined as regions of the genome that have undergone positive selection in the human lineage, but not in other primate species. Positive selection is a process where certain genetic variations are favored over others, leading to an increase in their frequency in the population over time.\nHARs are identified by comparing the human genome to the genomes of other primates, such as chimpanzees and macaques. Researchers use a variety of methods to identify HARs, including genome-wide association studies (GWAS), which involve analyzing the genetic variation of large numbers of individuals to identify associations between specific genetic variations and certain traits or diseases.\nOnce HARs are identified, researchers can use a variety of techniques to study them in more detail. For example, they can use functional studies to determine which genes are located within HARs and what functions they may be involved in. They can also use population genetics studies to determine how HARs have evolved over time and how they are distributed across different populations.\nOverall, the study of HARs is an important area of research in the field of human evolution and genetics, as it can provide insights into the genetic changes that have occurred in the human lineage and how these changes have contributed to the unique characteristics of modern humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Human accelerated regions (HARs) are defined as regions of the genome that have undergone positive selection in the human lineage, but not in other primate species.\n2. HARs are identified by comparing the human genome to the genomes of other primates, such as chimpanzees and macaques.\n3. Researchers use genome-wide association studies (GWAS) to identify HARs.\n4. Once identified, researchers can study HARs in more detail using techniques such as functional studies and population genetics studies.\n5. The study of HARs is an important area of research in the field of human evolution and genetics.",
    "vicuna-7b_fact": [
      "Human accelerated regions (HARs) are defined as regions of the genome that have undergone positive selection in the human lineage, but not in other primate species.",
      "HARs are identified by comparing the human genome to the genomes of other primates, such as chimpanzees and macaques.",
      "Researchers use genome-wide association studies (GWAS) to identify HARs.",
      "Once identified, researchers can study HARs in more detail using techniques such as functional studies and population genetics studies.",
      "The study of HARs is an important area of research in the field of human evolution and genetics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Researchers identify HARs by comparing regions in the human genome sequence that are highly conserved in other species but that have changed in humans since diverging from our primate ancestors.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1091,
    "user_query": "In which genomic positions is the histone variant macroH2A enriched?",
    "vicuna-7b_response": "MacroH2A is a type of histone variant that is enriched in specific genomic positions. MacroH2A is a large protein that is composed of multiple domains, including a histone fold domain, a chromodomain, and a KID repeat domain. The chromodomain of macroH2A is responsible for binding to specific DNA sequences, which can include GC-rich regions, transcription start sites, and other regulatory elements.\nMacroH2A has been shown to be enriched in a variety of genomic positions, including:\n1. Enhancers: MacroH2A has been shown to be enriched in enhancers, which are regions of the genome that play a role in the regulation of gene expression. Enhancers can be located far away from the genes they regulate, and they often contain a complex mixture of transcription factors, chromatin modifiers, and other proteins.\n2. Non-coding regions: MacroH2A has also been shown to be enriched in non-coding regions of the genome, including intergenic regions, introns, and other regions that do not contain protein-coding genes.\n3. Chromatin boundaries: MacroH2A has been shown to be enriched at the boundaries of chromatin domains, which are regions of the genome that are marked by specific histone modifications and other chromatin-associated proteins.\n4. Telomeres: MacroH2A has also been shown to be enriched at the ends of chromosomes, known as telomeres. Telomeres are repetitive DNA sequences that protect the ends of chromosomes from degradation and fusion.\nOverall, macroH2A is a versatile histone variant that can be found in a variety of genomic positions, and its enrichment in specific regions is thought to play a role in regulating gene expression and other cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. MacroH2A is a type of histone variant. \n2. MacroH2A has a histone fold domain, a chromodomain, and a KID repeat domain. \n3. The chromodomain of macroH2A is responsible for binding to specific DNA sequences. \n4. MacroH2A has been found to be enriched in enhancers, non-coding regions, chromatin boundaries and telomeres. \n5. MacroH2A's enrichment in specific regions is believed to play a role in regulating gene expression and other cellular processes.",
    "vicuna-7b_fact": [
      "MacroH2A is a type of histone variant.",
      "MacroH2A has a histone fold domain, a chromodomain, and a KID repeat domain.",
      "The chromodomain of macroH2A is responsible for binding to specific DNA sequences.",
      "MacroH2A has been found to be enriched in enhancers, non-coding regions, chromatin boundaries and telomeres.",
      "MacroH2A's enrichment in specific regions is believed to play a role in regulating gene expression and other cellular processes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: MacroH2A has a histone fold domain and a non-histone region, but not a KID repeat domain.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1093,
    "user_query": "From which sequence does the Alu repeat originate from?",
    "vicuna-7b_response": "The Alu repeat is a class of short, non-coding repetitive DNA sequences that are found in the human genome. These repeats are derived from a specific type of retrotransposon called an Alu element.\nAlu elements are short, non-coding RNA molecules that were once thought to be the result of reverse transcription of an RNA virus. However, it is now believed that Alu elements are actually the product of a retrotransposon, which is a type of mobile genetic element that can copy itself and insert itself into new locations in the genome.\nThe Alu repeat is derived from the Alu element by a process called \"copy number variation\". This process involves the duplication and subsequent divergence of the Alu element, leading to the creation of multiple copies of the element in the genome. These copies are then subject to mutation and evolution, leading to the diversity of Alu repeats that is found in the human genome today.\nOverall, the Alu repeat is derived from the Alu element, which is a type of retrotransposon that is capable of copying itself and inserting itself into new locations in the genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Alu repeat is a class of short, non-coding repetitive DNA sequences found in the human genome.\n2. Alu repeats are derived from a type of retrotransposon known as an Alu element.\n3. Alu elements are short, non-coding RNA molecules.\n4. Alu repeat originates from the Alu element through a process called \"copy number variation\".\n5. The Alu repeat is found in multiple copies in the genome due to mutation and evolution.",
    "vicuna-7b_fact": [
      "The Alu repeat is a class of short, non-coding repetitive DNA sequences found in the human genome.",
      "Alu repeats are derived from a type of retrotransposon known as an Alu element.",
      "Alu elements are short, non-coding RNA molecules.",
      "Alu repeat originates from the Alu element through a process called \"copy number variation\".",
      "The Alu repeat is found in multiple copies in the genome due to mutation and evolution."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Alu elements are short DNA sequences, not RNA molecules.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1099,
    "user_query": "Are there any HCV replication inhibitors available?",
    "vicuna-7b_response": "Yes, there are several HCV replication inhibitors available. Hepatitis C virus (HCV) is a viral infection that affects the liver and can cause serious health problems if left untreated. There are several drugs that can inhibit HCV replication and help treat the infection.\nOne class of drugs that can inhibit HCV replication is called direct-acting antivirals (DAAs). These drugs target specific proteins within the HCV virus and prevent it from replicating. Examples of DAAs include sofosbuvir, ledipasvir, and daclatasvir.\nAnother class of drugs that can inhibit HCV replication is called interferons. Interferons are a type of protein that helps the body's immune system fight off infections. They can help reduce the amount of HCV virus in the body and slow the progression of the infection.\nIn addition to these drugs, there are also vaccines available that can help prevent HCV infection. The HCV vaccine is made up of proteins from the HCV virus and is given in a series of shots over several months. It can help stimulate the body's immune system to produce antibodies that can protect against HCV infection.\nOverall, there are several HCV replication inhibitors available, including DAAs, interferons, and vaccines. It is important to work with a healthcare provider to determine the best treatment option for an individual's specific needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hepatitis C virus (HCV) is a viral infection that affects the liver.\n2. Direct-acting antivirals (DAAs) can inhibit HCV replication.\n3. Examples of DAAs include sofosbuvir, ledipasvir, and daclatasvir.\n4. Interferons are a type of protein that helps the body's immune system fight off infections and can help reduce the amount of HCV virus.\n5. There are vaccines available that can help prevent HCV infection.",
    "vicuna-7b_fact": [
      "Hepatitis C virus (HCV) is a viral infection that affects the liver.",
      "Direct-acting antivirals (DAAs) can inhibit HCV replication.",
      "Examples of DAAs include sofosbuvir, ledipasvir, and daclatasvir.",
      "Interferons are a type of protein that helps the body's immune system fight off infections and can help reduce the amount of HCV virus.",
      "There are vaccines available that can help prevent HCV infection."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Currently, there are no vaccines available that can help prevent HCV infection.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1108,
    "user_query": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
    "vicuna-7b_response": "Yes, PLK2 (Polo-like kinase 2) has been implicated in the phosphorylation of alpha-synuclein in Parkinson's disease.\nAlpha-synuclein is a protein that is known to play a role in the development of Parkinson's disease. Phosphorylation of alpha-synuclein has been shown to be involved in the progression of the disease. PLK2 has been found to be involved in the phosphorylation of alpha-synuclein, which may contribute to the development of Parkinson's disease.\nResearch has shown that PLK2 can phosphorylate alpha-synuclein at multiple sites, including Ser129 and Thr129. These phosphorylation events can lead to the formation of alpha-synuclein oligomers and fibrils, which are thought to play a role in the progression of Parkinson's disease.\nIn addition, PLK2 has been found to be upregulated in the brains of individuals with Parkinson's disease, suggesting that it may play a role in the development of the disease.\nOverall, while more research is needed to fully understand the role of PLK2 in alpha-synuclein phosphorylation and Parkinson's disease, it is clear that PLK2 is a key player in this process and may be a promising target for the development of new treatments for the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PLK2 (Polo-like kinase 2) has been implicated in the phosphorylation of alpha-synuclein in Parkinson's disease.\n2. Alpha-synuclein is a protein that plays a role in the development of Parkinson's disease.\n3. The phosphorylation of alpha-synuclein is involved in the progression of Parkinson's disease.\n4. PLK2 can phosphorylate alpha-synuclein at multiple sites, including Ser129 and Thr129.\n5. PLK2 has been found to be upregulated in the brains of individuals with Parkinson's disease.",
    "vicuna-7b_fact": [
      "PLK2 (Polo-like kinase 2) has been implicated in the phosphorylation of alpha-synuclein in Parkinson's disease.",
      "Alpha-synuclein is a protein that plays a role in the development of Parkinson's disease.",
      "The phosphorylation of alpha-synuclein is involved in the progression of Parkinson's disease.",
      "PLK2 can phosphorylate alpha-synuclein at multiple sites, including Ser129 and Thr129.",
      "PLK2 has been found to be upregulated in the brains of individuals with Parkinson's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: PLK2 can phosphorylate alpha-synuclein at Ser129. It does not phosphorylate at Thr129.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1111,
    "user_query": "Name five popular  computer  programs used to identify genes in genomic sequences",
    "vicuna-7b_response": "1. BLAST (Basic Local Alignment Search Tool)\n2. BLAT (BLAST-like Alignment Tool)\n3. GENEious\n4. GenBank\n5. NCBI Genome Browser",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BLAST is a computer program used to identify genes in genomic sequences.\n2. BLAT is also used for the same purpose.\n3. GENEious is another program used to identify genes.\n4. GenBank is a computer program used for identifying genes in genomic sequences.\n5. NCBI Genome Browser is a tool used for identifying genes in genomic sequences.",
    "vicuna-7b_fact": [
      "BLAST is a computer program used to identify genes in genomic sequences.",
      "BLAT is also used for the same purpose.",
      "GENEious is another program used to identify genes.",
      "GenBank is a computer program used for identifying genes in genomic sequences.",
      "NCBI Genome Browser is a tool used for identifying genes in genomic sequences."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: GENEious is a bioinformatics software platform used for research in biochemistry and molecular biology, not specifically for identifying genes.\n4. FALSE [correction]: GenBank is a database of genetic sequence data, not a program for identifying genes.\n5. FALSE [correction]: NCBI Genome Browser is a tool for viewing genomic sequences, not specifically for identifying genes.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1112,
    "user_query": "Which are the major transcription factors regulating glycolysis in mammals?",
    "vicuna-7b_response": "There are several transcription factors that play a role in regulating glycolysis in mammals. Here are some of the major ones:\n1. PGC-1α (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 alpha): PGC-1α is a transcriptional coactivator that plays a key role in regulating the expression of genes involved in energy metabolism, including those involved in glycolysis. PGC-1α is upregulated in response to increased energy demand and can activate the expression of genes involved in glucose uptake, glycolysis, and the tricarboxylic acid (TCA) cycle.\n2. HIF-1α (Hypoxia-Inducible Factor 1 alpha): HIF-1α is a transcription factor that plays a key role in regulating the response of cells to hypoxia (low oxygen levels). HIF-1α can activate the expression of genes involved in glycolysis and the TCA cycle in order to generate ATP under hypoxic conditions.\n3. Myc: Myc is a transcription factor that plays a role in regulating cell growth and proliferation. Myc can activate the expression of genes involved in glycolysis and the TCA cycle in order to generate ATP for cell growth and proliferation.\n4. C/EBPα (CCAAT/enhancer-binding protein α): C/EBPα is a transcription factor that plays a role in regulating the expression of genes involved in metabolism and energy production. C/EBPα can activate the expression of genes involved in glycolysis and the TCA cycle in order to generate ATP.\n5. SREBPs (sterol regulatory element-binding proteins): SREBPs are transcription factors that play a role in regulating the expression of genes involved in lipid metabolism and cholesterol synthesis. SREBPs can also activate the expression of genes involved in glycolysis and the TCA cycle in order to generate ATP.\nOverall, these transcription factors play a key role in regulating glycolysis in mammals by activating the expression of genes involved",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PGC-1α is a transcriptional coactivator that plays a key role in regulating the expression of genes involved in energy metabolism, including those involved in glycolysis.\n2. HIF-1α is a transcription factor that regulates the response of cells to hypoxia and can activate the expression of genes involved in glycolysis.\n3. Myc is a transcription factor that can activate the expression of genes involved in glycolysis for cell growth and proliferation.\n4. C/EBPα is a transcription factor that can activate the expression of genes involved in glycolysis for energy production.\n5. SREBPs are transcription factors that can activate the expression of genes involved in glycolysis for ATP generation.",
    "vicuna-7b_fact": [
      "PGC-1α is a transcriptional coactivator that plays a key role in regulating the expression of genes involved in energy metabolism, including those involved in glycolysis.",
      "HIF-1α is a transcription factor that regulates the response of cells to hypoxia and can activate the expression of genes involved in glycolysis.",
      "Myc is a transcription factor that can activate the expression of genes involved in glycolysis for cell growth and proliferation.",
      "C/EBPα is a transcription factor that can activate the expression of genes involved in glycolysis for energy production.",
      "SREBPs are transcription factors that can activate the expression of genes involved in glycolysis for ATP generation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: C/EBPα is a transcription factor that regulates the expression of genes involved in differentiation of fat cells and glucose metabolism; it isn't primarily involved in activating the expression of genes for glycolysis.\n5. FALSE [correction]: SREBPs are transcription factors that can activate the expression of genes involved in lipid homeostasis, not glycolysis for ATP generation.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1113,
    "user_query": "Mutations in which gene determine response to both erlotinib and gefitinib?",
    "vicuna-7b_response": "Mutations in the epidermal growth factor receptor (EGFR) gene can determine a patient's response to both erlotinib and gefitinib. These two drugs are both EGFR tyrosine kinase inhibitors, which target the EGFR protein and block its ability to stimulate cell growth and division.\nMutations in the EGFR gene can lead to the production of an abnormal EGFR protein that is more resistant to inhibition by these drugs. Specifically, certain mutations in the EGFR gene, such as exon 19 deletions or L858R mutations, have been shown to be associated with resistance to both erlotinib and gefitinib.\nTherefore, if a patient has a mutation in the EGFR gene that is associated with resistance to both erlotinib and gefitinib, they may not respond well to these drugs and may need to be treated with other EGFR inhibitors or other types of cancer therapies.\nIt is important to note that not all patients with EGFR mutations will experience resistance to both erlotinib and gefitinib, and that the response to these drugs can also be influenced by other factors such as the patient's individual characteristics and the specific characteristics of their cancer. Therefore, it is important for patients to work closely with their healthcare providers to determine the most appropriate treatment plan for their individual needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mutations in the epidermal growth factor receptor (EGFR) gene can determine a patient's response to both erlotinib and gefitinib.\n2. Erlotinib and gefitinib are both EGFR tyrosine kinase inhibitors.\n3. EGFR tyrosine kinase inhibitors target the EGFR protein and block its ability to stimulate cell growth and division.\n4. Certain mutations in the EGFR gene, such as exon 19 deletions or L858R mutations, have been shown to be associated with resistance to both erlotinib and gefitinib.\n5. Not all patients with EGFR mutations will experience resistance to both erlotinib and gefitinib, and the response to these drugs can also be influenced by other factors such as the patient's individual characteristics and the specific characteristics of their cancer.",
    "vicuna-7b_fact": [
      "Mutations in the epidermal growth factor receptor (EGFR) gene can determine a patient's response to both erlotinib and gefitinib.",
      "Erlotinib and gefitinib are both EGFR tyrosine kinase inhibitors.",
      "EGFR tyrosine kinase inhibitors target the EGFR protein and block its ability to stimulate cell growth and division.",
      "Certain mutations in the EGFR gene, such as exon 19 deletions or L858R mutations, have been shown to be associated with resistance to both erlotinib and gefitinib.",
      "Not all patients with EGFR mutations will experience resistance to both erlotinib and gefitinib, and the response to these drugs can also be influenced by other factors such as the patient's individual characteristics and the specific characteristics of their cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Certain mutations in the EGFR gene, such as exon 19 deletions or L858R mutations, have been shown to be associated with better response to both erlotinib and gefitinib.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1114,
    "user_query": "Which protein complexes contain mitofilin?",
    "vicuna-7b_response": "Mitofilin is a protein complex that is involved in the regulation of mitochondrial dynamics and function. It is composed of multiple subunits, including Mitofusin 1, Mitofusin 2, and Drp1 (Dynamin-related protein 1). Mitofusin 1 and Mitofusin 2 are responsible for the fusion of mitochondrial inner membrane vesicles, while Drp1 is involved in the fission of mitochondria.\nMitofilin is a key component of the mitochondrial quality control system, which helps to maintain the integrity of the mitochondrial network by removing damaged or dysfunctional mitochondria. It is also involved in the regulation of mitochondrial calcium uptake and release, which is important for maintaining proper calcium homeostasis within the mitochondria.\nOverall, Mitofilin is a crucial protein complex that plays a vital role in the regulation of mitochondrial dynamics and function, and is involved in a variety of cellular processes, including energy production, cell growth and division, and cell death.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mitofilin is a protein complex that is involved in the regulation of mitochondrial dynamics and function.\n2. Mitofilin is composed of multiple subunits, including Mitofusin 1, Mitofusin 2, and Drp1 (Dynamin-related protein 1).\n3. Mitofusin 1 and Mitofusin 2 are responsible for the fusion of mitochondrial inner membrane vesicles.\n4. Drp1 is involved in the fission of mitochondria.\n5. Mitofilin is involved in the regulation of mitochondrial calcium uptake and release.",
    "vicuna-7b_fact": [
      "Mitofilin is a protein complex that is involved in the regulation of mitochondrial dynamics and function.",
      "Mitofilin is composed of multiple subunits, including Mitofusin 1, Mitofusin 2, and Drp1 (Dynamin-related protein 1).",
      "Mitofusin 1 and Mitofusin 2 are responsible for the fusion of mitochondrial inner membrane vesicles.",
      "Drp1 is involved in the fission of mitochondria.",
      "Mitofilin is involved in the regulation of mitochondrial calcium uptake and release."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mitofilin is not composed of Mitofusin 1, Mitofusin 2, and Drp1. It is its own protein.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1120,
    "user_query": "Which computational frameworks are available for predicting enhancers?",
    "vicuna-7b_response": "There are several computational frameworks available for predicting enhancers, including:\n1. ENCODE: The Encyclopedia of DNA Elements project (ENCODE) is a large-scale effort to identify and characterize all functional elements in the human genome. ENCODE provides a variety of tools and resources for predicting enhancers, including the ENCODE Transcription Factor Binding Site Annotation (TFBSA) dataset, which includes ChIP-seq data for transcription factors and their binding sites across the human genome.\n2. CRISPR-Cas: The CRISPR-Cas system is a powerful tool for editing genes and identifying regulatory elements. CRISPR-Cas can be used to generate knockout cells or animals, and the resulting phenotypes can be used to identify regulatory elements that are essential for specific cellular processes.\n3. DNase-seq: DNase-seq is a technique that uses DNAse I to digest the DNA in cells, leaving behind only unmethylated regions. DNase-seq data can be used to identify active enhancers, as they tend to be associated with unmethylated regions.\n4. ChIP-seq: ChIP-seq is a technique that uses chromatin immunoprecipitation (ChIP) to identify the binding sites of transcription factors or other regulatory proteins. ChIP-seq data can be used to identify regulatory elements, including enhancers.\n5. Hi-C: Hi-C is a technique that uses DNA sequencing to map the three-dimensional structure of chromatin in cells. Hi-C data can be used to identify interactions between distant regulatory elements and their target genes.\nThese computational frameworks can be used in combination to identify and predict enhancers in the human genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ENCODE is a computational framework used for predicting enhancers.\n2. The CRISPR-Cas system is used for editing genes and identifying regulatory elements.\n3. DNase-seq is a technique that uses DNAse I to digest DNA in cells, which can be used to identify active enhancers.\n4. ChIP-seq uses chromatin immunoprecipitation (ChIP) to identify the binding sites of transcription factors or other regulatory proteins, helping identify regulatory elements including enhancers.\n5. Hi-C is a technique that uses DNA sequencing to map the three-dimensional structure of chromatin in cells and can be used to identify interactions between distant regulatory elements and their target genes.",
    "vicuna-7b_fact": [
      "ENCODE is a computational framework used for predicting enhancers.",
      "The CRISPR-Cas system is used for editing genes and identifying regulatory elements.",
      "DNase-seq is a technique that uses DNAse I to digest DNA in cells, which can be used to identify active enhancers.",
      "ChIP-seq uses chromatin immunoprecipitation (ChIP) to identify the binding sites of transcription factors or other regulatory proteins, helping identify regulatory elements including enhancers.",
      "Hi-C is a technique that uses DNA sequencing to map the three-dimensional structure of chromatin in cells and can be used to identify interactions between distant regulatory elements and their target genes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ENCODE is a project, not a computational framework, and its aim is to identify and categorize functional elements in the human genome, including enhancers.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1123,
    "user_query": "What is GRO-seq?",
    "vicuna-7b_response": "GRO-seq (Gene Expression Omnibus RNA-seq by sequencing) is a technique used to measure the expression levels of genes in a particular cell type or tissue. It involves isolating RNA from cells, then sequencing the RNA to determine which genes are actively expressed. This technique is often used to study the transcriptomes of different cell types or tissues, and can provide valuable insights into the biology of a particular organism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GRO-seq stands for Gene Expression Omnibus RNA-seq by sequencing.\n2. GRO-seq is a technique used to measure the expression levels of genes in a particular cell type or tissue.\n3. GRO-seq involves isolating RNA from cells and sequencing the RNA.\n4. The technique is used to determine which genes are actively expressed.\n5. GRO-seq is often used to study the transcriptomes of different cell types or tissues.",
    "vicuna-7b_fact": [
      "GRO-seq stands for Gene Expression Omnibus RNA-seq by sequencing.",
      "GRO-seq is a technique used to measure the expression levels of genes in a particular cell type or tissue.",
      "GRO-seq involves isolating RNA from cells and sequencing the RNA.",
      "The technique is used to determine which genes are actively expressed.",
      "GRO-seq is often used to study the transcriptomes of different cell types or tissues."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: GRO-seq stands for Global Run-On sequencing.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1134,
    "user_query": "Are Drosophila ultraconserved elements candidate ncRNAs?",
    "vicuna-7b_response": "Yes, Drosophila ultraconserved elements (UCAs) are considered to be candidate non-coding RNAs (ncRNAs). UCAs are short (typically less than 25 nucleotides) and highly conserved non-coding sequences that are found in the same location on each of the two homologous chromosomes in many eukaryotes, including Drosophila.\nUCAs have been shown to be transcribed in some organisms, and their transcription has been suggested to be regulated by epigenetic mechanisms such as DNA methylation and histone modifications. Additionally, UCAs have been shown to be involved in various biological processes, such as development, cellular differentiation, and stress response.\nHowever, it is important to note that the function of UCAs is not yet fully understood, and their role as ncRNAs is still being investigated. Some studies have suggested that UCAs may act as scaffolds for the assembly of protein complexes or as binding sites for regulatory proteins, but these hypotheses are still being tested.\nOverall, while UCAs are considered to be ncRNAs, their function and role in biological processes are still not well understood, and further research is needed to fully elucidate their function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Drosophila ultraconserved elements (UCAs) are considered to be candidate non-coding RNAs (ncRNAs).\n2. UCAs are short and highly conserved non-coding sequences found in many eukaryotes, including Drosophila.\n3. UCAs have been shown to be involved in several biological processes such as development, cellular differentiation, and stress response.\n4. The transcription of UCAs is suggested to be regulated by epigenetic mechanisms such as DNA methylation and histone modifications.\n5. The function and role of UCAs in biological processes are not yet fully understood and are still being investigated.",
    "vicuna-7b_fact": [
      "Drosophila ultraconserved elements (UCAs) are considered to be candidate non-coding RNAs (ncRNAs).",
      "UCAs are short and highly conserved non-coding sequences found in many eukaryotes, including Drosophila.",
      "UCAs have been shown to be involved in several biological processes such as development, cellular differentiation, and stress response.",
      "The transcription of UCAs is suggested to be regulated by epigenetic mechanisms such as DNA methylation and histone modifications.",
      "The function and role of UCAs in biological processes are not yet fully understood and are still being investigated."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1142,
    "user_query": "How are thyroid hormones involved in the development of diabetic cardiomyopathy?",
    "vicuna-7b_response": "Thyroid hormones play a crucial role in the development of diabetic cardiomyopathy, a complication of diabetes that affects the heart.\nDiabetes is a condition characterized by high blood sugar levels, which can damage the blood vessels, nerves, and organs in the body, including the heart. Over time, diabetes can lead to the development of diabetic cardiomyopathy, which is a weakening of the heart muscle that makes it harder for the heart to pump blood effectively.\nThyroid hormones play a role in the metabolism of glucose, which is an important factor in the development of diabetic cardiomyopathy. High levels of blood sugar can lead to the production of reactive oxygen species (ROS), which can damage the heart muscle and contribute to the development of diabetic cardiomyopathy. Thyroid hormones can help to regulate blood sugar levels and reduce the production of ROS, which can help to protect the heart from damage.\nIn addition, thyroid hormones play a role in the contraction and relaxation of the heart muscle, which is important for proper heart function. Thyroid hormones can help to regulate the contraction and relaxation of the heart muscle, which can help to maintain proper heart function and reduce the risk of diabetic cardiomyopathy.\nIn summary, thyroid hormones play a crucial role in the development of diabetic cardiomyopathy by regulating blood sugar levels, reducing the production of ROS, and maintaining proper heart function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Diabetic cardiomyopathy is a complication of diabetes that affects the heart.\n2. This condition is characterized by a weakening of the heart muscle that makes it harder for the heart to pump blood effectively.\n3. Thyroid hormones play a role in the metabolism of glucose, which is an important factor in the development of diabetic cardiomyopathy.\n4. High levels of blood sugar can lead to the production of reactive oxygen species (ROS), which can damage the heart muscle.\n5. Thyroid hormones also play a role in the contraction and relaxation of the heart muscle.",
    "vicuna-7b_fact": [
      "Diabetic cardiomyopathy is a complication of diabetes that affects the heart.",
      "This condition is characterized by a weakening of the heart muscle that makes it harder for the heart to pump blood effectively.",
      "Thyroid hormones play a role in the metabolism of glucose, which is an important factor in the development of diabetic cardiomyopathy.",
      "High levels of blood sugar can lead to the production of reactive oxygen species (ROS), which can damage the heart muscle.",
      "Thyroid hormones also play a role in the contraction and relaxation of the heart muscle."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-7b_response": "Angiogenin is a protein that is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus. It is also found in the nucleus of certain cells, such as those in the liver and kidney. Angiogenin is a glycoprotein that is involved in the regulation of cell growth and differentiation, and it has been implicated in the development of cancer. It is also a potent inducer of angiogenesis, the process by which new blood vessels are formed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.\n2. Angiogenin is also found in the nucleus of certain cells, specifically in the liver and kidney.\n3. Angiogenin is a glycoprotein.\n4. The protein angiogenin is involved in the regulation of cell growth and differentiation.\n5. Angiogenin has been implicated in the development of cancer.",
    "vicuna-7b_fact": [
      "Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.",
      "Angiogenin is also found in the nucleus of certain cells, specifically in the liver and kidney.",
      "Angiogenin is a glycoprotein.",
      "The protein angiogenin is involved in the regulation of cell growth and differentiation.",
      "Angiogenin has been implicated in the development of cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1151,
    "user_query": "Which bone protein is used in archaelogy for dating and species identification?",
    "vicuna-7b_response": "The bone protein that is commonly used in archaeology for dating and species identification is collagen. Collagen is a protein that is found in the bones, teeth, and other connective tissues of animals. It is a highly stable molecule that does not decay over time, making it an ideal material for use in dating and species identification techniques.\nOne such technique is radiocarbon dating, which uses the radioactive isotope carbon-14 to determine the age of organic materials, such as bone and other animal tissues. Collagen is the main protein found in bone, and it contains a high concentration of carbon, which makes it ideal for this type of dating.\nAnother technique that uses collagen for species identification is stable isotope analysis. This method compares the ratios of different isotopes of elements such as carbon, nitrogen, and oxygen in the collagen of a bone to those of other organisms. By comparing the ratios of these isotopes, scientists can determine the diet and environment of the animal that the bone came from, and thus identify the species.\nOverall, collagen is an important bone protein that is used in a variety of archaeological techniques for dating and species identification.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Collagen is a bone protein that is commonly used in archaeology for dating and species identification.\n2. Collagen is found in bones, teeth, and other animal connective tissues.\n3. Collagen is a stable molecule that does not decay over time.\n4. Radiocarbon dating uses carbon-14 to determine the age of organic materials like bone.\n5. Stable isotope analysis which uses collagen for species identification compares the ratios of different isotopes of elements like carbon, nitrogen, and oxygen in the collagen of a bone.",
    "vicuna-7b_fact": [
      "Collagen is a bone protein that is commonly used in archaeology for dating and species identification.",
      "Collagen is found in bones, teeth, and other animal connective tissues.",
      "Collagen is a stable molecule that does not decay over time.",
      "Radiocarbon dating uses carbon-14 to determine the age of organic materials like bone.",
      "Stable isotope analysis which uses collagen for species identification compares the ratios of different isotopes of elements like carbon, nitrogen, and oxygen in the collagen of a bone."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Collagen is a molecule that can decay over time, especially if the surrounding conditions favor its breakdown.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1156,
    "user_query": "Is armodafinil used for treatment of insomnia?",
    "vicuna-7b_response": "Yes, armodafinil is used for the treatment of insomnia. It is a medication that belongs to a class of drugs called wakefulness-promoting agents. Armodafinil is a stimulant that is similar to modafinil, but it has a longer half-life and is less likely to cause side effects such as nervousness and anxiety.\nArmodafinil is approved by the US Food and Drug Administration (FDA) for the treatment of excessive sleepiness caused by narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD). It is also used off-label for the treatment of insomnia.\nThe recommended dose of armodafinil for the treatment of insomnia is 150-250 mg once daily, taken in the morning. However, it is important to consult with a healthcare professional before taking armodafinil for insomnia, as it may not be suitable for everyone.\nIt is important to note that while armodafinil can help improve sleep quality and duration, it is not a substitute for good sleep hygiene and other sleep-promoting strategies. It is also important to follow the recommended dosage and duration of treatment, as well as any potential side effects or interactions with other medications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Armodafinil is a medication that belongs to a class of drugs called wakefulness-promoting agents.\n2. Armodafinil is a stimulant that is similar to modafinil.\n3. The US Food and Drug Administration (FDA) has approved armodafinil for the treatment of excessive sleepiness caused by narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD).\n4. Armodafinil is used off-label for the treatment of insomnia.\n5. The recommended dose of armodafinil for the treatment of insomnia is 150-250 mg once daily.",
    "vicuna-7b_fact": [
      "Armodafinil is a medication that belongs to a class of drugs called wakefulness-promoting agents.",
      "Armodafinil is a stimulant that is similar to modafinil.",
      "The US Food and Drug Administration (FDA) has approved armodafinil for the treatment of excessive sleepiness caused by narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD).",
      "Armodafinil is used off-label for the treatment of insomnia.",
      "The recommended dose of armodafinil for the treatment of insomnia is 150-250 mg once daily."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Armodafinil is used off-label for the treatment of conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and fatigue related to conditions like multiple sclerosis and depression, not insomnia.\n5. FALSE [correction]: Armodafinil would not be recommended for the treatment of insomnia as it promotes wakefulness. Its typical dosage for approved conditions is 150-250 mg once daily.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1159,
    "user_query": "What is Trypan blue used for?",
    "vicuna-7b_response": "Trypan blue is a dye used in cell viability assays to determine the health and vitality of cells. It is commonly used in biological research to assess the viability of cells, such as those in tissue culture or in vivo.\nTrypan blue is a cationic dye that is able to penetrate cells and bind to negatively charged cellular components, such as DNA and RNA. When cells are healthy and viable, their membranes are permeable and allow the dye to enter the cell. However, when cells are dead or dying, their membranes become more rigid and impermeable, preventing the dye from entering. As a result, viable cells will appear blue or purple under Trypan blue staining, while dead or dying cells will not take up the dye and will appear red or pink.\nTrypan blue is commonly used in combination with other stains, such as crystal violet or propidium iodide, to provide additional information about the health and viability of cells. For example, Trypan blue can be used to assess the overall viability of a population of cells, while other stains can be used to identify specific cell types or to detect DNA damage or other cellular changes.\nOverall, Trypan blue is a valuable tool for researchers and clinicians who need to assess the health and viability of cells, and it has many applications in fields such as cancer research, immunology, and regenerative medicine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Trypan blue is a dye used in cell viability assays to determine the health and vitality of cells.\n2. The dye is commonly used in biological research to assess the viability of cells.\n3. Trypan blue is a cationic dye that penetrates cells and binds to negatively charged cellular components, like DNA and RNA.\n4. Viable cells will appear blue or purple under Trypan blue staining, while dead or dying cells will not take up the dye and will appear red or pink.\n5. Trypan blue is commonly used in combination with other stains, such as crystal violet or propidium iodide, to provide additional information about the health and viability of cells.",
    "vicuna-7b_fact": [
      "Trypan blue is a dye used in cell viability assays to determine the health and vitality of cells.",
      "The dye is commonly used in biological research to assess the viability of cells.",
      "Trypan blue is a cationic dye that penetrates cells and binds to negatively charged cellular components, like DNA and RNA.",
      "Viable cells will appear blue or purple under Trypan blue staining, while dead or dying cells will not take up the dye and will appear red or pink.",
      "Trypan blue is commonly used in combination with other stains, such as crystal violet or propidium iodide, to provide additional information about the health and viability of cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Viable cells will not take up the Trypan blue stain and remain clear or colorless, whereas dead or dying cells will appear blue or purple because they take up the dye.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-7b_response": "Ranolazine is a medication that is used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. It works by blocking the late sodium current in heart cells, which helps to reduce the amount of energy required by the heart to contract and pump blood.\nOne of the ways in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the voltage-gated sodium channel. This channel is responsible for allowing sodium ions to flow into heart cells, which can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this channel, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nAnother way in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the late sodium current. This current is activated in response to increased intracellular calcium levels, and it can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this current, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nOverall, ranolazine can have a beneficial effect on kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel and the late sodium current, which can help to reduce the energy requirements of the heart and improve blood flow.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ranolazine is used to treat angina.\n2. Ranolazine works by blocking the late sodium current in heart cells.\n3. One of the ways in which ranolazine can affect kinase signaling activation in the heart is by blocking the activity of the voltage-gated sodium channel.\n4. Blocking this channel with ranolazine can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways.\n5. Ranolazine can reduce the energy requirements of the heart and improve blood flow by blocking the activity of the late sodium current and the voltage-gated sodium channel.",
    "vicuna-7b_fact": [
      "Ranolazine is used to treat angina.",
      "Ranolazine works by blocking the late sodium current in heart cells.",
      "One of the ways in which ranolazine can affect kinase signaling activation in the heart is by blocking the activity of the voltage-gated sodium channel.",
      "Blocking this channel with ranolazine can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways.",
      "Ranolazine can reduce the energy requirements of the heart and improve blood flow by blocking the activity of the late sodium current and the voltage-gated sodium channel."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ranolazine blocks the activity of the late sodium current in heart cells, but it is not known to affect kinase signaling activation directly by blocking the voltage-gated sodium channel.\n4. FALSE [correction]: It is not directly known that blocking the voltage-gated sodium channel with ranolazine can prevent the activation of PKC and other downstream signaling pathways. The exact mechanism of ranolazine on these pathways is not fully understood.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1164,
    "user_query": "Pridopidine has been tested for treatment of which disorder?",
    "vicuna-7b_response": "Pridopidine has been tested for the treatment of Huntington's disease.",
    "vicuna-7b_fact_raw": "The factual statement is: \n1. Pridopidine has been tested for the treatment of Huntington's disease.",
    "vicuna-7b_fact": [
      "Pridopidine has been tested for the treatment of Huntington's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 1166,
    "user_query": "Are CpG islands located close to housekeeping genes?",
    "vicuna-7b_response": "CpG islands are regions of DNA that contain a high proportion of cytosine residues followed by guanine residues (CpG dinucleotides) and are typically found in the promoter regions of genes. Housekeeping genes are genes that are constitutively expressed in all cells and tissues, and are not specific to any particular cell type or process.\nThere is no general rule that CpG islands must be located close to housekeeping genes. However, it is known that many housekeeping genes are located in CpG island-containing promoter regions. This is because CpG islands are thought to play a role in the regulation of gene expression by providing a binding site for transcriptional regulatory proteins.\nIn addition, some studies have shown that CpG islands are more likely to be found in the promoter regions of housekeeping genes than in the promoter regions of tissue-specific genes. However, this is not a universal rule, and there are many examples of housekeeping genes that do not have CpG islands in their promoter regions.\nIn summary, while there is no general rule that CpG islands must be located close to housekeeping genes, it is known that many housekeeping genes are located in CpG island-containing promoter regions, and that CpG islands may play a role in the regulation of gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CpG islands are regions of DNA that contain a high proportion of cytosine residues followed by guanine residues (CpG dinucleotides).\n2. CpG islands are typically found in the promoter regions of genes.\n3. Housekeeping genes are genes that are constitutively expressed in all cells and tissues, and are not specific to any particular cell type or process.\n4. Many housekeeping genes are located in CpG island-containing promoter regions.\n5. CpG islands are thought to play a role in the regulation of gene expression by providing a binding site for transcriptional regulatory proteins.",
    "vicuna-7b_fact": [
      "CpG islands are regions of DNA that contain a high proportion of cytosine residues followed by guanine residues (CpG dinucleotides).",
      "CpG islands are typically found in the promoter regions of genes.",
      "Housekeeping genes are genes that are constitutively expressed in all cells and tissues, and are not specific to any particular cell type or process.",
      "Many housekeeping genes are located in CpG island-containing promoter regions.",
      "CpG islands are thought to play a role in the regulation of gene expression by providing a binding site for transcriptional regulatory proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1178,
    "user_query": "Idarucizumab is an antidote of which drug?",
    "vicuna-7b_response": "Idarucizumab is an antidote for dabigatran, a blood thinner medication used to prevent blood clots. Dabigatran is a direct oral anticoagulant (DOAC) that works by inhibiting the activity of a specific enzyme in the body called thrombin. However, dabigatran can also lead to the formation of dangerous blood clots, which is why idarucizumab is used as an antidote to reverse its effects. Idarucizumab binds to dabigatran and helps to remove it from the body, restoring the blood's ability to clot normally.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Idarucizumab is an antidote for dabigatran.\n2. Dabigatran is a medication used to prevent blood clots.\n3. Dabigatran is a direct oral anticoagulant (DOAC).\n4. Dabigatran works by inhibiting the activity of a specific enzyme in the body called thrombin.\n5. Idarucizumab binds to dabigatran and helps to remove it from the body, restoring the blood's ability to clot normally.",
    "vicuna-7b_fact": [
      "Idarucizumab is an antidote for dabigatran.",
      "Dabigatran is a medication used to prevent blood clots.",
      "Dabigatran is a direct oral anticoagulant (DOAC).",
      "Dabigatran works by inhibiting the activity of a specific enzyme in the body called thrombin.",
      "Idarucizumab binds to dabigatran and helps to remove it from the body, restoring the blood's ability to clot normally."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1179,
    "user_query": "What are the main clinical characteristics of Pendred syndrome?",
    "vicuna-7b_response": "Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of smell. The main clinical characteristics of Pendred syndrome include:\n1. Congenital Hypothyroidism: Pendred syndrome is characterized by congenital hypothyroidism, which means that the thyroid gland does not produce enough thyroid hormones. This can lead to developmental delays, poor muscle tone, and a low body temperature.\n2. Deafness: Pendred syndrome is also associated with deafness, which is usually sensorineural in nature. This means that the deafness is caused by damage to the inner ear or the auditory nerve.\n3. Dysgeusia: Pendred syndrome can also cause a condition called dysgeusia, which is a reduced ability to taste. This can lead to a loss of taste sensation or a change in the way food tastes.\n4. Goitre: Pendred syndrome can also cause a goitre, which is an enlarged thyroid gland. This is due to the thyroid gland's attempts to compensate for the lack of thyroid hormones.\n5. Other features: Pendred syndrome can also cause other features such as intellectual disability, delayed puberty, and a wide nasal bridge.\nIt's important to note that Pendred syndrome is caused by mutations in the SLC34A2 gene, which encodes for the sodium iodide symporter. This gene is responsible for transporting iodine into the thyroid gland, where it is combined with tyrosine to form thyroid hormones.\nIn summary, Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of smell. The main clinical characteristics of Pendred syndrome include congenital hypothyroidism, deafness, dysgeusia, goitre, intellectual disability, delayed puberty, and a wide nasal bridge.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pendred syndrome is a genetic disorder that affects the development of the thyroid gland and the sense of smell.\n2. One of the main clinical characteristics of Pendred syndrome is congenital hypothyroidism.\n3. Another characteristic of Pendred syndrome is deafness, usually sensorineural.\n4. Pendred syndrome can lead to dysgeusia, a reduced ability to taste.\n5. Pendred syndrome is caused by mutations in the SLC34A2 gene, which encodes for the sodium iodide symporter.",
    "vicuna-7b_fact": [
      "Pendred syndrome is a genetic disorder that affects the development of the thyroid gland and the sense of smell.",
      "One of the main clinical characteristics of Pendred syndrome is congenital hypothyroidism.",
      "Another characteristic of Pendred syndrome is deafness, usually sensorineural.",
      "Pendred syndrome can lead to dysgeusia, a reduced ability to taste.",
      "Pendred syndrome is caused by mutations in the SLC34A2 gene, which encodes for the sodium iodide symporter."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Pendred syndrome is a genetic disorder that affects the development of the thyroid gland and the sense of hearing, not smell.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Pendred syndrome does not lead to dysgeusia. It is associated with hearing loss and thyroid problems.\n5. FALSE [correction]: Pendred syndrome is caused by mutations in the SLC26A4 gene, not the SLC34A2 gene.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1181,
    "user_query": "What is a popular mesaure of gene expression in RNA-seq experiments?",
    "vicuna-7b_response": "One popular measure of gene expression in RNA-seq experiments is the count of reads mapping to a specific gene. This is often referred to as the \"read count\" or \"read depth\" of a gene.\nAnother popular measure of gene expression is the \"fragments per kilobase of transcript per million mapped reads\" (FPKM). This metric is based on the number of reads that align to a specific gene, and then normalized by the size of the gene's transcript.\nAdditionally, there are other metrics such as \"transcripts per million\" (TPM) and \"exons per kilobase of transcript per million mapped reads\" (EPKM) that can be used to measure gene expression in RNA-seq experiments.\nIt's worth noting that the choice of the metric depends on the specific goals of the experiment and the characteristics of the samples being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A measure of gene expression in RNA-seq experiments is the count of reads mapping to a specific gene, often referred to as the \"read count\" or \"read depth\".\n2. Another measure of gene expression in RNA-seq experiments is the \"fragments per kilobase of transcript per million mapped reads\" (FPKM).\n3. The FPKM metric is based on the number of reads that align to a specific gene, then normalized by the size of the gene's transcript.\n4. Other metrics such as \"transcripts per million\" (TPM) and \"exons per kilobase of transcript per million mapped reads\" (EPKM) can also be used to measure gene expression in RNA-seq experiments.\n5. The chosen metric for measuring gene expression in RNA-seq experiments depends on the specific goals of the experiment and the characteristics of the samples being analyzed.",
    "vicuna-7b_fact": [
      "A measure of gene expression in RNA-seq experiments is the count of reads mapping to a specific gene, often referred to as the \"read count\" or \"read depth\".",
      "Another measure of gene expression in RNA-seq experiments is the \"fragments per kilobase of transcript per million mapped reads\" (FPKM).",
      "The FPKM metric is based on the number of reads that align to a specific gene, then normalized by the size of the gene's transcript.",
      "Other metrics such as \"transcripts per million\" (TPM) and \"exons per kilobase of transcript per million mapped reads\" (EPKM) can also be used to measure gene expression in RNA-seq experiments.",
      "The chosen metric for measuring gene expression in RNA-seq experiments depends on the specific goals of the experiment and the characteristics of the samples being analyzed."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Other metrics such as \"transcripts per million\" (TPM) can be used to measure gene expression in RNA-seq experiments, but \"exons per kilobase of transcript per million mapped reads\" (EPKM) is not a recognized metric.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1182,
    "user_query": "Is macroautophagy a selective degradation process?",
    "vicuna-7b_response": "Yes, macroautophagy is a selective degradation process. It is a process by which cells degrade and recycle their own components, including proteins, organelles, and other cellular structures.\nMacroautophagy is a type of autophagy, which is a general term for the process of self-eating by cells. Unlike other forms of autophagy, such as chaperone-mediated autophagy and mammalian cell autophagy, macroautophagy is a selective degradation process that targets specific cellular components for degradation.\nDuring macroautophagy, the cell creates a double-membrane structure called an autophagosome, which engulfs and encases the targeted component. The autophagosome then fuses with a lysosome, which contains enzymes that break down the encased component. This process allows the cell to recycle and reuse its own components, which can help to maintain cellular homeostasis and prevent the accumulation of damaged or unnecessary components.\nOverall, macroautophagy is a selective degradation process that plays an important role in maintaining cellular health and function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Macroautophagy is a selective degradation process.\n2. Macroautophagy is a process by which cells degrade and recycle their own components.\n3. Macroautophagy is a type of autophagy, a process of self-eating by cells.\n4. During macroautophagy, cells create a double-membrane structure called an autophagosome.\n5. The autophagosome fuses with a lysosome, which contains enzymes that break down the encased component.",
    "vicuna-7b_fact": [
      "Macroautophagy is a selective degradation process.",
      "Macroautophagy is a process by which cells degrade and recycle their own components.",
      "Macroautophagy is a type of autophagy, a process of self-eating by cells.",
      "During macroautophagy, cells create a double-membrane structure called an autophagosome.",
      "The autophagosome fuses with a lysosome, which contains enzymes that break down the encased component."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Macroautophagy is a non-selective degradation process.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1188,
    "user_query": "Which protein is affected by dusp8 activation?",
    "vicuna-7b_response": "DUSP8 (Dual Specificity Phosphatase 8) is a protein that is involved in regulating various cellular processes, including the immune response, inflammation, and cell survival. DUSP8 is a protein phosphatase, which means it removes phosphate groups from other proteins, thereby regulating their activity.\nThere are several proteins that are affected by DUSP8 activation. For example, DUSP8 has been shown to regulate the activity of the protein kinase C (PKC) family of enzymes, which are involved in various cellular processes, including cell proliferation, differentiation, and survival. DUSP8 has also been shown to regulate the activity of the protein kinase A (PKA) family of enzymes, which are involved in the regulation of various cellular processes, including the stress response, metabolism, and cell growth.\nIn addition, DUSP8 has been shown to regulate the activity of the protein kinase B (PKB/Akt) family of enzymes, which are involved in the regulation of various cellular processes, including cell survival, growth, and differentiation. DUSP8 has also been shown to regulate the activity of the protein kinase C (PKC) family of enzymes, which are involved in various cellular processes, including cell proliferation, differentiation, and survival.\nIn summary, DUSP8 is a protein that is involved in regulating various cellular processes, including the immune response, inflammation, and cell survival. DUSP8 has been shown to regulate the activity of several proteins, including the protein kinase C (PKC) family of enzymes, protein kinase A (PKA) family of enzymes, protein kinase B (PKB/Akt) family of enzymes, and others.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DUSP8 (Dual Specificity Phosphatase 8) is a protein phosphatase.\n2. DUSP8 removes phosphate groups from other proteins, thereby regulating their activity.\n3. DUSP8 has been shown to regulate the activity of the protein kinase C (PKC) family of enzymes.\n4. DUSP8 also regulates the activity of the protein kinase A (PKA) family of enzymes.\n5. The protein kinase B (PKB/Akt) family of enzymes' activity is also regulated by DUSP8.",
    "vicuna-7b_fact": [
      "DUSP8 (Dual Specificity Phosphatase 8) is a protein phosphatase.",
      "DUSP8 removes phosphate groups from other proteins, thereby regulating their activity.",
      "DUSP8 has been shown to regulate the activity of the protein kinase C (PKC) family of enzymes.",
      "DUSP8 also regulates the activity of the protein kinase A (PKA) family of enzymes.",
      "The protein kinase B (PKB/Akt) family of enzymes' activity is also regulated by DUSP8."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1191,
    "user_query": "Which drugs are utilized to treat eosinophilic esophagitis?",
    "vicuna-7b_response": "Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus that is characterized by the presence of eosinophils (a type of white blood cell) in the esophageal tissue. The exact cause of EoE is not known, but it is thought to be related to an immune system response to allergens or other substances in the environment.\nThe treatment of EoE typically involves a combination of dietary changes, medications, and, in some cases, allergy testing and desensitization. The specific treatment plan for an individual with EoE will depend on the severity of their symptoms and the underlying cause of the disease.\nHere are some of the medications that are commonly used to treat EoE:\n1. Proton pump inhibitors (PPIs): These medications reduce the production of stomach acid, which can help to alleviate symptoms of EoE such as heartburn and difficulty swallowing.\n2. Leukotriene modifiers: These medications help to reduce inflammation in the esophagus by blocking the action of leukotrienes, a type of chemical messenger that contributes to inflammation.\n3. Corticosteroids: These medications can help to reduce inflammation and swelling in the esophagus. They are often used in combination with other medications to achieve the best results.\n4. Mast cell stabilizers: These medications help to reduce the release of histamine and other chemicals that contribute to inflammation and swelling in the esophagus.\n5. Immunomodulators: These medications work by suppressing the immune system, which can help to reduce inflammation and swelling in the esophagus.\nIt is important to note that these medications may not be effective for everyone with EoE, and the most effective treatment plan will depend on the individual case. It is always best to consult with a healthcare professional for personalized treatment recommendations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eosinophilic esophagitis is a chronic inflammatory disease of the esophagus.\n2. The treatment of eosinophilic esophagitis typically involves a combination of dietary changes, medications, and, in some cases, allergy testing and desensitization.\n3. Proton pump inhibitors are used to reduce the production of stomach acid to alleviate symptoms of EoE.\n4. Corticosteroids, leukotriene modifiers, mast cell stabilizers and immunomodulators are types of medications commonly used to treat EoE.\n5. The most effective treatment plan for eosinophilic esophagitis will depend on the individual case.",
    "vicuna-7b_fact": [
      "Eosinophilic esophagitis is a chronic inflammatory disease of the esophagus.",
      "The treatment of eosinophilic esophagitis typically involves a combination of dietary changes, medications, and, in some cases, allergy testing and desensitization.",
      "Proton pump inhibitors are used to reduce the production of stomach acid to alleviate symptoms of EoE.",
      "Corticosteroids, leukotriene modifiers, mast cell stabilizers and immunomodulators are types of medications commonly used to treat EoE.",
      "The most effective treatment plan for eosinophilic esophagitis will depend on the individual case."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1194,
    "user_query": "What is the Her2 status in Li-Fraumeni syndrome?",
    "vicuna-7b_response": "Li-Fraumeni syndrome is a rare genetic disorder that increases the risk of developing certain types of cancer, including breast cancer. The Her2 status in Li-Fraumeni syndrome refers to the presence or absence of the HER2/neu gene amplification in breast cancer tumors that develop in individuals with this syndrome.\nIn general, breast cancer in individuals with Li-Fraumeni syndrome tends to be more aggressive and has a higher risk of recurrence than in the general population. The HER2/neu gene amplification, which is a marker of aggressive breast cancer, is more common in breast cancer tumors in individuals with Li-Fraumeni syndrome compared to the general population.\nHowever, the specific Her2 status in Li-Fraumeni syndrome can vary depending on the individual and the specific type of cancer that develops. It is important to consult with a medical professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Li-Fraumeni syndrome is a rare genetic disorder that increases the risk of developing certain types of cancer, including breast cancer.\n2. The Her2 status in Li-Fraumeni syndrome refers to the presence or absence of the HER2/neu gene amplification in breast cancer tumors that develop in individuals with this syndrome.\n3. Breast cancer in individuals with Li-Fraumeni syndrome tends to be more aggressive and has a higher risk of recurrence than in the general population.\n4. The HER2/neu gene amplification is more common in breast cancer tumors in individuals with Li-Fraumeni syndrome compared to the general population.\n5. The specific Her2 status in Li-Fraumeni syndrome can vary depending on the individual and the specific type of cancer that develops.",
    "vicuna-7b_fact": [
      "Li-Fraumeni syndrome is a rare genetic disorder that increases the risk of developing certain types of cancer, including breast cancer.",
      "The Her2 status in Li-Fraumeni syndrome refers to the presence or absence of the HER2/neu gene amplification in breast cancer tumors that develop in individuals with this syndrome.",
      "Breast cancer in individuals with Li-Fraumeni syndrome tends to be more aggressive and has a higher risk of recurrence than in the general population.",
      "The HER2/neu gene amplification is more common in breast cancer tumors in individuals with Li-Fraumeni syndrome compared to the general population.",
      "The specific Her2 status in Li-Fraumeni syndrome can vary depending on the individual and the specific type of cancer that develops."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1197,
    "user_query": "Why can't humans synthesize Neu5Gc (N-Glycolylneuraminic acid)?",
    "vicuna-7b_response": "Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid) because this molecule is not present in the human body. Neu5Gc is a type of sugar molecule that is found in many species, including animals, but it is not present in humans.\nThe human body relies on obtaining Neu5Gc from the diet or from other sources, such as through the process of glycosylation, which is the process of adding sugar molecules to proteins and lipids. However, the human body is not able to synthesize Neu5Gc on its own, and it is not necessary for human health.\nTherefore, the lack of Neu5Gc in the human body is not a problem, and there is no need for humans to synthesize this molecule.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid).\n2. Neu5Gc is a sugar molecule found in many species, but not in humans.\n3. The human body relies on obtaining Neu5Gc from the diet or from other sources, such as through glycosylation.\n4. Glycosylation is the process of adding sugar molecules to proteins and lipids.\n5. The lack of Neu5Gc in the human body is not a problem, and it is not necessary for human health.",
    "vicuna-7b_fact": [
      "Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid).",
      "Neu5Gc is a sugar molecule found in many species, but not in humans.",
      "The human body relies on obtaining Neu5Gc from the diet or from other sources, such as through glycosylation.",
      "Glycosylation is the process of adding sugar molecules to proteins and lipids.",
      "The lack of Neu5Gc in the human body is not a problem, and it is not necessary for human health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Neu5Gc is a sugar molecule found in many species, including traces in humans.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The absence of Neu5Gc in the human body can potentially lead to certain health problems, as some studies have found links between human antibodies against Neu5Gc and cancer progression.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1198,
    "user_query": "Which enzyme is inhibited by Orteronel?",
    "vicuna-7b_response": "Orteronel is a drug that is used to treat prostate cancer. It works by inhibiting the enzyme 17,20-lyase, which is involved in the production of androgens such as testosterone. By inhibiting this enzyme, Orteronel reduces the levels of androgens in the body, which can help to slow or stop the growth of prostate cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Orteronel is a drug used to treat prostate cancer.\n2. Orteronel works by inhibiting the enzyme 17,20-lyase.\n3. The enzyme 17,20-lyase is involved in the production of androgens like testosterone.\n4. Orteronel reduces the levels of androgens in the body.\n5. Reducing the levels of androgens can help slow or stop the growth of prostate cancer cells.",
    "vicuna-7b_fact": [
      "Orteronel is a drug used to treat prostate cancer.",
      "Orteronel works by inhibiting the enzyme 17,20-lyase.",
      "The enzyme 17,20-lyase is involved in the production of androgens like testosterone.",
      "Orteronel reduces the levels of androgens in the body.",
      "Reducing the levels of androgens can help slow or stop the growth of prostate cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1202,
    "user_query": "Elaborate on the TREAT-NMD initiative for DMD patients",
    "vicuna-7b_response": "TREAT-NMD (Treatment Research in Neuromuscular Diseases) is an international initiative aimed at improving the treatment options for patients with neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The initiative is a collaboration between researchers, clinicians, industry, and patient organizations, and is funded by the European Union.\nThe TREAT-NMD initiative focuses on developing new treatments for neuromuscular diseases by providing support for clinical trials and other research projects. The initiative also aims to improve the diagnosis and management of neuromuscular diseases, and to increase awareness of these diseases among healthcare professionals and the general public.\nFor DMD patients, the TREAT-NMD initiative has supported several clinical trials aimed at developing new treatments for the disease. These trials have focused on various approaches, including gene therapy, pharmacological treatments, and regenerative medicine. The TREAT-NMD initiative has also supported research into the underlying causes of DMD and the development of biomarkers that can be used to diagnose and monitor the disease.\nIn addition to supporting research, the TREAT-NMD initiative has also provided education and training opportunities for healthcare professionals, researchers, and patient organizations. This has helped to improve the standard of care for DMD patients and has increased awareness of the disease among healthcare professionals.\nOverall, the TREAT-NMD initiative has made significant contributions to the development of new treatments for DMD and has improved the standard of care for patients with the disease. The initiative continues to be an important resource for researchers and clinicians working to improve the lives of patients with neuromuscular diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TREAT-NMD (Treatment Research in Neuromuscular Diseases) is an international initiative that aims to improve treatment options for patients with neuromuscular diseases including Duchenne muscular dystrophy (DMD).\n2. TREAT-NMD is funded by the European Union.\n3. The initiative has supported several clinical trials aimed at developing new treatments for DMD, focusing on gene therapy, pharmacological treatments, and regenerative medicine.\n4. TREAT-NMD has also supported research into the underlying causes of DMD and the development of biomarkers for diagnosis and disease monitoring.\n5. The TREAT-NMD initiative has provided education and training opportunities for healthcare professionals, researchers, and patient organizations.",
    "vicuna-7b_fact": [
      "TREAT-NMD (Treatment Research in Neuromuscular Diseases) is an international initiative that aims to improve treatment options for patients with neuromuscular diseases including Duchenne muscular dystrophy (DMD).",
      "TREAT-NMD is funded by the European Union.",
      "The initiative has supported several clinical trials aimed at developing new treatments for DMD, focusing on gene therapy, pharmacological treatments, and regenerative medicine.",
      "TREAT-NMD has also supported research into the underlying causes of DMD and the development of biomarkers for diagnosis and disease monitoring.",
      "The TREAT-NMD initiative has provided education and training opportunities for healthcare professionals, researchers, and patient organizations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1207,
    "user_query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "vicuna-7b_response": "Peutz-Jeghers syndrome is a rare genetic disorder characterized by the development of benign tumors called hamartomas in the gastrointestinal tract, as well as pigmented macules (dark spots) on the skin and mucous membranes. LKB1 is a serine/threonine kinase that plays a role in regulating cell growth and division, and it has been shown to be involved in the development of some types of cancer, including gastrointestinal cancers.\nStudies have shown that mutations in the LKB1 gene can lead to the development of Peutz-Jeghers syndrome, as well as an increased risk of gastrointestinal tumors. The exact mechanism by which LKB1 mutations lead to the development of these tumors is not fully understood, but it is thought to involve disruptions in the regulation of cell growth and division.\nIn summary, LKB1 is involved in the development of Peutz-Jeghers syndrome by regulating cell growth and division, and mutations in the LKB1 gene can lead to the development of gastrointestinal tumors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Peutz-Jeghers syndrome is a rare genetic disorder characterized by the development of benign tumors called hamartomas in the gastrointestinal tract, and pigmented macules on the skin and mucous membranes.\n2. LKB1 is a serine/threonine kinase that is involved in regulating cell growth and division.\n3. Mutations in the LKB1 gene can lead to the development of Peutz-Jeghers syndrome.\n4. LKB1 mutations can increase the risk of gastrointestinal tumors.\n5. LKB1 is involved in the development of some types of cancer, including gastrointestinal cancers.",
    "vicuna-7b_fact": [
      "Peutz-Jeghers syndrome is a rare genetic disorder characterized by the development of benign tumors called hamartomas in the gastrointestinal tract, and pigmented macules on the skin and mucous membranes.",
      "LKB1 is a serine/threonine kinase that is involved in regulating cell growth and division.",
      "Mutations in the LKB1 gene can lead to the development of Peutz-Jeghers syndrome.",
      "LKB1 mutations can increase the risk of gastrointestinal tumors.",
      "LKB1 is involved in the development of some types of cancer, including gastrointestinal cancers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1213,
    "user_query": "Which is the major function of sororin?",
    "vicuna-7b_response": "Sororin is a protein that plays a crucial role in the regulation of cell division and is primarily expressed in the testis. The major function of sororin is to regulate the progression of spermatogenesis by controlling the proliferation and differentiation of spermatogonial stem cells.\nSororin is a member of the BTB (broad complex, tramtrack, and bric a brac) protein family, which is characterized by the presence of a BTB motif in their amino acid sequence. The BTB motif is involved in the regulation of cell growth and differentiation by interacting with other proteins and modulating their activity.\nIn the testis, sororin is expressed in the Sertoli cells, which are responsible for the support and nourishment of spermatogonia. Sororin is also expressed in the Leydig cells, which are responsible for the production of testosterone.\nSororin has been shown to play a role in the regulation of the expression of genes involved in spermatogenesis, including genes involved in the proliferation and differentiation of spermatogonial stem cells. It has also been shown to play a role in the regulation of the expression of genes involved in the development of the male reproductive system.\nOverall, sororin is an important protein in the regulation of spermatogenesis and the development of the male reproductive system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sororin is a protein that plays a crucial role in the regulation of cell division.\n2. The major function of sororin is to regulate the progression of spermatogenesis by controlling the proliferation and differentiation of spermatogonial stem cells.\n3. Sororin is a member of the BTB protein family, which is characterized by a BTB motif in their amino acid sequence.\n4. Sororin is expressed in the Sertoli cells and Leydig cells in the testis.\n5. Sororin has been shown to regulate the expression of genes involved in spermatogenesis and the development of the male reproductive system.",
    "vicuna-7b_fact": [
      "Sororin is a protein that plays a crucial role in the regulation of cell division.",
      "The major function of sororin is to regulate the progression of spermatogenesis by controlling the proliferation and differentiation of spermatogonial stem cells.",
      "Sororin is a member of the BTB protein family, which is characterized by a BTB motif in their amino acid sequence.",
      "Sororin is expressed in the Sertoli cells and Leydig cells in the testis.",
      "Sororin has been shown to regulate the expression of genes involved in spermatogenesis and the development of the male reproductive system."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: Sororin is not a member of the BTB protein family. \n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1216,
    "user_query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "vicuna-7b_response": "Desvenlafaxine is the active metabolite of venlafaxine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders. The recommended starting dose of desvenlafaxine is 50 mg once daily, but it can be increased to a maximum dose of 100 mg once daily based on individual patient response and tolerability.\nIt is important to note that desvenlafaxine is not approved for use at a dose of 50 mg/day. The FDA has only approved desvenlafaxine at doses up to 100 mg/day. Therefore, it is not recommended to use desvenlafaxine at a dose of 50 mg/day without consulting a healthcare professional.\nIf you are experiencing symptoms of depression or anxiety, it is important to work with your healthcare provider to determine the appropriate treatment plan for you. They will consider various factors, including your medical history, current medications, and other health conditions, to determine the best course of treatment for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Desvenlafaxine is the active metabolite of venlafaxine.\n2. Venlafaxine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders.\n3. The recommended starting dose of desvenlafaxine is 50 mg once daily.\n4. Desvenlafaxine can be increased to a maximum dose of 100 mg once daily.\n5. The FDA has only approved desvenlafaxine at doses up to 100 mg/day.",
    "vicuna-7b_fact": [
      "Desvenlafaxine is the active metabolite of venlafaxine.",
      "Venlafaxine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders.",
      "The recommended starting dose of desvenlafaxine is 50 mg once daily.",
      "Desvenlafaxine can be increased to a maximum dose of 100 mg once daily.",
      "The FDA has only approved desvenlafaxine at doses up to 100 mg/day."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1219,
    "user_query": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?",
    "vicuna-7b_response": "Ferric carboxymaltose is a medication that is used to treat iron deficiency anemia in patients with inflammatory bowel disease (IBD). It works by increasing the amount of iron in the body, which can help to improve the production of red blood cells and treat anemia.\nFerric carboxymaltose is typically given as an intravenous (IV) infusion, and the dosage and frequency of treatment will depend on the individual patient and the severity of their anemia. It is important to note that ferric carboxymaltose should only be used under the supervision of a healthcare professional, as it can have side effects and may not be suitable for all patients.\nIn addition to treating anemia, ferric carboxymaltose may also be used to prevent the need for blood transfusions in patients with IBD who are at risk of developing anemia. However, the use of ferric carboxymaltose for this purpose is not as well established as its use for treating anemia, and more research is needed to fully understand its effectiveness in this context.\nOverall, ferric carboxymaltose can be an effective treatment option for anemia in patients with IBD, but it is important to discuss the potential benefits and risks of this medication with a healthcare professional before starting treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ferric carboxymaltose is a medication used to treat iron deficiency anemia in patients with inflammatory bowel disease.\n2. Ferric carboxymaltose works by increasing the amount of iron in the body.\n3. Ferric carboxymaltose is typically given as an intravenous (IV) infusion.\n4. Ferric carboxymaltose can potentially prevent the need for blood transfusions in patients with IBD who are at risk of developing anemia.\n5. The use of ferric carboxymaltose should be under the supervision of a healthcare professional.",
    "vicuna-7b_fact": [
      "Ferric carboxymaltose is a medication used to treat iron deficiency anemia in patients with inflammatory bowel disease.",
      "Ferric carboxymaltose works by increasing the amount of iron in the body.",
      "Ferric carboxymaltose is typically given as an intravenous (IV) infusion.",
      "Ferric carboxymaltose can potentially prevent the need for blood transfusions in patients with IBD who are at risk of developing anemia.",
      "The use of ferric carboxymaltose should be under the supervision of a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1220,
    "user_query": "Which disease is treated with Eliglustat?",
    "vicuna-7b_response": "Eliglustat is a medication that is used to treat a rare genetic disorder called Gaucher disease. Gaucher disease is a genetic disorder that affects the body's ability to break down a certain type of fat (lipid) called glucocerebroside. This build-up of glucocerebroside in the body can cause a variety of symptoms, including anemia, bone pain, and organ damage. Eliglustat works by increasing the amount of a certain enzyme in the body that helps to break down glucocerebroside, which can help to reduce the build-up of this substance and improve symptoms of Gaucher disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eliglustat is used to treat Gaucher disease.\n2. Gaucher disease is a genetic disorder that affects the body's ability to break down a specific type of fat called glucocerebroside.\n3. The accumulation of glucocerebroside in the body can cause anemia, bone pain, and organ damage.\n4. Eliglustat works by increasing the amount of a certain enzyme in the body that helps to break down glucocerebroside. \n5. Eliglustat can help to reduce the build-up of glucocerebroside and improve symptoms of Gaucher disease.",
    "vicuna-7b_fact": [
      "Eliglustat is used to treat Gaucher disease.",
      "Gaucher disease is a genetic disorder that affects the body's ability to break down a specific type of fat called glucocerebroside.",
      "The accumulation of glucocerebroside in the body can cause anemia, bone pain, and organ damage.",
      "Eliglustat works by increasing the amount of a certain enzyme in the body that helps to break down glucocerebroside.",
      "Eliglustat can help to reduce the build-up of glucocerebroside and improve symptoms of Gaucher disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eliglustat works by reducing the production of glucocerebroside.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-7b_response": "VSR endonuclease is a type of restriction endonuclease that is involved in the regulation of genetic recombination in bacteria. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\nIn general, the expression of restriction endonucleases, including VSR endonuclease, is regulated by the growth phase of bacteria. The expression of these enzymes is typically higher during the exponential phase of growth and lower during the stationary phase.\nThe regulation of VSR endonuclease expression is also influenced by the availability of certain nutrients and the presence of certain signaling molecules. For example, the expression of VSR endonuclease can be induced by the presence of certain amino acids, such as glutamine, and can be repressed by the presence of certain inhibitors, such as antibiotics.\nIn summary, the regulation of VSR endonuclease expression is not independent of the growth phase of bacteria, but rather is influenced by a variety of factors, including the availability of nutrients and the presence of signaling molecules.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. VSR endonuclease is a type of restriction endonuclease that is involved in the regulation of genetic recombination in bacteria.\n2. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\n3. The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of growth and lower during the stationary phase.\n4. The regulation of VSR endonuclease expression is influenced by the availability of certain nutrients and the presence of certain signaling molecules.\n5. The expression of VSR endonuclease can be induced by the presence of certain amino acids, such as glutamine, and can be repressed by the presence of certain inhibitors, such as antibiotics.",
    "vicuna-7b_fact": [
      "VSR endonuclease is a type of restriction endonuclease that is involved in the regulation of genetic recombination in bacteria.",
      "The regulation of VSR endonuclease is not independent of the growth phase of bacteria.",
      "The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of growth and lower during the stationary phase.",
      "The regulation of VSR endonuclease expression is influenced by the availability of certain nutrients and the presence of certain signaling molecules.",
      "The expression of VSR endonuclease can be induced by the presence of certain amino acids, such as glutamine, and can be repressed by the presence of certain inhibitors, such as antibiotics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1230,
    "user_query": "What is the life expectancy of professional athletes in respect to the general population?",
    "vicuna-7b_response": "The life expectancy of professional athletes is generally higher than that of the general population. According to a study published in the Journal of the American Medical Association, the life expectancy of male professional football players is 5-10 years higher than that of the general population.\nThere are several factors that contribute to the higher life expectancy of professional athletes. Firstly, professional athletes tend to be in excellent physical condition, which can help to reduce the risk of many chronic diseases. Secondly, professional athletes often have access to top-notch medical care, which can help to detect and treat health problems early on.\nHowever, it's important to note that the life expectancy of professional athletes can vary widely depending on the sport and the individual's specific circumstances. For example, the life expectancy of boxers is generally lower than that of other professional athletes due to the high risk of head injuries and other health problems associated with the sport.\nOverall, while the life expectancy of professional athletes is generally higher than that of the general population, it's important to recognize that there are many factors that can affect an individual's health and longevity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The life expectancy of professional athletes is generally higher than that of the general population.\n2. According to a study in the Journal of the American Medical Association, male professional football players have a life expectancy 5-10 years higher than the general population.\n3. Professional athletes often have access to top-notch medical care.\n4. The life expectancy can vary widely among professional athletes depending on the sport and the individual's specific circumstances.\n5. The life expectancy of boxers is generally lower than that of other professional athletes.",
    "vicuna-7b_fact": [
      "The life expectancy of professional athletes is generally higher than that of the general population.",
      "According to a study in the Journal of the American Medical Association, male professional football players have a life expectancy 5-10 years higher than the general population.",
      "Professional athletes often have access to top-notch medical care.",
      "The life expectancy can vary widely among professional athletes depending on the sport and the individual's specific circumstances.",
      "The life expectancy of boxers is generally lower than that of other professional athletes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The life expectancy of professional athletes is not generally higher than that of the general population due to higher risks of injury and other health problems related to their profession.\n2. FALSE [correction]: According to a study in the Journal of the American Medical Association, male professional football players have a life expectancy 5-10 years lower than the general population.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1232,
    "user_query": "How does adrenergic signaling affect thyroid hormone receptors?",
    "vicuna-7b_response": "Adrenergic signaling refers to the effects of the neurotransmitter norepinephrine, which is released from the sympathetic nervous system. Thyroid hormone receptors are proteins that bind to thyroid hormones and regulate their activity in the body.\nAdrenergic signaling can affect thyroid hormone receptors in several ways. One way is by increasing the expression of thyroid hormone receptors in the body. This can be achieved through the activation of beta-adrenergic receptors, which are found in the heart, skeletal muscle, and other tissues. Activation of these receptors can lead to an increase in the expression of thyroid hormone receptors, which can result in an increase in the activity of thyroid hormones.\nAnother way adrenergic signaling can affect thyroid hormone receptors is by increasing the sensitivity of cells to thyroid hormones. This can be achieved through the activation of alpha-adrenergic receptors, which are found in the heart and other tissues. Activation of these receptors can lead to an increase in the sensitivity of cells to thyroid hormones, which can result in an increase in the activity of thyroid hormones.\nAdditionally, adrenergic signaling can affect thyroid hormone receptors by increasing the production of thyroid hormones. This can be achieved through the activation of beta-adrenergic receptors, which can lead to an increase in the production of thyroid hormones.\nIn summary, adrenergic signaling can affect thyroid hormone receptors by increasing their expression, sensitivity, and production. This can result in an increase in the activity of thyroid hormones, which can have a wide range of effects on the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Adrenergic signaling refers to the effects of the neurotransmitter norepinephrine, which is released from the sympathetic nervous system.\n2. Thyroid hormone receptors are proteins that bind to thyroid hormones and regulate their activity in the body.\n3. One way adrenergic signaling can affect thyroid hormone receptors is by increasing their expression through the activation of beta-adrenergic receptors, found in the heart, skeletal muscle and other tissues.\n4. Adrenergic signaling can also increase the sensitivity of cells to thyroid hormones through the activation of alpha-adrenergic receptors, found in the heart and other tissues.\n5. Adrenergic signaling can affect thyroid hormone receptors by increasing the production of thyroid hormones through the activation of beta-adrenergic receptors.",
    "vicuna-7b_fact": [
      "Adrenergic signaling refers to the effects of the neurotransmitter norepinephrine, which is released from the sympathetic nervous system.",
      "Thyroid hormone receptors are proteins that bind to thyroid hormones and regulate their activity in the body.",
      "One way adrenergic signaling can affect thyroid hormone receptors is by increasing their expression through the activation of beta-adrenergic receptors, found in the heart, skeletal muscle and other tissues.",
      "Adrenergic signaling can also increase the sensitivity of cells to thyroid hormones through the activation of alpha-adrenergic receptors, found in the heart and other tissues.",
      "Adrenergic signaling can affect thyroid hormone receptors by increasing the production of thyroid hormones through the activation of beta-adrenergic receptors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Adrenergic signaling doesn't directly increase the production of thyroid hormones. Instead, it can regulate the sensitivity and expression of the thyroid receptors, which in turn can impact the effect of the thyroid hormones on the body.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-7b_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Here are some of the most commonly used methods:\n1. TMHMM: TMHMM is a widely used software tool for the prediction of transmembrane helices in proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins. TMHMM can be used to predict the location and length of transmembrane helices, as well as the orientation of beta-strands within the barrel.\n2. PONDR-VLXT: PONDR-VLXT is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a probabilistic model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n3. BetaBarrel: BetaBarrel is a software tool that uses a combination of sequence and structural information to predict beta-barrel transmembrane proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n4. SOPMA: SOPMA is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a probabilistic model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n5. PredictProtein: PredictProtein is a web-based tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\nThese are some of the most commonly used computational tools for the prediction of beta-barrel transmembrane proteins. The choice of tool depends on the specific requirements of the user and the available resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TMHMM is a software tool for the prediction of transmembrane helices in proteins.\n2. PONDR-VLXT is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins.\n3. BetaBarrel is a software tool for predicting beta-barrel transmembrane proteins.\n4. SOPMA is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins.\n5. PredictProtein is a web-based tool for predicting transmembrane helices in proteins.",
    "vicuna-7b_fact": [
      "TMHMM is a software tool for the prediction of transmembrane helices in proteins.",
      "PONDR-VLXT is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins.",
      "BetaBarrel is a software tool for predicting beta-barrel transmembrane proteins.",
      "SOPMA is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins.",
      "PredictProtein is a web-based tool for predicting transmembrane helices in proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: PONDR-VLXT is a software tool used for predicting protein disorder.\n3. TRUE\n4. FALSE [correction]: SOPMA is a software tool used for secondary protein structure prediction.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1236,
    "user_query": "Is there any cross-talk between the Wnt and the Akt pathways?",
    "vicuna-7b_response": "Yes, there is cross-talk between the Wnt and the Akt pathways. The Wnt pathway is a signaling pathway that plays a crucial role in the regulation of cell proliferation, differentiation, and survival, while the Akt pathway is a signaling pathway that regulates various cellular processes, including metabolism, cell survival, and growth.\nResearch has shown that the Wnt and Akt pathways interact and regulate each other's activity in various cellular processes. For example, the Wnt pathway can activate the Akt pathway by phosphorylating Akt, leading to its activation and the subsequent activation of downstream signaling pathways involved in cell survival and growth. On the other hand, the Akt pathway can also inhibit the Wnt pathway by phosphorylating and inactivating beta-catenin, a key transcription factor involved in the Wnt signaling pathway.\nIn summary, the Wnt and Akt pathways interact and regulate each other's activity in various cellular processes, and this cross-talk plays an important role in the regulation of cell proliferation, differentiation, and survival.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is cross-talk between the Wnt and the Akt pathways.\n2. The Wnt pathway is a signaling pathway that plays a role in the regulation of cell proliferation, differentiation, and survival.\n3. The Akt pathway is a signaling pathway that regulates various cellular processes, including metabolism, cell survival, and growth.\n4. The Wnt pathway can activate the Akt pathway by phosphorylating Akt.\n5. The Akt pathway can inhibit the Wnt pathway by phosphorylating and inactivating beta-catenin, a key transcription factor involved in the Wnt signaling pathway.",
    "vicuna-7b_fact": [
      "There is cross-talk between the Wnt and the Akt pathways.",
      "The Wnt pathway is a signaling pathway that plays a role in the regulation of cell proliferation, differentiation, and survival.",
      "The Akt pathway is a signaling pathway that regulates various cellular processes, including metabolism, cell survival, and growth.",
      "The Wnt pathway can activate the Akt pathway by phosphorylating Akt.",
      "The Akt pathway can inhibit the Wnt pathway by phosphorylating and inactivating beta-catenin, a key transcription factor involved in the Wnt signaling pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1238,
    "user_query": "Is the Snord116 cluster associated with the Prader-Willi syndrome?",
    "vicuna-7b_response": "The Snord116 cluster is a genomic region on chromosome 11 that has been associated with the Prader-Willi syndrome (PWS). The Prader-Willi syndrome is a genetic disorder that is characterized by a range of physical and cognitive developmental delays, as well as a strong desire to eat and difficulty losing weight.\nThe Snord116 cluster is a region of the genome that contains a number of genes, including the SNRPN gene, which is responsible for the production of a protein called UBE3A. The SNRPN gene is located on the long arm of chromosome 15, and it is responsible for the production of a protein that is involved in the regulation of gene expression.\nThe SNRPN gene is also located in the Snord116 cluster, which is a region of the genome that contains a number of genes that are involved in the regulation of gene expression. The Snord116 cluster is located on chromosome 11, and it is associated with a number of genetic disorders, including the Prader-Willi syndrome.\nIn individuals with the Prader-Willi syndrome, the SNRPN gene is deleted or inactivated, which leads to a lack of UBE3A protein. This lack of UBE3A protein is thought to be responsible for the range of physical and cognitive developmental delays that are characteristic of the Prader-Willi syndrome.\nOverall, the Snord116 cluster is associated with the Prader-Willi syndrome, and the SNRPN gene is responsible for the production of the UBE3A protein, which is involved in the regulation of gene expression. The deletion or inactivation of the SNRPN gene in individuals with the Prader-Willi syndrome is thought to be responsible for the range of physical and cognitive developmental delays that are characteristic of the disorder.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Snord116 cluster is a genomic region on chromosome 11 that has been associated with the Prader-Willi syndrome.\n2. Prader-Willi syndrome is a genetic disorder characterized by a range of physical and cognitive developmental delays, as well as a strong desire to eat and difficulty losing weight.\n3. The SNRPN gene, which is responsible for the production of a protein called UBE3A, is located in the Snord116 cluster.\n4. The SNRPN gene is located on the long arm of chromosome 15.\n5. In individuals with Prader-Willi syndrome, the SNRPN gene is deleted or inactivated, resulting in a lack of UBE3A protein.",
    "vicuna-7b_fact": [
      "The Snord116 cluster is a genomic region on chromosome 11 that has been associated with the Prader-Willi syndrome.",
      "Prader-Willi syndrome is a genetic disorder characterized by a range of physical and cognitive developmental delays, as well as a strong desire to eat and difficulty losing weight.",
      "The SNRPN gene, which is responsible for the production of a protein called UBE3A, is located in the Snord116 cluster.",
      "The SNRPN gene is located on the long arm of chromosome 15.",
      "In individuals with Prader-Willi syndrome, the SNRPN gene is deleted or inactivated, resulting in a lack of UBE3A protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The SNRPN gene, responsible for producing the protein SNURF-SNRPN, not UBE3A, is located in the Snord116 cluster.\n4. TRUE\n5. FALSE [correction]: In individuals with Prader-Willi syndrome, the SNRPN gene may be deleted or inactivated, resulting in a lack of SNURF-SNRPN protein, not UBE3A.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1242,
    "user_query": "Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?",
    "vicuna-7b_response": "Nimodipine is a calcium channel blocker that is commonly used to prevent vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH). Vasospasm refers to the narrowing of blood vessels, which can occur after aSAH and lead to complications such as stroke, brain damage, and death.\nNimodipine works by relaxing the smooth muscle in blood vessels, which widens the blood vessels and improves blood flow. This can help prevent or treat vasospasm in aSAH patients.\nStudies have shown that nimodipine is effective in preventing vasospasm and reducing the risk of complications in aSAH patients. A randomized controlled trial published in the New England Journal of Medicine in 1994 found that nimodipine reduced the incidence of severe vasospasm and improved outcomes in aSAH patients when compared to placebo.\nHowever, it is important to note that nimodipine is not without risks. The drug can cause side effects such as headache, dizziness, and nausea, and it may not be effective in all patients. Additionally, nimodipine should not be used in patients with certain medical conditions, such as heart disease or kidney disease.\nIn summary, nimodipine is a commonly used medication to prevent vasospasm in aSAH patients. It has been shown to be effective in reducing the risk of complications and improving outcomes, but it is not without risks and should only be used under the guidance of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nimodipine is a calcium channel blocker used to prevent vasospasm in aneurysmal subarachnoid hemorrhage (aSAH) patients.\n2. Vasospasm, a narrowing of blood vessels, can lead to complications such as stroke, brain damage, and death.\n3. Nimodipine works by relaxing the smooth muscle in blood vessels, which improves blood flow.\n4. A randomized controlled trial published in the New England Journal of Medicine in 1994 found that nimodipine reduced the incidence of severe vasospasm and improved outcomes in aSAH patients.\n5. Nimodipine can potentially cause side effects like headache, dizziness, and nausea and may not be effective in all patients.",
    "vicuna-7b_fact": [
      "Nimodipine is a calcium channel blocker used to prevent vasospasm in aneurysmal subarachnoid hemorrhage (aSAH) patients.",
      "Vasospasm, a narrowing of blood vessels, can lead to complications such as stroke, brain damage, and death.",
      "Nimodipine works by relaxing the smooth muscle in blood vessels, which improves blood flow.",
      "A randomized controlled trial published in the New England Journal of Medicine in 1994 found that nimodipine reduced the incidence of severe vasospasm and improved outcomes in aSAH patients.",
      "Nimodipine can potentially cause side effects like headache, dizziness, and nausea and may not be effective in all patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1245,
    "user_query": "Where can we find the protein lacritin?",
    "vicuna-7b_response": "Lactatin is a protein that is found in milk. It is a whey protein that is produced by the action of proteolytic enzymes on casein, a major protein in milk. Lactatin is a high-quality protein that contains all the essential amino acids that the body needs to build and repair tissues. It is also a good source of calcium and has a low fat content.\nLactatin can be found in various forms such as powder, tablets, and capsules. It can be consumed as a dietary supplement or used as an ingredient in food products such as dairy products, bakery products, and sports nutrition products.\nIt is important to note that lactatin is a natural component of milk and is not added to milk as an ingredient. However, it can be extracted from milk and processed into a powder or other forms for consumption.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lactatin is a protein that is found in milk.\n2. Lactatin is a whey protein produced by the action of proteolytic enzymes on casein.\n3. Lactatin contains all the essential amino acids that the body needs to build and repair tissues.\n4. Lactatin can be found in various forms such as powder, tablets, and capsules.\n5. Lactatin is a natural component of milk and not added as an ingredient.",
    "vicuna-7b_fact": [
      "Lactatin is a protein that is found in milk.",
      "Lactatin is a whey protein produced by the action of proteolytic enzymes on casein.",
      "Lactatin contains all the essential amino acids that the body needs to build and repair tissues.",
      "Lactatin can be found in various forms such as powder, tablets, and capsules.",
      "Lactatin is a natural component of milk and not added as an ingredient."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: There is no protein called Lactatin found in milk.\n2. FALSE [correction]: There is no protein called Lactatin produced by the action of proteolytic enzymes on casein.\n3. FALSE [correction]: Lactatin, as defined in the statements, doesn't exist so it can't contain any amino acids.\n4. FALSE [correction]: There is no protein called Lactatin that can be found in various forms.\n5. FALSE [correction]: Lactatin is not a known component or ingredient of milk.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1247,
    "user_query": "What is the triple screening test performed during pregnancy measuring?",
    "vicuna-7b_response": "The triple screening test is a prenatal test that measures the levels of three substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol (E3). These substances are produced by the developing fetus and the placenta, and their levels can provide information about the risk of certain birth defects.\nThe triple screening test is typically performed between 15 and 20 weeks of pregnancy. It is a non-invasive test that involves a blood draw from the mother. The test measures the levels of these substances in the mother's blood and provides a risk assessment for certain birth defects, such as Down syndrome, spina bifida, and heart defects.\nIt is important to note that the triple screening test is not a diagnostic test, but rather a screening test. It can identify a higher risk of certain birth defects, but it cannot definitively diagnose a problem. If a woman has a high-risk result from the triple screening test, she may be offered additional testing, such as amniocentesis or chorionic villus sampling (CVS), to confirm the results and provide more information about the health of the fetus.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The triple screening test measures levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol (E3) in the mother's blood.\n2. These substances measured by the triple screening test are produced by the developing fetus and the placenta.\n3. The triple screening test is carried out between 15 and 20 weeks of pregnancy.\n4. The triple screening test provides a risk assessment for certain birth defects like Down syndrome, spina bifida, and heart defects.\n5. If a woman has a high-risk result from the triple screening test, she might be offered additional testing like amniocentesis or chorionic villus sampling (CVS).",
    "vicuna-7b_fact": [
      "The triple screening test measures levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol (E3) in the mother's blood.",
      "These substances measured by the triple screening test are produced by the developing fetus and the placenta.",
      "The triple screening test is carried out between 15 and 20 weeks of pregnancy.",
      "The triple screening test provides a risk assessment for certain birth defects like Down syndrome, spina bifida, and heart defects.",
      "If a woman has a high-risk result from the triple screening test, she might be offered additional testing like amniocentesis or chorionic villus sampling (CVS)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The triple screening test provides a risk assessment for certain birth defects like Down syndrome and neural tube defects, not heart defects.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1249,
    "user_query": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?",
    "vicuna-7b_response": "The Ragulator-RAG GTPases are a complex of proteins that play a crucial role in controlling mTOR activity. mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that regulates cell growth and metabolism. The Ragulator-RAG complex is responsible for activating mTOR by recruiting it to the lysosomal surface, where it can be activated by GTPases.\nOne of the proteins that interacts with the Ragulator-RAG GTPases to control mTOR activity is the Rheb GTPase. Rheb is a member of the GTPase superfamily and is involved in the regulation of cell growth and metabolism. It interacts with the Ragulator-RAG complex and promotes its activity, leading to the activation of mTOR.\nAnother protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is the TORC1 complex. TORC1 is a complex of proteins that includes mTOR and is responsible for regulating cell growth and metabolism. It interacts with the Ragulator-RAG complex and is activated by it, leading to the activation of mTOR.\nIn summary, the Ragulator-RAG GTPases interact with the Rheb GTPase and the TORC1 complex to control mTOR activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Ragulator-RAG GTPases are a complex of proteins that control mTOR activity.\n2. mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that regulates cell growth and metabolism.\n3. The Rheb GTPase is one of the proteins that interacts with the Ragulator-RAG GTPases to control mTOR activity.\n4. Rheb is a member of the GTPase superfamily and is involved in the regulation of cell growth and metabolism.\n5. Another protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is the TORC1 complex.",
    "vicuna-7b_fact": [
      "The Ragulator-RAG GTPases are a complex of proteins that control mTOR activity.",
      "mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that regulates cell growth and metabolism.",
      "The Rheb GTPase is one of the proteins that interacts with the Ragulator-RAG GTPases to control mTOR activity.",
      "Rheb is a member of the GTPase superfamily and is involved in the regulation of cell growth and metabolism.",
      "Another protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is the TORC1 complex."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-7b_response": "Galassi classification is used for the classification of skeletal disorders. It is a system of classification that was developed by the Italian radiologist, Galassi, in the 1970s. The Galassi classification system is based on the location and the type of bone lesion. It is widely used in radiology to describe and classify bone tumors and other bone disorders. The Galassi classification system is divided into three main categories: benign, malignant, and uncertain. Benign tumors are non-cancerous and do not spread to other parts of the body. Malignant tumors are cancerous and can spread to other parts of the body. Uncertain tumors are not clearly benign or malignant and require further evaluation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Galassi classification is used for the classification of skeletal disorders.\n2. The Galassi classification system was developed by an Italian radiologist, Galassi, in the 1970s.\n3. Galassi classification system is based on the location and the type of bone lesion.\n4. The system is widely used in radiology to describe and classify bone tumors and other bone disorders.\n5. The Galassi classification system is divided into three main categories: benign, malignant, and uncertain.",
    "vicuna-7b_fact": [
      "Galassi classification is used for the classification of skeletal disorders.",
      "The Galassi classification system was developed by an Italian radiologist, Galassi, in the 1970s.",
      "Galassi classification system is based on the location and the type of bone lesion.",
      "The system is widely used in radiology to describe and classify bone tumors and other bone disorders.",
      "The Galassi classification system is divided into three main categories: benign, malignant, and uncertain."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Galassi classification is used for the classification of petrous apex lesions.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Galassi classification system is divided into three types based on the extent of pneumatization of the petrous apex, not on the nature of the lesion (benign, malignant, uncertain).",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1258,
    "user_query": "List fluorescent reporter proteins.",
    "vicuna-7b_response": "Sure, here are some common fluorescent reporter proteins:\n1. Green Fluorescent Protein (GFP)\n2. Venus\n3. mCherry\n4. Yellow Fluorescent Protein (YFP)\n5. CFP (Cyan Fluorescent Protein)\n6. tdTomato\n7. Citrine\n8. DsRed\n9. Kaede\n10. TurboFP\nThese fluorescent proteins are commonly used in biological research and can be fused to other proteins to create fluorescent fusion proteins. They can be used for a variety of applications, including live cell imaging, fluorescence resonance energy transfer (FRET), and fluorescence activated cell sorting (FACS).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Green Fluorescent Protein (GFP) is a type of fluorescent reporter protein.\n2. mCherry is a type of fluorescent reporter protein.\n3. Yellow Fluorescent Protein (YFP) is a type of fluorescent reporter protein.\n4. Fluorescent proteins can be fused to other proteins to create fluorescent fusion proteins.\n5. Fluorescent proteins can be used for various applications including live cell imaging, fluorescence resonance energy transfer (FRET), and fluorescence activated cell sorting (FACS).",
    "vicuna-7b_fact": [
      "Green Fluorescent Protein (GFP) is a type of fluorescent reporter protein.",
      "mCherry is a type of fluorescent reporter protein.",
      "Yellow Fluorescent Protein (YFP) is a type of fluorescent reporter protein.",
      "Fluorescent proteins can be fused to other proteins to create fluorescent fusion proteins.",
      "Fluorescent proteins can be used for various applications including live cell imaging, fluorescence resonance energy transfer (FRET), and fluorescence activated cell sorting (FACS)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1259,
    "user_query": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
    "vicuna-7b_response": "MutT proteins are a family of DNA repair proteins that are found in bacteria. They play a crucial role in the repair of DNA lesions caused by mutagenic agents such as reactive oxygen species (ROS) and reactive nitrogen species (RNS).\nMutT proteins function by recognizing and binding to specific DNA lesions, such as base modifications, DNA strand breaks, and DNA cross-links. Once bound to the lesion, MutT proteins recruit other DNA repair proteins to the site, which then work together to repair the damage.\nOne of the key mechanisms by which MutT proteins act against DNA lesions is through their ability to recognize and bind to specific DNA lesions. MutT proteins have a high affinity for certain DNA lesions, such as 8-oxoguanine and 7,8-dihydro-8-oxoguanine, which are mutagenic base modifications that can occur as a result of exposure to ROS and RNS. By recognizing and binding to these lesions, MutT proteins can help to prevent their conversion into mutations.\nIn addition to their ability to recognize and bind to specific DNA lesions, MutT proteins also play a role in the repair of DNA strand breaks and DNA cross-links. When a strand break or cross-link occurs in the DNA, MutT proteins can help to repair the damage by recruiting other DNA repair proteins to the site and facilitating the repair process.\nOverall, MutT proteins play a crucial role in the repair of DNA lesions in bacteria, and their ability to recognize and bind to specific DNA lesions is a key mechanism by which they act against these lesions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MutT proteins are a family of DNA repair proteins that are found in bacteria.\n2. MutT proteins recognize and bind to specific DNA lesions, such as base modifications, DNA strand breaks, and DNA cross-links.\n3. MutT proteins recruit other DNA repair proteins to the site of a lesion to repair the damage.\n4. MutT proteins have a high affinity for certain DNA lesions, such as 8-oxoguanine and 7,8-dihydro-8-oxoguanine.\n5. MutT proteins play a role in the repair of DNA strand breaks and DNA cross-links by recruiting other DNA repair proteins to the site and facilitating the repair process.",
    "vicuna-7b_fact": [
      "MutT proteins are a family of DNA repair proteins that are found in bacteria.",
      "MutT proteins recognize and bind to specific DNA lesions, such as base modifications, DNA strand breaks, and DNA cross-links.",
      "MutT proteins recruit other DNA repair proteins to the site of a lesion to repair the damage.",
      "MutT proteins have a high affinity for certain DNA lesions, such as 8-oxoguanine and 7,8-dihydro-8-oxoguanine.",
      "MutT proteins play a role in the repair of DNA strand breaks and DNA cross-links by recruiting other DNA repair proteins to the site and facilitating the repair process."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1269,
    "user_query": "Which is the molecular function of the protein CCDC40?",
    "vicuna-7b_response": "CCDC40 is a protein that is involved in the regulation of cell growth and division. Specifically, it is a member of the coiled-coil domain-containing protein family and is known to interact with other proteins to regulate the activity of the cell cycle.\nOne of the molecular functions of CCDC40 is to promote the assembly of the spindle apparatus, which is responsible for separating the chromosomes during cell division. This is achieved through its interaction with other proteins, such as BUBR1, CDC20, and MKLP1, which are also involved in the regulation of the cell cycle.\nAdditionally, CCDC40 has been shown to play a role in the regulation of the actin cytoskeleton, which is a network of actin filaments that provides structural support to cells and helps to regulate their shape and movement. This is achieved through its interaction with other proteins, such as ARP2 and WASP, which are involved in the regulation of actin polymerization.\nOverall, CCDC40 is a protein that plays a critical role in the regulation of cell growth and division by promoting the assembly of the spindle apparatus and regulating the actin cytoskeleton.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CCDC40 is a protein that is involved in the regulation of cell growth and division.\n2. CCDC40 is a member of the coiled-coil domain-containing protein family and interacts with other proteins to regulate the activity of the cell cycle.\n3. One of the molecular functions of CCDC40 is to promote the assembly of the spindle apparatus, which is responsible for separating chromosomes during cell division.\n4. CCDC40 interacts with proteins such as BUBR1, CDC20, and MKLP1, which are also involved in the regulation of the cell cycle.\n5. CCDC40 plays a role in the regulation of the actin cytoskeleton and interacts with proteins such as ARP2 and WASP, which are involved in the regulation of actin polymerization.",
    "vicuna-7b_fact": [
      "CCDC40 is a protein that is involved in the regulation of cell growth and division.",
      "CCDC40 is a member of the coiled-coil domain-containing protein family and interacts with other proteins to regulate the activity of the cell cycle.",
      "One of the molecular functions of CCDC40 is to promote the assembly of the spindle apparatus, which is responsible for separating chromosomes during cell division.",
      "CCDC40 interacts with proteins such as BUBR1, CDC20, and MKLP1, which are also involved in the regulation of the cell cycle.",
      "CCDC40 plays a role in the regulation of the actin cytoskeleton and interacts with proteins such as ARP2 and WASP, which are involved in the regulation of actin polymerization."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CCDC40 is involved in cilia formation and not in spindle apparatus assembly.\n4. UNKNOWN\n5. FALSE [correction]: CCDC40 is not known to interact with ARP2 or WASP to regulate the actin cytoskeleton, it is involved in cilia formation.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1273,
    "user_query": "What is Cerebral Cavernous Malformation?",
    "vicuna-7b_response": "Cerebral cavernous malformation (CCM) is a rare, non-cancerous (benign) condition that affects the blood vessels in the brain. It is characterized by the formation of abnormal, dilated blood vessels (caverns) that can cause bleeding, inflammation, and other complications.\nCCM can occur at any age, but it is most common in children and young adults. The condition is often inherited, and it can cause a variety of symptoms, including seizures, headaches, and neurological problems.\nDiagnosis of CCM is typically made through a combination of medical history, physical examination, imaging tests such as MRI or CT scans, and a specialized test called angiography. Treatment options for CCM include surgery, embolization (blocking the blood vessels), and medications to reduce symptoms and prevent future complications.\nIt is important to note that CCM is not the same as an aneurysm, which is a weakened blood vessel that can burst and cause bleeding. While both conditions can cause similar symptoms, they are distinct and require different treatment approaches.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cerebral cavernous malformation (CCM) is a non-cancerous condition that affects the blood vessels in the brain.\n2. Cerebral cavernous malformation can cause bleeding, inflammation, and other complications.\n3. Cerebral cavernous malformation is characterized by the formation of abnormal, dilated blood vessels.\n4. Diagnosis of CCM can be made through medical history, physical examinations, and certain tests such as MRI, CT scans, and angiography.\n5. Treatment for CCM includes surgery, embolization, and medication.",
    "vicuna-7b_fact": [
      "Cerebral cavernous malformation (CCM) is a non-cancerous condition that affects the blood vessels in the brain.",
      "Cerebral cavernous malformation can cause bleeding, inflammation, and other complications.",
      "Cerebral cavernous malformation is characterized by the formation of abnormal, dilated blood vessels.",
      "Diagnosis of CCM can be made through medical history, physical examinations, and certain tests such as MRI, CT scans, and angiography.",
      "Treatment for CCM includes surgery, embolization, and medication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1275,
    "user_query": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?",
    "vicuna-7b_response": "The protein pathway that regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation is the PI3K/Akt/mTOR pathway.\nSGK1 (serum and glucocorticoid-regulated kinase 1) is a kinase that is activated by changes in the extracellular environment, such as changes in glucose levels or stress. When activated, SGK1 phosphorylates FOXO3a (forkhead box O3a) at specific sites, which leads to its degradation by the proteasome. This results in an increase in cell proliferation and a decrease in cellular differentiation.\nThe PI3K/Akt/mTOR pathway is a key regulator of cell growth and proliferation. It is activated by a variety of signals, including growth factors, nutrients, and stress signals. When activated, the PI3K/Akt/mTOR pathway leads to the production of cellular energy, the synthesis of proteins, and the inhibition of cellular stress responses.\nOne of the key components of the PI3K/Akt/mTOR pathway is the mTOR complex, which is composed of mTOR, raptor, and other proteins. When activated, the mTOR complex phosphorylates and activates downstream targets, including 4E-BP1 (eukaryotic translation initiation factor 4E-binding protein 1), which leads to an increase in the production of proteins and a decrease in the production of stress proteins.\nIn summary, the PI3K/Akt/mTOR pathway is the main pathway that regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation. When activated, the mTOR complex phosphorylates and activates downstream targets, leading to an increase in cellular growth and proliferation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SGK1 (serum and glucocorticoid-regulated kinase 1) is a kinase that is activated by changes in the extracellular environment.\n2. The PI3K/Akt/mTOR pathway regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation.\n3. When activated, SGK1 phosphorylates FOXO3a (forkhead box O3a) at specific sites, which leads to its degradation by the proteasome. \n4. The mTOR complex is a key component of the PI3K/Akt/mTOR pathway and is composed of mTOR, raptor, and other proteins.\n5. The mTOR complex phosphorylates and activates downstream targets, including 4E-BP1 (eukaryotic translation initiation factor 4E-binding protein 1).",
    "vicuna-7b_fact": [
      "SGK1 (serum and glucocorticoid-regulated kinase 1) is a kinase that is activated by changes in the extracellular environment.",
      "The PI3K/Akt/mTOR pathway regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation.",
      "When activated, SGK1 phosphorylates FOXO3a (forkhead box O3a) at specific sites, which leads to its degradation by the proteasome.",
      "The mTOR complex is a key component of the PI3K/Akt/mTOR pathway and is composed of mTOR, raptor, and other proteins.",
      "The mTOR complex phosphorylates and activates downstream targets, including 4E-BP1 (eukaryotic translation initiation factor 4E-binding protein 1)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1281,
    "user_query": "Is TNNI3K a cardiac-specific protein?",
    "vicuna-7b_response": "TNNI3K, also known as T-type calcium channel alpha-1 subunit, is a protein that is expressed primarily in cardiac muscle cells. It is a component of the T-type calcium channel, which plays a crucial role in regulating the flow of calcium ions into the heart muscle cells.\nThe expression of TNNI3K is highly specific to cardiac muscle cells, and its absence leads to a complete loss of T-type calcium channels in the heart. This is important because T-type calcium channels are responsible for regulating the contraction and relaxation of heart muscle cells, and their dysfunction has been implicated in a variety of cardiac disorders, including hypertension, arrhythmias, and heart failure.\nTherefore, TNNI3K can be considered a cardiac-specific protein that plays a critical role in the function of the heart.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TNNI3K is also known as T-type calcium channel alpha-1 subunit.\n2. TNNI3K is a protein expressed primarily in cardiac muscle cells.\n3. TNNI3K is a component of the T-type calcium channel.\n4. The T-type calcium channel regulates the flow of calcium ions into the heart muscle cells.\n5. Dysfunction of T-type calcium channels has been implicated in a variety of cardiac disorders, including hypertension, arrhythmias, and heart failure.",
    "vicuna-7b_fact": [
      "TNNI3K is also known as T-type calcium channel alpha-1 subunit.",
      "TNNI3K is a protein expressed primarily in cardiac muscle cells.",
      "TNNI3K is a component of the T-type calcium channel.",
      "The T-type calcium channel regulates the flow of calcium ions into the heart muscle cells.",
      "Dysfunction of T-type calcium channels has been implicated in a variety of cardiac disorders, including hypertension, arrhythmias, and heart failure."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: TNNI3K is not known as T-type calcium channel alpha-1 subunit. It's a cardiac-specific kinase.\n2. TRUE\n3. FALSE [correction]: TNNI3K is not a component of the T-type calcium channel, it is a kinase enzyme.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1287,
    "user_query": "Can the apoptosis regulator BAX trigger the release of cytochrome c?",
    "vicuna-7b_response": "Yes, the apoptosis regulator BAX can trigger the release of cytochrome c.\nCytochrome c is a protein found in the mitochondria of cells, which are responsible for generating energy for the cell. It is also involved in the process of apoptosis, which is a programmed cell death that occurs naturally in the body.\nBAX, or Bcl-2-associated X protein, is a protein that plays a role in the regulation of apoptosis. It is a pro-apoptotic protein, which means that it promotes the process of apoptosis. One way that BAX promotes apoptosis is by triggering the release of cytochrome c from the mitochondria.\nWhen BAX is activated, it forms a complex with another pro-apoptotic protein called Bak, which causes the outer mitochondrial membrane to become permeable. This allows cytochrome c to leak out of the mitochondria and into the cytosol, where it can activate other proteins that trigger apoptosis.\nIn summary, BAX can trigger the release of cytochrome c from the mitochondria, which can then activate the process of apoptosis in cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The apoptosis regulator BAX can trigger the release of cytochrome c.\n2. Cytochrome c is a protein found in the mitochondria of cells.\n3. BAX, or Bcl-2-associated X protein, is a pro-apoptotic protein.\n4. When BAX is activated, it forms a complex with the pro-apoptotic protein Bak, causing the outer mitochondrial membrane to become permeable.\n5. The release of cytochrome c from the mitochondria is a step in the process of apoptosis.",
    "vicuna-7b_fact": [
      "The apoptosis regulator BAX can trigger the release of cytochrome c.",
      "Cytochrome c is a protein found in the mitochondria of cells.",
      "BAX, or Bcl-2-associated X protein, is a pro-apoptotic protein.",
      "When BAX is activated, it forms a complex with the pro-apoptotic protein Bak, causing the outer mitochondrial membrane to become permeable.",
      "The release of cytochrome c from the mitochondria is a step in the process of apoptosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1289,
    "user_query": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients",
    "vicuna-7b_response": "BRAF inhibitors are a type of targeted therapy used to treat melanoma, a type of skin cancer. Some examples of BRAF inhibitors that have been tested in clinical trials for the treatment of melanoma patients include:\n* Vemurafenib (Zelboraf)\n* Trametinib (Mekinist)\n* Dabrafenib (Tafinlar)\n* Braftovi (encorafenib)\n* Erlotinib (Tarceva)\nIt's important to note that these are just a few examples and there may be other BRAF inhibitors that have been tested in clinical trials for the treatment of melanoma. It's always best to consult with a medical professional for the most up-to-date information on available treatments and clinical trials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BRAF inhibitors are a therapy type used to treat melanoma.\n2. Vemurafenib (Zelboraf) is a BRAF inhibitor that has been tested in clinical trials for melanoma treatment.\n3. Trametinib (Mekinist) is a BRAF inhibitor that has been tested in clinical trials for melanoma treatment.\n4. Dabrafenib (Tafinlar) is a BRAF inhibitor that has been tried in clinical trials for melanoma treatment.\n5. Braftovi (encorafenib) and Erlotinib (Tarceva) are also BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients.",
    "vicuna-7b_fact": [
      "BRAF inhibitors are a therapy type used to treat melanoma.",
      "Vemurafenib (Zelboraf) is a BRAF inhibitor that has been tested in clinical trials for melanoma treatment.",
      "Trametinib (Mekinist) is a BRAF inhibitor that has been tested in clinical trials for melanoma treatment.",
      "Dabrafenib (Tafinlar) is a BRAF inhibitor that has been tried in clinical trials for melanoma treatment.",
      "Braftovi (encorafenib) and Erlotinib (Tarceva) are also BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Trametinib (Mekinist) is a MEK inhibitor that has been tested in clinical trials for melanoma treatment.\n4. TRUE\n5. FALSE [correction]: Braftovi (encorafenib) is a BRAF inhibitor, however, Erlotinib (Tarceva) is an EGFR inhibitor, not a BRAF inhibitor.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1292,
    "user_query": "Which are the coactivators of the Yes-associated protein (yap)?",
    "vicuna-7b_response": "The coactivators of the Yes-associated protein (YAP) are a group of proteins that help to activate gene transcription by binding to the YAP protein and facilitating its interaction with other transcriptional regulators. Some of the known coactivators of YAP include:\n1. SRC-3/SRC-6: These are members of the steroid receptor coactivator (SRC) family of proteins, which are known to interact with YAP and enhance its transcriptional activity.\n2. PGC-1alpha: This protein is a transcriptional coactivator that has been shown to interact with YAP and promote its transcriptional activity in certain cell types.\n3. TAF1: This is a component of the general transcriptional machinery that helps to recruit other transcriptional regulators, including YAP, to the promoter region of target genes.\n4. CBP: This is a cyclic AMP-responsive element-binding protein that has been shown to interact with YAP and enhance its transcriptional activity in certain cell types.\n5. p300: This is another member of the SRC family of proteins that has been shown to interact with YAP and enhance its transcriptional activity in certain cell types.\nOverall, the coactivators of YAP play a critical role in regulating its transcriptional activity and thereby influencing cellular processes such as proliferation, differentiation, and survival.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The coactivators of the Yes-associated protein (YAP) are a group of proteins that help to activate gene transcription.\n2. SRC-3/SRC-6 are known coactivators of YAP and are members of the steroid receptor coactivator (SRC) family of proteins.\n3. PGC-1alpha, a transcriptional coactivator, has been shown to interact with YAP and promote its transcriptional activity in certain cell types.\n4. TAF1 is a component of the general transcriptional machinery that helps to recruit other transcriptional regulators, including YAP, to the promoter region of target genes.\n5. CBP and p300, which are members of the SRC family of proteins, have been shown to interact with YAP and enhance its transcriptional activity in certain cell types.",
    "vicuna-7b_fact": [
      "The coactivators of the Yes-associated protein (YAP) are a group of proteins that help to activate gene transcription.",
      "SRC-3/SRC-6 are known coactivators of YAP and are members of the steroid receptor coactivator (SRC) family of proteins.",
      "PGC-1alpha, a transcriptional coactivator, has been shown to interact with YAP and promote its transcriptional activity in certain cell types.",
      "TAF1 is a component of the general transcriptional machinery that helps to recruit other transcriptional regulators, including YAP, to the promoter region of target genes.",
      "CBP and p300, which are members of the SRC family of proteins, have been shown to interact with YAP and enhance its transcriptional activity in certain cell types."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1296,
    "user_query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "vicuna-7b_response": "During epithelial-mesenchymal transition (EMT), cells lose their cell-cell adhesion properties and acquire a more migratory and invasive phenotype. Several proteins are involved in this process and are associated with the loss of cell-cell adhesion. Here are some examples:\n1. E-cadherin: E-cadherin is a key adhesion protein that plays a crucial role in maintaining cell-cell adhesion. During EMT, E-cadherin is downregulated and replaced by other adhesion molecules such as N-cadherin and vimentin, which are involved in cell migration and invasion.\n2. Zonula occludens-1 (ZO-1): ZO-1 is a component of the tight junctions, which are structures that link adjacent cells and maintain cell-cell adhesion. During EMT, ZO-1 is downregulated and the tight junctions are disrupted, leading to the loss of cell-cell adhesion.\n3. Claudins: Claudins are another family of tight junction proteins that play a crucial role in maintaining cell-cell adhesion. During EMT, claudins are downregulated and the tight junctions are disrupted, leading to the loss of cell-cell adhesion.\n4. beta-catenin: beta-catenin is a key regulator of cell-cell adhesion and plays a crucial role in maintaining the integrity of the tight junctions. During EMT, beta-catenin is activated and promotes the loss of cell-cell adhesion.\n5. Snai1: Snai1, also known as snail, is a transcription factor that plays a crucial role in EMT. Snai1 activates genes involved in cell migration and invasion, including genes that are involved in the loss of cell-cell adhesion.\nOverall, these proteins are involved in the loss of cell-cell adhesion during EMT and are important for understanding the molecular mechanisms underlying this process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. E-cadherin is a key adhesion protein that is downregulated during epithelial-mesenchymal transition (EMT).\n2. Zonula occludens-1 (ZO-1) is a component of the tight junctions, which are disrupted during EMT.\n3. Claudins are a family of tight junction proteins that are downregulated during EMT.\n4. Beta-catenin is a regulator of cell-cell adhesion that is activated during EMT.\n5. Snai1, also known as snail, is a transcription factor that activates genes involved in the loss of cell-cell adhesion during EMT.",
    "vicuna-7b_fact": [
      "E-cadherin is a key adhesion protein that is downregulated during epithelial-mesenchymal transition (EMT).",
      "Zonula occludens-1 (ZO-1) is a component of the tight junctions, which are disrupted during EMT.",
      "Claudins are a family of tight junction proteins that are downregulated during EMT.",
      "Beta-catenin is a regulator of cell-cell adhesion that is activated during EMT.",
      "Snai1, also known as snail, is a transcription factor that activates genes involved in the loss of cell-cell adhesion during EMT."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1300,
    "user_query": "What is known about diseases associated with mutations in the CHCHD10 gene?",
    "vicuna-7b_response": "CHCHD10 is a gene that has been associated with several diseases, including:\n1. Intellectual disability: Mutations in the CHCHD10 gene have been linked to intellectual disability, which is characterized by significant impairments in cognitive and adaptive skills.\n2. Autism spectrum disorder: Some studies have suggested that mutations in the CHCHD10 gene may be associated with autism spectrum disorder (ASD), a neurodevelopmental disorder characterized by social impairments, communication difficulties, and repetitive behaviors.\n3. Epilepsy: Mutations in the CHCHD10 gene have been linked to an increased risk of developing epilepsy, a neurological disorder characterized by recurrent seizures.\n4. Cancer: Some studies have suggested that mutations in the CHCHD10 gene may be associated with an increased risk of certain types of cancer, including breast cancer and ovarian cancer.\nIt's important to note that more research is needed to fully understand the associations between CHCHD10 mutations and these various diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The CHCHD10 gene has been associated with several diseases.\n2. Mutations in the CHCHD10 gene have been linked to intellectual disability, characterized by significant impairments in cognitive and adaptive skills.\n3. Some studies have suggested that mutations in the CHCHD10 gene may be associated with autism spectrum disorder (ASD).\n4. Mutations in the CHCHD10 gene have been linked to an increased risk of developing epilepsy.\n5. Some studies have suggested that mutations in the CHCHD10 gene may be associated with an increased risk of certain types of cancer, including breast cancer and ovarian cancer.",
    "vicuna-7b_fact": [
      "The CHCHD10 gene has been associated with several diseases.",
      "Mutations in the CHCHD10 gene have been linked to intellectual disability, characterized by significant impairments in cognitive and adaptive skills.",
      "Some studies have suggested that mutations in the CHCHD10 gene may be associated with autism spectrum disorder (ASD).",
      "Mutations in the CHCHD10 gene have been linked to an increased risk of developing epilepsy.",
      "Some studies have suggested that mutations in the CHCHD10 gene may be associated with an increased risk of certain types of cancer, including breast cancer and ovarian cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-7b_response": "Shapiro syndrome is a rare genetic disorder characterized by a variety of symptoms, including:\n1. Elevated levels of uric acid in the blood (hyperuricemia)\n2. Gout: recurrent attacks of joint pain, swelling, and redness (inflammation) caused by the buildup of uric acid crystals in the joints.\n3. High blood pressure (hypertension)\n4. Kidney stones: small, hard deposits that form in the kidneys and can cause pain and other complications.\n5. Low blood counts: a decrease in the number of red blood cells, white blood cells, and platelets.\n6. Eye problems: such as cataracts, glaucoma, and other vision problems.\n7. Skin problems: such as psoriasis, eczema, and other skin rashes.\n8. Heart problems: such as high blood pressure, abnormal heart rhythms, and heart failure.\n9. Kidney problems: such as kidney stones, chronic kidney disease, and kidney failure.\n10. Joint pain and stiffness.\nIt's important to note that not all individuals with Shapiro syndrome will experience all of these symptoms, and the severity of symptoms can vary from person to person. Additionally, there are different types of Shapiro syndrome, and the symptoms can vary depending on the type.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Shapiro syndrome is a rare genetic disorder.\n2. One symptom of Shapiro syndrome can be elevated levels of uric acid in the blood (hyperuricemia).\n3. Another symptom can be recurrent Gout - joint pain, swelling, and inflammation caused by the buildup of uric acid crystals in the joints.\n4. Also, hypertensions or high blood pressure can be a symptom of Shapiro syndrome.\n5. Presence of kidney stones is also associated with Shapiro syndrome.\n6. Shapiro syndrome can cause low blood counts, a decrease in the number of red blood cells, white blood cells, and platelets.\n7. Eye problems, such as cataracts, glaucoma, and other vision problems, could be a symptom of Shapiro syndrome.\n8. Skin problems, including psoriasis, eczema, and other skin rashes can occur in people with Shapiro syndrome.\n9. The disorder can cause heart problems, such as high blood pressure, abnormal heart rhythms, and heart failure.\n10. Shapiro syndrome may result in kidney problems like kidney stones, chronic kidney disease, and kidney failure.",
    "vicuna-7b_fact": [
      "Shapiro syndrome is a rare genetic disorder.",
      "One symptom of Shapiro syndrome can be elevated levels of uric acid in the blood (hyperuricemia).",
      "Another symptom can be recurrent Gout - joint pain, swelling, and inflammation caused by the buildup of uric acid crystals in the joints.",
      "Also, hypertensions or high blood pressure can be a symptom of Shapiro syndrome.",
      "Presence of kidney stones is also associated with Shapiro syndrome.",
      "Shapiro syndrome can cause low blood counts, a decrease in the number of red blood cells, white blood cells, and platelets.",
      "Eye problems, such as cataracts, glaucoma, and other vision problems, could be a symptom of Shapiro syndrome.",
      "Skin problems, including psoriasis, eczema, and other skin rashes can occur in people with Shapiro syndrome.",
      "The disorder can cause heart problems, such as high blood pressure, abnormal heart rhythms, and heart failure.",
      ". Shapiro syndrome may result in kidney problems like kidney stones, chronic kidney disease, and kidney failure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Elevated levels of uric acid in the blood (hyperuricemia) is not a stated symptom of Shapiro syndrome.\n3. FALSE [correction]: Recurrent Gout is not a stated symptom of Shapiro syndrome.\n4. FALSE [correction]: Hypertensions or high blood pressure is not a stated symptom of Shapiro syndrome.\n5. FALSE [correction]: Presence of kidney stones is not a stated symptom of Shapiro syndrome.\n6. TRUE\n7. FALSE [correction]: Eye problems, such as cataracts, glaucoma, and other vision problems, are not stated symptoms of Shapiro syndrome.\n8. FALSE [correction]: Skin problems, including psoriasis, eczema, and other skin rashes, are not stated symptoms of Shapiro syndrome.\n9. FALSE [correction]: Heart problems, such as high blood pressure, abnormal heart rhythms, and heart failure are not stated symptoms of Shapiro syndrome.\n10. FALSE [correction]: Shapiro syndrome is not known to directly result in kidney problems like kidney stones, chronic kidney disease, and kidney failure.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false",
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1309,
    "user_query": "What is the role of the histidine rich calcium binding protein (HRC) in cardiomyopathy?",
    "vicuna-7b_response": "The histidine-rich calcium-binding protein (HRC) plays a crucial role in the development and progression of cardiomyopathy. HRC is a protein that is expressed in various tissues, including the heart, and is involved in the regulation of intracellular calcium levels.\nIn cardiomyopathy, HRC is believed to play a role in the pathogenesis of the disease by affecting calcium homeostasis in the heart. HRC has been shown to regulate the activity of calcium-handling proteins, such as the sarcoplasmic reticulum calcium- ATPase (SERCA) and the ryanodine receptor/Ca2+ release channel (RyR1), which are important for maintaining normal calcium homeostasis in the heart.\nStudies have shown that HRC levels are increased in the hearts of patients with dilated cardiomyopathy (DCM), a type of cardiomyopathy characterized by a dilated and weakened heart muscle. This increase in HRC levels has been associated with impaired calcium handling and increased susceptibility to arrhythmias in DCM patients.\nIn addition, HRC has also been shown to play a role in the development of hypertrophic cardiomyopathy (HCM), another type of cardiomyopathy characterized by abnormal thickening of the heart muscle. HRC has been shown to regulate the expression of genes involved in the development of cardiac hypertrophy, such as the atrial natriuretic peptide (ANP) and the beta-myosin heavy chain (beta-MHC).\nIn conclusion, HRC plays a crucial role in the regulation of calcium homeostasis in the heart and has been shown to be involved in the pathogenesis of cardiomyopathy, particularly in the development and progression of dilated and hypertrophic cardiomyopathy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The histidine-rich calcium-binding protein (HRC) is involved in the regulation of intracellular calcium levels.\n2. In cardiomyopathy, HRC is believed to affect calcium homeostasis in the heart.\n3. HRC regulates the activity of calcium-handling proteins such as the sarcoplasmic reticulum calcium- ATPase (SERCA) and the ryanodine receptor/Ca2+ release channel (RyR1).\n4. HRC levels are increased in the hearts of patients with dilated cardiomyopathy (DCM) and this increase is associated with impaired calcium handling and increased susceptibility to arrhythmias in DCM patients.\n5. HRC has been shown to regulate the expression of genes involved in the development of cardiac hypertrophy, such as the atrial natriuretic peptide (ANP) and the beta-myosin heavy chain (beta-MHC).",
    "vicuna-7b_fact": [
      "The histidine-rich calcium-binding protein (HRC) is involved in the regulation of intracellular calcium levels.",
      "In cardiomyopathy, HRC is believed to affect calcium homeostasis in the heart.",
      "HRC regulates the activity of calcium-handling proteins such as the sarcoplasmic reticulum calcium- ATPase (SERCA) and the ryanodine receptor/Ca2+ release channel (RyR1).",
      "HRC levels are increased in the hearts of patients with dilated cardiomyopathy (DCM) and this increase is associated with impaired calcium handling and increased susceptibility to arrhythmias in DCM patients.",
      "HRC has been shown to regulate the expression of genes involved in the development of cardiac hypertrophy, such as the atrial natriuretic peptide (ANP) and the beta-myosin heavy chain (beta-MHC)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1312,
    "user_query": "Which post-translational histone modifications are characteristic of facultative heterochromatin?",
    "vicuna-7b_response": "Facultative heterochromatin is a type of heterochromatin that can be either active or inactive depending on the needs of the cell. Post-translational histone modifications are chemical modifications that can be added to the histone proteins that make up the chromatin structure. Some of the post-translational histone modifications that are characteristic of facultative heterochromatin include:\n1. Histone H3 lysine 9 (H3K9) trimethylation: This modification is associated with the repression of gene expression. It is thought to be involved in the formation of a compact chromatin structure, which can silence genes.\n2. Histone H3 lysine 27 (H3K27) trimethylation: This modification is associated with the repression of gene expression. It is thought to be involved in the formation of a compact chromatin structure, which can silence genes.\n3. Histone H4 lysine 20 (H4K20) trimethylation: This modification is associated with the repression of gene expression. It is thought to be involved in the formation of a compact chromatin structure, which can silence genes.\n4. Histone H3 lysine 14 (H3K14) trimethylation: This modification is associated with the repression of gene expression. It is thought to be involved in the formation of a compact chromatin structure, which can silence genes.\n5. Histone H3 lysine 36 (H3K36) trimethylation: This modification is associated with the repression of gene expression. It is thought to be involved in the formation of a compact chromatin structure, which can silence genes.\nIt's important to note that these modifications can be found in different types of heterochromatin, and not only in facultative heterochromatin. Additionally, the presence of these modifications does not necessarily mean that the region is actively silencing genes, it could be inactive heterochromatin.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Facultative heterochromatin can be either active or inactive depending on the needs of the cell.\n2. Post-translational histone modifications are chemical modifications added to the histone proteins that make up the chromatin structure.\n3. Histone H3 lysine 9 (H3K9) trimethylation is a modification associated with the repression of gene expression.\n4. Histone H3 lysine 27 (H3K27) trimethylation is a modification associated with the repression of gene expression.\n5. Histone H3 lysine 36 (H3K36) trimethylation is a modification associated with the repression of gene expression.\n6. Histone H3 lysine 14 (H3K14) trimethylation is a modification associated with the repression of gene expression.\n7. Histone H4 lysine 20 (H4K20) trimethylation is a modification associated with the repression of gene expression.\n8. These modifications can be found in different types of heterochromatin, not only in facultative heterochromatin. \n9. The presence of these modifications does not necessarily mean that the region is actively silencing genes.",
    "vicuna-7b_fact": [
      "Facultative heterochromatin can be either active or inactive depending on the needs of the cell.",
      "Post-translational histone modifications are chemical modifications added to the histone proteins that make up the chromatin structure.",
      "Histone H3 lysine 9 (H3K9) trimethylation is a modification associated with the repression of gene expression.",
      "Histone H3 lysine 27 (H3K27) trimethylation is a modification associated with the repression of gene expression.",
      "Histone H3 lysine 36 (H3K36) trimethylation is a modification associated with the repression of gene expression.",
      "Histone H3 lysine 14 (H3K14) trimethylation is a modification associated with the repression of gene expression.",
      "Histone H4 lysine 20 (H4K20) trimethylation is a modification associated with the repression of gene expression.",
      "These modifications can be found in different types of heterochromatin, not only in facultative heterochromatin.",
      "The presence of these modifications does not necessarily mean that the region is actively silencing genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Histone H3 lysine 36 (H3K36) trimethylation is a modification generally associated with active gene expression, not with repression.\n6. UNKNOWN\n7. TRUE\n8. TRUE\n9. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1313,
    "user_query": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?",
    "vicuna-7b_response": "Aicardi-Goutieres syndrome (AGS) is a rare autoimmune disorder that affects the brain and the immune system. It is characterized by a triad of symptoms, including chronic fatigue, fever, and a distinctive rash on the torso. The exact cause of AGS is not known, but it is believed to be caused by mutations in certain genes.\nTo date, several mutations in genes have been associated with AGS. Some of the genes that have been implicated in the condition include:\n1. Meis1: Mutations in the MEIS1 gene have been identified in a small percentage of AGS cases.\n2. MAPK8IP2: Mutations in the MAPK8IP2 gene have been found in some patients with AGS.\n3. TYK2: Mutations in the TYK2 gene have been associated with a form of AGS that is characterized by a severe neurological involvement.\n4. STXBP1: Mutations in the STXBP1 gene have been identified in some patients with AGS.\n5. TYKC: Mutations in the TYKC gene have been associated with a rare form of AGS that is characterized by a severe neurological involvement.\nIt is important to note that not all cases of AGS are caused by mutations in these genes, and more research is needed to fully understand the genetic basis of the condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Aicardi-Goutieres syndrome (AGS) is a rare autoimmune disorder that affects the brain and the immune system.\n2. AGS is believed to be caused by mutations in certain genes.\n3. Mutations in the MEIS1 gene have been identified in some AGS cases.\n4. Some patients with AGS have mutations in the MAPK8IP2 gene.\n5. The TYK2 gene mutations have been associated with a form of AGS that has severe neurological involvement.",
    "vicuna-7b_fact": [
      "Aicardi-Goutieres syndrome (AGS) is a rare autoimmune disorder that affects the brain and the immune system.",
      "AGS is believed to be caused by mutations in certain genes.",
      "Mutations in the MEIS1 gene have been identified in some AGS cases.",
      "Some patients with AGS have mutations in the MAPK8IP2 gene.",
      "The TYK2 gene mutations have been associated with a form of AGS that has severe neurological involvement."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1317,
    "user_query": "What is the mechanism of action of abiraterone?",
    "vicuna-7b_response": "Abiraterone is a medication used to treat prostate cancer. Its mechanism of action involves inhibition of the enzyme 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD), which is involved in the conversion of androgen hormones such as testosterone to more potent forms.\nBy inhibiting 3-beta-HSD, abiraterone reduces the levels of these potent androgen hormones in the body, which in turn reduces the growth and proliferation of prostate cancer cells. Additionally, abiraterone can also reduce the production of other hormones that can promote the growth of prostate cancer cells, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH).\nOverall, abiraterone is a potent anti-androgen medication that works by reducing the levels of potent androgen hormones in the body, which can help to slow the growth and proliferation of prostate cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Abiraterone is a medication used to treat prostate cancer.\n2. Abiraterone's mechanism of action involves the inhibition of the enzyme 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD).\n3. 3-beta-HSD is involved in the conversion of androgen hormones such as testosterone to more potent forms.\n4. By inhibiting 3-beta-HSD, abiraterone reduces the levels of the potent androgen hormones in the body.\n5. Abiraterone can also reduce the production of other hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH).",
    "vicuna-7b_fact": [
      "Abiraterone is a medication used to treat prostate cancer.",
      "Abiraterone's mechanism of action involves the inhibition of the enzyme 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD).",
      "3-beta-HSD is involved in the conversion of androgen hormones such as testosterone to more potent forms.",
      "By inhibiting 3-beta-HSD, abiraterone reduces the levels of the potent androgen hormones in the body.",
      "Abiraterone can also reduce the production of other hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Abiraterone's mechanism of action involves the inhibition of the enzyme cytochrome P450 17A1 (CYP17A1).\n3. TRUE\n4. FALSE [correction]: By inhibiting CYP17A1, abiraterone reduces the levels of the potent androgen hormones in the body.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1318,
    "user_query": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?",
    "vicuna-7b_response": "Neprilysin, also known as neutral endopeptidase, is a protein that is naturally present in the brain and has been shown to have a positive effect on Alzheimer's disease. However, the brain has a natural defense mechanism that protects it from external substances, making it difficult to deliver drugs or other substances directly to the brain.\nOne way to deliver neprilysin to the brain is through the use of a drug called a \"vector.\" A vector is a carrier molecule that can transport a specific substance, such as neprilysin, across the blood-brain barrier. This barrier is a natural defense mechanism that protects the brain from external substances, but it also makes it difficult to deliver drugs or other substances directly to the brain.\nAnother way to deliver neprilysin to the brain is through the use of a gene therapy approach. In this approach, a vector is used to deliver a gene that encodes for neprilysin into the brain. Once the gene is expressed, the brain can produce its own neprilysin, which can help to clear the beta-amyloid protein that is associated with Alzheimer's disease.\nIt's important to note that both of these methods are still in the research phase and have not yet been approved for use in humans. However, they show promise as potential treatments for Alzheimer's disease and may lead to new and effective therapies in the future.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neprilysin, also known as neutral endopeptidase, is a protein that is naturally present in the brain and has been shown to have a positive effect on Alzheimer's disease.\n2. The brain has a natural defense mechanism that protects it from external substances.\n3. A vector is a carrier molecule that can transport a specific substance, such as neprilysin, across the blood-brain barrier.\n4. Gene therapy approach, using a vector can be used to deliver a gene that encodes for neprilysin into the brain.\n5. The methods of using a vector and gene therapy approach to deliver neprilysin to the brain are still in the research phase and have not yet been approved for use in humans.",
    "vicuna-7b_fact": [
      "Neprilysin, also known as neutral endopeptidase, is a protein that is naturally present in the brain and has been shown to have a positive effect on Alzheimer's disease.",
      "The brain has a natural defense mechanism that protects it from external substances.",
      "A vector is a carrier molecule that can transport a specific substance, such as neprilysin, across the blood-brain barrier.",
      "Gene therapy approach, using a vector can be used to deliver a gene that encodes for neprilysin into the brain.",
      "The methods of using a vector and gene therapy approach to deliver neprilysin to the brain are still in the research phase and have not yet been approved for use in humans."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-7b_response": "BRAG1 is a protein that is involved in the regulation of cell division. Mutations in the BRAG1 gene have been linked to the development of a rare genetic disorder called Bragg syndrome. Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system. The tumors that develop in Bragg syndrome are called brainstem gliomas and they are typically aggressive and difficult to treat.\nIt's important to note that Bragg syndrome is a very rare disorder and it's not very common for people to have mutations in the BRAG1 gene. However, it's important to be aware of the potential link between BRAG1 mutations and Bragg syndrome, as it can help in the diagnosis and treatment of the disorder.\nIt's also important to note that there are other genetic disorders that are linked to the development of brain tumors, such as neurofibromatosis type 2 (NF2) and tuberous sclerosis complex (TSC). These disorders are characterized by the development of benign or malignant tumors in the brain and other parts of the nervous system.\nIf you have any questions or concerns about Bragg syndrome or any other genetic disorders, it's best to speak with a healthcare professional who can provide you with more information and guidance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BRAG1 is a protein that is involved in the regulation of cell division.\n2. Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.\n3. Bragg syndrome is characterized by the development of multiple tumors particularly in the brain, spinal cord, and other parts of the nervous system.\n4. The tumors that develop in Bragg syndrome are called brainstem gliomas.\n5. Other genetic disorders that are linked to the development of brain tumors include neurofibromatosis type 2 (NF2) and tuberous sclerosis complex (TSC).",
    "vicuna-7b_fact": [
      "BRAG1 is a protein that is involved in the regulation of cell division.",
      "Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.",
      "Bragg syndrome is characterized by the development of multiple tumors particularly in the brain, spinal cord, and other parts of the nervous system.",
      "The tumors that develop in Bragg syndrome are called brainstem gliomas.",
      "Other genetic disorders that are linked to the development of brain tumors include neurofibromatosis type 2 (NF2) and tuberous sclerosis complex (TSC)."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1328,
    "user_query": "What is the effect induced by sympathetic nervous system on pupil size?",
    "vicuna-7b_response": "The sympathetic nervous system (SNS) is a division of the autonomic nervous system that is responsible for the \"fight or flight\" response. When the SNS is activated, it causes the release of neurotransmitters such as norepinephrine and acetylcholine, which stimulate the sympathetic nerve fibers that innervate the eyes. This can lead to an increase in pupil size, also known as mydriasis.\nThe mydriasis caused by the SNS is a physiological response that occurs in response to stress, fear, or other stimuli that trigger the fight or flight response. It is an important mechanism for increasing the amount of light that enters the eye, which is necessary for quick and accurate visual perception in situations of danger or threat.\nIt is important to note that the SNS also has a role in regulating pupil size in response to changes in light intensity, temperature, and other environmental factors. In addition, the SNS can also cause a decrease in pupil size, known as miosis, which can occur in response to certain medications, such as opioids, or as a side effect of certain medical conditions, such as glaucoma.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The sympathetic nervous system is a division of the autonomic nervous system.\n2. The activation of sympathetic nervous system triggers the release of neurotransmitters such as norepinephrine and acetylcholine.\n3. The activation of sympathetic nervous system can lead to an increase in pupil size, also known as mydriasis.\n4. The SNS has a role in regulating pupil size in response to changes in light intensity, temperature, and other environmental factors.\n5. The SNS can also cause a decrease in pupil size, known as miosis, which can occur in response to certain medications, such as opioids, or as a side effect of certain medical conditions, such as glaucoma.",
    "vicuna-7b_fact": [
      "The sympathetic nervous system is a division of the autonomic nervous system.",
      "The activation of sympathetic nervous system triggers the release of neurotransmitters such as norepinephrine and acetylcholine.",
      "The activation of sympathetic nervous system can lead to an increase in pupil size, also known as mydriasis.",
      "The SNS has a role in regulating pupil size in response to changes in light intensity, temperature, and other environmental factors.",
      "The SNS can also cause a decrease in pupil size, known as miosis, which can occur in response to certain medications, such as opioids, or as a side effect of certain medical conditions, such as glaucoma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The regulation of pupil size in response to changes in light intensity is primarily a function of the parasympathetic nervous system, not the sympathetic nervous system.\n5. FALSE [correction]: The function of causing a decrease in pupil size, known as miosis, is primarily a function of the parasympathetic nervous system, not the sympathetic nervous system.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1329,
    "user_query": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?",
    "vicuna-7b_response": "Yes, p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.\nNF-kappaB is a transcription factor that plays a crucial role in regulating the immune response and inflammation. It is composed of five homo-dimeric subunits: p50, p65, p52, c-Rel, and RelB. These subunits can form heterodimers with each other, leading to the formation of different NF-kappaB complexes with distinct functions.\np100 is the precursor form of p50, which is a member of the Rel/NF-kappaB family of transcription factors. p100 is a large protein composed of 453 amino acids and is cleaved by the proteasome into p50 and a smaller protein called RelB. p50 is the active form of NF-kappaB, while RelB is a non-functional protein.\nTherefore, p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50, and it is cleaved by the proteasome to produce the active form of NF-kappaB.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.\n2. NF-kappaB is a transcription factor that plays a role in regulating the immune response and inflammation.\n3. NF-kappaB is composed of five homo-dimeric subunits: p50, p65, p52, c-Rel, and RelB.\n4. p100 is a large protein composed of 453 amino acids and is cleaved by the proteasome into p50 and a smaller protein called RelB.\n5. p50 is the active form of NF-kappaB, while RelB is a non-functional protein.",
    "vicuna-7b_fact": [
      "p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.",
      "NF-kappaB is a transcription factor that plays a role in regulating the immune response and inflammation.",
      "NF-kappaB is composed of five homo-dimeric subunits: p50, p65, p52, c-Rel, and RelB.",
      "p100 is a large protein composed of 453 amino acids and is cleaved by the proteasome into p50 and a smaller protein called RelB.",
      "p50 is the active form of NF-kappaB, while RelB is a non-functional protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: NF-kappaB is composed of five proteins that can form various homo- and heterodimers: p50, p65 (RelA), p52, c-Rel, and RelB.\n4. FALSE [correction]: p100 is a large protein composed of 900 amino acids and can be processed into p52, not p50; and it does not produce RelB.\n5. FALSE [correction]: RelB is a functional component of NF-kappaB; NF-kappaB is generally active as a heterodimer, commonly involving p50 or p52 combined with p65 (RelA), c-Rel, or RelB.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1331,
    "user_query": "Is there a difference in the rate between gene fusion and gene fission?",
    "vicuna-7b_response": "Yes, there is a difference in the rate between gene fusion and gene fission.\nGene fusion is the process of combining two or more genes into a single gene, while gene fission is the process of dividing a single gene into two or more genes.\nThe rate of gene fusion is generally slower than that of gene fission. This is because gene fusion requires the creation of new DNA sequences, which can be error-prone and may require additional steps to ensure the accuracy of the new sequence. In contrast, gene fission involves the simple splitting of an existing gene into two or more smaller genes, which is a faster process.\nOverall, the rate of gene fusion and fission can vary depending on the organism, the specific genes being fused or split, and the method used to perform the fusion or fission.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gene fusion is the process of combining two or more genes into a single gene.\n2. Gene fission is the process of dividing a single gene into two or more genes.\n3. The rate of gene fusion is generally slower than that of gene fission.\n4. Gene fusion requires the creation of new DNA sequences.\n5. The rate of gene fusion and fission can vary depending on the organism, the specific genes being fused or split, and the method used to perform the fusion or fission.",
    "vicuna-7b_fact": [
      "Gene fusion is the process of combining two or more genes into a single gene.",
      "Gene fission is the process of dividing a single gene into two or more genes.",
      "The rate of gene fusion is generally slower than that of gene fission.",
      "Gene fusion requires the creation of new DNA sequences.",
      "The rate of gene fusion and fission can vary depending on the organism, the specific genes being fused or split, and the method used to perform the fusion or fission."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Gene fusion doesn't necessarily require the creation of new DNA sequences, it often involves the combination of already existing ones.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1344,
    "user_query": "Which genes were found to be methylated in bladder cancer cells?",
    "vicuna-7b_response": "Several genes have been found to be methylated in bladder cancer cells. One such gene is the tumor suppressor gene, p16INK4a. p16INK4a is a cyclin-dependent kinase inhibitor that plays a role in regulating cell growth and division. It has been found to be frequently methylated in bladder cancer cells, leading to its silencing and the promotion of cell proliferation and survival.\nAnother gene that has been found to be methylated in bladder cancer cells is the homeobox gene, HOXA5. HOXA5 is a transcription factor that plays a role in the regulation of cell differentiation and development. It has been found to be methylated in bladder cancer cells, leading to its silencing and the promotion of cell proliferation and invasion.\nAdditionally, the gene encoding for the protein, p53, has also been found to be methylated in bladder cancer cells. p53 is a tumor suppressor gene that plays a critical role in regulating cell growth and division, and it has been found to be frequently methylated in bladder cancer cells, leading to its silencing and the promotion of cell proliferation and survival.\nOther genes that have been found to be methylated in bladder cancer cells include the gene encoding for the protein, E-cadherin, and the gene encoding for the protein, N-myc. E-cadherin is a cell-cell adhesion protein that plays a role in regulating cell growth and differentiation, and it has been found to be methylated in bladder cancer cells, leading to its silencing and the promotion of cell proliferation and invasion. N-myc is a transcription factor that plays a role in the regulation of cell growth and division, and it has been found to be methylated in bladder cancer cells, leading to its silencing and the promotion of cell proliferation and survival.\nOverall, these genes are examples of the many genes that have been found to be methylated in bladder cancer cells, and they highlight the importance of understanding the epigenetic changes that occur in this disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The p16INK4a gene, a tumor suppressor gene, has been found to be methylated in bladder cancer cells.\n2. The HOXA5 gene, a transcription factor involved in cell differentiation and development, has been found to be methylated in bladder cancer cells.\n3. The gene encoding the protein p53, a tumor suppressor gene, has been found to be methylated in bladder cancer cells.\n4. The gene encoding E-cadherin, a cell-cell adhesion protein, has been found to be methylated in bladder cancer cells. \n5. The gene encoding the protein N-myc, a transcription factor, has been found to be methylated in bladder cancer cells.",
    "vicuna-7b_fact": [
      "The p16INK4a gene, a tumor suppressor gene, has been found to be methylated in bladder cancer cells.",
      "The HOXA5 gene, a transcription factor involved in cell differentiation and development, has been found to be methylated in bladder cancer cells.",
      "The gene encoding the protein p53, a tumor suppressor gene, has been found to be methylated in bladder cancer cells.",
      "The gene encoding E-cadherin, a cell-cell adhesion protein, has been found to be methylated in bladder cancer cells.",
      "The gene encoding the protein N-myc, a transcription factor, has been found to be methylated in bladder cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1348,
    "user_query": "What is the characteristic domain of histone methyltransferases?",
    "vicuna-7b_response": "Histone methyltransferases (HMTs) are enzymes that add a methyl group to specific lysine residues on the histone proteins. These modifications can have a significant impact on the structure and function of chromatin, which in turn can regulate gene expression.\nThe characteristic domain of HMTs is the SET (SET-domain) or the HMT (HMT-domain), which are both involved in the methylation process. The SET domain is a conserved protein module that is found in many different types of enzymes, including HMTs, and is responsible for the methylation of lysine residues. The HMT domain is a specific domain found only in HMTs and is responsible for the recognition and binding of histone proteins.\nIn summary, the characteristic domain of HMTs is the SET or HMT domain, which are both involved in the methylation process of histone proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone methyltransferases (HMTs) are enzymes that add a methyl group to lysine residues on histone proteins.\n2. The modifications made by HMTs can impact the structure and function of chromatin.\n3. The SET and HMT domains are characteristic domains of histone methyltransferases.\n4. The SET domain is a conserved protein module found in many different types of enzymes, including HMTs, responsible for methylation of lysine residues.\n5. The HMT domain is a specific domain found only in HMTs and is responsible for the recognition and binding of histone proteins.",
    "vicuna-7b_fact": [
      "Histone methyltransferases (HMTs) are enzymes that add a methyl group to lysine residues on histone proteins.",
      "The modifications made by HMTs can impact the structure and function of chromatin.",
      "The SET and HMT domains are characteristic domains of histone methyltransferases.",
      "The SET domain is a conserved protein module found in many different types of enzymes, including HMTs, responsible for methylation of lysine residues.",
      "The HMT domain is a specific domain found only in HMTs and is responsible for the recognition and binding of histone proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1350,
    "user_query": "Which are the bioinformatics tools for gene structure prediction?",
    "vicuna-7b_response": "There are several bioinformatics tools available for gene structure prediction, including:\n1. GENECONV: A tool for converting between different gene annotation formats, including gene structure prediction programs such as GENECONV.\n2. GENEWISE: A tool for predicting the structure of human genes, including exon-intron boundaries and gene length.\n3. GENEID: A tool for identifying the gene structure of a given DNA sequence, including exon-intron boundaries and gene length.\n4. GENEPROFILE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n5. GENESTRUCTURE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n6. GENESS: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n7. GENESTRUCTURE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n8. GENESTRUCTURE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n9. GENESTRUCTURE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\n10. GENESTRUCTURE: A tool for predicting the structure of genes in a given genomic region, including exon-intron boundaries and gene length.\nThese are just a few examples of the many bioinformatics tools available for gene structure prediction. The choice of tool will depend on the specific requirements of the user and the nature of the genomic data being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GENECONV is a tool for converting between different gene annotation formats.\n2. GENEWISE is a tool for predicting the structure of human genes.\n3. GENEID is utilized for identifying the gene structure of a given DNA sequence.\n4. GENEPROFILE is used for predicting the structure of genes in a given genomic region.\n5. GENESTRUCTURE is a tool for predicting the structure of genes in a given genomic region.",
    "vicuna-7b_fact": [
      "GENECONV is a tool for converting between different gene annotation formats.",
      "GENEWISE is a tool for predicting the structure of human genes.",
      "GENEID is utilized for identifying the gene structure of a given DNA sequence.",
      "GENEPROFILE is used for predicting the structure of genes in a given genomic region.",
      "GENESTRUCTURE is a tool for predicting the structure of genes in a given genomic region."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1352,
    "user_query": "What is the correlation between SPARC expression and growth inhibition in human cancer?",
    "vicuna-7b_response": "The SPARC (secreted protein acidic and rich in cysteine) protein is a matricellular glycoprotein that has been shown to have both tumor-promoting and tumor-suppressing effects in various types of cancer.\nStudies have shown that SPARC expression is often increased in cancer cells and tissues, and this increased expression is associated with poor prognosis and increased aggressiveness of the cancer. Additionally, SPARC has been shown to promote cell proliferation, migration, and invasion, which are key steps in the development and progression of cancer.\nOn the other hand, SPARC has also been shown to have anti-tumorigenic effects by inhibiting angiogenesis, which is the process by which new blood vessels form and supply the growing tumor. This can lead to growth inhibition of the cancer.\nOverall, the correlation between SPARC expression and growth inhibition in human cancer is complex and depends on the specific context and type of cancer. While increased SPARC expression is generally associated with poor prognosis and increased aggressiveness of the cancer, it can also have anti-tumorigenic effects by inhibiting angiogenesis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SPARC is a matricellular glycoprotein.\n2. SPARC expression is often increased in cancer cells and tissues.\n3. Increased SPARC expression in cancer is associated with poor prognosis and increased aggressiveness of the cancer.\n4. SPARC can promote cell proliferation, migration, and invasion.\n5. SPARC can have anti-tumorigenic effects by inhibiting angiogenesis.",
    "vicuna-7b_fact": [
      "SPARC is a matricellular glycoprotein.",
      "SPARC expression is often increased in cancer cells and tissues.",
      "Increased SPARC expression in cancer is associated with poor prognosis and increased aggressiveness of the cancer.",
      "SPARC can promote cell proliferation, migration, and invasion.",
      "SPARC can have anti-tumorigenic effects by inhibiting angiogenesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1353,
    "user_query": "Which syndrome is associated with mutations in the LYST gene?",
    "vicuna-7b_response": "The syndrome associated with mutations in the LYST gene is called Lyst-Sjogren syndrome. It is a rare genetic disorder characterized by a combination of features including intellectual disability, distinctive facial features, and a variety of health problems such as hearing loss, vision problems, and kidney problems. The syndrome is caused by mutations in the LYST gene, which provides instructions for making a protein called lysosomal trafficking regulator protein 1. This protein is involved in the normal functioning of lysosomes, which are structures within cells that break down and recycle certain molecules. Lack of this protein can lead to the accumulation of waste products in the cells, which can cause the symptoms of Lyst-Sjogren syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lyst-Sjogren syndrome is associated with mutations in the LYST gene.\n2. Lyst-Sjogren syndrome is a rare genetic disorder characterized by intellectual disability, distinctive facial features, and various health problems including hearing loss, vision problems, and kidney problems.\n3. The LYST gene provides instructions for making a protein named lysosomal trafficking regulator protein 1.\n4. The lysosomal trafficking regulator protein 1 is involved in the normal functioning of lysosomes, which are structures within cells that break down and recycle certain molecules.\n5. Lack of lysosomal trafficking regulator protein 1 can lead to the accumulation of waste products in the cells, causing the symptoms of Lyst-Sjogren syndrome.",
    "vicuna-7b_fact": [
      "Lyst-Sjogren syndrome is associated with mutations in the LYST gene.",
      "Lyst-Sjogren syndrome is a rare genetic disorder characterized by intellectual disability, distinctive facial features, and various health problems including hearing loss, vision problems, and kidney problems.",
      "The LYST gene provides instructions for making a protein named lysosomal trafficking regulator protein 1.",
      "The lysosomal trafficking regulator protein 1 is involved in the normal functioning of lysosomes, which are structures within cells that break down and recycle certain molecules.",
      "Lack of lysosomal trafficking regulator protein 1 can lead to the accumulation of waste products in the cells, causing the symptoms of Lyst-Sjogren syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Chediak-Higashi syndrome, not Lyst-Sjogren syndrome, is a rare genetic disorder characterized by intellectual disability, distinctive facial features, and various health problems including hearing loss, vision problems, and kidney problems.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1354,
    "user_query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "vicuna-7b_response": "Yes, the presence of delayed enhancement has been documented in athletes performing strenuous exercise. Delayed enhancement is a magnetic resonance imaging (MRI) technique that can be used to detect changes in the brain that occur after injury or damage. In the case of athletes, delayed enhancement has been observed in the brains of athletes who have experienced concussions or other forms of head trauma.\nResearch has shown that athletes who have experienced concussions may have increased levels of delayed enhancement in certain areas of the brain, particularly in the frontal lobes. This increased level of delayed enhancement may be an indicator of brain injury and can help doctors to diagnose and treat concussions more effectively.\nIn addition to concussions, delayed enhancement has also been observed in athletes who have experienced other forms of head trauma, such as whiplash or other types of impact injuries. In these cases, delayed enhancement may be an indicator of more serious brain injury and can help doctors to determine the appropriate course of treatment.\nOverall, the presence of delayed enhancement in athletes performing strenuous exercise is a well-documented phenomenon, and it can be an important tool for diagnosing and treating head injuries in athletes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Delayed enhancement is a magnetic resonance imaging (MRI) technique that can be used to detect changes in the brain after injury or damage.\n2. Delayed enhancement has been documented in athletes who have experienced concussions or other forms of head trauma.\n3. Research has shown that athletes who have experienced concussions may have increased levels of delayed enhancement in certain areas of the brain, particularly in the frontal lobes.\n4. Delayed enhancement has also been observed in athletes who have experienced other forms of head trauma, such as whiplash or other types of impact injuries.\n5. Delayed enhancement can be an important tool for diagnosing and treating head injuries in athletes.",
    "vicuna-7b_fact": [
      "Delayed enhancement is a magnetic resonance imaging (MRI) technique that can be used to detect changes in the brain after injury or damage.",
      "Delayed enhancement has been documented in athletes who have experienced concussions or other forms of head trauma.",
      "Research has shown that athletes who have experienced concussions may have increased levels of delayed enhancement in certain areas of the brain, particularly in the frontal lobes.",
      "Delayed enhancement has also been observed in athletes who have experienced other forms of head trauma, such as whiplash or other types of impact injuries.",
      "Delayed enhancement can be an important tool for diagnosing and treating head injuries in athletes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1356,
    "user_query": "Name the factors required for selenoprotein synthesis in eukaryotes",
    "vicuna-7b_response": "Selenoproteins are a group of proteins that contain the element selenium, which is an essential trace element for human health. In eukaryotes, the synthesis of selenoproteins requires the following factors:\n1. Selenium: Selenium is an essential trace element that is required for the synthesis of selenoproteins.\n2. Selenocysteine: Selenocysteine is a unique amino acid that contains selenium. Selenocysteine is incorporated into selenoproteins through a unique post-transcriptional modification called seleno-cysteine insertion.\n3. Selenoprotein-specific tRNAs: Eukaryotes have specific transfer RNAs (tRNAs) that are capable of recognizing and accommodating selenocysteine. These tRNAs are called selenoprotein-specific tRNAs.\n4. Selenoprotein synthesis-specific enzymes: Eukaryotes have specific enzymes that are responsible for the synthesis of selenoproteins. These enzymes include the selenocysteine insertion machinery, which is responsible for the insertion of selenocysteine into selenoproteins.\n5. Selenoprotein maturation-specific enzymes: Eukaryotes have specific enzymes that are responsible for the maturation of selenoproteins. These enzymes include the selenoprotein maturation-specific enzymes, which are responsible for the final processing and folding of selenoproteins.\nIn summary, the synthesis of selenoproteins in eukaryotes requires the presence of selenium, selenocysteine, selenoprotein-specific tRNAs, selenoprotein synthesis-specific enzymes, and selenoprotein maturation-specific enzymes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Selenoproteins are a group of proteins that contain the element selenium.\n2. The synthesis of selenoproteins in eukaryotes requires selenium.\n3. Selenocysteine, a unique amino acid that contains selenium, is necessary for selenoprotein synthesis.\n4. Eukaryotes have specific transfer RNAs (tRNAs) that are capable of recognizing and accommodating selenocysteine.\n5. There are specific enzymes in eukaryotes that are responsible for the synthesis and maturation of selenoproteins.",
    "vicuna-7b_fact": [
      "Selenoproteins are a group of proteins that contain the element selenium.",
      "The synthesis of selenoproteins in eukaryotes requires selenium.",
      "Selenocysteine, a unique amino acid that contains selenium, is necessary for selenoprotein synthesis.",
      "Eukaryotes have specific transfer RNAs (tRNAs) that are capable of recognizing and accommodating selenocysteine.",
      "There are specific enzymes in eukaryotes that are responsible for the synthesis and maturation of selenoproteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1359,
    "user_query": "What is the role of TRH in hypertension?",
    "vicuna-7b_response": "TRH, or thyrotropin-releasing hormone, is a hormone that is produced by the hypothalamus in the brain. TRH stimulates the pituitary gland to produce thyroid-stimulating hormone (TSH), which in turn stimulates the production of thyroid hormones by the thyroid gland.\nIn hypertension, TRH has been shown to play a role in the regulation of blood pressure. TRH has been shown to have a direct effect on the renin-angiotensin-aldosterone system (RAAS), which is the body's main regulator of blood pressure. TRH has been shown to decrease the activity of the RAAS, which can lead to a decrease in blood pressure.\nAdditionally, TRH has been shown to have a direct effect on the sympathetic nervous system, which is responsible for the \"fight or flight\" response and is involved in the regulation of blood pressure. TRH has been shown to decrease the activity of the sympathetic nervous system, which can also lead to a decrease in blood pressure.\nOverall, TRH has been shown to have a potential role in the treatment of hypertension, although further research is needed to fully understand its effects on blood pressure and to determine the optimal dosage and duration of treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TRH, or thyrotropin-releasing hormone, is produced by the hypothalamus in the brain.\n2. TRH stimulates the pituitary gland to produce thyroid-stimulating hormone (TSH).\n3. TSH in turn stimulates the production of thyroid hormones by the thyroid gland.\n4. TRH has been shown to have a direct effect on the renin-angiotensin-aldosterone system (RAAS) in the regulation of blood pressure.\n5. TRH also has a direct effect on the sympathetic nervous system, which is involved in the regulation of blood pressure.",
    "vicuna-7b_fact": [
      "TRH, or thyrotropin-releasing hormone, is produced by the hypothalamus in the brain.",
      "TRH stimulates the pituitary gland to produce thyroid-stimulating hormone (TSH).",
      "TSH in turn stimulates the production of thyroid hormones by the thyroid gland.",
      "TRH has been shown to have a direct effect on the renin-angiotensin-aldosterone system (RAAS) in the regulation of blood pressure.",
      "TRH also has a direct effect on the sympathetic nervous system, which is involved in the regulation of blood pressure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1360,
    "user_query": "Is triadin involved in cardiac function?",
    "vicuna-7b_response": "Triadin is a protein that is involved in the regulation of cardiac function. It is a component of the tripartite motif-containing protein 22 (TRIM22) complex, which is a multi-protein complex that plays a role in the regulation of various cellular processes, including cardiac function.\nThe TRIM22 complex is composed of three main components: TRIM22, triadin, and coiled-coil domain-containing protein 1 (CCND1). TRIM22 is an E3 ubiquitin ligase, which means that it plays a role in the regulation of protein degradation by adding ubiquitin molecules to target proteins. The triadin and CCND1 components of the complex are thought to interact with TRIM22 to regulate its activity.\nIn the context of cardiac function, the TRIM22 complex has been shown to play a role in the regulation of cardiac contractility and heart rate. For example, studies have shown that the TRIM22 complex can regulate the activity of the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) pump, which is involved in the regulation of intracellular calcium levels in cardiac muscle cells. This can affect the contractility of the heart and ultimately impact cardiac function.\nOverall, triadin is an important component of the TRIM22 complex, which plays a role in the regulation of cardiac function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Triadin is a protein that is involved in the regulation of cardiac function.\n2. Triadin is a component of the tripartite motif-containing protein 22 (TRIM22) complex.\n3. The TRIM22 complex is composed of three main components: TRIM22, triadin, and coiled-coil domain-containing protein 1 (CCND1).\n4. TRIM22 is an E3 ubiquitin ligase, which plays a role in the regulation of protein degradation by adding ubiquitin molecules to target proteins.\n5. The TRIM22 complex can regulate the activity of the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) pump, which is involved in the regulation of intracellular calcium levels in cardiac muscle cells.",
    "vicuna-7b_fact": [
      "Triadin is a protein that is involved in the regulation of cardiac function.",
      "Triadin is a component of the tripartite motif-containing protein 22 (TRIM22) complex.",
      "The TRIM22 complex is composed of three main components: TRIM22, triadin, and coiled-coil domain-containing protein 1 (CCND1).",
      "TRIM22 is an E3 ubiquitin ligase, which plays a role in the regulation of protein degradation by adding ubiquitin molecules to target proteins.",
      "The TRIM22 complex can regulate the activity of the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) pump, which is involved in the regulation of intracellular calcium levels in cardiac muscle cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Triadin is not a component of the tripartite motif-containing protein 22 (TRIM22) complex.\n3. FALSE [correction]: The TRIM22 complex is not composed of TRIM22, triadin, and coiled-coil domain-containing protein 1 (CCND1).\n4. TRUE\n5. FALSE [correction]: The TRIM22 complex does not regulate the activity of the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) pump. This is a function of triadin.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1364,
    "user_query": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?",
    "vicuna-7b_response": "The protein required for Argonaute 2 (Ago2) recruitment to stress granules and P-bodies is known as TDP-4.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The protein TDP-4 is required for Argonaute 2 recruitment to stress granules and P-bodies.",
    "vicuna-7b_fact": [
      "The protein TDP-4 is required for Argonaute 2 recruitment to stress granules and P-bodies."
    ],
    "vicuna-7b_judge_raw": "UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 1365,
    "user_query": "Is Mammaprint approved by the United States Food and Drug Administration?",
    "vicuna-7b_response": "Mammaprint is a genetic test that analyzes the expression of 70 genes associated with the risk of breast cancer. The test is developed by Myriad Genetics, a company based in the United States.\nThe United States Food and Drug Administration (FDA) has approved the use of Mammaprint for the risk assessment of breast cancer in women with a family history of the disease. The test is intended for women with a personal or family history of breast cancer, as well as women with other risk factors for the disease.\nIt's important to note that the FDA has not approved Mammaprint for the diagnosis of breast cancer. The test is intended to be used as a risk assessment tool, in conjunction with other clinical and biological factors, to help inform decisions about preventive measures, such as chemoprevention or increased screening.\nIt's also important to note that the FDA has not approved Mammaprint for all women with a family history of breast cancer. The test is intended for women with a specific set of risk factors, and the FDA has established guidelines for the use of the test in different populations.\nIn summary, Mammaprint has been approved by the FDA for the risk assessment of breast cancer in women with a family history of the disease. The test is not intended for the diagnosis of breast cancer, but rather for the risk assessment of the disease. It's important to consult with a healthcare professional to determine if the test is appropriate for a specific individual.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mammaprint is a genetic test that analyzes the expression of 70 genes associated with the risk of breast cancer.\n2. The test is developed by Myriad Genetics.\n3. The United States Food and Drug Administration has approved Mammaprint for the risk assessment of breast cancer in women with a family history of the disease.\n4. The FDA has not approved Mammaprint for the diagnosis of breast cancer.\n5. The FDA has established guidelines for the use of Mammaprint in different populations.",
    "vicuna-7b_fact": [
      "Mammaprint is a genetic test that analyzes the expression of 70 genes associated with the risk of breast cancer.",
      "The test is developed by Myriad Genetics.",
      "The United States Food and Drug Administration has approved Mammaprint for the risk assessment of breast cancer in women with a family history of the disease.",
      "The FDA has not approved Mammaprint for the diagnosis of breast cancer.",
      "The FDA has established guidelines for the use of Mammaprint in different populations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mammaprint was developed by Agendia, not Myriad Genetics.\n3. FALSE [correction]: The United States Food and Drug Administration has approved Mammaprint for risk assessment of recurrence in breast cancer patients, not specifically in women with a family history of the disease.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1368,
    "user_query": "Which pharmacogenetic test is available for abacavir?",
    "vicuna-7b_response": "Abacavir is a medication that is used to treat HIV and AIDS. There are several pharmacogenetic tests that can be used to determine how a person will respond to abacavir.\nOne such test is the HLA-B*57:01 genetic test. This test looks at a person's genetic makeup and determines if they have a specific gene called HLA-B*57:01. People who have this gene are more likely to experience a severe allergic reaction to abacavir.\nAnother test that can be used to determine how a person will respond to abacavir is the Genotype-Guided Therapy (GGT) test. This test looks at a person's genetic makeup and determines if they have certain genetic variations that may affect how they metabolize abacavir.\nIt is important to note that these tests are not necessary for everyone who takes abacavir. However, if you have a history of severe allergic reactions to medications or if you have certain genetic variations that may affect how you metabolize medications, your healthcare provider may recommend that you consider taking these tests.\nIt is always best to consult with your healthcare provider if you have any questions about your medications or if you would like more information about pharmacogenetic testing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Abacavir is a medication used to treat HIV and AIDS.\n2. The HLA-B*57:01 genetic test is a pharmacogenetic test that can be used to determine a person's response to abacavir.\n3. People who carry the HLA-B*57:01 gene are more likely to experience a severe allergic reaction to abacavir.\n4. The Genotype-Guided Therapy (GGT) test can also be used to determine a person's response to abacavir.\n5. The Genotype-Guided Therapy (GGT) test identifies genetic variations that may affect how a person metabolizes abacavir.",
    "vicuna-7b_fact": [
      "Abacavir is a medication used to treat HIV and AIDS.",
      "The HLA-B*57:01 genetic test is a pharmacogenetic test that can be used to determine a person's response to abacavir.",
      "People who carry the HLA-B*57:01 gene are more likely to experience a severe allergic reaction to abacavir.",
      "The Genotype-Guided Therapy (GGT) test can also be used to determine a person's response to abacavir.",
      "The Genotype-Guided Therapy (GGT) test identifies genetic variations that may affect how a person metabolizes abacavir."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1370,
    "user_query": "Are nucleosomes positioned at DNA replication origins?",
    "vicuna-7b_response": "Yes, nucleosomes are positioned at DNA replication origins.\nNucleosomes are the basic units of chromatin, which is the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell. Nucleosomes consist of a histone protein complex surrounded by a DNA loop. The histone proteins help to compact the DNA and keep it from being exposed to the cell's environment.\nDNA replication origins are the regions of the DNA molecule where replication begins. These regions are typically found near the center of the chromosome and are marked by specific proteins and other molecules. Nucleosomes are positioned at these replication origins to help regulate the replication process.\nIn addition to their role in regulating replication, nucleosomes also play a role in other processes such as transcription and DNA repair. They are essential for the proper functioning of the cell's genetic material.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nucleosomes are positioned at DNA replication origins.\n2. Nucleosomes are the basic units of chromatin.\n3. Chromatin is the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell.\n4. DNA replication origins are the regions of the DNA molecule where replication begins.\n5. Nucleosomes play a role in other processes such as transcription and DNA repair.",
    "vicuna-7b_fact": [
      "Nucleosomes are positioned at DNA replication origins.",
      "Nucleosomes are the basic units of chromatin.",
      "Chromatin is the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell.",
      "DNA replication origins are the regions of the DNA molecule where replication begins.",
      "Nucleosomes play a role in other processes such as transcription and DNA repair."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Nucleosomes are not specifically positioned at DNA replication origins. They are repeating subunits of chromatin, containing DNA wound around histone protein cores.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1371,
    "user_query": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?",
    "vicuna-7b_response": "The most under-represented oligonucleotides in higher eukaryote genomes can vary depending on the specific organism and the length of the oligonucleotides being considered. However, some studies have identified certain oligonucleotide motifs that are commonly under-represented in higher eukaryote genomes.\nOne such motif is the \"CpG island\" sequence, which is a stretch of DNA that is rich in cytosine and guanine base pairs and often occurs in the promoter regions of genes. CpG islands are typically under-represented in the genomes of higher eukaryotes, as they are more commonly found in the genomes of prokaryotes and lower eukaryotes.\nAnother under-represented motif is the \"Alu\" sequence, which is a class of short interspersed repeat elements that are found in the genomes of many higher eukaryotes. Alu elements are typically composed of a repeat sequence of 32 nucleotides, and they can disrupt gene function by inserting themselves into the DNA sequence between genes.\nOther under-represented motifs in higher eukaryote genomes include transposable elements, such as long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), as well as repetitive sequences, such as microsatellites and minisatellites.\nIt's worth noting that the under-representation of certain motifs in higher eukaryote genomes can vary depending on the specific organism being considered. For example, the genomes of some higher eukaryotes may contain more CpG islands or Alu elements than others. Therefore, it's important to consider the specific organism being studied when identifying under-represented motifs in higher eukaryote genomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"CpG island\" sequence, a stretch of DNA rich in cytosine and guanine base pairs, is considered under-represented in the genomes of higher eukaryotes.\n2. CpG islands are more commonly found in the genomes of prokaryotes and lower eukaryotes.\n3. The \"Alu\" sequence, a class of short interspersed repeat elements, is another under-represented motif in the genomes of many higher eukaryotes.\n4. Alu elements are typically composed of a repeat sequence of 32 nucleotides.\n5. Certain other under-represented motifs in higher eukaryote genomes can include transposable elements, like long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), as well as repetitive sequences, like microsatellites and minisatellites.",
    "vicuna-7b_fact": [
      "The \"CpG island\" sequence, a stretch of DNA rich in cytosine and guanine base pairs, is considered under-represented in the genomes of higher eukaryotes.",
      "CpG islands are more commonly found in the genomes of prokaryotes and lower eukaryotes.",
      "The \"Alu\" sequence, a class of short interspersed repeat elements, is another under-represented motif in the genomes of many higher eukaryotes.",
      "Alu elements are typically composed of a repeat sequence of 32 nucleotides.",
      "Certain other under-represented motifs in higher eukaryote genomes can include transposable elements, like long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), as well as repetitive sequences, like microsatellites and minisatellites."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The \"CpG island\" sequence is typically over-represented or focused in certain areas in the genomes of higher eukaryotes, not under-represented.\n2. FALSE [correction]: CpG islands tend to be less common in the genomes of prokaryotes and don't differentiate between lower and higher eukaryotes.\n3. FALSE [correction]: The \"Alu\" sequence is abundant and widely dispersed throughout the genomes of many higher eukaryotes, not under-represented.\n4. FALSE [correction]: Alu elements are typically composed of a repeat sequence of about 300 nucleotides, not 32.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-7b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria, such as Bacillus subtilis, undergo mutations in response to environmental stress. This process is a form of genetic adaptation that allows bacteria to survive in harsh conditions.\nThere are several mechanisms that underlie adaptive mutagenesis in Bacillus subtilis:\n1. Mutation accumulation: As bacteria undergo stress, such as starvation or exposure to antibiotics, they experience DNA damage. This damage can lead to mutations in the bacterial genome. Over time, the accumulation of mutations can lead to the evolution of new traits that allow the bacteria to survive in their environment.\n2. DNA repair mechanisms: Bacteria have several mechanisms to repair DNA damage, such as base excision repair, nucleotide excision repair, and mismatch repair. However, these mechanisms are not perfect, and some DNA damage can go unrepaired, leading to mutations.\n3. Transposable elements: Transposable elements are DNA sequences that can move around the genome, sometimes disrupting the normal functioning of genes. In Bacillus subtilis, transposable elements have been shown to play a role in adaptive mutagenesis. They can cause mutations by inserting themselves into the genome or by disrupting the normal functioning of genes.\n4. CRISPR-Cas system: The CRISPR-Cas system is a defense mechanism that allows bacteria to protect themselves against viruses and other foreign DNA. However, it can also be used as a mechanism for adaptive mutagenesis. The Cas proteins can cut DNA, leading to mutations.\n5. Environmental stress: Environmental stress, such as starvation or exposure to antibiotics, can cause DNA damage and lead to mutations. This damage can be repaired by the bacteria's DNA repair mechanisms, leading to the evolution of new traits.\nOverall, adaptive mutagenesis is a complex process that involves multiple mechanisms, including mutation accumulation, DNA repair mechanisms, transposable elements, the CRISPR-Cas system, and environmental stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Adaptive mutagenesis is a process by which bacteria, like Bacillus subtilis, undergo mutations in response to environmental stress.\n2. Mutation accumulation is one of the mechanisms in Bacillus subtilis, where DNA damage leads to mutations in the bacterial genome, thereby allowing the bacteria to develop new survival traits.\n3. DNA repair mechanisms, including base excision repair, nucleotide excision repair, and mismatch repair, are part of the adaptive mutagenesis process in Bacillus subtilis but are not perfect.\n4. Transposable elements, DNA sequences that can move around the genome and can disrupt normal functioning of genes, play a role in adaptive mutagenesis in Bacillus subtilis.\n5. The CRISPR-Cas system in Bacillus subtilis, originally a defense mechanism against viruses and other foreign DNA, can be used as a mechanism for adaptive mutagenesis causing mutations.",
    "vicuna-7b_fact": [
      "Adaptive mutagenesis is a process by which bacteria, like Bacillus subtilis, undergo mutations in response to environmental stress.",
      "Mutation accumulation is one of the mechanisms in Bacillus subtilis, where DNA damage leads to mutations in the bacterial genome, thereby allowing the bacteria to develop new survival traits.",
      "DNA repair mechanisms, including base excision repair, nucleotide excision repair, and mismatch repair, are part of the adaptive mutagenesis process in Bacillus subtilis but are not perfect.",
      "Transposable elements, DNA sequences that can move around the genome and can disrupt normal functioning of genes, play a role in adaptive mutagenesis in Bacillus subtilis.",
      "The CRISPR-Cas system in Bacillus subtilis, originally a defense mechanism against viruses and other foreign DNA, can be used as a mechanism for adaptive mutagenesis causing mutations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The CRISPR-Cas system in Bacillus subtilis is a defense mechanism against viruses and foreign DNA but is not typically used for adaptive mutagenesis causing mutations.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1375,
    "user_query": "What personality traits can be evaluated with the Ten Item Personality Inventory.",
    "vicuna-7b_response": "The Ten Item Personality Inventory (TIP-10) is a self-report questionnaire that assesses several personality traits. The following personality traits can be evaluated with the TIP-10:\n1. Neuroticism: This trait refers to the tendency to experience negative emotions such as anxiety, sadness, and anger.\n2. Extraversion: This trait refers to the tendency to be outgoing, assertive, and sociable.\n3. Openness: This trait refers to the tendency to be open-minded, imaginative, and intellectually curious.\n4. Agreeableness: This trait refers to the tendency to be cooperative, empathetic, and sensitive to the feelings of others.\n5. Conscientiousness: This trait refers to the tendency to be organized, reliable, and responsible.\n6. Emotional stability: This trait refers to the ability to regulate emotions and cope with stress.\n7. Positive emotions: This trait refers to the tendency to experience positive emotions such as joy, contentment, and enthusiasm.\n8. Negative emotions: This trait refers to the tendency to experience negative emotions such as anger, sadness, and anxiety.\n9. Self-esteem: This trait refers to the overall sense of self-worth and confidence.\n10. Locus of control: This trait refers to the belief that one's life is controlled by external factors (external locus of control) or by one's own actions and decisions (internal locus of control).\nIt's important to note that the TIP-10 is a brief measure of personality and it's not intended to be used as a diagnostic tool, but rather as a tool for research and clinical purposes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Ten Item Personality Inventory (TIP-10) is a self-report questionnaire that assesses several personality traits.\n2. Neuroticism, extraversion, openness, agreeableness, and conscientiousness are some of the traits that can be evaluated with the TIP-10.\n3. Other traits that can be evaluated with the TIP-10 are emotional stability, positive emotions, negative emotions, self-esteem, and locus of control.\n4. The TIP-10 is not intended to be used as a diagnostic tool.\n5. The TIP-10 is used for research and clinical purposes.",
    "vicuna-7b_fact": [
      "The Ten Item Personality Inventory (TIP-10) is a self-report questionnaire that assesses several personality traits.",
      "Neuroticism, extraversion, openness, agreeableness, and conscientiousness are some of the traits that can be evaluated with the TIP-10.",
      "Other traits that can be evaluated with the TIP-10 are emotional stability, positive emotions, negative emotions, self-esteem, and locus of control.",
      "The TIP-10 is not intended to be used as a diagnostic tool.",
      "The TIP-10 is used for research and clinical purposes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1376,
    "user_query": "Which are the enzymes involved in the control of tubulin acetylation?",
    "vicuna-7b_response": "Tubulin acetylation is a post-translational modification that plays a crucial role in regulating microtubule dynamics and behavior. The enzymes involved in the control of tubulin acetylation are:\n1. Tubulin acetyltransferase (TAT): This enzyme is responsible for adding acetyl groups to the β-tubulin subunit of microtubules. TAT is a complex of several subunits, including alpha-tubulin, beta-tubulin, and gamma-tubulin. The activity of TAT is regulated by various factors, including pH, temperature, and the presence of inhibitors.\n2. Tubulin deacetylase (TDA): This enzyme removes acetyl groups from the β-tubulin subunit of microtubules. TDA is a complex of several subunits, including alpha-tubulin, beta-tubulin, and gamma-tubulin. The activity of TDA is regulated by various factors, including pH, temperature, and the presence of inhibitors.\n3. Microtubule-associated proteins (MAPs): MAPs are a diverse group of proteins that interact with microtubules and regulate their behavior. Some MAPs, such as kinesin and dynein, are motor proteins that move along microtubules and use energy from ATP hydrolysis to do so. Other MAPs, such as EB1 and STIL, are regulatory proteins that bind to microtubules and modulate their stability and dynamics.\nOverall, the balance between TAT and TDA activities, as well as the interactions between tubulin acetylation and MAPs, play a crucial role in regulating microtubule behavior and behavior, and are essential for various cellular processes, including cell division, intracellular transport, and signaling.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tubulin acetylation is a post-translational modification that regulates microtubule dynamics and behavior.\n2. Tubulin acetyltransferase (TAT) is an enzyme that adds acetyl groups to the β-tubulin subunit of microtubules.\n3. Tubulin deacetylase (TDA) is an enzyme that removes acetyl groups from the β-tubulin subunit of microtubules.\n4. Microtubule-associated proteins (MAPs) are a group of proteins that interact with microtubules and regulate their behavior.\n5. The balance between TAT and TDA activities, as well as the interactions between tubulin acetylation and MAPs, are essential for various cellular processes, including cell division, intracellular transport, and signaling.",
    "vicuna-7b_fact": [
      "Tubulin acetylation is a post-translational modification that regulates microtubule dynamics and behavior.",
      "Tubulin acetyltransferase (TAT) is an enzyme that adds acetyl groups to the β-tubulin subunit of microtubules.",
      "Tubulin deacetylase (TDA) is an enzyme that removes acetyl groups from the β-tubulin subunit of microtubules.",
      "Microtubule-associated proteins (MAPs) are a group of proteins that interact with microtubules and regulate their behavior.",
      "The balance between TAT and TDA activities, as well as the interactions between tubulin acetylation and MAPs, are essential for various cellular processes, including cell division, intracellular transport, and signaling."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1378,
    "user_query": "List all approved indications for Glivec",
    "vicuna-7b_response": "Glivec, also known as imatinib, is a medication that is used to treat certain types of cancer, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and advanced skin cancer (melanoma).\nThe approved indications for Glivec vary depending on the specific type of cancer being treated. Here are the approved indications for Glivec in each of these conditions:\n1. Chronic Myeloid Leukemia (CML): Glivec is approved for the treatment of adults and children with newly diagnosed chronic myeloid leukemia (CML) in the chronic phase. Glivec is also approved for the treatment of adults with CML who have a specific genetic mutation called the Philadelphia chromosome.\n2. Gastrointestinal Stromal Tumors (GIST): Glivec is approved for the treatment of adults and children with gastrointestinal stromal tumors (GIST) that are unresectable or metastatic.\n3. Advanced Skin Cancer (Melanoma): Glivec is approved for the treatment of adults with advanced skin cancer (melanoma) that has spread to other parts of the body.\nIt is important to note that these are the approved indications for Glivec in the United States. The medication may also be used off-label for other conditions, such as other types of cancer or for the treatment of certain blood disorders.\nIt is always best to consult with a healthcare professional for specific information regarding the use of Glivec and its approved indications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Glivec, also known as imatinib, is used to treat certain types of cancer.\n2. Glivec is approved for the treatment of adults and children with newly diagnosed chronic myeloid leukemia (CML).\n3. This medication is also approved for the treatment of adults with CML who have a specific genetic mutation called the Philadelphia chromosome.\n4. Glivec is approved for the treatment of adults and children with gastrointestinal stromal tumors (GIST) that are unresectable or metastatic.\n5. Glivec is approved for the treatment of adults with advanced skin cancer (melanoma) that has spread to other parts of the body.",
    "vicuna-7b_fact": [
      "Glivec, also known as imatinib, is used to treat certain types of cancer.",
      "Glivec is approved for the treatment of adults and children with newly diagnosed chronic myeloid leukemia (CML).",
      "This medication is also approved for the treatment of adults with CML who have a specific genetic mutation called the Philadelphia chromosome.",
      "Glivec is approved for the treatment of adults and children with gastrointestinal stromal tumors (GIST) that are unresectable or metastatic.",
      "Glivec is approved for the treatment of adults with advanced skin cancer (melanoma) that has spread to other parts of the body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Glivec is not approved for the treatment of adults with advanced skin cancer (melanoma) that has spread to other parts of the body.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1379,
    "user_query": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?",
    "vicuna-7b_response": "LINE-1 (L1) and Alu retrotransposition are two types of retrotransposition that can occur in the human genome. Retrotransposition is the process by which a DNA sequence is reverse transcribed into RNA, which is then integrated into a new location in the genome. L1 and Alu retrotransposition can lead to genetic instability and contribute to the development of certain diseases.\nThere are several proteins that have been shown to induce inhibition of L1 and Alu retrotransposition. One such protein is the human papillomavirus E6 protein, which is involved in the regulation of L1 retrotransposition. The E6 protein binds to and degrades the L1 long interspersed nuclear element-1 (LINE-1) protein, which is necessary for L1 retrotransposition.\nAnother protein that has been shown to inhibit L1 retrotransposition is the human papillomavirus E7 protein. The E7 protein also binds to and degrades the L1 protein, but it also has additional functions that inhibit L1 retrotransposition.\nIn addition to the human papillomavirus proteins, there are also other proteins that have been shown to inhibit L1 retrotransposition. For example, the protein S-phase promoting factor (SPF) has been shown to inhibit L1 retrotransposition by binding to and inhibiting the activity of the L1 integrase enzyme.\nSimilarly, there are also proteins that have been shown to inhibit Alu retrotransposition. For example, the protein Alu-binding protein 1 (ABP1) has been shown to bind to and inhibit the activity of the Alu integrase enzyme, which is necessary for Alu retrotransposition.\nOverall, there are several proteins that have been shown to induce inhibition of L1 and Alu retrotransposition, including the human papillomavirus E6 and E7 proteins, S-phase promoting factor (SPF), and Alu-binding protein 1 (ABP1).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LINE-1 (L1) and Alu retrotransposition are two types of retrotransposition that occur in the human genome.\n2. Retrotransposition is the process by which a DNA sequence is reverse transcribed into RNA, which is then integrated into a new location in the genome.\n3. The human papillomavirus E6 protein inhibits L1 retrotransposition by degrading the L1 long interspersed nuclear element-1 (LINE-1) protein.\n4. The human papillomavirus E7 protein also inhibits L1 retrotransposition by degrading the L1 protein.\n5. The protein S-phase promoting factor (SPF) inhibits L1 retrotransposition by binding to and inhibiting the activity of the L1 integrase enzyme.\n6. The protein Alu-binding protein 1 (ABP1) inhibits Alu retrotransposition by binding to and inhibiting the activity of the Alu integrase enzyme.",
    "vicuna-7b_fact": [
      "LINE-1 (L1) and Alu retrotransposition are two types of retrotransposition that occur in the human genome.",
      "Retrotransposition is the process by which a DNA sequence is reverse transcribed into RNA, which is then integrated into a new location in the genome.",
      "The human papillomavirus E6 protein inhibits L1 retrotransposition by degrading the L1 long interspersed nuclear element-1 (LINE-1) protein.",
      "The human papillomavirus E7 protein also inhibits L1 retrotransposition by degrading the L1 protein.",
      "The protein S-phase promoting factor (SPF) inhibits L1 retrotransposition by binding to and inhibiting the activity of the L1 integrase enzyme.",
      "The protein Alu-binding protein 1 (ABP1) inhibits Alu retrotransposition by binding to and inhibiting the activity of the Alu integrase enzyme."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Retrotransposition is the process by which an RNA sequence is reverse transcribed into DNA, which is then inserted into a new location in the genome.\n3. TRUE\n4. TRUE\n5. TRUE\n6. FALSE [correction]: There is no protein termed as \"Alu-binding protein 1 (ABP1)\" known to inhibit Alu retrotransposition by binding to and inhibiting the activity of the Alu integrase enzyme. Actually, Alu does not code for an integrase, instead, it relies on the machinery of LINE-1 for its mobilization.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1382,
    "user_query": "Describe the usefulness of Macrostomum lignano in ion channel and stem cell research",
    "vicuna-7b_response": "Macrostomum lignano is a species of freshwater crustacean that is commonly used in scientific research. One of the main reasons for its usefulness is its ability to regenerate lost limbs, which makes it an ideal model organism for studying regeneration and stem cell biology.\nIn terms of ion channels, Macrostomum lignano has been found to have a unique electrical activity that is different from other crustaceans. This electrical activity has been studied in relation to its behavior and movement, which can provide insights into the function of ion channels in other organisms.\nMoreover, Macrostomum lignano has been used as a model organism to study the effects of environmental pollutants on ion channels. This is because it is relatively easy to culture and manipulate in the laboratory, making it a convenient model for studying the effects of toxicants on ion channels.\nIn addition to its use in ion channel research, Macrostomum lignano has also been used in stem cell research. It has been found to have a population of multipotent stem cells that can give rise to different cell types, including muscle, nerve, and gonadal cells. This makes it an ideal model for studying the regulation and function of stem cells in crustaceans.\nOverall, Macrostomum lignano is a valuable model organism for studying ion channels and stem cell biology. Its unique characteristics and ease of manipulation in the laboratory make it an ideal tool for researchers studying these topics.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Macrostomum lignano is a species of freshwater crustacean.\n2. Macrostomum lignano is commonly used in scientific research due to its ability to regenerate lost limbs. \n3. Macrostomum lignano has a unique electrical activity different from other crustaceans.\n4. Macrostomum lignano has been used as a model organism to study the effects of environmental pollutants on ion channels.\n5. Macrostomum lignano has a population of multipotent stem cells that can give rise to different cell types, including muscle, nerve, and gonadal cells.",
    "vicuna-7b_fact": [
      "Macrostomum lignano is a species of freshwater crustacean.",
      "Macrostomum lignano is commonly used in scientific research due to its ability to regenerate lost limbs.",
      "Macrostomum lignano has a unique electrical activity different from other crustaceans.",
      "Macrostomum lignano has been used as a model organism to study the effects of environmental pollutants on ion channels.",
      "Macrostomum lignano has a population of multipotent stem cells that can give rise to different cell types, including muscle, nerve, and gonadal cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Macrostomum lignano is not a species of freshwater crustacean, but rather a species of free-living flatworm.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1384,
    "user_query": "Which drug is benserazide usually co-administered with?",
    "vicuna-7b_response": "Benserazide is a sulfonylurea drug that is commonly used to treat type 2 diabetes. It works by stimulating the release of insulin from the pancreas. Benserazide is often co-administered with other diabetes medications, such as metformin, to improve its effectiveness. Additionally, it can be used in combination with insulin or other sulfonylurea drugs to control blood sugar levels in patients with type 2 diabetes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Benserazide is a sulfonylurea drug used to treat type 2 diabetes.\n2. Benserazide works by stimulating the release of insulin from the pancreas.\n3. This drug is often co-administered with other diabetes medications, such as metformin.\n4. Benserazide can be used in combination with insulin or other sulfonylurea drugs to control blood sugar levels in patients with type 2 diabetes.",
    "vicuna-7b_fact": [
      "Benserazide is a sulfonylurea drug used to treat type 2 diabetes.",
      "Benserazide works by stimulating the release of insulin from the pancreas.",
      "This drug is often co-administered with other diabetes medications, such as metformin.",
      "Benserazide can be used in combination with insulin or other sulfonylurea drugs to control blood sugar levels in patients with type 2 diabetes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Benserazide is a peripheral decarboxylase inhibitor used in the treatment of Parkinson's disease, not type 2 diabetes.\n2. FALSE [correction]: Benserazide is not known to stimulate the release of insulin from the pancreas. It inhibits the peripheral decarboxylation of levodopa to dopamine, thereby increasing levels of levodopa available to cross the blood-brain barrier. \n3. FALSE [correction]: Benserazide is not typically administered with other diabetes medications like metformin. Instead, it is most commonly administered in combination with levodopa for the treatment of Parkinson’s disease.\n4. FALSE [correction]: Benserazide is used in combination with levodopa, not insulin or other sulfonylurea drugs, to control symptoms of Parkinson's disease.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1387,
    "user_query": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?",
    "vicuna-7b_response": "There are several biomedical text mining tools available for the detection of protein-protein interactions (PPIs). Here are some of the most popular ones:\n1. String-based methods: These methods use string matching algorithms to identify patterns in the text that suggest the presence of a PPI. Some popular string-based methods include the HUMAnN algorithm, the Gene Ontology (GO) algorithm, and the Textpresso algorithm.\n2. Machine learning-based methods: These methods use machine learning algorithms to identify patterns in the text that suggest the presence of a PPI. Some popular machine learning-based methods include the Support Vector Machine (SVM) algorithm, the Random Forest algorithm, and the Naive Bayes algorithm.\n3. Network-based methods: These methods use network analysis techniques to identify PPIs. Some popular network-based methods include the Cytoscape algorithm, the BioPlex algorithm, and the MCODE algorithm.\n4. Hybrid methods: These methods combine string-based, machine learning-based, and network-based methods to improve the accuracy of PPI detection. Some popular hybrid methods include the String-TUBA algorithm, the TextRank algorithm, and the Cytoscape-MCODE algorithm.\nIt's worth noting that the choice of tool depends on the specific requirements of the user, such as the size and complexity of the dataset, the accuracy requirements, and the computational resources available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are biomedical text mining tools available for the detection of protein-protein interactions (PPIs).\n2. Some popular string-based methods for detecting PPIs include the HUMAnN algorithm, the Gene Ontology (GO) algorithm, and the Textpresso algorithm.\n3. Machine learning-based methods, such as the Support Vector Machine (SVM) algorithm, the Random Forest algorithm, and the Naive Bayes algorithm, are also used for detecting protein-protein interactions.\n4. Network analysis techniques for identifying PPIs include the Cytoscape algorithm, the BioPlex algorithm, and the MCODE algorithm.\n5. Hybrid methods, which combine string-based, machine learning-based, and network-based methods, are also used in PPI detection. Some popular hybrid methods include the String-TUBA algorithm, the TextRank algorithm, and the Cytoscape-MCODE algorithm.",
    "vicuna-7b_fact": [
      "There are biomedical text mining tools available for the detection of protein-protein interactions (PPIs).",
      "Some popular string-based methods for detecting PPIs include the HUMAnN algorithm, the Gene Ontology (GO) algorithm, and the Textpresso algorithm.",
      "Machine learning-based methods, such as the Support Vector Machine (SVM) algorithm, the Random Forest algorithm, and the Naive Bayes algorithm, are also used for detecting protein-protein interactions.",
      "Network analysis techniques for identifying PPIs include the Cytoscape algorithm, the BioPlex algorithm, and the MCODE algorithm.",
      "Hybrid methods, which combine string-based, machine learning-based, and network-based methods, are also used in PPI detection. Some popular hybrid methods include the String-TUBA algorithm, the TextRank algorithm, and the Cytoscape-MCODE algorithm."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Some popular string-based methods for detecting PPIs include the STRING database, the BIANA tool, and the PSICQUIC webservice, not the HUMAnN algorithm, the Gene Ontology (GO) algorithm, and the Textpresso algorithm.\n3. TRUE\n4. FALSE [correction]: Network analysis techniques for identifying PPIs include the Cytoscape software, the BioPlex network, and the MCODE tool, not the Cytoscape algorithm, the BioPlex algorithm, and the MCODE algorithm.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1391,
    "user_query": "Can RNASeq be used for the analysis of nascent transcripts?",
    "vicuna-7b_response": "Yes, RNA-seq can be used for the analysis of nascent transcripts. RNA-seq is a powerful technique that allows researchers to measure the expression of all the genes in a cell or organism by sequencing the transcripts produced by those genes. By analyzing the transcriptome at different time points or under different conditions, researchers can gain insights into the dynamic expression of genes and the processes that regulate gene expression.\nOne of the key advantages of RNA-seq is that it can detect the transcripts produced by genes in the very early stages of their synthesis, known as nascent transcripts. These transcripts are the RNA copies of the genes that are being actively transcribed and translated into proteins. By analyzing nascent transcripts, researchers can gain insights into the regulation of gene expression at the transcriptional level, which can provide important information about the mechanisms that control gene expression.\nIn addition to detecting nascent transcripts, RNA-seq can also be used to analyze the stability and decay of transcripts, which can provide information about the post-transcriptional regulation of gene expression. Overall, RNA-seq is a powerful tool that can be used to study the transcriptome at all stages of gene expression, including the analysis of nascent transcripts.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA-seq can be used for the analysis of nascent transcripts.\n2. RNA-seq allows researchers to measure the gene expression in a cell or organism by sequencing the transcripts produced by those genes.\n3. RNA-seq can detect the transcripts produced by genes in the very early stages of their synthesis.\n4. Analyzing nascent transcripts can provide insights into the regulation of gene expression at the transcriptional level.\n5. RNA-seq can also be used to analyze the stability and decay of transcripts.",
    "vicuna-7b_fact": [
      "RNA-seq can be used for the analysis of nascent transcripts.",
      "RNA-seq allows researchers to measure the gene expression in a cell or organism by sequencing the transcripts produced by those genes.",
      "RNA-seq can detect the transcripts produced by genes in the very early stages of their synthesis.",
      "Analyzing nascent transcripts can provide insights into the regulation of gene expression at the transcriptional level.",
      "RNA-seq can also be used to analyze the stability and decay of transcripts."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1392,
    "user_query": "Do RNA:DNA hybrids preferentially form in high or low GC regions?",
    "vicuna-7b_response": "RNA:DNA hybrids can form in both high and low GC regions. However, the preference for forming RNA:DNA hybrids in a particular region depends on several factors, including the presence of specific proteins and enzymes, the local concentration of nucleotides, and the overall genetic context of the region.\nIn general, RNA:DNA hybrids are more likely to form in regions with a high concentration of nucleotides, as this increases the likelihood of encountering the correct base pairs for hybridization. However, the presence of specific proteins and enzymes, such as helicases and RNase H, can also facilitate the formation of RNA:DNA hybrids.\nThe genetic context of the region can also play a role in determining the likelihood of RNA:DNA hybrid formation. For example, regions with a high GC content may be more prone to the formation of RNA:DNA hybrids due to the increased stability of GC base pairs. On the other hand, regions with a low GC content may be less conducive to the formation of RNA:DNA hybrids, as the weaker hydrogen bonds between A and T bases may make it more difficult for the hybrid to form and stabilize.\nOverall, the formation of RNA:DNA hybrids is a complex process that depends on a variety of factors, and the preference for forming hybrids in a particular region can vary depending on the specific context.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA:DNA hybrids can form in both high and low GC regions.\n2. The formation of RNA:DNA hybrids is influenced by the presence of specific proteins and enzymes, the local concentration of nucleotides, and the overall genetic context of the region.\n3. High concentration of nucleotides increases the likelihood of RNA:DNA hybrids formation.\n4. The presence of specific proteins and enzymes, such as helicases and RNase H, can facilitate the formation of RNA:DNA hybrids.\n5. Regions with a high GC content may be more prone to the formation of RNA:DNA hybrids due to the increased stability of GC base pairs.",
    "vicuna-7b_fact": [
      "RNA:DNA hybrids can form in both high and low GC regions.",
      "The formation of RNA:DNA hybrids is influenced by the presence of specific proteins and enzymes, the local concentration of nucleotides, and the overall genetic context of the region.",
      "High concentration of nucleotides increases the likelihood of RNA:DNA hybrids formation.",
      "The presence of specific proteins and enzymes, such as helicases and RNase H, can facilitate the formation of RNA:DNA hybrids.",
      "Regions with a high GC content may be more prone to the formation of RNA:DNA hybrids due to the increased stability of GC base pairs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1397,
    "user_query": "Which drugs are included in TAS-102?",
    "vicuna-7b_response": "TAS-102 is a combination drug that contains two active ingredients: trifluridine and tipiracil. Trifluridine is a type of antiviral drug that is used to treat certain types of cancer, while tipiracil is a drug that is used to increase the effectiveness of trifluridine in the body. TAS-102 is used to treat colorectal cancer that has spread to other parts of the body and has become resistant to other treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TAS-102 is a combination drug that contains trifluridine and tipiracil.\n2. Trifluridine is a type of antiviral drug.\n3. Trifluridine is used to treat certain types of cancer.\n4. Tipiracil is a drug used to increase the effectiveness of trifluridine.\n5. TAS-102 is used to treat colorectal cancer that has spread to other parts of the body and has become resistant to other treatments.",
    "vicuna-7b_fact": [
      "TAS-102 is a combination drug that contains trifluridine and tipiracil.",
      "Trifluridine is a type of antiviral drug.",
      "Trifluridine is used to treat certain types of cancer.",
      "Tipiracil is a drug used to increase the effectiveness of trifluridine.",
      "TAS-102 is used to treat colorectal cancer that has spread to other parts of the body and has become resistant to other treatments."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Trifluridine is a type of antineoplastic or anticancer drug, not an antiviral.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-7b_response": "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that causes red, itchy, and scaly patches on the skin. The exact cause of eczema is not fully understood, but it is thought to be caused by a combination of genetic and environmental factors.\nSome of the known triggers that can cause eczema flare-ups include:\n1. Environmental allergens: Pollens, dust mites, and animal dander can trigger eczema flare-ups.\n2. Irritants: Soap, detergents, and other chemicals can cause eczema to flare up.\n3. Emotional stress: Stress can cause the skin to become more sensitive and prone to eczema flare-ups.\n4. Climate: Changes in temperature and humidity can cause eczema to flare up.\n5. Diet: Some foods, such as dairy and eggs, can trigger eczema flare-ups in some people.\nIt is important to note that everyone's experience with eczema is different, and what triggers one person's eczema may not trigger another person's. If you have eczema, it is important to work with your healthcare provider to identify your individual triggers and develop a plan to manage them.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.\n2. Eczema causes red, itchy, and scaly patches on the skin.\n3. The cause of eczema is thought to be a combination of genetic and environmental factors.\n4. Certain triggers that can cause eczema flare-ups include environmental allergens, irritants, emotional stress, climate changes, and diet.\n5. Not all triggers that cause an eczema flare-up in one individual will necessarily cause a flare-up in another.",
    "vicuna-7b_fact": [
      "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.",
      "Eczema causes red, itchy, and scaly patches on the skin.",
      "The cause of eczema is thought to be a combination of genetic and environmental factors.",
      "Certain triggers that can cause eczema flare-ups include environmental allergens, irritants, emotional stress, climate changes, and diet.",
      "Not all triggers that cause an eczema flare-up in one individual will necessarily cause a flare-up in another."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1400,
    "user_query": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
    "vicuna-7b_response": "Histatin 5, also known as Hst5, is a peptide found in human saliva. It has been shown to have antimicrobial properties and has been studied for its potential use in preventing or treating infections caused by Candida glabrata, a type of fungus that can cause yeast infections.\nResearch has shown that Hst5 can inhibit the growth of Candida glabrata by disrupting the fungal cell membrane and damaging the cell's internal structure. Additionally, Hst5 has been shown to interfere with the formation of Candida glabrata's cell wall, which is essential for the survival of the fungus.\nFurthermore, Hst5 has been found to be effective against drug-resistant strains of Candida glabrata, making it a promising candidate for the development of new antifungal treatments.\nHowever, it's important to note that more research is needed to fully understand the effects of Hst5 on Candida glabrata infections and to determine its safety and efficacy as a treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histatin 5 is a peptide found in human saliva.\n2. Histatin 5 has antimicrobial properties.\n3. Research has shown that Histatin 5 can inhibit the growth of Candida glabrata.\n4. Hst5 has been found to be effective against drug-resistant strains of Candida glabrata.\n5. More research is needed to fully understand the effects of Hst5 on Candida glabrata infections and to determine its safety and efficacy as a treatment.",
    "vicuna-7b_fact": [
      "Histatin 5 is a peptide found in human saliva.",
      "Histatin 5 has antimicrobial properties.",
      "Research has shown that Histatin 5 can inhibit the growth of Candida glabrata.",
      "Hst5 has been found to be effective against drug-resistant strains of Candida glabrata.",
      "More research is needed to fully understand the effects of Hst5 on Candida glabrata infections and to determine its safety and efficacy as a treatment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1402,
    "user_query": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?",
    "vicuna-7b_response": "Yes, there are conserved noncoding elements (CNEs) in plant genomes. CNEs are noncoding regions of the genome that are conserved across different plant species and are thought to play important roles in regulating gene expression.\nCNEs can be identified using a variety of computational methods, such as comparative genomics and chromosome conformation capture (Hi-C) experiments. These methods have shown that CNEs are often located in close proximity to gene promoters and can interact with regulatory proteins to regulate gene expression.\nIn addition to their role in regulating gene expression, CNEs have also been implicated in other important biological processes, such as epigenetic regulation, transcriptional regulation, and cellular differentiation.\nOverall, the presence of CNEs in plant genomes is an important aspect of plant biology and has implications for our understanding of how plants function and evolve.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are conserved noncoding elements (CNEs) in plant genomes.\n2. CNEs are thought to play important roles in regulating gene expression.\n3. Computational methods such as comparative genomics and chromosome conformation capture (Hi-C) experiments can identify CNEs.\n4. CNEs are often located in close proximity to gene promoters and can interact with regulatory proteins to regulate gene expression.\n5. CNEs have been implicated in other important biological processes, such as epigenetic regulation, transcriptional regulation, and cellular differentiation.",
    "vicuna-7b_fact": [
      "There are conserved noncoding elements (CNEs) in plant genomes.",
      "CNEs are thought to play important roles in regulating gene expression.",
      "Computational methods such as comparative genomics and chromosome conformation capture (Hi-C) experiments can identify CNEs.",
      "CNEs are often located in close proximity to gene promoters and can interact with regulatory proteins to regulate gene expression.",
      "CNEs have been implicated in other important biological processes, such as epigenetic regulation, transcriptional regulation, and cellular differentiation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1403,
    "user_query": "Which is the localization of the RIFIN family of proteins?",
    "vicuna-7b_response": "The RIFIN family of proteins is localized in various organisms, including humans, mice, and plants.\nIn humans, RIFIN proteins are primarily expressed in the brain and testis, and have been implicated in various cellular processes such as cell proliferation, differentiation, and apoptosis. RIFIN proteins are also involved in the regulation of the actin cytoskeleton, which is a network of actin filaments that provides structural support and enables cell movement.\nIn mice, RIFIN proteins have been shown to play a role in the development of the nervous system, particularly in the formation of neuronal connections. RIFIN proteins have also been implicated in the regulation of cell proliferation and differentiation in various tissues, including the intestine, skin, and bone marrow.\nIn plants, RIFIN proteins have been shown to play a role in the regulation of cell growth and division, particularly in the root and shoot apical meristems. RIFIN proteins have also been implicated in the regulation of cellular responses to stress, such as drought and salt stress.\nOverall, the localization of the RIFIN family of proteins varies depending on the organism, but they are expressed in a variety of tissues and have been implicated in various cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The RIFIN family of proteins can be found in various organisms including humans, mice, and plants.\n2. In humans, RIFIN proteins are primarily expressed in the brain and testis.\n3. RIFIN proteins have been implicated in cellular processes such as cell proliferation, differentiation, and apoptosis, and in the regulation of the actin cytoskeleton.\n4. In mice, RIFIN proteins are known to play a role in the development of the nervous system and in the regulation of cell proliferation and differentiation in various tissues.\n5. In plants, RIFIN proteins are implicated in the regulation of cell growth and division, particularly in the root and shoot apical meristems, and the regulation of cellular responses to stress.",
    "vicuna-7b_fact": [
      "The RIFIN family of proteins can be found in various organisms including humans, mice, and plants.",
      "In humans, RIFIN proteins are primarily expressed in the brain and testis.",
      "RIFIN proteins have been implicated in cellular processes such as cell proliferation, differentiation, and apoptosis, and in the regulation of the actin cytoskeleton.",
      "In mice, RIFIN proteins are known to play a role in the development of the nervous system and in the regulation of cell proliferation and differentiation in various tissues.",
      "In plants, RIFIN proteins are implicated in the regulation of cell growth and division, particularly in the root and shoot apical meristems, and the regulation of cellular responses to stress."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The RIFIN family of proteins are exclusive to certain species of malaria parasite Plasmodium, and not found in humans, mice, or plants.\n2. FALSE [correction]: RIFIN proteins are expressed in the red blood cells infected by Plasmodium species, not in the human brain and testis.\n3. UNKNOWN\n4. FALSE [correction]: Since RIFIN proteins are not found in mice, they do not play a role in the development of the nervous system and in the regulation of cell proliferation and differentiation in mice.\n5. FALSE [correction]: As RIFIN proteins are not found in plants, they have no known role in the regulation of plant cell growth, division, or stress response.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 1406,
    "user_query": "Is there any genetic determinant of hair pigmentation that could be useful in forensic analyses?",
    "vicuna-7b_response": "Yes, there are genetic determinants of hair pigmentation that can be useful in forensic analyses. Hair pigmentation is determined by the presence of melanin, which is a pigment responsible for the color of hair. The amount and type of melanin present in hair can vary greatly, and this variation can be used to determine the race or ethnicity of an individual.\nThere are several genetic factors that can affect the amount and type of melanin present in hair. For example, the MC1R gene, which is responsible for red hair, has been shown to be associated with lighter hair color. Similarly, the TYRP1 gene, which is responsible for brown hair color, has been shown to be associated with darker hair color.\nIn forensic analyses, the presence of these genetic determinants can be used to help identify an individual's race or ethnicity. For example, if an individual has red hair, it may be assumed that they have a genetic background that is associated with lighter hair color. Similarly, if an individual has dark brown hair, it may be assumed that they have a genetic background that is associated with darker hair color.\nHowever, it is important to note that genetic determinants of hair pigmentation are not the only factors that can affect hair color. Environmental factors, such as exposure to sunlight, can also affect the amount and type of melanin present in hair. Therefore, it is important to consider all relevant factors when analyzing hair pigmentation in forensic cases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hair pigmentation is determined by the presence of melanin.\n2. The amount and type of melanin in hair can be used to determine an individual's race or ethnicity.\n3. The MC1R gene is associated with red hair and lighter hair color.\n4. The TYRP1 gene is associated with brown hair and darker hair color.\n5. Environmental factors, such as exposure to sunlight, can also affect the amount and type of melanin present in hair.",
    "vicuna-7b_fact": [
      "Hair pigmentation is determined by the presence of melanin.",
      "The amount and type of melanin in hair can be used to determine an individual's race or ethnicity.",
      "The MC1R gene is associated with red hair and lighter hair color.",
      "The TYRP1 gene is associated with brown hair and darker hair color.",
      "Environmental factors, such as exposure to sunlight, can also affect the amount and type of melanin present in hair."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1408,
    "user_query": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?",
    "vicuna-7b_response": "Yes, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death.\nCPVT is a rare genetic disorder that affects the heart's electrical system, causing abnormal heart rhythms, including ventricular tachycardia. Ventricular tachycardia is a type of fast heart rhythm that originates in the lower chambers of the heart (ventricles). When ventricular tachycardia occurs, it can cause the heart to pump less effectively, leading to a decrease in blood flow to the body. If left untreated, ventricular tachycardia can lead to sudden cardiac death.\nCPVT is inherited in an autosomal dominant pattern, which means that having one copy of the gene (from one parent) is enough to cause the disorder. The condition affects both men and women, and it can occur at any age, although it is most commonly diagnosed in young adults.\nIf you have been diagnosed with CPVT, it is important to work closely with your healthcare provider to manage your condition and reduce your risk of sudden cardiac death. This may include medications to help control your heart rhythms, lifestyle changes, and implantable cardioverter-defibrillator (ICD) placement.\nIf you have any concerns about your risk of sudden cardiac death or your treatment options, it is important to speak with your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death.\n2. CPVT is a rare genetic disorder that affects the heart's electrical system.\n3. Ventricular tachycardia is a fast heart rhythm that originates in the lower chambers of the heart.\n4. CPVT is inherited in an autosomal dominant pattern, so having one copy of the gene from one parent is enough to cause the disorder.\n5. The condition affects both men and women, and can occur at any age but is most commonly diagnosed in young adults.",
    "vicuna-7b_fact": [
      "Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death.",
      "CPVT is a rare genetic disorder that affects the heart's electrical system.",
      "Ventricular tachycardia is a fast heart rhythm that originates in the lower chambers of the heart.",
      "CPVT is inherited in an autosomal dominant pattern, so having one copy of the gene from one parent is enough to cause the disorder.",
      "The condition affects both men and women, and can occur at any age but is most commonly diagnosed in young adults."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CPVT is typically inherited in an autosomal recessive pattern, meaning two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but do not show signs and symptoms of the condition.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1411,
    "user_query": "Is the ACE inhibitor indicated for lung cancer treatment?",
    "vicuna-7b_response": "No, ACE inhibitors are not indicated for the treatment of lung cancer. ACE inhibitors are a type of medication that is used to treat conditions such as high blood pressure and heart failure, but they are not used to treat lung cancer.\nLung cancer is a type of cancer that affects the lungs and is characterized by the abnormal growth of cells in the lungs. There are several different types of lung cancer, including small cell lung cancer and non-small cell lung cancer.\nTreatment options for lung cancer vary depending on the stage and type of the cancer, but may include surgery, radiation therapy, chemotherapy, and targeted therapy. There is currently no cure for lung cancer, but treatment can help to slow the progression of the disease and improve symptoms.\nIf you have been diagnosed with lung cancer, it is important to speak with your healthcare provider about the best treatment options for you. They can help you understand your options and determine the most appropriate course of treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ACE inhibitors are not indicated for the treatment of lung cancer.\n2. ACE inhibitors are used to treat conditions such as high blood pressure and heart failure.\n3. Lung cancer affects the lungs and is characterized by the abnormal growth of cells in the lungs.\n4. There are several different types of lung cancer, including small cell lung cancer and non-small cell lung cancer.\n5. Treatment options for lung cancer can include surgery, radiation therapy, chemotherapy, and targeted therapy.",
    "vicuna-7b_fact": [
      "ACE inhibitors are not indicated for the treatment of lung cancer.",
      "ACE inhibitors are used to treat conditions such as high blood pressure and heart failure.",
      "Lung cancer affects the lungs and is characterized by the abnormal growth of cells in the lungs.",
      "There are several different types of lung cancer, including small cell lung cancer and non-small cell lung cancer.",
      "Treatment options for lung cancer can include surgery, radiation therapy, chemotherapy, and targeted therapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-7b_response": "Hydrochlorothiazide is a diuretic medication that is used to reduce the amount of water and salt in the body. It is primarily used to treat high blood pressure, but it can also be used to treat other conditions such as heart failure, kidney disease, and certain types of edema (swelling).\nHydrochlorothiazide works by increasing the amount of urine that the body produces, which helps to reduce the amount of fluid and salt in the body. This can help to lower blood pressure and reduce the risk of complications associated with high blood pressure, such as heart attack and stroke.\nIt is important to note that hydrochlorothiazide is not suitable for everyone, and it may not be appropriate for use in certain individuals. It is important to consult with a healthcare professional before starting treatment with hydrochlorothiazide to determine if it is the right treatment for you.\nIn addition to its use in treating high blood pressure, hydrochlorothiazide may also be used to treat other conditions such as diabetes insipidus, a condition in which the body is unable to regulate the amount of urine that it produces. It may also be used to treat certain types of kidney disease, such as nephrotic syndrome, and to prevent kidney damage in individuals who are at risk of developing kidney disease.\nIt is important to follow the dosage instructions provided by your healthcare professional when taking hydrochlorothiazide. It is also important to inform your healthcare professional of any other medications that you are taking, as hydrochlorothiazide can interact with certain medications and may not be suitable for everyone.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hydrochlorothiazide is a diuretic medication used to reduce the amount of water and salt in the body.\n2. Hydrochlorothiazide is primarily used to treat high blood pressure, and can also be used for conditions like heart failure, kidney disease, and certain types of edema (swelling).\n3. Hydrochlorothiazide functions by increasing the quantity of urine the body produces, which can help to lessen blood pressure and lower the risk of complications like heart attack and stroke.\n4. Hydrochlorothiazide could be used for other conditions, such as diabetes insipidus and nephrotic syndrome, and to hinder kidney damage in individuals who are at risk of developing kidney disease.\n5. Hydrochlorothiazide may interact with some medications, and therefore it is recommended to share the list of medication one is taking before starting treatment with a healthcare professional.",
    "vicuna-7b_fact": [
      "Hydrochlorothiazide is a diuretic medication used to reduce the amount of water and salt in the body.",
      "Hydrochlorothiazide is primarily used to treat high blood pressure, and can also be used for conditions like heart failure, kidney disease, and certain types of edema (swelling).",
      "Hydrochlorothiazide functions by increasing the quantity of urine the body produces, which can help to lessen blood pressure and lower the risk of complications like heart attack and stroke.",
      "Hydrochlorothiazide could be used for other conditions, such as diabetes insipidus and nephrotic syndrome, and to hinder kidney damage in individuals who are at risk of developing kidney disease.",
      "Hydrochlorothiazide may interact with some medications, and therefore it is recommended to share the list of medication one is taking before starting treatment with a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1418,
    "user_query": "Which genes are thought to be involved in medulloblastoma development?",
    "vicuna-7b_response": "Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum, which is located at the base of the brain. Several genes have been implicated in the development of medulloblastoma.\nOne of the most well-known genes involved in medulloblastoma development is the sonic hedgehog (SHH) gene. Mutations in the SHH gene have been identified in a significant percentage of medulloblastoma cases. The SHH gene produces a protein that plays a crucial role in the development of the cerebellum and other parts of the brain. When the SHH gene is mutated, it can cause the formation of abnormal cells that can lead to medulloblastoma.\nAnother gene that has been implicated in medulloblastoma development is the patched gene. The patched gene works in conjunction with the SHH gene to regulate cell growth and division. Mutations in the patched gene can disrupt this regulation and lead to the formation of medulloblastoma.\nOther genes that have been linked to medulloblastoma development include the smoothened gene, the Gli gene family, and the WNT gene family.\nIn summary, several genes have been implicated in the development of medulloblastoma, including the sonic hedgehog (SHH) gene, the patched gene, the smoothened gene, the Gli gene family, and the WNT gene family. Mutations in these genes can disrupt normal cell growth and division and lead to the formation of medulloblastoma.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum.\n2. The sonic hedgehog (SHH) gene has been implicated in the development of medulloblastoma.\n3. Mutations in the SHH gene have been identified in a significant percentage of medulloblastoma cases.\n4. Another gene that has been implicated in medulloblastoma development is the patched gene.\n5. Other genes linked to medulloblastoma development include the smoothened gene, the Gli gene family, and the WNT gene family.",
    "vicuna-7b_fact": [
      "Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum.",
      "The sonic hedgehog (SHH) gene has been implicated in the development of medulloblastoma.",
      "Mutations in the SHH gene have been identified in a significant percentage of medulloblastoma cases.",
      "Another gene that has been implicated in medulloblastoma development is the patched gene.",
      "Other genes linked to medulloblastoma development include the smoothened gene, the Gli gene family, and the WNT gene family."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1425,
    "user_query": "Which diseases can be treated with Afamelanotide?",
    "vicuna-7b_response": "Afamelanotide is a medication that is used to treat a condition called erythropoietic protoporphyria (EPP). EPP is a rare genetic disorder that affects the production of a protein called hemoglobin, which is responsible for carrying oxygen in the blood. This leads to a build-up of a toxic substance in the body, which can cause skin blisters, itching, and pain.\nAfamelanotide works by increasing the production of a protein called melanin, which helps to protect the skin from damage caused by sunlight. This can help to reduce the severity of symptoms in people with EPP.\nAfamelanotide has not been approved for the treatment of any other diseases or conditions. However, it is important to note that there are many other medications and treatments available for a wide range of medical conditions. If you have a specific question about a particular disease or condition, it is best to speak with a qualified healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Afamelanotide is used to treat erythropoietic protoporphyria (EPP).\n2. Erythropoietic protoporphyria (EPP) is a rare genetic disorder that affects the production of hemoglobin.\n3. EPP can cause skin blisters, itching, and pain due to a toxic substance build-up.\n4. Afamelanotide functions by increasing the production of melanin.\n5. Afamelanotide has not been approved for the treatment of any other diseases or conditions.",
    "vicuna-7b_fact": [
      "Afamelanotide is used to treat erythropoietic protoporphyria (EPP).",
      "Erythropoietic protoporphyria (EPP) is a rare genetic disorder that affects the production of hemoglobin.",
      "EPP can cause skin blisters, itching, and pain due to a toxic substance build-up.",
      "Afamelanotide functions by increasing the production of melanin.",
      "Afamelanotide has not been approved for the treatment of any other diseases or conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Afamelanotide has also been approved for the treatment of sun-related skin disorders like polymorphous light eruption.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1429,
    "user_query": "Which is the main calcium binding protein of the sarcoplasmic reticulum?",
    "vicuna-7b_response": "The main calcium binding protein of the sarcoplasmic reticulum is troponin C.\nThe sarcoplasmic reticulum is a type of endoplasmic reticulum that is found in muscle cells and is responsible for storing and releasing calcium ions. Troponin C is a protein complex that is responsible for regulating the interaction between the sarcoplasmic reticulum and the contractile proteins in muscle fibers.\nTroponin C is composed of three subunits: troponin C1, troponin C2, and troponin T. These subunits work together to bind calcium ions and regulate muscle contraction. When calcium ions bind to troponin C, they cause a conformational change in the protein that allows the contractile proteins in muscle fibers to interact and contract.\nOverall, troponin C is an important protein in the regulation of muscle contraction and is a key component of the calcium signaling pathway in muscle cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The main calcium binding protein of the sarcoplasmic reticulum is Troponin C.\n2. The sarcoplasmic reticulum is a type of endoplasmic reticulum found in muscle cells.\n3. The sarcoplasmic reticulum is responsible for storing and releasing calcium ions.\n4. Troponin C is composed of three subunits: troponin C1, troponin C2, and troponin T.\n5. Troponin C is an important protein in the regulation of muscle contraction and is a key component of the calcium signaling pathway in muscle cells.",
    "vicuna-7b_fact": [
      "The main calcium binding protein of the sarcoplasmic reticulum is Troponin C.",
      "The sarcoplasmic reticulum is a type of endoplasmic reticulum found in muscle cells.",
      "The sarcoplasmic reticulum is responsible for storing and releasing calcium ions.",
      "Troponin C is composed of three subunits: troponin C1, troponin C2, and troponin T.",
      "Troponin C is an important protein in the regulation of muscle contraction and is a key component of the calcium signaling pathway in muscle cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The main calcium binding protein of the sarcoplasmic reticulum is Calsequestrin.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Troponin is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not present in smooth muscle tissues.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1430,
    "user_query": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?",
    "vicuna-7b_response": "The UGT1A1*28 polymorphism has been studied in relation to irinotecan response in Caucasians, and the results have been inconsistent.\nSome studies have reported that the UGT1A1*28 polymorphism is associated with irinotecan response in Caucasians, with individuals with the wild-type genotype (UGT1A1*1/UGT1A1*1) having better response to irinotecan treatment. For example, a study by Tsao et al. (2004) found that the UGT1A1*28 polymorphism was associated with improved overall survival in patients with advanced colorectal cancer treated with irinotecan, and that the wild-type genotype was associated with a higher response rate and longer progression-free survival.\nHowever, other studies have not found a significant association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians. For example, a study by Yang et al. (2005) found no association between the UGT1A1*28 polymorphism and irinotecan response in patients with advanced colorectal cancer.\nIn summary, the evidence regarding the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians is mixed, and more research is needed to clarify the role of this polymorphism in irinotecan response.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UGT1A1*28 polymorphism has been studied in relation to the irinotecan response in Caucasians.\n2. Some studies reported that the UGT1A1*28 polymorphism is associated with irinotecan response in Caucasians, with wild-type genotype having better response.\n3. A study by Tsao et al. in 2004 found an association between the UGT1A1*28 polymorphism and improved overall survival in patients with advanced colorectal cancer treated with irinotecan.\n4. Some other studies, like the one by Yang et al.in 2005, have not found a significant association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians.\n5. The evidence regarding the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians is inconsistent.",
    "vicuna-7b_fact": [
      "The UGT1A1*28 polymorphism has been studied in relation to the irinotecan response in Caucasians.",
      "Some studies reported that the UGT1A1*28 polymorphism is associated with irinotecan response in Caucasians, with wild-type genotype having better response.",
      "A study by Tsao et al. in 2004 found an association between the UGT1A1*28 polymorphism and improved overall survival in patients with advanced colorectal cancer treated with irinotecan.",
      "Some other studies, like the one by Yang et al.in 2005, have not found a significant association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians.",
      "The evidence regarding the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians is inconsistent."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1433,
    "user_query": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.",
    "vicuna-7b_response": "Sure, here are some anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for the treatment of Alzheimer's disease:\n1. Bapineuzumab\n2. Solanezumab\n3. Gantenerumab\n4. Crenezumab\n5. Lymprocel\n6. BIIB092\n7. AN1792\n8. Aducanumab\nThese antibodies are designed to target and clear amyloid-beta plaques, a hallmark of Alzheimer's disease. However, the results of clinical trials have been mixed, and the efficacy and safety of these treatments are still being evaluated.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bapineuzumab has been investigated in clinical trials for the treatment of Alzheimer's disease.\n2. Solanezumab has been investigated in clinical trials for the treatment of Alzheimer's disease.\n3. Gantenerumab has been investigated in clinical trials for the treatment of Alzheimer's disease.\n4. Crenezumab has been investigated in clinical trials for the treatment of Alzheimer's disease.\n5. The antibodies like Bapineuzumab, Solanezumab, Gantenerumab, and Crenezumab are designed to target and clear amyloid-beta plaques, a hallmark of Alzheimer's disease.",
    "vicuna-7b_fact": [
      "Bapineuzumab has been investigated in clinical trials for the treatment of Alzheimer's disease.",
      "Solanezumab has been investigated in clinical trials for the treatment of Alzheimer's disease.",
      "Gantenerumab has been investigated in clinical trials for the treatment of Alzheimer's disease.",
      "Crenezumab has been investigated in clinical trials for the treatment of Alzheimer's disease.",
      "The antibodies like Bapineuzumab, Solanezumab, Gantenerumab, and Crenezumab are designed to target and clear amyloid-beta plaques, a hallmark of Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1434,
    "user_query": "Does MVIIA and MVIIC bind to the same calcium channel?",
    "vicuna-7b_response": "MVIIA and MVIIC are two different peptides that have been shown to bind to different types of calcium channels.\nMVIIA is a synthetic peptide that has been shown to bind to P/Q-type voltage-gated calcium channels, which are found in a variety of cell types, including neurons, cardiac muscle cells, and smooth muscle cells. MVIIA has been shown to inhibit the activity of these channels by blocking their activation by calcium ions.\nOn the other hand, MVIIC is a synthetic peptide that has been shown to bind to N-type voltage-gated calcium channels, which are found primarily in the brain and heart. MVIIC has been shown to inhibit the activity of these channels by blocking their activation by calcium ions.\nSo, while both MVIIA and MVIIC bind to calcium channels, they bind to different types of calcium channels and have different effects on channel activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MVIIA and MVIIC are two different synthetic peptides.\n2. MVIIA has been shown to bind to P/Q-type voltage-gated calcium channels.\n3. P/Q-type voltage-gated calcium channels are found in a variety of cell types, including neurons, cardiac muscle cells, and smooth muscle cells.\n4. MVIIC has been shown to bind to N-type voltage-gated calcium channels.\n5. N-type voltage-gated calcium channels are found primarily in the brain and heart.",
    "vicuna-7b_fact": [
      "MVIIA and MVIIC are two different synthetic peptides.",
      "MVIIA has been shown to bind to P/Q-type voltage-gated calcium channels.",
      "P/Q-type voltage-gated calcium channels are found in a variety of cell types, including neurons, cardiac muscle cells, and smooth muscle cells.",
      "MVIIC has been shown to bind to N-type voltage-gated calcium channels.",
      "N-type voltage-gated calcium channels are found primarily in the brain and heart."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: N-type voltage-gated calcium channels are found primarily in the brain and peripheral nervous system.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1437,
    "user_query": "What is SHAPE-Seq?",
    "vicuna-7b_response": "SHAPE-Seq (Single-cell Hi-C and Paired-end sequencing for Exploring Chromatin in Epigenetics) is a powerful technique used to study the three-dimensional organization of chromatin in individual cells. It combines the advantages of two different sequencing technologies: Hi-C (high-throughput chromatin conformation capture) and paired-end sequencing.\nHi-C allows researchers to map the physical interactions between DNA molecules in a cell, while paired-end sequencing provides genome-wide information about the DNA sequences. By combining these two techniques, researchers can gain a detailed understanding of how chromatin is organized in individual cells, and how this organization contributes to gene regulation.\nSHAPE-Seq has been used to study a wide range of biological processes, including cell differentiation, stem cell biology, and cancer. It has also been used to identify new regulatory elements and to understand the mechanisms underlying epigenetic regulation of gene expression.\nOverall, SHAPE-Seq is a powerful tool that has revolutionized our understanding of chromatin organization and gene regulation in individual cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SHAPE-Seq stands for Single-cell Hi-C and Paired-end sequencing for Exploring Chromatin in Epigenetics.\n2. SHAPE-Seq is a technique used to study the three-dimensional organization of chromatin in individual cells.\n3. SHAPE-Seq combines Hi-C (high-throughput chromatin conformation capture) and paired-end sequencing technologies.\n4. Hi-C allows researchers to map the physical interactions between DNA molecules in a cell and paired-end sequencing provides genome-wide information about the DNA sequences.\n5. SHAPE-Seq has been used in the study of cell differentiation, stem cell biology, and cancer.",
    "vicuna-7b_fact": [
      "SHAPE-Seq stands for Single-cell Hi-C and Paired-end sequencing for Exploring Chromatin in Epigenetics.",
      "SHAPE-Seq is a technique used to study the three-dimensional organization of chromatin in individual cells.",
      "SHAPE-Seq combines Hi-C (high-throughput chromatin conformation capture) and paired-end sequencing technologies.",
      "Hi-C allows researchers to map the physical interactions between DNA molecules in a cell and paired-end sequencing provides genome-wide information about the DNA sequences.",
      "SHAPE-Seq has been used in the study of cell differentiation, stem cell biology, and cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SHAPE-Seq stands for Selective 2ʹ-Hydroxyl Acylation analyzed by Primer Extension Sequencing.\n2. TRUE\n3. FALSE [correction]: SHAPE-Seq is a method which utilizes selective 2'-hydroxyl acylation and primer extension to study RNA structure, not the combination of Hi-C and paired-end sequencing.\n4. FALSE [correction]: Hi-C allows researchers to map the physical interactions between DNA molecules in a cell and paired-end sequencing provides genome-wide information about the DNA sequences, but these are not part of SHAPE-Seq technique.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1446,
    "user_query": "Describe Heyde syndrome.",
    "vicuna-7b_response": "Heyde syndrome, also known as \"sudden infant death syndrome (SIDS)\" type II, is a rare but serious condition that affects infants and young children. It is characterized by the sudden and unexpected death of an infant, usually during sleep, and is often associated with a specific pattern of brain injury known as \"triple-positive\" EEG.\nThe exact cause of Heyde syndrome is not known, but it is believed to be related to a disturbance in the regulation of breathing and arousal during sleep. Some research suggests that it may be caused by a genetic predisposition, as well as environmental factors such as exposure to tobacco smoke and certain infections.\nSymptoms of Heyde syndrome can be difficult to distinguish from other causes of sudden infant death, as the condition often presents with no obvious signs or symptoms. However, infants with Heyde syndrome may have a history of apnea (a pause in breathing during sleep) or other sleep disorders, and may be at a higher risk for developing other medical conditions such as gastroesophageal reflux disease (GERD) and congenital heart disease.\nDiagnosis of Heyde syndrome is typically made through a combination of clinical examination, laboratory tests, and neuroimaging studies such as CT scans or MRI. Treatment for Heyde syndrome is focused on managing any underlying medical conditions and improving the child's sleep environment to reduce the risk of sudden infant death. This may include using specialized sleep positioners, reducing exposure to tobacco smoke, and avoiding the use of certain types of bedding or soft bedding materials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Heyde syndrome, also known as \"sudden infant death syndrome (SIDS)\" type II, is a condition that affects infants and young children.\n2. The cause of Heyde syndrome is unknown but it is believed to be related to a disturbance in the regulation of breathing and arousal during sleep.\n3. Some research suggests that Heyde syndrome may be caused by a genetic predisposition, and environmental factors such as exposure to tobacco smoke and certain infections.\n4. The symptoms of Heyde syndrome can be hard to distinguish from other causes of sudden infant death, and may include a history of apnea or other sleep disorders.\n5. Treatment for Heyde syndrome includes managing any underlying medical conditions and improving the child's sleep environment to reduce the risk of sudden infant death.",
    "vicuna-7b_fact": [
      "Heyde syndrome, also known as \"sudden infant death syndrome (SIDS)\" type II, is a condition that affects infants and young children.",
      "The cause of Heyde syndrome is unknown but it is believed to be related to a disturbance in the regulation of breathing and arousal during sleep.",
      "Some research suggests that Heyde syndrome may be caused by a genetic predisposition, and environmental factors such as exposure to tobacco smoke and certain infections.",
      "The symptoms of Heyde syndrome can be hard to distinguish from other causes of sudden infant death, and may include a history of apnea or other sleep disorders.",
      "Treatment for Heyde syndrome includes managing any underlying medical conditions and improving the child's sleep environment to reduce the risk of sudden infant death."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Heyde syndrome is a condition characterized by the association of aortic stenosis and gastrointestinal bleeding and is not known as \"sudden infant death syndrome (SIDS)\" type II.\n2. FALSE [correction]: The cause of Heyde syndrome is thought to be due to an aortic valve narrowing leading to an increased bleeding tendency due to a gastrointestinal angiodysplasia. It is not related to a disturbance in the regulation of breathing and arousal during sleep.\n3. FALSE [correction]: The cause of Heyde syndrome is not considered to be related to genetic predisposition, environmental factors such as exposure to tobacco smoke and certain infections. It is an association between aortic stenosis and gastrointestinal bleeding.\n4. FALSE [correction]: The symptoms of Heyde syndrome are typically related to gastrointestinal bleeding and not typically related to apnea or other sleep disorders.\n5. FALSE [correction]: Treatment for Heyde syndrome often involves procedures to fix or replace the aortic valve, rather than improving sleep environment.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-7b_response": "Yes, silicon has been used in the treatment of incontinence. Silicon is a synthetic material that is commonly used in the production of medical devices, including devices used in the treatment of incontinence.\nOne type of silicon device used in the treatment of incontinence is a silicone urinary incontinence device. These devices are designed to be placed in the vagina and are intended to provide support to the urethra and bladder neck, reducing the risk of urinary leakage.\nSilicone urinary incontinence devices are typically made from a flexible, pliable material that is designed to conform to the shape of the vagina. They are often used in women who have stress urinary incontinence, which is a type of incontinence that occurs when the bladder is put under pressure, such as when coughing, sneezing, or laughing.\nIt is important to note that silicone urinary incontinence devices are not suitable for everyone, and they should only be used under the guidance of a healthcare professional. It is also important to follow the instructions provided by the manufacturer when using these devices.\nIn addition to silicone urinary incontinence devices, there are other types of silicon-based devices that are used in the treatment of incontinence, including silicone gel-filled implants and silicone-coated mesh devices. However, these devices are typically used in more severe cases of incontinence and are not suitable for everyone.\nOverall, silicon has been used in the treatment of incontinence, and silicone-based devices are one type of treatment option that may be recommended by a healthcare professional for certain types of incontinence.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Silicon is a synthetic material used in the production of medical devices, including devices used for the treatment of incontinence.\n2. Silicone urinary incontinence devices are one type of silicon device used in the treatment of incontinence. \n3. Silicone urinary incontinence devices are often used in women who have stress urinary incontinence.\n4. Silicone urinary incontinence devices should only be used under the guidance of a healthcare professional.\n5. Other types of silicon-based devices used in the treatment of incontinence include silicone gel-filled implants and silicone-coated mesh devices.",
    "vicuna-7b_fact": [
      "Silicon is a synthetic material used in the production of medical devices, including devices used for the treatment of incontinence.",
      "Silicone urinary incontinence devices are one type of silicon device used in the treatment of incontinence.",
      "Silicone urinary incontinence devices are often used in women who have stress urinary incontinence.",
      "Silicone urinary incontinence devices should only be used under the guidance of a healthcare professional.",
      "Other types of silicon-based devices used in the treatment of incontinence include silicone gel-filled implants and silicone-coated mesh devices."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Silicon is a naturally occurring element, not a synthetic material. It is often used in the production of medical devices, including those used for the treatment of incontinence.\n2. FALSE [correction]: Silicone urinary incontinence devices are one type of silicone device used in the treatment of incontinence. Silicon and silicone are not the same.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Other types of silicone-based devices used in the treatment of incontinence might include silicone gel-filled implants and silicone-coated mesh devices. Again, silicon and silicone are not the same.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1448,
    "user_query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "vicuna-7b_response": "The error prevention GO (8-oxo-G) system in Pseudomonas putida is composed of several proteins, including:\n1. 8-oxo-G DNA glycosylase: This enzyme recognizes and removes 8-oxo-G from DNA.\n2. 8-oxo-G DNA photolyase: This enzyme uses light energy to repair 8-oxo-G damage in DNA.\n3. 8-oxo-G DNA repair synthesis: This enzyme synthesizes new DNA strands to replace the damaged one.\n4. 8-oxo-G DNA ligase: This enzyme seals the new DNA strand to the undamaged one.\nThese proteins work together to prevent mutations caused by 8-oxo-G damage in DNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The error prevention GO system in Pseudomonas putida is composed of several proteins.\n2. 8-oxo-G DNA glycosylase is an enzyme in the GO system that recognizes and removes 8-oxo-G from DNA.\n3. 8-oxo-G DNA photolyase is an enzyme in the system that uses light energy to repair 8-oxo-G damage in DNA.\n4. 8-oxo-G DNA repair synthesis is another enzyme in the GO system that synthesizes new DNA strands to replace the damaged one.\n5. 8-oxo-G DNA ligase, another enzyme in the system, seals the new DNA strand to the undamaged one.",
    "vicuna-7b_fact": [
      "The error prevention GO system in Pseudomonas putida is composed of several proteins.",
      "8-oxo-G DNA glycosylase is an enzyme in the GO system that recognizes and removes 8-oxo-G from DNA.",
      "8-oxo-G DNA photolyase is an enzyme in the system that uses light energy to repair 8-oxo-G damage in DNA.",
      "8-oxo-G DNA repair synthesis is another enzyme in the GO system that synthesizes new DNA strands to replace the damaged one.",
      "8-oxo-G DNA ligase, another enzyme in the system, seals the new DNA strand to the undamaged one."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no enzyme called 8-oxo-G DNA photolyase in the GO system that repairs 8-oxo-G damage in DNA using light energy.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1449,
    "user_query": "List five applications of machine learning algorithms in medical diagnosis.",
    "vicuna-7b_response": "Sure, here are five applications of machine learning algorithms in medical diagnosis:\n1. Disease diagnosis: Machine learning algorithms can be used to diagnose various diseases based on symptoms, medical history, and other relevant data. For example, algorithms can be trained to diagnose diseases such as diabetes, cancer, and heart disease by analyzing medical images, blood tests, and other data.\n2. Predictive maintenance: Machine learning algorithms can be used to predict when medical equipment such as MRI machines or CT scanners are likely to fail. This can help healthcare providers schedule maintenance before a failure occurs, reducing downtime and improving patient care.\n3. Personalized medicine: Machine learning algorithms can be used to develop personalized treatment plans for individual patients based on their unique medical history, genetic information, and other factors. This can help healthcare providers tailor treatments to each patient's specific needs, improving patient outcomes.\n4. Drug discovery: Machine learning algorithms can be used to identify potential new drugs and optimize existing drugs based on their effectiveness and safety. This can help pharmaceutical companies develop new treatments for diseases such as Alzheimer's, Parkinson's, and cancer.\n5. Disease surveillance: Machine learning algorithms can be used to monitor disease outbreaks and track the spread of infectious diseases. This can help healthcare providers respond quickly to outbreaks and take preventive measures to reduce the spread of disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Machine learning algorithms can be used to diagnose various diseases such as diabetes, cancer, and heart disease.\n2. Machine learning can predict when medical equipment like MRI machines or CT scanners are likely to fail.\n3. Machine learning algorithms can be used to develop personalized treatment plans for individual patients.\n4. Machine learning algorithms can be used in drug discovery to identify potential new drugs and optimize existing medications.\n5. Machine learning algorithms can be utilized for disease surveillance, monitoring, and tracking the spread of infectious diseases.",
    "vicuna-7b_fact": [
      "Machine learning algorithms can be used to diagnose various diseases such as diabetes, cancer, and heart disease.",
      "Machine learning can predict when medical equipment like MRI machines or CT scanners are likely to fail.",
      "Machine learning algorithms can be used to develop personalized treatment plans for individual patients.",
      "Machine learning algorithms can be used in drug discovery to identify potential new drugs and optimize existing medications.",
      "Machine learning algorithms can be utilized for disease surveillance, monitoring, and tracking the spread of infectious diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1450,
    "user_query": "Does the 3D structure of  the genome remain stable during cell differentiation?",
    "vicuna-7b_response": "The 3D structure of the genome, also known as the three-dimensional (3D) chromatin architecture, can undergo significant changes during cell differentiation.\nDuring cell differentiation, the chromatin structure of a cell can become more compact and condensed, which can lead to changes in the accessibility of the genome to transcription factors and other regulatory proteins. This can result in the activation or repression of specific genes, which is necessary for the proper differentiation of cells.\nAdditionally, the 3D structure of the genome can also change due to the addition or removal of histone modifications, which are chemical tags that can be added to or removed from the DNA in the nucleus. These modifications can affect the accessibility of the genome to transcription factors and other regulatory proteins, and can play a role in the regulation of gene expression during cell differentiation.\nOverall, the 3D structure of the genome can be highly dynamic during cell differentiation, and changes in this structure can play a crucial role in the regulation of gene expression and the proper differentiation of cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 3D structure of the genome can undergo significant changes during cell differentiation.\n2. The chromatin structure of a cell can become more compact and condensed during cell differentiation.\n3. Changes in the chromatin structure can lead to changes in the accessibility of the genome to transcription factors and other regulatory proteins.\n4. The 3D structure of the genome can change due to the addition or removal of histone modifications.\n5. Changes in the 3D structure of the genome can play a crucial role in the regulation of gene expression and the proper differentiation of cells.",
    "vicuna-7b_fact": [
      "The 3D structure of the genome can undergo significant changes during cell differentiation.",
      "The chromatin structure of a cell can become more compact and condensed during cell differentiation.",
      "Changes in the chromatin structure can lead to changes in the accessibility of the genome to transcription factors and other regulatory proteins.",
      "The 3D structure of the genome can change due to the addition or removal of histone modifications.",
      "Changes in the 3D structure of the genome can play a crucial role in the regulation of gene expression and the proper differentiation of cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1453,
    "user_query": "What is 2d 4d ratio in athletes.",
    "vicuna-7b_response": "The 2D:4D ratio is a measure of the relative lengths of the second and fourth digit of the hand. It is often used as an indicator of prenatal androgen exposure, which can affect the development of certain physical characteristics in males and females.\nIn athletes, the 2D:4D ratio has been studied as a potential predictor of athletic performance. Some research has suggested that individuals with a lower 2D:4D ratio may have an advantage in certain sports that require quick and precise hand-eye coordination, such as tennis and baseball. However, it is important to note that the relationship between the 2D:4D ratio and athletic performance is not fully understood and more research is needed to confirm these findings.\nAdditionally, it's important to note that the 2D:4D ratio is just one of many factors that can influence athletic performance and it's not a direct indicator of athletic performance. Other factors such as genetics, training, nutrition, and environment play a much more important role.\nIt's also important to note that the 2D:4D ratio is not a direct indicator of athletic performance, and more research is needed to confirm the relationship between the 2D:4D ratio and athletic performance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 2D:4D ratio is a measure of the relative lengths of the second and fourth digit of the hand.\n2. The 2D:4D ratio is often used as an indicator of prenatal androgen exposure.\n3. In athletics, the 2D:4D ratio has been studied as a potential predictor of athletic performance.\n4. It's suggested that individuals with a lower 2D:4D ratio may have an advantage in certain sports such as tennis and baseball.\n5. The 2D:4D ratio is not a direct indicator of athletic performance, other factors like genetics, training, diet, and environment play a significant role.",
    "vicuna-7b_fact": [
      "The 2D:4D ratio is a measure of the relative lengths of the second and fourth digit of the hand.",
      "The 2D:4D ratio is often used as an indicator of prenatal androgen exposure.",
      "In athletics, the 2D:4D ratio has been studied as a potential predictor of athletic performance.",
      "It's suggested that individuals with a lower 2D:4D ratio may have an advantage in certain sports such as tennis and baseball.",
      "The 2D:4D ratio is not a direct indicator of athletic performance, other factors like genetics, training, diet, and environment play a significant role."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is a topic of ongoing research and debate. Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle. However, other studies have found no significant association between the moon and the rupture risk of intracranial aneurysms.\nIntracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain. They can be caused by a variety of factors, including genetics, high blood pressure, and smoking. When an intracranial aneurysm ruptures, it can cause a subarachnoid hemorrhage, which can lead to severe brain damage or death.\nThe moon's gravitational pull is thought to affect the Earth's tides and the pressure inside the body's fluids, including the blood inside an intracranial aneurysm. Some researchers have suggested that the moon's gravitational pull may cause changes in the pressure inside an aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle. However, other researchers have found no significant association between the moon and the rupture risk of intracranial aneurysms.\nOverall, the association between the moon cycle and rupture risk of intracranial aneurysms is not well understood, and more research is needed to determine the potential role of the moon's gravitational pull in this process. It is important to note that the risk of rupture of an intracranial aneurysm is influenced by many factors, including the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors such as high blood pressure and smoking.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.\n2. When an intracranial aneurysm ruptures, it can cause a subarachnoid hemorrhage.\n3. A ruptured intracranial aneurysm can lead to severe brain damage or death.\n4. The moon's gravitational pull is thought to affect the Earth's tides and the pressure inside the body's fluids.\n5. The risk of rupture of an intracranial aneurysm is influenced by factors like the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors such as high blood pressure and smoking.",
    "vicuna-7b_fact": [
      "Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.",
      "When an intracranial aneurysm ruptures, it can cause a subarachnoid hemorrhage.",
      "A ruptured intracranial aneurysm can lead to severe brain damage or death.",
      "The moon's gravitational pull is thought to affect the Earth's tides and the pressure inside the body's fluids.",
      "The risk of rupture of an intracranial aneurysm is influenced by factors like the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors such as high blood pressure and smoking."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The moon's gravitational pull is thought to affect the Earth's tides, but it has no known impact on the pressure inside the body's fluids.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1461,
    "user_query": "List functional roles of the FtsZ protein.",
    "vicuna-7b_response": "The FtsZ protein is a key component of the bacterial cell division machinery. It plays several functional roles in the process of cell division, including:\n1. Helping to form the division site: FtsZ forms a ring-shaped structure around the growing cell division site, which helps to localize other division-related proteins and initiate the process of cell division.\n2. Acting as a scaffold for other division-related proteins: FtsZ helps to organize and position other division-related proteins at the division site, allowing them to function properly and facilitate the process of cell division.\n3. Helping to create the division site: FtsZ helps to create the division site by pulling the cell membrane apart and creating a narrow channel through which the cell contents will be divided.\n4. Contributing to the formation of the division septum: FtsZ helps to form the division septum, a thickened band of material that separates the two daughter cells after cell division.\n5. Helping to maintain the shape of the cell: FtsZ helps to maintain the shape of the cell during the process of cell division, ensuring that the cell does not become too distended or too elongated.\nOverall, the FtsZ protein plays a crucial role in the process of bacterial cell division, helping to coordinate the activities of various division-related proteins and ensure that the process proceeds smoothly and efficiently.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The FtsZ protein is a key component of the bacterial cell division machinery.\n2. FtsZ forms a ring-shaped structure around the growing cell division site.\n3. FtsZ helps to organize and position other division-related proteins at the division site.\n4. FtsZ helps to create the division site by pulling the cell membrane apart and creating a narrow channel through which the cell contents will be divided.\n5. FtsZ contributes to the formation of the division septum, a thickened band of material that separates the two daughter cells after cell division.",
    "vicuna-7b_fact": [
      "The FtsZ protein is a key component of the bacterial cell division machinery.",
      "FtsZ forms a ring-shaped structure around the growing cell division site.",
      "FtsZ helps to organize and position other division-related proteins at the division site.",
      "FtsZ helps to create the division site by pulling the cell membrane apart and creating a narrow channel through which the cell contents will be divided.",
      "FtsZ contributes to the formation of the division septum, a thickened band of material that separates the two daughter cells after cell division."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: FtsZ does not pull the cell membrane apart to create a division site. It forms a ring at the division site which constricts, leading to cell division.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1463,
    "user_query": "Is there any evidence of dysregulated long non coding RNAs and Alzheimer's disease?",
    "vicuna-7b_response": "Yes, there is evidence of dysregulated long non-coding RNAs (lncRNAs) in Alzheimer's disease (AD).\nAD is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and synaptic dysfunction. Recent studies have suggested that lncRNAs play important roles in the pathogenesis of AD.\nFor example, a study published in the journal Nature Neuroscience in 2018 found that a lncRNA called HOTAIR was dysregulated in the brains of AD patients and that overexpression of HOTAIR in mouse models of AD exacerbated cognitive decline and synaptic dysfunction.\nAnother study published in the journal Neurobiology of Aging in 2019 found that a lncRNA called BCLESS-1 was downregulated in the brains of AD patients and that restoring BCLESS-1 expression in mouse models of AD improved memory and synaptic function.\nThese findings suggest that lncRNAs may play a critical role in the development and progression of AD and may represent potential therapeutic targets for the treatment of this disease.\nHowever, it is important to note that more research is needed to fully understand the role of lncRNAs in AD and to determine the best ways to target them therapeutically.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alzheimer's disease (AD) is characterized by progressive memory loss, cognitive decline, and synaptic dysfunction.\n2. Long non-coding RNAs (lncRNAs) have been suggested to play important roles in the pathogenesis of Alzheimer's disease (AD).\n3. A study published in the journal Nature Neuroscience in 2018 found that a lncRNA called HOTAIR was dysregulated in the brains of AD patients.\n4. Another study published in the journal Neurobiology of Aging in 2019 reported that a lncRNA called BCLESS-1 was downregulated in the brains of AD patients.\n5. Long non-coding RNAs may represent potential therapeutic targets for the treatment of Alzheimer's disease.",
    "vicuna-7b_fact": [
      "Alzheimer's disease (AD) is characterized by progressive memory loss, cognitive decline, and synaptic dysfunction.",
      "Long non-coding RNAs (lncRNAs) have been suggested to play important roles in the pathogenesis of Alzheimer's disease (AD).",
      "A study published in the journal Nature Neuroscience in 2018 found that a lncRNA called HOTAIR was dysregulated in the brains of AD patients.",
      "Another study published in the journal Neurobiology of Aging in 2019 reported that a lncRNA called BCLESS-1 was downregulated in the brains of AD patients.",
      "Long non-coding RNAs may represent potential therapeutic targets for the treatment of Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1469,
    "user_query": "What is known about type D personality trait in cancer patients?",
    "vicuna-7b_response": "Type D personality is a term used to describe a specific type of personality that is characterized by negative affectivity (i.e., chronic negative emotions such as anger, anxiety, and sadness) and social inhibition (i.e., difficulty in expressing emotions and interacting with others). Research has shown that individuals with type D personalities may be at increased risk for a variety of health problems, including cardiovascular disease and certain types of cancer.\nStudies have found that cancer patients with type D personalities may have a worse prognosis than those without this personality trait. For example, one study found that patients with type D personalities had a higher risk of death from cancer and a higher risk of recurrence of the cancer compared to those without this personality trait.\nIt is important to note that more research is needed to fully understand the relationship between type D personality and cancer, and it is not yet clear whether type D personality is a cause of cancer or if it is simply a marker of other risk factors. However, it is clear that individuals with type D personalities may be at increased risk for certain health problems, including cancer, and that it may be important for cancer patients to address their negative emotions and social inhibitions in order to improve their overall health and well-being.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Type D personality is characterized by negative affectivity and social inhibition.\n2. Research indicates that individuals with type D personalities may be at higher risk for a variety of health problems, including cardiovascular disease and certain types of cancer.\n3. Cancer patients with type D personalities may have a worse prognosis than those without this personality trait.\n4. Some studies suggest that patients with type D personality have a higher risk of death and recurrence of cancer.\n5. The relationship between type D personality and cancer is not yet fully understood and more research is needed.",
    "vicuna-7b_fact": [
      "Type D personality is characterized by negative affectivity and social inhibition.",
      "Research indicates that individuals with type D personalities may be at higher risk for a variety of health problems, including cardiovascular disease and certain types of cancer.",
      "Cancer patients with type D personalities may have a worse prognosis than those without this personality trait.",
      "Some studies suggest that patients with type D personality have a higher risk of death and recurrence of cancer.",
      "The relationship between type D personality and cancer is not yet fully understood and more research is needed."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1471,
    "user_query": "Which species may be used for the biotechnological production of itaconic acid?",
    "vicuna-7b_response": "Iaconic acid is a versatile chemical compound that can be produced biotechnologically from a variety of microorganisms. Some of the most commonly used species for the biotechnological production of itaconic acid are:\n1. Escherichia coli: This is a widely studied and commonly used bacterial species for biotechnological applications. E. coli can be engineered to produce itaconic acid through metabolic pathways such as the citric acid cycle or the shikimate pathway.\n2. Klebsiella pneumoniae: This bacterium has been shown to produce itaconic acid through the shikimate pathway, which is a common metabolic route for aromatic compound biosynthesis.\n3. Aspergillus terreus: This fungus has been reported to produce itaconic acid through the shikimate pathway, making it a promising candidate for biotechnological production.\n4. Aspergillus niger: This fungus has also been shown to produce itaconic acid through the shikimate pathway, making it a potential candidate for industrial-scale production.\nIt is important to note that the choice of microorganism for itaconic acid production depends on various factors, such as the desired product titer, productivity, and the availability of genetic tools and resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Itaconic acid is a chemical compound that can be produced biotechnologically from a variety of microorganisms.\n2. Escherichia coli is a bacterial species used for the biotechnological production of itaconic acid. \n3. Klebsiella pneumoniae is known to produce itaconic acid through the shikimate pathway.\n4. Itaconic acid can be produced through the shikimate pathway by a fungus called Aspergillus terreus.\n5. Aspergillus niger is a fungus that has been shown to produce itaconic acid through the shikimate pathway.",
    "vicuna-7b_fact": [
      "Itaconic acid is a chemical compound that can be produced biotechnologically from a variety of microorganisms.",
      "Escherichia coli is a bacterial species used for the biotechnological production of itaconic acid.",
      "Klebsiella pneumoniae is known to produce itaconic acid through the shikimate pathway.",
      "Itaconic acid can be produced through the shikimate pathway by a fungus called Aspergillus terreus.",
      "Aspergillus niger is a fungus that has been shown to produce itaconic acid through the shikimate pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Klebsiella pneumoniae isn't generally known to produce itaconic acid, and the shikimate pathway isn't involved in itaconic acid production.\n4. TRUE\n5. FALSE [correction]: Aspergillus niger is a fungus that has been shown to produce itaconic acid, but not specifically through the shikimate pathway.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1474,
    "user_query": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
    "vicuna-7b_response": "The methyl-directed mismatch repair system (MMR) in bacteria is a complex system that involves several proteins. The main proteins that constitute the MMR system in bacteria are:\n1. MutS: This is the primary mismatch repair protein in bacteria. It recognizes and binds to mismatched base pairs in DNA.\n2. MutL: This protein acts as a scaffold for the assembly of the MMR complex. It also helps to recruit other MMR proteins to the site of the mismatch.\n3. MutH: This protein helps to stabilize the MutS-MutL complex and enhances the binding of MutS to mismatched base pairs.\n4. MshA: This protein is involved in the recognition of methylated guanine residues in DNA. It helps to identify and repair methylation-induced mismatches.\n5. MshB: This protein is involved in the recognition of methylated cytosine residues in DNA. It helps to identify and repair methylation-induced mismatches.\nThese proteins work together to identify and repair mismatches in DNA, which helps to maintain the integrity of the genome and prevent mutations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Methyl-directed Mismatch Repair system (MMR) in bacteria involves several proteins.\n2. MutS is the primary mismatch repair protein in bacteria and it recognizes and binds to mismatched base pairs in DNA.\n3. MutL acts as a scaffold for the assembly of the MMR complex and recruits other MMR proteins to the site of the mismatch.\n4. MutH helps to stabilize the MutS-MutL complex and enhances the binding of MutS to mismatched base pairs.\n5. MshA is involved in the recognition of methylated guanine residues in DNA and helps to identify and repair methylation-induced mismatches.\n6. MshB is involved in the recognition of methylated cytosine residues in DNA and helps to identify and repair methylation-induced mismatches.",
    "vicuna-7b_fact": [
      "Methyl-directed Mismatch Repair system (MMR) in bacteria involves several proteins.",
      "MutS is the primary mismatch repair protein in bacteria and it recognizes and binds to mismatched base pairs in DNA.",
      "MutL acts as a scaffold for the assembly of the MMR complex and recruits other MMR proteins to the site of the mismatch.",
      "MutH helps to stabilize the MutS-MutL complex and enhances the binding of MutS to mismatched base pairs.",
      "MshA is involved in the recognition of methylated guanine residues in DNA and helps to identify and repair methylation-induced mismatches.",
      "MshB is involved in the recognition of methylated cytosine residues in DNA and helps to identify and repair methylation-induced mismatches."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MutH, not involved in stabilizing the MutS-MutL complex. Instead, it introduces a nick in the newly synthesized DNA strand at the GATC sequence.\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1476,
    "user_query": "Which is the vector of Louping ill virus?",
    "vicuna-7b_response": "The vector of the Louping ill virus is the tick species, Ixodes ricinus.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The vector of the Louping ill virus is the tick species, Ixodes ricinus.",
    "vicuna-7b_fact": [
      "The vector of the Louping ill virus is the tick species, Ixodes ricinus."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-7b_response": "Yes, the HU Antisense RNA (HuR) protein has been shown to regulate the splicing process. HuR is a nuclear protein that binds to messenger RNA (mRNA) and regulates the stability and translation of mRNAs, including those involved in splicing.\nHuR has been shown to interact with a variety of splicing factors, including the splicing factor SF2/ASF, which is involved in the recognition of exons and the recruitment of splicing complexes to the splice site. By binding to SF2/ASF, HuR may help to stabilize the splicing complex and promote the efficient recognition and splicing of exons.\nIn addition, HuR has been shown to interact with the splicing factor SC35, which is involved in the formation of the spliceosome, the complex that catalyzes the splicing reaction. By binding to SC35, HuR may help to recruit the spliceosome to the splice site and promote the efficient recognition and splicing of exons.\nOverall, the interaction of HuR with splicing factors suggests that HuR plays a critical role in the regulation of the splicing process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. HuR protein regulates the splicing process.\n2. HuR is a nuclear protein that binds to messenger RNA.\n3. HuR regulates the stability and translation of mRNAs, including those involved in splicing.\n4. HuR interacts with the splicing factor SF2/ASF, which is involved in the recognition of exons and the recruitment of splicing complexes to the splice site.\n5. HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome.",
    "vicuna-7b_fact": [
      "HuR protein regulates the splicing process.",
      "HuR is a nuclear protein that binds to messenger RNA.",
      "HuR regulates the stability and translation of mRNAs, including those involved in splicing.",
      "HuR interacts with the splicing factor SF2/ASF, which is involved in the recognition of exons and the recruitment of splicing complexes to the splice site.",
      "HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: HuR protein does not regulate the splicing process. Rather, it regulates mRNA stability and translation.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1478,
    "user_query": "Is Titin the largest single protein molecule found in Nature?",
    "vicuna-7b_response": "Yes, Titin is the largest single protein molecule found in nature. Titin is a protein found in muscle cells that plays a crucial role in muscle contraction and is responsible for maintaining the elasticity of muscle fibers. It is composed of many repetitive units called repeats, which are made up of a series of amino acids. The size of Titin can vary depending on the species, but in humans, it is estimated to be around 300 million atoms. This makes it the largest known protein molecule in nature.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Titin is the largest single protein molecule found in nature.\n2. Titin is a protein found in muscle cells.\n3. Titin plays a crucial role in muscle contraction and maintains the elasticity of muscle fibers.\n4. Titin is composed of many repetitive units called repeats, which are made up of a series of amino acids.\n5. In humans, Titin is estimated to be around 300 million atoms.",
    "vicuna-7b_fact": [
      "Titin is the largest single protein molecule found in nature.",
      "Titin is a protein found in muscle cells.",
      "Titin plays a crucial role in muscle contraction and maintains the elasticity of muscle fibers.",
      "Titin is composed of many repetitive units called repeats, which are made up of a series of amino acids.",
      "In humans, Titin is estimated to be around 300 million atoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1481,
    "user_query": "What is the the Menzerath-Altmann law?",
    "vicuna-7b_response": "The Menzerath-Altmann law, also known as the Menzerath-Altmann-Exner law, is a statistical principle that describes the distribution of syllable types in natural languages. It states that the frequency of a syllable type in a language is proportional to the logarithm of the number of words containing that syllable type.\nIn other words, the Menzerath-Altmann law states that the probability of encountering a certain type of syllable in a language is inversely proportional to the number of words containing that syllable type. This means that rare syllable types are more likely to appear in longer words, while common syllable types are more likely to appear in shorter words.\nThe Menzerath-Altmann law is named after its two discoverers, German linguists Ernst Menzerath and Wilhelm Altmann, and Austrian linguist Ludwig Exner, who independently developed the principle in the early 20th century. The law has been widely used in linguistics to analyze the structure of languages and to compare the syllable patterns of different languages.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Menzerath-Altmann law describes the distribution of syllable types in natural languages.\n2. According to the Menzerath-Altmann law, the frequency of a syllable type in a language is proportional to the logarithm of the number of words containing that syllable type.\n3. The Menzerath-Altmann law implies that rare syllable types tend to appear more in longer words, while more common syllable types appear more in shorter words.\n4. The Menzerath-Altmann law is named after linguists Ernst Menzerath, Wilhelm Altmann, and Ludwig Exner.\n5. This law is used in linguistics to analyze the structure of languages and to compare the syllable patterns of different languages.",
    "vicuna-7b_fact": [
      "The Menzerath-Altmann law describes the distribution of syllable types in natural languages.",
      "According to the Menzerath-Altmann law, the frequency of a syllable type in a language is proportional to the logarithm of the number of words containing that syllable type.",
      "The Menzerath-Altmann law implies that rare syllable types tend to appear more in longer words, while more common syllable types appear more in shorter words.",
      "The Menzerath-Altmann law is named after linguists Ernst Menzerath, Wilhelm Altmann, and Ludwig Exner.",
      "This law is used in linguistics to analyze the structure of languages and to compare the syllable patterns of different languages."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Menzerath-Altmann law describes the phenomenon that the larger the linguistic construct, the shorter its constituents tend to be.\n2. FALSE [correction]: The Menzerath-Altmann law doesn't describe the frequency of a syllable type in relation to the logarithm of the number of words containing that syllable type. Instead, it talks about the length of constituents in relation to the length of the whole.\n3. TRUE\n4. FALSE [correction]: The Menzerath-Altmann law is named after linguists Paul Menzerath and Gabriel Altmann.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1482,
    "user_query": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?",
    "vicuna-7b_response": "Lysosomal hydrolases are enzymes that are produced and stored in lysosomes and are responsible for breaking down various macromolecules, such as proteins, carbohydrates, and lipids. These enzymes are transported from the endoplasmic reticulum (ER) to the trans-Golgi network (TGN) for packaging and transport to their final destination.\nThere are several receptors that recognize lysosomal hydrolases in the TGN. One of the main receptors is the mannose 6-phosphate receptor (MPR). The MPR is a type I transmembrane protein that is expressed on the TGN and is responsible for recognizing and transporting lysosomal hydrolases that are modified with mannose 6-phosphate (Man-6-P). Man-6-P is a sugar molecule that is attached to the hydroxyl group of asparagine residues in certain lysosomal hydrolases, such as chondroitinase AC and chondroitinase ABC.\nIn addition to the MPR, there are other receptors that recognize lysosomal hydrolases in the TGN, such as the sortilin receptor and the cubilin receptor. These receptors recognize different types of ligands, such as sialic acid and cubilin, respectively, and are involved in the transport of lysosomal hydrolases to different destinations.\nOverall, the recognition and transport of lysosomal hydrolases in the TGN is a complex process that involves multiple receptors and pathways. The specific receptors that recognize lysosomal hydrolases in the TGN can vary depending on the type of hydrolase and its modification state.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Lysosomal hydrolases are enzymes stored in lysosomes that break down various macromolecules.\n2. These enzymes are transported from the endoplasmic reticulum (ER) to the trans-Golgi network (TGN) for packaging and transport to their final destination.\n3. One of the main receptors that recognize lysosomal hydrolases in the TGN is the mannose 6-phosphate receptor (MPR).\n4. MPR is a type I transmembrane protein that is expressed on the TGN and is responsible for recognizing and transporting lysosomal hydrolases modified with mannose 6-phosphate.\n5. There are other receptors like the sortilin receptor and the cubilin receptor that recognize lysosomal hydrolases in the TGN and are involved in transport of lysosomal hydrolases to different destinations.",
    "vicuna-7b_fact": [
      "Lysosomal hydrolases are enzymes stored in lysosomes that break down various macromolecules.",
      "These enzymes are transported from the endoplasmic reticulum (ER) to the trans-Golgi network (TGN) for packaging and transport to their final destination.",
      "One of the main receptors that recognize lysosomal hydrolases in the TGN is the mannose 6-phosphate receptor (MPR).",
      "MPR is a type I transmembrane protein that is expressed on the TGN and is responsible for recognizing and transporting lysosomal hydrolases modified with mannose 6-phosphate.",
      "There are other receptors like the sortilin receptor and the cubilin receptor that recognize lysosomal hydrolases in the TGN and are involved in transport of lysosomal hydrolases to different destinations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-7b_response": "Prothymosin alpha (PTMA) is a protein that plays a crucial role in the development and function of the thymus gland. The c-terminal peptide of PTMA, which is the part of the protein that is located at the end of the protein chain, has several known functions.\nOne of the known functions of the c-terminal peptide of PTMA is its ability to bind to and regulate the activity of other proteins. This binding can affect the activity of proteins involved in the development and maturation of T cells, which are a type of immune cell that is produced in the thymus gland.\nAnother known function of the c-terminal peptide of PTMA is its ability to regulate the expression of certain genes. This regulation can affect the production of proteins involved in the development and maturation of T cells, as well as the production of other proteins involved in the immune response.\nIn addition to its role in the development and function of the immune system, the c-terminal peptide of PTMA has also been shown to have a role in the regulation of cell growth and division. This regulation can affect the growth and division of T cells and other types of cells, and may play a role in the development of certain types of cancer.\nOverall, the c-terminal peptide of PTMA is a complex and multifunctional protein that plays a critical role in the development and function of the immune system, as well as in the regulation of cell growth and division.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prothymosin alpha (PTMA) is a protein involved in the development and function of the thymus gland.\n2. The c-terminal peptide of PTMA can bind to and regulate the activity of other proteins.\n3. PTMA's c-terminal peptide is involved in the development and maturation of T cells.\n4. The c-terminal peptide of PTMA is capable of regulating the expression of certain genes.\n5. PTMA's c-terminal peptide has a role in the regulation of cell growth and division and may influence the development of certain types of cancer.",
    "vicuna-7b_fact": [
      "Prothymosin alpha (PTMA) is a protein involved in the development and function of the thymus gland.",
      "The c-terminal peptide of PTMA can bind to and regulate the activity of other proteins.",
      "PTMA's c-terminal peptide is involved in the development and maturation of T cells.",
      "The c-terminal peptide of PTMA is capable of regulating the expression of certain genes.",
      "PTMA's c-terminal peptide has a role in the regulation of cell growth and division and may influence the development of certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1494,
    "user_query": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
    "vicuna-7b_response": "The Ada O6-alkylguanine alkyltransferase (AGT) is an enzyme that plays a crucial role in bacteria. It is responsible for repairing DNA damage caused by alkylating agents, which are chemicals that can damage DNA by adding alkyl groups to guanine bases.\nIn bacteria, AGT is a key enzyme in the nucleotide excision repair (NER) pathway, which is responsible for repairing DNA damage caused by a variety of agents, including alkylating agents. The NER pathway works by removing the damaged DNA strand and replacing it with a undamaged one.\nAGT is an important enzyme in the NER pathway because it is responsible for removing the alkyl groups from the damaged guanine base and replacing it with a undamaged base. This process is called alkyltransferase activity.\nIn summary, the Ada O6-alkylguanine alkyltransferase plays a crucial role in bacteria by repairing DNA damage caused by alkylating agents through the nucleotide excision repair pathway.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ada O6-alkylguanine alkyltransferase (AGT) is an enzyme present in bacteria.\n2. AGT is responsible for repairing DNA damage caused by alkylating agents.\n3. Alkylating agents can damage DNA by adding alkyl groups to guanine bases.\n4. In bacteria, AGT is a key enzyme in the nucleotide excision repair (NER) pathway.\n5. Ada O6-alkylguanine alkyltransferase removes the alkyl groups from the damaged guanine base and replaces it with an undamaged base in a process called alkyltransferase activity.",
    "vicuna-7b_fact": [
      "Ada O6-alkylguanine alkyltransferase (AGT) is an enzyme present in bacteria.",
      "AGT is responsible for repairing DNA damage caused by alkylating agents.",
      "Alkylating agents can damage DNA by adding alkyl groups to guanine bases.",
      "In bacteria, AGT is a key enzyme in the nucleotide excision repair (NER) pathway.",
      "Ada O6-alkylguanine alkyltransferase removes the alkyl groups from the damaged guanine base and replaces it with an undamaged base in a process called alkyltransferase activity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In bacteria, AGT is a key enzyme in the direct repair pathway, not the nucleotide excision repair (NER) pathway.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1503,
    "user_query": "Which is the clinical meaning of the presence of delayed enhancement in patients with hypertrophic cardiomyopathy?",
    "vicuna-7b_response": "The presence of delayed enhancement on cardiac magnetic resonance (CMR) imaging in patients with hypertrophic cardiomyopathy (HCM) is a marker of myocardial fibrosis and is associated with an increased risk of adverse outcomes such as heart failure and sudden cardiac death.\nHypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and leads to an abnormal thickening of the heart muscle. This thickening can cause the heart to become stiff and less able to pump blood effectively. Delayed enhancement is a CMR technique that measures the accumulation of water in the heart muscle after a contrast agent is injected. When myocardial fibrosis is present, the contrast agent is delayed in entering the fibrotic tissue, resulting in a delayed enhancement signal on the CMR image.\nThe presence of delayed enhancement in HCM has been shown to be a strong predictor of adverse outcomes, including heart failure and sudden cardiac death. It is therefore an important marker for identifying patients who may benefit from more aggressive treatment, such as medications to reduce fibrosis or implantable cardioverter-defibrillators to prevent sudden death.\nIn summary, the presence of delayed enhancement on CMR in patients with HCM is a marker of myocardial fibrosis and is associated with an increased risk of adverse outcomes. It is an important tool for identifying patients who may benefit from more aggressive treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The presence of delayed enhancement on cardiac magnetic resonance (CMR) imaging in patients with hypertrophic cardiomyopathy (HCM) is a marker of myocardial fibrosis.\n2. Delayed enhancement is associated with an increased risk of heart failure and sudden cardiac death in patients with HCM.\n3. Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and leads to an abnormal thickening of the heart muscle.\n4. Delayed enhancement is a CMR technique that measures the accumulation of water in the heart muscle after a contrast agent is injected.\n5. The presence of delayed enhancement in HCM has proven to be a crucial predictor of adverse outcomes, including heart failure and sudden cardiac death.",
    "vicuna-7b_fact": [
      "The presence of delayed enhancement on cardiac magnetic resonance (CMR) imaging in patients with hypertrophic cardiomyopathy (HCM) is a marker of myocardial fibrosis.",
      "Delayed enhancement is associated with an increased risk of heart failure and sudden cardiac death in patients with HCM.",
      "Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and leads to an abnormal thickening of the heart muscle.",
      "Delayed enhancement is a CMR technique that measures the accumulation of water in the heart muscle after a contrast agent is injected.",
      "The presence of delayed enhancement in HCM has proven to be a crucial predictor of adverse outcomes, including heart failure and sudden cardiac death."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Delayed enhancement is a CMR technique that measures the accumulation of contrast agent in heart muscle, which may indicate fibrosis or scarring.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1509,
    "user_query": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?",
    "vicuna-7b_response": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.\nAlpha-spectrin and beta-spectrin are two types of spectrin proteins that are found in the plasma membrane of cells. These proteins are responsible for forming a structural scaffold that helps to maintain the integrity of the plasma membrane. They do this by forming heterodimers, which are complexes made up of two different types of proteins that work together to perform a specific function.\nIn the case of alpha-spectrin and beta-spectrin, the two proteins form an antiparallel heterodimer. This means that the alpha-spectrin subunit is oriented in one direction, while the beta-spectrin subunit is oriented in the opposite direction. This orientation allows the two subunits to interact with each other in a way that helps to stabilize the plasma membrane.\nOverall, the formation of antiparallel heterodimers between alpha-spectrin and beta-spectrin subunits is an important aspect of the structure and function of the plasma membrane in cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alpha-spectrin and beta-spectrin are two types of spectrin proteins that are found in the plasma membrane of cells.\n2. These spectrin proteins form a structural scaffold that helps maintain the integrity of the plasma membrane.\n3. Alpha-spectrin and beta-spectrin form heterodimers.\n4. In terms of orientation, the alpha-spectrin subunit and the beta-spectrin subunit are in opposite directions which is described as an antiparallel heterodimer.\n5. The formation of antiparallel heterodimers between alpha-spectrin and beta-spectrin subunits is part of the structure and function of the plasma membrane in cells.",
    "vicuna-7b_fact": [
      "Alpha-spectrin and beta-spectrin are two types of spectrin proteins that are found in the plasma membrane of cells.",
      "These spectrin proteins form a structural scaffold that helps maintain the integrity of the plasma membrane.",
      "Alpha-spectrin and beta-spectrin form heterodimers.",
      "In terms of orientation, the alpha-spectrin subunit and the beta-spectrin subunit are in opposite directions which is described as an antiparallel heterodimer.",
      "The formation of antiparallel heterodimers between alpha-spectrin and beta-spectrin subunits is part of the structure and function of the plasma membrane in cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1510,
    "user_query": "Is gastro esophageal reflux related to burning mouth syndrome?",
    "vicuna-7b_response": "Gastroesophageal reflux disease (GERD) and burning mouth syndrome (BMS) are two separate conditions that can have some overlapping symptoms, but they are not the same condition.\nGERD is a condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn, regurgitation, and difficulty swallowing. GERD is typically treated with lifestyle changes, such as eating smaller meals, avoiding certain trigger foods and beverages, and losing weight, as well as medications to reduce stomach acid production.\nBMS, on the other hand, is a chronic or recurrent burning sensation in the mouth that is not related to any identifiable cause. It can affect the tongue, lips, gums, and other areas of the mouth, and it is often described as feeling like a burning sensation, tingling, itching, or pain. BMS can be difficult to diagnose and treat, and there is no specific medication that is used to treat it.\nWhile GERD and BMS can have some overlapping symptoms, such as a burning sensation in the mouth, they are not the same condition. GERD is caused by stomach acid flowing back up into the esophagus, while BMS is a condition that is not well understood and is not caused by stomach acid. If you are experiencing symptoms of GERD or BMS, it is important to speak with a healthcare provider to determine the underlying cause and appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gastroesophageal reflux disease (GERD) is a condition where stomach acid flows back up into the esophagus.\n2. Symptoms of GERD include heartburn, regurgitation, and difficulty swallowing.\n3. The typical treatment for GERD includes lifestyle changes and medications to reduce stomach acid production.\n4. Burning mouth syndrome (BMS) is a chronic or recurrent burning sensation in the mouth that is not related to any identifiable cause.\n5. GERD and BMS are not the same condition.",
    "vicuna-7b_fact": [
      "Gastroesophageal reflux disease (GERD) is a condition where stomach acid flows back up into the esophagus.",
      "Symptoms of GERD include heartburn, regurgitation, and difficulty swallowing.",
      "The typical treatment for GERD includes lifestyle changes and medications to reduce stomach acid production.",
      "Burning mouth syndrome (BMS) is a chronic or recurrent burning sensation in the mouth that is not related to any identifiable cause.",
      "GERD and BMS are not the same condition."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1511,
    "user_query": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?",
    "vicuna-7b_response": "The Vel blood group is a type of blood group system that is characterized by the presence of certain antigens on the surface of red blood cells. One of the antigens that is targeted by anti-Vel antibodies is called the Vel antigen.\nThe Vel antigen is a type of carbohydrate antigen that is found on the surface of red blood cells in individuals with the Vel blood group. Anti-Vel antibodies are produced by the body's immune system in response to the presence of the Vel antigen on the surface of red blood cells.\nAnti-Vel antibodies can cause a variety of problems, including hemolytic anemia, which is a condition in which the red blood cells are destroyed prematurely. In some cases, the presence of anti-Vel antibodies can also cause other health problems, such as jaundice and kidney disease.\nIt is important to note that the presence of anti-Vel antibodies does not necessarily indicate a problem. In many cases, the body produces these antibodies as a normal part of its immune response. However, in some cases, the presence of anti-Vel antibodies may indicate an underlying medical condition that requires treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Vel blood group is characterized by the presence of certain antigens on the surface of red blood cells.\n2. The Vel antigen is a type of carbohydrate antigen found on the surface of red blood cells in individuals with the Vel blood group.\n3. Anti-Vel antibodies target the Vel antigen.\n4. Presence of anti-Vel antibodies can lead to complications like hemolytic anemia, jaundice, and kidney disease.\n5. The body's immune system produces anti-Vel antibodies.",
    "vicuna-7b_fact": [
      "The Vel blood group is characterized by the presence of certain antigens on the surface of red blood cells.",
      "The Vel antigen is a type of carbohydrate antigen found on the surface of red blood cells in individuals with the Vel blood group.",
      "Anti-Vel antibodies target the Vel antigen.",
      "Presence of anti-Vel antibodies can lead to complications like hemolytic anemia, jaundice, and kidney disease.",
      "The body's immune system produces anti-Vel antibodies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Vel antigen is a type of protein, not carbohydrate, found on the surface of red blood cells in individuals with the Vel blood group.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-7b_response": "Cystatin C is a cysteine protease inhibitor that is found in various tissues and fluids in the human body. It is a small protein that is composed of 126 amino acids and is involved in regulating the activity of proteases, which are enzymes that break down other proteins.\nThere are several peptides that have been identified as playing a role in the fibrillization of cystatin C. One of these is the C-terminal peptide, which is located at the end of the protein and is composed of 12 amino acids. This peptide has been shown to be important for the formation of fibrils, which are the aggregates of cystatin C that are responsible for its fibrillization.\nOther peptides that have been implicated in cystatin C fibrillization include the N-terminal peptide, which is located at the beginning of the protein, and the middle peptide, which is located in the middle of the protein. These peptides may also play a role in the formation of fibrils, although their exact functions are not yet fully understood.\nOverall, the C-terminal peptide is one of the peptides that plays a pivotal role in human cystatin C fibrillization.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.\n2. Cystatin C is a small protein composed of 126 amino acids.\n3. The protein is involved in regulating the activity of proteases.\n4. The C-terminal peptide, composed of 12 amino acids, plays a pivotal role in human cystatin C fibrillization.\n5. The N-terminal and middle peptides have been implicated in cystatin C fibrillization.",
    "vicuna-7b_fact": [
      "Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.",
      "Cystatin C is a small protein composed of 126 amino acids.",
      "The protein is involved in regulating the activity of proteases.",
      "The C-terminal peptide, composed of 12 amino acids, plays a pivotal role in human cystatin C fibrillization.",
      "The N-terminal and middle peptides have been implicated in cystatin C fibrillization."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The N-terminal and middle region of cystatin C has not been directly implicated in cystatin C fibrillization. It's the C-terminal, not the N-terminal and middle peptides, that play a pivotal role.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1518,
    "user_query": "What is the use of MammaPrint and Oncotype DX?",
    "vicuna-7b_response": "MammaPrint and Oncotype DX are two different tests that are used to help determine the risk of recurrence of breast cancer in women who have been diagnosed with the disease.\nMammaPrint is a genomic test that analyzes the expression of 70 genes in breast cancer tumors. The test is used to predict the risk of recurrence of breast cancer in women who have been diagnosed with the disease. The test is typically used for women who have been diagnosed with early-stage breast cancer and are considering surgery as part of their treatment. The test can help doctors determine whether a woman is at high risk of recurrence and may need more aggressive treatment, such as chemotherapy, or whether she is at low risk and may be able to avoid chemotherapy.\nOncotype DX is a genomic test that analyzes the expression of 21 genes in breast cancer tumors. The test is used to predict the risk of recurrence of breast cancer in women who have been diagnosed with the disease. The test is typically used for women who have been diagnosed with early-stage breast cancer and are considering surgery as part of their treatment. The test can help doctors determine whether a woman is at high risk of recurrence and may need more aggressive treatment, such as chemotherapy, or whether she is at low risk and may be able to avoid chemotherapy.\nIt's important to note that these tests are not used to diagnose breast cancer, but rather to help determine the risk of recurrence in women who have already been diagnosed with the disease. The results of these tests should be discussed with a doctor to determine the best course of treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MammaPrint and Oncotype DX are tests used to determine the risk of recurrence of breast cancer in diagnosed women.\n2. MammaPrint is a genomic test that analyzes the expression of 70 genes in breast cancer tumors.\n3. Oncotype DX is a genomic test that analyzes the expression of 21 genes in breast cancer tumors.\n4. These tests are typically used for women who have been diagnosed with early-stage breast cancer and are considering surgery as part of their treatment.\n5. These tests are not used to diagnose breast cancer, but rather to help determine the risk of recurrence in women who have already been diagnosed with the disease.",
    "vicuna-7b_fact": [
      "MammaPrint and Oncotype DX are tests used to determine the risk of recurrence of breast cancer in diagnosed women.",
      "MammaPrint is a genomic test that analyzes the expression of 70 genes in breast cancer tumors.",
      "Oncotype DX is a genomic test that analyzes the expression of 21 genes in breast cancer tumors.",
      "These tests are typically used for women who have been diagnosed with early-stage breast cancer and are considering surgery as part of their treatment.",
      "These tests are not used to diagnose breast cancer, but rather to help determine the risk of recurrence in women who have already been diagnosed with the disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1520,
    "user_query": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?",
    "vicuna-7b_response": "There is limited research on the use of TRH (thyrotropin releasing hormone) in the treatment of amyotrophic lateral sclerosis (ALS). However, some studies have suggested that TRH may have potential therapeutic benefits in ALS.\nOne study published in the journal Neurology in 2012 found that TRH administration improved muscle strength and function in a small group of ALS patients. The study suggested that TRH may have a neuroprotective effect in ALS by reducing inflammation and promoting muscle regeneration.\nAnother study published in the journal Neurobiology of Disease in 2015 found that TRH administration improved motor function and reduced inflammation in a mouse model of ALS. The study suggested that TRH may have potential as a treatment for ALS by targeting the underlying pathology of the disease.\nWhile these studies are promising, more research is needed to fully understand the potential benefits of TRH in ALS. It is also important to note that TRH is not currently approved for the treatment of ALS, and its use in this context should be discussed with a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Some studies have suggested that thyrotropin releasing hormone (TRH) may have potential therapeutic benefits in amyotrophic lateral sclerosis (ALS).\n2. A 2012 study published in the journal Neurology found that TRH improved muscle strength and function in a small group of ALS patients.\n3. The 2012 study suggested TRH may have a neuroprotective effect in ALS by reducing inflammation and promoting muscle regeneration.\n4. A 2015 study published in the journal Neurobiology of Disease found that TRH administration improved motor function and reduced inflammation in a mouse model of ALS.\n5. TRH is not currently approved for the treatment of ALS.",
    "vicuna-7b_fact": [
      "Some studies have suggested that thyrotropin releasing hormone (TRH) may have potential therapeutic benefits in amyotrophic lateral sclerosis (ALS).",
      "A 2012 study published in the journal Neurology found that TRH improved muscle strength and function in a small group of ALS patients.",
      "The 2012 study suggested TRH may have a neuroprotective effect in ALS by reducing inflammation and promoting muscle regeneration.",
      "A 2015 study published in the journal Neurobiology of Disease found that TRH administration improved motor function and reduced inflammation in a mouse model of ALS.",
      "TRH is not currently approved for the treatment of ALS."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1524,
    "user_query": "What is the gold standard treatment for Iatrogenic male incontinence?",
    "vicuna-7b_response": "Iatrogenic male incontinence refers to incontinence that is caused by medical treatment or procedures. The gold standard treatment for iatrogenic male incontinence is surgery.\nThere are several types of surgical procedures that can be used to treat iatrogenic male incontinence, including:\n1. Sling procedures: A sling procedure involves placing a mesh or other material under the urethra to support it and prevent leakage.\n2. Artificial urinary sphincter (AUS) implantation: An AUS is a device that is placed around the urethra to help control urinary leakage.\n3. Bulking agents: A bulking agent, such as collagen or fat, can be injected into the urethra to improve its strength and prevent leakage.\n4. Neuro-urethral reconstruction: This procedure involves repairing or reconstructing the nerves and muscles that control the urinary sphincter to improve urinary control.\nIt is important to note that the most appropriate surgical procedure for iatrogenic male incontinence will depend on the specific cause of the incontinence and the individual patient's needs and preferences. It is best to consult with a urologist or other healthcare professional to determine the most appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Iatrogenic male incontinence refers to incontinence caused by medical treatment or procedures.\n2. The gold standard treatment for iatrogenic male incontinence is surgery.\n3. Sling procedures are a type of surgery used to treat iatrogenic male incontinence, and involve placing a mesh or other material under the urethra to prevent leakage.\n4. Artificial Urinary Sphincter (AUS) implantation is another surgical procedure for iatrogenic male incontinence that involves placing a device around the urethra to control urinary leakage.\n5. Involved in the surgical procedures for the treatment of iatrogenic male incontinence is the use of bulking agents – substances like collagen or fat that are injected into the urethra to improve its strength and prevent leakage.",
    "vicuna-7b_fact": [
      "Iatrogenic male incontinence refers to incontinence caused by medical treatment or procedures.",
      "The gold standard treatment for iatrogenic male incontinence is surgery.",
      "Sling procedures are a type of surgery used to treat iatrogenic male incontinence, and involve placing a mesh or other material under the urethra to prevent leakage.",
      "Artificial Urinary Sphincter (AUS) implantation is another surgical procedure for iatrogenic male incontinence that involves placing a device around the urethra to control urinary leakage.",
      "Involved in the surgical procedures for the treatment of iatrogenic male incontinence is the use of bulking agents – substances like collagen or fat that are injected into the urethra to improve its strength and prevent leakage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: While surgery is a treatment option for iatrogenic male incontinence, it is not the only treatment and thus not considered the \"gold standard\". Therapies can also include pelvic floor exercises, continence products, medications and behavioral changes or combinations of these methods.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1525,
    "user_query": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?",
    "vicuna-7b_response": "The main CHEK2 genetic variant that is thought to be involved in familial breast cancer is the 1100delC variant. This variant results in a frameshift mutation that leads to the production of a non-functional protein, which can increase the risk of breast cancer. The 1100delC variant is the most common CHEK2 variant associated with an increased risk of breast cancer, and it has been identified in many families with a history of breast cancer. Other CHEK2 variants have also been associated with an increased risk of breast cancer, but the 1100delC variant is the most well-established.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The main CHEK2 genetic variant thought to be involved in familial breast cancer is the 1100delC variant.\n2. The 1100delC variant results in a frameshift mutation.\n3. The 1100delC variant can increase the risk of breast cancer.\n4. The 1100delC variant is the most common CHEK2 variant associated with an increased risk of breast cancer.\n5. Other CHEK2 variants have also been associated with an increased risk of breast cancer.",
    "vicuna-7b_fact": [
      "The main CHEK2 genetic variant thought to be involved in familial breast cancer is the 1100delC variant.",
      "The 1100delC variant results in a frameshift mutation.",
      "The 1100delC variant can increase the risk of breast cancer.",
      "The 1100delC variant is the most common CHEK2 variant associated with an increased risk of breast cancer.",
      "Other CHEK2 variants have also been associated with an increased risk of breast cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1535,
    "user_query": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
    "vicuna-7b_response": "Yes, immune cells are affected in Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and eventual paralysis.\nResearch has shown that immune cells, such as T cells and macrophages, are involved in the pathogenesis of ALS. These immune cells are thought to contribute to the degeneration of motor neurons, which are the nerve cells that control muscle movement.\nIn addition, studies have shown that the immune system is activated in ALS patients, leading to an overproduction of certain immune cells, such as T cells and macrophages. This activation of the immune system may contribute to the progression of the disease.\nOverall, the involvement of immune cells in ALS suggests that immune modulation therapies may be a promising approach for treating this disease. However, more research is needed to fully understand the role of immune cells in ALS and to develop effective treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Immune cells are affected in Amyotrophic Lateral Sclerosis (ALS).\n2. Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n3. In ALS, immune cells such as T cells and macrophages contribute to the degeneration of motor neurons.\n4. Studies indicate that the immune system is activated in ALS patients, leading to an overproduction of certain immune cells.\n5. Immune modulation therapies may be a promising approach for treating ALS.",
    "vicuna-7b_fact": [
      "Immune cells are affected in Amyotrophic Lateral Sclerosis (ALS).",
      "Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "In ALS, immune cells such as T cells and macrophages contribute to the degeneration of motor neurons.",
      "Studies indicate that the immune system is activated in ALS patients, leading to an overproduction of certain immune cells.",
      "Immune modulation therapies may be a promising approach for treating ALS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1537,
    "user_query": "What is the mechanism of action of eprotirome?",
    "vicuna-7b_response": "Eprotirome is a drug that is used to treat fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by the abnormal formation of bone in the body. The mechanism of action of eprotirome is not fully understood, but it is believed to work by inhibiting the activity of a protein called transforming growth factor-beta (TGF-beta).\nTGF-beta is a protein that plays a key role in the development and maintenance of bone. In people with FOP, the overproduction of TGF-beta leads to the abnormal formation of bone, resulting in the accumulation of fibrous tissue and the restriction of movement. Eprotirome is thought to work by blocking the activity of TGF-beta, which helps to reduce the formation of bone and fibrous tissue, and improve the movement of people with FOP.\nIt is important to note that the exact mechanism of action of eprotirome is not fully understood, and further research is needed to fully understand how the drug works. Additionally, eprotirome is not a cure for FOP, and it is used as a treatment to help manage the symptoms of the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eprotirome is a drug used to treat fibrodysplasia ossificans progressiva (FOP).\n2. The mechanism of action of eprotirome is believed to work by inhibiting the activity of a protein called transforming growth factor-beta (TGF-beta).\n3. TGF-beta plays a key role in the development and maintenance of bone.\n4. Overproduction of TGF-beta in people with FOP leads to the abnormal formation of bone and fibrous tissue.\n5. Eprotirome is not a cure for FOP, it's used as a treatment to help manage the symptoms of the disease.",
    "vicuna-7b_fact": [
      "Eprotirome is a drug used to treat fibrodysplasia ossificans progressiva (FOP).",
      "The mechanism of action of eprotirome is believed to work by inhibiting the activity of a protein called transforming growth factor-beta (TGF-beta).",
      "TGF-beta plays a key role in the development and maintenance of bone.",
      "Overproduction of TGF-beta in people with FOP leads to the abnormal formation of bone and fibrous tissue.",
      "Eprotirome is not a cure for FOP, it's used as a treatment to help manage the symptoms of the disease."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Eprotirome is a drug designed for cholesterol management, not directly for fibrodysplasia ossificans progressiva (FOP).\n2. FALSE [correction]: Eprotirome works by modulating thyroid hormone receptors to reduce cholesterol, not by inhibiting TGF-beta.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Eprotirome has not been established or approved as a treatment to manage symptoms of FOP. It is utilized in cholesterol management.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1541,
    "user_query": "What is GDF10?",
    "vicuna-7b_response": "GDF10, also known as growth differentiation factor 10, is a protein that plays a crucial role in regulating cell growth and differentiation. It is a member of the transforming growth factor beta (TGF-beta) superfamily of proteins, which includes other important signaling molecules such as TGF-beta and bone morphogenetic proteins (BMPs).\nGDF10 is primarily expressed in various tissues, including the heart, skeletal muscle, and kidney, and has been shown to play a role in the development and maintenance of these tissues. It has also been implicated in the regulation of metabolism and insulin sensitivity, and has been studied as a potential therapeutic target for the treatment of metabolic disorders such as obesity and type 2 diabetes.\nIn addition to its role in cell growth and differentiation, GDF10 has also been shown to play a role in the regulation of inflammation and immune responses. It has been shown to inhibit the activation of immune cells such as T cells and macrophages, and may play a role in the regulation of autoimmune diseases.\nOverall, GDF10 is a complex and multifaceted protein that plays a critical role in regulating cell growth, differentiation, metabolism, and inflammation. Further research is needed to fully understand the functions of GDF10 and its potential as a therapeutic target for various diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GDF10, also known as growth differentiation factor 10, is a protein that plays a role in regulating cell growth and differentiation.\n2. GDF10 is a member of the transforming growth factor beta (TGF-beta) superfamily of proteins.\n3. GDF10 is primarily expressed in various tissues, including the heart, skeletal muscle, and kidney.\n4. GDF10 has been implicated in the regulation of metabolism and insulin sensitivity.\n5. GDF10 has been shown to play a role in the regulation of inflammation and immune responses.",
    "vicuna-7b_fact": [
      "GDF10, also known as growth differentiation factor 10, is a protein that plays a role in regulating cell growth and differentiation.",
      "GDF10 is a member of the transforming growth factor beta (TGF-beta) superfamily of proteins.",
      "GDF10 is primarily expressed in various tissues, including the heart, skeletal muscle, and kidney.",
      "GDF10 has been implicated in the regulation of metabolism and insulin sensitivity.",
      "GDF10 has been shown to play a role in the regulation of inflammation and immune responses."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1552,
    "user_query": "Which genetic defects are observed in Prader-Willi syndrome?",
    "vicuna-7b_response": "Prader-Willi syndrome is a genetic disorder caused by a deletion or mutation of genetic material on chromosome 15. The specific genetic defects that lead to Prader-Willi syndrome can vary, but some of the most common genetic changes include:\n1. Absence of genetic material on chromosome 15: This is the most common genetic defect associated with Prader-Willi syndrome. It occurs when a portion of chromosome 15 is missing, which can happen in different ways.\n2. Imprinting defects: In some cases, the genetic material on chromosome 15 is present, but there is an imprinting defect that prevents the gene from being expressed. This can happen when a parent with a chromosome 15 deletion or mutation carries a child, or when the child inherits the chromosome from one parent.\n3. Point mutations: Rarely, Prader-Willi syndrome can be caused by a point mutation, which is a change in a single gene. This type of mutation is less common than the other genetic defects, but it can still occur.\nThe specific genetic defect that causes Prader-Willi syndrome can affect the severity of the symptoms and the age of onset. For example, children with a chromosome 15 deletion may have more severe symptoms than those with a point mutation.\nIt's important to note that Prader-Willi syndrome can also occur as a result of a new genetic change, such as a spontaneous mutation or a genetic rearrangement. In these cases, the specific genetic defect may not be known.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prader-Willi syndrome is a genetic disorder caused by a deletion or mutation of genetic material on chromosome 15.\n2. The most common genetic defect associated with Prader-Willi syndrome is the absence of genetic material on chromosome 15.\n3. Imprinting defects on chromosome 15 can cause Prader-Willi syndrome.\n4. Rarely, a point mutation can cause Prader-Willi syndrome.\n5. The age of onset and severity of Prader-Willi syndrome symptoms can be affected by the specific genetic defect.",
    "vicuna-7b_fact": [
      "Prader-Willi syndrome is a genetic disorder caused by a deletion or mutation of genetic material on chromosome 15.",
      "The most common genetic defect associated with Prader-Willi syndrome is the absence of genetic material on chromosome 15.",
      "Imprinting defects on chromosome 15 can cause Prader-Willi syndrome.",
      "Rarely, a point mutation can cause Prader-Willi syndrome.",
      "The age of onset and severity of Prader-Willi syndrome symptoms can be affected by the specific genetic defect."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1555,
    "user_query": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?",
    "vicuna-7b_response": "There are several computational tools that are currently being used for the prediction of gene fusion events. Some of the most widely used tools include:\n1. GENE-DEPENDENT FUSION EVENTS (GDFE): GDFE is a computational tool that uses a combination of gene expression data and genomic data to predict gene fusions. It uses a machine learning algorithm to identify fusion events that are associated with specific gene expression patterns and genomic features.\n2. FUSION EVENTS DETECTION (FED): FED is another computational tool that uses a combination of gene expression data and genomic data to predict gene fusions. It uses a machine learning algorithm to identify fusion events that are associated with specific gene expression patterns and genomic features.\n3. FUSION EVENTS CLASSIFICATION (FEC): FEC is a computational tool that uses a combination of gene expression data and genomic data to predict gene fusions. It uses a machine learning algorithm to classify fusion events into different categories based on their associated gene expression patterns and genomic features.\n4. FUSION EVENTS DETECTION AND CLASSIFICATION (FUDC): FUDC is a computational tool that uses a combination of gene expression data and genomic data to predict gene fusions. It uses a machine learning algorithm to identify fusion events that are associated with specific gene expression patterns and genomic features, and then classify them into different categories.\n5. FUSION EVENTS DETECTION AND CLASSIFICATION (FUDC): FUDC is a computational tool that uses a combination of gene expression data and genomic data to predict gene fusions. It uses a machine learning algorithm to identify fusion events that are associated with specific gene expression patterns and genomic features, and then classify them into different categories.\nThese are some of the most widely used computational tools for the prediction of gene fusion events. However, it's worth noting that new tools are constantly being developed and it's important to stay up-to-date with the latest advances in this field.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GENE-DEPENDENT FUSION EVENTS (GDFE) is a computational tool used for the prediction of gene fusion events.\n2. GDFE uses a combination of gene expression data and genomic data.\n3. FUSION EVENTS DETECTION (FED) uses gene expression data and genomic data and a machine learning algorithm to predict gene fusions.\n4. FUSION EVENTS CLASSIFICATION (FEC) is another computational tool used in predicting gene fusion events.\n5. FUSION EVENTS DETECTION AND CLASSIFICATION (FUDC) identifies fusion events associated with specific gene expression patterns and genomic features, and then classifies them into different categories.",
    "vicuna-7b_fact": [
      "GENE-DEPENDENT FUSION EVENTS (GDFE) is a computational tool used for the prediction of gene fusion events.",
      "GDFE uses a combination of gene expression data and genomic data.",
      "FUSION EVENTS DETECTION (FED) uses gene expression data and genomic data and a machine learning algorithm to predict gene fusions.",
      "FUSION EVENTS CLASSIFICATION (FEC) is another computational tool used in predicting gene fusion events.",
      "FUSION EVENTS DETECTION AND CLASSIFICATION (FUDC) identifies fusion events associated with specific gene expression patterns and genomic features, and then classifies them into different categories."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1559,
    "user_query": "Are the proteins Erbin (LAP2) and Merlin cooperating?",
    "vicuna-7b_response": "Erbin (also known as LAP2) and Merlin are two different proteins that have been shown to interact with each other in certain cellular processes. However, their exact relationship and whether they are considered to be cooperating or not is still a topic of ongoing research.\nErbin is a protein that is primarily expressed in the brain and is involved in various cellular processes, including neuronal development and differentiation. It has been shown to interact with Merlin, a protein that is involved in the regulation of cellular processes such as cell growth and differentiation.\nOne of the functions of Erbin is to regulate the activity of the N-methyl-D-aspartate (NMDA) receptor, which is a type of ion channel that plays a crucial role in neural signaling. Erbin has been shown to interact with Merlin and to regulate its activity, which in turn can affect the activity of the NMDA receptor.\nIn addition to its interaction with Erbin, Merlin has also been shown to interact with other proteins, including tumor suppressor proteins and cytoskeletal proteins. Its exact role in cellular processes is still not fully understood, but it is thought to play a role in the regulation of cell growth and differentiation.\nOverall, while Erbin and Merlin have been shown to interact with each other, their exact relationship and whether they are considered to be cooperating or not is still a topic of ongoing research. Further studies are needed to fully understand the role of these proteins in cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Erbin (LAP2) and Merlin are two different proteins that have been shown to interact with each other in certain cellular processes.\n2. Erbin is a protein that is primarily expressed in the brain and is involved in various cellular processes, including neuronal development and differentiation.\n3. One of the functions of Erbin is to regulate the activity of the N-methyl-D-aspartate (NMDA) receptor.\n4. Merlin is a protein that is involved in the regulation of cellular processes such as cell growth and differentiation.\n5. Merlin has been shown to interact with tumor suppressor proteins and cytoskeletal proteins.",
    "vicuna-7b_fact": [
      "Erbin (LAP2) and Merlin are two different proteins that have been shown to interact with each other in certain cellular processes.",
      "Erbin is a protein that is primarily expressed in the brain and is involved in various cellular processes, including neuronal development and differentiation.",
      "One of the functions of Erbin is to regulate the activity of the N-methyl-D-aspartate (NMDA) receptor.",
      "Merlin is a protein that is involved in the regulation of cellular processes such as cell growth and differentiation.",
      "Merlin has been shown to interact with tumor suppressor proteins and cytoskeletal proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Erbin is known to regulate Ras/MAPK pathway, not the activity of the N-methyl-D-aspartate (NMDA) receptor.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1568,
    "user_query": "Which deficiency is the cause of restless leg syndrome",
    "vicuna-7b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, often accompanied by unpleasant sensations in the legs. The exact cause of RLS is not fully understood, but it is believed to be related to a deficiency in dopamine, a neurotransmitter that plays a role in movement control and mood regulation.\nThere are several potential causes of RLS, including genetic factors, certain medications, and medical conditions such as pregnancy, kidney disease, and anemia. In some cases, RLS may be related to an imbalance in other neurotransmitters, such as serotonin and norepinephrine.\nIt is important to note that RLS is not a harmful condition on its own, but it can significantly impact a person's quality of life. Treatment options for RLS include lifestyle changes, such as regular exercise and relaxation techniques, as well as medications that target dopamine or other neurotransmitters. In some cases, surgery may be considered as a last resort.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs.\n2. It is believed that RLS is related to a deficiency in dopamine.\n3. Potential causes of RLS include genetic factors, certain medications, and medical conditions such as pregnancy, kidney disease, and anemia.\n4. RLS is not a harmful condition on its own.\n5. Treatment options for RLS include lifestyle changes, medications, and, in some cases, surgery.",
    "vicuna-7b_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs.",
      "It is believed that RLS is related to a deficiency in dopamine.",
      "Potential causes of RLS include genetic factors, certain medications, and medical conditions such as pregnancy, kidney disease, and anemia.",
      "RLS is not a harmful condition on its own.",
      "Treatment options for RLS include lifestyle changes, medications, and, in some cases, surgery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While RLS may not cause significant physical harm, it can severely affect sleep and quality of life, and may result in mental distress.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1572,
    "user_query": "What is the role of eteplirsen in DMD patients?",
    "vicuna-7b_response": "Eteplirsen is a drug that is used to treat patients with Duchenne muscular dystrophy (DMD), a genetic disorder that affects muscle strength and function. Eteplirsen is a small molecule drug that is designed to enter the body and target the underlying cause of DMD, which is a genetic mutation that results in the absence of the dystrophin protein.\nThe dystrophin protein is essential for maintaining the structural integrity of muscle fibers and is responsible for protecting them from damage. In patients with DMD, the absence of the dystrophin protein leads to progressive muscle weakness and wasting, as well as a range of other symptoms.\nEteplirsen works by using a process called exon skipping, which allows the body to produce a shorter, but still functional, version of the dystrophin protein. This helps to compensate for the genetic mutation that causes DMD and can slow the progression of the disease.\nEteplirsen is approved for use in the United States, Europe, and other countries for the treatment of patients with DMD who have a genetic mutation that is amenable to exon 51 skipping. It is typically administered as an infusion once or twice a year, and the response to treatment can be monitored through regular muscle biopsies.\nOverall, the use of eteplirsen has been shown to improve muscle function and delay the progression of DMD in patients who have this genetic mutation. While it is not a cure for the disease, it can help to improve the quality of life for patients and their families.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eteplirsen is a drug used to treat patients with Duchenne muscular dystrophy (DMD).\n2. Eteplirsen targets the genetic mutation that causes the disease, which is the absence of dystrophin protein.\n3. The drug works by using a process called exon skipping, which allows the body to produce a shorter version of the dystrophin protein.\n4. Eteplirsen is approved for use in the United States, Europe, and other countries to treat patients with DMD who have a genetic mutation that is amenable to exon 51 skipping.\n5. The use of eteplirsen has been shown to improve muscle function and delay the progression of DMD in patients with this genetic mutation.",
    "vicuna-7b_fact": [
      "Eteplirsen is a drug used to treat patients with Duchenne muscular dystrophy (DMD).",
      "Eteplirsen targets the genetic mutation that causes the disease, which is the absence of dystrophin protein.",
      "The drug works by using a process called exon skipping, which allows the body to produce a shorter version of the dystrophin protein.",
      "Eteplirsen is approved for use in the United States, Europe, and other countries to treat patients with DMD who have a genetic mutation that is amenable to exon 51 skipping.",
      "The use of eteplirsen has been shown to improve muscle function and delay the progression of DMD in patients with this genetic mutation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eteplirsen is approved for use in the United States to treat patients with DMD who have a genetic mutation that is amenable to exon 51 skipping. It is not currently approved in Europe.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1573,
    "user_query": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.",
    "vicuna-7b_response": "Guadeloupe syndrome is a rare neurological disorder characterized by Parkinsonism with dementia. The clinical presentation of Guadeloupe syndrome typically includes:\n1. Parkinsonism symptoms: These include bradykinesia (slow movement), rigidity (stiffness), resting tremors, and postural instability.\n2. Dementia symptoms: These include difficulty with memory, language, and judgment, as well as changes in behavior and personality.\n3. Slowness of movement: Patients with Guadeloupe syndrome may move slowly and have difficulty initiating movement.\n4. Rigidity: Patients may experience stiffness and difficulty moving their limbs.\n5. Postural instability: Patients may have difficulty maintaining their balance and may fall frequently.\n6. Dementia: Patients may experience memory loss, difficulty with language, and changes in judgment and behavior.\n7. Slowness of speech: Patients may speak slowly and have difficulty finding the right words.\n8. Difficulty with writing: Patients may have difficulty writing and may experience tremors or stiffness in their hands.\n9. Sleep disturbances: Patients may experience insomnia or hypersomnia.\n10. Mood changes: Patients may experience changes in mood, such as depression or apathy.\nIt is important to note that the symptoms of Guadeloupe syndrome can vary from person to person and may also be influenced by other factors such as age, overall health, and the severity of the condition. A diagnosis of Guadeloupe syndrome is typically made by a neurologist after a thorough clinical examination and a review of the patient's medical history.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Guadeloupe syndrome is a rare neurological disorder characterized by Parkinsonism with dementia.\n2. The clinical presentation of Guadeloupe syndrome typically includes symptoms of Parkinsonism such as slow movement, stiffness, resting tremors, and postural instability.\n3. Patients with Guadeloupe syndrome may have dementia symptoms, such as difficulty with memory, language, judgment, as well as changes in behavior and personality.\n4. Other symptoms of Guadeloupe syndrome may include slowness of speech, difficulty with writing, sleep disturbances, and mood changes such as depression or apathy.\n5. A diagnosis of Guadeloupe syndrome is typically made by a neurologist after a thorough clinical examination and a review of the patient's medical history.",
    "vicuna-7b_fact": [
      "Guadeloupe syndrome is a rare neurological disorder characterized by Parkinsonism with dementia.",
      "The clinical presentation of Guadeloupe syndrome typically includes symptoms of Parkinsonism such as slow movement, stiffness, resting tremors, and postural instability.",
      "Patients with Guadeloupe syndrome may have dementia symptoms, such as difficulty with memory, language, judgment, as well as changes in behavior and personality.",
      "Other symptoms of Guadeloupe syndrome may include slowness of speech, difficulty with writing, sleep disturbances, and mood changes such as depression or apathy.",
      "A diagnosis of Guadeloupe syndrome is typically made by a neurologist after a thorough clinical examination and a review of the patient's medical history."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-7b_response": "The concentration of protein HIF-1α (hypoxia-inducible factor 1 alpha) can increase after the administration of the cytoprotective prodrug amifostine (ethyol) in certain circumstances.\nAmifostine is a cytoprotective agent that is commonly used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy. It works by binding to and inactivating endogenous and exogenous toxic compounds, including free radicals and other reactive oxygen species (ROS), before they can cause damage to cells.\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is by increasing the expression and activity of the transcription factor HIF-1α. HIF-1α is a key regulator of the cellular response to hypoxia (low oxygen levels), and its activation leads to the expression of genes involved in the synthesis of erythropoietin, angiogenesis, and other processes that help the body adapt to low oxygen conditions.\nIn some studies, amifostine has been shown to increase the expression and activity of HIF-1α in cancer cells, leading to the upregulation of genes involved in angiogenesis and the synthesis of erythropoietin. This can help to improve the delivery of oxygen to the tumor and promote the growth of new blood vessels, which can enhance the efficacy of cancer therapy.\nHowever, it is important to note that the effects of amifostine on HIF-1α concentration can vary depending on the specific context and the type of cancer being treated. In some cases, amifostine may not increase the concentration of HIF-1α, and its cytoprotective effects may be mediated through other mechanisms.\nOverall, the effect of amifostine on the concentration of HIF-1α depends on various factors, including the dose and duration of treatment, the type of cancer being treated, and the presence of other cytoprotective agents. Further research is needed to fully understand the mechanisms underlying the effects of amifostine on HIF-1α and its potential therapeutic applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The concentration of protein HIF-1α can increase after the administration of the cytoprotective prodrug amifostine (ethyol) in certain circumstances.\n2. Amifostine is a cytoprotective agent used in cancer therapy to protect health cells from the toxic effects of radiation and chemotherapy.\n3. Amifostine works by binding to and inactivating endogenous and exogenous toxic compounds, including free radicals and other reactive oxygen species (ROS).\n4. One of the ways amifostine can exert its cytoprotective effects is by increasing expression and activity of the transcription factor HIF-1α.\n5. Some studies have shown that amifostine can increase the expression and activity of HIF-1α in cancer cells, leading to the upregulation of genes involved in angiogenesis and the synthesis of erythropoietin.",
    "vicuna-7b_fact": [
      "The concentration of protein HIF-1α can increase after the administration of the cytoprotective prodrug amifostine (ethyol) in certain circumstances.",
      "Amifostine is a cytoprotective agent used in cancer therapy to protect health cells from the toxic effects of radiation and chemotherapy.",
      "Amifostine works by binding to and inactivating endogenous and exogenous toxic compounds, including free radicals and other reactive oxygen species (ROS).",
      "One of the ways amifostine can exert its cytoprotective effects is by increasing expression and activity of the transcription factor HIF-1α.",
      "Some studies have shown that amifostine can increase the expression and activity of HIF-1α in cancer cells, leading to the upregulation of genes involved in angiogenesis and the synthesis of erythropoietin."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1578,
    "user_query": "Which are the main histone modifications associated with enhancers?",
    "vicuna-7b_response": "Enhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes. Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin. These modifications can affect the accessibility of DNA to transcription factors and other proteins, and therefore play a crucial role in regulating gene expression.\nThere are several types of histone modifications that are associated with enhancers:\n1. Acetylation: Acetylation of histone H3 at lysine 27 (H3K27ac) is a mark of active enhancers. This modification is associated with the recruitment of transcriptional activators and the opening of the chromatin structure, allowing for the access of RNA polymerase to the promoter region of the gene.\n2. H3K4me1 and H3K4me3: These modifications, which involve the addition of a methyl group to lysine 4 of histone H3 (H3K4me1 and H3K4me3), are associated with the active transcription of genes. They are found in the promoter region of genes and are thought to be involved in the recruitment of transcriptional activators and the formation of a pre-initiation complex.\n3. H3K27me3: This modification involves the addition of a methyl group to lysine 27 of histone H3 (H3K27me3) and is associated with the repression of gene expression. It is found in the promoter region of genes and is thought to be involved in the formation of a repressive complex that blocks the access of RNA polymerase to the promoter region.\n4. H3K9ac: This modification involves the addition of a methyl group to lysine 9 of histone H3 (H3K9ac) and is associated with the active transcription of genes. It is found in the promoter region of genes and is thought to be involved in the recruitment of transcriptional activators and the formation of a pre-initiation complex.\nIn summary, the main histone modifications associated with enhancers are H3K27ac, H3K4me1, H3K",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Enhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes. \n2. Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin. \n3. Acetylation of histone H3 at lysine 27 (H3K27ac) is a mark of active enhancers and this modification is associated with the recruitment of transcriptional activators and the opening of the chromatin structure.\n4. H3K4me1 and H3K4me3 are histone modifications associated with the active transcription of genes and they are thought to be involved in the recruitment of transcriptional activators and the formation of a pre-initiation complex.\n5. H3K27me3 and H3K9ac are other types of histone modifications, associated with repression of gene expression and the active transcription of genes, respectively.",
    "vicuna-7b_fact": [
      "Enhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes.",
      "Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin.",
      "Acetylation of histone H3 at lysine 27 (H3K27ac) is a mark of active enhancers and this modification is associated with the recruitment of transcriptional activators and the opening of the chromatin structure.",
      "H3K4me1 and H3K4me3 are histone modifications associated with the active transcription of genes and they are thought to be involved in the recruitment of transcriptional activators and the formation of a pre-initiation complex.",
      "H3K27me3 and H3K9ac are other types of histone modifications, associated with repression of gene expression and the active transcription of genes, respectively."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1586,
    "user_query": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?",
    "vicuna-7b_response": "The ATAC (Assay for Transposase-Accessible Chromatin) technique is a method used to measure the accessibility of chromatin, which is the complex of DNA and proteins that make up chromosomes. The ATAC assay uses a transposase enzyme to create a series of small, repetitive DNA sequences called \"capture probes\" that bind to regions of chromatin that are accessible to the enzyme. These capture probes are then isolated and sequenced, allowing researchers to determine the accessibility of chromatin in a particular region of the genome.\nThe ATAC assay is particularly useful for studying the regulation of gene expression, as it can provide information about the chromatin accessibility of specific genes and regulatory regions. By measuring changes in chromatin accessibility over time or in response to different conditions, researchers can gain insights into the mechanisms that control gene expression and the regulation of cellular processes.\nOverall, the ATAC technique is a powerful tool for studying the regulation of gene expression and the function of chromatin in a variety of biological systems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ATAC (Assay for Transposase-Accessible Chromatin) technique measures chromatin accessibility.\n2. Chromatin is the complex of DNA and proteins that make up chromosomes.\n3. The ATAC assay uses a transposase enzyme to create \"capture probes\" which bind to accessible regions of chromatin.\n4. The capture probes made by ATAC assay are then isolated and sequenced.\n5. The ATAC technique is used to study the regulation of gene expression and the function of chromatin.",
    "vicuna-7b_fact": [
      "The ATAC (Assay for Transposase-Accessible Chromatin) technique measures chromatin accessibility.",
      "Chromatin is the complex of DNA and proteins that make up chromosomes.",
      "The ATAC assay uses a transposase enzyme to create \"capture probes\" which bind to accessible regions of chromatin.",
      "The capture probes made by ATAC assay are then isolated and sequenced.",
      "The ATAC technique is used to study the regulation of gene expression and the function of chromatin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1587,
    "user_query": "Which are the main NMD factors in Saccharomyces cerevisiae?",
    "vicuna-7b_response": "NMD (nonsense-mediated mRNA decay) is a process that degrades mRNAs that contain premature termination codons (PTCs). In the yeast Saccharomyces cerevisiae, there are several NMD factors that play important roles in this process.\nThe main NMD factors in S. cerevisiae are:\n1. Upf1: Upf1 is a key NMD factor that recognizes PTCs and promotes the degradation of mRNAs containing PTCs. It is a component of the NMD pathway and is required for the efficient degradation of mRNAs with PTCs.\n2. Upf2: Upf2 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n3. Upf3: Upf3 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n4. Nmd2: Nmd2 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n5. Nmd3: Nmd3 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n6. Nmd4: Nmd4 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n7. Nmd5: Nmd5 is a component of the NMD pathway that is involved in the recognition of PTCs. It interacts with Upf1 and helps to promote the degradation of mRNAs containing PTCs.\n8. Nmd6: Nmd6 is a component of the NMD pathway that is involved in the recognition of PTCs. It interact",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NMD (nonsense-mediated mRNA decay) is a process that degrades mRNAs that contain premature termination codons (PTCs).\n2. In Saccharomyces cerevisiae, main NMD factors include Upf1, Upf2, Upf3, Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6.\n3. Upf1 is a key NMD factor in S. cerevisiae that recognizes PTCs and promotes the degradation of mRNAs containing PTCs.\n4. Upf2, Upf3, Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6 in S. cerevisiae are all components of the NMD pathway and help to promote the degradation of mRNAs containing PTCs.\n5. The mentioned NMD factors in S. cerevisiae interact with Upf1 in the process of recognizing and degrading mRNAs with PTCs.",
    "vicuna-7b_fact": [
      "NMD (nonsense-mediated mRNA decay) is a process that degrades mRNAs that contain premature termination codons (PTCs).",
      "In Saccharomyces cerevisiae, main NMD factors include Upf1, Upf2, Upf3, Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6.",
      "Upf1 is a key NMD factor in S. cerevisiae that recognizes PTCs and promotes the degradation of mRNAs containing PTCs.",
      "Upf2, Upf3, Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6 in S. cerevisiae are all components of the NMD pathway and help to promote the degradation of mRNAs containing PTCs.",
      "The mentioned NMD factors in S. cerevisiae interact with Upf1 in the process of recognizing and degrading mRNAs with PTCs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: In Saccharomyces cerevisiae, main NMD factors include Upf1, Upf2, Upf3, not Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6.\n3. TRUE\n4. FALSE [correction]: Upf2, Upf3 are components of the NMD pathway in S. cerevisiae and they help to promote the degradation of mRNAs containing PTCs. Nmd2, Nmd3, Nmd4, Nmd5, and Nmd6 are not part of this process.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-7b_response": "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1). This modification is typically associated with transcriptional repression and is often found in developmental genes and in the heterochromatin of eukaryotic cells. Set7 is also known to deposit other histone marks, including H3K9me2 and H3K27me3, but these modifications are less common than H3K56me1.\nH3K9me2 is a mono-methylation of histone H3 on lysine 9 (H3K9me2), which is typically associated with transcriptional repression. Set7 has been shown to deposit H3K9me2 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nH3K27me3 is a trimethylation of histone H3 on lysine 27 (H3K27me3), which is also associated with transcriptional repression. Set7 has been shown to deposit H3K27me3 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nIt's important to note that while Set7 is known to deposit these other histone marks, H3K56me1 is the most common and well-studied modification associated with Set7.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).\n2. The H3K56me1 modification done by Set7 is typically associated with transcriptional repression.\n3. Set7 deposits histone marks including H3K9me2 and H3K27me3. \n4. Set7 deposits H3K9me2 at the boundary between active and inactive chromatin, acting as a repressor of transcription.\n5. Set7 also deposits H3K27me3 at the boundary between active and inactive chromatin, acting as a repressor of transcription.",
    "vicuna-7b_fact": [
      "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).",
      "The H3K56me1 modification done by Set7 is typically associated with transcriptional repression.",
      "Set7 deposits histone marks including H3K9me2 and H3K27me3.",
      "Set7 deposits H3K9me2 at the boundary between active and inactive chromatin, acting as a repressor of transcription.",
      "Set7 also deposits H3K27me3 at the boundary between active and inactive chromatin, acting as a repressor of transcription."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1592,
    "user_query": "Which genes are associated with Ehlers-Danlos syndrome type I/II?",
    "vicuna-7b_response": "Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the connective tissue in the body. There are several types of EDS, including type I, II, III, and IV.\nType I is the most common form of EDS and is characterized by joint hypermobility, skin hyperextensibility, and a loose, elastic skin. Type II is similar to type I, but it is less severe and does not involve joint hypermobility.\nBoth types I and II are caused by mutations in the COL5A1 and COL5A2 genes, which encode for type V collagen, a key component of the extracellular matrix that provides strength and elasticity to connective tissue.\nOther genes that have been associated with EDS include ADAMTS2, TNXB, and TGM3.\nIt's important to note that while these genes have been associated with EDS, not all individuals with mutations in these genes will develop the condition. Additionally, there may be other genetic and environmental factors that contribute to the development of EDS.\nIf you have concerns about your risk for EDS or would like more information about the condition, it's best to speak with a healthcare provider who can provide personalized advice and guidance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the connective tissue in the body.\n2. Type I EDS is characterized by joint hypermobility, skin hyperextensibility, and a loose, elastic skin.\n3. Both types I and II of EDS are caused by mutations in the COL5A1 and COL5A2 genes which encode for type V collagen.\n4. The genes ADAMTS2, TNXB, and TGM3 have also been associated with EDS.\n5. Not all individuals with mutations in these genes will develop the EDS condition.",
    "vicuna-7b_fact": [
      "Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the connective tissue in the body.",
      "Type I EDS is characterized by joint hypermobility, skin hyperextensibility, and a loose, elastic skin.",
      "Both types I and II of EDS are caused by mutations in the COL5A1 and COL5A2 genes which encode for type V collagen.",
      "The genes ADAMTS2, TNXB, and TGM3 have also been associated with EDS.",
      "Not all individuals with mutations in these genes will develop the EDS condition."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1593,
    "user_query": "Which factors are considered in the ABCD2 score?",
    "vicuna-7b_response": "The ABCD2 score is a tool used to evaluate the quality of evidence in systematic reviews and meta-analyses. The ABCD2 score is based on the following four factors:\n1. Allocation concealment: This refers to the method used to prevent the outcome of a trial from being known to the participants, the researchers, or the outcome assessors.\n2. Blinding of participants and personnel: This refers to the method used to prevent the participants or the personnel involved in the trial from knowing which treatment the participant is receiving.\n3. Blinding of outcome assessors: This refers to the method used to prevent the outcome assessors from knowing which treatment the participant is receiving.\n4. Description of the intervention: This refers to the description of the intervention provided in the trial, including the dose, route of administration, and duration of treatment.\nEach of these factors is rated on a four-point scale, with 0 representing no concealment or blinding and 1 representing concealment or blinding that is not satisfactory. The ABCD2 score is calculated by adding the scores for each of the four factors and dividing by the number of factors assessed. The maximum ABCD2 score is 4, and a score of 2 or higher indicates that the trial is of high quality.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ABCD2 score is a tool used to evaluate the quality of evidence in systematic reviews and meta-analyses.\n2. Allocation concealment, blinding of participants and personnel, blinding of outcome assessors, and description of the intervention are the four factors considered in the ABCD2 score.\n3. Each factor in the ABCD2 score is rated on a four-point scale.\n4. The maximum ABCD2 score is 4.\n5. An ABCD2 score of 2 or higher indicates that the trial is of high quality.",
    "vicuna-7b_fact": [
      "The ABCD2 score is a tool used to evaluate the quality of evidence in systematic reviews and meta-analyses.",
      "Allocation concealment, blinding of participants and personnel, blinding of outcome assessors, and description of the intervention are the four factors considered in the ABCD2 score.",
      "Each factor in the ABCD2 score is rated on a four-point scale.",
      "The maximum ABCD2 score is 4.",
      "An ABCD2 score of 2 or higher indicates that the trial is of high quality."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The ABCD2 score is a tool used to predict risk of stroke after a transient ischaemic attack.\n2. FALSE [correction]: Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes are the factors considered in the ABCD2 score.\n3. TRUE\n4. FALSE [correction]: The maximum ABCD2 score is 7.\n5. FALSE [correction]: An ABCD2 score of 4 or higher indicates a high risk of having a stroke.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1594,
    "user_query": "Is Tuberous Sclerosis a genetic disease?",
    "vicuna-7b_response": "Yes, Tuberous Sclerosis (TS) is a genetic disease. It is caused by mutations in one of two genes: TSC1 or TSC2. These genes provide instructions for making proteins that regulate cell growth. When these proteins are not made properly or are not functioning correctly, it can lead to the formation of benign tumors in various organs of the body, including the brain, heart, kidneys, and lungs.\nTS can also cause a range of other symptoms, including seizures, developmental delays, and skin lesions. The severity of the disease can vary widely from person to person, and some people with TS may have only mild symptoms while others may have more severe symptoms.\nThere is no cure for TS, but treatments are available to help manage the symptoms and prevent complications. These may include medications, surgery, and other medical interventions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tuberous Sclerosis (TS) is a genetic disease.\n2. TS is caused by mutations in one of two genes: TSC1 or TSC2.\n3. The disease can lead to the formation of benign tumors in various organs of the body, including the brain, heart, kidneys, and lungs.\n4. TS can cause other symptoms, including seizures, developmental delays, and skin lesions.\n5. There is no cure for TS, but treatments are available to help manage the symptoms and prevent complications.",
    "vicuna-7b_fact": [
      "Tuberous Sclerosis (TS) is a genetic disease.",
      "TS is caused by mutations in one of two genes: TSC1 or TSC2.",
      "The disease can lead to the formation of benign tumors in various organs of the body, including the brain, heart, kidneys, and lungs.",
      "TS can cause other symptoms, including seizures, developmental delays, and skin lesions.",
      "There is no cure for TS, but treatments are available to help manage the symptoms and prevent complications."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1598,
    "user_query": "What type of DNA repair pathways is initiated by AlkA glycosylase?",
    "vicuna-7b_response": "AlkA glycosylase is an enzyme that initiates a type of DNA repair pathway called base excision repair (BER). BER is a process that repairs DNA damage caused by the removal of a base from the DNA molecule. AlkA glycosylase is specifically involved in the initial step of BER, which is the recognition and removal of damaged bases from the DNA molecule. Once the damaged base is removed, the BER pathway can continue to repair the DNA damage by replacing the removed base and synthesizing a new strand of DNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. AlkA glycosylase initiates a type of DNA repair pathway called base excision repair (BER).\n2. Base excision repair is a process that repairs DNA damage caused by the removal of a base from the DNA molecule.\n3. AlkA glycosylase is involved in the initial step of BER, which is the recognition and removal of damaged bases from the DNA molecule.\n4. After the damaged base is removed, the BER pathway can repair the DNA damage by replacing the removed base and synthesizing a new strand of DNA.",
    "vicuna-7b_fact": [
      "AlkA glycosylase initiates a type of DNA repair pathway called base excision repair (BER).",
      "Base excision repair is a process that repairs DNA damage caused by the removal of a base from the DNA molecule.",
      "AlkA glycosylase is involved in the initial step of BER, which is the recognition and removal of damaged bases from the DNA molecule.",
      "After the damaged base is removed, the BER pathway can repair the DNA damage by replacing the removed base and synthesizing a new strand of DNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Base excision repair is a process that repairs DNA damage caused by oxidation, deamination or alkylation that distorts the double helix.\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1605,
    "user_query": "What is the mechanism of cementogenesis in pulp regeneration?",
    "vicuna-7b_response": "Cementogenesis is the process of the formation of cementum, which is the hard tissue that covers the root surface of a tooth. In pulp regeneration, cementogenesis plays a crucial role in the repair and regeneration of the pulp chamber and root canal.\nThe process of cementogenesis begins with the formation of a cementum-like matrix, which is composed of proteins, such as collagen and glycoproteins, and minerals, such as calcium and phosphorus. This matrix is formed by the activation of odontoblasts, which are specialized cells that are responsible for the formation and maintenance of cementum.\nOnce the cementum-like matrix is formed, it undergoes a process of mineralization, where the matrix is replaced by hydroxyapatite, a mineral that is similar to bone. This process is mediated by the activity of cells called osteoblasts, which are responsible for the formation of bone tissue.\nIn pulp regeneration, the process of cementogenesis is used to replace the damaged pulp tissue with healthy tissue. This is achieved by using various techniques, such as pulp capping, pulp protection, and pulp regeneration. These techniques involve the use of various materials, such as calcium hydroxide, mineral trioxide aggregate, and bioactive glass, to stimulate the formation of cementum-like matrix and promote the growth of new tissue.\nIn summary, cementogenesis is the mechanism of pulp regeneration in which the formation of cementum-like matrix and its mineralization is used to replace the damaged pulp tissue with healthy tissue. This process is mediated by the activation of odontoblasts and the activity of osteoblasts, and it is achieved by using various techniques and materials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cementogenesis refers to the formation of cementum, a hard tissue that covers a tooth's root surface. \n2. Odontoblasts, specialized cells for cementum formation and maintenance, contribute to the starting phase of cementogenesis.\n3. The cementum-like matrix, composed of proteins, collagen, glycoproteins, and minerals like calcium and phosphorous, is a key part of cementogenesis.\n4. The cementum-like matrix typically undergoes a process of mineralization, replacing it with hydroxyapatite, a bone-like mineral.\n5. Techniques used in pulp regeneration to stimulate cementogenesis include pulp capping, pulp protection, and pulp regeneration, using materials such as calcium hydroxide, mineral trioxide aggregate, and bioactive glass.",
    "vicuna-7b_fact": [
      "Cementogenesis refers to the formation of cementum, a hard tissue that covers a tooth's root surface.",
      "Odontoblasts, specialized cells for cementum formation and maintenance, contribute to the starting phase of cementogenesis.",
      "The cementum-like matrix, composed of proteins, collagen, glycoproteins, and minerals like calcium and phosphorous, is a key part of cementogenesis.",
      "The cementum-like matrix typically undergoes a process of mineralization, replacing it with hydroxyapatite, a bone-like mineral.",
      "Techniques used in pulp regeneration to stimulate cementogenesis include pulp capping, pulp protection, and pulp regeneration, using materials such as calcium hydroxide, mineral trioxide aggregate, and bioactive glass."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cementoblasts, not odontoblasts, are specialized cells for cementum formation and maintenance that contribute to the starting phase of cementogenesis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1606,
    "user_query": "What are the reported adverse effects of gabapentin used in children?",
    "vicuna-7b_response": "Gabapentin is a medication that is commonly used to treat neuropathic pain, epilepsy, and postherpetic neuralgia. When used in children, gabapentin can cause a variety of adverse effects. Some of the most common adverse effects of gabapentin in children include:\n* Dizziness\n* Drowsiness\n* Fatigue\n* Nausea\n* Vomiting\n* Diarrhea\n* Stomach pain\n* Headache\n* Fever\n* Infection\n* Rash\n* Insomnia\n* Agitation\n* Anxiety\n* Depression\n* Abnormal behavior\n* Suicidal thoughts\nIt is important to note that the frequency and severity of these adverse effects can vary depending on the child's age, weight, and the duration of treatment. Additionally, some of these adverse effects may be more common in children than in adults.\nIt is important to consult with a healthcare professional if you have concerns about the side effects of gabapentin in your child. They can provide you with more information and advice on how to manage these side effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gabapentin is used to treat neuropathic pain, epilepsy, and postherpetic neuralgia.\n2. When used in children, gabapentin can cause a variety of adverse effects.\n3. Common adverse effects of gabapentin in children include dizziness, drowsiness, fatigue, nausea, vomiting, diarrhea, stomach pain, headache, fever, infection, rash, insomnia, agitation, anxiety, depression, abnormal behavior, and suicidal thoughts.\n4. The frequency and severity of these adverse effects can vary depending on the child's age, weight, and the duration of treatment.\n5. Some side effects of gabapentin may be more common in children than in adults.",
    "vicuna-7b_fact": [
      "Gabapentin is used to treat neuropathic pain, epilepsy, and postherpetic neuralgia.",
      "When used in children, gabapentin can cause a variety of adverse effects.",
      "Common adverse effects of gabapentin in children include dizziness, drowsiness, fatigue, nausea, vomiting, diarrhea, stomach pain, headache, fever, infection, rash, insomnia, agitation, anxiety, depression, abnormal behavior, and suicidal thoughts.",
      "The frequency and severity of these adverse effects can vary depending on the child's age, weight, and the duration of treatment.",
      "Some side effects of gabapentin may be more common in children than in adults."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1617,
    "user_query": "What are the skeletal muscle satellite cells?",
    "vicuna-7b_response": "Skeletal muscle satellite cells, also known as muscle-derived stem cells, are a type of stem cell that are found in skeletal muscle tissue. These cells are responsible for repairing and regenerating muscle tissue after injury or exercise. They are also involved in the process of muscle growth and development.\nSatellite cells are found in the muscle fibers and are responsible for the formation of new muscle fibers. They are capable of differentiating into various types of muscle cells, including muscle fibers, myotubes, and even into other types of cells such as tendon and ligament cells.\nSatellite cells are also important in the process of muscle regeneration. After injury, satellite cells are activated and migrate to the site of injury, where they differentiate into muscle cells and help to repair the damaged tissue.\nIn addition to their role in muscle repair and regeneration, satellite cells are also involved in the process of muscle growth and development. They are responsible for the proliferation and differentiation of muscle fibers, and play a crucial role in the adaptation of muscle to physical exercise.\nOverall, satellite cells are an important cell type in the muscle tissue and play a crucial role in the process of muscle repair, regeneration, growth and development.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Skeletal muscle satellite cells, also known as muscle-derived stem cells, are found in skeletal muscle tissue.\n2. These cells are responsible for repairing and regenerating muscle tissue after injury or exercise.\n3. Satellite cells can differentiate into various types of muscle cells, including muscle fibers, myotubes, and even into other types of cells such as tendon and ligament cells.\n4. Satellite cells migrate to the site of injury, where they differentiate into muscle cells and help repair the damaged tissue.\n5. Satellite cells are responsible for the proliferation and differentiation of muscle fibers, and play a crucial role in the adaptation of muscle to physical exercise.",
    "vicuna-7b_fact": [
      "Skeletal muscle satellite cells, also known as muscle-derived stem cells, are found in skeletal muscle tissue.",
      "These cells are responsible for repairing and regenerating muscle tissue after injury or exercise.",
      "Satellite cells can differentiate into various types of muscle cells, including muscle fibers, myotubes, and even into other types of cells such as tendon and ligament cells.",
      "Satellite cells migrate to the site of injury, where they differentiate into muscle cells and help repair the damaged tissue.",
      "Satellite cells are responsible for the proliferation and differentiation of muscle fibers, and play a crucial role in the adaptation of muscle to physical exercise."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Satellite cells can differentiate into muscle cells such as muscle fibers and myotubes, but they do not typically differentiate into other types of cells such as tendon and ligament cells.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1618,
    "user_query": "What is the role of neurogranin in Alzheimer's disease patients?",
    "vicuna-7b_response": "Neurogranin is a protein that is involved in the formation and maintenance of synapses, which are the connections between neurons in the brain. In Alzheimer's disease, neurogranin levels are decreased, which may contribute to the loss of synapses and the decline in cognitive function that is observed in the disease. Additionally, neurogranin has been shown to play a role in the clearance of toxic proteins that are associated with Alzheimer's disease, suggesting that it may have a potential therapeutic role in the treatment of the disease. However, further research is needed to fully understand the role of neurogranin in Alzheimer's disease and to determine if it is a viable target for therapy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neurogranin is a protein involved in the formation and maintenance of synapses.\n2. In Alzheimer's disease, neurogranin levels are decreased.\n3. The decrease in neurogranin levels may contribute to the loss of synapses and decline in cognitive function in Alzheimer's disease.\n4. Neurogranin has been shown to play a role in the clearance of toxic proteins associated with Alzheimer's disease.\n5. Further research is needed to fully understand the role of neurogranin in Alzheimer's disease and to determine if it is a viable target for therapy.",
    "vicuna-7b_fact": [
      "Neurogranin is a protein involved in the formation and maintenance of synapses.",
      "In Alzheimer's disease, neurogranin levels are decreased.",
      "The decrease in neurogranin levels may contribute to the loss of synapses and decline in cognitive function in Alzheimer's disease.",
      "Neurogranin has been shown to play a role in the clearance of toxic proteins associated with Alzheimer's disease.",
      "Further research is needed to fully understand the role of neurogranin in Alzheimer's disease and to determine if it is a viable target for therapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: There is no evidence to suggest that Neurogranin plays a role in the clearance of toxic proteins associated with Alzheimer's disease. It's function is primarily focused on the formation and maintenance of synapses.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1619,
    "user_query": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?",
    "vicuna-7b_response": "Yes, triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas. T3 is a hormone produced by the thyroid gland that regulates metabolism in the body. It plays a key role in the regulation of glucose metabolism, which is essential for the proper functioning of the pancreas.\nInsulin is a hormone produced by the pancreas that regulates blood sugar levels. When blood sugar levels are high, insulin is released to help lower them. Conversely, when blood sugar levels are low, the pancreas releases glucagon, which helps raise them.\nT3 can affect the production and release of insulin from the pancreas by regulating the activity of the beta cells in the pancreas. Beta cells are responsible for producing and releasing insulin into the bloodstream. T3 can increase the activity of the beta cells, which can lead to an increase in insulin production and secretion.\nAdditionally, T3 can also affect the sensitivity of cells to insulin by increasing the number of insulin receptors on the surface of cells. This can make the body more responsive to insulin, which can help regulate blood sugar levels.\nOverall, T3 plays a crucial role in the regulation of insulin secretion from the pancreas, which is essential for maintaining proper glucose metabolism and preventing hyperglycemia or hypoglycemia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.\n2. T3 is a hormone produced by the thyroid gland that regulates metabolism in the body.\n3. Insulin is a hormone produced by the pancreas that regulates blood sugar levels.\n4. T3 can affect the production and release of insulin from the pancreas by regulating the activity of the beta cells.\n5. T3 can also affect the sensitivity of cells to insulin by increasing the number of insulin receptors on the surface of cells.",
    "vicuna-7b_fact": [
      "Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.",
      "T3 is a hormone produced by the thyroid gland that regulates metabolism in the body.",
      "Insulin is a hormone produced by the pancreas that regulates blood sugar levels.",
      "T3 can affect the production and release of insulin from the pancreas by regulating the activity of the beta cells.",
      "T3 can also affect the sensitivity of cells to insulin by increasing the number of insulin receptors on the surface of cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-7b_response": "Hepcidin is a protein that plays a crucial role in the regulation of iron metabolism in the body. The exact number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\nIn humans, hepcidin is composed of 296 amino acids and contains 10 disulfide bridges. These disulfide bridges are important for the stability and function of the protein.\nIt's worth noting that the number of disulfide bridges in a protein can vary depending on the species and the specific isoform of the protein. However, the general consensus is that hepcidin contains 10 disulfide bridges.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hepcidin is a protein that plays a crucial role in the regulation of iron metabolism in the body.\n2. The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\n3. In humans, hepcidin is composed of 296 amino acids.\n4. Human hepcidin contains 10 disulfide bridges.\n5. Disulfide bridges in proteins are important for the stability and function of the protein.",
    "vicuna-7b_fact": [
      "Hepcidin is a protein that plays a crucial role in the regulation of iron metabolism in the body.",
      "The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.",
      "In humans, hepcidin is composed of 296 amino acids.",
      "Human hepcidin contains 10 disulfide bridges.",
      "Disulfide bridges in proteins are important for the stability and function of the protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: In humans, hepcidin is composed of 25 amino acids.\n4. FALSE [correction]: Human hepcidin contains 4 disulfide bridges.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1622,
    "user_query": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?",
    "vicuna-7b_response": "Chk2, also known as checkpoint kinase 2, is a protein kinase that plays a crucial role in the cell cycle checkpoint response to DNA damage. Chk2 is activated when DNA damage is detected and phosphorylates a number of downstream targets to initiate the cell cycle checkpoint response.\nThere are several intramolecular phosphorylation sites on Chk2 that are involved in cell cycle control. These include:\n1. T68: This site is located in the activation loop of Chk2 and is phosphorylated by ATM (ataxia-telangiectasia mutated) in response to DNA damage. Phosphorylation of T68 activates Chk2 and triggers the cell cycle checkpoint response.\n2. S345: This site is located in the carboxy-terminal domain of Chk2 and is phosphorylated by CDC25C (cell division cycle protein 25C) in response to DNA damage. Phosphorylation of S345 leads to the degradation of Chk2, thereby terminating the cell cycle checkpoint response.\n3. Y681: This site is located in the carboxy-terminal domain of Chk2 and is phosphorylated by ATM in response to DNA damage. Phosphorylation of Y681 stabilizes Chk2 and prolongs the cell cycle checkpoint response.\n4. Y781: This site is located in the carboxy-terminal domain of Chk2 and is phosphorylated by CDC25C in response to DNA damage. Phosphorylation of Y781 leads to the degradation of Chk2, thereby terminating the cell cycle checkpoint response.\nIn summary, the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control are T68, S345, Y681, and Y781. These sites play a crucial role in regulating the cell cycle checkpoint response to DNA damage.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chk2, also known as checkpoint kinase 2, is a protein kinase that plays a crucial role in the cell cycle checkpoint response to DNA damage.\n2. T68 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by ATM in response to DNA damage.\n3. S345 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by CDC25C in response to DNA damage, leading to the degradation of Chk2.\n4. Y681 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by ATM in response to DNA damage, stabilizing Chk2 and prolonging the cell cycle checkpoint response.\n5. Y781 is another intramolecular phosphorylation site on Chk2 that gets phosphorylated by CDC25C in response to DNA damage, leading to the degradation of Chk2.",
    "vicuna-7b_fact": [
      "Chk2, also known as checkpoint kinase 2, is a protein kinase that plays a crucial role in the cell cycle checkpoint response to DNA damage.",
      "T68 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by ATM in response to DNA damage.",
      "S345 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by CDC25C in response to DNA damage, leading to the degradation of Chk2.",
      "Y681 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by ATM in response to DNA damage, stabilizing Chk2 and prolonging the cell cycle checkpoint response.",
      "Y781 is another intramolecular phosphorylation site on Chk2 that gets phosphorylated by CDC25C in response to DNA damage, leading to the degradation of Chk2."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: S345 is an intramolecular phosphorylation site on Chk2 that gets phosphorylated by ATM in response to DNA damage, leading to the activation of Chk2.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1628,
    "user_query": "Which receptors can be evaluated with the [18F]altanserin?",
    "vicuna-7b_response": "The radiotracer [18F]altanserin is primarily used for the evaluation of serotonin (5-HT) receptors in the brain. It is a radioligand that binds to the 5-HT2A, 5-HT2C, and 5-HT1D receptors, which are important for various neurological and psychiatric conditions such as depression, anxiety, and schizophrenia.\nThe [18F]altanserin PET scan can provide valuable information about the distribution and density of these receptors in the brain, which can be used to diagnose and monitor the treatment of these conditions. Additionally, the [18F]altanserin PET scan can be used to evaluate the effectiveness of certain drugs that target these receptors, such as anti-depressants and anti-psychotics.\nIt's important to note that the [18F]altanserin PET scan is not a direct measure of serotonin levels in the brain, but rather a measure of the density and distribution of the serotonin receptors. Therefore, it's important to interpret the results of the scan in conjunction with other clinical and laboratory data.\nIn summary, the [18F]altanserin PET scan is primarily used to evaluate the density and distribution of serotonin receptors in the brain, specifically the 5-HT2A, 5-HT2C, and 5-HT1D receptors, which are important for various neurological and psychiatric conditions such as depression, anxiety, and schizophrenia. It can also be used to evaluate the effectiveness of certain drugs that target these receptors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The radiotracer [18F]altanserin is primarily used for the evaluation of serotonin receptors in the brain.\n2. [18F]altanserin binds to the 5-HT2A, 5-HT2C, and 5-HT1D receptors.\n3. These receptors are important for various neurological and psychiatric conditions such as depression, anxiety, and schizophrenia.\n4. The [18F]altanserin PET scan can provide information about the distribution and density of these receptors.\n5. The [18F]altanserin PET scan can be used to evaluate the effectiveness of certain drugs that target these receptors, such as anti-depressants and anti-psychotics.",
    "vicuna-7b_fact": [
      "The radiotracer [18F]altanserin is primarily used for the evaluation of serotonin receptors in the brain.",
      "[18F]altanserin binds to the 5-HT2A, 5-HT2C, and 5-HT1D receptors.",
      "These receptors are important for various neurological and psychiatric conditions such as depression, anxiety, and schizophrenia.",
      "The [18F]altanserin PET scan can provide information about the distribution and density of these receptors.",
      "The [18F]altanserin PET scan can be used to evaluate the effectiveness of certain drugs that target these receptors, such as anti-depressants and anti-psychotics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: [18F]altanserin binds selectively to the 5-HT2A receptors.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1630,
    "user_query": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
    "vicuna-7b_response": "Thyrotropin (TSH) is a hormone produced by the pituitary gland that regulates the production and release of thyroid hormones by the thyroid gland. TSH receptors are found on the surface of thyroid cells and are activated by TSH, leading to an increase in the production and release of thyroid hormones.\nExtra-thyroidal tissues that have TSH receptors include:\n1. Ovaries: TSH receptors are found in the follicular cells of the ovaries, and TSH can stimulate the production of estrogen and progesterone.\n2. Adipose tissue: TSH receptors are found in adipose tissue, and TSH can stimulate the production of adiponectin, a hormone that regulates metabolism.\n3. Pancreas: TSH receptors are found in the pancreatic beta cells, and TSH can stimulate insulin secretion.\n4. Heart: TSH receptors are found in the heart, and TSH can affect heart rate and contractility.\n5. Bone: TSH receptors are found in bone cells, and TSH can affect bone metabolism.\nIt is important to note that while these extra-thyroidal tissues have TSH receptors, they are not responsible for the production of thyroid hormones. The production and release of thyroid hormones is solely the responsibility of the thyroid gland.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thyrotropin (TSH) receptors are found on the surface of thyroid cells and are activated by TSH.\n2. TSH receptors are found in the follicular cells of the ovaries.\n3. TSH receptors are found in adipose tissue.\n4. TSH receptors are found in pancreatic beta cells.\n5. TSH receptors are found in bone cells. \n6. TSH receptors are found in the heart. \n7. The production and release of thyroid hormones is solely the responsibility of the thyroid gland.",
    "vicuna-7b_fact": [
      "Thyrotropin (TSH) receptors are found on the surface of thyroid cells and are activated by TSH.",
      "TSH receptors are found in the follicular cells of the ovaries.",
      "TSH receptors are found in adipose tissue.",
      "TSH receptors are found in pancreatic beta cells.",
      "TSH receptors are found in bone cells.",
      "TSH receptors are found in the heart.",
      "The production and release of thyroid hormones is solely the responsibility of the thyroid gland."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: TSH receptors are not typically found in the follicular cells of the ovaries.\n3. TRUE\n4. FALSE [correction]: TSH receptors are not found in pancreatic beta cells.\n5. TRUE\n6. FALSE [correction]: TSH receptors are not typically found in the heart.\n7. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1631,
    "user_query": "Which histone modifications distinguish between promoters and enhancers?",
    "vicuna-7b_response": "Histone modifications play a crucial role in regulating gene expression by altering the accessibility of DNA to transcription factors and other proteins. While there are many different histone modifications that can be involved in regulating gene expression, some of the most well-known modifications that distinguish between promoters and enhancers include:\n1. H3K4me1/2/3: These modifications are typically found at promoters and are associated with the recruitment of RNA polymerase and other transcriptional machinery.\n2. H3K27me3: This modification is typically found at enhancers and is associated with the repression of transcription.\n3. H3K9ac: This modification is typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators.\n4. H3K27ac: This modification is also typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators.\n5. H3K3601: This modification is typically found at enhancers and is associated with the long-term maintenance of the open chromatin structure.\nIt's worth noting that these modifications can be found in different combinations and patterns, and that other modifications can also play a role in regulating gene expression. Additionally, the function of histone modifications can be influenced by other factors such as DNA methylation, non-coding RNAs, and chromatin accessibility.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone modifications can regulate gene expression by altering the accessibility of DNA to transcription factors and other proteins.\n2. H3K4me1/2/3 modifications are typically found at promoters and are associated with the recruitment of RNA polymerase and other transcriptional machinery.\n3. H3K27me3 modification is typically found at enhancers and is associated with the repression of transcription.\n4. H3K9ac modification is typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators.\n5. H3K27ac modification is also typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators.",
    "vicuna-7b_fact": [
      "Histone modifications can regulate gene expression by altering the accessibility of DNA to transcription factors and other proteins.",
      "H3K4me1/2/3 modifications are typically found at promoters and are associated with the recruitment of RNA polymerase and other transcriptional machinery.",
      "H3K27me3 modification is typically found at enhancers and is associated with the repression of transcription.",
      "H3K9ac modification is typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators.",
      "H3K27ac modification is also typically found at both promoters and enhancers and is associated with the recruitment of transcriptional activators."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: H3K27me3 modification is typically found at regions destined to be repressed and is associated with the repression of transcription.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1632,
    "user_query": "Where is the metaxin complex localized?",
    "vicuna-7b_response": "The metaxin complex is a protein complex that is localized in the cytoplasm of cells. It is composed of several subunits, including metaxin, metaxin-interacting protein 1 (MITP1), and metaxin-interacting protein 2 (MITP2). The metaxin complex plays a role in regulating cellular processes such as cell growth and differentiation, and it has been implicated in the development of certain types of cancer. The exact localization of the metaxin complex within the cell can vary depending on the specific subcellular structure or organelle in which it is found. For example, it has been observed in the endoplasmic reticulum, the Golgi apparatus, and the plasma membrane.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The metaxin complex is localized in the cytoplasm of cells.\n2. The metaxin complex is composed of several subunits, including metaxin, metaxin-interacting protein 1 (MITP1), and metaxin-interacting protein 2 (MITP2).\n3. The metaxin complex plays a role in regulating cellular processes such as cell growth and differentiation.\n4. The metaxin complex has been implicated in the development of certain types of cancer.\n5. The localization of the metaxin complex within the cell can vary depending on the specific subcellular structure or organelle, it has been observed in the endoplasmic reticulum, the Golgi apparatus, and the plasma membrane.",
    "vicuna-7b_fact": [
      "The metaxin complex is localized in the cytoplasm of cells.",
      "The metaxin complex is composed of several subunits, including metaxin, metaxin-interacting protein 1 (MITP1), and metaxin-interacting protein 2 (MITP2).",
      "The metaxin complex plays a role in regulating cellular processes such as cell growth and differentiation.",
      "The metaxin complex has been implicated in the development of certain types of cancer.",
      "The localization of the metaxin complex within the cell can vary depending on the specific subcellular structure or organelle, it has been observed in the endoplasmic reticulum, the Golgi apparatus, and the plasma membrane."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The metaxin complex is localized in the mitochondria of cells, not in the cytoplasm.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The metaxin complex is localized in the outer membrane of the mitochondria and is not typically found in the endoplasmic reticulum, the Golgi apparatus, or the plasma membrane.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1633,
    "user_query": "What are the major classes of retrotransposons active in the human genome?",
    "vicuna-7b_response": "Retrotransposons are mobile genetic elements that copy themselves to new locations in the genome by transcribing their DNA into RNA and then reverse transcribing the RNA back into DNA. There are several major classes of retrotransposons active in the human genome, including:\n1. Long Terminal Repeat (LTR) retrotransposons: These are the most common type of retrotransposon in the human genome. They have a specific structure that includes a long terminal repeat (LTR) region that contains the retrotransposon's reverse transcriptase and integrase enzymes. LTR retrotransposons can be further divided into two subtypes: long interspersed elements (L1) and short interspersed elements (SINEs).\n2. Non-LTR retrotransposons: These retrotransposons do not have the LTR structure and instead use other mechanisms to replicate. They include the Ty1-copia and MuLV retrotransposons.\n3. DNA transposons: These retrotransposons move by cutting and pasting DNA sequences between different locations in the genome. They include the Helitron and SIN3R families.\n4. RNA retrotransposons: These retrotransposons move by transcribing themselves from RNA to DNA. They include the Gypsy and copia-like retrotransposons.\nIt's worth noting that the activity of retrotransposons can vary greatly between different individuals and populations, and some retrotransposons may be more active in certain tissues or cell types than others. Additionally, the activity of retrotransposons can be influenced by a variety of factors, including genetic variation, epigenetic modifications, and the presence of mobile element-targeting enzymes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Retrotransposons are mobile genetic elements that copy themselves to new locations in the genome by transcribing their DNA into RNA and reverse transcribing the RNA back into DNA.\n2. There are several major classes of retrotransposons active in the human genome, including Long Terminal Repeat (LTR) retrotransposons, Non-LTR retrotransposons, DNA transposons, and RNA retrotransposons.\n3. LTR retrotransposons are the most common type of retrotransposon in the human genome.\n4. The activity of retrotransposons can vary greatly between different individuals and populations.\n5. Genetic variation, epigenetic modifications, and the presence of mobile element-targeting enzymes can influence the activity of retrotransposons.",
    "vicuna-7b_fact": [
      "Retrotransposons are mobile genetic elements that copy themselves to new locations in the genome by transcribing their DNA into RNA and reverse transcribing the RNA back into DNA.",
      "There are several major classes of retrotransposons active in the human genome, including Long Terminal Repeat (LTR) retrotransposons, Non-LTR retrotransposons, DNA transposons, and RNA retrotransposons.",
      "LTR retrotransposons are the most common type of retrotransposon in the human genome.",
      "The activity of retrotransposons can vary greatly between different individuals and populations.",
      "Genetic variation, epigenetic modifications, and the presence of mobile element-targeting enzymes can influence the activity of retrotransposons."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are several major classes of retrotransposons active in the human genome, including Long Terminal Repeat (LTR) retrotransposons, Non-LTR retrotransposons and SINEs (Short Interspersed Nuclear Elements). DNA and RNA retrotransposons are not existing categories. \n3. FALSE [correction]: LTR retrotransposons are not the most common type of retrotransposon in the human genome. Alu elements, a type of non-LTR retrotransposon, are much more common.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1634,
    "user_query": "Which are the clinical characteristics of Diamond-Blackfan anemia?",
    "vicuna-7b_response": "Diamond-Blackfan anemia (DBA) is a rare congenital disorder characterized by a deficiency in the production of red blood cells due to a genetic mutation. The clinical characteristics of DBA include:\n1. Macrocytic anemia: DBA is characterized by anemia, which is a condition in which the body does not have enough healthy red blood cells to carry oxygen to the body's tissues. Macrocytic anemia refers to anemia in which the red blood cells are larger than normal.\n2. Pallor: DBA can cause pallor, which is a lack of color in the skin, mucous membranes, and nail beds due to a lack of oxygen-carrying red blood cells.\n3. Excessive bleeding: DBA can cause excessive bleeding, which can occur due to a low platelet count and a deficiency in the production of red blood cells.\n4. Bone marrow failure: DBA is a bone marrow failure disorder, which means that the bone marrow is unable to produce enough healthy red blood cells, white blood cells, and platelets.\n5. Short stature: DBA can cause short stature due to the deficiency in the production of red blood cells, which is necessary for the growth and development of the body's tissues.\n6. Craniofacial abnormalities: DBA can cause craniofacial abnormalities, which are defects in the development of the head and face.\n7. Skin pigmentation abnormalities: DBA can cause skin pigmentation abnormalities, which are changes in the color of the skin due to a deficiency in the production of melanin.\nIt is important to note that the symptoms of DBA can vary from person to person and can range from mild to severe. If you or a loved one is experiencing any of these symptoms, it is important to consult with a healthcare professional for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Diamond-Blackfan anemia (DBA) is a rare congenital disorder characterized by a deficiency in the production of red blood cells due to a genetic mutation.\n2. DBA is characterized by macrocytic anemia, which refers to anemia in which the red blood cells are larger than normal.\n3. Diamond-Blackfan anemia can cause pallor, a lack of color in the skin, mucous membranes, and nail beds due to a lack of oxygen-carrying red blood cells.\n4. DBA can cause excessive bleeding, which can occur due to a low platelet count and a deficiency in the production of red blood cells.\n5. Diamond-Blackfan anemia is a bone marrow failure disorder, which means that the bone marrow is unable to produce enough healthy red blood cells, white blood cells, and platelets.",
    "vicuna-7b_fact": [
      "Diamond-Blackfan anemia (DBA) is a rare congenital disorder characterized by a deficiency in the production of red blood cells due to a genetic mutation.",
      "DBA is characterized by macrocytic anemia, which refers to anemia in which the red blood cells are larger than normal.",
      "Diamond-Blackfan anemia can cause pallor, a lack of color in the skin, mucous membranes, and nail beds due to a lack of oxygen-carrying red blood cells.",
      "DBA can cause excessive bleeding, which can occur due to a low platelet count and a deficiency in the production of red blood cells.",
      "Diamond-Blackfan anemia is a bone marrow failure disorder, which means that the bone marrow is unable to produce enough healthy red blood cells, white blood cells, and platelets."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1638,
    "user_query": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?",
    "vicuna-7b_response": "Cyclosporin A (CsA) is an immunosuppressive drug that is used to prevent the rejection of transplanted organs and tissues. It works by inhibiting the activity of T cells, which are a type of immune cell that plays a key role in the immune response.\nThe receptor that CsA binds to is called the cyclophilin D (CyP-D). CyP-D is a cyclophilin, which is a type of protein that is involved in the regulation of cellular processes, including the immune response. CsA binds to CyP-D and inhibits its activity, thereby suppressing the activity of T cells.\nIt is important to note that while CsA is an effective immunosuppressive drug, it can have several side effects, including nephrotoxicity (kidney damage), hypertension (high blood pressure), and neurotoxicity (nerve damage). Therefore, it is important to carefully monitor patients who are taking CsA and to adjust the dosage as needed to minimize the risk of side effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cyclosporin A (CsA) is an immunosuppressive drug used to prevent the rejection of transplanted organs and tissues.\n2. Cyclosporin A works by inhibiting the activity of T cells.\n3. The receptor that Cyclosporin A binds to is called the cyclophilin D (CyP-D).\n4. CyP-D is a cyclophilin, a type of protein involved in the regulation of cellular processes.\n5. CsA can have side effects, including nephrotoxicity, hypertension, and neurotoxicity.",
    "vicuna-7b_fact": [
      "Cyclosporin A (CsA) is an immunosuppressive drug used to prevent the rejection of transplanted organs and tissues.",
      "Cyclosporin A works by inhibiting the activity of T cells.",
      "The receptor that Cyclosporin A binds to is called the cyclophilin D (CyP-D).",
      "CyP-D is a cyclophilin, a type of protein involved in the regulation of cellular processes.",
      "CsA can have side effects, including nephrotoxicity, hypertension, and neurotoxicity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The receptor that Cyclosporin A binds to is called the cyclophilin A (CyP-A).\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1642,
    "user_query": "In which types of DNA repair is the UvrAB complex involved?",
    "vicuna-7b_response": "The UvrAB complex is involved in a type of DNA repair called nucleotide excision repair (NER). NER is a complex process that involves the recognition and removal of damaged or mutated DNA bases, as well as the replacement of the removed base with a correct base. The UvrAB complex is responsible for the recognition and removal of the damaged or mutated DNA base.\nNER is a highly conserved process that is present in all organisms, from bacteria to humans. It is essential for the maintenance of genome stability and is particularly important in the repair of UV-induced DNA damage. The UvrAB complex recognizes the damaged or mutated base through its interaction with the DNA lesion recognition proteins, such as the XPC protein. Once the damaged base is recognized, the UvrAB complex helps to recruit other repair proteins to the site of the damage, including the helicases, which help to unwind the DNA, and the endonucleases, which cut the DNA at the site of the damage.\nIn addition to NER, the UvrAB complex is also involved in other DNA repair processes, such as base excision repair (BER) and mismatch repair (MMR). However, these processes are not as well understood as NER, and more research is needed to fully understand the role of the UvrAB complex in these processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UvrAB complex is involved in nucleotide excision repair (NER).\n2. Nucleotide excision repair involves the recognition and removal of damaged or mutated DNA bases.\n3. NER is a process that is present in all organisms.\n4. The UvrAB complex is responsible for recognizing and removing the damaged or mutated DNA base.\n5. The UvrAB complex also participates in base excision repair (BER) and mismatch repair (MMR).",
    "vicuna-7b_fact": [
      "The UvrAB complex is involved in nucleotide excision repair (NER).",
      "Nucleotide excision repair involves the recognition and removal of damaged or mutated DNA bases.",
      "NER is a process that is present in all organisms.",
      "The UvrAB complex is responsible for recognizing and removing the damaged or mutated DNA base.",
      "The UvrAB complex also participates in base excision repair (BER) and mismatch repair (MMR)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: NER is a process that is present in many, but not all organisms. Some organisms may use different mechanisms of DNA repair.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-7b_response": "DNAJC11 is a protein encoded by a gene that is localized in various tissues and organisms.\nIn humans, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the endoplasmic reticulum (ER) and the mitochondria.\nIn mice, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the ER and the mitochondria.\nIn other organisms, such as zebrafish and fruit flies, DNAJC11 has been localized to the ER and the mitochondria.\nOverall, DNAJC11 is a protein that is localized in various tissues and organisms, including the ER and the mitochondria.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNAJC11 is a protein encoded by a gene.\n2. DNAJC11 is expressed in various tissues including brain, heart, liver, kidney, and pancreas in humans.\n3. DNAJC11 is also expressed in fetal tissues, such as the lung and intestine.\n4. DNAJC11 has been localized to the endoplasmic reticulum and the mitochondria.\n5. In other organisms, such as zebrafish and fruit flies, DNAJC11 has been localized to the ER and the mitochondria.",
    "vicuna-7b_fact": [
      "DNAJC11 is a protein encoded by a gene.",
      "DNAJC11 is expressed in various tissues including brain, heart, liver, kidney, and pancreas in humans.",
      "DNAJC11 is also expressed in fetal tissues, such as the lung and intestine.",
      "DNAJC11 has been localized to the endoplasmic reticulum and the mitochondria.",
      "In other organisms, such as zebrafish and fruit flies, DNAJC11 has been localized to the ER and the mitochondria."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1646,
    "user_query": "Which hormone abnormalities are characteristic to Pendred syndrome?",
    "vicuna-7b_response": "Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of smell. It is caused by a mutation in the SLC38A10 gene, which is responsible for the production of a protein called Pendrin.\nThe main characteristic of Pendred syndrome is an underactive thyroid gland (hypothyroidism), which can lead to low levels of thyroid hormones in the blood. This can cause symptoms such as weight gain, constipation, and cold intolerance.\nIn addition to hypothyroidism, people with Pendred syndrome may also have an abnormality in the sense of smell, known as hyposmia. This can affect their ability to detect certain odors and may lead to difficulty in identifying certain foods or medications.\nOther possible symptoms of Pendred syndrome can include hearing loss, developmental delays, and a small thyroid gland (goiter). However, not all people with Pendred syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person.\nIt is important to note that Pendred syndrome is a genetic disorder that is inherited in an autosomal recessive pattern. This means that a person must inherit two copies of the mutated SLC38A10 gene (one from each parent) to develop the condition. If you have a family history of Pendred syndrome or have been diagnosed with the condition, it is important to speak with a genetic counselor or healthcare provider to discuss your risk of passing the condition on to your children.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of smell.\n2. Pendred syndrome is caused by a mutation in the SLC38A10 gene.\n3. The main characteristic of Pendred syndrome is an underactive thyroid gland (hypothyroidism).\n4. People with Pendred syndrome may have an abnormality in the sense of smell, known as hyposmia.\n5. Pendred syndrome is inherited in an autosomal recessive pattern, meaning a person must inherit two copies of the mutated SLC38A10 gene to develop the condition.",
    "vicuna-7b_fact": [
      "Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of smell.",
      "Pendred syndrome is caused by a mutation in the SLC38A10 gene.",
      "The main characteristic of Pendred syndrome is an underactive thyroid gland (hypothyroidism).",
      "People with Pendred syndrome may have an abnormality in the sense of smell, known as hyposmia.",
      "Pendred syndrome is inherited in an autosomal recessive pattern, meaning a person must inherit two copies of the mutated SLC38A10 gene to develop the condition."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the sense of hearing.\n2. FALSE [correction]: Pendred syndrome is caused by mutations in the SLC26A4 gene.\n3. TRUE\n4. FALSE [correction]: People with Pendred syndrome may have an abnormality in the sense of hearing, known as sensorineural hearing loss.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1647,
    "user_query": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?",
    "vicuna-7b_response": "Long QT syndrome is a genetic disorder that affects the heart's electrical activity. It is caused by mutations in one of several genes that are involved in the normal functioning of the heart's electrical system. The mode of inheritance of Long QT syndrome can vary depending on the specific gene mutation that is responsible for the disorder.\nMost cases of Long QT syndrome are inherited in an autosomal dominant manner, which means that one copy of the mutated gene is sufficient to cause the disorder. In these cases, the mutation is present in one copy of the gene in each cell, and the disorder is inherited from one parent.\nHowever, some cases of Long QT syndrome are inherited in an autosomal recessive manner, which means that two copies of the mutated gene are required to cause the disorder. In these cases, the disorder is inherited from both parents, who are carriers of the mutated gene.\nIn rare cases, Long QT syndrome can be inherited in an X-linked recessive manner, which means that the disorder is caused by a mutation on the X chromosome. In these cases, the disorder affects mostly males, who have only one X chromosome, and females, who have two X chromosomes and are carriers of the mutated gene.\nIt is important to note that the mode of inheritance of Long QT syndrome can vary depending on the specific gene mutation that is responsible for the disorder. Therefore, it is important to consult with a genetic counselor or a healthcare provider to determine the specific mode of inheritance for an individual or family.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Long QT syndrome is a genetic disorder that affects the heart's electrical activity.\n2. The mode of inheritance of Long QT syndrome can vary depending on the specific gene mutation.\n3. Most cases of Long QT syndrome are inherited in an autosomal dominant manner.\n4. Some cases of Long QT syndrome are inherited in an autosomal recessive manner.\n5. In rare cases, Long QT syndrome can be inherited in an X-linked recessive manner, affecting mostly males and females who are carriers of the mutated gene.",
    "vicuna-7b_fact": [
      "Long QT syndrome is a genetic disorder that affects the heart's electrical activity.",
      "The mode of inheritance of Long QT syndrome can vary depending on the specific gene mutation.",
      "Most cases of Long QT syndrome are inherited in an autosomal dominant manner.",
      "Some cases of Long QT syndrome are inherited in an autosomal recessive manner.",
      "In rare cases, Long QT syndrome can be inherited in an X-linked recessive manner, affecting mostly males and females who are carriers of the mutated gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Long QT syndrome is not known to be inherited in an X-linked recessive manner.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1648,
    "user_query": "List programs suitable for protein docking",
    "vicuna-7b_response": "Protein docking is the process of predicting the three-dimensional structure of a protein-protein complex. There are several programs available for protein docking, some of which are:\n1. AutoDock: AutoDock is a widely used software for protein docking. It uses a combination of physics-based and empirical potentials to predict the binding affinity of a protein-protein complex.\n2. DOCK: DOCK is another popular protein docking software. It uses a genetic algorithm to optimize the position of the proteins in the complex.\n3. ROCS: ROCS (Robust Optimized Constraint Satisfaction) is a protein docking program that uses a constraint-based approach to predict the binding affinity of a protein-protein complex.\n4. GROMACS: GROMACS (Groningen Machine for Computational Science) is a molecular dynamics simulation package that includes a protein docking module. It uses a force field to simulate the interactions between the proteins in the complex.\n5. CLICK: CLICK (CLient-based KINdom) is a protein docking program that uses a client-server architecture. It uses a combination of physics-based and empirical potentials to predict the binding affinity of a protein-protein complex.\n6. FRED: FRED (Fast and Reliable Docking) is a protein docking program that uses a scoring function based on the electrostatic potential. It is known for its speed and accuracy.\nThese are some of the most popular protein docking programs available. The choice of software depends on the specific requirements of the user and the type of protein-protein complex being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Protein docking is the process of predicting the three-dimensional structure of a protein-protein complex.\n2. AutoDock is a widely used software for protein docking that uses a combination of physics-based and empirical potentials.\n3. DOCK is a protein docking software that uses a genetic algorithm to optimize the position of the proteins in the complex.\n4. ROCS is a protein docking program that uses a constraint-based approach.\n5. GROMACS is a molecular dynamics simulation package that includes a protein docking module.\n6. CLICK and FRED are other protein docking programs, with different approaches to predicting protein binding affinity.",
    "vicuna-7b_fact": [
      "Protein docking is the process of predicting the three-dimensional structure of a protein-protein complex.",
      "AutoDock is a widely used software for protein docking that uses a combination of physics-based and empirical potentials.",
      "DOCK is a protein docking software that uses a genetic algorithm to optimize the position of the proteins in the complex.",
      "ROCS is a protein docking program that uses a constraint-based approach.",
      "GROMACS is a molecular dynamics simulation package that includes a protein docking module.",
      "CLICK and FRED are other protein docking programs, with different approaches to predicting protein binding affinity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DOCK is a protein docking software but it uses a geometric matching algorithm instead of a genetic algorithm to optimize the position of the proteins in the complex.\n4. FALSE [correction]: ROCS is not a protein docking program. It's a software used for ligand-based virtual screening, comparing shapes and chemical features of molecules.\n5. FALSE [correction]: GROMACS is a molecular dynamics simulation package but it does not include a protein docking module.\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1649,
    "user_query": "Which genes have been found mutated in Gray platelet syndrome patients?",
    "vicuna-7b_response": "Gray platelet syndrome (GPS) is a rare genetic disorder characterized by the accumulation of abnormal platelets in the bloodstream. The condition is caused by mutations in the GPIBA gene, which encodes a protein called glycoprotein Ib-IX-V complex beta subunit. Mutations in this gene lead to the production of a non-functional protein, which disrupts the normal functioning of platelets and results in their accumulation in the bloodstream.\nSeveral studies have identified mutations in the GPIBA gene in patients with GPS. For example, a study published in the journal Blood in 2015 identified mutations in the GPIBA gene in 10 of 11 patients with GPS. Another study published in the journal Haematologica in 2017 identified mutations in the GPIBA gene in 11 of 12 patients with GPS.\nIn addition to the GPIBA gene, other genes have also been implicated in the development of GPS. For example, a study published in the journal Blood in 2018 identified mutations in the GPIBX gene, which encodes a protein similar to glycoprotein Ib-IX-V complex beta subunit, in two patients with GPS.\nOverall, mutations in the GPIBA and other genes have been identified in patients with GPS. Further research is needed to better understand the genetic basis of this condition and to develop effective treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gray platelet syndrome (GPS) is a rare genetic disorder.\n2. Mutations in the GPIBA gene lead to the production of a non-functional protein, disrupting the normal functioning of platelets.\n3. Several studies identified mutations in the GPIBA gene in patients with GPS.\n4. A study published in the journal \"Blood\" in 2018 identified mutations in the GPIBX gene in two patients with GPS.\n5. Other genes, including GPIBX, have also been implicated in the development of GPS.",
    "vicuna-7b_fact": [
      "Gray platelet syndrome (GPS) is a rare genetic disorder.",
      "Mutations in the GPIBA gene lead to the production of a non-functional protein, disrupting the normal functioning of platelets.",
      "Several studies identified mutations in the GPIBA gene in patients with GPS.",
      "A study published in the journal \"Blood\" in 2018 identified mutations in the GPIBX gene in two patients with GPS.",
      "Other genes, including GPIBX, have also been implicated in the development of GPS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: No specific study stating mutations in the GPIBX gene in patients with GPS has been identified.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1652,
    "user_query": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?",
    "vicuna-7b_response": "Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging technique that can be used to evaluate the structure and function of the heart. It is not typically used as a routine part of pre-participation screening for athletes.\nHowever, there are certain circumstances in which cardiac MRI may be indicated for athletes. For example, if an athlete has a family history of heart problems or has experienced symptoms such as chest pain, shortness of breath, or dizziness, a cardiac MRI may be recommended to evaluate their heart health.\nAdditionally, some sports organizations may require certain athletes to undergo cardiac MRI as part of their pre-participation screening process. This may be the case for athletes who are participating in high-risk sports, such as contact sports or sports that involve a lot of physical exertion.\nOverall, the decision to use cardiac MRI as part of pre-participation screening for athletes is made on a case-by-case basis, and depends on the individual's medical history and the specific requirements of the sport they are participating in.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging technique that can be used to evaluate the structure and function of the heart.\n2. Cardiac MRI is not typically used as a routine part of pre-participation screening for athletes.\n3. In certain circumstances, such as a family history of heart problems or symptoms like chest pain, shortness of breath, or dizziness, a cardiac MRI may be recommended for athletes.\n4. Some sports organizations may require athletes to undergo cardiac MRI as part of their pre-participation screening process.\n5. The decision to use cardiac MRI in pre-participation screening is made on a case-by-case basis, depending on the individual's medical history and the specific requirements of the sport.",
    "vicuna-7b_fact": [
      "Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging technique that can be used to evaluate the structure and function of the heart.",
      "Cardiac MRI is not typically used as a routine part of pre-participation screening for athletes.",
      "In certain circumstances, such as a family history of heart problems or symptoms like chest pain, shortness of breath, or dizziness, a cardiac MRI may be recommended for athletes.",
      "Some sports organizations may require athletes to undergo cardiac MRI as part of their pre-participation screening process.",
      "The decision to use cardiac MRI in pre-participation screening is made on a case-by-case basis, depending on the individual's medical history and the specific requirements of the sport."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While some sports organizations may require comprehensive medical evaluations, they do not typically mandate cardiac MRI as part of their pre-participation screening process.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-7b_response": "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species, meaning that they are found in similar forms in different organisms. UCEs are typically found in the 3' region of genes and are thought to be important for gene regulation.\nCopy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome. CNVs can be either gain, which means that a region of DNA is present in more copies than expected, or loss, which means that a region of DNA is present in fewer copies than expected.\nIt is possible that UCEs could be depleted among CNVs, meaning that CNVs are more likely to occur in regions of the genome that do not contain UCEs. However, the relationship between UCEs and CNVs is complex and not well understood. Some studies have suggested that UCEs may be more likely to be present in regions of the genome that are not affected by CNVs, while other studies have found that UCEs are more likely to be present in regions of the genome that are affected by CNVs.\nOverall, it is difficult to make generalizations about the relationship between UCEs and CNVs, as the relationship may vary depending on the specific context and the type of CNV that is being considered.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.\n2. UCEs are typically found in the 3' region of genes and are thought to be important for gene regulation.\n3. Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.\n4. CNVs can be either gain, which means that a region of DNA is present in more copies than expected, or loss, which means that a region of DNA is present in fewer copies than expected.\n5. The relationship between UCEs and CNVs is complex and not well understood.",
    "vicuna-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.",
      "UCEs are typically found in the 3' region of genes and are thought to be important for gene regulation.",
      "Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.",
      "CNVs can be either gain, which means that a region of DNA is present in more copies than expected, or loss, which means that a region of DNA is present in fewer copies than expected.",
      "The relationship between UCEs and CNVs is complex and not well understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: While UCEs are indeed thought to be important for gene regulation, they are not typically found in the 3' region of genes. They could be located in introns, intergenic regions, or protein-coding regions.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1660,
    "user_query": "Which population has a high frequency of the HLA-B*1502 allele?",
    "vicuna-7b_response": "The HLA-B*1502 allele is a genetic marker that is associated with a higher risk of severe skin reactions and mucosal blistering in patients treated with certain medications, including the immunosuppressant drug methotrexate. The frequency of the HLA-B*1502 allele varies among different populations, but it is most commonly found in individuals of Southeast Asian, Chinese, and Japanese descent.\nIn general, the frequency of the HLA-B*1502 allele is highest in individuals of Southeast Asian, Chinese, and Japanese descent, with frequencies ranging from 10-20% in these populations. In contrast, the frequency of the allele is much lower in other populations, with frequencies ranging from 1-10% in Caucasians and 0-1% in African Americans.\nIt is important to note that the frequency of the HLA-B*1502 allele can vary within a population, and that other factors, such as age, sex, and other genetic markers, can also influence the risk of severe skin reactions and mucosal blistering in patients treated with methotrexate. Therefore, genetic testing for the HLA-B*1502 allele should be interpreted in the context of a patient's individual clinical history and other genetic and environmental factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The HLA-B*1502 allele is a genetic marker associated with a higher risk of severe skin reactions and mucosal blistering in patients treated with certain medications, including methotrexate.\n2. The frequency of the HLA-B*1502 allele is highest in individuals of Southeast Asian, Chinese, and Japanese descent.\n3. The frequencies of the HLA-B*1502 allele range from 10-20% in Southeast Asian, Chinese, and Japanese populations.\n4. The frequency of the HLA-B*1502 allele is lower in Caucasians and African Americans, with frequencies ranging from 1-10% in Caucasians and 0-1% in African Americans.\n5. The frequency of the HLA-B*1502 allele can vary within a population, and factors such as age, sex, and different genetic markers can also influence the risk of severe skin reactions and mucosal blistering in patients treated with methotrexate.",
    "vicuna-7b_fact": [
      "The HLA-B*1502 allele is a genetic marker associated with a higher risk of severe skin reactions and mucosal blistering in patients treated with certain medications, including methotrexate.",
      "The frequency of the HLA-B*1502 allele is highest in individuals of Southeast Asian, Chinese, and Japanese descent.",
      "The frequencies of the HLA-B*1502 allele range from 10-20% in Southeast Asian, Chinese, and Japanese populations.",
      "The frequency of the HLA-B*1502 allele is lower in Caucasians and African Americans, with frequencies ranging from 1-10% in Caucasians and 0-1% in African Americans.",
      "The frequency of the HLA-B*1502 allele can vary within a population, and factors such as age, sex, and different genetic markers can also influence the risk of severe skin reactions and mucosal blistering in patients treated with methotrexate."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The HLA-B*1502 allele is a genetic marker associated with a higher risk of severe skin reactions and mucosal blistering in patients treated with certain medications, including carbamazepine, not methotrexate.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1663,
    "user_query": "What is the role of the Tsix gene during X chromosome inactivation?",
    "vicuna-7b_response": "The Tsix gene, also known as the X-linked silencing transcript (XIST), plays a crucial role in the process of X chromosome inactivation during development in females.\nX chromosome inactivation is a process that occurs in female mammals, where one of the two X chromosomes in each cell is randomly inactivated during embryonic development. This process is essential for maintaining the balance between the expression of X-linked genes and the prevention of X-linked overexpression, which can lead to developmental abnormalities.\nThe Tsix gene is responsible for the production of a non-coding RNA molecule that is specifically expressed on the inactive X chromosome. This RNA molecule, known as the XIST RNA, is responsible for the silencing of X-linked genes on the inactive X chromosome by forming a large, transcriptionally repressive complex that covers the entire X chromosome.\nThe XIST RNA is produced from the Tsix gene through a process called transcriptional silencing, where the gene is transcribed but the resulting RNA is rapidly degraded. This process ensures that the XIST RNA is only produced on the inactive X chromosome and not on the active X chromosome, where it would interfere with the expression of other genes.\nIn summary, the Tsix gene, through the production of the XIST RNA, plays a crucial role in the process of X chromosome inactivation by silencing X-linked genes on the inactive X chromosome, ensuring the proper balance between X-linked gene expression and preventing overexpression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Tsix gene plays a crucial role in the process of X chromosome inactivation during development in females.\n2. X chromosome inactivation occurs in female mammals, where one of the two X chromosomes in each cell is randomly inactivated during embryonic development.\n3. The Tsix gene is responsible for the production of a non-coding RNA molecule, known as the XIST RNA.\n4. The XIST RNA is responsible for the silencing of X-linked genes on the inactive X chromosome.\n5. The XIST RNA is produced from the Tsix gene through a process called transcriptional silencing.",
    "vicuna-7b_fact": [
      "The Tsix gene plays a crucial role in the process of X chromosome inactivation during development in females.",
      "X chromosome inactivation occurs in female mammals, where one of the two X chromosomes in each cell is randomly inactivated during embryonic development.",
      "The Tsix gene is responsible for the production of a non-coding RNA molecule, known as the XIST RNA.",
      "The XIST RNA is responsible for the silencing of X-linked genes on the inactive X chromosome.",
      "The XIST RNA is produced from the Tsix gene through a process called transcriptional silencing."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Tsix gene is not responsible for the production of XIST RNA. Instead, it suppresses the production of XIST on the active X chromosome.\n4. TRUE\n5. FALSE [correction]: The XIST RNA is not produced from the Tsix gene. It is produced from the XIST gene through a process called transcription.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-7b_response": "The Haspin kinase is a mitotic kinase that is active during the G2 phase of the cell cycle. It is not clear what the substrate of Haspin is during mitosis. However, it is known that Haspin phosphorylates several proteins, including the anaphase-promoting complex/cyclosome (APC/C), which is involved in the regulation of mitosis. Haspin also phosphorylates the protein BubR1, which is involved in the regulation of the spindle assembly checkpoint.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Haspin kinase is a mitotic kinase that is active during the G2 phase of the cell cycle.\n2. It is not clear what the substrate of Haspin is during mitosis.\n3. Haspin phosphorylates several proteins, including the anaphase-promoting complex/cyclosome (APC/C).\n4. APC/C is involved in the regulation of mitosis.\n5. Haspin also phosphorylates the protein BubR1, which is involved in the regulation of the spindle assembly checkpoint.",
    "vicuna-7b_fact": [
      "Haspin kinase is a mitotic kinase that is active during the G2 phase of the cell cycle.",
      "It is not clear what the substrate of Haspin is during mitosis.",
      "Haspin phosphorylates several proteins, including the anaphase-promoting complex/cyclosome (APC/C).",
      "APC/C is involved in the regulation of mitosis.",
      "Haspin also phosphorylates the protein BubR1, which is involved in the regulation of the spindle assembly checkpoint."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The primary substrate of Haspin during mitosis is histone H3.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1668,
    "user_query": "What is the advantage of neutral loss detection in phosphoproteomics?",
    "vicuna-7b_response": "Neutral loss detection is a method used in phosphoproteomics to identify and quantify phosphorylation events in a sample. One advantage of this method is that it allows for the detection of both phosphorylated and unphosphorylated forms of a protein, which can provide a more complete picture of the protein's activity and regulation. Additionally, neutral loss detection can be used to detect both specific and nonspecific phosphorylation events, which can help to distinguish between different types of phosphorylation events and improve the accuracy of the results. Overall, neutral loss detection is a valuable tool in phosphoproteomics that can provide important insights into the regulation and function of proteins in a sample.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neutral loss detection is a method used in phosphoproteomics to identify and quantify phosphorylation events in a sample.\n2. Neutral loss detection allows for the detection of both phosphorylated and unphosphorylated forms of a protein.\n3. This method can provide a more complete picture of a protein's activity and regulation.\n4. Neutral loss detection can be used to detect both specific and nonspecific phosphorylation events.\n5. The use of neutral loss detection can improve the accuracy of results in phosphoproteomics.",
    "vicuna-7b_fact": [
      "Neutral loss detection is a method used in phosphoproteomics to identify and quantify phosphorylation events in a sample.",
      "Neutral loss detection allows for the detection of both phosphorylated and unphosphorylated forms of a protein.",
      "This method can provide a more complete picture of a protein's activity and regulation.",
      "Neutral loss detection can be used to detect both specific and nonspecific phosphorylation events.",
      "The use of neutral loss detection can improve the accuracy of results in phosphoproteomics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1672,
    "user_query": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?",
    "vicuna-7b_response": "Bmi-1 is a protein that is involved in the regulation of the cell cycle. One of the cyclin-dependent kinase inhibitors that is regulated by Bmi-1 is p21.\np21 is a cyclin-dependent kinase inhibitor that plays a role in the regulation of the G1 phase of the cell cycle. It is also known as CDKN1A. p21 is a key regulator of the G1-S transition, which is the point at which the cell moves from the G1 phase of the cycle to the S phase, where DNA replication occurs.\nBmi-1 has been shown to regulate p21 expression at the transcriptional level. This means that Bmi-1 can control the amount of p21 protein that is produced in the cell. Bmi-1 has been shown to promote p21 expression in response to DNA damage, which helps to prevent the cell from entering the S phase until the DNA damage has been repaired.\nIn addition to p21, Bmi-1 has also been shown to regulate other cyclin-dependent kinase inhibitors, such as p27 and p57. However, the specific cyclin-dependent kinase inhibitor that is regulated by Bmi-1 may vary depending on the cell type and the specific conditions in which the cell is growing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bmi-1 is a protein that is involved in the regulation of the cell cycle.\n2. One of the cyclin-dependent kinase inhibitors that is regulated by Bmi-1 is p21.\n3. p21, also known as CDKN1A, plays a role in the regulation of the G1 phase of the cell cycle.\n4. p21 is a key regulator of the G1-S transition in the cell cycle.\n5. Bmi-1 has also been shown to regulate other cyclin-dependent kinase inhibitors, such as p27 and p57.",
    "vicuna-7b_fact": [
      "Bmi-1 is a protein that is involved in the regulation of the cell cycle.",
      "One of the cyclin-dependent kinase inhibitors that is regulated by Bmi-1 is p21.",
      "p21, also known as CDKN1A, plays a role in the regulation of the G1 phase of the cell cycle.",
      "p21 is a key regulator of the G1-S transition in the cell cycle.",
      "Bmi-1 has also been shown to regulate other cyclin-dependent kinase inhibitors, such as p27 and p57."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1675,
    "user_query": "List inhibtors targeting the mitochondrial permeability transition pore.",
    "vicuna-7b_response": "The mitochondrial permeability transition pore (MPTP) is a complex composed of several subunits that regulates the flow of ions and molecules between the mitochondrial intermembrane space and the cytosol. The MPTP plays a crucial role in the regulation of cellular homeostasis, and its dysfunction has been implicated in various diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer.\nSeveral inhibitors target the MPTP, including:\n1. Cyclosporine A: Cyclosporine A is a immunosuppressant drug that inhibits the MPTP by binding to the cyclophilin D subunit of the MPTP complex.\n2. Antimycin A: Antimycin A is a potent inhibitor of the MPTP that blocks the ATP-dependent opening of the pore.\n3. Carboxyatractyloside: Carboxyatractyloside is a peptide that inhibits the MPTP by binding to the subunit VDAC1 (voltage-dependent anion channel 1).\n4. Rolipram: Rolipram is a phosphodiesterase inhibitor that increases cyclic adenosine monophosphate (cAMP) levels, which in turn inhibits the MPTP.\n5. MitoQ: MitoQ is a mitochondria-targeted antioxidant that inhibits the MPTP by scavenging reactive oxygen species (ROS) and reducing mitochondrial membrane potential.\n6. TNP-ATP: TNP-ATP is a synthetic analog of ATP that inhibits the MPTP by competing with ATP for the pore subunits.\n7. UMI-36: UMI-36 is a natural product that inhibits the MPTP by binding to the subunit VDAC1.\nThese inhibitors have shown promise in preclinical studies for the treatment of various diseases, and some are currently in clinical trials. However, further research is needed to fully understand the mechanisms of action and the potential side effects of these inhibitors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The mitochondrial permeability transition pore (MPTP) regulates the flow of ions and molecules between the mitochondrial intermembrane space and the cytosol.\n2. Cyclosporine A inhibits the MPTP by binding to the cyclophilin D subunit of the MPTP complex.\n3. Antimycin A is a potent inhibitor of the MPTP that blocks the ATP-dependent opening of the pore.\n4. Carboxyatractyloside inhibits the MPTP by binding to subunit VDAC1 (voltage-dependent anion channel 1).\n5. MitoQ inhibits the MPTP by scavenging reactive oxygen species (ROS) and reducing mitochondrial membrane potential.",
    "vicuna-7b_fact": [
      "The mitochondrial permeability transition pore (MPTP) regulates the flow of ions and molecules between the mitochondrial intermembrane space and the cytosol.",
      "Cyclosporine A inhibits the MPTP by binding to the cyclophilin D subunit of the MPTP complex.",
      "Antimycin A is a potent inhibitor of the MPTP that blocks the ATP-dependent opening of the pore.",
      "Carboxyatractyloside inhibits the MPTP by binding to subunit VDAC1 (voltage-dependent anion channel 1).",
      "MitoQ inhibits the MPTP by scavenging reactive oxygen species (ROS) and reducing mitochondrial membrane potential."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Antimycin A is not an inhibitor of the MPTP. It's an inhibitor of the electron transport chain, which can induce MPTP opening, but it doesn't directly block MPTP.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1678,
    "user_query": "Which is the process that Conserved noncoding elements mostly regulate?",
    "vicuna-7b_response": "Conserved noncoding elements (CNEs) are regions of the genome that are highly conserved across different species and are thought to play important roles in regulating gene expression. CNEs can regulate gene expression through a variety of mechanisms, including chromatin modification, transcription factor binding, and RNA splicing.\nOne of the main functions of CNEs is to regulate the expression of nearby genes. CNEs can act as enhancers, which are regions of the genome that increase the expression of nearby genes, or as silencers, which decrease the expression of nearby genes. CNEs can also act as both enhancers and silencers, depending on the context in which they are found.\nIn addition to regulating the expression of nearby genes, CNEs can also regulate the expression of long-range genes, which are genes that are located far away from the CNE. Long-range regulation of gene expression is thought to be mediated by non-coding RNAs, such as microRNAs and long non-coding RNAs, which can bind to CNEs and regulate the expression of nearby genes.\nOverall, CNEs play an important role in regulating gene expression and are involved in a wide range of biological processes, including development, differentiation, and disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Conserved noncoding elements (CNEs) are regions of the genome that are highly conserved across different species.\n2. CNEs are thought to play important roles in regulating gene expression.\n3. One of the main functions of CNEs is to regulate the expression of nearby genes, acting as enhancers or silencers.\n4. CNEs can also regulate the expression of long-range genes.\n5. Regulation of gene expression by CNEs is thought to be mediated by non-coding RNAs, such as microRNAs and long non-coding RNAs.",
    "vicuna-7b_fact": [
      "Conserved noncoding elements (CNEs) are regions of the genome that are highly conserved across different species.",
      "CNEs are thought to play important roles in regulating gene expression.",
      "One of the main functions of CNEs is to regulate the expression of nearby genes, acting as enhancers or silencers.",
      "CNEs can also regulate the expression of long-range genes.",
      "Regulation of gene expression by CNEs is thought to be mediated by non-coding RNAs, such as microRNAs and long non-coding RNAs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1689,
    "user_query": "Is Achondroplasia associated with hearing loss?",
    "vicuna-7b_response": "Yes, achondroplasia is associated with hearing loss. People with achondroplasia have a higher risk of developing sensorineural hearing loss, which is a type of hearing loss that is caused by damage to the inner ear or the nerve pathways that transmit sound from the ear to the brain.\nThe exact prevalence of hearing loss in people with achondroplasia is not known, but studies have suggested that it occurs in up to 30% of individuals with the condition. The hearing loss is usually sensorineural in nature and can occur at any age, although it is more common in older individuals with the condition.\nThe hearing loss in achondroplasia is thought to be related to the genetic mutation that causes the condition. The mutation affects the development of the cartilage that forms the ear bones and the inner ear, leading to abnormalities in the structure and function of these organs.\nTreatment for hearing loss in individuals with achondroplasia typically involves hearing aids or cochlear implants, and in some cases, surgery may be necessary to address specific issues with the ear structure. It is important for individuals with achondroplasia to have their hearing regularly checked and to seek medical attention if they experience any changes in their hearing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is associated with a higher risk of developing sensorineural hearing loss.\n2. Sensorineural hearing loss is caused by damage to the inner ear or the nerve pathways that transmit sound from the ear to the brain.\n3. Studies have suggested that hearing loss occurs in up to 30% of individuals with achondroplasia.\n4. The hearing loss in achondroplasia is thought to be related to the genetic mutation that causes the condition.\n5. Treatment for hearing loss in individuals with achondroplasia typically involves hearing aids or cochlear implants, and in some cases, surgery may be necessary to address specific issues with the ear structure.",
    "vicuna-7b_fact": [
      "Achondroplasia is associated with a higher risk of developing sensorineural hearing loss.",
      "Sensorineural hearing loss is caused by damage to the inner ear or the nerve pathways that transmit sound from the ear to the brain.",
      "Studies have suggested that hearing loss occurs in up to 30% of individuals with achondroplasia.",
      "The hearing loss in achondroplasia is thought to be related to the genetic mutation that causes the condition.",
      "Treatment for hearing loss in individuals with achondroplasia typically involves hearing aids or cochlear implants, and in some cases, surgery may be necessary to address specific issues with the ear structure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1691,
    "user_query": "Is STAT3 transcription factor regulated by mTORC1?",
    "vicuna-7b_response": "Yes, STAT3 is a transcription factor that can be regulated by mTORC1. mTORC1 is a complex that regulates cell growth and metabolism, and it has been shown to regulate the expression of genes involved in cell proliferation and survival, including STAT3.\nThe mTORC1 complex is activated by growth factors and other signals that stimulate cell proliferation, and it regulates the expression of genes involved in cell growth and metabolism through the regulation of the translation of specific mRNAs. STAT3 is one of the genes that is regulated by mTORC1, and it has been shown to play a role in the regulation of cell growth and survival in response to growth factors and other signals.\nIn summary, STAT3 is a transcription factor that can be regulated by mTORC1, and mTORC1 regulates the expression of genes involved in cell growth and metabolism through the regulation of the translation of specific mRNAs, including STAT3.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. STAT3 is a transcription factor that can be regulated by mTORC1.\n2. mTORC1 is a complex that regulates cell growth and metabolism.\n3. mTORC1 has been shown to regulate the expression of genes involved in cell proliferation and survival, including STAT3.\n4. The mTORC1 complex is activated by growth factors and other signals that stimulate cell proliferation.\n5. STAT3 plays a role in the regulation of cell growth and survival in response to growth factors and other signals.",
    "vicuna-7b_fact": [
      "STAT3 is a transcription factor that can be regulated by mTORC1.",
      "mTORC1 is a complex that regulates cell growth and metabolism.",
      "mTORC1 has been shown to regulate the expression of genes involved in cell proliferation and survival, including STAT3.",
      "The mTORC1 complex is activated by growth factors and other signals that stimulate cell proliferation.",
      "STAT3 plays a role in the regulation of cell growth and survival in response to growth factors and other signals."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1693,
    "user_query": "List components of the CRSP/Med complex.",
    "vicuna-7b_response": "The CRSP/Med complex is a complex of proteins that plays a crucial role in the regulation of cell division and the maintenance of the cell cycle. The components of the CRSP/Med complex include:\n1. CRSP75/Med12: This is the largest subunit of the complex and is responsible for binding to and ubiquitinating specific target proteins.\n2. CRSP70/Med11: This subunit is responsible for binding to and stabilizing the CRSP75/Med12 complex.\n3. CRSP67/Med7: This subunit is responsible for binding to and stabilizing the CRSP70/Med11 complex.\n4. CRSP64/Med6: This subunit is responsible for binding to and stabilizing the CRSP67/Med7 complex.\n5. CRSP58/Med24: This subunit is responsible for binding to and stabilizing the CRSP64/Med6 complex.\n6. CRSP57/Med23: This subunit is responsible for binding to and stabilizing the CRSP58/Med24 complex.\n7. CRSP56/Med22: This subunit is responsible for binding to and stabilizing the CRSP57/Med23 complex.\n8. CRSP55/Med21: This subunit is responsible for binding to and stabilizing the CRSP56/Med22 complex.\n9. CRSP54/Med20: This subunit is responsible for binding to and stabilizing the CRSP55/Med21 complex.\n10. CRSP53/Med19: This subunit is responsible for binding to and stabilizing the CRSP54/Med20 complex.\n11. CRSP52/Med18: This subunit is responsible for binding to and stabilizing the CRSP53/Med19 complex.\n12. CRSP51/Med17: This subunit is responsible for binding to and stabilizing the CRSP52/Med18 complex.\n13. CRSP50/Med16: This subunit is responsible for binding to and stabilizing the CRSP51/Med17 complex.\n14. CRSP49/Med15: This subunit is responsible for binding to",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The CRSP/Med complex is a complex of proteins that plays a role in the regulation of cell division and the maintenance of the cell cycle.\n2. CRSP75/Med12 is the largest subunit of the CRSP/Med complex and is responsible for binding to and ubiquitinating specific target proteins.\n3. CRSP70/Med11 subunit is responsible for binding to and stabilizing the CRSP75/Med12 complex.\n4. CRSP67/Med7 subunit is responsible for binding to and stabilizing the CRSP70/Med11 complex.\n5. CRSP64/Med6 subunit is responsible for binding to and stabilizing the CRSP67/Med7 complex.",
    "vicuna-7b_fact": [
      "The CRSP/Med complex is a complex of proteins that plays a role in the regulation of cell division and the maintenance of the cell cycle.",
      "CRSP75/Med12 is the largest subunit of the CRSP/Med complex and is responsible for binding to and ubiquitinating specific target proteins.",
      "CRSP70/Med11 subunit is responsible for binding to and stabilizing the CRSP75/Med12 complex.",
      "CRSP67/Med7 subunit is responsible for binding to and stabilizing the CRSP70/Med11 complex.",
      "CRSP64/Med6 subunit is responsible for binding to and stabilizing the CRSP67/Med7 complex."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-7b_response": "Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells. They are not considered to be true viruses, but rather a unique class of infectious agents that are capable of replicating themselves using a single-stranded RNA as a template.\nThe mechanism of viroid replication involves the following steps:\n1. Entry: Viroids enter host cells through receptor-mediated endocytosis or by binding to specific cellular receptors.\n2. Uncoating: The viroid is released from the endosome and transported to the cytoplasm, where it is uncoated from the endosome membrane.\n3. RNA replication: The viroid RNA is replicated using the host cell's ribonucleoprotein (RNP) complex. The RNP complex is composed of ribonucleic acid (RNA), ribosomes, and proteins. The viroid RNA is incorporated into the RNP complex, which then transcribes the viroid RNA into complementary DNA (cDNA) using the host cell's enzymes.\n4. cDNA integration: The cDNA is integrated into the host cell's genome, either as a single copy or as multiple copies, depending on the viroid species.\n5. Replication: The cDNA is transcribed into RNA, which is then translated into proteins by the host cell's ribosomes. The proteins produced by the host cell are used by the viroid to replicate itself.\n6. Cycle: The replicated viroid RNA is released from the host cell and can infect other cells, starting the replication cycle again.\nIt's important to note that viroid replication is a self-replicating process, meaning that the viroid RNA can replicate itself without the need for a helper virus or other external factors. This makes viroids unique among infectious agents and makes them a significant threat to plant health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells.\n2. Viroids are not considered to be true viruses, but rather a unique class of infectious agents.\n3. The mechanism of viroid replication involves entry into host cells through receptor-mediated endocytosis or by binding to specific cellular receptors.\n4. The viroid RNA is replicated using the host cell's ribonucleoprotein (RNP) complex.\n5. The replicated viroid RNA is released from the host cell and can infect other cells, starting the replication cycle again.",
    "vicuna-7b_fact": [
      "Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells.",
      "Viroids are not considered to be true viruses, but rather a unique class of infectious agents.",
      "The mechanism of viroid replication involves entry into host cells through receptor-mediated endocytosis or by binding to specific cellular receptors.",
      "The viroid RNA is replicated using the host cell's ribonucleoprotein (RNP) complex.",
      "The replicated viroid RNA is released from the host cell and can infect other cells, starting the replication cycle again."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The viroid RNA is replicated using the host cell's RNA polymerase, not ribonucleoprotein (RNP) complex.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1698,
    "user_query": "Mutation of which gene is associated with McLeod syndrome?",
    "vicuna-7b_response": "McLeod syndrome is a rare genetic disorder caused by mutations in the ROM2 gene. The ROM2 gene provides instructions for making a protein called retinol-binding protein 2, which is involved in the transport of vitamin A throughout the body. Mutations in the ROM2 gene can lead to a deficiency of vitamin A, which can cause the symptoms of McLeod syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. McLeod syndrome is a rare genetic disorder caused by mutations in the ROM2 gene.\n2. The ROM2 gene provides instructions for making a protein called retinol-binding protein 2.\n3. Retinol-binding protein 2 aids in the transport of vitamin A throughout the body.\n4. Mutations in the ROM2 gene can lead to a deficiency of vitamin A.\n5. A deficiency of vitamin A can cause the symptoms of McLeod syndrome.",
    "vicuna-7b_fact": [
      "McLeod syndrome is a rare genetic disorder caused by mutations in the ROM2 gene.",
      "The ROM2 gene provides instructions for making a protein called retinol-binding protein 2.",
      "Retinol-binding protein 2 aids in the transport of vitamin A throughout the body.",
      "Mutations in the ROM2 gene can lead to a deficiency of vitamin A.",
      "A deficiency of vitamin A can cause the symptoms of McLeod syndrome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: McLeod syndrome is a rare genetic disorder caused by mutations in the XK gene, not the ROM2 gene.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: There isn't a science-based link established between mutations in the ROM2 gene and vitamin A deficiency.\n5. FALSE [correction]: McLeod syndrome's symptoms are not caused by Vitamin A deficiency but by the lack of Kx protein due to the mutation in the XK gene.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1699,
    "user_query": "Is RIP1 (RIP-1) part of the necrosome?",
    "vicuna-7b_response": "Yes, RIP1 (Receptor-interacting protein 1) is part of the necrosome. The necrosome is a complex that is involved in the regulation of cell death and inflammation. RIP1 is a key component of the necrosome and plays a critical role in the regulation of cell death and inflammation. RIP1 interacts with a variety of proteins, including TNF-α (Tumor necrosis factor-alpha), TRAF2 (TNF receptor-associated factor 2), and RIP2 (Receptor-interacting protein 2), to form the necrosome complex. The necrosome complex is involved in the regulation of cell death and inflammation, and dysregulation of the necrosome complex has been implicated in the development of various diseases, including cancer and autoimmune diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RIP1 (Receptor-interacting protein 1) is part of the necrosome.\n2. The necrosome is a complex that is involved in the regulation of cell death and inflammation.\n3. RIP1 interacts with TNF-α (Tumor necrosis factor-alpha), TRAF2 (TNF receptor-associated factor 2), and RIP2 (Receptor-interacting protein 2) to form the necrosome complex.\n4. The necrosome complex is involved in the regulation of cell death and inflammation.\n5. Dysregulation of the necrosome complex has been implicated in the development of various diseases, including cancer and autoimmune diseases.",
    "vicuna-7b_fact": [
      "RIP1 (Receptor-interacting protein 1) is part of the necrosome.",
      "The necrosome is a complex that is involved in the regulation of cell death and inflammation.",
      "RIP1 interacts with TNF-α (Tumor necrosis factor-alpha), TRAF2 (TNF receptor-associated factor 2), and RIP2 (Receptor-interacting protein 2) to form the necrosome complex.",
      "The necrosome complex is involved in the regulation of cell death and inflammation.",
      "Dysregulation of the necrosome complex has been implicated in the development of various diseases, including cancer and autoimmune diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1700,
    "user_query": "Which is the molecular target of the immunosuppressant drug Rapamycin?",
    "vicuna-7b_response": "Rapamycin is an immunosuppressant drug that works by inhibiting the activity of the mammalian target of rapamycin (mTOR) protein. mTOR is a serine/threonine kinase that regulates cell growth and metabolism, and it is overactive in many diseases, including cancer and autoimmune disorders. By inhibiting mTOR, rapamycin reduces the growth and proliferation of cells, which makes it an effective treatment for these conditions.\nRapamycin is primarily used as an immunosuppressant drug after organ transplantation to prevent the rejection of the transplanted organ by the immune system. It works by suppressing the activity of T cells, which are a key component of the immune system and play a central role in the rejection of transplanted organs. By suppressing T cell activity, rapamycin allows the transplanted organ to establish itself in the recipient's body and avoid rejection.\nIn addition to its use as an immunosuppressant drug, rapamycin has also shown promise in the treatment of other diseases, including cancer, diabetes, and inflammatory disorders. However, the exact molecular target of rapamycin in these diseases is not fully understood, and further research is needed to fully explore its therapeutic potential.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Rapamycin is an immunosuppressant drug that inhibits the activity of the mammalian target of rapamycin (mTOR) protein.\n2. mTOR is a serine/threonine kinase that regulates cell growth and metabolism.\n3. mTOR is overactive in many diseases, including cancer and autoimmune disorders.\n4. Rapamycin is used as an immunosuppressant drug following organ transplantation to prevent rejection of the transplanted organ.\n5. By suppressing T cell activity, rapamycin helps to prevent the rejection of transplanted organs.",
    "vicuna-7b_fact": [
      "Rapamycin is an immunosuppressant drug that inhibits the activity of the mammalian target of rapamycin (mTOR) protein.",
      "mTOR is a serine/threonine kinase that regulates cell growth and metabolism.",
      "mTOR is overactive in many diseases, including cancer and autoimmune disorders.",
      "Rapamycin is used as an immunosuppressant drug following organ transplantation to prevent rejection of the transplanted organ.",
      "By suppressing T cell activity, rapamycin helps to prevent the rejection of transplanted organs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1702,
    "user_query": "PBT2 has been tested for which disorder?",
    "vicuna-7b_response": "PBT2, or 3-phenyl-3-butyl-1,2-dihydro-2H-1,4-benzoxazepin-2-one, has been tested for several disorders, including:\n1. Depression: PBT2 has shown potential as an antidepressant in animal models, with studies suggesting that it may work by increasing the levels of the neurotransmitter serotonin in the brain.\n2. Anxiety: PBT2 has also shown potential as an anxiolytic, or anti-anxiety drug, in animal studies.\n3. Alzheimer's disease: PBT2 has been studied for its potential to treat Alzheimer's disease, with some studies suggesting that it may have neuroprotective effects and improve cognitive function in animal models of the disease.\n4. Parkinson's disease: PBT2 has been studied for its potential to treat Parkinson's disease, with some studies suggesting that it may have neuroprotective effects and improve motor function in animal models of the disease.\n5. Schizophrenia: PBT2 has been studied for its potential to treat schizophrenia, with some studies suggesting that it may have antipsychotic effects in animal models of the disease.\nIt's important to note that while PBT2 has shown promise in these studies, more research is needed to fully understand its potential as a treatment for these disorders in humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PBT2 has been tested for its potential as an antidepressant.\n2. Studies have suggested that PBT2 works by increasing the levels of serotonin in the brain.\n3. PBT2 has shown potential as an anxiolytic, or anti-anxiety drug, in animal studies.\n4. PBT2 has been studied for its potential to treat Alzheimer's disease and Parkinson's disease.\n5. PBT2 has been studied for its potential antipsychotic effects in the treatment of schizophrenia.",
    "vicuna-7b_fact": [
      "PBT2 has been tested for its potential as an antidepressant.",
      "Studies have suggested that PBT2 works by increasing the levels of serotonin in the brain.",
      "PBT2 has shown potential as an anxiolytic, or anti-anxiety drug, in animal studies.",
      "PBT2 has been studied for its potential to treat Alzheimer's disease and Parkinson's disease.",
      "PBT2 has been studied for its potential antipsychotic effects in the treatment of schizophrenia."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1704,
    "user_query": "How does long-range epigenetic silencing (LRES) occur?",
    "vicuna-7b_response": "Long-range epigenetic silencing (LRES) is a mechanism that helps to maintain the stability of the epigenetic state of a gene by silencing the expression of a gene that is located far away from the silencing center. This mechanism is important for the proper regulation of gene expression during development and in response to environmental cues.\nLRES occurs through the action of small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), which are produced by the RNA-induced silencing complex (RISC). These small RNA molecules are derived from the transcription of genes that are involved in the silencing of a target gene.\nThe small RNA molecules are then loaded onto the RISC, which recognizes and binds to the complementary sequence of the target gene. Once bound, the RISC cleaves the target mRNA, leading to the degradation of the mRNA and the silencing of the target gene.\nLRES can occur through two different mechanisms: transcription-dependent and transcription-independent. Transcription-dependent LRES occurs through the action of miRNAs, which are derived from the transcription of genes that are involved in the silencing of a target gene. Transcription-independent LRES occurs through the action of siRNAs, which are derived from the transcription of genes that are not involved in the silencing of a target gene.\nIn summary, LRES is a mechanism that helps to maintain the stability of the epigenetic state of a gene by silencing the expression of a gene that is located far away from the silencing center. This mechanism is important for the proper regulation of gene expression during development and in response to environmental cues. LRES occurs through the action of small RNA molecules, such as miRNAs and siRNAs, which are produced by the RNA-induced silencing complex (RISC) and recognize and bind to the complementary sequence of the target gene. Once bound, the RISC cleaves the target mRNA, leading to the degradation of the mRNA and the silencing of the target gene. LRES can occur through two different mechanisms: transcription-dependent and transcription-independent.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Long-range epigenetic silencing (LRES) is a mechanism that silences the expression of a gene located far from the silencing center to maintain the stability of the gene's epigenetic state.\n2. LRES occurs through the action of small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs).\n3. These small RNA molecules are produced by the RNA-induced silencing complex (RISC).\n4. Once these small RNA molecules are loaded onto the RISC and recognize and bind to the complementary sequence of the target gene, the target mRNA is cleaved, leading to its degradation and the silencing of the target gene.\n5. LRES can occur through two different mechanisms: transcription-dependent and transcription-independent.",
    "vicuna-7b_fact": [
      "Long-range epigenetic silencing (LRES) is a mechanism that silences the expression of a gene located far from the silencing center to maintain the stability of the gene's epigenetic state.",
      "LRES occurs through the action of small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs).",
      "These small RNA molecules are produced by the RNA-induced silencing complex (RISC).",
      "Once these small RNA molecules are loaded onto the RISC and recognize and bind to the complementary sequence of the target gene, the target mRNA is cleaved, leading to its degradation and the silencing of the target gene.",
      "LRES can occur through two different mechanisms: transcription-dependent and transcription-independent."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Long-range epigenetic silencing (LRES) usually refers to a mechanism that silences the expression of multiple contiguous genes located in specific chromosomal regions.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: To our current knowledge, LRES usually occurs through silencing the promoter activity of tumor suppressor genes which can be achieved by DNA methylation or by modifying histones. Further clarification or specification on the two \"transcription-dependent and transcription-independent\" mechanisms is required.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1706,
    "user_query": "Can RNAPolII function as an RNA-dependent RNA-polymerase?",
    "vicuna-7b_response": "RNAPolII, or RNA polymerase II, is a type of RNA polymerase that is responsible for synthesizing RNA molecules in eukaryotic cells. RNA polymerase II is a complex enzyme that consists of several subunits, and it is responsible for synthesizing the majority of the RNA molecules in a eukaryotic cell.\nRNA polymerase II is a specialized enzyme that is capable of synthesizing RNA molecules from DNA templates. It is able to do this by recognizing specific sequences of nucleotides in the DNA template and using them as a guide to synthesize an RNA molecule that is complementary to the template.\nRNA polymerase II is not capable of synthesizing RNA molecules from RNA templates. It is only able to synthesize RNA molecules from DNA templates. This is because RNA polymerase II is a DNA-dependent RNA polymerase, and it is not able to synthesize RNA molecules from RNA templates.\nIn summary, RNAPolII is a type of RNA polymerase that is capable of synthesizing RNA molecules from DNA templates, but it is not capable of synthesizing RNA molecules from RNA templates.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNAPolII, or RNA polymerase II, synthesizes RNA molecules in eukaryotic cells.\n2. RNA polymerase II is a complex enzyme that consists of several subunits.\n3. RNA polymerase II synthesizes the majority of the RNA molecules in a eukaryotic cell.\n4. RNA polymerase II synthesizes RNA molecules from DNA templates.\n5. RNA polymerase II is not able to synthesize RNA molecules from RNA templates.",
    "vicuna-7b_fact": [
      "RNAPolII, or RNA polymerase II, synthesizes RNA molecules in eukaryotic cells.",
      "RNA polymerase II is a complex enzyme that consists of several subunits.",
      "RNA polymerase II synthesizes the majority of the RNA molecules in a eukaryotic cell.",
      "RNA polymerase II synthesizes RNA molecules from DNA templates.",
      "RNA polymerase II is not able to synthesize RNA molecules from RNA templates."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1708,
    "user_query": "List sclerostin interaction partners.",
    "vicuna-7b_response": "Sclerostin is a protein that plays a role in the regulation of bone growth and remodeling. It is produced by osteocytes, the cells that make up the bone matrix, and acts as a negative regulator of the Wnt signaling pathway. Sclerostin binds to the LRP5/6 receptors on the surface of osteoblasts and inhibits the production of the Wnt protein, which is involved in the regulation of bone formation.\nSclerostin has been shown to interact with a number of proteins, including:\n1. DKK1 (Dickkopf-related protein 1): DKK1 is a protein that also acts as a negative regulator of the Wnt signaling pathway and has been shown to bind to sclerostin and inhibit its activity.\n2. Sostdc1 (Sclerostin-like protein 1): Sostdc1 is a protein that is structurally similar to sclerostin and has been shown to bind to sclerostin and inhibit its activity.\n3. LRP5 (Low-density lipoprotein receptor-related protein 5): LRP5 is a receptor that sclerostin binds to and inhibits the production of the Wnt protein.\n4. LRP6 (Low-density lipoprotein receptor-related protein 6): LRP6 is a receptor that sclerostin binds to and inhibits the production of the Wnt protein.\n5. BMPR1B (Bone morphogenetic protein receptor 1B): BMPR1B is a receptor that has been shown to interact with sclerostin and inhibit its activity.\n6. SOST (Sclerostin): SOST is the gene that encodes sclerostin and has been shown to interact with its own product, inhibiting its activity.\nThese interactions are important in the regulation of bone growth and remodeling, and dysregulation of these interactions has been implicated in the development of diseases such as osteoporosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sclerostin is a protein that plays a role in the regulation of bone growth and remodeling.\n2. Sclerostin binds to the LRP5/6 receptors on the surface of osteoblasts and inhibits the production of the Wnt protein.\n3. DKK1 (Dickkopf-related protein 1) has been shown to bind to sclerostin and inhibit its activity.\n4. Sostdc1 (Sclerostin-like protein 1) has been shown to bind to sclerostin and inhibit its activity.\n5. BMPR1B (Bone morphogenetic protein receptor 1B) has been shown to interact with sclerostin and inhibit its activity.",
    "vicuna-7b_fact": [
      "Sclerostin is a protein that plays a role in the regulation of bone growth and remodeling.",
      "Sclerostin binds to the LRP5/6 receptors on the surface of osteoblasts and inhibits the production of the Wnt protein.",
      "DKK1 (Dickkopf-related protein 1) has been shown to bind to sclerostin and inhibit its activity.",
      "Sostdc1 (Sclerostin-like protein 1) has been shown to bind to sclerostin and inhibit its activity.",
      "BMPR1B (Bone morphogenetic protein receptor 1B) has been shown to interact with sclerostin and inhibit its activity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DKK1 binds and inhibits Wnt proteins, not sclerostin.\n4. FALSE [correction]: Sostdc1, while related to sclerostin, doesn't bind directly to it nor inhibit its activity.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1711,
    "user_query": "Which are currently available software tools for detecting rare codon clusters in coding sequences?",
    "vicuna-7b_response": "There are several software tools available for detecting rare codon clusters in coding sequences. Here are some of the most popular ones:\n1. RareCodonFinder: This is a web-based tool that uses a hidden Markov model to identify rare codon clusters in coding sequences. It can be accessed through the website <https://www.ncbi.nlm.nih.gov/tools/genomics/cdd/rarecodonfinder/>.\n2. CodonCluster: This is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences. It can be downloaded from the website <https://github.com/mikro-lab/CodonCluster>.\n3. CodonRare: This is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences. It can be downloaded from the website <https://github.com/mikro-lab/CodonRare>.\n4. CodonClusterFinder: This is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences. It can be downloaded from the website <https://github.com/mikro-lab/CodonClusterFinder>.\n5. CodonRareFinder: This is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences. It can be downloaded from the website <https://github.com/mikro-lab/CodonRareFinder>.\nThese tools can be useful for identifying rare codon clusters in coding sequences, which can be important for understanding the evolution of genes and proteins. However, it is important to note that the results obtained from these tools may vary depending on the specific sequence and the parameters used. Therefore, it is recommended to carefully evaluate the results and consult with experts in the field if necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RareCodonFinder is a web-based tool that uses a hidden Markov model to identify rare codon clusters in coding sequences. \n2. CodonCluster is an available software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.\n3. CodonRare is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.\n4. CodonClusterFinder is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.\n5. CodonRareFinder is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.",
    "vicuna-7b_fact": [
      "RareCodonFinder is a web-based tool that uses a hidden Markov model to identify rare codon clusters in coding sequences.",
      "CodonCluster is an available software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.",
      "CodonRare is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.",
      "CodonClusterFinder is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences.",
      "CodonRareFinder is a software tool that uses a genetic algorithm to identify rare codon clusters in coding sequences."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1714,
    "user_query": "Where does CTCF colocalize with cohesin?",
    "vicuna-7b_response": "CTCF (CCCTC-binding factor) and cohesin are two important chromosomal proteins that play crucial roles in regulating gene expression and maintaining the structure of chromosomes. While CTCF and cohesin have distinct functions, they can also be found in the same regions of the genome and can interact with each other.\nCTCF is a transcriptional regulator that binds to DNA sequences called CTCF motifs, which are found in the promoter regions of genes. CTCF can also bind to insulators, which are DNA sequences that block the interaction between enhancers and promoters, thereby regulating the expression of genes. CTCF has been shown to play a role in the regulation of gene expression during development, and it has also been implicated in the regulation of stem cell pluripotency.\nCohesin is a complex composed of the proteins SMC1, SMC3, and SA2H, which forms a compact structure around the DNA in the vicinity of replication forks. Cohesin is involved in the maintenance of chromosome structure and the regulation of gene expression. Cohesin also plays a role in the repair of DNA damage and the regulation of DNA replication.\nWhile CTCF and cohesin are not directly involved in the same biological process, they can be found in the same regions of the genome and can interact with each other. For example, CTCF has been shown to bind to cohesin-containing complexes and to regulate the activity of cohesin-bound genes. Additionally, cohesin has been shown to be recruited to CTCF-bound regions of the genome, suggesting that the two proteins can interact and function together in regulating gene expression.\nIn summary, while CTCF and cohesin have distinct functions, they can also be found in the same regions of the genome and can interact with each other. CTCF can bind to cohesin-containing complexes and regulate the activity of cohesin-bound genes, while cohesin can be recruited to CTCF-bound regions of the genome. These interactions may play a role in the regulation of gene expression during development and in the maintenance of chromosome structure.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC-binding factor) and cohesin are chromosomal proteins that play roles in regulating gene expression and maintaining the structure of chromosomes.\n2. CTCF is a transcriptional regulator that binds to DNA sequences called CTCF motifs, which are found in the promoter regions of genes.\n3. Cohesin is a complex composed of the proteins SMC1, SMC3, and SA2H, and is involved in the maintenance of chromosome structure and the regulation of gene expression.\n4. CTCF and cohesin can be found in the same regions of the genome and can interact with each other.\n5. CTCF can bind to cohesin-containing complexes and regulate the activity of cohesin-bound genes, while cohesin can be recruited to CTCF-bound regions of the genome.",
    "vicuna-7b_fact": [
      "CTCF (CCCTC-binding factor) and cohesin are chromosomal proteins that play roles in regulating gene expression and maintaining the structure of chromosomes.",
      "CTCF is a transcriptional regulator that binds to DNA sequences called CTCF motifs, which are found in the promoter regions of genes.",
      "Cohesin is a complex composed of the proteins SMC1, SMC3, and SA2H, and is involved in the maintenance of chromosome structure and the regulation of gene expression.",
      "CTCF and cohesin can be found in the same regions of the genome and can interact with each other.",
      "CTCF can bind to cohesin-containing complexes and regulate the activity of cohesin-bound genes, while cohesin can be recruited to CTCF-bound regions of the genome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Cohesin is a complex composed of the proteins SMC1, SMC3, SCC1/RAD21 and SA1/SA2, and is involved in the maintenance of chromosome structure and the regulation of gene expression.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1715,
    "user_query": "Name triad of Wernicke encephalopathy.",
    "vicuna-7b_response": "Wernicke encephalopathy is a neurological disorder that is caused by a deficiency in the neurotransmitter, thiamine (vitamin B1). It is characterized by a triad of symptoms:\n1. Confusion: The patient may experience confusion, disorientation, and memory loss.\n2. Oculomotor apraxia: This is a condition where the patient has difficulty with eye movements, such as blinking or following objects with their eyes.\n3. Wernicke's paradoxical rigidity: This is a condition where the patient experiences stiffness or rigidity in their limbs, which can make it difficult for them to move or perform tasks.\nIt is important to note that Wernicke encephalopathy is often seen in individuals who have a history of alcohol abuse, as thiamine deficiency is a common complication of heavy alcohol consumption.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Wernicke encephalopathy is a neurological disorder caused by a deficiency in thiamine (vitamin B1).\n2. Wernicke encephalopathy is characterized by confusion, oculomotor apraxia, and Wernicke's paradoxical rigidity.\n3. Confusion in Wernicke encephalopathy may involve disorientation and memory loss.\n4. Oculomotor apraxia, a symptom of Wernicke encephalopathy, is a condition where the patient has difficulty with eye movements.\n5. Thiamine deficiency, the cause of Wernicke encephalopathy, is often seen in individuals with a history of alcohol abuse.",
    "vicuna-7b_fact": [
      "Wernicke encephalopathy is a neurological disorder caused by a deficiency in thiamine (vitamin B1).",
      "Wernicke encephalopathy is characterized by confusion, oculomotor apraxia, and Wernicke's paradoxical rigidity.",
      "Confusion in Wernicke encephalopathy may involve disorientation and memory loss.",
      "Oculomotor apraxia, a symptom of Wernicke encephalopathy, is a condition where the patient has difficulty with eye movements.",
      "Thiamine deficiency, the cause of Wernicke encephalopathy, is often seen in individuals with a history of alcohol abuse."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Wernicke encephalopathy is characterized by confusion, nystagmus (involuntary eye movement), and ataxia (inability to coordinate muscle movements), not oculomotor apraxia and Wernicke's paradoxical rigidity.\n3. TRUE\n4. FALSE [correction]: Oculomotor apraxia is not a symptom of Wernicke encephalopathy. Instead, nystagmus and ophthalmoplegia (weakness or paralysis of the muscles in the eye) are common eye-related symptoms.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-7b_response": "Fibronectin is a protein that is found in the extracellular matrix and plays a role in cell adhesion and migration. It is not typically considered a serum biomarker for Duchenne muscular dystrophy (DMD).\nDMD is a genetic disorder that affects muscle strength and function. It is caused by a mutation in the dystrophin gene, which results in a lack of dystrophin protein in muscle cells. The hallmark of DMD is progressive muscle weakness and wasting, particularly in the legs.\nThere are several serum biomarkers that have been studied in DMD, including creatine kinase (CK), muscle enzymes such as aldolase and aspartate aminotransferase (AST/ALT), and muscle-specific proteins such as myoglobin and troponin. These biomarkers can be used to diagnose DMD and monitor disease progression.\nHowever, it is important to note that fibronectin is not a specific biomarker for DMD, and its levels in the serum are not typically used to diagnose or monitor the disease. Further research is needed to determine the potential role of fibronectin in DMD.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fibronectin is a protein that is found in the extracellular matrix and plays a role in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is a genetic disorder caused by a mutation in the dystrophin gene.\n3. The lack of dystrophin protein in muscle cells is a characteristic of DMD.\n4. Serum biomarkers such as creatine kinase (CK), muscle enzymes like aldolase and aspartate aminotransferase (AST/ALT), and muscle-specific proteins such as myoglobin and troponin, have been studied in DMD.\n5. Fibronectin is not a specific serum biomarker for Duchenne muscular dystrophy.",
    "vicuna-7b_fact": [
      "Fibronectin is a protein that is found in the extracellular matrix and plays a role in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is a genetic disorder caused by a mutation in the dystrophin gene.",
      "The lack of dystrophin protein in muscle cells is a characteristic of DMD.",
      "Serum biomarkers such as creatine kinase (CK), muscle enzymes like aldolase and aspartate aminotransferase (AST/ALT), and muscle-specific proteins such as myoglobin and troponin, have been studied in DMD.",
      "Fibronectin is not a specific serum biomarker for Duchenne muscular dystrophy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1732,
    "user_query": "What is the association between number of pregnancies and rheumatoid arthritis",
    "vicuna-7b_response": "There is some evidence to suggest that there may be an association between the number of pregnancies a woman has and the risk of developing rheumatoid arthritis (RA).\nStudies have shown that women who have had more pregnancies are at a lower risk of developing RA compared to women who have had fewer pregnancies. This association is thought to be due to the fact that pregnancy can have a protective effect on the immune system, which may help to reduce the risk of developing autoimmune diseases like RA.\nAdditionally, some research has suggested that the hormonal changes that occur during pregnancy may also play a role in reducing the risk of developing RA. For example, pregnancy is associated with an increase in the production of progesterone, which has been shown to have anti-inflammatory effects and may help to reduce the risk of developing autoimmune diseases.\nIt's important to note that more research is needed to fully understand the association between the number of pregnancies and the risk of developing RA. Additionally, other factors such as genetics and environmental exposures may also play a role in the development of this disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Some studies suggest that there is an association between the number of pregnancies a woman has and the risk of developing rheumatoid arthritis.\n2. Women who have had more pregnancies are at a lower risk of developing RA compared to women who have had fewer pregnancies.\n3. Pregnancy can have a protective effect on the immune system, which may reduce the risk of autoimmune diseases like RA.\n4. Hormonal changes during pregnancy, such as increased production of progesterone, may help reduce the risk of developing autoimmune diseases.\n5. Other factors like genetics and environmental exposures may play a role in the development of rheumatoid arthritis.",
    "vicuna-7b_fact": [
      "Some studies suggest that there is an association between the number of pregnancies a woman has and the risk of developing rheumatoid arthritis.",
      "Women who have had more pregnancies are at a lower risk of developing RA compared to women who have had fewer pregnancies.",
      "Pregnancy can have a protective effect on the immune system, which may reduce the risk of autoimmune diseases like RA.",
      "Hormonal changes during pregnancy, such as increased production of progesterone, may help reduce the risk of developing autoimmune diseases.",
      "Other factors like genetics and environmental exposures may play a role in the development of rheumatoid arthritis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1737,
    "user_query": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?",
    "vicuna-7b_response": "Amifostine is a prodrug that is used as a radioprotective agent to protect healthy cells from the harmful effects of radiation therapy. However, it is not currently approved for use in chemotherapy.\nChemotherapy is a treatment that uses drugs to kill cancer cells. These drugs can damage healthy cells as well, which can lead to side effects such as hair loss, nausea, and fatigue. One way to protect healthy cells during chemotherapy is to use a drug called cyclophosphamide. This drug can reduce the production of white blood cells, which can help to protect healthy cells from the harmful effects of chemotherapy.\nAnother way to protect healthy cells during chemotherapy is to use a drug called granulocyte colony-stimulating factor (G-CSF). This drug can help to increase the production of white blood cells, which can help to protect healthy cells from infection.\nIt is important to note that the use of prodrugs like amifostine in chemotherapy is still being studied, and more research is needed to determine its effectiveness and safety.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Amifostine is a prodrug used to protect healthy cells from the effects of radiation therapy.\n2. Amifostine is not currently approved for use in chemotherapy.\n3. One way to protect healthy cells during chemotherapy is to use a drug called cyclophosphamide.\n4. Another agent used to protect cells during chemotherapy is granulocyte colony-stimulating factor (G-CSF).\n5. The use of prodrugs like amifostine in chemotherapy is still under study.",
    "vicuna-7b_fact": [
      "Amifostine is a prodrug used to protect healthy cells from the effects of radiation therapy.",
      "Amifostine is not currently approved for use in chemotherapy.",
      "One way to protect healthy cells during chemotherapy is to use a drug called cyclophosphamide.",
      "Another agent used to protect cells during chemotherapy is granulocyte colony-stimulating factor (G-CSF).",
      "The use of prodrugs like amifostine in chemotherapy is still under study."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Amifostine is approved for use in chemotherapy to reduce the side effects of treatment.\n3. FALSE [correction]: Cyclophosphamide is a chemotherapy drug itself and is not a drug used to protect healthy cells during chemotherapy.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1738,
    "user_query": "Which is the main difference between Alu and B1 repeats?",
    "vicuna-7b_response": "Alu and B1 repeats are two types of repetitive DNA sequences that are found in the human genome. While they share some similarities, there are also some key differences between them.\nAlu repeats are short (typically 32 nucleotides) and have a high degree of sequence identity with each other. They are also highly methylated, which helps to silence their expression. Alu repeats are thought to have arisen from a mobile element called Alu, which was integrated into the human genome millions of years ago. They are found in all human chromosomes and are the most abundant type of repetitive DNA in the genome.\nB1 repeats, on the other hand, are longer (typically 200-300 nucleotides) and have a lower degree of sequence identity with each other. They are also less methylated than Alu repeats, which suggests that they are less silenced. B1 repeats are also thought to have arisen from a mobile element called B1, which was integrated into the human genome millions of years ago. They are found in all human chromosomes as well, but are less abundant than Alu repeats.\nIn summary, the main difference between Alu and B1 repeats is their size and degree of sequence identity. Alu repeats are short and highly methylated, while B1 repeats are longer and less methylated.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alu repeats are short, typically 32 nucleotides, and have a high degree of sequence identity with each other.\n2. Alu repeats are highly methylated and are the most abundant type of repetitive DNA in the human genome.\n3. Alu repeats are thought to have arisen from a mobile element called Alu that was integrated into the human genome millions of years ago.\n4. B1 repeats are longer, typically 200-300 nucleotides, and have a lower degree of sequence identity with each other.\n5. B1 repeats are less methylated than Alu repeats and are less abundant in the human genome.",
    "vicuna-7b_fact": [
      "Alu repeats are short, typically 32 nucleotides, and have a high degree of sequence identity with each other.",
      "Alu repeats are highly methylated and are the most abundant type of repetitive DNA in the human genome.",
      "Alu repeats are thought to have arisen from a mobile element called Alu that was integrated into the human genome millions of years ago.",
      "B1 repeats are longer, typically 200-300 nucleotides, and have a lower degree of sequence identity with each other.",
      "B1 repeats are less methylated than Alu repeats and are less abundant in the human genome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Alu repeats are short, typically around 300 nucleotides, and have a high degree of sequence identity with each other.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1740,
    "user_query": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?",
    "vicuna-7b_response": "Ethylnitrosourea (ENU) is a chemical mutagen that is commonly used in laboratory research to induce mutations in model organisms such as mice, rats, and fruit flies. The frequency of mutations induced by ENU varies depending on the species, the dose of the mutagen, and the genetic background of the organisms being studied.\nIn mice, for example, the frequency of mutations induced by ENU can range from 1-10% of the offspring, depending on the dose of the mutagen and the genetic background of the mice. The frequency of mutations can also be influenced by the specific genes that are being targeted by the mutagen.\nIn general, ENU is a relatively efficient mutagen that can induce a wide range of mutations, including point mutations, deletions, and insertions. However, the specific frequency of mutations induced by ENU will depend on the specific conditions of the experiment.\nIt's important to note that ENU is a potent mutagen and should be used with caution in laboratory research. The use of ENU should be approved by an Institutional Biosafety Committee (IBC) and the experiments should be conducted under strict containment conditions to minimize the risk of mutations in humans and other organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ethylnitrosourea (ENU) is a chemical mutagen used in laboratory research to induce mutations in model organisms like mice, rats, and fruit flies.\n2. The frequency of mutations induced by ENU can range from 1-10% of the offspring in mice, depending on the dose of the mutagen and the genetic background of the mice.\n3. ENU can induce a wide range of mutations, including point mutations, deletions, and insertions.\n4. The use of ENU should be approved by an Institutional Biosafety Committee (IBC).\n5. Experiments using ENU should be conducted under strict containment conditions to minimize the risk of mutations in humans and other organisms.",
    "vicuna-7b_fact": [
      "Ethylnitrosourea (ENU) is a chemical mutagen used in laboratory research to induce mutations in model organisms like mice, rats, and fruit flies.",
      "The frequency of mutations induced by ENU can range from 1-10% of the offspring in mice, depending on the dose of the mutagen and the genetic background of the mice.",
      "ENU can induce a wide range of mutations, including point mutations, deletions, and insertions.",
      "The use of ENU should be approved by an Institutional Biosafety Committee (IBC).",
      "Experiments using ENU should be conducted under strict containment conditions to minimize the risk of mutations in humans and other organisms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The use of ENU should be approved by an Institutional Animal Care and Use Committee (IACUC), not an Institutional Biosafety Committee (IBC).\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1758,
    "user_query": "Has Glucose-6-phosphate dehydrogenase (G6PD) deficiency an X-linked inheritance?",
    "vicuna-7b_response": "Yes, Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder.\nG6PD is a enzyme that is responsible for catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconate in the pentose phosphate pathway. This pathway is important for the production of NADPH, which is used in the production of ATP and the detoxification of certain drugs and toxins.\nG6PD deficiency is caused by mutations in the G6PD gene, which is located on the X chromosome. The G6PD gene has a large X-linked recessive mutation rate, which means that the gene is more likely to be mutated in males than in females. This is because males only have one X chromosome, while females have two X chromosomes. If a male has a mutation in the G6PD gene, he will be affected by the disorder, while a female with the same mutation will be a carrier of the disorder.\nIn summary, G6PD deficiency is an X-linked recessive disorder caused by mutations in the G6PD gene, which is located on the X chromosome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder.\n2. G6PD is an enzyme that catalyzes the conversion of glucose-6-phosphate to 6-phosphogluconate in the pentose phosphate pathway.\n3. The pentose phosphate pathway is important for the production of NADPH.\n4. G6PD deficiency is caused by mutations in the G6PD gene, which is located on the X chromosome.\n5. The G6PD gene, located on the X chromosome, has a large X-linked recessive mutation rate, meaning the gene is more likely to be mutated in males than in females.",
    "vicuna-7b_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder.",
      "G6PD is an enzyme that catalyzes the conversion of glucose-6-phosphate to 6-phosphogluconate in the pentose phosphate pathway.",
      "The pentose phosphate pathway is important for the production of NADPH.",
      "G6PD deficiency is caused by mutations in the G6PD gene, which is located on the X chromosome.",
      "The G6PD gene, located on the X chromosome, has a large X-linked recessive mutation rate, meaning the gene is more likely to be mutated in males than in females."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1760,
    "user_query": "Which mutated genes are associated with the Tourette's syndrome?",
    "vicuna-7b_response": "Tourette's syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics. While the exact cause of Tourette's syndrome is not fully understood, research has identified several genetic mutations that are associated with the condition.\nOne of the most well-known genetic mutations associated with Tourette's syndrome is a mutation in the CHRNA7 gene. This gene provides instructions for making a protein that is involved in the function of nerve cells in the brain. Mutations in this gene have been linked to an increased risk of developing Tourette's syndrome.\nAnother gene that has been associated with Tourette's syndrome is the GAD67 gene. This gene provides instructions for making an enzyme called glutamic acid decarboxylase, which is involved in the regulation of neurotransmitter activity in the brain. Mutations in the GAD67 gene have been found to increase the risk of developing Tourette's syndrome.\nOther genes that have been associated with Tourette's syndrome include the DAT1, MET, and MAP2K4 genes. These genes provide instructions for making proteins that are involved in various aspects of brain function, including neurotransmitter regulation and cell signaling.\nIt's important to note that while these genetic mutations are associated with an increased risk of developing Tourette's syndrome, not everyone with a mutation in one of these genes will develop the condition. Additionally, there may be other genetic and environmental factors that contribute to the development of Tourette's syndrome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tourette's syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics.\n2. A genetic mutation in the CHRNA7 gene is associated with Tourette's syndrome.\n3. The CHRNA7 gene provides instructions for making a protein that is involved in the function of nerve cells in the brain.\n4. The GAD67 gene, which provides instructions for an enzyme involved in neurotransmitter regulation, is associated with Tourette's syndrome when it is mutated.\n5. The DAT1, MET, and MAP2K4 genes, associated with various aspects of brain function, are also associated with Tourette's syndrome when mutated.",
    "vicuna-7b_fact": [
      "Tourette's syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics.",
      "A genetic mutation in the CHRNA7 gene is associated with Tourette's syndrome.",
      "The CHRNA7 gene provides instructions for making a protein that is involved in the function of nerve cells in the brain.",
      "The GAD67 gene, which provides instructions for an enzyme involved in neurotransmitter regulation, is associated with Tourette's syndrome when it is mutated.",
      "The DAT1, MET, and MAP2K4 genes, associated with various aspects of brain function, are also associated with Tourette's syndrome when mutated."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: A genetic mutation in the SLITRK1 gene has been associated with Tourette's syndrome, not the CHRNA7 gene.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-7b_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. ENCODE (Encyclopedia Of DNA Elements) project: This project aims to identify all functional elements in the human genome, including regulatory elements that control gene expression. The ENCODE project has generated a large amount of data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n2. Roadmap Epigenomics Project: This project aims to map the epigenomes of several human cell types and tissues, and to identify the regulatory elements that control gene expression. The Roadmap Epigenomics Project has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n3. Epigenomics Project of the Human Cell: This project aims to map the epigenomes of several human cell types and tissues, and to identify the regulatory elements that control gene expression. The Epigenomics Project of the Human Cell has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n4. ENCODE Drug Response Project: This project aims to identify the regulatory elements that control gene expression in response to drugs, and to use this information to develop new drugs and personalized therapies.\n5. ENCODE Transcription Factor Binding Project: This project aims to identify the transcription factors that bind to regulatory elements in the human genome, and to use this information to understand how gene expression is regulated.\nThese are some of the major epigenome projects that are contained in the DeepBlue epigenomic data server.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) project.\n2. ENCODE project aims to identify all functional elements in the human genome, including regulatory elements that control gene expression.\n3. The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.\n4. Roadmap Epigenomics Project aims to map the epigenomes of several human cell types and tissues and identify the regulatory elements that control gene expression.\n5. The DeepBlue epigenomic data server contains data from the Epigenomics Project of the Human Cell.",
    "vicuna-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) project.",
      "ENCODE project aims to identify all functional elements in the human genome, including regulatory elements that control gene expression.",
      "The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.",
      "Roadmap Epigenomics Project aims to map the epigenomes of several human cell types and tissues and identify the regulatory elements that control gene expression.",
      "The DeepBlue epigenomic data server contains data from the Epigenomics Project of the Human Cell."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1765,
    "user_query": "Is the toxin produced by Clostridium botulinum always deadly?",
    "vicuna-7b_response": "Clostridium botulinum is a bacterium that produces a toxin that is one of the most potent neurotoxins known. The toxin produced by this bacterium is called botulinum toxin, and it can be extremely dangerous if ingested or inhaled.\nThe toxin produced by Clostridium botulinum is highly toxic and can cause a condition called botulism. Botulism is a serious illness that can lead to paralysis and death if left untreated. The toxin works by blocking the release of a neurotransmitter called acetylcholine, which is essential for muscle function. This can lead to muscle weakness and paralysis, and in severe cases, it can cause respiratory failure and death.\nWhile the toxin produced by Clostridium botulinum is always deadly if ingested or inhaled, the severity of the illness can vary depending on the amount of toxin ingested and the speed at which treatment is received. In some cases, botulism can be treated with antitoxin and supportive care, but in severe cases, a patient may require ventilatory support or even a tracheostomy.\nIt is important to note that Clostridium botulinum is a common bacterium that can be found in soil, water, and the gastrointestinal tracts of animals and humans. It is not always harmful, but it can be dangerous if the toxin is ingested or inhaled. Therefore, it is important to practice good hygiene and food safety practices to prevent the spread of botulism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Clostridium botulinum is a bacterium that produces botulinum toxin, one of the most potent neurotoxins known.\n2. The toxin produced by Clostridium botulinum can cause a condition called botulism.\n3. Botulism can lead to paralysis and death if left untreated.\n4. The severity of botulism can vary depending on the amount of toxin ingested and the speed at which treatment is received.\n5. Clostridium botulinum is a common bacterium that can be found in soil, water, and the gastrointestinal tracts of animals and humans.",
    "vicuna-7b_fact": [
      "Clostridium botulinum is a bacterium that produces botulinum toxin, one of the most potent neurotoxins known.",
      "The toxin produced by Clostridium botulinum can cause a condition called botulism.",
      "Botulism can lead to paralysis and death if left untreated.",
      "The severity of botulism can vary depending on the amount of toxin ingested and the speed at which treatment is received.",
      "Clostridium botulinum is a common bacterium that can be found in soil, water, and the gastrointestinal tracts of animals and humans."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Clostridium botulinum can be found in soil and water, but it is not commonly found in the gastrointestinal tracts of healthy animals and humans.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1777,
    "user_query": "Which gene-defect causes the Vel-blood type?",
    "vicuna-7b_response": "The gene defect that causes the VEL-blood type is the RhD gene. The RhD gene is located on chromosome 1 and encodes for the RhD protein, which is involved in the regulation of red blood cell formation.\nThe VEL-blood type is also known as the \"Rh-negative\" blood type, which refers to individuals who do not have the RhD protein on the surface of their red blood cells. This is caused by a genetic variation in the RhD gene, where the gene is either missing or not functioning properly.\nIndividuals with the VEL-blood type can receive blood transfusions from individuals with the VEL-blood type, but they cannot receive blood transfusions from individuals with the VER-blood type, as their red blood cells have the RhD protein on the surface.\nIt's important to note that the RhD gene is just one of the many genes that can cause blood type variations, and there are many other genetic and environmental factors that can affect blood type.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The RhD gene defect causes the VEL-blood type.\n2. The RhD gene is located on chromosome 1.\n3. The RhD gene encodes for the RhD protein, which is involved in the regulation of red blood cell formation.\n4. The \"Rh-negative\" blood type is also known as the VEL-blood type.\n5. Individuals with the VEL-blood type cannot receive blood transfusions from individuals with the VER-blood type.",
    "vicuna-7b_fact": [
      "The RhD gene defect causes the VEL-blood type.",
      "The RhD gene is located on chromosome 1.",
      "The RhD gene encodes for the RhD protein, which is involved in the regulation of red blood cell formation.",
      "The \"Rh-negative\" blood type is also known as the VEL-blood type.",
      "Individuals with the VEL-blood type cannot receive blood transfusions from individuals with the VER-blood type."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The RhD gene defect does not cause the VEL-blood type. This is caused by absence of the SMIM1 gene.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The \"Rh-negative\" blood type is not known as the VEL-blood type. Rh-negative refers to the absence of RhD antigens.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1782,
    "user_query": "What are the exonic splice enhancers?",
    "vicuna-7b_response": "Exonic splice enhancers are non-coding regions located upstream of an exon that enhance the inclusion of the exon into the mature mRNA. They do this by recruiting proteins that promote the splicing of the exon, such as the spliceosome. Exonic splice enhancers are important for the proper expression of genes, as they ensure that the exon is included in the mature mRNA even in the presence of alternative splicing events.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Exonic splice enhancers are non-coding regions located upstream of an exon.\n2. They enhance the inclusion of the exon into the mature mRNA.\n3. Exonic splice enhancers recruit proteins that promote the splicing of the exon, such as the spliceosome.\n4. Exonic splice enhancers are important for the proper expression of genes.\n5. They ensure that the exon is included in the mature mRNA even in the presence of alternative splicing events.",
    "vicuna-7b_fact": [
      "Exonic splice enhancers are non-coding regions located upstream of an exon.",
      "They enhance the inclusion of the exon into the mature mRNA.",
      "Exonic splice enhancers recruit proteins that promote the splicing of the exon, such as the spliceosome.",
      "Exonic splice enhancers are important for the proper expression of genes.",
      "They ensure that the exon is included in the mature mRNA even in the presence of alternative splicing events."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Exonic splice enhancers are sequences located within the exon, not upstream of it.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1784,
    "user_query": "What is Neisseria adhesin A?",
    "vicuna-7b_response": "Neisseria adhesin A is a protein found on the surface of certain strains of the bacteria Neisseria, which includes the species Neisseria meningitidis and Neisseria gonorrhoeae. These bacteria are known to cause a variety of infections, including meningitis, sepsis, and gonorrhea.\nNeisseria adhesin A is a type of adhesin, which is a protein that allows the bacteria to attach to and colonize certain surfaces in the body. In the case of Neisseria, adhesin A allows the bacteria to attach to and colonize mucosal surfaces, such as the respiratory and genitourinary tracts.\nThe function of Neisseria adhesin A is to help the bacteria evade the host's immune system and establish an infection. It does this by binding to specific receptors on the surface of host cells, allowing the bacteria to enter and colonize the cells.\nIn addition to its role in colonization, Neisseria adhesin A has also been implicated in the pathogenesis of certain Neisseria infections. For example, in meningitis caused by Neisseria meningitidis, adhesin A has been shown to contribute to the bacteria's ability to evade the host's immune response and cause disease.\nOverall, Neisseria adhesin A is an important protein for the pathogenesis of certain Neisseria infections, and its study may provide insights into the mechanisms of these infections and potential targets for the development of new treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neisseria adhesin A is a protein found on the surface of certain strains of the bacteria Neisseria.\n2. The bacteria Neisseria includes the species Neisseria meningitidis and Neisseria gonorrhoeae.\n3. Neisseria adhesin A helps the bacteria attach to and colonize certain surfaces in the body, such as the respiratory and genitourinary tracts.\n4. The function of Neisseria adhesin A is to help the bacteria evade the host's immune system and establish an infection.\n5. Neisseria adhesin A has been implicated in the pathogenesis of certain Neisseria infections, such as meningitis caused by Neisseria meningitidis.",
    "vicuna-7b_fact": [
      "Neisseria adhesin A is a protein found on the surface of certain strains of the bacteria Neisseria.",
      "The bacteria Neisseria includes the species Neisseria meningitidis and Neisseria gonorrhoeae.",
      "Neisseria adhesin A helps the bacteria attach to and colonize certain surfaces in the body, such as the respiratory and genitourinary tracts.",
      "The function of Neisseria adhesin A is to help the bacteria evade the host's immune system and establish an infection.",
      "Neisseria adhesin A has been implicated in the pathogenesis of certain Neisseria infections, such as meningitis caused by Neisseria meningitidis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1785,
    "user_query": "Which R package is used for the detection of chromosomal abnormalities from microarray data?",
    "vicuna-7b_response": "The R package that is commonly used for the detection of chromosomal abnormalities from microarray data is \"limma\".\nlimma is a bioconductor package that provides a set of tools for the analysis of microarray data. It is particularly useful for the detection of chromosomal abnormalities, such as copy number changes, which can be caused by a variety of genetic disorders.\nThe limma package provides several functions for the analysis of microarray data, including normalization, statistical testing, and visualization. One of the most commonly used functions in the detection of chromosomal abnormalities is the \"subclass\" function, which uses a classification algorithm to identify clusters of genes that are differentially expressed between two groups of samples.\nIn addition to the subclass function, limma also provides other functions such as the limmaGUI, which is a graphical user interface for the limma package, and the limmaDocumentation, which provides detailed documentation on the use of the limma package.\nOverall, limma is a powerful and widely used R package for the analysis of microarray data, and it is particularly useful for the detection of chromosomal abnormalities.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The R package \"limma\" is used for the detection of chromosomal abnormalities from microarray data.\n2. Limma is a bioconductor package that provides a set of tools for the analysis of microarray data.\n3. One of the most commonly used functions in the detection of chromosomal abnormalities in the \"limma\" package is the \"subclass\" function.\n4. The \"limma\" package provides a graphical user interface called limmaGUI.\n5. The \"limma\" package provides detailed documentation through limmaDocumentation.",
    "vicuna-7b_fact": [
      "The R package \"limma\" is used for the detection of chromosomal abnormalities from microarray data.",
      "Limma is a bioconductor package that provides a set of tools for the analysis of microarray data.",
      "One of the most commonly used functions in the detection of chromosomal abnormalities in the \"limma\" package is the \"subclass\" function.",
      "The \"limma\" package provides a graphical user interface called limmaGUI.",
      "The \"limma\" package provides detailed documentation through limmaDocumentation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The \"limma\" package does not provide a graphical user interface called limmaGUI.\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-7b_response": "One tool that employs self-organizing maps (SOMs) for analyzing synonymous codon usage is the program CodonRun.\nCodonRun is a bioinformatics tool that uses SOMs to analyze synonymous codon usage in DNA sequences. It can identify codons that are used more frequently than others and can also predict the effect of mutations on codon usage. CodonRun can be used to analyze both prokaryotic and eukaryotic DNA sequences.\nThe tool can be useful for understanding the impact of mutations on gene expression and protein synthesis, as well as for identifying potential optimization strategies for gene expression in different organisms.\nIt's worth noting that there are other tools that can be used for analyzing synonymous codon usage, such as the program CodonWise, which also uses SOMs to identify codon usage patterns.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.\n2. CodonRun can identify codons that are used more frequently than others.\n3. CodonRun can also predict the effect of mutations on codon usage.\n4. CodonRun can be used to analyze both prokaryotic and eukaryotic DNA sequences.\n5. The program CodonWise also uses SOMs to identify codon usage patterns.",
    "vicuna-7b_fact": [
      "The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.",
      "CodonRun can identify codons that are used more frequently than others.",
      "CodonRun can also predict the effect of mutations on codon usage.",
      "CodonRun can be used to analyze both prokaryotic and eukaryotic DNA sequences.",
      "The program CodonWise also uses SOMs to identify codon usage patterns."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-7b_response": "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory (RAIL) at the University of California, Berkeley. It stands for \"Mobile and Independent NDY-based Intelligent Drawer\".\nMINDY-1 is a two-legged robot that is designed to be mobile and autonomous. It is equipped with sensors and software that allow it to navigate its environment and avoid obstacles. It also has a drawer-like structure that can be used to store and retrieve objects.\nMINDY-1 was developed as a research platform for the study of legged locomotion and autonomous navigation. It has been used in a variety of research studies, including those focused on balance control, gait planning, and obstacle avoidance.\nIn addition to its research applications, MINDY-1 has also been used in educational settings to introduce students to the principles of robotics and artificial intelligence. It is a popular platform for demonstrating the capabilities of humanoid robots and the potential applications of robotics in various fields.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory (RAIL) at the University of California, Berkeley.\n2. MINDY-1 stands for \"Mobile and Independent NDY-based Intelligent Drawer\".\n3. MINDY-1 is designed to be mobile and autonomous.\n4. MINDY-1 has been used as a research platform for the study of legged locomotion and autonomous navigation.\n5. MINDY-1 has been used in educational settings to introduce students to the principles of robotics and artificial intelligence.",
    "vicuna-7b_fact": [
      "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory (RAIL) at the University of California, Berkeley.",
      "MINDY-1 stands for \"Mobile and Independent NDY-based Intelligent Drawer\".",
      "MINDY-1 is designed to be mobile and autonomous.",
      "MINDY-1 has been used as a research platform for the study of legged locomotion and autonomous navigation.",
      "MINDY-1 has been used in educational settings to introduce students to the principles of robotics and artificial intelligence."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1805,
    "user_query": "What is BioCreative?",
    "vicuna-7b_response": "BioCreative is a series of challenges organized by the European Bioinformatics Institute (EMBL-EBI) aimed at developing and evaluating tools for the biomedical domain. The challenges focus on specific tasks such as information extraction, text mining, and natural language processing. The goal of BioCreative is to promote the development of tools and resources that can be used to support the analysis of large-scale biomedical data sets. The challenges are held every two years and involve both a development and an evaluation phase. The evaluation phase involves providing a set of annotated data for participants to use in developing their tools. The development phase is an opportunity for researchers to showcase their latest tools and techniques.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BioCreative is a series of challenges organized by the European Bioinformatics Institute (EMBL-EBI).\n2. BioCreative focuses on tasks such as information extraction, text mining, and natural language processing in the biomedical domain.\n3. The goal of BioCreative is to develop tools and resources for analyzing large-scale biomedical data sets.\n4. BioCreative challenges are held every two years.\n5. The challenges have both a development phase and an evaluation phase.",
    "vicuna-7b_fact": [
      "BioCreative is a series of challenges organized by the European Bioinformatics Institute (EMBL-EBI).",
      "BioCreative focuses on tasks such as information extraction, text mining, and natural language processing in the biomedical domain.",
      "The goal of BioCreative is to develop tools and resources for analyzing large-scale biomedical data sets.",
      "BioCreative challenges are held every two years.",
      "The challenges have both a development phase and an evaluation phase."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: BioCreative is a community-wide effort for evaluating text mining and information extraction systems applied to the biological domain and is not organized by the European Bioinformatics Institute (EMBL-EBI).\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1808,
    "user_query": "What type of mutation is causing the industrial melanism phenotype in peppered moths?",
    "vicuna-7b_response": "The industrial melanism phenotype in peppered moths is caused by a mutation in the gene that codes for the pigment melanin. The mutation results in an increase in the amount of melanin produced, leading to a darker coloration in the moths. This phenotype is known as industrial melanism because it was first observed in the United Kingdom during the Industrial Revolution, when air pollution caused by the burning of coal darkened the surfaces of buildings, trees, and other objects. The darker coloration of the peppered moths provided an effective camouflage against predators, and the mutation became widespread in populations of peppered moths in polluted areas. However, as air pollution levels decreased and the coloration of the moths returned to a lighter color, the mutation became less advantageous and its frequency in the population decreased.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The industrial melanism phenotype in peppered moths is caused by a mutation in the gene that codes for the pigment melanin.\n2. The mutation results in an increase in the amount of melanin produced, leading to a darker coloration in the moths.\n3. This phenotype was first observed in the United Kingdom during the Industrial Revolution.\n4. The mutation became widespread in populations of peppered moths in polluted areas.\n5. The frequency of the mutation in the population decreased as air pollution levels went down and the coloration of the moths turned lighter.",
    "vicuna-7b_fact": [
      "The industrial melanism phenotype in peppered moths is caused by a mutation in the gene that codes for the pigment melanin.",
      "The mutation results in an increase in the amount of melanin produced, leading to a darker coloration in the moths.",
      "This phenotype was first observed in the United Kingdom during the Industrial Revolution.",
      "The mutation became widespread in populations of peppered moths in polluted areas.",
      "The frequency of the mutation in the population decreased as air pollution levels went down and the coloration of the moths turned lighter."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-7b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the most popular ones include:\n1. MEME: MEME (Multiple Experiment Markup Language) is a software tool that can be used to identify motifs in DNA or protein sequences. It can be used to identify conserved regions in genomic sequences, and can output the results in various formats.\n2. ConservED: ConservED is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\n3. RepeatMasker: RepeatMasker is a software tool that can be used to identify repetitive elements in genomic sequences. It can also be used to identify conserved regions, and can output the results in various formats.\n4. MACS: MACS (Model-based Analysis of ChIP-seq) is a software tool that can be used to identify enriched regions in genomic sequences. It can be used to identify conserved regions, and can output the results in various formats.\n5. GENE-EST: GENE-EST is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software package will depend on the specific requirements of the user and the type of data that is available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MEME (Multiple Experiment Markup Language) is a software tool used to identify motifs in DNA or protein sequences.\n2. ConservED is a software tool used to identify conserved regions in multiple species.\n3. RepeatMasker is a software tool used to identify repetitive elements in genomic sequences.\n4. MACS (Model-based Analysis of ChIP-seq) is a software tool used to identify enriched regions in genomic sequences.\n5. GENE-EST is a software tool used to identify conserved regions in multiple species.",
    "vicuna-7b_fact": [
      "MEME (Multiple Experiment Markup Language) is a software tool used to identify motifs in DNA or protein sequences.",
      "ConservED is a software tool used to identify conserved regions in multiple species.",
      "RepeatMasker is a software tool used to identify repetitive elements in genomic sequences.",
      "MACS (Model-based Analysis of ChIP-seq) is a software tool used to identify enriched regions in genomic sequences.",
      "GENE-EST is a software tool used to identify conserved regions in multiple species."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: GENE-EST is a software tool used to analyze expressed sequence tags (ESTs).",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1812,
    "user_query": "What is Eteplirsen (Exondys 51)?",
    "vicuna-7b_response": "Eteplirsen is a drug that is used to treat a genetic disorder called Duchenne muscular dystrophy (DMD). DMD is a progressive muscle-wasting disorder that affects mostly boys and is caused by a deficiency of dystrophin, a protein that is essential for maintaining muscle strength and function.\nEteplirsen is an enzyme replacement therapy that works by increasing the production of a functional dystrophin protein in the body. It is specifically designed to treat patients with DMD who have a genetic mutation called a nonsense mutation, which causes the production of a shortened and non-functional dystrophin protein.\nEteplirsen is given as an infusion once every three weeks, and it has been shown to slow the progression of DMD in patients with this specific genetic mutation. The drug has been approved by regulatory authorities in several countries, including the United States, Europe, and Japan.\nIt is important to note that Eteplirsen is not a cure for DMD, and it is not effective in treating patients with other genetic mutations that cause the disorder. Additionally, the drug has been associated with serious side effects, including an increased risk of infections and cardiac events, and it should only be used under the supervision of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Eteplirsen is a drug used to treat Duchenne muscular dystrophy (DMD).\n2. Duchenne muscular dystrophy is a progressive muscle-wasting disorder caused by a deficiency of dystrophin.\n3. Eteplirsen works by increasing the production of a functional dystrophin protein.\n4. Eteplirsen has been approved by regulatory authorities in the United States, Europe, and Japan.\n5. Eteplirsen has been associated with serious side effects, including an increased risk of infections and cardiac events.",
    "vicuna-7b_fact": [
      "Eteplirsen is a drug used to treat Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy is a progressive muscle-wasting disorder caused by a deficiency of dystrophin.",
      "Eteplirsen works by increasing the production of a functional dystrophin protein.",
      "Eteplirsen has been approved by regulatory authorities in the United States, Europe, and Japan.",
      "Eteplirsen has been associated with serious side effects, including an increased risk of infections and cardiac events."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eteplirsen has been approved by the Food and Drug Administration in the United States but not in Europe and Japan.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1813,
    "user_query": "What are the SINEUPs?",
    "vicuna-7b_response": "SINEUPs are a type of artificial neural network architecture that is commonly used in deep learning. They are called \"SINE\" (Stochastic Inverse Evolution) \"UP\" (Unrolled Perceptron) because they are a combination of these two architectures.\nSINEs are a type of recurrent neural network (RNN) that are trained using a stochastic gradient descent algorithm. They are called \"inverse\" because they are trained in a backwards direction, starting with the output of the network and working backwards to the input. This allows the network to learn a \"inverse\" relationship between the input and output.\nUPs, on the other hand, are a type of feedforward neural network that is unrolled multiple times. This means that the network is trained to perform the same computation multiple times in a row, allowing it to learn more complex patterns in the data.\nWhen combined, SINEUPs have the advantage of both RNNs and feedforward networks. They can learn long-term dependencies in the data, as well as complex patterns. They are commonly used in tasks such as language modeling, speech recognition, and image classification.\nIn summary, SINEUPs are a type of artificial neural network architecture that combines the advantages of SINEs and UPs, and are commonly used in deep learning for tasks such as language modeling, speech recognition, and image classification.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SINEUPs are a type of artificial neural network architecture used in deep learning.\n2. SINE is a type of recurrent neural network that are trained using a stochastic gradient descent algorithm.\n3. \"UP\" is a type of feedforward neural network that is unrolled multiple times.\n4. SINEUPs combine the advantages of both recurrent and feedforward networks.\n5. SINEUPs are commonly used in tasks such as language modeling, speech recognition, and image classification.",
    "vicuna-7b_fact": [
      "SINEUPs are a type of artificial neural network architecture used in deep learning.",
      "SINE is a type of recurrent neural network that are trained using a stochastic gradient descent algorithm.",
      "\"UP\" is a type of feedforward neural network that is unrolled multiple times.",
      "SINEUPs combine the advantages of both recurrent and feedforward networks.",
      "SINEUPs are commonly used in tasks such as language modeling, speech recognition, and image classification."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SINEUPs are not a type of artificial neural network architecture, they are non-coding RNA molecules used to increase translation of a target protein.\n2. FALSE [correction]: SINE is not a type of recurrent neural network. It represents Short Interspersed Nuclear Elements in genetics.\n3. UNKNOWN\n4. FALSE [correction]: SINEUPs do not combine the advantages of both recurrent and feedforward networks. They are a class of non-coding RNA molecules with a function to up-regulate protein translation.\n5. FALSE [correction]: SINEUPs are not used in tasks such as language modeling, speech recognition, and image classification. They are utilized in the field of biology and medicine to enhance protein production.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 1815,
    "user_query": "What is the mechanism of action of raxibacumab?",
    "vicuna-7b_response": "Raxibacumab is a monoclonal antibody that binds to and neutralizes a specific protein called C-reactive protein (CRP). CRP is a protein that is produced by the liver in response to inflammation and is a key player in the body's immune response.\nThe mechanism of action of raxibacumab is to bind to CRP and prevent it from binding to and activating the complement system, which is a group of proteins that play a key role in the immune response. By neutralizing CRP, raxibacumab reduces the inflammation that is caused by the complement system, which can help to prevent or treat a variety of conditions, including sepsis, pneumonia, and acute respiratory distress syndrome (ARDS).\nRaxibacumab is given as an intravenous (IV) infusion and is typically administered in conjunction with other treatments for these conditions. It is not a first-line treatment for any of these conditions, but it can be used in patients who do not respond to other treatments or who have severe inflammation that is causing organ damage.\nOverall, the mechanism of action of raxibacumab is to neutralize CRP and prevent it from activating the complement system, which can help to reduce inflammation and prevent or treat a variety of conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Raxibacumab is a monoclonal antibody that binds to and neutralizes a specific protein called C-reactive protein (CRP).\n2. C-reactive protein is produced by the liver in response to inflammation and plays a key role in the body's immune response.\n3. The mechanism of action of raxibacumab is to bind to CRP and prevent it from binding to and activating the complement system.\n4. Raxibacumab is given as an intravenous (IV) infusion and is typically administered in conjunction with other treatments for conditions such as sepsis, pneumonia, and acute respiratory distress syndrome (ARDS).\n5. Raxibacumab is not a first-line treatment for conditions such as sepsis, pneumonia, and ARDS but can be used in patients who do not respond to other treatments or who have severe inflammation causing organ damage.",
    "vicuna-7b_fact": [
      "Raxibacumab is a monoclonal antibody that binds to and neutralizes a specific protein called C-reactive protein (CRP).",
      "C-reactive protein is produced by the liver in response to inflammation and plays a key role in the body's immune response.",
      "The mechanism of action of raxibacumab is to bind to CRP and prevent it from binding to and activating the complement system.",
      "Raxibacumab is given as an intravenous (IV) infusion and is typically administered in conjunction with other treatments for conditions such as sepsis, pneumonia, and acute respiratory distress syndrome (ARDS).",
      "Raxibacumab is not a first-line treatment for conditions such as sepsis, pneumonia, and ARDS but can be used in patients who do not respond to other treatments or who have severe inflammation causing organ damage."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Raxibacumab is a monoclonal antibody that binds to and neutralizes anthrax toxin, not C-reactive protein (CRP).\n2. TRUE\n3. FALSE [correction]: The mechanism of action of raxibacumab is to bind the protective antigen component of the anthrax toxin, preventing it from binding to the cellular receptors and blocking the entry of the toxin into cells.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1817,
    "user_query": "Is SUMOylation a post-translational modification in eukaryotes?",
    "vicuna-7b_response": "SUMOylation is a post-translational modification in eukaryotes. It is a process in which a small protein called SUMO (Small Ubiquitin-like Modifier) is covalently attached to other proteins. This modification can regulate the stability, localization, and activity of target proteins. SUMOylation is involved in various cellular processes, including protein degradation, protein-protein interactions, and transcriptional regulation. It is an important mechanism for regulating the function of proteins in eukaryotic cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SUMOylation is a post-translational modification in eukaryotes.\n2. SUMOylation is a process in which a small protein called SUMO (Small Ubiquitin-like Modifier) is covalently attached to other proteins.\n3. SUMOylation can regulate the stability, localization, and activity of target proteins.\n4. The process of SUMOylation is involved in various cellular processes, including protein degradation, protein-protein interactions, and transcriptional regulation.\n5. SUMOylation is an important mechanism for regulating the function of proteins in eukaryotic cells.",
    "vicuna-7b_fact": [
      "SUMOylation is a post-translational modification in eukaryotes.",
      "SUMOylation is a process in which a small protein called SUMO (Small Ubiquitin-like Modifier) is covalently attached to other proteins.",
      "SUMOylation can regulate the stability, localization, and activity of target proteins.",
      "The process of SUMOylation is involved in various cellular processes, including protein degradation, protein-protein interactions, and transcriptional regulation.",
      "SUMOylation is an important mechanism for regulating the function of proteins in eukaryotic cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1823,
    "user_query": "Is Annexin V an apoptotic marker?",
    "vicuna-7b_response": "Yes, Annexin V is an apoptotic marker.\nApoptosis, also known as programmed cell death, is a process of cellular self-destruction that occurs naturally in multicellular organisms. It is a crucial process that helps to remove damaged or unnecessary cells, and it plays an important role in maintaining tissue homeostasis and preventing disease.\nAnnexin V is a protein that is commonly used as a marker for apoptosis. It binds to phosphatidylserine (PS) on the inner leaflet of the plasma membrane, which is a characteristic feature of apoptotic cells. When a cell undergoes apoptosis, its PS molecules move from the outer to the inner leaflet of the plasma membrane, making them more accessible to Annexin V. Therefore, by measuring the amount of Annexin V-positive cells in a sample, researchers can determine whether cells are undergoing apoptosis.\nIn conclusion, Annexin V is an apoptotic marker that is commonly used in research to detect and quantify apoptosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Annexin V is an apoptotic marker.\n2. Annexin V is a protein that binds to phosphatidylserine on the inner leaflet of the plasma membrane.\n3. Phosphatidylserine on the plasma membrane is a characteristic feature of apoptotic cells.\n4. The PS molecules move from the outer to the inner leaflet of the plasma membrane when a cell undergoes apoptosis.\n5. By measuring the amount of Annexin V-positive cells in a sample, researchers can determine whether cells are undergoing apoptosis.",
    "vicuna-7b_fact": [
      "Annexin V is an apoptotic marker.",
      "Annexin V is a protein that binds to phosphatidylserine on the inner leaflet of the plasma membrane.",
      "Phosphatidylserine on the plasma membrane is a characteristic feature of apoptotic cells.",
      "The PS molecules move from the outer to the inner leaflet of the plasma membrane when a cell undergoes apoptosis.",
      "By measuring the amount of Annexin V-positive cells in a sample, researchers can determine whether cells are undergoing apoptosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The phosphatidylserine (PS) molecules move from the inner to the outer leaflet of the plasma membrane when a cell undergoes apoptosis.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1825,
    "user_query": "What are PD-1 inhibitors?",
    "vicuna-7b_response": "PD-1 inhibitors are a type of cancer immunotherapy drug that works by blocking the PD-1 protein on immune cells. PD-1 (programmed cell death protein 1) is a protein found on the surface of immune cells that helps regulate the immune system. When PD-1 binds to its ligands (PD-L1 and PD-L2), it inhibits the immune system and prevents it from attacking cancer cells.\nBy blocking PD-1, PD-1 inhibitors allow the immune system to recognize and attack cancer cells, leading to the destruction of cancer cells and improved outcomes for patients. PD-1 inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and bladder cancer.\nPD-1 inhibitors work by blocking the PD-1 protein on immune cells, allowing the immune system to recognize and attack cancer cells.\nPD-1 inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and bladder cancer.\nIt is important to note that PD-1 inhibitors are not a cure for cancer and may not work for all patients. They are typically used in combination with other treatments, such as surgery, chemotherapy, and radiation therapy. Additionally, PD-1 inhibitors can have side effects, such as fatigue, diarrhea, and skin rash. It is important to discuss the potential benefits and risks of PD-1 inhibitors with a healthcare provider before starting treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PD-1 inhibitors are a type of cancer immunotherapy drug.\n2. PD-1 (programmed cell death protein 1) is a protein found on the surface of immune cells that helps regulate the immune system.\n3. PD-1 inhibitors work by blocking the PD-1 protein, allowing the immune system to recognize and attack cancer cells.\n4. PD-1 inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and bladder cancer.\n5. PD-1 inhibitors can have side effects, such as fatigue, diarrhea, and skin rash.",
    "vicuna-7b_fact": [
      "PD-1 inhibitors are a type of cancer immunotherapy drug.",
      "PD-1 (programmed cell death protein 1) is a protein found on the surface of immune cells that helps regulate the immune system.",
      "PD-1 inhibitors work by blocking the PD-1 protein, allowing the immune system to recognize and attack cancer cells.",
      "PD-1 inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and bladder cancer.",
      "PD-1 inhibitors can have side effects, such as fatigue, diarrhea, and skin rash."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1828,
    "user_query": "Is Migalastat used for treatment of Fabry Disease?",
    "vicuna-7b_response": "Yes, Migalastat is used for the treatment of Fabry disease.\nFabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A, which results in the accumulation of a fatty substance called globotriaosylceramide (GL-3) in the cells of various organs and tissues. Migalastat is a medication that helps to increase the amount of functional alpha-galactosidase A in the body, which can help to reduce the accumulation of GL-3 and improve symptoms of Fabry disease.\nMigalastat is approved for use in adults with Fabry disease who are unable to produce enough of the enzyme on their own. It is typically taken as a daily oral tablet.\nIt is important to note that Migalastat is not a cure for Fabry disease, but it can help to reduce the symptoms and slow down the progression of the disease. It is important to work closely with your healthcare provider to determine the best treatment plan for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Migalastat is used for the treatment of Fabry disease.\n2. Fabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A.\n3. Migalastat is a medication that helps to increase the amount of functional alpha-galactosidase A in the body.\n4. Migalastat is approved for use in adults with Fabry disease who can't produce enough of the enzyme on their own.\n5. Migalastat is not a cure for Fabry disease, but can help to reduce symptoms and slow down its progression.",
    "vicuna-7b_fact": [
      "Migalastat is used for the treatment of Fabry disease.",
      "Fabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A.",
      "Migalastat is a medication that helps to increase the amount of functional alpha-galactosidase A in the body.",
      "Migalastat is approved for use in adults with Fabry disease who can't produce enough of the enzyme on their own.",
      "Migalastat is not a cure for Fabry disease, but can help to reduce symptoms and slow down its progression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Migalastat is approved for use in adults with Fabry disease who have certain genetic variants that are responsive to Migalastat. \n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1829,
    "user_query": "Where are Paneth cells located?",
    "vicuna-7b_response": "Paneth cells are a type of epithelial cell found in the small intestine. They are located in the base of the villi, which are the finger-like projections that line the small intestine and increase its surface area for absorption of nutrients. Paneth cells are responsible for producing antimicrobial peptides that help protect the small intestine from harmful bacteria. They are also involved in the maturation of immune cells, such as dendritic cells, which play a crucial role in the immune response.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Paneth cells are a type of epithelial cell found in the small intestine.\n2. Paneth cells are located in the base of the villi.\n3. Villi are the finger-like projections that increase the surface area of the small intestine for absorption of nutrients.\n4. Paneth cells are responsible for producing antimicrobial peptides.\n5. Paneth cells are involved in the maturation of immune cells, such as dendritic cells.",
    "vicuna-7b_fact": [
      "Paneth cells are a type of epithelial cell found in the small intestine.",
      "Paneth cells are located in the base of the villi.",
      "Villi are the finger-like projections that increase the surface area of the small intestine for absorption of nutrients.",
      "Paneth cells are responsible for producing antimicrobial peptides.",
      "Paneth cells are involved in the maturation of immune cells, such as dendritic cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Paneth cells are located at the base of the crypts, not the villi.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While Paneth cells do interact with the immune system, they are not involved in the maturation of immune cells such as dendritic cells. They mainly secrete antimicrobial peptides to control the intestinal microbiota.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1832,
    "user_query": "Which pipelines are used for analyzing data from ChIP-nexus experiments?",
    "vicuna-7b_response": "ChIP-nexus is a technique used to analyze chromatin interactions in a high-throughput manner. The analysis of data from ChIP-nexus experiments typically involves several pipelines, including:\n1. Chromatin immunoprecipitation (ChIP) pipeline: This pipeline is used to identify the binding sites of a specific protein of interest (such as a transcription factor) to the chromatin. This is done by immunoprecipitating the protein of interest from the chromatin using an antibody, followed by sequencing of the immunoprecipitated DNA.\n2. Nexus pipeline: The Nexus pipeline is used to identify the interactions between different proteins that bind to the chromatin. This is done by sequencing the DNA that was immunoprecipitated in the ChIP pipeline, and then using computational methods to identify the interactions between the proteins.\n3. Data analysis pipeline: Once the data from the ChIP and Nexus pipelines is generated, it is typically analyzed using a variety of bioinformatics tools to identify patterns and trends in the data. This may include identifying enriched gene ontology terms, identifying regulatory regions, and identifying potential targets for drug development.\nOverall, the analysis of data from ChIP-nexus experiments typically involves a combination of experimental and computational techniques to identify chromatin interactions and understand the underlying biology of the system being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ChIP-nexus is a technique used to analyze chromatin interactions in a high-throughput manner.\n2. Chromatin immunoprecipitation (ChIP) pipeline is used to identify the binding sites of a specific protein of interest to the chromatin.\n3. Nexus pipeline is used to identify the interactions between different proteins that bind to the chromatin. \n4. Data from the ChIP and Nexus pipelines is typically analyzed using a variety of bioinformatics tools.\n5. Analysis of data from ChIP-nexus experiments involves a combination of experimental and computational techniques.",
    "vicuna-7b_fact": [
      "ChIP-nexus is a technique used to analyze chromatin interactions in a high-throughput manner.",
      "Chromatin immunoprecipitation (ChIP) pipeline is used to identify the binding sites of a specific protein of interest to the chromatin.",
      "Nexus pipeline is used to identify the interactions between different proteins that bind to the chromatin.",
      "Data from the ChIP and Nexus pipelines is typically analyzed using a variety of bioinformatics tools.",
      "Analysis of data from ChIP-nexus experiments involves a combination of experimental and computational techniques."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Nexus is not a pipeline but rather is a part of ChIP-nexus, a technique used for high-resolution mapping of protein-DNA interactions.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1833,
    "user_query": "What do statins do?",
    "vicuna-7b_response": "Statins are a type of medication that are used to lower cholesterol levels in the blood. They work by inhibiting the production of cholesterol in the liver, which helps to reduce the amount of cholesterol that is present in the bloodstream.\nStatins are commonly prescribed for people who have high cholesterol levels or who are at risk of developing heart disease or stroke due to high cholesterol. They can also be used to treat other conditions, such as high blood pressure and diabetes, that are related to high cholesterol levels.\nIt is important to note that statins can have side effects, such as muscle pain and liver damage. It is important to talk to your doctor about the potential risks and benefits of taking statins before starting treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Statins are used to lower cholesterol levels in the blood.\n2. These medications work by inhibiting the production of cholesterol in the liver.\n3. Statins are commonly prescribed for people who have high cholesterol levels or who are at risk of developing heart disease or stroke.\n4. Statins can also be used to treat other conditions such as high blood pressure and diabetes, that are related to high cholesterol levels.\n5. The use of statins can have side effects, such as muscle pain and liver damage.",
    "vicuna-7b_fact": [
      "Statins are used to lower cholesterol levels in the blood.",
      "These medications work by inhibiting the production of cholesterol in the liver.",
      "Statins are commonly prescribed for people who have high cholesterol levels or who are at risk of developing heart disease or stroke.",
      "Statins can also be used to treat other conditions such as high blood pressure and diabetes, that are related to high cholesterol levels.",
      "The use of statins can have side effects, such as muscle pain and liver damage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Statins are not used to treat high blood pressure and diabetes. They are used for managing high cholesterol levels and reducing the risk of heart disease and stroke.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1835,
    "user_query": "Do statins cause diabetes?",
    "vicuna-7b_response": "Statins are a class of drugs that are commonly used to lower cholesterol levels in the blood. They are generally considered safe and effective, but there is some evidence to suggest that they may increase the risk of developing diabetes.\nStudies have shown that statins can cause an increase in blood sugar levels, which can lead to a diagnosis of diabetes. However, the risk of developing diabetes while taking statins is generally low, and the overall benefits of taking statins for lowering cholesterol levels still outweigh the potential risks.\nIt's important to note that the risk of developing diabetes while taking statins may vary depending on several factors, such as the type of statin being used, the dose, and the individual's overall health and medical history. If you are taking statins and experience any symptoms of diabetes, such as increased thirst, frequent urination, or fatigue, it's important to speak with your doctor. They can help you determine the best course of action based on your individual health needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Statins are a class of drugs used to lower cholesterol levels in the blood.\n2. There is evidence suggesting that statins may increase the risk of developing diabetes.\n3. Studies have shown that statins can cause an increase in blood sugar levels.\n4. The risk of developing diabetes while taking statins is generally low.\n5. The risk of developing diabetes while taking statins may vary depending on several factors, such as the type of statin being used, the dose, and the individual's overall health and medical history.",
    "vicuna-7b_fact": [
      "Statins are a class of drugs used to lower cholesterol levels in the blood.",
      "There is evidence suggesting that statins may increase the risk of developing diabetes.",
      "Studies have shown that statins can cause an increase in blood sugar levels.",
      "The risk of developing diabetes while taking statins is generally low.",
      "The risk of developing diabetes while taking statins may vary depending on several factors, such as the type of statin being used, the dose, and the individual's overall health and medical history."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1841,
    "user_query": "What is the composition of the gamma-secretase complex?",
    "vicuna-7b_response": "The gamma-secretase complex is a multi-subunit complex that plays a key role in the cleavage of amyloid precursor protein (APP) and other membrane-bound proteins. The complex is composed of four main subunits:\n1. Nicastrin: Nicastrin is a type I transmembrane protein that is responsible for binding the amyloid precursor protein (APP) to the complex.\n2. Aph1: Aph1 is a type II transmembrane protein that is responsible for binding the complex to the plasma membrane.\n3. Presenilin: Presenilin is a type I transmembrane protein that is the catalytic subunit of the complex. It contains a protease domain that is responsible for cleaving the APP protein.\n4. Pen-2: Pen-2 is a type II transmembrane protein that is responsible for binding to the gamma-secretase complex and regulating its activity.\nIn addition to these four main subunits, the gamma-secretase complex may also contain other accessory proteins that help to regulate its activity and localization. These accessory proteins include:\n1. APH-2: APH-2 is a type II transmembrane protein that is responsible for binding to the gamma-secretase complex and regulating its activity.\n2. Tau: Tau is a microtubule-associated protein that has been shown to interact with the gamma-secretase complex and regulate its activity.\n3. APP-CTF: APP-CTF is a soluble fragment of the amyloid precursor protein that can bind to the gamma-secretase complex and regulate its activity.\nOverall, the composition of the gamma-secretase complex is complex and involves multiple subunits that work together to regulate the cleavage of APP and other membrane-bound proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The gamma-secretase complex plays a key role in the cleavage of amyloid precursor protein (APP) and other membrane-bound proteins.\n2. The gamma-secretase complex is composed of four main subunits: Nicastrin, Aph1, Presenilin, and Pen-2. \n3. Nicastrin is a type I transmembrane protein that is responsible for binding the amyloid precursor protein (APP) to the complex.\n4. Aph1 is a type II transmembrane protein that is responsible for binding the complex to the plasma membrane.\n5. Presenilin is a type I transmembrane protein that is the catalytic subunit of the complex and contains a protease domain that is responsible for cleaving the APP protein.\n6. Pen-2 is a type II transmembrane protein that is responsible for binding to the gamma-secretase complex and regulating its activity. \n7. The gamma-secretase complex may also contain accessory proteins including APH-2, Tau, and APP-CTF.",
    "vicuna-7b_fact": [
      "The gamma-secretase complex plays a key role in the cleavage of amyloid precursor protein (APP) and other membrane-bound proteins.",
      "The gamma-secretase complex is composed of four main subunits: Nicastrin, Aph1, Presenilin, and Pen-2.",
      "Nicastrin is a type I transmembrane protein that is responsible for binding the amyloid precursor protein (APP) to the complex.",
      "Aph1 is a type II transmembrane protein that is responsible for binding the complex to the plasma membrane.",
      "Presenilin is a type I transmembrane protein that is the catalytic subunit of the complex and contains a protease domain that is responsible for cleaving the APP protein.",
      "Pen-2 is a type II transmembrane protein that is responsible for binding to the gamma-secretase complex and regulating its activity.",
      "The gamma-secretase complex may also contain accessory proteins including APH-2, Tau, and APP-CTF."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Aph1 is a type I transmembrane protein that is responsible for keeping the complex stable.\n5. TRUE\n6. TRUE\n7. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1844,
    "user_query": "What is the role of the UBC9 enzyme in the protein sumoylation pathway?",
    "vicuna-7b_response": "The UBC9 enzyme plays a crucial role in the protein sumoylation pathway. Sumoylation is a post-translational modification that involves the attachment of small ubiquitin-like modifier (SUMO) proteins to other proteins. UBC9 is an E2 enzyme that is responsible for activating the SUMO pathway by covalently linking SUMO to target proteins.\nThe UBC9 enzyme functions by activating the SUMO pathway by covalently linking SUMO to target proteins. It does this by catalyzing the transfer of a SUMO molecule from a SUMO activating enzyme (E1) to a target protein (E3). This results in the formation of a SUMO-protein ligase complex, which then adds the SUMO molecule to the target protein.\nThe UBC9 enzyme is involved in a variety of cellular processes, including transcription regulation, cell cycle progression, and protein degradation. It has been shown to play a role in the regulation of several key proteins, including p53, a tumor suppressor protein that is involved in the regulation of cell growth and division.\nOverall, the UBC9 enzyme is an essential component of the protein sumoylation pathway, and its dysfunction has been implicated in a variety of diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UBC9 enzyme plays a role in the protein sumoylation pathway.\n2. Sumoylation is a post-translational modification that involves the attachment of small ubiquitin-like modifier (SUMO) proteins to other proteins.\n3. UBC9 is an E2 enzyme that activates the SUMO pathway by covalently linking SUMO to target proteins.\n4. The UBC9 enzyme is involved in several cellular processes, including transcription regulation, cell cycle progression, and protein degradation.\n5. Dysfunction of the UBC9 enzyme has been implicated in various diseases, including cancer.",
    "vicuna-7b_fact": [
      "The UBC9 enzyme plays a role in the protein sumoylation pathway.",
      "Sumoylation is a post-translational modification that involves the attachment of small ubiquitin-like modifier (SUMO) proteins to other proteins.",
      "UBC9 is an E2 enzyme that activates the SUMO pathway by covalently linking SUMO to target proteins.",
      "The UBC9 enzyme is involved in several cellular processes, including transcription regulation, cell cycle progression, and protein degradation.",
      "Dysfunction of the UBC9 enzyme has been implicated in various diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: UBC9 is an E2 enzyme that catalyzes the covalent attachment of SUMO to target proteins, rather than activating the SUMO pathway.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1849,
    "user_query": "What is the role of cohesins at the IFNG locus?",
    "vicuna-7b_response": "Cohesins are protein complexes that help to maintain the integrity of chromosomes by holding together sister chromatids, homologous chromosomes, or chromosomal regions. At the interferon-gamma (IFNG) locus, cohesins play a crucial role in regulating the expression of the IFNG gene.\nThe IFNG locus is located on chromosome 9 and contains several regulatory elements that control the expression of the IFNG gene. One of these regulatory elements is the interferon-gamma enhancer (IFNG-E), which is a region of DNA that contains binding sites for transcription factors that regulate the expression of the IFNG gene.\nCohesins are involved in the regulation of the IFNG-E by holding together sister chromatids or homologous chromosomes, which helps to maintain the integrity of the IFNG-E region. This helps to ensure that the binding sites for transcription factors are properly positioned and that the IFNG gene is properly regulated.\nIn addition to their role in maintaining the integrity of the IFNG locus, cohesins also play a role in the regulation of the IFNG gene by holding together chromosomal regions that contain the IFNG gene. This helps to ensure that the IFNG gene is properly regulated and that the IFNG protein is produced in the correct amounts.\nOverall, cohesins play a crucial role in regulating the expression of the IFNG gene by maintaining the integrity of the IFNG locus and ensuring that the binding sites for transcription factors are properly positioned.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cohesins are protein complexes that assist in maintaining the integrity of chromosomes by holding together sister chromatids, homologous chromosomes, or chromosomal regions.\n2. The interferon-gamma (IFNG) locus contains several regulatory elements regulating the expression of the IFNG gene.\n3. IFNG locus is located on chromosome 9.\n4. Cohesins maintain the integrity of IFNG-E region by preserving sister chromatids or homologous chromosomes.\n5. Cohesins also regulate the expression of the IFNG gene by holding together chromosomal regions that contain the IFNG gene.",
    "vicuna-7b_fact": [
      "Cohesins are protein complexes that assist in maintaining the integrity of chromosomes by holding together sister chromatids, homologous chromosomes, or chromosomal regions.",
      "The interferon-gamma (IFNG) locus contains several regulatory elements regulating the expression of the IFNG gene.",
      "IFNG locus is located on chromosome 9.",
      "Cohesins maintain the integrity of IFNG-E region by preserving sister chromatids or homologous chromosomes.",
      "Cohesins also regulate the expression of the IFNG gene by holding together chromosomal regions that contain the IFNG gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The IFNG locus is located on chromosome 12.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1853,
    "user_query": "Could hypophosphatemic rickets cause craniosynostosis?",
    "vicuna-7b_response": "Hypophosphatemic rickets is a rare inherited disorder that affects the development of bones, leading to rickets, a condition characterized by soft, deformed bones. Craniosynostosis is a condition where one or more of the sutures in an infant's skull close too early, causing the skull to become abnormally shaped.\nWhile there is some evidence to suggest that hypophosphatemic rickets may be associated with an increased risk of craniosynostosis, the exact relationship between the two conditions is not well understood. Some studies have suggested that hypophosphatemic rickets may be a contributing factor in the development of craniosynostosis, while others have found no association between the two conditions.\nIt is important to note that hypophosphatemic rickets is a genetic disorder that is caused by mutations in one of several genes that are involved in the development of bones. Craniosynostosis, on the other hand, is a congenital condition that is caused by genetic and environmental factors. While both conditions may affect bone development, they are distinct disorders with different underlying causes.\nIn summary, while there is some evidence to suggest that hypophosphatemic rickets may be associated with an increased risk of craniosynostosis, the exact relationship between the two conditions is not well understood. It is important to consult with a healthcare professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hypophosphatemic rickets is a rare inherited disorder that affects the development of bones, leading to rickets, a condition characterized by soft, deformed bones.\n2. Craniosynostosis is a condition where one or more of the sutures in an infant's skull close too early, causing the skull to become abnormally shaped.\n3. Hypophosphatemic rickets is a genetic disorder that is caused by mutations in one of several genes that are involved in the development of bones.\n4. Craniosynostosis is a congenital condition that is caused by genetic and environmental factors.\n5. While there is some evidence to suggest that hypophosphatemic rickets may be associated with an increased risk of craniosynostosis, the exact relationship between the two conditions is not well understood.",
    "vicuna-7b_fact": [
      "Hypophosphatemic rickets is a rare inherited disorder that affects the development of bones, leading to rickets, a condition characterized by soft, deformed bones.",
      "Craniosynostosis is a condition where one or more of the sutures in an infant's skull close too early, causing the skull to become abnormally shaped.",
      "Hypophosphatemic rickets is a genetic disorder that is caused by mutations in one of several genes that are involved in the development of bones.",
      "Craniosynostosis is a congenital condition that is caused by genetic and environmental factors.",
      "While there is some evidence to suggest that hypophosphatemic rickets may be associated with an increased risk of craniosynostosis, the exact relationship between the two conditions is not well understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1854,
    "user_query": "Is vortioxetine effective for treatment of depression?",
    "vicuna-7b_response": "Vortioxetine is a medication that is used to treat depression. It is a serotonin modulator and stimulator, also known as a SSMIs (selective serotonin modulator and stimulator). Vortioxetine works by increasing the levels of serotonin, a neurotransmitter that is involved in mood regulation, in the brain.\nStudies have shown that vortioxetine is effective in treating depression. In fact, it has been approved by the FDA for the treatment of major depressive disorder in adults. The efficacy of vortioxetine has been demonstrated in several clinical trials, which have shown that it is effective in improving symptoms of depression, such as sadness, loss of interest, and difficulty sleeping.\nIt is important to note that like all medications, vortioxetine may have side effects. Some of the most common side effects include nausea, dizziness, and headache. It is important to discuss the potential side effects with your healthcare provider before starting treatment with vortioxetine.\nIn summary, vortioxetine is an effective medication for the treatment of depression, and it has been approved by the FDA for this use. However, as with any medication, it is important to discuss the potential benefits and risks with your healthcare provider before starting treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vortioxetine is a medication used to treat depression.\n2. Vortioxetine works by increasing the levels of serotonin in the brain.\n3. Vortioxetine has been approved by the FDA for the treatment of major depressive disorder in adults.\n4. The efficacy of vortioxetine in treating depression has been demonstrated in several clinical trials.\n5. Some common side effects of vortioxetine include nausea, dizziness, and headache.",
    "vicuna-7b_fact": [
      "Vortioxetine is a medication used to treat depression.",
      "Vortioxetine works by increasing the levels of serotonin in the brain.",
      "Vortioxetine has been approved by the FDA for the treatment of major depressive disorder in adults.",
      "The efficacy of vortioxetine in treating depression has been demonstrated in several clinical trials.",
      "Some common side effects of vortioxetine include nausea, dizziness, and headache."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1859,
    "user_query": "Where do the Schwann cells and melanocytes originate from?",
    "vicuna-7b_response": "Schwann cells and melanocytes are two different types of cells that play important roles in the development and function of the nervous system and skin, respectively.\nSchwann cells are a type of glial cell that are responsible for myelination, the process by which they wrap around and insulate nerve fibers. They are derived from neural crest cells, which are a type of stem cell that give rise to a variety of different cell types, including melanocytes, smooth muscle cells, and glial cells.\nMelanocytes are cells that produce melanin, the pigment that gives skin, hair, and eyes their color. They are found in the skin and hair follicles and are derived from neural crest cells as well.\nIn summary, Schwann cells and melanocytes originate from neural crest cells, which are a type of stem cell that give rise to a variety of different cell types.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Schwann cells are a type of glial cell that are responsible for the process of myelination.\n2. Schwann cells originate from neural crest cells.\n3. Melanocytes are cells that produce melanin, which gives skin, hair, and eyes their color.\n4. Melanocytes are found in the skin and hair follicles.\n5. Melanocytes also originate from neural crest cells.",
    "vicuna-7b_fact": [
      "Schwann cells are a type of glial cell that are responsible for the process of myelination.",
      "Schwann cells originate from neural crest cells.",
      "Melanocytes are cells that produce melanin, which gives skin, hair, and eyes their color.",
      "Melanocytes are found in the skin and hair follicles.",
      "Melanocytes also originate from neural crest cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-7b_response": "The PIEZO2 gene is a gene that encodes for a protein called Piezo2, which is a member of the Piezo family of ion channels. Piezo2 is expressed in various tissues, including the inner ear, heart, and blood vessels, and plays a role in sensing mechanical stimuli such as pressure and touch.\nThere are several diseases that have been associated with mutations or dysfunction of the PIEZO2 gene. Here are three examples:\n1. Autosomal recessive non-syndromic hearing loss: Mutations in the PIEZO2 gene have been identified as a cause of non-syndromic hearing loss, which is a genetic condition that results in hearing impairment without any other associated symptoms.\n2. Hypertension: Dysfunction of the Piezo2 channel has been implicated in the development of hypertension, or high blood pressure. This is because Piezo2 plays a role in regulating blood pressure by sensing changes in blood volume and blood pressure.\n3. Congenital malformations, including cleft lip and palate: Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate. This is because Piezo2 is expressed in the developing embryo, and its dysfunction can disrupt normal development and lead to malformations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The PIEZO2 gene encodes for a protein called Piezo2.\n2. Piezo2 is expressed in various tissues, including the inner ear, heart, and blood vessels.\n3. Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.\n4. Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.\n5. Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate.",
    "vicuna-7b_fact": [
      "The PIEZO2 gene encodes for a protein called Piezo2.",
      "Piezo2 is expressed in various tissues, including the inner ear, heart, and blood vessels.",
      "Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.",
      "Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.",
      "Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Mutations in the PIEZO2 gene have not been identified as a prevalent cause of autosomal recessive non-syndromic hearing loss. Most cases are not currently linked to PIEZO2, but rather other genes, often those directly related to the structure and function of the internal ear.\n4. TRUE\n5. FALSE [correction]: Mutations in the PIEZO2 gene have not been associated with congenital malformations such as cleft lip and palate. They have been associated with certain syndromes involving musculoskeletal abnormalities, however.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1862,
    "user_query": "Where is the protein slitrk1 localized?",
    "vicuna-7b_response": "Slitrk1 is a protein that is localized to the endoplasmic reticulum (ER) in mammalian cells. The ER is a membrane-bound organelle that is responsible for various cellular processes, including protein folding, lipid metabolism, and calcium homeostasis.\nSlitrk1 is a member of the sterile alpha motif and transmembrane domain containing protein 1 (SAMD1) family, which is characterized by the presence of a sterile alpha motif and multiple transmembrane domains. The exact function of Slitrk1 is not fully understood, but it has been shown to play a role in ER function and to be involved in the regulation of ER morphology.\nIn addition to its localization to the ER, Slitrk1 has also been shown to be present in the Golgi apparatus, a organelle that is involved in the processing and transport of proteins and lipids. However, the exact localization of Slitrk1 in the Golgi apparatus is not well understood and may vary depending on the cell type and context.\nOverall, Slitrk1 is a protein that is localized to the ER and Golgi apparatus in mammalian cells, and its exact localization and function may depend on the cell type and context.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The protein Slitrk1 is localized to the endoplasmic reticulum (ER) in mammalian cells.\n2. Slitrk1 is a member of the sterile alpha motif and transmembrane domain containing protein 1 (SAMD1) family.\n3. Slitrk1 protein has been shown to play a role in ER function and to be involved in the regulation of ER morphology.\n4. Slitrk1 has been found in the Golgi apparatus, which is involved in the processing and transport of proteins and lipids.\n5. The exact localization and function of the Slitrk1 protein may depend on the cell type and context.",
    "vicuna-7b_fact": [
      "The protein Slitrk1 is localized to the endoplasmic reticulum (ER) in mammalian cells.",
      "Slitrk1 is a member of the sterile alpha motif and transmembrane domain containing protein 1 (SAMD1) family.",
      "Slitrk1 protein has been shown to play a role in ER function and to be involved in the regulation of ER morphology.",
      "Slitrk1 has been found in the Golgi apparatus, which is involved in the processing and transport of proteins and lipids.",
      "The exact localization and function of the Slitrk1 protein may depend on the cell type and context."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Slitrk1 is a member of the SLIT And NTRK Like Family.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1863,
    "user_query": "Describe clinical manifestation of the Harlequin syndrome.",
    "vicuna-7b_response": "The Harlequin syndrome is a rare genetic disorder characterized by a range of symptoms, including skin hyperpigmentation, eye abnormalities, and neurological problems. The clinical manifestations of the Harlequin syndrome can vary from person to person, but some common symptoms include:\n1. Skin hyperpigmentation: This is the most common symptom of the Harlequin syndrome and is characterized by patches of dark, irregularly shaped pigmentation on the skin. These patches are usually found on the face, neck, and trunk, but they can also appear on other parts of the body.\n2. Eye abnormalities: The Harlequin syndrome can also cause eye problems, such as cataracts, glaucoma, and nystagmus (involuntary eye movements). These eye problems can lead to vision loss if left untreated.\n3. Neurological problems: The Harlequin syndrome can also affect the nervous system, leading to problems with movement, balance, and coordination. Some people with the disorder may experience muscle weakness, tremors, or difficulty with speech and swallowing.\n4. Developmental delays: Children with the Harlequin syndrome may experience developmental delays, such as delayed motor skills, speech, and cognitive development.\nIt's important to note that the severity of the symptoms can vary from person to person, and some people with the Harlequin syndrome may have only a few of these symptoms, while others may have many more. If you or a loved one is experiencing any of these symptoms, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Harlequin syndrome is a rare genetic disorder.\n2. Harlequin syndrome is characterized by skin hyperpigmentation, eye abnormalities, neurological problems, and in some cases developmental delays.\n3. Common symptoms include patches of dark, irregularly shaped pigmentation on the skin, usually appearing on the face, neck, and trunk.\n4. Harlequin syndrome may cause specific eye problems such as cataracts, glaucoma, and nystagmus which can potentially lead to vision loss if left untreated.\n5. The syndrome can also affect the nervous system, causing problems with movement, balance, coordination, and in some cases muscle weakness, tremors, or difficulty with speech and swallowing.",
    "vicuna-7b_fact": [
      "Harlequin syndrome is a rare genetic disorder.",
      "Harlequin syndrome is characterized by skin hyperpigmentation, eye abnormalities, neurological problems, and in some cases developmental delays.",
      "Common symptoms include patches of dark, irregularly shaped pigmentation on the skin, usually appearing on the face, neck, and trunk.",
      "Harlequin syndrome may cause specific eye problems such as cataracts, glaucoma, and nystagmus which can potentially lead to vision loss if left untreated.",
      "The syndrome can also affect the nervous system, causing problems with movement, balance, coordination, and in some cases muscle weakness, tremors, or difficulty with speech and swallowing."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Harlequin syndrome is not characterized by skin hyperpigmentation, eye abnormalities or neurological problems. It's a neurological condition where the individual displays unilateral diminished sweating and flushing of the face.\n3. FALSE [correction]: Harlequin syndrome doesn't cause patches of dark pigmentation on the skin. Instead, it causes flushing and sweating on one side of the face. \n4. FALSE [correction]: Harlequin syndrome is not directly associated with cataracts, glaucoma, or nystagmus. It is a syndrome marked by asymmetrical sweating and flushing on the upper anterior part of the thorax, neck, and face.\n5. FALSE [correction]: Harlequin syndrome does not cause problems with movement, balance, coordination, muscle weakness, tremors, or difficulty with speech and swallowing. It is characterized by a lack of sweating (anhidrosis) and flushing of skin on one side of the face (unilateral).",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1864,
    "user_query": "What is the role of the constitutive photomorphogenesis 9 signalosome (CSN)?",
    "vicuna-7b_response": "The constitutive photomorphogenesis 9 (CPH9) signalosome is a complex of proteins that plays a crucial role in regulating plant growth and development in response to light. The CPH9 signalosome is composed of several subunits, including CPH9, CRY2, and HY5, which are all involved in the regulation of photomorphogenesis.\nIn the absence of light, the CPH9 signalosome promotes the degradation of CRY2, which is a key regulator of the photomorphogenic response to light. This allows for the activation of photomorphogenic genes, such as those involved in the regulation of stem elongation and leaf expansion.\nIn the presence of light, the CPH9 signalosome is inactivated, and CRY2 is stabilized. This leads to the repression of photomorphogenic genes and the promotion of the differentiation of leaves into sophisticated structures that are well-suited to photosynthesis.\nOverall, the CPH9 signalosome plays a crucial role in the regulation of plant growth and development in response to light, and its function is essential for the proper growth and development of plants.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The constitutive photomorphogenesis 9 (CPH9) signalosome is a complex of proteins.\n2. The CPH9 signalosome is involved in regulating plant growth and development in response to light.\n3. The CPH9 signalosome includes several subunits, such as CPH9, CRY2, and HY5.\n4. In the absence of light, the CPH9 signalosome promotes the degradation of CRY2.\n5. In the presence of light, the CPH9 signalosome is inactivated, and CRY2 is stabilized.",
    "vicuna-7b_fact": [
      "The constitutive photomorphogenesis 9 (CPH9) signalosome is a complex of proteins.",
      "The CPH9 signalosome is involved in regulating plant growth and development in response to light.",
      "The CPH9 signalosome includes several subunits, such as CPH9, CRY2, and HY5.",
      "In the absence of light, the CPH9 signalosome promotes the degradation of CRY2.",
      "In the presence of light, the CPH9 signalosome is inactivated, and CRY2 is stabilized."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-7b_response": "ERAP1 and ERAP2 are two proteins that are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway, which is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.\nERAP1 and ERAP2 are the two main components of the ERAD pathway. They form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER. Once bound, the ERAP1-ERAP2 complex targets the misfolded proteins for degradation by the proteasome, a protein complex that breaks down proteins into smaller peptides for recycling or disposal.\nThe ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAD pathway. It allows for the specific recognition and binding of misfolded proteins, which is necessary for their efficient degradation. Additionally, the dimerization of ERAP1 and ERAP2 also helps to stabilize the complex and ensure that it is able to function properly over time.\nIn summary, ERAP1-ERAP2 dimerization is promoted by the interaction between these two proteins, which allows them to recognize and bind to misfolded proteins in the ER, leading to their efficient degradation by the proteasome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ERAP1 and ERAP2 are two proteins that are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.\n2. The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.\n3. ERAP1 and ERAP2 form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER.\n4. The ERAP1-ERAP2 complex targets the misfolded proteins for degradation by the proteasome.\n5. ERAP1-ERAP2 dimerization is essential for the specific recognition and binding of misfolded proteins, and their efficient degradation.",
    "vicuna-7b_fact": [
      "ERAP1 and ERAP2 are two proteins that are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.",
      "The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.",
      "ERAP1 and ERAP2 form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER.",
      "The ERAP1-ERAP2 complex targets the misfolded proteins for degradation by the proteasome.",
      "ERAP1-ERAP2 dimerization is essential for the specific recognition and binding of misfolded proteins, and their efficient degradation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ERAP1 and ERAP2 are two proteins that are involved in antigen processing, not the endoplasmic reticulum-associated degradation (ERAD) pathway.\n2. TRUE\n3. FALSE [correction]: ERAP1 and ERAP2 do not form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER, rather they both independently aid in antigen processing.\n4. FALSE [correction]: The ERAP1-ERAP2 complex does not target misfolded proteins for degradation by the proteasome as they do not form a complex. They independently contribute to antigen presentation.\n5. FALSE [correction]: ERAP1-ERAP2 dimerization is not essential for the specific recognition and binding of misfolded proteins, and their efficient degradation because these proteins do not dimerize.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1868,
    "user_query": "What is plantar fasciitis",
    "vicuna-7b_response": "Plantar fasciitis is a common condition that affects the heel and sole of the foot. It is caused by inflammation of the plantar fascia, a thick band of tissue that runs along the bottom of the foot. The plantar fascia helps to support the arch of the foot and plays a role in foot movement.\nThe most common symptom of plantar fasciitis is pain in the heel and sole of the foot, particularly when taking the first steps in the morning or after sitting or resting for a long period of time. The pain is usually worse after physical activity and can worsen over time if left untreated.\nThere are several factors that can contribute to the development of plantar fasciitis, including:\n* Overpronation: when the foot rolls inward too much when walking or running\n* High arches or flat feet\n* Being overweight or obese\n* Wearing shoes with poor arch support or a lack of cushioning\n* Having a tight Achilles tendon\nTreatment for plantar fasciitis typically includes rest, ice, physical therapy, and over-the-counter pain medications. In severe cases, a doctor may recommend a corticosteroid injection or extracorporeal shock wave therapy. In some cases, surgery may be necessary.\nIt is important to see a doctor if you are experiencing persistent heel pain, as plantar fasciitis can lead to more serious complications if left untreated.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Plantar fasciitis is a condition that affects the heel and sole of the foot.\n2. The condition is caused by inflammation of the plantar fascia, a thick band of tissue that runs along the bottom of the foot.\n3. Common symptoms of plantar fasciitis include pain in the heel and sole of the foot, especially upon taking first steps after a period of rest or inactivity.\n4. Several factors can contribute to the development of plantar fasciitis, such as overpronation, high arches or flat feet, being overweight, wearing poorly cushioned shoes, and having a tight Achilles tendon.\n5. The treatment for plantar fasciitis typically includes rest, ice, physical therapy, pain medications, corticosteroid injections, shock wave therapy, or possibly surgery.",
    "vicuna-7b_fact": [
      "Plantar fasciitis is a condition that affects the heel and sole of the foot.",
      "The condition is caused by inflammation of the plantar fascia, a thick band of tissue that runs along the bottom of the foot.",
      "Common symptoms of plantar fasciitis include pain in the heel and sole of the foot, especially upon taking first steps after a period of rest or inactivity.",
      "Several factors can contribute to the development of plantar fasciitis, such as overpronation, high arches or flat feet, being overweight, wearing poorly cushioned shoes, and having a tight Achilles tendon.",
      "The treatment for plantar fasciitis typically includes rest, ice, physical therapy, pain medications, corticosteroid injections, shock wave therapy, or possibly surgery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1869,
    "user_query": "Which is the enzymatic activity of OTULIN?",
    "vicuna-7b_response": "OTULIN is a protein that is produced by the salivary glands of the African clawed frog, Xenopus laevis. It is a member of the serine protease family of enzymes and is primarily known for its role in the immune system.\nOTULIN is a potent antimicrobial protein that has been shown to have activity against a wide range of bacteria, fungi, and viruses. It is able to lyse bacteria by cleaving their peptidoglycan cell walls, and it also has activity against other types of microorganisms.\nIn addition to its antimicrobial activity, OTULIN has also been shown to have other enzymatic activities. For example, it has been shown to have proteolytic activity, which means that it can cleave other proteins. It has also been shown to have some activity as a nuclease, which means that it can cleave nucleic acids.\nOverall, OTULIN is a versatile enzyme that has a number of different activities, including antimicrobial activity, proteolytic activity, and nuclease activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. OTULIN is a protein produced by the salivary glands of the African clawed frog, Xenopus laevis.\n2. OTULIN is a member of the serine protease family of enzymes.\n3. OTULIN plays a role in the immune system.\n4. OTULIN has been shown to have activity against bacteria, fungi, and viruses.\n5. OTULIN has proteolytic and nuclease activity.",
    "vicuna-7b_fact": [
      "OTULIN is a protein produced by the salivary glands of the African clawed frog, Xenopus laevis.",
      "OTULIN is a member of the serine protease family of enzymes.",
      "OTULIN plays a role in the immune system.",
      "OTULIN has been shown to have activity against bacteria, fungi, and viruses.",
      "OTULIN has proteolytic and nuclease activity."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: OTULIN is not produced by the salivary glands of the African clawed frog, Xenopus laevis; it's a human protein involved in the immune system.\n2. FALSE [correction]: OTULIN is not a member of the serine protease family of enzymes; it is a ubiquitin-specific enzyme.\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: OTULIN has proteolytic activity but it does not have nuclease activity.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1874,
    "user_query": "Is there an association between Muenke Syndrome and FGFR3 gene mutation?",
    "vicuna-7b_response": "Yes, there is an association between Muenke syndrome and FGFR3 gene mutation. Muenke syndrome, also known as brachydactyly type B (BDB), is a genetic disorder characterized by short stature, short fingers and toes (brachydactyly), and distinctive facial features. FGFR3 gene mutations have been identified as a cause of Muenke syndrome.\nThe FGFR3 gene provides instructions for making a protein called fibroblast growth factor receptor 3 (FGFR3). This protein plays a role in the development of bones and other tissues. Mutations in the FGFR3 gene can cause Muenke syndrome by disrupting the normal function of the FGFR3 protein.\nIndividuals with Muenke syndrome may have short stature, short fingers and toes, a broad nasal bridge, a flat face with a broad forehead, and a low hairline in the back of the head. They may also have hearing loss, and some may have learning difficulties.\nThe diagnosis of Muenke syndrome is based on the presence of characteristic physical features and a genetic test that can detect mutations in the FGFR3 gene. Treatment for Muenke syndrome is not curative, but it may include measures to manage the symptoms and improve quality of life.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is an association between Muenke syndrome and FGFR3 gene mutation. \n2. Muenke syndrome, also known as brachydactyly type B (BDB), is a genetic disorder characterized by short stature, short fingers and toes, and distinctive facial features.\n3. The FGFR3 gene provides instructions for making a protein called fibroblast growth factor receptor 3 (FGFR3), which plays a role in the development of bones and other tissues.\n4. Mutations in the FGFR3 gene can cause Muenke syndrome by disrupting the normal function of the FGFR3 protein.\n5. The diagnosis of Muenke syndrome is based on the presence of characteristic physical features and a genetic test that can detect mutations in the FGFR3 gene.",
    "vicuna-7b_fact": [
      "There is an association between Muenke syndrome and FGFR3 gene mutation.",
      "Muenke syndrome, also known as brachydactyly type B (BDB), is a genetic disorder characterized by short stature, short fingers and toes, and distinctive facial features.",
      "The FGFR3 gene provides instructions for making a protein called fibroblast growth factor receptor 3 (FGFR3), which plays a role in the development of bones and other tissues.",
      "Mutations in the FGFR3 gene can cause Muenke syndrome by disrupting the normal function of the FGFR3 protein.",
      "The diagnosis of Muenke syndrome is based on the presence of characteristic physical features and a genetic test that can detect mutations in the FGFR3 gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Muenke syndrome, also known as FGFR3-related craniosynostosis, is a genetic disorder characterized by premature closure of certain bones of the skull, a distinctive head shape, and broad, thumbed great toes. It is not the same as brachydactyly type B.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1875,
    "user_query": "Which R package is used for visualization of linear and circular karyotypes?",
    "vicuna-7b_response": "The R package used for visualization of linear and circular karyotypes is \"circos\".",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The R package \"circos\" is used for visualization of linear and circular karyotypes.",
    "vicuna-7b_fact": [
      "The R package \"circos\" is used for visualization of linear and circular karyotypes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 1882,
    "user_query": "What is Bartter syndrome?",
    "vicuna-7b_response": "Bartter syndrome is a rare genetic disorder that affects the kidneys' ability to regulate the levels of electrolytes such as sodium, potassium, and chloride. It is characterized by low levels of these electrolytes in the blood, which can lead to a range of symptoms including dehydration, muscle weakness, and kidney stones.\nBartter syndrome is caused by mutations in one of several genes that are involved in the regulation of electrolyte levels. It is typically inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the gene (one from each parent) to develop the condition.\nThere is no cure for Bartter syndrome, but treatment can help manage the symptoms and prevent complications. This may include medications to help regulate electrolyte levels, fluid replacement therapy, and dietary changes. In some cases, dialysis or kidney transplant may be necessary.\nIt is important for individuals with Bartter syndrome to work closely with their healthcare provider to develop a treatment plan that meets their specific needs. With proper management, many individuals with Bartter syndrome can lead healthy, active lives.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bartter syndrome is a rare genetic disorder that affects the kidneys' ability to regulate the levels of electrolytes such as sodium, potassium, and chloride.\n2. Bartter syndrome is characterized by low levels of these electrolytes in the blood, causing a range of symptoms including dehydration, muscle weakness, and kidney stones.\n3. The cause of Bartter syndrome is mutations in one of several genes involved in the regulation of electrolyte levels, typically inherited in an autosomal recessive pattern.\n4. There is currently no cure for Bartter syndrome, but treatment including medications, fluid replacement therapy, and dietary changes can manage the symptoms and prevent complications.\n5. In some severe cases of Bartter syndrome, dialysis or kidney transplant may be necessary.",
    "vicuna-7b_fact": [
      "Bartter syndrome is a rare genetic disorder that affects the kidneys' ability to regulate the levels of electrolytes such as sodium, potassium, and chloride.",
      "Bartter syndrome is characterized by low levels of these electrolytes in the blood, causing a range of symptoms including dehydration, muscle weakness, and kidney stones.",
      "The cause of Bartter syndrome is mutations in one of several genes involved in the regulation of electrolyte levels, typically inherited in an autosomal recessive pattern.",
      "There is currently no cure for Bartter syndrome, but treatment including medications, fluid replacement therapy, and dietary changes can manage the symptoms and prevent complications.",
      "In some severe cases of Bartter syndrome, dialysis or kidney transplant may be necessary."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1884,
    "user_query": "List RNA modifications databases",
    "vicuna-7b_response": "There are several databases that provide information on RNA modifications:\n1. The RNA Modification Database (RMD) - This database provides information on RNA modifications, including their locations, modifications, and functional roles. It also includes information on the enzymes that modify RNA.\n2. The Encyclopedia of RNA Modification (ERM) - This database provides comprehensive information on RNA modifications, including their locations, modifications, and functional roles. It also includes information on the enzymes that modify RNA.\n3. The RNA Modification Atlas - This database provides information on RNA modifications, including their locations, modifications, and functional roles. It also includes information on the enzymes that modify RNA.\n4. The RNA Modification Disease Database (RMDD) - This database provides information on RNA modifications and their role in disease. It includes information on the enzymes that modify RNA and the diseases associated with RNA modifications.\n5. The RNA Modification Functional Annotation Database (RMFAD) - This database provides information on RNA modifications and their functional roles. It includes information on the enzymes that modify RNA and the functional roles of RNA modifications.\nThese databases are valuable resources for researchers studying RNA modifications and their role in various biological processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The RNA Modification Database (RMD) provides information on RNA modifications, including their locations, modifications, functional roles, and on the enzymes that modify RNA.\n2. The Encyclopedia of RNA Modification (ERM) provides comprehensive information on RNA modifications, their locations, modifications, functional roles, and on the enzymes that modify RNA.\n3. The RNA Modification Atlas provides information on RNA modifications, including their locations, modifications, functional roles, and on the enzymes that modify RNA.\n4. The RNA Modification Disease Database (RMDD) provides information on RNA modifications and their role in disease, including information on the enzymes that modify RNA and the diseases associated with RNA modifications.\n5. The RNA Modification Functional Annotation Database (RMFAD) provides information on RNA modifications and their functional roles, including information on the enzymes that modify RNA and the functional roles of RNA modifications.",
    "vicuna-7b_fact": [
      "The RNA Modification Database (RMD) provides information on RNA modifications, including their locations, modifications, functional roles, and on the enzymes that modify RNA.",
      "The Encyclopedia of RNA Modification (ERM) provides comprehensive information on RNA modifications, their locations, modifications, functional roles, and on the enzymes that modify RNA.",
      "The RNA Modification Atlas provides information on RNA modifications, including their locations, modifications, functional roles, and on the enzymes that modify RNA.",
      "The RNA Modification Disease Database (RMDD) provides information on RNA modifications and their role in disease, including information on the enzymes that modify RNA and the diseases associated with RNA modifications.",
      "The RNA Modification Functional Annotation Database (RMFAD) provides information on RNA modifications and their functional roles, including information on the enzymes that modify RNA and the functional roles of RNA modifications."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no Encyclopedia of RNA Modification(ERM). The corrected statement can be the RNA Modification Database (RMD) provides comprehensive information on RNA modifications, their locations, modifications, functional roles, and on the enzymes that modify RNA.\n3. UNKNOWN\n4. FALSE [correction]: There is no RNA Modification Disease Database (RMDD). A correct statement could be \"RNA modification research has linked these modifications to several diseases\".\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1888,
    "user_query": "What gene is mutated in Sickle Cell Anemia?",
    "vicuna-7b_response": "Sickle Cell Anemia is a genetic disorder caused by a mutation in the hemoglobin gene. The mutation results in the production of abnormal hemoglobin, which is characterized by the substitution of a valine for glutamic acid at position 6 of the beta chain of the hemoglobin molecule. This leads to the formation of abnormal hemoglobin polymers that are prone to aggregation and sickling, which causes the characteristic red blood cells to assume a sickle shape and leads to a variety of clinical manifestations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sickle Cell Anemia is caused by a mutation in the hemoglobin gene.\n2. The mutation in Sickle Cell Anemia involves the substitution of a valine for glutamic acid at position 6 of the beta chain of the hemoglobin molecule.\n3. This mutation causes the production of abnormal hemoglobin.\n4. Abnormal hemoglobin polymers that are prone to aggregation and sickling are formed due to this mutation.\n5. The mutation leads to red blood cells assuming a sickle shape.",
    "vicuna-7b_fact": [
      "Sickle Cell Anemia is caused by a mutation in the hemoglobin gene.",
      "The mutation in Sickle Cell Anemia involves the substitution of a valine for glutamic acid at position 6 of the beta chain of the hemoglobin molecule.",
      "This mutation causes the production of abnormal hemoglobin.",
      "Abnormal hemoglobin polymers that are prone to aggregation and sickling are formed due to this mutation.",
      "The mutation leads to red blood cells assuming a sickle shape."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE \n3. TRUE \n4. TRUE \n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1889,
    "user_query": "What is the function of the Indian hedgehog protein in chondrocytes?",
    "vicuna-7b_response": "The Indian hedgehog protein (IHH) plays a crucial role in the development and maintenance of chondrocytes, which are cells responsible for the production of cartilage. IHH is a member of the Hedgehog family of proteins, which are involved in the regulation of cell proliferation, differentiation, and survival.\nIn chondrocytes, IHH regulates the expression of genes involved in the synthesis of cartilage matrix components, such as collagen and proteoglycans. It also promotes the differentiation of chondrocytes into cartilage-producing cells. Additionally, IHH has been shown to play a role in the regulation of the extracellular matrix (ECM) remodeling process, which is essential for the maintenance of healthy cartilage.\nDysregulation of IHH signaling has been implicated in the pathogenesis of several chondrodysplasias and osteochondrodysplasias, such as achondroplasia and thanatophoric dysplasia, which are characterized by abnormal cartilage development and growth.\nIn summary, the Indian hedgehog protein plays a crucial role in the development and maintenance of chondrocytes by regulating the expression of genes involved in cartilage matrix synthesis, promoting chondrocyte differentiation, and regulating the ECM remodeling process. Dysregulation of IHH signaling has been implicated in the pathogenesis of several chondrodysplasias and osteochondrodysplasias.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Indian hedgehog protein, also known as IHH, plays a significant role in the development and maintenance of chondrocytes.\n2. Chondrocytes are cells responsible for the production of cartilage.\n3. In chondrocytes, the Indian hedgehog protein regulates the expression of genes involved in the synthesis of cartilage matrix components.\n4. The Indian hedgehog protein has a function in promoting the differentiation of chondrocytes into cells that produce cartilage.\n5. Dysregulation of IHH signaling has been implicated in the pathogenesis of several chondrodysplasias and osteochondrodysplasias, such as achondroplasia and thanatophoric dysplasia.",
    "vicuna-7b_fact": [
      "The Indian hedgehog protein, also known as IHH, plays a significant role in the development and maintenance of chondrocytes.",
      "Chondrocytes are cells responsible for the production of cartilage.",
      "In chondrocytes, the Indian hedgehog protein regulates the expression of genes involved in the synthesis of cartilage matrix components.",
      "The Indian hedgehog protein has a function in promoting the differentiation of chondrocytes into cells that produce cartilage.",
      "Dysregulation of IHH signaling has been implicated in the pathogenesis of several chondrodysplasias and osteochondrodysplasias, such as achondroplasia and thanatophoric dysplasia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-7b_response": "R-spondin 1 and noggin are both proteins that play important roles in the development and maintenance of the gallbladder.\nR-spondin 1 is a protein that is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder. R-spondin 1 also promotes the formation of tight junctions between epithelial cells, which are important for maintaining the integrity of the epithelial lining.\nNoggin is a protein that is expressed in the developing embryo and is involved in the regulation of bone morphogenetic protein (BMP) signaling. BMP signaling is important for the development of many tissues, including the gallbladder. Noggin inhibits BMP signaling, which is important for the development of the gallbladder. Noggin also promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder.\nIn non-damaged gallbladders, R-spondin 1 and noggin work together to promote the development and maintenance of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.\nIn summary, R-spondin 1 and noggin play important roles in the development and maintenance of the gallbladder. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. R-spondin 1 and noggin are proteins that play important roles in the development and maintenance of the gallbladder.\n2. R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of its epithelial lining.\n3. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells, which make up the lining of the gallbladder.\n4. Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of many tissues, including the gallbladder.\n5. In non-damaged gallbladders, R-spondin 1 and noggin work together to promote the development and maintenance of the gallbladder's epithelial lining.",
    "vicuna-7b_fact": [
      "R-spondin 1 and noggin are proteins that play important roles in the development and maintenance of the gallbladder.",
      "R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of its epithelial lining.",
      "R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells, which make up the lining of the gallbladder.",
      "Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of many tissues, including the gallbladder.",
      "In non-damaged gallbladders, R-spondin 1 and noggin work together to promote the development and maintenance of the gallbladder's epithelial lining."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1897,
    "user_query": "Which is the genome browser database for DNA shape annotations?",
    "vicuna-7b_response": "There are several genome browser databases that allow users to annotate DNA shape, including:\n1. the UCSC Genome Browser: This is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations. Users can view and annotate DNA sequences, as well as access a variety of tools and resources for analyzing genomic data.\n2. the Ensembl Genome Browser: This is another free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations. Ensembl allows users to view and annotate DNA sequences, as well as access a variety of tools and resources for analyzing genomic data.\n3. the Genome Analysis Toolkit (GATK): This is a suite of tools for analyzing genomic data, including DNA shape annotations. GATK provides a variety of tools for annotating DNA sequences, including the BWA aligner and the GATK best practices for base quality score recalibration.\n4. the Integrative Genomics Viewer (IGV): This is a free, online genome browser that allows users to view and annotate DNA sequences from a variety of sources, including the UCSC Genome Browser and the Ensembl Genome Browser. IGV provides a variety of tools for analyzing genomic data, including the ability to view and annotate DNA shape.\nOverall, there are several genome browser databases that allow users to annotate DNA shape, and the choice of which one to use will depend on the specific needs and preferences of the user.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UCSC Genome Browser is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations.\n2. The Ensembl Genome Browser is another free, online genome browser that offers access to a wide range of genomic data, including DNA shape annotations.\n3. Genome Analysis Toolkit (GATK) is a suite of tools used for analyzing genomic data, including DNA shape annotations.\n4. The Integrative Genomics Viewer (IGV) is a free, online genome browser that allows users to view and annotate DNA sequences from a variety of sources, including the UCSC Genome Browser and the Ensembl Genome Browser.\n5. Users can view and annotate DNA sequences on the aforementioned browsers.",
    "vicuna-7b_fact": [
      "The UCSC Genome Browser is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations.",
      "The Ensembl Genome Browser is another free, online genome browser that offers access to a wide range of genomic data, including DNA shape annotations.",
      "Genome Analysis Toolkit (GATK) is a suite of tools used for analyzing genomic data, including DNA shape annotations.",
      "The Integrative Genomics Viewer (IGV) is a free, online genome browser that allows users to view and annotate DNA sequences from a variety of sources, including the UCSC Genome Browser and the Ensembl Genome Browser.",
      "Users can view and annotate DNA sequences on the aforementioned browsers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Genome Analysis Toolkit (GATK) is a suite of tools used for variant discovery and genotyping in high-throughput DNA sequencing data.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1903,
    "user_query": "Where is the respirasome located?",
    "vicuna-7b_response": "The respirasome is a complex of proteins that is involved in the electron transport chain and is located in the mitochondria of eukaryotic cells. The electron transport chain is responsible for generating ATP through the process of cellular respiration. The respirasome is composed of several subunits, including cytochrome c, cytochrome c oxidase, and various accessory proteins. The respirasome is located in the inner mitochondrial membrane and is responsible for the transfer of electrons from NADH to oxygen, resulting in the production of ATP.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The respirasome is a complex of proteins that is involved in the electron transport chain.\n2. The respirasome is located in the mitochondria of eukaryotic cells.\n3. The electron transport chain is responsible for generating ATP through the process of cellular respiration.\n4. The respirasome is composed of several subunits, including cytochrome c, cytochrome c oxidase, and various accessory proteins.\n5. The respirasome is located in the inner mitochondrial membrane and is responsible for the transfer of electrons from NADH to oxygen, resulting in the production of ATP.",
    "vicuna-7b_fact": [
      "The respirasome is a complex of proteins that is involved in the electron transport chain.",
      "The respirasome is located in the mitochondria of eukaryotic cells.",
      "The electron transport chain is responsible for generating ATP through the process of cellular respiration.",
      "The respirasome is composed of several subunits, including cytochrome c, cytochrome c oxidase, and various accessory proteins.",
      "The respirasome is located in the inner mitochondrial membrane and is responsible for the transfer of electrons from NADH to oxygen, resulting in the production of ATP."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The respirasome is composed of several subunits, including Complex I, Complex III, Complex IV, and various accessory proteins.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1906,
    "user_query": "What kind of analyses are performed with the software tool \"unipept\"",
    "vicuna-7b_response": "\"unipept\" is a software tool used for peptide identification and quantitation in mass spectrometry (MS) data. It performs various analyses to identify and quantitate peptides in MS/MS data, including:\n1. Peptide identification: \"unipept\" uses a combination of database searching and de novo sequencing to identify peptides in the MS/MS data. It can search against multiple databases, including Swiss-Prot, UniProt, and MS-GF+, and can also perform de novo sequencing using various algorithms.\n2. Peptide quantitation: \"unipept\" calculates the relative abundance of each identified peptide in the MS/MS data. It uses various algorithms to estimate the abundance of each peptide, including the ratio of the peak areas, the number of ion counts, and the normalized collision energy (NCE).\n3. Peptide fragmentation analysis: \"unipept\" can also perform fragmentation analysis of identified peptides to confirm their identities. It can generate and display the fragmentation spectra of each identified peptide, which can help to confirm the peptide sequence and identify post-translational modifications.\n4. Database searching: \"unipept\" can perform database searching to identify peptides in the MS/MS data. It can search against multiple databases, including Swiss-Prot, UniProt, and MS-GF+, and can also perform de novo sequencing using various algorithms.\n5. De novo sequencing: \"unipept\" can perform de novo sequencing to identify peptides in the MS/MS data. It can use various algorithms, such as the SEQUEST algorithm, to perform de novo sequencing and identify peptides in the MS/MS data.\nOverall, \"unipept\" is a powerful tool for peptide identification and quantitation in MS data, and it can perform various analyses to help identify and quantitate peptides in complex MS data.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. \"unipept\" is a software tool used for peptide identification and quantitation in mass spectrometry (MS) data.\n2. \"unipept\" uses a combination of database searching and de novo sequencing to identify peptides.\n3. The software can search against multiple databases, including Swiss-Prot, UniProt, and MS-GF+.\n4. \"unipept\" calculates the relative abundance of each identified peptide in the MS/MS data using various algorithms.\n5. \"unipept\" can perform fragmentation analysis of identified peptides to confirm their identities.",
    "vicuna-7b_fact": [
      "\"unipept\" is a software tool used for peptide identification and quantitation in mass spectrometry (MS) data.",
      "\"unipept\" uses a combination of database searching and de novo sequencing to identify peptides.",
      "The software can search against multiple databases, including Swiss-Prot, UniProt, and MS-GF+.",
      "\"unipept\" calculates the relative abundance of each identified peptide in the MS/MS data using various algorithms.",
      "\"unipept\" can perform fragmentation analysis of identified peptides to confirm their identities."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1907,
    "user_query": "What is the role of gamma-secreatase complex in Alzheimer's Disease?",
    "vicuna-7b_response": "Gamma-secretase complex is a protein complex that plays a crucial role in the development of Alzheimer's disease. It is a key enzyme involved in the production of beta-amyloid peptides, which are known to accumulate in the brains of individuals with Alzheimer's disease.\nThe gamma-secretase complex is composed of three proteins: presenilin, nicastrin, and APH-1. These proteins work together to cleave specific amino acids from the amyloid precursor protein (APP), releasing a peptide called beta-amyloid. This process is thought to be involved in the formation of beta-amyloid plaques, which are a hallmark of Alzheimer's disease.\nResearch has shown that mutations in the genes that encode for the gamma-secretase complex can lead to an increase in beta-amyloid production, which may contribute to the development of Alzheimer's disease. Additionally, inhibitors of the gamma-secretase complex have been developed as potential therapeutic agents for the treatment of Alzheimer's disease.\nIn summary, the gamma-secretase complex plays a crucial role in the development of Alzheimer's disease by producing beta-amyloid peptides, which are known to accumulate in the brains of individuals with the disease. Mutations in the genes that encode for the gamma-secretase complex can lead to an increase in beta-amyloid production, which may contribute to the development of Alzheimer's disease. Inhibitors of the gamma-secretase complex have been developed as potential therapeutic agents for the treatment of Alzheimer's disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The gamma-secretase complex is a protein complex that is involved in the development of Alzheimer's disease.\n2. This complex is composed of three proteins: presenilin, nicastrin, and APH-1.\n3. Its role includes producing beta-amyloid peptides, known to accumulate in the brains of individuals with Alzheimer's disease.\n4. Research indicates that mutations in the genes encoding for the gamma-secretase complex can increase beta-amyloid production.\n5. Inhibitors of the gamma-secretase complex have been developed as potential therapeutic agents for the treatment of Alzheimer's disease.",
    "vicuna-7b_fact": [
      "The gamma-secretase complex is a protein complex that is involved in the development of Alzheimer's disease.",
      "This complex is composed of three proteins: presenilin, nicastrin, and APH-1.",
      "Its role includes producing beta-amyloid peptides, known to accumulate in the brains of individuals with Alzheimer's disease.",
      "Research indicates that mutations in the genes encoding for the gamma-secretase complex can increase beta-amyloid production.",
      "Inhibitors of the gamma-secretase complex have been developed as potential therapeutic agents for the treatment of Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gamma-secretase complex is composed of four proteins- presenilin, nicastrin, APH-1 and PEN-2.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1912,
    "user_query": "List peptide fragmentations methods in mass spectrometry",
    "vicuna-7b_response": "There are several methods for peptide fragmentation in mass spectrometry, including:\n1. Collision-induced dissociation (CID): This is the most commonly used method for peptide fragmentation in MS. It involves colliding the peptide ions with a gas phase molecule, such as N2 or CO, which causes the peptide to break apart.\n2. Electron capture dissociation (ECD): This method involves the use of an electron transfer agent, such as 2,5-dihydroxybenzoic acid (DHB), to induce the loss of electrons from the peptide, leading to fragmentation.\n3. High-energy collisional dissociation (HCD): This method involves colliding the peptide ions with a metal target, such as a gold or platinum surface, which causes the peptide to break apart.\n4. Top-down mass spectrometry: This method involves breaking up a larger peptide or protein molecule into smaller fragments using a laser or other high-energy source.\n5. Tandem mass spectrometry: This method involves fragmenting a peptide ion in the first stage of mass spectrometry, and then fragmenting the resulting ions in a second stage to generate higher-mass ions.\nThese are some of the most commonly used methods for peptide fragmentation in mass spectrometry. The choice of method depends on the specific goals of the experiment and the properties of the peptide being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Collision-induced dissociation (CID) is a method for peptide fragmentation in mass spectrometry, involving the collision of peptide ions with a gas phase molecule.\n2. Electron capture dissociation (ECD) is another method, involving use of an electron transfer agent to induce the loss of electrons from the peptide.\n3. High-energy collisional dissociation (HCD) in mass spectrometry involves colliding the peptide ions with a metal target to cause peptide fragmentation.\n4. Top-down mass spectrometry method involves breaking up a larger peptide or protein molecule into smaller fragments using a laser or other high-energy source.\n5. Tandem mass spectrometry involves fragmenting a peptide ion in the first stage, and then fragmenting the resulting ions in a second stage to generate higher-mass ions.",
    "vicuna-7b_fact": [
      "Collision-induced dissociation (CID) is a method for peptide fragmentation in mass spectrometry, involving the collision of peptide ions with a gas phase molecule.",
      "Electron capture dissociation (ECD) is another method, involving use of an electron transfer agent to induce the loss of electrons from the peptide.",
      "High-energy collisional dissociation (HCD) in mass spectrometry involves colliding the peptide ions with a metal target to cause peptide fragmentation.",
      "Top-down mass spectrometry method involves breaking up a larger peptide or protein molecule into smaller fragments using a laser or other high-energy source.",
      "Tandem mass spectrometry involves fragmenting a peptide ion in the first stage, and then fragmenting the resulting ions in a second stage to generate higher-mass ions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Electron capture dissociation (ECD) is another method, involving the use of free low-energy electrons to induce peptide fragmentation in mass spectrometry.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tandem mass spectrometry involves fragmenting a peptide ion in the first stage, and then analyzing the resulting ions in a second stage to provide sequence information.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1915,
    "user_query": "Which infection can be prevented with Dapivirine?",
    "vicuna-7b_response": "Dapivirine is a medication that is used to prevent the transmission of HIV, the virus that causes AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and works by blocking the activity of the HIV virus's reverse transcriptase enzyme, which is necessary for the virus to replicate and infect cells.\nDapivirine is typically used as an additional form of HIV prevention for people who are at high risk of contracting the virus, such as those who have multiple sexual partners, use injection drugs, or have a sexual partner who is HIV-positive. It is typically used in combination with other forms of HIV prevention, such as condoms and pre-exposure prophylaxis (PrEP).\nDapivirine is not a treatment for HIV or AIDS, but rather a preventive measure. If you think you may have been exposed to HIV, it is important to seek medical attention as soon as possible to begin appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dapivirine is a medication used to prevent HIV transmission.\n2. Dapivirine works by blocking the HIV virus's reverse transcriptase enzyme.\n3. Dapivirine is typically used for people at high risk of contracting HIV.\n4. Dapivirine is used in combination with other forms of HIV prevention, such as condoms and pre-exposure prophylaxis (PrEP).\n5. Dapivirine is not a treatment for HIV or AIDS.",
    "vicuna-7b_fact": [
      "Dapivirine is a medication used to prevent HIV transmission.",
      "Dapivirine works by blocking the HIV virus's reverse transcriptase enzyme.",
      "Dapivirine is typically used for people at high risk of contracting HIV.",
      "Dapivirine is used in combination with other forms of HIV prevention, such as condoms and pre-exposure prophylaxis (PrEP).",
      "Dapivirine is not a treatment for HIV or AIDS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1917,
    "user_query": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?",
    "vicuna-7b_response": "Gamma knife is a non-invasive surgical procedure that uses gamma radiation to treat brain tumors and other conditions. It is not typically used to treat Obsessive-Compulsive Disorder (OCD).\nOCD is a mental health disorder characterized by persistent and uncontrollable thoughts, feelings, and behaviors that a person has to perform repeatedly. It is typically treated with a combination of medication and psychotherapy.\nThere are some medications that are used to treat OCD, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin in the brain, which is a neurotransmitter that helps regulate mood and emotions.\nCognitive-behavioral therapy (CBT) is another type of psychotherapy that is used to treat OCD. CBT helps people with OCD to identify and change negative thoughts and behaviors that contribute to their symptoms.\nIn some cases, a healthcare provider may recommend a combination of medication and CBT for treating OCD. In rare cases, if other treatments have not been effective, a healthcare provider may consider using gamma knife for treating OCD, but this is not a common practice.\nIn summary, while gamma knife is not typically used to treat OCD, there are other treatments available such as medication and psychotherapy that are more commonly used to manage the symptoms of OCD.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gamma knife is a non-invasive surgical procedure that uses gamma radiation primarily to treat brain tumors and other conditions.\n2. Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by persistent and uncontrollable thoughts, feelings, and behaviors that are repeatedly performed.\n3. OCD is typically treated with a combination of medication and psychotherapy.\n4. Medications like selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are used to treat OCD by increasing levels of serotonin in the brain.\n5. Cognitive-behavioral therapy (CBT) is a type of psychotherapy that helps people with OCD to identify and change negative thoughts and behaviors that contribute to their symptoms.",
    "vicuna-7b_fact": [
      "Gamma knife is a non-invasive surgical procedure that uses gamma radiation primarily to treat brain tumors and other conditions.",
      "Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by persistent and uncontrollable thoughts, feelings, and behaviors that are repeatedly performed.",
      "OCD is typically treated with a combination of medication and psychotherapy.",
      "Medications like selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are used to treat OCD by increasing levels of serotonin in the brain.",
      "Cognitive-behavioral therapy (CBT) is a type of psychotherapy that helps people with OCD to identify and change negative thoughts and behaviors that contribute to their symptoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1918,
    "user_query": "What is the mechanism of action of the biguanide class of diabetes drugs?",
    "vicuna-7b_response": "The biguanide class of diabetes drugs, also known as the \"oral hypoglycemics,\" work by increasing the sensitivity of muscle and fat cells to insulin, which in turn lowers blood sugar levels.\nThe biguanide class of drugs includes metformin, which is the most commonly used oral hypoglycemic in the treatment of type 2 diabetes. Metformin works by inhibiting gluconeogenesis, the production of glucose from non-carbohydrate sources, in the liver. This leads to a decrease in the amount of glucose produced by the liver and an increase in the uptake of glucose by muscle and fat cells, which in turn lowers blood sugar levels.\nIn addition to its glucose-lowering effects, metformin has also been shown to have anti-inflammatory and anti-oxidant effects, which may contribute to its overall beneficial effects on cardiovascular health in people with diabetes.\nIt's important to note that the biguanide class of drugs is not suitable for everyone with diabetes, and the decision to use these drugs should be made on an individual basis, in consultation with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The biguanide class of diabetes drugs increases the sensitivity of muscle and fat cells to insulin, which lowers blood sugar levels. \n2. Metformin is a drug in the biguanide class and is the most commonly used oral hypoglycemic in the treatment of type 2 diabetes.\n3. Metformin works by inhibiting gluconeogenesis in the liver.\n4. The use of metformin leads to a decrease in the amount of glucose produced by the liver and an increase in the uptake of glucose by muscle and fat cells.\n5. Metformin has anti-inflammatory and anti-oxidant effects which may be beneficial for cardiovascular health in people with diabetes.",
    "vicuna-7b_fact": [
      "The biguanide class of diabetes drugs increases the sensitivity of muscle and fat cells to insulin, which lowers blood sugar levels.",
      "Metformin is a drug in the biguanide class and is the most commonly used oral hypoglycemic in the treatment of type 2 diabetes.",
      "Metformin works by inhibiting gluconeogenesis in the liver.",
      "The use of metformin leads to a decrease in the amount of glucose produced by the liver and an increase in the uptake of glucose by muscle and fat cells.",
      "Metformin has anti-inflammatory and anti-oxidant effects which may be beneficial for cardiovascular health in people with diabetes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1919,
    "user_query": "Where is the proteasome located?",
    "vicuna-7b_response": "The proteasome is a complex within cells that is responsible for breaking down proteins that are no longer needed or are damaged. It is located in the cytoplasm of most cells, but it can also be found in the endoplasmic reticulum and the nucleus of certain cells. The proteasome is an important part of the cell's protein quality control system, and it plays a role in many cellular processes, including protein synthesis, cell growth and division, and the response to stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The proteasome is responsible for breaking down proteins that are no longer needed or are damaged within cells.\n2. The proteasome is located in the cytoplasm of most cells.\n3. The proteasome can also be found in the endoplasmic reticulum and the nucleus of certain cells.\n4. The proteasome is a part of the cell's protein quality control system.\n5. The proteasome plays a role in many cellular processes, including protein synthesis, cell growth and division, and the response to stress.",
    "vicuna-7b_fact": [
      "The proteasome is responsible for breaking down proteins that are no longer needed or are damaged within cells.",
      "The proteasome is located in the cytoplasm of most cells.",
      "The proteasome can also be found in the endoplasmic reticulum and the nucleus of certain cells.",
      "The proteasome is a part of the cell's protein quality control system.",
      "The proteasome plays a role in many cellular processes, including protein synthesis, cell growth and division, and the response to stress."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1923,
    "user_query": "List available circular RNA prediction tools.",
    "vicuna-7b_response": "There are several tools available for predicting circular RNAs (circRNAs). Here are some of the most popular ones:\n1. CircRNAFinder: This is a web-based tool that uses a deep learning algorithm to predict circRNAs from genomic sequences. It can predict both human and mouse circRNAs.\n2. RNA-seqAnalyzer: This is a bioinformatics tool that can predict circRNAs from RNA-seq data. It can also perform other analyses such as gene expression analysis and splicing analysis.\n3. CircularRNA: This is a bioinformatics tool that can predict circRNAs from genomic sequences. It can also perform other analyses such as gene expression analysis and splicing analysis.\n4. CircRNAPredict: This is a web-based tool that uses a deep learning algorithm to predict circRNAs from genomic sequences. It can predict both human and mouse circRNAs.\n5. CircularRNAAnalyzer: This is a bioinformatics tool that can predict circRNAs from RNA-seq data. It can also perform other analyses such as gene expression analysis and splicing analysis.\nThese are just a few examples of the many tools available for predicting circRNAs. It's important to note that the accuracy of these tools can vary depending on the quality of the input data and the specific algorithm used. Therefore, it's important to carefully evaluate the results and consult with a bioinformatics expert if necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CircRNAFinder is a tool that is used to predict circular RNAs from genomic sequences using a deep learning algorithm.\n2. RNA-seqAnalyzer is a bioinformatics tool used for predicting circular RNAs from RNA-seq data and performing other analyses like gene expression analysis and splicing analysis.\n3. CircularRNA is a bioinformatics tool which is used to predict circular RNAs from genomic sequences and perform other analyses.\n4. CircRNAPredict uses a deep learning algorithm to predict circular RNAs from genomic sequences.\n5. CircularRNAAnalyzer is used to predict circular RNAs from RNA-seq data and can also perform other analyses such as gene expression analysis and splicing analysis.",
    "vicuna-7b_fact": [
      "CircRNAFinder is a tool that is used to predict circular RNAs from genomic sequences using a deep learning algorithm.",
      "RNA-seqAnalyzer is a bioinformatics tool used for predicting circular RNAs from RNA-seq data and performing other analyses like gene expression analysis and splicing analysis.",
      "CircularRNA is a bioinformatics tool which is used to predict circular RNAs from genomic sequences and perform other analyses.",
      "CircRNAPredict uses a deep learning algorithm to predict circular RNAs from genomic sequences.",
      "CircularRNAAnalyzer is used to predict circular RNAs from RNA-seq data and can also perform other analyses such as gene expression analysis and splicing analysis."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1924,
    "user_query": "Which disease is treated with Nusinersen?",
    "vicuna-7b_response": "Nusinersen is a treatment for spinal muscular atrophy (SMA). SMA is a genetic disorder that affects the nerve cells in the spinal cord that control muscle movement. Nusinersen is a drug that is administered through an infusion and works by increasing the production of a protein called SMN1, which is missing or reduced in people with SMA. Nusinersen has been shown to improve muscle strength and overall function in people with SMA, and it has been approved for use in several countries for the treatment of SMA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nusinersen is a treatment for spinal muscular atrophy (SMA).\n2. Spinal muscular atrophy is a genetic disorder that affects the nerve cells in the spinal cord that control muscle movement.\n3. Nusinersen is administered through an infusion.\n4. The drug Nusinersen works by increasing the production of a protein called SMN1.\n5. Nusinersen has been approved for use in several countries for the treatment of SMA.",
    "vicuna-7b_fact": [
      "Nusinersen is a treatment for spinal muscular atrophy (SMA).",
      "Spinal muscular atrophy is a genetic disorder that affects the nerve cells in the spinal cord that control muscle movement.",
      "Nusinersen is administered through an infusion.",
      "The drug Nusinersen works by increasing the production of a protein called SMN1.",
      "Nusinersen has been approved for use in several countries for the treatment of SMA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Nusinersen is administered through a spinal injection, not an infusion.\n4. FALSE [correction]: The drug Nusinersen works by increasing the production of a protein called SMN2, not SMN1.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1925,
    "user_query": "Which disease the London mutation involved in?",
    "vicuna-7b_response": "The London mutation is a genetic mutation that is involved in the development of cystic fibrosis (CF). CF is a genetic disorder that affects the exocrine glands, leading to the accumulation of thick, sticky mucus in the lungs, pancreas, and other organs. The London mutation is one of the most common mutations that cause CF, and it results in the production of a non-functional CFTR protein.\nCFTR is a chloride channel that is responsible for regulating the flow of salt and water in and out of cells. In people with CF, the mutation in the CFTR gene leads to the production of a non-functional protein that cannot properly regulate the flow of salt and water in and out of cells. This leads to the accumulation of thick, sticky mucus in the lungs and other organs, which can cause respiratory problems, digestive problems, and other complications.\nThe London mutation is named after the city where it was first identified, and it is also known as the ΔF508 mutation. It is the most common mutation in the UK, and it accounts for about 70% of all CF cases in the country. The London mutation is also found in people from other countries, including the United States, Canada, and Australia.\nIn summary, the London mutation is a genetic mutation that is involved in the development of cystic fibrosis, a genetic disorder that affects the exocrine glands and leads to the accumulation of thick, sticky mucus in the lungs, pancreas, and other organs. The London mutation results in the production of a non-functional CFTR protein, and it is the most common mutation in the UK and other countries.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The London mutation is a genetic mutation that is involved in the development of cystic fibrosis (CF).\n2. CF is a genetic disorder that affects the exocrine glands, leading to the accumulation of thick, sticky mucus in the lungs, pancreas, and other organs.\n3. The London mutation results in the production of a non-functional CFTR protein.\n4. The London mutation is also known as the ΔF508 mutation.\n5. The London mutation accounts for about 70% of all CF cases in the UK.",
    "vicuna-7b_fact": [
      "The London mutation is a genetic mutation that is involved in the development of cystic fibrosis (CF).",
      "CF is a genetic disorder that affects the exocrine glands, leading to the accumulation of thick, sticky mucus in the lungs, pancreas, and other organs.",
      "The London mutation results in the production of a non-functional CFTR protein.",
      "The London mutation is also known as the ΔF508 mutation.",
      "The London mutation accounts for about 70% of all CF cases in the UK."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The F508del mutation, not the London mutation, is a genetic mutation involved in the development of cystic fibrosis (CF).\n2. TRUE\n3. FALSE [correction]: The F508del mutation, not the London mutation, results in the production of a non-functional CFTR protein.\n4. FALSE [correction]: The ΔF508 mutation, not the London mutation, is a common mutation in cystic fibrosis.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1930,
    "user_query": "Viliuisk encephalomyelitis is diagnosed in which geographical area?",
    "vicuna-7b_response": "Viliuisk encephalomyelitis is a viral infection that primarily affects the central nervous system of humans and animals. It is caused by the Vesiculovirus, which is a member of the Rhabdoviridae family. The virus is primarily found in Eastern Europe and Asia, with the highest incidence of the disease occurring in Russia and the surrounding countries. The disease is also known as Vesiculovirus disease or Rabbit haemorrhagic disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Viliuisk encephalomyelitis primarily affects the central nervous system of humans and animals.\n2. Viliuisk encephalomyelitis is caused by the Vesiculovirus.\n3. Vesiculovirus is a member of the Rhabdoviridae family.\n4. The Vesiculovirus is primarily found in Eastern Europe and Asia.\n5. The highest incidence of Viliuisk encephalomyelitis occurs in Russia and the surrounding countries.",
    "vicuna-7b_fact": [
      "Viliuisk encephalomyelitis primarily affects the central nervous system of humans and animals.",
      "Viliuisk encephalomyelitis is caused by the Vesiculovirus.",
      "Vesiculovirus is a member of the Rhabdoviridae family.",
      "The Vesiculovirus is primarily found in Eastern Europe and Asia.",
      "The highest incidence of Viliuisk encephalomyelitis occurs in Russia and the surrounding countries."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Viliuisk encephalomyelitis is of unknown cause. Its suspected it might be an autoimmune disorder or due to a yet unidentified infectious agent.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1934,
    "user_query": "What makes telomerase a good drug target?",
    "vicuna-7b_response": "Telomerase is a good drug target due to its role in the regulation of telomere length and its potential association with various diseases. Telomeres are repetitive DNA sequences that are found at the ends of chromosomes and play a crucial role in maintaining the integrity of the genome. Telomerase is an enzyme that adds telomeric repeats to the ends of telomeres, thereby maintaining their length and preventing chromosomal degradation.\nTelomerase activity is increased in various types of cancer cells, which suggests that it may be a promising drug target for the treatment of cancer. Inhibition of telomerase activity has been shown to induce apoptosis (programmed cell death) in cancer cells, leading to their death and potentially reducing the risk of cancer progression.\nFurthermore, telomerase activity is also increased in certain degenerative diseases, such as Alzheimer's disease and Parkinson's disease. Inhibition of telomerase activity has been shown to reduce the accumulation of protein aggregates and improve cognitive function in animal models of these diseases.\nOverall, telomerase is a good drug target due to its potential association with various diseases and its role in the regulation of telomere length. Inhibition of telomerase activity has been shown to have therapeutic potential in the treatment of cancer and degenerative diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Telomerase is an enzyme that adds telomeric repeats to the ends of telomeres.\n2. Telomerase plays a role in maintaining the integrity of the genome.\n3. The activity of telomerase is often increased in different types of cancer cells.\n4. Inhibition of telomerase activity can lead to apoptosis in cancer cells.\n5. Telomerase activity is also increased in certain degenerative diseases such as Alzheimer's disease and Parkinson's disease.",
    "vicuna-7b_fact": [
      "Telomerase is an enzyme that adds telomeric repeats to the ends of telomeres.",
      "Telomerase plays a role in maintaining the integrity of the genome.",
      "The activity of telomerase is often increased in different types of cancer cells.",
      "Inhibition of telomerase activity can lead to apoptosis in cancer cells.",
      "Telomerase activity is also increased in certain degenerative diseases such as Alzheimer's disease and Parkinson's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: There's no direct evidence to suggest that increased telomerase activity is associated with degenerative diseases such as Alzheimer's or Parkinson's disease. However, research is still ongoing to understand the role of telomerase in these conditions.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-7b_response": "Yes, NADPH oxidase 5 (Nox5) requires multiple subunits for its function. Nox5 is a subunit of the NADPH oxidase complex, which is responsible for generating reactive oxygen species (ROS) in cells. The NADPH oxidase complex is composed of several subunits, including p22phox, p47phox, p67phox, and Nox5.\nThe p22phox, p47phox, and p67phox subunits are required for the assembly and activation of the NADPH oxidase complex. These subunits interact with Nox5 to form the functional NADPH oxidase complex, which is localized in the plasma membrane of cells.\nIn the absence of these subunits, the NADPH oxidase complex is not assembled or activated, and ROS generation is impaired. This can lead to a variety of cellular dysfunctions, including inflammation, oxidative stress, and cell death.\nTherefore, Nox5 requires the p22phox, p47phox, and p67phox subunits for its function as a subunit of the NADPH oxidase complex.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NADPH oxidase 5 (Nox5) requires multiple subunits for its function.\n2. Nox5 is a subunit of the NADPH oxidase complex, which generates reactive oxygen species (ROS) in cells.\n3. The NADPH oxidase complex includes subunits p22phox, p47phox, p67phox, and Nox5.\n4. The absence of these subunits impairs the assembly and activation of the NADPH oxidase complex and ROS generation.\n5. Nox5 requires the p22phox, p47phox, and p67phox subunits for its function as a subunit of the NADPH oxidase complex.",
    "vicuna-7b_fact": [
      "NADPH oxidase 5 (Nox5) requires multiple subunits for its function.",
      "Nox5 is a subunit of the NADPH oxidase complex, which generates reactive oxygen species (ROS) in cells.",
      "The NADPH oxidase complex includes subunits p22phox, p47phox, p67phox, and Nox5.",
      "The absence of these subunits impairs the assembly and activation of the NADPH oxidase complex and ROS generation.",
      "Nox5 requires the p22phox, p47phox, and p67phox subunits for its function as a subunit of the NADPH oxidase complex."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: NADPH oxidase 5 (Nox5) doesn't require multiple subunits for its function, it is functional as a standalone enzyme.\n2. TRUE\n3. FALSE [correction]: The NADPH oxidase complex includes subunits p22phox, p47phox, p67phox, but not Nox5. Nox5 is a standalone enzyme.\n4. TRUE\n5. FALSE [correction]: Nox5 doesn't require the p22phox, p47phox, and p67phox subunits for its function. It operates independently.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1940,
    "user_query": "What is the doRiNA database?",
    "vicuna-7b_response": "The doRiNA database is a database of RNA sequences and associated information. RNA, or ribonucleic acid, is a type of molecule that plays a crucial role in the expression of genetic information in living organisms. The doRiNA database contains information on the sequence and structure of RNA molecules, as well as information on their function and expression in different organisms.\nThe doRiNA database is a valuable resource for researchers in the field of RNA biology, as it provides a comprehensive and easily accessible collection of RNA sequence and structural data. This information can be used to study the function of RNA molecules in various biological processes, such as gene expression, RNA splicing, and RNA silencing.\nThe doRiNA database also includes tools for analyzing and comparing RNA sequences, such as tools for identifying conserved regions and predicting RNA structure. These tools can be used to gain insights into the function and evolution of RNA molecules, and to identify potential targets for therapeutic intervention.\nOverall, the doRiNA database is an important resource for researchers in the field of RNA biology, and provides a valuable source of information on the structure and function of RNA molecules.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The doRiNA database is a database of RNA sequences and associated information.\n2. RNA is a type of molecule that plays a crucial role in the expression of genetic information in living organisms.\n3. The doRiNA database contains information on the sequence and structure of RNA molecules, as well as their function and expression in different organisms.\n4. The doRiNA database includes tools for analyzing and comparing RNA sequences.\n5. These tools within the doRiNA database can be used to gain insights into the function and evolution of RNA molecules, and to identify potential targets for therapeutic intervention.",
    "vicuna-7b_fact": [
      "The doRiNA database is a database of RNA sequences and associated information.",
      "RNA is a type of molecule that plays a crucial role in the expression of genetic information in living organisms.",
      "The doRiNA database contains information on the sequence and structure of RNA molecules, as well as their function and expression in different organisms.",
      "The doRiNA database includes tools for analyzing and comparing RNA sequences.",
      "These tools within the doRiNA database can be used to gain insights into the function and evolution of RNA molecules, and to identify potential targets for therapeutic intervention."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1942,
    "user_query": "Is pseudouridine a RNA modification?",
    "vicuna-7b_response": "Yes, pseudouridine is a type of RNA modification. It is a modified base in RNA that is formed by the attachment of a pseudouracil moiety to the ribose sugar of the nucleotide. The attachment of the pseudouracil moiety results in the formation of a new base pair with adenine, which can lead to changes in the properties of the RNA molecule. Pseudouridine is found in many organisms and is involved in a variety of cellular processes, including translation, splicing, and gene regulation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pseudouridine is a type of RNA modification.\n2. This modification is formed by the attachment of a pseudouracil moiety to the ribose sugar of the nucleotide.\n3. The attachment of the pseudouracil moiety leads to the formation of a new base pair with adenine.\n4. Pseudouridine can lead to changes in the properties of the RNA molecule.\n5. Pseudouridine is involved in a variety of cellular processes, including translation, splicing, and gene regulation.",
    "vicuna-7b_fact": [
      "Pseudouridine is a type of RNA modification.",
      "This modification is formed by the attachment of a pseudouracil moiety to the ribose sugar of the nucleotide.",
      "The attachment of the pseudouracil moiety leads to the formation of a new base pair with adenine.",
      "Pseudouridine can lead to changes in the properties of the RNA molecule.",
      "Pseudouridine is involved in a variety of cellular processes, including translation, splicing, and gene regulation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: This modification is formed by the isomerization of uridine.\n3. FALSE [correction]: The attachment of the pseudouracil moiety does not lead to the formation of a new base pair with adenine. The base pairing properties of RNA are not altered by the presence of pseudouridine.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1943,
    "user_query": "What does the human ABCC gene  product do?",
    "vicuna-7b_response": "The ABCC gene product, also known as breast cancer resistance protein (BCRP), is a transporter protein that is expressed in various tissues throughout the body. It is responsible for transporting a wide range of compounds, including drugs, toxins, and other substances, out of cells.\nIn the context of breast cancer, BCRP has been shown to play a role in the resistance of cancer cells to chemotherapy drugs. This is because BCRP can actively pump chemotherapy drugs out of cancer cells, making them less effective at killing the cells.\nResearch has also shown that BCRP can play a role in the transport of other substances, such as vitamins, fat-soluble compounds, and other molecules.\nOverall, the ABCC gene product, BCRP, is an important protein that plays a role in the transport of a wide range of compounds in the body, and its function has implications for the treatment of cancer and other diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ABCC gene product, also known as breast cancer resistance protein (BCRP), is a transporter protein expressed in various tissues throughout the body.\n2. BCRP is responsible for transporting a range of compounds – including drugs, toxins, and other substances – out of cells.\n3. In the context of breast cancer, BCRP has been shown to confer resistance to chemotherapy drugs by pumping them out of cancer cells.\n4. BCRP has been shown to also play a role in the transport of vitamins, fat-soluble compounds, and other molecules.\n5. The function of the ABCC gene product has implications for the treatment of diseases, including cancer.",
    "vicuna-7b_fact": [
      "The ABCC gene product, also known as breast cancer resistance protein (BCRP), is a transporter protein expressed in various tissues throughout the body.",
      "BCRP is responsible for transporting a range of compounds – including drugs, toxins, and other substances – out of cells.",
      "In the context of breast cancer, BCRP has been shown to confer resistance to chemotherapy drugs by pumping them out of cancer cells.",
      "BCRP has been shown to also play a role in the transport of vitamins, fat-soluble compounds, and other molecules.",
      "The function of the ABCC gene product has implications for the treatment of diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The ABCG2 gene product, not ABCC, is also known as breast cancer resistance protein (BCRP), it's a transporter protein expressed in various tissues throughout the body.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-7b_response": "Furin and hepcidin are two different proteins that have a connection in the regulation of iron metabolism.\nHepcidin is a hormone produced by cells in the liver that plays a key role in regulating the amount of iron available in the body. It does this by binding to iron transporters in the duodenum, preventing iron from being absorbed from the diet. Hepcidin production is regulated by the body's need for iron, with higher levels of hepcidin being produced when iron stores are low and vice versa.\nFurin is an enzyme that plays a role in the processing of proteins. It is involved in the cleavage of certain proteins, including hepcidin, to release the active form of the protein. This is important because the inactive form of hepcidin is not as effective at regulating iron metabolism.\nIn summary, furin and hepcidin are connected in the regulation of iron metabolism because furin is involved in the processing of hepcidin, allowing it to function properly and regulate the amount of iron available in the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Furin and hepcidin are two different proteins that have a connection in the regulation of iron metabolism.\n2. Hepcidin is a hormone produced by cells in the liver that plays a key role in regulating the amount of iron available in the body.\n3. Hepcidin regulates iron absorption by binding to iron transporters in the duodenum.\n4. Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.\n5. The processing by furin allows hepcidin to function properly and regulate the amount of iron available in the body.",
    "vicuna-7b_fact": [
      "Furin and hepcidin are two different proteins that have a connection in the regulation of iron metabolism.",
      "Hepcidin is a hormone produced by cells in the liver that plays a key role in regulating the amount of iron available in the body.",
      "Hepcidin regulates iron absorption by binding to iron transporters in the duodenum.",
      "Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.",
      "The processing by furin allows hepcidin to function properly and regulate the amount of iron available in the body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1951,
    "user_query": "What is the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's?",
    "vicuna-7b_response": "I'm sorry, but I don't have access to specific data on the incidence of X-linked adrenoleukodystrophy (ALD) in Australia and New Zealand in the late 1990's. However, I can provide some general information about the disease and its prevalence.\nX-linked adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and the adrenal glands. It is caused by a deficiency of a specific enzyme called ATP-binding cassette transporter (ABCD1), which is responsible for breaking down a fatty substance called very-long-chain fatty acids (VLCFA). When this enzyme is deficient, VLCFA accumulates in the cells of the nervous system and the adrenal glands, leading to progressive damage and dysfunction.\nALD is inherited in an X-linked recessive pattern, which means that males are more severely affected than females. The incidence of the disease is estimated to be about 1 in 20,000 male births worldwide. The prevalence of the disease varies by population, with higher incidences reported in certain populations, such as the Ashkenazi Jewish population.\nThere is no cure for X-linked adrenoleukodystrophy (ALD), and the disease is usually fatal in the late teenage years to early adulthood. However, there are treatments available that can slow the progression of the disease and manage its symptoms.\nI hope this information is helpful. If you have any further questions or need more information, please don't hesitate to ask.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. X-linked adrenoleukodystrophy (ALD) is a genetic disorder that affects the nervous system and the adrenal glands.\n2. ALD is caused by a deficiency of a specific enzyme called ATP-binding cassette transporter (ABCD1).\n3. This enzyme is responsible for breaking down a fatty substance called very-long-chain fatty acids (VLCFA).\n4. The incidence of X-linked adrenoleukodystrophy (ALD) is approximately 1 in 20,000 male births worldwide.\n5. The disease is usually fatal in the late teenage years to early adulthood.",
    "vicuna-7b_fact": [
      "X-linked adrenoleukodystrophy (ALD) is a genetic disorder that affects the nervous system and the adrenal glands.",
      "ALD is caused by a deficiency of a specific enzyme called ATP-binding cassette transporter (ABCD1).",
      "This enzyme is responsible for breaking down a fatty substance called very-long-chain fatty acids (VLCFA).",
      "The incidence of X-linked adrenoleukodystrophy (ALD) is approximately 1 in 20,000 male births worldwide.",
      "The disease is usually fatal in the late teenage years to early adulthood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1952,
    "user_query": "Can telomere length shortening be reversed by telomerase?",
    "vicuna-7b_response": "Yes, telomere length shortening can be reversed by telomerase. Telomerase is an enzyme that adds DNA repeats to the ends of telomeres, which helps to maintain their length and stability.\nTelomeres are repetitive DNA sequences that are found at the ends of chromosomes. They act as protective caps that prevent chromosomes from deteriorating or fusing with one another. Telomeres shorten with each cell division, and when they reach a critical length, cells may undergo senescence or apoptosis.\nTelomerase is naturally present in some cells, such as stem cells and immune cells, and it can also be introduced into other cells through gene therapy. When telomerase is introduced into cells, it can add DNA repeats to the ends of telomeres, thereby reversing telomere shortening and potentially reversing the effects of aging.\nHowever, it is important to note that telomerase therapy is not without risks. Overexpression of telomerase can lead to the development of tumors, and the use of telomerase in gene therapy is still in its early stages and requires further research.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Telomerase is an enzyme that adds DNA repeats to the ends of telomeres.\n2. Telomeres are repetitive DNA sequences found at the ends of chromosomes.\n3. Telomeres shorten with each cell division, leading potentially to cell senescence or apoptosis.\n4. Telomerase is naturally present in some cells such as stem cells and immune cells.\n5. Overexpression of telomerase can lead to the development of tumors.",
    "vicuna-7b_fact": [
      "Telomerase is an enzyme that adds DNA repeats to the ends of telomeres.",
      "Telomeres are repetitive DNA sequences found at the ends of chromosomes.",
      "Telomeres shorten with each cell division, leading potentially to cell senescence or apoptosis.",
      "Telomerase is naturally present in some cells such as stem cells and immune cells.",
      "Overexpression of telomerase can lead to the development of tumors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1953,
    "user_query": "Is ABCE1 involved in ribosomal recycling?",
    "vicuna-7b_response": "ABCE1, also known as the anaphase-promoting complex or cyclosome, is a multi-subunit E3 ubiquitin ligase that plays a crucial role in the regulation of the anaphase of the cell cycle. It is involved in the degradation of specific proteins through the ubiquitination and proteasomal degradation pathway.\nHowever, there is limited information available on the involvement of ABCE1 in ribosomal recycling. Ribosomal recycling is the process by which ribosomes are returned to the cytoplasm after they have been released from the rough endoplasmic reticulum (ER) and have served their function in protein synthesis.\nIt is possible that ABCE1 may play a role in the regulation of ribosomal recycling, but more research is needed to determine the specific mechanisms by which it does so.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ABCE1 is also known as the anaphase-promoting complex or cyclosome.\n2. ABCE1 is a multi-subunit E3 ubiquitin ligase that plays a crucial role in the regulation of the anaphase of the cell cycle.\n3. ABCE1 is involved in the degradation of specific proteins through the ubiquitination and proteasomal degradation pathway.\n4. Ribosomal recycling is the process by which ribosomes are returned to the cytoplasm after they have served their function in protein synthesis.\n5. The involvement of ABCE1 in ribosomal recycling is currently indeterminate and requires more research for confirmation.",
    "vicuna-7b_fact": [
      "ABCE1 is also known as the anaphase-promoting complex or cyclosome.",
      "ABCE1 is a multi-subunit E3 ubiquitin ligase that plays a crucial role in the regulation of the anaphase of the cell cycle.",
      "ABCE1 is involved in the degradation of specific proteins through the ubiquitination and proteasomal degradation pathway.",
      "Ribosomal recycling is the process by which ribosomes are returned to the cytoplasm after they have served their function in protein synthesis.",
      "The involvement of ABCE1 in ribosomal recycling is currently indeterminate and requires more research for confirmation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: APC/C (Anaphase-promoting complex/cyclosome) is different from ABCE1. They carry out different functions within the cell.\n2. FALSE [correction]: APC/C not ABCE1 is a multi-subunit E3 ubiquitin ligase that plays a crucial role in the regulation of the anaphase of the cell cycle.\n3. FALSE [correction]: Again, it's the APC/C not ABCE1 that is involved in the degradation of specific proteins through the ubiquitination and proteasomal degradation pathway.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1955,
    "user_query": "Does oculocutaneous albinism show an autosomal recessive inheritance?",
    "vicuna-7b_response": "Yes, oculocutaneous albinism is an autosomal recessive genetic disorder. This means that the condition is caused by a mutation in both copies of the gene that codes for the production of melanin, a pigment that gives color to the skin, hair, and eyes.\nPeople with oculocutaneous albinism have a deficiency in melanin production, which results in a lack of pigment in their skin, hair, and eyes. This lack of pigmentation can lead to vision problems, such as photophobia (sensitivity to light) and nystagmus (involuntary eye movements), as well as skin sensitivity to sunlight and an increased risk of skin cancer.\nOculocutaneous albinism is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene (one from each parent) to develop the condition. If an individual only inherits one copy of the gene, they will be a carrier of the condition but will not show any symptoms themselves.\nIt is important to note that there are several types of oculocutaneous albinism, each with its own specific genetic cause and symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oculocutaneous albinism is an autosomal recessive genetic disorder.\n2. The condition is caused by a mutation in both copies of the gene that codes for the production of melanin.\n3. People with oculocutaneous albinism have a deficiency in melanin production.\n4. Oculocutaneous albinism is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the gene to develop the condition.\n5. There are several types of oculocutaneous albinism, each with its own specific genetic cause and symptoms.",
    "vicuna-7b_fact": [
      "Oculocutaneous albinism is an autosomal recessive genetic disorder.",
      "The condition is caused by a mutation in both copies of the gene that codes for the production of melanin.",
      "People with oculocutaneous albinism have a deficiency in melanin production.",
      "Oculocutaneous albinism is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the gene to develop the condition.",
      "There are several types of oculocutaneous albinism, each with its own specific genetic cause and symptoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-7b_response": "The largest metabolic gene cluster in yeast is the PHO5 cluster, which is located on chromosome V. The PHO5 cluster encodes enzymes involved in the biosynthesis of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, which are essential for cell growth. The PHO5 cluster is composed of 18 genes, and it is the largest metabolic gene cluster in yeast in terms of the number of genes it encodes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The largest metabolic gene cluster in yeast is the PHO5 cluster.\n2. The PHO5 cluster is located on chromosome V.\n3. The PHO5 cluster encodes enzymes involved in the biosynthesis of phenylalanine, tyrosine, and tryptophan.\n4. These aromatic amino acids are essential for cell growth.\n5. The PHO5 cluster is composed of 18 genes.",
    "vicuna-7b_fact": [
      "The largest metabolic gene cluster in yeast is the PHO5 cluster.",
      "The PHO5 cluster is located on chromosome V.",
      "The PHO5 cluster encodes enzymes involved in the biosynthesis of phenylalanine, tyrosine, and tryptophan.",
      "These aromatic amino acids are essential for cell growth.",
      "The PHO5 cluster is composed of 18 genes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1958,
    "user_query": "Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?",
    "vicuna-7b_response": "ApoE is a protein that is primarily produced in the liver and is involved in the transport and metabolism of lipids in the body. There are three isoforms of ApoE: ApoE2, ApoE3, and ApoE4.\nApoE4 is the isoform that is most strongly associated with an increased risk of atherosclerosis and Alzheimer's disease. ApoE4 is thought to increase the risk of atherosclerosis by promoting the formation of plaques in the arteries, which can lead to heart attacks and strokes. ApoE4 is also associated with an increased risk of Alzheimer's disease, although the exact mechanism by which ApoE4 contributes to this condition is not fully understood.\nIt is important to note that while ApoE4 is the isoform most strongly associated with an increased risk of atherosclerosis and Alzheimer's disease, having one or two copies of the ApoE4 gene does not guarantee that a person will develop these conditions. Other genetic and environmental factors also play a role in the development of these conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ApoE is a protein primarily produced in the liver that is involved in lipid transport and metabolism.\n2. There are three isoforms of ApoE: ApoE2, ApoE3, and ApoE4.\n3. The ApoE4 isoform is most strongly associated with an increased risk of atherosclerosis and Alzheimer's disease.\n4. ApoE4 is thought to increase the risk of atherosclerosis by promoting the formation of plaques in the arteries.\n5. Having one or two copies of the ApoE4 gene does not guarantee that a person will develop atherosclerosis or Alzheimer's disease.",
    "vicuna-7b_fact": [
      "ApoE is a protein primarily produced in the liver that is involved in lipid transport and metabolism.",
      "There are three isoforms of ApoE: ApoE2, ApoE3, and ApoE4.",
      "The ApoE4 isoform is most strongly associated with an increased risk of atherosclerosis and Alzheimer's disease.",
      "ApoE4 is thought to increase the risk of atherosclerosis by promoting the formation of plaques in the arteries.",
      "Having one or two copies of the ApoE4 gene does not guarantee that a person will develop atherosclerosis or Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1960,
    "user_query": "What organism causes woolsorter's disease",
    "vicuna-7b_response": "Woolsorter's disease, also known as pneumoconiosis, is a lung disease caused by inhaling fine dust particles, such as those found in mines, factories, and other workplaces. The most common cause of woolsorter's disease is inhalation of the mineral crystals of silica, which are found in many types of rocks and sand. Other causes of woolsorter's disease include inhalation of coal dust, asbestos, and other mineral dusts. The disease can cause progressive scarring of the lungs, leading to difficulty breathing, coughing, and shortness of breath.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Woolsorter's disease is also known as pneumoconiosis.\n2. Woolsorter's disease is a lung disease caused by inhaling fine dust particles.\n3. The most common cause of woolsorter's disease is inhalation of the mineral crystals of silica.\n4. Other causes of woolsorter's disease include inhalation of coal dust, asbestos, and other mineral dusts.\n5. Woolsorter's disease can cause progressive scarring of the lungs, leading to difficulty breathing, coughing, and shortness of breath.",
    "vicuna-7b_fact": [
      "Woolsorter's disease is also known as pneumoconiosis.",
      "Woolsorter's disease is a lung disease caused by inhaling fine dust particles.",
      "The most common cause of woolsorter's disease is inhalation of the mineral crystals of silica.",
      "Other causes of woolsorter's disease include inhalation of coal dust, asbestos, and other mineral dusts.",
      "Woolsorter's disease can cause progressive scarring of the lungs, leading to difficulty breathing, coughing, and shortness of breath."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Woolsorter's disease, also known as anthrax, is not the same as pneumoconiosis.\n2. FALSE [correction]: Woolsorter's disease, is caused by inhalation of spores of the bacterium Bacillus anthracis, not dust particles.\n3. FALSE [correction]: Woolsorter's disease is caused by inhalation of spores of the bacterium Bacillus anthracis, not silica.\n4. FALSE [correction]: Woolsorter's disease is caused by Bacillus anthracis, not by inhalation of coal dust, asbestos, or other mineral dusts. \n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1963,
    "user_query": "Which protein complexes recognize centromeric (CEN) DNA in yeast?",
    "vicuna-7b_response": "In yeast, several protein complexes recognize centromeric (CEN) DNA. Here are some of the most important ones:\n1. The CENP-A/CENP-C complex: This complex is responsible for the assembly and maintenance of the kinetochore, which is the structure that attaches the centromere to the spindle apparatus during cell division. The complex consists of the CENP-A protein, which is the core centromeric DNA-binding protein, and the CENP-C protein, which is involved in the recruitment of other kinetochore proteins.\n2. The SMC complex: The SMC (Structural Maintenance of Chromosomes) complex is responsible for the assembly and maintenance of the mitotic spindle. It recognizes and binds to the CEN DNA sequence through its subunit, the SMC protein.\n3. The cohesin complex: The cohesin complex is responsible for maintaining the integrity of the genome during cell division. It recognizes and binds to the CEN DNA sequence through its subunit, the SMC protein.\n4. The Ndc80 complex: The Ndc80 complex is responsible for the assembly and maintenance of the kinetochore. It recognizes and binds to the CEN DNA sequence through its subunit, the Ndc80 protein.\nThese are just a few examples of the protein complexes that recognize centromeric DNA in yeast. Other complexes, such as the Aurora kinase complex and the condensin complex, also play a role in centromere recognition and maintenance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In yeast, several protein complexes recognize centromeric (CEN) DNA.\n2. The CENP-A/CENP-C complex in yeast is responsible for the assembly and maintenance of the kinetochore.\n3. The SMC complex in yeast is responsible for the assembly and maintenance of the mitotic spindle and recognizes and binds to the CEN DNA sequence.\n4. The cohesin complex in yeast is responsible for maintaining the integrity of the genome during cell division and recognizes and binds to the CEN DNA sequence.\n5. The Ndc80 complex in yeast is responsible for the assembly and maintenance of the kinetochore and recognizes and binds to the CEN DNA sequence.",
    "vicuna-7b_fact": [
      "In yeast, several protein complexes recognize centromeric (CEN) DNA.",
      "The CENP-A/CENP-C complex in yeast is responsible for the assembly and maintenance of the kinetochore.",
      "The SMC complex in yeast is responsible for the assembly and maintenance of the mitotic spindle and recognizes and binds to the CEN DNA sequence.",
      "The cohesin complex in yeast is responsible for maintaining the integrity of the genome during cell division and recognizes and binds to the CEN DNA sequence.",
      "The Ndc80 complex in yeast is responsible for the assembly and maintenance of the kinetochore and recognizes and binds to the CEN DNA sequence."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The cohesin complex in yeast is responsible for maintaining the sister chromatid cohesion during cell division, not for recognizing and binding to the CEN DNA sequence. \n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1966,
    "user_query": "What is the function of yeast Clr4 on chromatin?",
    "vicuna-7b_response": "Clr4 is a component of the SWR1 complex, which is involved in the degradation of histone variants and non-histone proteins in the nucleus of eukaryotic cells. The SWR1 complex is composed of several subunits, including Clr4, and it is responsible for recognizing and targeting specific proteins for degradation by the proteasome.\nIn the case of yeast, Clr4 is specifically involved in the degradation of histone variant H2A.Z, which is a marker of transcriptionally active chromatin. The degradation of H2A.Z by the SWR1 complex is thought to play a role in the regulation of gene expression by promoting the accessibility of transcription factors to their target genes.\nIn addition to its role in the degradation of histone variants and non-histone proteins, Clr4 has also been shown to play a role in the regulation of DNA replication and repair. For example, Clr4 has been shown to be involved in the recruitment of replication machinery to specific regions of the genome, and it has also been implicated in the repair of DNA damage.\nOverall, the function of Clr4 in the SWR1 complex is to recognize and target specific proteins for degradation by the proteasome, which is important for the regulation of gene expression and the maintenance of chromosome structure and function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Clr4 is a component of the SWR1 complex.\n2. The SWR1 complex degrades histone variants and non-histone proteins in the nucleus of eukaryotic cells.\n3. In yeast, Clr4 assists in the degradation of histone variant H2A.Z.\n4. The decay of H2A.Z by the SWR1 complex is considered to influence gene expression regulation.\n5. Clr4 is involved in the regulation of DNA replication and repair.",
    "vicuna-7b_fact": [
      "Clr4 is a component of the SWR1 complex.",
      "The SWR1 complex degrades histone variants and non-histone proteins in the nucleus of eukaryotic cells.",
      "In yeast, Clr4 assists in the degradation of histone variant H2A.Z.",
      "The decay of H2A.Z by the SWR1 complex is considered to influence gene expression regulation.",
      "Clr4 is involved in the regulation of DNA replication and repair."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Clr4 is not a component of the SWR1 complex. It’s a methyltransferase involved in heterochromatic gene silencing.\n2. FALSE [correction]: The SWR1 complex doesn't degrade histone variants and non-histone proteins, rather it swaps histone H2A with the histone variant H2A.Z in the chromatin of eukaryotic cells.  \n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-7b_response": "LIMT (Long intergenic non-coding RNA METastasis) is a lncRNA (long non-coding RNA) that has been shown to play a role in the regulation of metastasis, which is the spread of cancer cells from one organ or tissue to another.\nResearch has shown that LIMT is upregulated in a variety of cancer types, including breast, lung, and colon cancer, and that it promotes the migration and invasion of cancer cells. Additionally, studies have shown that LIMT can interact with and regulate the expression of various genes involved in the metastatic process, including genes involved in cell adhesion, migration, and invasion.\nOverall, the role of LIMT in the regulation of metastasis is an area of active research, and further studies are needed to fully understand the mechanisms by which LIMT promotes the spread of cancer cells and to develop targeted therapies that can inhibit its function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LIMT is a long non-coding RNA.\n2. LIMT plays a role in the regulation of metastasis, which is the spread of cancer cells from one organ or tissue to another.\n3. LIMT is upregulated in a variety of cancer types, including breast, lung, and colon cancer.\n4. Studies have shown that LIMT can regulate the expression of various genes involved in the metastatic process.\n5. Research is still being conducted to fully understand the mechanisms of how LIMT promotes the spread of cancer cells.",
    "vicuna-7b_fact": [
      "LIMT is a long non-coding RNA.",
      "LIMT plays a role in the regulation of metastasis, which is the spread of cancer cells from one organ or tissue to another.",
      "LIMT is upregulated in a variety of cancer types, including breast, lung, and colon cancer.",
      "Studies have shown that LIMT can regulate the expression of various genes involved in the metastatic process.",
      "Research is still being conducted to fully understand the mechanisms of how LIMT promotes the spread of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1969,
    "user_query": "What are Kupffer cells and what is their role?",
    "vicuna-7b_response": "Kupffer cells, also known as hepatic macrophages, are a type of immune cell found in the liver. They play a crucial role in the immune system by phagocytosing (engulfing and destroying) foreign substances, such as bacteria and debris, that enter the liver. Kupffer cells also help to remove damaged or necrotic cells and contribute to the regeneration of liver tissue.\nIn addition to their role in immune defense, Kupffer cells also secrete various cytokines and growth factors that help to regulate liver function and maintain liver health. They are also involved in the metabolism of certain drugs and xenobiotics (foreign substances that are not normally present in the body), helping to detoxify and eliminate them from the body.\nOverall, Kupffer cells play a vital role in maintaining liver health and function by removing foreign substances, regulating liver function, and contributing to the regeneration of liver tissue.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Kupffer cells, also known as hepatic macrophages, are a type of immune cell found in the liver.\n2. Kupffer cells play a role in the immune system by engulfing and destroying foreign substances like bacteria and debris that enter the liver.\n3. Kupffer cells contribute to the regeneration of liver tissue.\n4. Kupffer cells secrete various cytokines and growth factors that regulate liver function.\n5. Kupffer cells are involved in the metabolism of certain drugs and xenobiotics, contributing to their detoxification and elimination from the body.",
    "vicuna-7b_fact": [
      "Kupffer cells, also known as hepatic macrophages, are a type of immune cell found in the liver.",
      "Kupffer cells play a role in the immune system by engulfing and destroying foreign substances like bacteria and debris that enter the liver.",
      "Kupffer cells contribute to the regeneration of liver tissue.",
      "Kupffer cells secrete various cytokines and growth factors that regulate liver function.",
      "Kupffer cells are involved in the metabolism of certain drugs and xenobiotics, contributing to their detoxification and elimination from the body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1976,
    "user_query": "What is the aim of the TRAP assay?",
    "vicuna-7b_response": "The TRAP (Tumor Regression Grade and Number) assay is a method used to assess the effectiveness of cancer therapies in terms of tumor regression. The aim of the TRAP assay is to determine the degree of tumor regression and the number of tumors that have been affected by the therapy. This information can be used to evaluate the efficacy of the therapy and to guide further treatment decisions. The TRAP assay is typically used in preclinical studies to evaluate the effectiveness of cancer therapies, and it may also be used in clinical trials to assess the safety and efficacy of new treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TRAP (Tumor Regression Grade and Number) assay is a method used to assess the effectiveness of cancer therapies.\n2. The aim of the TRAP assay is to determine the degree of tumor regression and the number of tumors affected by the therapy.\n3. The results from a TRAP assay can be used to evaluate the efficacy of the therapy and guide further treatment decisions.\n4. The TRAP assay is typically used in preclinical studies to evaluate the effectiveness of cancer therapies.\n5. The TRAP assay may also be used in clinical trials to assess the safety and efficacy of new treatments.",
    "vicuna-7b_fact": [
      "The TRAP (Tumor Regression Grade and Number) assay is a method used to assess the effectiveness of cancer therapies.",
      "The aim of the TRAP assay is to determine the degree of tumor regression and the number of tumors affected by the therapy.",
      "The results from a TRAP assay can be used to evaluate the efficacy of the therapy and guide further treatment decisions.",
      "The TRAP assay is typically used in preclinical studies to evaluate the effectiveness of cancer therapies.",
      "The TRAP assay may also be used in clinical trials to assess the safety and efficacy of new treatments."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1979,
    "user_query": "Which disease is associated with mutations in SLC40A1 gene?",
    "vicuna-7b_response": "The disease associated with mutations in the SLC40A1 gene is called cystinosis. Cystinosis is a rare genetic disorder that affects the kidneys and eyes. It is caused by a deficiency of the protein cystine, which accumulates in the body and damages various organs and tissues.\nThe SLC40A1 gene provides instructions for making a protein called cystinosin, which is responsible for transporting cystine out of cells. Mutations in the SLC40A1 gene can lead to a deficiency of cystinosin, which results in the accumulation of cystine and the development of cystinosis.\nThe symptoms of cystinosis vary depending on the age of onset and the severity of the disease. In infants, the most common symptoms include poor growth, vomiting, and a swollen abdomen. In older children and adults, the symptoms may include kidney failure, vision loss, and a buildup of fluid in the brain (hydrocephalus).\nCystinosis is an inherited disorder, and it is usually diagnosed in childhood. Treatment for cystinosis typically involves a low-protein diet, medications to help remove the accumulated cystine from the body, and regular eye exams to monitor vision loss. In severe cases, kidney transplantation may be necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The disease associated with mutations in the SLC40A1 gene is called cystinosis.\n2. Cystinosis is a rare genetic disorder that affects the kidneys and eyes.\n3. The SLC40A1 gene provides instructions for making a protein called cystinosin.\n4. Mutations in the SLC40A1 gene can lead to a deficiency of cystinosin, which results in the accumulation of cystine and the development of cystinosis.\n5. Cystinosis is usually diagnosed in childhood.",
    "vicuna-7b_fact": [
      "The disease associated with mutations in the SLC40A1 gene is called cystinosis.",
      "Cystinosis is a rare genetic disorder that affects the kidneys and eyes.",
      "The SLC40A1 gene provides instructions for making a protein called cystinosin.",
      "Mutations in the SLC40A1 gene can lead to a deficiency of cystinosin, which results in the accumulation of cystine and the development of cystinosis.",
      "Cystinosis is usually diagnosed in childhood."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The disease associated with mutations in the SLC40A1 gene is not cystinosis but rather, it is involved in a condition called ferroportin disease.\n2. TRUE\n3. FALSE [correction]: The CTNS gene provides instructions for making a protein called cystinosin, not the SLC40A1 gene.\n4. FALSE [correction]: Mutations in the CTNS gene can lead to a deficiency of cystinosin, which results in the accumulation of cystine and the development of cystinosis, not the SLC40A1 gene.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1982,
    "user_query": "Is lenvatinib effective for renal cell carcinoma?",
    "vicuna-7b_response": "Lenvatinib is a medication that is approved for the treatment of certain types of kidney cancer, including renal cell carcinoma. It is typically used for patients who have already received other treatments and have a type of kidney cancer called refractory or progressive disease.\nLenvatinib works by blocking the action of certain proteins that help cancer cells grow and survive. It has been shown to improve survival and delay the progression of kidney cancer in some patients.\nIt is important to note that not all patients with renal cell carcinoma will benefit from treatment with lenvatinib, and the effectiveness of the medication can vary depending on the individual. Your doctor will be able to determine if lenvatinib is a suitable treatment option for you based on your specific medical history and condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lenvatinib is a medication approved for the treatment of certain types of kidney cancer, including renal cell carcinoma.\n2. Lenvatinib is typically used for patients who have a type of kidney cancer called refractory or progressive disease.\n3. Lenvatinib works by blocking the action of certain proteins that help cancer cells grow and survive.\n4. Lenvatinib has been shown to improve survival and delay the progression of kidney cancer in some patients.\n5. The effectiveness of lenvatinib can vary depending on the individual.",
    "vicuna-7b_fact": [
      "Lenvatinib is a medication approved for the treatment of certain types of kidney cancer, including renal cell carcinoma.",
      "Lenvatinib is typically used for patients who have a type of kidney cancer called refractory or progressive disease.",
      "Lenvatinib works by blocking the action of certain proteins that help cancer cells grow and survive.",
      "Lenvatinib has been shown to improve survival and delay the progression of kidney cancer in some patients.",
      "The effectiveness of lenvatinib can vary depending on the individual."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-7b_response": "The R/Bioconductor package used for performing SNP enrichment analysis is called \"SNPEff\".",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The \"SNPEff\" is an R/Bioconductor package used for performing SNP enrichment analysis.",
    "vicuna-7b_fact": [
      "The \"SNPEff\" is an R/Bioconductor package used for performing SNP enrichment analysis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The \"SNPEff\" is a genetic variant annotation and functional effect prediction toolbox. It can be used with many different organisms.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 1988,
    "user_query": "Describe crowned dens syndrome.",
    "vicuna-7b_response": "Crown-down syndrome, also known as Trisomy 18, is a genetic disorder caused by the presence of an extra copy of chromosome 18. This extra genetic material leads to a range of physical and developmental problems, including a small head size, low birth weight, and heart defects.\nIndividuals with crown-down syndrome typically have distinctive facial features, such as a flat face with an upward slant to the eyes, a small mouth, and a broad nose. They may also have low-set ears, a small jaw, and a protruding tongue.\nIn terms of development, individuals with crown-down syndrome typically have developmental delays and may have intellectual disability. They may also have feeding and swallowing difficulties, which can lead to poor weight gain and poor growth.\nCrown-down syndrome is typically diagnosed through a combination of genetic testing and prenatal testing, such as amniocentesis or chorionic villus sampling (CVS).\nThere is no cure for crown-down syndrome, and treatment is focused on managing the symptoms and improving quality of life. This may include surgery to correct heart defects, physical therapy to improve mobility and strength, and speech therapy to help with feeding and swallowing.\nIt is important to note that crown-down syndrome is a serious condition and can be life-threatening. While some individuals with the disorder may live into adulthood, the majority of cases result in stillbirth or early death.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Crown-down syndrome, also known as Trisomy 18, is a genetic disorder caused by an extra copy of chromosome 18.\n2. Individuals with crown-down syndrome typically have distinctive facial features and may have developmental issues.\n3. Crown-down syndrome is typically diagnosed through genetic and prenatal testing, such as amniocentesis or chorionic villus sampling (CVS).\n4. There is no cure for crown-down syndrome, and treatment is typically focused on symptom management and improving quality of life.\n5. While some individuals with crown-down syndrome may live into adulthood, the majority of cases result in stillbirth or early death.",
    "vicuna-7b_fact": [
      "Crown-down syndrome, also known as Trisomy 18, is a genetic disorder caused by an extra copy of chromosome 18.",
      "Individuals with crown-down syndrome typically have distinctive facial features and may have developmental issues.",
      "Crown-down syndrome is typically diagnosed through genetic and prenatal testing, such as amniocentesis or chorionic villus sampling (CVS).",
      "There is no cure for crown-down syndrome, and treatment is typically focused on symptom management and improving quality of life.",
      "While some individuals with crown-down syndrome may live into adulthood, the majority of cases result in stillbirth or early death."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Edwards syndrome, not Crown-down syndrome, is also known as Trisomy 18, and caused by an extra copy of chromosome 18.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1989,
    "user_query": "Does CRISPR inversion of CTCF sites alter genome topology?",
    "vicuna-7b_response": "CRISPR-Cas9 is a powerful tool for genome editing, and one of its applications is to alter the genome topology by inverting the orientation of specific DNA sequences. One of the key regulatory elements that can affect genome topology is the CCCTC-binding factor (CTCF).\nCTCF is a zinc-finger transcription factor that binds to DNA sequences in a site-specific manner and can organize chromatin structure by forming nucleoprotein complexes. CTCF binding sites are often found in the vicinity of gene promoters and can regulate gene expression by recruiting other transcriptional regulators.\nWhen CRISPR-Cas9 is used to invert CTCF sites, it can alter the genome topology by changing the orientation of the CTCF binding sites. This can have a significant impact on the regulation of gene expression, as the orientation of the CTCF binding sites can affect the accessibility of the promoter region to the transcriptional machinery.\nIn summary, CRISPR-Cas9-mediated inversion of CTCF sites can alter genome topology and potentially affect gene expression. However, the specific effects of this manipulation will depend on the context of the genome and the specific target sites.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CRISPR-Cas9 is used for genome editing.\n2. One of the applications of CRISPR-Cas9 is to alter the genome topology by inverting specific DNA sequences.\n3. CTCF (CCCTC-binding factor) is a zinc-finger transcription factor that binds to DNA sequences in a site-specific manner to organize chromatin structure.\n4. CTCF binding sites are often found near gene promoters and can regulate gene expression by attracting other transcriptional regulators.\n5. Using CRISPR-Cas9 to invert CTCF sites can change the genome topology by changing the orientation of CTCF binding sites, which can affect the promoter region's accessibility to the transcriptional machinery.",
    "vicuna-7b_fact": [
      "CRISPR-Cas9 is used for genome editing.",
      "One of the applications of CRISPR-Cas9 is to alter the genome topology by inverting specific DNA sequences.",
      "CTCF (CCCTC-binding factor) is a zinc-finger transcription factor that binds to DNA sequences in a site-specific manner to organize chromatin structure.",
      "CTCF binding sites are often found near gene promoters and can regulate gene expression by attracting other transcriptional regulators.",
      "Using CRISPR-Cas9 to invert CTCF sites can change the genome topology by changing the orientation of CTCF binding sites, which can affect the promoter region's accessibility to the transcriptional machinery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1999,
    "user_query": "What is Mondor's disease?",
    "vicuna-7b_response": "Mondor's disease, also known as \"cold sore\" or \"herpes labialis,\" is a viral infection of the skin on the face, lips, or mouth. It is caused by the herpes simplex virus type 1 (HSV-1) and is highly contagious. The virus is spread through direct contact with an infected person or through contact with an object that has the virus on it.\nSymptoms of Mondor's disease typically appear as a small, painful blister on the lip or around the mouth. The blister will eventually burst and leave a sore that can take several weeks to heal. The sore may be painful and can be sensitive to touch.\nThere is no cure for Mondor's disease, but there are treatments available to help manage the symptoms and reduce the risk of spreading the virus to others. These treatments include topical creams, ointments, and oral medications. It is important to practice good hygiene, such as washing your hands frequently and avoiding close contact with people who have the virus, to reduce the risk of spreading the virus.\nIt is important to note that Mondor's disease is different from herpes zoster, which is caused by the herpes zoster virus and is also known as \"shingles.\"",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mondor's disease is also known as \"cold sore\" or \"herpes labialis.\"\n2. Mondor's disease is a viral infection of the skin that affects the face, lips, or mouth.\n3. The herpes simplex virus type 1 (HSV-1) causes Mondor's disease.\n4. The symptoms of Mondor's Disease include a small, painful blister that can burst and leave a sore.\n5. There is no cure for Mondor's disease but treatments are available to manage the symptoms and reduce the spread of the virus.",
    "vicuna-7b_fact": [
      "Mondor's disease is also known as \"cold sore\" or \"herpes labialis.\"",
      "Mondor's disease is a viral infection of the skin that affects the face, lips, or mouth.",
      "The herpes simplex virus type 1 (HSV-1) causes Mondor's disease.",
      "The symptoms of Mondor's Disease include a small, painful blister that can burst and leave a sore.",
      "There is no cure for Mondor's disease but treatments are available to manage the symptoms and reduce the spread of the virus."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Mondor's disease is not also known as \"cold sore\" or \"herpes labialis.\" It is a rare condition involving a superficial thrombophlebitis of the veins of the thoracoabdominal wall.\n2. FALSE [correction]: Mondor's disease is not a viral infection of the skin that affects the face, lips, or mouth. Rather it involves the veins mostly in the chest area.\n3. FALSE [correction]: The herpes simplex virus type 1 (HSV-1) does not cause Mondor's disease. HSV-1 causes cold sores or herpes labialis.\n4. FALSE [correction]: The symptoms of Mondor's disease usually include pain and tension upon movement, or touch in the area of the chest or breast, not a painful blister that bursts and leaves a sore.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2000,
    "user_query": "List metalloenzyme inhibitors.",
    "vicuna-7b_response": "Metalloenzymes are enzymes that contain a metal ion as part of their active site. Some examples of metalloenzymes include:\n1. Hemoglobin (a metalloprotein that carries oxygen in red blood cells)\n2. Myoglobin (a metalloprotein that stores and releases muscle protein)\n3. Cytochrome P450 (a group of metalloenzymes involved in drug metabolism)\n4. Carbonic anhydrase (an enzyme that catalyzes the conversion of carbonic acid to carbon dioxide)\n5. Peptidases (enzymes that break down peptide bonds in proteins)\nSome examples of metalloenzyme inhibitors include:\n1. Chloramphenicol (an antibiotic that inhibits the activity of peptidases)\n2. Penicillamine (an anti-rheumatic drug that inhibits the activity of cytochrome P450)\n3. Nitisinone (a drug used to treat the genetic disorder tyrosinemia, which is caused by a deficiency in the enzyme ferrous iron ammonia-tyrosine ligase)\n4. Zinc (an essential trace element that can act as an inhibitor of metalloenzymes)\n5. Copper (an essential trace element that can act as an inhibitor of metalloenzymes)\nIt's important to note that the inhibition of metalloenzymes can have both beneficial and harmful effects, depending on the specific enzyme and the inhibitor used.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Metalloenzymes are enzymes that contain a metal ion as part of their active site.\n2. Hemoglobin, Myoglobin, Cytochrome P450, Carbonic anhydrase and Peptidases are examples of metalloenzymes.\n3. Chloramphenicol, Penicillamine, Nitisinone, Zinc and Copper are examples of metalloenzyme inhibitors.\n4. Chloramphenicol is an antibiotic that inhibits the activity of peptidases.\n5. Nitisinone treats the genetic disorder tyrosinemia, which is caused by a deficiency in the enzyme ferrous iron ammonia-tyrosine ligase.",
    "vicuna-7b_fact": [
      "Metalloenzymes are enzymes that contain a metal ion as part of their active site.",
      "Hemoglobin, Myoglobin, Cytochrome P450, Carbonic anhydrase and Peptidases are examples of metalloenzymes.",
      "Chloramphenicol, Penicillamine, Nitisinone, Zinc and Copper are examples of metalloenzyme inhibitors.",
      "Chloramphenicol is an antibiotic that inhibits the activity of peptidases.",
      "Nitisinone treats the genetic disorder tyrosinemia, which is caused by a deficiency in the enzyme ferrous iron ammonia-tyrosine ligase."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chloramphenicol, Penicillamine, and Nitisinone are examples of metalloenzyme inhibitors, but Zinc and Copper are often required for metalloenzymes to function, not inhibitors.\n4. FALSE [correction]: Chloramphenicol is an antibiotic that inhibits bacterial protein synthesis, but it does not specifically inhibit peptidases.\n5. FALSE [correction]: Nitisinone treats the genetic disorder tyrosinemia, which is caused by a deficiency in the enzyme fumarylacetoacetate hydrolase, not ferrous iron ammonia-tyrosine ligase.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2007,
    "user_query": "Is the mouse Sry gene locus free of repetitive sequences?",
    "vicuna-7b_response": "The Sry gene is located on the Y chromosome and is responsible for the initiation of male sex determination in mammals. The Sry gene is not free of repetitive sequences, as it contains a number of long interspersed nuclear element (LINE) and short interspersed nuclear element (SINE) repeats. These repetitive sequences can make up a significant portion of the Sry gene and can affect its function.\nThe Sry gene is also known to undergo frequent copy number variations (CNVs) and deletions, which can lead to changes in the expression of the gene and potentially affect its role in male sex determination.\nIt's worth noting that the Sry gene is not the only gene involved in male sex determination, and other genes such as Sry-box transcription factor Sox9, WT1, and Sry-related HMG-box gene Sox9 also play important roles in this process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Sry gene is located on the Y chromosome.\n2. The Sry gene initiates male sex determination in mammals.\n3. The Sry gene contains long interspersed nuclear element (LINE) and short interspersed nuclear element (SINE) repeats.\n4. The Sry gene can undergo frequent copy number variations (CNVs) and deletions.\n5. Other genes such as Sry-box transcription factor Sox9, WT1, and Sry-related HMG-box gene Sox9 also play roles in male sex determination.",
    "vicuna-7b_fact": [
      "The Sry gene is located on the Y chromosome.",
      "The Sry gene initiates male sex determination in mammals.",
      "The Sry gene contains long interspersed nuclear element (LINE) and short interspersed nuclear element (SINE) repeats.",
      "The Sry gene can undergo frequent copy number variations (CNVs) and deletions.",
      "Other genes such as Sry-box transcription factor Sox9, WT1, and Sry-related HMG-box gene Sox9 also play roles in male sex determination."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: While genetic variations can occur, it is not specific or frequent for the Sry gene to undergo copy number variations (CNVs) and deletions.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2011,
    "user_query": "Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?",
    "vicuna-7b_response": "Oculocutaneous 1 (OCA1)-type albinism is caused by a mutation in the tyrosinase gene, specifically in the tyrosinase-related protein 2 (TRP2) subunit. The TRP2 subunit is responsible for the catalytic activity of the tyrosinase enzyme, which is responsible for the conversion of tyrosine to dopachrome, a key step in the production of melanin. Mutations in the TRP2 subunit can lead to reduced or absent tyrosinase activity, resulting in the accumulation of tyrosine and the development of albinism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oculocutaneous 1 (OCA1)-type albinism is caused by a mutation in the tyrosinase gene.\n2. The mutation specifically occurs in the tyrosinase-related protein 2 (TRP2) subunit.\n3. The TRP2 subunit is responsible for the catalytic activity of the tyrosinase enzyme.\n4. The tyrosinase enzyme converts tyrosine to dopachrome, which is a key step in the production of melanin.\n5. Mutations in the TRP2 subunit can lead to reduced or absent tyrosinase activity, resulting in the accumulation of tyrosine and the development of albinism.",
    "vicuna-7b_fact": [
      "Oculocutaneous 1 (OCA1)-type albinism is caused by a mutation in the tyrosinase gene.",
      "The mutation specifically occurs in the tyrosinase-related protein 2 (TRP2) subunit.",
      "The TRP2 subunit is responsible for the catalytic activity of the tyrosinase enzyme.",
      "The tyrosinase enzyme converts tyrosine to dopachrome, which is a key step in the production of melanin.",
      "Mutations in the TRP2 subunit can lead to reduced or absent tyrosinase activity, resulting in the accumulation of tyrosine and the development of albinism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The mutation specifically occurs in the tyrosinase (TYR) gene, not the TRP2 subunit.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2014,
    "user_query": "Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?",
    "vicuna-7b_response": "In the yeast Saccharomyces cerevisiae, the replacement of H2A by H2A.Z is mediated by the protein complex known as the H2A-H2B chaperone.\nThe H2A-H2B chaperone is responsible for the proper assembly and disassembly of the H2A and H2B histone variants in the nucleus of the yeast cell. H2A and H2B are two types of histone proteins that are responsible for the organization of DNA within the nucleus.\nH2A and H2B histone variants are assembled into a complex with the H2A-H2B chaperone, which helps to regulate the expression of certain genes. The H2A-H2B chaperone also plays a role in the replacement of H2A by H2A.Z, which is a process that is important for the proper functioning of the nucleus.\nThe H2A-H2B chaperone is composed of several different subunits, including the H2A-H2B heterodimer, the H2A.Z-specific chaperone, and the H2A.Z protein itself. The H2A-H2B heterodimer is responsible for the binding of H2A and H2B histone variants, while the H2A.Z-specific chaperone is responsible for the binding of H2A.Z. The H2A.Z protein is then added to the complex, which helps to promote the replacement of H2A by H2A.Z.\nOverall, the H2A-H2B chaperone is an important protein complex that plays a crucial role in the regulation of gene expression in the yeast Saccharomyces cerevisiae.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In Saccharomyces cerevisiae, the replacement of H2A by H2A.Z is mediated by the protein complex known as the H2A-H2B chaperone.\n2. The H2A-H2B chaperone is responsible for the assembly and disassembly of the H2A and H2B histone variants in the nucleus of the yeast cell.\n3. The H2A-H2B chaperone helps to regulate the expression of certain genes.\n4. The H2A-H2B chaperone is composed of several different subunits, including the H2A-H2B heterodimer, the H2A.Z-specific chaperone, and the H2A.Z protein itself.\n5. The H2A.H2B chaperone plays a crucial role in the regulation of gene expression in the yeast Saccharomyces cerevisiae.",
    "vicuna-7b_fact": [
      "In Saccharomyces cerevisiae, the replacement of H2A by H2A.Z is mediated by the protein complex known as the H2A-H2B chaperone.",
      "The H2A-H2B chaperone is responsible for the assembly and disassembly of the H2A and H2B histone variants in the nucleus of the yeast cell.",
      "The H2A-H2B chaperone helps to regulate the expression of certain genes.",
      "The H2A-H2B chaperone is composed of several different subunits, including the H2A-H2B heterodimer, the H2A.Z-specific chaperone, and the H2A.Z protein itself.",
      "The H2A.H2B chaperone plays a crucial role in the regulation of gene expression in the yeast Saccharomyces cerevisiae."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-7b_response": "Radial glial cells are a type of glial cell that play a crucial role in the development of the central nervous system, including the formation of the ependymal cells that line the ventricular system of the brain. The key players in radial glial specification to ependymal cells are transcription factors.\nOne of the most important transcription factors in the specification of radial glial cells to ependymal cells is the transcription factor Sox2. Sox2 is expressed in radial glial cells during embryonic development and is necessary for the differentiation of these cells into ependymal cells.\nAnother important transcription factor in the specification of radial glial cells to ependymal cells is the transcription factor Nkx2.1. Nkx2.1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nAdditionally, the transcription factor Ascl1 is also important in the specification of radial glial cells to ependymal cells. Ascl1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nFinally, the transcription factor Foxj1 is also important in the specification of radial glial cells to ependymal cells. Foxj1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nIn summary, the key players in radial glial specification to ependymal cells are transcription factors such as Sox2, Nkx2.1, Ascl1 and Foxj1. These transcription factors are necessary for the differentiation of radial glial cells into ependymal cells, and play a crucial role in the development of the central nervous system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Radial glial cells play a crucial role in the development of the central nervous system, including the formation of the ependymal cells.\n2. The key players in radial glial specification to ependymal cells are transcription factors.\n3. The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.\n4. Transcription factor Nkx2.1 is significant in the specification of radial glial cells to ependymal cells.\n5. Transcription factors Ascl1 and Foxj1 are important in the specification of radial glial cells to ependymal cells.",
    "vicuna-7b_fact": [
      "Radial glial cells play a crucial role in the development of the central nervous system, including the formation of the ependymal cells.",
      "The key players in radial glial specification to ependymal cells are transcription factors.",
      "The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "Transcription factor Nkx2.1 is significant in the specification of radial glial cells to ependymal cells.",
      "Transcription factors Ascl1 and Foxj1 are important in the specification of radial glial cells to ependymal cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2018,
    "user_query": "What fruit causes Jamaican vomiting sickness?",
    "vicuna-7b_response": "Jamaican vomiting sickness, also known as \"Jamaican vomiting bug\" or \"stomach bug,\" is caused by a virus called Norovirus. It is not caused by a specific fruit.\nNorovirus is highly contagious and can be spread through contaminated food or water, or by touching contaminated surfaces and then touching your mouth or face. It can also be spread from an infected person to others through close contact.\nSymptoms of Jamaican vomiting sickness typically include nausea, vomiting, diarrhea, stomach cramps, and fever. These symptoms usually resolve on their own within a few days, but dehydration can occur if the symptoms are severe or last for an extended period of time.\nTo prevent the spread of Jamaican vomiting sickness, it is important to wash your hands frequently with soap and water, especially after using the bathroom or before preparing or eating food. Avoid preparing food for others if you are experiencing symptoms, and stay home from work or school if you are sick to prevent spreading the virus to others.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Jamaican vomiting sickness is also known as \"Jamaican vomiting bug\" or \"stomach bug.\"\n2. The sickness is caused by a virus called Norovirus.\n3. Norovirus can be spread through contaminated food or water, touching contaminated surfaces, or from an infected person to others.\n4. Symptoms of Jamaican vomiting sickness include nausea, vomiting, diarrhea, stomach cramps, and fever.\n5. To prevent the spread of this sickness, you should wash your hands frequently, avoid preparing food for others when you have symptoms and stay home when you are sick.",
    "vicuna-7b_fact": [
      "Jamaican vomiting sickness is also known as \"Jamaican vomiting bug\" or \"stomach bug.\"",
      "The sickness is caused by a virus called Norovirus.",
      "Norovirus can be spread through contaminated food or water, touching contaminated surfaces, or from an infected person to others.",
      "Symptoms of Jamaican vomiting sickness include nausea, vomiting, diarrhea, stomach cramps, and fever.",
      "To prevent the spread of this sickness, you should wash your hands frequently, avoid preparing food for others when you have symptoms and stay home when you are sick."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Jamaican vomiting sickness is caused by the unripe fruit of the ackee tree, not referred to as \"Jamaican vomiting bug\" or \"stomach bug.\"\n2. FALSE [correction]: Jamaican vomiting sickness is caused by the toxic compound hypoglycin A found in unripe ackee fruit, not Norovirus.\n3. FALSE [correction]: The sickness can be contracted by consuming unripe ackee fruit, not typically spread through the means mentioned.\n4. TRUE\n5. FALSE [correction]: To prevent Jamaican vomiting sickness, one should abstain from consuming unripe ackee fruit. Basic hygiene like frequent hand washing remains generally good practice but it is not specific prevention in this case.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2022,
    "user_query": "What are Degrons?",
    "vicuna-7b_response": "Degrons are a type of cryptocurrency that was created in 2014. They are based on the Bitcoin protocol and use the same blockchain technology, but with some key differences.\nOne of the main differences between Degrons and Bitcoin is that Degrons have a block time of 6 seconds, compared to Bitcoin's block time of 10 minutes. This means that Degrons can process more transactions per second than Bitcoin, making them faster and more efficient for certain use cases.\nAnother key difference is that Degrons have a maximum supply of 210 million units, compared to Bitcoin's maximum supply of 21 million units. This means that Degrons have more room for growth and may be more attractive to investors.\nDegrons also have some unique features, such as the ability to create \"colored coins\" which can represent assets such as stocks, bonds, or real estate. This allows for the creation of new financial instruments and use cases for blockchain technology.\nOverall, Degrons are a promising cryptocurrency that offers fast transactions, a large maximum supply, and unique features that make it an attractive option for investors and users of blockchain technology.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Degrons are a type of cryptocurrency that was created in 2014.\n2. Degrons are based on the Bitcoin protocol and use the same blockchain technology.\n3. Degrons have a block time of 6 seconds.\n4. Degrons have a maximum supply of 210 million units.\n5. Degrons include a feature for the creation of \"colored coins\" which can represent assets such as stocks, bonds, or real estate.",
    "vicuna-7b_fact": [
      "Degrons are a type of cryptocurrency that was created in 2014.",
      "Degrons are based on the Bitcoin protocol and use the same blockchain technology.",
      "Degrons have a block time of 6 seconds.",
      "Degrons have a maximum supply of 210 million units.",
      "Degrons include a feature for the creation of \"colored coins\" which can represent assets such as stocks, bonds, or real estate."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Degrons are not a type of cryptocurrency. They are specific peptide sequences that are targeted for protein degradation in a cell.\n2. FALSE [correction]: Degrons are not based on the Bitcoin protocol nor use blockchain technology as they are not a cryptocurrency.\n3. FALSE [correction]: The concept of block time is only applicable to cryptocurrencies and therefore doesn't apply to Degrons.\n4. FALSE [correction]: The notion of maximum supply doesn't apply to Degrons as they are not a type of cryptocurrency.\n5. FALSE [correction]: Degrons do not include a feature for the creation of \"colored coins\" as they are not a form of digital currency.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2023,
    "user_query": "Which disease is associated with mutated Sox2?",
    "vicuna-7b_response": "Sox2 is a transcription factor that plays a crucial role in the development of the central nervous system. Mutations in the SOX2 gene have been associated with a variety of diseases, including:\n1. Patau syndrome: This is a rare genetic disorder that is characterized by the presence of an extra copy of chromosome 13. Patau syndrome is caused by a mutation in the SOX2 gene, which results in the production of an abnormal Sox2 protein that cannot perform its normal functions.\n2. Edwards syndrome: This is another rare genetic disorder that is characterized by the presence of an extra copy of chromosome 18. Edwards syndrome is caused by a mutation in the SOX2 gene, which results in the production of an abnormal Sox2 protein that cannot perform its normal functions.\n3. Cat eye syndrome: This is a rare genetic disorder that is characterized by a variety of physical and developmental abnormalities. Cat eye syndrome is caused by a mutation in the SOX2 gene, which results in the production of an abnormal Sox2 protein that cannot perform its normal functions.\nIt is important to note that these are just a few examples of the diseases that can be associated with mutations in the SOX2 gene. There are many other genetic and chromosomal disorders that can also be caused by mutations in the SOX2 gene.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sox2 is a transcription factor that plays a crucial role in the development of the central nervous system.\n2. Mutations in the SOX2 gene have been associated with a variety of diseases.\n3. Patau syndrome, a rare genetic disorder characterized by the presence of an extra copy of chromosome 13, is caused by a mutation in the SOX2 gene.\n4. Edwards syndrome, another rare genetic disorder characterized by the presence of an extra copy of chromosome 18, is caused by a mutation in the SOX2 gene.\n5. Cat eye syndrome, a rare genetic disorder characterized by physical and developmental abnormalities, is caused by a mutation in the SOX2 gene.",
    "vicuna-7b_fact": [
      "Sox2 is a transcription factor that plays a crucial role in the development of the central nervous system.",
      "Mutations in the SOX2 gene have been associated with a variety of diseases.",
      "Patau syndrome, a rare genetic disorder characterized by the presence of an extra copy of chromosome 13, is caused by a mutation in the SOX2 gene.",
      "Edwards syndrome, another rare genetic disorder characterized by the presence of an extra copy of chromosome 18, is caused by a mutation in the SOX2 gene.",
      "Cat eye syndrome, a rare genetic disorder characterized by physical and developmental abnormalities, is caused by a mutation in the SOX2 gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Patau syndrome is not caused by a mutation in the SOX2 gene, it is caused by the presence of an extra copy of chromosome 13.\n4. FALSE [correction]: Edwards syndrome is not caused by a mutation in the SOX2 gene, it is caused by the presence of an extra copy of chromosome 18.\n5. FALSE [correction]: Cat eye syndrome is not caused by a mutation in the SOX2 gene, it is caused by a duplication of a small portion of chromosome 22.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2024,
    "user_query": "Is the enzyme EPRS phosphorylated?",
    "vicuna-7b_response": "EPRS, also known as epidermal growth factor receptor phosphorylation substrate, is an enzyme that is involved in the regulation of cell growth and division. The enzyme EPRS is not phosphorylated.\nEPRS is a protein that is involved in the signaling pathway of the epidermal growth factor receptor (EGFR). EGFR is a receptor tyrosine kinase that is activated by binding to its ligand, epidermal growth factor (EGF). Activation of EGFR leads to the phosphorylation of several downstream targets, including EPRS.\nEPRS is a scaffold protein that serves as a binding site for several other proteins, including kinases and phosphatases. The phosphorylation of EPRS by kinases can lead to its activation and the phosphorylation of downstream targets. However, EPRS itself is not phosphorylated.\nIn summary, EPRS is not phosphorylated. It is an enzyme that is involved in the regulation of cell growth and division by serving as a binding site for several other proteins, including kinases and phosphatases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. EPRS, also known as epidermal growth factor receptor phosphorylation substrate, is an enzyme that is involved in the regulation of cell growth and division.\n2. The enzyme EPRS is not phosphorylated.\n3. EPRS is a protein that is involved in the signaling pathway of the epidermal growth factor receptor (EGFR).\n4. EGFR is a receptor tyrosine kinase that is activated by binding to its ligand, epidermal growth factor (EGF).\n5. EPRS is a scaffold protein that serves as a binding site for several other proteins, including kinases and phosphatases.",
    "vicuna-7b_fact": [
      "EPRS, also known as epidermal growth factor receptor phosphorylation substrate, is an enzyme that is involved in the regulation of cell growth and division.",
      "The enzyme EPRS is not phosphorylated.",
      "EPRS is a protein that is involved in the signaling pathway of the epidermal growth factor receptor (EGFR).",
      "EGFR is a receptor tyrosine kinase that is activated by binding to its ligand, epidermal growth factor (EGF).",
      "EPRS is a scaffold protein that serves as a binding site for several other proteins, including kinases and phosphatases."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: EPRS, stands for Glutamyl-Prolyl-tRNA Synthetase, not epidermal growth factor receptor phosphorylation substrate.\n2. UNKNOWN\n3. FALSE [correction]: EPRS is not directly involved in the signaling pathway of the epidermal growth factor receptor (EGFR). It is involved in the process of protein synthesis.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2038,
    "user_query": "Which disease(s) are caused by HEX A deficiency?",
    "vicuna-7b_response": "HEX A deficiency is a genetic disorder caused by a mutation in the HEXA gene, which codes for the enzyme glucose-6-phosphate dehydrogenase (G6PD). This enzyme is involved in the metabolism of glucose and plays a role in the protection of red blood cells from oxidative stress.\nIndividuals with HEX A deficiency are at increased risk of developing certain diseases and conditions, including:\n1. G6PD deficiency: This is the most common manifestation of HEX A deficiency and is characterized by reduced activity of the G6PD enzyme. This can lead to an increased susceptibility to certain types of anemia, particularly in response to exposure to certain drugs, such as aspirin and certain antimalarials.\n2. Hemolytic anemia: G6PD deficiency can also lead to hemolytic anemia, which is a type of anemia characterized by the destruction of red blood cells. This can occur in response to exposure to certain drugs or toxins, as well as in response to infections or other stressors.\n3. Neurological disorders: Some studies have suggested that HEX A deficiency may be associated with an increased risk of certain neurological disorders, such as migraines and epilepsy. However, the evidence for this is still limited and more research is needed to fully understand the potential link between HEX A deficiency and these conditions.\n4. Premature aging: Some studies have also suggested that HEX A deficiency may be associated with premature aging, although this is still a topic of debate and more research is needed to fully understand the potential link between HEX A deficiency and premature aging.\nOverall, HEX A deficiency can lead to a range of health problems, including anemia, hemolytic anemia, and an increased risk of certain neurological disorders and premature aging. However, the specific symptoms and severity of these conditions can vary widely depending on the individual and the underlying cause of the deficiency.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. HEX A deficiency is a genetic disorder caused by a mutation in the HEXA gene.\n2. The HEXA gene codes for the enzyme glucose-6-phosphate dehydrogenase (G6PD).\n3. G6PD is involved in the metabolism of glucose and plays a role in the protection of red blood cells from oxidative stress.\n4. Individuals with HEX A deficiency are at an increased risk of developing G6PD deficiency, which can lead to increased susceptibility to certain types of anemia.\n5. HEX A deficiency may also be associated with an increased risk of certain neurological disorders and premature aging, although more research is needed to establish this.",
    "vicuna-7b_fact": [
      "HEX A deficiency is a genetic disorder caused by a mutation in the HEXA gene.",
      "The HEXA gene codes for the enzyme glucose-6-phosphate dehydrogenase (G6PD).",
      "G6PD is involved in the metabolism of glucose and plays a role in the protection of red blood cells from oxidative stress.",
      "Individuals with HEX A deficiency are at an increased risk of developing G6PD deficiency, which can lead to increased susceptibility to certain types of anemia.",
      "HEX A deficiency may also be associated with an increased risk of certain neurological disorders and premature aging, although more research is needed to establish this."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The HEXA gene codes for the alpha subunit of the lysosomal enzyme beta-hexosaminidase A.\n3. FALSE [correction]: G6PD is indeed involved in the metabolism of glucose and plays a role in protection of red blood cells from oxidative stress, but it is not coded by HEXA gene.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2046,
    "user_query": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?",
    "vicuna-7b_response": "The JASPAR 2016 open-access database of transcription factor binding profiles includes several additions compared to previous versions of JASPAR. Some of the notable additions include:\n1. New transcription factor binding profiles: JASPAR 2016 includes new profiles for several transcription factors, including GATA1, GATA2, GATA3, NF-E2, NF-E2-related factor 2 (NRF2), and TCF3.\n2. Improved data quality: JASPAR 2016 includes updated and improved data from the original JASPAR database, including new experimental validation and improved computational modeling.\n3. New functional annotation: JASPAR 2016 includes new functional annotations for many of the transcription factors, including information on their role in various biological processes and cellular pathways.\n4. New tools and resources: JASPAR 2016 includes new tools and resources for working with transcription factor binding profiles, including a new web-based interface and improved software tools for data analysis and visualization.\nOverall, the additions in JASPAR 2016 provide researchers with a more comprehensive and up-to-date resource for studying transcription factor binding profiles and their role in gene regulation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. JASPAR 2016 includes new profiles for several transcription factors, including GATA1, GATA2, GATA3, NF-E2, NF-E2-related factor 2 (NRF2), and TCF3.\n2. The database JASPAR 2016 includes updated and improved data from the original JASPAR database.\n3. The database JASPAR 2016 includes new experimental validation and improved computational modeling.\n4. The database JASPAR 2016 includes new functional annotations for many of the transcription factors including information on their role in various biological processes and cellular pathways.\n5. The database JASPAR 2016 includes new tools and resources for working with transcription factor binding profiles, including a new web-based interface and improved software tools for data analysis and visualization.",
    "vicuna-7b_fact": [
      "JASPAR 2016 includes new profiles for several transcription factors, including GATA1, GATA2, GATA3, NF-E2, NF-E2-related factor 2 (NRF2), and TCF3.",
      "The database JASPAR 2016 includes updated and improved data from the original JASPAR database.",
      "The database JASPAR 2016 includes new experimental validation and improved computational modeling.",
      "The database JASPAR 2016 includes new functional annotations for many of the transcription factors including information on their role in various biological processes and cellular pathways.",
      "The database JASPAR 2016 includes new tools and resources for working with transcription factor binding profiles, including a new web-based interface and improved software tools for data analysis and visualization."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2047,
    "user_query": "What is the function of the protein tafazzin?",
    "vicuna-7b_response": "Tafazzin is a protein that plays a critical role in the assembly and function of mitochondrial translation machinery. Mitochondria are organelles found in cells that are responsible for producing ATP, the energy currency of the cell. Mitochondrial translation is the process of translating mRNA molecules into proteins within the mitochondria. Tafazzin is a component of the mitochondrial translation initiation factor 3 (IF3) complex, which is responsible for recognizing and binding to the start codon of an mRNA molecule to initiate translation.\nIn addition to its role in mitochondrial translation initiation, tafazzin has also been implicated in the regulation of mitochondrial dynamics and the maintenance of mitochondrial genome stability. Mutations in the tafazzin gene have been associated with a number of human diseases, including mitochondrial disease, neurodegenerative disorders, and cancer.\nOverall, tafazzin is an essential protein that plays a critical role in the proper functioning of mitochondria and has important implications for human health and disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tafazzin is a protein that is involved in the assembly and function of mitochondrial translation machinery.\n2. Tafazzin is a component of the mitochondrial translation initiation factor 3 (IF3) complex.\n3. Mitochondrial translation is the process of translating mRNA molecules into proteins within the mitochondria.\n4. Tafazzin has a role in the regulation of mitochondrial dynamics and the maintenance of mitochondrial genome stability.\n5. Mutations in the tafazzin gene have been associated with diseases such as mitochondrial disease, neurodegenerative disorders, and cancer.",
    "vicuna-7b_fact": [
      "Tafazzin is a protein that is involved in the assembly and function of mitochondrial translation machinery.",
      "Tafazzin is a component of the mitochondrial translation initiation factor 3 (IF3) complex.",
      "Mitochondrial translation is the process of translating mRNA molecules into proteins within the mitochondria.",
      "Tafazzin has a role in the regulation of mitochondrial dynamics and the maintenance of mitochondrial genome stability.",
      "Mutations in the tafazzin gene have been associated with diseases such as mitochondrial disease, neurodegenerative disorders, and cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Tafazzin is a protein involved in the remodeling of cardiolipin, a lipid that resides within the inner mitochondrial membrane.\n2. FALSE [correction]: Tafazzin is not a component of the mitochondrial translation initiation factor 3 (IF3) complex. It is a mitochondrial phospholipid-transacylase.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2051,
    "user_query": "Where is base J found in the genome of Leishmania tarentolae?",
    "vicuna-7b_response": "Base J is not found in the genome of Leishmania tarentolae. Leishmania tarentolae is a protozoan parasite that causes leishmaniasis, a disease transmitted by the bite of infected sandflies. The genome of Leishmania tarentolae was sequenced in 2008 and was found to contain approximately 22.5 million base pairs. The genome of Leishmania tarentolae was found to contain 6,778 protein-coding genes, 57 RNA genes, and 27 tRNA genes. Base J is not one of the 6,778 protein-coding genes, 57 RNA genes, or 27 tRNA genes found in the genome of Leishmania tarentolae.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Base J is not found in the genome of Leishmania tarentolae.\n2. Leishmania tarentolae is a protozoan parasite that causes leishmaniasis.\n3. The disease leishmaniasis is transmitted by the bite of infected sandflies.\n4. The genome of Leishmania tarentolae was sequenced in 2008 and contains approximately 22.5 million base pairs.\n5. The genome of Leishmania tarentolae contains 6,778 protein-coding genes, 57 RNA genes, and 27 tRNA genes.",
    "vicuna-7b_fact": [
      "Base J is not found in the genome of Leishmania tarentolae.",
      "Leishmania tarentolae is a protozoan parasite that causes leishmaniasis.",
      "The disease leishmaniasis is transmitted by the bite of infected sandflies.",
      "The genome of Leishmania tarentolae was sequenced in 2008 and contains approximately 22.5 million base pairs.",
      "The genome of Leishmania tarentolae contains 6,778 protein-coding genes, 57 RNA genes, and 27 tRNA genes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Leishmania tarentolae is a protozoan parasite but it does not cause leishmaniasis. It is used often in research as a model organism.\n3. TRUE\n4. FALSE [correction]: The genome of Leishmania tarentolae was sequenced in 2012 and contains approximately 32.8 million base pairs.\n5. FALSE [correction]: The genome of Leishmania tarentolae contains approximately 10,200 protein-coding genes. The accurate number of RNA genes and tRNA genes is not specified.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2052,
    "user_query": "Which tool is available for predicting regulatory interactions from ChIP-seq data?",
    "vicuna-7b_response": "There are several tools available for predicting regulatory interactions from ChIP-seq data. Some of the most popular tools include:\n1. ENCODE: ENCODE (Encyclopedia Of DNA Elements) is a large-scale project that aims to identify all functional elements in the human genome. ENCODE provides a suite of tools for analyzing ChIP-seq data, including tools for predicting regulatory interactions.\n2. MACS: MACS (Model-based Analysis of ChIP-seq) is a widely used tool for analyzing ChIP-seq data. MACS includes a module for predicting regulatory interactions based on chromatin accessibility and other features.\n3. GENEVESTIGATOR: GENEVESTIGATOR is a tool for identifying transcription factor binding sites and predicting their functional impact on gene expression. GENEVESTIGATOR can also be used to predict regulatory interactions based on ChIP-seq data.\n4. TRANSFAC: TRANSFAC is a database of transcription factor binding sites and regulatory motifs. TRANSFAC includes a tool for predicting regulatory interactions based on ChIP-seq data.\n5. ChIPSig: ChIPSig is a tool for identifying regulatory interactions based on ChIP-seq data. ChIPSig uses a machine learning approach to predict regulatory interactions between transcription factors and target genes.\nThese are just a few examples of the many tools available for predicting regulatory interactions from ChIP-seq data. The choice of tool will depend on the specific requirements of the user and the nature of the data being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ENCODE (Encyclopedia Of DNA Elements) is a tool that can be used for predicting regulatory interactions from ChIP-seq data.\n2. MACS (Model-based Analysis of ChIP-seq) is a widely used tool for analyzing ChIP-seq data and includes a module for predicting regulatory interactions.\n3. GENEVESTIGATOR is a tool that can be used to identify transcription factor binding sites and predict their impact on gene expression and regulatory interactions from ChIP-seq data.\n4. TRANSFAC is a database that includes a tool for predicting regulatory interactions based on ChIP-seq data.\n5. ChIPSig uses a machine learning approach to predict regulatory interactions between transcription factors and target genes based on ChIP-seq data.",
    "vicuna-7b_fact": [
      "ENCODE (Encyclopedia Of DNA Elements) is a tool that can be used for predicting regulatory interactions from ChIP-seq data.",
      "MACS (Model-based Analysis of ChIP-seq) is a widely used tool for analyzing ChIP-seq data and includes a module for predicting regulatory interactions.",
      "GENEVESTIGATOR is a tool that can be used to identify transcription factor binding sites and predict their impact on gene expression and regulatory interactions from ChIP-seq data.",
      "TRANSFAC is a database that includes a tool for predicting regulatory interactions based on ChIP-seq data.",
      "ChIPSig uses a machine learning approach to predict regulatory interactions between transcription factors and target genes based on ChIP-seq data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [Correction]: TRANSFAC is a database that provides data about transcription factors, their genomic binding sites and regulated genes but it does not have a tool for predicting regulatory interactions based on ChIP-seq data.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2053,
    "user_query": "Where are the unipolar brush cells localized?",
    "vicuna-7b_response": "Unipolar brush cells are a type of neuron found in the olfactory bulb, which is the part of the brain responsible for processing smells. These cells are characterized by their unique dendritic field, which is confined to a specific region of the olfactory bulb.\nUnipolar brush cells have a single dendrite that is densely covered with synapses, which are the connections between neurons. This dendrite is specialized for receiving input from other neurons in the olfactory bulb, and it is thought to play a key role in the integration of olfactory information.\nIn addition to their unique dendritic field, unipolar brush cells also have a characteristic pattern of electrical activity. They fire in a \"burst\" pattern, in which they fire a series of action potentials in quick succession. This pattern of activity is thought to help the brain to distinguish between different odors and to enhance the overall olfactory sensitivity.\nOverall, unipolar brush cells are an important type of neuron in the olfactory system, and their unique properties and functions are the subject of ongoing research.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Unipolar brush cells are a type of neuron found in the olfactory bulb.\n2. The olfactory bulb is the part of the brain responsible for processing smells.\n3. Unipolar brush cells have a single dendrite that is densely covered with synapses.\n4. The dendrite on unipolar brush cells is specialized for receiving input from other neurons in the olfactory bulb.\n5. Unipolar brush cells fire in a \"burst\" pattern.",
    "vicuna-7b_fact": [
      "Unipolar brush cells are a type of neuron found in the olfactory bulb.",
      "The olfactory bulb is the part of the brain responsible for processing smells.",
      "Unipolar brush cells have a single dendrite that is densely covered with synapses.",
      "The dendrite on unipolar brush cells is specialized for receiving input from other neurons in the olfactory bulb.",
      "Unipolar brush cells fire in a \"burst\" pattern."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Unipolar brush cells are a type of neuron found in the cerebellum, not in the olfactory bulb.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The dendrite on unipolar brush cells is specialized for receiving input from granule cells in the cerebellum, not from neurons in the olfactory bulb.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2054,
    "user_query": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?",
    "vicuna-7b_response": "Diffuse Intrinsic Pontine Glioma (DIPG) is a highly aggressive and incurable brain tumor that primarily affects children. While there is no known cause or clear risk factors for DIPG, research has identified several driver mutations that are associated with the development and progression of this disease.\nOne of the most well-known driver mutations for DIPG is the IDH1 mutation. IDH1 is an enzyme that plays a role in the metabolism of cells, and the mutation leads to the production of a non-functional enzyme that can promote the production of oncogenic metabolites. IDH1 mutations have been identified in over 50% of DIPG cases, making it one of the most common driver mutations for this disease.\nAnother driver mutation that has been identified for DIPG is the TP53 mutation. TP53 is a tumor suppressor gene that plays a critical role in maintaining genomic stability and preventing the development of cancer. TP53 mutations are found in approximately 20% of DIPG cases and can lead to the loss of TP53 function, which can promote the development and progression of this disease.\nIn addition to IDH1 and TP53 mutations, other driver mutations that have been identified for DIPG include PTEN mutations, NF1 mutations, and CDKN2A/B mutations.\nOverall, while there is no known cure for DIPG, understanding the driver mutations that are associated with this disease can help inform targeted therapies and improve outcomes for patients.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Diffuse Intrinsic Pontine Glioma (DIPG) is a highly aggressive and incurable brain tumor that primarily affects children.\n2. The IDH1 mutation is a well-known driver mutation for DIPG and has been identified in over 50% of DIPG cases.\n3. IDH1 is an enzyme that plays a role in the metabolism of cells, and its mutation can promote the production of oncogenic metabolites. \n4. The TP53 mutation, which plays a critical role in maintaining genomic stability and preventing cancer, is found in around 20% of DIPG cases. \n5. Other driver mutations for DIPG include PTEN mutations, NF1 mutations, and CDKN2A/B mutations.",
    "vicuna-7b_fact": [
      "Diffuse Intrinsic Pontine Glioma (DIPG) is a highly aggressive and incurable brain tumor that primarily affects children.",
      "The IDH1 mutation is a well-known driver mutation for DIPG and has been identified in over 50% of DIPG cases.",
      "IDH1 is an enzyme that plays a role in the metabolism of cells, and its mutation can promote the production of oncogenic metabolites.",
      "The TP53 mutation, which plays a critical role in maintaining genomic stability and preventing cancer, is found in around 20% of DIPG cases.",
      "Other driver mutations for DIPG include PTEN mutations, NF1 mutations, and CDKN2A/B mutations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The H3 K27M mutation, not the IDH1 mutation, is a well-known driver mutation for DIPG and has been identified in over 70% of DIPG cases.\n3. TRUE\n4. FALSE [correction]: The TP53 mutation, which plays a critical role in maintaining genomic stability and preventing cancer, is found in approximately 70-80% of DIPG cases.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2059,
    "user_query": "What is the enzymatic activity of PARL?",
    "vicuna-7b_response": "PARL, or Partner of Arl8b-Like protein, is an enzyme that plays a crucial role in the regulation of RNA polymerase II transcription. PARL is a component of the Paf1 complex, which is responsible for recruiting transcriptional elongation factors to the genome.\nThe enzymatic activity of PARL is related to its ability to interact with other proteins and modulate their activity. PARL has been shown to interact with a variety of proteins, including transcription elongation factors, histone-modifying enzymes, and RNA-binding proteins.\nOne of the key functions of PARL is to promote the interaction between transcription elongation factors and RNA polymerase II. This interaction is important for the proper regulation of gene expression and the efficient elongation of transcription.\nIn addition to its role in transcription elongation, PARL has also been implicated in the regulation of other cellular processes, including DNA damage repair and the response to stress.\nOverall, the enzymatic activity of PARL is critical for the proper functioning of the cell and the regulation of gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PARL, or Partner of Arl8b-Like protein, is an enzyme that plays a role in the regulation of RNA polymerase II transcription.\n2. PARL is a component of the Paf1 complex.\n3. The Paf1 complex is responsible for recruiting transcriptional elongation factors to the genome.\n4. PARL promotes the interaction between transcription elongation factors and RNA polymerase II.\n5. Apart from its role in transcription elongation, PARL has also been implicated in DNA damage repair and the response to stress.",
    "vicuna-7b_fact": [
      "PARL, or Partner of Arl8b-Like protein, is an enzyme that plays a role in the regulation of RNA polymerase II transcription.",
      "PARL is a component of the Paf1 complex.",
      "The Paf1 complex is responsible for recruiting transcriptional elongation factors to the genome.",
      "PARL promotes the interaction between transcription elongation factors and RNA polymerase II.",
      "Apart from its role in transcription elongation, PARL has also been implicated in DNA damage repair and the response to stress."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2064,
    "user_query": "What is the mechanism of action of verubecestat?",
    "vicuna-7b_response": "Verubecestat is a medication that is used to treat Alzheimer's disease. It works by inhibiting the production of beta-amyloid, a protein that is believed to play a role in the development of Alzheimer's disease.\nThe mechanism of action of verubecestat is based on the idea that beta-amyloid is a key player in the formation of the neurotoxic plaques that are found in the brains of people with Alzheimer's disease. By inhibiting the production of beta-amyloid, verubecestat is able to reduce the formation of these plaques and slow the progression of the disease.\nIn addition to its effect on beta-amyloid, verubecestat has also been shown to have an effect on tau, another protein that is believed to play a role in the development of Alzheimer's disease. By targeting both beta-amyloid and tau, verubecestat may be able to provide a more comprehensive approach to treating Alzheimer's disease.\nIt's important to note that while verubecestat has shown promise in clinical trials, it is not yet approved for use in the United States. Further research is needed to fully understand the mechanism of action of this medication and its potential benefits for people with Alzheimer's disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Verubecestat is a medication used to treat Alzheimer's disease.\n2. Verubecestat works by inhibiting the production of beta-amyloid.\n3. Beta-amyloid protein is believed to play a role in the development of Alzheimer's disease.\n4. Verubecestat has been shown to have an effect on tau, another protein believed to play a role in the development of Alzheimer's disease.\n5. Verubecestat is not yet approved for use in the United States.",
    "vicuna-7b_fact": [
      "Verubecestat is a medication used to treat Alzheimer's disease.",
      "Verubecestat works by inhibiting the production of beta-amyloid.",
      "Beta-amyloid protein is believed to play a role in the development of Alzheimer's disease.",
      "Verubecestat has been shown to have an effect on tau, another protein believed to play a role in the development of Alzheimer's disease.",
      "Verubecestat is not yet approved for use in the United States."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Verubecestat was a drug developed for the treatment of Alzheimer's disease but clinical trials were halted due to lack of effectiveness.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-7b_response": "Triple negative gliomas (TNGs) are a type of brain tumor that do not express the proteins normally found on the surface of most brain tumors, such as glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE). Instead, TNGs express other proteins, such as epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\nTNGs are also characterized by the absence of positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). This is why they are called \"triple negative\" - they do not express any of the three main proteins that are typically found on the surface of brain tumors.\nIn addition to these characteristic markers, TNGs are also characterized by their aggressive behavior and poor prognosis. They tend to grow quickly and invade surrounding tissue, and they are often resistant to radiation and chemotherapy.\nOverall, the diagnosis of TNGs is based on a combination of histological and immunohistochemical features, as well as the absence of expression of the typical markers of other types of brain tumors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Triple negative gliomas (TNGs) are a type of brain tumor that do not express the proteins glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).\n2. The proteins expressed by TNGs include epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\n3. TNGs are characterized by the absence of positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).\n4. Triple negative gliomas often exhibit aggressive behavior, grow quickly and are resistant to radiation and chemotherapy.\n5. The diagnosis of TNGs is based on histological and immunohistochemical features and the absence of expression of typical markers of other types of brain tumors.",
    "vicuna-7b_fact": [
      "Triple negative gliomas (TNGs) are a type of brain tumor that do not express the proteins glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).",
      "The proteins expressed by TNGs include epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).",
      "TNGs are characterized by the absence of positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).",
      "Triple negative gliomas often exhibit aggressive behavior, grow quickly and are resistant to radiation and chemotherapy.",
      "The diagnosis of TNGs is based on histological and immunohistochemical features and the absence of expression of typical markers of other types of brain tumors."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2068,
    "user_query": "What is the function of gasdermin D?",
    "vicuna-7b_response": "Gasdermin D is a member of the gasdermin family of genes, which encode proteins that play a role in cell death and inflammation. Gasdermin D is particularly important in the process of pyroptosis, which is a form of programmed cell death that occurs in response to infection or tissue damage.\nGasdermin D is a cytosolic protein that is released from the endoplasmic reticulum in response to cellular stress, and it forms pores in the plasma membrane that lead to the release of pro-inflammatory cytokines and the death of the cell. Gasdermin D has also been shown to play a role in the clearance of apoptotic cells, which helps to prevent the spread of cell death and inflammation.\nOverall, the function of gasdermin D is to play a role in cell death and inflammation, particularly in response to infection or tissue damage.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gasdermin D is a member of the gasdermin family of genes.\n2. The proteins encoded by the gasdermin family of genes have a role in cell death and inflammation.\n3. Gasdermin D plays a role in the process of pyroptosis.\n4. Gasdermin D forms pores in the plasma membrane that lead to the release of pro-inflammatory cytokines and cell death.\n5. Gasdermin D plays a role in the clearance of apoptotic cells.",
    "vicuna-7b_fact": [
      "Gasdermin D is a member of the gasdermin family of genes.",
      "The proteins encoded by the gasdermin family of genes have a role in cell death and inflammation.",
      "Gasdermin D plays a role in the process of pyroptosis.",
      "Gasdermin D forms pores in the plasma membrane that lead to the release of pro-inflammatory cytokines and cell death.",
      "Gasdermin D plays a role in the clearance of apoptotic cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Gasdermin D does not play a direct role in the clearance of apoptotic cells. Its function is more associated with pyroptosis, a form of programmed cell death that leads to inflammation.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-7b_response": "TOPAZ1 is a cryptocurrency that was created in 2017. It is a privacy-focused cryptocurrency that uses a technology called \"Zero Knowledge Proofs\" to provide users with enhanced privacy and security. TOPAZ1 is based on the Zerocoin protocol, which was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\nTOPAZ1 aims to provide users with the ability to conduct private transactions without the need for a trusted third party, such as a bank or government. This is achieved by using a technique called \"Zero Knowledge Proofs\" to verify transactions without revealing the underlying details of the transaction.\nTOPAZ1 also uses a decentralized governance model, where the network is governed by a group of elected community members known as \"stewards\". The stewards are responsible for making decisions about the future development of the TOPAZ1 network, such as implementing new features or upgrading the network's security.\nIn summary, TOPAZ1 is a privacy-focused cryptocurrency that uses Zero Knowledge Proofs to provide users with enhanced privacy and security. It is based on the Zerocoin protocol and uses a decentralized governance model to ensure that the network is governed by the community.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TOPAZ1 is a cryptocurrency that was created in 2017.\n2. TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" to provide enhanced privacy and security.\n3. TOPAZ1 is based on the Zerocoin protocol, developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\n4. TOPAZ1 uses a decentralized governance model, where the network is governed by elected community members known as \"stewards\".\n5. TOPAZ1 provides users the ability to conduct private transactions without the need for a trusted third party.",
    "vicuna-7b_fact": [
      "TOPAZ1 is a cryptocurrency that was created in 2017.",
      "TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" to provide enhanced privacy and security.",
      "TOPAZ1 is based on the Zerocoin protocol, developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.",
      "TOPAZ1 uses a decentralized governance model, where the network is governed by elected community members known as \"stewards\".",
      "TOPAZ1 provides users the ability to conduct private transactions without the need for a trusted third party."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2070,
    "user_query": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?",
    "vicuna-7b_response": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder that affects the production of an enzyme called glucose-6-phosphate dehydrogenase (G6PD). This enzyme is responsible for breaking down a type of compound called NADP, which is involved in the metabolism of glucose.\nThe symptoms of G6PD deficiency can vary depending on the severity of the deficiency and the presence of other factors that may affect the body's ability to handle certain compounds. Some common symptoms of G6PD deficiency include:\n* Jaundice (yellowing of the skin and whites of the eyes) in newborns, which may be accompanied by other symptoms such as fever, vomiting, and poor feeding.\n* Elevated levels of bilirubin in the blood (hyperbilirubinemia), which can lead to jaundice and yellowing of the skin and whites of the eyes.\n* Red blood cells that are more susceptible to damage from certain compounds, such as certain antibiotics and certain types of food dyes.\n* Occasional episodes of yellowing of the skin and whites of the eyes (jaundice) that may be triggered by stress, infections, or other factors.\nIt's important to note that not everyone with G6PD deficiency will experience these symptoms, and some people with the disorder may not experience any symptoms at all. Additionally, G6PD deficiency is not typically a serious condition on its own, but it can be a sign of an underlying genetic disorder or other health problem. If you have concerns about G6PD deficiency or any other health issue, it's always a good idea to speak with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder that affects the production of the G6PD enzyme.\n2. The G6PD enzyme is responsible for breaking down NADP, a compound involved in the metabolism of glucose.\n3. Some common symptoms of G6PD deficiency include jaundice in newborns, fever, vomiting, poor feeding, and elevated levels of bilirubin.\n4. Red blood cells of people with G6PD deficiency are more susceptible to damage from compounds like certain antibiotics and food dyes.\n5. Not everyone with G6PD deficiency will experience all or any of these symptoms.",
    "vicuna-7b_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder that affects the production of the G6PD enzyme.",
      "The G6PD enzyme is responsible for breaking down NADP, a compound involved in the metabolism of glucose.",
      "Some common symptoms of G6PD deficiency include jaundice in newborns, fever, vomiting, poor feeding, and elevated levels of bilirubin.",
      "Red blood cells of people with G6PD deficiency are more susceptible to damage from compounds like certain antibiotics and food dyes.",
      "Not everyone with G6PD deficiency will experience all or any of these symptoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The G6PD enzyme is responsible for protecting red blood cells from potentially harmful byproducts of metabolism, not for breaking down NADP.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2071,
    "user_query": "Has the gorilla genome been determined?",
    "vicuna-7b_response": "Yes, the gorilla genome has been determined. In 2012, a team of scientists led by the International Gorilla Conservation Programme (IGCP) published a draft of the gorilla genome sequence in the journal \"Nature\". The study used DNA from a western lowland gorilla named \"Mike\" who lived at the San Diego Zoo.\nThe gorilla genome is similar to that of humans and chimpanzees, and scientists have used this information to gain insights into the evolution of the human species. The study found that gorillas and humans share about 98.8% of their genes, and that gorillas have unique genetic variations that could help scientists understand the evolution of the human immune system and other traits.\nThe study also found that gorillas have a unique genetic variation that could help scientists understand the evolution of the human brain. This variation, which is found in a region of the genome called \"MCPH1\", is associated with changes in the development of the cerebral cortex, the part of the brain responsible for higher-order thinking and language.\nOverall, the study of the gorilla genome has provided valuable insights into the evolution of the human species and the biology of gorillas.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The gorilla genome has been determined.\n2. In 2012, the International Gorilla Conservation Programme (IGCP) published a draft of the gorilla genome sequence in the journal \"Nature\".\n3. The gorilla genome was sequenced from DNA of a western lowland gorilla named \"Mike\" who lived at the San Diego Zoo.\n4. Gorillas and humans share about 98.8% of their genes.\n5. The MCPH1 region of the gorilla genome could help scientists understand the evolution of the human brain.",
    "vicuna-7b_fact": [
      "The gorilla genome has been determined.",
      "In 2012, the International Gorilla Conservation Programme (IGCP) published a draft of the gorilla genome sequence in the journal \"Nature\".",
      "The gorilla genome was sequenced from DNA of a western lowland gorilla named \"Mike\" who lived at the San Diego Zoo.",
      "Gorillas and humans share about 98.8% of their genes.",
      "The MCPH1 region of the gorilla genome could help scientists understand the evolution of the human brain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gorilla genome sequence was published by an international consortium of research organizations, not the International Gorilla Conservation Programme (IGCP), in the journal \"Nature\".\n3. FALSE [correction]: The gorilla genome was sequenced from DNA of a female western lowland gorilla named \"Kamilah\" who lived at the San Diego Zoo.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2073,
    "user_query": "Are mutations in the C9orf72  gene associated with macular degeneration?",
    "vicuna-7b_response": "Yes, mutations in the C9orf72 gene have been associated with a form of macular degeneration known as chromosome 9 open reading frame 72 (C9ORF72) repeat expansion disease. This disease is characterized by the expansion of a repeat sequence in the C9orf72 gene, which leads to the production of abnormal proteins that are thought to play a role in the development of the disease.\nThe C9orf72 repeat expansion disease is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), which are both progressive neurodegenerative disorders. The disease is also associated with a range of other symptoms, including macular degeneration.\nMacular degeneration is a condition that affects the macula, which is the part of the retina responsible for central vision. In C9orf72 repeat expansion disease, the abnormal proteins produced by the expanded repeat sequence can cause damage to the retina and lead to macular degeneration.\nWhile the exact mechanisms by which the abnormal proteins produced by the C9orf72 repeat expansion cause macular degeneration are not fully understood, researchers believe that the proteins may interfere with the normal functioning of the retina and lead to the development of the disease.\nOverall, mutations in the C9orf72 gene are associated with a range of neurological symptoms, including macular degeneration, and are a significant cause of inherited ALS and FTD.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mutations in the C9orf72 gene have been associated with a form of macular degeneration known as chromosome 9 open reading frame 72 (C9ORF72) repeat expansion disease.\n2. The repeat sequence expansion in the C9orf72 gene results in the production of abnormal proteins. \n3. These abnormal proteins are thought to play a role in the development of macular degeneration and other diseases.\n4. The C9orf72 repeat expansion disease is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).\n5. Macular degeneration affects the macula, which is the part of the retina responsible for central vision.",
    "vicuna-7b_fact": [
      "Mutations in the C9orf72 gene have been associated with a form of macular degeneration known as chromosome 9 open reading frame 72 (C9ORF72) repeat expansion disease.",
      "The repeat sequence expansion in the C9orf72 gene results in the production of abnormal proteins.",
      "These abnormal proteins are thought to play a role in the development of macular degeneration and other diseases.",
      "The C9orf72 repeat expansion disease is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
      "Macular degeneration affects the macula, which is the part of the retina responsible for central vision."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Mutations in the C9orf72 gene have been associated with a form of neurodegenerative disease, not macular degeneration. Specifically, it's known as chromosome 9 open reading frame 72 (C9ORF72) repeat expansion disease.\n2. TRUE\n3. FALSE [correction]: These abnormal proteins are thought to play a role in the development of neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia, not macular degeneration.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and function of various cell types, including hematopoietic cells. GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA, which results in the production of different protein isoforms with distinct functions.\nThe gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. The GATA-1 gene is located on chromosome X and consists of 17 exons that are spliced together to produce the GATA-1 mRNA. The alternative splicing of the GATA-1 mRNA results in the production of different isoforms of GATA-1, each with a unique combination of exons.\nThe specific splicing events that give rise to the different GATA-1 isoforms are regulated by a complex network of transcription factors and cofactors, as well as by the presence of specific regulatory elements in the GATA-1 gene promoter. Some of the transcription factors that have been shown to regulate GATA-1 splicing include the GATA-1 binding protein 1 (GATA1BP1), the GATA-1 binding protein 2 (GATA1BP2), and the GATA-1 binding protein 3 (GATA1BP3).\nIn summary, the gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself, and the specific splicing events that give rise to the different GATA-1 isoforms are regulated by a complex network of transcription factors and cofactors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The GATA-1 gene controls the expression of its own isoforms.\n2. GATA-1 is a transcription factor and has a role in the development and function of various cell types, including hematopoietic cells.\n3. GATA-1 isoforms are produced by the alternative splicing of the GATA-1 mRNA.\n4. The GATA-1 gene consists of 17 exons and is located on chromosome X.\n5. The GATA-1 splicing is regulated by a complex network of transcription factors and cofactors, including GATA-1 binding protein 1 (GATA1BP1), the GATA-1 binding protein 2 (GATA1BP2), and the GATA-1 binding protein 3 (GATA1BP3).",
    "vicuna-7b_fact": [
      "The GATA-1 gene controls the expression of its own isoforms.",
      "GATA-1 is a transcription factor and has a role in the development and function of various cell types, including hematopoietic cells.",
      "GATA-1 isoforms are produced by the alternative splicing of the GATA-1 mRNA.",
      "The GATA-1 gene consists of 17 exons and is located on chromosome X.",
      "The GATA-1 splicing is regulated by a complex network of transcription factors and cofactors, including GATA-1 binding protein 1 (GATA1BP1), the GATA-1 binding protein 2 (GATA1BP2), and the GATA-1 binding protein 3 (GATA1BP3)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The GATA-1 gene consists of 6 exons and is located on the X chromosome.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-7b_response": "MIRA-seq (Mutation Identification by Deep Sequencing) is a powerful technique used to identify somatic mutations in a genome. It is a high-throughput sequencing-based approach that involves capturing and sequencing the entire exome (all protein-coding genes) of a sample, followed by a targeted sequencing of the remaining genome.\nThe exome capture step uses a specific set of probes to enrich for the coding regions of the genome, while the remaining genome is sequenced using a targeted sequencing approach. This allows for the identification of both coding and non-coding mutations, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs).\nMIRA-seq is particularly useful for studying somatic mutations, which are mutations that occur in cells other than the germline cells (sperm or egg cells). These mutations can be caused by various factors, such as environmental exposures, aging, or genetic predisposition, and can lead to the development of cancer or other diseases.\nBy using MIRA-seq, researchers can identify somatic mutations in a genome and study their impact on the development and progression of diseases. This technique has been used to study a wide range of diseases, including cancer, neurological disorders, and genetic diseases.\nIn summary, MIRA-seq is a powerful technique used to identify somatic mutations in a genome, which can provide valuable insights into the development and progression of various diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MIRA-seq (Mutation Identification by Deep Sequencing) is a technique used to identify somatic mutations in a genome.\n2. MIRA-seq involves capturing and sequencing the entire exome of a sample, followed by a targeted sequencing of the remaining genome.\n3. Exome capture step in MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.\n4. MIRA-seq can identify both coding and non-coding mutations, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs).\n5. MIRA-seq has been used to study a wide range of diseases, including cancer, neurological disorders, and genetic diseases.",
    "vicuna-7b_fact": [
      "MIRA-seq (Mutation Identification by Deep Sequencing) is a technique used to identify somatic mutations in a genome.",
      "MIRA-seq involves capturing and sequencing the entire exome of a sample, followed by a targeted sequencing of the remaining genome.",
      "Exome capture step in MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.",
      "MIRA-seq can identify both coding and non-coding mutations, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs).",
      "MIRA-seq has been used to study a wide range of diseases, including cancer, neurological disorders, and genetic diseases."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2077,
    "user_query": "How does Ssu72 mediate gene looping?",
    "vicuna-7b_response": "Ssu72 is a protein that plays a crucial role in regulating gene expression in eukaryotes. It is a component of the RNA polymerase II (RNAPII) complex, which is responsible for transcribing DNA into RNA. Ssu72 is involved in the process of transcription elongation, which is the process of RNAPII moving along the DNA template and synthesizing RNA.\nOne of the functions of Ssu72 is to mediate gene looping. Gene looping is a process by which the DNA between two genes is wrapped around each other, creating a loop. This looping can affect the expression of the genes involved, as it can bring the genes closer together and allow for the exchange of regulatory factors.\nSsu72 has been shown to play a role in mediating gene looping by interacting with the DNA and RNA involved in the loop. It has been shown to bind to the DNA in the loop and to the RNA transcribed from the loop. This binding can help to stabilize the loop and to regulate the expression of the genes involved.\nOverall, Ssu72 is an important protein in the regulation of gene expression, and its role in mediating gene looping is just one of its many functions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Ssu72 is a protein that regulates gene expression in eukaryotes.\n2. It is a component of the RNA polymerase II (RNAPII) complex.\n3. The RNA polymerase II (RNAPII) complex is responsible for transcribing DNA into RNA.\n4. Ssu72 is involved in the process of transcription elongation.\n5. Ssu72 plays a role in mediating gene looping by interacting with the DNA and RNA involved in the loop.",
    "vicuna-7b_fact": [
      "Ssu72 is a protein that regulates gene expression in eukaryotes.",
      "It is a component of the RNA polymerase II (RNAPII) complex.",
      "The RNA polymerase II (RNAPII) complex is responsible for transcribing DNA into RNA.",
      "Ssu72 is involved in the process of transcription elongation.",
      "Ssu72 plays a role in mediating gene looping by interacting with the DNA and RNA involved in the loop."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2081,
    "user_query": "What is the Glasgow Coma score?",
    "vicuna-7b_response": "The Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness in a person following a head injury or other neurological event. It is based on a person's eye opening, verbal response, and motor response. The GCS is scored on a scale of 3 to 15, with higher scores indicating a better level of consciousness. The GCS is widely used in emergency departments and intensive care units to quickly assess the severity of head injury and guide treatment decisions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness following a head injury or other neurological event.\n2. The Glasgow Coma Scale is based on a person's eye opening, verbal response, and motor response.\n3. The Glasgow Coma Scale is scored on a scale of 3 to 15.\n4. Higher scores on the Glasgow Coma Scale indicate a better level of consciousness.\n5. The GCS is widely used in emergency departments and intensive care units.",
    "vicuna-7b_fact": [
      "The Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness following a head injury or other neurological event.",
      "The Glasgow Coma Scale is based on a person's eye opening, verbal response, and motor response.",
      "The Glasgow Coma Scale is scored on a scale of 3 to 15.",
      "Higher scores on the Glasgow Coma Scale indicate a better level of consciousness.",
      "The GCS is widely used in emergency departments and intensive care units."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2083,
    "user_query": "Which is the main cause of the Patau syndrome?",
    "vicuna-7b_response": "Patau syndrome, also known as trisomy 18, is a genetic disorder caused by an extra copy of chromosome 18 in the body's cells. This extra copy results in the development of abnormalities in various organs and systems in the body, leading to the symptoms associated with the condition.\nThe main cause of Patau syndrome is a problem during the formation of the sperm or egg that results in the extra copy of chromosome 18. This can occur due to a variety of factors, including genetic mutations, environmental factors, or a combination of both.\nIn some cases, Patau syndrome can be caused by a problem during the formation of the placenta, which can result in the extra copy of chromosome 18 being present in the developing fetus.\nIt's important to note that Patau syndrome is a rare condition, affecting approximately 1 in every 5,000 live births. If you have concerns about Patau syndrome or any other genetic disorder, it's important to speak with a healthcare professional for further guidance and support.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Patau syndrome, also known as trisomy 18, is caused by an extra copy of chromosome 18 in the body's cells.\n2. This extra chromosome copy in Patau syndrome can be due to a problem during the formation of the sperm or egg.\n3. In some cases, Patau syndrome can be caused by a problem during the formation of the placenta.\n4. Patau syndrome is a rare condition, affecting approximately 1 in every 5,000 live births.\n5. Genetic mutations and environmental factors can contribute to the occurrence of Patau syndrome.",
    "vicuna-7b_fact": [
      "Patau syndrome, also known as trisomy 18, is caused by an extra copy of chromosome 18 in the body's cells.",
      "This extra chromosome copy in Patau syndrome can be due to a problem during the formation of the sperm or egg.",
      "In some cases, Patau syndrome can be caused by a problem during the formation of the placenta.",
      "Patau syndrome is a rare condition, affecting approximately 1 in every 5,000 live births.",
      "Genetic mutations and environmental factors can contribute to the occurrence of Patau syndrome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Patau syndrome, also known as trisomy 13, is caused by an extra copy of chromosome 13 in the body's cells.\n2. TRUE\n3. FALSE [correction]: Patau syndrome is not typically caused by problems during the formation of the placenta. It is generally due to a problem during the formation of the sperm or egg.\n4. FALSE [correction]: Patau syndrome is a rare condition, affecting approximately 1 in every 10,000 to 21,700 live births.\n5. FALSE [correction]: Patau syndrome is not attributed to genetic mutations or environmental factors. It is typically caused by an extra chromosome 13 due to a random event during the formation of the reproductive cells.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2085,
    "user_query": "Is Musclin a secretory peptide?",
    "vicuna-7b_response": "Musclin is a peptide hormone that is primarily produced by the muscle cells. It is a 25-amino acid peptide that is encoded by the musclin gene. Musclin is a member of the relaxin family of peptides, which also includes relaxin, insulin-like growth factor-1, and activin.\nMusclin is primarily produced by the muscle cells in response to muscle contraction and exercise. It is released into the bloodstream and acts on various tissues, including the liver, adipose tissue, and muscle tissue.\nMusclin has several functions in the body. It has been shown to regulate glucose metabolism and insulin sensitivity, and it may also play a role in muscle growth and repair. It has also been shown to have anti-inflammatory properties and to promote the growth and differentiation of muscle cells.\nIn summary, Musclin is a secretory peptide that is primarily produced by the muscle cells in response to muscle contraction and exercise. It acts on various tissues and has several functions in the body, including regulating glucose metabolism, insulin sensitivity, muscle growth and repair, and anti-inflammatory properties.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Musclin is a peptide hormone primarily produced by muscle cells.\n2. Musclin is a 25-amino acid peptide that is encoded by the musclin gene.\n3. Musclin is a member of the relaxin family of peptides.\n4. Musclin is produced in response to muscle contraction and exercise, and is released into the bloodstream.\n5. Musclin helps regulate glucose metabolism, insulin sensitivity, and has anti-inflammatory properties.",
    "vicuna-7b_fact": [
      "Musclin is a peptide hormone primarily produced by muscle cells.",
      "Musclin is a 25-amino acid peptide that is encoded by the musclin gene.",
      "Musclin is a member of the relaxin family of peptides.",
      "Musclin is produced in response to muscle contraction and exercise, and is released into the bloodstream.",
      "Musclin helps regulate glucose metabolism, insulin sensitivity, and has anti-inflammatory properties."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Musclin is not a member of the relaxin family of peptides. It is an exercise-induced myokine encoded by the MUSC gene in muscles.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2091,
    "user_query": "What happens to H2AX upon DNA bouble strand breaks?",
    "vicuna-7b_response": "H2AX is a protein that is involved in the repair of DNA double-strand breaks (DSBs). When a DSB occurs, H2AX becomes phosphorylated on its serine residue, which serves as a marker for the presence of a DSB. This phosphorylation event triggers a series of events that lead to the recruitment of repair machinery to the break site.\nThe phosphorylated form of H2AX, known as γH2AX, can also interact with other proteins, such as 53BP1 and BRCA1, to form complexes that help to coordinate the repair of DSBs. These complexes may also play a role in the recognition and repair of other types of DNA damage, such as single-strand breaks and base damage.\nOverall, H2AX plays a critical role in the response to DNA damage and in the repair of DNA breaks.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. H2AX is a protein that is involved in the repair of DNA double-strand breaks (DSBs).\n2. When a DNA double-strand break occurs, H2AX becomes phosphorylated on its serine residue.\n3. The phosphorylation on H2AX serves as a marker for the presence of a DSB.\n4. The phosphorylated form of H2AX, known as γH2AX, can interact with other proteins such as 53BP1 and BRCA1 to form complexes that help repair DSBs.\n5. H2AX plays a critical role in the response to DNA damage and in the repair of DNA breaks.",
    "vicuna-7b_fact": [
      "H2AX is a protein that is involved in the repair of DNA double-strand breaks (DSBs).",
      "When a DNA double-strand break occurs, H2AX becomes phosphorylated on its serine residue.",
      "The phosphorylation on H2AX serves as a marker for the presence of a DSB.",
      "The phosphorylated form of H2AX, known as γH2AX, can interact with other proteins such as 53BP1 and BRCA1 to form complexes that help repair DSBs.",
      "H2AX plays a critical role in the response to DNA damage and in the repair of DNA breaks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2095,
    "user_query": "What is the inheritance of Barth syndrome?",
    "vicuna-7b_response": "Barth syndrome is an inherited disorder caused by a deficiency of the protein cardiolipin. Cardiolipin is a key component of the inner membrane of mitochondria, and its deficiency leads to a range of symptoms, including heart problems, muscle weakness, and fatigue.\nBarth syndrome is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the gene (one from each parent) to develop the disorder. The gene responsible for Barth syndrome is located on chromosome 10 and is called the BTHS gene.\nPeople with Barth syndrome have a deficiency of the protein cardiolipin, which is essential for the proper functioning of the mitochondria. Mitochondria are the energy-producing organelles in cells, and they rely on cardiolipin to generate ATP, the energy molecule that powers cellular processes. Without enough cardiolipin, the mitochondria cannot function properly, leading to a range of symptoms.\nIn summary, Barth syndrome is an inherited disorder caused by a deficiency of the protein cardiolipin, which is essential for the proper functioning of the mitochondria. It is inherited in an autosomal recessive pattern, and people with the disorder have a deficiency of cardiolipin.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Barth syndrome is an inherited disorder caused by a deficiency of the protein cardiolipin.\n2. The gene responsible for Barth syndrome is located on chromosome 10 and is called the BTHS gene.\n3. Barth syndrome is inherited in an autosomal recessive pattern.\n4. People with Barth syndrome have a deficiency of the protein cardiolipin.\n5. Mitochondria, the energy-producing organelles in cells, rely on cardiolipin to generate ATP, the energy molecule.",
    "vicuna-7b_fact": [
      "Barth syndrome is an inherited disorder caused by a deficiency of the protein cardiolipin.",
      "The gene responsible for Barth syndrome is located on chromosome 10 and is called the BTHS gene.",
      "Barth syndrome is inherited in an autosomal recessive pattern.",
      "People with Barth syndrome have a deficiency of the protein cardiolipin.",
      "Mitochondria, the energy-producing organelles in cells, rely on cardiolipin to generate ATP, the energy molecule."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Barth syndrome is caused by mutations in the TAZ gene which is located on the X chromosome, not chromosome 10.\n3. FALSE [correction]: Barth syndrome is inherited in an X-linked recessive pattern, not autosomal recessive. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2096,
    "user_query": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals",
    "vicuna-7b_response": "Cryptococcus neoformans is a type of fungus that can cause serious infections in immunocompromised individuals, including skin infections. However, it is not a common cause of skin infections in immunocompromised individuals.\nCryptococcus neoformans is primarily known for causing meningitis and other central nervous system infections in immunocompromised individuals, such as those with HIV/AIDS. The fungus can also cause infections in other parts of the body, such as the lungs, bones, and skin.\nWhile skin infections caused by Cryptococcus neoformans are possible, they are relatively rare. In immunocompromised individuals, other fungal infections, such as those caused by Candida species, are more common causes of skin infections.\nIf you are experiencing a skin infection and are immunocompromised, it is important to seek medical attention promptly. Your healthcare provider will be able to determine the cause of your infection and provide appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cryptococcus neoformans is a type of fungus that can cause serious infections in immunocompromised individuals.\n2. Cryptococcus neoformans is primarily known for causing meningitis and other central nervous system infections in immunocompromised individuals.\n3. Cryptococcus neoformans can also cause infections in other parts of the body, such as the lungs, bones, and skin.\n4. Skin infections caused by Cryptococcus neoformans in immunocompromised individuals are relatively rare.\n5. Other fungal infections, such as those caused by Candida species, are more common causes of skin infections in immunocompromised individuals.",
    "vicuna-7b_fact": [
      "Cryptococcus neoformans is a type of fungus that can cause serious infections in immunocompromised individuals.",
      "Cryptococcus neoformans is primarily known for causing meningitis and other central nervous system infections in immunocompromised individuals.",
      "Cryptococcus neoformans can also cause infections in other parts of the body, such as the lungs, bones, and skin.",
      "Skin infections caused by Cryptococcus neoformans in immunocompromised individuals are relatively rare.",
      "Other fungal infections, such as those caused by Candida species, are more common causes of skin infections in immunocompromised individuals."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2098,
    "user_query": "What are sirtuins?",
    "vicuna-7b_response": "Sirtuins are a family of enzymes that regulate cellular metabolism and play a role in the aging process. They are NAD+-dependent deacetylases, meaning they remove acetyl groups from proteins, DNA, and RNA. Sirtuins have been shown to regulate a variety of cellular processes, including metabolism, inflammation, and stress response. They are also involved in the regulation of gene expression and have been implicated in the prevention of age-related diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sirtuins are a family of enzymes that regulate cellular metabolism.\n2. Sirtuins play a role in the aging process.\n3. Sirtuins are NAD+-dependent deacetylases.\n4. Sirtuins can regulate metabolism, inflammation, and stress response in cells.\n5. Sirtuins are involved in the regulation of gene expression and may help in the prevention of age-related diseases.",
    "vicuna-7b_fact": [
      "Sirtuins are a family of enzymes that regulate cellular metabolism.",
      "Sirtuins play a role in the aging process.",
      "Sirtuins are NAD+-dependent deacetylases.",
      "Sirtuins can regulate metabolism, inflammation, and stress response in cells.",
      "Sirtuins are involved in the regulation of gene expression and may help in the prevention of age-related diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2100,
    "user_query": "Which technique led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C?",
    "vicuna-7b_response": "The technique that led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C is gene knockdown.\nHOXD10 is a homeobox transcription factor that plays a critical role in the development and function of lymphatic vessels. Researchers used RNA interference to knockdown HOXD10 expression in lymphatic endothelial cells and found that this led to an increase in lymphatic vessel formation and a decrease in lymphatic vessel maturation. These results suggest that HOXD10 plays a role in regulating lymphatic endothelial responses to VEGF-C, a key regulator of lymphatic vessel formation and maturation.\nOverall, this study highlights the importance of HOXD10 in regulating lymphatic endothelial responses to VEGF-C and provides new insights into the mechanisms underlying lymphatic vessel formation and maturation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was elucidated using the gene knockdown technique.\n2. HOXD10 is a homeobox transcription factor that plays a critical role in the development and function of lymphatic vessels.\n3. The researchers used RNA interference to knockdown HOXD10 expression in lymphatic endothelial cells.\n4. The knockdown of HOXD10 led to an increase in lymphatic vessel formation and a decrease in lymphatic vessel maturation.\n5. VEGF-C is a key regulator of lymphatic vessel formation and maturation.",
    "vicuna-7b_fact": [
      "The role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was elucidated using the gene knockdown technique.",
      "HOXD10 is a homeobox transcription factor that plays a critical role in the development and function of lymphatic vessels.",
      "The researchers used RNA interference to knockdown HOXD10 expression in lymphatic endothelial cells.",
      "The knockdown of HOXD10 led to an increase in lymphatic vessel formation and a decrease in lymphatic vessel maturation.",
      "VEGF-C is a key regulator of lymphatic vessel formation and maturation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2101,
    "user_query": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?",
    "vicuna-7b_response": "Obeticholic acid is a medication that is used to treat a condition called primary biliary cholangitis (PBC). PBC is a chronic autoimmune disorder that affects the liver and causes inflammation and damage to the bile ducts. Obeticholic acid works by blocking a protein called farnesoid X receptor (FXR), which is involved in regulating the production of bile in the liver. By blocking FXR, obeticholic acid can help to reduce inflammation and damage to the bile ducts in PBC.\nObeticholic acid is typically used in people with PBC who have difficulty with the traditional treatment options, such as ursodeoxycholic acid. It is also used in people who have had an inadequate response to these treatments.\nIt is important to note that obeticholic acid is not a cure for PBC, and it is not suitable for everyone with the condition. It is important to consult with a healthcare professional before starting treatment with obeticholic acid to determine if it is the right treatment option for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Obeticholic acid is used to treat primary biliary cholangitis (PBC).\n2. PBC is a chronic autoimmune disorder that affects the liver and causes inflammation and damage to the bile ducts.\n3. Obeticholic acid works by blocking a protein called farnesoid X receptor (FXR).\n4. FXR is involved in the regulation of bile production in the liver.\n5. Obeticholic acid is used in people with PBC who have difficulty with traditional treatments or have had an inadequate response to these treatments.",
    "vicuna-7b_fact": [
      "Obeticholic acid is used to treat primary biliary cholangitis (PBC).",
      "PBC is a chronic autoimmune disorder that affects the liver and causes inflammation and damage to the bile ducts.",
      "Obeticholic acid works by blocking a protein called farnesoid X receptor (FXR).",
      "FXR is involved in the regulation of bile production in the liver.",
      "Obeticholic acid is used in people with PBC who have difficulty with traditional treatments or have had an inadequate response to these treatments."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Obeticholic acid works by activating a protein called farnesoid X receptor (FXR).\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2102,
    "user_query": "What alternate indication has Vanoxerine been repositioned for?",
    "vicuna-7b_response": "Vanoxerine is an atypical antipsychotic medication that was originally developed and approved for the treatment of schizophrenia. However, it has since been repositioned for the treatment of bipolar disorder.\nBipolar disorder is a mental health condition characterized by episodes of mania (a period of abnormally elevated or irritable mood) and depression (a period of sadness, hopelessness, and loss of interest in activities). Vanoxerine is believed to work by blocking the action of dopamine in the brain, which can help to regulate mood and reduce symptoms of mania and depression.\nIt's important to note that Vanoxerine is not a first-line treatment for bipolar disorder, and it may not be suitable for everyone. It's important to work with a healthcare professional to determine the most appropriate treatment plan for an individual's specific needs and circumstances.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vanoxerine is an atypical antipsychotic medication.\n2. Vanoxerine was originally developed and approved for the treatment of schizophrenia.\n3. Vanoxerine has been repositioned for the treatment of bipolar disorder.\n4. Bipolar disorder is a mental health condition characterized by periods of mania and depression.\n5. Vanoxerine is not a first-line treatment for bipolar disorder.",
    "vicuna-7b_fact": [
      "Vanoxerine is an atypical antipsychotic medication.",
      "Vanoxerine was originally developed and approved for the treatment of schizophrenia.",
      "Vanoxerine has been repositioned for the treatment of bipolar disorder.",
      "Bipolar disorder is a mental health condition characterized by periods of mania and depression.",
      "Vanoxerine is not a first-line treatment for bipolar disorder."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Vanoxerine is a dopamine reuptake inhibitor, not an atypical antipsychotic medication.\n2. FALSE [correction]: Vanoxerine was originally developed as a cardiac medication, not for the treatment of schizophrenia.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2105,
    "user_query": "Does the word ovine refers to goats?",
    "vicuna-7b_response": "No, the word \"ovine\" refers to sheep or goats. It is a term used in zoology to describe animals of the family Bovidae that have a characteristic shape to their horns, which resemble the letter \"O\" when viewed from the side. Ovines are typically grazing animals that are known for their wool and are raised for meat, milk, and wool.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The term \"ovine\" refers to sheep or goats.\n2. The term is used in zoology to describe animals of the family Bovidae.\n3. Animals classified as ovine possess horns that have a characteristic shape.\n4. Ovines are typically grazing animals.\n5. Ovines are known for their wool and are raised for meat, milk, and wool.",
    "vicuna-7b_fact": [
      "The term \"ovine\" refers to sheep or goats.",
      "The term is used in zoology to describe animals of the family Bovidae.",
      "Animals classified as ovine possess horns that have a characteristic shape.",
      "Ovines are typically grazing animals.",
      "Ovines are known for their wool and are raised for meat, milk, and wool."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The term \"ovine\" refers to sheep not goats.\n2. FALSE [correction]: The term \"ovine\" is used in zoology to describe animals of the family Ovidae, which includes sheep.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-7b_response": "ARCALYST is a prescription medication used to treat adults and children with cryopyrin-associated periodic syndromes (CAPS), such as familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). It is given as an injection under the skin (subcutaneous injection) or into a muscle (intramuscular injection).\nThe main indication of ARCALYST is to reduce the frequency and severity of flares of symptoms associated with CAPS, such as fever, fatigue, and joint pain. ARCALYST works by blocking the action of a protein called interleukin-1 beta (IL-1β), which plays a role in the inflammatory response.\nIt is important to note that ARCALYST is not a cure for CAPS and may not completely eliminate all symptoms. It is also not recommended for use in people with certain medical conditions, such as a history of heart attack or stroke, or certain types of cancer.\nIt is important to consult with a healthcare provider to determine if ARCALYST is appropriate for a specific patient and to receive proper instructions on how to use the medication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ARCALYST is a prescription medication used to treat adults and children with cryopyrin-associated periodic syndromes (CAPS).\n2. CAPS include conditions like familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).\n3. ARCALYST is given as an injection under the skin (subcutaneous injection) or into a muscle (intramuscular injection).\n4. ARCALYST works by blocking the action of a protein called interleukin-1 beta (IL-1β).\n5. ARCALYST is not a cure for CAPS and may not completely eliminate all symptoms.",
    "vicuna-7b_fact": [
      "ARCALYST is a prescription medication used to treat adults and children with cryopyrin-associated periodic syndromes (CAPS).",
      "CAPS include conditions like familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).",
      "ARCALYST is given as an injection under the skin (subcutaneous injection) or into a muscle (intramuscular injection).",
      "ARCALYST works by blocking the action of a protein called interleukin-1 beta (IL-1β).",
      "ARCALYST is not a cure for CAPS and may not completely eliminate all symptoms."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ARCALYST is given as an injection under the skin (subcutaneous injection), not into a muscle (intramuscular injection).\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2114,
    "user_query": "Where is the TAZ (G4.5) is located in humans?",
    "vicuna-7b_response": "The TAZ (also known as the transcriptional coactivator with PDZ-binding motif) is a protein that is involved in regulating gene expression. It is expressed in various tissues throughout the body, but its exact location in humans can vary depending on the specific tissue and cell type.\nIn general, TAZ is found in cells of the immune system, including T cells, B cells, and macrophages. It is also expressed in certain types of cancer cells, such as breast cancer cells and prostate cancer cells.\nIn the brain, TAZ is found in neurons and glial cells, and it has been implicated in the regulation of synaptic plasticity and memory formation.\nIt is important to note that the exact location and expression patterns of TAZ can vary depending on the specific context and research study.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TAZ, also known as the transcriptional coactivator with PDZ-binding motif, is a protein that is involved in regulating gene expression.\n2. TAZ is found in cells of the immune system, including T cells, B cells, and macrophages.\n3. TAZ is expressed in certain types of cancer cells, such as breast cancer cells and prostate cancer cells.\n4. In the brain, TAZ is found in neurons and glial cells.\n5. TAZ has been implicated in the regulation of synaptic plasticity and memory formation.",
    "vicuna-7b_fact": [
      "The TAZ, also known as the transcriptional coactivator with PDZ-binding motif, is a protein that is involved in regulating gene expression.",
      "TAZ is found in cells of the immune system, including T cells, B cells, and macrophages.",
      "TAZ is expressed in certain types of cancer cells, such as breast cancer cells and prostate cancer cells.",
      "In the brain, TAZ is found in neurons and glial cells.",
      "TAZ has been implicated in the regulation of synaptic plasticity and memory formation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2115,
    "user_query": "What do nerve-associated peripheral glial progenitors give rise to?",
    "vicuna-7b_response": "Nerve-associated peripheral glial progenitors are a type of stem cell that give rise to various types of glial cells, which are non-neuronal cells that support and protect neurons in the peripheral nervous system.\nGlial cells play an important role in the function of the nervous system by providing support and protection to neurons, regulating the flow of information within the nervous system, and helping to maintain the structure of the nervous tissue.\nThe specific types of glial cells that can be derived from nerve-associated peripheral glial progenitors include oligodendrocytes, which produce the myelin sheath that insulates and protects nerve fibers in the central and peripheral nervous systems, and Schwann cells, which also produce the myelin sheath in the peripheral nervous system.\nOther types of glial cells that can be derived from nerve-associated peripheral glial progenitors include astrocytes, which are the most abundant glial cell type in the brain and spinal cord, and microglia, which are the resident immune cells of the central nervous system.\nOverall, nerve-associated peripheral glial progenitors have the potential to give rise to a wide range of glial cells that play important roles in the function and maintenance of the nervous system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nerve-associated peripheral glial progenitors are a type of stem cell that give rise to various types of glial cells.\n2. Glial cells support and protect neurons in the peripheral nervous system.\n3. Glial cells help maintain the structure of the nervous tissue.\n4. Specific types of glial cells derived from nerve-associated peripheral glial progenitors include oligodendrocytes and Schwann cells.\n5. Astrocytes are the most abundant glial cell type in the brain and spinal cord.",
    "vicuna-7b_fact": [
      "Nerve-associated peripheral glial progenitors are a type of stem cell that give rise to various types of glial cells.",
      "Glial cells support and protect neurons in the peripheral nervous system.",
      "Glial cells help maintain the structure of the nervous tissue.",
      "Specific types of glial cells derived from nerve-associated peripheral glial progenitors include oligodendrocytes and Schwann cells.",
      "Astrocytes are the most abundant glial cell type in the brain and spinal cord."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Specific types of glial cells derived from nerve-associated peripheral glial progenitors include Schwann cells. Oligodendrocytes are derived from a distinct set of progenitors in the central nervous system.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2117,
    "user_query": "Is Lennox-Gastaut Syndrome usually diagnosed in older adults?",
    "vicuna-7b_response": "Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically affects children and adolescents. However, it can also occur in adults, particularly in older adults.\nLGS is characterized by frequent, severe seizures that are difficult to control with medication. It is often accompanied by developmental delays, intellectual disability, and other neurological abnormalities.\nThe exact cause of LGS is not known, but it is believed to be related to abnormalities in brain development and function. It is often associated with genetic mutations or conditions such as tuberous sclerosis complex.\nDiagnosis of LGS typically involves a thorough medical history, physical examination, and various diagnostic tests such as electroencephalography (EEG), magnetic resonance imaging (MRI), and genetic testing.\nTreatment for LGS typically involves a combination of medications, dietary modifications, and other therapies such as vagus nerve stimulation or ketogenic diet. In some cases, surgery may be considered as a treatment option.\nIt is important to note that LGS can be a challenging condition to manage, and a multidisciplinary approach involving neurologists, epileptologists, psychologists, and other healthcare professionals may be necessary to provide comprehensive care for individuals with LGS.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically affects children and adolescents.\n2. LGS can occur in adults, particularly in older adults.\n3. Lennox-Gastaut Syndrome is characterized by frequent, severe seizures that are difficult to control with medication.\n4. Diagnosis of LGS typically involves a thorough medical history, physical examination, and various diagnostic tests.\n5. Treatment for LGS typically involves a combination of medications, dietary modifications, and other therapies.",
    "vicuna-7b_fact": [
      "Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically affects children and adolescents.",
      "LGS can occur in adults, particularly in older adults.",
      "Lennox-Gastaut Syndrome is characterized by frequent, severe seizures that are difficult to control with medication.",
      "Diagnosis of LGS typically involves a thorough medical history, physical examination, and various diagnostic tests.",
      "Treatment for LGS typically involves a combination of medications, dietary modifications, and other therapies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: LGS is primarily a disorder of childhood but continues into adulthood, it is not particularly associated with older adults.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2119,
    "user_query": "Describe ATR-16 syndrome.",
    "vicuna-7b_response": "ATR-16 syndrome is a rare genetic disorder caused by mutations in the ATR gene. The ATR gene provides instructions for making a protein called ATR, which plays a critical role in maintaining the structure of chromosomes.\nIndividuals with ATR-16 syndrome typically have a range of physical and developmental problems, including intellectual disability, delayed development, and growth delay. They may also have distinctive facial features, such as a broad forehead, a flat nasal bridge, and a small jaw.\nOther common symptoms of ATR-16 syndrome include hearing loss, vision problems, and abnormalities of the hands and feet, such as webbed or missing fingers and toes. Some individuals with the condition may also have heart defects or other structural abnormalities.\nATR-16 syndrome is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene (one from each parent) to develop the condition. There is no cure for ATR-16 syndrome, and treatment is focused on managing the symptoms and addressing any specific issues that arise.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ATR-16 syndrome is a rare genetic disorder caused by mutations in the ATR gene.\n2. The ATR gene provides instructions for making a protein called ATR, which plays a critical role in maintaining the structure of chromosomes.\n3. Common symptoms of ATR-16 syndrome include intellectual disability, delayed development, growth delay, distinctive facial features, hearing loss, vision problems, and abnormalities of hands and feet.\n4. Some individuals with ATR-16 syndrome may have heart defects or other structural abnormalities.\n5. ATR-16 syndrome is inherited in an autosomal recessive pattern, and treatment focuses on managing the symptoms and addressing any specific issues that arise.",
    "vicuna-7b_fact": [
      "ATR-16 syndrome is a rare genetic disorder caused by mutations in the ATR gene.",
      "The ATR gene provides instructions for making a protein called ATR, which plays a critical role in maintaining the structure of chromosomes.",
      "Common symptoms of ATR-16 syndrome include intellectual disability, delayed development, growth delay, distinctive facial features, hearing loss, vision problems, and abnormalities of hands and feet.",
      "Some individuals with ATR-16 syndrome may have heart defects or other structural abnormalities.",
      "ATR-16 syndrome is inherited in an autosomal recessive pattern, and treatment focuses on managing the symptoms and addressing any specific issues that arise."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2120,
    "user_query": "What is the results of inactivated ANGPLT3?",
    "vicuna-7b_response": "Angiopoietin-like 3 (ANGPTL3) is a protein that plays a role in regulating triglyceride metabolism in the body. When ANGPTL3 is inactivated, it can lead to an increase in triglyceride levels in the blood. This can have a number of potential effects on the body, including increasing the risk of cardiovascular disease.\nInactivation of ANGPTL3 can occur through a number of mechanisms, including genetic mutations that result in a loss of function of the protein. In some cases, inactivation of ANGPTL3 may be the result of pharmacological intervention, such as the use of drugs that inhibit the activity of the protein.\nOverall, the effects of inactivated ANGPTL3 on the body will depend on the specific circumstances and the degree to which the protein is inactivated. In some cases, inactivation of ANGPTL3 may be beneficial, while in other cases it may be harmful. It is important to consult with a healthcare professional for guidance on the potential effects of inactivated ANGPTL3 on the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Angiopoietin-like 3 (ANGPTL3) is a protein involved in regulating triglyceride metabolism in the body.\n2. Inactivation of ANGPTL3 can lead to an increase in triglyceride levels in the blood.\n3. Increased triglyceride levels can heighten the risk of cardiovascular disease.\n4. Inactivation of ANGPTL3 can occur through genetic mutations or pharmacological interventions.\n5. The specific effects of inactivated ANGPTL3 on the body will depend on the individual circumstances and the degree of inactivation.",
    "vicuna-7b_fact": [
      "Angiopoietin-like 3 (ANGPTL3) is a protein involved in regulating triglyceride metabolism in the body.",
      "Inactivation of ANGPTL3 can lead to an increase in triglyceride levels in the blood.",
      "Increased triglyceride levels can heighten the risk of cardiovascular disease.",
      "Inactivation of ANGPTL3 can occur through genetic mutations or pharmacological interventions.",
      "The specific effects of inactivated ANGPTL3 on the body will depend on the individual circumstances and the degree of inactivation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Inactivation of ANGPTL3 can lead to a decrease in triglyceride levels in the blood.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2127,
    "user_query": "Which deep learning-based algorithms are used for enhancer prediction?",
    "vicuna-7b_response": "Deep learning-based algorithms are increasingly being used for enhancer prediction, as they have shown promising results in recent years. Some of the commonly used deep learning-based algorithms for enhancer prediction include:\n1. Convolutional Neural Networks (CNNs): CNNs are a type of deep learning algorithm that are particularly well-suited for image and signal processing tasks. They have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n2. Recurrent Neural Networks (RNNs): RNNs are a type of deep learning algorithm that are particularly well-suited for processing sequential data. They have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n3. Long Short-Term Memory (LSTM) Networks: LSTMs are a type of RNN that are particularly well-suited for processing long-term dependencies in data. They have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n4. Generative Adversarial Networks (GANs): GANs are a type of deep learning algorithm that are particularly well-suited for generating new data that resembles existing data. They have been used for enhancer prediction by generating new genomic data that contains potential enhancers.\n5. Transformers: Transformers are a type of deep learning algorithm that are particularly well-suited for processing sequential data. They have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhers.\nThese are just a few examples of the deep learning-based algorithms that are used for enhancer prediction. The choice of algorithm will depend on the specific characteristics of the genomic data being analyzed and the desired level of accuracy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Deep learning-based algorithms are used for enhancer prediction.\n2. Convolutional Neural Networks (CNNs) have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n3. Recurrent Neural Networks (RNNs) have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n4. Long Short-Term Memory (LSTM) Networks have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.\n5. Generative Adversarial Networks (GANs) have been used for enhancer prediction by generating new genomic data that contains potential enhancers.\n6. Transformers have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.",
    "vicuna-7b_fact": [
      "Deep learning-based algorithms are used for enhancer prediction.",
      "Convolutional Neural Networks (CNNs) have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.",
      "Recurrent Neural Networks (RNNs) have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.",
      "Long Short-Term Memory (LSTM) Networks have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers.",
      "Generative Adversarial Networks (GANs) have been used for enhancer prediction by generating new genomic data that contains potential enhancers.",
      "Transformers have been used for enhancer prediction by processing genomic data to identify patterns that correspond to enhancers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2128,
    "user_query": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?",
    "vicuna-7b_response": "Yes, Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin. Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen. The disorder is caused by a mutation or deletion in the gene that codes for beta globin, one of the two proteins that make up hemoglobin.\nThe mutation or deletion in the beta globin gene results in the production of abnormal beta globin chains, which are not functional and cannot bind to the normal alpha globin chains. This leads to the accumulation of abnormal beta globin chains in the red blood cells, which are eventually destroyed by the body, resulting in anemia.\nThere are several types of Beta-Thalassemia, and the severity of the disorder depends on the type and the number of mutations or deletions in the beta globin gene. Some people with Beta-Thalassemia may have mild anemia and require no treatment, while others may require regular blood transfusions and other medical interventions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for beta globin.\n2. Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin.\n3. The mutation or deletion in the beta globin gene results in the production of abnormal beta globin chains.\n4. The accumulation of abnormal beta globin chains in the red blood cells can result in anemia.\n5. There are several types of Beta-Thalassemia, and the severity of the disorder depends on the type and the number of mutations or deletions in the beta globin gene.",
    "vicuna-7b_fact": [
      "Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for beta globin.",
      "Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin.",
      "The mutation or deletion in the beta globin gene results in the production of abnormal beta globin chains.",
      "The accumulation of abnormal beta globin chains in the red blood cells can result in anemia.",
      "There are several types of Beta-Thalassemia, and the severity of the disorder depends on the type and the number of mutations or deletions in the beta globin gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The mutation or deletion in the beta globin gene results in reduced production or absence of beta globin chains. This causes an imbalance in the ratio between alpha and beta globin, causing the excess alpha globin to precipitate and damage the red blood cells, leading to anemia.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2132,
    "user_query": "What is the mechanism of action of Romosozumab?",
    "vicuna-7b_response": "Romosozumab is a monoclonal antibody that targets and inhibits the activity of sclerostin, a protein that regulates bone formation and growth. By inhibiting sclerostin, romosozumab increases the production of osteoblasts, the cells responsible for bone formation, and enhances the activity of osteoclasts, the cells responsible for bone resorption. This leads to an increase in bone formation and a decrease in bone resorption, resulting in an overall increase in bone mineral density (BMD) and a reduction in the risk of fractures. Romosozumab is primarily used for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Romosozumab is a monoclonal antibody that targets and inhibits the activity of sclerostin.\n2. Sclerostin is a protein that regulates bone formation and growth.\n3. Romosozumab increases the production of osteoblasts, which are responsible for bone formation.\n4. It also enhances the activity of osteoclasts, the cells responsible for bone absorption.\n5. Romosozumab is used for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture.",
    "vicuna-7b_fact": [
      "Romosozumab is a monoclonal antibody that targets and inhibits the activity of sclerostin.",
      "Sclerostin is a protein that regulates bone formation and growth.",
      "Romosozumab increases the production of osteoblasts, which are responsible for bone formation.",
      "It also enhances the activity of osteoclasts, the cells responsible for bone absorption.",
      "Romosozumab is used for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Romosozumab actually inhibits the activity of osteoclasts, the cells responsible for bone absorption.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2134,
    "user_query": "What is the function of the Mis18 protein?",
    "vicuna-7b_response": "Mis18 is a protein that plays a critical role in the DNA replication process in eukaryotes. It is a component of the replication machinery and is involved in the initiation and elongation stages of DNA replication.\nDuring the initiation stage, Mis18 helps to recruit the replication machinery to the origins of replication, which are the regions on the DNA where replication begins. It does this by interacting with other proteins, such as Cdc45 and Mcm proteins, which are also involved in the initiation of DNA replication.\nDuring the elongation stage, Mis18 helps to hold the replication fork, which is the region on the DNA where the replication process occurs, open. This is important because the replication fork needs to be open in order for the replication machinery to be able to access the DNA and synthesize new DNA strands.\nIn addition to its role in the initiation and elongation stages of DNA replication, Mis18 has also been shown to play a role in the repair of damaged DNA. It has been shown to interact with other proteins involved in DNA repair, such as Rad51 and Rad54, and to help recruit these proteins to sites of DNA damage.\nOverall, Mis18 is an important protein that plays a critical role in the DNA replication process in eukaryotes. Its ability to recruit the replication machinery to the origins of replication, hold the replication fork open, and participate in DNA repair makes it an essential component of the replication process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mis18 is a protein that plays a critical role in the DNA replication process in eukaryotes.\n2. Mis18 is involved in the initiation and elongation stages of DNA replication.\n3. During the initiation stage, Mis18 helps to recruit the replication machinery to the origins of replication.\n4. In the elongation stage, Mis18 helps hold the replication fork open.\n5. Mis18 plays a role in the repair of damaged DNA and helps recruit proteins such as Rad51 and Rad54 to sites of DNA damage.",
    "vicuna-7b_fact": [
      "Mis18 is a protein that plays a critical role in the DNA replication process in eukaryotes.",
      "Mis18 is involved in the initiation and elongation stages of DNA replication.",
      "During the initiation stage, Mis18 helps to recruit the replication machinery to the origins of replication.",
      "In the elongation stage, Mis18 helps hold the replication fork open.",
      "Mis18 plays a role in the repair of damaged DNA and helps recruit proteins such as Rad51 and Rad54 to sites of DNA damage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2135,
    "user_query": "Are hepadnaviral minichromosomes free of nucleosomes?",
    "vicuna-7b_response": "Hepadnaviral minichromosomes are not free of nucleosomes.\nHepadnaviral minichromosomes are small, circular DNA molecules that are present in the genomes of hepadnaviruses, which are a group of viruses that infect animals and humans. These minichromosomes are composed of a single-stranded DNA molecule that is approximately 10-15 kilobases in length and contains a small number of genes that are required for viral replication and gene expression.\nWhile hepadnaviral minichromosomes are relatively small compared to the size of the entire viral genome, they still contain a number of regulatory elements, including enhancers, silencers, and promoters, that are involved in the control of gene expression. One of the regulatory elements that is present on hepadnaviral minichromosomes is the nucleosome, which is a basic unit of chromatin that consists of a histone protein complex wrapped around a DNA molecule.\nTherefore, while hepadnaviral minichromosomes are not completely free of nucleosomes, they do contain a small number of these regulatory elements that are involved in the control of gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hepadnaviral minichromosomes are not free of nucleosomes.\n2. Hepadnaviral minichromosomes are small, circular DNA molecules that are present in the genomes of hepadnaviruses.\n3. Hepadnaviruses are a group of viruses that infect animals and humans.\n4. These minichromosomes are composed of a single-stranded DNA molecule that is approximately 10-15 kilobases in length and contains a small number of genes required for viral replication and gene expression.\n5. The regulatory elements present on hepadnaviral minichromosomes include enhancers, silencers, promoters, and nucleosomes.",
    "vicuna-7b_fact": [
      "Hepadnaviral minichromosomes are not free of nucleosomes.",
      "Hepadnaviral minichromosomes are small, circular DNA molecules that are present in the genomes of hepadnaviruses.",
      "Hepadnaviruses are a group of viruses that infect animals and humans.",
      "These minichromosomes are composed of a single-stranded DNA molecule that is approximately 10-15 kilobases in length and contains a small number of genes required for viral replication and gene expression.",
      "The regulatory elements present on hepadnaviral minichromosomes include enhancers, silencers, promoters, and nucleosomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hepadnaviral minichromosomes are composed of a double-stranded DNA molecule that is approximately 3.2 kilobases in length and contains a small number of genes required for viral replication and gene expression.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2136,
    "user_query": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on chromosome 5?",
    "vicuna-7b_response": "Cri Du Chat syndrome is a genetic disorder caused by a deletion or mutation in the 5q13.3 region of the genome, which includes the TCF4 gene. The TCF4 gene is located on the long (q) arm of chromosome 5 and is responsible for encoding a transcription factor that plays a critical role in the development of the central nervous system.\nThe Cri Du Chat syndrome is characterized by a wide range of physical and developmental abnormalities, including intellectual disability, small stature, low-set ears, abnormal facial features, and a high-pitched cry (the \"cri du chat\" or \"cat's cry\") that is often heard in newborns.\nThe deletion or mutation in the TCF4 gene leads to a loss of function of the TCF4 protein, which results in the development of the characteristic features of Cri Du Chat syndrome. The deletion or mutation can occur in any part of the TCF4 gene, and the size and location of the deletion or mutation can vary from one person to another.\nIn some cases, the deletion or mutation in the TCF4 gene can be associated with an expansion of a repeat in the gene. This is known as a copy number variation (CNV). A CNV can occur in the TCF4 gene itself or in the surrounding region, and it can range in size from a few repeat units to thousands of repeat units.\nThe presence of a CNV in the TCF4 gene or in the surrounding region does not necessarily mean that a person will develop Cri Du Chat syndrome. However, it can increase the risk of developing the disorder, and it can also affect the severity of the symptoms.\nIn summary, Cri Du Chat syndrome is caused by a deletion or mutation in the TCF4 gene, which is located on chromosome 5. The deletion or mutation leads to a loss of function of the TCF4 protein and results in the characteristic features of the disorder. In some cases, the deletion or mutation can be associated with an expansion of a repeat in the gene, which is known as a CNV. The presence of a CNV can increase the risk of developing Cri Du Chat syndrome and can also",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cri Du Chat syndrome is a genetic disorder caused by a deletion or mutation in the 5q13.3 region of the genome, which includes the TCF4 gene.\n2. The TCF4 gene is located on the long (q) arm of chromosome 5 and is responsible for encoding a transcription factor that plays a critical role in the development of the central nervous system.\n3. The deletion or mutation in the TCF4 gene leads to a loss of function of the TCF4 protein, which results in the development of the characteristic features of Cri Du Chat syndrome.\n4. The deletion or mutation in the TCF4 gene can be associated with an expansion of a repeat in the gene, known as a copy number variation (CNV). \n5. The presence of a CNV in the TCF4 gene or the surrounding region can increase the risk of developing Cri Du Chat syndrome.",
    "vicuna-7b_fact": [
      "Cri Du Chat syndrome is a genetic disorder caused by a deletion or mutation in the 5q13.3 region of the genome, which includes the TCF4 gene.",
      "The TCF4 gene is located on the long (q) arm of chromosome 5 and is responsible for encoding a transcription factor that plays a critical role in the development of the central nervous system.",
      "The deletion or mutation in the TCF4 gene leads to a loss of function of the TCF4 protein, which results in the development of the characteristic features of Cri Du Chat syndrome.",
      "The deletion or mutation in the TCF4 gene can be associated with an expansion of a repeat in the gene, known as a copy number variation (CNV).",
      "The presence of a CNV in the TCF4 gene or the surrounding region can increase the risk of developing Cri Du Chat syndrome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cri Du Chat syndrome is a genetic disorder caused by a deletion on the short (p) arm of chromosome 5, not the 5q13.3 region which includes the TCF4 gene.\n2. TRUE\n3. FALSE [correction]: The deletion or mutation in the TCF4 gene is associated with Pitt-Hopkins syndrome, not Cri Du Chat syndrome.\n4. UNKNOWN\n5. FALSE [correction]: A CNV in the TCF4 gene or the surrounding region can increase the risk of developing Pitt-Hopkins syndrome, not Cri Du Chat syndrome.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2141,
    "user_query": "Is osteocrin expressed exclusively in the bone?",
    "vicuna-7b_response": "Osteocrin is a protein that is expressed exclusively in the bone. It is a member of the bone morphogenetic protein (BMP) family and plays a critical role in the development and maintenance of bone.\nOsteocrin is produced by osteoblasts, the cells responsible for bone formation, and is involved in the regulation of bone growth and remodeling. It binds to and activates the BMP receptor II, which then signals through the phosphatidylinositol 3-kinase (PI3K)/Akt pathway to promote the differentiation and proliferation of osteoblasts.\nIn addition to its role in bone development and remodeling, osteocrin has also been implicated in the regulation of bone mass and the prevention of bone loss. It has been shown to promote the differentiation of osteoclasts, the cells responsible for breaking down bone, and to inhibit their activity.\nOverall, osteocrin is an important protein in the regulation of bone growth and remodeling, and its dysregulation has been implicated in the development of bone diseases such as osteoporosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Osteocrin is a protein that is expressed exclusively in the bone.\n2. Osteocrin is a member of the bone morphogenetic protein (BMP) family.\n3. Osteocrin is produced by osteoblasts, the cells responsible for bone formation.\n4. Osteocrin binds to and activates the BMP receptor II, which then signals through the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.\n5. Dysregulation of osteocrin has been implicated in the development of bone diseases such as osteoporosis.",
    "vicuna-7b_fact": [
      "Osteocrin is a protein that is expressed exclusively in the bone.",
      "Osteocrin is a member of the bone morphogenetic protein (BMP) family.",
      "Osteocrin is produced by osteoblasts, the cells responsible for bone formation.",
      "Osteocrin binds to and activates the BMP receptor II, which then signals through the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.",
      "Dysregulation of osteocrin has been implicated in the development of bone diseases such as osteoporosis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Osteocrin is a protein that is not only expressed in the bone, but also in other tissues like the muscle and heart.\n2. FALSE [correction]: Osteocrin is not a member of the bone morphogenetic protein (BMP) family, but it's a secreted natriuretic peptide family.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2142,
    "user_query": "What is  Achondroplasia?",
    "vicuna-7b_response": "Achondroplasia is a genetic disorder that affects bone growth and development. It is the most common form of short-limbed dwarfism, affecting approximately 1 in every 25,000 births worldwide.\nPeople with achondroplasia have short limbs and a disproportionately large head compared to their body. They also have a characteristic facial appearance, including a flat face, wide forehead, and prominent jaw.\nThe disorder is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which is responsible for regulating bone growth. This mutation results in the production of an abnormal protein that interferes with normal bone development.\nAchondroplasia is typically diagnosed at birth or in early childhood. There is no cure for the disorder, but treatment can help manage the symptoms and improve quality of life. This may include physical therapy, orthopedic braces, and surgery.\nIt is important to note that people with achondroplasia are otherwise healthy and have normal intelligence. They can lead full and active lives with appropriate support and accommodations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is a genetic disorder that affects bone growth and development.\n2. Achondroplasia is the most common form of short-limbed dwarfism, affecting approximately 1 in every 25,000 births worldwide.\n3. Achondroplasia results in a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene which regulates bone growth.\n4. Achondroplasia is typically diagnosed at birth or in early childhood and noticeable symptoms include short limbs, large head, flat face, wide forehead, and prominent jaw.\n5. There is currently no cure for achondroplasia, but the symptoms can be managed with treatment options like physical therapy, orthopedic braces, and surgery.",
    "vicuna-7b_fact": [
      "Achondroplasia is a genetic disorder that affects bone growth and development.",
      "Achondroplasia is the most common form of short-limbed dwarfism, affecting approximately 1 in every 25,000 births worldwide.",
      "Achondroplasia results in a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene which regulates bone growth.",
      "Achondroplasia is typically diagnosed at birth or in early childhood and noticeable symptoms include short limbs, large head, flat face, wide forehead, and prominent jaw.",
      "There is currently no cure for achondroplasia, but the symptoms can be managed with treatment options like physical therapy, orthopedic braces, and surgery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2156,
    "user_query": "Do circRNAs remain untranslated?",
    "vicuna-7b_response": "Circular RNAs (circRNAs) are a type of non-coding RNA that are produced from a single strand of RNA that is repeatedly looped back onto itself. Unlike most non-coding RNAs, circRNAs are not translated into proteins. Instead, they are thought to play a role in RNA stability and localization, and they have been implicated in a variety of cellular processes, including gene regulation, cellular metabolism, and cellular stress response.\nWhile some circRNAs may be translated into proteins under certain conditions, it is generally thought that the majority of circRNAs are not translated. Instead, they are thought to function as RNA molecules, potentially interacting with other RNA molecules and proteins to regulate gene expression.\nOverall, circRNAs are an exciting area of research, and their role in cellular processes is still being explored. While it is not yet fully understood, it is clear that circRNAs play an important role in regulating gene expression and cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Circular RNAs (circRNAs) are a type of non-coding RNA that are produced from a single strand of RNA that is looped back onto itself.\n2. CircRNAs are not typically translated into proteins.\n3. CircRNAs are thought to play a role in RNA stability and localization.\n4. CircRNAs have been implicated in a variety of cellular processes, including gene regulation, cellular metabolism, and cellular stress response.\n5. Some circRNAs may be translated into proteins under certain conditions.",
    "vicuna-7b_fact": [
      "Circular RNAs (circRNAs) are a type of non-coding RNA that are produced from a single strand of RNA that is looped back onto itself.",
      "CircRNAs are not typically translated into proteins.",
      "CircRNAs are thought to play a role in RNA stability and localization.",
      "CircRNAs have been implicated in a variety of cellular processes, including gene regulation, cellular metabolism, and cellular stress response.",
      "Some circRNAs may be translated into proteins under certain conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2158,
    "user_query": "What is Uhl's anomaly?",
    "vicuna-7b_response": "Uhl's anomaly is a rare congenital disorder characterized by the absence of the distal part of the radius and ulna, as well as the carpals and tarsals. It is also known as the \"thumb-foot\" or \"thumb-hand\" anomaly.\nThe condition is caused by a defect in the development of the limb bud during the fourth week of gestation. This leads to the underdevelopment or absence of the bones in the forearm and hand.\nUhl's anomaly is a severe disorder that can result in a wide range of physical and developmental problems. Children with the condition may have limited mobility, deformities of the hands and feet, and may require surgery to correct the deformities.\nIn addition to physical challenges, individuals with Uhl's anomaly may also experience developmental delays and learning difficulties. They may require special education and therapy to help them reach their full potential.\nIt is important to note that Uhl's anomaly is a rare condition, and the exact prevalence is not known. However, it is estimated that it occurs in approximately 1 in every 20,000 births.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Uhl's anomaly is a rare congenital disorder marked by the absence of certain bones in the radius, ulna, carpals, and tarsals.\n2. The disorder is also referred to as the \"thumb-foot\" or \"thumb-hand\" anomaly.\n3. The condition is caused by a defect in the development of the limb bud during the fourth week of gestation.\n4. Individuals with Uhl's anomaly can have physical and developmental issues, including limited mobility, deformities, learning difficulties, and may require surgery or special education.\n5. Uhl's anomaly is estimated to occur in approximately 1 in every 20,000 births.",
    "vicuna-7b_fact": [
      "Uhl's anomaly is a rare congenital disorder marked by the absence of certain bones in the radius, ulna, carpals, and tarsals.",
      "The disorder is also referred to as the \"thumb-foot\" or \"thumb-hand\" anomaly.",
      "The condition is caused by a defect in the development of the limb bud during the fourth week of gestation.",
      "Individuals with Uhl's anomaly can have physical and developmental issues, including limited mobility, deformities, learning difficulties, and may require surgery or special education.",
      "Uhl's anomaly is estimated to occur in approximately 1 in every 20,000 births."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Uhl's anomaly is a rare congenital heart disorder marked by the almost complete absence of the myocardium (muscle) in one of the heart's ventricles.\n2. FALSE [correction]: The disorder Uhl's anomaly does not have the alternative names \"thumb-foot\" or \"thumb-hand\" anomaly.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2159,
    "user_query": "Is autophagy the process where bacteria ingest viral particles?",
    "vicuna-7b_response": "Autophagy is a process by which cells degrade and recycle their own components, including proteins and organelles. It is a fundamental cellular process that plays a crucial role in maintaining cellular homeostasis and survival under stress conditions.\nAutophagy is not directly involved in the process of bacteria ingesting viral particles. However, it is possible that some viruses may use autophagy as a mechanism to infect cells. For example, some viruses have evolved to manipulate the autophagy pathway to their advantage.\nOne example is the bacteriophage T4, which infects Escherichia coli bacteria. T4 uses a protein called the \"tail fiber\" to induce the formation of autophagosomes, which are structures that form during autophagy and eventually fuse with lysosomes to degrade the contents. The T4 tail fiber also inhibits the fusion of autophagosomes with lysosomes, allowing the virus to remain within the autophagosome and avoid degradation.\nIn summary, while autophagy is not directly involved in the process of bacteria ingesting viral particles, some viruses may use autophagy as a mechanism to infect cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process by which cells degrade and recycle their own components, including proteins and organelles.\n2. Autophagy plays a crucial role in maintaining cellular homeostasis and survival under stress conditions.\n3. Autophagy is not directly involved in the process of bacteria ingesting viral particles.\n4. Some viruses may use autophagy as a mechanism to infect cells.\n5. The bacteriophage T4 uses a protein called the \"tail fiber\" to induce the formation of autophagosomes and inhibits the fusion of autophagosomes with lysosomes.",
    "vicuna-7b_fact": [
      "Autophagy is a process by which cells degrade and recycle their own components, including proteins and organelles.",
      "Autophagy plays a crucial role in maintaining cellular homeostasis and survival under stress conditions.",
      "Autophagy is not directly involved in the process of bacteria ingesting viral particles.",
      "Some viruses may use autophagy as a mechanism to infect cells.",
      "The bacteriophage T4 uses a protein called the \"tail fiber\" to induce the formation of autophagosomes and inhibits the fusion of autophagosomes with lysosomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2161,
    "user_query": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?",
    "vicuna-7b_response": "The pre-replication complex (pre-RC) is a complex of proteins that is involved in the initiation of DNA replication in eukaryotes. The pre-RC is composed of the following components:\n1. Cdc6: A kinase that is involved in the activation of the MCM helicase, which is responsible for unwinding the DNA helix and initiating replication.\n2. Cdc45: A protein that is involved in the assembly of the pre-RC and in the protection of the replication fork from DNA damage.\n3. Cdc6-bindin g protein (Cbp): A protein that binds to Cdc6 and helps to regulate its activity.\n4. MCM helicase: A group of proteins that are responsible for unwinding the DNA helix and initiating replication. There are several different types of MCM helicases, including MCM2-7, which are also known as the minichromosome maintenance (MCM) proteins.\n5. Single-stranded DNA binding protein (SSB protein): A protein that binds to single-stranded DNA and helps to protect it from damage and degradation.\nThese components of the pre-RC work together to initiate DNA replication in eukaryotes by unwinding the DNA helix and creating a replication fork.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The pre-replication complex (pre-RC) is involved in the initiation of DNA replication in eukaryotes.\n2. Cdc6 is a kinase that is involved in the activation of the MCM helicase.\n3. Cdc45 is a protein involved in the assembly of the pre-RC and in the protection of the replication fork from DNA damage.\n4. The MCM helicase is responsible for unwinding the DNA helix and initiating replication. \n5. Single-stranded DNA binding protein (SSB protein) is a protein that binds to single-stranded DNA and helps to protect it from damage and degradation.",
    "vicuna-7b_fact": [
      "The pre-replication complex (pre-RC) is involved in the initiation of DNA replication in eukaryotes.",
      "Cdc6 is a kinase that is involved in the activation of the MCM helicase.",
      "Cdc45 is a protein involved in the assembly of the pre-RC and in the protection of the replication fork from DNA damage.",
      "The MCM helicase is responsible for unwinding the DNA helix and initiating replication.",
      "Single-stranded DNA binding protein (SSB protein) is a protein that binds to single-stranded DNA and helps to protect it from damage and degradation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cdc6 is not a kinase but a protein that is involved in the formation of the pre-RC and the initiation of DNA replication.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2162,
    "user_query": "What is the inheritance of hypophosphatemic rickets?",
    "vicuna-7b_response": "Hypophosphatemic rickets is a genetic disorder that is caused by a deficiency of phosphate in the blood. It is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene (one from each parent) to develop the disorder.\nThe disorder is caused by mutations in the PHEX gene, which encodes for an enzyme called fibroblast growth factor 23 (FGF23). FGF23 is involved in regulating phosphate levels in the body by inhibiting the production of phosphate in the kidneys. When the PHEX gene is mutated, it leads to a deficiency of FGF23, which in turn leads to high levels of phosphate in the blood.\nHypophosphatemic rickets can cause a wide range of symptoms, including growth retardation, bowing of the legs, and bone pain. It is important to diagnose and treat the disorder early to prevent long-term complications such as rickets, osteomalacia, and osteoporosis. Treatment typically involves increasing the intake of phosphate-rich foods and supplements, and in severe cases, medications may be prescribed to help regulate phosphate levels in the blood.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hypophosphatemic rickets is a genetic disorder that is caused by a deficiency of phosphate in the blood.\n2. Hypophosphatemic rickets is inherited in an autosomal recessive pattern.\n3. The disorder is caused by mutations in the PHEX gene.\n4. The PHEX gene encodes for an enzyme called fibroblast growth factor 23 (FGF23) that regulates phosphate levels in the body.\n5. Symptoms of Hypophosphatemic rickets include growth retardation, bowing of the legs, and bone pain.",
    "vicuna-7b_fact": [
      "Hypophosphatemic rickets is a genetic disorder that is caused by a deficiency of phosphate in the blood.",
      "Hypophosphatemic rickets is inherited in an autosomal recessive pattern.",
      "The disorder is caused by mutations in the PHEX gene.",
      "The PHEX gene encodes for an enzyme called fibroblast growth factor 23 (FGF23) that regulates phosphate levels in the body.",
      "Symptoms of Hypophosphatemic rickets include growth retardation, bowing of the legs, and bone pain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hypophosphatemic rickets is generally inherited in an X-linked dominant pattern, not autosomal recessive.\n3. TRUE\n4. FALSE [correction]: The PHEX gene encodes for a protein that interacts with fibroblast growth factor 23 (FGF23), but doesn't directly encode FGF23 itself. This interaction plays a role in regulating phosphate levels.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2167,
    "user_query": "Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?",
    "vicuna-7b_response": "There are several servers available for generating modes of pseudo components of DNA, RNA, and protein sequences. Some of the popular ones include:\n1. RNAalifold: This is a web-based server that uses a hidden Markov model (HMM) to predict RNA secondary structure. It can also generate multiple folding models for a given RNA sequence.\n2. DNAfold: This is a web-based server that uses a Markov model to predict DNA secondary structure. It can also generate multiple folding models for a given DNA sequence.\n3. Proteinfold: This is a web-based server that uses a Markov model to predict protein secondary structure. It can also generate multiple folding models for a given protein sequence.\n4. Mfold: This is a command-line tool that can be used to predict RNA and DNA secondary structure. It can also generate multiple folding models for a given sequence.\n5. RNAalifold-3.0: This is a web-based server that uses a hidden Markov model (HMM) to predict RNA secondary structure. It can also generate multiple folding models for a given RNA sequence.\n6. DNAfold-3.0: This is a web-based server that uses a Markov model to predict DNA secondary structure. It can also generate multiple folding models for a given DNA sequence.\n7. Proteinfold-3.0: This is a web-based server that uses a Markov model to predict protein secondary structure. It can also generate multiple folding models for a given protein sequence.\nThese are some of the popular servers available for generating modes of pseudo components of DNA, RNA, and protein sequences. The choice of server depends on the specific requirements of the user and the nature of the sequence being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNAalifold is a web-based server that uses a hidden Markov model to predict RNA secondary structure.\n2. DNAfold is a web-based server that uses a Markov model to predict DNA secondary structure.\n3. Proteinfold is a web-based server that uses a Markov model to predict protein secondary structure.\n4. Mfold is a command-line tool used to predict RNA and DNA secondary structure.\n5. DNAfold-3.0 is a web-based server that uses a Markov model to predict DNA secondary structure.",
    "vicuna-7b_fact": [
      "RNAalifold is a web-based server that uses a hidden Markov model to predict RNA secondary structure.",
      "DNAfold is a web-based server that uses a Markov model to predict DNA secondary structure.",
      "Proteinfold is a web-based server that uses a Markov model to predict protein secondary structure.",
      "Mfold is a command-line tool used to predict RNA and DNA secondary structure.",
      "DNAfold-3.0 is a web-based server that uses a Markov model to predict DNA secondary structure."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: RNAalifold is a software tool that uses an energy-minimization algorithm to predict RNA secondary structure.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2169,
    "user_query": "Which class of genes are mutated in Diamond Blackfan Anemia patients?",
    "vicuna-7b_response": "Diamond Blackfan Anemia (DBA) is a genetic disorder characterized by the failure of the bone marrow to produce enough red blood cells. The disease is caused by mutations in genes that are involved in the development and maturation of blood cells.\nThe most common genetic mutation associated with DBA is a mutation in the ribosomal protein gene RPS14. This gene provides instructions for making a protein that is part of the ribosome, a structure that helps to translate the genetic code into proteins. Mutations in RPS14 can disrupt the normal function of the ribosome and lead to the production of abnormal red blood cells.\nOther genes that have been identified as causing DBA include ARA, which encodes a protein involved in the development of the bone marrow, and ELANE, which encodes a protein that helps to regulate the production of red blood cells.\nIn addition to these genes, mutations in several other genes have been associated with DBA, including PTPN11, GATA1, and EZH2.\nOverall, mutations in genes involved in the development and maturation of blood cells are the most common cause of DBA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Diamond Blackfan Anemia (DBA) is a genetic disorder characterized by the failure of the bone marrow to produce enough red blood cells.\n2. The most common genetic mutation associated with DBA is a mutation in the ribosomal protein gene RPS14.\n3. Mutations in RPS14 can disrupt the normal function of the ribosome and lead to the production of abnormal red blood cells.\n4. Other genes that have been identified as causing DBA include ARA, and ELANE.\n5. Mutations in PTPN11, GATA1, and EZH2 genes have also been associated with DBA.",
    "vicuna-7b_fact": [
      "Diamond Blackfan Anemia (DBA) is a genetic disorder characterized by the failure of the bone marrow to produce enough red blood cells.",
      "The most common genetic mutation associated with DBA is a mutation in the ribosomal protein gene RPS14.",
      "Mutations in RPS14 can disrupt the normal function of the ribosome and lead to the production of abnormal red blood cells.",
      "Other genes that have been identified as causing DBA include ARA, and ELANE.",
      "Mutations in PTPN11, GATA1, and EZH2 genes have also been associated with DBA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The most common genetic mutation associated with DBA is a mutation in the ribosomal protein genes RPS19.\n3. TRUE\n4. FALSE [correction]: Other genes that have been identified as causing DBA include RPL5, RPL11, and RPL35A.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-7b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when two acrocentric chromosomes (chromosomes that have their centromeres located at the ends of the chromosome) exchange genetic material. The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.\nChromosome 13 is a small acrocentric chromosome that contains 138 million base pairs (MWP) and 68 genes. It is involved in various genetic disorders such as Down syndrome, Williams syndrome, and Turner syndrome.\nChromosome 14 is also a small acrocentric chromosome that contains 145 MWP and 68 genes. It is involved in various genetic disorders such as Patau syndrome, Edwards syndrome, and Miller-Dieker syndrome.\nWhen these two chromosomes exchange genetic material, they form a Robertsonian translocation, which results in the formation of a derivative chromosome that contains part of chromosomes 13 and 14. The derivative chromosome is typically smaller than the original chromosomes and is not balanced, meaning that it contains an extra or missing portion of genetic material. This can lead to various genetic disorders and health problems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Robertsonian translocation is a type of chromosomal abnormality that occurs when two acrocentric chromosomes exchange genetic material.\n2. The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.\n3. Chromosome 13 contains 138 million base pairs (MWP) and 68 genes.\n4. Chromosome 14 contains 145 MWP and 68 genes.\n5. A Robertsonian translocation forms a derivative chromosome that contains part of chromosomes 13 and 14.",
    "vicuna-7b_fact": [
      "Robertsonian translocation is a type of chromosomal abnormality that occurs when two acrocentric chromosomes exchange genetic material.",
      "The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.",
      "Chromosome 13 contains 138 million base pairs (MWP) and 68 genes.",
      "Chromosome 14 contains 145 MWP and 68 genes.",
      "A Robertsonian translocation forms a derivative chromosome that contains part of chromosomes 13 and 14."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chromosome 13 contains approximately 114 million base pairs and hundreds of genes.\n4. FALSE [correction]: Chromosome 14 contains approximately 107 million base pairs and between 800-1200 genes.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2171,
    "user_query": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?",
    "vicuna-7b_response": "Tirilazad is a drug that has been studied for its potential to treat aneurysmal subarachnoid haemorrhage, but it has not been proven to be effective in clinical trials.\nAneurysmal subarachnoid haemorrhage is a serious condition in which a blood vessel in the brain bursts, causing bleeding in the space surrounding the brain. It is a medical emergency that requires immediate treatment to prevent long-term damage or death.\nTirilazad is a drug that is thought to work by reducing inflammation and oxidative stress, which may help to protect the brain from damage caused by the bleeding. However, there have been no large-scale clinical trials that have shown that tirilazad is effective in treating aneurysmal subarachnoid haemorrhage.\nIt is important to note that there are many different treatments available for aneurysmal subarachnoid haemorrhage, and the best treatment for an individual patient will depend on a variety of factors, including the size and location of the aneurysm, the patient's overall health, and the severity of the bleeding.\nIf you or someone you know is experiencing symptoms of aneurysmal subarachnoid haemorrhage, it is important to seek medical attention immediately.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tirilazad is a drug that has been studied for its potential to treat aneurysmal subarachnoid haemorrhage.\n2. It is yet to be proven through clinical trials that tirilazad is effective in treating aneurysmal subarachnoid haemorrhage.\n3. Aneurysmal subarachnoid haemorrhage is a condition where a blood vessel in the brain ruptures, causing bleeding in the surrounding space.\n4. This medical condition is a medical emergency that requires immediate treatment to prevent long-term damage or death.\n5. Tirilazad is thought to work by reducing inflammation and oxidative stress, potentially protecting the brain from damage caused by bleeding.",
    "vicuna-7b_fact": [
      "Tirilazad is a drug that has been studied for its potential to treat aneurysmal subarachnoid haemorrhage.",
      "It is yet to be proven through clinical trials that tirilazad is effective in treating aneurysmal subarachnoid haemorrhage.",
      "Aneurysmal subarachnoid haemorrhage is a condition where a blood vessel in the brain ruptures, causing bleeding in the surrounding space.",
      "This medical condition is a medical emergency that requires immediate treatment to prevent long-term damage or death.",
      "Tirilazad is thought to work by reducing inflammation and oxidative stress, potentially protecting the brain from damage caused by bleeding."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2175,
    "user_query": "List viral vectors used in gene therapy.",
    "vicuna-7b_response": "Viral vectors are used as delivery vehicles for genetic material in gene therapy. Here are some of the most commonly used viral vectors in gene therapy:\n1. Adeno-associated virus (AAV)\n2. Retroviruses (such as HIV)\n3. Lentiviruses (such as HIV)\n4. Herpes simplex virus (HSV)\n5. Adenovirus\n6. Sindbis virus\n7. Vesicular stomatitis virus (VSV)\n8. Semliki Forest virus (SFV)\nEach of these viral vectors has its own unique characteristics and advantages, and the choice of vector depends on the specific application and the target cells or tissues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Viral vectors are used as delivery vehicles for genetic material in gene therapy.\n2. Adeno-associated virus (AAV) is commonly used in gene therapy.\n3. Retroviruses such as HIV are also used as viral vectors in gene therapy.\n4. Lentiviruses (like HIV), Herpes simplex virus (HSV) and Adenovirus are used in gene therapy.\n5. Sindbis virus, Vesicular stomatitis virus (VSV), and Semliki Forest virus (SFV) serve as viral vectors in gene therapy.",
    "vicuna-7b_fact": [
      "Viral vectors are used as delivery vehicles for genetic material in gene therapy.",
      "Adeno-associated virus (AAV) is commonly used in gene therapy.",
      "Retroviruses such as HIV are also used as viral vectors in gene therapy.",
      "Lentiviruses (like HIV), Herpes simplex virus (HSV) and Adenovirus are used in gene therapy.",
      "Sindbis virus, Vesicular stomatitis virus (VSV), and Semliki Forest virus (SFV) serve as viral vectors in gene therapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Sindbis virus, Vesicular stomatitis virus (VSV), and Semliki Forest virus (SFV) are generally not used as viral vectors in gene therapy.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2178,
    "user_query": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).",
    "vicuna-7b_response": "Thrombotic thrombocytopenic purpura (TTP) is a rare, acute, and often life-threatening disorder characterized by the formation of blood clots in small blood vessels throughout the body, leading to a decrease in platelet count (thrombocytopenia) and the presence of purpuric rash on the skin. The classical symptoms of TTP include:\n1. Purpuric rash: This is a reddish-purple rash that often appears on the skin of the legs, arms, and trunk. The rash is usually non-blanching, meaning that it does not disappear when pressed with a finger.\n2. Thrombocytopenia: TTP is characterized by a low platelet count (thrombocytopenia) in the blood. This can lead to easy bruising, bleeding gums, and other signs of bleeding.\n3. Neurological symptoms: TTP can cause a variety of neurological symptoms, including headache, confusion, seizures, and stroke.\n4. Fever: TTP can cause fever, which is often high and can be accompanied by chills and sweating.\n5. Weight loss: TTP can cause weight loss, which is often due to the decreased ability of the body to absorb nutrients.\n6. Elevated liver enzymes: TTP can cause elevated levels of liver enzymes in the blood, which can indicate liver damage.\n7. Renal dysfunction: TTP can cause kidney dysfunction, which can lead to decreased urine output, swelling, and other signs of kidney damage.\nIt is important to note that these symptoms can vary from person to person and can also be present in other conditions. If you or someone you know is experiencing these symptoms, it is important to consult with a healthcare professional for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Thrombotic thrombocytopenic purpura (TTP) is a disorder distinguished by the formation of blood clots in small blood vessels throughout the body.\n2. TTP leads to a decrease in platelet count, known as thrombocytopenia, and the presence of purpuric rash on the skin.\n3. Some of the classical symptoms of TTP include a reddish-purple, non-blanching rash, low platelet count, fever, weight loss, and elevated liver enzymes.\n4. TTP can also lead to kidney dysfunction which subsequently may reduce urine output and cause swelling.\n5. The symptoms of TTP can vary from person to person and could also be present in other conditions.",
    "vicuna-7b_fact": [
      "Thrombotic thrombocytopenic purpura (TTP) is a disorder distinguished by the formation of blood clots in small blood vessels throughout the body.",
      "TTP leads to a decrease in platelet count, known as thrombocytopenia, and the presence of purpuric rash on the skin.",
      "Some of the classical symptoms of TTP include a reddish-purple, non-blanching rash, low platelet count, fever, weight loss, and elevated liver enzymes.",
      "TTP can also lead to kidney dysfunction which subsequently may reduce urine output and cause swelling.",
      "The symptoms of TTP can vary from person to person and could also be present in other conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2181,
    "user_query": "Which is the major RNA editing enzyme in Drosophila melanogaster?",
    "vicuna-7b_response": "In Drosophila melanogaster, the major RNA editing enzyme is known as ADAR1 (Adenosine Deaminase Acting on RNA 1). ADAR1 is responsible for editing adenosine to inosine in RNA molecules, which can lead to changes in the amino acid sequence of proteins that are produced from the RNA. ADAR1 is involved in a variety of cellular processes, including development, stress response, and immune function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In Drosophila melanogaster, the major RNA editing enzyme is ADAR1.\n2. ADAR1 edits adenosine to inosine in RNA molecules.\n3. The editing activity of ADAR1 can lead to changes in the amino acid sequence of proteins.\n4. ADAR1 is involved in development, stress response, and immune function.",
    "vicuna-7b_fact": [
      "In Drosophila melanogaster, the major RNA editing enzyme is ADAR1.",
      "ADAR1 edits adenosine to inosine in RNA molecules.",
      "The editing activity of ADAR1 can lead to changes in the amino acid sequence of proteins.",
      "ADAR1 is involved in development, stress response, and immune function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2182,
    "user_query": "What is the CEGA catalog?",
    "vicuna-7b_response": "The CEGA catalog is a database of genes and their associated gene products. CEGA stands for \"Comprehensive Eukaryotic Gene Expression Database\". The catalog is a resource for researchers studying gene expression in various organisms, including humans.\nThe CEGA catalog contains information on the expression of genes in different tissues and under different conditions, such as different stages of development or different diseases. This information is derived from a variety of sources, including microarray experiments, RNA sequencing data, and other gene expression data.\nThe CEGA catalog provides a wealth of information for researchers studying gene expression, including gene expression levels, expression patterns, and information on the function of gene products. This information can be used to identify genes that are associated with specific diseases or to study the role of gene products in various biological processes.\nOverall, the CEGA catalog is a valuable resource for researchers studying gene expression and the function of gene products in various organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CEGA stands for \"Comprehensive Eukaryotic Gene Expression Database\".\n2. The CEGA catalog is a database of genes and their associated gene products.\n3. The CEGA catalog contains information on the expression of genes in different tissues and under different conditions.\n4. The information in the CEGA catalog is derived from a variety of sources, including microarray experiments, RNA sequencing data, and other gene expression data.\n5. The CEGA catalog can provide information such as gene expression levels, expression patterns, and information on the function of gene products.",
    "vicuna-7b_fact": [
      "CEGA stands for \"Comprehensive Eukaryotic Gene Expression Database\".",
      "The CEGA catalog is a database of genes and their associated gene products.",
      "The CEGA catalog contains information on the expression of genes in different tissues and under different conditions.",
      "The information in the CEGA catalog is derived from a variety of sources, including microarray experiments, RNA sequencing data, and other gene expression data.",
      "The CEGA catalog can provide information such as gene expression levels, expression patterns, and information on the function of gene products."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CEGA stands for \"Comprehensive Gene Expression Analysis\".\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2183,
    "user_query": "Which protein is associated with hyperemesis gravidarum during pregrancy?",
    "vicuna-7b_response": "Hyperemesis gravidarum is a severe form of morning sickness that affects pregnant women. The exact cause of hyperemesis gravidarum is not known, but it is thought to be related to hormonal changes during pregnancy.\nThere is no specific protein that is associated with hyperemesis gravidarum. However, some research suggests that women with hyperemesis gravidarum may have an imbalance of certain hormones, such as ghrelin and leptin, which can affect appetite and food intake. Additionally, some studies have suggested that women with hyperemesis gravidarum may have an increased risk of developing vitamin and mineral deficiencies due to poor nutrition.\nIt is important to note that while hyperemesis gravidarum can be a challenging condition, it is generally not a life-threatening condition for the mother or the baby. Treatment options for hyperemesis gravidarum may include changes in diet, vitamin supplements, and, in some cases, medication to control nausea and vomiting.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hyperemesis gravidarum is a severe form of morning sickness that affects pregnant women.\n2. The exact cause of hyperemesis gravidarum is not known.\n3. Some research suggests that women with hyperemesis gravidarum may have an imbalance of certain hormones, such as ghrelin and leptin.\n4. Some studies have suggested that women with hyperemesis gravidarum may have an increased risk of developing vitamin and mineral deficiencies due to poor nutrition.\n5. Treatment options for hyperemesis gravidarum may include changes in diet, vitamin supplements, and medication to control nausea and vomiting.",
    "vicuna-7b_fact": [
      "Hyperemesis gravidarum is a severe form of morning sickness that affects pregnant women.",
      "The exact cause of hyperemesis gravidarum is not known.",
      "Some research suggests that women with hyperemesis gravidarum may have an imbalance of certain hormones, such as ghrelin and leptin.",
      "Some studies have suggested that women with hyperemesis gravidarum may have an increased risk of developing vitamin and mineral deficiencies due to poor nutrition.",
      "Treatment options for hyperemesis gravidarum may include changes in diet, vitamin supplements, and medication to control nausea and vomiting."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2187,
    "user_query": "Is edema a symptom of nephrotic syndrome?",
    "vicuna-7b_response": "Yes, edema is a symptom of nephrotic syndrome. Nephrotic syndrome is a kidney disorder characterized by the loss of large amounts of protein in the urine, low levels of albumin in the blood, and high levels of cholesterol and triglycerides in the blood. Edema, or swelling, is a common symptom of nephrotic syndrome because the kidneys are not able to filter out excess fluids from the body properly. This can lead to fluid accumulation in the tissues, causing edema in various parts of the body, such as the feet, ankles, and hands.\nNephrotic syndrome can be caused by a variety of underlying conditions, including diabetes, high blood pressure, and certain genetic disorders. Treatment for nephrotic syndrome typically involves medications to manage blood pressure and reduce protein loss in the urine, as well as dietary changes and lifestyle modifications to help manage edema. In some cases, dialysis or a kidney transplant may be necessary.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Edema is a symptom of nephrotic syndrome.\n2. Nephrotic syndrome is a kidney disorder characterized by large amounts of protein loss in the urine, low blood albumin levels, and high blood cholesterol and triglyceride levels.\n3. Edema in nephrotic syndrome is caused by the kidneys being unable to properly filter excess fluids, leading to fluid accumulation in tissues.\n4. Underlying conditions like diabetes, high blood pressure, and certain genetic disorders can cause nephrotic syndrome.\n5. Treatment for nephrotic syndrome can include medications, dietary changes, lifestyle modifications, and in some cases, dialysis or a kidney transplant.",
    "vicuna-7b_fact": [
      "Edema is a symptom of nephrotic syndrome.",
      "Nephrotic syndrome is a kidney disorder characterized by large amounts of protein loss in the urine, low blood albumin levels, and high blood cholesterol and triglyceride levels.",
      "Edema in nephrotic syndrome is caused by the kidneys being unable to properly filter excess fluids, leading to fluid accumulation in tissues.",
      "Underlying conditions like diabetes, high blood pressure, and certain genetic disorders can cause nephrotic syndrome.",
      "Treatment for nephrotic syndrome can include medications, dietary changes, lifestyle modifications, and in some cases, dialysis or a kidney transplant."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2195,
    "user_query": "Borden classification is used for which disease?",
    "vicuna-7b_response": "Borden classification is used for the classification of breast cancer. It is a system for classifying breast cancer based on the degree of differentiation of the cancer cells. The degree of differentiation refers to the degree to which the cancer cells resemble normal, non-cancerous cells in terms of their appearance and behavior.\nBorden classification is based on the degree of differentiation of the cancer cells, which is determined by examining the cancer cells under a microscope. The classification system includes four grades, ranging from well-differentiated (Grade 1) to poorly differentiated (Grade 4).\nWell-differentiated breast cancer cells are similar to normal cells and are less likely to spread to other parts of the body. Poorly differentiated breast cancer cells, on the other hand, are more aggressive and are more likely to spread to other parts of the body.\nBorden classification is used to help determine the prognosis and treatment options for breast cancer patients. It is important to note that Borden classification is not used to diagnose breast cancer, but rather to classify the type of breast cancer that has been diagnosed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Borden classification is used for the classification of breast cancer.\n2. Borden classification is based on the degree of differentiation of the cancer cells.\n3. The grading system of the Borden classification ranges from well-differentiated (Grade 1) to poorly differentiated (Grade 4).\n4. Well-differentiated breast cancer cells are similar to normal cells and are less likely to spread to other parts of the body, whereas poorly differentiated cells are more aggressive and likely to spread.\n5. Borden classification is used to help determine the prognosis and treatment options for breast cancer patients, not for diagnosis.",
    "vicuna-7b_fact": [
      "Borden classification is used for the classification of breast cancer.",
      "Borden classification is based on the degree of differentiation of the cancer cells.",
      "The grading system of the Borden classification ranges from well-differentiated (Grade 1) to poorly differentiated (Grade 4).",
      "Well-differentiated breast cancer cells are similar to normal cells and are less likely to spread to other parts of the body, whereas poorly differentiated cells are more aggressive and likely to spread.",
      "Borden classification is used to help determine the prognosis and treatment options for breast cancer patients, not for diagnosis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Borden classification is used for the classification of cranial dural arteriovenous fistulas, not breast cancer.\n2. FALSE [correction]: Borden classification is based on the venous drainage pattern of the dural arteriovenous fistulas, not the degree of differentiation of cancer cells.\n3. FALSE [correction]: The grading system of the Borden classification ranges from no cortical venous drainage or venous ectasia (Grade 1) to venous ectasia or cortical venous reflux (Grade 3).\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2203,
    "user_query": "List cardinal features of the Triple A syndrome.",
    "vicuna-7b_response": "Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene. It is characterized by a triad of symptoms: alacrima (absence of tear production), anhidrosis (absence of sweat production), and achalasia (difficulty swallowing). These symptoms are caused by a deficiency in the neurotransmitter proopiomelanocortin (POMC).\nIn addition to the cardinal features of alacrima, anhidrosis, and achalasia, Triple A syndrome can also cause other symptoms such as:\n* Low blood pressure\n* Hypotonia (low muscle tone)\n* Delayed development\n* Short stature\n* Poor feeding and weight gain in infancy\n* Recurrent respiratory infections\n* Abnormalities in the skin, hair, and nails\n* Mental retardation\n* Seizures\n* Gastrointestinal problems such as constipation and abdominal pain\nIt is important to note that not all individuals with Triple A syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene.\n2. The syndrome is characterized by a triad of symptoms: alacrima, anhidrosis, and achalasia.\n3. Triple A syndrome can cause other symptoms such as low blood pressure, hypotonia, delayed development, short stature, poor feeding, and weight gain in infancy.\n4. The syndrome can also cause recurrent respiratory infections, abnormalities in the skin, hair, and nails, mental retardation, seizures, and gastrointestinal problems.\n5. Not all individuals with Triple A syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person.",
    "vicuna-7b_fact": [
      "Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene.",
      "The syndrome is characterized by a triad of symptoms: alacrima, anhidrosis, and achalasia.",
      "Triple A syndrome can cause other symptoms such as low blood pressure, hypotonia, delayed development, short stature, poor feeding, and weight gain in infancy.",
      "The syndrome can also cause recurrent respiratory infections, abnormalities in the skin, hair, and nails, mental retardation, seizures, and gastrointestinal problems.",
      "Not all individuals with Triple A syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Triple A syndrome is a rare genetic disorder caused by mutations in the AAAS gene.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2205,
    "user_query": "Does the Abelson-related gene (ARG) gene encode for a serine kinase?",
    "vicuna-7b_response": "The Abelson-related gene (ARG) is a gene that encodes for a protein called Abelson kinase, also known as ABL. The Abelson kinase is a serine-threonine kinase, which means that it can phosphorylate both serine and threonine residues on its substrates.\nThe Abelson kinase is a key regulator of cell proliferation and differentiation, and it plays a role in the development of various types of cancer. It is a member of the tyrosine kinase family of enzymes, which are a class of enzymes that catalyze the transfer of a phosphate group from ATP to a substrate protein, resulting in the formation of ADP and a phosphorylated substrate.\nThe Abelson kinase is involved in the regulation of cell growth and differentiation, and it is often overexpressed in cancer cells. It is a key regulator of the mitogen-activated protein kinase (MAPK) signaling pathway, which is involved in the regulation of cell proliferation, differentiation, and survival.\nIn summary, the Abelson-related gene (ARG) gene encodes for the Abelson kinase, which is a serine-threonine kinase that plays a role in the regulation of cell growth and differentiation, and it is often overexpressed in cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Abelson-related gene (ARG) encodes for a protein called Abelson kinase or ABL.\n2. The Abelson kinase is a serine-threonine kinase, which means it can phosphorylate both serine and threonine residues on its substrates.\n3. Abelson kinase is involved in the regulation of cell growth and differentiation.\n4. This kinase is often overexpressed in cancer cells.\n5. Abelson kinase is a key regulator of the mitogen-activated protein kinase (MAPK) signaling pathway.",
    "vicuna-7b_fact": [
      "The Abelson-related gene (ARG) encodes for a protein called Abelson kinase or ABL.",
      "The Abelson kinase is a serine-threonine kinase, which means it can phosphorylate both serine and threonine residues on its substrates.",
      "Abelson kinase is involved in the regulation of cell growth and differentiation.",
      "This kinase is often overexpressed in cancer cells.",
      "Abelson kinase is a key regulator of the mitogen-activated protein kinase (MAPK) signaling pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Abelson kinase is a tyrosine kinase, which means it can phosphorylate tyrosine residues on its substrates.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Abelson kinase is a key regulator of multiple signaling pathways, not specifically the mitogen-activated protein kinase (MAPK) signaling pathway.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2207,
    "user_query": "Is Prochlorococcus the most abundant photosynthetic organism?",
    "vicuna-7b_response": "Prochlorococcus is a type of photosynthetic bacteria that is found in the ocean. It is considered to be one of the most abundant photosynthetic organisms in the ocean, but it is not the most abundant.\nThe most abundant photosynthetic organism in the ocean is a type of algae called Emiliania huxleyi. This algae is found in the upper layers of the ocean and plays a crucial role in the ocean's food web.\nProchlorococcus, on the other hand, is found in the deep ocean, in the euphotic zone, which is the layer of the ocean where sunlight can penetrate. It is thought to play an important role in the ocean's carbon cycle, as it is able to use carbon dioxide to produce energy through photosynthesis.\nIt's worth noting that the abundance of Prochlorococcus can vary greatly depending on the location and time of year. In some areas, it may be the most abundant photosynthetic organism, while in other areas, it may be outcompeted by other organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prochlorococcus is a type of photosynthetic bacteria found in the ocean.\n2. Prochlorococcus is not the most abundant photosynthetic organism in the ocean.\n3. The most abundant photosynthetic organism in the ocean is a type of algae called Emiliania huxleyi.\n4. Prochlorococcus is found in the euphotic zone of the ocean, the layer where sunlight can penetrate.\n5. The abundance of Prochlorococcus can vary greatly depending on the location and time of year.",
    "vicuna-7b_fact": [
      "Prochlorococcus is a type of photosynthetic bacteria found in the ocean.",
      "Prochlorococcus is not the most abundant photosynthetic organism in the ocean.",
      "The most abundant photosynthetic organism in the ocean is a type of algae called Emiliania huxleyi.",
      "Prochlorococcus is found in the euphotic zone of the ocean, the layer where sunlight can penetrate.",
      "The abundance of Prochlorococcus can vary greatly depending on the location and time of year."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Prochlorococcus is considered the most abundant photosynthetic organism in the ocean.\n3. FALSE [correction]: The most abundant photosynthetic organism in the ocean is Prochlorococcus, not Emiliania huxleyi.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2208,
    "user_query": "List 3 features of IRVAN syndrome.",
    "vicuna-7b_response": "IRVAN syndrome is a rare genetic disorder characterized by a triad of symptoms: intrauterine growth restriction, retardation of brain development, and abnormalities of the genitourinary system. Here are three key features of IRVAN syndrome:\n1. Intrauterine growth restriction: IRVAN syndrome is associated with intrauterine growth restriction, which means that the fetus does not grow at a normal rate in the womb. This can lead to low birth weight and other complications.\n2. Retardation of brain development: IRVAN syndrome is also associated with retardation of brain development, which can result in intellectual disability and other cognitive impairments.\n3. Abnormalities of the genitourinary system: IRVAN syndrome is characterized by abnormalities of the genitourinary system, including hypospadias (a birth defect of the penis), undescended testicles, and other genital abnormalities. These abnormalities can affect the normal development of male sexual characteristics and can lead to infertility.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. IRVAN syndrome is a rare genetic disorder characterized by intrauterine growth restriction, retardation of brain development, and abnormalities of the genitourinary system.\n2. Intrauterine growth restriction is a symptom of IRVAN syndrome, potentially causing low birth weight and other complications.\n3. Brain development retardation, potentially leading to intellectual disability and other cognitive impairments, is associated with IRVAN syndrome.\n4. IRVAN syndrome is characterized by genitourinary system abnormalities, which can include issues like hypospadias, undescended testicles, and other genital abnormalities.\n5. The genitourinary abnormalities common with IRVAN syndrome can impact the normal development of male sexual characteristics and may potentially lead to infertility.",
    "vicuna-7b_fact": [
      "IRVAN syndrome is a rare genetic disorder characterized by intrauterine growth restriction, retardation of brain development, and abnormalities of the genitourinary system.",
      "Intrauterine growth restriction is a symptom of IRVAN syndrome, potentially causing low birth weight and other complications.",
      "Brain development retardation, potentially leading to intellectual disability and other cognitive impairments, is associated with IRVAN syndrome.",
      "IRVAN syndrome is characterized by genitourinary system abnormalities, which can include issues like hypospadias, undescended testicles, and other genital abnormalities.",
      "The genitourinary abnormalities common with IRVAN syndrome can impact the normal development of male sexual characteristics and may potentially lead to infertility."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2211,
    "user_query": "List active ingredients of the Stribild polypill.",
    "vicuna-7b_response": "Stribild is a fixed-dose combination medication that contains several active ingredients, including:\n* Tenofovir disoproxil fumarate (TDF)\n* Emtricitabine (FTC)\n* Efavirenz (EFV)\n* Tenofovir alafenamide (TAF)\nTDF, FTC, and EFV are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the activity of HIV reverse transcriptase, an enzyme that is essential for the replication of the virus.\nTAF is a prodrug of tenofovir, another NRTI. It is metabolized to tenofovir in the body, and has a lower potential for kidney and bone toxicity compared to TDF.\nStribild is indicated for the treatment of HIV-1 infection in adults and children who weigh at least 40 kg. It is taken once daily, and is an effective treatment option for people who have never taken HIV medication before or who have not responded to other HIV treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Stribild contains active ingredients: Tenofovir disoproxil fumarate (TDF), Emtricitabine (FTC), Efavirenz (EFV), and Tenofovir alafenamide (TAF).\n2. TDF, FTC, and EFV are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the activity of HIV reverse transcriptase.\n3. TAF is a prodrug of tenofovir, another NRTI and it has a lower potential for kidney and bone toxicity compared to TDF.\n4. Stribild is indicated for the treatment of HIV-1 infection in adults and children who weigh at least 40 kg.\n5. Stribild is taken once daily.",
    "vicuna-7b_fact": [
      "Stribild contains active ingredients: Tenofovir disoproxil fumarate (TDF), Emtricitabine (FTC), Efavirenz (EFV), and Tenofovir alafenamide (TAF).",
      "TDF, FTC, and EFV are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the activity of HIV reverse transcriptase.",
      "TAF is a prodrug of tenofovir, another NRTI and it has a lower potential for kidney and bone toxicity compared to TDF.",
      "Stribild is indicated for the treatment of HIV-1 infection in adults and children who weigh at least 40 kg.",
      "Stribild is taken once daily."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Stribild contains active ingredients: elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate.\n2. FALSE [correction]: TDF and FTC are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the activity of HIV reverse transcriptase. EFV is a non-nucleoside reverse transcriptase inhibitor (NNRTI).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2215,
    "user_query": "Does the histone chaperone ASF1 interact with histones H1/H2?",
    "vicuna-7b_response": "Yes, the histone chaperone ASF1 interacts with histones H1 and H2.\nASF1 (Adaptin Superfamily Member 1) is a protein that plays a critical role in the assembly and disassembly of histone proteins. It is a histone chaperone that helps to regulate the stability and distribution of histone proteins within the nucleus.\nASF1 interacts with a variety of histone proteins, including histone H1 and histone H2. These interactions are important for the proper assembly and disassembly of histone proteins, and are necessary for the proper functioning of the nucleus.\nIn addition to its interactions with histone proteins, ASF1 also interacts with other proteins involved in chromatin structure and gene expression, including the histone-modifying enzymes HDAC1 and HDAC2.\nOverall, ASF1 is an important protein that plays a critical role in the regulation of chromatin structure and gene expression. Its interactions with histone proteins, such as H1 and H2, are essential for the proper functioning of the nucleus and the regulation of gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The histone chaperone ASF1 interacts with histones H1 and H2.\n2. ASF1 (Adaptin Superfamily Member 1) is a protein that plays a role in the assembly and disassembly of histone proteins.\n3. ASF1 contributes to the regulation of the stability and distribution of histone proteins within the nucleus.\n4. ASF1 also interacts with other proteins involved in chromatin structure and gene expression, including the histone-modifying enzymes HDAC1 and HDAC2.\n5. The interactions ASF1 has with histone proteins are critical for the proper functioning of the nucleus and the regulation of gene expression.",
    "vicuna-7b_fact": [
      "The histone chaperone ASF1 interacts with histones H1 and H2.",
      "ASF1 (Adaptin Superfamily Member 1) is a protein that plays a role in the assembly and disassembly of histone proteins.",
      "ASF1 contributes to the regulation of the stability and distribution of histone proteins within the nucleus.",
      "ASF1 also interacts with other proteins involved in chromatin structure and gene expression, including the histone-modifying enzymes HDAC1 and HDAC2.",
      "The interactions ASF1 has with histone proteins are critical for the proper functioning of the nucleus and the regulation of gene expression."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The histone chaperone ASF1 interacts with histones H3 and H4, not H1 and H2.\n2. FALSE [correction]: ASF1 (Anti-Silencing Function 1) is a histone chaperone that plays a role in the assembly and disassembly of histone proteins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2218,
    "user_query": "How many times is CLAST faster than BLAST?",
    "vicuna-7b_response": "It is difficult to determine the exact number of times that CLAST is faster than BLAST, as the performance of these two algorithms can vary depending on the specific application and the nature of the data being analyzed.\nIn general, CLAST (Composite Local Alignment Search Tool) is a more computationally intensive algorithm than BLAST (Basic Local Alignment Search Tool), which makes it more sensitive to the quality of the input data and the specific parameters used. As a result, CLAST may be more likely to outperform BLAST in certain situations, such as when dealing with noisy or low-quality data, or when searching for longer or more complex alignments.\nHowever, BLAST is generally considered to be more accurate and reliable than CLAST, particularly when dealing with well-aligned and high-quality data. BLAST is also faster and more widely used, which makes it easier to implement and compare across different applications.\nIn summary, the performance of CLAST versus BLAST will depend on the specific requirements of the application and the nature of the data being analyzed. In some cases, CLAST may be faster or more effective than BLAST, while in others BLAST may be more appropriate.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CLAST is a more computationally intensive algorithm than BLAST.\n2. CLAST may outperform BLAST when dealing with noisy or low-quality data, or when searching for longer or more complex alignments.\n3. BLAST is generally considered to be more accurate and reliable than CLAST when dealing with well-aligned and high-quality data.\n4. BLAST is faster and more widely used than CLAST.\n5. The performance of CLAST versus BLAST will depend on the specific application and the nature of the data being analyzed.",
    "vicuna-7b_fact": [
      "CLAST is a more computationally intensive algorithm than BLAST.",
      "CLAST may outperform BLAST when dealing with noisy or low-quality data, or when searching for longer or more complex alignments.",
      "BLAST is generally considered to be more accurate and reliable than CLAST when dealing with well-aligned and high-quality data.",
      "BLAST is faster and more widely used than CLAST.",
      "The performance of CLAST versus BLAST will depend on the specific application and the nature of the data being analyzed."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2221,
    "user_query": "Which tool is used for the identification of recurrent variants in noncoding regions?",
    "vicuna-7b_response": "There are several tools that can be used for the identification of recurrent variants in noncoding regions. One such tool is the \"Recurrent Variant Analyzer\" (RVA), which is a software tool developed by the 1000 Genomes Project. RVA is designed to identify recurrent variants in noncoding regions of the human genome, and it can be used to identify both germline and somatic variants.\nAnother tool that can be used for the identification of recurrent variants in noncoding regions is the \"Variant Effect Predictor\" (VEP), which is a web-based tool developed by the Broad Institute. VEP uses a machine learning approach to predict the functional impact of variants based on their effect on gene expression, protein function, and other factors.\nThere are also several other tools that can be used for the identification of recurrent variants in noncoding regions, including the \"Recurrent Variant Analyzer for Noncoding Regions\" (RVANR), the \"Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation\" (RVANR-FA), and the \"Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation and Disease Association\" (RVANR-FAD).\nOverall, there are several tools available for the identification of recurrent variants in noncoding regions, and the choice of tool will depend on the specific needs and goals of the user.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Recurrent Variant Analyzer (RVA) is a software tool developed by the 1000 Genomes Project used for identification of recurrent variants in noncoding regions.\n2. RVA is designed to identify both germline and somatic variants in noncoding regions of the human genome.\n3. The Variant Effect Predictor (VEP) is a web-based tool developed by the Broad Institute used for identifying recurrent variants in noncoding regions.\n4. VEP uses a machine learning approach to predict the functional impact of variants based on their effect on gene expression, protein function, and other factors.\n5. Other tools for the identification of recurrent variants in noncoding regions include the Recurrent Variant Analyzer for Noncoding Regions (RVANR), the Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation (RVANR-FA), and the Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation and Disease Association (RVANR-FAD).",
    "vicuna-7b_fact": [
      "The Recurrent Variant Analyzer (RVA) is a software tool developed by the 1000 Genomes Project used for identification of recurrent variants in noncoding regions.",
      "RVA is designed to identify both germline and somatic variants in noncoding regions of the human genome.",
      "The Variant Effect Predictor (VEP) is a web-based tool developed by the Broad Institute used for identifying recurrent variants in noncoding regions.",
      "VEP uses a machine learning approach to predict the functional impact of variants based on their effect on gene expression, protein function, and other factors.",
      "Other tools for the identification of recurrent variants in noncoding regions include the Recurrent Variant Analyzer for Noncoding Regions (RVANR), the Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation (RVANR-FA), and the Recurrent Variant Analyzer for Noncoding Regions with Functional Annotation and Disease Association (RVANR-FAD)."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. FALSE [correction]: The Variant Effect Predictor (VEP) is a tool developed by the Ensembl project, not the Broad Institute, used for predicting the functional impact of genetic variants.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2222,
    "user_query": "What body parts are also known as phalanges?",
    "vicuna-7b_response": "The body parts that are also known as phalanges are the bones in the fingers and toes. There are 10 phalanges in each hand and 10 phalanges in each foot. Each phalanx is made up of several bones, and they are the bones that make up the tips of the fingers and toes. The phalanges are important for the movement and function of the hands and feet, and they play a crucial role in the sense of touch.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phalanges are the bones in the fingers and toes.\n2. There are 10 phalanges in each hand.\n3. There are 10 phalanges in each foot.\n4. Each phalanx is made up of several bones.\n5. Phalanges are important for the movement and function of the hands and feet.",
    "vicuna-7b_fact": [
      "Phalanges are the bones in the fingers and toes.",
      "There are 10 phalanges in each hand.",
      "There are 10 phalanges in each foot.",
      "Each phalanx is made up of several bones.",
      "Phalanges are important for the movement and function of the hands and feet."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are 14 phalanges in each hand.\n3. FALSE [correction]: There are 14 phalanges in each foot.\n4. FALSE [correction]: Each phalanx is made up of a single bone.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2223,
    "user_query": "Are selenium supplements recommended for prostate cancer prevention?",
    "vicuna-7b_response": "Selenium is an essential trace element that plays a crucial role in the functioning of the immune system, thyroid function, and antioxidant defense. However, the relationship between selenium and prostate cancer is not well understood.\nThere have been some studies that suggest that selenium supplements may have a protective effect against prostate cancer. For example, a study published in the Journal of the National Cancer Institute found that men with higher selenium levels had a lower risk of developing prostate cancer.\nHowever, other studies have found no association between selenium supplements and prostate cancer risk. For example, a study published in the Journal of the American Medical Association found that selenium supplements did not reduce the risk of prostate cancer in men.\nIt is important to note that prostate cancer is a complex disease that is influenced by many factors, including genetics, lifestyle, and environmental exposures. Therefore, it is difficult to attribute any potential protective effect of selenium supplements to a single factor.\nIn conclusion, while some studies suggest that selenium supplements may have a protective effect against prostate cancer, the evidence is not strong enough to recommend selenium supplements for prostate cancer prevention. It is important to speak with a healthcare provider before taking any supplements, including selenium supplements, to discuss the potential benefits and risks based on individual health status and other factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Selenium is an essential trace element that plays a crucial role in the functioning of the immune system, thyroid function, and antioxidant defense.\n2. Some studies suggest that selenium supplements may have a protective effect against prostate cancer.\n3. A study in the Journal of the National Cancer Institute found that men with higher selenium levels had a lower risk of developing prostate cancer.\n4. Other studies, including one in the Journal of the American Medical Association, found no association between selenium supplements and prostate cancer risk.\n5. Prostate cancer is a complex disease that is influenced by many factors, including genetics, lifestyle, and environmental exposures.",
    "vicuna-7b_fact": [
      "Selenium is an essential trace element that plays a crucial role in the functioning of the immune system, thyroid function, and antioxidant defense.",
      "Some studies suggest that selenium supplements may have a protective effect against prostate cancer.",
      "A study in the Journal of the National Cancer Institute found that men with higher selenium levels had a lower risk of developing prostate cancer.",
      "Other studies, including one in the Journal of the American Medical Association, found no association between selenium supplements and prostate cancer risk.",
      "Prostate cancer is a complex disease that is influenced by many factors, including genetics, lifestyle, and environmental exposures."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2227,
    "user_query": "Is Downs syndrome associated with decreased risk of leukemia?",
    "vicuna-7b_response": "Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. This extra genetic material can affect the development and function of cells in the body, including blood cells.\nThere is some evidence to suggest that people with Down syndrome may have a decreased risk of developing certain types of leukemia, such as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). This is thought to be due to the fact that the extra genetic material in people with Down syndrome can disrupt the normal function of blood cells, making it more difficult for cancer to develop.\nHowever, it is important to note that people with Down syndrome are still at an increased risk of developing other types of cancer, such as solid tumors, and that the overall risk of developing cancer is higher for individuals with Down syndrome compared to the general population.\nIt is also important to note that the risk of developing cancer can vary greatly depending on the specific genetic makeup of an individual with Down syndrome, as well as other factors such as age, lifestyle, and access to medical care.\nOverall, it is important for individuals with Down syndrome to receive regular cancer screenings and to follow the recommendations of their healthcare provider to reduce their risk of developing cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21.\n2. The extra genetic material in people with Down syndrome can affect the development and function of cells in the body, including blood cells.\n3. People with Down syndrome may have a decreased risk of developing acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).\n4. People with Down syndrome are at an increased risk of developing other types of cancer, such as solid tumors.\n5. The overall risk of developing cancer is higher for individuals with Down syndrome compared to the general population.",
    "vicuna-7b_fact": [
      "Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21.",
      "The extra genetic material in people with Down syndrome can affect the development and function of cells in the body, including blood cells.",
      "People with Down syndrome may have a decreased risk of developing acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).",
      "People with Down syndrome are at an increased risk of developing other types of cancer, such as solid tumors.",
      "The overall risk of developing cancer is higher for individuals with Down syndrome compared to the general population."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: People with Down syndrome have an increased risk of developing certain types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).\n4. FALSE [correction]: People with Down syndrome are generally at a reduced risk of developing many types of solid tumors compared with the general population.\n5. FALSE [correction]: The overall risk of developing cancer is lower for individuals with Down syndrome compared to the general population, despite the increased risk for certain types of leukemia.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2230,
    "user_query": "Hy's law measures failure for what organ?",
    "vicuna-7b_response": "Hy's law measures failure for the renal tubular cells in the kidneys.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. Hy's law measures failure for the renal tubular cells in the kidneys.",
    "vicuna-7b_fact": [
      "Hy's law measures failure for the renal tubular cells in the kidneys."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Hy's law is a measure used to predict severe drug-induced liver injury, not failure of renal tubular cells in the kidneys.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-7b_response": "There are several R packages that can be used for the identification of pediatric brain tumors, including:\n1. Brain-Tumor-Classifier: This package uses machine learning algorithms to classify brain tumors into different categories, including pediatric brain tumors.\n2. R-CNN: This package is a deep learning framework that can be used for object detection, including the detection of brain tumors in pediatric MRI scans.\n3. TensorFlow: This is a popular deep learning framework that can be used for a variety of tasks, including image classification and object detection.\n4. H2O.ai: This package is a machine learning platform that can be used for a variety of tasks, including the identification of pediatric brain tumors.\n5. Caret: This package is a collection of functions for planning, fitting, and assessing machine learning models, including those used for the identification of pediatric brain tumors.\nIt's important to note that the choice of package will depend on the specific task and the data that is available. It's also important to consult with a medical professional before using any package for diagnostic purposes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Brain-Tumor-Classifier R package can be used to classify brain tumors into different categories.\n2. R-CNN is a deep learning framework that can be used for object detection, including the detection of brain tumors in pediatric MRI scans.\n3. TensorFlow can be used for tasks such as image classification and object detection.\n4. H2O.ai is a machine learning platform that can be used for tasks including the identification of pediatric brain tumors.\n5. The Caret R package includes functions for planning, fitting, and assessing machine learning models, including those used for pediatric brain tumor identification.",
    "vicuna-7b_fact": [
      "The Brain-Tumor-Classifier R package can be used to classify brain tumors into different categories.",
      "R-CNN is a deep learning framework that can be used for object detection, including the detection of brain tumors in pediatric MRI scans.",
      "TensorFlow can be used for tasks such as image classification and object detection.",
      "H2O.ai is a machine learning platform that can be used for tasks including the identification of pediatric brain tumors.",
      "The Caret R package includes functions for planning, fitting, and assessing machine learning models, including those used for pediatric brain tumor identification."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2243,
    "user_query": "Which factors drive replisome disassembly during DNA replication termination and mitosis?",
    "vicuna-7b_response": "During DNA replication termination and mitosis, the replisome disassembles in a process that is regulated by several factors. These factors include:\n1. Replication fork progression: As the replication fork moves closer to the end of the chromosome, the replisome disassembles to allow for the completion of the replication process.\n2. Replication fork stalling: If the replication fork stalls, the replisome disassembles to allow for the completion of the replication process.\n3. Replication fork collapse: If the replication fork collapses, the replisome disassembles to allow for the completion of the replication process.\n4. Replication fork restart: If the replication fork restarts, the replisome disassembles to allow for the completion of the replication process.\n5. Chromosome structure: The structure of the chromosome can also influence the disassembly of the replisome. For example, the presence of heterochromatin can inhibit the disassembly of the replisome.\n6. Chromosome size: The size of the chromosome can also influence the disassembly of the replisome. Larger chromosomes may require more time for the replisome to disassemble.\n7. Chromosome position: The position of the chromosome on the chromosome can also influence the disassembly of the replisome. For example, chromosomes that are positioned closer to the spindle pole can be more easily disassembled.\n8. Chromosome condensation: The degree of chromosome condensation can also influence the disassembly of the replisome. For example, more condensed chromosomes may require more time for the replisome to disassemble.\n9. Chromosome replication history: The history of replication of the chromosome can also influence the disassembly of the replisome. For example, chromosomes that have undergone multiple rounds of replication may require more time for the replisome to disassemble.\n10. Chromosome damage: Chromosome damage can also influence the disassembly of the replisome. For example, chromos",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Replication fork progression is a factor that drives replisome disassembly during DNA replication termination and mitosis.\n2. Replication fork stalling can cause the replisome to disassemble during DNA replication termination and mitosis.\n3. The disassembly of the replisome during DNA replication termination and mitosis can be triggered by replication fork collapse.\n4. If the replication fork restarts, the replisome disassembles.\n5. The presence of heterochromatin in the chromosome structure can inhibit the disassembly of the replisome. \n6. The size of the chromosome can influence the disassembly of the replisome.\n7. The position of the chromosome can influence the disassembly of the replisome.\n8. The degree of chromosome condensation can influence the disassembly of the replisome.\n9. The history of replication of the chromosome can influence the disassembly of the replisome.\n10. Chromosome damage can also influence the disassembly of the replisome.",
    "vicuna-7b_fact": [
      "Replication fork progression is a factor that drives replisome disassembly during DNA replication termination and mitosis.",
      "Replication fork stalling can cause the replisome to disassemble during DNA replication termination and mitosis.",
      "The disassembly of the replisome during DNA replication termination and mitosis can be triggered by replication fork collapse.",
      "If the replication fork restarts, the replisome disassembles.",
      "The presence of heterochromatin in the chromosome structure can inhibit the disassembly of the replisome.",
      "The size of the chromosome can influence the disassembly of the replisome.",
      "The position of the chromosome can influence the disassembly of the replisome.",
      "The degree of chromosome condensation can influence the disassembly of the replisome.",
      "The history of replication of the chromosome can influence the disassembly of the replisome.",
      ". Chromosome damage can also influence the disassembly of the replisome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: If the replication fork restarts, the replisome does not necessarily disassemble. Depending on the specific circumstances and mechanisms at play, it can potentially be restored and replication can resume.\n5. UNKNOWN\n6. UNKNOWN\n7. UNKNOWN\n8. UNKNOWN\n9. UNKNOWN\n10. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2244,
    "user_query": "Does RNA polymerase II have RNA cleavage activity?",
    "vicuna-7b_response": "RNA polymerase II is an enzyme that is responsible for synthesizing RNA molecules from DNA templates in all organisms that have a nucleus. It is a key component of the cell's protein-synthesizing machinery and plays a crucial role in the expression of genetic information.\nRNA polymerase II does not have RNA cleavage activity. Instead, it is responsible for adding nucleotides to the 5' end of an RNA molecule, using the template provided by the DNA strand. This process is known as transcription and involves the synthesis of a complementary RNA strand from a DNA template.\nOnce the RNA polymerase II enzyme has synthesized an RNA molecule to the end of the gene, it dissociates from the DNA template and the newly synthesized RNA molecule is released. The RNA molecule can then be used for various cellular processes, such as translation into proteins or for other regulatory functions.\nIn summary, RNA polymerase II is an enzyme that is responsible for synthesizing RNA molecules from DNA templates, but it does not have RNA cleavage activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA polymerase II is an enzyme that synthesizes RNA molecules from DNA templates in all organisms that have a nucleus.\n2. RNA polymerase II does not have RNA cleavage activity.\n3. RNA polymerase II adds nucleotides to the 5' end of an RNA molecule, using the template provided by the DNA strand.\n4. The process of adding nucleotides to the 5' end of an RNA molecule by RNA polymerase II is known as transcription.\n5. Once the RNA polymerase II enzyme has synthesized an RNA molecule to the end of the gene, it dissociates from the DNA template and the newly synthesized RNA molecule is released.",
    "vicuna-7b_fact": [
      "RNA polymerase II is an enzyme that synthesizes RNA molecules from DNA templates in all organisms that have a nucleus.",
      "RNA polymerase II does not have RNA cleavage activity.",
      "RNA polymerase II adds nucleotides to the 5' end of an RNA molecule, using the template provided by the DNA strand.",
      "The process of adding nucleotides to the 5' end of an RNA molecule by RNA polymerase II is known as transcription.",
      "Once the RNA polymerase II enzyme has synthesized an RNA molecule to the end of the gene, it dissociates from the DNA template and the newly synthesized RNA molecule is released."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: RNA polymerase II adds nucleotides to the 3' end of an RNA molecule, using the template provided by the DNA strand.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2245,
    "user_query": "Is there a sequence bias in MNase digestion patterns?",
    "vicuna-7b_response": "Yes, there can be a sequence bias in MNase digestion patterns. MNase (Mini-mutase) is an enzyme that cuts DNA at specific sites, creating small DNA fragments that are typically 100-200 base pairs in length. The specificity of MNase for cutting at certain sites can be influenced by the sequence of nucleotides surrounding the cutting site.\nFor example, MNase tends to cut more frequently at guanine-rich regions of the DNA, such as G-rich regions near the transcription start site (TSS) of a gene. This is because guanine residues are more prone to hydrolysis by MNase, leading to more frequent cutting at these regions.\nIn addition, MNase can also cut more frequently at regions of the DNA that are rich in A-T base pairs, as A-T base pairs are more stable than G-C base pairs and are less likely to be cleaved by MNase.\nOverall, the specificity of MNase for cutting DNA can be influenced by the sequence of nucleotides surrounding the cutting site, leading to a potential sequence bias in MNase digestion patterns.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MNase, also known as Mini-mutase, is an enzyme that cuts DNA at specific sites.\n2. The DNA fragments created by MNase are typically 100-200 base pairs in length.\n3. MNase tends to cut more frequently at guanine-rich regions of the DNA, such as G-rich regions near the transcription start site (TSS) of a gene.\n4. Guanine residues are more prone to hydrolysis by MNase, leading to more frequent cutting at these regions.\n5. MNase can also cut more frequently at regions of the DNA that are rich in A-T base pairs, as A-T base pairs are more stable than G-C base pairs and are less likely to be cleaved by MNase.",
    "vicuna-7b_fact": [
      "MNase, also known as Mini-mutase, is an enzyme that cuts DNA at specific sites.",
      "The DNA fragments created by MNase are typically 100-200 base pairs in length.",
      "MNase tends to cut more frequently at guanine-rich regions of the DNA, such as G-rich regions near the transcription start site (TSS) of a gene.",
      "Guanine residues are more prone to hydrolysis by MNase, leading to more frequent cutting at these regions.",
      "MNase can also cut more frequently at regions of the DNA that are rich in A-T base pairs, as A-T base pairs are more stable than G-C base pairs and are less likely to be cleaved by MNase."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MNase, also known as Micrococcal nuclease, is an enzyme that cuts DNA at specific sites.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: MNase does not cut more frequently at A-T rich regions because these areas are more stable. MNase tends to cut more frequently at regions that are more accessible, or less tightly wound and these are typically A-T rich regions.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-7b_response": "Yes, Nemo is a zinc finger protein. Zinc finger proteins are proteins that contain a zinc ion in their structure and are involved in regulating gene expression. Nemo is a zinc finger protein that is involved in the regulation of gene expression in the nervous system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nemo is a zinc finger protein.\n2. Zinc finger proteins contain a zinc ion in their structure.\n3. Zinc finger proteins are involved in regulating gene expression.\n4. Nemo is involved in the regulation of gene expression in the nervous system.",
    "vicuna-7b_fact": [
      "Nemo is a zinc finger protein.",
      "Zinc finger proteins contain a zinc ion in their structure.",
      "Zinc finger proteins are involved in regulating gene expression.",
      "Nemo is involved in the regulation of gene expression in the nervous system."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-7b_response": "TFIIS (Transcription Factor IIS) is a transcriptional elongation factor that plays a critical role in the initiation and elongation of RNA polymerase II transcription. TFIIS interacts with the RNA polymerase II holoenzyme and helps to recruit and stabilize the transcription elongation factor EF-1α.\nIn terms of nucleosome positioning, TFIIS does not directly affect nucleosome positioning. Nucleosomes are composed of histone proteins that are arranged around DNA in a way that compacts the DNA and allows it to be more easily packaged into the cell's nucleus. Nucleosomes are typically found at the core of the chromatin fiber, and their positioning is determined by the interactions between the histone tails and the DNA.\nHowever, TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process. For example, TFIIS can help to recruit the transcription elongation factor EF-1α to the promoter region, which can lead to the disassembly of nucleosomes and the opening up of the chromatin structure. This can allow for the transcriptional machinery to access the DNA and initiate transcription.\nIn summary, while TFIIS does not directly affect nucleosome positioning, it can indirectly influence nucleosome positioning by influencing the transcriptional elongation process.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TFIIS (Transcription Factor IIS) is a transcriptional elongation factor.\n2. TFIIS plays a critical role in the initiation and elongation of RNA polymerase II transcription.\n3. TFIIS interacts with the RNA polymerase II holoenzyme and helps to recruit and stabilize the transcription elongation factor EF-1α.\n4. Nucleosomes are composed of histone proteins that are arranged around DNA.\n5. TFIIS can help to recruit the transcription elongation factor EF-1α to the promoter region, which can lead to the disassembly of nucleosomes and the opening up of the chromatin structure.",
    "vicuna-7b_fact": [
      "TFIIS (Transcription Factor IIS) is a transcriptional elongation factor.",
      "TFIIS plays a critical role in the initiation and elongation of RNA polymerase II transcription.",
      "TFIIS interacts with the RNA polymerase II holoenzyme and helps to recruit and stabilize the transcription elongation factor EF-1α.",
      "Nucleosomes are composed of histone proteins that are arranged around DNA.",
      "TFIIS can help to recruit the transcription elongation factor EF-1α to the promoter region, which can lead to the disassembly of nucleosomes and the opening up of the chromatin structure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TFIIS interacts with RNA polymerase II during the transcription elongation process but does not recruit or stabilize the transcription elongation factor EF-1α.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2250,
    "user_query": "What is metaSPAdes?",
    "vicuna-7b_response": "metaSPAdes is a software tool that is used for analyzing and visualizing large-scale genomic data. It is a web-based application that allows users to perform a variety of analyses, including genome assembly, variant calling, and gene expression analysis.\nmetaSPAdes is based on the SPAdes algorithm, which is a popular software tool for genome assembly. The tool uses a combination of computational and statistical methods to assemble large genomic datasets into smaller, more manageable pieces called contigs. These contigs can then be used for further analysis, such as identifying genes and studying gene expression patterns.\nIn addition to genome assembly, metaSPAdes also provides a variety of other tools for analyzing genomic data. For example, it includes a variant caller that can identify genetic variations between different individuals or species, as well as a tool for studying gene expression patterns in different tissues or conditions.\nOverall, metaSPAdes is a powerful tool for genomic researchers and is widely used in the scientific community.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. metaSPAdes is a software tool used for analyzing and visualizing large-scale genomic data.\n2. It is a web-based application.\n3. metaSPAdes is based on the SPAdes algorithm.\n4. The tool uses computational and statistical methods to assemble large genomic datasets into smaller pieces called contigs.\n5. Included in metaSPAdes are tools for identifying genetic variations between individuals or species and studying gene expression patterns.",
    "vicuna-7b_fact": [
      "metaSPAdes is a software tool used for analyzing and visualizing large-scale genomic data.",
      "It is a web-based application.",
      "metaSPAdes is based on the SPAdes algorithm.",
      "The tool uses computational and statistical methods to assemble large genomic datasets into smaller pieces called contigs.",
      "Included in metaSPAdes are tools for identifying genetic variations between individuals or species and studying gene expression patterns."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: metaSPAdes is not a web-based application; it is a standalone software that is typically run on a command line interface.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: metaSPAdes is a tool for assembling genome sequences from metagenomic data; it does not directly include tools for identifying genetic variations or studying gene expression patterns. Functions for these analyses would require additional bioinformatics tools.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2257,
    "user_query": "What is the difference between ganglion mother cells (GMC) and intermediate neural precursor cells (INP) in Drosophila?",
    "vicuna-7b_response": "In Drosophila, ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two types of neural progenitor cells that play different roles in the development of the nervous system.\nGMCs are a type of neural progenitor cell that give rise to the neurons of the ventral nerve cord, which is the part of the nervous system that runs along the ventral (bottom) side of the animal. GMCs are characterized by their ability to divide and give rise to daughter cells that will differentiate into neurons. They are also capable of giving rise to glial cells, which are non-neuronal cells that support the function of the nervous system.\nINPs, on the other hand, are a type of neural progenitor cell that give rise to the neurons of the brain and the ventral nerve cord. INPs are more versatile than GMCs, as they are capable of giving rise to both neurons and glial cells. They are also more pluripotent than GMCs, meaning that they have the ability to give rise to a wider range of cell types.\nOne key difference between GMCs and INPs is the location where they give rise to neurons. GMCs give rise to neurons in the ventral nerve cord, while INPs give rise to neurons in the brain and the ventral nerve cord. Additionally, GMCs are more restricted in their ability to give rise to glial cells, while INPs have a greater potential to give rise to glial cells.\nOverall, GMCs and INPs play different roles in the development of the nervous system in Drosophila, with GMCs giving rise to neurons in the ventral nerve cord and INPs giving rise to neurons in the brain and the ventral nerve cord, as well as glial cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In Drosophila, ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are types of neural progenitor cells.\n2. GMCs give rise to the neurons of the ventral nerve cord in Drosophila.\n3. GMCs are capable of dividing and generating daughter cells that can differentiate into neurons and glial cells.\n4. INPs in Drosophila can generate neurons for both the brain and the ventral nerve cord.\n5. INPs possess greater pluripotency than GMCs, meaning that they can produce a wider variety of cell types, including glial cells.",
    "vicuna-7b_fact": [
      "In Drosophila, ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are types of neural progenitor cells.",
      "GMCs give rise to the neurons of the ventral nerve cord in Drosophila.",
      "GMCs are capable of dividing and generating daughter cells that can differentiate into neurons and glial cells.",
      "INPs in Drosophila can generate neurons for both the brain and the ventral nerve cord.",
      "INPs possess greater pluripotency than GMCs, meaning that they can produce a wider variety of cell types, including glial cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-7b_response": "The origins of replication close to yeast centromeres fire early.\nCentromeres are the regions of the chromosome where the two sister chromatids are joined during cell division, and they are also the sites where the replication originates. In yeast, the origins of replication are located close to the centromeres, and they fire early during the S phase of the cell cycle.\nThis is in contrast to origins located far from the centromeres, which fire later in the S phase. The early firing of origins close to the centromeres ensures that replication occurs before the chromosomes are separated during cell division, ensuring that each daughter cell receives an exact copy of the genetic material.\nOverall, the timing of replication origin firing is critical for maintaining genetic stability and ensuring proper cell division.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Centromeres are the regions of the chromosome where the two sister chromatids are joined during cell division.\n2. In yeast, the origins of replication are located close to the centromeres.\n3. The origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.\n4. Origins of replication located far from the centromeres fire later in the S phase.\n5. The timing of replication origin firing is critical for maintaining genetic stability and ensuring proper cell division.",
    "vicuna-7b_fact": [
      "Centromeres are the regions of the chromosome where the two sister chromatids are joined during cell division.",
      "In yeast, the origins of replication are located close to the centromeres.",
      "The origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.",
      "Origins of replication located far from the centromeres fire later in the S phase.",
      "The timing of replication origin firing is critical for maintaining genetic stability and ensuring proper cell division."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: In yeast, the origins of replication are not necessarily located close to the centromeres.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-7b_response": "Mammalian GA-sequences are a type of non-coding RNA that are found in the nuclei of mammalian cells. They are characterized by the presence of a specific sequence called the GA-sequence, which is composed of the nucleotides guanine, adenine, and cytosine.\nIn addition to the GA-sequence, mammalian GA-sequences also contain a specific type of modification called N6-methyladenosine (m6A). This modification is thought to play a role in regulating the expression of genes and is involved in a variety of cellular processes, including development, differentiation, and cellular metabolism.\nMammalian GA-sequences are found in a variety of tissues and cell types, and their expression is regulated by a complex network of transcription factors, epigenetic modifications, and other regulatory mechanisms.\nOverall, mammalian GA-sequences are an important class of non-coding RNA that play a critical role in regulating gene expression and cellular processes in mammalian cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.\n2. The GA-sequence is made up of the nucleotides guanine, adenine, and cytosine.\n3. Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).\n4. The N6-methyladenosine (m6A) modification in mammalian GA-sequences is believed to play a role in regulating gene expression and is involved in various cellular processes.\n5. Expression of mammalian GA-sequences is regulated by a complex network of transcription factors, epigenetic modifications, and other regulatory mechanisms.",
    "vicuna-7b_fact": [
      "Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.",
      "The GA-sequence is made up of the nucleotides guanine, adenine, and cytosine.",
      "Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).",
      "The N6-methyladenosine (m6A) modification in mammalian GA-sequences is believed to play a role in regulating gene expression and is involved in various cellular processes.",
      "Expression of mammalian GA-sequences is regulated by a complex network of transcription factors, epigenetic modifications, and other regulatory mechanisms."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2272,
    "user_query": "What is the origin of XUT transcripts in yeast?",
    "vicuna-7b_response": "XUT transcripts in yeast are derived from the Xeroderma Pigmentosum group A (XPA) gene. XPA is a protein that plays a critical role in the repair of DNA damage caused by ultraviolet (UV) light. Mutations in the XPA gene can lead to the development of skin cancer and other diseases.\nIn yeast, the XPA gene is involved in the DNA damage response pathway, which is a cellular mechanism that detects and repairs DNA damage. The XPA protein is recruited to sites of DNA damage and functions as a scaffold protein to bring together other proteins involved in the repair process.\nThe XUT transcripts in yeast are derived from a non-coding region of the XPA gene called the XPA upstream transcript (XUT). This non-coding region contains a promoter sequence that can be used to drive the expression of genes. In yeast, the XUT transcript is produced from this promoter sequence and is involved in the regulation of XPA gene expression.\nOverall, the origin of XUT transcripts in yeast is derived from the XPA gene and plays a role in the DNA damage response pathway.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. XUT transcripts in yeast are derived from the Xeroderma Pigmentosum group A (XPA) gene.\n2. XPA is a protein that plays a role in the repair of DNA damage caused by ultraviolet (UV) light.\n3. Mutations in the XPA gene can lead to the development of skin cancer and other diseases.\n4. In yeast, the XPA gene is involved in the DNA damage response pathway.\n5. XUT transcripts in yeast are produced from the promoter sequence in the non-coding region of the XPA gene, which is involved in the regulation of XPA gene expression.",
    "vicuna-7b_fact": [
      "XUT transcripts in yeast are derived from the Xeroderma Pigmentosum group A (XPA) gene.",
      "XPA is a protein that plays a role in the repair of DNA damage caused by ultraviolet (UV) light.",
      "Mutations in the XPA gene can lead to the development of skin cancer and other diseases.",
      "In yeast, the XPA gene is involved in the DNA damage response pathway.",
      "XUT transcripts in yeast are produced from the promoter sequence in the non-coding region of the XPA gene, which is involved in the regulation of XPA gene expression."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: XUT transcripts in yeast are not derived from the Xeroderma Pigmentosum group A (XPA) gene. It is likely derived from other genes in yeast that has not been mentioned in the context.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In yeast, it would not be the XPA gene involved in the DNA damage response pathway as it is a human gene. Yeast use other genes for this function.\n5. FALSE [correction]: XUT transcripts in yeast are not produced from the promoter sequence in the non-coding region of the XPA gene as this is a human gene and not present in yeast.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2274,
    "user_query": "Is autophagy modulated in a circadian fashion?",
    "vicuna-7b_response": "Yes, autophagy is modulated in a circadian fashion. Autophagy is a cellular process that involves the breakdown of damaged organelles, proteins, and other cellular components. It is a crucial process for maintaining cellular homeostasis and has been implicated in various physiological and pathological processes.\nResearch has shown that autophagy is regulated by a complex interplay of genetic and environmental factors, including the circadian clock. The circadian clock is a biological mechanism that regulates various physiological processes, including metabolism, in response to the daily light-dark cycle.\nStudies have shown that the expression of genes involved in autophagy, such as beclin 1 and Atg5, is regulated in a circadian fashion in various cell types. For example, in mice, the expression of beclin 1, a key regulator of autophagy, is highest during the day and decreases at night. Similarly, the expression of other autophagy-related genes, such as Atg7 and Atg16L, also follows a circadian pattern.\nFurthermore, studies have shown that the circadian clock regulates the expression of genes involved in the autophagy pathway through the action of transcription factors, such as CLOCK and BMAL1, and the production of cyclical molecules, such as cyclic AMP (cAMP) and cyclic GMP (cGMP).\nOverall, these findings suggest that autophagy is modulated in a circadian fashion, and the circadian clock plays a crucial role in regulating the expression of genes involved in the autophagy pathway.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a cellular process that involves the breakdown of damaged organelles, proteins, and other cellular components.\n2. Autophagy is crucial for maintaining cellular homeostasis.\n3. Autophagy is regulated by a complex interplay of genetic and environmental factors, including the circadian clock.\n4. Studies have shown that the expression of genes involved in autophagy is regulated in a circadian fashion.\n5. The circadian clock regulates the expression of genes involved in the autophagy pathway through the action of transcription factors, such as CLOCK and BMAL1, and the production of cyclical molecules, such as cyclic AMP (cAMP) and cyclic GMP (cGMP).",
    "vicuna-7b_fact": [
      "Autophagy is a cellular process that involves the breakdown of damaged organelles, proteins, and other cellular components.",
      "Autophagy is crucial for maintaining cellular homeostasis.",
      "Autophagy is regulated by a complex interplay of genetic and environmental factors, including the circadian clock.",
      "Studies have shown that the expression of genes involved in autophagy is regulated in a circadian fashion.",
      "The circadian clock regulates the expression of genes involved in the autophagy pathway through the action of transcription factors, such as CLOCK and BMAL1, and the production of cyclical molecules, such as cyclic AMP (cAMP) and cyclic GMP (cGMP)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2275,
    "user_query": "Is Drk essential for anesthesia-resistant memory (ARM) in Drosophila?",
    "vicuna-7b_response": "Drk, also known as Drosophila reaper, is a protein that plays a crucial role in the regulation of cell death and the immune response in Drosophila. While Drk has been shown to be involved in the regulation of anesthesia-resistant memory (ARM), the exact role it plays in this process is not yet fully understood.\nStudies have shown that Drk is required for the development of ARM in Drosophila. For example, a study published in the journal Neuron in 2012 found that Drk is necessary for the formation of a specific type of memory called contextual fear conditioning, which is a form of ARM. The study also found that Drk regulates the expression of genes involved in the immune response and the clearance of dead cells, suggesting that it may play a role in the regulation of the immune response during memory formation.\nAnother study published in the journal Science in 2015 found that Drk is required for the expression of a gene called CG5829, which is involved in the regulation of the immune response. The study also found that Drk regulates the expression of genes involved in the clearance of dead cells, suggesting that it may play a role in the regulation of the immune response during memory formation.\nOverall, while more research is needed to fully understand the role of Drk in the regulation of anesthesia-resistant memory in Drosophila, it is clear that Drk is involved in the regulation of the immune response and cell death during memory formation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Drk, or Drosophila reaper, is a protein that regulates cell death and the immune response in Drosophila.\n2. Studies have shown that Drk is required for the development of anesthesia-resistant memory (ARM) in Drosophila.\n3. A 2012 study in the journal Neuron found that Drk is necessary for the formation of contextual fear conditioning, a form of ARM.\n4. The same 2012 study in the journal Neuron found that Drk regulates the expression of genes involved in the immune response and the clearance of dead cells.\n5. A 2015 study published in the journal Science found that Drk is required for the expression of a gene called CG5829.",
    "vicuna-7b_fact": [
      "Drk, or Drosophila reaper, is a protein that regulates cell death and the immune response in Drosophila.",
      "Studies have shown that Drk is required for the development of anesthesia-resistant memory (ARM) in Drosophila.",
      "A 2012 study in the journal Neuron found that Drk is necessary for the formation of contextual fear conditioning, a form of ARM.",
      "The same 2012 study in the journal Neuron found that Drk regulates the expression of genes involved in the immune response and the clearance of dead cells.",
      "A 2015 study published in the journal Science found that Drk is required for the expression of a gene called CG5829."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2284,
    "user_query": "Has IVIG been tested in clinical trials for the treatment of Alzheimer's disease?",
    "vicuna-7b_response": "Yes, intravenous immunoglobulin (IVIG) has been tested in clinical trials for the treatment of Alzheimer's disease.\nIVIG is a preparation of pooled human immunoglobulin G (IgG) that contains antibodies from thousands of donors. It has been studied as a potential treatment for Alzheimer's disease due to its potential to reduce amyloid beta plaques and tau tangles, which are thought to play a role in the development of the disease.\nThere have been several clinical trials that have investigated the use of IVIG in Alzheimer's disease. One of the most notable trials was the phase 3 trial called ANNOUNCE, which was conducted by Biogen. The trial involved 1,312 participants with early Alzheimer's disease and found that IVIG did not significantly improve cognitive function or daily living activities compared to placebo.\nHowever, it is important to note that the results of these trials may not necessarily reflect the experiences of all individuals who have used IVIG for the treatment of Alzheimer's disease. Some people may have had positive experiences with IVIG, while others may not have seen any benefits.\nIt is also important to note that there are other potential treatments for Alzheimer's disease, including medications that can help manage symptoms and supportive care to improve quality of life. If you are interested in exploring treatment options for Alzheimer's disease, it is best to speak with a healthcare professional who can provide personalized advice and guidance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intravenous immunoglobulin (IVIG) has been tested in clinical trials for the treatment of Alzheimer's disease.\n2. IVIG is a preparation of pooled human immunoglobulin G (IgG) that contains antibodies from thousands of donors.\n3. IVIG has been studied for its potential to reduce amyloid beta plaques and tau tangles in Alzheimer's disease.\n4. The phase 3 trial called ANNOUNCE, conducted by Biogen, involved 1,312 participants with early Alzheimer's disease and found that IVIG did not significantly improve cognitive function or daily living activities compared to placebo.\n5. There are other potential treatments for Alzheimer's disease, including medications that can help manage symptoms and supportive care to improve quality of life.",
    "vicuna-7b_fact": [
      "Intravenous immunoglobulin (IVIG) has been tested in clinical trials for the treatment of Alzheimer's disease.",
      "IVIG is a preparation of pooled human immunoglobulin G (IgG) that contains antibodies from thousands of donors.",
      "IVIG has been studied for its potential to reduce amyloid beta plaques and tau tangles in Alzheimer's disease.",
      "The phase 3 trial called ANNOUNCE, conducted by Biogen, involved 1,312 participants with early Alzheimer's disease and found that IVIG did not significantly improve cognitive function or daily living activities compared to placebo.",
      "There are other potential treatments for Alzheimer's disease, including medications that can help manage symptoms and supportive care to improve quality of life."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The phase 3 trial, called Gamme Ventoux, conducted by Baxter, was the one that involved IVIG and Alzheimer's disease. It found that IVIG had no significant impact on cognitive decline in Alzheimer's patients compared to a placebo.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2285,
    "user_query": "Which type of urinary incontinence is diagnosed with the Q tip test?",
    "vicuna-7b_response": "The Q-tip test is not a diagnostic test for any type of urinary incontinence. The Q-tip test is a test used to assess the size and shape of the vaginal canal and the position of the urethra. It is typically performed during a pelvic examination by a healthcare provider.\nUrinary incontinence is the involuntary leakage of urine and can be caused by a variety of factors, including pregnancy, childbirth, menopause, chronic cough, and certain medical conditions. There are several types of urinary incontinence, including stress incontinence, urge incontinence, and mixed incontinence.\nStress incontinence is caused by pressure on the bladder, such as when coughing, sneezing, or laughing. Urge incontinence is characterized by a sudden, intense urge to urinate that is difficult to control. Mixed incontinence is a combination of stress and urge incontinence.\nIf you are experiencing symptoms of urinary incontinence, it is important to speak with a healthcare provider for proper evaluation and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Q-tip test is used to assess the size and shape of the vaginal canal and the position of the urethra.\n2. Urinary incontinence is the involuntary leakage of urine.\n3. There are several types of urinary incontinence, including stress incontinence, urge incontinence, and mixed incontinence.\n4. Stress incontinence is caused by pressure on the bladder such as when coughing, sneezing, or laughing.\n5. Urge incontinence is characterized by a sudden, intense urge to urinate that is difficult to control.",
    "vicuna-7b_fact": [
      "The Q-tip test is used to assess the size and shape of the vaginal canal and the position of the urethra.",
      "Urinary incontinence is the involuntary leakage of urine.",
      "There are several types of urinary incontinence, including stress incontinence, urge incontinence, and mixed incontinence.",
      "Stress incontinence is caused by pressure on the bladder such as when coughing, sneezing, or laughing.",
      "Urge incontinence is characterized by a sudden, intense urge to urinate that is difficult to control."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Q-tip test is used to assess the angle and movement of the urethra and identify if incontinence is stress-related.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2288,
    "user_query": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication",
    "vicuna-7b_response": "Cdc48 is a key protein involved in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast. Cdc48 is a member of the AAA+ (ATPases associated with diverse cellular activities) family of proteins and is known as the \"p97\" of budding yeast. Cdc48 is involved in the degradation of a wide range of proteins, including those that are misfolded or damaged.\nIn the context of the disassembly of ubiquitylated CMG helicase, Cdc48 acts as a chaperone and helps to recruit other proteins to the site of degradation. The following are some of the partners of Cdc48 that are important for the disassembly of ubiquitylated CMG helicase:\n1. Ufd1: Ufd1 is a ubiquitin-binding domain protein that interacts with the C-terminus of Cdc48. Ufd1 helps to recruit ubiquitinated proteins to Cdc48 for degradation.\n2. Cdc48-interacting protein 1 (Cip1): Cip1 is a member of the anaphase-promoting complex/cyclosome (APC/C) and interacts with Cdc48 to promote its degradation.\n3. Cdc48-interacting protein 2 (Cip2): Cip2 is a member of the APC/C and interacts with Cdc48 to promote its degradation.\n4. Skp1: Skp1 is a member of the F-box protein family and interacts with Cdc48 to promote its degradation.\n5. SCF complex: The SCF complex is a multi-protein complex that includes Skp1, Cdc48, and other proteins. The SCF complex recognizes and ubiquitinates target proteins, leading to their degradation by the 26S proteasome.\nOverall, these partners of Cdc48 are important for the disassembly of ubiquitylated CMG helicase at the end of chromosome replication by promoting the degradation of misfold",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cdc48 is a key protein involved in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast.\n2. Cdc48 is a member of the AAA+ (ATPases associated with diverse cellular activities) family of proteins.\n3. Ufd1 is a ubiquitin-binding domain protein that interacts with the C-terminus of Cdc48 for degradation of ubiquitinated proteins.\n4. Cdc48-interacting protein 1 (Cip1) interacts with Cdc48 to promote its degradation.\n5. The SCF complex is a multi-protein complex that includes Skp1, Cdc48, and other proteins and leads to the degradation of target proteins by the 26S proteasome.",
    "vicuna-7b_fact": [
      "Cdc48 is a key protein involved in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast.",
      "Cdc48 is a member of the AAA+ (ATPases associated with diverse cellular activities) family of proteins.",
      "Ufd1 is a ubiquitin-binding domain protein that interacts with the C-terminus of Cdc48 for degradation of ubiquitinated proteins.",
      "Cdc48-interacting protein 1 (Cip1) interacts with Cdc48 to promote its degradation.",
      "The SCF complex is a multi-protein complex that includes Skp1, Cdc48, and other proteins and leads to the degradation of target proteins by the 26S proteasome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cdc48-interacting protein 1 (Cip1) interacts with Cdc48 to promote the degradation of other proteins, not Cdc48 itself.\n5. FALSE [correction]: The SCF complex is a multi-protein complex that includes Skp1, Cullin-1, F-box protein and not Cdc48. It does lead to the degradation of target proteins by the 26S proteasome.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "vicuna-7b_response": "The number of Groucho-related genes (GRG) in the mouse genome is not a fixed number, as the genome is constantly evolving and new genes are being discovered. However, as of the latest mouse genome assembly (mm10), there are 10 known Groucho-related genes (GRG1-GRG10) that have been identified. These genes are also known as the Groucho family of genes, and they play a role in regulating the expression of other genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The number of Groucho-related genes (GRG) in the mouse genome is not a fixed number.\n2. There are 10 known Groucho-related genes (GRG1-GRG10) in the latest mouse genome assembly (mm10).\n3. These genes are also known as the Groucho family of genes.\n4. Groucho-related genes play a role in regulating the expression of other genes.",
    "vicuna-7b_fact": [
      "The number of Groucho-related genes (GRG) in the mouse genome is not a fixed number.",
      "There are 10 known Groucho-related genes (GRG1-GRG10) in the latest mouse genome assembly (mm10).",
      "These genes are also known as the Groucho family of genes.",
      "Groucho-related genes play a role in regulating the expression of other genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2295,
    "user_query": "Which are the main manifestations of Ohdo syndrome?",
    "vicuna-7b_response": "Ohdo syndrome is a rare genetic disorder caused by mutations in the OHDO1 gene. The main manifestations of Ohdo syndrome are:\n1. Intellectual disability: Children with Ohdo syndrome often have significant intellectual disability and delayed development.\n2. Developmental delays: Children with Ohdo syndrome may experience delays in reaching developmental milestones such as crawling, walking, and talking.\n3. Speech and language delays: Children with Ohdo syndrome may have difficulty speaking and understanding language, and may have a limited vocabulary.\n4. Seizures: Some children with Ohdo syndrome may experience seizures, which are episodes of abnormal brain activity that can cause convulsions, muscle spasms, and loss of consciousness.\n5. Muscle weakness and stiffness: Children with Ohdo syndrome may experience muscle weakness and stiffness, particularly in the legs and arms.\n6. Dental problems: Children with Ohdo syndrome may have abnormalities in the development of their teeth and jaws.\n7. Heart problems: Some children with Ohdo syndrome may have abnormalities in the structure and function of their heart.\n8. Eye problems: Children with Ohdo syndrome may have abnormalities in the development of their eyes, including strabismus (crossed eyes) and nystagmus (rapid, involuntary movements of the eyes).\nIt's important to note that the severity of symptoms can vary greatly among individuals with Ohdo syndrome, and some people may experience only a few of these symptoms. Additionally, some people with Ohdo syndrome may have other health problems that are not related to the disorder. If you or a loved one has been diagnosed with Ohdo syndrome, it's important to work with a healthcare provider who is knowledgeable about the disorder and can provide appropriate care and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ohdo syndrome is a rare genetic disorder caused by mutations in the OHDO1 gene.\n2. The main manifestations of Ohdo syndrome include intellectual disability and developmental delays.\n3. Children with Ohdo syndrome may experience speech and language delays.\n4. Some children with Ohdo syndrome may experience seizures.\n5. Children with Ohdo syndrome may also experience muscle weakness, dental problems, and heart and eye problems.",
    "vicuna-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder caused by mutations in the OHDO1 gene.",
      "The main manifestations of Ohdo syndrome include intellectual disability and developmental delays.",
      "Children with Ohdo syndrome may experience speech and language delays.",
      "Some children with Ohdo syndrome may experience seizures.",
      "Children with Ohdo syndrome may also experience muscle weakness, dental problems, and heart and eye problems."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Ohdo syndrome is a rare genetic disorder not limited to mutations in the OHDO1 gene. Mutations in several other genes like SMC1A, KAT6B can also cause this syndrome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2296,
    "user_query": "Which algorithm is used by the UCSC Genome Browser?",
    "vicuna-7b_response": "The UCSC Genome Browser uses a variety of algorithms to support its functionality, but one of the most important algorithms used by the browser is BLAST.\nBLAST (Basic Local Alignment Search Tool) is a widely used bioinformatics tool that compares large DNA or protein sequences to a database of known sequences to identify similarities and alignments. BLAST is used by the UCSC Genome Browser to identify and map genes to their corresponding genomic locations, as well as to identify similarities between different species and to identify potential functional elements in the genome.\nIn addition to BLAST, the UCSC Genome Browser also uses a variety of other algorithms to support its functionality, including:\n* Aligners: algorithms that align DNA or protein sequences to identify similarities and alignments.\n* Clustering algorithms: algorithms that group similar DNA or protein sequences together.\n* Gene finding algorithms: algorithms that identify and map genes to their corresponding genomic locations.\n* Variation detection algorithms: algorithms that identify variations in DNA or protein sequences, such as single nucleotide polymorphisms (SNPs) and insertions/deletions (indels).\nOverall, the UCSC Genome Browser uses a combination of algorithms and tools to support its functionality and provide valuable insights into the structure and function of genomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The UCSC Genome Browser uses the BLAST algorithm.\n2. BLAST (Basic Local Alignment Search Tool) is a bioinformatics tool that compares large DNA or protein sequences to a database of known sequences.\n3. BLAST is used by the UCSC Genome Browser to identify and map genes to their corresponding genomic locations.\n4. The UCSC Genome Browser uses aligners, clustering algorithms, gene finding algorithms, and variation detection algorithms.\n5. The UCSC Genome Browser uses a combination of algorithms and tools to support its functionality and provide insights into the structure and function of genomes.",
    "vicuna-7b_fact": [
      "The UCSC Genome Browser uses the BLAST algorithm.",
      "BLAST (Basic Local Alignment Search Tool) is a bioinformatics tool that compares large DNA or protein sequences to a database of known sequences.",
      "BLAST is used by the UCSC Genome Browser to identify and map genes to their corresponding genomic locations.",
      "The UCSC Genome Browser uses aligners, clustering algorithms, gene finding algorithms, and variation detection algorithms.",
      "The UCSC Genome Browser uses a combination of algorithms and tools to support its functionality and provide insights into the structure and function of genomes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The UCSC Genome Browser does not use the BLAST algorithm but uses algorithms like BLAT (BLAST-like alignment tool) for sequence searching.\n2. TRUE\n3. FALSE [correction]: BLAST isn't used by the UCSC Genome Browser but BLAT is used to identify and map genes to their corresponding genomic locations.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2297,
    "user_query": "Which aminoacid position in the human CREB protein is phosphorylated?",
    "vicuna-7b_response": "The human CREB protein (CREB) is a transcription factor that plays a crucial role in the regulation of gene expression. CREB is phosphorylated at multiple positions, including Ser133, Thr142, and Ser377.\nPhosphorylation of CREB at Ser133 is mediated by the PKA (protein kinase A) enzyme, which is activated by the hormone epinephrine. This phosphorylation event leads to the dissociation of CREB from the inhibitory protein CBP (CREB-binding protein) and the recruitment of the coactivator p300, which facilitates the transcription of target genes.\nPhosphorylation of CREB at Thr142 is mediated by the PKC (protein kinase C) enzyme, which is activated by a variety of stimuli, including inflammatory cytokines and growth factors. This phosphorylation event leads to the recruitment of the coactivator p300 and the transcription of target genes.\nPhosphorylation of CREB at Ser377 is mediated by the PKA enzyme, which is activated by the hormone epinephrine. This phosphorylation event leads to the dissociation of CREB from the inhibitory protein CBP and the recruitment of the coactivator p300, which facilitates the transcription of target genes.\nIn summary, the human CREB protein is phosphorylated at multiple positions, including Ser133, Thr142, and Ser377. These phosphorylation events play a crucial role in the regulation of gene expression and the control of various cellular processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The human CREB protein is phosphorylated at Ser133, Thr142, and Ser377.\n2. Phosphorylation of CREB at Ser133 is mediated by the PKA (protein kinase A) enzyme.\n3. After phosphorylation at Ser133, CREB dissociates from CBP and recruits p300.\n4. Phosphorylation of CREB at Thr142 is mediated by the PKC (protein kinase C) enzyme.\n5. Phosphorylation of CREB at Ser377 is mediated by the PKA (protein kinase A) enzyme.",
    "vicuna-7b_fact": [
      "The human CREB protein is phosphorylated at Ser133, Thr142, and Ser377.",
      "Phosphorylation of CREB at Ser133 is mediated by the PKA (protein kinase A) enzyme.",
      "After phosphorylation at Ser133, CREB dissociates from CBP and recruits p300.",
      "Phosphorylation of CREB at Thr142 is mediated by the PKC (protein kinase C) enzyme.",
      "Phosphorylation of CREB at Ser377 is mediated by the PKA (protein kinase A) enzyme."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: After phosphorylation at Ser133, CREB associates with CBP and recruits p300.\n4. FALSE [correction]: Phosphorylation of CREB at Thr142 is mediated by the calcium/calmodulin-dependent protein kinases (CaMKs).\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2298,
    "user_query": "Which gene is the paralog of yeast UPC2?",
    "vicuna-7b_response": "The paralog of yeast UPC2 is likely to be UPC2P.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. UPC2P is the paralog of yeast UPC2.",
    "vicuna-7b_fact": [
      "UPC2P is the paralog of yeast UPC2."
    ],
    "vicuna-7b_judge_raw": "UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 2299,
    "user_query": "Where is the enzyme PM20D1 localized?",
    "vicuna-7b_response": "The enzyme PM20D1 is localized in the mitochondria of eukaryotic cells. It is a mitochondrial protein that is involved in the biosynthesis of isoprenoids, which are important components of many cellular signaling pathways. PM20D1 is a member of the Mitochondrial Protein Import Factor (MPIF) family, which is responsible for importing proteins into the mitochondria. The exact localization of PM20D1 within the mitochondria is not well understood, but it is thought to be associated with the inner membrane.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The enzyme PM20D1 is localized in the mitochondria of eukaryotic cells.\n2. PM20D1 is a mitochondrial protein that is involved in the biosynthesis of isoprenoids.\n3. Isoprenoids are important components of many cellular signaling pathways.\n4. PM20D1 is a member of the Mitochondrial Protein Import Factor (MPIF) family.\n5. The MPIF family is responsible for importing proteins into the mitochondria.",
    "vicuna-7b_fact": [
      "The enzyme PM20D1 is localized in the mitochondria of eukaryotic cells.",
      "PM20D1 is a mitochondrial protein that is involved in the biosynthesis of isoprenoids.",
      "Isoprenoids are important components of many cellular signaling pathways.",
      "PM20D1 is a member of the Mitochondrial Protein Import Factor (MPIF) family.",
      "The MPIF family is responsible for importing proteins into the mitochondria."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2301,
    "user_query": "How does increased GDF15 affect body weight?",
    "vicuna-7b_response": "Growth differentiation factor 15 (GDF15) is a protein that is produced by cells in the body and plays a role in regulating metabolism and body weight. Increased levels of GDF15 have been associated with obesity and weight gain.\nResearch has shown that GDF15 can increase appetite and food intake, leading to weight gain. Additionally, GDF15 can affect the metabolism of fat and carbohydrates, leading to an increase in body weight.\nStudies have also shown that GDF15 may play a role in the development of insulin resistance, a condition in which the body becomes less sensitive to the effects of insulin, a hormone that helps regulate blood sugar levels. Insulin resistance is a risk factor for obesity and type 2 diabetes, and it is thought that GDF15 may contribute to the development of these conditions by increasing insulin resistance.\nOverall, increased levels of GDF15 are associated with an increased risk of obesity and weight gain, and may contribute to the development of insulin resistance and other metabolic disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Growth differentiation factor 15 (GDF15) is a protein produced by cells in the body.\n2. GDF15 plays a role in regulating metabolism and body weight.\n3. Increased levels of GDF15 have been associated with obesity and weight gain.\n4. GDF15 can increase appetite and food intake, leading to weight gain.\n5. GDF15 may contribute to the development of insulin resistance, a condition that is a risk factor for obesity and type 2 diabetes.",
    "vicuna-7b_fact": [
      "Growth differentiation factor 15 (GDF15) is a protein produced by cells in the body.",
      "GDF15 plays a role in regulating metabolism and body weight.",
      "Increased levels of GDF15 have been associated with obesity and weight gain.",
      "GDF15 can increase appetite and food intake, leading to weight gain.",
      "GDF15 may contribute to the development of insulin resistance, a condition that is a risk factor for obesity and type 2 diabetes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Increased levels of GDF15 have been associated with weight loss and appetite suppression.\n4. FALSE [correction]: GDF15 can reduce appetite and food intake, contributing to weight loss.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-7b_response": "RNA polymerase II is a complex enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, including the catalytic subunit, which carries the RNA cleavage activity.\nThe catalytic subunit of RNA polymerase II is called the C-terminal domain (CTD). The CTD is responsible for the synthesis of the RNA polymerase II transcript, which is the primary template for transcription. The CTD also carries the RNA cleavage activity of the enzyme, which is necessary for the proper initiation and elongation of transcription.\nThe CTD is composed of a series of repeating units, called the C-repeat region, which are linked by a variable region. Each repeat unit contains a high-affinity site for the general transcription factor TFIIS, which is responsible for recruiting the enzyme to the promoter region of the DNA template. The CTD also contains a low-affinity site for the transcription elongation factor EF-1, which is responsible for the translocation of the enzyme along the DNA template.\nIn addition to the CTD, RNA polymerase II also contains several other subunits, including the largest subunit, which is responsible for the binding of the enzyme to the DNA template, and the sigma subunit, which is responsible for the recognition of the promoter region of the DNA template.\nOverall, the C-terminal domain of RNA polymerase II is responsible for the synthesis of the RNA polymerase II transcript and the RNA cleavage activity of the enzyme, which are necessary for the proper initiation and elongation of transcription.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RNA polymerase II is responsible for transcribing DNA into RNA.\n2. The catalytic subunit of RNA polymerase II carries the RNA cleavage activity.\n3. The catalytic subunit of RNA polymerase II is called the C-terminal domain (CTD). \n4. The CTD is responsible for the synthesis of the RNA polymerase II transcript.\n5. The C-terminal domain of RNA polymerase II is responsible for the RNA cleavage activity of the enzyme.",
    "vicuna-7b_fact": [
      "RNA polymerase II is responsible for transcribing DNA into RNA.",
      "The catalytic subunit of RNA polymerase II carries the RNA cleavage activity.",
      "The catalytic subunit of RNA polymerase II is called the C-terminal domain (CTD).",
      "The CTD is responsible for the synthesis of the RNA polymerase II transcript.",
      "The C-terminal domain of RNA polymerase II is responsible for the RNA cleavage activity of the enzyme."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: RNA cleavage activity is associated with snapback RNA synthesis, not specifically to the catalytic subunit of RNA polymerase II.\n3. FALSE [correction]: The C-terminal domain (CTD) is a part of RNA polymerase II, not specifically the catalytic subunit.\n4. TRUE\n5. FALSE [correction]: The C-terminal domain of RNA polymerase II is involved in the process of transcription, not specifically in RNA cleavage activity.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2306,
    "user_query": "How many PML isoforms exist in the human genome?",
    "vicuna-7b_response": "There are 18 PML (Promyelocytic Leukemia) isoforms that have been identified in the human genome. These isoforms are the result of alternative splicing of the PML gene, which encodes a nuclear protein that plays a role in the regulation of cell growth and apoptosis. The PML isoforms differ in their N-terminal domains and can have different functions depending on the isoform and the cell type in which they are expressed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are 18 PML (Promyelocytic Leukemia) isoforms identified in the human genome.\n2. The PML isoforms are the result of alternative splicing of the PML gene.\n3. The PML gene encodes a nuclear protein.\n4. This nuclear protein plays a role in the regulation of cell growth and apoptosis.\n5. The PML isoforms differ in their N-terminal domains and can have different functions depending on the isoform and the cell type in which they are expressed.",
    "vicuna-7b_fact": [
      "There are 18 PML (Promyelocytic Leukemia) isoforms identified in the human genome.",
      "The PML isoforms are the result of alternative splicing of the PML gene.",
      "The PML gene encodes a nuclear protein.",
      "This nuclear protein plays a role in the regulation of cell growth and apoptosis.",
      "The PML isoforms differ in their N-terminal domains and can have different functions depending on the isoform and the cell type in which they are expressed."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2312,
    "user_query": "Which tendons are affected in the Dequervain's tenosynovitis?",
    "vicuna-7b_response": "De Quervain's tenosynovitis is a condition that affects the tendons on the thumb side of the wrist. The tendons in question are the tendons that run from the thumb side of the wrist to the thumb itself, and they are called the abductor pollicis brevis and the extensor pollicis brevis. These tendons are responsible for moving the thumb and thumb joint, and when they become inflamed, it can cause pain and difficulty moving the thumb.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. De Quervain's tenosynovitis is a condition that affects the tendons on the thumb side of the wrist.\n2. The affected tendons in De Quervain's tenosynovitis are called the abductor pollicis brevis and the extensor pollicis brevis.\n3. The abductor pollicis brevis and the extensor pollicis brevis tendons run from the thumb side of the wrist to the thumb.\n4. These tendons are responsible for moving the thumb and thumb joint.\n5. Inflammation of these tendons can cause pain and difficulty moving the thumb.",
    "vicuna-7b_fact": [
      "De Quervain's tenosynovitis is a condition that affects the tendons on the thumb side of the wrist.",
      "The affected tendons in De Quervain's tenosynovitis are called the abductor pollicis brevis and the extensor pollicis brevis.",
      "The abductor pollicis brevis and the extensor pollicis brevis tendons run from the thumb side of the wrist to the thumb.",
      "These tendons are responsible for moving the thumb and thumb joint.",
      "Inflammation of these tendons can cause pain and difficulty moving the thumb."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The affected tendons in De Quervain's tenosynovitis are called the abductor pollicis longus and the extensor pollicis brevis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2314,
    "user_query": "What does davunetide do to microtubules?",
    "vicuna-7b_response": "Davunetide is a small molecule inhibitor that targets the dynamin-2 protein, which is involved in the formation and maintenance of microtubules.\nMicrotubules are dynamic structures that play a crucial role in various cellular processes, including cell division, intracellular transport, and cell shape. Dynamin-2 is a GTPase protein that is involved in the formation and maintenance of microtubules by regulating the assembly and disassembly of microtubules.\nDavunetide is a specific inhibitor of dynamin-2 and has been shown to disrupt microtubule formation and stability in various cell types. This effect is thought to be due to the inhibition of dynamin-2 activity, which leads to the disassembly of microtubules.\nIn addition to its effect on microtubules, davunetide has also been shown to have other effects on cellular processes, including the inhibition of cell migration and the induction of cell death.\nOverall, davunetide is a potent inhibitor of dynamin-2 and has the potential to be used as a therapeutic agent for the treatment of diseases that are associated with abnormal microtubule formation and maintenance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Davunetide is a small molecule inhibitor that targets the dynamin-2 protein.\n2. Dynamin-2 protein is involved in the formation and maintenance of microtubules.\n3. Microtubules play a crucial role in various cellular processes, such as cell division, intracellular transport, and cell shape.\n4. Davunetide can disrupt microtubule formation and stability in various cell types through the inhibition of dynamin-2 activity.\n5. Davunetide has potential use as a therapeutic agent for the treatment of diseases associated with abnormal microtubule formation and maintenance.",
    "vicuna-7b_fact": [
      "Davunetide is a small molecule inhibitor that targets the dynamin-2 protein.",
      "Dynamin-2 protein is involved in the formation and maintenance of microtubules.",
      "Microtubules play a crucial role in various cellular processes, such as cell division, intracellular transport, and cell shape.",
      "Davunetide can disrupt microtubule formation and stability in various cell types through the inhibition of dynamin-2 activity.",
      "Davunetide has potential use as a therapeutic agent for the treatment of diseases associated with abnormal microtubule formation and maintenance."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Dynamin-2 protein is involved in the scission of new vesicles from the plasma membrane and the Golgi network.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2317,
    "user_query": "Which proteins are controlling sterol metabolism in S. cerevisiae?",
    "vicuna-7b_response": "Sterol metabolism in S. cerevisiae is controlled by a complex network of proteins. Some of the key proteins involved in regulating sterol metabolism in this yeast species are:\n1. Ergosterol peroxidase (ERG2): This enzyme is responsible for the peroxidation of ergosterol, which is a key step in the biosynthesis of sterols.\n2. 3-beta-hydroxysterol delta-9-delta-8-lyase (HYR1): This enzyme catalyzes the conversion of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an early intermediate in the biosynthesis of sterols.\n3. 7-alpha-hydroxylase (HYR2): This enzyme catalyzes the conversion of 24-ethylcholest-7-ene to 7-alpha-hydroxycholest-7-ene, another key intermediate in sterol biosynthesis.\n4. 3-beta-hydroxy-delta-5-sterol reductase (ERG1): This enzyme catalyzes the reduction of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an important step in the biosynthesis of sterols.\n5. Steroidogenic acute regulatory protein (SAR1): This transcription factor is involved in the regulation of sterol biosynthesis in S. cerevisiae. It binds to the promoter region of genes involved in sterol biosynthesis and regulates their expression.\n6. Stanniocalcin-like protein 1 (STC1): This protein is involved in the regulation of sterol homeostasis in S. cerevisiae. It functions as a transcriptional repressor and helps to maintain the balance between the synthesis and degradation of sterols.\nThese are just a few of the many proteins involved in regulating sterol metabolism in S. cerevisiae. The precise set of proteins involved in sterol metabolism can vary depending on the specific strain of yeast and the conditions in which it is",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sterol metabolism in S. cerevisiae is controlled by a complex network of proteins.\n2. Ergosterol peroxidase (ERG2) is responsible for the peroxidation of ergosterol, which is a key step in the biosynthesis of sterols.\n3. 3-beta-hydroxysterol delta-9-delta-8-lyase (HYR1) catalyzes the conversion of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an early intermediate in the biosynthesis of sterols.\n4. 7-alpha-hydroxylase (HYR2) catalyzes the conversion of 24-ethylcholest-7-ene to 7-alpha-hydroxycholest-7-ene, another key intermediate in sterol biosynthesis.\n5. 3-beta-hydroxy-delta-5-sterol reductase (ERG1) catalyzes the reduction of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an important step in the biosynthesis of sterols.",
    "vicuna-7b_fact": [
      "Sterol metabolism in S. cerevisiae is controlled by a complex network of proteins.",
      "Ergosterol peroxidase (ERG2) is responsible for the peroxidation of ergosterol, which is a key step in the biosynthesis of sterols.",
      "3-beta-hydroxysterol delta-9-delta-8-lyase (HYR1) catalyzes the conversion of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an early intermediate in the biosynthesis of sterols.",
      "7-alpha-hydroxylase (HYR2) catalyzes the conversion of 24-ethylcholest-7-ene to 7-alpha-hydroxycholest-7-ene, another key intermediate in sterol biosynthesis.",
      "3-beta-hydroxy-delta-5-sterol reductase (ERG1) catalyzes the reduction of 3-beta-hydroxysterol to 24-ethylcholest-7-ene, an important step in the biosynthesis of sterols."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Ergosterol peroxidase (ERG2) is involved in sterol biosynthesis, but it is not responsible for the peroxidation of ergosterol.\n3. FALSE [correction]: 3-beta-hydroxysterol delta-14-reductase (ERG24) catalyzes the conversion of fecosterol to episterol. HYR1 isn't the enzyme responsible for this process.\n4. UNKNOWN\n5. FALSE [correction]: 3-beta-hydroxy-delta-5-sterol reductase (ERG1) catalyzes the removal of the C-14 methyl group, leading to the formation of 4,4-dimethylzymosterol. It does not convert 3-beta-hydroxysterol to 24-ethylcholest-7-ene.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2318,
    "user_query": "Which enzymes are responsible for base J creation in Trypanosoma brucei?",
    "vicuna-7b_response": "Base J is a modified nucleotide found in the DNA of Trypanosoma brucei, a parasitic protozoan that causes African trypanosomiasis or sleeping sickness in humans and animals. The enzymes responsible for the creation of base J in T. brucei are called \"base J synthases\".\nBase J synthases are a family of enzymes that modify nucleotides by adding a methyl group to the 2'-position of the ribose sugar, resulting in the formation of base J. In T. brucei, there are two known base J synthases: TbMSP1 and TbMSP2.\nTbMSP1 is a cytosolic enzyme that is expressed in all life cycle stages of T. brucei, while TbMSP2 is a mitochondrial enzyme that is expressed only in the bloodstream form of the parasite. Both enzymes are essential for the survival of T. brucei, as they are required for the synthesis of base J, which is a key component of the parasite's DNA.\nIn summary, base J synthases are the enzymes responsible for the creation of base J in Trypanosoma brucei. These enzymes are essential for the survival of the parasite and play a crucial role in the modification of its DNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Base J is a modified nucleotide found in the DNA of Trypanosoma brucei.\n2. The enzymes responsible for the creation of base J in T. brucei are called \"base J synthases\".\n3. In T. brucei, there are two known base J synthases: TbMSP1 and TbMSP2.\n4. TbMSP1 is a cytosolic enzyme that is expressed in all life cycle stages of T. brucei, while TbMSP2 is a mitochondrial enzyme expressed only in the bloodstream form of the parasite.\n5. Both TbMSP1 and TbMSP2 enzymes are essential for the survival of T. brucei, as they are required for the synthesis of base J.",
    "vicuna-7b_fact": [
      "Base J is a modified nucleotide found in the DNA of Trypanosoma brucei.",
      "The enzymes responsible for the creation of base J in T. brucei are called \"base J synthases\".",
      "In T. brucei, there are two known base J synthases: TbMSP1 and TbMSP2.",
      "TbMSP1 is a cytosolic enzyme that is expressed in all life cycle stages of T. brucei, while TbMSP2 is a mitochondrial enzyme expressed only in the bloodstream form of the parasite.",
      "Both TbMSP1 and TbMSP2 enzymes are essential for the survival of T. brucei, as they are required for the synthesis of base J."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-7b_response": "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features such as a broad nasal bridge and a flat nasal tip. The genetic basis of Ohdo syndrome has been identified as a mutation in the GFI1 gene.\nGFI1 is a transcription factor that plays a crucial role in the development of several organs, including the brain and the face. Mutations in the GFI1 gene can lead to reduced expression of this protein, which can result in the developmental abnormalities seen in individuals with Ohdo syndrome.\nThe GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13. The specific mutation that causes Ohdo syndrome is a deletion of a small piece of the GFI1 gene, which results in a frameshift and the production of a non-functional protein.\nIndividuals with Ohdo syndrome may also have other medical issues, such as seizures, heart defects, and kidney problems. The severity of the symptoms can vary among individuals, and the diagnosis is typically made through a combination of clinical examination, genetic testing, and other diagnostic procedures.\nTreatment for Ohdo syndrome is primarily supportive, and may include therapy, medication, and surgery to address specific medical issues. There is currently no cure for the disorder, but early intervention and support can help improve the quality of life for individuals with Ohdo syndrome and their families.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.\n2. The genetic basis of Ohdo syndrome has been identified as a mutation in the GFI1 gene.\n3. The GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13.\n4. The mutation that causes Ohdo syndrome is a deletion of a small piece of the GFI1 gene.\n5. There is currently no cure for Ohdo syndrome, but treatment may include therapy, medication, and surgery to address specific medical issues.",
    "vicuna-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.",
      "The genetic basis of Ohdo syndrome has been identified as a mutation in the GFI1 gene.",
      "The GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13.",
      "The mutation that causes Ohdo syndrome is a deletion of a small piece of the GFI1 gene.",
      "There is currently no cure for Ohdo syndrome, but treatment may include therapy, medication, and surgery to address specific medical issues."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The genetic basis of Ohdo syndrome has been identified as a mutation in the KAT6B gene, not the GFI1 gene.\n3. UNKNOWN\n4. FALSE [correction]: The mutation that causes Ohdo syndrome is not a deletion of a small piece of the GFI1 gene, it's a mutation in the KAT6B gene.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2326,
    "user_query": "How may CTCF mediate splicing?",
    "vicuna-7b_response": "CTCF (also known as CCCTC binding factor) is a transcriptional regulator that plays a crucial role in many cellular processes, including splicing. CTCF is a zinc finger transcription factor that can bind to DNA sequences in a sequence-specific manner.\nOne of the functions of CTCF is to regulate alternative splicing, which is the process by which a single gene can produce multiple mRNA transcripts with different combinations of exons. CTCF can bind to exon-intron boundaries and regulate the access of splicing factors to these regions. By doing so, CTCF can either promote or repress the inclusion of specific exons, leading to different splicing patterns and thus different protein isoforms.\nCTCF can also bind to non-coding RNAs, such as microRNAs (miRNAs), and regulate their activity. miRNAs are small RNAs that can regulate gene expression by binding to messenger RNAs (mRNAs) and inducing their degradation or translational repression. CTCF can bind to miRNA genes and regulate their expression, which can in turn affect the splicing patterns of target genes.\nIn summary, CTCF plays a crucial role in regulating alternative splicing and can affect the expression of specific protein isoforms through its binding to exon-intron boundaries and non-coding RNAs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC binding factor) is a transcriptional regulator.\n2. CTCF plays a crucial role in cellular processes, including splicing.\n3. CTCF can regulate alternative splicing, a process by which a single gene can produce multiple mRNA transcripts.\n4. CTCF can bind to non-coding RNAs, such as microRNAs (miRNAs) and regulate their activity.\n5. CTCF plays a crucial role in regulating alternative splicing and can affect the expression of specific protein isoforms through its binding to exon-intron boundaries and non-coding RNAs.",
    "vicuna-7b_fact": [
      "CTCF (CCCTC binding factor) is a transcriptional regulator.",
      "CTCF plays a crucial role in cellular processes, including splicing.",
      "CTCF can regulate alternative splicing, a process by which a single gene can produce multiple mRNA transcripts.",
      "CTCF can bind to non-coding RNAs, such as microRNAs (miRNAs) and regulate their activity.",
      "CTCF plays a crucial role in regulating alternative splicing and can affect the expression of specific protein isoforms through its binding to exon-intron boundaries and non-coding RNAs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2329,
    "user_query": "What is the function of the TFIIS transcriptional factor (Dst1) in yeast?",
    "vicuna-7b_response": "TFIIS is a transcriptional factor that plays a critical role in the initiation of transcription in eukaryotes. In the case of yeast, TFIIS is a key component of the RNA polymerase II (RNAPII) transcriptional machinery, which is responsible for the transcription of most genes in the yeast genome.\nTFIIS is recruited to the promoter region of a gene by the TATA box binding protein (TBP) and the TFIIB factor. Once TFIIS is in place, it serves as a scaffold for the assembly of the rest of the transcriptional machinery, including the TBP, TFIIB, RNAPII, and the CCAAT box binding transcriptional factor (CBF). This assembly of factors is required for the initiation of transcription.\nIn addition to its role in the assembly of the transcriptional machinery, TFIIS also plays a role in the regulation of transcription. For example, TFIIS has been shown to interact with transcriptional repressors, such as the GCN4 transcriptional repressor, and to help recruit histone deacetylases (HDACs) to the genome, which can lead to the repression of transcription.\nOverall, TFIIS is an essential component of the transcriptional machinery in yeast, and plays a critical role in the initiation and regulation of transcription.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TFIIS is a transcriptional factor that plays a crucial role in the initiation of transcription in eukaryotes.\n2. In yeast, TFIIS is a part of the RNA polymerase II transcriptional machinery that is responsible for the transcription of most genes in its genome.\n3. TFIIS is recruited to the promoter region of a gene by the TATA box binding protein and the TFIIB factor.\n4. TFIIS serves as a scaffold for the assembly of the other parts of the transcriptional machinery which include TBP, TFIIB, RNAPII, and the CCAAT box binding transcriptional factor.\n5. TFIIS interacts with transcriptional repressors and plays a role in recruiting histone deacetylases to the genome, which can lead to the repression of transcription.",
    "vicuna-7b_fact": [
      "TFIIS is a transcriptional factor that plays a crucial role in the initiation of transcription in eukaryotes.",
      "In yeast, TFIIS is a part of the RNA polymerase II transcriptional machinery that is responsible for the transcription of most genes in its genome.",
      "TFIIS is recruited to the promoter region of a gene by the TATA box binding protein and the TFIIB factor.",
      "TFIIS serves as a scaffold for the assembly of the other parts of the transcriptional machinery which include TBP, TFIIB, RNAPII, and the CCAAT box binding transcriptional factor.",
      "TFIIS interacts with transcriptional repressors and plays a role in recruiting histone deacetylases to the genome, which can lead to the repression of transcription."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [Correction]: TFIIS is a transcriptional factor that plays a crucial role in transcription elongation, not initiation, in eukaryotes.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-7b_response": "The R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is called \"affy\".\naffy is a package in the R/Bioconductor framework that provides tools for the analysis of gene expression data. It is specifically designed for the Affymetrix GeneChip platform, but it can also be used with data from other microarray platforms.\naffy provides a number of functions for the analysis of gene expression data, including:\n* Normalization of expression data to remove variation due to differences in library size and other technical factors\n* Detection of differentially expressed genes between two groups (e.g. healthy vs. diseased)\n* Clustering of genes based on their expression patterns\n* Heatmap visualization of expression data\naffy has been widely used in the analysis of gene expression data in psychiatric disease research, particularly in the analysis of data from the Affymetrix GeneChip Human Genome U133 Plus 2.0 array.\nIt's worth noting that there are other R/Bioconductor packages that can be used for the analysis of psychiatric disease genes, such as \"limma\" and \"edgeR\", but affy is specifically designed for the analysis of gene expression data from microarray platforms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"affy\".\n2. The affy package is designed for the Affymetrix GeneChip platform.\n3. The affy package can also be used with data from other microarray platforms.\n4. The affy package provides functions for the normalization of expression data, detection of differentially expressed genes, clustering of genes based on their expression patterns, and heatmap visualization of expression data.\n5. Other R/Bioconductor packages that can be used for the analysis of psychiatric disease genes include \"limma\" and \"edgeR\".",
    "vicuna-7b_fact": [
      "The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"affy\".",
      "The affy package is designed for the Affymetrix GeneChip platform.",
      "The affy package can also be used with data from other microarray platforms.",
      "The affy package provides functions for the normalization of expression data, detection of differentially expressed genes, clustering of genes based on their expression patterns, and heatmap visualization of expression data.",
      "Other R/Bioconductor packages that can be used for the analysis of psychiatric disease genes include \"limma\" and \"edgeR\"."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The R/Bioconductor package developed for the analysis of gene expression data is called \"affy\", it is not specified towards psychiatric disease genes.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2335,
    "user_query": "What is the function of the gene MDA5?",
    "vicuna-7b_response": "MDA5, also known as RIG-I-like receptor (RLR), is a type I interferon-induced gene that plays a critical role in the innate immune response to viral infections. The main function of MDA5 is to recognize and activate the immune response to viral RNA, including RNA from various types of viruses such as influenza, hepatitis C, and West Nile.\nWhen MDA5 recognizes viral RNA, it activates a signaling pathway that leads to the production of type I interferons, which in turn activate the immune system to fight the viral infection. MDA5 also plays a role in the clearance of viral RNA from infected cells, which is important for preventing the spread of the virus.\nIn addition to its role in the immune response to viral infections, MDA5 has also been implicated in the regulation of cellular processes such as cell growth and differentiation. However, the exact function of MDA5 in these processes is not well understood.\nOverall, MDA5 is an important component of the innate immune system that plays a critical role in recognizing and responding to viral infections.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MDA5, also known as RIG-I-like receptor (RLR), is a type I interferon-induced gene.\n2. MDA5 plays a critical role in the innate immune response to viral infections.\n3. The main function of MDA5 is to recognize and activate the immune response to viral RNA.\n4. Activation of MDA5 leads to the production of type I interferons.\n5. MDA5 is involved in the clearance of viral RNA from infected cells.",
    "vicuna-7b_fact": [
      "MDA5, also known as RIG-I-like receptor (RLR), is a type I interferon-induced gene.",
      "MDA5 plays a critical role in the innate immune response to viral infections.",
      "The main function of MDA5 is to recognize and activate the immune response to viral RNA.",
      "Activation of MDA5 leads to the production of type I interferons.",
      "MDA5 is involved in the clearance of viral RNA from infected cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2336,
    "user_query": "Which is the conserved motif of DEAD box proteins?",
    "vicuna-7b_response": "DEAD box proteins are characterized by the presence of a conserved motif called the DEAD (Asp-Glu-Ala-Asp) box. This motif is located in the C-terminal region of the protein and is responsible for the ATPase activity of DEAD box proteins. The DEAD box motif is composed of four amino acids: Asp-Glu-Ala-Asp, which are involved in the hydrolysis of ATP. The DEAD box motif is found in a wide variety of proteins, including RNA helicases, RNA-binding proteins, and other proteins that are involved in RNA metabolism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DEAD box proteins are characterized by the presence of a conserved motif called the DEAD (Asp-Glu-Ala-Asp) box.\n2. The DEAD box motif is located in the C-terminal region of the protein.\n3. The DEAD box motif is responsible for the ATPase activity of DEAD box proteins.\n4. The DEAD box motif is composed of four amino acids: Asp-Glu-Ala-Asp.\n5. The DEAD box motif is found in a variety of proteins, including RNA helicases, RNA-binding proteins, and proteins involved in RNA metabolism.",
    "vicuna-7b_fact": [
      "DEAD box proteins are characterized by the presence of a conserved motif called the DEAD (Asp-Glu-Ala-Asp) box.",
      "The DEAD box motif is located in the C-terminal region of the protein.",
      "The DEAD box motif is responsible for the ATPase activity of DEAD box proteins.",
      "The DEAD box motif is composed of four amino acids: Asp-Glu-Ala-Asp.",
      "The DEAD box motif is found in a variety of proteins, including RNA helicases, RNA-binding proteins, and proteins involved in RNA metabolism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2338,
    "user_query": "Describe GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types)",
    "vicuna-7b_response": "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a toolkit developed by researchers from the University of California, San Francisco (UCSF) that aims to help scientists identify the underlying cell types associated with a given disease. GARLIC uses a combination of genetic data and gene expression data to predict the cell types that are most likely to be associated with a given disease.\nThe toolkit uses a technique called genome-wide association studies (GWAS) to identify genetic variants that are associated with a given disease. GWAS involves analyzing the genetic variation of individuals with the disease and comparing it to the genetic variation of individuals without the disease. By identifying genetic variants that are more common in individuals with the disease, researchers can identify potential genetic markers for the disease.\nOnce genetic markers have been identified, GARLIC uses gene expression data to predict the cell types that are most likely to be associated with the disease. Gene expression data is collected by measuring the expression levels of genes in different cell types. By comparing the gene expression patterns of individuals with the disease to those without the disease, GARLIC can identify cell types that are associated with the disease.\nGARLIC then uses machine learning algorithms to predict the cell types that are most likely to be associated with the disease based on the genetic and gene expression data. The toolkit also includes a web-based interface that allows users to input data and generate predictions.\nOverall, GARLIC is a powerful tool that can help scientists identify the underlying cell types associated with a given disease, which can provide important insights into the biology of the disease and potentially lead to new therapeutic targets.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) was developed by researchers from the University of California, San Francisco.\n2. GARLIC uses genetic data and gene expression data to predict the cell types associated with a given disease.\n3. The toolkit uses a method called genome-wide association studies (GWAS) to identify genetic variants associated with a specific disease.\n4. In addition to genetic markers, GARLIC uses gene expression data to predict disease-associated cell types.\n5. GARLIC uses machine learning algorithms for predictions and includes a web-based interface that allows users to generate predictions.",
    "vicuna-7b_fact": [
      "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) was developed by researchers from the University of California, San Francisco.",
      "GARLIC uses genetic data and gene expression data to predict the cell types associated with a given disease.",
      "The toolkit uses a method called genome-wide association studies (GWAS) to identify genetic variants associated with a specific disease.",
      "In addition to genetic markers, GARLIC uses gene expression data to predict disease-associated cell types.",
      "GARLIC uses machine learning algorithms for predictions and includes a web-based interface that allows users to generate predictions."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2345,
    "user_query": "What is the function of yeast TERRA RNAs?",
    "vicuna-7b_response": "TERRA (Transcription Elongation-related RNA) RNAs are a class of non-coding RNAs that play a critical role in the function of the RNA polymerase II transcription machinery in yeast.\nTERRA RNAs are transcribed from the TERRA gene, which is located on chromosome XII of the yeast genome. The TERRA RNA is a long non-coding RNA that is transcribed from the TERRA gene and is involved in the transcription elongation process.\nThe function of TERRA RNAs is to interact with the transcription elongation factor TFIIS, which is a key component of the RNA polymerase II transcription machinery. TERRA RNAs bind to TFIIS and help to recruit it to the transcription elongation complex, where it plays a role in the process of transcription elongation.\nIn addition to their role in transcription elongation, TERRA RNAs have also been shown to play a role in the regulation of gene expression. For example, TERRA RNAs have been shown to interact with other transcriptional regulators, such as the transcription factor GCN4, and to play a role in the regulation of gene expression in response to changes in the cellular environment.\nOverall, the function of TERRA RNAs is to play a critical role in the function of the RNA polymerase II transcription machinery in yeast, by interacting with TFIIS and regulating gene expression in response to changes in the cellular environment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TERRA (Transcription Elongation-related RNA) RNAs are a class of non-coding RNAs that function in the RNA polymerase II transcription machinery in yeast.\n2. TERRA RNAs are transcribed from the TERRA gene, which is located on chromosome XII of the yeast genome.\n3. TERRA RNAs interact with the transcription elongation factor TFIIS.\n4. TERRA RNAs help to recruit TFIIS to the transcription elongation complex, where it plays a role in the process of transcription elongation.\n5. TERRA RNAs interact with other transcriptional regulators, such as the transcription factor GCN4, and regulate gene expression in response to changes in the cellular environment.",
    "vicuna-7b_fact": [
      "TERRA (Transcription Elongation-related RNA) RNAs are a class of non-coding RNAs that function in the RNA polymerase II transcription machinery in yeast.",
      "TERRA RNAs are transcribed from the TERRA gene, which is located on chromosome XII of the yeast genome.",
      "TERRA RNAs interact with the transcription elongation factor TFIIS.",
      "TERRA RNAs help to recruit TFIIS to the transcription elongation complex, where it plays a role in the process of transcription elongation.",
      "TERRA RNAs interact with other transcriptional regulators, such as the transcription factor GCN4, and regulate gene expression in response to changes in the cellular environment."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: TERRA (Telomeric Repeat-containing RNA) RNAs are a class of non-coding RNAs that function in the maintenance of telomeres. \n2. FALSE [correction]: TERRA RNAs are not transcribed from a specific TERRA gene but from telomeric regions of the chromosome. The chromosome location can vary.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2347,
    "user_query": "Do bacteria from the genus Morexella cause respiratory infections?",
    "vicuna-7b_response": "Yes, bacteria from the genus Moraxella can cause respiratory infections. Moraxella catarrhalis is one of the most common causes of respiratory tract infections, particularly in the upper respiratory tract, such as the nose and throat. It can cause symptoms such as nasal congestion, runny nose, cough, and sore throat. Moraxella bacteria are usually treated with antibiotics, such as penicillin or azithromycin. It's important to consult a doctor for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bacteria from the genus Moraxella can cause respiratory infections. \n2. Moraxella catarrhalis is one of the most common causes of respiratory tract infections.\n3. Moraxella catarrhalis usually affects the upper respiratory tract, such as the nose and throat.\n4. Moraxella bacteria are usually treated with antibiotics, such as penicillin or azithromycin.\n5. Symptoms of Moraxella catarrhalis infections can include nasal congestion, runny nose, cough, and sore throat.",
    "vicuna-7b_fact": [
      "Bacteria from the genus Moraxella can cause respiratory infections.",
      "Moraxella catarrhalis is one of the most common causes of respiratory tract infections.",
      "Moraxella catarrhalis usually affects the upper respiratory tract, such as the nose and throat.",
      "Moraxella bacteria are usually treated with antibiotics, such as penicillin or azithromycin.",
      "Symptoms of Moraxella catarrhalis infections can include nasal congestion, runny nose, cough, and sore throat."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Moraxella bacteria are usually treated with antibiotics, but they are often resistant to penicillin. Azithromycin can be effective.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2349,
    "user_query": "Do chromatin features predict genes associated with eQTLs?",
    "vicuna-7b_response": "Yes, chromatin features can predict genes associated with eQTLs. eQTLs, or expression quantitative trait loci, are genetic variations that affect gene expression levels. Chromatin features are the physical and chemical properties of chromatin, the complex of DNA and proteins that make up chromosomes.\nStudies have shown that chromatin features can be used to predict the likelihood of a gene being associated with an eQTL. This is because chromatin features can affect gene expression by regulating the access of transcription factors to the DNA. By analyzing chromatin features, researchers can identify patterns that are associated with eQTLs and use this information to predict which genes are likely to be associated with eQTLs.\nFor example, studies have shown that chromatin accessibility, which is the degree to which the DNA can be accessed by transcription factors, is associated with eQTLs. This suggests that chromatin accessibility may be a useful chromatin feature for predicting eQTLs. Other chromatin features that have been associated with eQTLs include histone modifications, DNA methylation, and chromosome conformation.\nOverall, while chromatin features are not the only factors that can predict eQTLs, they can be a useful tool for identifying genes that are likely to be associated with eQTLs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. eQTLs, or expression quantitative trait loci, are genetic variations that affect gene expression levels.\n2. Chromatin features can predict genes associated with eQTLs.\n3. Chromatin features can affect gene expression by regulating the access of transcription factors to the DNA.\n4. Studies have shown that chromatin accessibility, a chromatin feature, is associated with eQTLs.\n5. Other chromatin features that have been associated with eQTLs include histone modifications, DNA methylation, and chromosome conformation.",
    "vicuna-7b_fact": [
      "eQTLs, or expression quantitative trait loci, are genetic variations that affect gene expression levels.",
      "Chromatin features can predict genes associated with eQTLs.",
      "Chromatin features can affect gene expression by regulating the access of transcription factors to the DNA.",
      "Studies have shown that chromatin accessibility, a chromatin feature, is associated with eQTLs.",
      "Other chromatin features that have been associated with eQTLs include histone modifications, DNA methylation, and chromosome conformation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2350,
    "user_query": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta",
    "vicuna-7b_response": "Osteogenesis imperfecta (OI) is a genetic disorder that affects bone development and strength. There are several types of OI, and the most severe form is known as autosomal recessive osteogenesis imperfecta (AR-OI).\nThe genetic basis of AR-OI is complex, and several genes have been identified as contributing to the condition. Here are the six genes that have been associated with AR-OI:\n1. COL1A1: This gene provides instructions for making type I collagen, which is a key protein found in bone. Mutations in the COL1A1 gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.\n2. COL1A2: This gene provides instructions for making type I collagen, which is a key protein found in bone. Mutations in the COL1A2 gene can also lead to reduced production of type I collagen, which can result in weak and fragile bones.\n3. CRTAP: This gene provides instructions for making a protein that is involved in the production of type I collagen. Mutations in the CRTAP gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.\n4. ITGB4: This gene provides instructions for making a protein that is involved in the development and maintenance of bone. Mutations in the ITGB4 gene can lead to reduced bone density and fragile bones.\n5. PLOD1: This gene provides instructions for making a protein that is involved in the production of type I collagen. Mutations in the PLOD1 gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.\n6. SLC4A10: This gene provides instructions for making a protein that is involved in the transport of collagen across cell membranes. Mutations in the SLC4A10 gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.\nIt's important to note that these are just a few of the genes that have been associated with AR-OI, and there may be other genetic factors that contribute to the condition. Additionally, the severity of the condition can vary widely among",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Osteogenesis imperfecta is a genetic disorder that affects bone development and strength.\n2. There are several types of Osteogenesis imperfecta, and the most severe form is known as autosomal recessive osteogenesis imperfecta.\n3. The COL1A1 gene provides instructions for making type I collagen and mutations in this gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.\n4. Mutations in the COL1A2 gene can also lead to reduced production of type I collagen, resulting in weak and fragile bones.\n5. The CRTAP, PLOD1, ITGB4, and SLC4A10 genes are also associated with Osteogenesis imperfecta. Mutations in these genes can lead to reduced production of type I collagen or reduced bone density.\n",
    "vicuna-7b_fact": [
      "Osteogenesis imperfecta is a genetic disorder that affects bone development and strength.",
      "There are several types of Osteogenesis imperfecta, and the most severe form is known as autosomal recessive osteogenesis imperfecta.",
      "The COL1A1 gene provides instructions for making type I collagen and mutations in this gene can lead to reduced production of type I collagen, which can result in weak and fragile bones.",
      "Mutations in the COL1A2 gene can also lead to reduced production of type I collagen, resulting in weak and fragile bones.",
      "The CRTAP, PLOD1, ITGB4, and SLC4A10 genes are also associated with Osteogenesis imperfecta. Mutations in these genes can lead to reduced production of type I collagen or reduced bone density."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are several types of Osteogenesis imperfecta, but they are not categorized as \"autosomal recessive osteogenesis imperfecta\". The types are primarily distinguished by their severity and the specifics of their symptoms.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2354,
    "user_query": "What is the mode of action of teriparatide?",
    "vicuna-7b_response": "Teriparatide is a synthetic parathyroid hormone analog that is used to treat osteoporosis in postmenopausal women and men. It works by stimulating the formation of new bone tissue in the body, primarily by increasing the activity of osteoblasts, the cells responsible for bone formation.\nTeriparatide is administered as an injection under the skin, usually once a day. It is typically used in patients who are at high risk of fractures due to osteoporosis, and is often used in combination with other osteoporosis treatments.\nThe exact mechanism of action of teriparatide is not fully understood, but it is thought to work by activating specific receptors on bone cells, which then triggers a series of events that lead to increased bone formation.\nIt is important to note that teriparatide is not a first-line treatment for osteoporosis, and should only be used under the guidance of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Teriparatide is a synthetic parathyroid hormone analog.\n2. Teriparatide is used to treat osteoporosis in postmenopausal women and men.\n3. This drug works by stimulating the formation of new bone tissue in the body, primarily by increasing the activity of osteoblasts.\n4. Teriparatide is administered as an injection under the skin, usually once a day.\n5. Teriparatide is not a first-line treatment for osteoporosis.",
    "vicuna-7b_fact": [
      "Teriparatide is a synthetic parathyroid hormone analog.",
      "Teriparatide is used to treat osteoporosis in postmenopausal women and men.",
      "This drug works by stimulating the formation of new bone tissue in the body, primarily by increasing the activity of osteoblasts.",
      "Teriparatide is administered as an injection under the skin, usually once a day.",
      "Teriparatide is not a first-line treatment for osteoporosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2355,
    "user_query": "What is the Strelka workflow?",
    "vicuna-7b_response": "The Strelka workflow is a design and architecture thinking methodology developed by the Strelka Institute, a Moscow-based think tank focused on urbanism and architecture. The workflow is a structured approach to problem-solving that combines research, analysis, and prototyping to generate innovative solutions to complex design challenges.\nThe Strelka workflow consists of several stages, including:\n1. Research: The first stage involves gathering information about the problem or challenge at hand. This includes researching the context, history, and current state of the project site, as well as identifying key stakeholders and their needs.\n2. Analysis: In this stage, the information gathered in the research phase is analyzed to identify patterns, trends, and opportunities. This analysis is used to develop a deeper understanding of the problem and to identify potential solutions.\n3. Prototyping: The third stage involves creating prototypes or models of potential solutions. This can include physical models, digital models, or other types of prototypes. The goal of prototyping is to test and refine the solutions, and to gather feedback from stakeholders.\n4. Testing: The final stage involves testing the prototypes in a real-world setting. This can include conducting user testing, pilot projects, or other types of testing to ensure that the solutions are effective and can be implemented on a larger scale.\nThe Strelka workflow is a flexible and adaptable approach that can be applied to a wide range of design challenges, from urban planning to architecture and beyond. It emphasizes collaboration, experimentation, and iterative design, and is designed to generate innovative solutions that are grounded in research and analysis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Strelka workflow is a design and architecture thinking methodology developed by the Strelka Institute.\n2. The Strelka Institute is a Moscow-based think tank focused on urbanism and architecture.\n3. The Strelka workflow consists of several stages including Research, Analysis, Prototyping, and Testing.\n4. The goal of prototyping in the Strelka workflow is to test and refine solutions, and to gather feedback from stakeholders.\n5. The Strelka workflow can be applied to a variety of design challenges, such as urban planning and architecture.",
    "vicuna-7b_fact": [
      "The Strelka workflow is a design and architecture thinking methodology developed by the Strelka Institute.",
      "The Strelka Institute is a Moscow-based think tank focused on urbanism and architecture.",
      "The Strelka workflow consists of several stages including Research, Analysis, Prototyping, and Testing.",
      "The goal of prototyping in the Strelka workflow is to test and refine solutions, and to gather feedback from stakeholders.",
      "The Strelka workflow can be applied to a variety of design challenges, such as urban planning and architecture."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2359,
    "user_query": "Describe mechanism of action of Ozanimod.",
    "vicuna-7b_response": "Ozanimod is a medication that is used to treat multiple sclerosis (MS) and relapsing remitting multiple sclerosis (RRMS). It works by targeting a specific protein called S1P1, which is found on the surface of immune cells called T cells.\nWhen ozanimod binds to S1P1, it prevents these T cells from migrating to the brain and spinal cord, where they can cause inflammation and damage to the nervous system. By reducing the number of T cells in the central nervous system, ozanimod can help to reduce the frequency and severity of MS symptoms.\nIn addition to its effects on T cells, ozanimod also has immunosuppressive properties, which can help to reduce the overall activity of the immune system. This can help to reduce the risk of autoimmune attacks on the nervous system, which is a key feature of MS.\nOverall, the mechanism of action of ozanimod is complex and involves multiple steps, but its main effect is to reduce the inflammation and damage caused by T cells in the central nervous system. This can help to improve symptoms and slow the progression of MS.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ozanimod is a medication used for treating multiple sclerosis (MS) and relapsing remitting multiple sclerosis (RRMS).\n2. Ozanimod works by targeting a protein called S1P1 on the surface of T cells.\n3. The medicine prevents T cells from migrating to the brain and spinal cord where they can cause inflammation and damage.\n4. Ozanimod reduces the number of T cells in the central nervous system, helping to decrease the frequency and severity of MS symptoms.\n5. Ozanimod has immunosuppressive properties that reduce overall activity of the immune system, potentially lowering the risk of autoimmune attacks on the nervous system.",
    "vicuna-7b_fact": [
      "Ozanimod is a medication used for treating multiple sclerosis (MS) and relapsing remitting multiple sclerosis (RRMS).",
      "Ozanimod works by targeting a protein called S1P1 on the surface of T cells.",
      "The medicine prevents T cells from migrating to the brain and spinal cord where they can cause inflammation and damage.",
      "Ozanimod reduces the number of T cells in the central nervous system, helping to decrease the frequency and severity of MS symptoms.",
      "Ozanimod has immunosuppressive properties that reduce overall activity of the immune system, potentially lowering the risk of autoimmune attacks on the nervous system."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-7b_response": "Intracerebral hemorrhage, also known as a stroke, is a medical emergency that occurs when there is bleeding within the brain. The swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage.\nThe swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain. This pattern is caused by the movement of blood within the brain, which can cause the brain tissue to become distorted and twisted. The swirl sign is often seen in the early stages of intracerebral hemorrhage, and it can help doctors to diagnose the condition and determine the severity of the bleeding.\nThe swirl sign is not always present in all cases of intracerebral hemorrhage, and it is not a specific diagnostic indicator. However, it can be a useful tool for doctors to help diagnose and manage this serious medical condition.\nIn summary, the swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage. It is characterized by a swirling pattern of blood within the affected hemisphere of the brain, and it can help doctors to diagnose and manage this serious medical condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intracerebral hemorrhage is a medical emergency that occurs when there is bleeding within the brain.\n2. The swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage.\n3. The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.\n4. The swirl sign is often seen in the early stages of intracerebral hemorrhage.\n5. The swirl sign is not always present in all cases of intracerebral hemorrhage.",
    "vicuna-7b_fact": [
      "Intracerebral hemorrhage is a medical emergency that occurs when there is bleeding within the brain.",
      "The swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage.",
      "The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.",
      "The swirl sign is often seen in the early stages of intracerebral hemorrhage.",
      "The swirl sign is not always present in all cases of intracerebral hemorrhage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2361,
    "user_query": "What is Morgellons disease?",
    "vicuna-7b_response": "Morgellons disease is a mysterious and little-understood condition that affects the skin and can also involve other parts of the body. It is characterized by the presence of unusual fibers or filaments that protrude from the skin, as well as other symptoms such as lesions, rashes, and fatigue.\nThe exact cause of Morgellons disease is not known, but it is believed to be a multifactorial condition that involves both environmental and genetic factors. Some researchers have suggested that it may be related to exposure to toxic chemicals or other environmental toxins, while others have proposed that it may be caused by a type of bacterial or viral infection.\nThere is currently no cure for Morgellons disease, and treatment options are limited. Many people with the condition find relief from symptoms by using natural remedies such as essential oils, herbal remedies, and dietary changes. Some people also find relief through therapy or support groups.\nIt is important to note that Morgellons disease is not a recognized medical condition by the mainstream medical community, and many healthcare professionals are not familiar with it. As a result, it can be difficult for people with the condition to receive an accurate diagnosis and appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Morgellons disease is a condition that affects the skin and can also involve other parts of the body.\n2. Morgellons disease is characterized by the presence of unusual fibers or filaments that protrude from the skin, as well as other symptoms such as lesions, rashes, and fatigue.\n3. The exact cause of Morgellons disease is not known.\n4. There is currently no cure for Morgellons disease.\n5. Morgellons disease is not a recognized medical condition by the mainstream medical community.",
    "vicuna-7b_fact": [
      "Morgellons disease is a condition that affects the skin and can also involve other parts of the body.",
      "Morgellons disease is characterized by the presence of unusual fibers or filaments that protrude from the skin, as well as other symptoms such as lesions, rashes, and fatigue.",
      "The exact cause of Morgellons disease is not known.",
      "There is currently no cure for Morgellons disease.",
      "Morgellons disease is not a recognized medical condition by the mainstream medical community."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2363,
    "user_query": "What is the asosciation between the eustachian tube and the palatine muscle of the uvula?",
    "vicuna-7b_response": "The eustachian tube is a narrow passageway that connects the middle ear to the back of the nose and throat. The palatine muscle of the uvula is a muscle located at the back of the throat, near the uvula. There is no direct association between the eustachian tube and the palatine muscle of the uvula.\nThe eustachian tube has a important function, it helps to equalize the pressure in the middle ear, by allowing air to flow from the nose and throat into the middle ear. This helps to prevent the feeling of fullness or discomfort that can occur when flying or diving, for example.\nThe palatine muscle of the uvula, on the other hand, is responsible for the movement of the uvula, which is the small, triangular shaped structure located at the back of the throat. The uvula vibrates when you swallow, and it also plays a role in speech, as it helps to produce certain sounds.\nIt's important to note that the eustachian tube and the palatine muscle of the uvula are separate structures, and they do not have any direct association with each other.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The eustachian tube is a narrow passageway that connects the middle ear to the back of the nose and throat.\n2. The palatine muscle of the uvula is a muscle located at the back of the throat, near the uvula.\n3. The eustachian tube helps to equalize the pressure in the middle ear by allowing air to flow from the nose and throat into the middle ear.\n4. The palatine muscle of the uvula is responsible for the movement of the uvula.\n5. The uvula plays a role in speech and it vibrates when you swallow.",
    "vicuna-7b_fact": [
      "The eustachian tube is a narrow passageway that connects the middle ear to the back of the nose and throat.",
      "The palatine muscle of the uvula is a muscle located at the back of the throat, near the uvula.",
      "The eustachian tube helps to equalize the pressure in the middle ear by allowing air to flow from the nose and throat into the middle ear.",
      "The palatine muscle of the uvula is responsible for the movement of the uvula.",
      "The uvula plays a role in speech and it vibrates when you swallow."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2366,
    "user_query": "Which virus can be diagnosed with the monospot test?",
    "vicuna-7b_response": "The monospot test is used to diagnose a specific type of virus called the rubella virus. The monospot test is a blood test that is used to detect the presence of antibodies to the rubella virus in a person's blood. If a person has been infected with the rubella virus, their body will produce antibodies to fight the virus, and these antibodies will be detected by the monospot test.\nThe monospot test is typically used to screen pregnant women for immunity to rubella, as rubella can cause serious birth defects in a developing fetus if the mother is infected during pregnancy. The test is also used to screen blood donors to ensure that they are not infected with the rubella virus.\nThe monospot test is not used to diagnose other types of viruses. If you have a question about a different type of virus, please let me know and I will do my best to provide you with an answer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The monospot test is used to diagnose the rubella virus.\n2. The monospot test detects the presence of antibodies to the rubella virus in a person's blood.\n3. Antibodies to the rubella virus are produced by the body once a person is infected.\n4. The monospot test is used to screen pregnant women for immunity to rubella.\n5. The test is also used to screen blood donors to ensure that they are not infected with the rubella virus.",
    "vicuna-7b_fact": [
      "The monospot test is used to diagnose the rubella virus.",
      "The monospot test detects the presence of antibodies to the rubella virus in a person's blood.",
      "Antibodies to the rubella virus are produced by the body once a person is infected.",
      "The monospot test is used to screen pregnant women for immunity to rubella.",
      "The test is also used to screen blood donors to ensure that they are not infected with the rubella virus."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The monospot test is used to diagnose infectious mononucleosis, not the rubella virus.\n2. FALSE [correction]: The monospot test detects the presence of antibodies to the Epstein-Barr virus (which causes mononucleosis), not the rubella virus.\n3. TRUE\n4. FALSE [correction]: A different test, not the monospot test, is used to screen pregnant women for immunity to rubella.\n5. FALSE [correction]: The test used to screen blood donors for rubella is not the monospot test but a specific test for rubella antibodies.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2376,
    "user_query": "What is the most common histological diagnosis of \"butterfly glioma\"?",
    "vicuna-7b_response": "A butterfly glioma is a type of brain tumor that typically occurs in the cerebral hemispheres, particularly in the temporal lobe. The most common histological diagnosis of a butterfly glioma is a glioma, which is a type of tumor that arises from glial cells, which are supportive cells of the brain.\nGliomas are classified into four main types based on their histological characteristics: astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Gliomas are further classified into grades based on the degree of cellular atypia and mitotic activity.\nGlioblastoma multiforme (GBM) is the most common and aggressive type of glioma and is often referred to as a butterfly glioma because of its characteristic appearance on imaging studies. GBM is a grade IV astrocytoma that typically arises in the temporal lobe and is characterized by a high degree of cellular atypia and mitotic activity.\nIt is important to note that while butterfly glioma is a descriptive term used to describe the appearance of a glioma on imaging studies, it is not a specific diagnosis and can refer to any type of glioma that arises in the cerebral hemispheres.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A butterfly glioma is a type of brain tumor that typically occurs in the cerebral hemispheres, particularly in the temporal lobe.\n2. The most common histological diagnosis of a butterfly glioma is a glioma, which arises from glial cells.\n3. Gliomas are classified into four main types based on their histological characteristics: astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas.\n4. Glioblastoma multiforme (GBM) is the most common and aggressive type of glioma and is often referred to as a butterfly glioma.\n5. GBM is characterized by a high degree of cellular atypia and mitotic activity.",
    "vicuna-7b_fact": [
      "A butterfly glioma is a type of brain tumor that typically occurs in the cerebral hemispheres, particularly in the temporal lobe.",
      "The most common histological diagnosis of a butterfly glioma is a glioma, which arises from glial cells.",
      "Gliomas are classified into four main types based on their histological characteristics: astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas.",
      "Glioblastoma multiforme (GBM) is the most common and aggressive type of glioma and is often referred to as a butterfly glioma.",
      "GBM is characterized by a high degree of cellular atypia and mitotic activity."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: A butterfly glioma is a type of brain tumor that typically occurs across two lobes of the brain, spread across the corpus callosum.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2377,
    "user_query": "Which chromosomes are implicated in the Emanuel syndrome?",
    "vicuna-7b_response": "Emanuel syndrome is a rare genetic disorder caused by mutations in the SLC22A1 gene. This gene provides instructions for making a protein called solute carrier family 22 member 1, which is involved in the transport of certain molecules across cell membranes. The SLC22A1 gene is located on chromosome X, specifically on Xq26.\nThe Emanuel syndrome is characterized by a wide range of symptoms, including intellectual disability, developmental delays, distinctive facial features, and a variety of other physical abnormalities. The severity of the symptoms can vary greatly from person to person, and some individuals with the syndrome may have only mild symptoms while others may have more severe symptoms.\nIn summary, the Emanuel syndrome is caused by mutations in the SLC22A1 gene located on chromosome Xq26.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Emanuel syndrome is a rare genetic disorder caused by mutations in the SLC22A1 gene.\n2. The SLC22A1 gene provides instructions for making a protein called solute carrier family 22 member 1.\n3. This protein is involved in the transport of certain molecules across cell membranes.\n4. The SLC22A1 gene is located on chromosome X, specifically on Xq26.\n5. The Emanuel syndrome is characterized by intellectual disability, developmental delays, distinctive facial features, and a variety of other physical abnormalities.",
    "vicuna-7b_fact": [
      "Emanuel syndrome is a rare genetic disorder caused by mutations in the SLC22A1 gene.",
      "The SLC22A1 gene provides instructions for making a protein called solute carrier family 22 member 1.",
      "This protein is involved in the transport of certain molecules across cell membranes.",
      "The SLC22A1 gene is located on chromosome X, specifically on Xq26.",
      "The Emanuel syndrome is characterized by intellectual disability, developmental delays, distinctive facial features, and a variety of other physical abnormalities."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Emanuel syndrome is a rare genetic disorder caused by duplications of genetic material in a specific region of chromosome 11 and 22 not by mutations in the SLC22A1 gene.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The SLC22A1 gene is located on chromosome 6, specifically on 6q26 not on chromosome X.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2379,
    "user_query": "Are loop domains preserved upon cohesin loss?",
    "vicuna-7b_response": "Loop domains are regions of chromatin that are enriched for certain types of DNA sequences, such as transcription factor binding sites or histone modifications. Cohesin is a protein complex that plays a role in the regulation of chromatin structure and gene expression.\nIn general, the presence of cohesin is thought to be important for maintaining the integrity of loop domains. However, the precise relationship between cohesin and loop domains is not well understood.\nThere is some evidence to suggest that cohesin loss can lead to the destabilization of loop domains. For example, studies have shown that cohesin loss can lead to the breakage and rearrangement of chromatin loops, which can disrupt the function of nearby genes.\nOn the other hand, it is also possible that cohesin loss can lead to the formation of new loop domains. For example, cohesin has been shown to play a role in the formation and maintenance of chromatin loops that are involved in gene regulation.\nOverall, the relationship between cohesin and loop domains is complex and likely depends on a variety of factors, including the specific type of loop domain in question and the context in which it is found.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Loop domains are regions of chromatin that are enriched for certain types of DNA sequences.\n2. Cohesin is a protein complex that plays a role in the regulation of chromatin structure and gene expression.\n3. The presence of cohesin is considered important for maintaining the integrity of loop domains.\n4. Research suggests that cohesin loss can lead to the destabilization of loop domains.\n5. Cohesin has been shown to play a role in the formation and maintenance of chromatin loops that are involved in gene regulation.",
    "vicuna-7b_fact": [
      "Loop domains are regions of chromatin that are enriched for certain types of DNA sequences.",
      "Cohesin is a protein complex that plays a role in the regulation of chromatin structure and gene expression.",
      "The presence of cohesin is considered important for maintaining the integrity of loop domains.",
      "Research suggests that cohesin loss can lead to the destabilization of loop domains.",
      "Cohesin has been shown to play a role in the formation and maintenance of chromatin loops that are involved in gene regulation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Loop domains are regions of chromatin that are looped out from the main DNA sequence to facilitate access to genetic information, not specifically enriched for certain types of DNA sequences. \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2380,
    "user_query": "Which workflow in Bioconductor has been developed for accessing human RNA-seq samples?",
    "vicuna-7b_response": "The workflow in Bioconductor for accessing human RNA-seq samples is the \"rnaseq\" package. This package provides tools for processing and analyzing RNA-seq data from human samples. It includes functions for aligning RNA-seq reads to the human genome, quantifying gene expression, and identifying differentially expressed genes. The rnaseq package is widely used in the scientific community for analyzing RNA-seq data from human samples.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bioconductor has a workflow called the \"rnaseq\" package for accessing human RNA-seq samples.\n2. The \"rnaseq\" package includes tools for processing and analyzing RNA-seq data from human samples.\n3. It includes functions for aligning RNA-seq reads to the human genome.\n4. The \"rnaseq\" package assists in quantifying gene expression and identifying differentially expressed genes.\n5. The \"rnaseq\" package is widely used in the scientific community for analyzing human RNA-seq data.",
    "vicuna-7b_fact": [
      "Bioconductor has a workflow called the \"rnaseq\" package for accessing human RNA-seq samples.",
      "The \"rnaseq\" package includes tools for processing and analyzing RNA-seq data from human samples.",
      "It includes functions for aligning RNA-seq reads to the human genome.",
      "The \"rnaseq\" package assists in quantifying gene expression and identifying differentially expressed genes.",
      "The \"rnaseq\" package is widely used in the scientific community for analyzing human RNA-seq data."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2387,
    "user_query": "List polyubiquitin binding proteins involved in NF-kappaB signaling.",
    "vicuna-7b_response": "Sure, here are some polyubiquitin binding proteins involved in NF-kappaB signaling:\n1. TBK1 (TANK-binding kinase 1)\n2. IKKα (IκB kinase alpha)\n3. IKKβ (IκB kinase beta)\n4. TBK1-IKK complex\n5. NEMO (NF-kappaB essential modulator)\n6. p65 (RelA)\n7. p50 (RelB)\n8. c-Rel\n9. RelE\n10. p105 (gag-associated kinase)\n11. p100 (NF-kappaB1)\n12. TRAF2 (tumor necrosis factor receptor-associated factor 2)\n13. TRAF3 (tumor necrosis factor receptor-associated factor 3)\n14. TRAF5 (tumor necrosis factor receptor-associated factor 5)\n15. TRAF6 (tumor necrosis factor receptor-associated factor 6)\n16. TRAF1 (tumor necrosis factor receptor-associated factor 1)\n17. TRAF4 (tumor necrosis factor receptor-associated factor 4)\n18. TRAF7 (tumor necrosis factor receptor-associated factor 7)\n19. TRAF8 (tumor necrosis factor receptor-associated factor 8)\n20. TRAF9 (tumor necrosis factor receptor-associated factor 9)\n21. TRAF10 (tumor necrosis factor receptor-associated factor 10)\n22. TRAF11 (tumor necrosis factor receptor-associated factor 11)\n23. TRAF12 (tumor necrosis factor receptor-associated factor 12)\n24. TRAF13 (tumor necrosis factor receptor-associated factor 13)\n25. TRA",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TBK1 is a polyubiquitin binding protein involved in NF-kappaB signaling.\n2. IKKα is a polyubiquitin binding protein involved in NF-kappaB signaling.\n3. IKKβ is a polyubiquitin binding protein involved in NF-kappaB signaling.\n4. NEMO is a polyubiquitin binding protein involved in NF-kappaB signaling.\n5. p65 is a polyubiquitin binding protein involved in NF-kappaB signaling.",
    "vicuna-7b_fact": [
      "TBK1 is a polyubiquitin binding protein involved in NF-kappaB signaling.",
      "IKKα is a polyubiquitin binding protein involved in NF-kappaB signaling.",
      "IKKβ is a polyubiquitin binding protein involved in NF-kappaB signaling.",
      "NEMO is a polyubiquitin binding protein involved in NF-kappaB signaling.",
      "p65 is a polyubiquitin binding protein involved in NF-kappaB signaling."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: IKKα is not a polyubiquitin binding protein. It is a kinase that phosphorylates inhibitors of NF-kappaB signaling.\n3. FALSE [correction]: IKKβ is not a polyubiquitin binding protein. It is a kinase that phosphorylates inhibitors of NF-kappaB signaling.\n4. TRUE\n5. FALSE [correction]: p65 is not a polyubiquitin binding protein. It is a subunit of NF-kappaB that translocates to the nucleus to activate transcription.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2388,
    "user_query": "What are the prednisone side effects in DMD patients?",
    "vicuna-7b_response": "Prednisone is a corticosteroid medication that is commonly used to treat Duchenne muscular dystrophy (DMD) patients. While prednisone can be effective in managing the symptoms of DMD, it can also cause side effects. Some of the most common side effects of prednisone in DMD patients include:\n1. Weight gain: Prednisone can cause an increase in appetite, leading to weight gain.\n2. Cushing's syndrome: Prednisone can cause the body to produce too much cortisol, leading to Cushing's syndrome.\n3. Osteoporosis: Prednisone can cause bone loss, leading to an increased risk of osteoporosis.\n4. Cataracts: Prednisone can cause the development of cataracts, which are cloudy areas in the lens of the eye.\n5. Mood changes: Prednisone can cause mood changes, such as irritability, anxiety, and depression.\n6. Acne: Prednisone can cause the development of acne.\n7. Gastric ulcers: Prednisone can cause the development of gastric ulcers.\n8. Glaucoma: Prednisone can cause an increase in intraocular pressure, leading to glaucoma.\nIt is important to note that these are not all the side effects of prednisone in DMD patients, and that each patient may experience different side effects. It is important to discuss the potential side effects of prednisone with a healthcare provider before starting treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prednisone is a corticosteroid medication used to treat Duchenne muscular dystrophy (DMD) patients.\n2. Common side effects of prednisone in DMD patients include weight gain.\n3. Prednisone can cause the body to produce too much cortisol, leading to Cushing's syndrome.\n4. One of the side effects of using Prednisone can lead to an increased risk of osteoporosis.\n5. Prednisone can result in the development of cataracts, mood changes, acne, gastric ulcers, and glaucoma in DMD patients.\n5. Each patient may experience different side effects from using Prednisone.",
    "vicuna-7b_fact": [
      "Prednisone is a corticosteroid medication used to treat Duchenne muscular dystrophy (DMD) patients.",
      "Common side effects of prednisone in DMD patients include weight gain.",
      "Prednisone can cause the body to produce too much cortisol, leading to Cushing's syndrome.",
      "One of the side effects of using Prednisone can lead to an increased risk of osteoporosis.",
      "Prednisone can result in the development of cataracts, mood changes, acne, gastric ulcers, and glaucoma in DMD patients.",
      "Each patient may experience different side effects from using Prednisone."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-7b_response": "ROF1, also known as RNA polymerase II factor 1, is a transcription factor that plays a crucial role in the regulation of gene expression in Arabidopsis thaliana. ROF1 is induced in response to various stimuli, including environmental stressors such as heat, cold, drought, and salinity, as well as abiotic stressors such as UV-B and oxidative stress.\nROF1 is also induced by various hormones, including abscisic acid (ABA), ethylene, and jasmonic acid. ABA is a plant hormone that plays a key role in the response to drought stress, and ROF1 is induced by ABA in a variety of tissues, including roots, leaves, and flowers.\nIn addition to environmental and hormonal stimuli, ROF1 is also induced by various pathogens, including fungi and bacteria. ROF1 is upregulated in response to the presence of pathogens, and it has been shown to play a role in the defense response to infection.\nOverall, ROF1 is induced by a variety of stimuli, including environmental stressors, hormones, and pathogens, and it plays a crucial role in the regulation of gene expression in response to these stimuli.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ROF1, or RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.\n2. Environmental stressors such as heat, cold, drought, salinity, UV-B, and oxidative stress can induce ROF1 expression.\n3. Hormones like abscisic acid (ABA), ethylene, and jasmonic acid can also induce ROF1 expression.\n4. Abscisic acid (ABA), one of the hormones that induce ROF1, plays a key role in the plant's response to drought stress.\n5. Pathogens such as fungi and bacteria can induce the expression of ROF1.",
    "vicuna-7b_fact": [
      "ROF1, or RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.",
      "Environmental stressors such as heat, cold, drought, salinity, UV-B, and oxidative stress can induce ROF1 expression.",
      "Hormones like abscisic acid (ABA), ethylene, and jasmonic acid can also induce ROF1 expression.",
      "Abscisic acid (ABA), one of the hormones that induce ROF1, plays a key role in the plant's response to drought stress.",
      "Pathogens such as fungi and bacteria can induce the expression of ROF1."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2393,
    "user_query": "What is the preferred orientation of CTCF binding sites for chromatin looping?",
    "vicuna-7b_response": "CTCF (CCCTC-binding factor) is a transcriptional regulator that plays a crucial role in the regulation of gene expression by forming insulating loops between distant enhancers and promoters. The preferred orientation of CTCF binding sites for chromatin looping is head-to-head (HTH) or head-to-tail (HT) orientation.\nIn the HTH orientation, the CTCF binding sites are located on opposite strands of the DNA molecule, with the binding sites on one strand facing towards the other strand. This orientation allows for the formation of a stable loop between the distant enhancers and promoters, as the binding sites on opposite strands can interact with each other to form a loop.\nIn the HT orientation, the CTCF binding sites are located on the same strand of the DNA molecule. This orientation is less favored for chromatin looping, as the binding sites on the same strand cannot interact with each other to form a loop. However, in some cases, the HT orientation can still be functional for looping, depending on the specific context and the presence of other factors that can facilitate the formation of a loop.\nOverall, the preferred orientation of CTCF binding sites for chromatin looping is HTH or HT, as this orientation allows for the formation of stable loops between distant enhancers and promoters.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC-binding factor) is a transcriptional regulator that plays a role in the regulation of gene expression by forming insulating loops between distant enhancers and promoters.\n2. The preferred orientation of CTCF binding sites for chromatin looping is head-to-head (HTH) or head-to-tail (HT) orientation.\n3. In the HTH orientation, the CTCF binding sites are located on opposite strands of the DNA molecule.\n4. In the HT orientation, the CTCF binding sites are located on the same strand of the DNA molecule.\n5. The HT orientation is less favored for chromatin looping as the binding sites on the same strand cannot interact with each other to form a loop.",
    "vicuna-7b_fact": [
      "CTCF (CCCTC-binding factor) is a transcriptional regulator that plays a role in the regulation of gene expression by forming insulating loops between distant enhancers and promoters.",
      "The preferred orientation of CTCF binding sites for chromatin looping is head-to-head (HTH) or head-to-tail (HT) orientation.",
      "In the HTH orientation, the CTCF binding sites are located on opposite strands of the DNA molecule.",
      "In the HT orientation, the CTCF binding sites are located on the same strand of the DNA molecule.",
      "The HT orientation is less favored for chromatin looping as the binding sites on the same strand cannot interact with each other to form a loop."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the HT orientation, the CTCF binding sites are located on opposite strands of the DNA molecule.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2395,
    "user_query": "How many amino acids does davunetide consist of?",
    "vicuna-7b_response": "Davunetide is a synthetic peptide that consists of 36 amino acids. It is a potent and selective agonist of the metabotropic glutamate receptor subtype 5 (mGlu5), which is a type of glutamate receptor that plays a role in various neurological processes, including learning and memory.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Davunetide is a synthetic peptide.\n2. Davunetide consists of 36 amino acids.\n3. Davunetide is a potent and selective agonist of the metabotropic glutamate receptor subtype 5 (mGlu5).\n4. The metabotropic glutamate receptor subtype 5 (mGlu5) is a type of glutamate receptor.\n5. The metabotropic glutamate receptor subtype 5 (mGlu5) plays a role in various neurological processes, including learning and memory.",
    "vicuna-7b_fact": [
      "Davunetide is a synthetic peptide.",
      "Davunetide consists of 36 amino acids.",
      "Davunetide is a potent and selective agonist of the metabotropic glutamate receptor subtype 5 (mGlu5).",
      "The metabotropic glutamate receptor subtype 5 (mGlu5) is a type of glutamate receptor.",
      "The metabotropic glutamate receptor subtype 5 (mGlu5) plays a role in various neurological processes, including learning and memory."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Davunetide consists of 8 amino acids.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-7b_response": "Hereditary renal amyloidosis is a rare genetic disorder characterized by the accumulation of an abnormal protein called amyloid in the kidneys. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR). TTR is a plasma protein that is normally found in the blood and is involved in the transport of thyroid hormones and vitamin A. In hereditary renal amyloidosis, mutations in the TTR gene cause the production of an abnormal TTR protein that accumulates in the kidneys and leads to the formation of amyloid fibrils. Other less common causes of hereditary renal amyloidosis include the presence of other abnormal proteins such as immunoglobulin light chains and the presence of wild-type transthyretin (TTR-Wt).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hereditary renal amyloidosis is a genetic disorder characterized by the accumulation of amyloid, an abnormal protein, in the kidneys.\n2. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).\n3. TTR is a plasma protein found in the blood that is involved in the transport of thyroid hormones and vitamin A.\n4. In hereditary renal amyloidosis, mutations in the TTR gene cause the production of an abnormal TTR protein that forms amyloid fibrils in the kidneys.\n5. Other less common causes of hereditary renal amyloidosis can include abnormal proteins such as immunoglobulin light chains and wild-type transthyretin (TTR-Wt).",
    "vicuna-7b_fact": [
      "Hereditary renal amyloidosis is a genetic disorder characterized by the accumulation of amyloid, an abnormal protein, in the kidneys.",
      "The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).",
      "TTR is a plasma protein found in the blood that is involved in the transport of thyroid hormones and vitamin A.",
      "In hereditary renal amyloidosis, mutations in the TTR gene cause the production of an abnormal TTR protein that forms amyloid fibrils in the kidneys.",
      "Other less common causes of hereditary renal amyloidosis can include abnormal proteins such as immunoglobulin light chains and wild-type transthyretin (TTR-Wt)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2401,
    "user_query": "Where do centromeres locate according to the Rabl orientation of eukaryotic nuclei?",
    "vicuna-7b_response": "Centromeres are located in the middle of the chromosomes in eukaryotic cells, according to the Rabl orientation of the nucleus. The Rabl orientation refers to the way in which the chromosomes are arranged in the nucleus, with the centromeres located in the middle of the chromosomes and the telomeres located at the ends. This orientation is named after the Austrian anatomist, Franz Rabl, who first described it in the 19th century.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The centromeres are located in the middle of the chromosomes in eukaryotic cells according to the Rabl orientation.\n2. The Rabl orientation refers to the arrangement of chromosomes in the nucleus with the centromeres in the middle and the telomeres at the ends.\n3. The Rabl orientation is named after the Austrian anatomist, Franz Rabl.\n4. Franz Rabl first described the Rabl orientation in the 19th century.",
    "vicuna-7b_fact": [
      "The centromeres are located in the middle of the chromosomes in eukaryotic cells according to the Rabl orientation.",
      "The Rabl orientation refers to the arrangement of chromosomes in the nucleus with the centromeres in the middle and the telomeres at the ends.",
      "The Rabl orientation is named after the Austrian anatomist, Franz Rabl.",
      "Franz Rabl first described the Rabl orientation in the 19th century."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Rabl orientation refers to the arrangement of chromosomes in the nucleus with the centromeres positioned near the nuclear envelope and the telomeres oriented towards the interior.\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2404,
    "user_query": "What is the mode of action of the drug Prolia?",
    "vicuna-7b_response": "Prolia is a medication that is used to treat osteoporosis in postmenopausal women and men. It is a biologic drug that is administered as an injection.\nProlia works by inhibiting the activity of a protein called osteoclast-activating factor (PLAF), which is involved in the breakdown of bone. By inhibiting PLAF, Prolia helps to increase bone density and reduce the risk of fractures.\nIt is important to note that Prolia is not a first-line treatment for osteoporosis and should only be used in patients who have a high risk of fractures or who have already experienced a fracture. It is also important to note that Prolia should only be administered by a healthcare professional and that patients should be monitored for any potential side effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prolia is used to treat osteoporosis in postmenopausal women and men.\n2. Prolia is a biologic drug that is administered as an injection.\n3. Prolia works by inhibiting the activity of a protein called osteoclast-activating factor (PLAF).\n4. Prolia is not a first-line treatment for osteoporosis and should only be used in patients who have a high risk of fractures or have already experienced a fracture.\n5. Prolia should only be administered by a healthcare professional and patients should be monitored for any potential side effects.",
    "vicuna-7b_fact": [
      "Prolia is used to treat osteoporosis in postmenopausal women and men.",
      "Prolia is a biologic drug that is administered as an injection.",
      "Prolia works by inhibiting the activity of a protein called osteoclast-activating factor (PLAF).",
      "Prolia is not a first-line treatment for osteoporosis and should only be used in patients who have a high risk of fractures or have already experienced a fracture.",
      "Prolia should only be administered by a healthcare professional and patients should be monitored for any potential side effects."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Prolia works by inhibiting the activity of a protein called RANK Ligand.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-7b_response": "Yes, the proteome of mouse hippocampus has been analyzed. The hippocampus is a brain structure involved in learning and memory, and its proteome, or the set of all proteins expressed in a particular cell or tissue type, has been studied extensively in mice.\nSeveral studies have used proteomic techniques, such as two-dimensional gel electrophoresis and mass spectrometry, to identify and quantify the proteins expressed in the mouse hippocampus. These studies have identified thousands of proteins, including both protein-coding genes and non-coding RNAs, as well as proteins involved in various biological processes such as neurotransmission, synaptic plasticity, and cellular metabolism.\nOne study published in the journal Molecular and Cellular Proteomics in 2012 used a combination of mass spectrometry and bioinformatics approaches to identify over 7,000 proteins in the mouse hippocampus. Another study published in the journal Neuroscience Letters in 2016 used two-dimensional gel electrophoresis to identify over 1,000 proteins in the mouse hippocampus, including proteins involved in synaptic plasticity and neuronal signaling.\nOverall, the proteome of mouse hippocampus has been extensively studied, and these studies have provided important insights into the biology of this brain structure and the mechanisms underlying learning and memory.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The proteome of mouse hippocampus has been analyzed.\n2. The hippocampus is a brain structure involved in learning and memory.\n3. Several studies have used proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry.\n4. A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.\n5. A study published in the journal Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus, including proteins involved in synaptic plasticity and neuronal signaling.",
    "vicuna-7b_fact": [
      "The proteome of mouse hippocampus has been analyzed.",
      "The hippocampus is a brain structure involved in learning and memory.",
      "Several studies have used proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry.",
      "A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.",
      "A study published in the journal Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus, including proteins involved in synaptic plasticity and neuronal signaling."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-7b_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are a type of chromosome that have their centromeres located at the ends of the chromosome, whereas mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes have their centromeres located at the ends of the chromosome.\n3. Mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes have their centromeres located at the ends of the chromosome.",
      "Mouse chromosomes have their centromeres located in the middle of the chromosome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Mouse chromosomes are acrocentric.\n2. TRUE\n3. FALSE [correction]: Mouse chromosomes do not have their centromeres located in the middle of the chromosome, but near one end, as they are acrocentric.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2414,
    "user_query": "Which disease risk can be estimated with the Stop-Bang questionnaire?",
    "vicuna-7b_response": "The Stop-Bang questionnaire is commonly used to assess the risk of obstructive sleep apnea (OSA). OSA is a sleep disorder characterized by repeated episodes of upper airway obstruction during sleep, which can lead to a variety of negative health effects. The Stop-Bang questionnaire is a tool that helps healthcare providers determine if a patient may have OSA by asking a series of questions about symptoms such as snoring, daytime sleepiness, and difficulty breathing while sleeping. The questionnaire takes into account the patient's age, gender, and body mass index (BMI) to determine the risk of OSA. The questionnaire is not intended to diagnose OSA, but rather to identify patients who may be at risk for the condition and require further evaluation and testing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea (OSA).\n2. Obstructive sleep apnea is a sleep disorder characterized by repeated episodes of upper airway obstruction during sleep.\n3. The Stop-Bang questionnaire helps healthcare providers determine if a patient may have OSA by asking a series of questions about symptoms like snoring, daytime sleepiness, and difficulty breathing while sleeping.\n4. The Stop-Bang questionnaire takes into account the patient's age, gender, and body mass index (BMI) to determine the risk of OSA.\n5. The questionnaire is not intended to diagnose OSA, but rather to identify patients who may be at risk for the condition and require further evaluation and testing.",
    "vicuna-7b_fact": [
      "The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea (OSA).",
      "Obstructive sleep apnea is a sleep disorder characterized by repeated episodes of upper airway obstruction during sleep.",
      "The Stop-Bang questionnaire helps healthcare providers determine if a patient may have OSA by asking a series of questions about symptoms like snoring, daytime sleepiness, and difficulty breathing while sleeping.",
      "The Stop-Bang questionnaire takes into account the patient's age, gender, and body mass index (BMI) to determine the risk of OSA.",
      "The questionnaire is not intended to diagnose OSA, but rather to identify patients who may be at risk for the condition and require further evaluation and testing."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2415,
    "user_query": "List indications for palivizumab for treatment of RSV-induced bronchiolitis.",
    "vicuna-7b_response": "Palivizumab is a medication used to prevent respiratory syncytial virus (RSV) infection in high-risk infants and children. It is not used to treat RSV-induced bronchiolitis. However, here are some indications for palivizumab that may be relevant:\n* Palivizumab is indicated for the prevention of RSV infection in high-risk infants and children, including those with:\n\t+ Chronic lung disease of infancy (CLDI)\n\t+ Congenital heart disease\n\t+ Hemodynamically significant patent ductus arteriosus (PDA)\n\t+ Certain immune system disorders, such as severe combined immunodeficiency (SCID)\n\t+ Certain neuromuscular disorders, such as spinal muscular atrophy (SMA)\n* Palivizumab is also indicated for the prevention of RSV infection in premature infants, including those born before 37 weeks of gestation and those with a birth weight of less than 1500 grams.\n* Palivizumab is not recommended for the treatment of RSV-induced bronchiolitis. However, if your child has been diagnosed with RSV-induced bronchiolitis, it is important to follow the advice of their healthcare provider and to seek medical attention if their symptoms worsen or if they experience difficulty breathing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Palivizumab is used to prevent respiratory syncytial virus (RSV) infection in high-risk infants and children.\n2. Palivizumab can be used for chronic lung disease of infancy, congenital heart disease, certain immune system disorders such as severe combined immunodeficiency, and certain neuromuscular disorders, such as spinal muscular atrophy.\n3. Palivizumab is also used for the prevention of RSV infection in premature infants, particularly those born before 37 weeks of gestation and those with a birth weight of less than 1500 grams.\n4. Palivizumab is not recommended for the treatment of RSV-induced bronchiolitis.\n5. Palivizumab can be used in those with Hemodynamically significant patent ductus arteriosus (PDA).",
    "vicuna-7b_fact": [
      "Palivizumab is used to prevent respiratory syncytial virus (RSV) infection in high-risk infants and children.",
      "Palivizumab can be used for chronic lung disease of infancy, congenital heart disease, certain immune system disorders such as severe combined immunodeficiency, and certain neuromuscular disorders, such as spinal muscular atrophy.",
      "Palivizumab is also used for the prevention of RSV infection in premature infants, particularly those born before 37 weeks of gestation and those with a birth weight of less than 1500 grams.",
      "Palivizumab is not recommended for the treatment of RSV-induced bronchiolitis.",
      "Palivizumab can be used in those with Hemodynamically significant patent ductus arteriosus (PDA)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-7b_response": "One example of an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is GEN-1.\nGEN-1 is an siRNA drug that targets the Hedgehog signaling pathway, which is known to play a role in the development and progression of pancreatic cancer. By inhibiting the Hedgehog pathway, GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.\nGEN-1 is currently being studied in a phase 1b/2 clinical trial in patients with advanced pancreatic cancer. The trial is evaluating the safety and efficacy of GEN-1 in combination with chemotherapy and is expected to enroll up to 100 patients.\nIt's important to note that siRNA-based drugs are still in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GEN-1 is an siRNA-based drug in clinical trials for the treatment of pancreatic cancer.\n2. GEN-1 targets the Hedgehog signaling pathway, which is associated with the development and progression of pancreatic cancer.\n3. The drug has shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.\n4. GEN-1 is currently being studied in a phase 1b/2 clinical trial in patients with advanced pancreatic cancer.\n5. The trial is expected to enroll up to 100 patients and it is evaluating the safety and efficacy of GEN-1 in combination with chemotherapy.",
    "vicuna-7b_fact": [
      "GEN-1 is an siRNA-based drug in clinical trials for the treatment of pancreatic cancer.",
      "GEN-1 targets the Hedgehog signaling pathway, which is associated with the development and progression of pancreatic cancer.",
      "The drug has shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.",
      "GEN-1 is currently being studied in a phase 1b/2 clinical trial in patients with advanced pancreatic cancer.",
      "The trial is expected to enroll up to 100 patients and it is evaluating the safety and efficacy of GEN-1 in combination with chemotherapy."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-7b_response": "The HPG pore is a type of protein channel that is found in the plasma membrane of certain types of cells, including neurons and endocrine cells. It is also known as the high-affinity potassium channel or the tetrameric potassium channel.\nThe HPG pore is a complex structure that is composed of four identical subunits, each of which contains six transmembrane domains. These domains form a pore that is selective for potassium ions, allowing them to pass through the channel while blocking the passage of other ions.\nThe HPG pore plays an important role in regulating the flow of potassium ions across the plasma membrane, which is essential for a variety of cellular processes, including electrical signaling, muscle contraction, and hormone secretion. Dysfunction of the HPG pore has been implicated in a number of diseases, including epilepsy, migraines, and certain types of cancer.\nOverall, the HPG pore is a critical component of the cell membrane that plays a crucial role in regulating the flow of ions and other molecules across the membrane, which is essential for normal cellular function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The HPG pore is a type of protein channel found in the plasma membrane of certain types of cells, including neurons and endocrine cells.\n2. The HPG pore is also known as the high-affinity potassium channel or the tetrameric potassium channel.\n3. The HPG pore is composed of four identical subunits, each containing six transmembrane domains, forming a pore selective for potassium ions.\n4. The HPG pore plays a vital role in regulating the flow of potassium ions across the plasma membrane.\n5. Dysfunction of the HPG pore has been implicated in certain diseases, including epilepsy, migraines, and certain types of cancer.",
    "vicuna-7b_fact": [
      "The HPG pore is a type of protein channel found in the plasma membrane of certain types of cells, including neurons and endocrine cells.",
      "The HPG pore is also known as the high-affinity potassium channel or the tetrameric potassium channel.",
      "The HPG pore is composed of four identical subunits, each containing six transmembrane domains, forming a pore selective for potassium ions.",
      "The HPG pore plays a vital role in regulating the flow of potassium ions across the plasma membrane.",
      "Dysfunction of the HPG pore has been implicated in certain diseases, including epilepsy, migraines, and certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2422,
    "user_query": "Which R/Bioconductor package has been developed for cancer subtype identification?",
    "vicuna-7b_response": "One R/Bioconductor package that has been developed for cancer subtype identification is the \"subtype\" package. This package provides a set of functions for cancer subtype identification using gene expression data. It uses a combination of unsupervised and supervised methods to identify different subtypes of cancer, and it can also be used to compare the similarity between different samples. The subtype package is available on the Bioconductor website and can be installed using the devtools package.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"subtype\" package is an R/Bioconductor package developed for cancer subtype identification.\n2. The \"subtype\" package uses gene expression data for cancer subtype identification.\n3. This package uses a combination of unsupervised and supervised methods to identify different subtypes of cancer.\n4. The \"subtype\" package can be used to compare the similarity between different samples.\n5. The subtype package is available on the Bioconductor website and can be installed using the devtools package.",
    "vicuna-7b_fact": [
      "The \"subtype\" package is an R/Bioconductor package developed for cancer subtype identification.",
      "The \"subtype\" package uses gene expression data for cancer subtype identification.",
      "This package uses a combination of unsupervised and supervised methods to identify different subtypes of cancer.",
      "The \"subtype\" package can be used to compare the similarity between different samples.",
      "The subtype package is available on the Bioconductor website and can be installed using the devtools package."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2423,
    "user_query": "Is Solanezumab effective for Alzheimer's Disease?",
    "vicuna-7b_response": "Solanezumab is a monoclonal antibody that has been studied for the treatment of Alzheimer's disease. It is designed to bind to and clear amyloid beta, a protein that is believed to play a role in the development of Alzheimer's disease.\nThere have been several clinical trials of solanezumab, including the phase 3 trials EXPEDITION1 and EXPEDITION2, which were designed to evaluate the safety and efficacy of the drug in people with mild to moderate Alzheimer's disease. These trials showed that solanezumab was not effective in slowing the progression of the disease.\nWhile solanezumab did not show significant efficacy in these trials, it is still an active area of research, and other studies are ongoing to determine its potential role in the treatment of Alzheimer's disease. It is important to note that Alzheimer's disease is a complex and multifactorial disorder, and there is currently no cure for the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Solanezumab is a monoclonal antibody that has been studied for the treatment of Alzheimer's disease. \n2. Solanezumab is designed to bind to and clear amyloid beta, a protein that plays a role in the development of Alzheimer's disease.\n3. Solanezumab was evaluated in phase 3 trials EXPEDITION1 and EXPEDITION2.\n4. The trials EXPEDITION1 and EXPEDITION2 showed that solanezumab was not effective in slowing the progression of Alzheimer's disease.\n5. Alzheimer's disease is a complex and multifactorial disorder for which there is currently no cure.",
    "vicuna-7b_fact": [
      "Solanezumab is a monoclonal antibody that has been studied for the treatment of Alzheimer's disease.",
      "Solanezumab is designed to bind to and clear amyloid beta, a protein that plays a role in the development of Alzheimer's disease.",
      "Solanezumab was evaluated in phase 3 trials EXPEDITION1 and EXPEDITION2.",
      "The trials EXPEDITION1 and EXPEDITION2 showed that solanezumab was not effective in slowing the progression of Alzheimer's disease.",
      "Alzheimer's disease is a complex and multifactorial disorder for which there is currently no cure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2424,
    "user_query": "Are organisms in the genus Morexella associated with sepsis?",
    "vicuna-7b_response": "Yes, organisms in the genus Morexella are associated with sepsis. Morexella is a genus of bacteria that is commonly found in the human gut and is known to be part of the normal gut microbiota. However, under certain conditions, such as when the gut microbiota is disrupted, Morexella can potentially cause infections, including sepsis.\nMorexella species have been isolated from various sites of infection, including bloodstream infections, urinary tract infections, and wound infections. They are known to produce a variety of virulence factors, such as proteases, lipases, and cytotoxins, which can contribute to their pathogenicity.\nIt is important to note that not all Morexella species are pathogenic and that the potential for infection depends on various factors, including the host's immune status and the presence of other microorganisms that can contribute to sepsis. Therefore, while Morexella can be associated with sepsis, it is not a common cause of sepsis and should not be considered a major risk factor for sepsis without further evaluation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Morexella is a genus of bacteria that is commonly found in the human gut.\n2. Under certain conditions, Morexella can potentially cause infections, including sepsis.\n3. Morexella species have been isolated from various sites of infection, including bloodstream infections, urinary tract infections, and wound infections.\n4. Morexella species are known to produce a variety of virulence factors, such as proteases, lipases, and cytotoxins.\n5. Not all Morexella species are pathogenic.",
    "vicuna-7b_fact": [
      "Morexella is a genus of bacteria that is commonly found in the human gut.",
      "Under certain conditions, Morexella can potentially cause infections, including sepsis.",
      "Morexella species have been isolated from various sites of infection, including bloodstream infections, urinary tract infections, and wound infections.",
      "Morexella species are known to produce a variety of virulence factors, such as proteases, lipases, and cytotoxins.",
      "Not all Morexella species are pathogenic."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Moraxella, not Morexella, is a genus of bacteria that is commonly found in the human respiratory tract, not the gut.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2427,
    "user_query": "Which R/bioconductor package has been developed to aid in epigenomic analysis?",
    "vicuna-7b_response": "The R/bioconductor package that has been developed to aid in epigenomic analysis is called \"Epigenomics\".\nEpigenomics is a bioconductor package that provides tools for analyzing epigenetic data, including DNA methylation and histone modification data. It includes functions for processing and analyzing data from various epigenetic assays, such as bisulfite sequencing and ChIP-seq.\nSome of the key features of Epigenomics include:\n* Bisulfite conversion: The package provides functions for converting DNA sequences to a format that can be used for bisulfite sequencing.\n* Bisulfite sequencing: The package provides functions for aligning and processing bisulfite sequencing data.\n* ChIP-seq: The package provides functions for aligning and processing ChIP-seq data.\n* Hidden Markov models: The package provides functions for modeling and predicting DNA methylation states.\n* Heatmaps: The package provides functions for visualizing DNA methylation data.\nEpigenomics is widely used in the field of epigenetics and has been used in a variety of applications, including the study of cancer, development, and aging.\nIn summary, Epigenomics is a bioconductor package that provides tools for analyzing epigenetic data, including DNA methylation and histone modification data. It includes functions for processing and analyzing data from various epigenetic assays, such as bisulfite sequencing and ChIP-seq. It is widely used in the field of epigenetics and has been used in a variety of applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The R/bioconductor package developed for epigenomic analysis is called \"Epigenomics\".\n2. Epigenomics provides tools for analyzing epigenetic data, including DNA methylation and histone modification data.\n3. The Epigenomics package includes functions for processing and analyzing data from epigenetic assays such as bisulfite sequencing and ChIP-seq.\n4. Epigenomics is used in the field of epigenetics for a variety of applications, including the study of cancer, development, and aging.\n5. Key features of Epigenomics include Bisulfite conversion, Bisulfite sequencing, ChIP-seq, Hidden Markov models, and Heatmaps for visualizing DNA methylation data.",
    "vicuna-7b_fact": [
      "The R/bioconductor package developed for epigenomic analysis is called \"Epigenomics\".",
      "Epigenomics provides tools for analyzing epigenetic data, including DNA methylation and histone modification data.",
      "The Epigenomics package includes functions for processing and analyzing data from epigenetic assays such as bisulfite sequencing and ChIP-seq.",
      "Epigenomics is used in the field of epigenetics for a variety of applications, including the study of cancer, development, and aging.",
      "Key features of Epigenomics include Bisulfite conversion, Bisulfite sequencing, ChIP-seq, Hidden Markov models, and Heatmaps for visualizing DNA methylation data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2431,
    "user_query": "What is miravirsen?",
    "vicuna-7b_response": "Miravirsen is a synthetic, non-nucleoside reverse transcriptase inhibitor (NNRTI) that is being developed as a potential treatment for HIV/AIDS. It works by blocking the activity of the HIV reverse transcriptase enzyme, which is essential for the replication of the virus.\nMiravirsen is designed to have a unique mechanism of action compared to other NNRTIs, as it does not require the viral integrase enzyme to incorporate the drug into the viral DNA. Instead, miravirsen is thought to bind to the reverse transcriptase enzyme and prevent its activity by interfering with its ability to synthesize new viral DNA.\nMiravirsen has shown promise in early clinical trials, with some studies suggesting that it may be effective at reducing viral load and increasing CD4+ T cell counts in HIV-infected individuals. However, more research is needed to fully understand the safety and efficacy of this drug.\nIt's important to note that miravirsen is still in the development stage and has not yet been approved by regulatory authorities for use in the treatment of HIV/AIDS.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Miravirsen is a synthetic, non-nucleoside reverse transcriptase inhibitor (NNRTI).\n2. The drug is being developed as a potential treatment for HIV/AIDS.\n3. Miravirsen blocks the activity of the HIV reverse transcriptase enzyme which is essential for the virus replication.\n4. The drug has shown promise in early clinical trials for reducing viral load and increasing CD4+ T cell counts in HIV-infected individuals.\n5. Miravirsen is still in development stage and not yet approved by regulatory authorities for use in the treatment of HIV/AIDS.",
    "vicuna-7b_fact": [
      "Miravirsen is a synthetic, non-nucleoside reverse transcriptase inhibitor (NNRTI).",
      "The drug is being developed as a potential treatment for HIV/AIDS.",
      "Miravirsen blocks the activity of the HIV reverse transcriptase enzyme which is essential for the virus replication.",
      "The drug has shown promise in early clinical trials for reducing viral load and increasing CD4+ T cell counts in HIV-infected individuals.",
      "Miravirsen is still in development stage and not yet approved by regulatory authorities for use in the treatment of HIV/AIDS."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Miravirsen is an antiviral drug that uses an entirely different mechanism from NNRTIs. It is a synthetic antisense oligonucleotide, which binds to microRNA-122.\n2. FALSE [correction]: The drug is being developed as a potential treatment for Hepatitis C, not HIV/AIDS.\n3. FALSE [correction]: Miravirsen blocks the activity of the miR-122, a liver-specific microRNA essential for Hepatitis C virus replication, not HIV.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2435,
    "user_query": "Which are the main transcriptional activators of circadian oscillations?",
    "vicuna-7b_response": "The main transcriptional activators of circadian oscillations are the transcription factors CLOCK and BMAL1. These proteins form a complex with the nuclear receptor PERIOD (PER1, PER2) and the transcriptional coactivator TRAP1. The CLOCK-BMAL1 complex binds to the promoter regions of target genes, including PER1 and PER2, and recruits the TRAP1 coactivator to these promoters, leading to increased transcription of these genes. The resulting increase in PER1 and PER2 protein levels leads to the positive feedback loop that drives the circadian clock.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The transcription factors CLOCK and BMAL1 are the main transcriptional activators of circadian oscillations.\n2. These proteins form a complex with the nuclear receptor PERIOD (PER1, PER2) and the transcriptional coactivator TRAP1.\n3. The CLOCK-BMAL1 complex binds to the promoter regions of target genes, including PER1 and PER2.\n4. The CLOCK-BMAL1 complex recruits the TRAP1 coactivator to these promoters.\n5. The increase in PER1 and PER2 protein levels leads to the positive feedback loop that drives the circadian clock.",
    "vicuna-7b_fact": [
      "The transcription factors CLOCK and BMAL1 are the main transcriptional activators of circadian oscillations.",
      "These proteins form a complex with the nuclear receptor PERIOD (PER1, PER2) and the transcriptional coactivator TRAP1.",
      "The CLOCK-BMAL1 complex binds to the promoter regions of target genes, including PER1 and PER2.",
      "The CLOCK-BMAL1 complex recruits the TRAP1 coactivator to these promoters.",
      "The increase in PER1 and PER2 protein levels leads to the positive feedback loop that drives the circadian clock."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The CLOCK-BMAL1 complex forms a complex with the proteins PERIOD (PER1, PER2) and CRYPTOCHROME (CRY1, CRY2), not the transcriptional coactivator TRAP1.\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The increase in PER1 and PER2 protein levels leads to the negative feedback loop that drives the circadian clock.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2444,
    "user_query": "List the ten types of conjoined twins.",
    "vicuna-7b_response": "Sure, here are ten types of conjoined twins:\n1. Craniopagus twins: These are the most common type of conjoined twins, where the twins are joined at the top of the head.\n2. Thoracopagus twins: These twins are joined at the chest, and have separate heads, arms, and legs.\n3. Omegasynochorionic twins: These twins are joined at the placenta, and share a single chorion, which is the outermost membrane surrounding the embryo.\n4. Monochorionic diamniotic twins: These twins are also joined at the placenta, but have separate chorions and amniotic sacs.\n5. Ischiorectal twins: These twins are joined at the buttocks, and have separate legs and anuses.\n6. Sacrococcygeal twins: These twins are joined at the tailbone, and have separate legs and anuses.\n7. Cervical teratoma twins: These twins are joined at the neck, and have a tumor containing hair, teeth, and other tissues.\n8. Cardiovascular conjoined twins: These twins have a shared heart and blood vessels, and may also have other congenital heart defects.\n9. Gastrointestinal conjoined twins: These twins have a shared digestive system, and may also have other congenital abnormalities.\n10. Mesenteric conjoined twins: These twins have a shared mesentery, which is the tissue that attaches the intestines to the abdominal wall.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Craniopagus twins are the most common type of conjoined twins, who are joined at the top of the head.\n2. Thoracopagus twins are conjoined at the chest, having separate heads, arms, and legs.\n3. Omegasynochorionic twins are joined at the placenta, sharing a single chorion.\n4. Monochorionic diamniotic twins are joined at the placenta, but have separate chorions and amniotic sacs.\n5. Ischiorectal twins are joined at the buttocks, having separate legs and anuses.",
    "vicuna-7b_fact": [
      "Craniopagus twins are the most common type of conjoined twins, who are joined at the top of the head.",
      "Thoracopagus twins are conjoined at the chest, having separate heads, arms, and legs.",
      "Omegasynochorionic twins are joined at the placenta, sharing a single chorion.",
      "Monochorionic diamniotic twins are joined at the placenta, but have separate chorions and amniotic sacs.",
      "Ischiorectal twins are joined at the buttocks, having separate legs and anuses."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Craniopagus twins are not the most common type of conjoined twins, they are the rarest and are joined at the head.\n2. TRUE\n3. FALSE [correction]: The term \"omegasynochorionic twins\" is not recognized in medical terminology. Terms such as monochorionic twins (twins that share a single chorion and placenta) or dichorionic twins (twins that have separate chorions and placentae) are used.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2449,
    "user_query": "Is cilengitide effective for treatment of glioblastoma?",
    "vicuna-7b_response": "Cilengitide is a monoclonal antibody that is used in the treatment of glioblastoma, a type of brain cancer. It is typically used in combination with other treatments, such as radiation and chemotherapy.\nCilengitide works by blocking the ability of tumor cells to form blood vessels, which is necessary for their growth and survival. By starving the tumor of blood, cilengitide can slow down the growth and spread of glioblastoma.\nThere have been several clinical trials that have investigated the use of cilengitide in the treatment of glioblastoma. While the results have been mixed, some studies have shown that cilengitide can improve survival rates in patients with this type of cancer.\nIt is important to note that glioblastoma is a complex and aggressive type of cancer, and the treatment options available can vary depending on the individual patient and the stage of the disease. It is always best to consult with a medical professional for the most up-to-date information on the use of cilengitide or any other treatment for glioblastoma.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cilengitide is a monoclonal antibody that is used in the treatment of glioblastoma.\n2. Glioblastoma is a type of brain cancer.\n3. Cilengitide is typically used in combination with other treatments, such as radiation and chemotherapy.\n4. Cilengitide works by blocking the ability of tumor cells to form blood vessels. \n5. Clinical trials have been conducted to investigate the use of cilengitide in the treatment of glioblastoma.",
    "vicuna-7b_fact": [
      "Cilengitide is a monoclonal antibody that is used in the treatment of glioblastoma.",
      "Glioblastoma is a type of brain cancer.",
      "Cilengitide is typically used in combination with other treatments, such as radiation and chemotherapy.",
      "Cilengitide works by blocking the ability of tumor cells to form blood vessels.",
      "Clinical trials have been conducted to investigate the use of cilengitide in the treatment of glioblastoma."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cilengitide is not a monoclonal antibody but a selective integrin inhibitor used in cancer treatments including glioblastoma.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2455,
    "user_query": "Is LDB1-mediated enhancer looping dependent on cohesin?",
    "vicuna-7b_response": "LDB1 (Lysine-rich beta-merophosphatase 1) is a protein that has been shown to play a role in regulating gene expression by forming complexes with other proteins, including cohesin. Cohesin is a protein complex that is involved in the regulation of chromosome stability and the maintenance of genome integrity.\nThere is evidence to suggest that LDB1-mediated enhancer looping may be dependent on cohesin. For example, studies have shown that LDB1 can interact with cohesin and that cohesin is required for the formation of LDB1 complexes. Additionally, it has been shown that cohesin is required for the proper regulation of gene expression by LDB1.\nHowever, it is important to note that the relationship between LDB1 and cohesin in the regulation of enhancer looping is not fully understood and further research is needed to clarify this relationship.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LDB1 (Lysine-rich beta-merophosphatase 1) is a protein that is involved in regulating gene expression by forming complexes with other proteins.\n2. Cohesin is a protein complex that is involved in the regulation of chromosome stability and the maintenance of genome integrity.\n3. There is evidence to suggest that LDB1-mediated enhancer looping may be dependent on cohesin.\n4. Studies have shown that LDB1 can interact with cohesin.\n5. It has been shown that cohesin is needed for the proper regulation of gene expression by LDB1.",
    "vicuna-7b_fact": [
      "LDB1 (Lysine-rich beta-merophosphatase 1) is a protein that is involved in regulating gene expression by forming complexes with other proteins.",
      "Cohesin is a protein complex that is involved in the regulation of chromosome stability and the maintenance of genome integrity.",
      "There is evidence to suggest that LDB1-mediated enhancer looping may be dependent on cohesin.",
      "Studies have shown that LDB1 can interact with cohesin.",
      "It has been shown that cohesin is needed for the proper regulation of gene expression by LDB1."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: LDB1 (LIM domain binding 1) is a protein that is involved in regulating gene expression by forming complexes with other proteins.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2456,
    "user_query": "Describe nursemaid's elbow injury.",
    "vicuna-7b_response": "Nursemaid's elbow, also known as \"fallen arch syndrome,\" is a common injury in young children, particularly those under the age of two. It occurs when the arch of the foot drops, causing the elbow to bend and the wrist to flex. This can cause pain and discomfort in the elbow, as well as difficulty bending and straightening the arm.\nThe injury typically occurs when a child is supported by their hands and feet, such as when being lifted by their caregiver. This can cause the arch of the foot to collapse, leading to the elbow injury.\nSymptoms of nursemaid's elbow may include pain and swelling in the elbow, difficulty bending and straightening the arm, and a limp or weakness in the affected arm. In severe cases, the child may also experience numbness or tingling in the hand or fingers.\nTreatment for nursemaid's elbow typically involves rest, ice, and pain relief medication. In some cases, a brace or cast may be used to immobilize the elbow and promote healing. Physical therapy may also be recommended to help improve strength and flexibility in the affected arm.\nPrevention of nursemaid's elbow involves proper support and positioning of the child's body when they are being lifted or carried. It is important to avoid lifting a child by their hands or feet, and to instead support their entire body with one hand on the child's back and the other under their bottom.\nIn summary, nursemaid's elbow is a common injury in young children caused by the collapse of the arch of the foot. Symptoms include pain, swelling, difficulty bending and straightening the arm, and numbness or tingling in the hand or fingers. Treatment typically involves rest, ice, pain relief medication, and physical therapy. Prevention involves proper support and positioning of the child's body when being lifted or carried.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nursemaid's elbow is a common injury in young children particularly those under the age of two.\n2. The injury, nursemaid's elbow, occurs when the arch of the foot drops, causing the elbow to bend and the wrist to flex.\n3. The injury typically happens when a child is supported by their hands and feet such as when being lifted by their caregiver.\n4. Symptoms of nursemaid's elbow may include pain and swelling in the elbow, difficulty bending and straightening the arm, and a limp or weakness in the affected arm.\n5. Treatment for nursemaid's elbow typically involves rest, ice, pain relief medication, and in some cases a brace or cast, and physical therapy.",
    "vicuna-7b_fact": [
      "Nursemaid's elbow is a common injury in young children particularly those under the age of two.",
      "The injury, nursemaid's elbow, occurs when the arch of the foot drops, causing the elbow to bend and the wrist to flex.",
      "The injury typically happens when a child is supported by their hands and feet such as when being lifted by their caregiver.",
      "Symptoms of nursemaid's elbow may include pain and swelling in the elbow, difficulty bending and straightening the arm, and a limp or weakness in the affected arm.",
      "Treatment for nursemaid's elbow typically involves rest, ice, pain relief medication, and in some cases a brace or cast, and physical therapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The injury, nursemaid's elbow, occurs when there is a strong pull on the child's arm or a sudden jerk, causing the radius (one of the bones in the forearm) to slip out of place from where it normally attaches to the elbow joint.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Treatment for nursemaid's elbow typically involves a health care professional performing a procedure to move the bone back into place, called a reduction. This is usually followed by the child regaining use of the arm within a few minutes.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2458,
    "user_query": "What is mechanism of action of Benralizumab?",
    "vicuna-7b_response": "Benralizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha subunit. It is used to treat severe asthma and eosinophilic esophagitis.\nThe mechanism of action of benralizumab is to bind to the IL-5 receptor alpha subunit on the surface of eosinophils, which are a type of white blood cell that plays a role in allergic reactions and inflammation. By binding to the IL-5 receptor, benralizumab inhibits the action of IL-5, a cytokine that attracts eosinophils to the site of inflammation. This reduces the number of eosinophils in the airways and decreases inflammation, which can improve asthma symptoms.\nIn eosinophilic esophagitis, benralizumab works by reducing the number of eosinophils in the esophagus, which can help to alleviate symptoms such as difficulty swallowing, chest pain, and vomiting.\nOverall, the mechanism of action of benralizumab is to target the IL-5 receptor alpha subunit to inhibit the action of IL-5 and reduce the number of eosinophils in the airways or esophagus, which can improve symptoms of severe asthma and eosinophilic esophagitis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Benralizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha subunit.\n2. Benralizumab is used to treat severe asthma and eosinophilic esophagitis.\n3. The mechanism of action of benralizumab is to bind to the IL-5 receptor alpha subunit on the surface of eosinophils.\n4. By inhibiting the action of IL-5, benralizumab can reduce the number of eosinophils in the airways and decrease inflammation.\n5. In eosinophilic esophagitis, benralizumab works by reducing the number of eosinophils in the esophagus.",
    "vicuna-7b_fact": [
      "Benralizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha subunit.",
      "Benralizumab is used to treat severe asthma and eosinophilic esophagitis.",
      "The mechanism of action of benralizumab is to bind to the IL-5 receptor alpha subunit on the surface of eosinophils.",
      "By inhibiting the action of IL-5, benralizumab can reduce the number of eosinophils in the airways and decrease inflammation.",
      "In eosinophilic esophagitis, benralizumab works by reducing the number of eosinophils in the esophagus."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Benralizumab is used to treat severe asthma and eosinophilic disorders, but not specifically eosinophilic esophagitis.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2459,
    "user_query": "Is there any link between ERCC1-XPF and cohesin?",
    "vicuna-7b_response": "Yes, there is a link between ERCC1-XPF and cohesin. ERCC1-XPF is a complex that consists of the ERCC1 (XPF) subunit and the ERCC4 (XPG) subunit. The ERCC1-XPF complex is involved in the repair of DNA damage, specifically in the removal of damaged base pairs from DNA.\nCohesin is a protein complex that plays a role in the regulation of gene expression by controlling the separation of sister chromatids during cell division. It has been shown that the ERCC1-XPF complex can also function in the regulation of cohesin-mediated gene silencing.\nIn summary, the ERCC1-XPF complex and cohesin have a link in the regulation of gene expression and DNA repair.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ERCC1-XPF is a complex that consists of the ERCC1 (XPF) subunit and the ERCC4 (XPG) subunit.\n2. The ERCC1-XPF complex is involved in the repair of DNA damage, specifically in the removal of damaged base pairs from DNA.\n3. Cohesin is a protein complex that plays a role in the regulation of gene expression by controlling the separation of sister chromatids during cell division. \n4. The ERCC1-XPF complex can also function in the regulation of cohesin-mediated gene silencing.\n5. The ERCC1-XPF complex and cohesin have a link in the regulation of gene expression and DNA repair.",
    "vicuna-7b_fact": [
      "ERCC1-XPF is a complex that consists of the ERCC1 (XPF) subunit and the ERCC4 (XPG) subunit.",
      "The ERCC1-XPF complex is involved in the repair of DNA damage, specifically in the removal of damaged base pairs from DNA.",
      "Cohesin is a protein complex that plays a role in the regulation of gene expression by controlling the separation of sister chromatids during cell division.",
      "The ERCC1-XPF complex can also function in the regulation of cohesin-mediated gene silencing.",
      "The ERCC1-XPF complex and cohesin have a link in the regulation of gene expression and DNA repair."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ERCC1-XPF is a complex that consists of the ERCC1 and XPF (ERCC4) proteins/subunits.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2461,
    "user_query": "Does Evolocumab improve cognitive function?",
    "vicuna-7b_response": "Evolocumab is a medication that is used to lower cholesterol levels in the blood. While there is some evidence to suggest that evolocumab may have a positive impact on cognitive function, the evidence is not conclusive.\nResearch has shown that high cholesterol levels are associated with an increased risk of cognitive decline and dementia. Evolocumab works by inhibiting the production of a protein called PCSK9, which helps to regulate cholesterol levels in the blood. By lowering cholesterol levels, evolocumab may help to reduce the risk of cognitive decline and improve cognitive function.\nHowever, it is important to note that the evidence for this is still preliminary and more research is needed to fully understand the potential impact of evolocumab on cognitive function. Additionally, it is important to note that cognitive function is a complex and multifactorial process that is influenced by a variety of factors, including age, genetics, lifestyle, and overall health.\nIf you have concerns about your cognitive function, it is important to speak with a healthcare professional who can evaluate your overall health and provide guidance on how to improve cognitive function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Evolocumab is a medication used to lower cholesterol levels.\n2. High cholesterol levels are associated with an increased risk of cognitive decline and dementia.\n3. Evolocumab works by inhibiting the production of a protein called PCSK9, which helps to regulate cholesterol levels in the blood.\n4. Lowering cholesterol levels may help to reduce the risk of cognitive decline and improve cognitive function.\n5. The evidence suggesting that evolocumab may improve cognitive functions is not yet conclusive.",
    "vicuna-7b_fact": [
      "Evolocumab is a medication used to lower cholesterol levels.",
      "High cholesterol levels are associated with an increased risk of cognitive decline and dementia.",
      "Evolocumab works by inhibiting the production of a protein called PCSK9, which helps to regulate cholesterol levels in the blood.",
      "Lowering cholesterol levels may help to reduce the risk of cognitive decline and improve cognitive function.",
      "The evidence suggesting that evolocumab may improve cognitive functions is not yet conclusive."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2462,
    "user_query": "Can radius fracture cause carpal tunnel syndrome?",
    "vicuna-7b_response": "Yes, a radius fracture can potentially cause carpal tunnel syndrome.\nCarpal tunnel syndrome is a condition caused by compression of the median nerve as it passes through the wrist at the carpal tunnel. This compression can be caused by a variety of factors, including swelling, inflammation, and changes in the structure of the carpal tunnel.\nA radius fracture can cause swelling and inflammation in the wrist, which can put pressure on the median nerve and cause carpal tunnel syndrome. Additionally, a fracture may cause changes in the structure of the carpal tunnel, such as narrowing of the space where the nerve passes through, which can also contribute to the development of carpal tunnel syndrome.\nIt's important to note that not all radius fractures will cause carpal tunnel syndrome, and not all cases of carpal tunnel syndrome are caused by a radius fracture. However, if you are experiencing symptoms of carpal tunnel syndrome, such as numbness, tingling, or pain in your hand and wrist, it's important to see a healthcare provider for an evaluation. They may recommend treatment options such as rest, splinting, physical therapy, or in some cases, surgery to relieve the pressure on the median nerve and improve symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Carpal tunnel syndrome is a condition caused by compression of the median nerve as it passes through the wrist at the carpal tunnel.\n2. A radius fracture can cause swelling and inflammation in the wrist, which can put pressure on the median nerve and cause carpal tunnel syndrome.\n3. A radius fracture may cause changes in the structure of the carpal tunnel, such as narrowing of the space where the nerve passes through. \n4. Not all radius fractures will cause carpal tunnel syndrome, and not all cases of carpal tunnel syndrome are caused by a radius fracture. \n5. Symptoms of carpal tunnel syndrome include numbness, tingling, or pain in your hand and wrist.",
    "vicuna-7b_fact": [
      "Carpal tunnel syndrome is a condition caused by compression of the median nerve as it passes through the wrist at the carpal tunnel.",
      "A radius fracture can cause swelling and inflammation in the wrist, which can put pressure on the median nerve and cause carpal tunnel syndrome.",
      "A radius fracture may cause changes in the structure of the carpal tunnel, such as narrowing of the space where the nerve passes through.",
      "Not all radius fractures will cause carpal tunnel syndrome, and not all cases of carpal tunnel syndrome are caused by a radius fracture.",
      "Symptoms of carpal tunnel syndrome include numbness, tingling, or pain in your hand and wrist."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2464,
    "user_query": "Is Marfan syndrome associated with chordal rupture?",
    "vicuna-7b_response": "Marfan syndrome is a genetic disorder that affects the connective tissue in the body. It is associated with a number of different health problems, including an increased risk of chordal rupture.\nChordal rupture is a condition in which the chordae tendineae, which are fibrous cords that connect the papillary muscles to the mitral valve, become stretched or damaged. This can lead to mitral valve regurgitation, which is a condition in which blood flows backward through the valve instead of flowing forward.\nMarfan syndrome is caused by a mutation in the fibrillin gene, which is responsible for producing a protein that helps to strengthen connective tissue. This mutation can lead to weakened connective tissue throughout the body, including in the heart. As a result, people with Marfan syndrome are at an increased risk of developing chordal rupture and mitral valve regurgitation.\nIt is important for people with Marfan syndrome to have regular check-ups with their healthcare provider, including regular echocardiograms to monitor their heart health. If chordal rupture or mitral valve regurgitation is detected, treatment may include medications to reduce symptoms or surgery to repair or replace the valve.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Marfan syndrome is a genetic disorder that affects the connective tissue in the body.\n2. Marfan syndrome is associated with an increased risk of chordal rupture.\n3. Chordal rupture is a condition in which the chordae tendineae become stretched or damaged, leading to mitral valve regurgitation.\n4. Marfan syndrome is caused by a mutation in the fibrillin gene, which helps to strengthen connective tissue.\n5. Treatment for chordal rupture or mitral valve regurgitation in people with Marfan syndrome may include medications or surgery.",
    "vicuna-7b_fact": [
      "Marfan syndrome is a genetic disorder that affects the connective tissue in the body.",
      "Marfan syndrome is associated with an increased risk of chordal rupture.",
      "Chordal rupture is a condition in which the chordae tendineae become stretched or damaged, leading to mitral valve regurgitation.",
      "Marfan syndrome is caused by a mutation in the fibrillin gene, which helps to strengthen connective tissue.",
      "Treatment for chordal rupture or mitral valve regurgitation in people with Marfan syndrome may include medications or surgery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2465,
    "user_query": "What is the mechanism of action of Fremanezumab?",
    "vicuna-7b_response": "Fremanezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), a molecule involved in the transmission of pain signals in the central nervous system. By binding to CGRP, fremanezumab blocks the binding of CGRP to its receptors, thereby reducing the release of pain-causing substances from nerve endings.\nThe mechanism of action of fremanezumab is similar to that of other CGRP antagonists, such as erenumab and galcanezumab. These drugs have been shown to be effective in the treatment of migraines, a condition characterized by recurrent headaches that are often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light and sound.\nIn addition to its effect on migraines, fremanezumab has also been studied for its potential use in the treatment of other pain conditions, such as chronic low back pain and postherpetic neuralgia. However, more research is needed to fully understand the mechanism of action of fremanezumab in these conditions and to determine its safety and efficacy in these populations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fremanezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP).\n2. CGRP is a molecule involved in the transmission of pain signals in the central nervous system.\n3. Fremanezumab, by binding to CGRP, blocks the binding of CGRP to its receptors and reduces the release of pain-causing substances from nerve endings.\n4. Drugs such as fremanezumab, erenumab, and galcanezumab have been effective in treating migraines.\n5. Fremanezumab has been studied for potential use in the treatment of other pain conditions like chronic low back pain and postherpetic neuralgia.",
    "vicuna-7b_fact": [
      "Fremanezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP).",
      "CGRP is a molecule involved in the transmission of pain signals in the central nervous system.",
      "Fremanezumab, by binding to CGRP, blocks the binding of CGRP to its receptors and reduces the release of pain-causing substances from nerve endings.",
      "Drugs such as fremanezumab, erenumab, and galcanezumab have been effective in treating migraines.",
      "Fremanezumab has been studied for potential use in the treatment of other pain conditions like chronic low back pain and postherpetic neuralgia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2466,
    "user_query": "Is trastuzumab associated cardiotoxicity reversible?",
    "vicuna-7b_response": "Trastuzumab, also known as Herceptin, is a monoclonal antibody used to treat certain types of breast cancer. While trastuzumab can cause cardiotoxicity, which is a side effect that affects the heart, the reversibility of this toxicity depends on several factors.\nTrastuzumab binds to the HER2/neu receptor on cancer cells and inhibits their growth and proliferation. However, it can also affect the heart by increasing the workload and decreasing the pumping function of the heart. This can lead to symptoms such as chest pain, shortness of breath, and fatigue.\nThe reversibility of trastuzumab-associated cardiotoxicity depends on several factors, including the duration of treatment, the dose of trastuzumab administered, and the presence of other risk factors for cardiotoxicity. In general, the risk of cardiotoxicity decreases over time as the body eliminates the drug from the system.\nIn some cases, trastuzumab-associated cardiotoxicity may be reversible with treatment. For example, if a patient stops taking trastuzumab and their heart function improves, it may indicate that the cardiotoxicity is reversible. However, in other cases, the damage to the heart may be permanent and irreversible.\nIt is important to note that the reversibility of trastuzumab-associated cardiotoxicity is not the same for all patients. Some patients may experience complete recovery of their heart function, while others may experience permanent damage. Therefore, it is essential to monitor patients for signs of cardiotoxicity during and after treatment with trastuzumab.\nIn conclusion, the reversibility of trastuzumab-associated cardiotoxicity depends on several factors and may vary from patient to patient. While some patients may experience complete recovery of their heart function, others may experience permanent damage. Therefore, it is essential to monitor patients for signs of cardiotoxicity during and after treatment with trastuzumab.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Trastuzumab, also known as Herceptin, is a monoclonal antibody used to treat certain types of breast cancer.\n2. Trastuzumab can cause cardiotoxicity, a side effect that affects the heart.\n3. Trastuzumab binds to the HER2/neu receptor on cancer cells and inhibits their growth and proliferation.\n4. The reversibility of trastuzumab-associated cardiotoxicity depends on several factors, including the duration of treatment, the dose of trastuzumab administered, and the presence of other risk factors for cardiotoxicity.\n5. In some cases, trastuzumab-associated cardiotoxicity may be reversible with treatment, however, in other cases, the damage to the heart may be permanent and irreversible.",
    "vicuna-7b_fact": [
      "Trastuzumab, also known as Herceptin, is a monoclonal antibody used to treat certain types of breast cancer.",
      "Trastuzumab can cause cardiotoxicity, a side effect that affects the heart.",
      "Trastuzumab binds to the HER2/neu receptor on cancer cells and inhibits their growth and proliferation.",
      "The reversibility of trastuzumab-associated cardiotoxicity depends on several factors, including the duration of treatment, the dose of trastuzumab administered, and the presence of other risk factors for cardiotoxicity.",
      "In some cases, trastuzumab-associated cardiotoxicity may be reversible with treatment, however, in other cases, the damage to the heart may be permanent and irreversible."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2470,
    "user_query": "Describe mechanism of action of Nusinersen.",
    "vicuna-7b_response": "Nusinersen is a medication that is used to treat spinal muscular atrophy (SMA), a genetic disorder that affects the nervous system and causes muscle weakness and loss of motor function. The mechanism of action of nusinersen is based on its ability to increase the production of a protein called survival motor neuron (SMN) protein.\nSMA is caused by a genetic mutation that results in the absence or reduced production of the SMN protein. This leads to the degeneration of motor neurons, which are the cells that control muscle movement. Nusinersen works by restoring the production of the SMN protein, which helps to protect motor neurons and improve muscle function.\nNusinersen is administered as an infusion into a vein, and it is typically given once a month. The medication is able to cross the blood-brain barrier and reach the motor neurons in the spinal cord, where it can have a therapeutic effect.\nIn clinical trials, nusinersen has been shown to be effective in improving motor function and reducing the progression of SMA in patients with the disease. It has also been shown to be safe and well-tolerated in clinical trials.\nOverall, the mechanism of action of nusinersen is based on its ability to increase the production of the SMN protein, which helps to protect motor neurons and improve muscle function. It is administered as an infusion and has been shown to be effective in improving motor function and reducing the progression of SMA in patients with the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nusinersen is used to treat spinal muscular atrophy (SMA).\n2. The mechanism of action of Nusinersen is based on its ability to increase the production of survival motor neuron (SMN) protein.\n3. SMA is caused by a genetic mutation that results in the absence or reduced production of the SMN protein.\n4. Nusinersen is administered as an infusion into a vein, typically once a month.\n5. In clinical trials, Nusinersen has been shown to be effective in improving motor function and reducing the progression of SMA.",
    "vicuna-7b_fact": [
      "Nusinersen is used to treat spinal muscular atrophy (SMA).",
      "The mechanism of action of Nusinersen is based on its ability to increase the production of survival motor neuron (SMN) protein.",
      "SMA is caused by a genetic mutation that results in the absence or reduced production of the SMN protein.",
      "Nusinersen is administered as an infusion into a vein, typically once a month.",
      "In clinical trials, Nusinersen has been shown to be effective in improving motor function and reducing the progression of SMA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nusinersen is administered via intrathecal injection, not an infusion into a vein.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-7b_response": "The 959 Nematode Genomes initiative is a large-scale project aimed at sequencing and analyzing the genomes of 959 species of roundworms, also known as nematodes. Nematodes are a diverse group of parasitic and free-living organisms that play important roles in many ecosystems, including as model organisms for biological research.\nThe 959 Nematode Genomes initiative is a collaborative effort between researchers from around the world, with the goal of generating a comprehensive understanding of the genetic diversity and evolutionary history of nematodes. By sequencing and analyzing the genomes of a large number of nematode species, researchers hope to gain insights into the genetic basis of nematode biology, evolution, and ecology, as well as to identify new targets for the development of drugs and other interventions to control nematode-transmitted diseases.\nThe 959 Nematode Genomes initiative is an ambitious project that will require significant resources and expertise, but it has the potential to revolutionize our understanding of nematode biology and to lead to important advances in biotechnology and medicine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 959 Nematode Genomes initiative is a project aimed at sequencing and analyzing the genomes of 959 species of roundworms or nematodes.\n2. The project is a collaborative effort between researchers from around the world.\n3. The goal of the initiative is to generate a comprehensive understanding of the genetic diversity and evolutionary history of nematodes.\n4. The initiative aims to identify new targets for the development of drugs and other interventions to control nematode-transmitted diseases.\n5. The 959 Nematode Genomes initiative could potentially lead to advances in biotechnology and medicine.",
    "vicuna-7b_fact": [
      "The 959 Nematode Genomes initiative is a project aimed at sequencing and analyzing the genomes of 959 species of roundworms or nematodes.",
      "The project is a collaborative effort between researchers from around the world.",
      "The goal of the initiative is to generate a comprehensive understanding of the genetic diversity and evolutionary history of nematodes.",
      "The initiative aims to identify new targets for the development of drugs and other interventions to control nematode-transmitted diseases.",
      "The 959 Nematode Genomes initiative could potentially lead to advances in biotechnology and medicine."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2475,
    "user_query": "What is the drug target(s) for Belsomra?",
    "vicuna-7b_response": "Belsomra, also known as suvorexant, is a medication that is used to treat insomnia. It works by targeting a specific receptor in the brain called orexin-1 receptor. Orexin-1 receptor is involved in regulating the sleep-wake cycle and Belsomra blocks the action of orexin-1 receptor, leading to drowsiness and improved sleep.\nBelsomra is a selective orexin receptor antagonist, which means it only blocks the action of orexin-1 receptor and not orexin-2 receptor. This specificity is important as it reduces the risk of side effects such as next-day dysphoria and cognitive impairment that are commonly associated with non-selective orexin receptor antagonists.\nIt's important to note that Belsomra is not a cure for insomnia and it should be used as part of a overall sleep strategy that includes good sleep hygiene, a consistent sleep schedule and other measures to improve sleep.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Belsomra, also known as suvorexant, is used to treat insomnia.\n2. Belsomra targets a specific receptor in the brain called orexin-1 receptor.\n3. Orexin-1 receptor plays a role in the regulation of the sleep-wake cycle.\n4. Belsomra operates as a selective orexin receptor antagonist, blocking only the orexin-1 receptor but not the orexin-2 receptor.\n5. Belsomra is not a cure for insomnia and should be used as part of an overall sleep strategy.",
    "vicuna-7b_fact": [
      "Belsomra, also known as suvorexant, is used to treat insomnia.",
      "Belsomra targets a specific receptor in the brain called orexin-1 receptor.",
      "Orexin-1 receptor plays a role in the regulation of the sleep-wake cycle.",
      "Belsomra operates as a selective orexin receptor antagonist, blocking only the orexin-1 receptor but not the orexin-2 receptor.",
      "Belsomra is not a cure for insomnia and should be used as part of an overall sleep strategy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Belsomra targets both the orexin-1 and orexin-2 receptors in the brain.\n3. TRUE\n4. FALSE [correction]: Belsomra operates as a dual orexin receptor antagonist, blocking both the orexin-1 and orexin-2 receptors.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2476,
    "user_query": "Can canagliflozin cause euglycemic diabetic ketoacidosis?",
    "vicuna-7b_response": "Canagliflozin is a medication that is used to treat type 2 diabetes. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which means that it works by increasing the amount of glucose that is removed from the body through urine.\nEuglycemic diabetic ketoacidosis (E-DKA) is a rare complication of diabetes that can occur in people with type 1 diabetes who have a severe insulin deficiency. It is characterized by high levels of ketones in the blood (ketoacidosis) and low blood sugar (hypoglycemia).\nCanagliflozin is not known to cause E-DKA. In fact, SGLT2 inhibitors like canagliflozin are generally considered to be safe and effective medications for treating type 2 diabetes. However, as with any medication, it is possible for a person to experience side effects while taking canagliflozin.\nIf you are taking canagliflozin and experience symptoms of ketoacidosis, such as high blood sugar, high levels of ketones in the urine or blood, nausea, vomiting, or abdominal pain, it is important to seek medical attention immediately. It is also important to follow your doctor's instructions for taking your medication and to attend regular check-ups to monitor your blood sugar levels and overall health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Canagliflozin is a medication used to treat type 2 diabetes.\n2. Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n3. Euglycemic diabetic ketoacidosis (E-DKA) can occur in people with severe insulin deficiency.\n4. Canagliflozin is not known to cause E-DKA.\n5. E-DKA is characterized by high levels of ketones in the blood and low blood sugar.",
    "vicuna-7b_fact": [
      "Canagliflozin is a medication used to treat type 2 diabetes.",
      "Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Euglycemic diabetic ketoacidosis (E-DKA) can occur in people with severe insulin deficiency.",
      "Canagliflozin is not known to cause E-DKA.",
      "E-DKA is characterized by high levels of ketones in the blood and low blood sugar."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Canagliflozin is associated with an increased risk of E-DKA (Euglycemic diabetic ketoacidosis).\n5. FALSE [correction]: E-DKA is characterized by high levels of ketones in the blood and normal or slightly reduced blood sugar.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2478,
    "user_query": "Is there an association between Klinefelter syndrome and breast cancer?",
    "vicuna-7b_response": "Klinefelter syndrome is a genetic condition that affects males and is characterized by the presence of an extra X chromosome in the body. This extra X chromosome can lead to a variety of physical and developmental characteristics, including tall stature, breast development, and learning difficulties.\nThere is some evidence to suggest that individuals with Klinefelter syndrome may be at an increased risk of developing breast cancer. This increased risk is thought to be due to the presence of extra X chromosomes, which can lead to the overexpression of certain genes that are involved in the development and growth of breast tissue.\nHowever, it is important to note that the overall risk of breast cancer for individuals with Klinefelter syndrome is still relatively low, and the majority of individuals with this condition will not develop breast cancer. Additionally, the risk of breast cancer can vary depending on a number of factors, including age, family history, and lifestyle factors.\nIf you have concerns about your risk of breast cancer or any other health issues, it is always a good idea to speak with a healthcare provider. They can help you understand your individual risk factors and develop a plan to manage them.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Klinefelter syndrome is a genetic condition that affects males and is characterized by the presence of an extra X chromosome in the body.\n2. Klinefelter syndrome can lead to a variety of physical and developmental characteristics, including tall stature, breast development, and learning difficulties.\n3. There is some evidence to suggest that individuals with Klinefelter syndrome may be at an increased risk of developing breast cancer.\n4. The overall risk of breast cancer for individuals with Klinefelter syndrome is still relatively low, and the majority of individuals with this condition will not develop breast cancer.\n5. The risk of breast cancer can vary depending on a number of factors, including age, family history, and lifestyle factors.",
    "vicuna-7b_fact": [
      "Klinefelter syndrome is a genetic condition that affects males and is characterized by the presence of an extra X chromosome in the body.",
      "Klinefelter syndrome can lead to a variety of physical and developmental characteristics, including tall stature, breast development, and learning difficulties.",
      "There is some evidence to suggest that individuals with Klinefelter syndrome may be at an increased risk of developing breast cancer.",
      "The overall risk of breast cancer for individuals with Klinefelter syndrome is still relatively low, and the majority of individuals with this condition will not develop breast cancer.",
      "The risk of breast cancer can vary depending on a number of factors, including age, family history, and lifestyle factors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2479,
    "user_query": "Which R packages have been developed for the discovery of mutational signatures in cancer?",
    "vicuna-7b_response": "There are several R packages that have been developed for the discovery of mutational signatures in cancer. Some of the most popular ones include:\n1. MuSe: MuSe is an R package for the discovery of mutational signatures in cancer. It uses a machine learning approach to identify mutational signatures in cancer genomic data.\n2. CancerMutationSignatures: CancerMutationSignatures is an R package that uses a machine learning approach to identify mutational signatures in cancer genomic data. It is based on the MutationSignatures package, but includes additional features and functions.\n3. MutationSignatures: MutationSignatures is an R package that uses a machine learning approach to identify mutational signatures in cancer genomic data. It is based on the CancerMutationSignatures package, but includes additional features and functions.\n4. CancerGem: CancerGem is an R package that provides a suite of functions for the analysis of cancer genomic data. It includes functions for the discovery of mutational signatures, as well as other features such as somatic mutation analysis and copy number analysis.\n5. CancerGene: CancerGene is an R package that provides a suite of functions for the analysis of cancer genomic data. It includes functions for the discovery of mutational signatures, as well as other features such as somatic mutation analysis and copy number analysis.\nThese packages can be used to identify mutational signatures in cancer genomic data, which can provide insights into the genetic changes that occur in cancer cells and can be used to identify potential therapeutic targets.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MuSe is an R package that has been developed for the discovery of mutational signatures in cancer.\n2. CancerMutationSignatures is an R package developed for the discovery of mutational signatures in cancer and is based on the MutationSignatures package.\n3. MutationSignatures is an R package developed for the discovery of mutational signatures in cancer and is based on the CancerMutationSignatures package.\n4. CancerGem is an R package developed for the analysis of cancer genomic data, including the discovery of mutational signatures.\n5. CancerGene is an R package that provides functions for the analysis of cancer genomic data, including the discovery of mutational signatures.",
    "vicuna-7b_fact": [
      "MuSe is an R package that has been developed for the discovery of mutational signatures in cancer.",
      "CancerMutationSignatures is an R package developed for the discovery of mutational signatures in cancer and is based on the MutationSignatures package.",
      "MutationSignatures is an R package developed for the discovery of mutational signatures in cancer and is based on the CancerMutationSignatures package.",
      "CancerGem is an R package developed for the analysis of cancer genomic data, including the discovery of mutational signatures.",
      "CancerGene is an R package that provides functions for the analysis of cancer genomic data, including the discovery of mutational signatures."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no evidence of a package called CancerMutationSignatures that is based on the MutationSignatures package.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2484,
    "user_query": "Which data simulator is available for CLIP-SEQ experiments?",
    "vicuna-7b_response": "CLIP-SEQ (CLIP-seq and SEC-seq) experiments are a powerful tool for studying protein-DNA interactions in vivo. There are several data simulators available for CLIP-SEQ experiments, including:\n1. ChIP-seq simulator: This simulator generates synthetic DNA sequences that mimic the properties of the native chromatin environment. It can be used to simulate different chromatin states, such as open or closed chromatin, and can be used to study the effects of different histone modifications on protein-DNA interactions.\n2. CLIP-seq simulator: This simulator generates synthetic DNA sequences that mimic the properties of the native chromatin environment and can be used to study the effects of different histone modifications on protein-DNA interactions.\n3. SEC-seq simulator: This simulator generates synthetic DNA sequences that mimic the properties of the native chromatin environment and can be used to study the effects of different histone modifications on protein-DNA interactions.\n4. Hi-C simulator: This simulator generates synthetic DNA sequences that mimic the properties of the native chromatin environment and can be used to study the three-dimensional structure of chromatin and the interactions between proteins and DNA.\nIt's important to note that the choice of simulator will depend on the specific goals of the experiment and the type of data that is being generated. It's recommended to consult with a specialist in the field to determine the best simulator for your specific needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CLIP-SEQ experiments are used for studying protein-DNA interactions in vivo.\n2. For CLIP-SEQ experiments, several data simulators are available, including ChIP-seq simulator, CLIP-seq simulator, SEC-seq simulator, and Hi-C simulator.\n3. A ChIP-seq simulator generates synthetic DNA sequences to simulate different chromatin states and study the effects of different histone modifications on protein-DNA interactions.\n4. CLIP-seq and SEC-seq simulators generate synthetic DNA sequences to study the effects of different histone modifications on protein-DNA interactions.\n5. A Hi-C simulator is used to study the three-dimensional structure of chromatin and the interactions between proteins and DNA.",
    "vicuna-7b_fact": [
      "CLIP-SEQ experiments are used for studying protein-DNA interactions in vivo.",
      "For CLIP-SEQ experiments, several data simulators are available, including ChIP-seq simulator, CLIP-seq simulator, SEC-seq simulator, and Hi-C simulator.",
      "A ChIP-seq simulator generates synthetic DNA sequences to simulate different chromatin states and study the effects of different histone modifications on protein-DNA interactions.",
      "CLIP-seq and SEC-seq simulators generate synthetic DNA sequences to study the effects of different histone modifications on protein-DNA interactions.",
      "A Hi-C simulator is used to study the three-dimensional structure of chromatin and the interactions between proteins and DNA."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CLIP-SEQ experiments are used for studying protein-RNA interactions in vivo.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CLIP-seq simulator generates synthetic RNA sequences to simulate protein-RNA interactions, and SEC-seq simulator generates synthetic sequences to study RNA export from the nucleus to the cytoplasm.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2487,
    "user_query": "Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?",
    "vicuna-7b_response": "Yes, Dlx1 and Dlx2 transcription factors play important roles in the development and differentiation of cortical interneurons.\nDlx1 and Dlx2 are members of the distal-less family of transcription factors, which are expressed in a variety of tissues and cell types during development. In the developing brain, Dlx1 and Dlx2 are expressed in a subset of neural progenitor cells that give rise to cortical interneurons.\nStudies have shown that Dlx1 and Dlx2 are necessary for the proper development of cortical interneurons. For example, knockdown of Dlx1 or Dlx2 in mice results in abnormal development of cortical interneurons, with reduced numbers of neurons and altered patterns of connectivity.\nIn addition, Dlx1 and Dlx2 have been shown to play a role in the maturation and function of cortical interneurons. For example, Dlx1 and Dlx2 have been shown to regulate the expression of genes involved in synaptic transmission and plasticity in cortical interneurons.\nOverall, Dlx1 and Dlx2 are important transcription factors that play a critical role in the development and maturation of cortical interneurons, which are important for proper functioning of the cerebral cortex.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dlx1 and Dlx2 transcription factors play a significant role in the development and differentiation of cortical interneurons.\n2. Dlx1 and Dlx2 are members of the distal-less family of transcription factors.\n3. Dlx1 and Dlx2 are expressed in a subset of neural progenitor cells that give rise to cortical interneurons.\n4. Knockdown of Dlx1 or Dlx2 in mice results in abnormal development of cortical interneurons.\n5. Dlx1 and Dlx2 regulate the expression of genes involved in synaptic transmission and plasticity in cortical interneurons.",
    "vicuna-7b_fact": [
      "Dlx1 and Dlx2 transcription factors play a significant role in the development and differentiation of cortical interneurons.",
      "Dlx1 and Dlx2 are members of the distal-less family of transcription factors.",
      "Dlx1 and Dlx2 are expressed in a subset of neural progenitor cells that give rise to cortical interneurons.",
      "Knockdown of Dlx1 or Dlx2 in mice results in abnormal development of cortical interneurons.",
      "Dlx1 and Dlx2 regulate the expression of genes involved in synaptic transmission and plasticity in cortical interneurons."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2489,
    "user_query": "What is SMiLE-seq?",
    "vicuna-7b_response": "SMiLE-seq (Single-cell Mapping of Intra-cellular Expression using Long-read sequencing) is a powerful technique used to study the heterogeneity of single cells at the transcriptomic level. It involves isolating individual cells, converting their RNA into cDNA, and then sequencing the cDNA using long-read sequencing technologies such as PacBio or Oxford Nanopore.\nThe resulting data provides a comprehensive view of the transcriptome of each individual cell, including both coding and non-coding RNAs, as well as splicing variants. This information can be used to identify cell subtypes, understand cellular processes, and develop personalized medicine.\nSMiLE-seq has been used in a variety of applications, including studying the immune system, understanding the development and differentiation of tissues, and identifying cancer subtypes. It has also been used to study the transcriptomes of single cells from various organisms, including humans, mice, and zebrafish.\nOverall, SMiLE-seq is a powerful tool that allows researchers to gain a deeper understanding of the complexity of single cells and their functions, and has the potential to revolutionize our understanding of biology and medicine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SMiLE-seq stands for Single-cell Mapping of Intra-cellular Expression using Long-read sequencing.\n2. SMiLE-seq is used to study the heterogeneity of single cells at the transcriptomic level.\n3. The technique involves isolating individual cells, converting their RNA into cDNA, and then sequencing the cDNA using long-read sequencing technologies such as PacBio or Oxford Nanopore.\n4. SMiLE-seq data includes coding and non-coding RNAs and splicing variants.\n5. SMiLE-seq has been used in a variety of applications, including studying the immune system, understanding the development and differentiation of tissues, and identifying cancer subtypes.",
    "vicuna-7b_fact": [
      "SMiLE-seq stands for Single-cell Mapping of Intra-cellular Expression using Long-read sequencing.",
      "SMiLE-seq is used to study the heterogeneity of single cells at the transcriptomic level.",
      "The technique involves isolating individual cells, converting their RNA into cDNA, and then sequencing the cDNA using long-read sequencing technologies such as PacBio or Oxford Nanopore.",
      "SMiLE-seq data includes coding and non-coding RNAs and splicing variants.",
      "SMiLE-seq has been used in a variety of applications, including studying the immune system, understanding the development and differentiation of tissues, and identifying cancer subtypes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2493,
    "user_query": "Describe JACUSA",
    "vicuna-7b_response": "JACUSA is a hypothetical particle that is a candidate for dark matter. It is a weakly interacting massive particle (WIMP) that is thought to be a major component of the universe's dark matter.\nJACUSA is a type of WIMP that is predicted by theories of particle physics that attempt to unify the fundamental forces of nature, such as the Standard Model and supersymmetry. These theories suggest that JACUSA is a heavy, stable particle that interacts only weakly with normal matter through the exchange of other particles, such as photons or Z bosons.\nJACUSA is also known as a \"neutralino,\" which is a type of WIMP that is a mixture of the particles that make up the photon and the Z boson. The neutralino is a hypothetical particle that is predicted by theories that attempt to unify the fundamental forces of nature, such as the Standard Model and supersymmetry.\nJACUSA is a hypothetical particle that is a candidate for dark matter. It is a weakly interacting massive particle (WIMP) that is thought to be a major component of the universe's dark matter. JACUSA is a type of WIMP that is predicted by theories of particle physics that attempt to unify the fundamental forces of nature, such as the Standard Model and supersymmetry. These theories suggest that JACUSA is a heavy, stable particle that interacts only weakly with normal matter through the exchange of other particles, such as photons or Z bosons. JACUSA is also known as a \"neutralino,\" which is a type of WIMP that is a mixture of the particles that make up the photon and the Z boson.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. JACUSA is a hypothetical particle that is a candidate for dark matter.\n2. JACUSA is a type of weakly interacting massive particle (WIMP).\n3. Theories of particle physics that attempt to unify the fundamental forces of nature, such as the Standard Model and supersymmetry, predict the presence of JACUSA.\n4. JACUSA is predicted to be a heavy stable particle that interacts weakly with normal matter.\n5. JACUSA is also referred to as a \"neutralino\".",
    "vicuna-7b_fact": [
      "JACUSA is a hypothetical particle that is a candidate for dark matter.",
      "JACUSA is a type of weakly interacting massive particle (WIMP).",
      "Theories of particle physics that attempt to unify the fundamental forces of nature, such as the Standard Model and supersymmetry, predict the presence of JACUSA.",
      "JACUSA is predicted to be a heavy stable particle that interacts weakly with normal matter.",
      "JACUSA is also referred to as a \"neutralino\"."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2507,
    "user_query": "CURB65 score is used for stratification of which disease?",
    "vicuna-7b_response": "CURB65 score is used for stratification of sepsis.",
    "vicuna-7b_fact_raw": "The factual statement is: \n1. CURB65 score is used for stratification of sepsis.",
    "vicuna-7b_fact": [
      "CURB65 score is used for stratification of sepsis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CURB65 score is used for stratification of community-acquired pneumonia, not sepsis.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 2509,
    "user_query": "Is creatinine assessment included in the MELD score?",
    "vicuna-7b_response": "Yes, creatinine assessment is included in the MELD (Model for End-Stage Liver Disease) score. The MELD score is a scoring system used to assess the severity of liver disease and to determine the urgency of liver transplantation. The MELD score is calculated based on the patient's serum creatinine level, bilirubin level, and international normalized ratio (INR).\nThe MELD score is calculated using the following formula:\nMELD score = (serum creatinine level x 1.0) + (bilirubin level x 3.0) + (INR x 1.5)\nThe serum creatinine level is a measure of kidney function, and the bilirubin level and INR are measures of liver function. The MELD score ranges from 6 to 40, with higher scores indicating more severe liver disease.\nIn addition to creatinine, the MELD score also takes into account other factors such as the patient's age, sex, and underlying medical conditions. The MELD score is used to determine the patient's urgency for liver transplantation and to prioritize patients for transplantation.\nIn summary, creatinine assessment is an important factor in the MELD score, which is used to assess the severity of liver disease and to determine the urgency of liver transplantation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Creatinine assessment is included in the MELD (Model for End-Stage Liver Disease) score.\n2. The MELD score is used to assess the severity of liver disease and to determine the urgency of liver transplantation.\n3. The MELD score is calculated based on the patient's serum creatinine level, bilirubin level, and international normalized ratio (INR).\n4. The MELD score ranges from 6 to 40, with higher scores indicating more severe liver disease.\n5. Apart from the mentioned factors, the MELD score also takes into account the patient's age, sex, and underlying medical conditions.",
    "vicuna-7b_fact": [
      "Creatinine assessment is included in the MELD (Model for End-Stage Liver Disease) score.",
      "The MELD score is used to assess the severity of liver disease and to determine the urgency of liver transplantation.",
      "The MELD score is calculated based on the patient's serum creatinine level, bilirubin level, and international normalized ratio (INR).",
      "The MELD score ranges from 6 to 40, with higher scores indicating more severe liver disease.",
      "Apart from the mentioned factors, the MELD score also takes into account the patient's age, sex, and underlying medical conditions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The MELD score does not take into account the patient's age, sex, and underlying medical conditions. It is solely based on the patient's serum creatinine level, bilirubin level, and international normalized ratio (INR).",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2516,
    "user_query": "What cellular process are okazaki fragments associated with?",
    "vicuna-7b_response": "Okazaki fragments are associated with the process of DNA replication. During DNA replication, the cell's machinery reads the DNA molecule and creates a complementary strand. This process is called semiconservative replication, and it involves the synthesis of new strands using an existing template strand.\nOkazaki fragments are short pieces of DNA that are synthesized by the enzyme DNA polymerase during the process of DNA replication. These fragments are named after the Japanese biochemist Shirou Ohara, who first described them in the 1960s.\nOkazaki fragments are synthesized by the enzyme DNA polymerase in the 5' to 3' direction, using the template strand as a guide. The enzyme adds nucleotides to the fragment one at a time, and each addition creates a new bond between the nucleotides. As the fragment grows, it becomes longer and longer, until it reaches the same length as the template strand.\nOnce the fragment is complete, it is released from the template strand and becomes a new strand of DNA. This process continues until both strands of the DNA molecule are fully replicated.\nIn summary, Okazaki fragments are associated with the process of DNA replication, which is the process by which cells synthesize new strands of DNA using an existing template strand. During replication, the enzyme DNA polymerase synthesizes short fragments in the 5' to 3' direction, using the template strand as a guide. These fragments are then released from the template strand and become new strands of DNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Okazaki fragments are associated with the process of DNA replication.\n2. Okazaki fragments are short pieces of DNA that are synthesized by the enzyme DNA polymerase during the process of DNA replication.\n3. Okazaki fragments were first described by the Japanese biochemist, Shirou Ohara, in the 1960s.\n4. During DNA replication, Okazaki fragments are synthesized by the enzyme DNA polymerase in the 5' to 3' direction using the template strand as a guide.\n5. Once an Okazaki fragment is complete, it is released from the template strand and becomes a new strand of DNA.",
    "vicuna-7b_fact": [
      "Okazaki fragments are associated with the process of DNA replication.",
      "Okazaki fragments are short pieces of DNA that are synthesized by the enzyme DNA polymerase during the process of DNA replication.",
      "Okazaki fragments were first described by the Japanese biochemist, Shirou Ohara, in the 1960s.",
      "During DNA replication, Okazaki fragments are synthesized by the enzyme DNA polymerase in the 5' to 3' direction using the template strand as a guide.",
      "Once an Okazaki fragment is complete, it is released from the template strand and becomes a new strand of DNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Okazaki fragments were first described by the Japanese scientists Reiji and Tsuneko Okazaki, not Shirou Ohara.\n4. TRUE\n5. FALSE [correction]: Once an Okazaki fragment is complete, it is not released but rather it is linked to other Okazaki fragments by the enzyme DNA ligase to form a continuous DNA strand.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2518,
    "user_query": "Clue cells are characteristics to which causative bacteria of vaginitis?",
    "vicuna-7b_response": "Clue cells are a type of epithelial cell found in the vaginal mucosa that are involved in the detection and clearance of bacterial infections. They are often used as a diagnostic tool for vaginitis, which is an inflammation of the vagina that can be caused by a variety of factors, including bacterial infections.\nCertain types of bacteria, such as Gardnerella vaginalis and Mycoplasma hominis, are commonly associated with vaginitis. These bacteria can cause an overgrowth of normal vaginal bacteria, leading to symptoms such as itching, discharge, and pain.\nIn some cases, vaginitis can be caused by other types of bacteria, such as Streptococcus agalactiae (also known as group B streptococcus or GBS) or Staphylococcus aureus. These bacteria can cause more severe symptoms and may require more aggressive treatment.\nIt's important to note that not all vaginal discharge is caused by bacterial infections, and some types of discharge can be normal. If you are experiencing symptoms of vaginitis, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Clue cells are a type of epithelial cell found in the vaginal mucosa that are involved in the detection and clearance of bacterial infections.\n2. Clue cells are often used as a diagnostic tool for vaginitis, an inflammation of the vagina.\n3. Gardnerella vaginalis and Mycoplasma hominis are commonly associated with vaginitis.\n4. Vaginitis can be caused by other types of bacteria, such as Streptococcus agalactiae (also known as group B streptococcus or GBS) or Staphylococcus aureus.\n5. Not all vaginal discharge is caused by bacterial infections, and some types of discharge can be normal.",
    "vicuna-7b_fact": [
      "Clue cells are a type of epithelial cell found in the vaginal mucosa that are involved in the detection and clearance of bacterial infections.",
      "Clue cells are often used as a diagnostic tool for vaginitis, an inflammation of the vagina.",
      "Gardnerella vaginalis and Mycoplasma hominis are commonly associated with vaginitis.",
      "Vaginitis can be caused by other types of bacteria, such as Streptococcus agalactiae (also known as group B streptococcus or GBS) or Staphylococcus aureus.",
      "Not all vaginal discharge is caused by bacterial infections, and some types of discharge can be normal."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Clue cells are a type of epithelial cell coated with bacteria found in the vaginal mucosa suggesting bacterial vaginosis, not necessarily involved in the detection and clearance of bacterial infections.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2519,
    "user_query": "What is included in the fourth generation HIV test?",
    "vicuna-7b_response": "The fourth generation HIV test is a blood test that detects both HIV-1 and HIV-2 antibodies in the blood. It can detect the virus as early as 2-8 weeks after infection and can differentiate between HIV-1 and HIV-2. The test is highly accurate and can detect 99.7% of HIV-positive individuals. The fourth generation HIV test is also able to detect the virus in its early stages, which is important for early treatment and prevention. The test is usually done by taking a blood sample and the results are usually available within 2-3 weeks. It's important to note that the fourth generation HIV test is not a cure for HIV, but it can help in early detection and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The fourth generation HIV test is a blood test that detects both HIV-1 and HIV-2 antibodies.\n2. This test can detect the virus as early as 2-8 weeks after infection.\n3. The fourth generation HIV test can detect 99.7% of HIV-positive individuals.\n4. The fourth generation HIV test is able to detect the virus in its early stages.\n5. The results of the fourth generation HIV test are usually available within 2-3 weeks.",
    "vicuna-7b_fact": [
      "The fourth generation HIV test is a blood test that detects both HIV-1 and HIV-2 antibodies.",
      "This test can detect the virus as early as 2-8 weeks after infection.",
      "The fourth generation HIV test can detect 99.7% of HIV-positive individuals.",
      "The fourth generation HIV test is able to detect the virus in its early stages.",
      "The results of the fourth generation HIV test are usually available within 2-3 weeks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: While fourth generation HIV tests are very accurate, they may not detect 99.7% of HIV-positive individuals as accuracy can vary.\n4. TRUE\n5. FALSE [correction]: The results of the fourth generation HIV test are usually available within a few hours to a few days.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2520,
    "user_query": "Which disease is diagnosed using the Finkelstein's test?",
    "vicuna-7b_response": "Finkelstein's test is a diagnostic test used to detect a condition called congenital adrenal hyperplasia (CAH). CAH is a genetic disorder that affects the adrenal glands, which are responsible for producing hormones that regulate various bodily functions.\nFinkelstein's test is performed by measuring the ratio of 17-hydroxyprogesterone to 17-ketosteroids in the urine. This test is used to diagnose CAH, which is caused by a deficiency in the enzyme 21-hydroxylase, which is responsible for converting 21-carbon precursors into steroid hormones.\nIn individuals with CAH, the enzyme deficiency leads to the accumulation of 17-hydroxyprogesterone, which is converted into androgens, such as testosterone. This can lead to virilization of female fetuses and infants, as well as other signs and symptoms of CAH, such as ambiguous genitalia, pubic hair, and acne.\nFinkelstein's test is an important diagnostic tool for identifying individuals with CAH, as early diagnosis and treatment can help to prevent the serious health complications that can arise from this condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Finkelstein's test is used to diagnose congenital adrenal hyperplasia (CAH).\n2. CAH is a genetic disorder that affects the adrenal glands, which are responsible for producing hormones.\n3. Finkelstein's test measures the ratio of 17-hydroxyprogesterone to 17-ketosteroids in the urine.\n4. CAH is caused by a deficiency in the enzyme 21-hydroxylase, which converts 21-carbon precursors into steroid hormones.\n5. The enzyme deficiency in individuals with CAH leads to the accumulation of 17-hydroxyprogesterone, which is converted into androgens, such as testosterone.",
    "vicuna-7b_fact": [
      "Finkelstein's test is used to diagnose congenital adrenal hyperplasia (CAH).",
      "CAH is a genetic disorder that affects the adrenal glands, which are responsible for producing hormones.",
      "Finkelstein's test measures the ratio of 17-hydroxyprogesterone to 17-ketosteroids in the urine.",
      "CAH is caused by a deficiency in the enzyme 21-hydroxylase, which converts 21-carbon precursors into steroid hormones.",
      "The enzyme deficiency in individuals with CAH leads to the accumulation of 17-hydroxyprogesterone, which is converted into androgens, such as testosterone."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Finkelstein's test is used to diagnose De Quervain's tenosynovitis, not congenital adrenal hyperplasia (CAH).\n2. TRUE\n3. FALSE [correction]: The 17-hydroxyprogesterone test, not Finkelstein's test, measures the ratio of 17-hydroxyprogesterone to 17-ketosteroids in the urine.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2521,
    "user_query": "For which type of cancer can uc.189 be used as a potential prognostic biomarker?",
    "vicuna-7b_response": "UC.189 is a protein that has been identified as a potential prognostic biomarker for certain types of cancer. Specifically, research has shown that UC.189 may be useful in predicting the prognosis of patients with breast cancer, colorectal cancer, and ovarian cancer.\nIn breast cancer, studies have shown that high levels of UC.189 in the blood may be associated with a worse prognosis, including a higher risk of recurrence and death. In colorectal cancer, UC.189 has been found to be elevated in patients with advanced disease and a poor prognosis. Additionally, in ovarian cancer, UC.189 has been shown to be associated with poor prognosis and may be used as a predictive marker for chemotherapy resistance.\nIt's important to note that these findings are still preliminary and further research is needed to fully understand the role of UC.189 as a prognostic biomarker for these cancers.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. UC.189 is a protein that has been identified as a potential prognostic biomarker for certain types of cancer.\n2. UC.189 may be useful in predicting the prognosis of patients with breast cancer, colorectal cancer, and ovarian cancer.\n3. High levels of UC.189 in the blood may be associated with a worse prognosis of breast cancer, including a higher risk of recurrence and death.\n4. In colorectal cancer, UC.189 has been found to be elevated in patients with advanced disease and a poor prognosis.\n5. In ovarian cancer, UC.189 has been associated with poor prognosis and may be used as a predictive marker for chemotherapy resistance.",
    "vicuna-7b_fact": [
      "UC.189 is a protein that has been identified as a potential prognostic biomarker for certain types of cancer.",
      "UC.189 may be useful in predicting the prognosis of patients with breast cancer, colorectal cancer, and ovarian cancer.",
      "High levels of UC.189 in the blood may be associated with a worse prognosis of breast cancer, including a higher risk of recurrence and death.",
      "In colorectal cancer, UC.189 has been found to be elevated in patients with advanced disease and a poor prognosis.",
      "In ovarian cancer, UC.189 has been associated with poor prognosis and may be used as a predictive marker for chemotherapy resistance."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2525,
    "user_query": "Which package in Bioconductor has been developed with the aim to analyze differential DNA loops from sequencing data?",
    "vicuna-7b_response": "The package in Bioconductor that has been developed with the aim to analyze differential DNA loops from sequencing data is called \"differentialGRO\".\ndifferentialGRO is a Bioconductor package that provides tools for the analysis of differential chromatin interactions from sequencing data. It is designed to analyze differential DNA loops, which are regions of the genome where the distance between two genomic positions is significantly different between two conditions. The package provides several functions for the analysis of differential chromatin interactions, including the calculation of the distance between two genomic positions, the identification of differential DNA loops, and the visualization of the results.\nThe package is based on the assumption that the distance between two genomic positions is a good indicator of the strength of the interaction between those positions. Therefore, the package can be used to identify regions of the genome where the interaction between two genomic positions is significantly different between two conditions. This can be useful for the study of gene regulation and the identification of regulatory elements in the genome.\nIn summary, the package \"differentialGRO\" in Bioconductor is designed to analyze differential DNA loops from sequencing data and can be used to identify regions of the genome where the interaction between two genomic positions is significantly different between two conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The package in Bioconductor developed to analyze differential DNA loops from sequencing data is called \"differentialGRO.\" \n2. DifferentialGRO is a Bioconductor package that provides tools for the analysis of differential chromatin interactions from sequencing data. \n3. The package provides several functions for the analysis of differential chromatin interactions, including calculation of the distance between two genomic positions, identification of differential DNA loops, and visualization of the results. \n4. The \"differentialGRO\" package is based on the assumption that the distance between two genomic positions is a good indicator of the strength of the interaction between those positions. \n5. \"differentialGRO\" can be used to identify regions of the genome where the interaction between two genomic positions is significantly different between two conditions.",
    "vicuna-7b_fact": [
      "The package in Bioconductor developed to analyze differential DNA loops from sequencing data is called \"differentialGRO.\"",
      "DifferentialGRO is a Bioconductor package that provides tools for the analysis of differential chromatin interactions from sequencing data.",
      "The package provides several functions for the analysis of differential chromatin interactions, including calculation of the distance between two genomic positions, identification of differential DNA loops, and visualization of the results.",
      "The \"differentialGRO\" package is based on the assumption that the distance between two genomic positions is a good indicator of the strength of the interaction between those positions.",
      "\"differentialGRO\" can be used to identify regions of the genome where the interaction between two genomic positions is significantly different between two conditions."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The package in Bioconductor developed to analyze differential DNA loops from sequencing data is called \"diffloop.\"\n2. FALSE [correction]: Diffloop is a Bioconductor package that provides tools for the analysis of differential chromatin interactions from sequencing data.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2526,
    "user_query": "Which disease can be diagnosed with the \"probe to bone\" test?",
    "vicuna-7b_response": "The \"probe to bone\" test is typically used to diagnose a condition called osteoporosis. Osteoporosis is a disease that causes bones to become weak and brittle, making them more susceptible to fractures. The \"probe to bone\" test involves inserting a small probe into the bone to measure its density. This test can help healthcare providers determine if a person has osteoporosis or if they are at risk for developing the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"probe to bone\" test is used to diagnose osteoporosis.\n2. Osteoporosis is a disease that causes bones to become weak and brittle.\n3. Osteoporosis makes bones more susceptible to fractures.\n4. The \"probe to bone\" test involves inserting a small probe into the bone to measure its density.\n5. The \"probe to bone\" test can help determine if a person is at risk for developing osteoporosis.",
    "vicuna-7b_fact": [
      "The \"probe to bone\" test is used to diagnose osteoporosis.",
      "Osteoporosis is a disease that causes bones to become weak and brittle.",
      "Osteoporosis makes bones more susceptible to fractures.",
      "The \"probe to bone\" test involves inserting a small probe into the bone to measure its density.",
      "The \"probe to bone\" test can help determine if a person is at risk for developing osteoporosis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The \"probe to bone\" test is used to diagnose osteomyelitis, not osteoporosis.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The \"probe to bone\" test is a clinical test for detecting lower limb osteomyelitis, where pressure is applied to a suspected ulcer with a sterile blunt probe in an attempt to touch the underlying bone.\n5. FALSE [correction]: The \"probe to bone\" test is used in the diagnosis of osteomyelitis, not for determining risk of developing osteoporosis. To assess the risk of osteoporosis, bone density tests or DEXA scans are usually conducted.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2527,
    "user_query": "Can doxycycline cause photosensitivity?",
    "vicuna-7b_response": "Doxycycline is a type of antibiotic that is commonly used to treat a variety of bacterial infections. While it is generally well-tolerated, it can cause photosensitivity, which is an increased sensitivity to sunlight.\nPhotosensitivity is a common side effect of doxycycline and can occur in up to 10% of people who take the medication. It is more likely to occur in people who are taking higher doses of the medication or who have been taking it for a longer period of time.\nSymptoms of photosensitivity can include redness, itching, and burning of the skin after exposure to sunlight. In some cases, blistering and swelling of the skin may also occur.\nTo reduce the risk of photosensitivity, it is important to avoid excessive exposure to sunlight and to wear protective clothing and sunscreen when outdoors. If you experience any symptoms of photosensitivity while taking doxycycline, you should contact your healthcare provider.\nIt is important to note that other medications, such as tetracyclines, can also cause photosensitivity. If you are taking any medications and experience symptoms of photosensitivity, you should contact your healthcare provider for further evaluation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Doxycycline is an antibiotic used to treat various bacterial infections.\n2. Doxycycline can cause photosensitivity, an increased sensitivity to sunlight.\n3. Photosensitivity is a common side effect of doxycycline, occurring in up to 10% of the people who take the medication.\n4. Symptoms of photosensitivity include redness, itching, burning of the skin, and in some cases, blistering and swelling of the skin after exposure to sunlight.\n5. Tetracyclines, like doxycycline, can also cause photosensitivity.",
    "vicuna-7b_fact": [
      "Doxycycline is an antibiotic used to treat various bacterial infections.",
      "Doxycycline can cause photosensitivity, an increased sensitivity to sunlight.",
      "Photosensitivity is a common side effect of doxycycline, occurring in up to 10% of the people who take the medication.",
      "Symptoms of photosensitivity include redness, itching, burning of the skin, and in some cases, blistering and swelling of the skin after exposure to sunlight.",
      "Tetracyclines, like doxycycline, can also cause photosensitivity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2530,
    "user_query": "What is the normal body temperature in dogs?",
    "vicuna-7b_response": "The normal body temperature for dogs is between 101.5°F (38.6°C) and 102.5°F (39.2°C). However, it's important to note that body temperature can vary depending on factors such as age, breed, and overall health. For example, very young or very old dogs may have lower temperatures, while dogs with certain health conditions may have higher temperatures. If you're concerned about your dog's temperature, it's best to consult with a veterinarian for further guidance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The normal body temperature for dogs is between 101.5°F (38.6°C) and 102.5°F (39.2°C).\n2. Body temperature in dogs can vary depending on factors such as age, breed, and overall health.\n3. Very young or very old dogs may have lower body temperatures.\n4. Dogs with certain health conditions may have higher body temperatures.\n5. If concerning a dog's temperature, consulting with a veterinarian is recommended.",
    "vicuna-7b_fact": [
      "The normal body temperature for dogs is between 101.5°F (38.6°C) and 102.5°F (39.2°C).",
      "Body temperature in dogs can vary depending on factors such as age, breed, and overall health.",
      "Very young or very old dogs may have lower body temperatures.",
      "Dogs with certain health conditions may have higher body temperatures.",
      "If concerning a dog's temperature, consulting with a veterinarian is recommended."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2531,
    "user_query": "List symptoms of Heerfordt syndrome.",
    "vicuna-7b_response": "Heerfordt syndrome is a rare genetic disorder that affects the eyes and other parts of the body. The symptoms of Heerfordt syndrome can vary from person to person, but some common symptoms include:\n1. Nystagmus: This is a condition where the eyes involuntarily move back and forth.\n2. Strabismus: This is a condition where the eyes are misaligned.\n3. Photophobia: This is sensitivity to light.\n4. Astigmatism: This is a condition where the shape of the cornea is irregular, causing vision problems.\n5. Cataracts: This is a clouding of the lens in the eye.\n6. Hearing loss: Some people with Heerfordt syndrome may experience hearing loss.\n7. Developmental delays: Children with Heerfordt syndrome may experience delays in their development.\n8. Intellectual disability: Some people with Heerfordt syndrome may have intellectual disabilities.\n9. Small stature: People with Heerfordt syndrome may be of below-average height.\n10. Dental abnormalities: Some people with Heerfordt syndrome may have abnormalities in their teeth.\nIt's important to note that not all people with Heerfordt syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person. If you or someone you know is experiencing any of these symptoms, it's important to speak with a healthcare provider for further evaluation and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Heerfordt syndrome is a rare genetic disorder that affects the eyes and other parts of the body.\n2. Nystagmus, a condition where the eyes involuntarily move back and forth, can be a symptom of Heerfordt syndrome.\n3. Strabismus, misalignment of the eyes, is another symptom of Heerfordt syndrome.\n4. Photophobia, or sensitivity to light, is also a symptom of Heerfordt syndrome.\n5. Some people with Heerfordt syndrome may experience hearing loss.",
    "vicuna-7b_fact": [
      "Heerfordt syndrome is a rare genetic disorder that affects the eyes and other parts of the body.",
      "Nystagmus, a condition where the eyes involuntarily move back and forth, can be a symptom of Heerfordt syndrome.",
      "Strabismus, misalignment of the eyes, is another symptom of Heerfordt syndrome.",
      "Photophobia, or sensitivity to light, is also a symptom of Heerfordt syndrome.",
      "Some people with Heerfordt syndrome may experience hearing loss."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Heerfordt syndrome, also known as uveoparotid fever, is a rare manifestation of sarcoidosis, not a genetic disorder. It can affect the eyes, the salivary glands, and sometimes the facial nerves.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Photophobia is not typically associated with Heerfordt syndrome.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2532,
    "user_query": "In quadruped mammals, what bones make up the stifle?",
    "vicuna-7b_response": "In quadruped mammals, the stifle is also known as the hock, and it is a joint that connects the femur (thigh bone) to the tibia (shin bone) and fibula (smaller bone in the leg). The stifle is made up of several bones, including the femur, tibia, and fibula. The femur is the largest bone in the body, and it provides the majority of the leg's strength and support. The tibia and fibula are smaller bones that work together with the femur to provide stability and movement to the leg. The stifle joint is important for movement and locomotion in quadruped mammals, as it allows the animal to bend and straighten its leg.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In quadruped mammals, the stifle is also known as the hock.\n2. The stifle joint connects the femur to the tibia and fibula.\n3. The stifle is made up of the femur, tibia, and fibula.\n4. The femur is the largest bone in the body and provides the majority of the leg's strength and support.\n5. The stifle joint allows the animal to bend and straighten its leg, crucial for movement and locomotion in quadruped mammals.",
    "vicuna-7b_fact": [
      "In quadruped mammals, the stifle is also known as the hock.",
      "The stifle joint connects the femur to the tibia and fibula.",
      "The stifle is made up of the femur, tibia, and fibula.",
      "The femur is the largest bone in the body and provides the majority of the leg's strength and support.",
      "The stifle joint allows the animal to bend and straighten its leg, crucial for movement and locomotion in quadruped mammals."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: In quadruped mammals, the stifle is equivalent to the human knee, not the hock.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2535,
    "user_query": "Which tool exists for microsatellite (SSR) loci detection and primer design?",
    "vicuna-7b_response": "There are several tools available for microsatellite (SSR) locus detection and primer design. Some popular options include:\n1. MICRO-CHECKER: MICRO-CHECKER is a widely used software tool for genotyping and genetic analysis. It can be used to identify and analyze microsatellites, as well as to design primers for PCR amplification.\n2. POPGENE: POPGENE is a comprehensive population genetics software package that includes tools for microsatellite analysis. It can be used to identify and analyze microsatellites, as well as to design primers for PCR amplification.\n3. GENEPOP: GENEPOP is another population genetics software package that includes tools for microsatellite analysis. It can be used to identify and analyze microsatellites, as well as to design primers for PCR amplification.\n4. Primer3: Primer3 is a web-based tool for designing PCR primers. It can be used to design primers for microsatellite loci, and it includes features for optimizing primer performance.\n5. LAMPER: LAMPER is a software tool for designing PCR primers for use in loop-mediated isothermal amplification (LAMP) reactions. It can be used to design primers for microsatellite loci, and it includes features for optimizing primer performance.\nThese are just a few examples of the many tools available for microsatellite locus detection and primer design. The choice of tool will depend on the specific needs of the user and the resources available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MICRO-CHECKER is a software tool used for genotyping and genetic analysis including microsatellite analysis and primer design.\n2. POPGENE is a comprehensive population genetics software package that includes tools for microsatellite analysis and primer design.\n3. GENEPOP is a population genetics software package with tools for microsatellite analysis and primer design.\n4. Primer3 is a web-based tool for designing PCR primers, including those for microsatellite loci.\n5. LAMPER is a software tool for designing PCR primers for use in loop-mediated isothermal amplification (LAMP) reactions, including primers for microsatellite loci.",
    "vicuna-7b_fact": [
      "MICRO-CHECKER is a software tool used for genotyping and genetic analysis including microsatellite analysis and primer design.",
      "POPGENE is a comprehensive population genetics software package that includes tools for microsatellite analysis and primer design.",
      "GENEPOP is a population genetics software package with tools for microsatellite analysis and primer design.",
      "Primer3 is a web-based tool for designing PCR primers, including those for microsatellite loci.",
      "LAMPER is a software tool for designing PCR primers for use in loop-mediated isothermal amplification (LAMP) reactions, including primers for microsatellite loci."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: POPGENE is a comprehensive population genetics software package but it does not include tools for primer design.\n3. FALSE [correction]: GENEPOP is a population genetics software package but it does not include tools for primer design.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2544,
    "user_query": "What is the preDIVA clinical trial?",
    "vicuna-7b_response": "The preDIVA clinical trial is a study that aims to evaluate the safety and efficacy of a new drug called BAY1841788 in women with advanced breast cancer who have not responded to other treatments. The trial is being conducted by the pharmaceutical company Bayer, and it is currently recruiting participants.\nThe preDIVA trial is a phase 3, multicenter, randomized, double-blind, placebo-controlled study. It will enroll approximately 400 patients with advanced breast cancer who have not responded to previous treatments. The patients will be randomly assigned to receive either BAY1841788 or a placebo, and they will be followed for 24 weeks.\nThe primary objective of the study is to evaluate the efficacy of BAY1841788 in terms of progression-free survival, which is the length of time during and after the treatment during which the patient's cancer does not get worse. The secondary objectives of the study include evaluating the safety and tolerability of BAY1841788, as well as its impact on quality of life and other clinical endpoints.\nThe preDIVA trial is expected to provide important information about the safety and efficacy of BAY1841788 in women with advanced breast cancer, and it may help to define the role of this drug in the treatment of this disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The preDIVA clinical trial evaluates the safety and efficacy of a drug called BAY1841788 in women with advanced breast cancer.\n2. This trial is conducted by the pharmaceutical company Bayer.\n3. The preDIVA trial is a phase 3, multicenter, randomized, double-blind, placebo-controlled study.\n4. The trial will enroll approximately 400 patients who will be followed for 24 weeks.\n5. The primary objective of this study is to evaluate the efficacy of BAY1841788 in terms of progression-free survival.",
    "vicuna-7b_fact": [
      "The preDIVA clinical trial evaluates the safety and efficacy of a drug called BAY1841788 in women with advanced breast cancer.",
      "This trial is conducted by the pharmaceutical company Bayer.",
      "The preDIVA trial is a phase 3, multicenter, randomized, double-blind, placebo-controlled study.",
      "The trial will enroll approximately 400 patients who will be followed for 24 weeks.",
      "The primary objective of this study is to evaluate the efficacy of BAY1841788 in terms of progression-free survival."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2548,
    "user_query": "Milwaukee protocol was tested for treatment of which disease?",
    "vicuna-7b_response": "The Milwaukee protocol is a treatment protocol for multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The Milwaukee protocol is a comprehensive treatment plan that includes medications, physical therapy, and other interventions to manage the symptoms of MS and slow the progression of the disease. The protocol was developed by researchers at the Medical College of Wisconsin and has been widely used since the 1980s.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Milwaukee protocol is a treatment protocol for multiple sclerosis (MS).\n2. Multiple sclerosis is an autoimmune disease that affects the central nervous system.\n3. The Milwaukee protocol includes medications, physical therapy, and other interventions to manage the symptoms of MS and slow the disease progression.\n4. The protocol was developed by researchers at the Medical College of Wisconsin.\n5. The Milwaukee protocol has been widely used since the 1980s.",
    "vicuna-7b_fact": [
      "The Milwaukee protocol is a treatment protocol for multiple sclerosis (MS).",
      "Multiple sclerosis is an autoimmune disease that affects the central nervous system.",
      "The Milwaukee protocol includes medications, physical therapy, and other interventions to manage the symptoms of MS and slow the disease progression.",
      "The protocol was developed by researchers at the Medical College of Wisconsin.",
      "The Milwaukee protocol has been widely used since the 1980s."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Milwaukee protocol is a treatment protocol for rabies, not multiple sclerosis (MS).\n2. TRUE\n3. FALSE [correction]: The Milwaukee protocol uses an aggressive treatment strategy including induced coma and antiviral mediation mainly for rabies patients.\n4. TRUE\n5. FALSE [correction]: The Milwaukee Protocol was first reported in the medical literature in 2004.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2552,
    "user_query": "Is the consumption of chocolate associated with an increase in cardiovascular disease?",
    "vicuna-7b_response": "The consumption of chocolate has been a topic of debate when it comes to its association with cardiovascular disease. While some studies have suggested that moderate consumption of chocolate may have health benefits, such as reducing the risk of heart disease, other studies have found that chocolate consumption may be associated with an increased risk of cardiovascular disease.\nOne of the main reasons for this association is the high sugar and fat content of chocolate. Chocolate is a rich source of saturated and unsaturated fats, which can increase LDL (bad) cholesterol levels and contribute to the development of cardiovascular disease. Additionally, chocolate is high in sugar, which can contribute to weight gain and other risk factors for cardiovascular disease.\nHowever, it's important to note that not all chocolate is created equal. Dark chocolate, which is rich in flavonoids, has been shown to have potential health benefits. Flavonoids are a type of antioxidant that may help to reduce inflammation and improve blood flow, which can help to reduce the risk of cardiovascular disease.\nIn conclusion, while moderate consumption of chocolate may have some potential health benefits, it's important to be mindful of the overall nutritional content of the chocolate and to consume it in moderation. It's also important to note that chocolate is not a miracle food and should not be relied upon as a sole source of nutrition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Some studies suggest that moderate consumption of chocolate may reduce the risk of heart disease.\n2. Other studies have found that chocolate consumption may be associated with an increased risk of cardiovascular disease.\n3. Chocolate is a rich source of saturated and unsaturated fats, which can increase LDL (bad) cholesterol levels.\n4. Chocolate is high in sugar, which can contribute to weight gain and other risk factors for cardiovascular disease.\n5. Dark chocolate, rich in flavonoids, may have potential health benefits like reducing inflammation and improving blood flow.",
    "vicuna-7b_fact": [
      "Some studies suggest that moderate consumption of chocolate may reduce the risk of heart disease.",
      "Other studies have found that chocolate consumption may be associated with an increased risk of cardiovascular disease.",
      "Chocolate is a rich source of saturated and unsaturated fats, which can increase LDL (bad) cholesterol levels.",
      "Chocolate is high in sugar, which can contribute to weight gain and other risk factors for cardiovascular disease.",
      "Dark chocolate, rich in flavonoids, may have potential health benefits like reducing inflammation and improving blood flow."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chocolate, especially dark chocolate, is a rich source of fats, but mainly monounsaturated and polyunsaturated fats, not saturated. The fats in chocolate do not typically increase LDL (bad) cholesterol levels.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2553,
    "user_query": "What is the association of circular RNA to breast cancer?",
    "vicuna-7b_response": "Circular RNA (circRNA) has been shown to play a role in the development and progression of breast cancer.\nOne study found that circRNA expression was increased in breast cancer tissues compared to normal breast tissues, and that this increased expression was associated with poor prognosis in breast cancer patients. Additionally, another study found that circRNA expression was associated with the development of breast cancer metastasis.\nFurthermore, circRNA has been shown to regulate the expression of genes involved in breast cancer progression, such as those involved in cell proliferation, apoptosis, and angiogenesis.\nOverall, the association of circRNA to breast cancer is a growing area of research, and further studies are needed to fully understand the role of circRNA in the development and progression of breast cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CircRNA has been shown to play a role in the development and progression of breast cancer.\n2. One study found increased circRNA expression in breast cancer tissues compared to normal breast tissues.\n3. Increased circRNA expression is associated with poor prognosis in breast cancer patients, according to a study.\n4. Another study found that circRNA expression is associated with the development of breast cancer metastasis.\n5. CircRNA has been shown to regulate the expression of genes involved in breast cancer progression, such as those involved in cell proliferation, apoptosis, and angiogenesis.",
    "vicuna-7b_fact": [
      "CircRNA has been shown to play a role in the development and progression of breast cancer.",
      "One study found increased circRNA expression in breast cancer tissues compared to normal breast tissues.",
      "Increased circRNA expression is associated with poor prognosis in breast cancer patients, according to a study.",
      "Another study found that circRNA expression is associated with the development of breast cancer metastasis.",
      "CircRNA has been shown to regulate the expression of genes involved in breast cancer progression, such as those involved in cell proliferation, apoptosis, and angiogenesis."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-7b_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the popular R packages for NIPT analysis include:\n1. \"nipstest\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n2. \"nipstools\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n3. \"nipstestR\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n4. \"nipstoolsR\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n5. \"nipstest.r\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n6. \"nipstools.r\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\nIt's worth noting that these packages are not the only ones available, and new packages may be developed in the future. It's always a good idea to check the package documentation and examples before using it for your specific analysis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"nipstest\" is an R package developed for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.\n2. The \"nipstools\" is an R package that provides functions for processing, analyzing, and visualizing NIPT data.\n3. The \"nipstestR\" is an R package that has been developed for analyzing and interpreting NIPT data.\n4. The \"nipstoolsR\" is an R package developed for processing, analyzing, and visualizing NIPT data.\n5. \"nipstest.r\" and \"nipstools.r\" are R packages developed for analyzing and interpreting, and processing and visualizing NIPT data respectively.",
    "vicuna-7b_fact": [
      "The \"nipstest\" is an R package developed for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.",
      "The \"nipstools\" is an R package that provides functions for processing, analyzing, and visualizing NIPT data.",
      "The \"nipstestR\" is an R package that has been developed for analyzing and interpreting NIPT data.",
      "The \"nipstoolsR\" is an R package developed for processing, analyzing, and visualizing NIPT data.",
      "\"nipstest.r\" and \"nipstools.r\" are R packages developed for analyzing and interpreting, and processing and visualizing NIPT data respectively."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2558,
    "user_query": "Is the gene CDKN2A nevogenic?",
    "vicuna-7b_response": "The gene CDKN2A is a tumor suppressor gene that has been implicated in the development of several types of cancer, including melanoma, breast cancer, and colon cancer. The gene encodes a protein called p16INK4a, which plays a role in regulating cell growth and division.\nResearch has shown that mutations in the CDKN2A gene can lead to the production of non-functional p16INK4a protein, which can disrupt the normal cell cycle control and promote cell proliferation. This can lead to the development of cancer.\nIn addition, the CDKN2A gene has been shown to be a key player in the development of melanoma, the most dangerous form of skin cancer. Mutations in the CDKN2A gene have been found in about 50% of melanoma cases, and these mutations can lead to the production of non-functional p16INK4a protein.\nOverall, while the CDKN2A gene is not directly related to neurogenesis, it is a key player in the development of cancer and has been implicated in the development of several types of cancer, including melanoma.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The CDKN2A gene is a tumor suppressor gene.\n2. The CDKN2A gene is associated with the development of several types of cancer, including melanoma, breast cancer, and colon cancer.\n3. The protein encoded by the CDKN2A gene is p16INK4a, which regulates cell growth and division.\n4. Mutations in the CDKN2A gene can lead to the production of non-functional p16INK4a protein, promoting cell proliferation.\n5. About 50% of melanoma cases have been found with mutations in the CDKN2A gene.",
    "vicuna-7b_fact": [
      "The CDKN2A gene is a tumor suppressor gene.",
      "The CDKN2A gene is associated with the development of several types of cancer, including melanoma, breast cancer, and colon cancer.",
      "The protein encoded by the CDKN2A gene is p16INK4a, which regulates cell growth and division.",
      "Mutations in the CDKN2A gene can lead to the production of non-functional p16INK4a protein, promoting cell proliferation.",
      "About 50% of melanoma cases have been found with mutations in the CDKN2A gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: About 20% of familial melanoma cases have been found with mutations in the CDKN2A gene.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2559,
    "user_query": "Are there ways of joint Bayesian inference of risk variants?",
    "vicuna-7b_response": "Yes, there are ways of joint Bayesian inference of risk variants. Joint modeling of multiple risk variants can be performed using Bayesian methods, which allow for the incorporation of prior knowledge and the simultaneous estimation of multiple parameters.\nOne approach to joint modeling of risk variants is to use a Bayesian additive regression model (BARM) framework. BARM is a flexible framework that can be used to model the relationship between multiple risk variants and the outcome of interest. In a BARM framework, each risk variant is modeled as a linear predictor of the outcome, and the effects of the risk variants are modeled as independent normal distributions. The model can be extended to include non-linear effects and other covariates.\nAnother approach is to use a Bayesian hierarchical model, which allows for the incorporation of prior knowledge about the distribution of the effects of the risk variants. In a Bayesian hierarchical model, the effects of the risk variants are modeled as normal distributions with mean and variance parameters that are estimated from the data. The prior distribution of the mean and variance parameters can be specified based on prior knowledge or expert judgment.\nIn both approaches, the Bayesian framework allows for the incorporation of prior knowledge and the estimation of uncertainty in the parameters of the model. This can be useful for identifying which risk variants are most likely to be associated with the outcome and for quantifying the strength of the association.\nIt is important to note that the choice of method will depend on the specific research question and the available data. In addition, it is important to carefully consider the assumptions of the model and the validity of the methods used.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Joint modeling of multiple risk variants can be performed using Bayesian methods.\n2. One approach to joint modeling of risk variants is through a Bayesian additive regression model (BARM) framework. \n3. BARM is a framework that models each risk variant as a linear predictor of the outcome.\n4. Another approach of joint modeling is using a Bayesian hierarchical model, which incorporates prior knowledge about the distribution of the effects of the risk variants.\n5. The method chosen for joint Bayesian inference of risk variants would depend on the specific research question and the available data.",
    "vicuna-7b_fact": [
      "Joint modeling of multiple risk variants can be performed using Bayesian methods.",
      "One approach to joint modeling of risk variants is through a Bayesian additive regression model (BARM) framework.",
      "BARM is a framework that models each risk variant as a linear predictor of the outcome.",
      "Another approach of joint modeling is using a Bayesian hierarchical model, which incorporates prior knowledge about the distribution of the effects of the risk variants.",
      "The method chosen for joint Bayesian inference of risk variants would depend on the specific research question and the available data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2561,
    "user_query": "Has intepirdine been evaluated in clinical trials? (November 2017)",
    "vicuna-7b_response": "Yes, intepirdine has been evaluated in clinical trials. Intepirdine is a drug that is being developed for the treatment of Parkinson's disease and other movement disorders. It is an agonist of the dopamine transporter, which is a protein found in the brain that plays a role in the regulation of dopamine, a neurotransmitter that is important for movement control.\nIntepirdine has been studied in several clinical trials, including Phase 3 trials. These trials have evaluated the safety and efficacy of intepirdine in people with Parkinson's disease. The results of these trials have shown that intepirdine can improve symptoms of Parkinson's disease, such as tremors, stiffness, and slowness of movement. In addition, intepirdine has been shown to be well-tolerated in clinical trials, with most side effects being mild and transient.\nOverall, the results of clinical trials have shown that intepirdine is a promising treatment for Parkinson's disease and other movement disorders. However, more research is needed to fully understand the safety and efficacy of this drug.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intepirdine has been evaluated in clinical trials.\n2. Intepirdine is a drug being developed for the treatment of Parkinson's disease and other movement disorders.\n3. Intepirdine is an agonist of the dopamine transporter, a protein found in the brain.\n4. The drug has gone through several clinical trials, including Phase 3 trials.\n5. The results of these trials showed that intepirdine can improve symptoms of Parkinson's disease, such as tremors, stiffness, and slowness of movement.",
    "vicuna-7b_fact": [
      "Intepirdine has been evaluated in clinical trials.",
      "Intepirdine is a drug being developed for the treatment of Parkinson's disease and other movement disorders.",
      "Intepirdine is an agonist of the dopamine transporter, a protein found in the brain.",
      "The drug has gone through several clinical trials, including Phase 3 trials.",
      "The results of these trials showed that intepirdine can improve symptoms of Parkinson's disease, such as tremors, stiffness, and slowness of movement."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Intepirdine is being developed for the treatment of Alzheimer's disease and other related dementias, not Parkinson's disease and other movement disorders.\n3. FALSE [correction]: Intepirdine is an antagonist of the 5-HT6 receptor, not an agonist of the dopamine transporter.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2565,
    "user_query": "Does armodafinil improve fatigue of glioma patients?",
    "vicuna-7b_response": "Armodafinil is a medication that is used to treat conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is not specifically approved for the treatment of fatigue in glioma patients.\nGlioma is a type of brain tumor that can cause a variety of symptoms, including fatigue. Fatigue is a common symptom in people with cancer, and it can be caused by a number of factors, including the cancer itself, treatment side effects, and underlying health conditions.\nThere is limited research on the use of armodafinil in the treatment of fatigue in glioma patients. However, some studies have suggested that armodafinil may be effective in improving wakefulness and reducing fatigue in people with narcolepsy and other sleep disorders.\nIt is important to note that the use of armodafinil for the treatment of fatigue in glioma patients has not been extensively studied, and more research is needed to determine its effectiveness and safety in this context.\nIf you are a glioma patient experiencing fatigue, it is important to discuss your symptoms with your healthcare provider. They can help you determine the cause of your fatigue and recommend appropriate treatment options.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Armodafinil is a medication used to treat conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. \n2. Armodafinil is not specifically approved for the treatment of fatigue in glioma patients. \n3. Glioma is a type of brain tumor that can cause a variety of symptoms, including fatigue. \n4. Some studies suggest that armodafinil may be effective in improving wakefulness and reducing fatigue in people with narcolepsy and other sleep disorders.\n5. The use of armodafinil for the treatment of fatigue in glioma patients has not been extensively studied.",
    "vicuna-7b_fact": [
      "Armodafinil is a medication used to treat conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder.",
      "Armodafinil is not specifically approved for the treatment of fatigue in glioma patients.",
      "Glioma is a type of brain tumor that can cause a variety of symptoms, including fatigue.",
      "Some studies suggest that armodafinil may be effective in improving wakefulness and reducing fatigue in people with narcolepsy and other sleep disorders.",
      "The use of armodafinil for the treatment of fatigue in glioma patients has not been extensively studied."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2566,
    "user_query": "What is the role of tankyrases in response to Double Strand Breaks (DSBs)?",
    "vicuna-7b_response": "Tankyrases are a family of enzymes that play a critical role in the repair of DNA double strand breaks (DSBs). Tankyrases are responsible for the removal of the 2'-hydroxyl group from the 5' end of RNA primers used in the repair of DSBs. This process is called \"primase activity\" and is essential for the proper repair of DSBs.\nTankyrases are composed of three subunits, TNK1, TNK2, and TNK3, and are found in all eukaryotes. They are involved in the initiation of DNA repair by activating the RecQ helicase, which is responsible for unwinding the DNA strands around the DSB. Tankyrases also play a role in the recruitment of other repair proteins to the site of the DSB.\nIn summary, tankyrases are essential for the proper repair of DNA double strand breaks and play a critical role in the initiation of DNA repair by activating the RecQ helicase and recruiting other repair proteins to the site of the DSB.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tankyrases are a family of enzymes that participate in the repair of DNA double strand breaks.\n2. Tankyrases are involved in the removal of the 2'-hydroxyl group from the 5' end of RNA primers used in DNA repair.\n3. Tankyrases are composed of three subunits, TNK1, TNK2, and TNK3.\n4. Tankyrases are found in all eukaryotes.\n5. These enzymes play a role in the initiation of DNA repair by activating the RecQ helicase and recruiting other repair proteins.",
    "vicuna-7b_fact": [
      "Tankyrases are a family of enzymes that participate in the repair of DNA double strand breaks.",
      "Tankyrases are involved in the removal of the 2'-hydroxyl group from the 5' end of RNA primers used in DNA repair.",
      "Tankyrases are composed of three subunits, TNK1, TNK2, and TNK3.",
      "Tankyrases are found in all eukaryotes.",
      "These enzymes play a role in the initiation of DNA repair by activating the RecQ helicase and recruiting other repair proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tankyrases are not involved in the removal of the 2'-hydroxyl group from the 5' end of RNA primers used in DNA repair.\n3. FALSE [correction]: Tankyrases are composed of two known subunits, TNKS1 and TNKS2.\n4. FALSE [correction]: Tankyrases are found in many, but not all, eukaryotic organisms.\n5. FALSE [correction]: Tankyrases do not activate the RecQ helicase to initiate DNA repair. They have roles in telomere maintenance, Wnt signal pathway, and mitotic spindle assembly.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2569,
    "user_query": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
    "vicuna-7b_response": "There are several methods available for whole genome identification of pathogenic regulatory variants in mendelian disease. Here are some of the most commonly used methods:\n1. Whole-exome sequencing (WES): This method involves sequencing only the exons (the protein-coding regions) of the genome. This approach can identify pathogenic mutations in the coding regions of genes, but it may miss regulatory variants that do not affect the protein-coding sequence.\n2. Targeted sequencing: This method involves sequencing a panel of genes that are known to be associated with a specific disease or condition. This approach can identify pathogenic mutations in the genes of interest, but it may not capture the full spectrum of regulatory variants that affect gene expression.\n3. Chromatin immunoprecipitation sequencing (ChIP-seq): This method involves identifying the regions of the genome that are bound by specific transcription factors or other regulatory proteins. By analyzing the binding patterns of these proteins, researchers can identify regulatory variants that affect gene expression.\n4. RNA sequencing (RNA-seq): This method involves sequencing the messenger RNA (mRNA) molecules that are produced from the genome. By analyzing the expression patterns of different genes, researchers can identify regulatory variants that affect gene expression.\n5. Multi-omics data integration: This method involves combining data from multiple omics datasets (e.g., genomic, transcriptomic, epigenomic, and phenotypic data) to identify regulatory variants that affect gene expression.\nOverall, the choice of method will depend on the specific research question, the available resources, and the expertise of the research team.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Whole-exome sequencing is a method that involves sequencing only the exons of a genome.\n2. Targeted sequencing is a method that involves sequencing a panel of genes known to be associated with a specific disease or condition.\n3. Chromatin immunoprecipitation sequencing identifies the regions of the genome bound by specific transcription factors or regulatory proteins.\n4. RNA sequencing involves sequencing the messenger RNA molecules produced from the genome.\n5. Multi-omics data integration involves combining data from multiple omics datasets to identify regulatory variants that affect gene expression.",
    "vicuna-7b_fact": [
      "Whole-exome sequencing is a method that involves sequencing only the exons of a genome.",
      "Targeted sequencing is a method that involves sequencing a panel of genes known to be associated with a specific disease or condition.",
      "Chromatin immunoprecipitation sequencing identifies the regions of the genome bound by specific transcription factors or regulatory proteins.",
      "RNA sequencing involves sequencing the messenger RNA molecules produced from the genome.",
      "Multi-omics data integration involves combining data from multiple omics datasets to identify regulatory variants that affect gene expression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2577,
    "user_query": "Is Citrobacter rodentium pathogenic?",
    "vicuna-7b_response": "Citrobacter rodentium is a species of bacteria that is commonly found in the gastrointestinal tracts of rodents. It is not considered to be pathogenic to humans or other mammals.\nCitrobacter rodentium is a member of the genus Citrobacter, which is a part of the family Enterobacteriaceae. It is a gram-negative, rod-shaped bacterium that is facultatively anaerobic, meaning that it can grow in the presence or absence of oxygen.\nCitrobacter rodentium is typically found in the gastrointestinal tracts of rodents, and it is not known to cause disease in these animals. However, it has been shown to be pathogenic in certain animal models, such as mice and rats.\nIn humans, Citrobacter rodentium has been isolated from clinical specimens on rare occasions, but it is not known to cause disease. It is not considered to be a significant pathogen for humans.\nOverall, Citrobacter rodentium is not considered to be pathogenic to humans or other mammals. It is primarily a species of bacteria that is found in the gastrointestinal tracts of rodents, and it is not known to cause disease in these animals or in humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Citrobacter rodentium is a species of bacteria found in the gastrointestinal tracts of rodents.\n2. Citrobacter rodentium belongs to the genus Citrobacter, which is part of the family Enterobacteriaceae.\n3. Citrobacter rodentium is a gram-negative, rod-shaped bacterium that is facultatively anaerobic.\n4. Citrobacter rodentium has been shown to be pathogenic in certain animal models, such as mice and rats.\n5. Citrobacter rodentium is not known to cause disease in humans or rodents.",
    "vicuna-7b_fact": [
      "Citrobacter rodentium is a species of bacteria found in the gastrointestinal tracts of rodents.",
      "Citrobacter rodentium belongs to the genus Citrobacter, which is part of the family Enterobacteriaceae.",
      "Citrobacter rodentium is a gram-negative, rod-shaped bacterium that is facultatively anaerobic.",
      "Citrobacter rodentium has been shown to be pathogenic in certain animal models, such as mice and rats.",
      "Citrobacter rodentium is not known to cause disease in humans or rodents."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Citrobacter rodentium is known to cause disease in rodents and has been used as a model to study pathogenicity in humans.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2578,
    "user_query": "List two human monoclonal antibodies against Clostridium difficile toxins.",
    "vicuna-7b_response": "Sure, here are two human monoclonal antibodies against Clostridium difficile toxins:\n1. RTI-133: RTI-133 is a human monoclonal antibody that binds to Clostridium difficile toxin A. It has been shown to be effective in the treatment of C. difficile infections, and has been approved for use in several countries.\n2. Vancocin: Vancocin is a human monoclonal antibody that binds to both Clostridium difficile toxins A and B. It has been used for the treatment of C. difficile infections for over 30 years, and is considered a first-line treatment for severe C. difficile infections.\nBoth RTI-133 and Vancocin have been shown to be effective in treating C. difficile infections, and have been approved for use in various countries. However, it's important to note that the choice of treatment depends on various factors, such as the severity of the infection, the patient's medical history, and the availability of treatment options.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RTI-133 is a human monoclonal antibody that binds to Clostridium difficile toxin A.\n2. RTI-133 has been shown to be effective in treating C. difficile infections and has been approved for use in several countries.\n3. Vancocin is a human monoclonal antibody that binds to both Clostridium difficile toxins A and B.\n4. Vancocin has been used for the treatment of C. difficile infections for over 30 years, and is considered a first-line treatment for severe infections.\n5. Both RTI-133 and Vancocin have been approved for use in various countries for treating C. difficile infections.",
    "vicuna-7b_fact": [
      "RTI-133 is a human monoclonal antibody that binds to Clostridium difficile toxin A.",
      "RTI-133 has been shown to be effective in treating C. difficile infections and has been approved for use in several countries.",
      "Vancocin is a human monoclonal antibody that binds to both Clostridium difficile toxins A and B.",
      "Vancocin has been used for the treatment of C. difficile infections for over 30 years, and is considered a first-line treatment for severe infections.",
      "Both RTI-133 and Vancocin have been approved for use in various countries for treating C. difficile infections."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. FALSE [correction]: Vancocin is an antibiotic and is not a human monoclonal antibody. It works by preventing the growth of bacteria.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2579,
    "user_query": "List ribosomal biogenesis proteins.",
    "vicuna-7b_response": "Ribosomal biogenesis proteins are a group of proteins that are involved in the process of ribosomal synthesis and assembly. These proteins are responsible for the formation of ribosomes, which are the cellular structures that are responsible for protein synthesis. Some of the ribosomal biogenesis proteins include:\n1. Ribosomal proteins: These are the proteins that make up the ribosomal subunits. They are synthesized in the cytoplasm and transported to the rough endoplasmic reticulum, where they are incorporated into the ribosomal subunits.\n2. Ribosomal RNA (rRNA): This is the RNA that makes up the majority of the ribosome. It is synthesized in the nucleolus and transported to the cytoplasm, where it is incorporated into the ribosomal subunits.\n3. Ribosomal proteins synthesis factors: These are proteins that are involved in the synthesis of ribosomal proteins. They include transcription factors, RNA polymerase, and elongation factors.\n4. Ribosomal proteins processing factors: These are proteins that are involved in the processing of ribosomal proteins. They include proteases, chaperones, and methyltransferases.\n5. Ribosomal proteins assembly factors: These are proteins that are involved in the assembly of ribosomal proteins. They include chaperones, GTPases, and ATPases.\nIt's important to note that this is not an exhaustive list, and there are many other proteins that are involved in ribosomal biogenesis. Additionally, the process of ribosomal biogenesis is a complex and dynamic process that is regulated by a variety of factors, including transcription, translation, and post-transcriptional modifications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ribosomal biogenesis proteins are involved in the process of ribosomal synthesis and assembly. \n2. Ribosomal proteins make up the ribosomal subunits and are synthesized in the cytoplasm before being transported to the rough endoplasmic reticulum.\n3. Ribosomal RNA (rRNA) makes up the majority of the ribosome and is synthesized in the nucleolus before being transported to the cytoplasm.\n4. Ribosomal proteins synthesis factors include transcription factors, RNA polymerase, and elongation factors.\n5. Ribosomal proteins processing factors include proteases, chaperones, and methyltransferases.\n6. Ribosomal proteins assembly factors include chaperones, GTPases, and ATPases.",
    "vicuna-7b_fact": [
      "Ribosomal biogenesis proteins are involved in the process of ribosomal synthesis and assembly.",
      "Ribosomal proteins make up the ribosomal subunits and are synthesized in the cytoplasm before being transported to the rough endoplasmic reticulum.",
      "Ribosomal RNA (rRNA) makes up the majority of the ribosome and is synthesized in the nucleolus before being transported to the cytoplasm.",
      "Ribosomal proteins synthesis factors include transcription factors, RNA polymerase, and elongation factors.",
      "Ribosomal proteins processing factors include proteases, chaperones, and methyltransferases.",
      "Ribosomal proteins assembly factors include chaperones, GTPases, and ATPases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Ribosomal proteins make up the ribosomal subunits and are synthesized in the cytoplasm before being transported to the nucleolus.\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-7b_response": "Long repeat expansions are a type of genetic mutation that can cause a variety of diseases, including Huntington's disease, myotonic dystrophy, and fragile X syndrome. There are several algorithms that can be used to detect long repeat expansions, including:\n1. PCR-based methods: These methods use polymerase chain reaction (PCR) to amplify specific regions of the genome and then sequence the amplified regions. PCR can be used to detect repeat expansions by amplifying a specific region of the genome and then sequencing the amplified region to identify repeat expansions.\n2. Sequencing-based methods: These methods use next-generation sequencing (NGS) to sequence the entire genome or specific regions of the genome. Sequencing can be used to detect repeat expansions by identifying repeat expansions in the sequenced regions.\n3. Microarray-based methods: These methods use microarrays to detect repeat expansions by comparing the expression of specific genes to a reference genome. Microarrays can be used to detect repeat expansions by identifying genes that are differentially expressed between individuals with and without repeat expansions.\nOverall, the choice of algorithm for detecting long repeat expansions will depend on the specific disease being studied and the available resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Long repeat expansions are a type of genetic mutation that can cause diseases like Huntington's disease, myotonic dystrophy, and fragile X syndrome.\n2. PCR-based methods can be used to detect long repeat expansions. These methods amplify specific regions of the genome and then sequence the amplified regions.\n3. Sequencing-based methods are also used to detect long repeat expansions, using next-generation sequencing to sequence the entire genome or specific regions.\n4. Microarray-based methods can be used to detect repeat expansions by comparing the expression of specific genes to a reference genome.\n5. The choice of algorithm for detecting long repeat expansions varies depending on the specific disease being studied and the available resources.",
    "vicuna-7b_fact": [
      "Long repeat expansions are a type of genetic mutation that can cause diseases like Huntington's disease, myotonic dystrophy, and fragile X syndrome.",
      "PCR-based methods can be used to detect long repeat expansions. These methods amplify specific regions of the genome and then sequence the amplified regions.",
      "Sequencing-based methods are also used to detect long repeat expansions, using next-generation sequencing to sequence the entire genome or specific regions.",
      "Microarray-based methods can be used to detect repeat expansions by comparing the expression of specific genes to a reference genome.",
      "The choice of algorithm for detecting long repeat expansions varies depending on the specific disease being studied and the available resources."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Microarray-based methods detect variations in gene expression levels rather than repeat expansions directly. Comparing the expression of specific genes to a reference genome is part of the process, but repeat expansions are usually detected via sequencing or PCR-based methods.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2588,
    "user_query": "Are osteoclasts specialized in bone degradation?",
    "vicuna-7b_response": "Yes, osteoclasts are specialized cells that are responsible for bone degradation. They are formed by the fusion of monocytes and macrophages and are the primary cells responsible for the resorption of bone tissue. Osteoclasts secrete a variety of enzymes and acidic proteins that break down the mineral matrix of bone, leading to bone resorption. They are involved in a number of physiological and pathological processes, including bone remodeling, bone repair, and bone disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Osteoclasts are specialized cells responsible for bone degradation.\n2. Osteoclasts are formed by the fusion of monocytes and macrophages.\n3. Osteoclasts are the primary cells responsible for the resorption of bone tissue.\n4. Osteoclasts secrete a variety of enzymes and acidic proteins that break down the mineral matrix of bone.\n5. Osteoclasts are involved in a number of physiological and pathological processes, including bone remodeling, bone repair, and bone disease.",
    "vicuna-7b_fact": [
      "Osteoclasts are specialized cells responsible for bone degradation.",
      "Osteoclasts are formed by the fusion of monocytes and macrophages.",
      "Osteoclasts are the primary cells responsible for the resorption of bone tissue.",
      "Osteoclasts secrete a variety of enzymes and acidic proteins that break down the mineral matrix of bone.",
      "Osteoclasts are involved in a number of physiological and pathological processes, including bone remodeling, bone repair, and bone disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-7b_response": "BET (Bromodomain and Extra-terminal domain) proteins are a family of proteins that contain bromodomains and extra-terminal domains. Bromodomains are protein recognition modules that bind to acetylated lysine residues, while extra-terminal domains are involved in regulating the activity of bromodomains.\nThere are several subfamilies of BET proteins, including BET bromodomains, BET tandem bromodomains, BET-like proteins, and BET-specific proteins. BET bromodomains are the most well-known subfamily and are involved in regulating the transcription of genes involved in cell growth and differentiation.\nBET proteins play a role in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions. Dysregulation of BET proteins has been implicated in a number of diseases, including cancer, neurodegeneration, and immune disorders.\nSome examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. BET proteins are a family of proteins that contain bromodomains and extra-terminal domains.\n2. Bromodomains are protein recognition modules that bind to acetylated lysine residues.\n3. Extra-terminal domains in BET proteins are involved in regulating the activity of bromodomains.\n4. BET proteins play a role in transcriptional regulation, chromatin remodeling, and protein-protein interactions.\n5. Some examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2.",
    "vicuna-7b_fact": [
      "BET proteins are a family of proteins that contain bromodomains and extra-terminal domains.",
      "Bromodomains are protein recognition modules that bind to acetylated lysine residues.",
      "Extra-terminal domains in BET proteins are involved in regulating the activity of bromodomains.",
      "BET proteins play a role in transcriptional regulation, chromatin remodeling, and protein-protein interactions.",
      "Some examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Some examples of BET proteins include BRD4, BRD3, BRD2, and BRDT. BAP1, BAP3, BAPL1, and BAPL2 are not recognized as BET proteins.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2593,
    "user_query": "How does neuronal activity affect neuroligin-3?",
    "vicuna-7b_response": "Neuronal activity can affect neuroligin-3 in several ways.\nNeuroligin-3 is a postsynaptic protein that is involved in the formation and maintenance of synapses, the junctions between neurons. Neuronal activity can affect neuroligin-3 by regulating its expression and localization at synapses. For example, increased neuronal activity can lead to increased expression of neuroligin-3, which can promote the formation and maintenance of synapses. On the other hand, decreased neuronal activity can lead to decreased expression of neuroligin-3, which can reduce the number of synapses.\nIn addition, neuronal activity can affect neuroligin-3 by modulating its interactions with other synaptic proteins. For example, neuroligin-3 can interact with NMDA receptors, which are activated by neuronal activity, to regulate synaptic strength and plasticity. This interaction can be modulated by neuronal activity, which can affect the strength and duration of synaptic connections.\nOverall, neuronal activity plays a crucial role in regulating the expression, localization, and interactions of neuroligin-3 at synapses, which can affect synaptic strength and plasticity and ultimately influence neural circuit function.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neuroligin-3 is a postsynaptic protein that is involved in the formation and maintenance of synapses.\n2. Neuroligin-3's expression and localization at synapses can be regulated by neuronal activity.\n3. Increased neuronal activity can increase the expression of neuroligin-3 and promote the formation and maintenance of synapses.\n4. Decreased neuronal activity can decrease the expression of neuroligin-3, reducing the number of synapses.\n5. Neuroligin-3 can interact with NMDA receptors to regulate synaptic strength and plasticity, an interaction that can be modulated by neuronal activity.",
    "vicuna-7b_fact": [
      "Neuroligin-3 is a postsynaptic protein that is involved in the formation and maintenance of synapses.",
      "Neuroligin-3's expression and localization at synapses can be regulated by neuronal activity.",
      "Increased neuronal activity can increase the expression of neuroligin-3 and promote the formation and maintenance of synapses.",
      "Decreased neuronal activity can decrease the expression of neuroligin-3, reducing the number of synapses.",
      "Neuroligin-3 can interact with NMDA receptors to regulate synaptic strength and plasticity, an interaction that can be modulated by neuronal activity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2596,
    "user_query": "What is PARP inhibitor (PARPi) resistance?",
    "vicuna-7b_response": "PARP inhibitors (PARPis) are a class of drugs that target the poly(ADP-ribose) polymerase enzyme, which is involved in DNA repair. PARPis have shown promise in the treatment of various types of cancer, particularly ovarian and breast cancer. However, like any other cancer treatment, resistance to PARPis can develop.\nPARP inhibitor resistance refers to the ability of cancer cells to evade the effects of PARPis by developing mechanisms that bypass or overcome the drug's action. There are several mechanisms that have been identified as contributing to PARP inhibitor resistance, including:\n1. Altered DNA repair pathways: Cancer cells may develop mutations in DNA repair genes that allow them to bypass the effects of PARPis and repair damaged DNA.\n2. Reduced PARP expression: Some cancer cells may have reduced expression of the PARP enzyme, making them less sensitive to PARPis.\n3. Altered cellular metabolism: PARPis require a lot of energy to function, and some cancer cells may develop mechanisms to reduce their energy requirements, making them less susceptible to the drug.\n4. Development of cross-resistance: Cancer cells may develop resistance to PARPis by developing cross-resistance to other drugs that target similar mechanisms.\nUnderstanding the mechanisms of PARP inhibitor resistance is important for developing strategies to overcome it and improve the efficacy of PARPis as a cancer treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PARP inhibitors (PARPis) are a class of drugs that target the poly(ADP-ribose) polymerase enzyme involved in DNA repair.\n2. PARPis have shown promise in the treatment of various types of cancer, particularly ovarian and breast cancer.\n3. Resistance can develop to PARP inhibitors, which is referred to as PARP inhibitor resistance.\n4. Altered DNA repair pathways, reduced PARP enzyme expression, altered cellular metabolism, and development of cross-resistance are potential mechanisms for PARP inhibitor resistance.\n5. Understanding the mechanisms of PARP inhibitor resistance is important for developing strategies to overcome it and improve the efficacy of PARPis as a cancer treatment.",
    "vicuna-7b_fact": [
      "PARP inhibitors (PARPis) are a class of drugs that target the poly(ADP-ribose) polymerase enzyme involved in DNA repair.",
      "PARPis have shown promise in the treatment of various types of cancer, particularly ovarian and breast cancer.",
      "Resistance can develop to PARP inhibitors, which is referred to as PARP inhibitor resistance.",
      "Altered DNA repair pathways, reduced PARP enzyme expression, altered cellular metabolism, and development of cross-resistance are potential mechanisms for PARP inhibitor resistance.",
      "Understanding the mechanisms of PARP inhibitor resistance is important for developing strategies to overcome it and improve the efficacy of PARPis as a cancer treatment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2597,
    "user_query": "What is the association of the protein RAB10 and Alzheimers disease?",
    "vicuna-7b_response": "RAB10 is a protein that is involved in the transport of various substances within cells, including proteins and lipids. There is some evidence to suggest that alterations in the expression or function of RAB10 may be associated with the development of Alzheimer's disease.\nOne study published in the journal \"Neurobiology of Aging\" found that RAB10 was downregulated in the brains of individuals with Alzheimer's disease compared to healthy controls. Additionally, another study published in the journal \"Acta Neuropathologica\" found that alterations in the expression of RAB10 were associated with the development of Alzheimer's disease in a mouse model of the disease.\nHowever, it is important to note that more research is needed to fully understand the association between RAB10 and Alzheimer's disease. Additionally, it is also important to note that there are many other factors that can contribute to the development of Alzheimer's disease, and it is likely that RAB10 is just one of many players in this complex disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RAB10 is a protein that is involved in the transport of proteins and lipids within cells.\n2. There's evidence indicating that alterations in the expression or function of RAB10 may be associated with the development of Alzheimer's disease.\n3. A study published in the journal \"Neurobiology of Aging\" reported that RAB10 was downregulated in the brains of individuals with Alzheimer's disease compared to healthy controls.\n4. Another study in the journal \"Acta Neuropathologica\" found alterations in the expression of RAB10 associated with the development of Alzheimer's disease in a mouse model.\n5. Other factors besides RAB10 can contribute to the development of Alzheimer's disease.",
    "vicuna-7b_fact": [
      "RAB10 is a protein that is involved in the transport of proteins and lipids within cells.",
      "There's evidence indicating that alterations in the expression or function of RAB10 may be associated with the development of Alzheimer's disease.",
      "A study published in the journal \"Neurobiology of Aging\" reported that RAB10 was downregulated in the brains of individuals with Alzheimer's disease compared to healthy controls.",
      "Another study in the journal \"Acta Neuropathologica\" found alterations in the expression of RAB10 associated with the development of Alzheimer's disease in a mouse model.",
      "Other factors besides RAB10 can contribute to the development of Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2599,
    "user_query": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?",
    "vicuna-7b_response": "Yes, a bite from the Lone Star Tick, Amblyomma americanum, can cause a person to develop an allergy to red meat. The allergy is caused by a protein found in the tick's saliva, which can trigger an immune response in some people. This allergy is also known as alpha-gal syndrome, and it affects people who have been bitten by the tick and develop an allergy to a specific carbohydrate found in red meat, poultry, and other animal products.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A bite from the Lone Star Tick, Amblyomma americanum, can cause a person to develop an allergy to red meat.\n2. The allergy is caused by a protein found in the tick's saliva.\n3. This protein can trigger an immune response in some people.\n4. The allergy is also known as alpha-gal syndrome.\n5. Alpha-gal syndrome affects people who develop an allergy to a specific carbohydrate found in red meat, poultry, and other animal products.",
    "vicuna-7b_fact": [
      "A bite from the Lone Star Tick, Amblyomma americanum, can cause a person to develop an allergy to red meat.",
      "The allergy is caused by a protein found in the tick's saliva.",
      "This protein can trigger an immune response in some people.",
      "The allergy is also known as alpha-gal syndrome.",
      "Alpha-gal syndrome affects people who develop an allergy to a specific carbohydrate found in red meat, poultry, and other animal products."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Alpha-gal syndrome affects people who develop an allergy to a specific carbohydrate found in red meat, NOT poultry and other animal products.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2600,
    "user_query": "What are pQTLs?",
    "vicuna-7b_response": "pQTLs, or positional quantitative trait loci, refer to genetic variations that are associated with a specific trait or trait variation in a particular location on a chromosome. These variations can be either positive or negative and can affect the expression of a gene or the function of a gene product. pQTLs are often used in genetics research to identify the genetic basis of complex traits and to better understand the relationship between genetics and phenotype.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. pQTLs stand for positional quantitative trait loci.\n2. pQTLs are genetic variations that are associated with a specific trait or trait variation in a particular location on a chromosome.\n3. These variations can be either positive or negative.\n4. pQTLs can affect the expression of a gene or the function of a gene product.\n5. pQTLs are used in genetics research to identify the genetic basis of complex traits.",
    "vicuna-7b_fact": [
      "pQTLs stand for positional quantitative trait loci.",
      "pQTLs are genetic variations that are associated with a specific trait or trait variation in a particular location on a chromosome.",
      "These variations can be either positive or negative.",
      "pQTLs can affect the expression of a gene or the function of a gene product.",
      "pQTLs are used in genetics research to identify the genetic basis of complex traits."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2603,
    "user_query": "What is the \"protein inference problem\"?",
    "vicuna-7b_response": "The protein inference problem is a computational problem in bioinformatics that involves predicting the three-dimensional structure of a protein from its amino acid sequence. This problem is important because the three-dimensional structure of a protein is closely related to its function, and understanding the structure of a protein can help scientists design drugs that target specific proteins or develop vaccines against infectious diseases.\nThe protein inference problem is typically solved using computational methods such as homology modeling, ab initio protein structure prediction, and structure-based drug design. These methods involve using algorithms and computational models to simulate the behavior of proteins and predict their three-dimensional structures based on their amino acid sequences.\nDespite the advances in computational methods, the protein inference problem is still a challenging problem, and there is ongoing research to improve the accuracy and efficiency of these methods.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The protein inference problem is a computational problem in bioinformatics.\n2. The protein inference problem involves predicting the three-dimensional structure of a protein from its amino acid sequence.\n3. The three-dimensional structure of a protein is closely related to its function.\n4. The protein inference problem is typically solved using computational methods such as homology modeling, ab initio protein structure prediction, and structure-based drug design.\n5. There is ongoing research to improve the accuracy and efficiency of methods used to solve the protein inference problem.",
    "vicuna-7b_fact": [
      "The protein inference problem is a computational problem in bioinformatics.",
      "The protein inference problem involves predicting the three-dimensional structure of a protein from its amino acid sequence.",
      "The three-dimensional structure of a protein is closely related to its function.",
      "The protein inference problem is typically solved using computational methods such as homology modeling, ab initio protein structure prediction, and structure-based drug design.",
      "There is ongoing research to improve the accuracy and efficiency of methods used to solve the protein inference problem."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The protein inference problem involves predicting the existence of a protein based on peptide evidence, not predicting its three-dimensional structure.\n3. TRUE\n4. FALSE [correction]: The problem of predicting the three-dimensional structure of a protein from its amino acid sequence is typically solved using computational methods such as homology modeling, ab initio protein structure prediction, and structure-based drug design, not the protein inference problem.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2604,
    "user_query": "What is the link between lithium use during pregnancy and Ebstein anomaly?",
    "vicuna-7b_response": "Lithium is a medication that is commonly used to treat bipolar disorder. It is not known to cause Ebstein anomaly, which is a congenital heart defect that affects the tricuspid valve in the heart. There is no established link between lithium use during pregnancy and the development of Ebstein anomaly in the fetus.\nEbstein anomaly is a rare congenital heart defect that affects the tricuspid valve in the heart. The tricuspid valve is located between the right atrium and the right ventricle, and it plays a crucial role in ensuring that blood flows in the correct direction through the heart. In people with Ebstein anomaly, the tricuspid valve is malformed, which can lead to a range of complications, including heart failure, arrhythmias, and stroke.\nThere are a number of factors that can increase the risk of developing Ebstein anomaly, including genetics, environmental factors, and exposure to certain medications. However, there is no evidence to suggest that lithium use during pregnancy is one of these factors.\nIt is important to note that while lithium is not known to cause Ebstein anomaly, it is still a medication that should be used with caution during pregnancy. Women who are taking lithium and who are planning to become pregnant should discuss their options with their healthcare provider, who can help them determine the best course of action.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lithium is a medication that is commonly used to treat bipolar disorder.\n2. Ebstein anomaly is a congenital heart defect that affects the tricuspid valve in the heart.\n3. There is no established link between lithium use during pregnancy and the development of Ebstein anomaly in the fetus.\n4. Factors that can increase the risk of developing Ebstein anomaly include genetics, environmental factors, and exposure to certain medications.\n5. Lithium should be used with caution during pregnancy, according to health experts.",
    "vicuna-7b_fact": [
      "Lithium is a medication that is commonly used to treat bipolar disorder.",
      "Ebstein anomaly is a congenital heart defect that affects the tricuspid valve in the heart.",
      "There is no established link between lithium use during pregnancy and the development of Ebstein anomaly in the fetus.",
      "Factors that can increase the risk of developing Ebstein anomaly include genetics, environmental factors, and exposure to certain medications.",
      "Lithium should be used with caution during pregnancy, according to health experts."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Some studies suggest a potential link between lithium use during early pregnancy and an increased risk of Ebstein anomaly in the fetus.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2605,
    "user_query": "Does verubecestat activate BACE?",
    "vicuna-7b_response": "Verubecestat is a medication that is being studied for its potential to treat Alzheimer's disease. It is a BACE inhibitor, which means that it works by blocking an enzyme called Beta-Amyloid Cleaving Enzyme (BACE). BACE is one of the enzymes that is involved in the production of beta-amyloid, a protein that is thought to play a role in the development of Alzheimer's disease. By blocking BACE, verubecestat may help to reduce the production of beta-amyloid and potentially slow the progression of the disease. However, it is important to note that verubecestat is still in the early stages of development and more research is needed to fully understand its potential effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Verubecestat is currently being studied for its potential to treat Alzheimer's disease.\n2. Verubecestat is a BACE inhibitor.\n3. BACE refers to Beta-Amyloid Cleaving Enzyme.\n4. Beta-amyloid protein is thought to play a role in the development of Alzheimer's disease.\n5. Verubecestat aims to reduce the production of beta-amyloid by blocking BACE.",
    "vicuna-7b_fact": [
      "Verubecestat is currently being studied for its potential to treat Alzheimer's disease.",
      "Verubecestat is a BACE inhibitor.",
      "BACE refers to Beta-Amyloid Cleaving Enzyme.",
      "Beta-amyloid protein is thought to play a role in the development of Alzheimer's disease.",
      "Verubecestat aims to reduce the production of beta-amyloid by blocking BACE."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2607,
    "user_query": "What is emicizumab?",
    "vicuna-7b_response": "Emicizumab is a medication that is used to treat people with a rare genetic disorder called hemophilia A. Hemophilia A is a genetic disorder in which the blood does not clot properly, leading to excessive bleeding. Emicizumab is a medication that is given as an injection and works by preventing the blood from clotting too quickly. This helps to reduce the frequency and severity of bleeding episodes in people with hemophilia A. Emicizumab is marketed under the brand name Hemlibra and is approved for use in over 50 countries worldwide.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Emicizumab is a medication used to treat hemophilia A.\n2. Hemophilia A is a genetic disorder in which the blood does not clot properly.\n3. Emicizumab is given as an injection.\n4. Emicizumab works by preventing the blood from clotting too quickly.\n5. Emicizumab is marketed under the brand name Hemlibra and is approved for use in over 50 countries worldwide.",
    "vicuna-7b_fact": [
      "Emicizumab is a medication used to treat hemophilia A.",
      "Hemophilia A is a genetic disorder in which the blood does not clot properly.",
      "Emicizumab is given as an injection.",
      "Emicizumab works by preventing the blood from clotting too quickly.",
      "Emicizumab is marketed under the brand name Hemlibra and is approved for use in over 50 countries worldwide."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Emicizumab works by restoring the clotting process to a level that is closer to that seen in individuals without hemophilia, not by preventing the blood from clotting too quickly.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2608,
    "user_query": "What illness is transmitted by the Lone Star Tick, Amblyomma americanum?",
    "vicuna-7b_response": "The Lone Star Tick, Amblyomma americanum, is known to transmit several types of illnesses to humans and animals. One of the most notable illnesses transmitted by the Lone Star Tick is Ehrlichiosis.\nEhrlichiosis is a bacterial infection caused by the bacterium Ehrlichia chaffeensis. It is transmitted to humans through the bite of the Lone Star Tick, and can cause fever, headache, muscle aches, and other flu-like symptoms. If left untreated, Ehrlichiosis can lead to more severe complications such as meningitis, encephalitis, and heart problems.\nAnother illness transmitted by the Lone Star Tick is Tularemia. Tularemia is a bacterial infection caused by the bacterium Francisella tularensis. It is transmitted to humans and animals through the bite of the Lone Star Tick, and can cause fever, swelling, and ulcers at the site of the bite. Tularemia can also affect the lungs, skin, and other organs, and can be fatal if left untreated.\nIn addition to Ehrlichiosis and Tularemia, the Lone Star Tick can also transmit other types of illnesses such as Rocky Mountain Spotted Fever, which is caused by the bacterium Rickettsia rickettsii, and is transmitted through the bite of the American Dog Tick.\nIt's important to note that not all tick bites result in illness, and the severity of the illness can vary depending on the individual and the type of tick. It's also important to seek medical attention if you suspect a tick-borne illness, as early diagnosis and treatment can help prevent severe complications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Lone Star Tick, Amblyomma americanum, is known to transmit several types of illnesses to humans and animals.\n2. The Lone Star Tick can transmit an illness called Ehrlichiosis, which is a bacterial infection caused by the bacterium Ehrlichia chaffeensis.\n3. If left untreated, Ehrlichiosis can lead to more severe complications such as meningitis, encephalitis, and heart problems.\n4. Tularemia, a bacterial infection caused by the bacterium Francisella tularensis, is another illness that can be transmitted by the Lone Star Tick.\n5. In addition to Ehrlichiosis and Tularemia, the Lone Star Tick can also transmit Rocky Mountain Spotted Fever, caused by the bacterium Rickettsia rickettsii.",
    "vicuna-7b_fact": [
      "The Lone Star Tick, Amblyomma americanum, is known to transmit several types of illnesses to humans and animals.",
      "The Lone Star Tick can transmit an illness called Ehrlichiosis, which is a bacterial infection caused by the bacterium Ehrlichia chaffeensis.",
      "If left untreated, Ehrlichiosis can lead to more severe complications such as meningitis, encephalitis, and heart problems.",
      "Tularemia, a bacterial infection caused by the bacterium Francisella tularensis, is another illness that can be transmitted by the Lone Star Tick.",
      "In addition to Ehrlichiosis and Tularemia, the Lone Star Tick can also transmit Rocky Mountain Spotted Fever, caused by the bacterium Rickettsia rickettsii."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-7b_response": "One algorithm that has been developed for prediction of protein subcellular localization using deep learning is called DeepLoc.\nDeepLoc is a deep learning-based method that uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict the subcellular localization of proteins. The method was developed by researchers from the University of California, San Francisco (UCSF) and was published in the journal Nature Biotechnology in 2018.\nDeepLoc uses a large dataset of protein sequences and their corresponding subcellular localization information to train its deep learning models. The models are trained to predict the subcellular localization of proteins based on their amino acid sequences, using features such as the presence of certain amino acids, the presence of certain motifs, and the presence of certain patterns of amino acids.\nDeepLoc has been shown to be highly accurate in predicting the subcellular localization of proteins, with an accuracy of over 90%. This makes it a valuable tool for researchers who are studying the subcellular localization of proteins, and for those who are developing new drugs or other therapeutics that target specific subcellular locations.\nOverall, DeepLoc is a powerful algorithm that has the potential to revolutionize the field of protein subcellular localization prediction, and it is likely to be widely used in the future for a variety of applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DeepLoc is an algorithm developed for prediction of protein subcellular localization using deep learning.\n2. DeepLoc uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs).\n3. The method was developed by researchers from the University of California, San Francisco (UCSF).\n4. DeepLoc was published in the journal Nature Biotechnology in 2018.\n5. DeepLoc has been shown to have an accuracy of over 90% in predicting the subcellular localization of proteins.",
    "vicuna-7b_fact": [
      "DeepLoc is an algorithm developed for prediction of protein subcellular localization using deep learning.",
      "DeepLoc uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs).",
      "The method was developed by researchers from the University of California, San Francisco (UCSF).",
      "DeepLoc was published in the journal Nature Biotechnology in 2018.",
      "DeepLoc has been shown to have an accuracy of over 90% in predicting the subcellular localization of proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2614,
    "user_query": "What is included in the Mentzer index?",
    "vicuna-7b_response": "The Mentzer index is a comprehensive index that provides access to the various topics and concepts discussed in the book \"The Strategic Deployment of Financial Resources\" by John Mentzer. The index is organized in a hierarchical manner, with main topics and subtopics listed underneath them.\nThe main topics covered in the Mentzer index include:\n* Financial management\n* Financial planning\n* Budgeting\n* Cost analysis\n* Funding\n* Capital budgeting\n* Capital structure\n* Financial forecasting\n* Risk management\n* Performance measurement\n* Decision making\nUnder each main topic, there are several subtopics that provide more detailed information on specific aspects of the topic. For example, under the main topic of \"Financial management,\" the subtopics include \"Financial management principles,\" \"Financial management practices,\" and \"Financial management tools.\"\nThe Mentzer index also includes a list of acronyms and abbreviations used in the book, which can be helpful for readers who are unfamiliar with certain terms or concepts.\nOverall, the Mentzer index is a valuable resource for readers of \"The Strategic Deployment of Financial Resources\" who are looking for a comprehensive guide to the various topics and concepts covered in the book.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Mentzer index is a comprehensive index for the book \"The Strategic Deployment of Financial Resources\" by John Mentzer.\n2. The Mentzer index is organized in a hierarchical manner.\n3. The main topics covered in the Mentzer index include financial management, financial planning, budgeting, cost analysis, funding, capital budgeting, capital structure, financial forecasting, risk management, performance measurement, and decision making.\n4. Each main topic in the Mentzer index includes several more detailed subtopics.\n5. The Mentzer index includes a list of acronyms and abbreviations used in the book.",
    "vicuna-7b_fact": [
      "The Mentzer index is a comprehensive index for the book \"The Strategic Deployment of Financial Resources\" by John Mentzer.",
      "The Mentzer index is organized in a hierarchical manner.",
      "The main topics covered in the Mentzer index include financial management, financial planning, budgeting, cost analysis, funding, capital budgeting, capital structure, financial forecasting, risk management, performance measurement, and decision making.",
      "Each main topic in the Mentzer index includes several more detailed subtopics.",
      "The Mentzer index includes a list of acronyms and abbreviations used in the book."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2615,
    "user_query": "Which disease is treated with Fexinidazole?",
    "vicuna-7b_response": "Fexinidazole is a medication that is used to treat a parasitic infection called trichomoniasis. Trichomoniasis is a sexually transmitted infection that is caused by the parasite Trichomonas vaginalis. It is estimated that over 180 million people worldwide are infected with trichomoniasis, and it is the most common curable sexually transmitted infection. Fexinidazole is the first oral treatment for trichomoniasis that has been proven to be effective in clinical trials. It works by targeting the parasite's metabolism and causing it to die off. Fexinidazole is generally well-tolerated, but it can cause nausea, vomiting, and diarrhea in some people.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fexinidazole is used to treat a parasitic infection called trichomoniasis.\n2. Trichomoniasis is a sexually transmitted infection.\n3. The infection is caused by the parasite Trichomonas vaginalis. \n4. Fexinidazole was the first oral treatment for trichomoniasis proven to be effective in clinical trials.\n5. Some side effects of Fexinidazole include nausea, vomiting, and diarrhea.",
    "vicuna-7b_fact": [
      "Fexinidazole is used to treat a parasitic infection called trichomoniasis.",
      "Trichomoniasis is a sexually transmitted infection.",
      "The infection is caused by the parasite Trichomonas vaginalis.",
      "Fexinidazole was the first oral treatment for trichomoniasis proven to be effective in clinical trials.",
      "Some side effects of Fexinidazole include nausea, vomiting, and diarrhea."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Fexinidazole is used to treat African trypanosomiasis (sleeping sickness), not trichomoniasis.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Fexinidazole wasn't the first oral treatment proven to be effective for trichomoniasis. Metronidazole and tinidazole are examples of oral treatments that have been used for trichomoniasis. Fexinidazole is the first oral treatment for sleeping sickness that doesn't require a hospitalization.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2620,
    "user_query": "Is DNA polymerase θ involved in DNA repair?",
    "vicuna-7b_response": "Yes, DNA polymerase θ is involved in DNA repair.\nDNA polymerase θ is a specialized DNA polymerase that is primarily responsible for the synthesis of the leading strand of DNA during replication. However, it also has a role in DNA repair.\nDNA polymerase θ can synthesize DNA strands using a template that is complementary to the damaged strand. This process is called template-directed synthesis, and it is an important mechanism for repairing DNA damage.\nIn addition to template-directed synthesis, DNA polymerase θ can also perform error-prone repair synthesis. This means that it can synthesize DNA strands using a template that is not complementary to the damaged strand. This process can result in the incorporation of incorrect nucleotides, which can lead to the formation of mutations.\nOverall, DNA polymerase θ plays an important role in the repair of DNA damage, and its activity is tightly regulated to ensure that the repair process is accurate and efficient.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNA polymerase θ is involved in DNA repair.\n2. DNA polymerase θ is primarily responsible for the synthesis of the leading strand of DNA during replication.\n3. The process where DNA polymerase θ synthesizes DNA strands using a template that is complementary to the damaged strand is called template-directed synthesis. \n4. DNA polymerase θ can perform error-prone repair synthesis, which could lead to the incorporation of incorrect nucleotides and result in mutations.\n5. The activity of DNA polymerase θ is tightly regulated to ensure the accuracy and efficiency of the DNA repair process.",
    "vicuna-7b_fact": [
      "DNA polymerase θ is involved in DNA repair.",
      "DNA polymerase θ is primarily responsible for the synthesis of the leading strand of DNA during replication.",
      "The process where DNA polymerase θ synthesizes DNA strands using a template that is complementary to the damaged strand is called template-directed synthesis.",
      "DNA polymerase θ can perform error-prone repair synthesis, which could lead to the incorporation of incorrect nucleotides and result in mutations.",
      "The activity of DNA polymerase θ is tightly regulated to ensure the accuracy and efficiency of the DNA repair process."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: DNA polymerase δ and ε are primarily responsible for the synthesis of the leading strand of DNA during replication, not DNA polymerase θ.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2623,
    "user_query": "Which algorithms are used for compression of SAM files?",
    "vicuna-7b_response": "SAM (Single-nucleotide polymorphism) files are commonly used in genetics and genomics research to store and manage data on genetic variations between individuals. There are several algorithms that can be used for compression of SAM files.\nOne common algorithm for compressing SAM files is the Burrows-Wheeler Transform (BWT). The BWT is a reversible transformation that rearranges the characters in a string in such a way that similar characters are grouped together, making it easier to compress.\nAnother algorithm that can be used for compressing SAM files is the Gzip algorithm. Gzip is a popular compression algorithm that uses a combination of Huffman coding and Lempel-Ziv-Welch (LZW) algorithm to compress the data.\nAdditionally, there are specialized compression algorithms that are designed specifically for compressing SAM files, such as SAMtools' SamtoolsCompress and BWA's bwaCompress. These algorithms take advantage of the specific characteristics of SAM files and can achieve better compression ratios than general-purpose compression algorithms.\nIn summary, SAM files can be compressed using several algorithms, including the BWT, Gzip, and specialized algorithms such as SamtoolsCompress and bwaCompress. The choice of algorithm will depend on the specific requirements of the application and the desired compression ratio.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAM (Single-nucleotide polymorphism) files are used in genetics and genomics research.\n2. One algorithm for compressing SAM files is the Burrows-Wheeler Transform (BWT).\n3. BWT is a reversible transformation that groups similar characters together.\n4. Another compression algorithm that can be used for SAM files is the Gzip algorithm.\n5. Specialized algorithms, such as SamtoolsCompress and bwaCompress, are designed specifically for compressing SAM files.",
    "vicuna-7b_fact": [
      "SAM (Single-nucleotide polymorphism) files are used in genetics and genomics research.",
      "One algorithm for compressing SAM files is the Burrows-Wheeler Transform (BWT).",
      "BWT is a reversible transformation that groups similar characters together.",
      "Another compression algorithm that can be used for SAM files is the Gzip algorithm.",
      "Specialized algorithms, such as SamtoolsCompress and bwaCompress, are designed specifically for compressing SAM files."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: As of the data available now, there are no specific algorithms called SamtoolsCompress and bwaCompress designed for compressing SAM files. But tools like SAMtools can handle SAM files, and BWA is a software package for mapping low-divergent sequences against a large reference genome, not specifically for compression.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2629,
    "user_query": "What drug cures hepatitis C?",
    "vicuna-7b_response": "Hepatitis C is a viral infection that affects the liver. There are several drugs that can cure hepatitis C, but the most effective treatment options vary depending on the genotype of the virus and other individual factors.\nThe most common treatment for hepatitis C is a combination of medications called direct-acting antivirals (DAAs). These drugs target specific proteins in the hepatitis C virus and inhibit its replication. There are several types of DAAs, and the most effective treatment regimen will depend on the genotype of the virus and other individual factors.\nThe most common genotypes of hepatitis C are genotypes 1, 2, and 3. Genotype 1 is the most difficult to treat, and a combination of DAAs is usually required to cure it. Genotype 2 and 3 can often be cured with a shorter course of treatment, usually 8-12 weeks.\nIn addition to DAAs, other treatments for hepatitis C include interferon and ribavirin, which are older drugs that can be used in combination with DAAs.\nIt's important to note that not all treatments are suitable for everyone, and the best treatment option will depend on the individual case. It's important to consult with a healthcare professional to determine the most appropriate treatment for hepatitis C.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hepatitis C is a viral infection that affects the liver.\n2. The most common treatment for hepatitis C is a combination of medications called direct-acting antivirals (DAAs).\n3. DAAs inhibit the replication of the hepatitis C virus by targeting specific proteins.\n4. The most common genotypes of hepatitis C are genotypes 1, 2, and 3.\n5. Genotype 1 of hepatitis C is the most difficult to treat and usually requires a combination of DAAs.",
    "vicuna-7b_fact": [
      "Hepatitis C is a viral infection that affects the liver.",
      "The most common treatment for hepatitis C is a combination of medications called direct-acting antivirals (DAAs).",
      "DAAs inhibit the replication of the hepatitis C virus by targeting specific proteins.",
      "The most common genotypes of hepatitis C are genotypes 1, 2, and 3.",
      "Genotype 1 of hepatitis C is the most difficult to treat and usually requires a combination of DAAs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: All types of hepatitis C, including genotype 1, can be effectively treated with direct-acting antivirals (DAAs). Treatment efficacy and duration may vary based on the specifics of the infection, but genotype 1 is not inherently the most difficult to treat.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2632,
    "user_query": "What can be predicted with the Wells criteria?",
    "vicuna-7b_response": "The Wells criteria is a set of diagnostic criteria used to diagnose a condition known as interstitial cystitis (IC). IC is a chronic bladder condition characterized by symptoms such as pain, pressure, and discomfort in the bladder and pelvic area. The Wells criteria are used to diagnose IC based on a patient's symptoms, urine test results, and other factors.\nThe Wells criteria include the following:\n1. Pain: Persistent bladder pain or discomfort that is present for at least 6 weeks.\n2. Inflammation: Abnormal findings on urine or bladder examination, such as red blood cells, white blood cells, or high levels of nitrite.\n3. Pressure: A sensation of increased pressure in the pelvic area or lower abdomen.\n4. Frequency: A need to urinate more often than usual, usually more than 8 times in 24 hours.\n5. Nocturia: Waking up at night to urinate more than once.\n6. Urgency: A strong, sudden need to urinate that cannot be delayed.\n7. Dyspareunia: Pain during sexual intercourse.\nThe Wells criteria are not a definitive diagnostic test for IC, but they are used to help diagnose the condition and rule out other possible causes of bladder symptoms. A healthcare professional will use the patient's symptoms, urine test results, and other factors to determine if the patient meets the criteria for IC.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Wells criteria is a set of diagnostic criteria used for diagnosing interstitial cystitis.\n2. Interstitial cystitis is a chronic bladder condition characterized by symptoms like pain, pressure, and discomfort in the bladder and pelvic area.\n3. The Wells criteria are used based on patient's symptoms, urine test results, and other factors.\n4. A symptom of IC, according to the Wells criteria, is the persistent bladder pain or discomfort for at least 6 weeks.\n5. The Wells criteria is not a definitive diagnostic test, but it helps to diagnose the condition and rule out other possibilities.",
    "vicuna-7b_fact": [
      "The Wells criteria is a set of diagnostic criteria used for diagnosing interstitial cystitis.",
      "Interstitial cystitis is a chronic bladder condition characterized by symptoms like pain, pressure, and discomfort in the bladder and pelvic area.",
      "The Wells criteria are used based on patient's symptoms, urine test results, and other factors.",
      "A symptom of IC, according to the Wells criteria, is the persistent bladder pain or discomfort for at least 6 weeks.",
      "The Wells criteria is not a definitive diagnostic test, but it helps to diagnose the condition and rule out other possibilities."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Wells criteria is a set of diagnostic criteria used for diagnosing deep vein thrombosis.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-7b_response": "MULTOVL is a cryptocurrency that is built on the MULTOS platform. MULTOS is a multi-application operating system for smart cards, which is designed to provide secure storage for a wide range of applications. MULTOVL is a cryptocurrency that runs on the MULTOS platform, allowing for the secure storage and transfer of MULTOVL tokens.\nMULTOVL is a decentralized cryptocurrency, meaning that it is not controlled by any central authority or institution. Instead, it is governed by a decentralized network of nodes that verify and record transactions on the blockchain. This makes MULTOVL resistant to censorship and manipulation, as there is no single point of control that can be seized or manipulated by a malicious actor.\nMULTOVL uses a proof-of-stake consensus algorithm, which is a type of consensus algorithm that is based on the amount of cryptocurrency that a user holds, rather than their ability to perform computational tasks. This makes MULTOVL more energy-efficient than proof-of-work algorithms, as it does not require the intense computational effort that proof-of-work algorithms do.\nMULTOVL tokens are issued on the MULTOS platform, and can be used to facilitate transactions on the MULTOVL blockchain. Users can send and receive MULTOVL tokens to one another, and can use them to purchase goods and services from merchants that accept MULTOVL.\nIn summary, MULTOVL is a cryptocurrency that is built on the MULTOS platform, allowing for the secure storage and transfer of MULTOVL tokens. It is a decentralized cryptocurrency that is governed by a decentralized network of nodes, and uses a proof-of-stake consensus algorithm to facilitate transactions on the blockchain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MULTOVL is a cryptocurrency that is built on the MULTOS platform.\n2. MULTOVL is a decentralized cryptocurrency, not controlled by any central authority or institution.\n3. MULTOVL utilizes a proof-of-stake consensus algorithm.\n4. MULTOVL tokens are issued on the MULTOS platform and can be used in transactions on the MULTOVL blockchain.\n5. MULTOS is a multi-application operating system for smart cards, providing secure storage for a range of applications.",
    "vicuna-7b_fact": [
      "MULTOVL is a cryptocurrency that is built on the MULTOS platform.",
      "MULTOVL is a decentralized cryptocurrency, not controlled by any central authority or institution.",
      "MULTOVL utilizes a proof-of-stake consensus algorithm.",
      "MULTOVL tokens are issued on the MULTOS platform and can be used in transactions on the MULTOVL blockchain.",
      "MULTOS is a multi-application operating system for smart cards, providing secure storage for a range of applications."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2643,
    "user_query": "What is the alternative lengthening of telomeres?",
    "vicuna-7b_response": "Alternative lengthening of telomeres (ALT) is a rare genetic disorder characterized by the abnormal elongation of telomeres, which are the protective caps on the ends of chromosomes. Telomeres normally shorten with each cell division, but in people with ALT, the telomeres can become elongated, leading to chromosomal abnormalities and an increased risk of cancer.\nALT is caused by mutations in the telomerase gene, which encodes an enzyme that plays a crucial role in maintaining telomere length. The mutations that cause ALT result in the production of a non-functional telomerase enzyme, which is unable to elongate telomeres properly.\nPeople with ALT typically develop cancer at an early age, often in their teens or twenties. The cancer that develops in people with ALT is often aggressive and difficult to treat, and can affect any part of the body.\nThere is no cure for ALT, and treatment is focused on managing the symptoms and preventing complications. This may include surgery, chemotherapy, and radiation therapy, as well as supportive care to manage symptoms such as pain and fatigue.\nIn summary, alternative lengthening of telomeres (ALT) is a rare genetic disorder characterized by the abnormal elongation of telomeres, which can lead to chromosomal abnormalities and an increased risk of cancer. People with ALT typically develop cancer at an early age, and there is no cure for the disorder. Treatment is focused on managing symptoms and preventing complications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alternative lengthening of telomeres (ALT) is a rare genetic disorder characterized by the abnormal elongation of telomeres.\n2. Telomeres in people with ALT can become elongated, leading to chromosomal abnormalities and an increased risk of cancer.\n3. ALT is caused by mutations in the telomerase gene, which ENCODES an enzyme that plays a crucial role in maintaining telomere length.\n4. People with ALT typically develop cancer at an early age, often in their teens or twenties.\n5. There is no cure for ALT, and treatment is focused on managing the symptoms and preventing complications.",
    "vicuna-7b_fact": [
      "Alternative lengthening of telomeres (ALT) is a rare genetic disorder characterized by the abnormal elongation of telomeres.",
      "Telomeres in people with ALT can become elongated, leading to chromosomal abnormalities and an increased risk of cancer.",
      "ALT is caused by mutations in the telomerase gene, which ENCODES an enzyme that plays a crucial role in maintaining telomere length.",
      "People with ALT typically develop cancer at an early age, often in their teens or twenties.",
      "There is no cure for ALT, and treatment is focused on managing the symptoms and preventing complications."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Alternative lengthening of telomeres (ALT) is not a genetic disorder. It is a mechanism in which certain cells, including some cancer cells, can extend their telomeres independent of the enzyme telomerase.\n2. TRUE\n3. FALSE [correction]: ALT is not caused by mutations in the telomerase gene. It is a mechanism independent of telomerase used by some cells to extend their telomeres.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2646,
    "user_query": "What is break induced replication?",
    "vicuna-7b_response": "Break-induced replication (BIR) is a mechanism used by some bacteria to replicate their DNA when they encounter a break in their chromosome. BIR allows bacteria to continue replicating their genome even when they encounter obstacles or damage to their DNA.\nBIR occurs when a bacterium encounters a break in its chromosome and replicates the broken ends of the DNA. This process is different from the standard replication process, which involves replicating the entire chromosome in one piece.\nBIR is a mechanism that allows bacteria to continue replicating their genome even when they encounter obstacles or damage to their DNA. This is important for bacteria that are exposed to stressful conditions, such as high temperatures or radiation, which can cause breaks in their DNA.\nBIR is a complex process that involves the use of specialized enzymes and proteins. The mechanism of BIR is still not fully understood, but it is thought to involve the use of specialized enzymes, such as helicases and primases, to unwind and replicate the broken ends of the DNA.\nOverall, break-induced replication is an important mechanism that allows bacteria to continue replicating their genome even when they encounter obstacles or damage to their DNA. This mechanism is essential for the survival and replication of bacteria in a wide range of environments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Break-induced replication (BIR) is a mechanism used by some bacteria to replicate their DNA when they encounter a break in their chromosome.\n2. BIR allows bacteria to continue replicating their genome even when they encounter obstacles or damage to their DNA.\n3. Break-induced replication involves replicating the broken ends of the DNA in the bacterial chromosome.\n4. BIR is a complex process that involves the use of specialized enzymes and proteins, such as helicases and primases.\n5. Break-induced replication is essential for the survival and replication of bacteria in a wide range of environments.",
    "vicuna-7b_fact": [
      "Break-induced replication (BIR) is a mechanism used by some bacteria to replicate their DNA when they encounter a break in their chromosome.",
      "BIR allows bacteria to continue replicating their genome even when they encounter obstacles or damage to their DNA.",
      "Break-induced replication involves replicating the broken ends of the DNA in the bacterial chromosome.",
      "BIR is a complex process that involves the use of specialized enzymes and proteins, such as helicases and primases.",
      "Break-induced replication is essential for the survival and replication of bacteria in a wide range of environments."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2653,
    "user_query": "Which is the enzymatic activity of nardilysin?",
    "vicuna-7b_response": "Nardilysin is an enzyme that is primarily found in the brain and is involved in the breakdown of the neurotransmitter dopamine. The enzymatic activity of nardilysin is the rate at which it catalyzes the hydrolysis of dopamine.\nNardilysin is a serine protease, which means that it uses the serine amino acid residue in its active site to catalyze the hydrolysis of peptide bonds in proteins and peptides. The enzymatic activity of nardilysin is regulated by a number of factors, including pH, temperature, and the presence of inhibitors.\nThe enzymatic activity of nardilysin is important for maintaining proper levels of dopamine in the brain, as it helps to regulate dopamine release and reuptake. Dysregulation of nardilysin activity has been implicated in a number of neurological disorders, including Parkinson's disease and schizophrenia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nardilysin is an enzyme that is primarily found in the brain.\n2. Nardilysin is involved in the breakdown of the neurotransmitter dopamine.\n3. Nardilysin is a serine protease.\n4. The enzymatic activity of nardilysin is regulated by factors such as pH, temperature, and the presence of inhibitors.\n5. Dysregulation of nardilysin activity has been implicated in neurological disorders, including Parkinson's disease and schizophrenia.",
    "vicuna-7b_fact": [
      "Nardilysin is an enzyme that is primarily found in the brain.",
      "Nardilysin is involved in the breakdown of the neurotransmitter dopamine.",
      "Nardilysin is a serine protease.",
      "The enzymatic activity of nardilysin is regulated by factors such as pH, temperature, and the presence of inhibitors.",
      "Dysregulation of nardilysin activity has been implicated in neurological disorders, including Parkinson's disease and schizophrenia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: Nardilysin is a metalloprotease, not a serine protease.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2657,
    "user_query": "Are AAV vectors considered for the treatment of retinal dystrophies?",
    "vicuna-7b_response": "Yes, AAV (adeno-associated virus) vectors are considered for the treatment of retinal dystrophies. AAV vectors are a type of gene therapy that can be used to deliver healthy copies of a gene to cells in the body, including cells in the retina.\nRetinal dystrophies are a group of inherited eye disorders that cause progressive vision loss. They are caused by mutations in genes that are important for the function of retinal cells. AAV vectors can be used to deliver healthy copies of these genes to retinal cells, which can help to restore the function of these cells and improve vision.\nThere have been several clinical trials using AAV vectors for the treatment of retinal dystrophies, and some of these trials have shown promising results. For example, a clinical trial using an AAV vector to deliver a healthy copy of the RPE65 gene to patients with a specific type of retinal dystrophy showed improved vision in some patients.\nIt's important to note that not all retinal dystrophies can be treated with AAV vectors, and the effectiveness of AAV vector therapy can vary depending on the specific type of dystrophy and the underlying genetic cause. However, AAV vectors are a promising approach for the treatment of some retinal dystrophies, and further research is needed to fully understand their potential.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. AAV (adeno-associated virus) vectors are considered for the treatment of retinal dystrophies.\n2. Retinal dystrophies are a group of inherited eye disorders that cause progressive vision loss.\n3. AAV vectors can deliver healthy copies of genes to retinal cells.\n4. There have been several clinical trials using AAV vectors for the treatment of retinal dystrophies.\n5. A clinical trial using an AAV vector to deliver a healthy copy of the RPE65 gene to patients with a specific type of retinal dystrophy showed improved vision in some patients.",
    "vicuna-7b_fact": [
      "AAV (adeno-associated virus) vectors are considered for the treatment of retinal dystrophies.",
      "Retinal dystrophies are a group of inherited eye disorders that cause progressive vision loss.",
      "AAV vectors can deliver healthy copies of genes to retinal cells.",
      "There have been several clinical trials using AAV vectors for the treatment of retinal dystrophies.",
      "A clinical trial using an AAV vector to deliver a healthy copy of the RPE65 gene to patients with a specific type of retinal dystrophy showed improved vision in some patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-7b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes. Metformin is a medication that is commonly used to treat type 2 diabetes, and some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.\nHowever, the relationship between metformin treatment and GDF15 levels is not straightforward, and more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. Some studies have found that metformin treatment is associated with decreased levels of GDF15 in patients with type 2 diabetes, while others have found no association or have reported conflicting results.\nIt is also important to note that GDF15 is a complex and multifaceted protein with many potential functions, and its role in metformin treatment may depend on various factors, such as the individual's underlying health status, the dose and duration of metformin treatment, and other medications or lifestyle factors that may affect GDF15 levels.\nIn summary, while GDF15 has been studied as a potential biomarker for metformin treatment, the relationship between the two is not yet fully understood, and more research is needed to clarify their relationship.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions.\n2. Metformin is a medication that is commonly used to treat type 2 diabetes.\n3. Some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.\n4. Some studies have found that metformin treatment is associated with decreased levels of GDF15 in patients with type 2 diabetes.\n5. The relationship between metformin treatment and GDF15 levels is not fully understood and is the subject of ongoing research.",
    "vicuna-7b_fact": [
      "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions.",
      "Metformin is a medication that is commonly used to treat type 2 diabetes.",
      "Some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.",
      "Some studies have found that metformin treatment is associated with decreased levels of GDF15 in patients with type 2 diabetes.",
      "The relationship between metformin treatment and GDF15 levels is not fully understood and is the subject of ongoing research."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Some studies have suggested that metformin may have anti-cancer effects, but not by reducing the levels of GDF15 in the body.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2662,
    "user_query": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
    "vicuna-7b_response": "Yes, oncogene-induced DNA replication stress can inhibit genomic instability.\nDNA replication stress occurs when the replication machinery encounters obstacles that hinder the normal progression of DNA replication. This can be caused by oncogenes, which are genes that promote cell growth and division, but can also cause genomic instability.\nOncogenes can cause DNA replication stress by interfering with the normal progression of DNA replication, leading to the formation of replication fork blocks. These blocks can cause the accumulation of DNA damage, which can lead to genomic instability.\nHowever, it is important to note that not all oncogenes cause DNA replication stress, and not all DNA replication stress leads to genomic instability. The extent to which oncogene-induced DNA replication stress inhibits genomic instability depends on various factors, including the specific oncogene, the cell type, and the presence of other genetic and environmental factors.\nIn summary, oncogene-induced DNA replication stress can inhibit genomic instability by causing DNA damage and preventing the normal progression of DNA replication. However, the extent to which this occurs depends on various factors and may not always result in genomic instability.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Oncogene-induced DNA replication stress can inhibit genomic instability.\n2. DNA replication stress occurs when the replication machinery encounters obstacles that hinder the normal progression of DNA replication.\n3. Oncogenes can cause DNA replication stress by interfering with the normal progression of DNA replication.\n4. Oncogenes can lead to the formation of replication fork blocks, which can cause DNA damage and potentially lead to genomic instability. \n5. The extent to which oncogene-induced DNA replication stress inhibits genomic instability depends on the specific oncogene, the cell type, and the presence of other genetic and environmental factors.",
    "vicuna-7b_fact": [
      "Oncogene-induced DNA replication stress can inhibit genomic instability.",
      "DNA replication stress occurs when the replication machinery encounters obstacles that hinder the normal progression of DNA replication.",
      "Oncogenes can cause DNA replication stress by interfering with the normal progression of DNA replication.",
      "Oncogenes can lead to the formation of replication fork blocks, which can cause DNA damage and potentially lead to genomic instability.",
      "The extent to which oncogene-induced DNA replication stress inhibits genomic instability depends on the specific oncogene, the cell type, and the presence of other genetic and environmental factors."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Oncogene-induced DNA replication stress can promote genomic instability.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-7b_response": "Recursive splicing is a process in which a small RNA molecule called a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and then recruits other proteins to cleave the mRNA into smaller pieces, leading to the degradation of the target gene. Recursive splicing can occur in both short and long introns.\nIntrons are the non-coding regions of the genome that are present between the exons, which are the coding regions. Introns can be either short or long. Short introns are those that are less than 1 kilobase (kb) in length, while long introns are those that are greater than 1 kb in length.\nRecursive splicing can occur in both short and long introns. In the case of short introns, recursive splicing can be more common because the small size of these introns makes them more accessible to the miRNA molecule. This is because the small size of the intron means that the miRNA molecule can bind to the intron more easily, leading to a higher probability of recursive splicing occurring.\nIn contrast, long introns are less accessible to the miRNA molecule because they are larger and more difficult to bind to. This means that recursive splicing is less likely to occur in long introns. However, it is important to note that the likelihood of recursive splicing occurring in a particular intron depends on a variety of factors, including the specific miRNA molecule involved, the target gene, and the cellular context in which the process is occurring.\nIn summary, recursive splicing can occur in both short and long introns, but it is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Recursive splicing involves a microRNA (miRNA) binding to the messenger RNA (mRNA) of a target gene which leads to the degradation of the target gene. \n2. Recursive splicing can occur in both short and long introns.\n3. Introns are the non-coding regions of the genome that are present between the exons.\n4. Short introns are those that are less than 1 kilobase (kb) in length, while long introns are those that are greater than 1 kb in length.\n5. Recursive splicing is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule.",
    "vicuna-7b_fact": [
      "Recursive splicing involves a microRNA (miRNA) binding to the messenger RNA (mRNA) of a target gene which leads to the degradation of the target gene.",
      "Recursive splicing can occur in both short and long introns.",
      "Introns are the non-coding regions of the genome that are present between the exons.",
      "Short introns are those that are less than 1 kilobase (kb) in length, while long introns are those that are greater than 1 kb in length.",
      "Recursive splicing is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Recursive splicing involves a mechanism in which a spliceosome removes introns and ligates exons in a gene transcript. It does not involve miRNA binding to mRNA leading to target gene degradation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: It is unknown whether recursive splicing is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule. The relationship between miRNA and recursive splicing is not well-established.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2667,
    "user_query": "Is transcription of eRNA bidirectional?",
    "vicuna-7b_response": "eRNA (exosome RNA) is a small RNA molecule that is produced by cells and plays a role in the transport of various molecules, including miRNAs, across cell membranes. The transcription of eRNA is not bidirectional.\nTranscription is the process by which DNA is copied into RNA in the cell. In the case of eRNA, the transcription of eRNA is not bidirectional because it is not produced by the transcription of DNA. Instead, eRNA is produced by the cleavage of longer RNA molecules, such as messenger RNA (mRNA), by the enzyme called dicer.\nDicer cleaves the longer RNA molecules into small RNA fragments, including eRNA, which are then transported across cell membranes by the exosome. The transcription of eRNA is therefore a one-way process, from longer RNA molecules to eRNA.\nIn summary, the transcription of eRNA is not bidirectional, but instead is a one-way process from longer RNA molecules to eRNA.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. eRNA (exosome RNA) is a small RNA molecule that is produced by cells.\n2. eRNA plays a role in the transport of various molecules, including miRNAs, across cell membranes.\n3. The transcription of eRNA is not bidirectional because it is not produced by the transcription of DNA.\n4. Instead, eRNA is produced by the cleavage of longer RNA molecules, such as messenger RNA (mRNA), by the enzyme called dicer.\n5. Dicer cleaves the longer RNA molecules into small RNA fragments, including eRNA, which are then transported across cell membranes by the exosome.",
    "vicuna-7b_fact": [
      "eRNA (exosome RNA) is a small RNA molecule that is produced by cells.",
      "eRNA plays a role in the transport of various molecules, including miRNAs, across cell membranes.",
      "The transcription of eRNA is not bidirectional because it is not produced by the transcription of DNA.",
      "Instead, eRNA is produced by the cleavage of longer RNA molecules, such as messenger RNA (mRNA), by the enzyme called dicer.",
      "Dicer cleaves the longer RNA molecules into small RNA fragments, including eRNA, which are then transported across cell membranes by the exosome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: eRNA (enhancer RNA) is a type of non-coding RNA transcribed from enhancer regions of DNA and involved in gene activation, not produced by cells.\n2. FALSE [correction]: The role of eRNA is involved in gene activation and regulation of transcription, but not in the transport of various molecules across cell membranes.\n3. FALSE [correction]: The transcription of eRNA is typically bidirectional, it is produced from specific regions of DNA known as enhancers.\n4. FALSE [correction]: eRNA is not produced by the cleavage of longer RNA molecules. Instead, they are transcribed directly from DNA.\n5. FALSE [correction]: Dicer is involved in cleavage of precursor miRNA, not eRNA, in the RNA interference pathway. eRNA molecules are not transported across cell membranes by the exosome.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2668,
    "user_query": "Is the protein pelota a ribosomal rescue factor?",
    "vicuna-7b_response": "Pelota is not a commonly known term in the context of ribosomal rescue factors. However, based on the information available, it is not clear if pelota is a protein or a specific factor that plays a role in ribosomal rescue.\nRibosomes are complex molecular machines that are responsible for protein synthesis in all living organisms. They consist of two subunits, the small subunit and the large subunit, which are responsible for different functions. The small subunit is responsible for binding to messenger RNA (mRNA) and translating the genetic code into a polypeptide chain, while the large subunit is responsible for binding to transfer RNA (tRNA) and amino acids to assemble the polypeptide chain into a protein.\nThere are several factors that play a role in the function of ribosomes, including chaperones, which help to fold and stabilize newly synthesized proteins, and translation elongation factors, which help to facilitate the process of protein synthesis. However, there is no information available that suggests that pelota is a ribosomal rescue factor.\nIn summary, while pelota is not a commonly known term in the context of ribosomal rescue factors, it is not clear if it is a protein or specific factor that plays a role in ribosomal rescue. Further research is needed to determine the function of pelota.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ribosomes are responsible for protein synthesis in all living organisms.\n2. Ribosomes consist of two subunits: the small subunit and the large subunit.\n3. The small subunit of a ribosome is responsible for binding to messenger RNA and translating the genetic code into a polypeptide chain.\n4. The large subunit of a ribosome is responsible for binding to transfer RNA and amino acids to assemble the polypeptide chain into a protein.\n5. Chaperones and translation elongation factors are two factors that play a role in the function of ribosomes.",
    "vicuna-7b_fact": [
      "Ribosomes are responsible for protein synthesis in all living organisms.",
      "Ribosomes consist of two subunits: the small subunit and the large subunit.",
      "The small subunit of a ribosome is responsible for binding to messenger RNA and translating the genetic code into a polypeptide chain.",
      "The large subunit of a ribosome is responsible for binding to transfer RNA and amino acids to assemble the polypeptide chain into a protein.",
      "Chaperones and translation elongation factors are two factors that play a role in the function of ribosomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2671,
    "user_query": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
    "vicuna-7b_response": "Yes, it is believed that a mutation in the Zika virus (ZIKV) prM protein can lead to microcephaly in newborn infants.\nZIKV is a flavivirus that was first detected in Brazil in 2015 and has since spread to become a global health concern. The virus is primarily transmitted through the bite of an infected Aedes species mosquito, and it can also be transmitted from a pregnant woman to her fetus during pregnancy.\nMicrocephaly is a condition in which a baby's head is significantly smaller than expected, and it can be caused by a variety of factors, including infections during pregnancy. ZIKV has been strongly linked to microcephaly, and it is believed that the virus can cross the placenta and infect the developing fetus, leading to microcephaly and other birth defects.\nResearch has shown that a mutation in the ZIKV prM protein can lead to the production of non-structural protein NS4A, which has been shown to be toxic to neural progenitor cells in the developing fetus. This can lead to the death of these cells, which are necessary for the proper development of the brain and other nervous system tissues. As a result, the baby may be born with microcephaly or other brain abnormalities.\nIt is important to note that not all cases of microcephaly are caused by ZIKV, and other factors such as genetic conditions and exposure to toxic substances can also contribute to this condition. However, ZIKV is a significant risk factor for microcephaly, and it is important for pregnant women and their partners to take steps to avoid mosquito bites and to seek medical care if they suspect that they may have been infected with ZIKV.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A mutation in the Zika virus (ZIKV) prM protein can lead to microcephaly in newborn infants.\n2. The Zika virus (ZIKV) is a flavivirus that was first detected in Brazil in 2015.\n3. The ZIKV is primarily transmitted through the bite of an infected Aedes species mosquito and from a pregnant woman to her fetus during pregnancy.\n4. A mutation in the ZIKV prM protein can lead to the production of non-structural protein NS4A, which has been shown to be toxic to neural progenitor cells.\n5. Not all cases of microcephaly are caused by ZIKV as genetic conditions and exposure to toxic substances can also contribute to this condition.",
    "vicuna-7b_fact": [
      "A mutation in the Zika virus (ZIKV) prM protein can lead to microcephaly in newborn infants.",
      "The Zika virus (ZIKV) is a flavivirus that was first detected in Brazil in 2015.",
      "The ZIKV is primarily transmitted through the bite of an infected Aedes species mosquito and from a pregnant woman to her fetus during pregnancy.",
      "A mutation in the ZIKV prM protein can lead to the production of non-structural protein NS4A, which has been shown to be toxic to neural progenitor cells.",
      "Not all cases of microcephaly are caused by ZIKV as genetic conditions and exposure to toxic substances can also contribute to this condition."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The Zika virus (ZIKV) is a flavivirus that was first identified in Uganda's Zika forest in 1947.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2673,
    "user_query": "What is the basis of the Sp3 procedure used in proteomics?",
    "vicuna-7b_response": "The Sp3 procedure is a method used in proteomics to identify and quantify proteins in a sample. The basis of the Sp3 procedure is the use of a combination of techniques, including mass spectrometry and liquid chromatography, to separate and analyze proteins in a sample.\nIn the Sp3 procedure, a protein sample is first separated by liquid chromatography, which separates the proteins based on their size, charge, and other properties. The separated proteins are then ionized and sent through a mass spectrometer, which measures their mass-to-charge ratio and provides information about their chemical structure.\nThe mass spectrometer also provides information about the abundance of each protein in the sample, which is used to identify and quantify the proteins. This information is used to create a list of peptides and proteins present in the sample, which is known as a proteomic profile.\nThe Sp3 procedure is a powerful tool for identifying and quantifying proteins in a sample, and it has many applications in fields such as biomedical research, drug discovery, and food safety.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Sp3 procedure is a method used in proteomics to identify and quantify proteins in a sample.\n2. The Sp3 procedure involves the use of techniques like mass spectrometry and liquid chromatography.\n3. In the Sp3 procedure, a protein sample is first separated by liquid chromatography based on the proteins' size, charge, and other properties.\n4. The separated proteins are then ionized and sent through a mass spectrometer, which measures their mass-to-charge ratio and provides information about their chemical structure.\n5. The Sp3 procedure is used in biomedical research, drug discovery, and food safety.",
    "vicuna-7b_fact": [
      "The Sp3 procedure is a method used in proteomics to identify and quantify proteins in a sample.",
      "The Sp3 procedure involves the use of techniques like mass spectrometry and liquid chromatography.",
      "In the Sp3 procedure, a protein sample is first separated by liquid chromatography based on the proteins' size, charge, and other properties.",
      "The separated proteins are then ionized and sent through a mass spectrometer, which measures their mass-to-charge ratio and provides information about their chemical structure.",
      "The Sp3 procedure is used in biomedical research, drug discovery, and food safety."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The SP3 (Single-Pot Solid-Phase-enhanced Sample Preparation) procedure is a method used in proteomics to prepare proteins for analysis but does not directly identify or quantify them.\n2. TRUE\n3. TRUE\n4. TRUE \n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2678,
    "user_query": "What is ATAC-seq?",
    "vicuna-7b_response": "ATAC-seq (Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing) is a powerful technique used to study chromatin accessibility and transcriptional regulation in cells. ATAC-seq involves the isolation of transposable element-derived DNA fragments, followed by sequencing of these fragments to identify regions of chromatin that are accessible to transposases, which are enzymes that can move around the genome and integrate into new locations.\nThe ATAC-seq approach is based on the fact that transposable elements, such as retrotransposons and transposons, are often found in regions of chromatin that are accessible to transposases. By sequencing the DNA fragments that are derived from transposable elements, researchers can identify regions of chromatin that are accessible to transcriptional machinery and potentially regulated by transcription factors.\nATAC-seq has become a popular technique in the field of epigenetics and chromatin biology, as it allows researchers to study the accessibility of chromatin across the genome and identify potential regulatory elements that may be involved in gene expression. ATAC-seq data can be analyzed using various bioinformatics tools to identify chromatin accessibility patterns, transcription factor binding sites, and other regulatory elements.\nOverall, ATAC-seq is a powerful tool for studying chromatin accessibility and transcriptional regulation in cells, and has applications in a wide range of biological contexts, including disease research, developmental biology, and plant biology.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ATAC-seq stands for Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing.\n2. ATAC-seq is used to study chromatin accessibility and transcriptional regulation in cells.\n3. The technique involves isolating DNA fragments derived from transposable elements, such as retrotransposons and transposons.\n4. ATAC-seq is a popular technique in the field of epigenetics and chromatin biology.\n5. ATAC-seq has applications in disease research, developmental biology, and plant biology.",
    "vicuna-7b_fact": [
      "ATAC-seq stands for Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing.",
      "ATAC-seq is used to study chromatin accessibility and transcriptional regulation in cells.",
      "The technique involves isolating DNA fragments derived from transposable elements, such as retrotransposons and transposons.",
      "ATAC-seq is a popular technique in the field of epigenetics and chromatin biology.",
      "ATAC-seq has applications in disease research, developmental biology, and plant biology."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The ATAC-seq technique involves isolating DNA fragments which are accessible to a transposase enzyme to assess chromatin accessibility.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-7b_response": "The TALE-iD method is a technique used to identify and characterize specific regions of the genome, known as transposable elements (TEs). TE's are DNA sequences that can move and copy themselves within the genome, and they make up a significant portion of the human genome. The TALE-iD method uses a combination of computational and experimental approaches to identify and characterize specific TEs in the human genome.\nThe TALE-iD method is based on the use of transposase enzymes, which are proteins that can move TEs within the genome. By using transposase enzymes to move specific TEs in the genome, the TALE-iD method can identify the specific regions of the genome that are targeted by these enzymes. This information can then be used to identify and characterize specific TEs in the genome.\nThe TALE-iD method has a number of potential applications, including the identification of TEs that may be involved in disease, the study of the evolution of the human genome, and the development of new tools for genome engineering. Overall, the TALE-iD method is a powerful tool for understanding the role of TEs in the human genome and for studying the mechanisms that regulate their movement within the genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TALE-iD method is used to identify and characterize specific regions of the genome, known as transposable elements (TEs).\n2. Transposable elements are DNA sequences that can move and copy themselves within the genome.\n3. The TALE-iD method uses a combination of computational and experimental approaches.\n4. The TALE-iD method is based on the use of transposase enzymes.\n5. The TALE-iD method has applications in disease identification, genome evolution study, and genome engineering tool development.",
    "vicuna-7b_fact": [
      "The TALE-iD method is used to identify and characterize specific regions of the genome, known as transposable elements (TEs).",
      "Transposable elements are DNA sequences that can move and copy themselves within the genome.",
      "The TALE-iD method uses a combination of computational and experimental approaches.",
      "The TALE-iD method is based on the use of transposase enzymes.",
      "The TALE-iD method has applications in disease identification, genome evolution study, and genome engineering tool development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The TALE-iD method is based on the use of Transcription Activator-Like Effector (TALE) proteins.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2681,
    "user_query": "What is the function of penicillinase, also known as beta lactamase?",
    "vicuna-7b_response": "Penicillinase, also known as beta lactamase, is an enzyme that is produced by certain bacteria to break down penicillin and other beta-lactam antibiotics. These antibiotics are commonly used to treat a variety of bacterial infections, but the bacteria can develop resistance to them by producing penicillinase. Penicillinase breaks down the beta-lactam ring in the antibiotic, rendering it ineffective against the bacteria. This can lead to the development of bacterial resistance to penicillin and other beta-lactam antibiotics, making it important to use these drugs judiciously and to monitor for the development of resistance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Penicillinase, also known as beta lactamase, is an enzyme produced by certain bacteria.\n2. This enzyme, penicillinase, has the function to break down penicillin and other beta-lactam antibiotics.\n3. Penicillin and other beta-lactam antibiotics are commonly used to treat a variety of bacterial infections.\n4. The production of penicillinase by bacteria can lead to the development of bacterial resistance to penicillin and other beta-lactam antibiotics. \n5. Penicillinase breaks down the beta-lactam ring in the antibiotic, making it ineffective against the bacteria.",
    "vicuna-7b_fact": [
      "Penicillinase, also known as beta lactamase, is an enzyme produced by certain bacteria.",
      "This enzyme, penicillinase, has the function to break down penicillin and other beta-lactam antibiotics.",
      "Penicillin and other beta-lactam antibiotics are commonly used to treat a variety of bacterial infections.",
      "The production of penicillinase by bacteria can lead to the development of bacterial resistance to penicillin and other beta-lactam antibiotics.",
      "Penicillinase breaks down the beta-lactam ring in the antibiotic, making it ineffective against the bacteria."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2684,
    "user_query": "What is the dardarin protein?",
    "vicuna-7b_response": "The dardarin protein is a hypothetical protein that has been proposed to play a role in the regulation of cellular processes in the tardigrade, a type of microscopic animal that is known for its ability to survive extreme conditions such as radiation, desiccation, and extreme temperatures.\nThe dardarin protein is thought to be involved in the regulation of stress response pathways in tardigrades, and has been shown to be upregulated in response to various stressors such as heat, cold, and radiation.\nResearch on the dardarin protein has suggested that it may play a role in the protection of tardigrades against cellular damage and may be involved in the regulation of the tardigrade's ability to repair damaged DNA.\nOverall, the dardarin protein is an important molecule in the tardigrade's ability to survive extreme conditions and may provide insights into the mechanisms of stress response and cellular repair in other organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The dardarin protein is a hypothetical protein proposed to play a role in the regulation of cellular processes in the tardigrade.\n2. Tardigrades are known for their ability to survive extreme conditions such as radiation, desiccation, and extreme temperatures.\n3. The dardarin protein is thought to be involved in the regulation of stress response pathways in tardigrades.\n4. Dardarin protein has been shown to be upregulated in response to various stressors such as heat, cold, and radiation.\n5. Research suggests that dardarin protein may play a role in protecting tardigrades against cellular damage and in the regulation of the tardigrade's ability to repair damaged DNA.",
    "vicuna-7b_fact": [
      "The dardarin protein is a hypothetical protein proposed to play a role in the regulation of cellular processes in the tardigrade.",
      "Tardigrades are known for their ability to survive extreme conditions such as radiation, desiccation, and extreme temperatures.",
      "The dardarin protein is thought to be involved in the regulation of stress response pathways in tardigrades.",
      "Dardarin protein has been shown to be upregulated in response to various stressors such as heat, cold, and radiation.",
      "Research suggests that dardarin protein may play a role in protecting tardigrades against cellular damage and in the regulation of the tardigrade's ability to repair damaged DNA."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2685,
    "user_query": "In which syndrome is the RPS19 gene most frequently mutated?",
    "vicuna-7b_response": "The RPS19 gene is most frequently mutated in the Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML). The RPS19 gene provides instructions for making a protein called ribosomal protein S19, which is involved in the production of ribosomes, the cell structures that help make proteins.\nThe RPS19 gene mutation is a key event in the development of CML, which is a type of cancer that affects the bone marrow and blood cells. The mutation leads to the production of an abnormal protein that promotes the growth and survival of cancer cells in the bone marrow.\nThe RPS19 gene mutation is specific to CML and is not associated with other types of cancer. The mutation is detected through a blood test and is used to diagnose CML and monitor the response to treatment.\nIn summary, the RPS19 gene mutation is most frequently found in Philadelphia chromosome positive chronic myeloid leukemia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The RPS19 gene is most frequently mutated in the Philadelphia chromosome positive chronic myeloid leukemia.\n2. The RPS19 gene provides instructions for making a protein called ribosomal protein S19.\n3. The ribosomal protein S19 is involved in the production of ribosomes.\n4. The RPS19 gene mutation leads to the production of an abnormal protein that promotes the growth and survival of cancer cells in the bone marrow.\n5. The RPS19 gene mutation is specific to chronic myeloid leukemia and is not associated with other types of cancer.",
    "vicuna-7b_fact": [
      "The RPS19 gene is most frequently mutated in the Philadelphia chromosome positive chronic myeloid leukemia.",
      "The RPS19 gene provides instructions for making a protein called ribosomal protein S19.",
      "The ribosomal protein S19 is involved in the production of ribosomes.",
      "The RPS19 gene mutation leads to the production of an abnormal protein that promotes the growth and survival of cancer cells in the bone marrow.",
      "The RPS19 gene mutation is specific to chronic myeloid leukemia and is not associated with other types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2686,
    "user_query": "What type of sequences do enhancers evolve from?",
    "vicuna-7b_response": "Enhancers are non-coding DNA sequences that play a crucial role in the regulation of gene expression. They are typically located in close proximity to the promoters of genes and act as binding sites for transcription factors, which are proteins that regulate the expression of genes.\nEnhancers can evolve from a variety of different types of sequences, including promoters, enhancers, insulators, and other non-coding sequences. Enhancers can also evolve from other enhancers, allowing for the formation of complex regulatory networks that control the expression of genes.\nIn addition, enhancers can evolve from repetitive elements, such as Alu elements, which are short, non-coding RNA sequences that are found in the human genome. These repetitive elements can evolve into enhancers through a process called \"repeat-induced point mutation,\" in which the repetitive element is duplicated and mutated, leading to the creation of a new enhancer.\nOverall, enhancers can evolve from a variety of different types of sequences, and their evolution is an important aspect of the regulation of gene expression in the human genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Enhancers are non-coding DNA sequences that play a role in the regulation of gene expression.\n2. Enhancers can evolve from a variety of sequences, including promoters, enhancers, insulators, and other non-coding sequences.\n3. Enhancers can evolve from other enhancers, creating complex regulatory networks that control the expression of genes.\n4. Enhancers can evolve from repetitive elements such as Alu elements in the human genome.\n5. Repetitive elements can evolve into enhancers through a process called \"repeat-induced point mutation,\" leading to the creation of a new enhancer.",
    "vicuna-7b_fact": [
      "Enhancers are non-coding DNA sequences that play a role in the regulation of gene expression.",
      "Enhancers can evolve from a variety of sequences, including promoters, enhancers, insulators, and other non-coding sequences.",
      "Enhancers can evolve from other enhancers, creating complex regulatory networks that control the expression of genes.",
      "Enhancers can evolve from repetitive elements such as Alu elements in the human genome.",
      "Repetitive elements can evolve into enhancers through a process called \"repeat-induced point mutation,\" leading to the creation of a new enhancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Repetitive elements can evolve into enhancers, but \"repeat-induced point mutation\" is a process in fungal genomes that leads to hypermutation and transcriptional silencing of repetitive sequences, not the creation of enhancers.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2687,
    "user_query": "What nerve is involved in carpal tunnel syndrome?",
    "vicuna-7b_response": "Carpal tunnel syndrome is a condition that occurs when there is pressure on the median nerve in the wrist. The median nerve is one of the nerves in the arm that controls the sensation and movement of the thumb, index, and middle fingers.\nThe carpal tunnel is a narrow, rigid passageway in the wrist that contains the median nerve, as well as tendons and ligaments. The carpal tunnel is surrounded by bones and a strong band of connective tissue called the transverse carpal ligament.\nWhen the tissues in the carpal tunnel become swollen or inflamed, they can put pressure on the median nerve, causing carpal tunnel syndrome. This can lead to symptoms such as numbness, tingling, and pain in the thumb, index, and middle fingers, as well as weakness in the hand.\nTreatment for carpal tunnel syndrome typically involves resting the hand and wrist, using splints or braces to keep the wrist in a neutral position, and avoiding activities that make the symptoms worse. In some cases, medications or injections may be used to reduce inflammation and relieve pain. Surgery may also be recommended in severe cases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Carpal tunnel syndrome is a condition that occurs when there is pressure on the median nerve in the wrist. \n2. The median nerve controls the sensation and movement of the thumb, index, and middle fingers.\n3. The carpal tunnel is a narrow, rigid passageway in the wrist that contains the median nerve, tendons and ligaments.\n4. The carpal tunnel is surrounded by bones and a strong band of connective tissue called the transverse carpal ligament.\n5. Treatment for carpal tunnel syndrome can involve resting the hand and wrist, using splints or braces, avoiding certain activities, medication, injections, and surgery in severe cases.",
    "vicuna-7b_fact": [
      "Carpal tunnel syndrome is a condition that occurs when there is pressure on the median nerve in the wrist.",
      "The median nerve controls the sensation and movement of the thumb, index, and middle fingers.",
      "The carpal tunnel is a narrow, rigid passageway in the wrist that contains the median nerve, tendons and ligaments.",
      "The carpal tunnel is surrounded by bones and a strong band of connective tissue called the transverse carpal ligament.",
      "Treatment for carpal tunnel syndrome can involve resting the hand and wrist, using splints or braces, avoiding certain activities, medication, injections, and surgery in severe cases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2689,
    "user_query": "Please list 3 diseases treated with Valtrex(valacyclovir)",
    "vicuna-7b_response": "Valtrex (valacyclovir) is an antiviral medication that is used to treat a variety of conditions caused by different types of viruses. Here are three diseases that are treated with Valtrex:\n1. Herpes Simplex Virus (HSV) Infections: Valtrex is used to treat both cold sores (herpes labialis) and genital herpes caused by HSV. It works by preventing the virus from reproducing and spreading in the body.\n2. Shingles (Herpes Zoster): Valtrex is also used to treat shingles, which is caused by the same virus that causes chickenpox (varicella-zoster virus). It is used to reduce the severity and duration of the pain and rash associated with shingles.\n3. Cold Sores: Valtrex is also used to treat cold sores, which are caused by the herpes simplex virus type 1 (HSV-1). It works by reducing the severity and duration of cold sores and preventing new outbreaks.\nIt's important to note that Valtrex is not a cure for these diseases, but it can help to manage the symptoms and reduce the frequency of outbreaks. It's important to follow the dosage instructions provided by your healthcare provider and to inform them of any side effects you may experience.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Valtrex (valacyclovir) is an antiviral medication.\n2. Valtrex is used to treat cold sores and genital herpes caused by Herpes Simplex Virus (HSV).\n3. Valtrex is used to treat shingles, which is caused by the varicella-zoster virus.\n4. Cold sores, which are caused by the herpes simplex virus type 1 (HSV-1), can be treated with Valtrex.\n5. Valtrex is not a cure for these diseases, but it can help to manage the symptoms and reduce the frequency of outbreaks.",
    "vicuna-7b_fact": [
      "Valtrex (valacyclovir) is an antiviral medication.",
      "Valtrex is used to treat cold sores and genital herpes caused by Herpes Simplex Virus (HSV).",
      "Valtrex is used to treat shingles, which is caused by the varicella-zoster virus.",
      "Cold sores, which are caused by the herpes simplex virus type 1 (HSV-1), can be treated with Valtrex.",
      "Valtrex is not a cure for these diseases, but it can help to manage the symptoms and reduce the frequency of outbreaks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2696,
    "user_query": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
    "vicuna-7b_response": "The high-altitude adaptation of Tibetans is a complex process that is influenced by a combination of genetic and environmental factors. While there is ongoing research in this area, there is currently no single gene that is responsible for the high-altitude adaptation of Tibetans.\nHowever, studies have identified several genetic variants that may contribute to the high-altitude adaptation of Tibetans. For example, a study published in the journal Nature Genetics in 2018 identified several genetic variants that are more common in Tibetans than in people from low-altitude regions. These variants are associated with the production of red blood cells, which are important for carrying oxygen to the body's tissues.\nAdditionally, research has suggested that the high-altitude adaptation of Tibetans may be influenced by the presence of certain genetic mutations that are associated with increased production of erythropoietin (EPO), a hormone that stimulates the production of red blood cells.\nIt's important to note that the high-altitude adaptation of Tibetans is a complex process that is influenced by a combination of genetic and environmental factors, and more research is needed to fully understand the genetic basis of this adaptation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The high-altitude adaptation of Tibetans is influenced by a combination of genetic and environmental factors.\n2. There is currently no single gene responsible for the high-altitude adaptation of Tibetans.\n3. A study published in the journal Nature Genetics in 2018 identified several genetic variants that are more common in Tibetans than in people from low-altitude regions. \n4. These genetic variants that are more common in Tibetans are associated with the production of red blood cells.\n5. The high-altitude adaptation of Tibetans may be influenced by genetic mutations associated with increased production of erythropoietin (EPO).",
    "vicuna-7b_fact": [
      "The high-altitude adaptation of Tibetans is influenced by a combination of genetic and environmental factors.",
      "There is currently no single gene responsible for the high-altitude adaptation of Tibetans.",
      "A study published in the journal Nature Genetics in 2018 identified several genetic variants that are more common in Tibetans than in people from low-altitude regions.",
      "These genetic variants that are more common in Tibetans are associated with the production of red blood cells.",
      "The high-altitude adaptation of Tibetans may be influenced by genetic mutations associated with increased production of erythropoietin (EPO)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2702,
    "user_query": "Which human gene encode for DNA polymerase θ?",
    "vicuna-7b_response": "DNA polymerase θ is a DNA polymerase enzyme that plays a crucial role in the repair of DNA damage caused by reactive oxygen species (ROS) and other oxidative stress. It is encoded by the POLQ gene on chromosome 17q21.\nThe POLQ gene contains 20 exons and is composed of 3 distinct domains: the catalytic domain, the replication factor C (RFC) domain, and the DNA binding domain. The POLQ gene is expressed in a wide range of tissues, including the liver, kidney, heart, and testis, and its expression is regulated by a variety of transcription factors, including the forkhead box protein A1 (FOXA1) and the androgen receptor (AR).\nDNA polymerase θ is a unique enzyme that possesses a number of distinctive features, including its ability to bypass a variety of DNA lesions, its high processivity, and its ability to synthesize DNA in the presence of ROS. It plays a critical role in the maintenance of genomic stability and is essential for the proper functioning of the cell.\nIn summary, the POLQ gene encodes for DNA polymerase θ, an enzyme that plays a crucial role in the repair of DNA damage caused by ROS and other oxidative stress. It is expressed in a wide range of tissues and is regulated by a variety of transcription factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNA polymerase θ is encoded by the POLQ gene on chromosome 17q21.\n2. The POLQ gene contains 20 exons and is composed of 3 distinct domains: the catalytic domain, the replication factor C (RFC) domain, and the DNA binding domain.\n3. The POLQ gene is expressed in a wide range of tissues including the liver, kidney, heart, and testis. \n4. DNA polymerase θ can bypass a variety of DNA lesions, exhibits high processivity, and can synthesize DNA in the presence of ROS.\n5. The expression of POLQ gene is regulated by a variety of transcription factors, including the forkhead box protein A1 (FOXA1) and the androgen receptor (AR).",
    "vicuna-7b_fact": [
      "DNA polymerase θ is encoded by the POLQ gene on chromosome 17q21.",
      "The POLQ gene contains 20 exons and is composed of 3 distinct domains: the catalytic domain, the replication factor C (RFC) domain, and the DNA binding domain.",
      "The POLQ gene is expressed in a wide range of tissues including the liver, kidney, heart, and testis.",
      "DNA polymerase θ can bypass a variety of DNA lesions, exhibits high processivity, and can synthesize DNA in the presence of ROS.",
      "The expression of POLQ gene is regulated by a variety of transcription factors, including the forkhead box protein A1 (FOXA1) and the androgen receptor (AR)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2705,
    "user_query": "Which are the two main bacterial phyla in human gut?",
    "vicuna-7b_response": "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes. These two phyla make up the majority of the gut microbiome, which is the community of microorganisms that live in the human gut.\nFirmicutes are characterized by their Gram-positive cell walls and are typically found in higher numbers in the gut. They include bacteria such as Bifidobacterium and Lactobacillus, which are known for their beneficial effects on human health.\nBacteroidetes, on the other hand, are characterized by their Gram-negative cell walls and are typically found in lower numbers in the gut. They include bacteria such as Bacteroides and Prevotella, which have also been shown to have beneficial effects on human health.\nIt's worth noting that the gut microbiome is a complex and dynamic ecosystem, and the relative proportions of different phyla can vary depending on factors such as age, diet, and overall health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes.\n2. Firmicutes and Bacteroidetes make up the majority of the gut microbiome.\n3. Firmicutes are characterized by their Gram-positive cell walls.\n4. Bacteroidetes are characterized by their Gram-negative cell walls.\n5. The relative proportions of different phyla in the gut microbiome can vary depending on factors such as age, diet, and overall health.",
    "vicuna-7b_fact": [
      "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes.",
      "Firmicutes and Bacteroidetes make up the majority of the gut microbiome.",
      "Firmicutes are characterized by their Gram-positive cell walls.",
      "Bacteroidetes are characterized by their Gram-negative cell walls.",
      "The relative proportions of different phyla in the gut microbiome can vary depending on factors such as age, diet, and overall health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2710,
    "user_query": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
    "vicuna-7b_response": "Cytochrome P450 enzymes, including CYP3A, are responsible for the metabolism of a wide variety of drugs and xenobiotics. Rifampicin is a drug that is used to treat tuberculosis and is known to induce CYP3A, which can lead to increased metabolism of other drugs and potential drug interactions.\nSome viruses that are treated with drugs that can induce CYP3A include:\n* HIV: Antiretroviral therapy for HIV often includes drugs that can induce CYP3A, such as efavirenz and nevirapine. This can lead to increased metabolism of other drugs, such as warfarin and theophylline, and potential drug interactions.\n* Hepatitis C: Interferon-alpha, a drug used to treat hepatitis C, can induce CYP3A and lead to increased metabolism of other drugs.\n* Chronic obstructive pulmonary disease (COPD): Some drugs used to treat COPD, such as beta-2 agonists and theophylline, can be metabolized by CYP3A and may be affected by rifampicin-induced CYP3A induction.\nIt's important to note that the specific drugs and dosages used to treat these viruses may vary, and the potential for drug interactions and CYP3A induction can depend on a variety of factors, including the individual patient's genetics and other medications being taken. It's important for healthcare providers to carefully monitor patients for potential drug interactions and adjust dosages as needed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cytochrome P450 enzymes, including CYP3A, are responsible for the metabolism of a wide variety of drugs and xenobiotics.\n2. Rifampicin is a drug that is used to treat tuberculosis and is known to induce CYP3A.\n3. Antiretroviral therapy for HIV often includes drugs that can induce CYP3A, such as efavirenz and nevirapine.\n4. Interferon-alpha, a drug used to treat hepatitis C, can induce CYP3A.\n5. Some drugs used to treat COPD, such as beta-2 agonists and theophylline, can be metabolized by CYP3A.",
    "vicuna-7b_fact": [
      "Cytochrome P450 enzymes, including CYP3A, are responsible for the metabolism of a wide variety of drugs and xenobiotics.",
      "Rifampicin is a drug that is used to treat tuberculosis and is known to induce CYP3A.",
      "Antiretroviral therapy for HIV often includes drugs that can induce CYP3A, such as efavirenz and nevirapine.",
      "Interferon-alpha, a drug used to treat hepatitis C, can induce CYP3A.",
      "Some drugs used to treat COPD, such as beta-2 agonists and theophylline, can be metabolized by CYP3A."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Interferon-alpha, a drug used to treat hepatitis C, does not induce CYP3A.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2712,
    "user_query": "Where is the EpCam protein mainly located?",
    "vicuna-7b_response": "The EpCam protein is mainly located on the surface of epithelial cells in various tissues, including the skin, gut, and respiratory tract. It is also found in some cancer cells, where it can be used as a biomarker for cancer diagnosis and prognosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The EpCam protein is mainly located on the surface of epithelial cells.\n2. The EpCam protein is found in various tissues, including the skin, gut, and respiratory tract.\n3. The EpCam protein is also found in some cancer cells.\n4. The EpCam protein can be used as a biomarker for cancer diagnosis and prognosis.",
    "vicuna-7b_fact": [
      "The EpCam protein is mainly located on the surface of epithelial cells.",
      "The EpCam protein is found in various tissues, including the skin, gut, and respiratory tract.",
      "The EpCam protein is also found in some cancer cells.",
      "The EpCam protein can be used as a biomarker for cancer diagnosis and prognosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2719,
    "user_query": "What is the clathrin triskelia structure?",
    "vicuna-7b_response": "The clathrin triskelia structure is a model that describes the organization of clathrin proteins into triskelia, which are three-stranded helical structures. Clathrin is a family of proteins that play a key role in the endocytosis process, which is the process by which cells take in extracellular matter.\nThe clathrin triskelia structure was first proposed in the 1980s and has since been extensively studied. The structure is thought to be responsible for the formation of clathrin-coated pits, which are invaginations of the plasma membrane that serve as the starting point for endocytosis.\nThe clathrin triskelia structure is composed of three clathrin heavy chains and three clathrin light chains, which are arranged in a helical configuration. The three chains are held together by non-covalent interactions, such as hydrogen bonds and electrostatic forces.\nThe clathrin triskelia structure is an important model for understanding the mechanism of endocytosis and has implications for a wide range of cellular processes, including signaling, trafficking, and the regulation of cell growth and differentiation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The clathrin triskelia structure is a model that describes the organization of clathrin proteins into three-stranded helical structures.\n2. Clathrin proteins play a key role in the endocytosis process, which involves cells taking in extracellular matter.\n3. The clathrin triskelia structure was first proposed in the 1980s.\n4. The structure is thought to be responsible for the formation of clathrin-coated pits, which are invaginations of the plasma membrane and serve as the starting point for endocytosis.\n5. The clathrin triskelia structure is composed of three clathrin heavy chains and three clathrin light chains, held together by non-covalent interactions.",
    "vicuna-7b_fact": [
      "The clathrin triskelia structure is a model that describes the organization of clathrin proteins into three-stranded helical structures.",
      "Clathrin proteins play a key role in the endocytosis process, which involves cells taking in extracellular matter.",
      "The clathrin triskelia structure was first proposed in the 1980s.",
      "The structure is thought to be responsible for the formation of clathrin-coated pits, which are invaginations of the plasma membrane and serve as the starting point for endocytosis.",
      "The clathrin triskelia structure is composed of three clathrin heavy chains and three clathrin light chains, held together by non-covalent interactions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2721,
    "user_query": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
    "vicuna-7b_response": "Brucella abortus is a bacterium that can cause a disease in humans and animals known as brucellosis. While it is possible for Brucella abortus to cause spontaneous abortions in humans, this is not a common occurrence.\nBrucella abortus primarily infects cattle, sheep, and goats, and can also infect humans who come into contact with infected animals or their products. The bacteria can cause a range of symptoms in humans, including fever, headache, and muscle and joint pain. In severe cases, brucellosis can also cause reproductive problems, such as spontaneous abortions.\nHowever, it is important to note that other factors can also contribute to spontaneous abortions in humans, such as genetic or hormonal imbalances, and it is not clear whether Brucella abortus is a significant cause of spontaneous abortions in humans.\nIn summary, while it is possible for Brucella abortus to cause spontaneous abortions in humans, this is not a common occurrence and other factors can also contribute to reproductive problems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Brucella abortus is a bacterium that can cause brucellosis in humans and animals.\n2. Brucella abortus can cause spontaneous abortions in humans, but this isn't a common occurrence.\n3. Brucella abortus primarily infects cattle, sheep, and goats.\n4. Humans can be infected with Brucella abortus by coming into contact with infected animals or their products. \n5. In severe cases, brucellosis can cause reproductive problems in humans such as spontaneous abortions.",
    "vicuna-7b_fact": [
      "Brucella abortus is a bacterium that can cause brucellosis in humans and animals.",
      "Brucella abortus can cause spontaneous abortions in humans, but this isn't a common occurrence.",
      "Brucella abortus primarily infects cattle, sheep, and goats.",
      "Humans can be infected with Brucella abortus by coming into contact with infected animals or their products.",
      "In severe cases, brucellosis can cause reproductive problems in humans such as spontaneous abortions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2722,
    "user_query": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
    "vicuna-7b_response": "The percentage of Neanderthal DNA in the human genome is estimated to be around 1-4%. This is based on the analysis of Neanderthal DNA that has been sequenced and compared to the human genome. The exact percentage can vary depending on the specific methods and data used for the analysis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The percentage of Neanderthal DNA in the human genome is estimated to be around 1-4%.\n2. This estimate is based on the analysis of Neanderthal DNA that has been sequenced and compared to the human genome.\n3. The exact percentage of Neanderthal DNA in the human genome can vary depending on the specific methods and data used for the analysis.",
    "vicuna-7b_fact": [
      "The percentage of Neanderthal DNA in the human genome is estimated to be around 1-4%.",
      "This estimate is based on the analysis of Neanderthal DNA that has been sequenced and compared to the human genome.",
      "The exact percentage of Neanderthal DNA in the human genome can vary depending on the specific methods and data used for the analysis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2723,
    "user_query": "What is Dupuytren's contracture?",
    "vicuna-7b_response": "Dupuytren's contracture is a condition that affects the hands and fingers. It is caused by a thickening of the tissue in the palm of the hand and the fingers, which can cause the fingers to bend into the palm and become difficult to straighten. This condition is most commonly found in men over the age of 40, and it is thought to be hereditary.\nThe exact cause of Dupuytren's contracture is not known, but it is thought to be related to an overproduction of collagen, a protein that is important for the structure of connective tissue. The thickening of the tissue in the palm and fingers can cause the fingers to become stuck in a bent position, making it difficult to use the hands for everyday activities.\nThere are several treatment options for Dupuytren's contracture, including medication, physical therapy, and surgery. The best treatment option will depend on the severity of the condition and the individual's specific needs.\nIt is important to see a healthcare professional if you are experiencing difficulty with the movement of your fingers or if you have any concerns about Dupuytren's contracture. With proper treatment, it is possible to manage the symptoms of this condition and improve the function of the hands.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dupuytren's contracture is a condition that affects the hands and fingers.\n2. Dupuytren's contracture is thought to be caused by an overproduction of collagen.\n3. Men over the age of 40 are most commonly affected by Dupuytren's contracture.\n4. Medication, physical therapy, and surgery are several treatment options for Dupuytren's contracture.\n5. Dupuytren's contracture can cause fingers to bend into the palm and become difficult to straighten.",
    "vicuna-7b_fact": [
      "Dupuytren's contracture is a condition that affects the hands and fingers.",
      "Dupuytren's contracture is thought to be caused by an overproduction of collagen.",
      "Men over the age of 40 are most commonly affected by Dupuytren's contracture.",
      "Medication, physical therapy, and surgery are several treatment options for Dupuytren's contracture.",
      "Dupuytren's contracture can cause fingers to bend into the palm and become difficult to straighten."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2728,
    "user_query": "Are human enhancers or promoters evolving faster?",
    "vicuna-7b_response": "Human enhancers and promoters are evolving at different rates.\nEnhancers are non-coding DNA sequences that act as binding sites for transcription factors, which control the expression of genes. Enhancers can be located far away from the genes they regulate and can be influenced by various environmental and genetic factors. Enhancers have been shown to evolve rapidly in response to changes in the environment and to play a role in the evolution of new traits.\nPromoters, on the other hand, are the regions of DNA that act as the initiation site for transcription of a gene into mRNA. Promoters are typically located in close proximity to the gene they regulate and are less likely to evolve rapidly.\nOverall, while both enhancers and promoters play important roles in gene regulation and evolution, they are evolving at different rates and in different ways.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Enhancers are non-coding DNA sequences that act as binding sites for transcription factors, which control the expression of genes.\n2. Enhancers can be located far away from the genes they regulate and can be influenced by various environmental and genetic factors.\n3. Enhancers have been shown to evolve rapidly in response to changes in the environment.\n4. Promoters are the regions of DNA that act as the initiation site for transcription of a gene into mRNA.\n5. Promoters are typically located in close proximity to the gene they regulate and are less likely to evolve rapidly.",
    "vicuna-7b_fact": [
      "Enhancers are non-coding DNA sequences that act as binding sites for transcription factors, which control the expression of genes.",
      "Enhancers can be located far away from the genes they regulate and can be influenced by various environmental and genetic factors.",
      "Enhancers have been shown to evolve rapidly in response to changes in the environment.",
      "Promoters are the regions of DNA that act as the initiation site for transcription of a gene into mRNA.",
      "Promoters are typically located in close proximity to the gene they regulate and are less likely to evolve rapidly."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2729,
    "user_query": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
    "vicuna-7b_response": "There are several antidotes available for anticoagulant drugs, including factor Xa inhibitors, as of November 2017. The three most commonly used antidotes for these drugs are:\n1. Vitamin K: Vitamin K is a natural substance that is essential for the production of clotting factors in the body. It can be given as an injection to reverse the effects of anticoagulant drugs, including factor Xa inhibitors.\n2. Prothrombin complex concentrates (PCC): PCCs are preparations of clotting factors that can be used to reverse the effects of anticoagulant drugs. They are particularly useful in cases where vitamin K is not effective or is not available.\n3. Activated prothrombin complex concentrate (aPCC): aPCC is a more concentrated form of PCC that can be used to reverse the effects of anticoagulant drugs more quickly and effectively than standard PCCs.\nIt is important to note that the choice of antidote will depend on the specific drug being used, the severity of the bleeding, and the patient's medical history. It is always best to consult with a healthcare professional before administering any antidote.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. As of November 2017, there are several antidotes available for anticoagulant drugs, including factor Xa inhibitors.\n2. Vitamin K is a natural substance that is essential for the production of clotting factors in the body and can be used as an antidote for anticoagulant drugs.\n3. Prothrombin complex concentrates (PCC) can be used to reverse the effects of anticoagulant drugs.\n4. Activated prothrombin complex concentrate (aPCC) is a more concentrated form of PCC that can be used to reverse the effects of anticoagulant drugs more quickly and effectively than standard PCCs.\n5. The choice of antidote for anticoagulant drugs will depend on the specific drug being used, the severity of the bleeding, and the patient's medical history.",
    "vicuna-7b_fact": [
      "As of November 2017, there are several antidotes available for anticoagulant drugs, including factor Xa inhibitors.",
      "Vitamin K is a natural substance that is essential for the production of clotting factors in the body and can be used as an antidote for anticoagulant drugs.",
      "Prothrombin complex concentrates (PCC) can be used to reverse the effects of anticoagulant drugs.",
      "Activated prothrombin complex concentrate (aPCC) is a more concentrated form of PCC that can be used to reverse the effects of anticoagulant drugs more quickly and effectively than standard PCCs.",
      "The choice of antidote for anticoagulant drugs will depend on the specific drug being used, the severity of the bleeding, and the patient's medical history."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2730,
    "user_query": "Which genes are associated with Epidermolysis Bullosa Simplex?",
    "vicuna-7b_response": "Epidermolysis bullosa simplex (EBS) is a rare genetic skin disorder characterized by fragile skin that blisters and tears easily, especially when under stress or friction. The condition is caused by mutations in the COL7A1 gene, which provides instructions for making a protein called type VII collagen. This protein is essential for the structure and function of the skin's anchoring fibrils, which help to hold the skin cells together.\nThere are three main types of EBS, each with varying severity and age of onset:\n1. EBS simplex: This is the mildest form of EBS, characterized by mild skin fragility and occasional blistering. It typically appears in infancy or early childhood and tends to improve with age.\n2. EBS junctional: This is the most common form of EBS, characterized by widespread blistering and scarring of the skin and mucous membranes. It typically appears in infancy or early childhood and can be severe.\n3. EBS dystrophic: This is the most severe form of EBS, characterized by widespread blistering and scarring of the skin and mucous membranes, as well as joint contractures and muscle weakness. It typically appears in infancy or early childhood and can be life-threatening.\nIn summary, EBS is caused by mutations in the COL7A1 gene, which provides instructions for making type VII collagen. The condition is characterized by fragile skin that blisters and tears easily, and there are three main types of EBS with varying severity and age of onset.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Epidermolysis bullosa simplex (EBS) is a rare genetic skin disorder characterized by fragile skin that blisters and tears easily.\n2. EBS is caused by mutations in the COL7A1 gene.\n3. The COL7A1 gene provides instructions for making a protein called type VII collagen that is essential for the structure and function of the skin's anchoring fibrils.\n4. There are three main types of EBS: EBS simplex, EBS junctional, and EBS dystrophic.\n5. Each type of EBS has varying severity and age of onset, and they are characterized by different levels of skin fragility, blistering, and other complications.",
    "vicuna-7b_fact": [
      "Epidermolysis bullosa simplex (EBS) is a rare genetic skin disorder characterized by fragile skin that blisters and tears easily.",
      "EBS is caused by mutations in the COL7A1 gene.",
      "The COL7A1 gene provides instructions for making a protein called type VII collagen that is essential for the structure and function of the skin's anchoring fibrils.",
      "There are three main types of EBS: EBS simplex, EBS junctional, and EBS dystrophic.",
      "Each type of EBS has varying severity and age of onset, and they are characterized by different levels of skin fragility, blistering, and other complications."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: EBS is usually caused by mutations in the KRT5 or KRT14 gene.\n3. FALSE [correction]: The COL7A1 gene provides instructions for making a protein that is used to assemble larger molecules called type VII collagen; these larger molecules play a significant role in the structure and strength of the skin. Mutations in this gene are often associated with a type of Epidermolysis bullosa called dystrophic Epidermolysis bullosa, not EBS.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2738,
    "user_query": "What part of the body is affected by mesotheliomia?",
    "vicuna-7b_response": "Mesothelioma is a rare and aggressive cancer that affects the mesothelium, which is the thin layer of tissue that covers the lungs, heart, and other internal organs. The mesothelium produces a lubricating fluid that helps protect these organs and allows them to move smoothly.\nMesothelioma can occur in the chest (pleural mesothelioma) or in the abdominal cavity (peritoneal mesothelioma). It can also occur in the tunica vaginalis testis, which is the membrane surrounding the testicles.\nMesothelioma is often associated with exposure to asbestos, which is a mineral fiber that was commonly used in construction and other industries. However, mesothelioma can also occur in people who have not been exposed to asbestos.\nSymptoms of mesothelioma can include chest pain, difficulty breathing, coughing, and a mass or lump in the chest or abdomen. Diagnosis is typically made through a combination of imaging tests, such as CT scans or PET scans, and biopsy.\nTreatment options for mesothelioma include surgery, radiation therapy, and chemotherapy. The prognosis for mesothelioma is poor, with a median survival time of around 18 months.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mesothelioma is a cancer that impacts the mesothelium, a thin layer of tissue that covers the lungs, heart, and other internal organs.\n2. Mesothelioma can occur in the chest, abdominal cavity, or the tunica vaginalis testis.\n3. Mesothelioma is often associated with exposure to asbestos, as per its most common cause.\n4. Diagnosis of mesothelioma is typically made through several imaging tests and biopsy.\n5. Treatment options for mesothelioma include surgery, radiation therapy, and chemotherapy and the prognosis is typically poor, with a median survival time of around 18 months.",
    "vicuna-7b_fact": [
      "Mesothelioma is a cancer that impacts the mesothelium, a thin layer of tissue that covers the lungs, heart, and other internal organs.",
      "Mesothelioma can occur in the chest, abdominal cavity, or the tunica vaginalis testis.",
      "Mesothelioma is often associated with exposure to asbestos, as per its most common cause.",
      "Diagnosis of mesothelioma is typically made through several imaging tests and biopsy.",
      "Treatment options for mesothelioma include surgery, radiation therapy, and chemotherapy and the prognosis is typically poor, with a median survival time of around 18 months."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2741,
    "user_query": "What is PNPPP?",
    "vicuna-7b_response": "PNPPP stands for \"Potassium Nitrate, Nitric Acid, Phosphoric Acid, and Peroxide\" and is a type of chemical reaction that is commonly used in the production of fertilizers.\nThe reaction involves the combination of potassium nitrate (KNO3), nitric acid (HNO3), phosphoric acid (H3PO4), and hydrogen peroxide (H2O2) in the presence of heat and pressure to produce a compound known as ammonium phosphate.\nThe process of PNPPP is used to produce a variety of fertilizers, including triple superphosphate, which is a common source of phosphorus for agricultural use.\nIt is important to note that the use of PNPPP and other chemical reactions in the production of fertilizers can have negative environmental impacts, including pollution of soil and water resources, and the release of greenhouse gases into the atmosphere.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PNPPP stands for \"Potassium Nitrate, Nitric Acid, Phosphoric Acid, and Peroxide\".\n2. PNPPP is a type of chemical reaction used in the production of fertilizers.\n3. The reaction involves the combination of potassium nitrate (KNO3), nitric acid (HNO3), phosphoric acid (H3PO4), and hydrogen peroxide (H2O2) to produce ammonium phosphate.\n4. The PNPPP process is used to produce fertilizers such as triple superphosphate, which is used for agricultural purposes.\n5. The use of PNPPP and other similar chemical reactions in the production of fertilizers can result in negative environmental impacts, including soil and water pollution and the emission of greenhouse gases.",
    "vicuna-7b_fact": [
      "PNPPP stands for \"Potassium Nitrate, Nitric Acid, Phosphoric Acid, and Peroxide\".",
      "PNPPP is a type of chemical reaction used in the production of fertilizers.",
      "The reaction involves the combination of potassium nitrate (KNO3), nitric acid (HNO3), phosphoric acid (H3PO4), and hydrogen peroxide (H2O2) to produce ammonium phosphate.",
      "The PNPPP process is used to produce fertilizers such as triple superphosphate, which is used for agricultural purposes.",
      "The use of PNPPP and other similar chemical reactions in the production of fertilizers can result in negative environmental impacts, including soil and water pollution and the emission of greenhouse gases."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2746,
    "user_query": "Which genomic positions are preferentially selected for transposon insertion?",
    "vicuna-7b_response": "Transposon insertion is a process by which mobile DNA elements, such as transposons, insert themselves into the genome of an organism. The preferential selection of genomic positions for transposon insertion can vary depending on the specific transposon and the organism in question.\nIn general, transposons tend to insert themselves into regions of the genome that are rich in certain DNA sequences, such as GC-rich regions or regions with a high degree of nucleotide variability. These regions are often referred to as \"hotspots\" for transposon insertion.\nAdditionally, transposons may preferentially insert themselves into regions of the genome that are rich in certain types of regulatory elements, such as enhancers or silencers. These regions can influence the expression of nearby genes and may be more likely to be targeted by transposons.\nIt's also worth noting that the preferential selection of genomic positions for transposon insertion can be influenced by the activity of the host organism's immune system. For example, some transposons may be recognized by the host's immune system and targeted for destruction, leading to preferential insertion into certain regions of the genome.\nOverall, the preferential selection of genomic positions for transposon insertion is a complex and multifaceted process that can vary depending on the specific transposon and the organism in question.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Transposon insertion is a process by which mobile DNA elements, such as transposons, insert themselves into the genome of an organism.\n2. The preferential selection of genomic positions for transposon insertion can vary depending on the specific transposon and the organism in question.\n3. Transposons tend to insert themselves into regions of the genome that are rich in certain DNA sequences, such as GC-rich regions or regions with a high degree of nucleotide variability.\n4. Transposons may preferentially insert themselves into regions of the genome that are rich in certain types of regulatory elements, such as enhancers or silencers.\n5. The preferential selection of genomic positions for transposon insertion can be influenced by the activity of the host organism's immune system.",
    "vicuna-7b_fact": [
      "Transposon insertion is a process by which mobile DNA elements, such as transposons, insert themselves into the genome of an organism.",
      "The preferential selection of genomic positions for transposon insertion can vary depending on the specific transposon and the organism in question.",
      "Transposons tend to insert themselves into regions of the genome that are rich in certain DNA sequences, such as GC-rich regions or regions with a high degree of nucleotide variability.",
      "Transposons may preferentially insert themselves into regions of the genome that are rich in certain types of regulatory elements, such as enhancers or silencers.",
      "The preferential selection of genomic positions for transposon insertion can be influenced by the activity of the host organism's immune system."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-7b_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. Common Lisp Image Processing (CLIP): CLIP is a library for image processing in Common Lisp. It provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n2. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n3. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n4. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n5. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\nIt's worth noting that these frameworks are not the only ones available, and there are many other libraries and frameworks that can be used for image processing in Lisp.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.\n2. CLIP provides a wide range of image processing functions such as filtering, thresholding, and morphological operations.\n3. Lisp-based Image Processing System (LIPS) provides functions for image processing.\n4. Lisp-based Image Processing Library (LIP) is another Lisp-based image processing library which offers a range of functions including filtering, thresholding, and morphological operations.\n5. There are several libraries and frameworks available for image processing in Lisp.",
    "vicuna-7b_fact": [
      "Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.",
      "CLIP provides a wide range of image processing functions such as filtering, thresholding, and morphological operations.",
      "Lisp-based Image Processing System (LIPS) provides functions for image processing.",
      "Lisp-based Image Processing Library (LIP) is another Lisp-based image processing library which offers a range of functions including filtering, thresholding, and morphological operations.",
      "There are several libraries and frameworks available for image processing in Lisp."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2751,
    "user_query": "List four features of the WHIM syndrome.",
    "vicuna-7b_response": "WHIM syndrome, also known as Wiskott-Aldrich syndrome-like with deficiency in complement component 5, is a rare genetic disorder characterized by a deficiency in the complement component 5 protein. This leads to a range of symptoms, including:\n1. Increased susceptibility to infections: Individuals with WHIM syndrome have a higher risk of developing infections due to their decreased ability to fight off pathogens.\n2. Low levels of platelets: Platelets are a type of blood cell that help with blood clotting. Individuals with WHIM syndrome often have low levels of platelets.\n3. Eczema-like rash: Some individuals with WHIM syndrome may develop an eczema-like rash on their skin.\n4. Autoimmune disorders: WHIM syndrome is associated with an increased risk of developing autoimmune disorders, such as autoimmune thrombocytopenia and autoimmune hemolytic anemia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. WHIM syndrome is a rare genetic disorder characterized by a deficiency in the complement component 5 protein.\n2. Individuals with WHIM syndrome have a higher risk of developing infections due to their decreased ability to fight off pathogens.\n3. Individuals with WHIM syndrome often have low levels of platelets.\n4. Some individuals with WHIM syndrome may develop an eczema-like rash on their skin.\n5. WHIM syndrome is associated with an increased risk of developing autoimmune disorders, such as autoimmune thrombocytopenia and autoimmune hemolytic anemia.",
    "vicuna-7b_fact": [
      "WHIM syndrome is a rare genetic disorder characterized by a deficiency in the complement component 5 protein.",
      "Individuals with WHIM syndrome have a higher risk of developing infections due to their decreased ability to fight off pathogens.",
      "Individuals with WHIM syndrome often have low levels of platelets.",
      "Some individuals with WHIM syndrome may develop an eczema-like rash on their skin.",
      "WHIM syndrome is associated with an increased risk of developing autoimmune disorders, such as autoimmune thrombocytopenia and autoimmune hemolytic anemia."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: WHIM syndrome is a rare genetic disorder characterized by a deficiency in the CXCR4 protein, not the complement component 5 protein.\n2. TRUE\n3. FALSE [correction]: Individuals with WHIM syndrome often have high levels of platelets, not low levels. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2753,
    "user_query": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?",
    "vicuna-7b_response": "The gut microbiome of infants is typically dominated by bacteria from the phylum Firmicutes and the class Bacteroidetes. However, following exposure to furry pets, other bacteria may be enriched in the gut microbiome of infants.\nStudies have shown that exposure to furry pets, such as dogs and cats, can lead to an increase in the abundance of certain bacteria in the gut microbiome of infants. For example, a study published in the journal Microbiome in 2020 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Blautia coccoides in the gut microbiome of infants. Blautia coccoides is a member of the phylum Firmicutes.\nAdditionally, exposure to furry pets has been shown to increase the abundance of other bacteria in the gut microbiome of infants, such as members of the class Bacteroidetes. For example, a study published in the journal Microbiome in 2019 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Prevotella bryantii in the gut microbiome of infants. Prevotella bryantii is a member of the class Bacteroidetes.\nOverall, exposure to furry pets can lead to an increase in the abundance of bacteria from the phylum Firmicutes and the class Bacteroidetes in the gut microbiome of infants. However, the specific bacteria that are enriched in the gut microbiome of infants following exposure to furry pets can vary depending on the study and the specific bacteria being measured.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The gut microbiome of infants is typically dominated by bacteria from the phylum Firmicutes and the class Bacteroidetes.\n2. Exposure to furry pets, such as dogs and cats, can lead to an increase in the abundance of certain bacteria in the gut microbiome of infants.\n3. A study published in the journal Microbiome in 2020 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Blautia coccoides in the gut microbiome of infants.\n4. A study published in the journal Microbiome in 2019 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Prevotella bryantii in the gut microbiome of infants.\n5. Exposure to furry pets can lead to an increase in the abundance of bacteria from the phylum Firmicutes and the class Bacteroidetes in the gut microbiome of infants.",
    "vicuna-7b_fact": [
      "The gut microbiome of infants is typically dominated by bacteria from the phylum Firmicutes and the class Bacteroidetes.",
      "Exposure to furry pets, such as dogs and cats, can lead to an increase in the abundance of certain bacteria in the gut microbiome of infants.",
      "A study published in the journal Microbiome in 2020 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Blautia coccoides in the gut microbiome of infants.",
      "A study published in the journal Microbiome in 2019 found that exposure to dogs during early life was associated with an increase in the abundance of the bacterium Prevotella bryantii in the gut microbiome of infants.",
      "Exposure to furry pets can lead to an increase in the abundance of bacteria from the phylum Firmicutes and the class Bacteroidetes in the gut microbiome of infants."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2755,
    "user_query": "Is Baloxavir effective for influenza?",
    "vicuna-7b_response": "Baloxavir marboxil, also known as Xofluza, is a medication that is approved for the treatment of influenza (the flu) in people 12 years of age and older. It is a single-dose oral antiviral drug that works by targeting the flu virus at an early stage of its replication.\nStudies have shown that Baloxavir marboxil is effective in reducing the severity and duration of flu symptoms when taken within 48 hours of getting sick. The drug works by blocking the release of new flu virus particles, which helps to reduce the spread of the virus in the body.\nIt is important to note that while Baloxavir marboxil can help to shorten the duration of the flu, it is not a substitute for getting vaccinated against the flu. Vaccination is the best way to prevent the spread of influenza and protect against serious complications such as pneumonia and hospitalization.\nOverall, Baloxavir marboxil is a promising new treatment option for influenza, and it is generally well-tolerated with a low risk of side effects. However, as with any medication, it is important to talk to your healthcare provider before taking Baloxavir marboxil to determine if it is right for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Baloxavir marboxil, also known as Xofluza, is approved for the treatment of influenza in people aged 12 and older.\n2. Baloxavir marboxil is a single-dose oral antiviral drug.\n3. Baloxavir marboxil works by targeting the flu virus at an early stage of its replication.\n4. Baloxavir marboxil can reduce the severity and duration of flu symptoms if taken within 48 hours of getting sick.\n5. Baloxavir marboxil is not a substitute for getting vaccinated against the flu.",
    "vicuna-7b_fact": [
      "Baloxavir marboxil, also known as Xofluza, is approved for the treatment of influenza in people aged 12 and older.",
      "Baloxavir marboxil is a single-dose oral antiviral drug.",
      "Baloxavir marboxil works by targeting the flu virus at an early stage of its replication.",
      "Baloxavir marboxil can reduce the severity and duration of flu symptoms if taken within 48 hours of getting sick.",
      "Baloxavir marboxil is not a substitute for getting vaccinated against the flu."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-7b_response": "The genome of Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 100 million years ago, which resulted in the formation of a pair of homologous chromosomes. This event led to the duplication of approximately 90% of the yeast genes, with each duplicate gene being present on one of the two homologous chromosomes.\nThe duplication event had a profound impact on the evolution of the yeast genome, leading to the expansion of gene families, the emergence of new functions, and the adaptation of the organism to its environment. The duplicated genes have been subject to various forms of evolutionary change, including gene loss, functional divergence, and neo-functionalization, which has contributed to the complexity and diversity of the yeast genome.\nIn summary, approximately 90% of the genes in the genome of Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The genome of Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 100 million years ago.\n2. This event led to the duplication of approximately 90% of the yeast genes.\n3. Each duplicate gene is present on one of the pair of homologous chromosomes formed due to this event.\n4. The ancient genome duplication has had a major impact on the yeast genome evolution such as expansion of gene families, emergence of new functions, and adaption to its environment.\n5. Approximately 90% of the genes in the genome of Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
    "vicuna-7b_fact": [
      "The genome of Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 100 million years ago.",
      "This event led to the duplication of approximately 90% of the yeast genes.",
      "Each duplicate gene is present on one of the pair of homologous chromosomes formed due to this event.",
      "The ancient genome duplication has had a major impact on the yeast genome evolution such as expansion of gene families, emergence of new functions, and adaption to its environment.",
      "Approximately 90% of the genes in the genome of Saccharomyces cerevisiae are the result of an ancient whole genome duplication event."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "vicuna-7b_response": "Estrogen-related receptor β (Esrrb) is a nuclear receptor that is primarily expressed in the brain and testis. It is a member of the nuclear receptor superfamily and belongs to the estrogen receptor (ER) family of transcription factors. Esrrb is known to play a role in the regulation of various biological processes, including cell proliferation, differentiation, and apoptosis.\nThere are several ligands that have been identified as binding to Esrrb, including estrogens, androgens, and various synthetic compounds. However, the specific complex that is bound by Esrrb is not well characterized.\nIt is important to note that Esrrb is a transcription factor, and its activity is regulated by the binding of its ligands to its DNA-binding domain. The binding of ligands to Esrrb can lead to the formation of a complex that includes the receptor, coactivators, and corepressors, which can then interact with DNA to regulate the expression of target genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Estrogen-related receptor β (Esrrb) is a nuclear receptor primarily expressed in the brain and testis.\n2. Esrrb is a member of the nuclear receptor superfamily and belongs to the estrogen receptor (ER) family of transcription factors.\n3. Esrrb is involved in the regulation of cell proliferation, differentiation, and apoptosis.\n4. Several ligands, including estrogens, androgens, and various synthetic compounds, can bind to Esrrb.\n5. The activity of Estrogen-related receptor β is regulated by the binding of its ligands to its DNA-binding domain.",
    "vicuna-7b_fact": [
      "Estrogen-related receptor β (Esrrb) is a nuclear receptor primarily expressed in the brain and testis.",
      "Esrrb is a member of the nuclear receptor superfamily and belongs to the estrogen receptor (ER) family of transcription factors.",
      "Esrrb is involved in the regulation of cell proliferation, differentiation, and apoptosis.",
      "Several ligands, including estrogens, androgens, and various synthetic compounds, can bind to Esrrb.",
      "The activity of Estrogen-related receptor β is regulated by the binding of its ligands to its DNA-binding domain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The activity of Estrogen-related receptor β (Esrrb) is regulated by the binding of its ligands to its ligand-binding domain, not its DNA-binding domain.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2773,
    "user_query": "Which database associates human noncoding SNPs with their three-dimensional interacting genes?",
    "vicuna-7b_response": "There are several databases that associate human noncoding SNPs with their three-dimensional interacting genes. One such database is the Human Protein Reference Database (HPRD), which is a comprehensive database of human proteins that includes information on their three-dimensional structure, interactions, and functional annotations.\nHPRD provides a tool called the \"Human Protein Interaction Database\" (HPIDB), which allows users to search for human proteins based on their three-dimensional structure and interactions. The database also includes information on the genes that encode these proteins, including noncoding SNPs that may affect their function.\nAnother database that associates human noncoding SNPs with their three-dimensional interacting genes is the \"Human Gene Mutation Database\" (HGMD), which is a comprehensive database of human genetic mutations that includes information on their functional impact on gene products. The database also includes information on the genes that are affected by these mutations, including noncoding SNPs that may affect their function.\nIn addition to these databases, there are several other databases that provide information on the three-dimensional structure and interactions of human proteins, including the \"PDBsum\" database, the \"InterPro\" database, and the \"KEGG\" database. These databases can be used to identify genes that are associated with noncoding SNPs and to understand the functional impact of these SNPs on gene products.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Human Protein Reference Database (HPRD) is a comprehensive database of human proteins that includes information on their three-dimensional structure, interactions, and functional annotations.\n2. The HPRD provides a tool called the \"Human Protein Interaction Database\" (HPIDB) which allows for searches for human proteins based on their three-dimensional structure and interactions.\n3. The \"Human Gene Mutation Database\" (HGMD) is a comprehensive database of human genetic mutations that includes information on their functional impact on gene products.\n4. The HGMD includes information on the genes that are affected by these mutations, including noncoding SNPs that may affect their function.\n5. The \"PDBsum\" database, the \"InterPro\" database, and the \"KEGG\" database are other databases that provide information on the three-dimensional structure and interactions of human proteins.",
    "vicuna-7b_fact": [
      "The Human Protein Reference Database (HPRD) is a comprehensive database of human proteins that includes information on their three-dimensional structure, interactions, and functional annotations.",
      "The HPRD provides a tool called the \"Human Protein Interaction Database\" (HPIDB) which allows for searches for human proteins based on their three-dimensional structure and interactions.",
      "The \"Human Gene Mutation Database\" (HGMD) is a comprehensive database of human genetic mutations that includes information on their functional impact on gene products.",
      "The HGMD includes information on the genes that are affected by these mutations, including noncoding SNPs that may affect their function.",
      "The \"PDBsum\" database, the \"InterPro\" database, and the \"KEGG\" database are other databases that provide information on the three-dimensional structure and interactions of human proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Human Protein Reference Database (HPRD) provides a range of information on human proteins, but it does not contain a specific tool called \"Human Protein Interaction Database\" (HPIDB).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2778,
    "user_query": "What is the role of fucokinase?",
    "vicuna-7b_response": "Fucokinase is an enzyme that plays a crucial role in the metabolism of fucose, a type of sugar that is found in certain types of glycoproteins and glycolipids. Fucose is a modified sugar that is attached to the terminal position of a sugar molecule, and it is found in a wide variety of organisms, including bacteria, plants, and animals.\nFucokinase is responsible for the transfer of a phosphate group from ATP to fucose, which is the first step in the metabolism of fucose. This enzyme is found in the endoplasmic reticulum and the Golgi apparatus of eukaryotic cells, and it is responsible for the synthesis of fucose-containing glycoproteins and glycolipids.\nFucokinase is an important enzyme in the biosynthesis of glycoproteins and glycolipids, which are involved in a wide variety of cellular processes, including cell adhesion, signaling, and recognition. Dysfunction of fucokinase can lead to a variety of diseases, including congenital disorders of glycosylation, which are characterized by abnormalities in the structure of glycoproteins and glycolipids.\nIn summary, fucokinase is an enzyme that plays a crucial role in the metabolism of fucose, and it is involved in the synthesis of fucose-containing glycoproteins and glycolipids. Dysfunction of fucokinase can lead to a variety of diseases, including congenital disorders of glycosylation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fucokinase is an enzyme that plays a crucial role in the metabolism of fucose.\n2. Fucokinase transfers a phosphate group from ATP to fucose, which is the first step in the metabolism of fucose.\n3. Fucokinase is found in the endoplasmic reticulum and the Golgi apparatus of eukaryotic cells.\n4. The enzyme is responsible for the synthesis of fucose-containing glycoproteins and glycolipids.\n5. Dysfunction of fucokinase can lead to a variety of diseases, including congenital disorders of glycosylation.",
    "vicuna-7b_fact": [
      "Fucokinase is an enzyme that plays a crucial role in the metabolism of fucose.",
      "Fucokinase transfers a phosphate group from ATP to fucose, which is the first step in the metabolism of fucose.",
      "Fucokinase is found in the endoplasmic reticulum and the Golgi apparatus of eukaryotic cells.",
      "The enzyme is responsible for the synthesis of fucose-containing glycoproteins and glycolipids.",
      "Dysfunction of fucokinase can lead to a variety of diseases, including congenital disorders of glycosylation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2785,
    "user_query": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "vicuna-7b_response": "Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two different types of genetic events that can occur in eukaryotic organisms, including yeast. WGDs involve the duplication of an entire genome, while SSDs involve the duplication of smaller segments of DNA, typically less than 1 Mb in size.\nIn general, the degree of divergence between the duplicated copies of a gene or other DNA sequence following a WGD or SSD event will depend on several factors, including the size of the duplicated region, the timing of the duplication event, and the evolutionary pressures acting on the duplicated copies.\nStudies of yeast have shown that WGDs can lead to the formation of new genes and the evolution of new functions, as well as the generation of genetic diversity through the duplication of regulatory elements and other non-coding sequences. However, the degree of divergence between the duplicated copies of a gene following a WGD event is likely to be greater than that observed following an SSD event, as the duplicated copies of a gene will have been subjected to different selective pressures and may have undergone different levels of divergence due to mutation and other evolutionary processes.\nOverall, the degree of divergence between the duplicated copies of a gene following a WGD or SSD event will depend on a variety of factors, and more research is needed to fully understand the effects of these different types of genetic events on the evolution of eukaryotic genomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two different types of genetic events that can occur in eukaryotic organisms.\n2. WGDs involve the duplication of an entire genome, while SSDs involve the duplication of smaller segments of DNA, typically less than 1 Mb in size.\n3. The degree of divergence between the duplicated copies of a gene or other DNA sequence following a WGD or SSD will depend on several factors, including the size of the duplicated region, the timing of the duplication event, and the evolutionary pressures.\n4. Studies of yeast have shown that WGDs can lead to the formation of new genes and the evolution of new functions, as well as the generation of genetic diversity.\n5. The degree of divergence between the duplicated copies of a gene following a WGD event is likely to be greater than that observed following an SSD event.",
    "vicuna-7b_fact": [
      "Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two different types of genetic events that can occur in eukaryotic organisms.",
      "WGDs involve the duplication of an entire genome, while SSDs involve the duplication of smaller segments of DNA, typically less than 1 Mb in size.",
      "The degree of divergence between the duplicated copies of a gene or other DNA sequence following a WGD or SSD will depend on several factors, including the size of the duplicated region, the timing of the duplication event, and the evolutionary pressures.",
      "Studies of yeast have shown that WGDs can lead to the formation of new genes and the evolution of new functions, as well as the generation of genetic diversity.",
      "The degree of divergence between the duplicated copies of a gene following a WGD event is likely to be greater than that observed following an SSD event."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The degree of divergence between the duplicated copies of a gene following a WGD event is not necessarily greater than that observed following an SSD event. It depends on several factors, including the rate of mutation, the nature of the selection pressures acting on the duplicates, and the time since the duplication event.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2791,
    "user_query": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Erythropoietin (EPO) is a hormone that is produced by the kidneys and plays a role in the production of red blood cells. EPO has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, but the evidence for its effectiveness is limited.\nThere is some evidence to suggest that EPO may have neuroprotective effects in animal models of ALS. Studies have shown that EPO can protect motor neurons, the type of neurons that are affected in ALS, from damage caused by chemical toxins. However, these studies were conducted in animal models and it is not clear whether the same effects would be seen in humans.\nThere have been a few small clinical trials that have investigated the use of EPO in ALS, but the results have been mixed. Some studies have shown that EPO may slow the progression of the disease, while others have not found any benefit.\nIt is important to note that the use of EPO as a treatment for ALS is not without risks. EPO is a blood product and its use can increase the risk of blood clots, which can be life-threatening. Additionally, EPO can cause anemia, which can be managed with iron supplements, but can also cause fatigue and other symptoms.\nOverall, while there is some preliminary evidence to suggest that EPO may be effective in treating ALS, more research is needed to determine its safety and effectiveness as a treatment for this disease. It is important to discuss the potential benefits and risks of any treatment with a healthcare provider before starting it.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Erythropoietin (EPO) is a hormone that is produced by the kidneys and plays a role in the production of red blood cells.\n2. EPO has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.\n3. Some studies have suggested that EPO may have neuroprotective effects in animal models of ALS.\n4. The use of EPO as a treatment for ALS can potentially increase the risk of blood clots and cause anemia.\n5. More research is needed to determine the safety and effectiveness of EPO as a treatment for ALS.",
    "vicuna-7b_fact": [
      "Erythropoietin (EPO) is a hormone that is produced by the kidneys and plays a role in the production of red blood cells.",
      "EPO has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.",
      "Some studies have suggested that EPO may have neuroprotective effects in animal models of ALS.",
      "The use of EPO as a treatment for ALS can potentially increase the risk of blood clots and cause anemia.",
      "More research is needed to determine the safety and effectiveness of EPO as a treatment for ALS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The use of EPO as a treatment for ALS can potentially increase the risk of blood clots but it does not cause anemia. It stimulates the production of red blood cells which actually helps in reducing anemia.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2795,
    "user_query": "Is chlorotoxin a peptide?",
    "vicuna-7b_response": "Chlorotoxin is a peptide. It is a toxic peptide found in the marine sponge Cladorhiza species. Chlorotoxin is composed of 11 amino acids and has a unique structure that includes a disulfide bond. The peptide is known for its cytotoxic and cytostatic properties, which make it a potential therapeutic agent for cancer treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Chlorotoxin is a peptide.\n2. Chlorotoxin is found in the marine sponge Cladorhiza species.\n3. Chlorotoxin is composed of 11 amino acids.\n4. The structure of Chlorotoxin includes a disulfide bond.\n5. Chlorotoxin is known for its cytotoxic and cytostatic properties.",
    "vicuna-7b_fact": [
      "Chlorotoxin is a peptide.",
      "Chlorotoxin is found in the marine sponge Cladorhiza species.",
      "Chlorotoxin is composed of 11 amino acids.",
      "The structure of Chlorotoxin includes a disulfide bond.",
      "Chlorotoxin is known for its cytotoxic and cytostatic properties."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Chlorotoxin is found in the venom of the deathstalker scorpion (Leiurus quinquestriatus).\n3. FALSE [correction]: Chlorotoxin is composed of 36 amino acids.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2797,
    "user_query": "Is selenocysteine an aminoacid?",
    "vicuna-7b_response": "Selenocysteine is not an amino acid. It is a non-protein-coding amino acid that is incorporated into proteins as part of a post-translational modification called seleno-amino acid incorporation. Selenocysteine is a derivative of the amino acid cysteine, and it is incorporated into proteins at specific sites called selenocysteine-containing proteins. These proteins play important roles in cellular metabolism and are involved in various biological processes, including antioxidant defense, thyroid hormone metabolism, and cell growth and division.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Selenocysteine is a non-protein-coding amino acid.\n2. Selenocysteine is incorporated into proteins as part of a post-translational modification called seleno-amino acid incorporation.\n3. Selenocysteine is a derivative of the amino acid cysteine.\n4. Selenocysteine is incorporated into proteins at specific sites called selenocysteine-containing proteins.\n5. Selenocysteine-containing proteins are involved in various biological processes, including antioxidant defense, thyroid hormone metabolism, and cell growth and division.",
    "vicuna-7b_fact": [
      "Selenocysteine is a non-protein-coding amino acid.",
      "Selenocysteine is incorporated into proteins as part of a post-translational modification called seleno-amino acid incorporation.",
      "Selenocysteine is a derivative of the amino acid cysteine.",
      "Selenocysteine is incorporated into proteins at specific sites called selenocysteine-containing proteins.",
      "Selenocysteine-containing proteins are involved in various biological processes, including antioxidant defense, thyroid hormone metabolism, and cell growth and division."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Selenocysteine is a protein-coding amino acid.\n2. FALSE [correction]: Selenocysteine is incorporated into proteins during translation, not as a post-translational modification.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2812,
    "user_query": "Which is the basis of the ATAC-Seq protocol?",
    "vicuna-7b_response": "ATAC-Seq (Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing) is a powerful technique used to study chromatin accessibility and transcriptional regulation. The basis of the ATAC-Seq protocol is the use of transposases to access chromatin regions that are otherwise inaccessible to DNA polymerase.\nThe ATAC-Seq protocol typically involves the following steps:\n1. Cell isolation and preparation: The cells of interest are isolated and prepared for library construction.\n2. Transposase treatment: The cells are treated with transposases, which are enzymes that can recognize and cut DNA at specific sites. This allows the transposases to access chromatin regions that are otherwise inaccessible to DNA polymerase.\n3. Library construction: The treated cells are then subjected to library construction, which involves the enrichment of chromatin-associated DNA fragments.\n4. Sequencing: The resulting libraries are then sequenced using next-generation sequencing (NGS) technologies, such as Illumina or PacBio sequencing.\n5. Data analysis: The sequencing data is then analyzed to identify regions of chromatin that are accessible to transposases, which can be used to infer chromatin accessibility and transcriptional regulation.\nOverall, the ATAC-Seq protocol provides a powerful tool for studying chromatin accessibility and transcriptional regulation, and has been widely used in a variety of applications, including the study of gene regulation, epigenetics, and disease biology.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ATAC-Seq stands for Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing. \n2. The basis of ATAC-Seq protocol is the use of transposases to access chromatin regions that are inaccessible to DNA polymerase. \n3. The ATAC-Seq protocol involves cell isolation and preparation, transposase treatment, library construction, sequencing and data analysis.\n4. Transposases are enzymes used in the protocol that can recognize and cut DNA at specific sites.\n5. The ATAC-Seq protocol has been used in the study of subjects such as gene regulation, epigenetics, and disease biology.",
    "vicuna-7b_fact": [
      "ATAC-Seq stands for Assay for Transposase-Accessible Chromatin by Next-Generation Sequencing.",
      "The basis of ATAC-Seq protocol is the use of transposases to access chromatin regions that are inaccessible to DNA polymerase.",
      "The ATAC-Seq protocol involves cell isolation and preparation, transposase treatment, library construction, sequencing and data analysis.",
      "Transposases are enzymes used in the protocol that can recognize and cut DNA at specific sites.",
      "The ATAC-Seq protocol has been used in the study of subjects such as gene regulation, epigenetics, and disease biology."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2813,
    "user_query": "What is vcfanno?",
    "vicuna-7b_response": "VCFanno is a tool that is used to annotate and manipulate vcf files. VCF stands for Variation",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. VCFanno is a tool that is used to annotate and manipulate vcf files.\n2. VCF stands for Variation.",
    "vicuna-7b_fact": [
      "VCFanno is a tool that is used to annotate and manipulate vcf files.",
      "VCF stands for Variation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: VCF stands for Variant Call Format.",
    "vicuna-7b_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2816,
    "user_query": "What are the \"Ohnologs\"?",
    "vicuna-7b_response": "The Ohnologs are a fictional race of beings in the anime and manga series \"One Punch Man\". They are a highly advanced and powerful race of beings that are capable of controlling the elements and possess immense physical strength. They are often depicted as being incredibly powerful and mysterious, and are considered to be some of the strongest beings in the series.\nIn the series, the Ohnologs are often referred to as the \"gods of destruction\" due to their immense power and destructive capabilities. They are also known for their unique appearance, with some being depicted as humanoid figures while others are depicted as giant, monstrous beings.\nIt is worth noting that the Ohnologs are not actually real beings, but rather a fictional creation of the series' creator, ONE.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Ohnologs are a fictional race of beings in the anime and manga series \"One Punch Man\".\n2. The Ohnologs are depicted as a highly advanced and powerful race of beings.\n3. They are referred to as the \"gods of destruction\" in the series.\n4. They are known for their unique appearance, with some being depicted as humanoid figures while others are depicted as giant, monstrous beings.\n5. The Ohnologs are a fictional creation of the series' creator, ONE.",
    "vicuna-7b_fact": [
      "The Ohnologs are a fictional race of beings in the anime and manga series \"One Punch Man\".",
      "The Ohnologs are depicted as a highly advanced and powerful race of beings.",
      "They are referred to as the \"gods of destruction\" in the series.",
      "They are known for their unique appearance, with some being depicted as humanoid figures while others are depicted as giant, monstrous beings.",
      "The Ohnologs are a fictional creation of the series' creator, ONE."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Ohnologs are a biological term referring to genes duplicated via whole genome duplication, they are not a fictional race in \"One Punch Man\".\n2. FALSE [correction]: As the Ohnologs are not depicted in \"One Punch Man\", it cannot be said they are a highly advanced and powerful race of beings in that series.\n3. FALSE [correction]: The term \"Ohnolog\" is not associated with the term \"gods of destruction\" in any series.\n4. FALSE [correction]: Since Ohnologs are not a fictional race in \"One Punch Man\", they don't have any specific appearance within that series.\n5. FALSE [correction]: The term Ohnologs is a biological term and not a creation of the series creator, ONE.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2818,
    "user_query": "Describe OligoSTORM",
    "vicuna-7b_response": "OligoSTORM is a powerful and versatile tool for designing and analyzing DNA oligonucleotides. It is a web-based platform that allows users to design oligonucleotides with user-defined properties, such as specific base compositions, lengths, and modifications.\nOligoSTORM uses a combination of algorithms and software tools to optimize the design of oligonucleotides for a wide range of applications, including PCR amplification, sequencing, and functional assays. The platform also includes tools for analyzing and visualizing the designed oligonucleotides, as well as for predicting their properties and potential off-target effects.\nOne of the key features of OligoSTORM is its ability to handle a wide range of user-defined constraints, such as specific base compositions, GC contents, and modifications. This allows users to design oligonucleotides with specific properties, such as increased stability or improved specificity for a particular target.\nOligoSTORM also includes a number of advanced features, such as the ability to design oligonucleotides with user-defined loop structures and to analyze the potential off-target effects of the designed oligonucleotides.\nOverall, OligoSTORM is a powerful and flexible tool for designing and analyzing DNA oligonucleotides, and it is widely used by researchers in a variety of fields, including molecular biology, genetics, and biotechnology.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. OligoSTORM is a tool for designing and analyzing DNA oligonucleotides.\n2. The platform uses a combination of algorithms and software tools.\n3. OligoSTORM is capable of designing oligonucleotides for applications such as PCR amplification, sequencing, and functional assays.\n4. It has the ability to handle a wide range of user-defined constraints.\n5. OligoSTORM is used by researchers in molecular biology, genetics, and biotechnology.",
    "vicuna-7b_fact": [
      "OligoSTORM is a tool for designing and analyzing DNA oligonucleotides.",
      "The platform uses a combination of algorithms and software tools.",
      "OligoSTORM is capable of designing oligonucleotides for applications such as PCR amplification, sequencing, and functional assays.",
      "It has the ability to handle a wide range of user-defined constraints.",
      "OligoSTORM is used by researchers in molecular biology, genetics, and biotechnology."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2825,
    "user_query": "What forms part of the senescence associated secretory phenotype, or SASP?",
    "vicuna-7b_response": "The senescence associated secretory phenotype, or SASP, is a group of secreted factors that are produced by cells during the process of senescence. Senescence is a natural process of cellular aging that occurs in all cells, and it is characterized by the irreversible growth arrest and the accumulation of cellular damage.\nThe SASP is a complex mixture of cytokines, chemokines, growth factors, and other signaling molecules that are produced by senescent cells. These factors can have both beneficial and detrimental effects on the surrounding tissue, depending on the context.\nSome of the factors that are part of the SASP include:\n* Cytokines such as IL-6, TGF-β, and IL-8, which can promote inflammation and tissue remodeling.\n* Chemokines such as MCP-1 and RANTES, which can attract immune cells to the site of senescent cells.\n* Growth factors such as PDGF-BB and VEGF, which can promote angiogenesis and tissue regeneration.\n* Signaling molecules such as p53 and p16INK4a, which can regulate cellular proliferation and apoptosis.\nThe SASP is thought to play a role in various age-related diseases, including cancer, atherosclerosis, and osteoarthritis. It is also believed to contribute to the aging process itself by promoting inflammation, fibrosis, and tissue degeneration.\nIn summary, the SASP is a complex mixture of secreted factors that are produced by cells during the process of senescence. It includes cytokines, chemokines, growth factors, and other signaling molecules that can have both beneficial and detrimental effects on the surrounding tissue.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The senescence associated secretory phenotype (SASP) is a group of secreted factors produced by cells during senescence.\n2. Senescence is characterized by the irreversible growth arrest and the accumulation of cellular damage.\n3. SASP is a mixture of cytokines, chemokines, growth factors, and other signaling molecules.\n4. SASP is thought to play a role in age-related diseases such as cancer, atherosclerosis, and osteoarthritis.\n5. It is believed that SASP contributes to the aging process by promoting inflammation, fibrosis, and tissue degeneration.",
    "vicuna-7b_fact": [
      "The senescence associated secretory phenotype (SASP) is a group of secreted factors produced by cells during senescence.",
      "Senescence is characterized by the irreversible growth arrest and the accumulation of cellular damage.",
      "SASP is a mixture of cytokines, chemokines, growth factors, and other signaling molecules.",
      "SASP is thought to play a role in age-related diseases such as cancer, atherosclerosis, and osteoarthritis.",
      "It is believed that SASP contributes to the aging process by promoting inflammation, fibrosis, and tissue degeneration."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2826,
    "user_query": "How many pseudogenes are contained in the C. elegans genome?",
    "vicuna-7b_response": "The C. elegans genome contains approximately 19,000 protein-coding genes, and it is estimated that around 10-20% of these genes are pseudogenes. This means that there are approximately 1900-3800 pseudogenes in the C. elegans genome. However, the exact number of pseudogenes in the C. elegans genome can vary depending on the source and the method used to identify them.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The C. elegans genome contains approximately 19,000 protein-coding genes.\n2. It is estimated that around 10-20% of the genes in the C. elegans genome are pseudogenes.\n3. There are approximately 1900-3800 pseudogenes in the C. elegans genome.\n4. The exact number of pseudogenes in the C. elegans genome can vary depending on the source and the method used to identify them.",
    "vicuna-7b_fact": [
      "The C. elegans genome contains approximately 19,000 protein-coding genes.",
      "It is estimated that around 10-20% of the genes in the C. elegans genome are pseudogenes.",
      "There are approximately 1900-3800 pseudogenes in the C. elegans genome.",
      "The exact number of pseudogenes in the C. elegans genome can vary depending on the source and the method used to identify them."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2827,
    "user_query": "What is a Aquaporin channel?",
    "vicuna-7b_response": "Aquaporins are a family of water-selective channels found in the membranes of cells. They play a crucial role in the regulation of water transport in various organisms, including humans. Aquaporins are responsible for the transport of water and other small molecules across cell membranes, and they are involved in a wide range of physiological processes, such as the regulation of blood pressure, the maintenance of cell volume, and the transport of nutrients and waste products.\nThere are several different types of aquaporins, each with its own unique structure and function. Aquaporins are classified into three main groups based on their size and function: aquaporins-1 (AQP1), aquaporins-2 (AQP2), and aquaporins-3 (AQP3). AQP1 is found primarily in the brain and in the kidneys, where it plays a role in regulating the balance of water and electrolytes. AQP2 is found in the lungs, where it helps to regulate the exchange of oxygen and carbon dioxide. AQP3 is found in the small intestine, where it helps to regulate the absorption of water and nutrients.\nAquaporins are important for maintaining the proper function of various organs and systems in the body. For example, the regulation of water balance by AQP1 in the brain is critical for the proper function of the nervous system. Similarly, the regulation of water and electrolyte balance by AQP2 in the lungs is important for the proper function of the respiratory system. The regulation of water and nutrient absorption by AQP3 in the small intestine is important for the proper function of the digestive system.\nIn summary, Aquaporins are a family of water-selective channels found in the membranes of cells, they play a crucial role in the regulation of water transport in various organisms, including humans. Aquaporins are responsible for the transport of water and other small molecules across cell membranes, and they are involved in a wide range of physiological processes, such as the regulation of blood pressure, the maintenance of cell volume, and the transport of nutrients and waste products. There are several different types of aquaporins, each with its own unique structure",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Aquaporins are water-selective channels found in the membranes of cells.\n2. Aquaporins are involved in a wide range of physiological processes, including the regulation of blood pressure, maintenance of cell volume, and the transport of nutrients and waste products.\n3. There are several types of Aquaporins, including Aquaporins-1, Aquaporins-2, and Aquaporins-3.\n4. Aquaporin-1 is primarily found in the brain and kidneys, where it regulates the balance of water and electrolytes.\n5. Aquaporin-3 is found in the small intestine, where it regulates the absorption of water and nutrients.",
    "vicuna-7b_fact": [
      "Aquaporins are water-selective channels found in the membranes of cells.",
      "Aquaporins are involved in a wide range of physiological processes, including the regulation of blood pressure, maintenance of cell volume, and the transport of nutrients and waste products.",
      "There are several types of Aquaporins, including Aquaporins-1, Aquaporins-2, and Aquaporins-3.",
      "Aquaporin-1 is primarily found in the brain and kidneys, where it regulates the balance of water and electrolytes.",
      "Aquaporin-3 is found in the small intestine, where it regulates the absorption of water and nutrients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2832,
    "user_query": "Is durvalumab used for lung cancer treatment?",
    "vicuna-7b_response": "Durvalumab is a type of drug called a monoclonal antibody that is used to treat various types of cancer, including lung cancer. It is specifically approved for the treatment of non-small cell lung cancer (NSCLC) in patients who have previously received chemotherapy.\nDurvalumab works by targeting the PD-L1 protein on the surface of cancer cells. PD-L1 is a protein that helps cancer cells evade the immune system and can also contribute to the development of tumors. By blocking PD-L1, durvalumab helps to activate the immune system and attack the cancer cells.\nDurvalumab is typically given as an intravenous (IV) infusion and is usually administered in combination with another drug called platinum-based chemotherapy. The exact dosage and treatment schedule will depend on the individual patient and the specific type of lung cancer they have.\nIt is important to note that durvalumab is not a cure for lung cancer and may not work for all patients. However, it can help to slow the growth of the cancer and improve the symptoms of the disease. If you have been diagnosed with lung cancer and are considering durvalumab as a treatment option, it is important to discuss the potential benefits and risks with your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Durvalumab is a monoclonal antibody used to treat various types of cancer, including lung cancer.\n2. Durvalumab is specifically approved for the treatment of non-small cell lung cancer (NSCLC) in patients who have previously received chemotherapy.\n3. Durvalumab works by targeting the PD-L1 protein on the surface of cancer cells and activating the immune system to attack the cancer cells.\n4. Durvalumab is typically given as an intravenous (IV) infusion in combination with platinum-based chemotherapy.\n5. Durvalumab is not a cure for lung cancer and may not work for all patients.",
    "vicuna-7b_fact": [
      "Durvalumab is a monoclonal antibody used to treat various types of cancer, including lung cancer.",
      "Durvalumab is specifically approved for the treatment of non-small cell lung cancer (NSCLC) in patients who have previously received chemotherapy.",
      "Durvalumab works by targeting the PD-L1 protein on the surface of cancer cells and activating the immune system to attack the cancer cells.",
      "Durvalumab is typically given as an intravenous (IV) infusion in combination with platinum-based chemotherapy.",
      "Durvalumab is not a cure for lung cancer and may not work for all patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2836,
    "user_query": "Describe information obtained by immunophenotyping.",
    "vicuna-7b_response": "Immunophenotyping is a laboratory technique used to identify and characterize cells in the body based on their surface antigens. It involves the use of monoclonal antibodies, which are specific antibodies that recognize and bind to a particular antigen, to identify and isolate specific cell populations.\nThe information obtained from immunophenotyping can be used to diagnose various diseases, monitor the response to treatment, and to understand the biology of normal and abnormal cell development.\nFor example, in cancer diagnosis, immunophenotyping can be used to identify specific cancer cells and differentiate them from normal cells. This information can be used to determine the stage of the cancer and to guide treatment decisions.\nIn addition, immunophenotyping can be used to identify specific immune cell populations, such as T cells, B cells, and natural killer cells, and to understand their role in the immune response.\nOverall, immunophenotyping is a powerful tool for understanding the cellular and immune response in various diseases and for guiding diagnosis and treatment decisions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Immunophenotyping identifies and characterizes cells in the body based on their surface antigens.\n2. The technique of immunophenotyping involves the use of monoclonal antibodies.\n3. Immunophenotyping is utilized to diagnose diseases, monitor responses to treatment, and understand cell development.\n4. In cancer diagnosis, immunophenotyping can differentiate between cancer cells and normal cells.\n5. Immunophenotyping can be used to identify specific immune cell populations such as T cells, B cells, and natural killer cells.",
    "vicuna-7b_fact": [
      "Immunophenotyping identifies and characterizes cells in the body based on their surface antigens.",
      "The technique of immunophenotyping involves the use of monoclonal antibodies.",
      "Immunophenotyping is utilized to diagnose diseases, monitor responses to treatment, and understand cell development.",
      "In cancer diagnosis, immunophenotyping can differentiate between cancer cells and normal cells.",
      "Immunophenotyping can be used to identify specific immune cell populations such as T cells, B cells, and natural killer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-7b_response": "ZCCHC17 is a protein that plays a role in the regulation of the cell cycle. Specifically, it is a member of the Zinc Finger CCCH Zinc Finger Proteins family, which are known to be involved in the regulation of various cellular processes, including cell cycle progression.\nThe exact function of ZCCHC17 in the cell cycle is not fully understood, but it is thought to play a role in the regulation of the G1 phase of the cell cycle. During this phase, cells undergo DNA replication and cell growth, and ZCCHC17 may be involved in the regulation of these processes.\nAdditionally, ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4, suggesting that it may play a role in the regulation of these proteins and their activity.\nOverall, while more research is needed to fully understand the role of ZCCHC17 in the cell cycle, it is clear that it plays a critical role in the regulation of this process and may be a promising target for the development of new cancer therapies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ZCCHC17 is a protein that plays a role in the regulation of the cell cycle.\n2. ZCCHC17 is a member of the Zinc Finger CCCH Zinc Finger Proteins family.\n3. ZCCHC17 is thought to play a role in the regulation of the G1 phase of the cell cycle.\n4. ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4.\n5. The regulation of the cell cycle by ZCCHC17 may be a promising target for the development of new cancer therapies.",
    "vicuna-7b_fact": [
      "ZCCHC17 is a protein that plays a role in the regulation of the cell cycle.",
      "ZCCHC17 is a member of the Zinc Finger CCCH Zinc Finger Proteins family.",
      "ZCCHC17 is thought to play a role in the regulation of the G1 phase of the cell cycle.",
      "ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4.",
      "The regulation of the cell cycle by ZCCHC17 may be a promising target for the development of new cancer therapies."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2844,
    "user_query": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "vicuna-7b_response": "Epidural anesthesia is a common method of pain management during labor. It involves the injection of a local anesthetic into the epidural space, which is the area around the spinal cord. The anesthetic numbs the lower half of the body, including the uterus, making labor more manageable.\nThe Apgar score is a measure of the physical condition of a newborn baby at one minute after birth. It is used to assess the baby's overall health and to identify any potential problems. The Apgar score is based on five factors:\n1. Heart rate: The baby's heart rate should be 100-160 beats per minute.\n2. Respiratory effort: The baby should be making active, effective breathing movements.\n3. Skin color: The baby's skin color should be pink or purple.\n4. Muscle tone: The baby's muscle tone should be flexible.\n5. Reflex irritability: The baby should be responsive to stimuli and have a strong cry.\nEpidural anesthesia itself does not affect the Apgar score of the infant. However, there are some potential risks associated with epidural anesthesia that could potentially affect the baby's Apgar score. For example, if the anesthetic causes the baby's heart rate to drop too low, it could affect the baby's heart rate factor in the Apgar score. Additionally, if the anesthetic causes the baby to become too relaxed or sedated, it could affect the baby's muscle tone factor in the Apgar score.\nIt is important to note that the Apgar score is just one measure of a newborn's health, and it should not be used as the sole indicator of a baby's overall health. A healthcare provider will assess the baby's overall condition and may perform additional tests to ensure that the baby is healthy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Epidural anesthesia involves the injection of a local anesthetic into the epidural space, which is the area around the spinal cord.\n2. The Apgar score is a measure of the physical condition of a newborn baby at one minute after birth.\n3. The Apgar score is based on five factors: heart rate, respiratory effort, skin color, muscle tone, and reflex irritability.\n4. Epidural anesthesia does not affect the Apgar score of the infant, but potential risks associated with epidural anesthesia could potentially affect the baby's Apgar score.\n5. The Apgar score is just one measure of a newborn's health, and it should not be used as the sole indicator of a baby's overall health.",
    "vicuna-7b_fact": [
      "Epidural anesthesia involves the injection of a local anesthetic into the epidural space, which is the area around the spinal cord.",
      "The Apgar score is a measure of the physical condition of a newborn baby at one minute after birth.",
      "The Apgar score is based on five factors: heart rate, respiratory effort, skin color, muscle tone, and reflex irritability.",
      "Epidural anesthesia does not affect the Apgar score of the infant, but potential risks associated with epidural anesthesia could potentially affect the baby's Apgar score.",
      "The Apgar score is just one measure of a newborn's health, and it should not be used as the sole indicator of a baby's overall health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2846,
    "user_query": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "vicuna-7b_response": "Phospholipid hydroperoxide glutathione peroxidase (PHGP) is a selenoprotein. Selenoproteins are proteins that contain the element selenium, which is an essential trace element for many biological processes. PHGP is a selenium-containing enzyme that plays a critical role in the protection of cell membranes from oxidative damage. It is found in many tissues, including the liver, kidney, and heart, and is involved in the detoxification of lipid peroxides, which are highly reactive molecules that can cause damage to cell membranes and other important biological molecules.\nSelenium is an essential trace element that is required for the proper functioning of many enzymes and proteins in the body. Selenoproteins are a class of proteins that contain selenium-containing amino acid sequences, and they play important roles in many biological processes, including the regulation of gene expression, the immune response, and the detoxification of harmful substances. PHGP is one of several selenoproteins that are involved in the protection of cell membranes from oxidative damage.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phospholipid hydroperoxide glutathione peroxidase (PHGP) is a selenoprotein.\n2. Selenoproteins contain the element selenium.\n3. PHGP is an enzyme that plays a role in the protection of cell membranes from oxidative damage.\n4. PHGP is found in many tissues including the liver, kidney, and heart.\n5. PHGP is involved in the detoxification of lipid peroxides.",
    "vicuna-7b_fact": [
      "Phospholipid hydroperoxide glutathione peroxidase (PHGP) is a selenoprotein.",
      "Selenoproteins contain the element selenium.",
      "PHGP is an enzyme that plays a role in the protection of cell membranes from oxidative damage.",
      "PHGP is found in many tissues including the liver, kidney, and heart.",
      "PHGP is involved in the detoxification of lipid peroxides."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2851,
    "user_query": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "vicuna-7b_response": "TIAM1 (TGFβ-inducible early gene 1) is a protein that has been shown to play a role in the progression of colorectal cancer (CRC). Studies have suggested that high levels of TIAM1 expression in tumor cells may contribute to the development of aggressive and metastatic CRC.\nOne study published in the journal Cancer Research found that TIAM1 expression was significantly higher in CRC tissues compared to normal colon tissues. Additionally, the study found that TIAM1 expression was associated with poor prognosis in CRC patients.\nAnother study published in the journal Clinical Cancer Research found that TIAM1 expression was associated with poor overall survival in patients with stage III colon cancer.\nHowever, it is important to note that more research is needed to fully understand the role of TIAM1 in the progression of CRC. Additionally, other factors such as the tumor microenvironment, patient characteristics, and treatment options may also play a role in the progression of CRC.\nIn summary, TIAM1 has been shown to be associated with the progression of colorectal cancer, but more research is needed to fully understand its role in the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TIAM1 is a protein that plays a role in the progression of colorectal cancer (CRC).\n2. High levels of TIAM1 expression in tumor cells may contribute to the development of aggressive and metastatic CRC.\n3. A study published in the journal Cancer Research found that TIAM1 expression was significantly higher in CRC tissues compared to normal colon tissues.\n4. The same study found that TIAM1 expression was associated with poor prognosis in CRC patients.\n5. Another study published in the journal Clinical Cancer Research found that TIAM1 expression was associated with poor overall survival in patients with stage III colon cancer.",
    "vicuna-7b_fact": [
      "TIAM1 is a protein that plays a role in the progression of colorectal cancer (CRC).",
      "High levels of TIAM1 expression in tumor cells may contribute to the development of aggressive and metastatic CRC.",
      "A study published in the journal Cancer Research found that TIAM1 expression was significantly higher in CRC tissues compared to normal colon tissues.",
      "The same study found that TIAM1 expression was associated with poor prognosis in CRC patients.",
      "Another study published in the journal Clinical Cancer Research found that TIAM1 expression was associated with poor overall survival in patients with stage III colon cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2854,
    "user_query": "Is pacritinib effective for treatment of myelofibrosis?",
    "vicuna-7b_response": "Pacritinib is a medication that is being studied for the treatment of myelofibrosis, a type of bone marrow disorder. Myelofibrosis is a condition in which the bone marrow becomes scarred and does not produce enough healthy blood cells.\nPacritinib is a medication that is designed to target a specific protein called JAK2, which is involved in the growth and survival of cells in the bone marrow. By inhibiting the activity of JAK2, pacritinib may help to reduce the scarring in the bone marrow and improve the production of healthy blood cells in people with myelofibrosis.\nThere have been several clinical trials of pacritinib in people with myelofibrosis, and some of these studies have shown that the medication can help to reduce the symptoms of the condition, such as fatigue, abnormal bleeding, and an enlarged spleen. However, it is important to note that not all patients respond to pacritinib, and the medication can have side effects.\nOverall, while pacritinib has shown promise in the treatment of myelofibrosis, more research is needed to fully understand its effectiveness and safety in people with the condition. It is important to discuss the potential benefits and risks of pacritinib with a healthcare provider who is familiar with the medication and can provide personalized advice.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pacritinib is being studied for the treatment of myelofibrosis.\n2. Myelofibrosis is a condition in which the bone marrow becomes scarred and does not produce enough healthy blood cells.\n3. Pacritinib is designed to target a specific protein called JAK2, which is involved in the growth and survival of cells in the bone marrow.\n4. Several clinical trials of pacritinib have shown that the medication can help to reduce the symptoms of myelofibrosis.\n5. More research is needed to fully understand the effectiveness and safety of pacritinib in people with myelofibrosis.",
    "vicuna-7b_fact": [
      "Pacritinib is being studied for the treatment of myelofibrosis.",
      "Myelofibrosis is a condition in which the bone marrow becomes scarred and does not produce enough healthy blood cells.",
      "Pacritinib is designed to target a specific protein called JAK2, which is involved in the growth and survival of cells in the bone marrow.",
      "Several clinical trials of pacritinib have shown that the medication can help to reduce the symptoms of myelofibrosis.",
      "More research is needed to fully understand the effectiveness and safety of pacritinib in people with myelofibrosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-7b_response": "The nuclear pore basket is a complex structure in the nuclear envelope that regulates the movement of molecules between the nucleus and the cytoplasm. The proteins that form the nuclear pore basket in human cells include:\n1. FG-nucleoporin proteins: These proteins are the major components of the nuclear pore complex and are responsible for forming the structural framework of the pore.\n2. Transcription factors: These proteins play a role in regulating gene expression and can interact with RNA polymerase to initiate transcription.\n3. Nuclear transport receptors: These proteins are responsible for recognizing and transporting molecules across the nuclear pore.\n4. Adaptor proteins: These proteins help to coordinate the movement of molecules across the nuclear pore and can also play a role in regulating gene expression.\n5. Nuclear pore complex associated proteins: These proteins are involved in the regulation of nuclear pore complex function and can also play a role in the transport of molecules across the pore.\nIt's important to note that the composition of the nuclear pore basket can vary depending on the cell type and the stage of the cell cycle.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The nuclear pore basket is a structure in the nuclear envelope that regulates the movement of molecules between the nucleus and the cytoplasm in human cells.\n2. FG-nucleoporin proteins form part of nuclear pore basket and they form the structural framework of the pore.\n3. Transcription factors are proteins that form the nuclear pore basket and they regulate gene expression.\n4. Nuclear transport receptors are involved in the formation of the nuclear pore; they recognize and transport molecules across the nuclear pore.\n5. Adaptor proteins help to coordinate molecular movement across the nuclear pore and also play a role in gene expression.\n6. Nuclear pore complex associated proteins contribute to the nuclear pore basket and are involved in the regulation of nuclear pore complex function.",
    "vicuna-7b_fact": [
      "The nuclear pore basket is a structure in the nuclear envelope that regulates the movement of molecules between the nucleus and the cytoplasm in human cells.",
      "FG-nucleoporin proteins form part of nuclear pore basket and they form the structural framework of the pore.",
      "Transcription factors are proteins that form the nuclear pore basket and they regulate gene expression.",
      "Nuclear transport receptors are involved in the formation of the nuclear pore; they recognize and transport molecules across the nuclear pore.",
      "Adaptor proteins help to coordinate molecular movement across the nuclear pore and also play a role in gene expression.",
      "Nuclear pore complex associated proteins contribute to the nuclear pore basket and are involved in the regulation of nuclear pore complex function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Transcription factors do not form the nuclear pore basket; they are proteins that bind to specific DNA sequences controlling the rate of transcription of genetic information from DNA to messenger RNA.\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2862,
    "user_query": "Does lucatumumab bind to CD140?",
    "vicuna-7b_response": "Lucatumumab is a monoclonal antibody that targets the CD140 molecule, also known as BTLA (B-cell maturation antigen). Lucatumumab is used in the treatment of certain types of cancer, including melanoma and non-Hodgkin lymphoma.\nCD140 is a cell surface receptor that is expressed on a variety of immune cells, including T cells, B cells, and myeloid cells. It is thought to play a role in regulating the immune response and may be involved in the suppression of T cell activation.\nLucatumumab works by binding to CD140 on the surface of cancer cells, which may help to stimulate the immune system to recognize and attack the cancer cells. It is not yet clear whether lucatumumab binds to other molecules besides CD140, but it is known to be highly specific for CD140.\nOverall, lucatumumab is a promising therapeutic agent that has shown efficacy in clinical trials for the treatment of certain types of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lucatumumab is a monoclonal antibody that targets the CD140 molecule.\n2. CD140 is also known as BTLA (B-cell maturation antigen).\n3. Lucatumumab is used in the treatment of certain types of cancer, including melanoma and non-Hodgkin lymphoma.\n4. CD140 is a cell surface receptor that is expressed on a variety of immune cells, including T cells, B cells, and myeloid cells.\n5. Lucatumumab has shown efficacy in clinical trials for the treatment of certain types of cancer.",
    "vicuna-7b_fact": [
      "Lucatumumab is a monoclonal antibody that targets the CD140 molecule.",
      "CD140 is also known as BTLA (B-cell maturation antigen).",
      "Lucatumumab is used in the treatment of certain types of cancer, including melanoma and non-Hodgkin lymphoma.",
      "CD140 is a cell surface receptor that is expressed on a variety of immune cells, including T cells, B cells, and myeloid cells.",
      "Lucatumumab has shown efficacy in clinical trials for the treatment of certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Lucatumumab is a monoclonal antibody that targets the CD40 molecule.\n2. FALSE [correction]: CD140 is also known as PDGFR (Platelet-derived growth factor receptor), not BTLA (B-cell maturation antigen).\n3. UNKNOWN\n4. FALSE [correction]: CD140, also known as PDGFR, is a cell surface receptor expressed mainly on cells of mesenchymal origin, not on a variety of immune cells.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2872,
    "user_query": "Which molecule is targeted by Olaratumab?",
    "vicuna-7b_response": "Olaratumab is a monoclonal antibody that targets the platelet-derived growth factor receptor alpha (PDGFRα). It is used in the treatment of certain types of cancer, including soft tissue sarcomas and breast cancer. Olaratumab binds to PDGFRα and inhibits its activity, which can slow the growth and spread of cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Olaratumab is a monoclonal antibody.\n2. Olaratumab targets the platelet-derived growth factor receptor alpha (PDGFRα).\n3. Olaratumab is used in the treatment of certain types of cancer, including soft tissue sarcomas and breast cancer.\n4. Olaratumab binds to PDGFRα and inhibits its activity.\n5. The activity of Olaratumab can slow the growth and spread of cancer cells.",
    "vicuna-7b_fact": [
      "Olaratumab is a monoclonal antibody.",
      "Olaratumab targets the platelet-derived growth factor receptor alpha (PDGFRα).",
      "Olaratumab is used in the treatment of certain types of cancer, including soft tissue sarcomas and breast cancer.",
      "Olaratumab binds to PDGFRα and inhibits its activity.",
      "The activity of Olaratumab can slow the growth and spread of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Olaratumab is used in the treatment of certain types of cancer, specifically advanced soft tissue sarcoma. There is no mention of its usage in treating breast cancer.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2874,
    "user_query": "Are phagosomal proteins ubiquitinated?",
    "vicuna-7b_response": "Yes, phagosomal proteins can be ubiquitinated. Ubiquitination is a post-translational modification that involves the attachment of ubiquitin molecules to a lysine residue on a target protein. This modification can regulate various cellular processes, including protein degradation, trafficking, and signaling.\nIn the case of phagosomes, ubiquitinated proteins have been identified that play a role in phagosome maturation and clearance. For example, ubiquitinated proteins have been shown to be involved in the degradation of phagosomal components, such as mitochondria and endosomes, to ensure efficient phagocytosis. Additionally, ubiquitinated proteins have been implicated in the regulation of phagosome-lysosome fusion, which is essential for the degradation of phagocytosed material.\nOverall, ubiquitination plays an important role in regulating various aspects of phagosome biology, including protein degradation, trafficking, and clearance.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phagosomal proteins can be ubiquitinated.\n2. Ubiquitination is a post-translational modification that involves the attachment of ubiquitin molecules to a lysine residue on a target protein.\n3. This modification can regulate various cellular processes, including protein degradation, trafficking, and signaling.\n4. Ubiquitinated proteins have been identified that play a role in phagosome maturation and clearance.\n5. Ubiquitinated proteins have been implicated in the regulation of phagosome-lysosome fusion, which is essential for the degradation of phagocytosed material.",
    "vicuna-7b_fact": [
      "Phagosomal proteins can be ubiquitinated.",
      "Ubiquitination is a post-translational modification that involves the attachment of ubiquitin molecules to a lysine residue on a target protein.",
      "This modification can regulate various cellular processes, including protein degradation, trafficking, and signaling.",
      "Ubiquitinated proteins have been identified that play a role in phagosome maturation and clearance.",
      "Ubiquitinated proteins have been implicated in the regulation of phagosome-lysosome fusion, which is essential for the degradation of phagocytosed material."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2876,
    "user_query": "Does tremelimumab improve survival of mesothelioma patients?",
    "vicuna-7b_response": "Tremelimumab is an immune checkpoint inhibitor drug that has been studied for its potential to treat mesothelioma, a rare and aggressive form of cancer that affects the lining of the lungs, chest wall, and abdominal cavity.\nSeveral clinical trials have been conducted to evaluate the effectiveness of tremelimumab in treating mesothelioma. The results of these trials have been mixed, with some studies showing promise for the drug's ability to extend survival, while others have not found a significant benefit.\nA phase III clinical trial known as the \"Anti-Programmed Death-1 Antibody in Malignant Pleural Mesothelioma\" (APDIMM) study was conducted to evaluate the safety and efficacy of tremelimumab in combination with pemetrexed and platinum-based chemotherapy in patients with unresectable mesothelioma. The study found that the addition of tremelimumab to standard chemotherapy did not significantly improve overall survival compared to chemotherapy alone.\nHowever, another phase III clinical trial known as the \"EORTC 17031-Mesothelioma\" study found that tremelimumab in combination with pemetrexed and cisplatin significantly improved overall survival compared to chemotherapy alone in patients with unresectable mesothelioma.\nIt is important to note that the results of these studies may not be generalizable to all patients, and the effectiveness of tremelimumab may vary depending on the individual patient's characteristics and the specific treatment regimen used.\nIn summary, the evidence regarding the effectiveness of tremelimumab in improving survival of mesothelioma patients is mixed, and more research is needed to fully understand its potential benefits and risks. It is important for patients to discuss the potential benefits and risks of any treatment options with their healthcare provider, and to consider participating in clinical trials that may provide access to new and innovative treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tremelimumab is an immune checkpoint inhibitor drug.\n2. Tremelimumab has been studied for its potential to treat mesothelioma.\n3. The Anti-Programmed Death-1 Antibody in Malignant Pleural Mesothelioma (APDIMM) study found that the addition of tremelimumab to standard chemotherapy did not significantly improve overall survival compared to chemotherapy alone.\n4. The \"EORTC 17031-Mesothelioma\" study found that tremelimumab in combination with pemetrexed and cisplatin significantly improved overall survival compared to chemotherapy alone in patients with unresectable mesothelioma.\n5. The effectiveness of tremelimumab may vary depending on the individual patient's characteristics and the specific treatment regimen used.",
    "vicuna-7b_fact": [
      "Tremelimumab is an immune checkpoint inhibitor drug.",
      "Tremelimumab has been studied for its potential to treat mesothelioma.",
      "The Anti-Programmed Death-1 Antibody in Malignant Pleural Mesothelioma (APDIMM) study found that the addition of tremelimumab to standard chemotherapy did not significantly improve overall survival compared to chemotherapy alone.",
      "The \"EORTC 17031-Mesothelioma\" study found that tremelimumab in combination with pemetrexed and cisplatin significantly improved overall survival compared to chemotherapy alone in patients with unresectable mesothelioma.",
      "The effectiveness of tremelimumab may vary depending on the individual patient's characteristics and the specific treatment regimen used."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2878,
    "user_query": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?",
    "vicuna-7b_response": "The TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases (RTKs) are composed of three membrane proteins: Tyro3, Axl, and Mer. These proteins are also known as TAM receptors.\nTyro3 is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine. It is a receptor for the TAM family of RTKs and plays a role in cell proliferation and differentiation.\nAxl is also a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine. It is a receptor for the TAM family of RTKs and has been implicated in cell proliferation, angiogenesis, and metastasis.\nMer is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine. It is a receptor for the TAM family of RTKs and has been implicated in cell proliferation, angiogenesis, and metastasis.\nTogether, these three membrane proteins constitute the TAM family of RTKs and play important roles in cell proliferation, differentiation, and angiogenesis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases (RTKs) consists of three membrane proteins: Tyro3, Axl, and Mer.\n2. Tyro3 is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.\n3. Axl is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.\n4. Mer is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.\n5. These proteins of the TAM family have important roles in cell proliferation, differentiation, and angiogenesis.",
    "vicuna-7b_fact": [
      "The TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases (RTKs) consists of three membrane proteins: Tyro3, Axl, and Mer.",
      "Tyro3 is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.",
      "Axl is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.",
      "Mer is a transmembrane protein that is expressed in various tissues, including the liver, kidney, and intestine.",
      "These proteins of the TAM family have important roles in cell proliferation, differentiation, and angiogenesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2880,
    "user_query": "What is CPX351?",
    "vicuna-7b_response": "CPX351 is a proprietary compound that is used in scientific research and drug discovery. It is a potent and selective inhibitor of the enzyme carbonic anhydrase IX (CA9), which is overexpressed in many types of cancer cells.\nCarbonic anhydrase IX is an important enzyme in the regulation of cellular pH and is involved in the development of several types of cancer, including breast, ovarian, and lung cancer. By inhibiting CA9, CPX351 can disrupt the ability of cancer cells to regulate their pH, leading to cell death.\nCPX351 has shown promise in preclinical studies as a potential treatment for cancer, and clinical trials are currently underway to evaluate its safety and efficacy in humans.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CPX351 is a proprietary compound used in scientific research and drug discovery.\n2. CPX351 is a potent and selective inhibitor of the enzyme carbonic anhydrase IX (CA9).\n3. CA9 is overexpressed in several types of cancer cells, including breast, ovarian, and lung cancer.\n4. By inhibiting CA9, CPX351 can disrupt the ability of cancer cells to regulate their pH, which can lead to cell death.\n5. Clinical trials are currently underway to evaluate the safety and efficacy of CPX351 in humans.",
    "vicuna-7b_fact": [
      "CPX351 is a proprietary compound used in scientific research and drug discovery.",
      "CPX351 is a potent and selective inhibitor of the enzyme carbonic anhydrase IX (CA9).",
      "CA9 is overexpressed in several types of cancer cells, including breast, ovarian, and lung cancer.",
      "By inhibiting CA9, CPX351 can disrupt the ability of cancer cells to regulate their pH, which can lead to cell death.",
      "Clinical trials are currently underway to evaluate the safety and efficacy of CPX351 in humans."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CPX351 is not a proprietary compound used in scientific research and drug discovery but a proprietary, liposome-encapsulated combination of daunorubicin and cytarabine for the treatment of certain types of leukemia.\n2. FALSE [correction]: CPX351 does not inhibit the enzyme carbonic anhydrase IX (CA9). It is a combination chemotherapy that kills cancer cells by stopping them from dividing.\n3. TRUE\n4. FALSE [correction]: By being a combination chemotherapy of daunorubicin and cytarabine, CPX351 does not disrupt the ability of cancer cells to regulate their pH but stops them from dividing resulting into cell death.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2881,
    "user_query": "Is collagen the most abundant human protein?",
    "vicuna-7b_response": "Collagen is not the most abundant human protein. In fact, there are several proteins that are more abundant in the human body than collagen.\nThe most abundant protein in the human body is hemoglobin, which is a protein found in red blood cells and is responsible for carrying oxygen throughout the body. Hemoglobin makes up about 75% of the protein in red blood cells.\nOther proteins that are more abundant in the human body than collagen include albumin, which is a protein found in the blood and helps regulate fluid balance, and immunoglobulins, which are proteins that are part of the immune system and help fight off infections.\nCollagen is a structural protein that is found in the skin, bones, muscles, and other connective tissues. It is not the most abundant protein in the human body, but it is still an important protein that plays a crucial role in maintaining the structure and function of the body's connective tissues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Hemoglobin is the most abundant protein in the human body.\n2. Hemoglobin is a protein found in red blood cells and is responsible for carrying oxygen throughout the body.\n3. Albumin, a protein found in the blood that helps regulate fluid balance, is more abundant in the human body than collagen.\n4. Immunoglobulins, which are proteins that are part of the immune system and help fight off infections, are more abundant in the human body than collagen.\n5. Collagen is a structural protein that is found in the skin, bones, muscles, and other connective tissues.",
    "vicuna-7b_fact": [
      "Hemoglobin is the most abundant protein in the human body.",
      "Hemoglobin is a protein found in red blood cells and is responsible for carrying oxygen throughout the body.",
      "Albumin, a protein found in the blood that helps regulate fluid balance, is more abundant in the human body than collagen.",
      "Immunoglobulins, which are proteins that are part of the immune system and help fight off infections, are more abundant in the human body than collagen.",
      "Collagen is a structural protein that is found in the skin, bones, muscles, and other connective tissues."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Hemoglobin is not the most abundant protein in the human body. It is collagen.\n2. TRUE\n3. FALSE [correction]: Collagen, not albumin, is the most abundant protein in the human body.\n4. FALSE [correction]: Collagen is more abundant in the human body than immunoglobulins.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2886,
    "user_query": "What is the role of the Leucosporidium ice-binding protein",
    "vicuna-7b_response": "Leucosporidium is a genus of fungi that is commonly found in soil and plant debris. The ice-binding protein (IBP) is a type of protein found in the Leucosporidium fungi that plays a crucial role in the survival of these fungi in cold environments.\nThe IBP is responsible for binding ice crystals to the surface of the fungal cell, which helps to protect the cell from the damage caused by the formation of ice crystals. This is particularly important in cold environments where the temperature is below freezing, as ice crystals can cause significant damage to the cell membrane and other cellular components.\nThe IBP is also involved in the formation of ice-nucleating particles, which are small particles that can initiate the formation of ice crystals. By binding ice crystals to the surface of the fungal cell, the IBP helps to create a surface that is more conducive to the formation of ice crystals, which can then be used by other organisms to form ice.\nIn addition to its role in protecting the fungal cell from ice damage, the IBP may also play a role in the survival of the fungi by helping to regulate the temperature of the cell. By binding ice crystals to the surface of the cell, the IBP can help to reflect heat away from the cell, which can help to keep the cell at a lower temperature.\nOverall, the role of the Leucosporidium ice-binding protein is to protect the fungal cell from the damage caused by ice crystals, to initiate the formation of ice crystals, and to regulate the temperature of the cell. This helps the fungi to survive in cold environments and to initiate the formation of ice, which can be used by other organisms for various purposes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Leucosporidium is a genus of fungi that is commonly found in soil and plant debris.\n2. The ice-binding protein (IBP) is a type of protein found in the Leucosporidium fungi.\n3. The IBP is responsible for binding ice crystals to the surface of the fungal cell.\n4. The IBP plays a significant role in the formation of ice-nucleating particles.\n5. The role of the Leucosporidium ice-binding protein is to protect the fungal cell from the damage caused by ice crystals, initiate the formation of ice crystals, and regulate the temperature of the cell.",
    "vicuna-7b_fact": [
      "Leucosporidium is a genus of fungi that is commonly found in soil and plant debris.",
      "The ice-binding protein (IBP) is a type of protein found in the Leucosporidium fungi.",
      "The IBP is responsible for binding ice crystals to the surface of the fungal cell.",
      "The IBP plays a significant role in the formation of ice-nucleating particles.",
      "The role of the Leucosporidium ice-binding protein is to protect the fungal cell from the damage caused by ice crystals, initiate the formation of ice crystals, and regulate the temperature of the cell."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2892,
    "user_query": "Name 3 diseases for which lucatumumab is being tested?",
    "vicuna-7b_response": "Lucatumumab is a monoclonal antibody that is being tested for the treatment of various types of cancer. Some of the diseases for which lucatumumab is being tested include:\n1. Non-Hodgkin lymphoma: Lucatumumab is being tested in clinical trials for the treatment of non-Hodgkin lymphoma, a type of cancer that affects the immune system.\n2. Breast cancer: Lucatumumab is also being tested for the treatment of breast cancer, which is the most common cancer among women worldwide.\n3. Ovarian cancer: In addition, lucatumumab is being tested for the treatment of ovarian cancer, which is a type of cancer that affects the female reproductive system.\nIt is important to note that while lucatumumab shows promise in these clinical trials, it is not yet approved for use in the treatment of any of these diseases. Further research is needed to determine its safety and effectiveness.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lucatumumab is a monoclonal antibody.\n2. Lucatumumab is being tested for the treatment of non-Hodgkin lymphoma.\n3. Lucatumumab is being tested for the treatment of breast cancer.\n4. Lucatumumab is being tested for the treatment of ovarian cancer.\n5. Lucatumumab has not been approved for use in the treatment of any diseases.",
    "vicuna-7b_fact": [
      "Lucatumumab is a monoclonal antibody.",
      "Lucatumumab is being tested for the treatment of non-Hodgkin lymphoma.",
      "Lucatumumab is being tested for the treatment of breast cancer.",
      "Lucatumumab is being tested for the treatment of ovarian cancer.",
      "Lucatumumab has not been approved for use in the treatment of any diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE \n2. TRUE \n3. UNKNOWN \n4. UNKNOWN \n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2893,
    "user_query": "Which transcription factor binding site is contained in Alu repeats?",
    "vicuna-7b_response": "Alu repeats are a class of transposable elements that are found in the human genome. They are characterized by their repetitive sequence of nucleotides, which can be as long as 32 nucleotides. Alu repeats are capable of jumping from one location in the genome to another, which can lead to the creation of new genetic variations.\nTranscription factors are proteins that bind to specific DNA sequences and regulate the expression of genes. There are many different types of transcription factors, each with its own specific binding site. Some transcription factors bind to specific sequences of DNA, while others bind to non-coding RNA molecules.\nIt is not possible to determine which transcription factor binding site is contained in Alu repeats without more information. Alu repeats are known to contain a specific type of repetitive sequence, but it is not clear whether any transcription factors bind to this sequence.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Alu repeats are a class of transposable elements in the human genome.\n2. Alu repeats are characterized by their repetitive sequence of nucleotides, which can be as long as 32 nucleotides.\n3. Alu repeats are capable of jumping from one location in the genome to another, leading to the creation of new genetic variations.\n4. Transcription factors are proteins that bind to specific DNA sequences and regulate the expression of genes.\n5. The specific transcription factor binding site contained in Alu repeats is not definitively known.",
    "vicuna-7b_fact": [
      "Alu repeats are a class of transposable elements in the human genome.",
      "Alu repeats are characterized by their repetitive sequence of nucleotides, which can be as long as 32 nucleotides.",
      "Alu repeats are capable of jumping from one location in the genome to another, leading to the creation of new genetic variations.",
      "Transcription factors are proteins that bind to specific DNA sequences and regulate the expression of genes.",
      "The specific transcription factor binding site contained in Alu repeats is not definitively known."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Alu repeats are characterized by their repetitive sequence of nucleotides, which is approximately 300 nucleotides long.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2894,
    "user_query": "What is ferroptosis?",
    "vicuna-7b_response": "Ferroptosis is a type of cell death that occurs when a cell's iron homeostasis is disrupted. It is a form of regulated cell death that is triggered by the accumulation of reactive oxygen species (ROS) and the subsequent oxidation of iron within the cell.\nFerroptosis is distinct from other forms of cell death, such as necrosis and apoptosis, in that it is regulated and requires the presence of specific molecular signals. It is often referred to as \"iron-dependent regulated cell death\" or \"iron-mediated cell death.\"\nFerroptosis has been implicated in a variety of diseases, including cancer, neurodegenerative disorders, and infections caused by pathogenic bacteria. It has also been studied as a potential therapeutic target for the treatment of these diseases.\nOverall, ferroptosis is an important cellular process that plays a critical role in maintaining cellular homeostasis and preventing damage to the cell.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ferroptosis is a type of cell death that occurs when a cell's iron homeostasis is disrupted.\n2. Ferroptosis is triggered by the accumulation of reactive oxygen species (ROS) and the subsequent oxidation of iron within the cell.\n3. Ferroptosis is different from necrosis and apoptosis, as it is regulated and requires the presence of specific molecular signals.\n4. Ferroptosis has been implicated in diseases such as cancer, neurodegenerative disorders, and infection caused by pathogenic bacteria.\n5. Ferroptosis has been studied as a possible therapeutic target for the treatment of certain diseases.",
    "vicuna-7b_fact": [
      "Ferroptosis is a type of cell death that occurs when a cell's iron homeostasis is disrupted.",
      "Ferroptosis is triggered by the accumulation of reactive oxygen species (ROS) and the subsequent oxidation of iron within the cell.",
      "Ferroptosis is different from necrosis and apoptosis, as it is regulated and requires the presence of specific molecular signals.",
      "Ferroptosis has been implicated in diseases such as cancer, neurodegenerative disorders, and infection caused by pathogenic bacteria.",
      "Ferroptosis has been studied as a possible therapeutic target for the treatment of certain diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2896,
    "user_query": "Name 4 side effects of enasidenib",
    "vicuna-7b_response": "Enasidenib is a medication that is used to treat a specific type of blood cancer called acute myeloid leukemia (AML). Here are four potential side effects of enasidenib:\n1. Nausea: Enasidenib can cause nausea, which is a feeling of discomfort in the stomach and may cause a person to feel like they are going to vomit.\n2. Diarrhea: Some people taking enasidenib may experience diarrhea, which is the frequent passing of stools.\n3. Stomach pain: Enasidenib can cause stomach pain, which is a discomfort or pain in the stomach.\n4. Vomiting: Enasidenib can cause vomiting, which is the act of forcibly expelling the contents of the stomach through the mouth.\nIt is important to note that these are not all of the potential side effects of enasidenib, and that each person may experience different side effects. If you are taking enasidenib and experience any side effects, it is important to talk to your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Enasidenib is a medication used to treat acute myeloid leukemia (AML).\n2. One potential side effect of enasidenib is nausea.\n3. Diarrhea can be a side effect of enasidenib.\n4. Stomach pain is a potential side effect of enasidenib.\n5. Vomiting is another side effect that enasidenib can cause.",
    "vicuna-7b_fact": [
      "Enasidenib is a medication used to treat acute myeloid leukemia (AML).",
      "One potential side effect of enasidenib is nausea.",
      "Diarrhea can be a side effect of enasidenib.",
      "Stomach pain is a potential side effect of enasidenib.",
      "Vomiting is another side effect that enasidenib can cause."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2903,
    "user_query": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "vicuna-7b_response": "Dacomitinib is a medication that is used to treat certain types of non-small cell lung cancer. It is not currently approved for the treatment of glioblastoma, which is a type of brain cancer.\nGlioblastoma is a highly aggressive type of brain cancer that is difficult to treat. There are currently several different treatment options available for patients with glioblastoma, including surgery, radiation therapy, and chemotherapy.\nIt is important to note that the use of any medication, including dacomitinib, for the treatment of glioblastoma should be discussed with a healthcare provider. They can provide information on the risks and benefits of the medication and help determine the best treatment plan for the individual patient.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dacomitinib is a medication used to treat certain types of non-small cell lung cancer.\n2. Dacomitinib is not currently approved for the treatment of glioblastoma.\n3. Glioblastoma is a type of brain cancer.\n4. Glioblastoma is a highly aggressive type of brain cancer that is difficult to treat.\n5. The treatment options available for patients with glioblastoma include surgery, radiation therapy, and chemotherapy.",
    "vicuna-7b_fact": [
      "Dacomitinib is a medication used to treat certain types of non-small cell lung cancer.",
      "Dacomitinib is not currently approved for the treatment of glioblastoma.",
      "Glioblastoma is a type of brain cancer.",
      "Glioblastoma is a highly aggressive type of brain cancer that is difficult to treat.",
      "The treatment options available for patients with glioblastoma include surgery, radiation therapy, and chemotherapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2906,
    "user_query": "What is the function of Plasminogen activator inhibitor 1?",
    "vicuna-7b_response": "Plasminogen activator inhibitor 1 (PAI-1) is a protein that plays a crucial role in the regulation of blood clotting and fibrinolysis. It is a member of the serpin family of proteins, which are a type of antiprotease enzyme that inhibit other enzymes by forming a covalent complex with them.\nIn the context of blood clotting, PAI-1 inhibits the activity of plasmin, an enzyme that breaks down fibrin, a key component of blood clots. This helps to maintain the balance between clotting and fibrinolysis, and prevents excessive clotting that could lead to thrombosis.\nHowever, in some cases, high levels of PAI-1 can contribute to the development of thrombosis, particularly in individuals with a genetic predisposition. This is because PAI-1 can inhibit the activity of other proteins that help to dissolve blood clots, such as tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA).\nOverall, the function of PAI-1 is to regulate the balance between clotting and fibrinolysis, and to prevent excessive clotting that could lead to thrombosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Plasminogen activator inhibitor 1 (PAI-1) is a protein that plays a key role in the regulation of blood clotting and fibrinolysis.\n2. PAI-1 is a member of the serpin family of proteins.\n3. PAI-1 inhibits the activity of plasmin, an enzyme that breaks down fibrin, a key component of blood clots.\n4. High levels of PAI-1 can contribute to the development of thrombosis, particularly in individuals with a genetic predisposition.\n5. PAI-1 can inhibit the activity of other proteins that help to dissolve blood clots, such as tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA).",
    "vicuna-7b_fact": [
      "Plasminogen activator inhibitor 1 (PAI-1) is a protein that plays a key role in the regulation of blood clotting and fibrinolysis.",
      "PAI-1 is a member of the serpin family of proteins.",
      "PAI-1 inhibits the activity of plasmin, an enzyme that breaks down fibrin, a key component of blood clots.",
      "High levels of PAI-1 can contribute to the development of thrombosis, particularly in individuals with a genetic predisposition.",
      "PAI-1 can inhibit the activity of other proteins that help to dissolve blood clots, such as tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: PAI-1 inhibits the activity of tissue plasminogen activator (tPA) and urokinase type plasminogen activator (uPA), enzymes that convert plasminogen to plasmin, an enzyme that breaks down fibrin, a key component of blood clots.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2913,
    "user_query": "Endolymphatic hydrops is associated with Meniere’s disease. Please provide a summary of endoymphatic hydrops including the symptoms and affected body part.",
    "vicuna-7b_response": "Endolymphatic hydrops is a condition that occurs in the inner ear and is associated with Meniere's disease. It is characterized by an abnormal accumulation of endolymph fluid in the endolymphatic sac, which can lead to symptoms such as vertigo, tinnitus, hearing loss, and a feeling of fullness in the affected ear. The symptoms of endolymphatic hydrops typically wax and wane over time, with periods of relative stability followed by episodes of severe vertigo and hearing loss.\nThe affected body part in endolymphatic hydrops is the inner ear, which is responsible for hearing and balance. The inner ear contains the cochlea, which is responsible for hearing, and the vestibular system, which is responsible for balance. The endolymphatic sac is a small, fluid-filled structure located within the inner ear, and it plays a crucial role in regulating the pressure of endolymph fluid within the inner ear.\nEndolymphatic hydrops is a rare condition that affects approximately 10% of people with Meniere's disease. Meniere's disease is a condition that affects the inner ear and is characterized by recurrent episodes of vertigo, tinnitus, hearing loss, and a feeling of fullness in the affected ear. While the exact cause of endolymphatic hydrops is not known, it is thought to be related to an imbalance in the pressure of endolymph fluid within the inner ear.\nTreatment for endolymphatic hydrops typically involves a combination of medications, lifestyle changes, and surgery. Medications such as diuretics and antihistamines may be used to reduce the accumulation of endolymph fluid in the endolymphatic sac. Lifestyle changes such as reducing stress and avoiding exposure to loud noises may also be helpful. Surgery may be necessary in some cases to drain the endolymphatic sac and relieve the pressure on the inner ear.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Endolymphatic hydrops is a condition that occurs in the inner ear and is associated with Meniere's disease.\n2. The major symptoms of endolymphatic hydrops include vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear.\n3. The affected body part in endolymphatic hydrops is the inner ear, which is responsible for hearing and balance.\n4. Endolymphatic hydrops is a rare condition that affects approximately 10% of people with Meniere's disease.\n5. The treatment for endolymphatic hydrops often involves a combination of medications, lifestyle changes, and surgery.",
    "vicuna-7b_fact": [
      "Endolymphatic hydrops is a condition that occurs in the inner ear and is associated with Meniere's disease.",
      "The major symptoms of endolymphatic hydrops include vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear.",
      "The affected body part in endolymphatic hydrops is the inner ear, which is responsible for hearing and balance.",
      "Endolymphatic hydrops is a rare condition that affects approximately 10% of people with Meniere's disease.",
      "The treatment for endolymphatic hydrops often involves a combination of medications, lifestyle changes, and surgery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Endolymphatic hydrops is not rare in Meniere's disease. In fact, it is a hallmark of Meniere's disease and believed to be present in all people with this condition. The prevalence is not limited to 10% as suggested.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2916,
    "user_query": "Is there any role for HUWE1 in MYC signalling?",
    "vicuna-7b_response": "HUWE1 is a protein that has been shown to play a role in the regulation of the MYC oncogene. MYC is a transcription factor that is often overexpressed in cancer cells, and it has been implicated in the development of a variety of cancers. HUWE1 has been shown to interact with MYC and to play a role in the regulation of MYC-dependent transcription.\nIn particular, HUWE1 has been shown to bind to the MYC promoter and to inhibit the transcription of MYC-dependent genes. This inhibition of MYC transcription can occur through a number of mechanisms, including the recruitment of histone-modifying enzymes to the MYC promoter and the formation of a complex that includes HUWE1, histone-modifying enzymes, and transcriptional repressors.\nOverall, the role of HUWE1 in the regulation of MYC signaling is an active area of research, and it is possible that HUWE1 may be a potential target for the development of cancer therapies that target MYC-dependent cancers.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. HUWE1 is a protein that interacts with the MYC oncogene.\n2. MYC is a transcription factor that is often overexpressed in cancer cells.\n3. MYC has been implicated in the development of various types of cancers.\n4. HUWE1 binds to the MYC promoter and can inhibit the transcription of MYC-dependent genes.\n5. The role of HUWE1 in the regulation of MYC signaling is a subject of active research.",
    "vicuna-7b_fact": [
      "HUWE1 is a protein that interacts with the MYC oncogene.",
      "MYC is a transcription factor that is often overexpressed in cancer cells.",
      "MYC has been implicated in the development of various types of cancers.",
      "HUWE1 binds to the MYC promoter and can inhibit the transcription of MYC-dependent genes.",
      "The role of HUWE1 in the regulation of MYC signaling is a subject of active research."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-7b_response": "Gepotidacin is a type of topoisomerase inhibitor called a \"topoisomerase I inhibitor.\" It works by binding to and inhibiting the activity of topoisomerase I, an enzyme that is involved in the replication of DNA. This can lead to the formation of DNA breaks and the accumulation of DNA damage, ultimately resulting in cell death. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gepotidacin is a type of topoisomerase inhibitor.\n2. Gepotidacin is classified as a \"topoisomerase I inhibitor.\"\n3. Gepotidacin works by binding to and inhibiting the activity of topoisomerase I.\n4. Topoisomerase I is an enzyme involved in the replication of DNA.\n5. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact": [
      "Gepotidacin is a type of topoisomerase inhibitor.",
      "Gepotidacin is classified as a \"topoisomerase I inhibitor.\"",
      "Gepotidacin works by binding to and inhibiting the activity of topoisomerase I.",
      "Topoisomerase I is an enzyme involved in the replication of DNA.",
      "Gepotidacin is being studied as a potential treatment for various types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Gepotidacin is classified as a \"topoisomerase II inhibitor.\"\n3. FALSE [correction]: Gepotidacin works by binding to and inhibiting the activity of topoisomerase II.\n4. TRUE\n5. FALSE [correction]: Gepotidacin is being studied as a potential treatment for bacterial infections.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2941,
    "user_query": "Which disease is PGT121 used for?",
    "vicuna-7b_response": "PGT121 is a monoclonal antibody that is used for the treatment of cancer. Specifically, it is used to treat certain types of blood cancer, such as multiple myeloma and non-Hodgkin lymphoma. PGT121 works by targeting a specific protein called B-cell maturation antigen (BCMA), which is expressed on the surface of certain cancer cells. By targeting BCMA, PGT121 can help to kill cancer cells and may also help to stimulate the immune system to attack the cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PGT121 is a monoclonal antibody used for the treatment of cancer.\n2. PGT121 is used to treat certain types of blood cancer, including multiple myeloma and non-Hodgkin lymphoma.\n3. PGT121 works by targeting a specific protein called B-cell maturation antigen (BCMA).\n4. BCMA is expressed on the surface of certain cancer cells.\n5. By targeting BCMA, PGT121 can kill cancer cells and may also stimulate the immune system to attack the cancer.",
    "vicuna-7b_fact": [
      "PGT121 is a monoclonal antibody used for the treatment of cancer.",
      "PGT121 is used to treat certain types of blood cancer, including multiple myeloma and non-Hodgkin lymphoma.",
      "PGT121 works by targeting a specific protein called B-cell maturation antigen (BCMA).",
      "BCMA is expressed on the surface of certain cancer cells.",
      "By targeting BCMA, PGT121 can kill cancer cells and may also stimulate the immune system to attack the cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: PGT121 is a monoclonal antibody studied for the treatment of HIV, not cancer.\n2. FALSE [correction]: PGT121 is not used to treat any type of cancer. Its potential use is in combating HIV.\n3. FALSE [correction]: PGT121 does not target BCMA, it is believed to target a specific area on HIV's envelope spike, preventing the virus from invading the body's cells.\n4. TRUE\n5. FALSE [correction]: By potentially targeting the HIV envelope spike, PGT121 can potentially prevent the virus from invading the body's cells. It does not directly kill cancer cells or stimulate the immune system to attack cancer.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-7b_response": "SPW stands for \"Single Page Web\" and refers to a type of web application that is built using a single HTML page. This page contains all the necessary elements for the application, including the user interface, data storage, and logic.\nIn a SPW application, the user interface is typically built using a front-end framework such as React, Angular, or Vue.js. The front-end code is responsible for rendering the user interface and handling user interactions.\nThe data storage for a SPW application is typically provided by a back-end server, which can be built using a variety of technologies such as Node.js, Python, or Java. The back-end server can be hosted on a cloud platform such as AWS, Google Cloud, or Microsoft Azure.\nThe logic for a SPW application is typically implemented using a server-side programming language such as Node.js, Python, or Java. This code can be used to handle user authentication, data validation, and other business logic.\nOne of the main advantages of a SPW application is that it can provide a seamless user experience by loading all the necessary data and functionality on a single page. This can make it easier for users to navigate and interact with the application.\nHowever, a SPW application can also have some limitations. For example, it can be difficult to update or change the application's functionality without reloading the entire page. Additionally, a SPW application may not be suitable for applications that require complex user authentication or data validation.\nOverall, the choice of whether to use a SPW or a multi-page web application depends on the specific requirements of the application and the preferences of the development team.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SPW stands for \"Single Page Web\" and refers to a type of web application that is built using a single HTML page.\n2. The user interface of a SPW application is typically built using a front-end framework such as React, Angular, or Vue.js.\n3. The data storage for a SPW application is typically provided by a back-end server, which can be built using a variety of technologies such as Node.js, Python, or Java.\n4. The logic for a SPW application is typically implemented using a server-side programming language such as Node.js, Python, or Java.\n5. One main advantage of a SPW application is that it can provide a seamless user experience by loading all the necessary data and functionality on a single page.",
    "vicuna-7b_fact": [
      "SPW stands for \"Single Page Web\" and refers to a type of web application that is built using a single HTML page.",
      "The user interface of a SPW application is typically built using a front-end framework such as React, Angular, or Vue.js.",
      "The data storage for a SPW application is typically provided by a back-end server, which can be built using a variety of technologies such as Node.js, Python, or Java.",
      "The logic for a SPW application is typically implemented using a server-side programming language such as Node.js, Python, or Java.",
      "One main advantage of a SPW application is that it can provide a seamless user experience by loading all the necessary data and functionality on a single page."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SPW stands for \"Single Page Web Application\" and refers to a web application that loads a single HTML page and updates that page as the user interacts with the application.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The logic for a SPW application is typically implemented using Javascript in conjunction with any front-end framework like React, Angular, or Vue.js. Although server-side programming languages like Node.js, Python, or Java can be used, they typically deal more with back end requirements such as databases, authentication and server-side logic.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2950,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes?",
    "vicuna-7b_response": "One algorithm that has been developed for finding conserved non-coding elements (CNEs) in genomes is the \"Conservation of Non-Coding Elements\" (CONCE) algorithm.\nThe CONCE algorithm is a computational tool that uses a combination of sequence and phylogenetic information to identify conserved non-coding elements in genomes. The algorithm first identifies conserved non-coding regions in the human genome using a sliding window approach, and then uses this information to identify conserved non-coding elements in other species.\nThe CONCE algorithm uses a combination of sequence and phylogenetic information to identify conserved non-coding elements in genomes. The algorithm first identifies conserved non-coding regions in the human genome using a sliding window approach, and then uses this information to identify conserved non-coding elements in other species.\nThe algorithm uses a sliding window approach to identify conserved non-coding regions in the human genome. It starts by identifying the most conserved regions in the human genome using a sliding window approach, and then uses this information to identify conserved non-coding elements in other species.\nThe algorithm then uses a phylogenetic approach to identify conserved non-coding elements in other species. It uses a phylogenetic tree to identify the most conserved regions in the genome of different species, and then uses this information to identify conserved non-coding elements in other species.\nThe algorithm also uses a statistical approach to identify conserved non-coding elements in other species. It uses a statistical test to identify the most conserved regions in the genome of different species, and then uses this information to identify conserved non-coding elements in other species.\nIn summary, the CONCE algorithm is a computational tool that uses a combination of sequence and phylogenetic information to identify conserved non-coding elements in genomes. It is a powerful tool for identifying conserved non-coding elements in genomes, and has been used to identify many conserved non-coding elements in the human genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"Conservation of Non-Coding Elements\" (CONCE) algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes.\n2. The CONCE algorithm is a computational tool that uses a combination of sequence and phylogenetic information to identify conserved non-coding elements in genomes.\n3. The algorithm first identifies conserved non-coding regions in the human genome using a sliding window approach.\n4. The algorithm then uses a phylogenetic approach to identify conserved non-coding elements in other species.\n5. The CONCE algorithm also uses a statistical approach to identify conserved non-coding elements in other species.",
    "vicuna-7b_fact": [
      "The \"Conservation of Non-Coding Elements\" (CONCE) algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes.",
      "The CONCE algorithm is a computational tool that uses a combination of sequence and phylogenetic information to identify conserved non-coding elements in genomes.",
      "The algorithm first identifies conserved non-coding regions in the human genome using a sliding window approach.",
      "The algorithm then uses a phylogenetic approach to identify conserved non-coding elements in other species.",
      "The CONCE algorithm also uses a statistical approach to identify conserved non-coding elements in other species."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2953,
    "user_query": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "vicuna-7b_response": "Yes, ivosidenib (also known as AG-221) has been approved by the FDA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation known as IDH2 mutation. The drug was approved in August 2017 under the trade name Idhifa.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ivosidenib, also known as AG-221, is a drug.\n2. Ivosidenib has been approved by the FDA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML).\n3. Treatment with ivosidenib is specifically for AML patients who have an IDH2 mutation.\n4. The FDA approved ivosidenib in August 2017.\n5. The trade name of ivosidenib is Idhifa.",
    "vicuna-7b_fact": [
      "Ivosidenib, also known as AG-221, is a drug.",
      "Ivosidenib has been approved by the FDA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML).",
      "Treatment with ivosidenib is specifically for AML patients who have an IDH2 mutation.",
      "The FDA approved ivosidenib in August 2017.",
      "The trade name of ivosidenib is Idhifa."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Treatment with ivosidenib is specifically for AML patients who have an IDH1 mutation, not IDH2.\n4. FALSE [correction]: The FDA approved ivosidenib in July 2018.\n5. FALSE [correction]: The trade name of ivosidenib is Tibsovo, not Idhifa.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-7b_response": "STING (Stimulator of Interferon Genes) agonists are a class of drugs that activate the STING pathway, which plays a crucial role in the immune system's response to viral infections. STING agonists have been shown to have potent antiviral effects and have been studied for the treatment of various viral infections, including influenza, SARS-CoV-2 (the virus that causes COVID-19), and Ebola virus.\nSome examples of STING agonists include:\n1. MK-8628: This is a small molecule STING agonist that has been shown to be effective against a wide range of viruses, including influenza, SARS-CoV-2, and Ebola virus.\n2. GS-9620: This is another small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.\n3. CX804: This is a STING agonist that has been shown to be effective against influenza in animal models.\n4. TLR7 agonists: TLR7 (Toll-like receptor 7) agonists, which include imiquimod and resiquimod, have been shown to activate the STING pathway and have antiviral effects.\nIt's important to note that while STING agonists show promise as antiviral drugs, they are still in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. STING (Stimulator of Interferon Genes) agonists are a class of drugs that activate the STING pathway.\n2. The STING pathway plays a crucial role in the immune system's response to viral infections.\n3. Some examples of STING agonists include MK-8628, GS-9620, CX804, and TLR7 agonists.\n4. MK-8628, a STING agonist, has been shown to be effective against a wide range of viruses, including influenza, SARS-CoV-2, and Ebola virus.\n5. STING agonists are in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact": [
      "STING (Stimulator of Interferon Genes) agonists are a class of drugs that activate the STING pathway.",
      "The STING pathway plays a crucial role in the immune system's response to viral infections.",
      "Some examples of STING agonists include MK-8628, GS-9620, CX804, and TLR7 agonists.",
      "MK-8628, a STING agonist, has been shown to be effective against a wide range of viruses, including influenza, SARS-CoV-2, and Ebola virus.",
      "STING agonists are in the early stages of development and more research is needed to fully understand their safety and efficacy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Some examples of STING agonists include MK-1454, ADU-S100 (MIW815), and BMS-986301. TLR7 agonists are a different class of immune system modulators.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-7b_response": "SLIC-CAGE is a method for analyzing and classifying the structure of proteins. It stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\nThe SLIC-CAGE method uses a combination of sequence information and structural information to predict the contact and geometry information of a protein. It does this by first analyzing the amino acid sequence of the protein, and then using this information to predict the contact and geometry information.\nThe SLIC-CAGE method is based on the idea that the contact and geometry information of a protein is determined by the sequence of amino acids in the protein. This is because the sequence of amino acids in a protein determines the shape of the protein, and the shape of the protein determines the interactions between the protein and other molecules.\nThe SLIC-CAGE method is a powerful tool for analyzing and classifying the structure of proteins. It has been used to study the structure and function of a wide range of proteins, including enzymes, receptors, and transporters.\nOverall, SLIC-CAGE is a useful tool for understanding the structure and function of proteins, and it has many potential applications in fields such as biotechnology and medicine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SLIC-CAGE is a method for analyzing and classifying the structure of proteins.\n2. SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\n3. The SLIC-CAGE method uses sequence and structural information to predict the contact and geometry information of a protein.\n4. The method is based on the idea that the contact and geometry information of a protein is determined by the sequence of amino acids.\n5. SLIC-CAGE has been used to study the structure and function of a wide range of proteins, including enzymes, receptors, and transporters.",
    "vicuna-7b_fact": [
      "SLIC-CAGE is a method for analyzing and classifying the structure of proteins.",
      "SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".",
      "The SLIC-CAGE method uses sequence and structural information to predict the contact and geometry information of a protein.",
      "The method is based on the idea that the contact and geometry information of a protein is determined by the sequence of amino acids.",
      "SLIC-CAGE has been used to study the structure and function of a wide range of proteins, including enzymes, receptors, and transporters."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SLIC-CAGE is a method for studying gene expression, not the structure of proteins.\n2. TRUE\n3. FALSE [correction]: The SLIC-CAGE method uses gene expression data, not sequence and structural information of proteins.\n4. FALSE [correction]: This method is based on the idea that gene expression can reveal significant information about biological processes, not the sequence of amino acids in proteins.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2967,
    "user_query": "What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the autosomal recessive mutation in the gene encoding the low-density lipoprotein receptor-related protein 5 (LRP5). This mutation is found in about 20-30% of CVID patients of European descent.\nCVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections. The disorder can be inherited in an autosomal recessive or autosomal dominant manner, and the genetic basis of CVID is complex, with multiple genes and genetic modifiers involved.\nThe LRP5 gene provides instructions for making a protein that is involved in the development and maintenance of the immune system. Mutations in this gene can disrupt the function of the protein, leading to reduced levels of immunoglobulins and an increased susceptibility to infections.\nIt is important to note that CVID can also be caused by mutations in other genes, such as the Shwachman-Diamond syndrome (SDS) gene, the phagocyte-activating chemokine (CCL3) gene, and the complement component 3 (C3) gene, among others. Therefore, a thorough genetic testing and counseling should be performed to identify the specific genetic cause of CVID in each individual patient.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The autosomal recessive mutation in the gene encoding the low-density lipoprotein receptor-related protein 5 (LRP5) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. This mutation is found in about 20-30% of CVID patients of European descent.\n3. CVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections. \n4. The LRP5 gene provides instructions for making a protein that is involved in the development and maintenance of the immune system. \n5. CVID can also be caused by mutations in other genes, such as the Shwachman-Diamond syndrome (SDS) gene, the phagocyte-activating chemokine (CCL3) gene, and the complement component 3 (C3) gene, among others.",
    "vicuna-7b_fact": [
      "The autosomal recessive mutation in the gene encoding the low-density lipoprotein receptor-related protein 5 (LRP5) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "This mutation is found in about 20-30% of CVID patients of European descent.",
      "CVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections.",
      "The LRP5 gene provides instructions for making a protein that is involved in the development and maintenance of the immune system.",
      "CVID can also be caused by mutations in other genes, such as the Shwachman-Diamond syndrome (SDS) gene, the phagocyte-activating chemokine (CCL3) gene, and the complement component 3 (C3) gene, among others."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The autosomal recessive mutation in the gene encoding the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B), also known as the TACI gene, is a common monogenic cause of common variable immunodeficiency (CVID) in Europeans, not the low-density lipoprotein receptor-related protein 5 (LRP5).\n2. FALSE [correction]: The frequency of a particular mutation in CVID patients can vary widely, but the prevalence rate of TACI mutations, not LRP5 mutations, in patients with CVID is approximately 10%.\n3. TRUE\n4. FALSE [correction]: The LRP5 gene provides instructions for making a protein that is involved in bone and eye development, not the development and maintenance of the immune system. \n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2968,
    "user_query": "List two indications of Letermovir?",
    "vicuna-7b_response": "Letermovir is an antiviral drug used to prevent the replication of certain types of viruses, including cytomegalovirus (CMV). Here are two indications of letermovir:\n1. Prevention of CMV infection in adult recipients of hematopoietic stem cell transplants (HSCT)\n2. Prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those undergoing solid organ transplantation, those with advanced human immunodeficiency virus (HIV) infection, and those with compromised immune systems.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Letermovir is an antiviral drug used to prevent the replication of certain types of viruses, including cytomegalovirus (CMV).\n2. Letermovir can be used for the prevention of CMV infection in adult recipients of hematopoietic stem cell transplants (HSCT).\n3. Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those undergoing solid organ transplantation.\n4. Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those with advanced human immunodeficiency virus (HIV) infection.\n5. Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those with compromised immune systems.",
    "vicuna-7b_fact": [
      "Letermovir is an antiviral drug used to prevent the replication of certain types of viruses, including cytomegalovirus (CMV).",
      "Letermovir can be used for the prevention of CMV infection in adult recipients of hematopoietic stem cell transplants (HSCT).",
      "Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those undergoing solid organ transplantation.",
      "Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those with advanced human immunodeficiency virus (HIV) infection.",
      "Letermovir can be used for the prevention of CMV disease in adult and pediatric patients at risk of CMV infection, including those with compromised immune systems."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Letermovir can be used for the prevention of CMV infection in adult recipients of hematopoietic stem cell transplants (HSCT), not for those undergoing solid organ transplantation.\n4. FALSE [correction]: Letermovir is not indicated for the prevention of CMV infection in patients with advanced HIV infection.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2969,
    "user_query": "What is achalasia?",
    "vicuna-7b_response": "Achalasia is a rare disorder of the muscles of the esophagus that makes it difficult for food to pass from the mouth into the stomach. It is caused by a problem with the nerve cells that control the muscles in the lower esophagus.\nThe main symptom of achalasia is difficulty swallowing, which can lead to regurgitation of food or vomiting. Other symptoms may include chest pain, heartburn, and difficulty breathing.\nAchalasia is typically diagnosed through a physical examination and a series of tests, including an esophageal manometry and a barium swallow. Treatment options for achalasia include medications, botulinum toxin injections, and surgery.\nIt is important to note that achalasia is a chronic condition and symptoms may worsen over time. However, with proper treatment, most people with achalasia can lead a normal life.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Achalasia is a rare disorder of the muscles of the esophagus.\n2. This disorder makes it difficult for food to pass from the mouth into the stomach.\n3. The main symptom of achalasia is difficulty swallowing, which can lead to regurgitation of food or vomiting.\n4. Achalasia is typically diagnosed through a physical examination and a series of tests, including an esophageal manometry and a barium swallow.\n5. Achalasia is a chronic condition and symptoms may worsen over time.",
    "vicuna-7b_fact": [
      "Achalasia is a rare disorder of the muscles of the esophagus.",
      "This disorder makes it difficult for food to pass from the mouth into the stomach.",
      "The main symptom of achalasia is difficulty swallowing, which can lead to regurgitation of food or vomiting.",
      "Achalasia is typically diagnosed through a physical examination and a series of tests, including an esophageal manometry and a barium swallow.",
      "Achalasia is a chronic condition and symptoms may worsen over time."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2972,
    "user_query": "When is serum AFP used as marker?",
    "vicuna-7b_response": "Serum alpha-fetoprotein (AFP) is used as a marker in various medical conditions, including:\n1. Fetal development: AFP is produced by the liver of the developing fetus and can be detected in the blood of the pregnant woman. AFP levels in the mother's blood can be used to monitor fetal growth and development, and to detect potential fetal abnormalities such as Down syndrome.\n2. Tumors: AFP is often elevated in patients with certain types of tumors, such as hepatocellular carcinoma (HCC), a type of liver cancer. Elevated AFP levels can be used as an indicator of HCC, and may help in the diagnosis and management of this condition.\n3. Pancreatic cancer: AFP is often elevated in patients with pancreatic cancer, and can be used as a marker for this disease.\n4. Other conditions: AFP may also be used to monitor the effectiveness of treatment for certain conditions, such as hepatitis B or C.\nIt is important to note that AFP levels can be affected by various factors, including pregnancy, liver disease, and certain medications. Therefore, AFP levels should be interpreted in the context of the patient's medical history and other clinical findings.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Serum alpha-fetoprotein (AFP) is used as a marker in various medical conditions.\n2. AFP is produced by the liver of the developing fetus and can be detected in the blood of the pregnant woman.\n3. Elevated AFP levels can be used as an indicator of hepatocellular carcinoma, a type of liver cancer. \n4. AFP is often elevated in patients with pancreatic cancer, and can be used as a marker for this disease.\n5. AFP may also be used to monitor the effectiveness of treatment for certain conditions, such as hepatitis B or C.",
    "vicuna-7b_fact": [
      "Serum alpha-fetoprotein (AFP) is used as a marker in various medical conditions.",
      "AFP is produced by the liver of the developing fetus and can be detected in the blood of the pregnant woman.",
      "Elevated AFP levels can be used as an indicator of hepatocellular carcinoma, a type of liver cancer.",
      "AFP is often elevated in patients with pancreatic cancer, and can be used as a marker for this disease.",
      "AFP may also be used to monitor the effectiveness of treatment for certain conditions, such as hepatitis B or C."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: AFP is not typically used as a marker for pancreatic cancer.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-7b_response": "LEM-3, also known as Leucine-rich repeat-containing protein 3, is a protein that plays a role in various cellular processes. The specific roles of LEM-3 are not well understood, but it is thought to be involved in regulating cell growth and division, as well as in the development of certain diseases.\nOne of the functions of LEM-3 is to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division. This complex is responsible for phosphorylating and activating the CDK2 kinase, which then phosphorylates and activates other proteins involved in cell division. LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and to inhibit its activity, suggesting that it plays a role in regulating cell division.\nIn addition to its role in cell division, LEM-3 has also been implicated in the development of certain diseases. For example, it has been shown to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer. This suggests that LEM-3 may play a role in the development and progression of these diseases.\nOverall, while the specific roles of LEM-3 are not well understood, it is clear that it plays a role in regulating cell growth and division, and may be involved in the development of certain diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LEM-3, also known as Leucine-rich repeat-containing protein 3, is a protein involved in various cellular processes.\n2. One of the functions of LEM-3 is to regulate the activity of the CDK2/cyclin A1 complex involved in cell division.\n3. LEM-3 binds to the CDK2/cyclin A1 complex and inhibits its activity, suggesting its role in regulating cell division.\n4. LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer.\n5. LEM-3 may play a role in the development and progression of certain diseases, including some cancers.",
    "vicuna-7b_fact": [
      "LEM-3, also known as Leucine-rich repeat-containing protein 3, is a protein involved in various cellular processes.",
      "One of the functions of LEM-3 is to regulate the activity of the CDK2/cyclin A1 complex involved in cell division.",
      "LEM-3 binds to the CDK2/cyclin A1 complex and inhibits its activity, suggesting its role in regulating cell division.",
      "LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer.",
      "LEM-3 may play a role in the development and progression of certain diseases, including some cancers."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2981,
    "user_query": "What is the most common pediatric glioma?",
    "vicuna-7b_response": "The most common pediatric glioma is astrocytoma.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. Astrocytoma is the most common pediatric glioma.",
    "vicuna-7b_fact": [
      "Astrocytoma is the most common pediatric glioma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 2983,
    "user_query": "List uniparental disomy (UPD) detection algorithms",
    "vicuna-7b_response": "Uniparental disomy (UPD) is a genetic condition in which one copy of a chromosome is present in two copies, resulting in a duplication of the genetic material. UPD can occur in various ways, including through meiotic non-disjunction or mitotic non-disjunction.\nThere are several algorithms that can be used to detect UPD, including:\n1. Fluorescence in situ hybridization (FISH): FISH is a technique that uses fluorescent probes to detect specific regions of chromosomes. FISH can be used to detect UPD by labeling one copy of a chromosome and then comparing it to the other copy.\n2. Array-based comparative genomic hybridization (aCGH): aCGH is a technique that uses microarrays to detect copy number variations, including UPD. aCGH can detect UPD by comparing the copy number of a specific region of chromosomes between two samples.\n3. High-resolution melting (HRM) analysis: HRM is a technique that uses temperature-dependent melting of DNA to detect variations in the DNA sequence. HRM can be used to detect UPD by comparing the melting temperature of a specific region of chromosomes between two samples.\n4. Single-nucleotide polymorphism (SNP) array: SNP array is a technique that uses microarrays to detect single nucleotide variations in the DNA sequence. SNP array can be used to detect UPD by comparing the genotype of a specific region of chromosomes between two samples.\n5. Copy number variation (CNV) analysis: CNV analysis is a technique that uses microarrays to detect variations in the copy number of specific regions of chromosomes. CNV analysis can be used to detect UPD by comparing the copy number of a specific region of chromosomes between two samples.\nThese are some of the most commonly used algorithms for UPD detection. The choice of algorithm will depend on the specific research question and the available resources.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Uniparental disomy (UPD) is a genetic condition where one copy of a chromosome is present in two copies.\n2. Fluorescence in situ hybridization (FISH) is an action that uses fluorescent probes to detect specific regions of chromosomes and can be used to detect UPD.\n3. Array-based comparative genomic hybridization (aCGH) is used to detect UPD by comparing the copy number of a specific region of chromosomes between two samples.\n4. High-resolution melting (HRM) analysis can be used to detect UPD by comparing the melting temperature of a specific region of chromosomes between two samples.\n5. Single-nucleotide polymorphism (SNP) array and Copy number variation (CNV) analysis can also be used to detect UPD by comparing the genotype and copy number of a specific region of chromosomes between two samples, respectively.",
    "vicuna-7b_fact": [
      "Uniparental disomy (UPD) is a genetic condition where one copy of a chromosome is present in two copies.",
      "Fluorescence in situ hybridization (FISH) is an action that uses fluorescent probes to detect specific regions of chromosomes and can be used to detect UPD.",
      "Array-based comparative genomic hybridization (aCGH) is used to detect UPD by comparing the copy number of a specific region of chromosomes between two samples.",
      "High-resolution melting (HRM) analysis can be used to detect UPD by comparing the melting temperature of a specific region of chromosomes between two samples.",
      "Single-nucleotide polymorphism (SNP) array and Copy number variation (CNV) analysis can also be used to detect UPD by comparing the genotype and copy number of a specific region of chromosomes between two samples, respectively."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Uniparental disomy (UPD) is a genetic condition where both copies of a chromosome or part of a chromosome are inherited from one parent, rather than one copy from each parent.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2987,
    "user_query": "List major features of TEMPI Syndrome.",
    "vicuna-7b_response": "TEMPI Syndrome is a rare genetic disorder that affects multiple systems in the body. Some of the major features of TEMPI Syndrome include:\n1. Developmental delays: Children with TEMPI Syndrome often have significant delays in their physical and cognitive development.\n2. Intellectual disability: Many individuals with TEMPI Syndrome have mild to severe intellectual disability.\n3. Speech and language delays: Children with TEMPI Syndrome may have difficulty speaking, understanding language, and producing sounds.\n4. Seizures: TEMPI Syndrome is often associated with seizures, which can be difficult to control.\n5. Muscle weakness and joint stiffness: Many individuals with TEMPI Syndrome experience muscle weakness and joint stiffness, which can affect their mobility and daily activities.\n6. Feeding difficulties: Some children with TEMPI Syndrome may have difficulty feeding and swallowing, which can lead to weight loss and malnutrition.\n7. Heart problems: TEMPI Syndrome is associated with abnormalities of the heart and blood vessels, which can lead to high blood pressure and other cardiovascular problems.\n8. Eye problems: Some individuals with TEMPI Syndrome may experience vision problems, such as cataracts or glaucoma.\n9. Dental problems: Children with TEMPI Syndrome may have difficulty with tooth development and may experience tooth decay and other dental problems.\n10. Short stature: Many individuals with TEMPI Syndrome are shorter than average due to growth hormone deficiency.\nIt's important to note that the specific features of TEMPI Syndrome can vary greatly from person to person, and some individuals may experience only a few of these symptoms. Additionally, some of these symptoms may be less severe in some individuals than in others.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TEMPI Syndrome is a rare genetic disorder that affects multiple systems in the body.\n2. Children with TEMPI Syndrome often have significant developmental delays in their physical and cognitive development.\n3. Many individuals with TEMPI Syndrome experience muscle weakness and joint stiffness.\n4. Some children with TEMPI Syndrome have difficulty feeding and swallowing, which can lead to weight loss and malnutrition.\n5. Many individuals with TEMPI Syndrome are shorter than average due to growth hormone deficiency.",
    "vicuna-7b_fact": [
      "TEMPI Syndrome is a rare genetic disorder that affects multiple systems in the body.",
      "Children with TEMPI Syndrome often have significant developmental delays in their physical and cognitive development.",
      "Many individuals with TEMPI Syndrome experience muscle weakness and joint stiffness.",
      "Some children with TEMPI Syndrome have difficulty feeding and swallowing, which can lead to weight loss and malnutrition.",
      "Many individuals with TEMPI Syndrome are shorter than average due to growth hormone deficiency."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2990,
    "user_query": "What is nyctinasty in plants?",
    "vicuna-7b_response": "Nyctinasty is a type of plant movement that involves the closing of leaves or other plant parts at night and their opening during the day. This movement is typically seen in plants that are adapted to low light conditions, such as those found in forests or understory vegetation.\nNyctinasty is caused by the contraction of specialized cells called nyctinastic cells, which are located near the margins of the plant parts. The contraction of these cells causes the plant parts to fold inward, protecting them from damage caused by direct sunlight and high temperatures.\nThe process of nyctinasty is regulated by the plant's circadian rhythm, which is a biological process that helps the plant adapt to the daily changes in light and temperature. The circadian rhythm triggers the nyctinastic cells to contract at night, causing the plant parts to fold inward.\nNyctinasty is an important adaptation for plants that grow in low light conditions, as it helps them conserve energy and protect themselves from damage caused by direct sunlight. Some examples of plants that exhibit nyctinasty include ferns, mosses, and many types of trees, such as oak and maple.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nyctinasty is a type of plant movement that involves the closing of leaves or other plant parts at night and their opening during the day.\n2. Specialized cells called nyctinastic cells cause this movement, which contracts and causes the plant parts to fold inward.\n3. The process of nyctinasty is regulated by the plant's circadian rhythm.\n4. Nyctinasty is an important adaptation for plants that grow in low light conditions.\n5. Some examples of plants that exhibit nyctinasty include ferns, mosses, and many types of trees, such as oak and maple.",
    "vicuna-7b_fact": [
      "Nyctinasty is a type of plant movement that involves the closing of leaves or other plant parts at night and their opening during the day.",
      "Specialized cells called nyctinastic cells cause this movement, which contracts and causes the plant parts to fold inward.",
      "The process of nyctinasty is regulated by the plant's circadian rhythm.",
      "Nyctinasty is an important adaptation for plants that grow in low light conditions.",
      "Some examples of plants that exhibit nyctinasty include ferns, mosses, and many types of trees, such as oak and maple."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The movement in nyctinasty is caused by changes in turgor pressure within cells at the base of the leaves or petals, not by 'nyctinastic cells'.\n3. TRUE\n4. FALSE [correction]: Nyctinasty is an important adaptation for plants which helps to protect them from cold night temperatures or from night-time herbivores. It doesn't specifically pertain to plants in low light conditions.\n5. FALSE [correction]: Some examples of plants that exhibit nyctinasty include legumes, Oxalis, and the prayer plant (Maranta leuconeura), not typically ferns, mosses, oak or maple trees.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-7b_response": "tmVar is a software package for managing and visualizing temporal data. It is developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna. Here is a list of the releases of tmVar:\n1. tmVar 1.0: This was the first release of tmVar, which was released in 2012. It was primarily designed for the analysis of RNA-seq data.\n2. tmVar 1.1: This release was released in 2013 and included several new features, including the ability to analyze ChIP-seq data and the ability to visualize the results of the analysis using interactive heatmaps.\n3. tmVar 1.2: This release was released in 2014 and included several new features, including the ability to analyze single-cell RNA-seq data and the ability to perform batch processing of large datasets.\n4. tmVar 1.3: This release was released in 2015 and included several new features, including the ability to perform differential expression analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n5. tmVar 1.4: This release was released in 2016 and included several new features, including the ability to perform functional enrichment analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n6. tmVar 1.5: This release was released in 2017 and included several new features, including the ability to perform clustering analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n7. tmVar 1.6: This release was released in 2018 and included several new features, including the ability to perform network analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n8. tmVar 1.7: This release was released in 2019 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n9. tmVar 1.8: This release was released in 2020 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n10. tmVar 1.9:",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. tmVar is a software package developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.\n2. tmVar 1.0 was the first release and it was released in 2012.\n3. tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.\n4. tmVar 1.2 was released in 2014 and had the ability to analyze single-cell RNA-seq data.\n5. tmVar 1.4 was released in 2016 with the ability to perform functional enrichment analysis.\n6. tmVar 1.8 was released in 2020 and included features such as batch processing of large datasets.",
    "vicuna-7b_fact": [
      "tmVar is a software package developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.",
      "tmVar 1.0 was the first release and it was released in 2012.",
      "tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.",
      "tmVar 1.2 was released in 2014 and had the ability to analyze single-cell RNA-seq data.",
      "tmVar 1.4 was released in 2016 with the ability to perform functional enrichment analysis.",
      "tmVar 1.8 was released in 2020 and included features such as batch processing of large datasets."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2993,
    "user_query": "Which deep learning algorithm has been developed for variant calling?",
    "vicuna-7b_response": "One deep learning algorithm that has been developed for variant calling is called \"Variant Decomposition using Deep Learning\" (VaDeep). VaDeep is a deep learning algorithm that uses a neural network to predict the likelihood of a variant being present in a genome. It has been shown to be effective in identifying variants in genomic data, and has been used in a number of studies to identify genetic variants associated with various diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A deep learning algorithm called \"Variant Decomposition using Deep Learning\" (VaDeep) has been developed for variant calling.\n2. VaDeep uses a neural network to predict the likelihood of a variant being present in a genome.\n3. VaDeep has been effective in identifying variants in genomic data.\n4. VaDeep has been used in several studies to identify genetic variants associated with various diseases.",
    "vicuna-7b_fact": [
      "A deep learning algorithm called \"Variant Decomposition using Deep Learning\" (VaDeep) has been developed for variant calling.",
      "VaDeep uses a neural network to predict the likelihood of a variant being present in a genome.",
      "VaDeep has been effective in identifying variants in genomic data.",
      "VaDeep has been used in several studies to identify genetic variants associated with various diseases."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3000,
    "user_query": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III).",
    "vicuna-7b_response": "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a rare genetic disorder caused by a deficiency in the activity of the enzyme alpha-L-iduronidase. This enzyme is responsible for breaking down a specific type of sugar called heparan sulfate, which is found in many tissues in the body. Without enough alpha-L-iduronidase, heparan sulfate accumulates in the body, leading to progressive damage to various organs and tissues.\nThe four genes that are responsible for MPS-III are:\n1. SBS (sulfobetaine sulfatase) gene: This gene provides instructions for making the enzyme sulfobetaine sulfatase, which is involved in breaking down heparan sulfate. Mutations in the SBS gene can lead to a deficiency in sulfobetaine sulfatase activity and result in MPS-III.\n2. HGS (heparan sulfate 6-sulfatase) gene: This gene provides instructions for making the enzyme heparan sulfate 6-sulfatase, which is responsible for breaking down a specific type of heparan sulfate called heparan sulfate 6-sulfate. Mutations in the HGS gene can also lead to a deficiency in heparan sulfate 6-sulfatase activity and result in MPS-III.\n3. GALNS (N-acetylglucosamine 6-sulfatase) gene: This gene provides instructions for making the enzyme N-acetylglucosamine 6-sulfatase, which is responsible for breaking down a specific type of sugar called N-acetylglucosamine 6-sulfate. Mutations in the GALNS gene can lead to a deficiency in N-acetylglucosamine 6-sulfatase activity and result in MPS-III.\n4. SAA1 (sulfamidase) gene: This gene provides instructions for making the enzyme sulfamidase, which is involved in breaking down a specific type of sugar called N",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sanfilippo syndrome is a rare genetic disorder caused by a deficiency in the activity of the enzyme alpha-L-iduronidase.\n2. The enzyme alpha-L-iduronidase is responsible for breaking down a specific type of sugar called heparan sulfate.\n3. The first gene involved in Sanfilippo syndrome is the SBS gene, which provides instructions for making the enzyme sulfobetaine sulfatase.\n4. The second gene involved in Sanfilippo syndrome is the HGS gene, providing instructions for making the enzyme heparan sulfate 6-sulfatase.\n5. The GALNS gene and SAA1 gene are also involved in Sanfilippo syndrome, they responsible for making the enzymes N-acetylglucosamine 6-sulfatase and sulfamidase, respectively.",
    "vicuna-7b_fact": [
      "Sanfilippo syndrome is a rare genetic disorder caused by a deficiency in the activity of the enzyme alpha-L-iduronidase.",
      "The enzyme alpha-L-iduronidase is responsible for breaking down a specific type of sugar called heparan sulfate.",
      "The first gene involved in Sanfilippo syndrome is the SBS gene, which provides instructions for making the enzyme sulfobetaine sulfatase.",
      "The second gene involved in Sanfilippo syndrome is the HGS gene, providing instructions for making the enzyme heparan sulfate 6-sulfatase.",
      "The GALNS gene and SAA1 gene are also involved in Sanfilippo syndrome, they responsible for making the enzymes N-acetylglucosamine 6-sulfatase and sulfamidase, respectively."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Sanfilippo syndrome is a rare genetic disorder caused by a deficiency in various enzymes that are responsible for breaking down a specific type of sugar molecule called heparan sulfate, not alpha-L-iduronidase.\n2. FALSE [correction]: The enzyme alpha-L-iduronidase is responsible for breaking down a specific type of sugar molecule called glycosaminoglycans (GAGs) but is not directly related to Sanfilippo syndrome.\n3. FALSE [correction]: The first gene involved in Sanfilippo syndrome is the SGSH gene, which provides instructions for making the enzyme sulfamidase.\n4. FALSE [correction]: The second gene involved in Sanfilippo syndrome is the NAGLU gene, providing instructions for making the enzyme alpha-N-acetylglucosaminidase.\n5. FALSE [correction]: The GALNS gene and SAA1 gene are not involved in Sanfilippo syndrome. The specific genes involved include SGSH, NAGLU, HGSNAT, and GNS, which are responsible for making different enzymes that contribute to the breakdown of heparan sulfate.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3002,
    "user_query": "List clinical disorders or diseases where uc.189 is involved?",
    "vicuna-7b_response": "UC.189 is a gene that is associated with several clinical disorders or diseases. Here is a list of some of the disorders where UC.189 is involved:\n1. Cystic fibrosis: Cystic fibrosis is a genetic disorder that affects the respiratory and digestive systems. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which includes UC.189.\n2. Primary ciliary dyskinesia (PCD): PCD is a genetic disorder that affects the respiratory and reproductive systems. It is caused by mutations in genes that are involved in ciliary function, including UC.189.\n3. Meconium ileus: Meconium ileus is a condition that occurs in newborns, where the first stool (meconium) becomes stuck in the intestines. It is caused by mutations in genes that are involved in ciliary function, including UC.189.\n4. Immunodeficiency: UC.189 is also involved in immunodeficiency disorders, such as X-linked agammaglobulinemia (XLA), where mutations in the UC.189 gene lead to a deficiency in B cells and an increased susceptibility to infections.\n5. Inflammatory bowel disease (IBD): Some studies have suggested that mutations in the UC.189 gene may be associated with an increased risk of developing inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. However, more research is needed to confirm this association.\nIt is important to note that these are just a few examples of disorders where UC.189 is involved, and there may be other disorders as well. If you have any specific questions or concerns about UC.189 and its involvement in disorders, it is best to consult with a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. UC.189 is a gene that is associated with several clinical disorders or diseases.\n2. Cystic fibrosis is a genetic disorder that is associated with the UC.189 gene. \n3. Primary ciliary dyskinesia is a genetic disorder that involves the UC.189 gene.\n4. UC.189 is associated with Meconium ileus, a condition that occurs in newborns.\n5. UC.189 is involved in immunodeficiency disorders, such as X-linked agammaglobulinemia.\n6. Some studies have suggested that mutations in the UC.189 gene may be associated with inflammatory bowel disease.",
    "vicuna-7b_fact": [
      "UC.189 is a gene that is associated with several clinical disorders or diseases.",
      "Cystic fibrosis is a genetic disorder that is associated with the UC.189 gene.",
      "Primary ciliary dyskinesia is a genetic disorder that involves the UC.189 gene.",
      "UC.189 is associated with Meconium ileus, a condition that occurs in newborns.",
      "UC.189 is involved in immunodeficiency disorders, such as X-linked agammaglobulinemia.",
      "Some studies have suggested that mutations in the UC.189 gene may be associated with inflammatory bowel disease."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3004,
    "user_query": "What is the role of metalloproteinase-17 (ADAM17) in NK cells?",
    "vicuna-7b_response": "Metalloproteinase-17 (ADAM17) plays a critical role in the regulation of natural killer (NK) cells. ADAM17 is a type of metalloproteinase, which are enzymes that break down proteins. ADAM17 is expressed on the surface of some immune cells, including NK cells, and it has been shown to play a role in the regulation of NK cell function.\nOne of the key functions of ADAM17 in NK cells is to regulate the expression of inhibitory receptors on the surface of NK cells. Inhibitory receptors are proteins that can bind to specific molecules on the surface of cells and inhibit the activity of NK cells. ADAM17 can cleave and remove the inhibitory receptors from the surface of NK cells, allowing them to become more active and better able to kill target cells.\nIn addition to regulating the expression of inhibitory receptors, ADAM17 has also been shown to play a role in the activation of NK cells. ADAM17 can cleave and activate certain proteins on the surface of NK cells, which can trigger the activation of NK cells and enhance their ability to kill target cells.\nOverall, ADAM17 plays a critical role in the regulation of NK cell function, and its dysregulation has been implicated in the development of certain diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Metalloproteinase-17 (ADAM17) plays a critical role in the regulation of natural killer (NK) cells.\n2. ADAM17 is a type of metalloproteinase, which are enzymes that break down proteins.\n3. One of the key functions of ADAM17 in NK cells is to regulate the expression of inhibitory receptors.\n4. ADAM17 can cleave and remove the inhibitory receptors from the surface of NK cells.\n5. The dysregulation of ADAM17 has been implicated in the development of certain diseases, including cancer.",
    "vicuna-7b_fact": [
      "Metalloproteinase-17 (ADAM17) plays a critical role in the regulation of natural killer (NK) cells.",
      "ADAM17 is a type of metalloproteinase, which are enzymes that break down proteins.",
      "One of the key functions of ADAM17 in NK cells is to regulate the expression of inhibitory receptors.",
      "ADAM17 can cleave and remove the inhibitory receptors from the surface of NK cells.",
      "The dysregulation of ADAM17 has been implicated in the development of certain diseases, including cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3005,
    "user_query": "What is the triad of Melkersson-Rosenthal syndrome?",
    "vicuna-7b_response": "Melkersson-Rosenthal syndrome is a rare autoimmune disorder that affects the facial nerve, causing facial weakness and a droopy eyelid (ptosis). It is also known as Wegener's granulomatosis with polyangiitis. The triad of Melkersson-Rosenthal syndrome includes the following three features:\n1. Facial nerve weakness: This is the most common symptom of Melkersson-Rosenthal syndrome. It can cause weakness or paralysis of the muscles on one side of the face, including the forehead, eyelid, and cheek.\n2. Ptosis: This is a droopy eyelid that can cause difficulty seeing and double vision.\n3. Oral ulcers: Melkersson-Rosenthal syndrome can also cause painless, recurrent ulcers to form on the roof of the mouth, as well as on the tongue and lips. These ulcers are usually round and shallow, and they can be very painful.\nIn addition to these three main features, Melkersson-Rosenthal syndrome can also cause other symptoms, such as nasal congestion, sinus infections, and hearing loss. The condition is typically diagnosed through a combination of physical examination, medical history, and laboratory tests. Treatment typically involves medications to manage symptoms and prevent complications, as well as surgery in some cases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Melkersson-Rosenthal syndrome is a rare autoimmune disorder that affects the facial nerve.\n2. The triad of Melkersson-Rosenthal syndrome includes facial nerve weakness, ptosis, and oral ulcers.\n3. Facial nerve weakness in Melkersson-Rosenthal syndrome can cause weakness or paralysis of the muscles on one side of the face.\n4. Ptosis in this syndrome results in a droopy eyelid that can cause difficulty seeing and double vision.\n5. Melkersson-Rosenthal syndrome may cause painless, recurrent ulcers on the roof of the mouth, tongue and lips.",
    "vicuna-7b_fact": [
      "Melkersson-Rosenthal syndrome is a rare autoimmune disorder that affects the facial nerve.",
      "The triad of Melkersson-Rosenthal syndrome includes facial nerve weakness, ptosis, and oral ulcers.",
      "Facial nerve weakness in Melkersson-Rosenthal syndrome can cause weakness or paralysis of the muscles on one side of the face.",
      "Ptosis in this syndrome results in a droopy eyelid that can cause difficulty seeing and double vision.",
      "Melkersson-Rosenthal syndrome may cause painless, recurrent ulcers on the roof of the mouth, tongue and lips."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Melkersson-Rosenthal syndrome is a rare neuro-mucocutaneous disorder, not an autoimmune disorder, that affects the facial nerve.\n2. FALSE [correction]: The triad of Melkersson-Rosenthal syndrome includes facial palsy, orofacial swelling, and a fissured tongue, not ptosis and oral ulcers.\n3. TRUE\n4. FALSE [correction]: Ptosis is not a commonly associated symptom of Melkersson-Rosenthal syndrome. The syndrome often presents with facial palsy, swelling, and a fissured tongue.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3006,
    "user_query": "Is galcanezumab effective for treatment of migraine?",
    "vicuna-7b_response": "Galcanezumab is a monoclonal antibody that is used to treat migraines. It works by blocking the calcitonin gene-related peptide (CGRP), which is involved in the development of migraines.\nStudies have shown that galcanezumab is effective in reducing the frequency and severity of migraines. In fact, a clinical trial found that patients who received galcanezumab had a significant reduction in the number of monthly migraine days compared to those who received a placebo.\nAdditionally, galcanezumab has been shown to be well-tolerated, with most side effects being mild and temporary.\nIt's important to note that while galcanezumab is effective for treating migraines, it may not work for everyone. It's always best to consult with a healthcare professional to determine the best treatment plan for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Galcanezumab is a monoclonal antibody used for the treatment of migraines.\n2. Galcanezumab works by blocking the calcitonin gene-related peptide (CGRP).\n3. Studies have shown that galcanezumab reduces the frequency and severity of migraines.\n4. A clinical trial found that patients who received galcanezumab had a significant reduction in the number of monthly migraine days compared to those who received a placebo.\n5. Galcanezumab has been shown to be well-tolerated, with most side effects being mild and temporary.",
    "vicuna-7b_fact": [
      "Galcanezumab is a monoclonal antibody used for the treatment of migraines.",
      "Galcanezumab works by blocking the calcitonin gene-related peptide (CGRP).",
      "Studies have shown that galcanezumab reduces the frequency and severity of migraines.",
      "A clinical trial found that patients who received galcanezumab had a significant reduction in the number of monthly migraine days compared to those who received a placebo.",
      "Galcanezumab has been shown to be well-tolerated, with most side effects being mild and temporary."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3011,
    "user_query": "Fecal transplantation is used to treat infection with what bacteria?",
    "vicuna-7b_response": "Fecal transplantation is used to treat infection with Clostridioides difficile (C. difficile) bacteria. C. difficile is a type of bacteria that can cause diarrhea and colitis (inflammation of the colon) in people who have recently taken antibiotics. Fecal transplantation involves transferring feces from a healthy donor to the patient, which can help restore the balance of bacteria in the gut and treat C. difficile infection.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fecal transplantation is used to treat infection with Clostridioides difficile bacteria.\n2. Clostridioides difficile is a type of bacteria that can cause diarrhea and colitis.\n3. The disease caused by C. difficile often occurs in people who have recently taken antibiotics.\n4. Fecal transplantation involves transferring feces from a healthy donor to the patient.\n5. The purpose of fecal transplantation is to help restore the balance of bacteria in the gut and treat C. difficile infection.",
    "vicuna-7b_fact": [
      "Fecal transplantation is used to treat infection with Clostridioides difficile bacteria.",
      "Clostridioides difficile is a type of bacteria that can cause diarrhea and colitis.",
      "The disease caused by C. difficile often occurs in people who have recently taken antibiotics.",
      "Fecal transplantation involves transferring feces from a healthy donor to the patient.",
      "The purpose of fecal transplantation is to help restore the balance of bacteria in the gut and treat C. difficile infection."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3015,
    "user_query": "What are the CADD scores?",
    "vicuna-7b_response": "CADD scores are a measure of cognitive and memory function. Cognitive Assessment through Defense Analytics (CADD) is a computer-based test used to assess cognitive abilities in military personnel. The CADD test consists of several subtests that assess different cognitive abilities, including attention, memory, processing speed, and problem-solving.\nThe CADD test is designed to be quick and easy to administer, and it can be used to identify individuals who may be at risk for cognitive impairment or who may need additional support to perform their duties. The test is also used to monitor the effects of training and operational stress on cognitive function.\nThe CADD test is administered in a standardized environment and is designed to be fair and unbiased. The test is scored based on the number of correct answers given by the individual, and the scores are used to identify areas of strength and weakness.\nIt's important to note that CADD scores are just one tool used to assess cognitive function, and they should not be used as the sole indicator of an individual's cognitive abilities. Cognitive function can be influenced by a variety of factors, including genetics, lifestyle, and environmental factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CADD scores are a measure of cognitive and memory function.\n2. Cognitive Assessment through Defense Analytics (CADD) is a computer-based test used to assess cognitive abilities in military personnel.\n3. The CADD test consists of several subtests that assess different cognitive abilities, including attention, memory, processing speed, and problem-solving.\n4. The CADD test can be used to identify individuals who may be at risk for cognitive impairment or who may need additional support to perform their duties.\n5. The CADD test is administered in a standardized environment and is scored based on the number of correct answers.",
    "vicuna-7b_fact": [
      "CADD scores are a measure of cognitive and memory function.",
      "Cognitive Assessment through Defense Analytics (CADD) is a computer-based test used to assess cognitive abilities in military personnel.",
      "The CADD test consists of several subtests that assess different cognitive abilities, including attention, memory, processing speed, and problem-solving.",
      "The CADD test can be used to identify individuals who may be at risk for cognitive impairment or who may need additional support to perform their duties.",
      "The CADD test is administered in a standardized environment and is scored based on the number of correct answers."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-7b_response": "There are several databases that contain information on somatic mutations in normal cells. Here are a few examples:\n1. The Cancer Genome Atlas (TCGA) database: This database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database: This database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database: This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB): This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\nThese are just a few examples of databases that contain information on somatic mutations in normal cells. There are many other databases available, and the specific database that is most relevant to a particular question will depend on the type of information being sought.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control. \n5. There are numerous databases available that contain information on somatic mutations in normal cells.",
    "vicuna-7b_fact": [
      "The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.",
      "The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.",
      "The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.",
      "The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.",
      "There are numerous databases available that contain information on somatic mutations in normal cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The National Cancer Institute's (NCI) doesn't maintain a SEQUENOM database. However, NCI supports multiple cancer genomic data repositories with information on somatic mutations, including the Cancer Genomics Hub (CGHub) and Genomic Data Commons (GDC).\n4. FALSE [correction]: The European Bioinformatics Institute's (EBI) database for somatic mutations is COSMIC (Catalogue of Somatic Mutations in Cancer), not SMDB. It contains information on somatic mutations in various types of human cancer.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3023,
    "user_query": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
    "vicuna-7b_response": "The periodontal disease associated bacteria that is also associated with Alzheimer's disease is Porphyromonas gingivalis.\nPorphyromonas gingivalis is a gram-negative, facultative anaerobic bacterium that is commonly found in the oral cavity and is a major contributor to periodontal disease. Recent studies have also suggested a possible association between P. gingivalis and Alzheimer's disease.\nResearch has shown that P. gingivalis can penetrate the blood-brain barrier and reach the brain, where it can trigger an inflammatory response that may contribute to the development of Alzheimer's disease. Additionally, P. gingivalis has been found in the brains of Alzheimer's disease patients, suggesting that the bacterium may play a role in the disease process.\nWhile more research is needed to fully understand the relationship between P. gingivalis and Alzheimer's disease, it is important for individuals to maintain good oral hygiene to reduce the risk of periodontal disease, which can also help to reduce the risk of developing Alzheimer's disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Porphyromonas gingivalis is associated with both periodontal disease and Alzheimer's disease.\n2. Porphyromonas gingivalis is a gram-negative, facultative anaerobic bacterium found in the oral cavity.\n3. The bacterium Porphyromonas gingivalis is a major contributor to periodontal disease.\n4. Porphyromonas gingivalis can penetrate the blood-brain barrier and reach the brain.\n5. Porphyromonas gingivalis has been found in the brains of Alzheimer's disease patients.",
    "vicuna-7b_fact": [
      "Porphyromonas gingivalis is associated with both periodontal disease and Alzheimer's disease.",
      "Porphyromonas gingivalis is a gram-negative, facultative anaerobic bacterium found in the oral cavity.",
      "The bacterium Porphyromonas gingivalis is a major contributor to periodontal disease.",
      "Porphyromonas gingivalis can penetrate the blood-brain barrier and reach the brain.",
      "Porphyromonas gingivalis has been found in the brains of Alzheimer's disease patients."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3025,
    "user_query": "How does the Cholera toxin enter a cell?",
    "vicuna-7b_response": "Cholera toxin is a protein toxin produced by the bacterium Vibrio cholerae. It is a major cause of cholera, a diarrheal disease that can lead to severe dehydration and death if left untreated.\nCholera toxin enters a cell through specific receptors on the surface of the host cell. The toxin binds to these receptors, which are present on the surface of epithelial cells in the small intestine, and triggers a chain of events that leads to the release of large amounts of water and electrolytes into the intestinal lumen.\nThe binding of cholera toxin to its receptor triggers a conformational change in the toxin, which leads to the cleavage of a large protein called ADP-ribosylation factor (ARF) from the cell membrane. This cleavage event activates a signaling pathway that ultimately leads to the secretion of large amounts of water and electrolytes into the intestinal lumen.\nThe entry of cholera toxin into the host cell is a complex process that involves several steps, including binding to receptors, activation of signaling pathways, and the release of water and electrolytes into the intestinal lumen. Understanding the mechanism of entry of cholera toxin into host cells is important for the development of effective treatments and vaccines against cholera.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cholera toxin is a protein toxin produced by the bacterium Vibrio cholerae.\n2. Cholera toxin enters a cell through receptors on the surface of the host cell.\n3. These cell receptors are present on the surface of epithelial cells in the small intestine.\n4. The conformational change and cleavage of a large protein called ADP-ribosylation factor (ARF) from the cell membrane is triggered by the binding of cholera toxin to its receptor.\n5. Understanding the mechanism of entry of cholera toxin into host cells is pertinent for the development of effective treatments and vaccines against cholera.",
    "vicuna-7b_fact": [
      "Cholera toxin is a protein toxin produced by the bacterium Vibrio cholerae.",
      "Cholera toxin enters a cell through receptors on the surface of the host cell.",
      "These cell receptors are present on the surface of epithelial cells in the small intestine.",
      "The conformational change and cleavage of a large protein called ADP-ribosylation factor (ARF) from the cell membrane is triggered by the binding of cholera toxin to its receptor.",
      "Understanding the mechanism of entry of cholera toxin into host cells is pertinent for the development of effective treatments and vaccines against cholera."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The conformational change and cleavage of a large protein called ADP-ribosylation factor (ARF) from the cell membrane is not triggered by the binding of cholera toxin to its receptor. Cholera toxin activates adenylate cyclase, leading to an increased level of cyclic AMP within the cell.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3027,
    "user_query": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "vicuna-7b_response": "Mogamulizumab is a monoclonal antibody that is used to treat cutaneous T-cell lymphoma (CTCL). It is specifically approved for the treatment of CTCL that is resistant to, or has recurred following, at least one prior systemic therapy.\nMogamulizumab works by binding to the cell surface receptor CXCR4, which is expressed on certain types of cancer cells, including CTCL cells. By binding to CXCR4, mogamulizumab may help to slow the growth and spread of cancer cells, and may also stimulate the immune system to attack the cancer cells.\nStudies have shown that mogamulizumab can be effective in treating CTCL, with many patients experiencing improvements in their skin lesions and overall health. However, as with any treatment, mogamulizumab may cause side effects, and it is important to discuss the potential benefits and risks of the treatment with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mogamulizumab is a monoclonal antibody used to treat cutaneous T-cell lymphoma (CTCL).\n2. It is specifically approved for the treatment of CTCL that is resistant to, or has recurred following, at least one prior systemic therapy.\n3. Mogamulizumab works by binding to the cell surface receptor CXCR4.\n4. CXCR4 is expressed on certain types of cancer cells, including CTCL cells.\n5. Studies have shown that mogamulizumab can be effective in treating CTCL.",
    "vicuna-7b_fact": [
      "Mogamulizumab is a monoclonal antibody used to treat cutaneous T-cell lymphoma (CTCL).",
      "It is specifically approved for the treatment of CTCL that is resistant to, or has recurred following, at least one prior systemic therapy.",
      "Mogamulizumab works by binding to the cell surface receptor CXCR4.",
      "CXCR4 is expressed on certain types of cancer cells, including CTCL cells.",
      "Studies have shown that mogamulizumab can be effective in treating CTCL."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Mogamulizumab works by binding to the cell surface receptor CCR4.\n4. FALSE [correction]: CCR4 is expressed on certain types of cancer cells, including CTCL cells.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3028,
    "user_query": "Which enzymes are inhibited by Duvelisib?",
    "vicuna-7b_response": "Duvelisib is a medication that is used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Duvelisib works by inhibiting a protein called PI3K-delta, which is involved in the growth and survival of cancer cells.\nDuvelisib has been shown to inhibit several enzymes, including:\n1. PI3K-delta: As mentioned earlier, Duvelisib is primarily known for its ability to inhibit PI3K-delta.\n2. JAK1: Duvelisib also inhibits JAK1, which is another protein involved in the growth and survival of cancer cells.\n3. JAK2: Duvelisib has been shown to inhibit JAK2, which is a protein that plays a role in the development and progression of certain types of blood cancers.\n4. CSF1R: Duvelisib has also been shown to inhibit CSF1R, which is a protein that is involved in the growth and survival of certain types of immune cells, including myeloid cells.\nOverall, Duvelisib is a medication that has been shown to inhibit several enzymes that are involved in the growth and survival of cancer cells, which makes it an effective treatment for certain types of blood cancers.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Duvelisib is a medication that is used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).\n2. Duvelisib works by inhibiting a protein called PI3K-delta.\n3. Duvelisib is capable of inhibiting the enzyme JAK1.\n4. Duvelisib can inhibit the enzyme JAK2.\n5. Duvelisib has been shown to inhibit the enzyme CSF1R.",
    "vicuna-7b_fact": [
      "Duvelisib is a medication that is used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).",
      "Duvelisib works by inhibiting a protein called PI3K-delta.",
      "Duvelisib is capable of inhibiting the enzyme JAK1.",
      "Duvelisib can inhibit the enzyme JAK2.",
      "Duvelisib has been shown to inhibit the enzyme CSF1R."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Duvelisib does not inhibit the enzyme JAK1, it inhibits PI3K-delta and PI3K-gamma.\n4. FALSE [correction]: Duvelisib does not inhibit the enzyme JAK2, it inhibits PI3K-delta and PI3K-gamma.\n5. FALSE [correction]: Duvelisib does not inhibit the enzyme CSF1R, it inhibits PI3K-delta and PI3K-gamma.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3029,
    "user_query": "List search engines used in proteomics.",
    "vicuna-7b_response": "Proteomics is the study of proteins and their interactions within a cell or organism. There are several search engines that can be used in proteomics research, including:\n1. UniProt: A comprehensive protein information resource that provides a central hub for protein information, including protein sequences, structures, functions, and interactions.\n2. Protein Data Bank (PDB): A database of three-dimensional structural data for proteins, nucleic acids, and complex assemblies.\n3. NCBI Gene: A database of genes and their functions, including information on protein sequences, structures, and functions.\n4. Bioinformatics Resource Center (BIRC): A collection of tools and resources for bioinformatics research, including tools for protein sequence analysis, structure prediction, and functional annotation.\n5. InterPro: A database of protein domains and families, which can be used to predict the function of a protein based on its domain structure.\n6. Swiss-Prot: A comprehensive protein information resource that provides a central hub for protein information, including protein sequences, structures, functions, and interactions.\n7. ProteomeXchange: A repository for proteomics data, including mass spectrometry-based proteomics data, which can be used to identify and quantify proteins in a sample.\nThese search engines can be used to gain insights into the proteins and protein interactions in a cell or organism, which can be used to better understand cellular processes and diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Proteomics is the study of proteins and their interactions within a cell or organism.\n2. UniProt is a comprehensive protein information resource that provides a central hub for protein information.\n3. The Protein Data Bank (PDB) is a database of three-dimensional structural data for proteins, nucleic acids, and complex assemblies.\n4. NCBI Gene is a database of genes and their functions, including information on protein sequences, structures, and functions.\n5. The Bioinformatics Resource Center (BIRC) is a collection of tools and resources for bioinformatics research.\n6. InterPro is a database of protein domains and families.\n7. Swiss-Prot provides a central hub for protein information.\n8. ProteomeXchange is a repository for proteomics data, including mass spectrometry-based proteomics data.",
    "vicuna-7b_fact": [
      "Proteomics is the study of proteins and their interactions within a cell or organism.",
      "UniProt is a comprehensive protein information resource that provides a central hub for protein information.",
      "The Protein Data Bank (PDB) is a database of three-dimensional structural data for proteins, nucleic acids, and complex assemblies.",
      "NCBI Gene is a database of genes and their functions, including information on protein sequences, structures, and functions.",
      "The Bioinformatics Resource Center (BIRC) is a collection of tools and resources for bioinformatics research.",
      "InterPro is a database of protein domains and families.",
      "Swiss-Prot provides a central hub for protein information.",
      "ProteomeXchange is a repository for proteomics data, including mass spectrometry-based proteomics data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Bioinformatics Resource Center (BIRC) is not a general term for a collection of tools and resources for bioinformatics research. Specific organizations might use \"BIRC\" as an acronym, but it's not universally recognized in the context presented.\n6. TRUE\n7. TRUE\n8. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3035,
    "user_query": "Is Lasmiditan effective for migraine?",
    "vicuna-7b_response": "Lasmiditan is a medication that is used to treat migraines. It is a selective serotonin receptor agonist, which means that it works by activating certain receptors in the brain to help alleviate migraine symptoms.\nStudies have shown that Lasmiditan can be effective in reducing the frequency and severity of migraines. It is typically taken as a tablet or a dissolving film, and the full effect is usually seen within 2 hours of taking the medication.\nIt is important to note that Lasmiditan is not suitable for everyone, and it may not be effective for everyone who takes it. Some people may experience side effects such as dizziness, nausea, or fatigue. It is also important to talk to your doctor before taking Lasmiditan, as they will be able to determine if it is the right medication for you based on your medical history and other factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lasmiditan is a medication used to treat migraines.\n2. Lasmiditan works by activating certain receptors in the brain.\n3. Studies indicate that Lasmiditan can reduce the frequency and severity of migraines.\n4. The full effect of Lasmiditan is generally seen within 2 hours of taking the medication.\n5. Lasmiditan can cause side effects such as dizziness, nausea, or fatigue.",
    "vicuna-7b_fact": [
      "Lasmiditan is a medication used to treat migraines.",
      "Lasmiditan works by activating certain receptors in the brain.",
      "Studies indicate that Lasmiditan can reduce the frequency and severity of migraines.",
      "The full effect of Lasmiditan is generally seen within 2 hours of taking the medication.",
      "Lasmiditan can cause side effects such as dizziness, nausea, or fatigue."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-7b_response": "Yes, there are several graph kernel libraries available implemented in Java. Some of the popular ones include:\n1. JUNG: JUNG is a Java library for working with graph data structures. It provides a set of classes for creating, manipulating, and analyzing graphs. JUNG is a popular choice for graph processing in Java.\n2. igraph: igraph is a C++ library for working with graphs. It provides a set of classes for creating, manipulating, and analyzing graphs. igraph also has a Java wrapper library called JAGL that allows Java developers to use igraph in their Java applications.\n3. GraphX: GraphX is a distributed graph processing library for Apache Spark. It provides a set of high-level abstractions for creating, manipulating, and analyzing graphs. GraphX is designed to work with large-scale graphs and can be used with Spark on Hadoop clusters.\n4. NetworkX: NetworkX is a Python library for working with graphs. It provides a set of classes for creating, manipulating, and analyzing graphs. NetworkX also has a Java wrapper library called JythonX that allows Java developers to use NetworkX in their Java applications.\nThese are just a few examples of the graph kernel libraries available implemented in Java. Each library has its own strengths and weaknesses, so it's important to evaluate them based on your specific requirements and use case.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. JUNG is a Java library for creating, manipulating, and analyzing graph data structures.\n2. igraph is a C++ library for working with graphs and has a Java wrapper library called JAGL.\n3. GraphX is a distributed graph processing library for Apache Spark and is designed for large-scale graphs.\n4. NetworkX is a Python library for working with graphs and has a Java wrapper library called JythonX.\n5. There are several graph kernel libraries available implemented in Java.",
    "vicuna-7b_fact": [
      "JUNG is a Java library for creating, manipulating, and analyzing graph data structures.",
      "igraph is a C++ library for working with graphs and has a Java wrapper library called JAGL.",
      "GraphX is a distributed graph processing library for Apache Spark and is designed for large-scale graphs.",
      "NetworkX is a Python library for working with graphs and has a Java wrapper library called JythonX.",
      "There are several graph kernel libraries available implemented in Java."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: NetworkX is a Python library for working with graphs, but there isn't a Java wrapper library called JythonX.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3044,
    "user_query": "What is COG112?",
    "vicuna-7b_response": "COG112 is a course offered by the University of California, San Diego (UCSD) Extension. The course is designed to provide an introduction to the principles and practices of computer programming using the Python programming language. The course covers topics such as data types, variables, control structures, functions, and object-oriented programming.\nThe course is intended for students who have little or no prior experience in programming and is suitable for anyone who wants to learn how to program in Python. The course is also suitable for students who are already familiar with another programming language and want to learn Python.\nThe course is taught by a UCSD Extension instructor and is offered online, which means that students can access the course materials and complete the coursework from anywhere with an internet connection. The course is self-paced, which means that students can complete the course in as little as a few weeks or as long as a few months, depending on their schedule.\nUpon completion of the course, students will have a solid understanding of the Python programming language and will be able to write simple programs using Python. They will also have a foundation in programming concepts that they can build upon to learn more advanced programming languages and techniques.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. COG112 is a course offered by the University of California, San Diego (UCSD) Extension.\n2. COG112 provides an introduction to the principles and practices of computer programming using the Python programming language.\n3. COG112 is intended for students who have little or no prior experience in programming.\n4. The course is taught by a UCSD Extension instructor and is offered online.\n5. Upon completion of COG112, students will have a solid understanding of the Python programming language and will be able to write simple programs using Python.",
    "vicuna-7b_fact": [
      "COG112 is a course offered by the University of California, San Diego (UCSD) Extension.",
      "COG112 provides an introduction to the principles and practices of computer programming using the Python programming language.",
      "COG112 is intended for students who have little or no prior experience in programming.",
      "The course is taught by a UCSD Extension instructor and is offered online.",
      "Upon completion of COG112, students will have a solid understanding of the Python programming language and will be able to write simple programs using Python."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-7b_response": "The SHERLOCKv2 platform integrates four key advances:\n1. **Deep Learning**: SHERLOCKv2 uses deep learning algorithms to analyze and interpret medical images, including CT scans, MRIs, and X-rays. These algorithms can detect and diagnose a wide range of medical conditions, including cancer, cardiovascular disease, and neurological disorders.\n2. **Computer Vision**: SHERLOCKv2 also uses computer vision techniques to analyze medical images and extract relevant information, such as the location and size of tumors or other abnormalities.\n3. **Natural Language Processing**: SHERLOCKv2 uses natural language processing (NLP) to enable physicians to interact with the platform using natural language, rather than having to navigate complex user interfaces. This makes it easier for physicians to access the platform's capabilities and get the information they need to make informed decisions.\n4. **Machine Learning**: SHERLOCKv2 uses machine learning algorithms to continually improve its accuracy and performance over time. As the platform processes more data and makes more accurate diagnoses, it can learn from its mistakes and improve its performance, leading to better outcomes for patients.\nOverall, the integration of these four advances into the SHERLOCKv2 platform enables physicians to access powerful medical imaging analysis capabilities that can help them make more accurate diagnoses and improve patient outcomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SHERLOCKv2 uses deep learning algorithms to analyze and interpret medical images.\n2. Computer vision techniques are used in SHERLOCKv2 to analyze medical images and extract relevant information.\n3. SHERLOCKv2 uses natural language processing to enable physicians to interact with the platform using natural language.\n4. Machine learning algorithms are used in SHERLOCKv2 to continually improve its accuracy and performance over time.\n5. The integration of these four advances into the SHERLOCKv2 platform aims to help physicians to make more accurate diagnoses and improve patient outcomes.",
    "vicuna-7b_fact": [
      "SHERLOCKv2 uses deep learning algorithms to analyze and interpret medical images.",
      "Computer vision techniques are used in SHERLOCKv2 to analyze medical images and extract relevant information.",
      "SHERLOCKv2 uses natural language processing to enable physicians to interact with the platform using natural language.",
      "Machine learning algorithms are used in SHERLOCKv2 to continually improve its accuracy and performance over time.",
      "The integration of these four advances into the SHERLOCKv2 platform aims to help physicians to make more accurate diagnoses and improve patient outcomes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3055,
    "user_query": "What is MOV10?",
    "vicuna-7b_response": "MOV10 is a programming language developed by Google. It is a low-level, high-performance language that is designed to be used for system programming and operating system development. MOV10 is a statically typed language and is designed to be fast and efficient, with a focus on low-level control over hardware resources. It is used by Google in their internal systems and is not intended for general-purpose programming.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MOV10 is a programming language developed by Google.\n2. MOV10 is a low-level, high-performance language.\n3. The programming language is intended for system programming and operating system development.\n4. MOV10 is a statically typed language.\n5. The programming language is used by Google in their internal systems.",
    "vicuna-7b_fact": [
      "MOV10 is a programming language developed by Google.",
      "MOV10 is a low-level, high-performance language.",
      "The programming language is intended for system programming and operating system development.",
      "MOV10 is a statically typed language.",
      "The programming language is used by Google in their internal systems."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MOV10 is not a programming language. It is a gene that in humans is encoded by the MOV10 protein\n2. FALSE [correction]: As MOV10 is not a programming language, it cannot be classified as low-level or high performance.\n3. FALSE [correction]: MOV10 is not intended for system programming and operating system development as it is not a programming language.\n4. FALSE [correction]: The statement is incorrect as MOV10 is not a programming language, therefore it can't be a statically typed one.\n5. FALSE [correction]: Google does not use MOV10 in their internal systems as it is not a programming language.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3057,
    "user_query": "Which cancer is associated with increased levels of Serum alpha fetoprotein (AFP) ?",
    "vicuna-7b_response": "Serum alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver of a developing fetus. In adults, AFP is produced by the liver and is found in the blood. Elevated levels of AFP in the blood may indicate the presence of a liver cancer called hepatocellular carcinoma (HCC). HCC is the most common type of liver cancer and is associated with an increased risk of death. Other conditions that can cause elevated AFP levels include hepatitis, cirrhosis, and pregnancy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Serum alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver of a developing fetus.\n2. In adults, AFP is produced by the liver and can be found in the blood.\n3. Elevated levels of AFP in the blood may indicate the presence of hepatocellular carcinoma (HCC).\n4. HCC is the most common type of liver cancer and is associated with an increased risk of death.\n5. Hepatitis, cirrhosis, and pregnancy can also cause elevated AFP levels.",
    "vicuna-7b_fact": [
      "Serum alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver of a developing fetus.",
      "In adults, AFP is produced by the liver and can be found in the blood.",
      "Elevated levels of AFP in the blood may indicate the presence of hepatocellular carcinoma (HCC).",
      "HCC is the most common type of liver cancer and is associated with an increased risk of death.",
      "Hepatitis, cirrhosis, and pregnancy can also cause elevated AFP levels."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3060,
    "user_query": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "vicuna-7b_response": "The interaction between MOV10 and RNASEH2 has been shown to play a role in regulating L1 retrotransposition.\nMOV10 is a protein that is involved in the clearance of RNA and RNA-protein complexes from the cell. It has been shown to interact with RNASEH2, a protein that is involved in the degradation of RNA.\nStudies have shown that the interaction between MOV10 and RNASEH2 can affect the activity of the L1 retrotransposition machinery. For example, it has been shown that inhibition of the interaction between MOV10 and RNASEH2 can increase the activity of the L1 retrotransposition machinery, leading to an increase in L1 retrotransposition.\nOverall, the interaction between MOV10 and RNASEH2 appears to play a role in regulating L1 retrotransposition, and further research is needed to fully understand the mechanisms underlying this interaction.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The interaction between MOV10 and RNASEH2 regulates L1 retrotransposition.\n2. MOV10 is a protein involved in the clearance of RNA and RNA-protein complexes from the cell. \n3. RNASEH2 is a protein involved in the degradation of RNA.\n4. Studies have shown that the inhibition of the interaction between MOV10 and RNASEH2 can increase the activity of the L1 retrotransposition machinery. \n5. This interaction has been shown to affect the activity of the L1 retrotransposition machinery.",
    "vicuna-7b_fact": [
      "The interaction between MOV10 and RNASEH2 regulates L1 retrotransposition.",
      "MOV10 is a protein involved in the clearance of RNA and RNA-protein complexes from the cell.",
      "RNASEH2 is a protein involved in the degradation of RNA.",
      "Studies have shown that the inhibition of the interaction between MOV10 and RNASEH2 can increase the activity of the L1 retrotransposition machinery.",
      "This interaction has been shown to affect the activity of the L1 retrotransposition machinery."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3063,
    "user_query": "List features of the Triple A syndrome.",
    "vicuna-7b_response": "Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene. The features of Triple A syndrome can vary from person to person, but some common symptoms include:\n1. Abnormal growth and development: Children with Triple A syndrome may have slow growth and development, and may be shorter than expected for their age.\n2. Feeding difficulties: Many children with Triple A syndrome have trouble feeding and may have a poor appetite.\n3. Hypoglycemia: Children with Triple A syndrome are at risk of developing low blood sugar (hypoglycemia), which can cause symptoms such as dizziness, weakness, and confusion.\n4. Obesity: Many children with Triple A syndrome are overweight or obese, which can increase their risk of developing health problems such as diabetes and heart disease.\n5. Hyperphagia: Children with Triple A syndrome may have an increased appetite and eat more than usual.\n6. Hypertrichosis: Children with Triple A syndrome may have excessive hair growth on their face, chest, and back.\n7. Hypothalamic dysfunction: The hypothalamus is a part of the brain that plays a role in regulating metabolism, appetite, and other functions. Children with Triple A syndrome may have problems with the hypothalamus, which can affect their growth and development.\n8. Mental retardation: Many children with Triple A syndrome have mild to severe mental retardation.\n9. Seizures: Some children with Triple A syndrome may have seizures or other neurological symptoms.\n10. Skin lesions: Some children with Triple A syndrome may have skin lesions or other skin problems.\nIt's important to note that not all children with Triple A syndrome will have all of these symptoms, and the severity of the symptoms can vary from person to person. If you have concerns about your child's development or health, it's important to speak with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene.\n2. Common symptoms of Triple A syndrome can vary but may include abnormal growth and development, feeding difficulties, and hypoglycemia.\n3. Many children with Triple A syndrome are overweight or obese.\n4. Hypertrichosis, hypothalamic dysfunction, mental retardation, seizures, and skin lesions are also possible symptoms for children with Triple A syndrome.\n5. The severity of the symptoms of Triple A syndrome can vary from person to person.",
    "vicuna-7b_fact": [
      "Triple A syndrome is a rare genetic disorder caused by mutations in the POMC gene.",
      "Common symptoms of Triple A syndrome can vary but may include abnormal growth and development, feeding difficulties, and hypoglycemia.",
      "Many children with Triple A syndrome are overweight or obese.",
      "Hypertrichosis, hypothalamic dysfunction, mental retardation, seizures, and skin lesions are also possible symptoms for children with Triple A syndrome.",
      "The severity of the symptoms of Triple A syndrome can vary from person to person."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Triple A syndrome is a rare genetic disorder caused by mutations in the AAAS gene, not the POMC gene.\n2. FALSE [correction]: Common symptoms of Triple A syndrome may include alacrima, achalasia, and adrenal insufficiency. Abnormal growth and other symptoms mentioned are not typically associated with this condition.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3065,
    "user_query": "Which protein is the Mitochondrial carrier homolog 2 (MTCH2) receptor for?",
    "vicuna-7b_response": "Mitochondrial carrier homolog 2 (MTCH2) is a protein that is involved in the transport of molecules across the mitochondrial membrane. It is a member of the mitochondrial carrier protein family, which includes other proteins such as mitochondrial carrier protein 1 (MCP1) and mitochondrial carrier protein 2 (MCP2).\nMTCH2 is primarily localized to the inner mitochondrial membrane and is thought to play a role in the transport of small molecules such as amino acids, nucleotides, and lipids. It is also involved in the regulation of mitochondrial function and energy metabolism.\nThere is limited information available on the specific receptor that MTCH2 binds to, but it is likely that it interacts with other proteins or molecules on the inner mitochondrial membrane to facilitate the transport of its substrates.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Mitochondrial carrier homolog 2 (MTCH2) is a protein involved in the transport of molecules across the mitochondrial membrane.\n2. MTCH2 is a member of the mitochondrial carrier protein family.\n3. It is primarily localized to the inner mitochondrial membrane.\n4. MTCH2 plays a role in the transport of small molecules such as amino acids, nucleotides, and lipids.\n5. The protein is also involved in the regulation of mitochondrial function and energy metabolism.",
    "vicuna-7b_fact": [
      "Mitochondrial carrier homolog 2 (MTCH2) is a protein involved in the transport of molecules across the mitochondrial membrane.",
      "MTCH2 is a member of the mitochondrial carrier protein family.",
      "It is primarily localized to the inner mitochondrial membrane.",
      "MTCH2 plays a role in the transport of small molecules such as amino acids, nucleotides, and lipids.",
      "The protein is also involved in the regulation of mitochondrial function and energy metabolism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3066,
    "user_query": "What is PhenomeCentral?",
    "vicuna-7b_response": "PhenomeCentral is a platform that aims to provide a comprehensive and user-friendly solution for phenotypic data analysis. Phenotypic data refers to the observable characteristics or traits of an organism, such as its physical appearance, behavior, or response to environmental stimuli.\nPhenomeCentral offers a range of tools and resources for analyzing and visualizing phenotypic data, including tools for data integration, data quality control, and data visualization. The platform also provides a range of pre-built analysis pipelines that can be used to analyze phenotypic data from different sources, such as gene expression data, genetic data, and imaging data.\nOne of the key features of PhenomeCentral is its ability to handle large-scale phenotypic data. The platform is designed to handle datasets that are too large to be analyzed using traditional methods, and it provides tools for distributed computing that allow users to analyze data in parallel across multiple machines.\nOverall, PhenomeCentral is a powerful tool for researchers and clinicians who are interested in understanding the complex relationships between genetics, environment, and phenotype. It provides a range of tools and resources that can be used to analyze and interpret phenotypic data, and it is particularly well-suited for researchers who are working with large-scale datasets.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PhenomeCentral is a platform for phenotypic data analysis.\n2. Phenotypic data refers to the observable traits or characteristics of an organism.\n3. PhenomeCentral provides tools for data integration, data quality control, and data visualization.\n4. The platform offers pre-built analysis pipelines for analyzing different types of data, such as gene expression data, genetic data, and imaging data.\n5. PhenomeCentral is capable of handling large-scale phenotypic data and provides tools for distributed computing for data analysis across multiple machines.",
    "vicuna-7b_fact": [
      "PhenomeCentral is a platform for phenotypic data analysis.",
      "Phenotypic data refers to the observable traits or characteristics of an organism.",
      "PhenomeCentral provides tools for data integration, data quality control, and data visualization.",
      "The platform offers pre-built analysis pipelines for analyzing different types of data, such as gene expression data, genetic data, and imaging data.",
      "PhenomeCentral is capable of handling large-scale phenotypic data and provides tools for distributed computing for data analysis across multiple machines."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3072,
    "user_query": "List sirtuin inhibitors.",
    "vicuna-7b_response": "Sirtuins are a family of NAD+-dependent protein deacetylases that play a crucial role in various cellular processes, including metabolism, aging, and stress response. Sirtuin inhibitors are compounds that block the activity of sirtuins, and they have been shown to have various biological effects, including improving metabolism, reducing inflammation, and promoting longevity. Some examples of sirtuin inhibitors include:\n1. Resveratrol: Resveratrol is a polyphenol found in grapes, berries, and other fruits and vegetables. It has been shown to activate sirtuins and improve metabolism.\n2. Sodium butyrate: Sodium butyrate is a compound that is produced by gut bacteria and has been shown to activate sirtuins and improve metabolism.\n3. Nicotinamide mononucleotide (NMN): NMN is a compound that is a precursor to NAD+, the coenzyme that sirtuins use to deacetylate proteins. It has been shown to activate sirtuins and improve metabolism.\n4. Sirtinol: Sirtinol is a synthetic sirtuin inhibitor that has been shown to improve metabolism and reduce inflammation in animal studies.\n5. Methylene blue: Methylene blue is a compound that has been shown to activate sirtuins and improve metabolism in animal studies.\nIt's important to note that the use of sirtuin inhibitors is still in the experimental stage and more research is needed to fully understand their effects on the human body. Additionally, it's always recommended to consult with a healthcare professional before taking any supplement or medication.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Sirtuins are a family of NAD+-dependent protein deacetylases that play a crucial role in various cellular processes, including metabolism, aging, and stress response.\n2. Sirtuin inhibitors are compounds that block the activity of sirtuins.\n3. Examples of sirtuin inhibitors include Resveratrol, Sodium butyrate, Nicotinamide mononucleotide (NMN), Sirtinol, and Methylene blue.\n4. Resveratrol is a polyphenol found in grapes, berries, and other fruits and vegetables.\n5. The use of sirtuin inhibitors is still in the experimental stage and more research is needed to fully understand their effects on the human body.",
    "vicuna-7b_fact": [
      "Sirtuins are a family of NAD+-dependent protein deacetylases that play a crucial role in various cellular processes, including metabolism, aging, and stress response.",
      "Sirtuin inhibitors are compounds that block the activity of sirtuins.",
      "Examples of sirtuin inhibitors include Resveratrol, Sodium butyrate, Nicotinamide mononucleotide (NMN), Sirtinol, and Methylene blue.",
      "Resveratrol is a polyphenol found in grapes, berries, and other fruits and vegetables.",
      "The use of sirtuin inhibitors is still in the experimental stage and more research is needed to fully understand their effects on the human body."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Resveratrol, Sodium butyrate, and Nicotinamide mononucleotide (NMN) are not sirtuin inhibitors, but rather, they are considered sirtuin activators. \n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3073,
    "user_query": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "vicuna-7b_response": "The NLM Medical Text Indexer (MTI) is a tool that was developed by the National Library of Medicine (NLM) to extract medical terms and concepts from unstructured text. It is still useful and relevant today, as it can be used to extract relevant information from large amounts of unstructured text, such as clinical notes, electronic health records, and research articles.\nThe MTI is particularly useful for indexing and organizing large collections of medical text data, such as those found in electronic health records. It can also be used to extract information for use in natural language processing (NLP) applications, such as sentiment analysis, information retrieval, and machine learning.\nHowever, it is important to note that the MTI is not a replacement for more advanced NLP tools and techniques. It is best used in conjunction with other NLP tools to extract the most relevant information from unstructured text. Additionally, the MTI is not able to understand the context of the text, so it may not always extract the correct information.\nIn summary, the NLM Medical Text Indexer (MTI) is still a useful and relevant tool for extracting medical terms and concepts from unstructured text. It can be used in conjunction with other NLP tools to extract the most relevant information from large collections of medical text data.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The NLM Medical Text Indexer (MTI) was developed by the National Library of Medicine (NLM).\n2. The MTI is used to extract medical terms and concepts from unstructured text.\n3. The MTI can be used for indexing and organizing large collections of medical text data, such as those found in electronic health records.\n4. The MTI can be used to extract information for use in natural language processing (NLP) applications.\n5. The MTI is not a replacement for more advanced NLP tools and techniques.",
    "vicuna-7b_fact": [
      "The NLM Medical Text Indexer (MTI) was developed by the National Library of Medicine (NLM).",
      "The MTI is used to extract medical terms and concepts from unstructured text.",
      "The MTI can be used for indexing and organizing large collections of medical text data, such as those found in electronic health records.",
      "The MTI can be used to extract information for use in natural language processing (NLP) applications.",
      "The MTI is not a replacement for more advanced NLP tools and techniques."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3075,
    "user_query": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
    "vicuna-7b_response": "As of 2018, the standard of care for Clostridium difficile (C. difficile) infection is metronidazole or vancomycin. These antibiotics are considered first-line treatments for C. difficile infection and are effective in treating most cases of the infection. However, the choice of antibiotic may vary depending on the severity of the infection, the patient's medical history, and other factors. It is important to note that C. difficile infection can be a serious and potentially life-threatening condition, and it is important to seek medical attention if you suspect that you or someone you know may have C. difficile infection.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. As of 2018, the standard of care for Clostridium difficile infection is metronidazole or vancomycin.\n2. Metronidazole and vancomycin are considered first-line treatments for C. difficile infection.\n3. The choice of antibiotic for C. difficile infection may vary depending on the severity of the infection, the patient's medical history, and other factors.\n4. C. difficile infection can be a serious and potentially life-threatening condition.\n5. It is recommended to seek medical attention if you suspect that you or someone you know may have C. difficile infection.",
    "vicuna-7b_fact": [
      "As of 2018, the standard of care for Clostridium difficile infection is metronidazole or vancomycin.",
      "Metronidazole and vancomycin are considered first-line treatments for C. difficile infection.",
      "The choice of antibiotic for C. difficile infection may vary depending on the severity of the infection, the patient's medical history, and other factors.",
      "C. difficile infection can be a serious and potentially life-threatening condition.",
      "It is recommended to seek medical attention if you suspect that you or someone you know may have C. difficile infection."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: As of 2018, the first-line treatment for Clostridium difficile infection is vancomycin or fidaxomicin, not metronidazole.\n2. FALSE [correction]: Vancomycin and fidaxomicin are considered first-line treatments for C. difficile infection, not metronidazole.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3077,
    "user_query": "Which features are evaluated with the CRAFFT screening test?",
    "vicuna-7b_response": "The CRAFFT (Chemical Related Assessment of Functioning, Fatigue, and Tension) screening test is a brief, 10-item questionnaire used to identify individuals who may be at risk for substance use disorders. The CRAFFT test assesses several features, including:\n1. Chemical-related functioning: The test evaluates the individual's ability to perform daily activities and manage responsibilities while under the influence of substances.\n2. Fatigue: The test assesses the individual's level of fatigue and energy, which may be affected by substance use.\n3. Tension: The test evaluates the individual's level of anxiety and stress, which may be reduced by substance use.\n4. Anhedonia: The test assesses the individual's ability to experience pleasure, which may be affected by substance use.\n5. Attention and concentration: The test evaluates the individual's ability to focus and pay attention, which may be affected by substance use.\n6. Memory: The test assesses the individual's memory and learning, which may be affected by substance use.\n7. Mood: The test evaluates the individual's mood and emotional state, which may be affected by substance use.\n8. Insight: The test assesses the individual's ability to recognize the negative consequences of their substance use.\n9. Tolerance: The test evaluates the individual's need for increasing amounts of substance to achieve the desired effect.\n10. Withdrawal: The test assesses the individual's experience of withdrawal symptoms when they stop using substances.\nIt is important to note that the CRAFFT test is not a diagnostic tool and should not be used to diagnose substance use disorders. It is intended to identify individuals who may be at risk for substance use disorders and should be used in conjunction with other assessments and evaluations.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The CRAFFT screening test is a 10-item questionnaire used to identify individuals who may be at risk for substance use disorders.\n2. The CRAFFT test assesses chemical-related functioning, fatigue, tension, anhedonia, attention and concentration, memory, mood, insight, tolerance, and withdrawal.\n3. The test evaluates the individual's ability to perform daily activities and responsibilities under the influence of substances.\n4. The test also assesses an individual's experience of withdrawal symptoms when they stop using substances.\n5. The CRAFFT test is not a diagnostic tool and should not be used to diagnose substance use disorders.",
    "vicuna-7b_fact": [
      "The CRAFFT screening test is a 10-item questionnaire used to identify individuals who may be at risk for substance use disorders.",
      "The CRAFFT test assesses chemical-related functioning, fatigue, tension, anhedonia, attention and concentration, memory, mood, insight, tolerance, and withdrawal.",
      "The test evaluates the individual's ability to perform daily activities and responsibilities under the influence of substances.",
      "The test also assesses an individual's experience of withdrawal symptoms when they stop using substances.",
      "The CRAFFT test is not a diagnostic tool and should not be used to diagnose substance use disorders."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The CRAFFT screening test is a 6-item questionnaire used to identify individuals who may be at risk for substance use disorders.\n2. FALSE [correction]: The CRAFFT test is an acronym for key words in the test (Car, Relax, Alone, Forget, Friends, Trouble).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-7b_response": "The bartender algorithm is a simple algorithm used in artificial intelligence and machine learning to solve a variety of problems. It is called the \"bartender algorithm\" because it is often used to solve problems that involve finding the shortest path between two points in a graph.\nThe algorithm works by starting at a random point in the graph and then moving to the nearest unvisited point. It then moves to the nearest unvisited point from that point, and so on, until it reaches a goal state. The algorithm uses a priority queue to keep track of the most promising moves, and it also maintains a graph of the current state of the search.\nThe bartender algorithm is a greedy algorithm, which means that it makes the locally optimal choice at each step. This can make it very efficient for solving problems with a large number of possible solutions, as it is able to quickly converge on the optimal solution.\nThe bartender algorithm is often used in conjunction with other search algorithms, such as depth-first search and breadth-first search, to solve more complex problems. It is also used in a variety of other applications, such as scheduling and resource allocation.\nOverall, the bartender algorithm is a simple but powerful algorithm that is widely used in artificial intelligence and machine learning.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The bartender algorithm is an algorithm used in artificial intelligence and machine learning.\n2. This algorithm works by starting at a random point in a graph and then moving to the nearest unvisited point.\n3. The bartender algorithm uses a priority queue to keep track of the most promising moves.\n4. The bartender algorithm is a greedy algorithm, making the locally optimal choice at each step.\n5. The bartender algorithm is often used in conjunction with other search algorithms, such as depth-first search and breadth-first search.",
    "vicuna-7b_fact": [
      "The bartender algorithm is an algorithm used in artificial intelligence and machine learning.",
      "This algorithm works by starting at a random point in a graph and then moving to the nearest unvisited point.",
      "The bartender algorithm uses a priority queue to keep track of the most promising moves.",
      "The bartender algorithm is a greedy algorithm, making the locally optimal choice at each step.",
      "The bartender algorithm is often used in conjunction with other search algorithms, such as depth-first search and breadth-first search."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3082,
    "user_query": "List two drugs that are included in the Akynzeo pill?",
    "vicuna-7b_response": "Akynzeo is a medication that is used to treat gastrointestinal (GI) disorders, such as irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC). Akynzeo is a combination medication that contains two drugs:\n1. Linaclotide: Linaclotide is a guanylate cyclase-C (GC-C) agonist. It works by increasing the levels of a chemical called cyclic guanosine monophosphate (cGMP) in the gut, which helps to relax the muscles in the intestine and improve bowel movements.\n2. Pasireotide: Pasireotide is a somatostatin analog. It works by mimicking the action of a natural hormone called somatostatin, which helps to regulate various bodily functions, including the release of hormones and the contraction of muscles. Pasireotide helps to reduce the release of certain hormones from the pancreas, which can help to improve blood sugar control in people with diabetes.\nBy combining these two drugs in one pill, Akynzeo provides a convenient and effective treatment option for people with GI disorders who need to take multiple medications to manage their symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Akynzeo is a medication used to treat gastrointestinal disorders such as irritable bowel syndrome and chronic idiopathic constipation.\n2. Akynzeo is a combination medication that contains Linaclotide and Pasireotide.\n3. Linaclotide is a guanylate cyclase-C agonist that increases the levels of cyclic guanosine monophosphate in the gut.\n4. Pasireotide is a somatostatin analog that mimics the action of the natural hormone somatostatin.\n5. Pasireotide helps to improve blood sugar control in people with diabetes.",
    "vicuna-7b_fact": [
      "Akynzeo is a medication used to treat gastrointestinal disorders such as irritable bowel syndrome and chronic idiopathic constipation.",
      "Akynzeo is a combination medication that contains Linaclotide and Pasireotide.",
      "Linaclotide is a guanylate cyclase-C agonist that increases the levels of cyclic guanosine monophosphate in the gut.",
      "Pasireotide is a somatostatin analog that mimics the action of the natural hormone somatostatin.",
      "Pasireotide helps to improve blood sugar control in people with diabetes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Akynzeo is a medication used to prevent nausea and vomiting caused by chemotherapy.\n2. FALSE [correction]: Akynzeo is a combination medication that contains Netupitant and Palonosetron.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Pasireotide can actually cause high blood sugar. It is used to treat Cushing's disease and acromegaly, not diabetes.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3087,
    "user_query": "Safinamide is approved for treatment of which disease?",
    "vicuna-7b_response": "Safinamide is approved for the treatment of multiple sclerosis (MS). It is used to reduce the frequency of episodes of disability and increase the number of days between exacerbations in people with relapsing-remitting multiple sclerosis (RRMS). Safinamide is also used to reduce the number of new brain lesions in people with secondary progressive multiple sclerosis (SPMS).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Safinamide is approved for the treatment of multiple sclerosis (MS).\n2. It is used to reduce the frequency of episodes of disability in people with relapsing-remitting multiple sclerosis (RRMS).\n3. Safinamide aims to increase the number of days between exacerbations in people with RRMS.\n4. Safinamide is also used to reduce the number of new brain lesions in people with secondary progressive multiple sclerosis (SPMS).",
    "vicuna-7b_fact": [
      "Safinamide is approved for the treatment of multiple sclerosis (MS).",
      "It is used to reduce the frequency of episodes of disability in people with relapsing-remitting multiple sclerosis (RRMS).",
      "Safinamide aims to increase the number of days between exacerbations in people with RRMS.",
      "Safinamide is also used to reduce the number of new brain lesions in people with secondary progressive multiple sclerosis (SPMS)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Safinamide is approved for the treatment of Parkinson's disease, not Multiple Sclerosis (MS).\n2. FALSE [correction]: Safinamide is used to improve motor symptoms in patients with Parkinson's disease, not to reduce the frequency of disability episodes in people with RRMS.\n3. FALSE [correction]: Safinamide is not used to increase the number of days between exacerbations in people with RRMS. \n4. FALSE [correction]: Safinamide is not used to reduce the number of new brain lesions in people with SPMS.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3091,
    "user_query": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?",
    "vicuna-7b_response": "The Cas13 based diagnostic test for the Zika and dengue viruses is called the \"Cas13 Dengue/Zika Diagnostic Kit\".",
    "vicuna-7b_fact_raw": "The factual statement is: \n1. The Cas13 based diagnostic test for the Zika and dengue viruses is named the \"Cas13 Dengue/Zika Diagnostic Kit\".",
    "vicuna-7b_fact": [
      "The Cas13 based diagnostic test for the Zika and dengue viruses is named the \"Cas13 Dengue/Zika Diagnostic Kit\"."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3092,
    "user_query": "What are CRISPR-Cas12a proteins?",
    "vicuna-7b_response": "CRISPR-Cas12a proteins are a type of CRISPR-Cas system that uses a different enzyme, Cas12a, to cut DNA. The CRISPR-Cas12a system is used for gene editing and has been shown to be more efficient and specific than other CRISPR-Cas systems.\nThe CRISPR-Cas12a system consists of two main components: a guide RNA and the Cas12a enzyme. The guide RNA is designed to recognize a specific DNA sequence, and the Cas12a enzyme cuts the DNA at the site specified by the guide RNA. This allows for precise editing of the genome.\nThe CRISPR-Cas12a system has several advantages over other CRISPR-Cas systems. For example, it is more efficient at cutting DNA, and it is less likely to cause off-target effects. Additionally, the CRISPR-Cas12a system can be used to edit RNA, which has implications for the treatment of certain diseases.\nOverall, the CRISPR-Cas12a system is a powerful tool for gene editing and has the potential to be used in a variety of applications, including medicine and agriculture.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CRISPR-Cas12a proteins are a type of CRISPR-Cas system that uses a different enzyme, Cas12a, to cut DNA.\n2. The CRISPR-Cas12a system is used for gene editing.\n3. The CRISPR-Cas12a system is more efficient and specific than other CRISPR-Cas systems.\n4. The CRISPR-Cas12a system consists of a guide RNA and the Cas12a enzyme.\n5. The CRISPR-Cas12a system can be used to edit RNA.",
    "vicuna-7b_fact": [
      "CRISPR-Cas12a proteins are a type of CRISPR-Cas system that uses a different enzyme, Cas12a, to cut DNA.",
      "The CRISPR-Cas12a system is used for gene editing.",
      "The CRISPR-Cas12a system is more efficient and specific than other CRISPR-Cas systems.",
      "The CRISPR-Cas12a system consists of a guide RNA and the Cas12a enzyme.",
      "The CRISPR-Cas12a system can be used to edit RNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: The CRISPR-Cas12a system is used for DNA editing, not RNA.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3094,
    "user_query": "Can cardiospheres be produced from skin fibroblasts?",
    "vicuna-7b_response": "Yes, cardiospheres can be produced from skin fibroblasts. Cardiospheres are a type of cell-based therapy that is derived from cardiac progenitor cells, which are found in the heart. These cells have the ability to differentiate into various types of heart cells, including cardiomyocytes, smooth muscle cells, and endothelial cells.\nSkin fibroblasts are a type of cell found in the skin that are responsible for producing collagen and other extracellular matrix components. These cells can be isolated from skin tissue and cultured in the laboratory. When skin fibroblasts are exposed to certain growth factors and signaling molecules, they can be induced to differentiate into cardiac progenitor cells.\nOnce these cardiac progenitor cells have been generated, they can be cultured in a specific medium that promotes their differentiation into cardiospheres. Cardiospheres are small, spherical structures that contain a high number of cardiac progenitor cells. These cells can then be used for cell-based therapy in the heart.\nIn summary, skin fibroblasts can be used to generate cardiac progenitor cells, which can then be differentiated into cardiospheres for cell-based therapy in the heart.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cardiospheres are a type of cell-based therapy derived from cardiac progenitor cells.\n2. Cardiac progenitor cells have the ability to differentiate into various types of heart cells, including cardiomyocytes, smooth muscle cells, and endothelial cells.\n3. Skin fibroblasts are a type of cell found in the skin that produce collagen and other extracellular matrix components.\n4. Skin fibroblasts can be induced to differentiate into cardiac progenitor cells when exposed to certain growth factors and signaling molecules.\n5. Cardiac progenitor cells can be cultured to generate cardiospheres containing a high number of cardiac progenitor cells.",
    "vicuna-7b_fact": [
      "Cardiospheres are a type of cell-based therapy derived from cardiac progenitor cells.",
      "Cardiac progenitor cells have the ability to differentiate into various types of heart cells, including cardiomyocytes, smooth muscle cells, and endothelial cells.",
      "Skin fibroblasts are a type of cell found in the skin that produce collagen and other extracellular matrix components.",
      "Skin fibroblasts can be induced to differentiate into cardiac progenitor cells when exposed to certain growth factors and signaling molecules.",
      "Cardiac progenitor cells can be cultured to generate cardiospheres containing a high number of cardiac progenitor cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3095,
    "user_query": "What the chromsomal location of the gene that is deleted in Potocki-Shaffer syndrome?",
    "vicuna-7b_response": "Potocki-Shaffer syndrome is a genetic disorder caused by a deletion in the long (q) arm of chromosome 9. The gene that is deleted in this syndrome is called SLC22A1, which encodes for a solute carrier protein. The specific chromosomal location of the deletion is 9q34.3.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Potocki-Shaffer syndrome is a genetic disorder caused by a deletion in the long (q) arm of chromosome 9.\n2. The gene that is deleted in Potocki-Shaffer syndrome is called SLC22A1. \n3. SLC22A1 gene encodes for a solute carrier protein.\n4. The specific chromosomal location of the deletion in Potocki-Shaffer syndrome is 9q34.3.",
    "vicuna-7b_fact": [
      "Potocki-Shaffer syndrome is a genetic disorder caused by a deletion in the long (q) arm of chromosome 9.",
      "The gene that is deleted in Potocki-Shaffer syndrome is called SLC22A1.",
      "SLC22A1 gene encodes for a solute carrier protein.",
      "The specific chromosomal location of the deletion in Potocki-Shaffer syndrome is 9q34.3."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The genes that are deleted in Potocki-Shaffer syndrome are PHF21A and ALX4.\n3. TRUE \n4. FALSE [correction]: The specific chromosomal location of the deletion in Potocki-Shaffer syndrome is 9p21.2-9p22.2.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3099,
    "user_query": "List features of the DOOR syndrome.",
    "vicuna-7b_response": "The DOOR syndrome is a rare genetic disorder that is characterized by a combination of symptoms. Some of the key features of the DOOR syndrome include:\n1. Developmental delay: Children with the DOOR syndrome typically have delayed development, both in terms of physical and cognitive milestones.\n2. Optic nerve hypoplasia: This is a condition in which the optic nerve is underdeveloped, leading to vision problems such as blindness or visual impairment.\n3. Ovarian dysgenesis: This is a condition in which the ovaries do not develop properly, leading to infertility and a higher risk of ovarian cancer.\n4. Renal dysgenesis: This is a condition in which the kidneys do not develop properly, leading to kidney problems and a higher risk of kidney disease.\n5. Retardation of growth: Children with the DOOR syndrome may have a lower than average height and weight, and may not reach their expected growth milestones.\n6. Hearing loss: Some children with the DOOR syndrome may have hearing loss.\n7. Cleft palate: This is a condition in which the roof of the mouth is not fully formed, leading to a gap in the palate.\n8. Heart defects: Some children with the DOOR syndrome may have heart defects, such as a hole in the heart or a narrowing of the blood vessels.\nIt's important to note that not all children with the DOOR syndrome will have all of these symptoms, and the severity of the symptoms can vary from person to person. If you have concerns about your child's development or health, it's important to speak with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The DOOR syndrome is a rare genetic disorder.\n2. Children with the DOOR syndrome may have developmental delay, both in terms of physical and cognitive milestones.\n3. Optic nerve hypoplasia, a condition in which the optic nerve is underdeveloped and causes vision problems, is a key feature of the DOOR syndrome.\n4. Ovarian dysgenesis, where the ovaries do not develop properly, leading to infertility and a higher risk of ovarian cancer, could be a symptom of the DOOR syndrome.\n5. Some children with the DOOR syndrome may have hearing loss and heart defects.",
    "vicuna-7b_fact": [
      "The DOOR syndrome is a rare genetic disorder.",
      "Children with the DOOR syndrome may have developmental delay, both in terms of physical and cognitive milestones.",
      "Optic nerve hypoplasia, a condition in which the optic nerve is underdeveloped and causes vision problems, is a key feature of the DOOR syndrome.",
      "Ovarian dysgenesis, where the ovaries do not develop properly, leading to infertility and a higher risk of ovarian cancer, could be a symptom of the DOOR syndrome.",
      "Some children with the DOOR syndrome may have hearing loss and heart defects."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ovarian dysgenesis is not a typical symptom of the DOOR syndrome. The acronym DOOR stands for deafness, onychodystrophy, osteodystrophy, and mental retardation.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-7b_response": "There are several web-based pedigree editors available, including:\n1. Geni: Geni is a popular web-based genealogy and family tree application that allows users to create and manage their family trees online. It offers a range of features, including collaboration tools, photo sharing, and integration with other genealogy websites.\n2. WeRelate: WeRelate is a free, open-source genealogy website that allows users to create and share family trees. It offers a range of features, including collaboration tools, research tools, and integration with other genealogy websites.\n3. Ancestry: Ancestry is a paid genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\n4. MyHeritage: MyHeritage is a paid genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\n5. FamilySearch: FamilySearch is a free genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\nThese are just a few examples of the many web-based pedigree editors available. It's worth noting that some of these tools may offer different features and pricing plans, so it's important to research and compare the options to find the one that best meets your needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are several web-based pedigree editors, including Geni, WeRelate, Ancestry, MyHeritage, and FamilySearch.\n2. Geni is a web-based genealogy and family tree application that offers features like collaboration tools, photo sharing, and integration with other genealogy websites.\n3. WeRelate is a free, open-source genealogy website offering features including collaboration and research tools, and integration with other genealogy websites.\n4. Ancestry is a paid genealogy website that provides tools for researching and managing family trees, collaboration with other users, and access to genealogy records.\n5. MyHeritage is a paid genealogy website offering tools for researching and managing family trees, collaboration with other users, and access to genealogy records.",
    "vicuna-7b_fact": [
      "There are several web-based pedigree editors, including Geni, WeRelate, Ancestry, MyHeritage, and FamilySearch.",
      "Geni is a web-based genealogy and family tree application that offers features like collaboration tools, photo sharing, and integration with other genealogy websites.",
      "WeRelate is a free, open-source genealogy website offering features including collaboration and research tools, and integration with other genealogy websites.",
      "Ancestry is a paid genealogy website that provides tools for researching and managing family trees, collaboration with other users, and access to genealogy records.",
      "MyHeritage is a paid genealogy website offering tools for researching and managing family trees, collaboration with other users, and access to genealogy records."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3101,
    "user_query": "What is the mechanism of action of Solriamfetol?",
    "vicuna-7b_response": "Solriamfetol is a medication that is used to treat excessive sleepiness caused by sleep disorders such as narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD). It works by increasing the levels of certain chemicals in the brain, including dopamine, norepinephrine, and histamine, which are involved in regulating wakefulness and arousal.\nSolriamfetol works by targeting the orexin system, which is a part of the brain's reward and arousal system. The orexin system helps to regulate wakefulness and arousal, and it is disrupted in sleep disorders such as narcolepsy and OSA. By increasing the levels of dopamine, norepinephrine, and histamine in the brain, Solriamfetol helps to restore the normal functioning of the orexin system and improve excessive sleepiness.\nIn addition to its mechanism of action on the orexin system, Solriamfetol also has a direct effect on the brain's sleep-wake cycle. It increases the amount of time spent in a state of wakefulness and reduces the amount of time spent sleeping. This makes it an effective treatment for sleep disorders that are characterized by excessive sleepiness and difficulty staying awake during the day.\nOverall, Solriamfetol's mechanism of action involves increasing the levels of certain chemicals in the brain to restore the normal functioning of the orexin system and improve excessive sleepiness caused by sleep disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Solriamfetol is a medication used to treat excessive sleepiness caused by sleep disorders such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder.\n2. Solriamfetol works by increasing the levels of certain chemicals in the brain, including dopamine, norepinephrine, and histamine.\n3. These chemicals are involved in regulating wakefulness and arousal.\n4. Solriamfetol targets the orexin system, which helps to regulate wakefulness and arousal.\n5. Solriamfetol increases the amount of time spent in a state of wakefulness and reduces the amount of time spent sleeping.",
    "vicuna-7b_fact": [
      "Solriamfetol is a medication used to treat excessive sleepiness caused by sleep disorders such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder.",
      "Solriamfetol works by increasing the levels of certain chemicals in the brain, including dopamine, norepinephrine, and histamine.",
      "These chemicals are involved in regulating wakefulness and arousal.",
      "Solriamfetol targets the orexin system, which helps to regulate wakefulness and arousal.",
      "Solriamfetol increases the amount of time spent in a state of wakefulness and reduces the amount of time spent sleeping."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [Correction]: Solriamfetol does not target the orexin system; it promotes wakefulness by increasing the levels of dopamine, norepinephrine, and histamine in the brain.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3102,
    "user_query": "What is the difference between the nuclease Cas13a and C2c2",
    "vicuna-7b_response": "Cas13a and C2c2 are both nucleases, which are enzymes that cut DNA, but they have some key differences.\nCas13a, also known as CRISPR-associated protein 13, is a nuclease that is commonly used in the CRISPR-Cas9 gene editing system. It is a RNA-guided endonuclease that recognizes a specific DNA sequence and cleaves the DNA at a site downstream of the recognition sequence. Cas13a is typically used to delete or disrupt specific genes in cells.\nC2c2, on the other hand, is a different type of nuclease. It is a double-stranded DNA-specific endonuclease that cleaves DNA at a site that is 2 nucleotides away from a specific recognition sequence. C2c2 is not used in the CRISPR-Cas9 system, but it has been studied for its potential use in gene editing and other applications.\nIn summary, Cas13a is a nuclease that is used in the CRISPR-Cas9 gene editing system, while C2c2 is a different type of nuclease that has potential applications in gene editing and other areas.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cas13a and C2c2 are both enzymes known as nucleases that cut DNA.\n2. Cas13a, also known as CRISPR-associated protein 13, is a RNA-guided endonuclease.\n3. Cas13a recognizes a specific DNA sequence and cleaves the DNA at a site downstream of the recognition sequence.\n4. Cas13a is commonly used in the CRISPR-Cas9 gene editing system to delete or disrupt specific genes in cells.\n5. C2c2 is a double-stranded DNA-specific endonuclease that cleaves DNA at a site that is 2 nucleotides away from a specific recognition sequence and is not used in the CRISPR-Cas9 system.",
    "vicuna-7b_fact": [
      "Cas13a and C2c2 are both enzymes known as nucleases that cut DNA.",
      "Cas13a, also known as CRISPR-associated protein 13, is a RNA-guided endonuclease.",
      "Cas13a recognizes a specific DNA sequence and cleaves the DNA at a site downstream of the recognition sequence.",
      "Cas13a is commonly used in the CRISPR-Cas9 gene editing system to delete or disrupt specific genes in cells.",
      "C2c2 is a double-stranded DNA-specific endonuclease that cleaves DNA at a site that is 2 nucleotides away from a specific recognition sequence and is not used in the CRISPR-Cas9 system."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cas13a and C2c2 are both enzymes known as nucleases that cut RNA, not DNA.\n2. TRUE\n3. FALSE [correction]: Cas13a recognizes a specific RNA sequence and cleaves the RNA at a site downstream of the recognition sequence.\n4. FALSE [correction]: Cas13a is not used in the CRISPR-Cas9 gene editing system, which targets DNA. Cas13a is used in RNA-targeting CRISPR systems.\n5. FALSE [correction]: C2c2, also known as Cas13a, is an RNA-targeting endonuclease, not a DNA-targeting endonuclease, and is not used in the CRISPR-Cas9 system.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3103,
    "user_query": "Phlorotannin is extracted from what plant?",
    "vicuna-7b_response": "Phlorotannins are a type of natural product found in brown seaweeds, such as kelp and bladderwrack. These compounds are known for their potential health benefits and have been studied for their anti-inflammatory, antiviral, and anticancer properties. While there are many different species of brown seaweeds that contain phlorotannins, some of the most commonly studied include Fucus vesiculosus, Ascophyllum nodosum, and Laminaria digitata.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Phlorotannins are a type of natural product found in brown seaweeds.\n2. Kelp and bladderwrack are types of brown seaweeds containing phlorotannins.\n3. Phlorotannins have been studied for their anti-inflammatory, antiviral, and anticancer properties.\n4. Different species of brown seaweeds such as Fucus vesiculosus, Ascophyllum nodosum, and Laminaria digitata are known to contain phlorotannins.",
    "vicuna-7b_fact": [
      "Phlorotannins are a type of natural product found in brown seaweeds.",
      "Kelp and bladderwrack are types of brown seaweeds containing phlorotannins.",
      "Phlorotannins have been studied for their anti-inflammatory, antiviral, and anticancer properties.",
      "Different species of brown seaweeds such as Fucus vesiculosus, Ascophyllum nodosum, and Laminaria digitata are known to contain phlorotannins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3104,
    "user_query": "Where are pannexins localized?",
    "vicuna-7b_response": "Pannexins are a family of ion channels that are primarily localized in the plasma membrane of various cell types. They are found in a variety of organisms, including animals, plants, and bacteria, and have been identified in a wide range of tissues, including the brain, heart, liver, and kidney.\nPannexins are thought to play a role in various physiological processes, including the regulation of cell volume, the modulation of electrical signaling, and the maintenance of cellular homeostasis. They have also been implicated in the development of various diseases, including cancer and neurological disorders.\nIn summary, pannexins are primarily localized in the plasma membrane of various cell types and have been identified in a wide range of tissues. They are thought to play a role in various physiological processes and have been implicated in the development of various diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pannexins are a family of ion channels.\n2. Pannexins are primarily localized in the plasma membrane of various cell types.\n3. Pannexins are found in a variety of organisms, including animals, plants, and bacteria.\n4. Pannexins have been identified in a wide range of tissues, such as brain, heart, liver and kidney.\n5. Pannexins are thought to play a role in various physiological processes and have been implicated in the development of diseases, including cancer and neurological disorders.",
    "vicuna-7b_fact": [
      "Pannexins are a family of ion channels.",
      "Pannexins are primarily localized in the plasma membrane of various cell types.",
      "Pannexins are found in a variety of organisms, including animals, plants, and bacteria.",
      "Pannexins have been identified in a wide range of tissues, such as brain, heart, liver and kidney.",
      "Pannexins are thought to play a role in various physiological processes and have been implicated in the development of diseases, including cancer and neurological disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Pannexins are found in animals, but not in plants and bacteria.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3105,
    "user_query": "What is the mechanism of action of cariprazine?",
    "vicuna-7b_response": "Cariprazine is an atypical antipsychotic drug that works by targeting several neurotransmitter systems in the brain. It is a partial dopamine agonist and serotonin partial agonist, as well as an antagonist of histamine and adrenergic receptors.\nThe drug's mechanism of action is complex and involves several steps. First, cariprazine binds to dopamine receptors in the brain, which can lead to an increase in dopamine levels in the synapse. This increase in dopamine can lead to a reduction in psychotic symptoms such as delusions and hallucinations.\nCariprazine also binds to serotonin receptors, which can lead to an increase in serotonin levels in the brain. This increase in serotonin can lead to a reduction in symptoms such as agitation and aggression.\nAdditionally, cariprazine blocks histamine receptors, which can lead to a reduction in extrapyramidal symptoms such as tremors and rigidity. It also blocks adrenergic receptors, which can lead to a reduction in hypertension and other cardiovascular symptoms.\nOverall, the mechanism of action of cariprazine involves targeting several neurotransmitter systems in the brain to reduce symptoms of psychosis and improve overall functioning.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cariprazine is an atypical antipsychotic drug that targets several neurotransmitter systems in the brain.\n2. Cariprazine is a partial dopamine agonist and serotonin partial agonist, and also an antagonist of histamine and adrenergic receptors.\n3. Cariprazine binds to dopamine receptors in the brain, resulting in an increase in dopamine levels in the synapse.\n4. Cariprazine binds to serotonin receptors, leading to an increase in serotonin levels in the brain.\n5. The mechanism of action of cariprazine involves a reduction in hypertension and other cardiovascular symptoms by blocking adrenergic receptors.",
    "vicuna-7b_fact": [
      "Cariprazine is an atypical antipsychotic drug that targets several neurotransmitter systems in the brain.",
      "Cariprazine is a partial dopamine agonist and serotonin partial agonist, and also an antagonist of histamine and adrenergic receptors.",
      "Cariprazine binds to dopamine receptors in the brain, resulting in an increase in dopamine levels in the synapse.",
      "Cariprazine binds to serotonin receptors, leading to an increase in serotonin levels in the brain.",
      "The mechanism of action of cariprazine involves a reduction in hypertension and other cardiovascular symptoms by blocking adrenergic receptors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Cariprazine binds to dopamine receptors in the brain, however, as a partial agonist, it doesn't necessarily result in an increase in dopamine levels in the synapse.\n4. FALSE [correction]: Cariprazine binds to serotonin receptors, but as a partial agonist, it doesn't necessarily lead to an increase in serotonin levels in the brain.\n5. FALSE [correction]: The mechanism of action of cariprazine primarily involves influencing neurotransmitter systems in the brain, the consequence on cardiovascular symptoms is not primary and the reduction of hypertension is not specifically mentioned.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-7b_response": "There are several curated databases that exist for spider venom toxins. Here are a few examples:\n1. SpiderTox: SpiderTox is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n2. SpiderVenomDB: SpiderVenomDB is a database of spider venom toxins that was developed by researchers at the University of California, San Diego. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\n3. Spider Venom Database: The Spider Venom Database is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n4. Spider Venom Toxins Database: The Spider Venom Toxins Database is a database of spider venom toxins that was developed by researchers at the University of California, Los Angeles. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\nThese databases are valuable resources for researchers studying spider venom toxins, as they provide detailed information on the toxins and their effects on human cells. They can also be useful for identifying potential therapeutic targets for treating spider venom-induced toxicity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SpiderTox is a database of spider venom toxins developed by researchers at the University of Melbourne.\n2. SpiderTox contains information on the toxins found in over 50 species of spiders.\n3. SpiderVenomDB is a database of spider venom toxins developed by researchers at the University of California, San Diego.\n4. SpiderVenomDB provides information on the toxins found in over 20 species of spiders.\n5. The Spider Venom Toxins Database, developed by researchers at the University of California, Los Angeles, includes information on the toxins found in over 20 species of spiders.",
    "vicuna-7b_fact": [
      "SpiderTox is a database of spider venom toxins developed by researchers at the University of Melbourne.",
      "SpiderTox contains information on the toxins found in over 50 species of spiders.",
      "SpiderVenomDB is a database of spider venom toxins developed by researchers at the University of California, San Diego.",
      "SpiderVenomDB provides information on the toxins found in over 20 species of spiders.",
      "The Spider Venom Toxins Database, developed by researchers at the University of California, Los Angeles, includes information on the toxins found in over 20 species of spiders."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3108,
    "user_query": "What is the difference between CRISPR-Cas12a and CRISPR-Cpf1?",
    "vicuna-7b_response": "CRISPR-Cas12a and CRISPR-Cpf1 are two different types of CRISPR-Cas systems that have been developed for genome editing.\nCRISPR-Cas12a is a type of CRISPR-Cas system that uses a single RNA molecule as a guide for targeting specific DNA sequences. The Cas12a enzyme then cuts the DNA at the targeted site, allowing for genetic modification. CRISPR-Cas12a is particularly effective for editing genes in mammalian cells, and has been used to treat genetic diseases in animals.\nCRISPR-Cpf1, on the other hand, uses a single RNA molecule as a guide for targeting specific DNA sequences, but the Cas12 enzyme is used to cut the DNA at the targeted site. CRISPR-Cpf1 is particularly effective for editing genes in plants and fungi, and has been used to improve crop yields and resistance to disease.\nIn summary, CRISPR-Cas12a and CRISPR-Cpf1 are both CRISPR-Cas systems that use RNA molecules as guides for targeting specific DNA sequences, but they differ in their effectiveness for editing genes in different organisms and their potential applications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CRISPR-Cas12a and CRISPR-Cpf1 are two different types of CRISPR-Cas systems.\n2. CRISPR-Cas12a uses a single RNA molecule as a guide for targeting specific DNA sequences.\n3. CRISPR-Cas12a is particularly effective for editing genes in mammalian cells.\n4. CRISPR-Cpf1 uses a single RNA molecule as a guide for targeting specific DNA sequences.\n5. CRISPR-Cpf1 is particularly effective for editing genes in plants and fungi.",
    "vicuna-7b_fact": [
      "CRISPR-Cas12a and CRISPR-Cpf1 are two different types of CRISPR-Cas systems.",
      "CRISPR-Cas12a uses a single RNA molecule as a guide for targeting specific DNA sequences.",
      "CRISPR-Cas12a is particularly effective for editing genes in mammalian cells.",
      "CRISPR-Cpf1 uses a single RNA molecule as a guide for targeting specific DNA sequences.",
      "CRISPR-Cpf1 is particularly effective for editing genes in plants and fungi."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: CRISPR-Cas12a and CRISPR-Cpf1 are the same type of CRISPR-Cas systems, with Cas12a being another name for Cpf1.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3109,
    "user_query": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection",
    "vicuna-7b_response": "Sure, here are two antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection:\n1. FaDA (Fc-domain depleted Actoxime)\n2. Dificid (fidaxomicin)\nBoth FaDA and Dificid are used to prevent recurrence of Clostridioides difficile (C. difficile) infection. C. difficile is a type of bacteria that can cause diarrhea and colitis (inflammation of the colon) in people who have recently taken antibiotics.\nFaDA is a monoclonal antibody that binds to the toxin A produced by C. difficile and neutralizes it. It is given as an intravenous infusion and is approved for use in adults and children aged 6 and older.\nDificid is also a monoclonal antibody that targets the toxin produced by C. difficile. It is given orally and is approved for use in adults and children aged 18 and older.\nBoth FaDA and Dificid have been shown to be effective in reducing the recurrence of C. difficile infection, although the exact mechanism of action of these drugs is not fully understood. It is important to note that these drugs should only be used under the guidance of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. FaDA (Fc-domain depleted Actoxime) and Dificid (fidaxomicin) are antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection.\n2. FaDA is a monoclonal antibody that binds to the toxin A produced by C. difficile.\n3. FaDA is given as an intravenous infusion and is approved for use in adults and children aged 6 and older.\n4. Dificid is a monoclonal antibody that targets the toxin produced by C. difficile.\n5. Dificid is given orally and is approved for use in adults and children aged 18 and older.",
    "vicuna-7b_fact": [
      "FaDA (Fc-domain depleted Actoxime) and Dificid (fidaxomicin) are antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection.",
      "FaDA is a monoclonal antibody that binds to the toxin A produced by C. difficile.",
      "FaDA is given as an intravenous infusion and is approved for use in adults and children aged 6 and older.",
      "Dificid is a monoclonal antibody that targets the toxin produced by C. difficile.",
      "Dificid is given orally and is approved for use in adults and children aged 18 and older."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Bezlotoxumab (with a brand name of Zinplava, not FaDA) and fidaxomicin (with a brand name of Dificid) are approved by the FDA for reducing the recurrence of Clostridium difficile infection.\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Dificid is an antibiotic, not a monoclonal antibody, that fights infection caused by C. difficile.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-7b_response": "Axitinib is a targeted therapy drug that is used to treat advanced renal cell carcinoma and advanced melanoma. It is not approved for the treatment of pancreatic cancer.\nThere have been some studies that have looked at the use of axitinib in combination with other drugs in the treatment of pancreatic cancer, but the results have been mixed and more research is needed to determine its effectiveness in this setting.\nIt's important to note that the prognosis for pancreatic cancer is generally poor, and the survival rate for this disease is low. The treatment options for pancreatic cancer are limited, and the effectiveness of any given treatment can vary depending on the individual patient and the stage of the disease.\nIf you have been diagnosed with pancreatic cancer and are considering treatment with axitinib or any other drug, it is important to speak with your healthcare provider about the potential benefits and risks of the treatment, as well as any clinical trials that may be available to you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Axitinib is a targeted therapy drug used to treat advanced renal cell carcinoma and advanced melanoma.\n2. Axitinib is not approved for the treatment of pancreatic cancer.\n3. There have been studies looking at the use of axitinib in combination with other drugs for pancreatic cancer treatment, but the results have been mixed.\n4. The prognosis for pancreatic cancer is generally poor, and the survival rate is low.\n5. The effectiveness of any given treatment for pancreatic cancer can vary depending on the individual patient and the stage of the disease.",
    "vicuna-7b_fact": [
      "Axitinib is a targeted therapy drug used to treat advanced renal cell carcinoma and advanced melanoma.",
      "Axitinib is not approved for the treatment of pancreatic cancer.",
      "There have been studies looking at the use of axitinib in combination with other drugs for pancreatic cancer treatment, but the results have been mixed.",
      "The prognosis for pancreatic cancer is generally poor, and the survival rate is low.",
      "The effectiveness of any given treatment for pancreatic cancer can vary depending on the individual patient and the stage of the disease."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Axitinib is a targeted therapy drug used to treat advanced renal cell carcinoma. It is not used in the treatment of advanced melanoma.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3112,
    "user_query": "Which Python tool has been developed for network-based stratification of tumor mutations?",
    "vicuna-7b_response": "The Python tool that has been developed for network-based stratification of tumor mutations is called \"Cluster 3.0\".",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The Python tool developed for network-based stratification of tumor mutations is called \"Cluster 3.0\".",
    "vicuna-7b_fact": [
      "The Python tool developed for network-based stratification of tumor mutations is called \"Cluster 3.0\"."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "vicuna-7b_response": "MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a role in regulating F-actin dynamics, which are the dynamics of the actin cytoskeleton. MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization.\nThe Arp2/3 complex is a complex of proteins that catalyzes the formation of branched actin filaments, which are essential for the dynamic reorganization of the actin cytoskeleton. MLP binds to the Arp2/3 complex and inhibits its activity, thereby regulating the formation of branched actin filaments and the dynamic reorganization of the actin cytoskeleton.\nIn this way, MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization. This interaction is an important mechanism by which MLP regulates the dynamic reorganization of the actin cytoskeleton and contributes to its role in cellular processes such as cell growth, migration, and differentiation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a role in regulating F-actin dynamics.\n2. MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex.\n3. The Arp2/3 complex is a complex of proteins that catalyzes the formation of branched actin filaments.\n4. MLP binds to the Arp2/3 complex and inhibits its activity.\n5. MLP's interaction with the Arp2/3 complex is an important mechanism by which MLP regulates the dynamic reorganization of the actin cytoskeleton and contributes to cellular processes such as cell growth, migration, and differentiation.",
    "vicuna-7b_fact": [
      "MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a role in regulating F-actin dynamics.",
      "MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex.",
      "The Arp2/3 complex is a complex of proteins that catalyzes the formation of branched actin filaments.",
      "MLP binds to the Arp2/3 complex and inhibits its activity.",
      "MLP's interaction with the Arp2/3 complex is an important mechanism by which MLP regulates the dynamic reorganization of the actin cytoskeleton and contributes to cellular processes such as cell growth, migration, and differentiation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3116,
    "user_query": "What is CVT-301?",
    "vicuna-7b_response": "CVT-301 is a course that focuses on the fundamentals of computer vision. It covers topics such as image processing, feature extraction, and object recognition. The course is designed to provide students with a solid understanding of the principles and techniques used in computer vision applications.\nThe course typically includes lectures, assignments, and projects that help students develop their skills in computer vision. The assignments and projects may involve using various software tools and programming languages to implement computer vision algorithms.\nCVT-301 is typically taken by students who are interested in pursuing careers in computer vision, machine learning, or related fields. It is a foundational course that provides a strong basis for further study in computer vision and related fields.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CVT-301 is a course that focuses on the principles of computer vision.\n2. The course covers topics such as image processing, feature extraction, and object recognition.\n3. The course involves lectures, assignments, and projects related to computer vision.\n4. The assignments and projects may involve using various software tools and programming languages to implement computer vision algorithms.\n5. CVT-301 is usually taken by students who are passionate about computer vision, machine learning, or related fields.",
    "vicuna-7b_fact": [
      "CVT-301 is a course that focuses on the principles of computer vision.",
      "The course covers topics such as image processing, feature extraction, and object recognition.",
      "The course involves lectures, assignments, and projects related to computer vision.",
      "The assignments and projects may involve using various software tools and programming languages to implement computer vision algorithms.",
      "CVT-301 is usually taken by students who are passionate about computer vision, machine learning, or related fields."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3117,
    "user_query": "Are there tools for visualizing and processing long-read sequencing data?",
    "vicuna-7b_response": "Yes, there are several tools available for visualizing and processing long-read sequencing data. Some of the most popular tools include:\n1. GATK Best Practices: GATK (Genome Analysis Toolkit) provides a set of best practices for processing long-read sequencing data. These best practices include tools for aligning, mapping, and variant calling.\n2. PacBio Studio: PacBio Studio is a software tool that is specifically designed for processing and analyzing long-read sequencing data. It provides tools for aligning, mapping, and variant calling, as well as tools for visualizing the sequencing data.\n3. HGAP: HGAP (Hierarchical Genome Assembly Program) is a software tool that is designed for processing and analyzing long-read sequencing data. It provides tools for aligning, mapping, and variant calling, as well as tools for visualizing the sequencing data.\n4. CASCADE: CASCADE (Computational Approaches for Sequence-based Analysis of Cancer) is a software toolkit that is designed for processing and analyzing long-read sequencing data. It provides tools for aligning, mapping, and variant calling, as well as tools for visualizing the sequencing data.\n5. Flye: Flye is a cloud-based platform that is designed for processing and analyzing long-read sequencing data. It provides tools for aligning, mapping, and variant calling, as well as tools for visualizing the sequencing data.\nThese are just a few examples of the tools available for processing and analyzing long-read sequencing data. The choice of tool will depend on the specific requirements of the project and the expertise of the user.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GATK Best Practices is a toolset for processing long-read sequencing data.\n2. PacBio Studio is a software tool specifically designed for processing and analyzing long-read sequencing data.\n3. HGAP (Hierarchical Genome Assembly Program) is a software tool designed for processing and analyzing long-read sequencing data.\n4. CASCADE (Computational Approaches for Sequence-based Analysis of Cancer) is a software toolkit designed for processing and analyzing long-read sequencing data.\n5. Flye is a cloud-based platform designed for processing and analyzing long-read sequencing data.",
    "vicuna-7b_fact": [
      "GATK Best Practices is a toolset for processing long-read sequencing data.",
      "PacBio Studio is a software tool specifically designed for processing and analyzing long-read sequencing data.",
      "HGAP (Hierarchical Genome Assembly Program) is a software tool designed for processing and analyzing long-read sequencing data.",
      "CASCADE (Computational Approaches for Sequence-based Analysis of Cancer) is a software toolkit designed for processing and analyzing long-read sequencing data.",
      "Flye is a cloud-based platform designed for processing and analyzing long-read sequencing data."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: GATK (Genome Analysis Toolkit) Best Practices is a set of recommended workflows for performing common tasks in genomic data analysis, such as variant calling and data pre-processing, not specifically for processing long-read sequencing data.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Flye is a de novo assembler for single molecule sequencing reads, such as those produced by PacBio and Oxford Nanopore, it is not a cloud-based platform.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3118,
    "user_query": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019).",
    "vicuna-7b_response": "There are several small interfering RNA (siRNA) drugs that have entered phase 2-3 clinical trials by 2019. Here are some examples:\n1. ALN-TTR020: This siRNA drug is being developed to treat transthyretin (TTR) amyloidosis, a rare and progressive genetic disorder. It is currently in phase 3 clinical trials.\n2. SGT-221: This siRNA drug is being developed to treat genetic diseases caused by mutations in the mitochondrial genome. It is currently in phase 2 clinical trials.\n3. ALN-CC5: This siRNA drug is being developed to treat complement-mediated diseases, such as age-related macular degeneration. It is currently in phase 3 clinical trials.\n4. ALN-PCS: This siRNA drug is being developed to treat plasma cell disorders, such as multiple myeloma. It is currently in phase 3 clinical trials.\n5. ALN-TMP2: This siRNA drug is being developed to treat transthyretin (TTR) amyloidosis. It is currently in phase 2 clinical trials.\nIt's worth noting that siRNA drugs are still in the early stages of development and it's possible that some of these drugs may not be successful in clinical trials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ALN-TTR020 is an siRNA drug in development for treating transthyretin (TTR) amyloidosis, and was in phase 3 clinical trials as of 2019.\n2. SGT-221, an siRNA drug for treating genetic diseases caused by mutations in the mitochondrial genome, had entered phase 2 clinical trials by 2019.\n3. ALN-CC5, an siRNA drug in development for treating complement-mediated diseases like age-related macular degeneration, was in phase 3 clinical trials as of 2019.\n4. ALN-PCS is an siRNA drug in development for treating plasma cell disorders, such as multiple myeloma, and was in phase 3 clinical trials as of 2019.\n5. ALN-TMP2, another siRNA drug for treating transthyretin (TTR) amyloidosis, had entered phase 2 clinical trials by 2019.",
    "vicuna-7b_fact": [
      "ALN-TTR020 is an siRNA drug in development for treating transthyretin (TTR) amyloidosis, and was in phase 3 clinical trials as of 2019.",
      "SGT-221, an siRNA drug for treating genetic diseases caused by mutations in the mitochondrial genome, had entered phase 2 clinical trials by 2019.",
      "ALN-CC5, an siRNA drug in development for treating complement-mediated diseases like age-related macular degeneration, was in phase 3 clinical trials as of 2019.",
      "ALN-PCS is an siRNA drug in development for treating plasma cell disorders, such as multiple myeloma, and was in phase 3 clinical trials as of 2019.",
      "ALN-TMP2, another siRNA drug for treating transthyretin (TTR) amyloidosis, had entered phase 2 clinical trials by 2019."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: ALN-CC5, an siRNA drug in development for treating complement-mediated diseases, was in phase 1/2 clinical trials as of 2019.\n4. FALSE [correction]: ALN-PCS is an siRNA drug in development for treating hypercholesterolemia, and was in phase 1 clinical trials as of 2019.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3119,
    "user_query": "Where is fatty acid binding protein 2 expressed?",
    "vicuna-7b_response": "Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues throughout the body. It is primarily expressed in the liver, but it is also found in the heart, kidney, intestine, and adipose tissue. FABP2 plays a role in the transport and metabolism of fatty acids, and it has been implicated in the development of insulin resistance and metabolic disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues throughout the body.\n2. FABP2 is primarily expressed in the liver.\n3. FABP2 is also found in the heart, kidney, intestine, and adipose tissue.\n4. FABP2 plays a role in the transport and metabolism of fatty acids.\n5. FABP2 has been implicated in the development of insulin resistance and metabolic disorders.",
    "vicuna-7b_fact": [
      "Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues throughout the body.",
      "FABP2 is primarily expressed in the liver.",
      "FABP2 is also found in the heart, kidney, intestine, and adipose tissue.",
      "FABP2 plays a role in the transport and metabolism of fatty acids.",
      "FABP2 has been implicated in the development of insulin resistance and metabolic disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: FABP2 is primarily expressed in the intestine.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3121,
    "user_query": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis",
    "vicuna-7b_response": "There are several computational tools that have been developed for the analysis of alternative polyadenylation (APA) sites. Some of the most popular tools include:\n1. ANCHOR: ANCHOR is a computational tool that uses a Bayesian approach to identify APA sites in the human genome. It uses a combination of genomic features, such as exon structure and splicing patterns, to predict APA sites.\n2. APAfinder: APAfinder is a web-based tool that uses a combination of genomic features, such as exon structure and splicing patterns, to predict APA sites. It also provides functional annotation of APA sites and allows for the comparison of APA sites across different samples.\n3. APASS: APASS is a computational tool that uses a probabilistic model to identify APA sites in the human genome. It uses a combination of genomic features, such as exon structure and splicing patterns, to predict APA sites and also provides functional annotation of APA sites.\n4. APAsearch: APAsearch is a computational tool that uses a combination of genomic features, such as exon structure and splicing patterns, to identify APA sites in the human genome. It also provides functional annotation of APA sites and allows for the comparison of APA sites across different samples.\n5. APAfinder: APAfinder is a web-based tool that uses a combination of genomic features, such as exon structure and splicing patterns, to predict APA sites. It also provides functional annotation of APA sites and allows for the comparison of APA sites across different samples.\n6. APAfinder: APAfinder is a web-based tool that uses a combination of genomic features, such as exon structure and splicing patterns, to predict APA sites. It also provides functional annotation of APA sites and allows for the comparison of APA sites across different samples.\nThese are some of the most popular computational tools for APA sites analysis, but there are many other tools available, each with its own strengths and weaknesses. It's important to evaluate the performance of different tools on different datasets and choose the one that best fits your needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ANCHOR is a computational tool for the analysis of alternative polyadenylation (APA) sites.\n2. APAfinder is a web-based tool that predicts and provides functional annotation of APA sites.\n3. APASS is a computational tool for identifying APA sites in the human genome.\n4. APAsearch is a computational tool that identifies APA sites in the human genome and provides functional annotation of them.\n5. Different computational tools have different strengths and weaknesses for APA sites analysis.",
    "vicuna-7b_fact": [
      "ANCHOR is a computational tool for the analysis of alternative polyadenylation (APA) sites.",
      "APAfinder is a web-based tool that predicts and provides functional annotation of APA sites.",
      "APASS is a computational tool for identifying APA sites in the human genome.",
      "APAsearch is a computational tool that identifies APA sites in the human genome and provides functional annotation of them.",
      "Different computational tools have different strengths and weaknesses for APA sites analysis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no known computational tool named APASS for identifying APA sites in the human genome.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3124,
    "user_query": "Which curated data resources for ChIP-seq data are available?",
    "vicuna-7b_response": "There are several curated data resources available for ChIP-seq data. Here are some of the most popular ones:\n1. ENCODE Project: The ENCODE (Encyclopedia Of DNA Elements) Project is a large-scale effort to identify and characterize all of the functional elements in the human genome. The ENCODE Chromatin Regulation Portal provides a comprehensive resource for ChIP-seq data, including data from a variety of cell types and tissues.\n2. ChIP-seq Peak Caller: ChIP-seq Peak Caller is a tool that allows users to call peaks in ChIP-seq data. The tool is based on the Homer software and is available on the UCSC Genome Browser website.\n3. ChIP-seq Data Repository: The ChIP-seq Data Repository is a public repository that provides access to ChIP-seq data from a variety of sources. The repository is maintained by the Broad Institute and is a great resource for researchers looking for ChIP-seq data from a wide range of organisms and cell types.\n4. ChIP-seq Peak Finder: ChIP-seq Peak Finder is a tool that allows users to find peaks in ChIP-seq data. The tool is based on the MACS (Model-based Analysis of ChIP-seq) software and is available on the UCSC Genome Browser website.\n5. ChIP-seq Peak Analysis: ChIP-seq Peak Analysis is a tool that allows users to analyze ChIP-seq data and identify peaks. The tool is based on the MACS software and is available on the UCSC Genome Browser website.\nThese are just a few examples of the many resources available for ChIP-seq data. It's important to note that the availability of data may vary depending on the organism and cell type being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ENCODE Project provides a comprehensive resource for ChIP-seq data, which includes data from various cell types and tissues.\n2. The ChIP-seq Peak Caller is a tool that can help call peaks in ChIP-seq data and is based on the Homer software.\n3. The ChIP-seq Data Repository is a public repository maintained by the Broad Institute, and it provides access to ChIP-seq data from a variety of sources.\n4. The ChIP-seq Peak Finder is a tool for finding peaks in ChIP-seq data, based on the MACS software.\n5. ChIP-seq Peak Analysis is another tool based on the MACS software that helps users analyze ChIP-seq data and identify peaks.",
    "vicuna-7b_fact": [
      "The ENCODE Project provides a comprehensive resource for ChIP-seq data, which includes data from various cell types and tissues.",
      "The ChIP-seq Peak Caller is a tool that can help call peaks in ChIP-seq data and is based on the Homer software.",
      "The ChIP-seq Data Repository is a public repository maintained by the Broad Institute, and it provides access to ChIP-seq data from a variety of sources.",
      "The ChIP-seq Peak Finder is a tool for finding peaks in ChIP-seq data, based on the MACS software.",
      "ChIP-seq Peak Analysis is another tool based on the MACS software that helps users analyze ChIP-seq data and identify peaks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The ChIP-seq Data Repository is a public repository maintained by the NCBI, and it provides access to ChIP-seq data from a variety of sources.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3126,
    "user_query": "What is the mechanism of action of Inclisiran?",
    "vicuna-7b_response": "Inclisiran is a novel RNA-targeting therapeutic that works by selectively inhibiting the production of a specific messenger RNA (mRNA) that encodes for a protein called PCSK9. PCSK9 is a protein that regulates the levels of low-density lipoprotein (LDL) cholesterol in the blood by promoting the removal of LDL receptors from the liver surface. By inhibiting the production of PCSK9, inclisiran increases the number of LDL receptors on the liver surface, leading to a significant reduction in LDL cholesterol levels.\nInclisiran is administered as an infusion once every 4 weeks and has been shown to reduce LDL cholesterol levels by up to 70% in patients with hypercholesterolemia. It is also effective in reducing the risk of cardiovascular events such as heart attack and stroke.\nInclisiran is a unique therapeutic that targets the underlying cause of hypercholesterolemia by directly targeting the mRNA that encodes for PCSK9, rather than just lowering the levels of LDL cholesterol by inhibiting its synthesis in the liver. This makes it a promising therapeutic for the treatment of hypercholesterolemia and other related cardiovascular diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Inclisiran is a novel RNA-targeting therapeutic that works by selectively inhibiting the production of a specific messenger RNA (mRNA) that encodes for PCSK9.\n2. PCSK9 is a protein that regulates levels of low-density lipoprotein (LDL) cholesterol in the blood.\n3. Inclisiran is administered as an infusion once every 4 weeks.\n4. Inclisiran has been shown to reduce LDL cholesterol levels by up to 70% in patients with hypercholesterolemia.\n5. Inclisiran can reduce the risk of cardiovascular events such as heart attack and stroke.",
    "vicuna-7b_fact": [
      "Inclisiran is a novel RNA-targeting therapeutic that works by selectively inhibiting the production of a specific messenger RNA (mRNA) that encodes for PCSK9.",
      "PCSK9 is a protein that regulates levels of low-density lipoprotein (LDL) cholesterol in the blood.",
      "Inclisiran is administered as an infusion once every 4 weeks.",
      "Inclisiran has been shown to reduce LDL cholesterol levels by up to 70% in patients with hypercholesterolemia.",
      "Inclisiran can reduce the risk of cardiovascular events such as heart attack and stroke."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Inclisiran is administered as an injection once every six months.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3127,
    "user_query": "Which tool has been developed for visualization of non-covalent contacts?",
    "vicuna-7b_response": "There are several tools available for visualizing non-covalent contacts, including:\n1. PyMOL: PyMOL is a popular molecular visualization tool that can be used to view and manipulate 3D molecular structures. PyMOL can also be used to visualize non-covalent contacts between molecules, such as hydrogen bonds and van der Waals forces.\n2. VMD: VMD is another molecular visualization tool that can be used to view and manipulate 3D molecular structures. VMD can also be used to visualize non-covalent contacts between molecules, such as hydrogen bonds and van der Waals forces.\n3. Autodock Vina: Autodock Vina is a computational tool that can be used to predict the binding of small molecules to a protein target. Autodock Vina can also be used to visualize non-covalent contacts between small molecules and proteins.\n4. GROMACS: GROMACS is a computational tool that can be used to simulate the behavior of molecular systems, including non-covalent interactions. GROMACS can be used to visualize non-covalent contacts between molecules in 3D.\n5. NAMD: NAMD is another computational tool that can be used to simulate the behavior of molecular systems, including non-covalent interactions. NAMD can be used to visualize non-covalent contacts between molecules in 3D.\nThese are some of the most popular tools for visualizing non-covalent contacts, but there are many other tools available as well. The choice of tool will depend on the specific needs of the user and the type of molecular system being studied.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PyMOL can be used to visualize non-covalent contacts between molecules such as hydrogen bonds and van der Waals forces.\n2. VMD is a molecular visualization tool that can depict non-covalent contacts between molecules.\n3. Autodock Vina is a computational tool used for predicting the binding of small molecules to a protein target that can visualize non-covalent contacts.\n4. GROMACS can simulate the behavior of molecular systems, including non-covalent interactions, and can be used to visualize these contacts.\n5. NAMD can simulate the behavior of molecular systems, including non-covalent interactions, and be used to visualize these contacts.",
    "vicuna-7b_fact": [
      "PyMOL can be used to visualize non-covalent contacts between molecules such as hydrogen bonds and van der Waals forces.",
      "VMD is a molecular visualization tool that can depict non-covalent contacts between molecules.",
      "Autodock Vina is a computational tool used for predicting the binding of small molecules to a protein target that can visualize non-covalent contacts.",
      "GROMACS can simulate the behavior of molecular systems, including non-covalent interactions, and can be used to visualize these contacts.",
      "NAMD can simulate the behavior of molecular systems, including non-covalent interactions, and be used to visualize these contacts."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Autodock Vina is a computational tool used for predicting the binding of small molecules to a protein target but does not have built in functions to visualize non-covalent contacts.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3130,
    "user_query": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "vicuna-7b_response": "Yes, apoE mimetics are being considered as a potential treatment for Alzheimer's disease. ApoE is a protein that is involved in the transport of cholesterol in the bloodstream and is also involved in the clearance of beta-amyloid, a toxic protein that accumulates in the brains of Alzheimer's disease patients.\nApoE mimetics are molecules that mimic the structure and function of the apoE protein and have been shown to clear beta-amyloid from the brain in animal models of Alzheimer's disease. Some apoE mimetics have also been shown to improve cognitive function in these models.\nThere are several apoE mimetics that are currently being studied in clinical trials for the treatment of Alzheimer's disease. These include small molecules, such as TG2330 and TG2766, and larger biologic molecules, such as aducanumab and BAN2401.\nWhile the results of these clinical trials have been promising, it is still too early to determine whether apoE mimetics will be an effective treatment for Alzheimer's disease. Further research is needed to fully understand the safety and efficacy of these molecules.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ApoE mimetics are being considered as a potential treatment for Alzheimer's disease.\n2. ApoE is a protein that is involved in the transport of cholesterol in the bloodstream and in the clearance of beta-amyloid.\n3. ApoE mimetics have been shown to clear beta-amyloid from the brain in animal models of Alzheimer's disease.\n4. Some apoE mimetics have been shown to improve cognitive function in animal models of Alzheimer's disease.\n5. There are several apoE mimetics being studied in clinical trials for the treatment of Alzheimer's disease, including TG2330, TG2766, aducanumab, and BAN2401.",
    "vicuna-7b_fact": [
      "ApoE mimetics are being considered as a potential treatment for Alzheimer's disease.",
      "ApoE is a protein that is involved in the transport of cholesterol in the bloodstream and in the clearance of beta-amyloid.",
      "ApoE mimetics have been shown to clear beta-amyloid from the brain in animal models of Alzheimer's disease.",
      "Some apoE mimetics have been shown to improve cognitive function in animal models of Alzheimer's disease.",
      "There are several apoE mimetics being studied in clinical trials for the treatment of Alzheimer's disease, including TG2330, TG2766, aducanumab, and BAN2401."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3135,
    "user_query": "What does Prevnar 13 consist of?",
    "vicuna-7b_response": "Prevnar 13 is a vaccine that is used to prevent invasive disease caused by Streptococcus pneumoniae (pneumococcus) in adults aged 50 years or older. The vaccine is a conjugate vaccine, which means that it contains a specific type of pneumococcal bacteria that is coated with a protein called CRM197. This protein helps the body's immune system to recognize and attack the bacteria.\nPrevnar 13 is made up of the following components:\n* The pneumococcal protein conjugate, which is made up of the following:\n\t+ Polysaccharide from the capsule of S. pneumoniae\n\t+ CRM197 protein\n* Sorbitol, sodium phosphate monobasic monohydrate, sodium phosphate dibasic anhydrate, and water for injection.\nThe vaccine is given as an injection (shot) into the muscle. The most common side effects of Prevnar 13 are pain, redness, and swelling at the injection site, as well as fatigue, headache, muscle pain, and chills. These side effects usually go away on their own within a few days.\nIt is important to note that Prevnar 13 is not a substitute for getting other recommended vaccines. It is important to follow the recommended vaccination schedule to protect against other serious diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prevnar 13 is a vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in adults aged 50 years or older.\n2. Prevnar 13 is a conjugate vaccine, containing a pneumococcal bacteria coated with a protein called CRM197.\n3. Prevnar 13's components include the pneumococcal protein conjugate, which consists of polysaccharide from the capsule of S. pneumoniae and CRM197 protein, along with sorbitol, sodium phosphate monobasic monohydrate, sodium phosphate dibasic anhydrate, and water for injection.\n4. Some common side effects of Prevnar 13 include pain, redness, and swelling at the injection site, fatigue, headache, muscle pain, and chills, which usually go away within a few days.\n5. Prevnar 13 is not a substitute for other recommended vaccines.",
    "vicuna-7b_fact": [
      "Prevnar 13 is a vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in adults aged 50 years or older.",
      "Prevnar 13 is a conjugate vaccine, containing a pneumococcal bacteria coated with a protein called CRM197.",
      "Prevnar 13's components include the pneumococcal protein conjugate, which consists of polysaccharide from the capsule of S. pneumoniae and CRM197 protein, along with sorbitol, sodium phosphate monobasic monohydrate, sodium phosphate dibasic anhydrate, and water for injection.",
      "Some common side effects of Prevnar 13 include pain, redness, and swelling at the injection site, fatigue, headache, muscle pain, and chills, which usually go away within a few days.",
      "Prevnar 13 is not a substitute for other recommended vaccines."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3137,
    "user_query": "What is the cause of a STAG3 truncating variant?",
    "vicuna-7b_response": "A STAG3 truncating variant is a genetic mutation that results in the deletion or truncation of the STAG3 gene. This can lead to a variety of health problems, including developmental delays, intellectual disability, and cancer predisposition. The exact cause of the mutation can vary, but it is often inherited from one's parents. In some cases, a STAG3 truncating variant can be caused by a new mutation that occurs spontaneously during the development of the fetus.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A STAG3 truncating variant is a genetic mutation that results in the deletion or truncation of the STAG3 gene.\n2. The STAG3 truncating variant can lead to developmental delays, intellectual disability, and cancer predisposition.\n3. The cause of the STAG3 truncating variant can often be inherited from one's parents.\n4. A STAG3 truncating variant can be caused by a new mutation that spontaneously occurs during the development of the fetus.",
    "vicuna-7b_fact": [
      "A STAG3 truncating variant is a genetic mutation that results in the deletion or truncation of the STAG3 gene.",
      "The STAG3 truncating variant can lead to developmental delays, intellectual disability, and cancer predisposition.",
      "The cause of the STAG3 truncating variant can often be inherited from one's parents.",
      "A STAG3 truncating variant can be caused by a new mutation that spontaneously occurs during the development of the fetus."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3138,
    "user_query": "Which tools have been developed for computing split-networks?",
    "vicuna-7b_response": "There are several tools that have been developed for computing split-networks, which are networks that are split into multiple components, each of which is connected to a subset of the nodes in the original network. Some of the tools that have been developed for computing split-networks include:\n1. NetworkX: NetworkX is a Python library for creating, manipulating, and analyzing networks. It provides a wide range of algorithms for computing split-networks, including algorithms for finding connected components, community detection, and more.\n2. igraph: igraph is a C++ library for creating, manipulating, and analyzing networks. It provides a wide range of algorithms for computing split-networks, including algorithms for finding connected components, community detection, and more.\n3. Gephi: Gephi is a Java-based network visualization and analysis tool. It provides a wide range of algorithms for computing split-networks, including algorithms for finding connected components, community detection, and more.\n4. Cytoscape: Cytoscape is a web-based platform for creating, manipulating, and analyzing networks. It provides a wide range of algorithms for computing split-networks, including algorithms for finding connected components, community detection, and more.\n5. Pajek: Pajek is a tool for processing and analyzing large-scale social networks. It provides a wide range of algorithms for computing split-networks, including algorithms for finding connected components, community detection, and more.\nThese are just a few examples of the tools that have been developed for computing split-networks. There are many other tools available, and the choice of tool will depend on the specific needs of the user.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NetworkX is a Python library developed for creating, manipulating, and analyzing networks.\n2. igraph is a C++ library developed for creating, manipulating, and analyzing networks.\n3. Gephi is a Java-based network visualization and analysis tool.\n4. Cytoscape is a web-based platform developed for creating, manipulating, and analyzing networks.\n5. Pajek is a tool developed for processing and analyzing large-scale social networks.",
    "vicuna-7b_fact": [
      "NetworkX is a Python library developed for creating, manipulating, and analyzing networks.",
      "igraph is a C++ library developed for creating, manipulating, and analyzing networks.",
      "Gephi is a Java-based network visualization and analysis tool.",
      "Cytoscape is a web-based platform developed for creating, manipulating, and analyzing networks.",
      "Pajek is a tool developed for processing and analyzing large-scale social networks."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: igraph is a library developed in C and C++, but it also has interfaces available in Python and R for creating, manipulating, and analyzing networks.\n3. TRUE\n4. FALSE [correction]: Cytoscape is a Java-based platform developed for creating, manipulating, and analyzing networks.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-7b_response": "ApoE mimetics are molecules that mimic the structure and function of the apoE protein, which is a major protein component of low-density lipoprotein (LDL) in the blood. ApoE mimetics have been studied as potential therapeutic agents for the treatment of various diseases, including Alzheimer's disease, atherosclerosis, and other conditions related to lipid metabolism. Here are three examples of apoE mimetics:\n1. Apolipoprotein E (apoE) mimetic peptides: These are short peptides that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature Medicine in 2012 found that a specific apoE mimetic peptide called PPMI-111 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.\n2. Apolipoprotein E (apoE) mimetic small molecules: These are small molecules that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature in 2018 found that a specific apoE mimetic small molecule called CNP (cyanopeptide) improved memory and learning in mice with Alzheimer's disease.\n3. Apolipoprotein E (apoE) mimetic nanoparticles: These are nanoparticles that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal ACS Nano in 2019 found that a specific apoE mimetic nanoparticle called NP-205 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ApoE mimetics are molecules that mimic the structure and function of the apoE protein, a major protein component of low-density lipoprotein (LDL) in the blood.\n2. ApoE mimetic peptides are short peptides that mimic the structure of apoE protein.\n3. A study published in Nature Medicine in 2012 found that a specific apoE mimetic peptide called PPMI-111 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.\n4. ApoE mimetic small molecules are another type of apoE mimetic.\n5. A study published in the journal ACS Nano in 2019 found that a specific apoE mimetic nanoparticle called NP-205 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.",
    "vicuna-7b_fact": [
      "ApoE mimetics are molecules that mimic the structure and function of the apoE protein, a major protein component of low-density lipoprotein (LDL) in the blood.",
      "ApoE mimetic peptides are short peptides that mimic the structure of apoE protein.",
      "A study published in Nature Medicine in 2012 found that a specific apoE mimetic peptide called PPMI-111 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.",
      "ApoE mimetic small molecules are another type of apoE mimetic.",
      "A study published in the journal ACS Nano in 2019 found that a specific apoE mimetic nanoparticle called NP-205 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-7b_response": "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells. There are sex differences in SAMHD1 activity that have been observed in various studies.\nIn general, SAMHD1 activity is higher in males than in females. This is due to the fact that males have a higher expression of SAMHD1 in their cells, particularly in the testes and prostate gland. In contrast, SAMHD1 expression is lower in female reproductive tissues and in the brain.\nStudies have also shown that SAMHD1 activity is lower in immune cells of females compared to males. This is thought to be due to the fact that females have a higher proportion of immune cells that are resistant to HIV-1 infection, such as CD4+ T cells and macrophages.\nIt is important to note that the sex differences in SAMHD1 activity are not absolute and can vary depending on the cell type and the context in which SAMHD1 is being studied. Additionally, the role of SAMHD1 in HIV-1 replication is complex and influenced by a variety of factors, including the viral strain, the presence of other antiviral drugs, and the host genetics.\nOverall, the sex differences in SAMHD1 activity are an area of active research, and further studies are needed to fully understand the role of SAMHD1 in HIV-1 replication and the mechanisms underlying the sex differences in SAMHD1 activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.\n2. According to various studies, SAMHD1 activity is generally higher in males than in females.\n3. The reason men have higher SAMHD1 activity is due to higher expression of SAMHD1 in cells, particularly in the testes and prostate gland.\n4. Studies have shown that SAMHD1 activity is lower in immune cells of females compared to males.\n5. The sex differences in SAMHD1 activity can vary depending on the cell type and the context in which SAMHD1 is being studied.",
    "vicuna-7b_fact": [
      "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.",
      "According to various studies, SAMHD1 activity is generally higher in males than in females.",
      "The reason men have higher SAMHD1 activity is due to higher expression of SAMHD1 in cells, particularly in the testes and prostate gland.",
      "Studies have shown that SAMHD1 activity is lower in immune cells of females compared to males.",
      "The sex differences in SAMHD1 activity can vary depending on the cell type and the context in which SAMHD1 is being studied."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3144,
    "user_query": "Is the protein Asporin related to disease?",
    "vicuna-7b_response": "Yes, Asporin is related to disease. Asporin is a protein that is involved in the development of certain diseases, including cancer.\nAsporin is a protein that is found in high levels in some types of cancer cells, and it has been shown to promote the growth and proliferation of cancer cells. This is thought to be due to the ability of Asporin to inhibit the activity of a protein called p53, which is a tumor suppressor protein that helps to prevent the development of cancer.\nIn addition to its role in cancer, Asporin has also been implicated in other diseases, including cardiovascular disease and osteoporosis. Some studies have suggested that high levels of Asporin in the blood may be a risk factor for these diseases, although more research is needed to fully understand the role of Asporin in these conditions.\nOverall, Asporin is a protein that is involved in the development of disease, and its levels in the body may be a risk factor for certain diseases, including cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Asporin is a protein related to disease.\n2. Asporin is involved in the development of certain diseases, including cancer.\n3. Asporin inhibits the activity of a protein called p53.\n4. Asporin has been implicated in diseases, including cardiovascular disease and osteoporosis. \n5. High levels of Asporin in the blood may be a risk factor for certain diseases.",
    "vicuna-7b_fact": [
      "Asporin is a protein related to disease.",
      "Asporin is involved in the development of certain diseases, including cancer.",
      "Asporin inhibits the activity of a protein called p53.",
      "Asporin has been implicated in diseases, including cardiovascular disease and osteoporosis.",
      "High levels of Asporin in the blood may be a risk factor for certain diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3147,
    "user_query": "Which cells secrete lactotransferrin?",
    "vicuna-7b_response": "Lactotransferrin is a protein that is primarily synthesized and secreted by the epithelial cells of the mammary gland in mammals. It is also secreted by some other epithelial cells in the body, such as those found in the small intestine, placenta, and testis. Lactotransferrin plays a critical role in the transport of iron across cell membranes and is also involved in the immune response by binding to and transporting iron-bound transferrin to immune cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lactotransferrin is a protein that is primarily synthesized and secreted by epithelial cells of the mammary gland in mammals.\n2. Lactotransferrin is also secreted by other epithelial cells found in the small intestine, placenta, and testis.\n3. Lactotransferrin plays a critical role in the transport of iron across cell membranes.\n4. Lactotransferrin is involved in the immune response by binding to and transporting iron-bound transferrin to immune cells.",
    "vicuna-7b_fact": [
      "Lactotransferrin is a protein that is primarily synthesized and secreted by epithelial cells of the mammary gland in mammals.",
      "Lactotransferrin is also secreted by other epithelial cells found in the small intestine, placenta, and testis.",
      "Lactotransferrin plays a critical role in the transport of iron across cell membranes.",
      "Lactotransferrin is involved in the immune response by binding to and transporting iron-bound transferrin to immune cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Lactotransferrin is involved in the immune response by binding to and neutralizing microorganisms, not by transporting iron-bound transferrin to immune cells.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3150,
    "user_query": "What is the function of the protein Magt1?",
    "vicuna-7b_response": "Magt1, also known as MAGUK protein 1, is a protein that plays a critical role in regulating the structure and function of the endoplasmic reticulum (ER) in cells. The ER is a organelle that is responsible for protein folding, lipid synthesis, and the transport of molecules within the cell.\nMagt1 is a member of the MAGUK (membrane-associated guanylate kinase) family of proteins, which are involved in the regulation of the structure and function of the ER. Magt1 is expressed in a wide range of tissues and cells, and it is thought to play a role in the regulation of the ER's morphology and the organization of the cytoskeleton.\nIn addition to its role in the regulation of the ER, Magt1 has also been shown to play a role in the regulation of cell growth and survival. For example, Magt1 has been shown to interact with and regulate the activity of the protein Akt, which is a key regulator of cell survival and proliferation.\nOverall, Magt1 is an important protein that plays a critical role in the regulation of the ER and in the regulation of cell growth and survival.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Magt1, also known as MAGUK protein 1, regulates the structure and function of the endoplasmic reticulum (ER) in cells.\n2. The endoplasmic reticulum (ER) is responsible for protein folding, lipid synthesis, and the transport of molecules within the cell.\n3. Magt1 is a member of the MAGUK (membrane-associated guanylate kinase) family of proteins.\n4. Magt1 is expressed in a wide range of tissues and cells.\n5. Magt1 plays a role in the regulation of cell growth and survival by interacting with and regulating the activity of the protein Akt.",
    "vicuna-7b_fact": [
      "Magt1, also known as MAGUK protein 1, regulates the structure and function of the endoplasmic reticulum (ER) in cells.",
      "The endoplasmic reticulum (ER) is responsible for protein folding, lipid synthesis, and the transport of molecules within the cell.",
      "Magt1 is a member of the MAGUK (membrane-associated guanylate kinase) family of proteins.",
      "Magt1 is expressed in a wide range of tissues and cells.",
      "Magt1 plays a role in the regulation of cell growth and survival by interacting with and regulating the activity of the protein Akt."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3152,
    "user_query": "What is the function of the transcriptional co-activator p300?",
    "vicuna-7b_response": "p300 is a transcriptional co-activator that plays a crucial role in regulating gene expression. It is a component of the transcriptional co-activator complexes, which are responsible for recruiting and activating transcription factors to specific DNA sequences. p300 is a ubiquitously expressed protein that is involved in the regulation of a wide range of biological processes, including cell growth, differentiation, and apoptosis.\np300 has been shown to play a role in the regulation of many different types of genes, including those involved in cell proliferation, angiogenesis, and inflammation. It has also been implicated in the development of certain types of cancer, and it has been shown to be overexpressed in a number of different tumor types.\nIn addition to its role in transcriptional co-activation, p300 has also been shown to have a number of other functions, including its ability to modify histones and other proteins, and its involvement in the regulation of the ubiquitin-proteasome pathway.\nOverall, p300 is a versatile protein that plays a critical role in regulating gene expression and has been implicated in a wide range of biological processes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. p300 is a transcriptional co-activator that regulates gene expression.\n2. p300 is a component of the transcriptional co-activator complexes, which recruit and activate transcription factors to specific DNA sequences.\n3. p300 is involved in the regulation of a wide range of biological processes, including cell growth, differentiation, and apoptosis.\n4. p300 has been implicated in the development of certain types of cancer and has been shown to be overexpressed in a number of different tumor types.\n5. p300 can modify histones and other proteins, and is involved in the regulation of the ubiquitin-proteasome pathway.",
    "vicuna-7b_fact": [
      "p300 is a transcriptional co-activator that regulates gene expression.",
      "p300 is a component of the transcriptional co-activator complexes, which recruit and activate transcription factors to specific DNA sequences.",
      "p300 is involved in the regulation of a wide range of biological processes, including cell growth, differentiation, and apoptosis.",
      "p300 has been implicated in the development of certain types of cancer and has been shown to be overexpressed in a number of different tumor types.",
      "p300 can modify histones and other proteins, and is involved in the regulation of the ubiquitin-proteasome pathway."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3158,
    "user_query": "What is a mitosome?",
    "vicuna-7b_response": "A mitosome is a subcellular structure found in some eukaryotic cells, particularly in red blood cells, that contains mitochondria and other organelles. It is thought to play a role in the energy metabolism of these cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A mitosome is a subcellular structure.\n2. Mitosomes are found in some eukaryotic cells.\n3. Red blood cells contain mitosomes.\n4. Mitosomes contain mitochondria and other organelles.\n5. Mitosomes are thought to play a role in the energy metabolism of cells.",
    "vicuna-7b_fact": [
      "A mitosome is a subcellular structure.",
      "Mitosomes are found in some eukaryotic cells.",
      "Red blood cells contain mitosomes.",
      "Mitosomes contain mitochondria and other organelles.",
      "Mitosomes are thought to play a role in the energy metabolism of cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Red blood cells do not contain mitosomes.\n4. FALSE [correction]: Mitosomes do not contain mitochondria and other organelles. They are a reduced form of mitochondria.\n5. FALSE [correction]: Mitosomes are not involved in energy metabolism, unlike mitochondria. They perform different functions, depending on the species and cell type.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3164,
    "user_query": "What is the effect of NFIA on astrocyte differentiation?",
    "vicuna-7b_response": "NFIA, or neurofilament light chain gene A, is a protein that plays a crucial role in the development and differentiation of astrocytes, which are a type of glial cell in the central nervous system.\nNFIA is a transcription factor, which means it regulates the expression of other genes by binding to specific DNA sequences. In the case of astrocyte differentiation, NFIA has been shown to play a role in the expression of genes involved in the maturation and development of these cells.\nStudies have shown that NFIA is expressed at high levels in immature astrocytes and is downregulated during the process of differentiation. This downregulation is thought to be important for the maturation of astrocytes, as it allows them to acquire their characteristic properties and functions.\nAdditionally, NFIA has been shown to play a role in the regulation of the extracellular matrix, which is the network of proteins and other molecules that surrounds and supports cells in the central nervous system. This regulation is thought to be important for the proper development and function of astrocytes and other glial cells.\nOverall, the effects of NFIA on astrocyte differentiation are complex and multifaceted, and further research is needed to fully understand its role in this process. However, it is clear that NFIA plays a critical role in the development and maturation of astrocytes, and its dysregulation has been implicated in a number of neurological disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NFIA, or neurofilament light chain gene A, is a protein that plays a role in the development and differentiation of astrocytes.\n2. Astrocytes are a type of glial cell in the central nervous system.\n3. NFIA acts as a transcription factor and regulates the expression of other genes by binding to specific DNA sequences.\n4. During the process of astrocyte differentiation, NFIA is expressed at high levels in immature astrocytes and is downregulated during differentiation.\n5. NFIA has been implicated in the regulation of the extracellular matrix, which supports cells in the central nervous system.",
    "vicuna-7b_fact": [
      "NFIA, or neurofilament light chain gene A, is a protein that plays a role in the development and differentiation of astrocytes.",
      "Astrocytes are a type of glial cell in the central nervous system.",
      "NFIA acts as a transcription factor and regulates the expression of other genes by binding to specific DNA sequences.",
      "During the process of astrocyte differentiation, NFIA is expressed at high levels in immature astrocytes and is downregulated during differentiation.",
      "NFIA has been implicated in the regulation of the extracellular matrix, which supports cells in the central nervous system."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: NFIA, or Nuclear factor I/A, is a protein that plays a role in the development and differentiation of astrocytes.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3165,
    "user_query": "What is the mode of action for Tocilizumab?",
    "vicuna-7b_response": "Tocilizumab is a monoclonal antibody that binds to and inhibits the activity of interleukin-6 (IL-6), a cytokine involved in the inflammatory response. It is used to treat a variety of autoimmune diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, and psoriatic arthritis. Tocilizumab works by reducing the production of IL-6, which helps to reduce inflammation and improve symptoms of the disease. It is administered as an injection under the skin or into a vein.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tocilizumab is a monoclonal antibody.\n2. Tocilizumab binds to and inhibits the activity of interleukin-6 (IL-6).\n3. IL-6 is a cytokine involved in the inflammatory response.\n4. Tocilizumab is used to treat a variety of autoimmune diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, and psoriatic arthritis.\n5. Tocilizumab reduces the production of IL-6, which helps to reduce inflammation and improve symptoms of the disease.",
    "vicuna-7b_fact": [
      "Tocilizumab is a monoclonal antibody.",
      "Tocilizumab binds to and inhibits the activity of interleukin-6 (IL-6).",
      "IL-6 is a cytokine involved in the inflammatory response.",
      "Tocilizumab is used to treat a variety of autoimmune diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, and psoriatic arthritis.",
      "Tocilizumab reduces the production of IL-6, which helps to reduce inflammation and improve symptoms of the disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Tocilizumab is used to treat a variety of autoimmune diseases, including rheumatoid arthritis and juvenile idiopathic arthritis but not ankylosing spondylitis and psoriatic arthritis.\n5. FALSE [correction]: Tocilizumab does not reduce the production of IL-6, but inhibits the activity of IL-6, which helps to reduce inflammation and improve symptoms of the disease.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3166,
    "user_query": "Where is the protein protamine 2 expressed?",
    "vicuna-7b_response": "Protamine 2 is a protein that is expressed in various tissues and organs in the human body. It is primarily found in the testes, where it plays a role in sperm maturation and fertilization. Protamine 2 is also found in the female reproductive system, particularly in the oviducts, where it helps to protect and transport sperm during fertilization. Additionally, Protamine 2 is expressed in the lungs, where it may play a role in the immune response to inhaled particles. It is also expressed in the liver, where it may help to regulate the levels of certain hormones in the body. Overall, Protamine 2 is a highly expressed protein in the reproductive and respiratory systems, and it may also have a role in immune regulation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Protamine 2 is a protein that is expressed in various tissues and organs in the human body.\n2. Protamine 2 is primarily found in the testes, where it plays a role in sperm maturation and fertilization.\n3. Protamine 2 is found in the female reproductive system, particularly in the oviducts, where it helps to protect and transport sperm during fertilization.\n4. Protamine 2 is expressed in the lungs, where it may play a role in the immune response to inhaled particles.\n5. Protamine 2 is also expressed in the liver, where it might help to regulate the levels of certain hormones.",
    "vicuna-7b_fact": [
      "Protamine 2 is a protein that is expressed in various tissues and organs in the human body.",
      "Protamine 2 is primarily found in the testes, where it plays a role in sperm maturation and fertilization.",
      "Protamine 2 is found in the female reproductive system, particularly in the oviducts, where it helps to protect and transport sperm during fertilization.",
      "Protamine 2 is expressed in the lungs, where it may play a role in the immune response to inhaled particles.",
      "Protamine 2 is also expressed in the liver, where it might help to regulate the levels of certain hormones."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Protamine 2 is not found in the female reproductive system; it is located in the sperm of the male reproductive system.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3173,
    "user_query": "Can prevnar 13 be used in children?",
    "vicuna-7b_response": "Prevnar 13 is a vaccine that is primarily used to prevent invasive pneumococcal disease (IPD) caused by the bacteria Streptococcus pneumoniae in adults aged 50 years or older. It is not approved for use in children under the age of 50.\nHowever, there are some limited circumstances where children may be considered for the use of Prevnar 13. For example, if a child has a severe immune system deficiency, such as sickle cell disease or a history of cancer treatment that damaged the immune system, they may be considered for the use of Prevnar 13. Additionally, some children who are at high risk of developing IPD due to other medical conditions, such as cerebral palsy or a cochlear implant, may also be considered for the use of Prevnar 13.\nIt is important to note that the decision to use Prevnar 13 in a child should be made on a case-by-case basis by a healthcare professional, taking into account the child's individual medical history and risk factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Prevnar 13 is a vaccine used to prevent invasive pneumococcal disease caused by the Streptococcus pneumoniae bacteria.\n2. Prevnar 13 is primarily approved for use in adults aged 50 years or older.\n3. Prevnar 13 is not approved for use in children under the age of 50.\n4. In some cases, children with severe immune system deficiencies or high-risk medical conditions may be considered for the use of Prevnar 13.\n5. The decision to use Prevnar 13 in a child should be made by a healthcare professional on a case-by-case basis.",
    "vicuna-7b_fact": [
      "Prevnar 13 is a vaccine used to prevent invasive pneumococcal disease caused by the Streptococcus pneumoniae bacteria.",
      "Prevnar 13 is primarily approved for use in adults aged 50 years or older.",
      "Prevnar 13 is not approved for use in children under the age of 50.",
      "In some cases, children with severe immune system deficiencies or high-risk medical conditions may be considered for the use of Prevnar 13.",
      "The decision to use Prevnar 13 in a child should be made by a healthcare professional on a case-by-case basis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Prevnar 13 is approved for use in adults aged 50 years or older, but it's also used regularly in children.\n3. FALSE [correction]: Prevnar 13 is approved for use in children, typically administered at 2, 4, 6, and 12-15 months of age.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3174,
    "user_query": "Was stelara developed by Amgen?",
    "vicuna-7b_response": "Yes, Stelara (ustekinumab) was developed by Amgen. Stelara is a biologic drug that is used to treat various autoimmune diseases, including psoriasis, psoriatic arthritis, and Crohn's disease. It works by targeting a specific protein called interleukin-12 and blocking its activity, which helps to reduce inflammation in the body. Stelara is given as an injection under the skin, and is typically administered every 12 weeks. It is considered a safe and effective treatment option for people with these conditions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Stelara (ustekinumab) was developed by Amgen.\n2. Stelara is a biologic drug that is used to treat autoimmune diseases, including psoriasis, psoriatic arthritis, and Crohn's disease.\n3. Stelara works by targeting a specific protein called interleukin-12 and blocking its activity.\n4. Stelara is given as an injection under the skin.\n5. Stelara is typically administered every 12 weeks.",
    "vicuna-7b_fact": [
      "Stelara (ustekinumab) was developed by Amgen.",
      "Stelara is a biologic drug that is used to treat autoimmune diseases, including psoriasis, psoriatic arthritis, and Crohn's disease.",
      "Stelara works by targeting a specific protein called interleukin-12 and blocking its activity.",
      "Stelara is given as an injection under the skin.",
      "Stelara is typically administered every 12 weeks."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Stelara (ustekinumab) was developed by Janssen Biotech, Inc., not Amgen.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3178,
    "user_query": "What is the cause of Krabbe disease?",
    "vicuna-7b_response": "Krabbe disease is a rare genetic disorder caused by a deficiency in the enzyme galactocerebrosidase. This enzyme is responsible for breaking down a specific type of fatty acid found in the brain and nervous system. Without enough of this enzyme, the fatty acids build up and cause damage to the nerve cells, leading to the symptoms of Krabbe disease.\nKrabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene (one from each parent) to develop the disease. The disease affects both males and females, and it can occur in any ethnic group.\nThe symptoms of Krabbe disease typically appear in the first few months of life. They may include:\n* Leaky gut syndrome\n* Seizures\n* Decreased muscle tone (hypotonia)\n* Lack of coordination (ataxia)\n* Lack of response to stimuli\n* Lack of muscle strength\n* Lack of consciousness\n* Lack of blinking\n* Lack of smiling\n* Lack of crawling\n* Lack of sitting\n* Lack of standing\n* Lack of walking\n* Lack of talking\n* Lack of understanding\n* Lack of responding\n* Lack of awareness\n* Lack of interest\n* Lack of pleasure\n* Lack of smiling\n* Lack of laughing\n* Lack of crying\n* Lack of feeding\n* Lack of growth\n* Lack of development\n* Lack of milestones\n* Lack of response to stimuli\n* Lack of response to pain\n* Lack of response to light\n* Lack of response to sound\n* Lack of response to touch\n* Lack of response to smell\n* Lack of response to taste\n* Lack of response to temperature\n* Lack of response to pressure\n* Lack of response to vibration\n* Lack of response to movement\n* Lack of response to speech\n* Lack of response to name\n* Lack of response to attention\n* Lack of response to affection\n* Lack of response to praise\n* Lack of response to toys\n* Lack of",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Krabbe disease is a rare genetic disorder caused by a deficiency in the enzyme galactocerebrosidase.\n2. The enzyme galactocerebrosidase is responsible for breaking down a specific type of fatty acid found in the brain and nervous system.\n3. Krabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene to develop the disease.\n4. The disease affects both males and females, and it can occur in any ethnic group.\n5. The symptoms of Krabbe disease typically appear in the first few months of life.",
    "vicuna-7b_fact": [
      "Krabbe disease is a rare genetic disorder caused by a deficiency in the enzyme galactocerebrosidase.",
      "The enzyme galactocerebrosidase is responsible for breaking down a specific type of fatty acid found in the brain and nervous system.",
      "Krabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene to develop the disease.",
      "The disease affects both males and females, and it can occur in any ethnic group.",
      "The symptoms of Krabbe disease typically appear in the first few months of life."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3182,
    "user_query": "What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",
    "vicuna-7b_response": "Noonan syndrome is an autosomal dominant disorder that affects multiple organ systems, including the skeletal, cardiac, and soft tissue development. The main features of Noonan syndrome include:\n1. Short stature: Children with Noonan syndrome are typically shorter than average.\n2. Low-set and malformed ears: The ears are often low-set and malformed, with folds of skin that may cover the outer part of the ear.\n3. Short neck: Children with Noonan syndrome often have a short neck.\n4. Rapid growth of the scalp hair: Hair growth on the scalp is rapid, and the hair may be thin and fine.\n5. Abnormal scapula: The shoulder blades (scapula) are often abnormally shaped.\n6. Abnormal chest wall: The chest wall may be abnormally shaped, with a sunken or indented appearance.\n7. Weak muscle tone: Children with Noonan syndrome often have low muscle tone (hypotonia), which can lead to delays in motor development.\n8. Short fourth finger: The fourth finger (ring finger) is often shorter than the other fingers.\n9. Abnormal breast development: Girls with Noonan syndrome may have abnormal breast development, with small breasts and underdeveloped nipples.\n10. Cleft palate: Children with Noonan syndrome may have a cleft palate, which is a gap in the roof of the mouth.\n11. Cardiac abnormalities: Children with Noonan syndrome may have abnormalities of the heart and great vessels, including a small size of the heart (hypoplastic left heart syndrome) and a narrowing of the main blood vessel that carries blood from the heart to the body (aortic stenosis).\n12. Bleeding problems: Children with Noonan syndrome may have bleeding problems, such as easy bruising and bleeding gums.\nIt's important to note that not all individuals with Noonan syndrome will have all of these features, and some may have additional features not listed here.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Noonan syndrome is an autosomal dominant disorder that affects multiple organ systems, including the skeletal, cardiac, and soft tissue development.\n2. Children with Noonan syndrome are typically shorter than average.\n3. The ears of individuals with Noonan syndrome are often low-set and malformed, with folds of skin that may cover the outer part of the ear.\n4. Hair growth on the scalp of individuals with Noonan syndrome is rapid, with the hair being thin and fine.\n5. Children with Noonan syndrome often have low muscle tone (hypotonia), which can lead to delays in motor development.",
    "vicuna-7b_fact": [
      "Noonan syndrome is an autosomal dominant disorder that affects multiple organ systems, including the skeletal, cardiac, and soft tissue development.",
      "Children with Noonan syndrome are typically shorter than average.",
      "The ears of individuals with Noonan syndrome are often low-set and malformed, with folds of skin that may cover the outer part of the ear.",
      "Hair growth on the scalp of individuals with Noonan syndrome is rapid, with the hair being thin and fine.",
      "Children with Noonan syndrome often have low muscle tone (hypotonia), which can lead to delays in motor development."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hair growth on the scalp of individuals with Noonan syndrome is often sparse and slow-growing, with the hair being curly or wooly in texture.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3186,
    "user_query": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "vicuna-7b_response": "Yes, there are several anti-amyloid antibody drugs that have been approved for the treatment of Alzheimer's disease. These drugs work by targeting and removing the amyloid beta protein, which is a key component of the plaques that form in the brains of people with Alzheimer's disease.\nOne example of an anti-amyloid antibody drug is called Bapineuzumab. Bapineuzumab was developed by Elan Corporation and Wyeth, and it was approved by the FDA in 2010 for the treatment of mild to moderate Alzheimer's disease. However, the drug was later withdrawn from the market after it was found to be ineffective and potentially harmful.\nAnother example of an anti-amyloid antibody drug is called Solanezumab. Solanezumab was developed by Eli Lilly and Company, and it was approved by the FDA in 2014 for the treatment of mild to moderate Alzheimer's disease. The drug works by binding to and removing amyloid beta protein from the brain.\nThere are also other anti-amyloid antibody drugs that are currently being developed and tested in clinical trials, including aducanumab, gantenerumab, and bimagrumab. These drugs have shown promise in reducing the amount of amyloid beta protein in the brains of people with Alzheimer's disease, and they are being studied as potential treatments for the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Anti-amyloid antibody drugs have been approved for the treatment of Alzheimer's disease.\n2. These drugs work by targeting and removing the amyloid beta protein.\n3. Bapineuzumab is an example of an anti-amyloid antibody drug for Alzheimer's disease, approved by the FDA in 2010 but later withdrawn from the market.\n4. Solanezumab is another example of an anti-amyloid antibody drug for Alzheimer's disease, approved by the FDA in 2014.\n5. Aducanumab, gantenerumab, and bimagrumab are anti-amyloid antibody drugs currently being tested in clinical trials for Alzheimer's disease.",
    "vicuna-7b_fact": [
      "Anti-amyloid antibody drugs have been approved for the treatment of Alzheimer's disease.",
      "These drugs work by targeting and removing the amyloid beta protein.",
      "Bapineuzumab is an example of an anti-amyloid antibody drug for Alzheimer's disease, approved by the FDA in 2010 but later withdrawn from the market.",
      "Solanezumab is another example of an anti-amyloid antibody drug for Alzheimer's disease, approved by the FDA in 2014.",
      "Aducanumab, gantenerumab, and bimagrumab are anti-amyloid antibody drugs currently being tested in clinical trials for Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Bapineuzumab is an example of an anti-amyloid antibody drug for Alzheimer's disease, but it was never approved by the FDA.\n4. FALSE [correction]: Solanezumab is another example of an anti-amyloid antibody drug for Alzheimer's disease, but it was never approved by the FDA.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3192,
    "user_query": "List places in the body where somatostatin is produced.",
    "vicuna-7b_response": "Somatostatin is a hormone that is produced by various cells in the body, including:\n1. Neurons in the hypothalamus and brainstem, which regulate the release of other hormones and neurotransmitters.\n2. Cells in the pancreas, which help regulate insulin secretion.\n3. Cells in the digestive system, particularly in the stomach and small intestine, which help regulate gastric acid secretion and food absorption.\n4. Cells in the lung, which help regulate the secretion of mucus.\n5. Cells in the thyroid gland, which help regulate the release of thyroid hormones.\nThese are some of the main places in the body where somatostatin is produced. It is also produced by other cells in the body, such as in the adrenal gland and in the ovaries and testes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Neurons in the hypothalamus and brainstem produce somatostatin.\n2. Cells in the pancreas produce somatostatin.\n3. Cells in the digestive system, particularly in the stomach and small intestine, produce somatostatin.\n4. Cells in the lung produce somatostatin.\n5. Cells in the thyroid gland produce somatostatin.",
    "vicuna-7b_fact": [
      "Neurons in the hypothalamus and brainstem produce somatostatin.",
      "Cells in the pancreas produce somatostatin.",
      "Cells in the digestive system, particularly in the stomach and small intestine, produce somatostatin.",
      "Cells in the lung produce somatostatin.",
      "Cells in the thyroid gland produce somatostatin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cells in the lung do not produce somatostatin.\n5. FALSE [correction]: Cells in the thyroid gland do not produce somatostatin.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3195,
    "user_query": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?",
    "vicuna-7b_response": "There are three types of immunoglobulin heavy chain containing antibodies found in human breast milk:\n1. IgA: This type of antibody is found in large quantities in mucous membranes and secretions, such as in the respiratory and gastrointestinal tracts. It helps to protect against infections in these areas.\n2. IgG: This is the most common type of antibody found in human breast milk, and it is responsible for providing passive immunity to the baby. It helps to protect against a wide range of infections, including bacterial and viral diseases.\n3. IgM: This type of antibody is produced early in the immune response and is involved in the initial response to a pathogen. It is less common in human breast milk, but it is still important for the baby's immune development.\nIt's important to note that human breast milk is not only a source of nutrition for the baby, but also provides a natural way to protect the baby from infections. The different types of antibodies found in human breast milk work together to provide a comprehensive immune response to a wide range of pathogens.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are three types of immunoglobulin heavy chain containing antibodies found in human breast milk: IgA, IgG, and IgM.\n2. IgA antibodies, found in large quantities in mucous membranes and secretions, help protect against infections in these areas.\n3. IgG is the most common type of antibody found in human breast milk, providing passive immunity against a range of infections, including bacterial and viral diseases.\n4. IgM antibodies are produced early in the immune response and are involved in the initial response to a pathogen.\n5. Human breast milk is a source of nutrition and also provides a natural means of protection against infections for babies.",
    "vicuna-7b_fact": [
      "There are three types of immunoglobulin heavy chain containing antibodies found in human breast milk: IgA, IgG, and IgM.",
      "IgA antibodies, found in large quantities in mucous membranes and secretions, help protect against infections in these areas.",
      "IgG is the most common type of antibody found in human breast milk, providing passive immunity against a range of infections, including bacterial and viral diseases.",
      "IgM antibodies are produced early in the immune response and are involved in the initial response to a pathogen.",
      "Human breast milk is a source of nutrition and also provides a natural means of protection against infections for babies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE \n3. FALSE [correction]: IgA, not IgG, is the most common type of antibody found in human breast milk, providing passive immunity against a range of infections, including bacterial and viral diseases.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3196,
    "user_query": "What is a exposome?",
    "vicuna-7b_response": "The exposome is a term used to describe the cumulative exposure to a wide range of environmental factors over the course of an individual's life. These factors can include chemicals, pollutants, radiation, and other substances that can potentially affect human health.\nThe exposome is a relatively new concept, but it has gained increasing attention in recent years due to the growing recognition of the importance of the environment in shaping human health outcomes. The exposome is different from other concepts that focus on individual exposures to specific substances, such as the \"toxome,\" which refers to the sum of all toxic substances and their effects on human health.\nThe exposome is a complex and multifaceted concept that encompasses a wide range of environmental factors and their effects on human health. It takes into account not only individual exposures to specific substances, but also the interactions between these exposures and other factors, such as genetics, lifestyle, and social factors.\nUnderstanding the exposome is important for identifying and addressing potential health risks associated with environmental factors. It can help to inform public health policies and interventions, and can also help to identify new areas for research and innovation in the field of environmental health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The exposome is a term used to describe the cumulative exposure to a range of environmental factors over the course of an individual's life.\n2. The concept of the exposome includes factors such as chemicals, pollutants, radiation, and other substances that can potentially affect human health.\n3. The exposome is different from the \"toxome,\" which refers to the sum of all toxic substances and their effects on human health.\n4. The exposome includes not only individual exposures to specific substances, but also the interactions between these exposures and other factors, such as genetics, lifestyle, and social factors.\n5. Understanding the exposome can inform public health policies and interventions, as well as identify new areas for research and innovation in the field of environmental health.",
    "vicuna-7b_fact": [
      "The exposome is a term used to describe the cumulative exposure to a range of environmental factors over the course of an individual's life.",
      "The concept of the exposome includes factors such as chemicals, pollutants, radiation, and other substances that can potentially affect human health.",
      "The exposome is different from the \"toxome,\" which refers to the sum of all toxic substances and their effects on human health.",
      "The exposome includes not only individual exposures to specific substances, but also the interactions between these exposures and other factors, such as genetics, lifestyle, and social factors.",
      "Understanding the exposome can inform public health policies and interventions, as well as identify new areas for research and innovation in the field of environmental health."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3202,
    "user_query": "Which gene therapy treatment is FDA approved for retinal dystrophy?",
    "vicuna-7b_response": "There are several gene therapy treatments that have been approved by the FDA for retinal dystrophy. One example is Spark Therapeutics' Luxturna, which was approved in 2018 for the treatment of a specific type of inherited retinal dystrophy called vision loss due to biallelic RPE65 mutation-associated retinal dystrophy. Luxturna uses a viral vector to deliver a healthy copy of the RPE65 gene to retinal cells, which can help to restore vision in patients with this condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are several gene therapy treatments that the FDA has approved for retinal dystrophy.\n2. Spark Therapeutics' Luxturna is an FDA-approved treatment for retinal dystrophy.\n3. Luxturna was approved by the FDA in 2018.\n4. Luxturna is used to treat retinal dystrophy associated with vision loss due to biallelic RPE65 mutation.\n5. Luxturna works by delivering a healthy copy of the RPE65 gene to retinal cells.",
    "vicuna-7b_fact": [
      "There are several gene therapy treatments that the FDA has approved for retinal dystrophy.",
      "Spark Therapeutics' Luxturna is an FDA-approved treatment for retinal dystrophy.",
      "Luxturna was approved by the FDA in 2018.",
      "Luxturna is used to treat retinal dystrophy associated with vision loss due to biallelic RPE65 mutation.",
      "Luxturna works by delivering a healthy copy of the RPE65 gene to retinal cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-7b_response": "RUNX2 is a transcription factor that plays a crucial role in the development and differentiation of many cell types, including astrocytes. While there is some evidence to suggest that RUNX2 may have a role in regulating astrocyte differentiation, the exact nature of this relationship is still not fully understood.\nStudies have shown that RUNX2 is expressed in astrocytes during development and in adult brains, and that it may be involved in the regulation of genes that are important for astrocyte function. For example, one study found that RUNX2 was required for the differentiation of astrocytes from neural stem cells in the mouse brain, and that it may play a role in the regulation of genes involved in the production of neurotransmitters and the maintenance of synaptic connections.\nHowever, other studies have suggested that RUNX2 may have a more complex role in astrocyte differentiation. For example, one study found that overexpression of RUNX2 in astrocytes in culture led to an increase in cell proliferation and a decrease in differentiation, suggesting that high levels of RUNX2 may inhibit astrocyte differentiation.\nOverall, while there is some evidence to suggest that RUNX2 may play a role in regulating astrocyte differentiation, the exact nature of this relationship is still not fully understood. Further research is needed to fully understand the role of RUNX2 in astrocyte development and differentiation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RUNX2 is a transcription factor that plays a role in the development and differentiation of many cell types, including astrocytes.\n2. RUNX2 is expressed in astrocytes during development and in adult brains.\n3. One study found that RUNX2 was required for the differentiation of astrocytes from neural stem cells in the mouse brain.\n4. Another study found that overexpression of RUNX2 in astrocytes led to an increase in cell proliferation and a decrease in differentiation.\n5. More research is needed to fully understand the role of RUNX2 in astrocyte development and differentiation.",
    "vicuna-7b_fact": [
      "RUNX2 is a transcription factor that plays a role in the development and differentiation of many cell types, including astrocytes.",
      "RUNX2 is expressed in astrocytes during development and in adult brains.",
      "One study found that RUNX2 was required for the differentiation of astrocytes from neural stem cells in the mouse brain.",
      "Another study found that overexpression of RUNX2 in astrocytes led to an increase in cell proliferation and a decrease in differentiation.",
      "More research is needed to fully understand the role of RUNX2 in astrocyte development and differentiation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3213,
    "user_query": "What is a lipin 1 protein doing?",
    "vicuna-7b_response": "Lipin 1 is a protein that plays a role in regulating lipid metabolism in the body. It is primarily expressed in the liver, but can also be found in other tissues such as adipose tissue and muscle. Lipin 1 is involved in the regulation of fatty acid uptake into cells, and has been shown to play a role in the development of insulin resistance and type 2 diabetes. Additionally, Lipin 1 has been implicated in the regulation of lipid storage in adipose tissue, and has been shown to play a role in the development of obesity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Lipin 1 is a protein that plays a role in regulating lipid metabolism in the body.\n2. Lipin 1 is primarily expressed in the liver.\n3. Lipin 1 is also found in other tissues such as adipose tissue and muscle.\n4. Lipin 1 is involved in the regulation of fatty acid uptake into cells.\n5. Lipin 1 has been shown to play roles in the development of insulin resistance, type 2 diabetes, and obesity.",
    "vicuna-7b_fact": [
      "Lipin 1 is a protein that plays a role in regulating lipid metabolism in the body.",
      "Lipin 1 is primarily expressed in the liver.",
      "Lipin 1 is also found in other tissues such as adipose tissue and muscle.",
      "Lipin 1 is involved in the regulation of fatty acid uptake into cells.",
      "Lipin 1 has been shown to play roles in the development of insulin resistance, type 2 diabetes, and obesity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3215,
    "user_query": "What protein is recruited by Crumbs to regulate tracheal development?",
    "vicuna-7b_response": "Crumbs is a protein that plays a crucial role in regulating tracheal development in Drosophila. Crumbs is a component of the tracheal system and is involved in the regulation of tracheal branching.\nRecent studies have shown that Crumbs interacts with the protein Zeste, which is a component of the tracheal system. Zeste is a transcriptional repressor that is involved in the regulation of tracheal development. The interaction between Crumbs and Zeste is important for the proper development of the tracheal system in Drosophila.\nIn summary, Crumbs is recruited by Zeste to regulate tracheal development in Drosophila.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Crumbs is a protein that plays a role in regulating tracheal development in Drosophila.\n2. Crumbs is a component of the tracheal system.\n3. Crumbs interacts with the protein Zeste.\n4. Zeste is a transcriptional repressor that is involved in the regulation of tracheal development.\n5. The interaction between Crumbs and Zeste is crucial for the proper development of the tracheal system in Drosophila.",
    "vicuna-7b_fact": [
      "Crumbs is a protein that plays a role in regulating tracheal development in Drosophila.",
      "Crumbs is a component of the tracheal system.",
      "Crumbs interacts with the protein Zeste.",
      "Zeste is a transcriptional repressor that is involved in the regulation of tracheal development.",
      "The interaction between Crumbs and Zeste is crucial for the proper development of the tracheal system in Drosophila."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3223,
    "user_query": "Name three binding partners of cofilin 2.",
    "vicuna-7b_response": "Cofilin 2 is a protein that plays a role in the regulation of actin cytoskeleton dynamics. It is a member of the cofilin family of proteins, which are actin-binding proteins that regulate actin filament dynamics by promoting their depolymerization and severing.\nCofilin 2 binds to both G-actin and F-actin, and it has been shown to regulate a variety of cellular processes, including cell motility, adhesion, and cytokinesis. Some of the binding partners of cofilin 2 include:\n1. Actin: Cofilin 2 binds to actin monomers and filaments with high affinity, promoting their depolymerization and severing.\n2. ADF/cofilin-like proteins: Cofilin 2 binds to ADF/cofilin-like proteins, which are related proteins that also regulate actin dynamics.\n3. Calmodulin: Cofilin 2 binds to calmodulin, a calcium-binding protein that regulates a variety of cellular processes, including actin cytoskeleton dynamics.\nOverall, cofilin 2 plays a critical role in regulating actin cytoskeleton dynamics and is involved in a variety of cellular processes. Its binding partners help to regulate its activity and contribute to its function in the cell.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cofilin 2 is a protein that plays a role in the regulation of actin cytoskeleton dynamics.\n2. Cofilin 2 binds to both G-actin and F-actin.\n3. One binding partner of cofilin 2 is actin.\n4. Another binding partner of cofilin 2 is ADF/cofilin-like proteins.\n5. Cofilin 2 also binds to calmodulin, a calcium-binding protein.",
    "vicuna-7b_fact": [
      "Cofilin 2 is a protein that plays a role in the regulation of actin cytoskeleton dynamics.",
      "Cofilin 2 binds to both G-actin and F-actin.",
      "One binding partner of cofilin 2 is actin.",
      "Another binding partner of cofilin 2 is ADF/cofilin-like proteins.",
      "Cofilin 2 also binds to calmodulin, a calcium-binding protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ADF/cofilin-like proteins do not bind with cofilin 2, they are a family of proteins which cofilin 2 belongs to.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3225,
    "user_query": "What is a SMR based BCI?",
    "vicuna-7b_response": "A SMR-based BCI (or Sensorimotor Rhythm-based BCI) is a type of brain-computer interface (BCI) that uses the Sensorimotor Rhythm (SMR) signal to detect and interpret brain signals.\nThe SMR signal is a type of brainwave that is associated with the voluntary movement of the body. It is typically measured over the left motor cortex, which is responsible for controlling the movement of the left side of the body. The SMR signal is typically characterized by a rhythmic pattern of brain activity that is synchronized with the user's movements.\nIn a SMR-based BCI, the user wears an electroencephalography (EEG) cap that measures the electrical activity of the brain. The EEG signal is then processed to extract the SMR signal, which is used to detect the user's intentions and movements.\nSMR-based BCIs have several advantages over other types of BCIs. For example, they are less prone to interference from other sources of electrical activity in the brain, such as muscle activity or eye movements. They also require less training and can be used by people with motor disabilities who may not be able to move their bodies.\nOverall, a SMR-based BCI is a promising technology that has the potential to improve the quality of life for people with disabilities and enhance communication between humans and machines.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A SMR-based BCI is a type of brain-computer interface that uses Sensorimotor Rhythm signal.\n2. A Sensorimotor Rhythm (SMR) signal, associated with voluntary body movement, is typically measured over the left motor cortex.\n3. In a SMR-based BCI, an electroencephalography (EEG) cap is used to measure the electrical activity of the brain.\n4. SMR-based BCIs are less prone to interference from other sources of electrical activity in the brain.\n5. SMR-based BCIs require less training and can be used by people with motor disabilities who may not be able to move their bodies.",
    "vicuna-7b_fact": [
      "A SMR-based BCI is a type of brain-computer interface that uses Sensorimotor Rhythm signal.",
      "A Sensorimotor Rhythm (SMR) signal, associated with voluntary body movement, is typically measured over the left motor cortex.",
      "In a SMR-based BCI, an electroencephalography (EEG) cap is used to measure the electrical activity of the brain.",
      "SMR-based BCIs are less prone to interference from other sources of electrical activity in the brain.",
      "SMR-based BCIs require less training and can be used by people with motor disabilities who may not be able to move their bodies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3226,
    "user_query": "Is myc a tumour suppressor gene?",
    "vicuna-7b_response": "Yes, MYC is a tumor suppressor gene. MYC is a transcription factor that plays a crucial role in the regulation of cell growth and differentiation. It is a member of the MYC oncogene family and is often overexpressed in various types of cancer, including lymphoma, leukemia, and breast cancer.\nThe overexpression of MYC can lead to uncontrolled cell growth and division, which can result in the formation of tumors. However, the normal function of MYC is to regulate the expression of genes involved in cell growth and differentiation, and its overexpression can lead to the suppression of these functions, resulting in the development of cancer.\nIn summary, MYC is a tumor suppressor gene that plays a crucial role in the regulation of cell growth and differentiation, but its overexpression can lead to the development of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MYC is a transcription factor that plays a role in the regulation of cell growth and differentiation.\n2. MYC is a member of the MYC oncogene family.\n3. MYC is often overexpressed in various types of cancer, including lymphoma, leukemia, and breast cancer.\n4. The overexpression of MYC can lead to uncontrolled cell growth and division, and potentially the formation of tumors.\n5. MYC regulates the expression of genes involved in cell growth and differentiation.",
    "vicuna-7b_fact": [
      "MYC is a transcription factor that plays a role in the regulation of cell growth and differentiation.",
      "MYC is a member of the MYC oncogene family.",
      "MYC is often overexpressed in various types of cancer, including lymphoma, leukemia, and breast cancer.",
      "The overexpression of MYC can lead to uncontrolled cell growth and division, and potentially the formation of tumors.",
      "MYC regulates the expression of genes involved in cell growth and differentiation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3227,
    "user_query": "Which syndrome is associated to SAMHD1 gene mutations?",
    "vicuna-7b_response": "SAMHD1 gene mutations are associated with the syndrome known as \"chronic progressive myelopathy\" or \"HIV-associated myelopathy\". This syndrome is characterized by progressive weakness and loss of sensation in the legs, as well as difficulty with balance and coordination. It is often seen in individuals with HIV infection, although it can also occur in individuals without HIV infection. The exact mechanism by which SAMHD1 mutations lead to chronic progressive myelopathy is not fully understood, but it is thought to involve dysregulation of the immune system and the nervous system.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAMHD1 gene mutations are associated with a syndrome known as \"chronic progressive myelopathy\" or \"HIV-associated myelopathy\".\n2. This syndrome is characterized by progressive weakness and loss of sensation in the legs, as well as difficulty with balance and coordination. \n3. It can be seen in individuals with HIV infection.\n4. The syndrome can also occur in individuals without HIV infection.\n5. It is thought the mutations lead to chronic progressive myelopathy through dysregulation of the immune system and the nervous system.",
    "vicuna-7b_fact": [
      "SAMHD1 gene mutations are associated with a syndrome known as \"chronic progressive myelopathy\" or \"HIV-associated myelopathy\".",
      "This syndrome is characterized by progressive weakness and loss of sensation in the legs, as well as difficulty with balance and coordination.",
      "It can be seen in individuals with HIV infection.",
      "The syndrome can also occur in individuals without HIV infection.",
      "It is thought the mutations lead to chronic progressive myelopathy through dysregulation of the immune system and the nervous system."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SAMHD1 gene mutations are associated with a syndrome known as \"Aicardi-Goutières syndrome\".\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3228,
    "user_query": "List proteins with RING domain.",
    "vicuna-7b_response": "RING (Really Interesting New Gene) domain is a protein domain that is found in a wide variety of proteins, including enzymes, transcription factors, and signaling proteins. RING domain proteins are characterized by a conserved sequence motif that includes a zinc-binding site and a catalytic histidine residue.\nHere is a list of some proteins that contain a RING domain:\n1. Ubiquitin\n2. Parkin\n3. Atg14\n4. Rpn4\n5. Rpn13\n6. Rpn16\n7. Rpn22\n8. Rpn23\n9. Rpn24\n10. Rpn25\n11. Rpn26\n12. Rpn27\n13. Rpn28\n14. Rpn29\n15. Rpn30\n16. Rpn31\n17. Rpn32\n18. Rpn33\n19. Rpn34\n20. Rpn35\n21. Rpn36\n22. Rpn37\n23. Rpn38\n24. Rpn39\n25. Rpn40\n26. Rpn41\n27. Rpn42\n28. Rpn43\n29. Rpn44\n30. Rpn45\n31. Rpn46\n32. Rpn47\n33. Rpn48\n34. Rpn49\n35. Rpn50\n36. Rpn51\n37. Rpn52\n38. Rpn53\n39. Rpn54\n40. Rpn55\n41. Rpn56\n42. Rpn57\n43. Rpn58\n44. Rpn59\n45. Rpn60\n46. Rpn61\n47. Rpn62\n48. Rpn63\n49. Rpn64\n50. Rpn65\n51. Rpn66\n52. Rpn67\n53. Rpn68\n54. Rpn6",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RING (Really Interesting New Gene) domain is a protein domain found in a variety of proteins.\n2. The RING domain proteins include enzymes, transcription factors, and signaling proteins.\n3. RING domain proteins have a conserved sequence motif that includes a zinc-binding site and a catalytic histidine residue.\n4. Ubiquitin is a protein that contains a RING domain.\n5. Parkin is a protein that contains a RING domain.",
    "vicuna-7b_fact": [
      "RING (Really Interesting New Gene) domain is a protein domain found in a variety of proteins.",
      "The RING domain proteins include enzymes, transcription factors, and signaling proteins.",
      "RING domain proteins have a conserved sequence motif that includes a zinc-binding site and a catalytic histidine residue.",
      "Ubiquitin is a protein that contains a RING domain.",
      "Parkin is a protein that contains a RING domain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ubiquitin is a protein that gets attached to other proteins via the action of a RING domain protein, but it does not itself contain a RING domain.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3230,
    "user_query": "What is the results of mutations in the gene autoimmune regulator?",
    "vicuna-7b_response": "Mutations in the gene autoimmune regulator (AIRE) can lead to autoimmune diseases. AIRE is a gene that encodes a protein with a critical role in the regulation of immune tolerance. The protein produced by this gene is expressed in the thymus, a gland responsible for the development and maturation of T cells, a type of immune cell.\nMutations in the AIRE gene can lead to a reduction in the expression of the protein, which can result in a decrease in the number of T cells that are able to recognize self-antigens. This can lead to a breakdown in immune tolerance and an overactive immune response, which can result in the development of autoimmune diseases.\nSome examples of autoimmune diseases that have been linked to mutations in the AIRE gene include autoimmune thyroid disease, type 1 diabetes, and autoimmune Addison's disease.\nIt's important to note that the relationship between AIRE mutations and autoimmune diseases is complex and not fully understood. Other genetic and environmental factors also play a role in the development of autoimmune diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autoimmune regulator (AIRE) is a gene that encodes a protein with a critical role in the regulation of immune tolerance.\n2. The protein produced by the AIRE gene is expressed in the thymus. \n3. The thymus is a gland responsible for the development and maturation of T cells, a type of immune cell.\n4. Mutations in the AIRE gene can lead to a reduction in the expression of the protein.\n5. A breakdown in immune tolerance and an overactive immune response can result in the development of autoimmune diseases. Some examples of these diseases include autoimmune thyroid disease, type 1 diabetes, and autoimmune Addison's disease.",
    "vicuna-7b_fact": [
      "Autoimmune regulator (AIRE) is a gene that encodes a protein with a critical role in the regulation of immune tolerance.",
      "The protein produced by the AIRE gene is expressed in the thymus.",
      "The thymus is a gland responsible for the development and maturation of T cells, a type of immune cell.",
      "Mutations in the AIRE gene can lead to a reduction in the expression of the protein.",
      "A breakdown in immune tolerance and an overactive immune response can result in the development of autoimmune diseases. Some examples of these diseases include autoimmune thyroid disease, type 1 diabetes, and autoimmune Addison's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3232,
    "user_query": "Is subdural empyema a complication of sinusitis?",
    "vicuna-7b_response": "Subdural empyema is a rare and serious complication of sinusitis that can occur when pus accumulates between the layers of the dura mater, which is the protective covering of the brain and spinal cord. It is typically caused by a bacterial infection that spreads from the sinuses to the brain.\nSinusitis is an inflammation of the sinuses, which are small air-filled cavities in the skull that produce mucus to keep the nasal passages moist. When the sinuses become inflamed, they can become blocked and allow bacteria to grow and spread. This can lead to a variety of complications, including subdural empyema.\nThe symptoms of subdural empyema can be severe and may include headache, neck stiffness, nausea, vomiting, fever, and altered mental status. The condition is typically diagnosed through a combination of physical examination, imaging tests such as CT scans, and laboratory tests.\nTreatment for subdural empyema typically involves surgery to drain the pus and repair any damage to the dura mater. Antibiotics may also be used to treat the underlying infection. In some cases, the infection may be so severe that it requires hospitalization and intensive care.\nIt is important to seek medical attention promptly if you experience any symptoms of subdural empyema, as the condition can be life-threatening if left untreated.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Subdural empyema is a rare and serious complication of sinusitis.\n2. Subdural empyema occurs when pus accumulates between the layers of the dura mater.\n3. Sinusitis is an inflammation of the sinuses.\n4. The symptoms of subdural empyema can include headache, neck stiffness, nausea, vomiting, fever, and altered mental status.\n5. Treatment for subdural empyema typically involves surgery and antibiotics.",
    "vicuna-7b_fact": [
      "Subdural empyema is a rare and serious complication of sinusitis.",
      "Subdural empyema occurs when pus accumulates between the layers of the dura mater.",
      "Sinusitis is an inflammation of the sinuses.",
      "The symptoms of subdural empyema can include headache, neck stiffness, nausea, vomiting, fever, and altered mental status.",
      "Treatment for subdural empyema typically involves surgery and antibiotics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3237,
    "user_query": "Is the crystal structure of Pim-1 available?",
    "vicuna-7b_response": "Yes, the crystal structure of Pim-1 is available. Pim-1 is a serine/threonine kinase that plays a role in cell proliferation and differentiation. The crystal structure of Pim-1 has been determined and is available in the Protein Data Bank (PDB) under the accession code 1P8R.\nThe Pim-1 crystal structure was determined using X-ray crystallography and consists of two identical subunits, each containing a kinase domain and a regulatory domain. The kinase domain of Pim-1 is composed of a catalytic core, a regulatory loop, and a hinge region. The regulatory domain of Pim-1 contains a DNA-binding motif and a coiled-coil region that interacts with the kinase domain.\nThe overall structure of Pim-1 is highly conserved among different species, with the exception of a few residues in the regulatory domain that are involved in DNA binding. The structure of Pim-1 provides insights into the mechanism of kinase activation and substrate recognition, and has been used to design inhibitors that target the kinase activity of Pim-1.\nOverall, the crystal structure of Pim-1 is an important resource for understanding the function and regulation of this kinase, and for the development of new therapeutics for the treatment of diseases associated with abnormal Pim-1 activity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The crystal structure of Pim-1 is available.\n2. Pim-1 is a serine/threonine kinase that plays a role in cell proliferation and differentiation.\n3. The crystal structure of Pim-1 is available in the Protein Data Bank (PDB) under the accession code 1P8R.\n4. The Pim-1 crystal structure consists of two identical subunits, each containing a kinase domain and a regulatory domain.\n5. The structure of Pim-1 provides insights into the mechanism of kinase activation and substrate recognition.",
    "vicuna-7b_fact": [
      "The crystal structure of Pim-1 is available.",
      "Pim-1 is a serine/threonine kinase that plays a role in cell proliferation and differentiation.",
      "The crystal structure of Pim-1 is available in the Protein Data Bank (PDB) under the accession code 1P8R.",
      "The Pim-1 crystal structure consists of two identical subunits, each containing a kinase domain and a regulatory domain.",
      "The structure of Pim-1 provides insights into the mechanism of kinase activation and substrate recognition."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3238,
    "user_query": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "vicuna-7b_response": "Yes, tumor-associated macrophages (TAMs) have a prognostic role in gliomas. TAMs are a type of immune cell that can be found in high numbers in many types of cancer, including gliomas. TAMs can promote tumor growth and progression by producing growth factors and inhibiting the immune response.\nStudies have shown that the number and activation state of TAMs in gliomas are associated with patient outcomes. Higher numbers of TAMs are associated with worse prognosis, while TAMs that are activated and producing pro-tumor cytokines are associated with worse outcomes.\nTherefore, the presence and activation state of TAMs in gliomas can be used as a prognostic indicator for patient outcomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tumor-associated macrophages (TAMs) have a prognostic role in gliomas.\n2. TAMs are a type of immune cell found in high numbers in many types of cancer, including gliomas.\n3. TAMs can promote tumor growth and progression by producing growth factors and inhibiting the immune response.\n4. The number and activation state of TAMs in gliomas are associated with patient outcomes.\n5. Higher numbers of activated TAMs producing pro-tumor cytokines are associated with worse patient outcomes.",
    "vicuna-7b_fact": [
      "Tumor-associated macrophages (TAMs) have a prognostic role in gliomas.",
      "TAMs are a type of immune cell found in high numbers in many types of cancer, including gliomas.",
      "TAMs can promote tumor growth and progression by producing growth factors and inhibiting the immune response.",
      "The number and activation state of TAMs in gliomas are associated with patient outcomes.",
      "Higher numbers of activated TAMs producing pro-tumor cytokines are associated with worse patient outcomes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-7b_response": "Yes, GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\nEMT is a crucial process in embryonic development, tissue repair, and cancer progression. It involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype, characterized by the expression of mesenchymal markers and the ability to migrate and proliferate in a three-dimensional environment.\nGRHL2 is a transcription factor that plays a crucial role in regulating the expression of genes involved in cell-cell adhesion, cell polarity, and the epithelial-to-mesenchymal transition (EMT). Over-expression of GRHL2 has been shown to disrupt cell-cell adhesion and promote EMT in various cell types, including epithelial cells.\nIn addition, GRHL2 has been shown to regulate the expression of genes involved in the mesenchymal phenotype, such as N-cadherin and vimentin, and to promote the migration and invasion of cancer cells.\nTherefore, it is likely that over-expression of GRHL2 would lead to EMT in epithelial cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\n2. EMT involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype, characterized by the expression of mesenchymal markers.\n3. GRHL2 is a transcription factor that plays a crucial role in regulating the expression of genes involved in cell-cell adhesion, cell polarity, and the EMT.\n4. Over-expression of GRHL2 has been shown to disrupt cell-cell adhesion and promote EMT in various cell types.\n5. GRHL2 has been shown to regulate the expression of genes involved in the mesenchymal phenotype, such as N-cadherin and vimentin.",
    "vicuna-7b_fact": [
      "GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).",
      "EMT involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype, characterized by the expression of mesenchymal markers.",
      "GRHL2 is a transcription factor that plays a crucial role in regulating the expression of genes involved in cell-cell adhesion, cell polarity, and the EMT.",
      "Over-expression of GRHL2 has been shown to disrupt cell-cell adhesion and promote EMT in various cell types.",
      "GRHL2 has been shown to regulate the expression of genes involved in the mesenchymal phenotype, such as N-cadherin and vimentin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Over-expression of GRHL2 has been shown to inhibit cell-cell adhesion disruption and suppress EMT in various cell types.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3245,
    "user_query": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "vicuna-7b_response": "Yes, the Fluzone intradermal and Fluzone intradermal quadrivalent vaccines are produced by different companies.\nFluzone intradermal is produced by Sanofi Pasteur, while Fluzone intradermal quadrivalent is produced by Seqirus.\nFluzone intradermal is an intradermal influenza vaccine that is administered into the skin, while Fluzone intradermal quadrivalent is an intradermal quadrivalent influenza vaccine that protects against four strains of influenza virus.\nBoth vaccines are approved by the FDA for use in the United States, and they are indicated for individuals aged 18 years and older.\nIt is important to note that while both vaccines are produced by different companies, they are both approved for use in the United States and are effective in preventing influenza.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Fluzone intradermal is produced by Sanofi Pasteur.\n2. The Fluzone intradermal quadrivalent is produced by Seqirus.\n3. Fluzone intradermal is an influenza vaccine that is administered into the skin.\n4. Fluzone intradermal quadrivalent is an influenza vaccine that protects against four strains of the virus.\n5. Both vaccines are approved by the FDA for use in the United States for individuals aged 18 years and older.",
    "vicuna-7b_fact": [
      "The Fluzone intradermal is produced by Sanofi Pasteur.",
      "The Fluzone intradermal quadrivalent is produced by Seqirus.",
      "Fluzone intradermal is an influenza vaccine that is administered into the skin.",
      "Fluzone intradermal quadrivalent is an influenza vaccine that protects against four strains of the virus.",
      "Both vaccines are approved by the FDA for use in the United States for individuals aged 18 years and older."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Fluzone intradermal quadrivalent is produced by Sanofi Pasteur.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3251,
    "user_query": "List features of the Currarino triad.",
    "vicuna-7b_response": "The Currarino triad is a rare congenital disorder characterized by the triad of congenital absence of the thumb, hypoplastic or absent great toes, and a high-arched or cleft foot. Here are some of the key features of the Currarino triad:\n1. Congenital absence of the thumb: This means that the thumb is not present at birth, which is a defining feature of the Currarino triad.\n2. Hypoplastic or absent great toes: The great toes are underdeveloped or missing, which can be a significant concern for foot function and mobility.\n3. High-arched or cleft foot: The foot is often arched or cleft, which can affect the way it looks and function.\n4. Rare congenital disorder: The Currarino triad is a very rare condition, affecting only a small number of people worldwide.\n5. Genetic basis: The Currarino triad is thought to have a genetic basis, with some studies suggesting that it may be caused by mutations in the TWIST1 gene.\n6. Other features: In addition to the triad of congenital absence of the thumb, hypoplastic or absent great toes, and high-arched or cleft foot, people with the Currarino triad may also experience other physical and developmental challenges.\nIt's important to note that the Currarino triad is a complex condition, and the specific features and symptoms can vary from person to person. If you have concerns about your own or your child's foot health, it's important to consult with a healthcare professional who can provide a proper diagnosis and recommend appropriate treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Currarino triad is a rare congenital disorder.\n2. This condition is characterized by the congenital absence of the thumb.\n3. The condition features hypoplastic or absent great toes.\n4. Individuals with the Currarino triad can have a high-arched or cleft foot.\n5. The Currarino triad is thought to have a genetic basis, possibly caused by mutations in the TWIST1 gene.",
    "vicuna-7b_fact": [
      "The Currarino triad is a rare congenital disorder.",
      "This condition is characterized by the congenital absence of the thumb.",
      "The condition features hypoplastic or absent great toes.",
      "Individuals with the Currarino triad can have a high-arched or cleft foot.",
      "The Currarino triad is thought to have a genetic basis, possibly caused by mutations in the TWIST1 gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Currarino triad is not characterized by the congenital absence of the thumb. It consists of a presacral mass, sacral anomaly, and anorectal malformation.\n3. FALSE [correction]: The Currarino triad does not feature hypoplastic or absent great toes. It consists of a presacral mass, sacral anomaly, and anorectal malformation.\n4. FALSE [correction]: There are no common reports of individuals with the Currarino triad having a high-arched or cleft foot.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3253,
    "user_query": "What are invasomes",
    "vicuna-7b_response": "Invasomes are a type of extracellular matrix (ECM) structure that is composed of a network of invasive growth factors and their receptors. They are found in various tissues, including the brain, and play a role in the regulation of cellular processes such as proliferation, differentiation, and migration.\nInvasomes are formed by the interaction of invasive growth factors, such as fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF), with their receptors. These interactions lead to the formation of a complex network of proteins that can influence the behavior of nearby cells.\nResearch has shown that invasomes can play a role in the development and progression of various diseases, including cancer. For example, invasomes have been found to promote the proliferation and migration of cancer cells, which can contribute to the formation of tumors.\nOverall, invasomes are an important aspect of cellular communication and play a critical role in the regulation of cellular processes in various tissues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Invasomes are a type of extracellular matrix structure composed of a network of invasive growth factors and their receptors.\n2. Invasomes can be found in various tissues including the brain. \n3. Invasomes are formed by the interaction of invasive growth factors, such as fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF), with their receptors.\n4. Invasomes can play a role in the development and progression of various diseases, such as cancer.\n5. Invasomes can promote the proliferation and migration of cancer cells, contributing to the formation of tumors.",
    "vicuna-7b_fact": [
      "Invasomes are a type of extracellular matrix structure composed of a network of invasive growth factors and their receptors.",
      "Invasomes can be found in various tissues including the brain.",
      "Invasomes are formed by the interaction of invasive growth factors, such as fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF), with their receptors.",
      "Invasomes can play a role in the development and progression of various diseases, such as cancer.",
      "Invasomes can promote the proliferation and migration of cancer cells, contributing to the formation of tumors."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Antigens, are proteins or carbohydrates that are expressed on the surface of cancer cells and can be recognized by the immune system. Some T-UCRs that have been implicated in lung cancer include:\n* TAG-72: A protein that is expressed in many types of cancer, including lung cancer.\n* MUC1: A mucin protein that is expressed in many epithelial tissues, including the lungs, and has been found to be overexpressed in some lung cancer cells.\n* CEA: A carcinoembryonic antigen that is expressed in many types of cancer, including lung cancer.\n* RNASEL: An RNA-editing enzyme that has been found to be overexpressed in some lung cancer cells and may play a role in the development of the disease.\nIt's important to note that these are just a few examples of T-UCRs that have been implicated in lung cancer, and there are many other T-UCRs that have been studied in this context. Additionally, the role of T-UCRs in lung cancer is an active area of research, and new T-UCRs may be identified in the future.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. T-UCRs are proteins or carbohydrates that are expressed on the surface of cancer cells.\n2. T-UCRs can be recognized by the immune system.\n3. Some T-UCRs that have been implicated in lung cancer include TAG-72, MUC1, CEA, and RNASEL.\n4. TAG-72, CEA and RNASEL are proteins that are expressed in many types of cancer, including lung cancer.\n5. MUC1 is a mucin protein that is expressed in many epithelial tissues, including the lungs, and has been found to be overexpressed in some lung cancer cells.",
    "vicuna-7b_fact": [
      "T-UCRs are proteins or carbohydrates that are expressed on the surface of cancer cells.",
      "T-UCRs can be recognized by the immune system.",
      "Some T-UCRs that have been implicated in lung cancer include TAG-72, MUC1, CEA, and RNASEL.",
      "TAG-72, CEA and RNASEL are proteins that are expressed in many types of cancer, including lung cancer.",
      "MUC1 is a mucin protein that is expressed in many epithelial tissues, including the lungs, and has been found to be overexpressed in some lung cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: T-UCRs (transcribed ultraconserved regions) are non-coding RNA molecules, not proteins or carbohydrates, that may be involved in the development of cancer.\n2. UNKNOWN\n3. FALSE [correction]: TAG-72, MUC1, CEA are proteins and not T-UCRs. RNASEL is a protein implicated in cancer but not a T-UCR.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3255,
    "user_query": "Can Daptacel be used instead of IPOL?",
    "vicuna-7b_response": "Daptacel and IPOL are both medications used to treat various medical conditions, but they have different mechanisms of action and uses.\nDaptacel is a vaccine used to prevent tetanus, diphtheria, and pertussis (whooping cough) in adults and children. It is given as an injection into the muscle.\nIPOL, on the other hand, is a medication used to treat various medical conditions, including high blood pressure, heart failure, and certain types of infections. It is given as an injection into a muscle or under the skin, or taken by mouth in the form of a tablet or capsule.\nTherefore, Daptacel and IPOL are not interchangeable and cannot be used as a substitute for each other. It is important to use the medication that has been prescribed by a healthcare professional for the specific condition being treated.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Daptacel is a vaccine used to prevent tetanus, diphtheria, and pertussis in adults and children.\n2. Daptacel is given as an injection into the muscle.\n3. IPOL is a medication used to treat conditions including high blood pressure, heart failure, and certain types of infections.\n4. IPOL can be given as an injection into a muscle or under the skin, or taken by mouth in the form of a tablet or capsule.\n5. Daptacel and IPOL are not interchangeable and cannot be used as substitutes for each other.",
    "vicuna-7b_fact": [
      "Daptacel is a vaccine used to prevent tetanus, diphtheria, and pertussis in adults and children.",
      "Daptacel is given as an injection into the muscle.",
      "IPOL is a medication used to treat conditions including high blood pressure, heart failure, and certain types of infections.",
      "IPOL can be given as an injection into a muscle or under the skin, or taken by mouth in the form of a tablet or capsule.",
      "Daptacel and IPOL are not interchangeable and cannot be used as substitutes for each other."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Daptacel is a vaccine used to prevent tetanus, diphtheria, and pertussis in children.\n2. TRUE\n3. FALSE [correction]: IPOL is a vaccine used to prevent poliovirus infection.\n4. FALSE [correction]: IPOL is administrated as an injection into a muscle or under the skin, it is not taken by mouth in the form of a tablet or capsule.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3256,
    "user_query": "Is ACE2 expressed on cell surfaces?",
    "vicuna-7b_response": "Yes, ACE2 (Angiotensin Converting Enzyme 2) is expressed on the surface of cells. ACE2 is a receptor for the SARS-CoV-2 virus, which causes COVID-19. The virus uses ACE2 to enter host cells and replicate.\nACE2 is primarily expressed on the surface of epithelial cells, such as those found in the lungs, but it can also be found on other types of cells, including endothelial cells, fibroblasts, and immune cells.\nIt is important to note that ACE2 is not the only receptor that SARS-CoV-2 uses to infect cells. The virus can also use other receptors, such as the ACE (Angiotensin Converting Enzyme) receptor, to enter host cells. However, ACE2 is the primary receptor for SARS-CoV-2 and is essential for the virus to cause disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ACE2 (Angiotensin Converting Enzyme 2) is expressed on the surface of cells. \n2. ACE2 is a receptor for the SARS-CoV-2 virus, which causes COVID-19. \n3. The SARS-CoV-2 virus uses ACE2 to enter host cells and replicate.\n4. ACE2 is primarily expressed on the surface of epithelial cells in the lungs but can also be found on other types of cells.\n5. The virus can also use other receptors, such as the ACE (Angiotensin Converting Enzyme) receptor, to enter host cells.",
    "vicuna-7b_fact": [
      "ACE2 (Angiotensin Converting Enzyme 2) is expressed on the surface of cells.",
      "ACE2 is a receptor for the SARS-CoV-2 virus, which causes COVID-19.",
      "The SARS-CoV-2 virus uses ACE2 to enter host cells and replicate.",
      "ACE2 is primarily expressed on the surface of epithelial cells in the lungs but can also be found on other types of cells.",
      "The virus can also use other receptors, such as the ACE (Angiotensin Converting Enzyme) receptor, to enter host cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The virus primarily uses the ACE2 receptor to enter host cells. There is currently no evidence that the SARS-CoV-2 virus can use the ACE receptor to enter host cells.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3259,
    "user_query": "List the cancers that are associated with SBLA syndrome.",
    "vicuna-7b_response": "SBLA syndrome, also known as Shprintzen syndrome, is a rare genetic disorder that is characterized by a combination of physical and developmental abnormalities. The syndrome is caused by mutations in the GPC3 gene, which encodes a protein that is involved in the development and function of the placenta.\nThe physical and developmental abnormalities associated with SBLA syndrome can vary from person to person, but some common features include:\n* Abnormalities of the genitals, such as undescended testicles or a small penis\n* Abnormalities of the urinary tract, such as kidney abnormalities or urinary tract infections\n* Developmental delays and intellectual disability\n* Abnormalities of the eyes, such as cataracts or glaucoma\n* Abnormalities of the ears, such as hearing loss or malformed ears\n* Abnormalities of the skeleton, such as short stature or abnormalities of the limbs\nCancer is not a common feature of SBLA syndrome, but some studies have suggested that individuals with the syndrome may have an increased risk of certain types of cancer, such as testicular cancer and kidney cancer. However, the exact risk of cancer in individuals with SBLA syndrome is not well understood and more research is needed to determine the association between SBLA syndrome and cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SBLA syndrome, also known as Shprintzen syndrome, is a rare genetic disorder.\n2. SBLA syndrome is caused by mutations in the GPC3 gene.\n3. The physical and developmental abnormalities of SBLA syndrome vary from person to person.\n4. Some common features of SBLA syndrome include genital, urinary tract, developmental, eye, ear, and skeletal abnormalities.\n5. Testicular and kidney cancers may have an increased risk in individuals with SBLA syndrome, although more research is needed.",
    "vicuna-7b_fact": [
      "SBLA syndrome, also known as Shprintzen syndrome, is a rare genetic disorder.",
      "SBLA syndrome is caused by mutations in the GPC3 gene.",
      "The physical and developmental abnormalities of SBLA syndrome vary from person to person.",
      "Some common features of SBLA syndrome include genital, urinary tract, developmental, eye, ear, and skeletal abnormalities.",
      "Testicular and kidney cancers may have an increased risk in individuals with SBLA syndrome, although more research is needed."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SBLA syndrome, also known as Sarcoma, Breast cancer, Leukemia and Adrenal gland cortical carcinoma syndrome, is a rare genetic disorder.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some common features of SBLA syndrome include predisposition to certain types of malignancies like sarcoma, breast cancer, leukemia, and adrenal cortical carcinoma.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3264,
    "user_query": "What is Invaplex 50?",
    "vicuna-7b_response": "Invaplex 50 is a medication that is used to treat a variety of medical conditions, including high blood pressure, heart failure, and certain types of infections. It is part of a class of drugs called angiotensin-converting enzyme (ACE) inhibitors, which work by relaxing blood vessels and improving blood flow.\nInvaplex 50 is a brand name medication that contains the active ingredient perindopril erbumine. It is available in tablet form and is typically taken once daily, with or without food.\nIt is important to note that Invaplex 50 is not suitable for everyone, and it may not be appropriate for use in certain medical conditions or in certain individuals. It is important to consult with a healthcare professional before starting treatment with Invaplex 50 to determine if it is the right medication for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Invaplex 50 is a medication used to treat high blood pressure, heart failure, and certain types of infections.\n2. Invaplex 50 is part of a class of drugs called angiotensin-converting enzyme (ACE) inhibitors.\n3. This medication works by relaxing blood vessels and improving blood flow.\n4. The active ingredient in Invaplex 50 is perindopril erbumine.\n5. Invaplex 50 is typically taken once daily, with or without food.",
    "vicuna-7b_fact": [
      "Invaplex 50 is a medication used to treat high blood pressure, heart failure, and certain types of infections.",
      "Invaplex 50 is part of a class of drugs called angiotensin-converting enzyme (ACE) inhibitors.",
      "This medication works by relaxing blood vessels and improving blood flow.",
      "The active ingredient in Invaplex 50 is perindopril erbumine.",
      "Invaplex 50 is typically taken once daily, with or without food."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3266,
    "user_query": "Which lncRNAS are regulated by SAM68?",
    "vicuna-7b_response": "SAM68 (also known as Lin28b) is a non-coding RNA binding protein that has been shown to regulate the expression of a number of long non-coding RNAs (lncRNAs). Here are some examples of lncRNAs that are regulated by SAM68:\n1. H19: H19 is a lncRNA that is often regulated by SAM68. SAM68 has been shown to bind to the H19 promoter and repress its expression.\n2. Xist: Xist is a lncRNA that is involved in the silencing of the X chromosome in male cells. SAM68 has been shown to bind to Xist and promote its expression.\n3. MALAT1: MALAT1 is a lncRNA that has been shown to be regulated by SAM68. SAM68 has been shown to bind to the MALAT1 promoter and repress its expression.\n4. HOTAIR: HOTAIR is a lncRNA that has been shown to be regulated by SAM68. SAM68 has been shown to bind to the HOTAIR promoter and repress its expression.\n5. GAS5: GAS5 is a lncRNA that has been shown to be regulated by SAM68. SAM68 has been shown to bind to the GAS5 promoter and repress its expression.\nOverall, SAM68 has been shown to regulate a number of lncRNAs, including H19, Xist, MALAT1, HOTAIR, and GAS5.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAM68 is a non-coding RNA binding protein.\n2. SAM68 has been shown to regulate the expression of a number of long non-coding RNAs (lncRNAs).\n3. SAM68 has been shown to bind to the H19 promoter and repress its expression.\n4. SAM68 has been shown to bind to Xist and promote its expression.\n5. SAM68 has been shown to bind to the GAS5 promoter and repress its expression.",
    "vicuna-7b_fact": [
      "SAM68 is a non-coding RNA binding protein.",
      "SAM68 has been shown to regulate the expression of a number of long non-coding RNAs (lncRNAs).",
      "SAM68 has been shown to bind to the H19 promoter and repress its expression.",
      "SAM68 has been shown to bind to Xist and promote its expression.",
      "SAM68 has been shown to bind to the GAS5 promoter and repress its expression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3267,
    "user_query": "How many proteins have been queried for protein partners by the Drosophila protein interaction map (DPiM)?",
    "vicuna-7b_response": "The Drosophila protein interaction map (DPiM) is a comprehensive resource that provides information on protein-protein interactions in Drosophila melanogaster. The DPiM has been updated several times, and the latest version (DPiM v3.0) includes information on over 10,000 proteins and their interactions.\nTo answer your question, the DPiM has queried for protein partners for many proteins, but it is not possible to provide an exact number. The DPiM includes data from a variety of sources, including yeast two-hybrid screens, affinity purification coupled with mass spectrometry (AP-MS), and other high-throughput interaction assays.\nIn general, the DPiM includes information on a wide range of proteins, including those involved in various biological processes such as development, growth, and metabolism. The DPiM is an important resource for the study of protein-protein interactions in Drosophila and has been widely used by researchers in the field.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Drosophila protein interaction map (DPiM) is a comprehensive resource that provides information on protein-protein interactions in Drosophila melanogaster.\n2. The DPiM has been updated multiple times.\n3. The latest version of DPiM, v3.0, includes information on over 10,000 proteins and their interactions.\n4. The DPiM includes data from various sources such as yeast two-hybrid screens, affinity purification coupled with mass spectrometry (AP-MS), and other high-throughput interaction assays.\n5. The DPiM is utilized in the study of protein-protein interactions in Drosophila and is widely used by researchers.",
    "vicuna-7b_fact": [
      "The Drosophila protein interaction map (DPiM) is a comprehensive resource that provides information on protein-protein interactions in Drosophila melanogaster.",
      "The DPiM has been updated multiple times.",
      "The latest version of DPiM, v3.0, includes information on over 10,000 proteins and their interactions.",
      "The DPiM includes data from various sources such as yeast two-hybrid screens, affinity purification coupled with mass spectrometry (AP-MS), and other high-throughput interaction assays.",
      "The DPiM is utilized in the study of protein-protein interactions in Drosophila and is widely used by researchers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-7b_response": "GPR151 is a G protein-coupled receptor that has been identified as an orphan receptor, meaning that it has not been shown to bind to any known ligands. However, recent studies have suggested that GPR151 may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.\nOne study published in the journal Molecular Endocrinology in 2012 found that GPR151 is expressed in various tissues, including the liver, adipose tissue, and skeletal muscle, and that it is involved in the regulation of glucose and lipid metabolism. The study also found that GPR151 is activated by a variety of compounds, including fatty acids and bile acids, which suggests that it may play a role in the regulation of lipid metabolism.\nAnother study published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells and that it is involved in the regulation of insulin secretion. The study found that activation of GPR151 by fatty acids increased insulin secretion in pancreatic beta cells, suggesting that it may play a role in the regulation of glucose metabolism.\nOverall, while more research is needed to fully understand the function of GPR151, recent studies have suggested that it may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GPR151 is identified as a G protein-coupled receptor.\n2. GPR151 is an orphan receptor that does not bind to any known ligands.\n3. One study found that GPR151 is expressed in various tissues such as the liver, adipose tissue, and skeletal muscle.\n4. Another study found that GPR151 is expressed in pancreatic beta cells and is involved in the regulation of insulin secretion.\n5. Various studies suggest that GPR151 may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.",
    "vicuna-7b_fact": [
      "GPR151 is identified as a G protein-coupled receptor.",
      "GPR151 is an orphan receptor that does not bind to any known ligands.",
      "One study found that GPR151 is expressed in various tissues such as the liver, adipose tissue, and skeletal muscle.",
      "Another study found that GPR151 is expressed in pancreatic beta cells and is involved in the regulation of insulin secretion.",
      "Various studies suggest that GPR151 may play a role in the regulation of metabolic processes, including glucose and lipid metabolism."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3269,
    "user_query": "Is Li–Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "vicuna-7b_response": "Yes, Li–Fraumeni syndrome is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development. It is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors, at an early age.\nLi–Fraumeni syndrome is caused by mutations in the TP53 gene, which is a tumor suppressor gene that plays a critical role in maintaining cellular homeostasis and preventing the development of cancer. When this gene is mutated, it can no longer function properly, leading to an increased risk of cancer.\nIndividuals with Li–Fraumeni syndrome have a 50% chance of inheriting the mutated TP53 gene from one of their parents, and if they do inherit the gene, they will develop the syndrome. However, not all individuals with the syndrome will develop cancer, as other factors, such as environmental exposures and lifestyle choices, can also contribute to cancer development.\nIt is important for individuals with Li–Fraumeni syndrome to be screened regularly for cancer, as early detection and treatment can significantly improve outcomes. Treatment options may include surgery, chemotherapy, and radiation therapy, depending on the type and location of the cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Li–Fraumeni syndrome is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development.\n2. Li–Fraumeni syndrome is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors, at an early age.\n3. Li–Fraumeni syndrome is caused by mutations in the TP53 gene.\n4. Individuals with Li–Fraumeni syndrome have a 50% chance of inheriting the mutated TP53 gene from one of their parents.\n5. It is important for individuals with Li–Fraumeni syndrome to be screened regularly for cancer.",
    "vicuna-7b_fact": [
      "Li–Fraumeni syndrome is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development.",
      "Li–Fraumeni syndrome is characterized by an increased risk of developing certain types of cancer, particularly sarcomas, breast cancer, and brain tumors, at an early age.",
      "Li–Fraumeni syndrome is caused by mutations in the TP53 gene.",
      "Individuals with Li–Fraumeni syndrome have a 50% chance of inheriting the mutated TP53 gene from one of their parents.",
      "It is important for individuals with Li–Fraumeni syndrome to be screened regularly for cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Li–Fraumeni syndrome is a rare, autosomal dominant, hereditary disorder that predisposes carriers to cancer development.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3271,
    "user_query": "Salzburg EEG criteria are used to diagnose which disorder?",
    "vicuna-7b_response": "The Salzburg EEG criteria are used to diagnose epilepsy.",
    "vicuna-7b_fact_raw": "The factual statement is: \n1. The Salzburg EEG criteria are used to diagnose epilepsy.",
    "vicuna-7b_fact": [
      "The Salzburg EEG criteria are used to diagnose epilepsy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 3272,
    "user_query": "List the components of the COMPASS complex",
    "vicuna-7b_response": "The COMPASS complex is a multi-subunit complex that plays a critical role in the regulation of transcription in eukaryotes. The components of the COMPASS complex include:\n1. COMPASS subunits: These are the core subunits of the complex, which include the histone-modifying enzymes such as histone methyltransferases (HMTs) and histone demethylases (HDMs).\n2. Co-factors: The COMPASS complex requires several co-factors for its function, including ATP, Mg2+, and nucleic acids.\n3. Chromatin: The COMPASS complex functions by modifying the chromatin structure and composition, which in turn regulates transcription.\n4. Transcriptional regulators: The COMPASS complex can interact with various transcriptional regulators, such as transcriptional activators and repressors, to regulate gene expression.\nOverall, the COMPASS complex plays a crucial role in the regulation of gene expression by modifying chromatin structure and composition, which in turn regulates transcription.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The COMPASS complex plays a critical role in the regulation of transcription in eukaryotes.\n2. The core subunits of the COMPASS complex include the histone-modifying enzymes such as histone methyltransferases (HMTs) and histone demethylases (HDMs).\n3. The COMPASS complex requires several co-factors for its function, including ATP, Mg2+, and nucleic acids.\n4. The COMPASS complex functions by modifying the chromatin structure and composition.\n5. The COMPASS complex can interact with various transcriptional regulators, such as transcriptional activators and repressors, to regulate gene expression.",
    "vicuna-7b_fact": [
      "The COMPASS complex plays a critical role in the regulation of transcription in eukaryotes.",
      "The core subunits of the COMPASS complex include the histone-modifying enzymes such as histone methyltransferases (HMTs) and histone demethylases (HDMs).",
      "The COMPASS complex requires several co-factors for its function, including ATP, Mg2+, and nucleic acids.",
      "The COMPASS complex functions by modifying the chromatin structure and composition.",
      "The COMPASS complex can interact with various transcriptional regulators, such as transcriptional activators and repressors, to regulate gene expression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3274,
    "user_query": "Central Vein Sign is characteristic to which disease?",
    "vicuna-7b_response": "The Central Vein Sign is a characteristic feature of aortic aneurysm. It is also known as the \"Golden Hour Sign\" and is used to diagnose aortic aneurysm. The Central Vein Sign is seen on a chest X-ray and is characterized by the presence of a central, well-defined, round or oval lucency, which represents the aortic lumen. The lucency is surrounded by a radiopaque halo, which is the aortic wall. The Central Vein Sign is highly specific for aortic aneurysm and is often used in combination with other imaging studies, such as CT or MRI, to confirm the diagnosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Central Vein Sign is a characteristic feature of aortic aneurysm.\n2. The Central Vein Sign is also known as the \"Golden Hour Sign\".\n3. This sign is used to diagnose aortic aneurysm.\n4. The Central Vein Sign is seen on a chest X-ray and characterized by a central, well-defined, round or oval lucency.\n5. The Central Vein Sign is often used in combination with other imaging studies, such as CT or MRI, to confirm the diagnosis.",
    "vicuna-7b_fact": [
      "The Central Vein Sign is a characteristic feature of aortic aneurysm.",
      "The Central Vein Sign is also known as the \"Golden Hour Sign\".",
      "This sign is used to diagnose aortic aneurysm.",
      "The Central Vein Sign is seen on a chest X-ray and characterized by a central, well-defined, round or oval lucency.",
      "The Central Vein Sign is often used in combination with other imaging studies, such as CT or MRI, to confirm the diagnosis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Central Vein Sign is a characteristic feature of Multiple Sclerosis, not aortic aneurysm.\n2. FALSE [correction]: The Central Vein Sign is not known as the \"Golden Hour Sign\".\n3. FALSE [correction]: This sign is used to diagnose Multiple Sclerosis, not aortic aneurysm.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3284,
    "user_query": "Do de novo truncating mutations in WASF1 cause cancer?",
    "vicuna-7b_response": "De novo truncating mutations in WASF1 have been associated with cancer, but the evidence is not conclusive.\nWASF1, or Wiskott-Aldrich syndrome factor 1, is a protein that plays a role in the immune system and is expressed in various tissues, including the blood, bone marrow, and lymphoid organs. Mutations in WASF1 have been identified in patients with Wiskott-Aldrich syndrome, a rare immune disorder characterized by severe recurrent infections, bleeding disorders, and autoimmune disease.\nStudies have suggested that de novo truncating mutations in WASF1 may also be associated with an increased risk of cancer. For example, a study published in the journal Cancer Research in 2018 found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing hematological malignancies, such as leukemia and lymphoma, compared to individuals without such mutations. However, the study did not find a significant association between WASF1 mutations and solid tumors.\nAnother study published in the journal Blood in 2019 found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing acute myeloid leukemia (AML) compared to individuals without such mutations. The study also found that the risk of developing AML was higher in individuals with mutations in the N-terminal domain of WASF1, which is involved in regulating cell growth and survival.\nOverall, while the evidence suggests that de novo truncating mutations in WASF1 may be associated with an increased risk of cancer, more research is needed to fully understand the relationship between WASF1 mutations and cancer development.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. WASF1 is a protein that plays a role in the immune system and is expressed in various tissues, including the blood, bone marrow, and lymphoid organs.\n2. Mutations in WASF1 have been identified in patients with Wiskott-Aldrich syndrome, a rare immune disorder characterized by severe recurrent infections, bleeding disorders, and autoimmune disease.\n3. A study published in 2018 in the journal Cancer Research found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing hematological malignancies.\n4. A study published in 2019 in the journal Blood found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing acute myeloid leukemia (AML).\n5. The risk of developing AML was higher in individuals with mutations in the N-terminal domain of WASF1, which is involved in regulating cell growth and survival.",
    "vicuna-7b_fact": [
      "WASF1 is a protein that plays a role in the immune system and is expressed in various tissues, including the blood, bone marrow, and lymphoid organs.",
      "Mutations in WASF1 have been identified in patients with Wiskott-Aldrich syndrome, a rare immune disorder characterized by severe recurrent infections, bleeding disorders, and autoimmune disease.",
      "A study published in 2018 in the journal Cancer Research found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing hematological malignancies.",
      "A study published in 2019 in the journal Blood found that individuals with de novo truncating mutations in WASF1 had a higher risk of developing acute myeloid leukemia (AML).",
      "The risk of developing AML was higher in individuals with mutations in the N-terminal domain of WASF1, which is involved in regulating cell growth and survival."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Mutations in the WAS gene have been identified in patients with Wiskott-Aldrich syndrome, not WASF1.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-7b_response": "Fluzone intradermal quadrivalent vaccine contains attenuated live viruses of four strains: influenza virus type A (H1N1), influenza virus type A (H3N2), influenza virus type B (Yamagata), and influenza virus type B (Victoria).",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fluzone intradermal quadrivalent vaccine contains attenuated live viruses.\n2. The vaccine contains the influenza virus type A (H1N1).\n3. The vaccine contains the influenza virus type A (H3N2).\n4. It contains the influenza virus type B (Yamagata).\n5. It also contains the influenza virus type B (Victoria).",
    "vicuna-7b_fact": [
      "Fluzone intradermal quadrivalent vaccine contains attenuated live viruses.",
      "The vaccine contains the influenza virus type A (H1N1).",
      "The vaccine contains the influenza virus type A (H3N2).",
      "It contains the influenza virus type B (Yamagata).",
      "It also contains the influenza virus type B (Victoria)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Fluzone intradermal quadrivalent vaccine contains inactivated (killed) viruses, not attenuated live viruses.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3300,
    "user_query": "How is Slc22a3 imprinted?",
    "vicuna-7b_response": "Slc22a3 is an imprinted gene, which means that it is inherited from the father and expressed only from the mother's allele. The gene is located on the X chromosome and is imprinted because it has a paternal uniparental isodisomy (PUPIT) marker. This means that the gene is inherited from the father and expressed only from the mother's allele. The gene is also expressed in a tissue-specific manner, with high levels of expression in the testis and low levels of expression in other tissues. The imprinting of Slc22a3 is important for normal development and function of the testis and is also involved in the regulation of glucose homeostasis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Slc22a3 is an imprinted gene that is inherited from the father and expressed only from the mother's allele.\n2. The Slc22a3 gene is located on the X chromosome.\n3. Slc22a3 has a paternal uniparental isodisomy (PUPIT) marker.\n4. The Slc22a3 gene is expressed in a tissue-specific manner, with high levels of expression in the testis and low levels of expression in other tissues.\n5. The imprinting of Slc22a3 is important for normal development and function of the testis and is also involved in the regulation of glucose homeostasis.",
    "vicuna-7b_fact": [
      "Slc22a3 is an imprinted gene that is inherited from the father and expressed only from the mother's allele.",
      "The Slc22a3 gene is located on the X chromosome.",
      "Slc22a3 has a paternal uniparental isodisomy (PUPIT) marker.",
      "The Slc22a3 gene is expressed in a tissue-specific manner, with high levels of expression in the testis and low levels of expression in other tissues.",
      "The imprinting of Slc22a3 is important for normal development and function of the testis and is also involved in the regulation of glucose homeostasis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Slc22a3 is an imprinted gene that is typically inherited from the mother and expressed only from the father's allele.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3302,
    "user_query": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "vicuna-7b_response": "Yes, the tyrosine kinase BTK (B cell maturation antigen) has been implicated in autoimmunity. BTK is a key signaling molecule in the B cell receptor signaling pathway, which plays a crucial role in the development and function of B cells, a type of immune cell that is involved in the immune response to infections.\nSeveral studies have suggested that BTK may play a role in the development of autoimmune diseases. For example, BTK has been shown to be involved in the regulation of immune cell activation and proliferation, which are processes that are important for the development of autoimmune diseases. Additionally, some studies have suggested that BTK may be involved in the regulation of the immune response to self-antigens, which are antigens that are present in the body and are recognized by the immune system as foreign.\nOverall, while more research is needed to fully understand the role of BTK in autoimmunity, it is clear that this molecule plays an important role in the immune system and may be involved in the development of autoimmune diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The tyrosine kinase BTK (B cell maturation antigen) has been implicated in autoimmunity.\n2. BTK is a key signaling molecule in the B cell receptor signaling pathway.\n3. The B cell receptor signaling pathway plays a crucial role in the development and function of B cells.\n4. BTK has been shown to be involved in the regulation of immune cell activation and proliferation.\n5. Some studies have suggested BTK may be involved in the regulation of the immune response to self-antigens.",
    "vicuna-7b_fact": [
      "The tyrosine kinase BTK (B cell maturation antigen) has been implicated in autoimmunity.",
      "BTK is a key signaling molecule in the B cell receptor signaling pathway.",
      "The B cell receptor signaling pathway plays a crucial role in the development and function of B cells.",
      "BTK has been shown to be involved in the regulation of immune cell activation and proliferation.",
      "Some studies have suggested BTK may be involved in the regulation of the immune response to self-antigens."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The tyrosine kinase BTK (Bruton's tyrosine kinase) has been implicated in autoimmunity.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3303,
    "user_query": "What is the BioPlex network?",
    "vicuna-7b_response": "The BioPlex network is a decentralized platform that aims to revolutionize the way biological data is collected, stored, and shared. It is built on top of the Ethereum blockchain and utilizes smart contracts to enable secure and transparent data management.\nThe BioPlex network is designed to be a decentralized, open-source platform that allows researchers, scientists, and other stakeholders to collaborate and share data in a secure and transparent manner. The platform is built on top of the Ethereum blockchain, which provides a secure and decentralized infrastructure for data storage and management.\nOne of the key features of the BioPlex network is its use of smart contracts. Smart contracts are self-executing contracts with the terms of the agreement between buyer and seller being directly written into lines of code. They are stored and replicated on the blockchain, ensuring that they are transparent, secure, and tamper-proof.\nThe BioPlex network also utilizes a token called the BIO token, which is used to incentivize participation and reward users for contributing data to the network. The BIO token can be used to access data on the network, participate in governance decisions, and more.\nOverall, the BioPlex network aims to create a more efficient and transparent system for biological data management, enabling researchers and scientists to collaborate more effectively and make breakthroughs in their fields.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The BioPlex network is a decentralized platform built on the Ethereum blockchain.\n2. BioPlex network uses smart contracts for data management.\n3. Smart contracts are self-executing contracts with the terms of the agreement between buyer and seller directly written into lines of code.\n4. BioPlex network includes a token called the BIO token, which rewards users for contributing data to the network.\n5. The BIO token can be used to access data, participate in governance decisions, and more on the BioPlex network.",
    "vicuna-7b_fact": [
      "The BioPlex network is a decentralized platform built on the Ethereum blockchain.",
      "BioPlex network uses smart contracts for data management.",
      "Smart contracts are self-executing contracts with the terms of the agreement between buyer and seller directly written into lines of code.",
      "BioPlex network includes a token called the BIO token, which rewards users for contributing data to the network.",
      "The BIO token can be used to access data, participate in governance decisions, and more on the BioPlex network."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3304,
    "user_query": "Which algorithm has been developed for detecting expansions of tandem repeats?",
    "vicuna-7b_response": "There are several algorithms that have been developed for detecting expansions of tandem repeats, also known as repeat expansion. One such algorithm is the \"Fast and Slow Variant Recognition Algorithm\" (FASVRA), which is a variant of the \"Variant Recognition Algorithm\" (VRA).\nThe VRA is a widely used algorithm for detecting repeat expansions in genomic sequences. It works by comparing the read depth of a repeat to the expected read depth, which is calculated based on the repeat length and the number of reads in the genome. If the read depth of the repeat is significantly higher or lower than expected, the VRA flags the repeat as a potential expansion.\nThe FASVRA is an improvement on the VRA because it uses two different read depth thresholds to detect repeat expansions. The first threshold is based on the expected read depth, as in the VRA. The second threshold is based on the standard deviation of the read depths of all repeats in the genome, which is used to identify rare or unusual repeat expansions.\nAnother algorithm for detecting repeat expansions is the \"RepeatMasker\" algorithm, which is a widely used tool for identifying repeat elements in genomic sequences. RepeatMasker uses a combination of computational and bioinformatic approaches to identify repeat elements, including tandem repeats, and can be used to identify both known and novel repeat elements.\nIn summary, there are several algorithms that have been developed for detecting expansions of tandem repeats, including the Fast and Slow Variant Recognition Algorithm (FASVRA) and the RepeatMasker algorithm. These algorithms can be used to identify and characterize repeat expansions in genomic sequences, which can be important for understanding the genetic basis of a wide range of diseases and other phenotypes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are several algorithms that have been developed for detecting expansions of tandem repeats, also known as repeat expansion.\n2. One such algorithm is the \"Fast and Slow Variant Recognition Algorithm\" (FASVRA), which is a variant of the \"Variant Recognition Algorithm\" (VRA).\n3. The Variant Recognition Algorithm works by comparing the read depth of a repeat to the expected read depth.\n4. The Fast and Slow Variant Recognition Algorithm uses two different read depth thresholds to detect repeat expansions.\n5. Another algorithm for detecting repeat expansions is the \"RepeatMasker\" algorithm.",
    "vicuna-7b_fact": [
      "There are several algorithms that have been developed for detecting expansions of tandem repeats, also known as repeat expansion.",
      "One such algorithm is the \"Fast and Slow Variant Recognition Algorithm\" (FASVRA), which is a variant of the \"Variant Recognition Algorithm\" (VRA).",
      "The Variant Recognition Algorithm works by comparing the read depth of a repeat to the expected read depth.",
      "The Fast and Slow Variant Recognition Algorithm uses two different read depth thresholds to detect repeat expansions.",
      "Another algorithm for detecting repeat expansions is the \"RepeatMasker\" algorithm."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The Variant Recognition Algorithm works by comparing the sequence to a library of known patterns or by checking for non-unique parts in the sequence.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3305,
    "user_query": "Which clotting factor is in the Andexxa?",
    "vicuna-7b_response": "Andexxa is a medication that is used to reverse the effects of the blood thinner, rivaroxaban, and apixaban. It is specifically designed to reverse the anticoagulant effects of these medications, which can lead to dangerous blood clots.\nAndexxa works by inhibiting the activity of the clotting factor X, which is one of the proteins involved in the coagulation cascade. By inhibiting the activity of factor X, Andexxa can help to reverse the anticoagulant effects of rivaroxaban and apixaban, and can help to prevent the formation of dangerous blood clots.\nIt is important to note that Andexxa is not a substitute for these medications, and should only be used in specific situations where the risk of bleeding outweighs the risk of blood clots. Andexxa should only be used under the supervision of a healthcare professional, and the patient should be closely monitored for any signs of bleeding or other adverse effects.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Andexxa is a medication that is used to reverse the effects of the blood thinner, rivaroxaban, and apixaban.\n2. Andexxa works by inhibiting the activity of the clotting factor X.\n3. Factor X is one of the proteins involved in the coagulation cascade.\n4. Andexxa should only be used where the risk of bleeding outweighs the risk of blood clots.\n5. Andexxa usage should be supervised by a healthcare professional and monitoring for signs of bleeding or other adverse effects is required.",
    "vicuna-7b_fact": [
      "Andexxa is a medication that is used to reverse the effects of the blood thinner, rivaroxaban, and apixaban.",
      "Andexxa works by inhibiting the activity of the clotting factor X.",
      "Factor X is one of the proteins involved in the coagulation cascade.",
      "Andexxa should only be used where the risk of bleeding outweighs the risk of blood clots.",
      "Andexxa usage should be supervised by a healthcare professional and monitoring for signs of bleeding or other adverse effects is required."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3315,
    "user_query": "What classes of drugs does Retapamulin belong to?",
    "vicuna-7b_response": "Retapamulin is an antibiotic medication that belongs to the class of drugs known as macrolides. Macrolides are a type of antibiotic that are effective against a wide range of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections. Retapamulin is specifically used to treat skin infections caused by bacteria, such as impetigo and other superficial skin infections. It is usually applied topically to the skin as a cream or ointment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Retapamulin is an antibiotic medication.\n2. Retapamulin belongs to the class of drugs known as macrolides.\n3. Macrolides are effective against a wide range of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections.\n4. Retapamulin is specifically used to treat skin infections caused by bacteria.\n5. Retapamulin is usually applied topically to the skin as a cream or ointment.",
    "vicuna-7b_fact": [
      "Retapamulin is an antibiotic medication.",
      "Retapamulin belongs to the class of drugs known as macrolides.",
      "Macrolides are effective against a wide range of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections.",
      "Retapamulin is specifically used to treat skin infections caused by bacteria.",
      "Retapamulin is usually applied topically to the skin as a cream or ointment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Retapamulin belongs to the class of drugs known as pleuromutilins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3322,
    "user_query": "Which T-UCR has been implicated in prostate cancer?",
    "vicuna-7b_response": "T-UCR, or T-cell receptor, has not been implicated in prostate cancer. However, T-cells are a type of immune cell that play a crucial role in the immune system's response to cancer.\nProstate cancer is a type of cancer that develops in the prostate gland, a small walnut-sized organ located below the bladder in men. The prostate gland produces fluids that make up a part of semen.\nWhile T-cells are not directly involved in the development of prostate cancer, they are important in the immune system's response to the cancer. Some studies have suggested that T-cells may play a role in the immune response to prostate cancer, and that T-cells that recognize and target specific proteins on the surface of prostate cancer cells may be able to help the immune system fight the cancer.\nThere are several types of T-cells, including CD4+ T-cells and CD8+ T-cells, which play different roles in the immune system. CD4+ T-cells are also known as T-helper cells, and they help to coordinate the immune response. CD8+ T-cells, also known as cytotoxic T-cells, directly kill infected cells or cancer cells.\nIn summary, while T-cells are not directly involved in the development of prostate cancer, they may play a role in the immune system's response to the cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. T-UCR, or T-cell receptor, has not been implicated in prostate cancer.\n2. Prostate cancer is a type of cancer that develops in the prostate gland.\n3. The prostate gland is a small walnut-sized organ located below the bladder in men.\n4. There are several types of T-cells, including CD4+ T-cells and CD8+ T-cells.\n5. CD8+ T-cells, also known as cytotoxic T-cells, directly kill infected cells or cancer cells.",
    "vicuna-7b_fact": [
      "T-UCR, or T-cell receptor, has not been implicated in prostate cancer.",
      "Prostate cancer is a type of cancer that develops in the prostate gland.",
      "The prostate gland is a small walnut-sized organ located below the bladder in men.",
      "There are several types of T-cells, including CD4+ T-cells and CD8+ T-cells.",
      "CD8+ T-cells, also known as cytotoxic T-cells, directly kill infected cells or cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3325,
    "user_query": "Which company sells the drug Afrezza since 2015?",
    "vicuna-7b_response": "The drug Afrezza has been sold by the company MannKind Corporation since 2015. Afrezza is a inhaled insulin medication used to treat adults with type 1 and type 2 diabetes. It is taken using a small, handheld inhaler device. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MannKind Corporation has been selling the drug Afrezza since 2015.\n2. Afrezza is an inhaled insulin medication used to treat adults with type 1 and type 2 diabetes.\n3. Afrezza is taken using a small, handheld inhaler device.\n4. MannKind Corporation was founded in 1991.\n5. MannKind Corporation is headquartered in Valencia, California.",
    "vicuna-7b_fact": [
      "MannKind Corporation has been selling the drug Afrezza since 2015.",
      "Afrezza is an inhaled insulin medication used to treat adults with type 1 and type 2 diabetes.",
      "Afrezza is taken using a small, handheld inhaler device.",
      "MannKind Corporation was founded in 1991.",
      "MannKind Corporation is headquartered in Valencia, California."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MannKind Corporation was founded in 1991 by Alfred E. Mann, with the intention of developing a patented technosphere material technology but actually incorporated in February 1991 as Pharmaceutical Discovery Corporation.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3327,
    "user_query": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "vicuna-7b_response": "Uc.63+ is a genetic mutation that has been associated with the development and progression of prostate cancer. The specific role of Uc.63+ in the development of sensitivity to treatment in prostate cancer is not well understood and requires further research.\nProstate cancer is a type of cancer that originates in the prostate gland, a small walnut-sized gland located below the bladder in men. Prostate cancer can be slow-growing or fast-growing, and can be either sensitive or resistant to treatment.\nUc.63+ is a genetic mutation that has been identified in some prostate cancer patients. It is caused by a change in the DNA sequence of the UCE gene, which is involved in the regulation of cell growth and division. The specific role of Uc.63+ in the development and progression of prostate cancer is not well understood, but it has been associated with more aggressive disease and a worse prognosis.\nThere are several treatment options available for prostate cancer, including surgery, radiation therapy, and chemotherapy. The effectiveness of these treatments can vary depending on the specific characteristics of the cancer, such as its grade, stage, and sensitivity to treatment.\nIn summary, while Uc.63+ has been associated with the development and progression of prostate cancer, its specific role in the development of sensitivity to treatment is not well understood and requires further research. The effectiveness of treatment for prostate cancer can vary depending on the specific characteristics of the cancer, and the best treatment approach is often determined on a case-by-case basis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Uc.63+ is a genetic mutation associated with the development and progression of prostate cancer.\n2. Prostate cancer originates in the prostate gland, a small walnut-sized gland located below the bladder in men.\n3. Uc.63+ is caused by a change in the DNA sequence of the UCE gene.\n4. The UCE gene is involved in the regulation of cell growth and division.\n5. Treatments for prostate cancer can include surgery, radiation therapy, and chemotherapy.",
    "vicuna-7b_fact": [
      "Uc.63+ is a genetic mutation associated with the development and progression of prostate cancer.",
      "Prostate cancer originates in the prostate gland, a small walnut-sized gland located below the bladder in men.",
      "Uc.63+ is caused by a change in the DNA sequence of the UCE gene.",
      "The UCE gene is involved in the regulation of cell growth and division.",
      "Treatments for prostate cancer can include surgery, radiation therapy, and chemotherapy."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3332,
    "user_query": "What is OAC CHV?",
    "vicuna-7b_response": "OAC CHV stands for \"Open Application Communication Channel for Healthcare and Wellness\". It is a protocol that allows for the secure and efficient exchange of healthcare data between different applications and systems.\nOAC CHV is designed to be used in a healthcare setting, where there is a need to share patient information between different providers and systems. The protocol uses a secure and standardized method of communication to ensure that patient data is protected and can be easily shared between different applications.\nOAC CHV is part of the Open Applications Connectivity (OAC) framework, which is a set of protocols and standards for securely connecting different applications and systems. The OAC framework is designed to be flexible and scalable, allowing it to be used in a wide range of healthcare settings and use cases.\nOverall, OAC CHV is a protocol that enables secure and efficient data exchange between different healthcare applications and systems, helping to improve patient care and outcomes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. OAC CHV stands for \"Open Application Communication Channel for Healthcare and Wellness\".\n2. OAC CHV is a protocol designed for the secure and efficient exchange of healthcare data.\n3. This protocol can be used to share patient information between different healthcare providers and systems.\n4. OAC CHV is part of the Open Applications Connectivity (OAC) framework.\n5. The Open Applications Connectivity (OAC) framework is a set of protocols and standards for securely connecting different applications and systems.",
    "vicuna-7b_fact": [
      "OAC CHV stands for \"Open Application Communication Channel for Healthcare and Wellness\".",
      "OAC CHV is a protocol designed for the secure and efficient exchange of healthcare data.",
      "This protocol can be used to share patient information between different healthcare providers and systems.",
      "OAC CHV is part of the Open Applications Connectivity (OAC) framework.",
      "The Open Applications Connectivity (OAC) framework is a set of protocols and standards for securely connecting different applications and systems."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3338,
    "user_query": "What does MVA85A stand for?",
    "vicuna-7b_response": "MVA85A stands for \"Mumps Virus Vaccine, Live, Attenuated, Second Dose\".",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. MVA85A stands for \"Mumps Virus Vaccine, Live, Attenuated, Second Dose\".",
    "vicuna-7b_fact": [
      "MVA85A stands for \"Mumps Virus Vaccine, Live, Attenuated, Second Dose\"."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MVA85A is a tuberculosis vaccine candidate, not a mumps vaccine.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3339,
    "user_query": "Can MVA85A confer immunity against smallpox?",
    "vicuna-7b_response": "MVA85A, also known as modified vaccinia Ankara, is a vaccine that is derived from the vaccinia virus and has been used to protect against smallpox. MVA85A is a live, attenuated vaccine that has been modified to reduce its ability to cause disease in humans.\nMVA85A has been shown to be highly effective in preventing smallpox in animal studies and has been used in smallpox vaccination campaigns in several countries. The vaccine is given as a single dose and is recommended for individuals who are at high risk of smallpox exposure, such as healthcare workers and laboratory personnel who work with smallpox virus.\nIt's important to note that MVA85A does not provide immediate immunity against smallpox. A booster dose of the vaccine may be needed to maintain immunity. Additionally, MVA85A is not recommended for individuals who have a weakened immune system or who are allergic to cow's milk protein.\nIn summary, MVA85A is a vaccine that has been shown to be effective in preventing smallpox and is recommended for individuals who are at high risk of smallpox exposure. However, it does not provide immediate immunity and a booster dose may be needed to maintain immunity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MVA85A is derived from the vaccinia virus and has been used to protect against smallpox.\n2. MVA85A has shown to be effective in preventing smallpox in animal studies.\n3. The MVA85A vaccine has been used in smallpox vaccination campaigns in several countries.\n4. MVA85A is a live, attenuated vaccine given as a single dose, recommended for individuals at high risk of smallpox exposure.\n5. MVA85A does not provide immediate immunity against smallpox, and a booster dose may be needed to maintain immunity.",
    "vicuna-7b_fact": [
      "MVA85A is derived from the vaccinia virus and has been used to protect against smallpox.",
      "MVA85A has shown to be effective in preventing smallpox in animal studies.",
      "The MVA85A vaccine has been used in smallpox vaccination campaigns in several countries.",
      "MVA85A is a live, attenuated vaccine given as a single dose, recommended for individuals at high risk of smallpox exposure.",
      "MVA85A does not provide immediate immunity against smallpox, and a booster dose may be needed to maintain immunity."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MVA85A is derived from the vaccinia virus but it has been developed as a potential tuberculosis vaccine, not for smallpox.\n2. UNKNOWN\n3. FALSE [correction]: MVA85A has not been used in smallpox vaccination campaigns as it is under investigation for tuberculosis, not smallpox.\n4. FALSE [correction]: MVA85A is a live, attenuated vaccine under investigation for tuberculosis, not smallpox, and therefore it is not specifically recommended for individuals at high risk of smallpox exposure.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3342,
    "user_query": "List cohesinopathies",
    "vicuna-7b_response": "Cohesinopathies are a group of genetic disorders that are caused by mutations in the cohesin complex, which is responsible for holding together chromosomes during cell division. Some examples of cohesinopathies include:\n1. Cornelia de Lange Syndrome (CdLS): CdLS is a genetic disorder that is caused by mutations in the cohesin complex. It is characterized by intellectual disability, growth delay, and distinctive facial features.\n2. Wolf-Hirschhorn Syndrome (WHS): WHS is a genetic disorder that is caused by a deletion on the short (p) arm of chromosome 4. It is characterized by intellectual disability, developmental delay, and distinctive facial features.\n3. Atelosteogenesis Type II: Atelosteogenesis Type II is a genetic disorder that is caused by mutations in the SMC4 gene, which is involved in the cohesin complex. It is characterized by abnormal bone development and growth, and intellectual disability.\n4. Spastic Paraplegia 27: SPG27 is a genetic disorder that is caused by mutations in the SMC5 gene, which is involved in the cohesin complex. It is characterized by progressive spastic paraplegia, which is a type of muscle weakness that affects the legs.\n5. Bardet-Biedl Syndrome (BBS): BBS is a genetic disorder that is caused by mutations in the BBS gene, which is involved in the cohesin complex. It is characterized by intellectual disability, obesity, and retinal degeneration.\nThese are just a few examples of cohesinopathies. There are many other genetic disorders that are caused by mutations in the cohesin complex, and the symptoms and severity of these disorders can vary widely.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cornelia de Lange Syndrome is a genetic disorder caused by mutations in the cohesin complex, and is characterized by intellectual disability, growth delay, and distinctive facial features.\n2. Wolf-Hirschhorn Syndrome is a genetic disorder caused by a deletion on the short (p) arm of chromosome 4, and is characterized by intellectual disability, developmental delay, and distinctive facial features.\n3. Atelosteogenesis Type II is a genetic disorder caused by mutations in the SMC4 gene, which is involved in the cohesin complex, and is characterized by abnormal bone development, growth, and intellectual disability.\n4. Spastic Paraplegia 27 is a genetic disorder caused by mutations in the SMC5 gene, which is involved in the cohesin complex, and is characterized by progressive spastic paraplegia.\n5. Bardet-Biedl Syndrome is a genetic disorder caused by mutations in the BBS gene and is characterized by intellectual disability, obesity, and retinal degeneration.",
    "vicuna-7b_fact": [
      "Cornelia de Lange Syndrome is a genetic disorder caused by mutations in the cohesin complex, and is characterized by intellectual disability, growth delay, and distinctive facial features.",
      "Wolf-Hirschhorn Syndrome is a genetic disorder caused by a deletion on the short (p) arm of chromosome 4, and is characterized by intellectual disability, developmental delay, and distinctive facial features.",
      "Atelosteogenesis Type II is a genetic disorder caused by mutations in the SMC4 gene, which is involved in the cohesin complex, and is characterized by abnormal bone development, growth, and intellectual disability.",
      "Spastic Paraplegia 27 is a genetic disorder caused by mutations in the SMC5 gene, which is involved in the cohesin complex, and is characterized by progressive spastic paraplegia.",
      "Bardet-Biedl Syndrome is a genetic disorder caused by mutations in the BBS gene and is characterized by intellectual disability, obesity, and retinal degeneration."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Atelosteogenesis Type II is a genetic disorder caused by mutations in the FLNB gene, which is involved in the process of bone mineralization, and is characterized by short stature, abnormal bone development and respiratory problems.\n4. TRUE\n5. FALSE [correction]: Bardet-Biedl Syndrome is a genetic disorder not caused by mutations in just one gene but multiple genes are involved. It is indeed characterized by intellectual disability, obesity, and retinal degeneration.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-7b_response": "The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, is a gene that encodes for a protein called TNF receptor 2. This protein is a receptor for the TNF-alpha cytokine, which plays a role in the immune system.\nThere are several variations in the TNFR2 gene that have been associated with Systemic Lupus Erythematosus (SLE), which is an autoimmune disease characterized by the production of autoantibodies and the formation of immune complexes that can cause damage to various organs and tissues in the body.\nOne of the most well-known variations in the TNFR2 gene that has been associated with SLE is a single nucleotide polymorphism (SNP) called rs1143679. This SNP results in the substitution of the amino acid arginine for glutamine at position 69 (R69Q) in the TNFR2 protein.\nStudies have shown that individuals with the R69Q variant of the TNFR2 gene are at increased risk for developing SLE compared to individuals without the variant. Additionally, the R69Q variant has been shown to reduce the ability of the TNFR2 protein to bind to TNF-alpha, which may contribute to the development of SLE by increasing the levels of TNF-alpha in the body.\nOverall, the TNFR2 gene and its variants, particularly the R69Q variant, are important genetic factors that contribute to the development of SLE.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, encodes for a protein called TNF receptor 2.\n2. The TNF receptor 2 is a receptor for the TNF-alpha cytokine, which plays a role in the immune system.\n3. A single nucleotide polymorphism (SNP) in the TNFR2 gene, called rs1143679, is associated with Systemic Lupus Erythematosus (SLE).\n4. The rs1143679 SNP results in the substitution of the amino acid arginine for glutamine at position 69 (R69Q) in the TNFR2 protein.\n5. The R69Q variant of the TNFR2 gene has been shown to reduce the ability of the TNFR2 protein to bind to TNF-alpha.",
    "vicuna-7b_fact": [
      "The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, encodes for a protein called TNF receptor 2.",
      "The TNF receptor 2 is a receptor for the TNF-alpha cytokine, which plays a role in the immune system.",
      "A single nucleotide polymorphism (SNP) in the TNFR2 gene, called rs1143679, is associated with Systemic Lupus Erythematosus (SLE).",
      "The rs1143679 SNP results in the substitution of the amino acid arginine for glutamine at position 69 (R69Q) in the TNFR2 protein.",
      "The R69Q variant of the TNFR2 gene has been shown to reduce the ability of the TNFR2 protein to bind to TNF-alpha."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3348,
    "user_query": "Is Figitumumab effective for non-small cell lung cancer?",
    "vicuna-7b_response": "Figitumumab is a monoclonal antibody that is used to treat non-small cell lung cancer. It is specifically used in combination with other treatments such as chemotherapy to improve the response rate and overall survival of patients with advanced non-small cell lung cancer.\nThe use of Figitumumab in non-small cell lung cancer was studied in a clinical trial called the \"PACIFIC\" trial. This trial involved over 500 patients with advanced non-small cell lung cancer who had not responded to other treatments. The trial found that the use of Figitumumab in combination with paclitaxel and carboplatin resulted in a significant improvement in overall survival compared to treatment with paclitaxel and carboplatin alone.\nIt is important to note that Figitumumab is not a first-line treatment for non-small cell lung cancer and is typically used in patients who have already received other treatments. Additionally, the use of Figitumumab may have side effects such as fatigue, nausea, and diarrhea.\nOverall, Figitumumab is a treatment option for patients with advanced non-small cell lung cancer, but it is important to discuss the benefits and risks of the treatment with a healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Figitumumab is a monoclonal antibody used to treat non-small cell lung cancer.\n2. Figitumumab is usually used in combination with other treatments such as chemotherapy.\n3. The PACIFIC trial studied the efficacy of Figitumumab in treating non-small cell lung cancer involving over 500 patients.\n4. Figitumumab in combination with paclitaxel and carboplatin showed significant improvement in overall survival compared to treatment with paclitaxel and carboplatin alone.\n5. Figitumumab is not a first-line treatment for non-small cell lung cancer.",
    "vicuna-7b_fact": [
      "Figitumumab is a monoclonal antibody used to treat non-small cell lung cancer.",
      "Figitumumab is usually used in combination with other treatments such as chemotherapy.",
      "The PACIFIC trial studied the efficacy of Figitumumab in treating non-small cell lung cancer involving over 500 patients.",
      "Figitumumab in combination with paclitaxel and carboplatin showed significant improvement in overall survival compared to treatment with paclitaxel and carboplatin alone.",
      "Figitumumab is not a first-line treatment for non-small cell lung cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3349,
    "user_query": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "vicuna-7b_response": "Yes, the LINCS L1000 data set contains gene expression data for drug-treated human cells.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. The LINCS L1000 data set contains gene expression data for drug-treated human cells.",
    "vicuna-7b_fact": [
      "The LINCS L1000 data set contains gene expression data for drug-treated human cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 3351,
    "user_query": "Which database exists that contains regulatory SNPs which affect predicted transcription factor binding site affinity?",
    "vicuna-7b_response": "There are several databases that contain regulatory single nucleotide polymorphisms (SNPs) that affect predicted transcription factor binding site affinity. Here are a few examples:\n1. The National Center for Biotechnology Information's (NCBI) SNP database (<https://www.ncbi.nlm.nih.gov/snps/>) contains a large collection of SNPs, including those that may affect transcription factor binding affinity.\n2. The Genome-Wide Association Studies (GWAS) database (<https://www.ncbi.nlm.nih.gov/gwas/>) contains information on genetic variants associated with various traits and diseases, including those that may affect transcription factor binding affinity.\n3. The Encyclopedia of DNA Elements (ENCODE) project (<https://www.encodeproject.org/>) provides a comprehensive catalog of functional elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.\n4. The Roadmap Epigenomics Project (<https://www.roadmapepigenomics.org/>) provides a comprehensive catalog of epigenetic marks and regulatory elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.\nThese databases can be useful resources for researchers studying the effects of regulatory SNPs on transcription factor binding affinity and gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The National Center for Biotechnology Information's (NCBI) SNP database contains a large collection of SNPs, including those that may affect transcription factor binding affinity.\n2. The Genome-Wide Association Studies (GWAS) database contains information on genetic variants associated with various traits and diseases, including those that may affect transcription factor binding affinity.\n3. The Encyclopedia of DNA Elements (ENCODE) project provides a comprehensive catalog of functional elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.\n4. The Roadmap Epigenomics Project provides a comprehensive catalog of epigenetic marks and regulatory elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.\n5. These databases can be used by researchers studying the effects of regulatory SNPs on transcription factor binding affinity and gene expression.",
    "vicuna-7b_fact": [
      "The National Center for Biotechnology Information's (NCBI) SNP database contains a large collection of SNPs, including those that may affect transcription factor binding affinity.",
      "The Genome-Wide Association Studies (GWAS) database contains information on genetic variants associated with various traits and diseases, including those that may affect transcription factor binding affinity.",
      "The Encyclopedia of DNA Elements (ENCODE) project provides a comprehensive catalog of functional elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.",
      "The Roadmap Epigenomics Project provides a comprehensive catalog of epigenetic marks and regulatory elements in the human genome, including transcription factor binding sites and regulatory SNPs that may affect their affinity.",
      "These databases can be used by researchers studying the effects of regulatory SNPs on transcription factor binding affinity and gene expression."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3352,
    "user_query": "Which R package has been developed for MS-based label-free phosphoproteomics?",
    "vicuna-7b_response": "There are several R packages that have been developed for MS-based label-free phosphoproteomics. One such package is \"PhosphoRS\", which is a comprehensive tool for the analysis of phosphorylation sites in proteins. It provides a wide range of features, including the ability to identify and quantify phosphorylation sites, as well as to compare phosphorylation levels between different samples. Another package that can be used for this purpose is \"PhosphoRS-MS\", which is a modification site prediction tool that can be used to identify phosphorylation sites in proteins. It can be used in conjunction with other MS-based tools to provide a complete analysis of phosphoproteomics data.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"PhosphoRS\" R package has been developed for MS-based label-free phosphoproteomics.\n2. \"PhosphoRS\" is a tool for the analysis of phosphorylation sites in proteins.\n3. The \"PhosphoRS\" package features the ability to identify and quantify phosphorylation sites, and to compare phosphorylation levels between different samples.\n4. Another package developed for MS-based label-free phosphoproteomics is \"PhosphoRS-MS\".\n5. The \"PhosphoRS-MS\" package is a modification site prediction tool that can identify phosphorylation sites in proteins.",
    "vicuna-7b_fact": [
      "The \"PhosphoRS\" R package has been developed for MS-based label-free phosphoproteomics.",
      "\"PhosphoRS\" is a tool for the analysis of phosphorylation sites in proteins.",
      "The \"PhosphoRS\" package features the ability to identify and quantify phosphorylation sites, and to compare phosphorylation levels between different samples.",
      "Another package developed for MS-based label-free phosphoproteomics is \"PhosphoRS-MS\".",
      "The \"PhosphoRS-MS\" package is a modification site prediction tool that can identify phosphorylation sites in proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "vicuna-7b_response": "Yes, there is a vaccine for peanut allergy. It is called the AR101 vaccine and it is the first and only FDA-approved vaccine for the prevention of peanut allergy in children.\nThe AR101 vaccine is administered in two doses, with the first dose given at 4-6 years of age and the second dose given 6-12 months later. The vaccine is designed to gradually increase the body's tolerance to peanut protein, which can help prevent the development of peanut allergy.\nIt is important to note that the vaccine is not a cure for peanut allergy and it does not eliminate the risk of an allergic reaction to peanuts. However, it can significantly reduce the risk of developing a peanut allergy and can provide long-term protection against the allergy.\nIt is also important to note that the vaccine is not recommended for individuals who have a severe allergy to peanuts or any other ingredients in the vaccine.\nIt is important to consult with a healthcare provider to determine if the vaccine is appropriate for you or your child.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There is a vaccine for peanut allergy called the AR101 vaccine.\n2. The AR101 vaccine is the first and only FDA-approved vaccine for the prevention of peanut allergy in children.\n3. The AR101 vaccine is administered in two doses, with the first dose given at 4-6 years of age and the second dose 6-12 months later.\n4. The vaccine is designed to increase the body's tolerance to peanut protein to prevent the development of a peanut allergy.\n5. AR101 vaccine is not recommended for individuals who have a severe allergy to peanuts or any other ingredients in the vaccine.",
    "vicuna-7b_fact": [
      "There is a vaccine for peanut allergy called the AR101 vaccine.",
      "The AR101 vaccine is the first and only FDA-approved vaccine for the prevention of peanut allergy in children.",
      "The AR101 vaccine is administered in two doses, with the first dose given at 4-6 years of age and the second dose 6-12 months later.",
      "The vaccine is designed to increase the body's tolerance to peanut protein to prevent the development of a peanut allergy.",
      "AR101 vaccine is not recommended for individuals who have a severe allergy to peanuts or any other ingredients in the vaccine."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The AR101, also known as Palforzia, isn't a vaccine, but an oral immunotherapy approved by FDA for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut in children.\n3. FALSE [correction]: The AR101 is not a vaccine and it doesn't have a two-dose schedule. It rather involves initial dose escalation, up-dosing, and daily maintenance doses.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3358,
    "user_query": "What is Soluvia?",
    "vicuna-7b_response": "Soluvia is a brand name for a medication called hydrochlorothiazide. It is a diuretic medication that is used to treat various medical conditions such as high blood pressure, heart failure, and swelling caused by excess fluid buildup. Soluvia works by increasing the amount of urine produced by the body, which helps to remove excess fluid and reduce blood pressure.\nSoluvia is available in tablet form and is usually taken once daily, usually in the morning. It is important to follow the dosage instructions provided by your healthcare provider and to continue taking the medication as directed to achieve the best results.\nIt is important to note that Soluvia is not suitable for everyone and may cause side effects such as dizziness, lightheadedness, and an increase in the need to urinate. If you experience any side effects while taking Soluvia, it is important to inform your healthcare provider.\nIt is also important to inform your healthcare provider if you have any medical conditions, such as liver or kidney disease, or if you are taking any other medications, as these may affect how Soluvia works or interact with other medications you are taking.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Soluvia is a brand name for a medication called hydrochlorothiazide.\n2. Soluvia is a diuretic medication used to treat conditions like high blood pressure, heart failure, and swelling caused by excess fluid buildup.\n3. Soluvia works by increasing the amount of urine produced by the body, helping to remove excess fluid and reduce blood pressure.\n4. This medication may cause side effects such as dizziness, lightheadedness, and an increase in the need to urinate.\n5. Certain medical conditions, such as liver or kidney disease, and other medications may affect how Soluvia works or interact with it.",
    "vicuna-7b_fact": [
      "Soluvia is a brand name for a medication called hydrochlorothiazide.",
      "Soluvia is a diuretic medication used to treat conditions like high blood pressure, heart failure, and swelling caused by excess fluid buildup.",
      "Soluvia works by increasing the amount of urine produced by the body, helping to remove excess fluid and reduce blood pressure.",
      "This medication may cause side effects such as dizziness, lightheadedness, and an increase in the need to urinate.",
      "Certain medical conditions, such as liver or kidney disease, and other medications may affect how Soluvia works or interact with it."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3361,
    "user_query": "What is the main difference between nascent and mature chromatin?",
    "vicuna-7b_response": "Nascent chromatin refers to the newly synthesized chromatin that is being assembled on the nuclear envelope during the S phase of the cell cycle. It is characterized by the presence of histone H1, which is not found in mature chromatin.\nMature chromatin, on the other hand, refers to the chromatin that has been fully assembled and compacted into a chromosome. It is characterized by the presence of histone variants, such as H2A, H2B, H3, and H4, which are responsible for the compaction of the chromatin into a compact structure.\nIn summary, the main difference between nascent and mature chromatin is the stage of chromatin assembly. Nascent chromatin is in the process of being assembled, while mature chromatin has been fully assembled and compacted.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nascent chromatin refers to the newly synthesized chromatin that is being assembled on the nuclear envelope during the S phase of the cell cycle.\n2. Nascent chromatin is characterized by the presence of histone H1.\n3. Mature chromatin refers to the chromatin that has been fully assembled and compacted into a chromosome.\n4. Mature chromatin is characterized by the presence of histone variants, such as H2A, H2B, H3, and H4.\n5. The main difference between nascent and mature chromatin is the stage of chromatin assembly.",
    "vicuna-7b_fact": [
      "Nascent chromatin refers to the newly synthesized chromatin that is being assembled on the nuclear envelope during the S phase of the cell cycle.",
      "Nascent chromatin is characterized by the presence of histone H1.",
      "Mature chromatin refers to the chromatin that has been fully assembled and compacted into a chromosome.",
      "Mature chromatin is characterized by the presence of histone variants, such as H2A, H2B, H3, and H4.",
      "The main difference between nascent and mature chromatin is the stage of chromatin assembly."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3362,
    "user_query": "Is CTCF bound at nucleosome free regions?",
    "vicuna-7b_response": "Yes, CTCF (CCCTC-binding factor) is known to be bound at nucleosome free regions. CTCF is a transcriptional regulator that plays a crucial role in the regulation of chromatin structure and gene expression. It is known to bind to DNA sequences that are located at nucleosome free regions, such as the intergenic regions, promoter and enhancer regions, and also at the boundary of chromosomes.\nCTCF binds to DNA sequences through its zinc finger motifs, which recognize specific DNA sequences. Once bound, CTCF can recruit other proteins to the site, such as transcriptional activators or repressors, to regulate gene expression.\nIn addition, CTCF has also been shown to play a role in the regulation of chromatin structure by forming higher-order chromatin structures, such as nucleosome-free domains, and by modulating the interactions between chromatin and histones.\nOverall, CTCF is an important factor in the regulation of gene expression and chromatin structure, and it is known to be bound at nucleosome free regions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC-binding factor) is known to be bound at nucleosome free regions.\n2. CTCF is a transcriptional regulator that plays a crucial role in the regulation of chromatin structure and gene expression.\n3. CTCF binds to DNA sequences through its zinc finger motifs.\n4. CTCF can recruit other proteins to its binding site, such as transcriptional activators or repressors, to regulate gene expression.\n5. CTCF plays a role in forming higher-order chromatin structures.",
    "vicuna-7b_fact": [
      "CTCF (CCCTC-binding factor) is known to be bound at nucleosome free regions.",
      "CTCF is a transcriptional regulator that plays a crucial role in the regulation of chromatin structure and gene expression.",
      "CTCF binds to DNA sequences through its zinc finger motifs.",
      "CTCF can recruit other proteins to its binding site, such as transcriptional activators or repressors, to regulate gene expression.",
      "CTCF plays a role in forming higher-order chromatin structures."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3364,
    "user_query": "Is PRDM9 essential for meiosis?",
    "vicuna-7b_response": "PRDM9 is a protein that plays a crucial role in the initiation and progression of meiosis. It is a member of the PRDM9 family of proteins, which includes several other proteins that are involved in the regulation of meiotic progression.\nPRDM9 is expressed in the germ cells of the testis and ovaries, and its expression is tightly regulated during meiosis. It is thought to play a role in the initiation of meiosis by promoting the formation of the first meiotic pairing of homologous chromosomes. This pairing is essential for the proper segregation of genetic material during meiosis and is required for the successful completion of meiosis and the production of viable gametes.\nIn addition to its role in the initiation of meiosis, PRDM9 is also involved in the progression of meiosis. It has been shown to play a role in the formation of the synaptonemal complex, a structure that is essential for the proper pairing and alignment of homologous chromosomes during meiosis. The synaptonemal complex is a key structure that is involved in the proper segregation of genetic material during meiosis and its formation is regulated by PRDM9.\nOverall, PRDM9 is an essential protein for the proper initiation and progression of meiosis. Its role in the regulation of meiotic progression and the formation of the synaptonemal complex make it a key player in the proper segregation of genetic material during meiosis and the production of viable gametes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PRDM9 is a protein that plays a crucial role in the initiation and progression of meiosis.\n2. PRDM9 is expressed in the germ cells of the testis and ovaries.\n3. PRDM9 promotes the formation of the first meiotic pairing of homologous chromosomes, a process that is essential for the proper segregation of genetic material during meiosis.\n4. PRDM9 is involved in the formation of the synaptonemal complex, a structure that aids the proper pairing and alignment of homologous chromosomes during meiosis.\n5. The formation of the synaptonemal complex is regulated by PRDM9.",
    "vicuna-7b_fact": [
      "PRDM9 is a protein that plays a crucial role in the initiation and progression of meiosis.",
      "PRDM9 is expressed in the germ cells of the testis and ovaries.",
      "PRDM9 promotes the formation of the first meiotic pairing of homologous chromosomes, a process that is essential for the proper segregation of genetic material during meiosis.",
      "PRDM9 is involved in the formation of the synaptonemal complex, a structure that aids the proper pairing and alignment of homologous chromosomes during meiosis.",
      "The formation of the synaptonemal complex is regulated by PRDM9."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-7b_response": "The mouse Fxy gene is located on chromosome 10 at position 10.10. The gene is composed of 10 exons and spans approximately 100 kilobases. The Fxy gene encodes for a protein that is involved in the regulation of cell growth and differentiation. The Fxy protein is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes involved in cell proliferation and apoptosis. The Fxy gene has been shown to be important in the development of various tissues, including the brain, heart, and skeletal muscle.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The mouse Fxy gene is located on chromosome 10 at position 10.10. \n2. The Fxy gene is composed of 10 exons and spans approximately 100 kilobases.\n3. The Fxy gene encodes for a protein that is involved in the regulation of cell growth and differentiation.\n4. The Fxy protein is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes.\n5. The Fxy gene plays a significant role in the development of various tissues, including the brain, heart, and skeletal muscle.",
    "vicuna-7b_fact": [
      "The mouse Fxy gene is located on chromosome 10 at position 10.10.",
      "The Fxy gene is composed of 10 exons and spans approximately 100 kilobases.",
      "The Fxy gene encodes for a protein that is involved in the regulation of cell growth and differentiation.",
      "The Fxy protein is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes.",
      "The Fxy gene plays a significant role in the development of various tissues, including the brain, heart, and skeletal muscle."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3367,
    "user_query": "What does a PET (Positron Excitation Tomography) measure?",
    "vicuna-7b_response": "PET (Positron Emission Tomography) is a medical imaging technique that measures the emission of positrons from a patient's body. Positrons are the antimatter counterpart of electrons, and when they are introduced into the body, they can bind to other atoms and molecules, creating a signal that can be detected by a PET scanner.\nPET scanners use a small amount of a radioactive tracer, which is typically a type of sugar or another molecule that is easily taken up by the body's cells. The tracer is injected into the patient, and then the PET scanner detects the emission of positrons from the tracer as it travels through the body. The emitted positrons are then detected by the scanner, and the data is used to create detailed images of the body's internal structures and functions.\nPET scans are commonly used to diagnose and monitor a variety of medical conditions, including cancer, heart disease, and neurological disorders. They can also be used to evaluate the effectiveness of certain treatments, such as radiation therapy or chemotherapy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PET (Positron Emission Tomography) is a medical imaging technique.\n2. The PET technique measures the emission of positrons from a patient's body.\n3. PET scanners use a small amount of a radioactive tracer which is typically a type of sugar or another molecule easily absorbed by the body's cells.\n4. PET scans are commonly used to diagnose and monitor medical conditions, including cancer, heart disease, and neurological disorders.\n5. PET scans can also be used to evaluate the effectiveness of certain treatments, such as radiation therapy or chemotherapy.",
    "vicuna-7b_fact": [
      "PET (Positron Emission Tomography) is a medical imaging technique.",
      "The PET technique measures the emission of positrons from a patient's body.",
      "PET scanners use a small amount of a radioactive tracer which is typically a type of sugar or another molecule easily absorbed by the body's cells.",
      "PET scans are commonly used to diagnose and monitor medical conditions, including cancer, heart disease, and neurological disorders.",
      "PET scans can also be used to evaluate the effectiveness of certain treatments, such as radiation therapy or chemotherapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3371,
    "user_query": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Minocycline is a tetracycline antibiotic that has been studied for its potential therapeutic effects in amyotrophic lateral sclerosis (ALS). While there have been some preclinical studies that suggest minocycline may have neuroprotective effects, there have been no large-scale clinical trials specifically investigating its use in ALS.\nOne small study published in the journal Neurology in 2011 looked at the effects of minocycline in a group of 12 patients with ALS. The study found that minocycline was well-tolerated and appeared to slow the progression of the disease, as measured by the ALS Functional Rating Scale (ALSFRS). However, this study was small and had a limited sample size, and more research is needed to confirm these findings.\nAnother study published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration in 2017 looked at the effects of minocycline in a mouse model of ALS. The study found that minocycline had neuroprotective effects and slowed the progression of the disease. However, this study was conducted in mice and more research is needed to determine if these effects would be seen in humans.\nOverall, while there is some preliminary evidence suggesting that minocycline may have potential therapeutic effects in ALS, more research is needed to confirm these findings and determine the safety and efficacy of the drug in humans. It is important to note that there are currently no FDA-approved treatments for ALS, and clinical trials are ongoing to evaluate new potential therapies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Minocycline is a tetracycline antibiotic.\n2. A small study published in the Journal of Neurology in 2011 found potential therapeutic effects of minocycline in a group of 12 patients with ALS.\n3. The study in 2011 used the ALS Functional Rating Scale (ALSFRS) to measure disease progression. \n4. A study published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration in 2017 suggested neuroprotective effects of minocycline in a mouse model of ALS.\n5. Currently, there are no FDA-approved treatments for ALS.",
    "vicuna-7b_fact": [
      "Minocycline is a tetracycline antibiotic.",
      "A small study published in the Journal of Neurology in 2011 found potential therapeutic effects of minocycline in a group of 12 patients with ALS.",
      "The study in 2011 used the ALS Functional Rating Scale (ALSFRS) to measure disease progression.",
      "A study published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration in 2017 suggested neuroprotective effects of minocycline in a mouse model of ALS.",
      "Currently, there are no FDA-approved treatments for ALS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [Correction]: There are FDA-approved treatments for ALS, such as Riluzole and Edaravone.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3374,
    "user_query": "What is the function of the ISW1 and CHD1 remodellers in yeast chromatin?",
    "vicuna-7b_response": "The ISW1 and CHD1 remodellers are two important chromatin-remodeling complexes in yeast that play crucial roles in regulating gene expression.\nThe ISW1 complex, also known as the ISWI chromatin remodeler, is composed of several subunits that are involved in the remodeling of chromatin structure. The ISW1 complex is responsible for the exchange of nucleosomes, which are the basic units of chromatin, and for the movement of chromatin along DNA. This allows for the accessibility of gene promoters and enhancers to transcription factors, which is essential for proper gene expression.\nThe CHD1 complex, on the other hand, is involved in the remodeling of chromatin structure through the recruitment of histone-modifying enzymes. The CHD1 complex is composed of several subunits, including the CHD1 protein, which is responsible for the recognition of specific DNA sequences. The CHD1 complex is able to modify the structure of chromatin by adding or removing histone modifications, which can either open up or close off gene promoters and enhancers.\nOverall, the ISW1 and CHD1 remodellers play important roles in regulating gene expression by modifying the structure of chromatin and allowing for access to gene promoters and enhancers.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ISW1 and CHD1 remodellers are two important chromatin-remodeling complexes in yeast that are involved in regulating gene expression.\n2. The ISW1 complex is composed of several subunits and is responsible for the exchange of nucleosomes and the movement of chromatin along DNA.\n3. The ISW1 complex aids the accessibility of gene promoters and enhancers to transcription factors which is essential for proper gene expression.\n4. The CHD1 complex is involved in the remodeling of chromatin structure through the recruitment of histone-modifying enzymes.\n5. The CHD1 complex can modify the structure of chromatin by adding or removing histone modifications which can either open up or close off gene promoters and enhancers.",
    "vicuna-7b_fact": [
      "The ISW1 and CHD1 remodellers are two important chromatin-remodeling complexes in yeast that are involved in regulating gene expression.",
      "The ISW1 complex is composed of several subunits and is responsible for the exchange of nucleosomes and the movement of chromatin along DNA.",
      "The ISW1 complex aids the accessibility of gene promoters and enhancers to transcription factors which is essential for proper gene expression.",
      "The CHD1 complex is involved in the remodeling of chromatin structure through the recruitment of histone-modifying enzymes.",
      "The CHD1 complex can modify the structure of chromatin by adding or removing histone modifications which can either open up or close off gene promoters and enhancers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3382,
    "user_query": "What is the difference between Daptacel and Pentacel?",
    "vicuna-7b_response": "Daptacel and Pentacel are both vaccines that protect against diphtheria, tetanus, and pertussis (also known as whooping cough). However, there are some key differences between the two vaccines.\nDaptacel is a diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine. It is given to children as part of the routine immunization schedule to protect against these three diseases. Daptacel is administered in five doses, with the first dose given at two months of age and the final dose given at 6 years of age.\nPentacel, on the other hand, is a combination vaccine that contains diphtheria and tetanus toxoids and acellular pertussis (DTaP), as well as inactivated poliovirus and Haemophilus influenzae type b (Hib) bacteria. It is also given to children as part of the routine immunization schedule, with the first dose given at two months of age and the final dose given at 18 months of age.\nThe main difference between Daptacel and Pentacel is that Pentacel also protects against poliovirus and Hib, in addition to diphtheria, tetanus, and pertussis. This makes Pentacel a more comprehensive vaccine that provides protection against a broader range of diseases.\nOverall, both Daptacel and Pentacel are effective vaccines that can help protect children against diphtheria, tetanus, pertussis, poliovirus, and Hib. The choice of which vaccine to use depends on the specific needs of the child and the recommendations of the child's healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Daptacel and Pentacel are vaccines that protect against diphtheria, tetanus, and pertussis.\n2. Daptacel is a diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine.\n3. Daptacel is administered in five doses, from two months to 6 years of age.\n4. Pentacel is a combination vaccine that contains diphtheria and tetanus toxoids and acellular pertussis (DTaP), as well as inactivated poliovirus and Haemophilus influenzae type b (Hib) bacteria.\n5. The first dose of Pentacel is given at two months of age and the final dose is given at 18 months of age.",
    "vicuna-7b_fact": [
      "Daptacel and Pentacel are vaccines that protect against diphtheria, tetanus, and pertussis.",
      "Daptacel is a diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine.",
      "Daptacel is administered in five doses, from two months to 6 years of age.",
      "Pentacel is a combination vaccine that contains diphtheria and tetanus toxoids and acellular pertussis (DTaP), as well as inactivated poliovirus and Haemophilus influenzae type b (Hib) bacteria.",
      "The first dose of Pentacel is given at two months of age and the final dose is given at 18 months of age."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The first dose of Pentacel is given at two months of age and the final dose is given between 4 to 6 years of age.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3389,
    "user_query": "What is herd immunity?",
    "vicuna-7b_response": "Herd immunity is a concept in epidemiology that refers to the protection of a population from infectious diseases that is achieved when a sufficient proportion of individuals in the population are immune to the disease. This can be achieved through vaccination, natural infection, or other means of immunity.\nWhen a large proportion of a population is immune to a particular disease, it becomes difficult for the disease to spread and maintain a foothold in the population. This is because there are fewer susceptible individuals for the virus or bacteria to infect, and the immune individuals can act as a barrier, preventing the disease from spreading further.\nHerd immunity is important because it helps to protect vulnerable individuals in the population who may not be able to receive vaccines or who may be too young to be vaccinated. It also helps to prevent the spread of infectious diseases in communities and can help to control the spread of diseases in populations that may be at risk of outbreaks.\nIt is important to note that herd immunity can be achieved through different levels of immunity, and different diseases may require different levels of immunity to be considered herd immune. Additionally, herd immunity can be compromised if the proportion of immune individuals in the population falls below a certain threshold, which can lead to outbreaks of the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Herd immunity is a concept in epidemiology that refers to the protection of a population from infectious diseases when a sufficient proportion of individuals in the population are immune to the disease.\n2. Herd immunity can be achieved through vaccination, natural infection, or other means of immunity.\n3. Herd immunity protects vulnerable individuals in the population who may not be able to receive vaccines or who may be too young to be vaccinated.\n4. Different diseases may require different levels of immunity to be considered herd immune.\n5. Herd immunity can be compromised if the proportion of immune individuals in the population falls below a certain threshold, which can lead to outbreaks of the disease.",
    "vicuna-7b_fact": [
      "Herd immunity is a concept in epidemiology that refers to the protection of a population from infectious diseases when a sufficient proportion of individuals in the population are immune to the disease.",
      "Herd immunity can be achieved through vaccination, natural infection, or other means of immunity.",
      "Herd immunity protects vulnerable individuals in the population who may not be able to receive vaccines or who may be too young to be vaccinated.",
      "Different diseases may require different levels of immunity to be considered herd immune.",
      "Herd immunity can be compromised if the proportion of immune individuals in the population falls below a certain threshold, which can lead to outbreaks of the disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3391,
    "user_query": "List the stages/types of Multiple Sclerosis.",
    "vicuna-7b_response": "Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS). The disease is characterized by inflammation and demyelination of the nerve cells, leading to a range of symptoms and disabilities. The stages or types of MS are based on the degree of disability and the number of lesions found on MRI scans.\nThere are four main types of MS:\n1. Relapsing-Remitting MS (RRMS): This is the most common form of MS, characterized by recurring attacks of neurological symptoms, followed by periods of remission.\n2. Primary Progressive MS (PPMS): In this form of MS, symptoms progressively worsen over time without any periods of remission.\n3. Secondary Progressive MS (SPMS): This form of MS begins as relapsing-remitting MS and then transforms into primary progressive MS.\n4. Progressive Relapsing MS (PRMS): This is a rare form of MS characterized by a steady decline in neurological function, punctuated by occasional relapses.\nIt's important to note that not all people with MS will fit neatly into one of these categories, and the disease can also present with a combination of these types. Additionally, there are other subtypes of MS that may be identified based on specific characteristics of the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system.\n2. The stages or types of Multiple Sclerosis are determined by the degree of disability and the number of lesions found on MRI scans.\n3. Relapsing-Remitting MS, the most common form, is characterized by recurring attacks of neurological symptoms, followed by periods of remission.\n4. Primary Progressive MS involves symptoms that progressively worsen over time without any periods of remission.\n5. Progressive Relapsing MS is a rare form of MS characterized by a steady decline in neurological function, punctuated by occasional relapses.",
    "vicuna-7b_fact": [
      "Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system.",
      "The stages or types of Multiple Sclerosis are determined by the degree of disability and the number of lesions found on MRI scans.",
      "Relapsing-Remitting MS, the most common form, is characterized by recurring attacks of neurological symptoms, followed by periods of remission.",
      "Primary Progressive MS involves symptoms that progressively worsen over time without any periods of remission.",
      "Progressive Relapsing MS is a rare form of MS characterized by a steady decline in neurological function, punctuated by occasional relapses."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Progressive Relapsing MS is not a currently recognized course of the disease by most of the medical community. There is Relapsing-Remitting MS, Secondary Progressive, Primary Progressive, and Progressive-Relapsing was previously a sub-category of Primary progressive. In this form of MS, a person’s disability gradually gets worse over time, just like primary progressive MS, but they also experience superimposed relapses, similar to relapsing-remitting MS. This form is considered relatively rare.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3396,
    "user_query": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "vicuna-7b_response": "No. Autophagy is the process by which a cell breaks down and recycles its own components, including proteins and organelles, to maintain cellular homeostasis. It is not a process by which a virus obtains nutrients from its host.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process through which a cell breaks down and recycles its own components.\n2. Proteins and organelles can be broken down and recycled by a cell via autophagy.\n3. The aim of autophagy is to maintain cellular homeostasis.\n4. Autophagy is not a process by which a virus obtains nutrients from its host.",
    "vicuna-7b_fact": [
      "Autophagy is a process through which a cell breaks down and recycles its own components.",
      "Proteins and organelles can be broken down and recycled by a cell via autophagy.",
      "The aim of autophagy is to maintain cellular homeostasis.",
      "Autophagy is not a process by which a virus obtains nutrients from its host."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Autophagy can be a process by which a virus obtains nutrients from its host.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-7b_response": "Methidiumpropyl-EDTA (MPE) sequencing is a method used to sequence DNA molecules by using MPE as a primer for DNA amplification. MPE is a modified nucleotide analog that contains a methidium group, which is a derivative of psoralen, and a propyl group. The methidium group allows MPE to bind to DNA through its intercalating properties, while the propyl group enhances the stability of the MPE-DNA complex.\nThe MPE-seq method involves the following steps:\n1. MPE is added to the DNA sample to make the MPE-DNA complex.\n2. The complex is denatured to separate the DNA strands.\n3. The denatured DNA is then amplified using PCR, with MPE as the primer.\n4. The amplified product is then sequenced using standard DNA sequencing techniques, such as capillary electrophoresis or Sanger sequencing.\nThe MPE-seq method has several advantages over other sequencing methods, such as its ability to sequence long DNA molecules, its high sensitivity and specificity, and its ability to sequence both DNA and RNA. However, it also has some limitations, such as the potential for cross-linking to other nucleic acids and the need for specialized equipment and expertise.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Methidiumpropyl-EDTA (MPE) sequencing is used to sequence DNA molecules.\n2. MPE is a modified nucleotide analog that contains a methidium group and a propyl group.\n3. The MPE-seq method involves adding MPE to a DNA sample to make the MPE-DNA complex, which is then denatured, amplified using PCR with MPE as the primer, and sequenced using standard DNA sequencing techniques.\n4. MPE-seq has several advantages over other sequencing methods, including the ability to sequence long DNA molecules, its high sensitivity and specificity, and its ability to sequence both DNA and RNA.\n5. However, MPE-seq also has limitations such as the potential for cross-linking to other nucleic acids and the need for specialized equipment and expertise.",
    "vicuna-7b_fact": [
      "Methidiumpropyl-EDTA (MPE) sequencing is used to sequence DNA molecules.",
      "MPE is a modified nucleotide analog that contains a methidium group and a propyl group.",
      "The MPE-seq method involves adding MPE to a DNA sample to make the MPE-DNA complex, which is then denatured, amplified using PCR with MPE as the primer, and sequenced using standard DNA sequencing techniques.",
      "MPE-seq has several advantages over other sequencing methods, including the ability to sequence long DNA molecules, its high sensitivity and specificity, and its ability to sequence both DNA and RNA.",
      "However, MPE-seq also has limitations such as the potential for cross-linking to other nucleic acids and the need for specialized equipment and expertise."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3399,
    "user_query": "Does CXorf21 escape X chromosome inactivation?",
    "vicuna-7b_response": "CXorf21 is a gene located on the X chromosome that encodes a protein with unknown function. The function of CXorf21 is not well understood, but it is thought to be involved in the regulation of gene expression.\nIn mammals, the X chromosome is subject to a process called X chromosome inactivation, in which one of the two X chromosomes in each cell is randomly inactivated for the lifetime of the cell. This process ensures that the dosage of X-linked genes is balanced between the two sexes, as males only have one X chromosome and females have two.\nThere is limited information available on the role of CXorf21 in X chromosome inactivation. Some studies have suggested that CXorf21 may be involved in the regulation of X chromosome inactivation, but the exact mechanism by which it does this is not well understood.\nIn summary, while there is some evidence to suggest that CXorf21 may be involved in the regulation of X chromosome inactivation, the exact role of the gene in this process is not well understood. Further research is needed to fully understand the function of CXorf21 and its role in X chromosome inactivation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CXorf21 is a gene located on the X chromosome.\n2. This gene encodes a protein with an unknown function.\n3. In mammals, one of the two X chromosomes in each cell undergoes X chromosome inactivation.\n4. X chromosome inactivation ensures that the dosage of X-linked genes is balanced between the two sexes.\n5. There is limited information on the role of CXorf21 in X chromosome inactivation.",
    "vicuna-7b_fact": [
      "CXorf21 is a gene located on the X chromosome.",
      "This gene encodes a protein with an unknown function.",
      "In mammals, one of the two X chromosomes in each cell undergoes X chromosome inactivation.",
      "X chromosome inactivation ensures that the dosage of X-linked genes is balanced between the two sexes.",
      "There is limited information on the role of CXorf21 in X chromosome inactivation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-7b_response": "GWAR is a web-based game development platform that allows users to create and share their own games. It is built using a combination of technologies, including HTML, CSS, JavaScript, and a few other web technologies.\nHTML (Hypertext Markup Language) is used to define the structure and content of a web page. It provides a way to define the different elements of a web page, such as headings, paragraphs, images, and links.\nCSS (Cascading Style Sheets) is used to define the visual style of a web page, such as colors, fonts, and layout. It allows developers to create a consistent look and feel for their web pages.\nJavaScript is used to add interactive elements to a web page. It allows developers to add animations, interactions, and other dynamic effects to their web pages.\nGWAR also uses a few other web technologies, such as WebGL (Web Graphics Library) for 3D graphics, and WebRTC (Web Real-Time Communication) for real-time communication between users.\nOverall, GWAR is built using a combination of web technologies that allow developers to create and share their own games on the web.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GWAR is a web-based game development platform.\n2. HTML (Hypertext Markup Language) is used in GWAR to define the structure and content of a web page.\n3. CSS (Cascading Style Sheets) is used in GWAR to define the visual style of a web page.\n4. JavaScript is used in GWAR to add interactive elements to a web page.\n5. GWAR uses WebGL (Web Graphics Library) for 3D graphics and WebRTC (Web Real-Time Communication) for real-time communication between users.",
    "vicuna-7b_fact": [
      "GWAR is a web-based game development platform.",
      "HTML (Hypertext Markup Language) is used in GWAR to define the structure and content of a web page.",
      "CSS (Cascading Style Sheets) is used in GWAR to define the visual style of a web page.",
      "JavaScript is used in GWAR to add interactive elements to a web page.",
      "GWAR uses WebGL (Web Graphics Library) for 3D graphics and WebRTC (Web Real-Time Communication) for real-time communication between users."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3401,
    "user_query": "Describe f-scLVM",
    "vicuna-7b_response": "f-scLVM is a type of linear vector model (LVM) that is used to model the relationship between a dependent variable and one or more independent variables. It is a type of multiple linear regression model that is used to predict the value of the dependent variable based on the values of the independent variables.\nIn f-scLVM, the dependent variable is modeled as a function of the independent variables, where the function is represented by a set of coefficients. The coefficients are estimated using a statistical method, such as ordinary least squares (OLS) regression, which minimizes the sum of the squared errors between the predicted and actual values of the dependent variable.\nThe f-scLVM is a generalization of the ordinary least squares (OLS) regression, where the OLS regression assumes that the errors are normally distributed and have a constant variance. The f-scLVM allows for the errors to have a different distribution and variance for each independent variable.\nThe f-scLVM is widely used in various fields such as economics, finance, engineering, and social sciences, to model complex relationships between variables. It is particularly useful when the relationship between the variables is non-linear, or when the errors have different variances for each independent variable.\nIn summary, f-scLVM is a multiple linear regression model that is used to predict the value of the dependent variable based on the values of the independent variables. It is a generalization of the ordinary least squares (OLS) regression that allows for the errors to have a different distribution and variance for each independent variable.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. f-scLVM is a type of linear vector model (LVM).\n2. f-scLVM is used to model the relationship between a dependent variable and one or more independent variables.\n3. In f-scLVM, the dependent variable is modeled as a function of the independent variables.\n4. f-scLVM is a generalization of the ordinary least squares (OLS) regression.\n5. f-scLVM is used in various fields such as economics, finance, engineering, and social sciences.",
    "vicuna-7b_fact": [
      "f-scLVM is a type of linear vector model (LVM).",
      "f-scLVM is used to model the relationship between a dependent variable and one or more independent variables.",
      "In f-scLVM, the dependent variable is modeled as a function of the independent variables.",
      "f-scLVM is a generalization of the ordinary least squares (OLS) regression.",
      "f-scLVM is used in various fields such as economics, finance, engineering, and social sciences."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3403,
    "user_query": "How large is a lncRNAs?",
    "vicuna-7b_response": "Long non-coding RNAs (lncRNAs) are a type of non-coding RNA molecule that is longer than 200 nucleotides in length. The size of lncRNAs can vary greatly, with some being only a few hundred nucleotides in length, while others can be several kilobases in length.\nThe size of lncRNAs can affect their function and regulation. For example, lncRNAs that are shorter in length may be more likely to be translated into proteins, while longer lncRNAs may have a more significant role in regulating gene expression through interactions with proteins and other RNA molecules.\nIt is also worth noting that the size of lncRNAs can be affected by the presence of introns and exons in the RNA molecule. Introns are sequences of DNA that are removed from the RNA molecule during the process of RNA splicing, while exons are the sequences that are retained in the final RNA product. The size of lncRNAs can be affected by the number and length of introns and exons in the RNA molecule.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNAs (lncRNAs) are a type of non-coding RNA molecule that is longer than 200 nucleotides in length.\n2. The size of lncRNAs can vary greatly.\n3. The size of lncRNAs can impact their function and regulation.\n4. Shorter lncRNAs may be more likely to be translated into proteins than longer ones.\n5. The size of lncRNAs can be affected by the presence of introns and exons in the RNA molecule.",
    "vicuna-7b_fact": [
      "Long non-coding RNAs (lncRNAs) are a type of non-coding RNA molecule that is longer than 200 nucleotides in length.",
      "The size of lncRNAs can vary greatly.",
      "The size of lncRNAs can impact their function and regulation.",
      "Shorter lncRNAs may be more likely to be translated into proteins than longer ones.",
      "The size of lncRNAs can be affected by the presence of introns and exons in the RNA molecule."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Long non-coding RNAs (lncRNAs) are not typically translated into proteins regardless of their length.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Xaliproden is a drug that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. However, the evidence regarding the effectiveness of xaliproden in improving the prognosis of ALS is limited and inconclusive.\nXaliproden is a selective agonist of the melanocortin-4 receptor (MC4R), which is a receptor that is involved in the regulation of appetite, metabolism, and inflammation. Some studies have suggested that xaliproden may have neuroprotective effects and may slow the progression of ALS in animal models of the disease. However, these studies have not been replicated in clinical trials in humans.\nThere have been two clinical trials of xaliproden in patients with ALS, but both of these trials were small and had limited power to detect a difference in the progression of the disease. The first trial found that xaliproden was well-tolerated and had no significant effect on the progression of the disease, while the second trial found that xaliproden was associated with a slight delay in the decline of respiratory function, but again, the study was not large enough to determine whether this was statistically significant.\nOverall, while xaliproden may have some potential as a treatment for ALS, the evidence regarding its effectiveness in improving the prognosis of the disease is limited and inconclusive. Further research is needed to determine the safety and efficacy of xaliproden in treating ALS.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Xaliproden is a drug that has been studied for treating amyotrophic lateral sclerosis (ALS).\n2. Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).\n3. The melanocortin-4 receptor (MC4R) is involved in the regulation of appetite, metabolism, and inflammation.\n4. There have been two clinical trials of xaliproden in patients with ALS.\n5. The evidence regarding the effectiveness of xaliproden in improving the prognosis of ALS is limited and inconclusive.",
    "vicuna-7b_fact": [
      "Xaliproden is a drug that has been studied for treating amyotrophic lateral sclerosis (ALS).",
      "Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).",
      "The melanocortin-4 receptor (MC4R) is involved in the regulation of appetite, metabolism, and inflammation.",
      "There have been two clinical trials of xaliproden in patients with ALS.",
      "The evidence regarding the effectiveness of xaliproden in improving the prognosis of ALS is limited and inconclusive."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Xaliproden is a neuroprotective agent, not a selective agonist of the melanocortin-4 receptor (MC4R).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3407,
    "user_query": "What is Telangiectasia?",
    "vicuna-7b_response": "Telangiectasia is a condition characterized by the presence of small, dilated blood vessels on the skin. These vessels are commonly referred to as \"spider veins\" or \"thread veins.\" They are usually red or blue in color and can appear on any part of the body, but are most commonly found on the legs, face, and chest.\nTelangiectasia can be caused by a variety of factors, including genetics, sun exposure, and certain medical conditions such as rosacea, varicose veins, and venous insufficiency. They can also be caused by hormonal changes, such as those experienced during pregnancy or menopause.\nTreatment options for telangiectasia include topical creams, sclerotherapy, laser therapy, and surgical removal. The choice of treatment will depend on the severity of the condition and the individual's specific needs and preferences.\nIt is important to note that while telangiectasia is generally not a serious condition, it can be a cosmetic concern for some individuals. If you are concerned about the appearance of telangiectasia on your skin, it is recommended to speak with a dermatologist or other healthcare provider for further evaluation and treatment options.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Telangiectasia is a condition characterized by the presence of small, dilated blood vessels on the skin.\n2. These vessels are commonly referred to as \"spider veins\" or \"thread veins.\"\n3. Telangiectasia can be caused by a variety of factors, including genetics, sun exposure, and certain medical conditions such as rosacea, varicose veins, and venous insufficiency.\n4. Treatment options for telangiectasia include topical creams, sclerotherapy, laser therapy, and surgical removal.\n5. While telangiectasia is generally not a serious condition, it can be a cosmetic concern for some individuals.",
    "vicuna-7b_fact": [
      "Telangiectasia is a condition characterized by the presence of small, dilated blood vessels on the skin.",
      "These vessels are commonly referred to as \"spider veins\" or \"thread veins.\"",
      "Telangiectasia can be caused by a variety of factors, including genetics, sun exposure, and certain medical conditions such as rosacea, varicose veins, and venous insufficiency.",
      "Treatment options for telangiectasia include topical creams, sclerotherapy, laser therapy, and surgical removal.",
      "While telangiectasia is generally not a serious condition, it can be a cosmetic concern for some individuals."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-7b_response": "The LiPS-A3S line is a transgenic line that was created by inserting the A3S promoter upstream of the luciferase gene. The A3S promoter is a constitutive promoter that is active in all tissues and cell types, and it is commonly used to drive the expression of genes in transgenic animals.\nIn the case of the LiPS-A3S line, the A3S promoter was used to drive the expression of the luciferase gene, which is a reporter gene that encodes an enzyme that catalyzes the conversion of a substrate (luciferin) to light. The luciferase gene was inserted into the genome of the mouse embryonic stem cells that were used to create the LiPS-A3S line, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.\nThe luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting. In this technique, a small piece of DNA that contains the luciferase gene is inserted into the genome of the mouse embryonic stem cells at a specific location, using a special enzyme called a recombinase. The recombinase is used to cut the DNA at a specific site, and then the luciferase gene is inserted into the resulting gap in the DNA. The A3S promoter is then used to drive the expression of the luciferase gene in the cells that contain the transgene.\nIn summary, the LiPS-A3S line was created by inserting the A3S promoter upstream of the luciferase gene, and the A3S promoter was used to drive the expression of the luciferase gene in the mouse embryonic stem cells that were used to create the line. The luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The LiPS-A3S line is a transgenic line created by inserting the A3S promoter upstream of the luciferase gene.\n2. The A3S promoter is active in all tissues and cell types.\n3. The luciferase gene is a reporter gene that encodes an enzyme that catalyzes the conversion of a substrate (luciferin) to light.\n4. The luciferase gene was inserted into the genome of the mouse embryonic stem cells that were used to create the LiPS-A3S line, and the A3S promoter was used to drive its expression.\n5. The technique to insert the luciferase gene into the genome is called gene targeting.",
    "vicuna-7b_fact": [
      "The LiPS-A3S line is a transgenic line created by inserting the A3S promoter upstream of the luciferase gene.",
      "The A3S promoter is active in all tissues and cell types.",
      "The luciferase gene is a reporter gene that encodes an enzyme that catalyzes the conversion of a substrate (luciferin) to light.",
      "The luciferase gene was inserted into the genome of the mouse embryonic stem cells that were used to create the LiPS-A3S line, and the A3S promoter was used to drive its expression.",
      "The technique to insert the luciferase gene into the genome is called gene targeting."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3411,
    "user_query": "What is a J pouch?",
    "vicuna-7b_response": "A J pouch is a type of surgical procedure used to treat ulcerative colitis, a chronic inflammatory bowel disease that affects the lining of the large intestine. In a J pouch procedure, the colon is removed and the remaining intestine is brought up to create a new pouch that acts as a reservoir for stool. The pouch is then connected to the anus, allowing the patient to pass stool in the same way as they did before the procedure.\nThe J pouch procedure is also known as a J pouch reconstruction or a J pouch surgery. It is typically performed laparoscopically, which means that the surgery is done using small incisions and specialized instruments. The procedure is typically done as a two-stage process, with the first stage involving the removal of the colon and the second stage involving the creation of the pouch and its connection to the anus.\nThe J pouch procedure has several potential benefits for patients with ulcerative colitis. It can help to improve symptoms such as diarrhea, bleeding, and discomfort, and can also reduce the risk of complications such as colon cancer. However, the J pouch procedure is not without risks, and it is important for patients to carefully consider the potential benefits and risks before deciding to undergo the procedure.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A J pouch is a surgical procedure used to treat ulcerative colitis.\n2. In a J pouch procedure, the colon is removed and the remaining intestine is brought up to create a new pouch that acts as a reservoir for stool.\n3. The J pouch procedure is also known as a J pouch reconstruction or a J pouch surgery.\n4. The J pouch procedure is typically performed laparoscopically, using small incisions and specialized instruments.\n5. The J pouch procedure can reduce the risk of complications such as colon cancer for patients with ulcerative colitis.",
    "vicuna-7b_fact": [
      "A J pouch is a surgical procedure used to treat ulcerative colitis.",
      "In a J pouch procedure, the colon is removed and the remaining intestine is brought up to create a new pouch that acts as a reservoir for stool.",
      "The J pouch procedure is also known as a J pouch reconstruction or a J pouch surgery.",
      "The J pouch procedure is typically performed laparoscopically, using small incisions and specialized instruments.",
      "The J pouch procedure can reduce the risk of complications such as colon cancer for patients with ulcerative colitis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3412,
    "user_query": "What is the function of the protein encoded by the gene NKCC2?",
    "vicuna-7b_response": "The protein encoded by the gene NKCC2 is a key regulator of the electrolyte balance in the body. It is responsible for reabsorbing the important electrolyte sodium (Na+) from the distal convoluted tubule of the kidney, which is essential for maintaining the proper balance of electrolytes in the body. The gene NKCC2 is located on chromosome X and is expressed in various tissues, including the kidney, adrenal gland, and placenta. Mutations in the NKCC2 gene have been associated with the development of certain kidney disorders, such as the Dent disease, which is characterized by the loss of function of the NKCC2 protein.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The protein encoded by the gene NKCC2 is a key regulator of the electrolyte balance in the body.\n2. The NKCC2 protein is responsible for reabsorbing sodium from the distal convoluted tubule of the kidney.\n3. The gene NKCC2 is located on chromosome X.\n4. The NKCC2 gene is expressed in various tissues, including the kidney, adrenal gland, and placenta.\n5. Mutations in the NKCC2 gene have been associated with the development of certain kidney disorders, such as Dent disease.",
    "vicuna-7b_fact": [
      "The protein encoded by the gene NKCC2 is a key regulator of the electrolyte balance in the body.",
      "The NKCC2 protein is responsible for reabsorbing sodium from the distal convoluted tubule of the kidney.",
      "The gene NKCC2 is located on chromosome X.",
      "The NKCC2 gene is expressed in various tissues, including the kidney, adrenal gland, and placenta.",
      "Mutations in the NKCC2 gene have been associated with the development of certain kidney disorders, such as Dent disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The NKCC2 protein is responsible for reabsorbing sodium, potassium, and chloride from the thick ascending limb of the loop of Henle in the kidney.\n3. FALSE [correction]: The gene NKCC2 is located on chromosome 15, not chromosome X.\n4. TRUE\n5. FALSE [correction]: Mutations in the NKCC2 gene have been associated with the development of certain kidney disorders, such as Bartter syndrome, not Dent disease.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3414,
    "user_query": "Is the protein MCL-1 anti-apoptotic?",
    "vicuna-7b_response": "Yes, MCL-1 is an anti-apoptotic protein that plays a critical role in the regulation of cell survival. MCL-1 is a member of the Bcl-2 family of proteins, which are known to regulate the process of programmed cell death (apoptosis).\nMCL-1 is expressed in a wide range of cell types and is known to inhibit the activation of caspases, which are the key executioners of apoptosis. MCL-1 does this by binding to and inhibiting the activity of pro-apoptotic proteins such as Bax and Bak.\nThe overexpression of MCL-1 has been shown to protect cells from various forms of cell death, including chemotherapy-induced apoptosis. Conversely, the loss of MCL-1 function has been shown to sensitize cells to apoptosis, making them more susceptible to cell death.\nIn summary, MCL-1 is an anti-apoptotic protein that plays a critical role in the regulation of cell survival by inhibiting the activation of caspases and protecting cells from apoptosis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MCL-1 is an anti-apoptotic protein.\n2. MCL-1 plays a critical role in the regulation of cell survival.\n3. MCL-1 is a member of the Bcl-2 family of proteins, which are known to regulate the process of programmed cell death (apoptosis).\n4. MCL-1 is known to inhibit the activation of caspases, which are the key executioners of apoptosis.\n5. The overexpression of MCL-1 has been shown to protect cells from various forms of cell death, including chemotherapy-induced apoptosis.",
    "vicuna-7b_fact": [
      "MCL-1 is an anti-apoptotic protein.",
      "MCL-1 plays a critical role in the regulation of cell survival.",
      "MCL-1 is a member of the Bcl-2 family of proteins, which are known to regulate the process of programmed cell death (apoptosis).",
      "MCL-1 is known to inhibit the activation of caspases, which are the key executioners of apoptosis.",
      "The overexpression of MCL-1 has been shown to protect cells from various forms of cell death, including chemotherapy-induced apoptosis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3417,
    "user_query": "Which disease is ZP-PTH used for?",
    "vicuna-7b_response": "ZP-PTH is a synthetic hormone that is used to treat osteoporosis in postmenopausal women. It is a recombinant version of parathyroid hormone, which is a naturally occurring hormone in the body that regulates the levels of calcium and phosphorus in the blood.\nOsteoporosis is a condition in which the bones become weak and brittle, increasing the risk of fractures. ZP-PTH works by increasing the levels of calcium in the blood, which in turn increases the formation of new bone tissue. This helps to strengthen the bones and reduce the risk of fractures.\nZP-PTH is typically administered via subcutaneous injection once a week. It is important to note that ZP-PTH is not suitable for everyone, and it should only be used under the guidance of a healthcare professional.",
    "vicuna-7b_fact_raw": "Here are the factual statements:\n1. ZP-PTH is used to treat osteoporosis in postmenopausal women.\n2. ZP-PTH is a synthetic hormone.\n3. ZP-PTH is a recombinant version of the parathyroid hormone.\n4. Osteoporosis is a condition in which the bones become weak and brittle.\n5. ZP-PTH is typically administered via subcutaneous injection once a week.",
    "vicuna-7b_fact": [
      "ZP-PTH is used to treat osteoporosis in postmenopausal women.",
      "ZP-PTH is a synthetic hormone.",
      "ZP-PTH is a recombinant version of the parathyroid hormone.",
      "Osteoporosis is a condition in which the bones become weak and brittle.",
      "ZP-PTH is typically administered via subcutaneous injection once a week."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3424,
    "user_query": "When was vaxchora first licensed by the FDA?",
    "vicuna-7b_response": "Vaxchora, also known as the cholera vaccine, was first licensed by the FDA in 2016. It is a single-dose, oral, and live attenuated vaccine that is approved for use in adults and children aged 1 year and older. Vaxchora is recommended for the prevention of cholera in individuals traveling to areas with a high risk of cholera, as well as for the post-exposure prophylaxis of cholera.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vaxchora, the cholera vaccine, was first licensed by the FDA in 2016.\n2. Vaxchora is a single-dose, oral, and live attenuated vaccine.\n3. Vaxchora is approved for use in adults and children aged 1 year and older.\n4. The vaccine is recommended for prevention of cholera in individuals traveling to areas with a high risk of cholera.\n5. Vaxchora is also recommended for the post-exposure prophylaxis of cholera.",
    "vicuna-7b_fact": [
      "Vaxchora, the cholera vaccine, was first licensed by the FDA in 2016.",
      "Vaxchora is a single-dose, oral, and live attenuated vaccine.",
      "Vaxchora is approved for use in adults and children aged 1 year and older.",
      "The vaccine is recommended for prevention of cholera in individuals traveling to areas with a high risk of cholera.",
      "Vaxchora is also recommended for the post-exposure prophylaxis of cholera."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Vaxchora is approved for use in adults aged 18 to 64 years old.\n4. TRUE\n5. FALSE [correction]: Vaxchora is not specifically recommended for post-exposure prophylaxis of cholera.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3427,
    "user_query": "Which type of distance is used in the R-package XenofilteR?",
    "vicuna-7b_response": "The R-package XenofilteR uses the \"phylogenetic distance\" to measure the evolutionary relationship between different species. Phylogenetic distance is a measure of the evolutionary relationship between different species based on their genetic similarity. It is calculated by comparing the DNA sequences of different species and determining the number of mutations that have occurred in the DNA sequences over time. XenofilteR uses phylogenetic distance to calculate the evolutionary relationships between different species and to identify the closest relatives of a particular species.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The R-package XenofilteR uses phylogenetic distance. \n2. Phylogenetic distance measures the evolutionary relationship between different species based on genetic similarity.\n3. Phylogenetic distance is calculated by comparing the DNA sequences of different species.\n4. It determines the number of mutations that have occurred in the DNA sequences over time.\n5. XenofilteR uses phylogenetic distance to identify the closest relatives of a particular species.",
    "vicuna-7b_fact": [
      "The R-package XenofilteR uses phylogenetic distance.",
      "Phylogenetic distance measures the evolutionary relationship between different species based on genetic similarity.",
      "Phylogenetic distance is calculated by comparing the DNA sequences of different species.",
      "It determines the number of mutations that have occurred in the DNA sequences over time.",
      "XenofilteR uses phylogenetic distance to identify the closest relatives of a particular species."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-7b_response": "There are several tools and frameworks that use deep learning to predict drug synergy. One example is the DeepDrug framework, which uses a deep neural network to predict the synergy between two drugs based on their chemical structure and pharmacological properties. Another example is the Drug Combination Analysis tool, which uses a combination of machine learning and bioinformatics techniques to predict the synergy between drugs. Additionally, there are also pre-trained models like DrugBank and Chemical Space that can be used for drug synergy prediction.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The DeepDrug framework uses a deep neural network to predict the synergy between two drugs.\n2. The synergy prediction by the DeepDrug framework is based on the drugs' chemical structure and pharmacological properties.\n3. The Drug Combination Analysis tool uses bioinformatics techniques alongside machine learning to predict drug synergy.\n4. Pre-trained models like DrugBank and Chemical Space can be used for drug synergy prediction.\n5. Several tools and frameworks exist that use deep learning for drug synergy prediction.",
    "vicuna-7b_fact": [
      "The DeepDrug framework uses a deep neural network to predict the synergy between two drugs.",
      "The synergy prediction by the DeepDrug framework is based on the drugs' chemical structure and pharmacological properties.",
      "The Drug Combination Analysis tool uses bioinformatics techniques alongside machine learning to predict drug synergy.",
      "Pre-trained models like DrugBank and Chemical Space can be used for drug synergy prediction.",
      "Several tools and frameworks exist that use deep learning for drug synergy prediction."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3431,
    "user_query": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Ozanezumab is a monoclonal antibody that is being studied as a potential treatment for amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and eventual paralysis.\nThere have been several clinical trials of ozanezumab in ALS, but the results have been mixed. Some studies have shown that ozanezumab can slow the progression of the disease, while others have not found a significant benefit.\nIt is important to note that ozanezumab is not currently approved by the FDA for the treatment of ALS. However, ongoing clinical trials are investigating its potential efficacy and safety in this population.\nIf you or someone you know has been diagnosed with ALS, it is important to speak with a healthcare provider about the most current treatment options, including ozanezumab and other available therapies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ozanezumab is a monoclonal antibody.\n2. Ozanezumab is being studied as a potential treatment for amyotrophic lateral sclerosis (ALS).\n3. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n4. There have been clinical trials investigating the efficacy of ozanezumab for the treatment of ALS.\n5. Ozanezumab is not currently approved by the FDA for the treatment of ALS.",
    "vicuna-7b_fact": [
      "Ozanezumab is a monoclonal antibody.",
      "Ozanezumab is being studied as a potential treatment for amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "There have been clinical trials investigating the efficacy of ozanezumab for the treatment of ALS.",
      "Ozanezumab is not currently approved by the FDA for the treatment of ALS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3432,
    "user_query": "Is Dexmecamylamine effective for depression?",
    "vicuna-7b_response": "Dexmecamylamine is a drug that has been studied for its potential to treat depression, but it has not been approved for this use by the FDA.\nDexmecamylamine is a selective serotonin reuptake inhibitor (SSRI) and works by increasing the levels of serotonin in the brain, which is a neurotransmitter that is involved in mood regulation.\nThere have been several studies that have investigated the effectiveness of dexmecamylamine for the treatment of depression, but the results have been mixed. Some studies have suggested that dexmecamylamine may be effective in treating depression, while others have found that it is not effective.\nIt is important to note that the FDA only approves drugs for use if they are shown to be safe and effective through clinical trials. If a drug has not been approved by the FDA, it means that it has not been shown to be safe and effective for the intended use.\nIt is always best to consult with a healthcare professional before taking any medication, including dexmecamylamine, as they can provide personalized advice based on your specific situation and health history.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dexmecamylamine is a drug that has been studied for its potential to treat depression.\n2. Dexmecamylamine is a selective serotonin reuptake inhibitor (SSRI).\n3. Dexmecamylamine works by increasing the levels of serotonin in the brain.\n4. Dexmecamylamine has not been approved for treating depression by the FDA.\n5. The FDA only approves drugs for use if they are shown to be safe and effective through clinical trials.",
    "vicuna-7b_fact": [
      "Dexmecamylamine is a drug that has been studied for its potential to treat depression.",
      "Dexmecamylamine is a selective serotonin reuptake inhibitor (SSRI).",
      "Dexmecamylamine works by increasing the levels of serotonin in the brain.",
      "Dexmecamylamine has not been approved for treating depression by the FDA.",
      "The FDA only approves drugs for use if they are shown to be safe and effective through clinical trials."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-7b_response": "There are several cloud-based platforms that have been developed for comparing genome-wide association studies (GWAS). Some examples include:\n1. GWAS Central: This is a cloud-based platform that provides a centralized repository for storing and analyzing GWAS data. It allows researchers to upload their data and perform analyses using a variety of statistical methods.\n2. The Global Alliance for Genomics and Health (GA4GH): This is a cloud-based platform that provides tools and resources for sharing and analyzing genomic data. It includes a variety of tools for comparing GWAS data, such as the GWAS Catalog and the Variation Effects Catalogue.\n3. The National Center for Biotechnology Information (NCBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the dbGaP database.\n4. The European Bioinformatics Institute (EBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).\nThese are just a few examples of cloud-based platforms that have been developed for comparing GWAS data. There are many other platforms available, and the best one for a particular researcher will depend on their specific needs and goals.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GWAS Central is a cloud-based platform providing a centralized repository for storing and analyzing genome-wide association studies data.\n2. The Global Alliance for Genomics and Health (GA4GH) is a cloud-based platform that provides tools for sharing and analyzing genomic data.\n3. The National Center for Biotechnology Information (NCBI) is a cloud-based platform that provides tools for analyzing GWAS data, including the dbGaP database.\n4. The European Bioinformatics Institute (EBI) is a cloud-based platform containing tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).\n5. There are numerous cloud-based platforms available for comparing genome-wide association studies (GWAS) data.",
    "vicuna-7b_fact": [
      "GWAS Central is a cloud-based platform providing a centralized repository for storing and analyzing genome-wide association studies data.",
      "The Global Alliance for Genomics and Health (GA4GH) is a cloud-based platform that provides tools for sharing and analyzing genomic data.",
      "The National Center for Biotechnology Information (NCBI) is a cloud-based platform that provides tools for analyzing GWAS data, including the dbGaP database.",
      "The European Bioinformatics Institute (EBI) is a cloud-based platform containing tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).",
      "There are numerous cloud-based platforms available for comparing genome-wide association studies (GWAS) data."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Global Alliance for Genomics and Health (GA4GH) is an international coalition, dedicated in facilitating the sharing of genomic and clinical data. \n3. FALSE [correction]: The National Center for Biotechnology Information (NCBI) is a part of the United States National Library of Medicine (NLM), a branch of the National Institutes of Health (NIH) which hosts bioinformatics tools and databases not specifically cloud-based. It does provide the dbGaP database for GWAS data.\n4. FALSE [correction]: The European Bioinformatics Institute (EBI) is a research institute, part of the European Molecular Biology Laboratory (EMBL) that provides databases and services for genomics research, not specifically cloud-based. It does host the European Genome-Phenome Archive (EGA) for GWAS data.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-7b_response": "CMB305 is a monoclonal antibody that targets the CD33 protein, which is expressed on the surface of certain cancer cells, including acute myeloid leukemia (AML) cells. CMB305 has been shown to have potential in the treatment of AML, and it is currently being studied in clinical trials for the treatment of other types of cancer as well, including sarcomas.\nSarcomas are a type of cancer that develops from the soft tissues of the body, such as muscle, fat, bone, and connective tissue. They are relatively rare cancers, and they can occur in both adults and children. There are many different subtypes of sarcomas, and the treatment options for each subtype can vary.\nCMB305 has been shown to have potential in the treatment of sarcomas in preclinical studies, but it has not yet been studied in clinical trials specifically for the treatment of sarcomas. However, given its potential activity against CD33-expressing cancer cells, it is possible that CMB305 could be a promising treatment option for some patients with sarcomas.\nIt is important to note that clinical trials are the best way to determine the safety and effectiveness of a treatment for a specific type of cancer. If you are interested in participating in a clinical trial for CMB305 or any other treatment for sarcomas, it is best to speak with your oncologist or a cancer specialist. They can provide you with more information about available clinical trials and help you determine whether participating in a trial is right for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CMB305 is a monoclonal antibody that targets the CD33 protein. \n2. CMB305 has shown potential in the treatment of acute myeloid leukemia (AML).\n3. CMB305 is currently being studied in clinical trials for the treatment of other types of cancer, including sarcomas.\n4. Sarcomas are a type of cancer that develops from the soft tissues of the body.\n5. Clinical trials are the best way to determine the safety and effectiveness of a treatment for a specific type of cancer.",
    "vicuna-7b_fact": [
      "CMB305 is a monoclonal antibody that targets the CD33 protein.",
      "CMB305 has shown potential in the treatment of acute myeloid leukemia (AML).",
      "CMB305 is currently being studied in clinical trials for the treatment of other types of cancer, including sarcomas.",
      "Sarcomas are a type of cancer that develops from the soft tissues of the body.",
      "Clinical trials are the best way to determine the safety and effectiveness of a treatment for a specific type of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3435,
    "user_query": "What is Quadracel?",
    "vicuna-7b_response": "Quadracel is a vaccine that is used to prevent respiratory syncytial virus (RSV) infection in infants, children, and adults who are at high risk of developing serious RSV disease. RSV is a common respiratory virus that can cause mild cold-like symptoms in healthy individuals, but it can also lead to serious lung infections in high-risk individuals, such as infants, children, and adults with compromised immune systems.\nQuadracel is a four-component vaccine that is administered as a single dose. It contains live, attenuated RSV virus that has been modified to prevent it from causing disease. The vaccine stimulates the immune system to produce antibodies that protect against RSV infection.\nQuadracel is approved for use in the United States for individuals who are 6 weeks through 64 years of age. It is particularly recommended for individuals who are at high risk of developing serious RSV disease, including:\n* Infants and children with chronic lung diseases, such as bronchopulmonary dysplasia and cystic fibrosis\n* Children and adults with compromised immune systems, such as those with HIV/AIDS, cancer, or organ transplants\n* Pregnant women\n* Individuals who are 65 years of age and older\nQuadracel is an effective and safe vaccine that can help prevent serious RSV disease in high-risk individuals. It is important to consult with a healthcare provider to determine if Quadracel is appropriate for you or your child.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Quadracel is a vaccine used to prevent respiratory syncytial virus (RSV) infection.\n2. Quadracel is a four-component vaccine that is administered as a single dose. \n3. The vaccine contains live, attenuated RSV virus that has been modified to prevent it from causing disease.\n4. Quadracel is approved for use in the United States for individuals who are 6 weeks through 64 years of age.\n5. Quadracel is particularly recommended for individuals who are at high risk of developing serious RSV disease, including infants and children with chronic lung diseases, individuals with compromised immune systems, pregnant women, and individuals who are 65 years of age and older.",
    "vicuna-7b_fact": [
      "Quadracel is a vaccine used to prevent respiratory syncytial virus (RSV) infection.",
      "Quadracel is a four-component vaccine that is administered as a single dose.",
      "The vaccine contains live, attenuated RSV virus that has been modified to prevent it from causing disease.",
      "Quadracel is approved for use in the United States for individuals who are 6 weeks through 64 years of age.",
      "Quadracel is particularly recommended for individuals who are at high risk of developing serious RSV disease, including infants and children with chronic lung diseases, individuals with compromised immune systems, pregnant women, and individuals who are 65 years of age and older."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Quadracel is a vaccine used to prevent diphtheria, pertussis, tetanus, and polio.\n2. TRUE\n3. FALSE [correction]: The Quadracel vaccine does not contain live, attenuated viruses. It contains inactivated forms and toxoids.\n4. FALSE [correction]: Quadracel is approved for use in the United States for individuals who are 4 to 6 years of age.\n5. FALSE [correction]: Quadracel vaccine is not specifically recommended for individuals at high risk of developing serious RSV disease. It is intended to prevent diphtheria, pertussis, tetanus, and polio in children from 4 to 6 years of age.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3436,
    "user_query": "What delivery system is used for the Fluzone Intradermal vaccine?",
    "vicuna-7b_response": "The Fluzone Intradermal vaccine is delivered using a needle and syringe. The vaccine is administered into the skin (dermis) of the upper arm, using a small needle and a special applicator. The intradermal delivery method is used to enhance the immune response to the vaccine by delivering the vaccine directly into the skin's dermis, which is closer to the immune cells that respond to the vaccine. The needle and syringe are sterile and disposable, and the vaccine is packaged in a single-dose vial. The vaccine is administered by a healthcare professional, usually in a doctor's office or clinic.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Fluzone Intradermal vaccine is delivered using a needle and syringe.\n2. This vaccine is administered into the skin of the upper arm.\n3. The intradermal delivery method is used for the Fluzone Intradermal vaccine.\n4. The needle and syringe used for Fluzone Intradermal vaccine are sterile and disposable.\n5. The vaccine is typically administered by a healthcare professional.",
    "vicuna-7b_fact": [
      "The Fluzone Intradermal vaccine is delivered using a needle and syringe.",
      "This vaccine is administered into the skin of the upper arm.",
      "The intradermal delivery method is used for the Fluzone Intradermal vaccine.",
      "The needle and syringe used for Fluzone Intradermal vaccine are sterile and disposable.",
      "The vaccine is typically administered by a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3450,
    "user_query": "How many genes belong to the KRAB-ZNF family in the human genome?",
    "vicuna-7b_response": "The KRAB-ZNF (Krueppel-associated box domain containing ZNF) family is a group of transcription factors that play important roles in regulating gene expression. The exact number of genes in the KRAB-ZNF family in the human genome is not well established, as the family is composed of a large number of genes with diverse functions and structures.\nAccording to the latest version of the genome annotation database ENSEMBL, there are currently 1279 genes in the KRAB-ZNF family in the human genome. However, this number is likely to change as new genes are discovered and annotated, and as the understanding of the KRAB-ZNF family expands.\nIt's worth noting that the KRAB-ZNF family is a large and diverse group of genes, and the number of genes in the family can vary depending on the source and the criteria used for annotation. Additionally, the KRAB-ZNF family is not the only family of transcription factors that includes genes with a KRAB domain, so the number of genes in the family may be higher than what is reported here.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The KRAB-ZNF (Krueppel-associated box domain containing ZNF) family is a group of transcription factors that play important roles in regulating gene expression.\n2. In the latest version of the genome annotation database ENSEMBL, there are 1279 genes in the KRAB-ZNF family in the human genome.\n3. The number of genes in the KRAB-ZNF family may change as new genes are discovered and annotated.\n4. The number of genes in the KRAB-ZNF family can vary depending on the source and the criteria used for annotation.\n5. The KRAB-ZNF family is not the only family of transcription factors that includes genes with a KRAB domain.",
    "vicuna-7b_fact": [
      "The KRAB-ZNF (Krueppel-associated box domain containing ZNF) family is a group of transcription factors that play important roles in regulating gene expression.",
      "In the latest version of the genome annotation database ENSEMBL, there are 1279 genes in the KRAB-ZNF family in the human genome.",
      "The number of genes in the KRAB-ZNF family may change as new genes are discovered and annotated.",
      "The number of genes in the KRAB-ZNF family can vary depending on the source and the criteria used for annotation.",
      "The KRAB-ZNF family is not the only family of transcription factors that includes genes with a KRAB domain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3451,
    "user_query": "Which molecule is targeted by Asciminib?",
    "vicuna-7b_response": "Asciminib is a drug that targets the Hedgehog signaling pathway, which is a key regulator of cell growth and differentiation in various tissues, including the skin, gut, and respiratory tract. The Hedgehog pathway is activated when a protein called Smoothened (SMO) binds to a lipid molecule called Sonic hedgehog (Shh). Asciminib works by inhibiting the binding of SMO to Shh, thereby blocking the activation of the Hedgehog pathway and preventing the growth and proliferation of cells that are dependent on this pathway. Asciminib is used to treat certain types of cancer, including basal cell carcinoma and medulloblastoma, which are caused by the overactivation of the Hedgehog pathway.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Asciminib is a drug that targets the Hedgehog signaling pathway.\n2. The Hedgehog pathway is a key regulator of cell growth and differentiation in various tissues including the skin, gut, and respiratory tract.\n3. The Hedgehog pathway is activated when a protein called Smoothened (SMO) binds to a lipid molecule called Sonic hedgehog (Shh).\n4. Asciminib works by inhibiting the binding of SMO to Shh.\n5. Asciminib is used to treat certain types of cancer, including basal cell carcinoma and medulloblastoma.",
    "vicuna-7b_fact": [
      "Asciminib is a drug that targets the Hedgehog signaling pathway.",
      "The Hedgehog pathway is a key regulator of cell growth and differentiation in various tissues including the skin, gut, and respiratory tract.",
      "The Hedgehog pathway is activated when a protein called Smoothened (SMO) binds to a lipid molecule called Sonic hedgehog (Shh).",
      "Asciminib works by inhibiting the binding of SMO to Shh.",
      "Asciminib is used to treat certain types of cancer, including basal cell carcinoma and medulloblastoma."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Asciminib is a drug that targets the BCR-ABL kinase protein, not the Hedgehog signaling pathway.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Asciminib works by inhibiting the BCR-ABL kinase protein, not the binding of SMO to Shh.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3453,
    "user_query": "What is characteristic to Fitz-Hugh–Curtis syndrome?",
    "vicuna-7b_response": "Fitz-Hugh–Curtis syndrome is a rare condition that is characterized by the simultaneous occurrence of two distinct clinical entities: pelvic inflammatory disease (PID) and mesenteric ischemia. PID is an infection of the reproductive organs that can cause inflammation and scarring of the fallopian tubes, ovaries, and other pelvic structures. Mesenteric ischemia is a condition in which the blood flow to the mesenteric arteries, which supply blood to the intestines, is reduced or blocked, leading to decreased blood flow and oxygenation to the intestines.\nThe characteristic symptoms of Fitz-Hugh–Curtis syndrome include abdominal pain, fever, and tenderness in the pelvic area. The pain may be severe and constant, or it may come and go. Other symptoms may include nausea, vomiting, diarrhea, and constipation. In some cases, the patient may also experience symptoms of mesenteric ischemia, such as abdominal distention, abdominal tenderness, and a low-grade fever.\nThe diagnosis of Fitz-Hugh–Curtis syndrome is typically made based on the patient's symptoms and medical history, as well as the results of diagnostic tests such as pelvic and abdominal imaging, blood tests, and cultures. The treatment of Fitz-Hugh–Curtis syndrome typically involves antibiotics to treat the PID, as well as blood transfusions and surgery to treat the mesenteric ischemia. In severe cases, the patient may require hospitalization and supportive care.\nIt is important to note that Fitz-Hugh–Curtis syndrome is a serious condition that requires prompt medical attention. If you or someone you know is experiencing symptoms of this condition, it is important to seek medical care immediately.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fitz-Hugh–Curtis syndrome is characterized by the simultaneous occurrence of pelvic inflammatory disease (PID) and mesenteric ischemia.\n2. Pelvic inflammatory disease is an infection of the reproductive organs causing inflammation and scarring of the fallopian tubes, ovaries, and other pelvic structures.\n3. Mesenteric ischemia is a condition in which there is a reduction or blockage in the blood flow to the mesenteric arteries that supply blood to the intestines.\n4. The characteristic symptoms of Fitz-Hugh–Curtis syndrome include abdominal pain, fever, and tenderness in the pelvic area, and symptoms may also include nausea, vomiting, diarrhea, and constipation.\n5. The treatment of Fitz-Hugh–Curtis syndrome typically involves antibiotics to treat the PID, as well as blood transfusions and surgery to treat the mesenteric ischemia.",
    "vicuna-7b_fact": [
      "Fitz-Hugh–Curtis syndrome is characterized by the simultaneous occurrence of pelvic inflammatory disease (PID) and mesenteric ischemia.",
      "Pelvic inflammatory disease is an infection of the reproductive organs causing inflammation and scarring of the fallopian tubes, ovaries, and other pelvic structures.",
      "Mesenteric ischemia is a condition in which there is a reduction or blockage in the blood flow to the mesenteric arteries that supply blood to the intestines.",
      "The characteristic symptoms of Fitz-Hugh–Curtis syndrome include abdominal pain, fever, and tenderness in the pelvic area, and symptoms may also include nausea, vomiting, diarrhea, and constipation.",
      "The treatment of Fitz-Hugh–Curtis syndrome typically involves antibiotics to treat the PID, as well as blood transfusions and surgery to treat the mesenteric ischemia."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Fitz-Hugh–Curtis syndrome is characterized by the simultaneous occurrence of pelvic inflammatory disease (PID) and perihepatitis, not mesenteric ischemia.\n2. TRUE \n3. TRUE\n4. TRUE\n5. FALSE [correction]: The treatment of Fitz-Hugh–Curtis syndrome typically involves antibiotics to treat the PID, but not blood transfusions and surgery for mesenteric ischemia, as this disease is not associated with Fitz-Hugh-Curtis syndrome.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3454,
    "user_query": "What is the trade name of sildenafil?",
    "vicuna-7b_response": "The trade name of sildenafil is Viagra.",
    "vicuna-7b_fact_raw": "The factual statement is: \n1. The trade name of sildenafil is Viagra.",
    "vicuna-7b_fact": [
      "The trade name of sildenafil is Viagra."
    ],
    "vicuna-7b_judge_raw": "1. TRUE",
    "vicuna-7b_judge": [
      "true"
    ]
  },
  {
    "id": 3455,
    "user_query": "How large is the SARS-CoV  proteome?",
    "vicuna-7b_response": "The SARS-CoV  proteome is the set of all proteins expressed by the SARS-CoV  virus. The exact size of the SARS-CoV  proteome is not yet fully understood, as the virus continues to evolve and new proteins may be discovered. However, as of 2021, the SARS-CoV  genome has been fully sequenced, and over 1,500 proteins have been identified.\nThe SARS-CoV  genome is composed of a single-stranded RNA genome, which is approximately 29,000 nucleotides in length. The virus encodes for a large number of proteins, which are synthesized using the ribosomal frame-shifting mechanism. This mechanism allows the virus to produce a large number of different proteins from a limited number of genes.\nThe SARS-CoV  proteome is composed of several different functional categories, including structural proteins, enzymes, regulatory proteins, and accessory proteins. Structural proteins are responsible for the formation of the virus particle, while enzymes are involved in various metabolic processes. Regulatory proteins control the expression of viral genes, and accessory proteins are involved in host cell interactions.\nOverall, the SARS-CoV  proteome is a complex and diverse set of proteins that play important roles in the replication and spread of the virus. Further research is needed to fully understand the functions of all the proteins in the SARS-CoV  proteome and how they contribute to the virus's pathogenesis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The SARS-CoV proteome is the set of all proteins expressed by the SARS-CoV virus.\n2. As of 2021, over 1,500 proteins have been identified in the SARS-CoV proteome.\n3. The SARS-CoV genome is approximately 29,000 nucleotides in length and is made of single-stranded RNA.\n4. The SARS-CoV proteome is composed of several functional categories, including structural proteins, enzymes, regulatory proteins, and accessory proteins.\n5. The SARS-CoV virus uses a ribosomal frame-shifting mechanism to synthesize proteins.",
    "vicuna-7b_fact": [
      "The SARS-CoV proteome is the set of all proteins expressed by the SARS-CoV virus.",
      "As of 2021, over 1,500 proteins have been identified in the SARS-CoV proteome.",
      "The SARS-CoV genome is approximately 29,000 nucleotides in length and is made of single-stranded RNA.",
      "The SARS-CoV proteome is composed of several functional categories, including structural proteins, enzymes, regulatory proteins, and accessory proteins.",
      "The SARS-CoV virus uses a ribosomal frame-shifting mechanism to synthesize proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3460,
    "user_query": "Can radiotherapy cause radiation induced osteosarcoma?",
    "vicuna-7b_response": "Yes, radiotherapy can cause radiation-induced osteosarcoma.\nOsteosarcoma is a type of bone cancer that occurs most commonly in children and adolescents. While the exact cause of osteosarcoma is not known, exposure to radiation is considered to be a risk factor for the development of the disease.\nRadiation-induced osteosarcoma typically occurs many years after the initial exposure to radiation, and the risk of developing the disease increases with the amount and dose of radiation received.\nPatients who have received radiation therapy to the head and neck, spine, or extremities have a higher risk of developing radiation-induced osteosarcoma. This risk is particularly high in individuals who received radiation therapy before the age of 15.\nIt is important to note that the risk of radiation-induced osteosarcoma is low, and the benefits of radiation therapy for the treatment of many types of cancer far outweigh the risks. However, it is important for patients and their families to be aware of the potential risks associated with radiation therapy and to discuss any concerns with their healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Radiotherapy can cause radiation-induced osteosarcoma.\n2. Osteosarcoma is a type of bone cancer that is most common in children and adolescents.\n3. The risk of developing osteosarcoma increases with the amount and dose of radiation received.\n4. Patients who have received radiation therapy to the head and neck, spine, or extremities have a higher risk of developing radiation-induced osteosarcoma.\n5. Individuals who received radiation therapy before the age of 15 have a particularly high risk of developing radiation-induced osteosarcoma.",
    "vicuna-7b_fact": [
      "Radiotherapy can cause radiation-induced osteosarcoma.",
      "Osteosarcoma is a type of bone cancer that is most common in children and adolescents.",
      "The risk of developing osteosarcoma increases with the amount and dose of radiation received.",
      "Patients who have received radiation therapy to the head and neck, spine, or extremities have a higher risk of developing radiation-induced osteosarcoma.",
      "Individuals who received radiation therapy before the age of 15 have a particularly high risk of developing radiation-induced osteosarcoma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-7b_response": "The Saint's Triad is a concept in Christian theology that refers to the three persons of the Trinity: the Father, the Son, and the Holy Spirit. The manifestations of the Saint's Triad are the ways in which these three persons are revealed and experienced in the world.\nThe Father is often revealed through creation, as the creator of the universe and all that exists within it. The Son is revealed through the person of Jesus Christ, who is believed to be the Son of God and the savior of humanity. The Holy Spirit is revealed through the work of the Holy Spirit, which includes the guidance of believers, the empowerment of the church, and the conviction of sinners.\nIn addition to these primary manifestations, the Saint's Triad is also revealed in the sacraments, such as baptism and communion, and in the lives of believers who are filled with the Holy Spirit and live in accordance with God's will.\nOverall, the manifestations of the Saint's Triad are diverse and multifaceted, reflecting the complexity and richness of the Christian faith.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Saint's Triad in Christian theology refers to the three persons of the Trinity: the Father, the Son, and the Holy Spirit.\n2. In Christian theology, the Father is often revealed through creation.\n3. The Son, in Christian theology, is revealed through the person of Jesus Christ.\n4. In Christian theology, the Holy Spirit is often revealed through the guidance of believers, the empowerment of the church, and the conviction of sinners.\n5. In Christian theology, the Saint's Triad is also revealed in the sacraments, such as baptism and communion.",
    "vicuna-7b_fact": [
      "The Saint's Triad in Christian theology refers to the three persons of the Trinity: the Father, the Son, and the Holy Spirit.",
      "In Christian theology, the Father is often revealed through creation.",
      "The Son, in Christian theology, is revealed through the person of Jesus Christ.",
      "In Christian theology, the Holy Spirit is often revealed through the guidance of believers, the empowerment of the church, and the conviction of sinners.",
      "In Christian theology, the Saint's Triad is also revealed in the sacraments, such as baptism and communion."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The concept described is called the Holy Trinity, not the Saint's Triad, in Christian theology.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Holy Trinity, not the Saint's Triad, is revealed in the sacraments, such as baptism and communion in Christian theology.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3463,
    "user_query": "Are male or female persons more prone to autoimmunity?",
    "vicuna-7b_response": "Autoimmunity is a condition in which the immune system mistakenly attacks healthy cells and tissues in the body. There is no evidence to suggest that male or female individuals are more prone to autoimmunity. Both men and women can develop autoimmune disorders.\nAutoimmune disorders can affect anyone, regardless of gender. However, certain autoimmune disorders, such as rheumatoid arthritis and lupus, are more common in women. This may be due to hormonal factors, as certain hormones, such as estrogen, can affect the immune system.\nIt is important to note that the exact causes of autoimmunity are not fully understood, and research is ongoing to identify the genetic and environmental factors that contribute to the development of autoimmune disorders.\nIn summary, there is no evidence to suggest that male or female individuals are more prone to autoimmunity. Both men and women can develop autoimmune disorders, and the exact causes of autoimmunity are not fully understood.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autoimmunity is a condition where the immune system mistakenly attacks healthy cells and tissues in the body.\n2. Both men and women can develop autoimmune disorders.\n3. Certain autoimmune disorders, such as rheumatoid arthritis and lupus, are more common in women.\n4. Certain hormones, such as estrogen, can affect the immune system.\n5. The exact causes of autoimmunity are not fully understood.",
    "vicuna-7b_fact": [
      "Autoimmunity is a condition where the immune system mistakenly attacks healthy cells and tissues in the body.",
      "Both men and women can develop autoimmune disorders.",
      "Certain autoimmune disorders, such as rheumatoid arthritis and lupus, are more common in women.",
      "Certain hormones, such as estrogen, can affect the immune system.",
      "The exact causes of autoimmunity are not fully understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3469,
    "user_query": "What is Fuchs' Uveitis?",
    "vicuna-7b_response": "Fuchs' uveitis is a type of inflammation of the uvea, which is the middle layer of the eye. The uvea contains several structures, including the iris, ciliary body, and choroid. Fuchs' uveitis is a chronic condition that can cause vision loss if left untreated.\nThe condition is named after the ophthalmologist who first described it, Friedrich Fuchs, in the early 20th century. It is also known as idiopathic membranous uveitis or non-infectious uveitis.\nThe exact cause of Fuchs' uveitis is not known, but it is thought to be an autoimmune disorder. This means that the body's immune system mistakenly attacks healthy cells and tissues in the eye.\nThe symptoms of Fuchs' uveitis can vary, but they typically include blurred vision, eye pain, redness, and sensitivity to light. The condition can also cause floaters, which are small, semi-transparent particles that float around in the field of vision.\nTreatment for Fuchs' uveitis typically involves using corticosteroids to reduce inflammation and prevent further damage to the eye. In some cases, other medications may also be used, such as immunosuppressants or antibiotics.\nIt is important to seek medical attention if you experience any symptoms of Fuchs' uveitis, as early treatment can help prevent vision loss.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fuchs' uveitis is a type of inflammation of the uvea, the middle layer of the eye.\n2. Fuchs' uveitis is a chronic condition that can cause vision loss if left untreated.\n3. The condition is named after the ophthalmologist who first described it, Friedrich Fuchs, in the early 20th century.\n4. The exact cause of Fuchs' uveitis is not known, but it is thought to be an autoimmune disorder.\n5. Treatment for Fuchs' uveitis typically involves using corticosteroids to reduce inflammation and prevent further damage to the eye.",
    "vicuna-7b_fact": [
      "Fuchs' uveitis is a type of inflammation of the uvea, the middle layer of the eye.",
      "Fuchs' uveitis is a chronic condition that can cause vision loss if left untreated.",
      "The condition is named after the ophthalmologist who first described it, Friedrich Fuchs, in the early 20th century.",
      "The exact cause of Fuchs' uveitis is not known, but it is thought to be an autoimmune disorder.",
      "Treatment for Fuchs' uveitis typically involves using corticosteroids to reduce inflammation and prevent further damage to the eye."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The condition is named after Ernst Fuchs, not Friedrich Fuchs. Ernst Fuchs was the ophthalmologist who first described this condition.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-7b_response": "LY6K, also known as Ly6K or CD272, is a protein that is expressed on the surface of immune cells, including T cells, B cells, and natural killer cells. It is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.\nThere is limited research on the relationship between LY6K expression and prognosis in NSCLC patients. However, some studies have suggested that overexpression of LY6K in cancer cells may be associated with better prognosis.\nFor example, one study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. The study suggested that LY6K may play a role in regulating the immune response to cancer and may be a potential target for immunotherapy in NSCLC.\nAnother study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery. The study suggested that LY6K may be a potential biomarker for identifying patients who are likely to benefit from immunotherapy.\nHowever, it is important to note that these studies are limited and more research is needed to fully understand the role of LY6K in NSCLC and its potential as a prognostic biomarker. Additionally, the prognosis of NSCLC patients can be influenced by many factors, including the stage and grade of the cancer, the presence of certain genetic mutations, and the response to treatment. Therefore, it is important for patients to discuss their individual prognosis with their healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LY6K is a protein that is expressed on the surface of immune cells and on some cancer cells, including non-small cell lung cancer cells.\n2. Some studies have suggested that overexpression of LY6K in cancer cells may be associated with better prognosis.\n3. A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n4. Another study published in the journal Clinical Cancer Research in 2018 associated high levels of LY6K expression with better survival in patients with advanced NSCLC who had undergone surgery.\n5. The prognosis of NSCLC patients can be influenced by many factors, including the stage and grade of the cancer, the presence of certain genetic mutations, and the response to treatment.",
    "vicuna-7b_fact": [
      "LY6K is a protein that is expressed on the surface of immune cells and on some cancer cells, including non-small cell lung cancer cells.",
      "Some studies have suggested that overexpression of LY6K in cancer cells may be associated with better prognosis.",
      "A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "Another study published in the journal Clinical Cancer Research in 2018 associated high levels of LY6K expression with better survival in patients with advanced NSCLC who had undergone surgery.",
      "The prognosis of NSCLC patients can be influenced by many factors, including the stage and grade of the cancer, the presence of certain genetic mutations, and the response to treatment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-7b_response": "During cytokinesis, the CDK (Cyclin-dependent kinase) targets specific phosphorylation sites on proteins to regulate their activity. The dephosphorylation of these targets is important for the completion of cytokinesis. Here are some examples of Cdk targets that are dephosphorylated during cytokinesis:\n1. Plk1 (Polo-like kinase 1) - Plk1 is a key regulator of centromeric cohesion and the formation of the mitotic spindle. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n2. Aurora B - Aurora B is a kinase that is involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n3. BubR1 - BubR1 is a kinase that is involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n4. Cdc14 - Cdc14 is a phosphatase that is involved in the dephosphorylation of proteins involved in the G2/M transition, including Cdc2/Cyclin B and Cdc25. It is dephosphorylated by Cdc28 during cytokinesis, allowing it to activate the transition from G2 to mitosis.\n5. Cdc28 - Cdc28 is a kinase that is involved in the regulation of the G2/M transition. It is dephosphorylated by Cdc14 during cytokinesis, allowing it to activate the transition from G2 to mitosis.\nThese are just a few examples of Cdk targets that are dephosphorylated during cytokinesis. The specific targets that are dephosphorylated can vary depending on the species and cell type.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. CDK (Cyclin-dependent kinase) targets specific phosphorylation sites on proteins to regulate their activity during cytokinesis.\n2. Plk1 (Polo-like kinase 1), a key regulator of centromeric cohesion and the formation of the mitotic spindle, is dephosphorylated by Cdk1 during cytokinesis.\n3. During cytokinesis, Aurora B, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is dephosphorylated by Cdk1.\n4. BubR1, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is dephosphorylated by Cdk1 during cytokinesis.\n5. Cdc14, a phosphatase involved in the dephosphorylation of proteins involved in the G2/M transition, is dephosphorylated by Cdc28 during cytokinesis.",
    "vicuna-7b_fact": [
      "CDK (Cyclin-dependent kinase) targets specific phosphorylation sites on proteins to regulate their activity during cytokinesis.",
      "Plk1 (Polo-like kinase 1), a key regulator of centromeric cohesion and the formation of the mitotic spindle, is dephosphorylated by Cdk1 during cytokinesis.",
      "During cytokinesis, Aurora B, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is dephosphorylated by Cdk1.",
      "BubR1, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is dephosphorylated by Cdk1 during cytokinesis.",
      "Cdc14, a phosphatase involved in the dephosphorylation of proteins involved in the G2/M transition, is dephosphorylated by Cdc28 during cytokinesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Plk1 (Polo-like kinase 1), a key regulator of centromeric cohesion and the formation of the mitotic spindle, is phosphorylated by Cdk1 during cytokinesis, not dephosphorylated.\n3. FALSE [correction]: During cytokinesis, Aurora B, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is phosphorylated by Cdk1, not dephosphorylated.\n4. FALSE [correction]: BubR1, a kinase involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint, is phosphorylated by Cdk1 during cytokinesis, not dephosphorylated.\n5. FALSE [correction]: Cdc14, a phosphatase involved in the dephosphorylation of proteins involved in the G2/M transition, is a phosphatase and therefore does not itself get dephosphorylated. It is actually activated, not dephosphorylated, during cytokinesis.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3474,
    "user_query": "What is dystopia canthorum?",
    "vicuna-7b_response": "Dystopia canthorum is a medical condition characterized by a turned-in or \"retracted\" appearance of the corners of the mouth. It is also known as \"ptosis palpebrarum\" or \"ptosis of the eyelids.\"\nDystopia canthorum can be caused by a variety of factors, including genetics, neurological disorders, and certain medications. It is often seen in conjunction with other conditions, such as ectrodactyly, a condition characterized by abnormalities of the hands and feet.\nThe condition can be diagnosed through a physical examination and may be confirmed through genetic testing. Treatment options for dystopia canthorum vary depending on the underlying cause, but may include surgery, physical therapy, or medication.\nIt is important to note that dystopia canthorum is not a common condition and is not typically associated with dystopia, a term that refers to a society or world in which the conditions are extremely unfavorable or unpleasant.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Dystopia canthorum is a medical condition characterized by a turned-in or \"retracted\" appearance of the corners of the mouth.\n2. The condition is also known as \"ptosis palpebrarum\" or \"ptosis of the eyelids.\"\n3. Diagnoses of dystopia canthorum may be made through a physical examination and may be confirmed through genetic testing.\n4. Treatment for dystopia canthorum could include surgery, physical therapy, or medication.\n5. It often appears in conjunction with ectrodactyly, a condition characterized by abnormalities of the hands and feet.",
    "vicuna-7b_fact": [
      "Dystopia canthorum is a medical condition characterized by a turned-in or \"retracted\" appearance of the corners of the mouth.",
      "The condition is also known as \"ptosis palpebrarum\" or \"ptosis of the eyelids.\"",
      "Diagnoses of dystopia canthorum may be made through a physical examination and may be confirmed through genetic testing.",
      "Treatment for dystopia canthorum could include surgery, physical therapy, or medication.",
      "It often appears in conjunction with ectrodactyly, a condition characterized by abnormalities of the hands and feet."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Dystopia canthorum is a medical condition characterized by a distinctive facial appearance with the inner corners of the eyes set more widely apart than usual.\n2. FALSE [correction]: The condition \"ptosis palpebrarum\" or \"ptosis of the eyelids\" is actually a drooping or falling of the upper or lower eyelid.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3476,
    "user_query": "What is Heterochromia Iridis?",
    "vicuna-7b_response": "Heterochromia iridum is a condition in which the iris of the eye is not of the same color. This means that one or both of the iris, the part of the eye that is responsible for the color of the eye, may be a different color than the other.\nHeterochromia iridum can be congenital, meaning that it is present at birth, or it can develop later in life. It can also be a symptom of certain medical conditions, such as iris atrophy or iris pigment epithelial tumors.\nThere are two types of heterochromia iridum: complete and partial. Complete heterochromia iridum occurs when one iris is completely different in color from the other, while partial heterochromia iridum occurs when only a part of the iris is a different color.\nHeterochromia iridum is a relatively rare condition, and it is estimated that it affects about 1 in every 1,000 people. It is not a medical emergency, but it can be a cosmetic concern for some people.\nIt is important to note that heterochromia iridum is not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as heterochromia iridum, which is a condition in which the iris of the eye is not of the same color, but it is also not the same as",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Heterochromia iridum is a condition in which the iris of one or both eyes is a different color from the other.\n2. Heterochromia iridum can be congenital or develop later in life.\n3. The condition can be a symptom of certain medical issues, such as iris atrophy or iris pigment epithelial tumors.\n4. There are two types of heterochromia iridum: complete and partial.\n5. Heterochromia iridum is a relatively rare condition, affecting approximately 1 in every 1,000 people.",
    "vicuna-7b_fact": [
      "Heterochromia iridum is a condition in which the iris of one or both eyes is a different color from the other.",
      "Heterochromia iridum can be congenital or develop later in life.",
      "The condition can be a symptom of certain medical issues, such as iris atrophy or iris pigment epithelial tumors.",
      "There are two types of heterochromia iridum: complete and partial.",
      "Heterochromia iridum is a relatively rare condition, affecting approximately 1 in every 1,000 people."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3483,
    "user_query": "Is Ubrogepant effective for migraine?",
    "vicuna-7b_response": "Ubrogepant is a medication that has been approved by the FDA for the treatment of migraines. It is a selective serotonin receptor agonist (SSRA) that works by activating serotonin receptors in the brain, which helps to reduce the severity of migraine symptoms.\nStudies have shown that Ubrogepant is effective in reducing the frequency and severity of migraines. In clinical trials, Ubrogepant has been shown to be effective in reducing the average number of monthly migraine days by more than 50% and the number of days with migraine-related symptoms by more than 50%.\nIt is important to note that Ubrogepant should only be used by individuals who have been diagnosed with migraines by a healthcare professional. It is also important to follow the dosing instructions provided by your healthcare provider and to talk to your healthcare provider about any side effects you may experience while taking Ubrogepant.\nOverall, Ubrogepant is a safe and effective medication for the treatment of migraines. If you are experiencing migraines, talk to your healthcare provider about whether Ubrogepant may be right for you.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Ubrogepant is an FDA-approved medication for the treatment of migraines.\n2. Ubrogepant is a selective serotonin receptor agonist (SSRA).\n3. Ubrogepant works by activating serotonin receptors in the brain, which helps to reduce the severity of migraine symptoms.\n4. Studies have shown that Ubrogepant reduces the average number of monthly migraine days and the number of days with migraine-related symptoms.\n5. Ubrogepant should only be used by individuals who have been diagnosed with migraines by a healthcare professional.",
    "vicuna-7b_fact": [
      "Ubrogepant is an FDA-approved medication for the treatment of migraines.",
      "Ubrogepant is a selective serotonin receptor agonist (SSRA).",
      "Ubrogepant works by activating serotonin receptors in the brain, which helps to reduce the severity of migraine symptoms.",
      "Studies have shown that Ubrogepant reduces the average number of monthly migraine days and the number of days with migraine-related symptoms.",
      "Ubrogepant should only be used by individuals who have been diagnosed with migraines by a healthcare professional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Ubrogepant is a calcitonin gene-related peptide receptor antagonist, not a selective serotonin receptor agonist (SSRA).\n3. FALSE [correction]: Ubrogepant works by blocking CGRP receptors which may reduce the severity of migraine symptoms.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3498,
    "user_query": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "vicuna-7b_response": "ProSavin, also known as autologous CD19-targeted T cell therapy, is a type of cancer immunotherapy that involves the isolation of a patient's own T cells, which are then modified to recognize and target cancer cells. In 2018, ProSavin had undergone phase III clinical trials, but it had not yet undergone phase IV clinical trials.\nPhase III clinical trials are typically the final stage of clinical trials before a treatment can be approved for use in the general population. These trials involve a large number of patients and are designed to assess the safety and efficacy of the treatment. The results of phase III clinical trials can help determine whether a treatment is effective and safe enough to be approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA).\nIt is important to note that the development of cancer treatments, including ProSavin, can be a complex and time-consuming process. The FDA typically requires multiple clinical trials to be conducted before a treatment can be approved for use. It is possible that ProSavin may undergo further clinical trials in the future, but as of 2021, it has not yet undergone phase IV clinical trials.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ProSavin is also known as autologous CD19-targeted T cell therapy.\n2. ProSavin is a type of cancer immunotherapy that involves the isolation of a patient's own T cells, which are then modified to recognize and target cancer cells.\n3. By 2018, ProSavin had undergone phase III clinical trials but not phase IV clinical trials.\n4. The U.S. Food and Drug Administration (FDA) typically requires multiple clinical trials to be conducted before a treatment can be approved for use.\n5. As of 2021, ProSavin has not yet undergone phase IV clinical trials.",
    "vicuna-7b_fact": [
      "ProSavin is also known as autologous CD19-targeted T cell therapy.",
      "ProSavin is a type of cancer immunotherapy that involves the isolation of a patient's own T cells, which are then modified to recognize and target cancer cells.",
      "By 2018, ProSavin had undergone phase III clinical trials but not phase IV clinical trials.",
      "The U.S. Food and Drug Administration (FDA) typically requires multiple clinical trials to be conducted before a treatment can be approved for use.",
      "As of 2021, ProSavin has not yet undergone phase IV clinical trials."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ProSavin is not known as autologous CD19-targeted T cell therapy. ProSavin is a gene therapy treatment for Parkinson's disease.\n2. FALSE [correction]: ProSavin is not a type of cancer immunotherapy. It is a gene therapy that works to introduce three genes required for dopamine synthesis to improve motor function in patients with Parkinson's disease.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3503,
    "user_query": "Are stretch enhancers transcribed more than super-enhancers?",
    "vicuna-7b_response": "Stretch enhancers and super-enhancers are both regulatory elements that can influence gene expression, but they differ in their transcriptional activity.\nStretch enhancers are long, non-coding RNA-bound regions that can act as enhancer elements to promote gene expression. They are typically located far away from the gene they regulate and can be transcribed at a lower rate than super-enhancers.\nSuper-enhancers, on the other hand, are highly active regions that contain multiple enhancers and other regulatory elements, such as transcription factor binding sites. They are typically located closer to the gene they regulate and can be transcribed at a higher rate than stretch enhancers.\nIn summary, while both stretch enhancers and super-enhancers can influence gene expression, super-enhancers are generally more active and transcribed at a higher rate than stretch enhancers.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Stretch enhancers are long, non-coding RNA-bound regions that act as enhancer elements to promote gene expression.\n2. Stretch enhancers are typically located far away from the gene they regulate.\n3. Super-enhancers are highly active regions that contain multiple enhancers and other regulatory elements such as transcription factor binding sites.\n4. Super-enhancers are typically located closer to the gene they regulate.\n5. Super-enhancers are generally more active and transcribed at a higher rate than stretch enhancers.",
    "vicuna-7b_fact": [
      "Stretch enhancers are long, non-coding RNA-bound regions that act as enhancer elements to promote gene expression.",
      "Stretch enhancers are typically located far away from the gene they regulate.",
      "Super-enhancers are highly active regions that contain multiple enhancers and other regulatory elements such as transcription factor binding sites.",
      "Super-enhancers are typically located closer to the gene they regulate.",
      "Super-enhancers are generally more active and transcribed at a higher rate than stretch enhancers."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Super-enhancers and stretch enhancers are both types of enhancers with high activity, and they do not necessarily have differential transcription rates.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3507,
    "user_query": "Which diagnostic test is approved for coronavirus infection screening?",
    "vicuna-7b_response": "There are several diagnostic tests that are approved for screening for COVID-19, the disease caused by the coronavirus. These tests include:\n1. Rapid antigen tests: These tests detect the presence of the coronavirus in a person's breath, saliva, or blood. They are fast and can provide results in as little as 15 minutes.\n2. Reverse transcription polymerase chain reaction (RT-PCR) tests: These tests detect the genetic material of the coronavirus in a person's respiratory secretions, such as saliva or sputum. They are more sensitive than rapid antigen tests and can detect the virus even when it is present at low levels.\n3. Immunofluorescence assays (IFA): These tests detect the antibodies that the body produces in response to the coronavirus infection. They are used to confirm a positive result from a rapid antigen or RT-PCR test.\nIt is important to note that all of these tests have been shown to be highly accurate in detecting COVID-19. However, it is also important to follow the guidelines of the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) for the proper use and interpretation of these tests.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Rapid antigen tests, reverse transcription polymerase chain reaction (RT-PCR) tests, and Immunofluorescence assays (IFA) are approved for screening for COVID-19.\n2. Rapid antigen tests detect the presence of the coronavirus in a person's breath, saliva, or blood and can provide results in as little as 15 minutes.\n3. Reverse transcription polymerase chain reaction (RT-PCR) tests detect the genetic material of the coronavirus in a person's respiratory secretions.\n4. Immunofluorescence assays (IFA) detect the antibodies that the body produces in response to the coronavirus infection and are used to confirm a positive result from a rapid antigen or RT-PCR test.\n5. According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), these tests have been shown to be highly accurate in detecting COVID-19.",
    "vicuna-7b_fact": [
      "Rapid antigen tests, reverse transcription polymerase chain reaction (RT-PCR) tests, and Immunofluorescence assays (IFA) are approved for screening for COVID-19.",
      "Rapid antigen tests detect the presence of the coronavirus in a person's breath, saliva, or blood and can provide results in as little as 15 minutes.",
      "Reverse transcription polymerase chain reaction (RT-PCR) tests detect the genetic material of the coronavirus in a person's respiratory secretions.",
      "Immunofluorescence assays (IFA) detect the antibodies that the body produces in response to the coronavirus infection and are used to confirm a positive result from a rapid antigen or RT-PCR test.",
      "According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), these tests have been shown to be highly accurate in detecting COVID-19."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Rapid antigen tests detect the presence of specific proteins (antigens) associated with the SARS-CoV-2 virus in a person's respiratory samples and can provide results in as little as 15 minutes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-7b_response": "Xanamem is a drug that is used to treat the symptoms of mild to moderate Alzheimer's disease. It is a type of drug called a cholinesterase inhibitor, which works by increasing the levels of a chemical in the brain called acetylcholine. Acetylcholine is important for memory and cognitive function.\nXanamem is typically taken as a pill, usually once daily. It is not a cure for Alzheimer's disease, but it can help improve symptoms such as memory loss, confusion, and disorientation.\nIt is important to note that Xanamem should only be used under the guidance of a healthcare professional, as it can have side effects and may not be suitable for everyone. It is also important to continue taking the medication as directed even if symptoms improve, as the drug works best when taken consistently.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Xanamem is a drug used to treat symptoms of mild to moderate Alzheimer's disease.\n2. Xanamem is a type of drug known as a cholinesterase inhibitor.\n3. This drug works by increasing levels of a chemical in the brain called acetylcholine.\n4. Xanamem is typically taken as a pill, usually once daily.\n5. Xanamem is not a cure for Alzheimer's, but can help improve symptoms such as memory loss, confusion, and disorientation.",
    "vicuna-7b_fact": [
      "Xanamem is a drug used to treat symptoms of mild to moderate Alzheimer's disease.",
      "Xanamem is a type of drug known as a cholinesterase inhibitor.",
      "This drug works by increasing levels of a chemical in the brain called acetylcholine.",
      "Xanamem is typically taken as a pill, usually once daily.",
      "Xanamem is not a cure for Alzheimer's, but can help improve symptoms such as memory loss, confusion, and disorientation."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Xanamem is not a cholinesterase inhibitor, it inhibits the production of cortisol in the brain.\n3. FALSE [correction]: Xanamem works by blocking the production of the stress hormone cortisol in the brain, not by increasing levels of acetylcholine.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3509,
    "user_query": "Can nrf2 activation lead to resistance to radiotherapy?",
    "vicuna-7b_response": "Yes, NRF2 activation has been shown to lead to resistance to radiotherapy in some cases.\nNRF2, or Nuclear Factor-Erythroid 2-Related Factor 2, is a transcription factor that plays a crucial role in the cell's response to oxidative stress. It has been shown to have a protective effect against radiation-induced damage, but excessive activation of NRF2 has been linked to resistance to radiotherapy.\nResearch has shown that NRF2 activation can lead to the upregulation of antioxidant enzymes and the downregulation of pro-apoptotic genes, which can protect cells from radiation-induced damage. However, excessive NRF2 activation can also lead to the upregulation of genes involved in DNA repair and cell survival, which can make cells more resistant to radiotherapy.\nIn addition, NRF2 activation has been shown to inhibit the activity of p53, a tumor suppressor gene that plays a crucial role in the cell's response to DNA damage. p53 is a key regulator of cell cycle arrest, apoptosis, and DNA repair, and its inhibition by NRF2 can lead to resistance to radiotherapy.\nOverall, while NRF2 activation can have a protective effect against radiation-induced damage, excessive activation can lead to resistance to radiotherapy. It is important to carefully balance the activation of NRF2 to ensure that it provides the necessary protection against oxidative stress while not interfering with the effects of radiotherapy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NRF2, or Nuclear Factor-Erythroid 2-Related Factor 2, is a transcription factor that plays a role in the cell's response to oxidative stress.\n2. NRF2 activation can lead to the upregulation of antioxidant enzymes and the downregulation of pro-apoptotic genes.\n3. NRF2 activation can also lead to the upregulation of genes involved in DNA repair and cell survival, which can make cells more resistant to radiotherapy.\n4. NRF2 activation has been shown to inhibit the activity of p53, a tumor suppressor gene that plays a significant role in the cell's response to DNA damage.\n5. Excessive activation of NRF2 can lead to resistance to radiotherapy.",
    "vicuna-7b_fact": [
      "NRF2, or Nuclear Factor-Erythroid 2-Related Factor 2, is a transcription factor that plays a role in the cell's response to oxidative stress.",
      "NRF2 activation can lead to the upregulation of antioxidant enzymes and the downregulation of pro-apoptotic genes.",
      "NRF2 activation can also lead to the upregulation of genes involved in DNA repair and cell survival, which can make cells more resistant to radiotherapy.",
      "NRF2 activation has been shown to inhibit the activity of p53, a tumor suppressor gene that plays a significant role in the cell's response to DNA damage.",
      "Excessive activation of NRF2 can lead to resistance to radiotherapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3513,
    "user_query": "What is the role of Scc2/Nipbl?",
    "vicuna-7b_response": "Scc2/Nipbl is a protein complex that plays a critical role in the regulation of DNA replication and repair in eukaryotic cells. It is composed of the Scc2 subunit, which is also known as the cohesin subunit, and the Nipbl subunit.\nThe Scc2/Nipbl complex functions by holding together DNA strands that have been replicated but have not yet been separated, a process known as sister chromatid cohesion. This helps to ensure that the two strands of DNA are properly aligned and can be separated during the process of anaphase.\nIn addition to its role in sister chromatid cohesion, the Scc2/Nipbl complex has also been implicated in the regulation of DNA repair. For example, studies have shown that the complex can bind to and regulate the activity of certain DNA repair genes, such as the BRCA1 gene.\nOverall, the Scc2/Nipbl complex is an important regulator of DNA replication and repair, and its dysfunction has been implicated in the development of certain types of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Scc2/Nipbl is a protein complex that plays a critical role in the regulation of DNA replication and repair in eukaryotic cells.\n2. The Scc2 subunit of the complex is also known as the cohesin subunit.\n3. The Scc2/Nipbl complex functions by maintaining sister chromatid cohesion.\n4. The Scc2/Nipbl complex can regulate the activity of certain DNA repair genes, such as the BRCA1 gene.\n5. Dysfunction of the Scc2/Nipbl complex has been implicated in the development of certain types of cancer.",
    "vicuna-7b_fact": [
      "Scc2/Nipbl is a protein complex that plays a critical role in the regulation of DNA replication and repair in eukaryotic cells.",
      "The Scc2 subunit of the complex is also known as the cohesin subunit.",
      "The Scc2/Nipbl complex functions by maintaining sister chromatid cohesion.",
      "The Scc2/Nipbl complex can regulate the activity of certain DNA repair genes, such as the BRCA1 gene.",
      "Dysfunction of the Scc2/Nipbl complex has been implicated in the development of certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Scc2 subunit of the complex is not a cohesin subunit, but it helps in loading cohesin onto DNA.\n3. FALSE [correction]: The Scc2/Nipbl complex functions by enabling cohesin to encircle DNA and maintain sister chromatid cohesion.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3515,
    "user_query": "Can brain derived exosomes carry APP molecules?",
    "vicuna-7b_response": "Yes, it is possible for brain-derived exosomes to carry APP (amyloid precursor protein) molecules. Exosomes are small, membrane-bound vesicles that are released by cells and can carry various types of molecules, including proteins, RNA, and DNA.\nAPP is a protein that is involved in the formation of beta-amyloid plaques, which are a hallmark of Alzheimer's disease. It is thought that the accumulation of beta-amyloid plaques in the brain is a key event in the development of Alzheimer's disease.\nExosomes are known to play a role in the transport of molecules between cells, and it is possible that exosomes released by brain cells could carry APP molecules. However, the exact mechanisms by which exosomes transport molecules are not fully understood, and further research is needed to determine the specific role of exosomes in the transport of APP and other molecules involved in Alzheimer's disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Brain-derived exosomes can carry APP (amyloid precursor protein) molecules.\n2. Exosomes are small, membrane-bound vesicles that are released by cells and can carry various types of molecules, including proteins, RNA, and DNA.\n3. The APP is a protein that is involved in the formation of beta-amyloid plaques, a hallmark of Alzheimer's disease.\n4. The accumulation of beta-amyloid plaques in the brain is a key event in the development of Alzheimer's disease.\n5. Exosomes play a role in the transport of molecules between cells.",
    "vicuna-7b_fact": [
      "Brain-derived exosomes can carry APP (amyloid precursor protein) molecules.",
      "Exosomes are small, membrane-bound vesicles that are released by cells and can carry various types of molecules, including proteins, RNA, and DNA.",
      "The APP is a protein that is involved in the formation of beta-amyloid plaques, a hallmark of Alzheimer's disease.",
      "The accumulation of beta-amyloid plaques in the brain is a key event in the development of Alzheimer's disease.",
      "Exosomes play a role in the transport of molecules between cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3517,
    "user_query": "Which are the main G1/S transcription factors in yeast?",
    "vicuna-7b_response": "In yeast, the main G1/S transcription factors are:\n1. Swi4/Swi6: These proteins are part of the Cdc6/Dbf4/Swi6 (CDS) complex, which is responsible for regulating the G1/S transition. The CDS complex binds to the promoters of genes involved in the G1 phase of the cell cycle and activates their transcription.\n2. Sfl1: This protein is a transcriptional repressor that plays a role in the regulation of the G1/S transition. Sfl1 binds to the promoters of genes involved in the G1 phase of the cell cycle and represses their transcription.\n3. Spt5: This protein is a transcriptional activator that plays a role in the regulation of the G1/S transition. Spt5 binds to the promoters of genes involved in the G1 phase of the cell cycle and activates their transcription.\n4. Tef1: This protein is a transcriptional activator that plays a role in the regulation of the G1/S transition. Tef1 binds to the promoters of genes involved in the G1 phase of the cell cycle and activates their transcription.\n5. Tup1: This protein is a transcriptional repressor that plays a role in the regulation of the G1/S transition. Tup1 binds to the promoters of genes involved in the G1 phase of the cell cycle and represses their transcription.\nThese are some of the main G1/S transcription factors in yeast, but there are other factors that also play a role in the regulation of the G1/S transition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. In yeast, Swi4/Swi6 proteins are part of the Cdc6/Dbf4/Swi6 (CDS) complex which regulates the G1/S transition.\n2. The CDS complex in yeast binds to the promoters of genes involved in the G1 phase and activates their transcription.\n3. Sfl1 protein in yeast is a transcriptional repressor that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and repressing their transcription.\n4. Spt5 protein in yeast is a transcriptional activator that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and activating their transcription.\n5. Tef1 protein in yeast is a transcriptional activator that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and activating their transcription.",
    "vicuna-7b_fact": [
      "In yeast, Swi4/Swi6 proteins are part of the Cdc6/Dbf4/Swi6 (CDS) complex which regulates the G1/S transition.",
      "The CDS complex in yeast binds to the promoters of genes involved in the G1 phase and activates their transcription.",
      "Sfl1 protein in yeast is a transcriptional repressor that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and repressing their transcription.",
      "Spt5 protein in yeast is a transcriptional activator that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and activating their transcription.",
      "Tef1 protein in yeast is a transcriptional activator that regulates the G1/S transition by binding to the promoters of genes involved in the G1 phase and activating their transcription."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-7b_response": "The Hof1-Cyk3 interaction plays a crucial role in the regulation of the cytochrome c oxidase (COX) complex in yeast. The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria of the cell.\nHof1 is a component of the COX complex and is responsible for the transfer of electrons from the cytochrome c protein to the copper centers of the complex. Cyk3 is a protein that interacts with Hof1 and is involved in the regulation of the COX complex.\nThe Hof1-Cyk3 interaction is important for the proper functioning of the COX complex, as it helps to maintain the proper conformation of Hof1 and ensures that it is in close proximity to the copper centers of the complex. This interaction is also important for the proper assembly of the COX complex and for the regulation of its activity.\nIn summary, the Hof1-Cyk3 interaction plays a critical role in the regulation of the cytochrome c oxidase complex in yeast, ensuring that it is properly assembled and functioning properly.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Hof1-Cyk3 interaction regulates the cytochrome c oxidase (COX) complex in yeast.\n2. The COX complex generates ATP from the oxidation of molecular oxygen in the mitochondria of the cell.\n3. Hof1 is a component of the COX complex and transfers electrons from the cytochrome c protein to the copper centers of the complex.\n4. Cyk3 is a protein that interacts with Hof1 and regulates the COX complex.\n5. The Hof1-Cyk3 interaction maintains the proper conformation of Hof1 and ensures that it is in close proximity to the copper centers of the complex.",
    "vicuna-7b_fact": [
      "The Hof1-Cyk3 interaction regulates the cytochrome c oxidase (COX) complex in yeast.",
      "The COX complex generates ATP from the oxidation of molecular oxygen in the mitochondria of the cell.",
      "Hof1 is a component of the COX complex and transfers electrons from the cytochrome c protein to the copper centers of the complex.",
      "Cyk3 is a protein that interacts with Hof1 and regulates the COX complex.",
      "The Hof1-Cyk3 interaction maintains the proper conformation of Hof1 and ensures that it is in close proximity to the copper centers of the complex."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3523,
    "user_query": "Is SATB1 positioned close to AT-rich sequences?",
    "vicuna-7b_response": "SATB1 (Sperm-Associated Transcription Factor 1) is a protein that plays a role in regulating gene expression during spermatogenesis. It is known to bind to AT-rich sequences, which are short stretches of DNA that contain a high number of adenine nucleotides. These sequences are often found in the promoter regions of genes and can act as binding sites for transcription factors like SATB1.\nSATB1 has been shown to bind to AT-rich sequences in the promoter regions of genes involved in spermatogenesis, suggesting that it plays a role in regulating their expression. Additionally, SATB1 has been shown to interact with other proteins that are involved in the regulation of spermatogenesis, including SPO11 and SPO12.\nOverall, SATB1 is positioned close to AT-rich sequences and plays a role in regulating gene expression during spermatogenesis by binding to these sequences in the promoter regions of genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SATB1 is a protein that is involved in regulating gene expression during spermatogenesis.\n2. SATB1 binds to AT-rich sequences, which are short stretches of DNA with a high number of adenine nucleotides.\n3. AT-rich sequences are often found in the promoter regions of genes where they can act as binding sites for transcription factors like SATB1.\n4. SATB1 has been shown to bind to AT-rich sequences in the promoter regions of genes involved in spermatogenesis, suggesting it plays a role in regulating their expression.\n5. SATB1 has been shown to interact with other proteins involved in the regulation of spermatogenesis, including SPO11 and SPO12.",
    "vicuna-7b_fact": [
      "SATB1 is a protein that is involved in regulating gene expression during spermatogenesis.",
      "SATB1 binds to AT-rich sequences, which are short stretches of DNA with a high number of adenine nucleotides.",
      "AT-rich sequences are often found in the promoter regions of genes where they can act as binding sites for transcription factors like SATB1.",
      "SATB1 has been shown to bind to AT-rich sequences in the promoter regions of genes involved in spermatogenesis, suggesting it plays a role in regulating their expression.",
      "SATB1 has been shown to interact with other proteins involved in the regulation of spermatogenesis, including SPO11 and SPO12."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3526,
    "user_query": "What is known about PAI-1 in longevity in humans?",
    "vicuna-7b_response": "PAI-1, or plasminogen activator inhibitor 1, is a protein that plays a role in regulating the activity of plasmin, an enzyme that helps to dissolve blood clots. High levels of PAI-1 have been associated with an increased risk of cardiovascular disease and atherosclerosis, which are conditions that can lead to premature death.\nStudies have also suggested that high levels of PAI-1 may be associated with a reduced lifespan in humans. For example, a study published in the journal Aging Cell in 2017 found that higher levels of PAI-1 were associated with a greater risk of mortality from all causes, including cardiovascular disease, in a group of elderly individuals.\nAnother study, published in the journal Circulation in 2018, found that higher levels of PAI-1 were associated with a greater risk of death from cardiovascular disease in a group of middle-aged and older adults.\nHowever, it is important to note that the relationship between PAI-1 and longevity is complex and not fully understood. Other factors, such as age, sex, and genetics, can also influence the levels of PAI-1 in the body and may play a role in determining lifespan.\nOverall, while there is some evidence to suggest that high levels of PAI-1 may be associated with a reduced lifespan in humans, more research is needed to fully understand the relationship between PAI-1 and longevity.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PAI-1, or plasminogen activator inhibitor 1, is a protein that regulates the activity of plasmin, an enzyme that helps to dissolve blood clots.\n2. High levels of PAI-1 have been associated with an increased risk of cardiovascular disease and atherosclerosis.\n3. A study published in the journal Aging Cell in 2017 found that higher levels of PAI-1 were associated with a greater risk of mortality from all causes in a group of elderly individuals.\n4. Another study published in the journal Circulation in 2018, found that higher levels of PAI-1 were associated with a greater risk of death from cardiovascular disease in a group of middle-aged and older adults.\n5. Factors such as age, sex, and genetics can influence the levels of PAI-1 in the body and may play a role in determining lifespan.",
    "vicuna-7b_fact": [
      "PAI-1, or plasminogen activator inhibitor 1, is a protein that regulates the activity of plasmin, an enzyme that helps to dissolve blood clots.",
      "High levels of PAI-1 have been associated with an increased risk of cardiovascular disease and atherosclerosis.",
      "A study published in the journal Aging Cell in 2017 found that higher levels of PAI-1 were associated with a greater risk of mortality from all causes in a group of elderly individuals.",
      "Another study published in the journal Circulation in 2018, found that higher levels of PAI-1 were associated with a greater risk of death from cardiovascular disease in a group of middle-aged and older adults.",
      "Factors such as age, sex, and genetics can influence the levels of PAI-1 in the body and may play a role in determining lifespan."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3530,
    "user_query": "What bacteria is associated with Gastric cancer and peptic ulcers?",
    "vicuna-7b_response": "Helicobacter pylori is a type of bacteria that is associated with gastric cancer and peptic ulcers. It is a gram-negative, microaerophilic bacterium that is known to colonize the stomach and cause chronic inflammation, leading to the development of gastric ulcers and an increased risk of gastric cancer.\nH. pylori infection is a major risk factor for gastric cancer, and it is estimated that up to 90% of gastric cancers worldwide are associated with this infection. The bacteria can enter the stomach through contaminated food or water, and it can also be transmitted from person to person through close contact.\nH. pylori infection can also cause peptic ulcers, which are sores that develop in the lining of the stomach or small intestine. The bacteria can damage the stomach lining and cause inflammation, leading to the formation of ulcers.\nTreatment for H. pylori infection typically involves a combination of antibiotics and antacids to eradicate the bacteria and reduce inflammation. Prevention measures include practicing good hygiene, avoiding raw or undercooked meat, and drinking plenty of water to reduce the risk of infection.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Helicobacter pylori is a type of bacteria associated with gastric cancer and peptic ulcers.\n2. H. pylori is a gram-negative, microaerophilic bacterium that colonizes the stomach.\n3. Up to 90% of gastric cancers worldwide are associated with H. pylori infection.\n4. The bacteria can be transmitted through contaminated food, water, or from person to person through close contact.\n5. Treatment for H. pylori infection typically involves a combination of antibiotics and antacids.",
    "vicuna-7b_fact": [
      "Helicobacter pylori is a type of bacteria associated with gastric cancer and peptic ulcers.",
      "H. pylori is a gram-negative, microaerophilic bacterium that colonizes the stomach.",
      "Up to 90% of gastric cancers worldwide are associated with H. pylori infection.",
      "The bacteria can be transmitted through contaminated food, water, or from person to person through close contact.",
      "Treatment for H. pylori infection typically involves a combination of antibiotics and antacids."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3532,
    "user_query": "What is the purpose of the 123 dihydrorhodamine assay?",
    "vicuna-7b_response": "The 123 dihydrorhodamine assay is a biochemical assay used to measure the activity of a specific enzyme in a sample. The assay involves the use of a fluorescent dye called dihydrorhodamine 123 (DHR 123), which is a substrate for the enzyme of interest.\nThe enzyme converts DHR 123 into a fluorescent product, which can be measured using a fluorescence spectrophotometer. The amount of fluorescent product produced is directly proportional to the activity of the enzyme in the sample.\nThe 123 dihydrorhodamine assay is commonly used to measure the activity of enzymes involved in various metabolic pathways, such as glycolysis, the citric acid cycle, and the electron transport chain. It is also used to measure the activity of enzymes involved in cellular signaling pathways, such as protein kinases and phosphatases.\nIn summary, the 123 dihydrorhodamine assay is a useful tool for measuring the activity of a specific enzyme in a sample, which can provide valuable information about the metabolic and signaling pathways in cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 123 dihydrorhodamine assay is a biochemical assay used to measure the activity of a specific enzyme in a sample.\n2. Dihydrorhodamine 123 (DHR 123) is a substrate used in this assay.\n3. The assay uses a fluorescence spectrophotometer to measure the amount of fluorescent product produced.\n4. The 123 dihydrorhodamine assay is commonly used to measure the activity of enzymes involved in several metabolic pathways, such as glycolysis, the citric acid cycle, and the electron transport chain.\n5. The 123 dihydrorhodamine assay is also used to measure the activity of enzymes involved in cellular signaling pathways, like protein kinases and phosphatases.",
    "vicuna-7b_fact": [
      "The 123 dihydrorhodamine assay is a biochemical assay used to measure the activity of a specific enzyme in a sample.",
      "Dihydrorhodamine 123 (DHR 123) is a substrate used in this assay.",
      "The assay uses a fluorescence spectrophotometer to measure the amount of fluorescent product produced.",
      "The 123 dihydrorhodamine assay is commonly used to measure the activity of enzymes involved in several metabolic pathways, such as glycolysis, the citric acid cycle, and the electron transport chain.",
      "The 123 dihydrorhodamine assay is also used to measure the activity of enzymes involved in cellular signaling pathways, like protein kinases and phosphatases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The 123 dihydrorhodamine assay is used to detect the production of reactive oxygen species, not the activity of enzymes in the mentioned metabolic pathways.\n5. FALSE [correction]: The 123 dihydrorhodamine assay does not measure the activity of enzymes involved in cellular signaling pathways, such as protein kinases and phosphatases. It is used to assess the production of reactive oxygen species.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3533,
    "user_query": "What is the mode of action of filgotinib?",
    "vicuna-7b_response": "Filgotinib is a JAK1-selective inhibitor that is used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. It works by inhibiting the activity of JAK1, which is a protein that plays a key role in the signaling pathway that leads to the production of pro-inflammatory cytokines. By inhibiting JAK1, filgotinib reduces the production of these cytokines and thereby reduces inflammation in the body.\nFilgotinib is taken orally and is usually taken once daily. It is usually well-tolerated, but like all medications, it can cause side effects. The most common side effects of filgotinib include diarrhea, nausea, and headache. Serious side effects are rare, but can include infections and liver problems.\nIt is important to note that filgotinib is not suitable for everyone and should only be used under the guidance of a healthcare professional. The decision to start or continue treatment with filgotinib should be based on a careful consideration of the potential benefits and risks of the medication, as well as the individual patient's medical history and current health status.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Filgotinib is a JAK1-selective inhibitor.\n2. Filgotinib is used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's disease.\n3. Filgotinib works by inhibiting the activity of JAK1 which reduces the production of pro-inflammatory cytokines, thereby reducing inflammation in the body.\n4. The medication is taken orally and typically once daily.\n5. Common side effects of filgotinib include diarrhea, nausea, and headache, while serious side effects may include infections and liver problems.",
    "vicuna-7b_fact": [
      "Filgotinib is a JAK1-selective inhibitor.",
      "Filgotinib is used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's disease.",
      "Filgotinib works by inhibiting the activity of JAK1 which reduces the production of pro-inflammatory cytokines, thereby reducing inflammation in the body.",
      "The medication is taken orally and typically once daily.",
      "Common side effects of filgotinib include diarrhea, nausea, and headache, while serious side effects may include infections and liver problems."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3535,
    "user_query": "What is RiboTag profiling?",
    "vicuna-7b_response": "RiboTag profiling is a technique used to study the dynamics of protein synthesis and degradation in cells. It involves the use of a small molecule called a RiboTag, which is attached to the N-terminus of a protein of interest. The RiboTag can then be detected and quantified using various methods, such as mass spectrometry or immunoprecipitation.\nBy using RiboTag profiling, researchers can gain insights into the regulation of protein synthesis and degradation, as well as the dynamics of protein expression and localization within cells. This technique can be used to study a wide range of biological processes, including cell cycle progression, signaling pathways, and protein-protein interactions.\nIn addition, RiboTag profiling can be used to study the effects of drugs or other compounds on protein synthesis and degradation, making it a valuable tool for drug discovery and development. Overall, RiboTag profiling is a powerful technique that can provide valuable insights into the regulation and dynamics of protein expression in cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. RiboTag profiling is used to study the dynamics of protein synthesis and degradation in cells.\n2. The technique involves the use of a small molecule called a RiboTag, which is attached to the N-terminus of a protein of interest.\n3. The RiboTag can be detected and quantified using methods such as mass spectrometry or immunoprecipitation.\n4. RiboTag profiling can be used to study a wide range of biological processes, including cell cycle progression, signaling pathways, and protein-protein interactions.\n5. This technique can be used to study the effects of drugs or other compounds on protein synthesis and degradation.",
    "vicuna-7b_fact": [
      "RiboTag profiling is used to study the dynamics of protein synthesis and degradation in cells.",
      "The technique involves the use of a small molecule called a RiboTag, which is attached to the N-terminus of a protein of interest.",
      "The RiboTag can be detected and quantified using methods such as mass spectrometry or immunoprecipitation.",
      "RiboTag profiling can be used to study a wide range of biological processes, including cell cycle progression, signaling pathways, and protein-protein interactions.",
      "This technique can be used to study the effects of drugs or other compounds on protein synthesis and degradation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: RiboTag profiling is used to study the translational activity of specifically expressed genes in specified cell types.\n2. FALSE [correction]: The technique involves the use of an epitope tagged ribosomal protein, which is introduced into a gene of interest.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3537,
    "user_query": "What is foliglurax?",
    "vicuna-7b_response": "Foliglurax is a drug that is used to treat certain types of epilepsy in dogs. It is a benzodiazepine, which is a class of drugs that work by reducing the activity of the central nervous system. Foliglurax is specifically used to treat partial seizures in dogs, which are seizures that affect a specific part of the brain.\nFoliglurax is available in tablet form and is typically given orally once or twice daily. The dosage of the drug will depend on the weight of the dog and the severity of the seizures. It is important to follow the dosage instructions provided by your veterinarian carefully, as overdose can be harmful to your dog.\nIt is important to note that Foliglurax should not be used in dogs with certain medical conditions, such as liver or kidney disease, or in dogs under the age of 6 months. It is also important to monitor your dog closely while they are taking Foliglurax, as it can cause drowsiness and may impair their ability to think and react.\nIf you have any questions or concerns about Foliglurax or your dog's treatment, it is important to speak with your veterinarian. They can provide you with more information and help you determine the best course of treatment for your dog.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Foliglurax is a drug used to treat certain types of epilepsy in dogs.\n2. Foliglurax is a benzodiazepine, reducing the activity of the central nervous system.\n3. This drug is used to treat partial seizures, which affect a specific part of the brain of a dog.\n4. Foliglurax comes in a tablet form and is typically given orally once or twice daily.\n5. Foliglurax should not be used in dogs with liver or kidney disease, or in dogs under the age of 6 months.",
    "vicuna-7b_fact": [
      "Foliglurax is a drug used to treat certain types of epilepsy in dogs.",
      "Foliglurax is a benzodiazepine, reducing the activity of the central nervous system.",
      "This drug is used to treat partial seizures, which affect a specific part of the brain of a dog.",
      "Foliglurax comes in a tablet form and is typically given orally once or twice daily.",
      "Foliglurax should not be used in dogs with liver or kidney disease, or in dogs under the age of 6 months."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3549,
    "user_query": "List symptoms of Allgrove syndrome.",
    "vicuna-7b_response": "Allgrove syndrome, also known as X-linked adrenal hypoplasia congenita, is a rare genetic disorder that affects the adrenal glands. The symptoms of Allgrove syndrome can vary from mild to severe, depending on the severity of the disorder. Here are some common symptoms of Allgrove syndrome:\n1. Hypoglycemia: Allgrove syndrome is characterized by low levels of glucose (sugar) in the blood, which can cause symptoms such as weakness, fatigue, irritability, and sweating.\n2. Hyperpigmentation: Some people with Allgrove syndrome may develop dark patches of skin on their face, neck, and other areas of the body. This is due to an excess of melanin, a pigment that gives skin its color.\n3. Developmental delays: Children with Allgrove syndrome may experience delays in their physical and cognitive development.\n4. Adrenal insufficiency: Allgrove syndrome is caused by a deficiency of the enzyme 21-hydroxylase, which is necessary for the production of cortisol and aldosterone. As a result, people with Allgrove syndrome may experience adrenal insufficiency, which can cause symptoms such as fatigue, weakness, and low blood pressure.\n5. Hypotension: Allgrove syndrome can also cause low blood pressure, which can lead to dizziness, lightheadedness, and fainting.\nIt's important to note that not all people with Allgrove syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person. If you suspect that you or your child may have Allgrove syndrome, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Allgrove syndrome, also known as X-linked adrenal hypoplasia congenita, is a genetic disorder that affects the adrenal glands.\n2. Some common symptoms of Allgrove syndrome include hypoglycemia, hyperpigmentation, developmental delays, adrenal insufficiency, and hypotension.\n3. People with Allgrove syndrome may experience low levels of glucose in the blood.\n4. Some people with Allgrove syndrome may develop dark patches of skin due to an excess of melanin.\n5. Allgrove syndrome is caused by a deficiency of the enzyme 21-hydroxylase, which can lead to adrenal insufficiency.",
    "vicuna-7b_fact": [
      "Allgrove syndrome, also known as X-linked adrenal hypoplasia congenita, is a genetic disorder that affects the adrenal glands.",
      "Some common symptoms of Allgrove syndrome include hypoglycemia, hyperpigmentation, developmental delays, adrenal insufficiency, and hypotension.",
      "People with Allgrove syndrome may experience low levels of glucose in the blood.",
      "Some people with Allgrove syndrome may develop dark patches of skin due to an excess of melanin.",
      "Allgrove syndrome is caused by a deficiency of the enzyme 21-hydroxylase, which can lead to adrenal insufficiency."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Allgrove syndrome, also known as Triple A syndrome, is a genetic disorder that affects the adrenal glands.\n2. FALSE [correction]: Some common symptoms of Allgrove syndrome include difficulty swallowing, abnormal tears production, and adrenal insufficiency.\n3. FALSE [correction]: People with Allgrove syndrome do not typically experience hypoglycemia, or low levels of glucose in the blood.\n4. FALSE [correction]: Hyperpigmentation or developing dark patches of skin due to an excess of melanin is not a common symptom of Allgrove syndrome.\n5. FALSE [correction]: Allgrove syndrome is caused by mutations in the AAAS gene, not by a deficiency of the enzyme 21-hydroxylase.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3551,
    "user_query": "How do the plasma concentrations of amantadine extended release and amantadine immediate release compare?",
    "vicuna-7b_response": "Amantadine extended release and amantadine immediate release are two different formulations of the same drug. The plasma concentrations of these two formulations can vary depending on the dosage, route of administration, and individual factors such as age, weight, and renal function.\nAmantadine extended release is designed to release the drug slowly and consistently over an extended period of time, typically 24 hours. This formulation is intended to provide a more consistent and predictable plasma concentration profile compared to amantadine immediate release.\nOn the other hand, amantadine immediate release is designed to release the drug quickly, providing a peak concentration in the blood within a few hours of administration. The plasma concentration of amantadine immediate release may vary more widely compared to amantadine extended release, depending on factors such as dosage, route of administration, and individual factors.\nIt is important to note that the choice of formulation and dosage regimen should be individualized based on the patient's needs and medical history. Your healthcare provider can help determine the appropriate dosage and formulation of amantadine for your specific needs.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Amantadine extended release and amantadine immediate release are two different formulations of the same drug. \n2. The plasma concentrations of amantadine extended release and immediate release can vary depending on dosage, route of administration, and individual factors such as age, weight, and renal function. \n3. Amantadine extended release is formulated to release the drug slowly and consistently over an extended period of time, typically 24 hours. \n4. Amantadine immediate release is designed to release the drug quickly, and can provide a peak concentration in the blood within a few hours of administration. \n5. The choice of formulation and dosage regimen of amantadine should be individualized based on the patient's needs and medical history.",
    "vicuna-7b_fact": [
      "Amantadine extended release and amantadine immediate release are two different formulations of the same drug.",
      "The plasma concentrations of amantadine extended release and immediate release can vary depending on dosage, route of administration, and individual factors such as age, weight, and renal function.",
      "Amantadine extended release is formulated to release the drug slowly and consistently over an extended period of time, typically 24 hours.",
      "Amantadine immediate release is designed to release the drug quickly, and can provide a peak concentration in the blood within a few hours of administration.",
      "The choice of formulation and dosage regimen of amantadine should be individualized based on the patient's needs and medical history."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3554,
    "user_query": "Which drugs are included in GI cocktail?",
    "vicuna-7b_response": "The GI cocktail is a combination of drugs used to induce general anesthesia in patients undergoing surgery. The specific drugs included in the GI cocktail may vary depending on the individual patient and the type of surgery being performed, but typically includes a combination of intravenous drugs such as propofol, fentanyl, and midazolam.\nPropofol is a sedative-hypnotic drug that is commonly used to induce and maintain anesthesia. It works by binding to specific receptors in the brain, which results in a decrease in consciousness and an inability to feel pain.\nFentanyl is an opioid analgesic that is used to provide pain relief during surgery. It works by binding to specific receptors in the brain and spinal cord, which results in a decrease in pain perception.\nMidazolam is a sedative-hypnotic drug that is used to induce and maintain anesthesia. It works by binding to specific receptors in the brain, which results in a decrease in consciousness and an inability to feel pain.\nOther drugs may be added to the GI cocktail depending on the specific needs of the patient and the type of surgery being performed. It is important to note that the use of any anesthetic drug carries risks, and the decision to use a particular drug or combination of drugs should be made by a qualified healthcare professional in consultation with the patient.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The GI cocktail is a combination of drugs used to induce general anesthesia in patients undergoing surgery.\n2. The GI cocktail typically includes intravenous drugs such as propofol, fentanyl, and midazolam.\n3. Propofol is a sedative-hypnotic drug commonly used to induce and maintain anesthesia.\n4. Fentanyl is an opioid analgesic used for pain relief during surgery.\n5. The use of any anesthetic drug carries risks and should be decided by a qualified healthcare professional in consultation with the patient.",
    "vicuna-7b_fact": [
      "The GI cocktail is a combination of drugs used to induce general anesthesia in patients undergoing surgery.",
      "The GI cocktail typically includes intravenous drugs such as propofol, fentanyl, and midazolam.",
      "Propofol is a sedative-hypnotic drug commonly used to induce and maintain anesthesia.",
      "Fentanyl is an opioid analgesic used for pain relief during surgery.",
      "The use of any anesthetic drug carries risks and should be decided by a qualified healthcare professional in consultation with the patient."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The GI cocktail, or green lizard, is a mixture of medications typically used to treat gastrointestinal discomfort, not to induce general anesthesia in patients undergoing surgery.\n2. FALSE [correction]: The GI cocktail typically includes Maalox, lidocaine, and Donnatal, not propofol, fentanyl, and midazolam.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3555,
    "user_query": "Is AZD5153 active in prostate cancer?",
    "vicuna-7b_response": "AZD5153 is a drug that is being studied for its potential to treat various types of cancer, including prostate cancer.\nAZD5153 is a small molecule inhibitor of the mammalian target of rapamycin (mTOR) pathway, which is a key regulator of cell growth and metabolism. The mTOR pathway is often activated in cancer cells, and inhibition of this pathway has been shown to slow the growth of cancer cells and improve survival in preclinical models of cancer.\nThere have been several clinical trials of AZD5153 in various types of cancer, including prostate cancer. These trials have shown that AZD5153 is generally well-tolerated and can cause tumor shrinkage in some patients. However, the results of these trials have been mixed, and the full potential of AZD5153 as a cancer treatment has yet to be fully realized.\nOverall, while AZD5153 has shown promise as a potential treatment for prostate cancer, more research is needed to fully understand its potential benefits and risks in this context.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. AZD5153 is being studied for its potential to treat various types of cancer, including prostate cancer.\n2. AZD5153 is a small molecule inhibitor of the mammalian target of rapamycin (mTOR) pathway.\n3. The mTOR pathway is often activated in cancer cells.\n4. There have been several clinical trials of AZD5153 in various types of cancer, including prostate cancer.\n5. The trials have shown that AZD5153 is generally well-tolerated and can cause tumor shrinkage in some patients.",
    "vicuna-7b_fact": [
      "AZD5153 is being studied for its potential to treat various types of cancer, including prostate cancer.",
      "AZD5153 is a small molecule inhibitor of the mammalian target of rapamycin (mTOR) pathway.",
      "The mTOR pathway is often activated in cancer cells.",
      "There have been several clinical trials of AZD5153 in various types of cancer, including prostate cancer.",
      "The trials have shown that AZD5153 is generally well-tolerated and can cause tumor shrinkage in some patients."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3556,
    "user_query": "Is GRG5 involved only in late embryonic mouse development?",
    "vicuna-7b_response": "GRG5 is a gene that encodes a protein called glycogenin 5. Glycogenin 5 is a component of the glycogenin complex, which is responsible for the synthesis of glycogen in the liver and other tissues.\nThe expression pattern of GRG5 during embryonic development has been studied in mice. GRG5 is expressed in the developing liver and pancreas during embryonic development, and its expression is highest during late embryonic development, specifically from E12.5 to E18.5.\nHowever, it is important to note that the expression pattern of GRG5 may vary between different species and tissues. Further studies are needed to fully understand the role of GRG5 in late embryonic development in mice and other organisms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GRG5 is a gene that encodes a protein called glycogenin 5.\n2. Glycogenin 5 is a component of the glycogenin complex, which is responsible for the synthesis of glycogen in the liver and other tissues.\n3. GRG5 is expressed in the developing liver and pancreas during embryonic development in mice.\n4. The expression of GRG5 is highest during late embryonic development in mice, specifically from E12.5 to E18.5.\n5. The expression pattern of GRG5 may vary between different species and tissues.",
    "vicuna-7b_fact": [
      "GRG5 is a gene that encodes a protein called glycogenin 5.",
      "Glycogenin 5 is a component of the glycogenin complex, which is responsible for the synthesis of glycogen in the liver and other tissues.",
      "GRG5 is expressed in the developing liver and pancreas during embryonic development in mice.",
      "The expression of GRG5 is highest during late embryonic development in mice, specifically from E12.5 to E18.5.",
      "The expression pattern of GRG5 may vary between different species and tissues."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3558,
    "user_query": "Describe the mechanism of action of a drug Elagolix.",
    "vicuna-7b_response": "Elagolix is a drug that is used to treat endometriosis, a condition in which tissue that normally lines the inside of the uterus grows outside of it, causing pain and other symptoms. The drug works by blocking the action of certain hormones that are involved in the growth and development of endometrial tissue.\nElagolix is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors in the body, but with a different mechanism of action than estrogen. It blocks the binding of estrogen to these receptors, which in turn reduces the growth and development of endometrial tissue.\nIn addition to treating endometriosis, Elagolix is also being studied for its potential use in treating other conditions, such as uterine fibroids and prostate cancer.\nIt's important to note that Elagolix is not a cure for endometriosis, but it can help to relieve symptoms and improve quality of life for people with the condition. It's also important to note that Elagolix should not be used in women who are pregnant or breastfeeding.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Elagolix is used to treat endometriosis.\n2. Elagolix works by blocking the action of certain hormones that are involved in the growth and development of endometrial tissue.\n3. Elagolix is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors in the body.\n4. It blocks the binding of estrogen to these receptors, which reduces the growth and development of endometrial tissue.\n5. Elagolix is being studied for its potential use in treating other conditions, such as uterine fibroids and prostate cancer.",
    "vicuna-7b_fact": [
      "Elagolix is used to treat endometriosis.",
      "Elagolix works by blocking the action of certain hormones that are involved in the growth and development of endometrial tissue.",
      "Elagolix is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors in the body.",
      "It blocks the binding of estrogen to these receptors, which reduces the growth and development of endometrial tissue.",
      "Elagolix is being studied for its potential use in treating other conditions, such as uterine fibroids and prostate cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist, not a selective estrogen receptor modulator (SERM).\n4. FALSE [correction]: Elagolix works by blocking the action of gonadotropin-releasing hormone, reducing the level of certain hormones in the body and preventing the growth and development of endometrial tissue.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3567,
    "user_query": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?",
    "vicuna-7b_response": "There are several algorithms that have been developed for analyzing CRISPR/Cas9 knockout screens data. Some of the most commonly used algorithms include:\n1. Cluster analysis: This algorithm is used to identify groups of genes that are functionally related based on their expression patterns or phenotypes. Cluster analysis can be used to identify genes that are affected by a specific knockout, as well as genes that are affected by multiple knockouts.\n2. Gene set enrichment analysis (GSEA): This algorithm is used to identify genes that are enriched in a specific biological process or pathway. GSEA can be used to identify genes that are affected by a specific knockout, as well as genes that are affected by multiple knockouts.\n3. Pathway analysis: This algorithm is used to identify genes that are involved in a specific biological pathway. Pathway analysis can be used to identify genes that are affected by a specific knockout, as well as genes that are affected by multiple knockouts.\n4. Machine learning algorithms: These algorithms can be used to identify genes that are affected by a specific knockout based on patterns in the data. Machine learning algorithms can be trained on large datasets of gene expression or phenotype data to identify genes that are affected by a specific knockout.\n5. Network analysis: This algorithm is used to identify genes that are connected to each other in a network of interactions. Network analysis can be used to identify genes that are affected by a specific knockout, as well as genes that are affected by multiple knockouts.\nThese are some of the most commonly used algorithms for analyzing CRISPR/Cas9 knockout screens data, but there are many other algorithms that can be used depending on the specific research question and the type of data being analyzed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Cluster analysis is used to identify functionally related groups of genes based on their expression patterns or phenotypes in CRISPR/Cas9 knockout screens data.\n2. Gene set enrichment analysis (GSEA) is utilized to identify genes that are enriched in a specific biological process or pathway in CRISPR/Cas9 knockout screens data.\n3. Pathway analysis is used to identify genes involved in a specific biological pathway in CRISPR/Cas9 knockout screens data.\n4. Machine learning algorithms can be applied to identify genes affected by a specific knockout based on patterns in the data in CRISPR/Cas9 knockout screens data.\n5. In the analysis of CRISPR/Cas9 knockout screens data, network analysis is used to identify genes that are connected to each other in a network of interactions.",
    "vicuna-7b_fact": [
      "Cluster analysis is used to identify functionally related groups of genes based on their expression patterns or phenotypes in CRISPR/Cas9 knockout screens data.",
      "Gene set enrichment analysis (GSEA) is utilized to identify genes that are enriched in a specific biological process or pathway in CRISPR/Cas9 knockout screens data.",
      "Pathway analysis is used to identify genes involved in a specific biological pathway in CRISPR/Cas9 knockout screens data.",
      "Machine learning algorithms can be applied to identify genes affected by a specific knockout based on patterns in the data in CRISPR/Cas9 knockout screens data.",
      "In the analysis of CRISPR/Cas9 knockout screens data, network analysis is used to identify genes that are connected to each other in a network of interactions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3569,
    "user_query": "PDQ39 questionnaires is design for which disease?",
    "vicuna-7b_response": "PDQ39 questionnaires are designed for patients with chronic obstructive pulmonary disease (COPD).",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. PDQ39 questionnaires are designed for patients with chronic obstructive pulmonary disease (COPD).",
    "vicuna-7b_fact": [
      "PDQ39 questionnaires are designed for patients with chronic obstructive pulmonary disease (COPD)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: PDQ39 questionnaires are designed for patients with Parkinson's Disease.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3570,
    "user_query": "Is palbociclib effective for glioblastoma?",
    "vicuna-7b_response": "Palbociclib is a medication that is primarily used to treat breast cancer. It is not approved for the treatment of glioblastoma, which is a type of brain cancer.\nGlioblastoma is a highly aggressive type of brain cancer that is difficult to treat. There are several different treatment options available for glioblastoma, including surgery, radiation therapy, and chemotherapy. However, these treatments are often not effective in controlling the growth of the cancer.\nThere are currently several clinical trials underway to evaluate the effectiveness of palbociclib in the treatment of glioblastoma. These trials are designed to determine whether palbociclib is safe and effective in treating this type of cancer.\nIt is important to note that while palbociclib may not be effective in treating glioblastoma, there are other medications that are being studied for the treatment of this type of cancer. If you are interested in learning more about treatment options for glioblastoma, it is best to speak with a medical professional.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Palbociclib is a medication primarily used to treat breast cancer.\n2. Palbociclib is not approved for the treatment of glioblastoma.\n3. Glioblastoma is a highly aggressive type of brain cancer.\n4. Treatment options available for glioblastoma include surgery, radiation therapy, and chemotherapy.\n5. There are clinical trials underway to evaluate the effectiveness of palbociclib in the treatment of glioblastoma.",
    "vicuna-7b_fact": [
      "Palbociclib is a medication primarily used to treat breast cancer.",
      "Palbociclib is not approved for the treatment of glioblastoma.",
      "Glioblastoma is a highly aggressive type of brain cancer.",
      "Treatment options available for glioblastoma include surgery, radiation therapy, and chemotherapy.",
      "There are clinical trials underway to evaluate the effectiveness of palbociclib in the treatment of glioblastoma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3572,
    "user_query": "Does the Mcm2-Ctf4-Polα axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "vicuna-7b_response": "Yes, the Mcm2-Ctf4-Polα axis plays a role in the transfer of histones to the leading strand DNA at the replication forks.\nThe Mcm2-Ctf4-Polα complex is a key component of the replicative helicase, which is responsible for unwinding the double helix of DNA and initiating the replication process. During replication, the helicase moves along the DNA template strand, generating a replication fork at which the leading and lagging strands are synthesized.\nHistones are proteins that are responsible for compacting DNA into chromatin, and they play a crucial role in the regulation of gene expression. Histones are also involved in the replication of DNA, and their transfer to the leading strand is an important step in this process.\nThe transfer of histones to the leading strand is facilitated by the Mcm2-Ctf4-Polα complex, which helps to unwind the DNA template and expose the histone-DNA complexes on the template strand. Once the histones are exposed, they can be transferred to the growing leading strand by the replicative helicase.\nIn summary, the Mcm2-Ctf4-Polα complex plays a critical role in the transfer of histones to the leading strand during DNA replication, helping to ensure the accurate and efficient replication of the genome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Mcm2-Ctf4-Polα axis is involved in the transfer of histones to the leading strand DNA at the replication forks.\n2. The Mcm2-Ctf4-Polα complex is a part of the replicative helicase.\n3. The replicative helicase is responsible for unwinding the double helix of DNA and initiating the replication process.\n4. Histones are proteins that play a role in the regulation of gene expression and the replication of DNA.\n5. The Mcm2-Ctf4-Polα complex helps to facilitate the transfer of histones to the leading strand during DNA replication.",
    "vicuna-7b_fact": [
      "The Mcm2-Ctf4-Polα axis is involved in the transfer of histones to the leading strand DNA at the replication forks.",
      "The Mcm2-Ctf4-Polα complex is a part of the replicative helicase.",
      "The replicative helicase is responsible for unwinding the double helix of DNA and initiating the replication process.",
      "Histones are proteins that play a role in the regulation of gene expression and the replication of DNA.",
      "The Mcm2-Ctf4-Polα complex helps to facilitate the transfer of histones to the leading strand during DNA replication."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3574,
    "user_query": "Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?",
    "vicuna-7b_response": "The gene that is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is the ATP1A3 gene.\nADLD is a rare genetic disorder characterized by progressive degeneration of the white matter of the brain, leading to demyelination and neurodegeneration. It is caused by mutations in the ATP1A3 gene, which encodes for the alpha-1 subunit of the mitochondrial ATP synthase.\nMutations in the ATP1A3 gene can lead to reduced ATP synthesis, which can cause energy deficiency in the brain cells, leading to demyelination and neurodegeneration.\nADLD is a progressive disorder, and the symptoms typically begin in adulthood, although they can also occur in childhood. The symptoms can vary widely, but typically include difficulty with coordination, speech, and walking, as well as cognitive decline and dementia.\nThere is currently no cure for ADLD, and treatment is primarily focused on managing symptoms and improving quality of life.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The ATP1A3 gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).\n2. ADLD is a rare genetic disorder characterized by progressive degeneration of the white matter of the brain.\n3. Mutations in the ATP1A3 gene, which encodes for the alpha-1 subunit of the mitochondrial ATP synthase, cause ADLD.\n4. Mutations in the ATP1A3 gene can lead to reduced ATP synthesis, causing energy deficiency in brain cells.\n5. There is currently no cure for ADLD, and treatment primarily focuses on managing symptoms and improving quality of life.",
    "vicuna-7b_fact": [
      "The ATP1A3 gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).",
      "ADLD is a rare genetic disorder characterized by progressive degeneration of the white matter of the brain.",
      "Mutations in the ATP1A3 gene, which encodes for the alpha-1 subunit of the mitochondrial ATP synthase, cause ADLD.",
      "Mutations in the ATP1A3 gene can lead to reduced ATP synthesis, causing energy deficiency in brain cells.",
      "There is currently no cure for ADLD, and treatment primarily focuses on managing symptoms and improving quality of life."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The LMNB1 gene, not the ATP1A3 gene, is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).\n2. TRUE\n3. FALSE [correction]: Mutations in the LMNB1 gene, not the ATP1A3 gene, cause ADLD.\n4. FALSE [correction]: Mutations in the ATP1A3 gene are associated with conditions like Alternating Hemiplegia of Childhood or Rapid-onset Dystonia-Parkinsonism, not reduced ATP synthesis.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3577,
    "user_query": "Which is the main epigenetic difference between poised and constitutive enhancers?",
    "vicuna-7b_response": "Poised enhancers and constitutive enhancers differ in their epigenetic regulation. Poised enhancers are typically in a \"bivalent\" state, meaning that they are bound by both activating and repressive epigenetic marks, such as histone modifications and DNA methylation. This allows for their activation in response to specific stimuli or cellular conditions. In contrast, constitutive enhancers are typically in a \"monovalent\" state, meaning that they are bound by only one type of epigenetic mark, and are always active.\nPoised enhancers are often found in the 5' region of genes, and are thought to play a role in regulating the expression of genes in a cell-type specific manner. They are also thought to be important for the regulation of developmental processes, such as cell differentiation and organogenesis.\nConstitutive enhancers, on the other hand, are often found in the 3' region of genes, and are thought to play a role in the regulation of gene expression in response to specific stimuli or cellular conditions. They are also thought to be important for the regulation of cellular processes such as proliferation and survival.\nIn summary, the main epigenetic difference between poised and constitutive enhancers is the way they are regulated. Poised enhancers are regulated in a cell-type specific manner and are activated in response to specific stimuli, while constitutive enhancers are always active.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Poised enhancers are typically in a \"bivalent\" state and are bound by both activating and repressive epigenetic marks.\n2. Poised enhancers can be activated in response to specific stimuli or cellular conditions.\n3. Poised enhancers are thought to be found predominantly in the 5' region of genes.\n4. Constitutive enhancers are typically in a \"monovalent\" state and are bound by one type of epigenetic mark and are always active.\n5. Constitutive enhancers are often found in the 3' region of genes.",
    "vicuna-7b_fact": [
      "Poised enhancers are typically in a \"bivalent\" state and are bound by both activating and repressive epigenetic marks.",
      "Poised enhancers can be activated in response to specific stimuli or cellular conditions.",
      "Poised enhancers are thought to be found predominantly in the 5' region of genes.",
      "Constitutive enhancers are typically in a \"monovalent\" state and are bound by one type of epigenetic mark and are always active.",
      "Constitutive enhancers are often found in the 3' region of genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Constitutive enhancers are not typically in a \"monovalent\" state and are not always active. They are bound by specific epigenetic marks which reflect their ongoing activity.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3586,
    "user_query": "What is gamma sterilization used for?",
    "vicuna-7b_response": "Gamma sterilization is a method of sterilization that uses gamma radiation to kill microorganisms in a product or material. It is commonly used to sterilize medical devices, pharmaceuticals, and food products.\nGamma radiation is a type of electromagnetic radiation that is emitted by the nucleus of an unstable atom. When this radiation is absorbed by the microorganisms in a product, it causes the DNA of the microorganisms to become damaged or destroyed, effectively killing them.\nGamma sterilization is a highly effective method of sterilization, as it can penetrate deep into the material or product and kill microorganisms that may be hidden or difficult to reach with other methods. It is also a non-chemical method of sterilization, which means that it does not rely on the use of chemicals or solvents to kill the microorganisms.\nOverall, gamma sterilization is a safe and effective method of sterilization that is commonly used in a variety of industries to ensure the safety and quality of products.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gamma sterilization is a method that uses gamma radiation to kill microorganisms in a product or material.\n2. Gamma sterilization is commonly used to sterilize medical devices, pharmaceuticals, and food products.\n3. Gamma radiation is a type of electromagnetic radiation emitted by the nucleus of an unstable atom.\n4. The process of gamma sterilization damages or destroys the DNA of the microorganisms, effectively killing them.\n5. Gamma sterilization is a non-chemical method of sterilization.",
    "vicuna-7b_fact": [
      "Gamma sterilization is a method that uses gamma radiation to kill microorganisms in a product or material.",
      "Gamma sterilization is commonly used to sterilize medical devices, pharmaceuticals, and food products.",
      "Gamma radiation is a type of electromagnetic radiation emitted by the nucleus of an unstable atom.",
      "The process of gamma sterilization damages or destroys the DNA of the microorganisms, effectively killing them.",
      "Gamma sterilization is a non-chemical method of sterilization."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3589,
    "user_query": "What is the current regulation of eye lens radiation exposure?",
    "vicuna-7b_response": "The regulation of eye lens radiation exposure is primarily governed by the International Commission on Radiation Protection (ICRP). The ICRP publishes recommendations for the protection of individuals against the harmful effects of ionizing radiation, including radiation exposure to the eye lens.\nThe ICRP recommends that exposure to ionizing radiation should be kept as low as reasonably achievable (ALARA) to minimize the risk of adverse effects, including radiation-induced cataracts. The ICRP also recommends that exposure to radiation should be limited to the minimum dose necessary to achieve the desired medical benefit.\nIn addition to the ICRP recommendations, many countries have established national regulations and guidelines for the protection of individuals against radiation exposure. These regulations and guidelines may vary depending on the specific circumstances of the exposure, such as the type of radiation, the dose level, and the intended medical purpose.\nIt is important to note that radiation exposure to the eye lens can also occur from non-ionizing sources, such as lasers and other optical sources. The regulation of non-ionizing radiation exposure is typically governed by other agencies, such as the Occupational Safety and Health Administration (OSHA) in the United States.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The International Commission on Radiation Protection (ICRP) primarily governs the regulation of eye lens radiation exposure.\n2. The ICRP publishes recommendations for the protection of individuals against the harmful effects of ionizing radiation.\n3. The ICRP recommends keeping exposure to ionizing radiation as low as reasonably achievable (ALARA) to minimize adverse effects.\n4. Several countries have national regulations and guidelines for the protection against radiation exposure.\n5. The regulation of non-ionizing radiation exposure can be governed by agencies such as the Occupational Safety and Health Administration (OSHA) in the United States.",
    "vicuna-7b_fact": [
      "The International Commission on Radiation Protection (ICRP) primarily governs the regulation of eye lens radiation exposure.",
      "The ICRP publishes recommendations for the protection of individuals against the harmful effects of ionizing radiation.",
      "The ICRP recommends keeping exposure to ionizing radiation as low as reasonably achievable (ALARA) to minimize adverse effects.",
      "Several countries have national regulations and guidelines for the protection against radiation exposure.",
      "The regulation of non-ionizing radiation exposure can be governed by agencies such as the Occupational Safety and Health Administration (OSHA) in the United States."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The International Commission on Radiation Protection (ICRP) provides guidelines and recommends standards for radiation protection, but it does not \"primarily govern\" regulations. Governing the regulation of radiation exposure is largely handled by national and international regulatory bodies.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3593,
    "user_query": "What is the cause of the disease Xeroderma Pigmentosum?",
    "vicuna-7b_response": "Xeroderma pigmentosum (XP) is a rare genetic disorder that affects the skin and the eyes. It is caused by a deficiency in an enzyme called \"ERCC1-XP,\" which is responsible for repairing damaged DNA.\nWhen the DNA in a cell is damaged, the ERCC1-XP enzyme helps to repair the damage by recognizing and removing damaged bases from the DNA molecule. Without this enzyme, the damaged DNA remains unrepaired, and the cell is unable to properly repair itself. This leads to the accumulation of mutations in the DNA, which can cause the cells to become cancerous.\nXP is a recessive disorder, which means that an individual must inherit two copies of the defective gene (one from each parent) to develop the disorder. The symptoms of XP can vary from person to person, but they typically include a high sensitivity to sunlight, light-colored skin that burns easily, and an increased risk of developing skin cancer.\nThere is no cure for XP, and the disorder is usually fatal if left untreated. However, there are treatments available that can help to manage the symptoms and reduce the risk of cancer. These treatments include avoiding sunlight, wearing protective clothing, and taking medications that can help to slow down the progression of the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Xeroderma pigmentosum (XP) is a rare genetic disorder that affects the skin and the eyes.\n2. XP is caused by a deficiency in an enzyme called \"ERCC1-XP,\" which is responsible for repairing damaged DNA.\n3. Without the \"ERCC1-XP\" enzyme, the damaged DNA remains unrepaired, leading to the accumulation of mutations in the DNA, which can cause the cells to become cancerous.\n4. XP is a recessive disorder, which means that an individual must inherit two copies of the defective gene to develop the disorder.\n5. There is no cure for XP, but treatments are available to manage symptoms and reduce the risk of cancer.",
    "vicuna-7b_fact": [
      "Xeroderma pigmentosum (XP) is a rare genetic disorder that affects the skin and the eyes.",
      "XP is caused by a deficiency in an enzyme called \"ERCC1-XP,\" which is responsible for repairing damaged DNA.",
      "Without the \"ERCC1-XP\" enzyme, the damaged DNA remains unrepaired, leading to the accumulation of mutations in the DNA, which can cause the cells to become cancerous.",
      "XP is a recessive disorder, which means that an individual must inherit two copies of the defective gene to develop the disorder.",
      "There is no cure for XP, but treatments are available to manage symptoms and reduce the risk of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: XP is caused by a deficiency in one of eight different proteins, not only \"ERCC1-XP,\" which are responsible for repairing damaged DNA.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.\nGastric cancer is a type of cancer that develops in the stomach. T-UCRs are a type of protein that plays a role in the development and progression of cancer. Research has shown that high levels of T-UCRs can promote the growth and spread of gastric cancer cells.\nSeveral studies have identified specific T-UCRs that have been implicated in gastric cancer. For example, a study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1, a specific type of T-UCR, were associated with poor outcomes in patients with gastric cancer. Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2, another type of T-UCR, were associated with poor survival in patients with gastric cancer.\nOverall, while more research is needed to fully understand the role of T-UCRs in gastric cancer, there is evidence to suggest that high levels of certain T-UCRs can promote the growth and spread of gastric cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tumor-Associated Urokinase-Type Plasminogen Activator Receptor (T-UCRs) have been implicated in gastric cancer.\n2. Gastric cancer is a type of cancer that develops in the stomach.\n3. High levels of T-UCRs can promote the growth and spread of gastric cancer cells.\n4. A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.\n5. A study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer.",
    "vicuna-7b_fact": [
      "Tumor-Associated Urokinase-Type Plasminogen Activator Receptor (T-UCRs) have been implicated in gastric cancer.",
      "Gastric cancer is a type of cancer that develops in the stomach.",
      "High levels of T-UCRs can promote the growth and spread of gastric cancer cells.",
      "A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.",
      "A study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3600,
    "user_query": "Which de novo mutation in FGFR cause achondroplasia?",
    "vicuna-7b_response": "Achondroplasia is caused by a de novo mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. This gene provides instructions for making a protein that plays a role in bone development. The specific mutation that causes achondroplasia is a substitution of the amino acid asparagine for aspartate at position 235 in the FGFR3 protein. This mutation leads to the formation of a non-functional protein that disrupts the normal function of the FGFR3 protein in bone development, resulting in the characteristic symptoms of achondroplasia.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is caused by a de novo mutation in the FGFR3 gene.\n2. The FGFR3 gene provides instructions for making a protein that plays a role in bone development.\n3. The specific mutation that causes achondroplasia is a substitution of the amino acid asparagine for aspartate at position 235 in the FGFR3 protein.\n4. This mutation leads to the formation of a non-functional protein.\n5. This disruption of the FGFR3 protein's function in bone development results in the characteristic symptoms of achondroplasia.",
    "vicuna-7b_fact": [
      "Achondroplasia is caused by a de novo mutation in the FGFR3 gene.",
      "The FGFR3 gene provides instructions for making a protein that plays a role in bone development.",
      "The specific mutation that causes achondroplasia is a substitution of the amino acid asparagine for aspartate at position 235 in the FGFR3 protein.",
      "This mutation leads to the formation of a non-functional protein.",
      "This disruption of the FGFR3 protein's function in bone development results in the characteristic symptoms of achondroplasia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: This mutation leads to an overactive protein, not a non-functional one.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3601,
    "user_query": "List types of DNA lesions caused by UV light.",
    "vicuna-7b_response": "DNA lesions caused by UV light can be broadly classified into two categories: thymine dimers and pyrimidine(6-4) photoproducts.\n1. Thymine dimers: Thymine dimers are formed when a thymine base in DNA is cross-linked with a pyrimidine base (usually cytosine) by UV radiation. This results in the formation of a stable adduct between the two bases, which can lead to mutations and chromosomal aberrations.\n2. Pyrimidine(6-4) photoproducts: Pyrimidine(6-4) photoproducts are formed when a pyrimidine base (usually thymine or cytosine) is damaged by UV radiation. This results in the formation of a cyclobutane pyrimidine dimer (CPD) or pyrimidine(6-4) pyrimidone photoproduct (6-4PP), which can also lead to mutations and chromosomal aberrations.\nIt is important to note that UV radiation can also cause other types of DNA damage, such as base modifications, single-strand breaks, and double-strand breaks. However, thymine dimers and pyrimidine(6-4) photoproducts are the most common types of DNA lesions caused by UV light.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. DNA lesions caused by UV light are broadly classified into two categories: thymine dimers and pyrimidine(6-4) photoproducts.\n2. Thymine dimers are formed when a thymine base in DNA is cross-linked with a pyrimidine base by UV radiation.\n3. Thymine dimers formation can lead to mutations and chromosomal aberrations.\n4. Pyrimidine(6-4) photoproducts are formed when a pyrimidine base is damaged by UV radiation.\n5. Pyrimidine(6-4) photoproducts formation can also lead to mutations and chromosomal aberrations.",
    "vicuna-7b_fact": [
      "DNA lesions caused by UV light are broadly classified into two categories: thymine dimers and pyrimidine(6-4) photoproducts.",
      "Thymine dimers are formed when a thymine base in DNA is cross-linked with a pyrimidine base by UV radiation.",
      "Thymine dimers formation can lead to mutations and chromosomal aberrations.",
      "Pyrimidine(6-4) photoproducts are formed when a pyrimidine base is damaged by UV radiation.",
      "Pyrimidine(6-4) photoproducts formation can also lead to mutations and chromosomal aberrations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Thymine dimers are formed when two adjacent thymine bases in DNA are cross-linked by UV radiation.\n3. TRUE\n4. FALSE [correction]: Pyrimidine(6-4) photoproducts are formed when two adjacent pyrimidine bases in DNA, specifically a thymine followed by a cytosine, are linked by UV radiation.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3604,
    "user_query": "Which software are used for the detection of selective sweeps?",
    "vicuna-7b_response": "There are several software packages that are commonly used for the detection of selective sweeps in genomic data. Some of the most popular ones include:\n1. GENEHUNTER: This is a software package that is specifically designed for the detection of positive selection in genomic data. It uses a variety of methods, including the branch-site model and the codon-based model, to identify genes that have undergone positive selection.\n2. LDPAIR: This is a software package that is used for the detection of linkage disequilibrium (LD) and the estimation of the time since the most recent common ancestor (TMRCA) of a haplotype. It can be used to identify genomic regions that have undergone positive selection by looking for high levels of LD in these regions.\n3. SIFT: This is a software package that is used for the prediction of non-synonymous single nucleotide polymorphisms (nsSNPs) that are likely to be deleterious or neutral. It can be used to identify genes that have undergone positive selection by looking for nsSNPs that are likely to be beneficial.\n4. HapMap: This is a database of genetic variation in human populations that was developed by the National Institutes of Health (NIH). It contains a large amount of genomic data that can be used to identify genomic regions that have undergone positive selection.\n5. GERMLINE: This is a software package that is used for the detection of positive selection in human populations. It uses a variety of methods, including the branch-site model and the codon-based model, to identify genes that have undergone positive selection.\nThese are just a few examples of the software packages that are commonly used for the detection of selective sweeps. The choice of software package will depend on the specific research question and the type of data that is available.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. GENEHUNTER is a software package that uses methods such as the branch-site model and the codon-based model to detect positive selection in genomic data.\n2. LDPAIR is a software used to detect linkage disequilibrium and estimate the time since the most recent common ancestor of a haplotype.\n3. SIFT is a software package used to predict non-synonymous single nucleotide polymorphisms and can help in identifying genes that have undergone positive selection.\n4. HapMap is a database of genetic variation in human populations developed by the National Institutes of Health.\n5. GERMLINE is a software package that is used to detect positive selection in human populations.",
    "vicuna-7b_fact": [
      "GENEHUNTER is a software package that uses methods such as the branch-site model and the codon-based model to detect positive selection in genomic data.",
      "LDPAIR is a software used to detect linkage disequilibrium and estimate the time since the most recent common ancestor of a haplotype.",
      "SIFT is a software package used to predict non-synonymous single nucleotide polymorphisms and can help in identifying genes that have undergone positive selection.",
      "HapMap is a database of genetic variation in human populations developed by the National Institutes of Health.",
      "GERMLINE is a software package that is used to detect positive selection in human populations."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE \n3. TRUE\n4. TRUE\n5. FALSE [correction]: GERMLINE is a software package that is used to rapidly and accurately identify shared segments of identity by descent (IBD) within individuals.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3606,
    "user_query": "What is Amyand hernia?",
    "vicuna-7b_response": "Amyand hernia is a type of hernia that occurs when the intestine protrudes through a weakened area in the abdominal wall. It is also known as an incisional hernia, and it typically occurs after surgery.\nAmyand hernia is named after the surgeon and anatomist, Nicholas Amyand, who first described the condition in the 18th century. It is a common complication after abdominal surgery, particularly after operations on the abdominal wall or in the pelvic area.\nThe symptoms of an Amyand hernia may include a lump or bulge in the abdominal area, pain or discomfort in the affected area, and difficulty or pain when coughing, straining, or lifting. If left untreated, an Amyand hernia can cause intestinal obstruction or strangulation, which can be life-threatening.\nTreatment for an Amyand hernia typically involves surgery to repair the hernia and strengthen the weakened area in the abdominal wall. The surgery is usually performed laparoscopically, which involves making small incisions in the abdomen and using specialized instruments to repair the hernia.\nIt is important for individuals who have had abdominal surgery to be aware of the signs and symptoms of an Amyand hernia and to seek medical attention if they develop any of these symptoms. With prompt treatment, most cases of Amyand hernia can be successfully managed.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Amyand hernia is a type of hernia where the intestine protrudes through a weakened area in the abdominal wall.\n2. The condition is named after the surgeon and anatomist, Nicholas Amyand, who first described it in the 18th century.\n3. Symptoms of an Amyand hernia may include a lump or bulge in the abdominal area, pain in the affected area, and difficulty or pain when coughing, straining, or lifting.\n4. If untreated, an Amyand hernia can cause intestinal obstruction or strangulation, both of which can be life-threatening.\n5. Treatment of an Amyand hernia typically involves surgery to repair the hernia and strengthen the weakened area in the abdominal wall.",
    "vicuna-7b_fact": [
      "Amyand hernia is a type of hernia where the intestine protrudes through a weakened area in the abdominal wall.",
      "The condition is named after the surgeon and anatomist, Nicholas Amyand, who first described it in the 18th century.",
      "Symptoms of an Amyand hernia may include a lump or bulge in the abdominal area, pain in the affected area, and difficulty or pain when coughing, straining, or lifting.",
      "If untreated, an Amyand hernia can cause intestinal obstruction or strangulation, both of which can be life-threatening.",
      "Treatment of an Amyand hernia typically involves surgery to repair the hernia and strengthen the weakened area in the abdominal wall."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Amyand hernia is a type of inguinal hernia where the appendix is found within the hernia sac.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-7b_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE.\nThe LSI is a composite score that is based on the presence and severity of 11 different organ systems that can be affected by SLE, such as the skin, joints, kidneys, and heart. Each organ system is assigned a score based on the degree of involvement, ranging from 0 to 3. The scores for each organ system are then added together to obtain the total LSI score, which ranges from 0 to 33.\nThe LSI score can be used to monitor the disease activity and response to treatment in patients with SLE. A higher LSI score indicates more severe disease activity, while a lower score indicates less severe disease activity. The LSI can also be used to identify patients who are at high risk of disease complications, such as kidney disease or lupus nephritis.\nIt is important to note that the LSI is just one tool that can be used to assess the severity of SLE. Other tools, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index, may also be used to assess disease activity and response to treatment.\nIn summary, the Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE. The LSI score can be used to monitor the disease activity and response to treatment in patients with SLE, and it can also be used to identify patients who are at high risk of disease complications.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI is a composite score that is based on the presence and severity of 11 different organ systems.\n3. Each organ system is assigned a score on the LSI from 0 to 3, and these scores are then added together for a total score that ranges from 0 to 33.\n4. A higher LSI score indicates more severe disease activity in SLE patients, while a lower score indicates less severe activity.\n5. Other tools, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index, can also be used to assess the severity of SLE.",
    "vicuna-7b_fact": [
      "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI is a composite score that is based on the presence and severity of 11 different organ systems.",
      "Each organ system is assigned a score on the LSI from 0 to 3, and these scores are then added together for a total score that ranges from 0 to 33.",
      "A higher LSI score indicates more severe disease activity in SLE patients, while a lower score indicates less severe activity.",
      "Other tools, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index, can also be used to assess the severity of SLE."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3610,
    "user_query": "Is g-H2AX a marker for double strand breaks?",
    "vicuna-7b_response": "g-H2AX is a marker for double strand breaks. It is a phosphorylated form of the histone variant H2AX, which is induced in response to DNA damage. The g-H2AX protein is recruited to sites of DNA damage, where it forms a complex with other proteins to initiate the DNA damage response. The phosphorylation of g-H2AX at serine 139 is a specific marker for double strand breaks, as it occurs in response to both ionizing radiation and certain chemotherapy drugs. The accumulation of g-H2AX at double strand breaks can be used as a marker for the presence of DNA damage and the efficacy of DNA damage response inhibitors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. g-H2AX is a marker for double strand breaks.\n2. It is a phosphorylated form of the histone variant H2AX, which is induced in response to DNA damage.\n3. The g-H2AX protein forms a complex with other proteins to initiate the DNA damage response at sites of DNA damage.\n4. The phosphorylation of g-H2AX at serine 139 is a specific marker for double strand breaks.\n5. The accumulation of g-H2AX at double strand breaks can be used as a marker for the presence of DNA damage and the efficacy of DNA damage response inhibitors.",
    "vicuna-7b_fact": [
      "g-H2AX is a marker for double strand breaks.",
      "It is a phosphorylated form of the histone variant H2AX, which is induced in response to DNA damage.",
      "The g-H2AX protein forms a complex with other proteins to initiate the DNA damage response at sites of DNA damage.",
      "The phosphorylation of g-H2AX at serine 139 is a specific marker for double strand breaks.",
      "The accumulation of g-H2AX at double strand breaks can be used as a marker for the presence of DNA damage and the efficacy of DNA damage response inhibitors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3611,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs)?",
    "vicuna-7b_response": "One algorithm that has been developed for finding conserved non-coding elements (CNEs) is the \"Conserved Non-Coding Element Finder\" (CNEF).\nCNEF is a computational tool that uses a combination of sequence and structural information to identify CNEs in a given genome. It works by first identifying conserved regions of non-coding DNA using a variety of sequence-based methods, such as the \"Conserved Non-Coding Elements (CNEs) Finder\" (CONE).\nOnce conserved regions have been identified, CNEF uses a combination of structural information, such as the presence of transcription factor binding sites and chromatin accessibility data, to further refine the list of potential CNEs.\nCNEF has been shown to be highly effective at identifying CNEs in a variety of organisms, including human, mouse, and fly. It has also been used to identify CNEs that are associated with a variety of biological processes, such as development and disease.\nOverall, CNEF is a powerful tool for identifying conserved non-coding elements in a genome, and has been widely used in the field of genomics and epigenetics.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The \"Conserved Non-Coding Element Finder\" (CNEF) is an algorithm developed for finding conserved non-coding elements (CNEs).\n2. CNEF uses a combination of sequence and structural information to identify CNEs in a given genome.\n3. CNEF identifies potential CNEs by analyzing transcription factor binding sites and chromatin accessibility data.\n4. CNEF has been effective at identifying CNEs in human, mouse, and fly species.\n5. The CNEF tool is applicable in the field of genomics and epigenetics.",
    "vicuna-7b_fact": [
      "The \"Conserved Non-Coding Element Finder\" (CNEF) is an algorithm developed for finding conserved non-coding elements (CNEs).",
      "CNEF uses a combination of sequence and structural information to identify CNEs in a given genome.",
      "CNEF identifies potential CNEs by analyzing transcription factor binding sites and chromatin accessibility data.",
      "CNEF has been effective at identifying CNEs in human, mouse, and fly species.",
      "The CNEF tool is applicable in the field of genomics and epigenetics."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3612,
    "user_query": "What type of antagonist is istradefylline?",
    "vicuna-7b_response": "Istradefylline is an antagonist of the muscarinic acetylcholine receptor type 1 (mAChR1). It is a selective and potent antagonist of mAChR1, which is involved in the regulation of various physiological processes, including cognition, memory, and movement. Istradefylline has been shown to have therapeutic potential in the treatment of cognitive impairment associated with Alzheimer's disease and other neurological disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Istradefylline is an antagonist of the muscarinic acetylcholine receptor type 1 (mAChR1).\n2. Istradefylline is a selective and potent antagonist of mAChR1.\n3. mAChR1 is involved in the regulation of various physiological processes, including cognition, memory, and movement.\n4. Istradefylline has potential therapeutic use in the treatment of cognitive impairment.\n5. The therapeutic potential of istradefylline relates to Alzheimer's disease and other neurological disorders.",
    "vicuna-7b_fact": [
      "Istradefylline is an antagonist of the muscarinic acetylcholine receptor type 1 (mAChR1).",
      "Istradefylline is a selective and potent antagonist of mAChR1.",
      "mAChR1 is involved in the regulation of various physiological processes, including cognition, memory, and movement.",
      "Istradefylline has potential therapeutic use in the treatment of cognitive impairment.",
      "The therapeutic potential of istradefylline relates to Alzheimer's disease and other neurological disorders."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Istradefylline is an antagonist of the adenosine A2A receptor, not the muscarinic acetylcholine receptor type 1 (mAChR1).\n2. FALSE [correction]: Istradefylline is a selective and potent antagonist of the adenosine A2A receptor, not mAChR1.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-7b_response": "ZSWIM6 is a gene that has been associated with several disorders caused by de novo mutations. Here are some of the disorders that have been linked to ZSWIM6 mutations:\n1. Schinzel-Giedion syndrome (SGS): SGS is a rare genetic disorder that is caused by mutations in the ZWS6 gene. It is characterized by intellectual disability, distinctive facial features, and abnormalities of the skull and limbs.\n2. Cerebral palsy: Cerebral palsy is a group of disorders that affect movement and posture. Some studies have suggested that ZWS6 mutations may be associated with cerebral palsy, but more research is needed to confirm this link.\n3. Autism spectrum disorder (ASD): ASD is a neurodevelopmental disorder that affects communication and social interaction. Some studies have suggested that ZWS6 mutations may be associated with ASD, but more research is needed to confirm this link.\n4. Microcephaly: Microcephaly is a condition in which a child's head is smaller than expected for their age. Some studies have suggested that ZWS6 mutations may be associated with microcephaly, but more research is needed to confirm this link.\nIt's important to note that these associations are still being studied and more research is needed to fully understand the role of ZSWIM6 mutations in these disorders.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ZSWIM6 is a gene that has been associated with several disorders caused by de novo mutations.\n2. Schinzel-Giedion syndrome is a rare genetic disorder that is caused by mutations in the ZWS6 gene.\n3. Cerebral palsy is a group of disorders that affect movement and posture and some studies have suggested an association with ZWS6 mutations.\n4. Autism spectrum disorder is a neurodevelopmental disorder that affects communication and social interaction and some studies have suggested an association with ZWS6 mutations.\n5. Microcephaly is a condition in which a child's head is smaller than expected for their age and some studies have suggested an association with ZWS6 mutations.",
    "vicuna-7b_fact": [
      "ZSWIM6 is a gene that has been associated with several disorders caused by de novo mutations.",
      "Schinzel-Giedion syndrome is a rare genetic disorder that is caused by mutations in the ZWS6 gene.",
      "Cerebral palsy is a group of disorders that affect movement and posture and some studies have suggested an association with ZWS6 mutations.",
      "Autism spectrum disorder is a neurodevelopmental disorder that affects communication and social interaction and some studies have suggested an association with ZWS6 mutations.",
      "Microcephaly is a condition in which a child's head is smaller than expected for their age and some studies have suggested an association with ZWS6 mutations."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Schinzel-Giedion syndrome is a rare genetic disorder that is caused by mutations in the SETBP1 gene.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3625,
    "user_query": "Which disease category is LB-100 mostly assessed for?",
    "vicuna-7b_response": "LB-100 is a drug that is primarily assessed for its effectiveness in treating various types of cancer. It is not primarily assessed for any other disease category.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LB-100 is a drug.\n2. LB-100 is primarily assessed for its effectiveness in treating various types of cancer.\n3. LB-100 is not primarily assessed for any other disease category.",
    "vicuna-7b_fact": [
      "LB-100 is a drug.",
      "LB-100 is primarily assessed for its effectiveness in treating various types of cancer.",
      "LB-100 is not primarily assessed for any other disease category."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-7b_response": "The Koos Classification is a system used to classify diseases of the musculoskeletal system, including the joints, muscles, bones, and tendons. Some examples of diseases that can be classified using the Koos Classification include:\n* Osteoarthritis: a degenerative joint disease that affects the cartilage that cushions the ends of bones and allows them to move smoothly.\n* Rheumatoid arthritis: an autoimmune disease that causes inflammation in the joints and can lead to joint damage and loss of function.\n* Osteoporosis: a condition in which the bones become weak and brittle, leading to an increased risk of fractures.\n* Tendinitis: inflammation of a tendon, which can cause pain and stiffness in the affected area.\n* Bursitis: inflammation of a bursa, which is a small, fluid-filled sac that acts as a cushion between bones, muscles, and tendons.\nThese are just a few examples of the many diseases that can be classified using the Koos Classification.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Koos Classification is a system used to classify diseases of the musculoskeletal system.\n2. Diseases that can be classified using the Koos Classification include Osteoarthritis, which is a degenerative joint disease that affects the cartilage.\n3. Rheumatoid arthritis can be classified using the Koos Classification system.\n4. Osteoporosis, a condition in which bones become weak and brittle, is another disease that can be classified with the Koos Classification.\n5. Tendinitis and Bursitis, inflammations of a tendon and a bursa respectively, can also be classified using the Koos Classification.",
    "vicuna-7b_fact": [
      "The Koos Classification is a system used to classify diseases of the musculoskeletal system.",
      "Diseases that can be classified using the Koos Classification include Osteoarthritis, which is a degenerative joint disease that affects the cartilage.",
      "Rheumatoid arthritis can be classified using the Koos Classification system.",
      "Osteoporosis, a condition in which bones become weak and brittle, is another disease that can be classified with the Koos Classification.",
      "Tendinitis and Bursitis, inflammations of a tendon and a bursa respectively, can also be classified using the Koos Classification."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Koos Classification is a system used to grade intracranial arteriovenous malformations.\n2. FALSE [correction]: Diseases that can be classified using the Koos Classification include intracranial arteriovenous malformations.\n3. FALSE [correction]: Rheumatoid arthritis cannot be classified using the Koos Classification system.\n4. FALSE [correction]: Osteoporosis cannot be classified with the Koos Classification.\n5. FALSE [correction]: Tendinitis and Bursitis cannot be classified using the Koos Classification.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-7b_response": "AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta. PI3K delta is a subunit of the PI3K enzyme complex, which plays a key role in regulating cell growth, survival, and metabolism.\nIn vivo studies have shown that AZD8601 can effectively inhibit the PI3K delta pathway in various types of cancer cells, leading to decreased cell proliferation, migration, and invasion. Additionally, AZD8601 has been shown to induce apoptosis (programmed cell death) in cancer cells, which can lead to a reduction in tumor size and growth.\nAZD8601 has also been shown to have anti-angiogenic effects, which means it can inhibit the formation of new blood vessels that tumors need to grow. This can lead to a reduction in the supply of oxygen and nutrients to the tumor, further reducing its growth and progression.\nOverall, AZD8601 has shown promising in vivo effects in preclinical studies and is currently being evaluated in clinical trials for the treatment of various types of cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. AZD8601 is a small molecule inhibitor of the phosphoinositide-3-kinase (PI3K) delta.\n2. PI3K delta is a part of the PI3K enzyme complex, playing a key role in regulating cell growth, survival, and metabolism.\n3. AZD8601 can inhibit the PI3K delta pathway in different types of cancer cells, leading to decreased cell proliferation, migration, and invasion.\n4. AZD8601 has been shown to induce apoptosis in cancer cells, potentially resulting in a reduction in tumor size and growth.\n5. AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels and reduce the supply of oxygen and nutrients to the tumor.",
    "vicuna-7b_fact": [
      "AZD8601 is a small molecule inhibitor of the phosphoinositide-3-kinase (PI3K) delta.",
      "PI3K delta is a part of the PI3K enzyme complex, playing a key role in regulating cell growth, survival, and metabolism.",
      "AZD8601 can inhibit the PI3K delta pathway in different types of cancer cells, leading to decreased cell proliferation, migration, and invasion.",
      "AZD8601 has been shown to induce apoptosis in cancer cells, potentially resulting in a reduction in tumor size and growth.",
      "AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels and reduce the supply of oxygen and nutrients to the tumor."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: AZD8601 is not a small molecule inhibitor of the phosphoinositide-3-kinase (PI3K) delta. It is an mRNA-based drug that encodes for the production of a protein known as VEGF-A.\n2. TRUE\n3. FALSE [correction]: AZD8601 does not inhibit the PI3K delta pathway in cancer cells. Instead, it is designed to promote the production of the VEGF-A protein, which can aid in tissue repair.\n4. UNKNOWN\n5. FALSE [correction]: AZD8601 does not have anti-angiogenic effects. Rather, its goal is to stimulate angiogenesis, or the formation of new blood vessels, due to the role of VEGF-A in this process.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3630,
    "user_query": "Which characteristics are used in the SLEDAI index for SLE patients?",
    "vicuna-7b_response": "The SLEDAI (SLE Disease Activity Index) is a tool used to measure the disease activity in systemic lupus erythematosus (SLE) patients. It is a composite index that assesses various aspects of SLE disease activity, including:\n1. Skin lesions: The presence and severity of skin lesions such as rashes, photosensitivity, and ulcers.\n2. Joint pain and swelling: The degree of joint pain and swelling, including the number of joints affected and the level of morning stiffness.\n3. Muscle and bone pain: The presence and severity of muscle and bone pain.\n4. Fever: The presence and frequency of fever.\n5. Malaise: The presence and severity of general feeling of illness or discomfort.\n6. Kidney involvement: The presence and severity of kidney involvement, including proteinuria (protein in the urine) and hematuria (blood in the urine).\n7. Neuropsychiatric involvement: The presence and severity of neuropsychiatric symptoms such as confusion, depression, and memory problems.\nThe SLEDAI index assigns a score to each of these categories, and the total score ranges from 0 to 42, with higher scores indicating more severe disease activity. The SLEDAI index is used to monitor the disease activity in SLE patients and to assess the response to treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The SLEDAI is a tool used to measure the disease activity in systemic lupus erythematosus (SLE) patients. \n2. The SLEDAI assesses the presence and severity of skin lesions such as rashes, photosensitivity, and ulcers.\n3. It measures the degree of joint pain and swelling, including the number of joints affected and the level of morning stiffness.\n4. Fever, malaise and the presence and severity of muscle and bone pain are included in the SLEDAI.\n5. The SLEDAI examines kidney involvement and neuropsychiatric symptoms such as confusion, depression, and memory problems.\n5. The SLEDAI index assigns a score to each of these categories, with the total score ranging from 0 to 42, with higher scores indicating more severe disease activity.",
    "vicuna-7b_fact": [
      "The SLEDAI is a tool used to measure the disease activity in systemic lupus erythematosus (SLE) patients.",
      "The SLEDAI assesses the presence and severity of skin lesions such as rashes, photosensitivity, and ulcers.",
      "It measures the degree of joint pain and swelling, including the number of joints affected and the level of morning stiffness.",
      "Fever, malaise and the presence and severity of muscle and bone pain are included in the SLEDAI.",
      "The SLEDAI examines kidney involvement and neuropsychiatric symptoms such as confusion, depression, and memory problems.",
      "The SLEDAI index assigns a score to each of these categories, with the total score ranging from 0 to 42, with higher scores indicating more severe disease activity."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3632,
    "user_query": "Describe the mechanism of action of Luspatercept.",
    "vicuna-7b_response": "Luspatercept is a medication that is used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes (MDS). It works by increasing the production of red blood cells, which are responsible for carrying oxygen throughout the body.\nThe mechanism of action of luspatercept involves the use of a protein called erythropoietin (EPO), which is a naturally occurring hormone in the body that stimulates the production of red blood cells. Luspatercept is a modified version of EPO that is designed to bind to a specific receptor on the surface of cells in the bone marrow, where red blood cells are produced.\nWhen luspatercept binds to this receptor, it activates a signaling pathway that stimulates the production of red blood cells. This leads to an increase in the number of red blood cells in the body, which can help to alleviate the symptoms of anemia in patients with beta-thalassemia and MDS.\nIn addition to increasing red blood cell production, luspatercept may also have other effects on the body, such as increasing the number of immature red blood cells (known as reticulocytes) and improving the function of existing red blood cells.\nOverall, the mechanism of action of luspatercept is based on the use of a modified version of EPO to stimulate the production of red blood cells in patients with anemia related to beta-thalassemia and MDS.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Luspatercept is a medication used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes.\n2. Luspatercept works by increasing the production of red blood cells.\n3. The mechanism of luspatercept involves the use of a protein called erythropoietin (EPO), a naturally occurring hormone that stimulates red blood cell production.\n4. Luspatercept is a modified version of EPO that binds to a specific receptor on cells in the bone marrow to stimulate red blood cell production.\n5. In addition to increasing red blood cell production, luspatercept can increase the number of immature red blood cells and improve the function of existing ones.",
    "vicuna-7b_fact": [
      "Luspatercept is a medication used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes.",
      "Luspatercept works by increasing the production of red blood cells.",
      "The mechanism of luspatercept involves the use of a protein called erythropoietin (EPO), a naturally occurring hormone that stimulates red blood cell production.",
      "Luspatercept is a modified version of EPO that binds to a specific receptor on cells in the bone marrow to stimulate red blood cell production.",
      "In addition to increasing red blood cell production, luspatercept can increase the number of immature red blood cells and improve the function of existing ones."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The mechanism of luspatercept does not involve the use of erythropoietin (EPO). Instead, it works by binding to select proteins to enhance late-stage erythroid maturation hence increasing red blood cell production.\n4. FALSE [correction]: Luspatercept is not a modified version of EPO. It is a recombinant fusion protein that binds to select proteins to enhance the process of red blood cell maturation.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3633,
    "user_query": "Which method has been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA?",
    "vicuna-7b_response": "There are several methods that have been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA. One such method is called \"ChIP-seq\" (Chromatin Immunoprecipitation Sequencing).\nChIP-seq involves isolating DNA that is bound to proteins using antibodies that recognize specific proteins. In the case of TSS mapping, the antibodies are used to isolate DNA that is bound to the transcription factor that binds to the TSS. The isolated DNA is then sequenced to identify the regions of the genome where the transcription factor is bound. By comparing the sequencing data to the known locations of the transcription factor, researchers can identify the TSSs in the genome.\nAnother method for TSS mapping is called \"DNA methylation-based TSS identification\". This method uses the fact that the transcription factor binding sites are often associated with specific DNA methylation patterns. By analyzing the methylation patterns in the genome, researchers can identify the TSSs in the genome.\nBoth of these methods are based on the idea that the transcription factor binding sites are associated with specific regions of the genome, and by analyzing these regions, researchers can identify the TSSs.\nIt's worth noting that there are other methods that can be used for TSS mapping, such as \"RNA-seq\" (RNA-seq) and \"ChIP-exo\" (ChIP-exo) but ChIP-seq and DNA methylation-based TSS identification are the most common and widely used methods.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are several methods developed for mapping of Transcription Start Sites (TSS) from nanograms of RNA.\n2. One method is called \"ChIP-seq\" which uses antibodies to isolate DNA bound to specific proteins.\n3. Another method for TSS mapping is \"DNA methylation-based TSS identification\" which analyzes DNA methylation patterns in the genome.\n4. Both ChIP-seq and DNA methylation-based TSS identification methods are based on the idea that transcription factor binding sites are associated with specific regions of the genome.\n5. Other methods such as \"RNA-seq\" and \"ChIP-exo\" are also used for TSS mapping.",
    "vicuna-7b_fact": [
      "There are several methods developed for mapping of Transcription Start Sites (TSS) from nanograms of RNA.",
      "One method is called \"ChIP-seq\" which uses antibodies to isolate DNA bound to specific proteins.",
      "Another method for TSS mapping is \"DNA methylation-based TSS identification\" which analyzes DNA methylation patterns in the genome.",
      "Both ChIP-seq and DNA methylation-based TSS identification methods are based on the idea that transcription factor binding sites are associated with specific regions of the genome.",
      "Other methods such as \"RNA-seq\" and \"ChIP-exo\" are also used for TSS mapping."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3637,
    "user_query": "Which mRNAs are sequestered in stress granules?",
    "vicuna-7b_response": "Stress granules are small, cytoplasmic granules that form in response to various forms of cellular stress, including nutrient starvation, heat shock, and oxidative stress. mRNAs that are sequestered in stress granules are typically those that are transcribed in response to the same stressors that trigger stress granule formation.\nOne example of an mRNA that is sequestered in stress granules is the heat shock mRNA (HSM). HSM is a small RNA that is transcribed in response to heat shock and other forms of cellular stress. It is transported to stress granules, where it acts as a repressor of protein synthesis by binding to specific sites on ribosomes and inhibiting their function.\nOther examples of mRNAs that are sequestered in stress granules include the HSP70 mRNA, which encodes a heat shock protein that is involved in protein folding and degradation, and the HSP90 mRNA, which encodes a chaperone that is involved in the folding and stabilization of client proteins.\nIn addition to HSM, HSP70, and HSP90, other mRNAs that have been shown to be sequestered in stress granules include the ribosomal protein L22 mRNA, the ribosomal protein L23 mRNA, and the ribosomal protein L28 mRNA.\nOverall, the mRNAs that are sequestered in stress granules are those that are transcribed in response to cellular stress and that play a role in the cell's response to that stress.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Stress granules are small, cytoplasmic granules that form in response to various forms of cellular stress, including nutrient starvation, heat shock, and oxidative stress.\n2. mRNAs that are sequestered in stress granules are typically those that are transcribed in response to the same stressors that trigger stress granule formation.\n3. An example of an mRNA that is sequestered in stress granules is the heat shock mRNA (HSM).\n4. Other mRNAs that are sequestered in stress granules include the HSP70 mRNA and the HSP90 mRNA.\n5. Additional mRNAs that have been shown to be sequestered in stress granules include the ribosomal protein L22 mRNA, the ribosomal protein L23 mRNA, and the ribosomal protein L28 mRNA.",
    "vicuna-7b_fact": [
      "Stress granules are small, cytoplasmic granules that form in response to various forms of cellular stress, including nutrient starvation, heat shock, and oxidative stress.",
      "mRNAs that are sequestered in stress granules are typically those that are transcribed in response to the same stressors that trigger stress granule formation.",
      "An example of an mRNA that is sequestered in stress granules is the heat shock mRNA (HSM).",
      "Other mRNAs that are sequestered in stress granules include the HSP70 mRNA and the HSP90 mRNA.",
      "Additional mRNAs that have been shown to be sequestered in stress granules include the ribosomal protein L22 mRNA, the ribosomal protein L23 mRNA, and the ribosomal protein L28 mRNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3638,
    "user_query": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?",
    "vicuna-7b_response": "PD-L1, or programmed death-ligand 1, is a protein that is expressed on certain cells, including cancer cells. It is also expressed on immune cells, such as T cells and macrophages. PD-L1 binds to PD-1, a protein expressed on T cells, and inhibits T-cell activation.\nThe use of PD-L1 as a biomarker for immunotherapy has been associated with several problems:\n1. Lack of specificity: PD-L1 is also expressed on normal cells, such as lung and gastrointestinal epithelial cells, which can lead to false positive results and the misidentification of tumors as immunogenic.\n2. Lack of sensitivity: PD-L1 expression is not always a reliable indicator of response to immunotherapy. Some tumors may express PD-L1 at low levels, and some patients may have high levels of PD-L1 expression but still not respond to immunotherapy.\n3. Lack of consistency: PD-L1 expression can vary between different tumor types and even within the same tumor type. This can make it difficult to compare results across studies and patients.\n4. Lack of predictive value: PD-L1 expression is not a reliable predictor of response to immunotherapy in all patients. Some patients may have high levels of PD-L1 expression but still not respond to immunotherapy, while others with low levels of PD-L1 expression may respond well.\n5. Lack of specificity for immunotherapy: PD-L1 expression is not specific to immunotherapy and can also be induced by other forms of therapy, such as chemotherapy and radiation therapy.\nOverall, while PD-L1 expression is a useful biomarker for immunotherapy, it is not a perfect indicator of response and should be used in conjunction with other biomarkers and clinical criteria to guide treatment decisions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. PD-L1 (programmed death-ligand 1) is a protein expressed on certain cells, including cancer cells and immune cells like T cells and macrophages.\n2. PD-L1 binds to PD-1, a protein expressed on T cells, and inhibits T-cell activation.\n3. Using PD-L1 as a biomarker for immunotherapy can lead to lack of specificity due to its expression on normal cells.\n4. PD-L1 expression is not always a reliable indicator of response to immunotherapy, causing issues of lack of sensitivity.\n5. PD-L1 expression varies among different tumor types and even within the same tumor type, resulting in issues of consistency.\n",
    "vicuna-7b_fact": [
      "PD-L1 (programmed death-ligand 1) is a protein expressed on certain cells, including cancer cells and immune cells like T cells and macrophages.",
      "PD-L1 binds to PD-1, a protein expressed on T cells, and inhibits T-cell activation.",
      "Using PD-L1 as a biomarker for immunotherapy can lead to lack of specificity due to its expression on normal cells.",
      "PD-L1 expression is not always a reliable indicator of response to immunotherapy, causing issues of lack of sensitivity.",
      "PD-L1 expression varies among different tumor types and even within the same tumor type, resulting in issues of consistency."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3639,
    "user_query": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "vicuna-7b_response": "Yes, poliosis circumscripta is another term for a white or unpigmented patch of hair or skin. It is a type of hair loss or alopecia that is characterized by the development of small, white or unpigmented patches on the scalp or other areas of the body. These patches are typically circular or oval in shape and may be accompanied by thinning or balding in the surrounding hair. Poliosis circumscripta is thought to be caused by a genetic mutation that affects the production of melanin, the pigment that gives hair and skin its color. It is a relatively rare condition, and there is currently no known cure. Treatment options may include medications to slow hair loss, hair transplant surgery, or cosmetic camouflage to cover the patches.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Poliosis circumscripta refers to a white or unpigmented patch of hair or skin.\n2. Poliosis circumscripta is a type of hair loss or alopecia.\n3. Poliosis circumscripta causes development of small, white patches on the scalp or on other body parts.\n4. It is a result of a genetic mutation that affects production of melanin, the pigment that colors hair and skin.\n5. Treatment options for poliosis circumscripta may include medications to slow hair loss, hair transplants, or cosmetic camouflage.",
    "vicuna-7b_fact": [
      "Poliosis circumscripta refers to a white or unpigmented patch of hair or skin.",
      "Poliosis circumscripta is a type of hair loss or alopecia.",
      "Poliosis circumscripta causes development of small, white patches on the scalp or on other body parts.",
      "It is a result of a genetic mutation that affects production of melanin, the pigment that colors hair and skin.",
      "Treatment options for poliosis circumscripta may include medications to slow hair loss, hair transplants, or cosmetic camouflage."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Poliosis circumscripta is not a type of hair loss or alopecia, but rather a decrease in pigment in hair, resulting in white or gray patches.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Currently, there are no specific treatments available to reverse poliosis circumscripta. Common approaches include cosmetic solutions such as hair dye or makeup, wearing a wig, or, in more extreme cases, tattooing the affected areas.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-7b_response": "SAHFS, or Secure Access to Healthcare Facilities and Systems, are created through a process called \"decentralization.\" Decentralization is the process of moving data and services from a centralized location to a distributed network of computers.\nIn the case of SAHFS, the decentralization process involves creating a network of computers that are connected to each other and to the internet. These computers are typically located in healthcare facilities, such as hospitals and clinics, and are used to store and process patient data.\nOnce the network is set up, the next step is to create a secure and reliable way for patients to access their data. This is typically done through the use of blockchain technology, which allows for secure and transparent data storage and sharing.\nIn addition to blockchain, other technologies such as encryption, access control, and auditing are used to ensure the security and privacy of patient data.\nIt's important to note that the process of creating SAHFS is complex and requires a significant amount of planning, implementation and maintenance. It's also important to note that the process of creating SAHFS is not only limited to healthcare facilities, but it can also be applied to other industries as well.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SAHFS, or Secure Access to Healthcare Facilities and Systems, are created through a procedure called \"decentralization.\"\n2. The decentralization process in SAHFS involves creating a network of computers connected to each other and the internet.\n3. These computers in the creation of SAHFS are typically located in healthcare facilities and are used to store and process patient data.\n4. For patients to access their data securely, SAHFS also uses blockchain technology.\n5. Other technologies such as encryption, access control, and auditing are also essential in ensuring the security and privacy of patient data in SAHFS.",
    "vicuna-7b_fact": [
      "SAHFS, or Secure Access to Healthcare Facilities and Systems, are created through a procedure called \"decentralization.\"",
      "The decentralization process in SAHFS involves creating a network of computers connected to each other and the internet.",
      "These computers in the creation of SAHFS are typically located in healthcare facilities and are used to store and process patient data.",
      "For patients to access their data securely, SAHFS also uses blockchain technology.",
      "Other technologies such as encryption, access control, and auditing are also essential in ensuring the security and privacy of patient data in SAHFS."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3641,
    "user_query": "What is another name for AZD0530?",
    "vicuna-7b_response": "AZD0530 is also known as \"sotagliflozin\".",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. AZD0530 is also known as sotagliflozin.",
    "vicuna-7b_fact": [
      "AZD0530 is also known as sotagliflozin."
    ],
    "vicuna-7b_judge_raw": "FALSE [correction]: AZD0530 is also known as saracatinib.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3647,
    "user_query": "What is the Match BAM to VCF method?",
    "vicuna-7b_response": "The Match BAM to VCF method is a process used to align a large BAM file (binary alignment map) with a reference VCF (Variant Call Format) file. The goal of this process is to identify the locations in the BAM file where variations or mutations occur, and to map these variations to the corresponding positions in the VCF file.\nThe process of aligning a BAM file to a VCF file typically involves the following steps:\n1. Sorting the BAM file by chromosome and position.\n2. Sorting the VCF file by chromosome and position.\n3. Using a matching algorithm to compare the BAM file with the VCF file, and identifying the locations in the BAM file where variations or mutations occur.\n4. Mapping the variations or mutations identified in the BAM file to the corresponding positions in the VCF file.\nThe Match BAM to VCF method is widely used in genetic research and clinical applications, such as identifying genetic variations that may be associated with certain diseases or traits.\nIt's worth noting that the Match BAM to VCF method is not always perfect, and it may not be able to identify all variations or mutations in the BAM file. Additionally, the accuracy of the method may depend on the quality of the BAM and VCF files, as well as the specific matching algorithm used.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Match BAM to VCF method is a process used to align a large BAM file with a reference VCF file.\n2. The goal of this process is to identify the locations in the BAM file where variations or mutations occur, and to map these variations to the corresponding positions in the VCF file.\n3. Sorting the BAM and VCF files by chromosome and position is typically part of the process.\n4. The Match BAM to VCF method can be used in genetic research and clinical applications such as identifying genetic variations associated with diseases or traits.\n5. The accuracy of the Match BAM to VCF method may depend on the quality of the BAM and VCF files and the specific matching algorithm used.",
    "vicuna-7b_fact": [
      "The Match BAM to VCF method is a process used to align a large BAM file with a reference VCF file.",
      "The goal of this process is to identify the locations in the BAM file where variations or mutations occur, and to map these variations to the corresponding positions in the VCF file.",
      "Sorting the BAM and VCF files by chromosome and position is typically part of the process.",
      "The Match BAM to VCF method can be used in genetic research and clinical applications such as identifying genetic variations associated with diseases or traits.",
      "The accuracy of the Match BAM to VCF method may depend on the quality of the BAM and VCF files and the specific matching algorithm used."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3649,
    "user_query": "Is SATB1 expressed in thymocytes?",
    "vicuna-7b_response": "Yes, SATB1 (sperm-associated transcript 1) is expressed in thymocytes. SATB1 is a nuclear protein that plays a role in the regulation of gene expression and is involved in the formation of the nuclear lamina, which is a structural component of the nucleus. SATB1 has also been shown to play a role in the development and differentiation of T cells, which are a type of immune cell produced in the thymus gland.\nSeveral studies have reported the expression of SATB1 in thymocytes. For example, one study using immunohistochemistry to detect SATB1 protein in thymus tissue found that SATB1 was expressed in both developing and mature T cells in the thymus. Another study using RNA sequencing to analyze gene expression in thymocytes found that SATB1 was expressed at high levels in thymus tissue and was highly enriched in T cell populations.\nOverall, the evidence suggests that SATB1 is expressed in thymocytes and plays a role in the development and differentiation of T cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SATB1 (sperm-associated transcript 1) is expressed in thymocytes.\n2. SATB1 is a nuclear protein that plays a role in the regulation of gene expression.\n3. SATB1 is involved in the formation of the nuclear lamina.\n4. SATB1 has been shown to play a role in the development and differentiation of T cells. \n5. T cells are a type of immune cell produced in the thymus gland.",
    "vicuna-7b_fact": [
      "SATB1 (sperm-associated transcript 1) is expressed in thymocytes.",
      "SATB1 is a nuclear protein that plays a role in the regulation of gene expression.",
      "SATB1 is involved in the formation of the nuclear lamina.",
      "SATB1 has been shown to play a role in the development and differentiation of T cells.",
      "T cells are a type of immune cell produced in the thymus gland."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: SATB1 is not involved in the formation of the nuclear lamina. It is however involved in organizing genomic DNA structure in the nucleus.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3652,
    "user_query": "Describe Twiddler Syndrome.",
    "vicuna-7b_response": "Twiddler Syndrome is a condition characterized by excessive hand movements or fidgeting. It is often seen in individuals with attention deficit hyperactivity disorder (ADHD) or other conditions that affect impulse control.\nThe term \"twiddler\" comes from the fact that people with this syndrome often twist, turn, or fiddle with objects in their hands, such as pencils, pens, or keys. This can be distracting to others and can interfere with daily activities such as school or work.\nTwiddler Syndrome can also manifest as other types of fidgeting, such as tapping, tapping, or shaking of the hands or feet. It is important to note that not all fidgeting is caused by Twiddler Syndrome, and that some fidgeting can be a normal part of daily life.\nIf you or someone you know is experiencing excessive hand movements or fidgeting, it is important to speak with a healthcare professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Twiddler Syndrome is characterized by excessive hand movements or fidgeting.\n2. Twiddler Syndrome is often seen in individuals with attention deficit hyperactivity disorder (ADHD) or other conditions that affect impulse control.\n3. The term \"twiddler\" comes from the fact that people with this syndrome often twist, turn, or fiddle with objects in their hands.\n4. Twiddler Syndrome can interfere with daily activities such as school or work.\n5. Some manifestations of Twiddler Syndrome include tapping or shaking of the hands or feet.",
    "vicuna-7b_fact": [
      "Twiddler Syndrome is characterized by excessive hand movements or fidgeting.",
      "Twiddler Syndrome is often seen in individuals with attention deficit hyperactivity disorder (ADHD) or other conditions that affect impulse control.",
      "The term \"twiddler\" comes from the fact that people with this syndrome often twist, turn, or fiddle with objects in their hands.",
      "Twiddler Syndrome can interfere with daily activities such as school or work.",
      "Some manifestations of Twiddler Syndrome include tapping or shaking of the hands or feet."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Twiddler Syndrome is a medical condition where patients manipulate medical devices, typically pacemakers or defibrillators, leading to malfunction.\n2. FALSE [correction]: Twiddler Syndrome is not commonly associated with ADHD or conditions affecting impulse control, but rather, usually seen in the elderly or obese patients with loose skin and subcutaneous tissue.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Twiddler Syndrome does not manifest as tapping or shaking of the hands or feet but involves manipulation and twisting of implanted medical devices.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3653,
    "user_query": "What are Drosophila's balancer chromosomes?",
    "vicuna-7b_response": "Drosophila melanogaster, also known as the fruit fly, has four pairs of chromosomes. The balancer chromosomes are a set of artificial chromosomes that are used to maintain the balance of the genetic material in the genome of Drosophila. These chromosomes are made up of sequences from different regions of the Drosophila genome and are used to replace missing or damaged chromosomes in the genome.\nThe balancer chromosomes were first developed in the 1970s by researchers at the Cold Spring Harbor Laboratory in New York. They were created by isolating and mapping the genes on the chromosomes and then using this information to create new chromosomes that could be introduced into the genome of Drosophila.\nThe balancer chromosomes are used in genetic crosses to study the effects of specific genes on the phenotype of the offspring. They are also used to create transgenic flies, which are flies that have been genetically modified to express a specific gene.\nIn summary, Drosophila's balancer chromosomes are artificial chromosomes that are used to maintain the balance of the genetic material in the genome of Drosophila. They were first developed in the 1970s and are used in genetic crosses and to create transgenic flies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Drosophila melanogaster, also known as the fruit fly, has four pairs of chromosomes.\n2. The balancer chromosomes are a set of artificial chromosomes that maintain the balance of the genetic material in the genome of Drosophila.\n3. The balancer chromosomes were first developed in the 1970s at the Cold Spring Harbor Laboratory in New York.\n4. Balancer chromosomes replace missing or damaged chromosomes in the genome of Drosophila.\n5. They are used in genetic crosses and to create transgenic flies.",
    "vicuna-7b_fact": [
      "Drosophila melanogaster, also known as the fruit fly, has four pairs of chromosomes.",
      "The balancer chromosomes are a set of artificial chromosomes that maintain the balance of the genetic material in the genome of Drosophila.",
      "The balancer chromosomes were first developed in the 1970s at the Cold Spring Harbor Laboratory in New York.",
      "Balancer chromosomes replace missing or damaged chromosomes in the genome of Drosophila.",
      "They are used in genetic crosses and to create transgenic flies."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Balancer chromosomes do not replace missing or damaged chromosomes, but prevent crossing over between homologous chromosomes in the genome of Drosophila.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3654,
    "user_query": "What is iodine thyroid blocking?",
    "vicuna-7b_response": "Iodine thyroid blocking refers to the process of preventing the absorption of iodine by the thyroid gland. The thyroid gland is a small gland located in the neck, and it plays a crucial role in regulating metabolism in the body. Iodine is a mineral that is essential for the proper functioning of the thyroid gland.\nThere are several reasons why a person may need to block the absorption of iodine by the thyroid gland. One reason is to treat an overactive thyroid gland, also known as hyperthyroidism. Hyperthyroidism occurs when the thyroid gland produces too much thyroid hormone, which can cause symptoms such as weight loss, anxiety, and an irregular heartbeat. In this case, blocking the absorption of iodine by the thyroid gland can help to reduce the production of thyroid hormone.\nAnother reason for iodine thyroid blocking is to treat an underactive thyroid gland, also known as hypothyroidism. Hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormone, which can cause symptoms such as fatigue, weight gain, and depression. In this case, blocking the absorption of iodine by the thyroid gland can help to increase the production of thyroid hormone.\nThere are several ways to block the absorption of iodine by the thyroid gland. One way is to use a medication called propylthiouracil (PTU), which works by interfering with the absorption of iodine by the thyroid gland. Another way is to use a medication called methimazole, which works by reducing the production of thyroid hormone by the gland.\nIt is important to note that iodine thyroid blocking should only be done under the supervision of a healthcare professional. The dosage and duration of treatment will depend on the individual's specific medical condition and response to treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Iodine thyroid blocking is a process that prevents the absorption of iodine by the thyroid gland.\n2. The thyroid gland is located in the neck and plays a role in regulating metabolism.\n3. Iodine is a mineral essential for the proper functioning of the thyroid gland.\n4. Propylthiouracil (PTU) is a medication used to interfere with thyroid gland's absorption of iodine.\n5. Another medication, methimazole, is used to reduce the production of thyroid hormone by the thyroid gland.",
    "vicuna-7b_fact": [
      "Iodine thyroid blocking is a process that prevents the absorption of iodine by the thyroid gland.",
      "The thyroid gland is located in the neck and plays a role in regulating metabolism.",
      "Iodine is a mineral essential for the proper functioning of the thyroid gland.",
      "Propylthiouracil (PTU) is a medication used to interfere with thyroid gland's absorption of iodine.",
      "Another medication, methimazole, is used to reduce the production of thyroid hormone by the thyroid gland."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Propylthiouracil (PTU) is a medication used to reduce the production of thyroid hormones, not to interfere with thyroid gland's absorption of iodine.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3658,
    "user_query": "What is the mechanism of action of rogaratinib?",
    "vicuna-7b_response": "Rogaratinib is a small molecule inhibitor of the fibroblast growth factor receptor (FGFR) family. It specifically binds to and inhibits the activity of FGFR1, FGFR2, FGFR3, and FGFR4, which are key regulators of cell proliferation, differentiation, and survival.\nThe mechanism of action of rogaratinib involves the inhibition of the FGFR-mediated signaling pathway. When rogaratinib binds to FGFR, it prevents the activation of downstream signaling molecules such as PI3K/Akt, ERK, and RAS/MAPK, which are involved in cell proliferation and survival. This leads to the inhibition of cell growth and proliferation, and ultimately results in the death of cancer cells.\nRogaratinib has been shown to be effective in the treatment of various types of cancer, including breast, ovarian, and gastric cancers. It has also shown promise in the treatment of fibrosis and other fibrotic diseases.\nOverall, the mechanism of action of rogaratinib is based on its ability to inhibit the FGFR-mediated signaling pathway, leading to the inhibition of cell growth and proliferation, and ultimately resulting in the death of cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Rogaratinib is a small molecule inhibitor of the fibroblast growth factor receptor (FGFR) family.\n2. Rogaratinib specifically binds to and inhibits the activity of FGFR1, FGFR2, FGFR3, and FGFR4.\n3. The mechanism of action of rogaratinib involves the inhibition of the FGFR-mediated signaling pathway. \n4. Rogaratinib has been shown to be effective in the treatment of various types of cancer, including breast, ovarian, and gastric cancers.\n5. Rogaratinib has shown promise in the treatment of fibrosis and other fibrotic diseases.",
    "vicuna-7b_fact": [
      "Rogaratinib is a small molecule inhibitor of the fibroblast growth factor receptor (FGFR) family.",
      "Rogaratinib specifically binds to and inhibits the activity of FGFR1, FGFR2, FGFR3, and FGFR4.",
      "The mechanism of action of rogaratinib involves the inhibition of the FGFR-mediated signaling pathway.",
      "Rogaratinib has been shown to be effective in the treatment of various types of cancer, including breast, ovarian, and gastric cancers.",
      "Rogaratinib has shown promise in the treatment of fibrosis and other fibrotic diseases."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3661,
    "user_query": "List diseases that are caused by the Meningococcus B?",
    "vicuna-7b_response": "Meningococcus B is a type of bacteria that can cause two different types of diseases: meningitis and septicemia. Meningitis is an infection of the membranes that surround the brain and spinal cord, while septicemia is an infection of the blood.\nMeningococcal meningitis is a serious and potentially life-threatening disease that can cause inflammation of the membranes surrounding the brain and spinal cord. It is caused by the bacterium Neisseria meningitidis, which includes Meningococcus B. Symptoms of meningococcal meningitis can include fever, headache, stiff neck, vomiting, and a rash.\nSepticemia, also known as blood poisoning, is a serious infection of the blood that can cause fever, chills, and organ failure. It is caused by the bacterium Neisseria meningitidis, which includes Meningococcus B.\nBoth meningitis and septicemia can be caused by other types of bacteria as well, but Meningococcus B is one of the most common causes of these diseases. It is important to seek medical attention immediately if you experience symptoms of meningitis or septicemia, as these diseases can be life-threatening if not treated promptly.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Meningococcus B is a type of bacteria that can cause meningitis and septicemia.\n2. Meningitis is an infection of the membranes that surround the brain and spinal cord.\n3. Septicemia, also known as blood poisoning, is an infection of the blood.\n4. Meningococcal meningitis and septicemia are caused by the bacterium Neisseria meningitidis, which includes Meningococcus B.\n5. Meningococcus B is one of the most common causes of the diseases meningitis and septicemia.",
    "vicuna-7b_fact": [
      "Meningococcus B is a type of bacteria that can cause meningitis and septicemia.",
      "Meningitis is an infection of the membranes that surround the brain and spinal cord.",
      "Septicemia, also known as blood poisoning, is an infection of the blood.",
      "Meningococcal meningitis and septicemia are caused by the bacterium Neisseria meningitidis, which includes Meningococcus B.",
      "Meningococcus B is one of the most common causes of the diseases meningitis and septicemia."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3664,
    "user_query": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved",
    "vicuna-7b_response": "TBC1 domain family member 16 (TBC1D16) is a protein that is involved in various cellular processes, including cell growth and division, and it has been implicated in the development of certain types of cancer. Here are some types of cancer where TBC1D16 is involved:\n1. Breast cancer: TBC1D16 has been shown to play a role in the development of breast cancer. Research has shown that high levels of TBC1D16 in breast cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.\n2. Prostate cancer: TBC1D16 has also been implicated in the development of prostate cancer. Studies have shown that high levels of TBC1D16 in prostate cancer cells can promote cell growth and survival, and may contribute to the development of resistance to hormone therapy.\n3. Colorectal cancer: TBC1D16 has been shown to play a role in the development of colorectal cancer. Research has shown that high levels of TBC1D16 in colorectal cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.\n4. Lung cancer: TBC1D16 has been implicated in the development of lung cancer. Studies have shown that high levels of TBC1D16 in lung cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.\n5. Pancreatic cancer: TBC1D16 has been shown to play a role in the development of pancreatic cancer. Research has shown that high levels of TBC1D16 in pancreatic cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.\nIt's important to note that while TBC1D16 has been implicated in the development of these types of cancer, it is not a direct cause of cancer. The development of cancer is a complex process that is influenced by a variety of genetic and environmental factors.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TBC1 domain family member 16 (TBC1D16) is a protein that is involved in various cellular processes, including cell growth and division.\n2. TBC1D16 has been implicated in the development of breast, prostate, colorectal, lung and pancreatic cancers.\n3. High levels of TBC1D16 in breast cancer cells promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.\n4. High levels of TBC1D16 in prostate cancer cells can promote cell growth and survival, and may contribute to the development of resistance to hormone therapy.\n5. High levels of TBC1D16 in colorectal, lung and pancreatic cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.",
    "vicuna-7b_fact": [
      "TBC1 domain family member 16 (TBC1D16) is a protein that is involved in various cellular processes, including cell growth and division.",
      "TBC1D16 has been implicated in the development of breast, prostate, colorectal, lung and pancreatic cancers.",
      "High levels of TBC1D16 in breast cancer cells promote cell growth and survival, and may contribute to the development of resistance to chemotherapy.",
      "High levels of TBC1D16 in prostate cancer cells can promote cell growth and survival, and may contribute to the development of resistance to hormone therapy.",
      "High levels of TBC1D16 in colorectal, lung and pancreatic cancer cells can promote cell growth and survival, and may contribute to the development of resistance to chemotherapy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3665,
    "user_query": "What does osanetant and talnetant have in common?",
    "vicuna-7b_response": "Osanetant and talnetant are both medications that belong to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). SSRIs are a type of antidepressant that work by increasing the levels of serotonin, a neurotransmitter in the brain, which can help improve mood and alleviate symptoms of depression.\nBoth osanetant and talnetant are used to treat depression, and they have similar mechanisms of action in terms of how they affect serotonin levels in the brain. However, they have some differences in terms of their specific chemical structures and the way they are metabolized by the body.\nOsanetant is a second-generation SSRI that is structurally different from the first-generation SSRIs, such as fluoxetine (Prozac) and sertraline (Zoloft). Osanetant is designed to have a lower risk of side effects, such as sexual dysfunction, than some of the older SSRIs.\nTalnetant is a third-generation SSRI that is structurally different from both first- and second-generation SSRIs. Talnetant is designed to have a higher affinity for the serotonin receptor, which can lead to more potent effects on serotonin levels in the brain.\nOverall, both osanetant and talnetant are effective antidepressants that work by increasing serotonin levels in the brain, but they have some differences in terms of their specific chemical structures and the way they are metabolized by the body.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Osanetant and talnetant are medications that belong to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). \n2. SSRIs work by increasing the levels of serotonin, a neurotransmitter in the brain.\n3. Both osanetant and talnetant are used to treat depression.\n4. Osanetant is a second-generation SSRI with a lower risk of side effects, such as sexual dysfunction, than some of the older SSRIs.\n5. Talnetant is a third-generation SSRI, and it is designed to have a higher affinity for the serotonin receptor, leading to more potent effects on serotonin levels in the brain.",
    "vicuna-7b_fact": [
      "Osanetant and talnetant are medications that belong to a class of drugs called selective serotonin reuptake inhibitors (SSRIs).",
      "SSRIs work by increasing the levels of serotonin, a neurotransmitter in the brain.",
      "Both osanetant and talnetant are used to treat depression.",
      "Osanetant is a second-generation SSRI with a lower risk of side effects, such as sexual dysfunction, than some of the older SSRIs.",
      "Talnetant is a third-generation SSRI, and it is designed to have a higher affinity for the serotonin receptor, leading to more potent effects on serotonin levels in the brain."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Osanetant and talnetant are not selective serotonin reuptake inhibitors (SSRIs); they are actually nonpeptide neurokinin 3 (NK3) receptor antagonists.\n2. TRUE\n3. FALSE [correction]: Neither osanetant nor talnetant are used in the treatment of depression; they are being investigated for use in the treatment of schizophrenia.\n4. FALSE [correction]: Osanetant is not a second-generation SSRI. It is a nonpeptide NK3 receptor antagonist.\n5. FALSE [correction]: Talnetant is not a third-generation SSRI. It is also a nonpeptide NK3 receptor antagonist.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3666,
    "user_query": "List SLC25A46-related pathologies",
    "vicuna-7b_response": "SLC25A46 is a gene that encodes for a protein called solute carrier family 25 member 46. The function of this protein is not well understood, but it is thought to be involved in the transport of small molecules across cell membranes.\nThere is currently no known association between SLC25A46 and any specific pathologies. However, it is important to note that genetic mutations in SLC25A46 have been identified in some individuals with certain inherited disorders. For example, mutations in SLC25A46 have been associated with a condition called \"congenital disorder of glycosylation type 1c\" (CDG1c), which is a genetic disorder characterized by abnormalities in the structure of certain carbohydrates in the body.\nAdditionally, some studies have suggested that mutations in SLC25A46 may be associated with an increased risk of certain cancers, such as breast cancer and ovarian cancer. However, more research is needed to fully understand the potential link between SLC25A46 and these pathologies.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SLC25A46 is a gene that encodes for a protein called solute carrier family 25 member 46.\n2. The function of SLC25A46 protein is thought to be involved in the transport of small molecules across cell membranes.\n3. Genetic mutations in SLC25A46 have been identified in some individuals with certain inherited disorders.\n4. Mutations in SLC25A46 have been associated with a condition called \"congenital disorder of glycosylation type 1c\" (CDG1c).\n5. Some studies have suggested that mutations in SLC25A46 may be associated with an increased risk of certain cancers, such as breast cancer and ovarian cancer.",
    "vicuna-7b_fact": [
      "SLC25A46 is a gene that encodes for a protein called solute carrier family 25 member 46.",
      "The function of SLC25A46 protein is thought to be involved in the transport of small molecules across cell membranes.",
      "Genetic mutations in SLC25A46 have been identified in some individuals with certain inherited disorders.",
      "Mutations in SLC25A46 have been associated with a condition called \"congenital disorder of glycosylation type 1c\" (CDG1c).",
      "Some studies have suggested that mutations in SLC25A46 may be associated with an increased risk of certain cancers, such as breast cancer and ovarian cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in SLC25A46 have been associated with conditions like optic atrophy, peripheral neuropathy, and cerebellar atrophy, not \"congenital disorder of glycosylation type 1c\" (CDG1c).\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-7b_response": "The PDZ domain is a protein interaction domain that plays a role in regulating the localization and stability of proteins. The SATB1 protein, also known as special AT-rich sequence binding protein 1, is a nuclear protein that is involved in the regulation of chromatin structure and transcription. The PDZ domain in SATB1 is thought to interact with other proteins and play a role in the regulation of SATB1's function. For example, the PDZ domain in SATB1 has been shown to interact with the protein hDlg, which is involved in the regulation of chromatin structure and transcription. Additionally, the PDZ domain in SATB1 has been shown to interact with the protein CASZ1, which is involved in the regulation of chromatin structure and transcription.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The PDZ domain is a protein interaction domain that helps regulate the localization and stability of proteins. \n2. SATB1 is a nuclear protein involved in the regulation of chromatin structure and transcription. \n3. The PDZ domain in SATB1 can interact with other proteins. \n4. The PDZ domain in SATB1 has been shown to interact with the protein hDlg. \n5. The PDZ domain in SATB1 has been shown to interact with the protein CASZ1.",
    "vicuna-7b_fact": [
      "The PDZ domain is a protein interaction domain that helps regulate the localization and stability of proteins.",
      "SATB1 is a nuclear protein involved in the regulation of chromatin structure and transcription.",
      "The PDZ domain in SATB1 can interact with other proteins.",
      "The PDZ domain in SATB1 has been shown to interact with the protein hDlg.",
      "The PDZ domain in SATB1 has been shown to interact with the protein CASZ1."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3675,
    "user_query": "Which are the databases for intrinsic protein disorders?",
    "vicuna-7b_response": "Intrinsic protein disorders are those that are not caused by mutations or other external factors, but are inherent to the protein structure. There are several databases that store information on intrinsic protein disorders. Here are some of the most notable ones:\n1. The Protein Data Bank (PDB): The PDB is a public database that stores three-dimensional structural data for proteins and nucleic acids. It contains information on intrinsic disorders, including disordered regions and disordered proteins.\n2. The Disordered Protein Database (DPD): The DPD is a database that focuses specifically on disordered proteins. It contains information on the location and length of disordered regions in proteins, as well as information on the stability and dynamics of these regions.\n3. The Intrinsically Disordered Protein Database (IDP): The IDP is a database that focuses specifically on intrinsically disordered proteins. It contains information on the location and length of disordered regions in proteins, as well as information on the stability and dynamics of these regions.\n4. The Disordered Protein and Peptide Structure Database (DPS): The DPS is a database that focuses specifically on disordered proteins and peptides. It contains information on the location and length of disordered regions in proteins and peptides, as well as information on the stability and dynamics of these regions.\n5. The Disordered Protein and Peptide Structure and Function Database (DPSF): The DPSF is a database that focuses specifically on disordered proteins and peptides. It contains information on the location and length of disordered regions in proteins and peptides, as well as information on the stability and dynamics of these regions.\nThese databases provide valuable information for researchers studying intrinsic protein disorders, and can be used to identify potential targets for therapeutic intervention.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Intrinsic protein disorders are those not caused by mutations or other external factors, but are inherent to the protein structure.\n2. The Protein Data Bank (PDB) is a public database that stores three-dimensional structural data for proteins and nucleic acids, including disordered regions and disordered proteins.\n3. The Disordered Protein Database (DPD) contains information on the location and length of disordered regions in proteins, as well as information on the stability and dynamics of these regions.\n4. Intrinsically Disordered Protein Database (IDP) focuses on intrinsically disordered proteins and has details about their location, length, stability, and dynamics.\n5. The Disordered Protein and Peptide Structure Database (DPS) and the Disordered Protein and Peptide Structure and Function Database (DPSF) focus on disordered proteins and peptides, containing information on their location, length, stability, and dynamics.",
    "vicuna-7b_fact": [
      "Intrinsic protein disorders are those not caused by mutations or other external factors, but are inherent to the protein structure.",
      "The Protein Data Bank (PDB) is a public database that stores three-dimensional structural data for proteins and nucleic acids, including disordered regions and disordered proteins.",
      "The Disordered Protein Database (DPD) contains information on the location and length of disordered regions in proteins, as well as information on the stability and dynamics of these regions.",
      "Intrinsically Disordered Protein Database (IDP) focuses on intrinsically disordered proteins and has details about their location, length, stability, and dynamics.",
      "The Disordered Protein and Peptide Structure Database (DPS) and the Disordered Protein and Peptide Structure and Function Database (DPSF) focus on disordered proteins and peptides, containing information on their location, length, stability, and dynamics."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3676,
    "user_query": "List the 5 different human immunoglobulin heavy chains.",
    "vicuna-7b_response": "There are five different human immunoglobulin heavy chains: alpha, delta, epsilon, gamma, and mu. These heavy chains are encoded by different genes and are expressed in different types of immunoglobulins.\nAlpha heavy chains are encoded by the IGH gene and are expressed in both the heavy and light chains of the IgA, IgD, and IgE immunoglobulins.\nDelta heavy chains are encoded by the IGHD gene and are expressed in the heavy chains of the IgD immunoglobulin.\nEpsilon heavy chains are encoded by the IGHV gene and are expressed in the heavy chains of the IgG, IgA, and IgE immunoglobulins. There are several subtypes of epsilon heavy chains, which are further classified based on their variable region genes.\nGamma heavy chains are encoded by the IGHJ gene and are expressed in the heavy chains of the IgG, IgA, and IgE immunoglobulins. There are several subtypes of gamma heavy chains, which are further classified based on their constant region genes.\nMu heavy chains are encoded by the IGHJ gene and are expressed in the heavy chains of the IgM immunoglobulin.\nIn summary, there are five different human immunoglobulin heavy chains: alpha, delta, epsilon, gamma, and mu. These heavy chains are encoded by different genes and are expressed in different types of immunoglobulins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are five different human immunoglobulin heavy chains: alpha, delta, epsilon, gamma, and mu.\n2. Alpha heavy chains are encoded by the IGH gene and are expressed in both the heavy and light chains of the IgA, IgD, and IgE immunoglobulins.\n3. Delta heavy chains are encoded by the IGHD gene and are expressed in the heavy chains of the IgD immunoglobulin.\n4. Epsilon heavy chains are encoded by the IGHV gene and are expressed in the heavy chains of the IgG, IgA, and IgE immunoglobulins.\n5. Mu heavy chains are encoded by the IGHJ gene and are expressed in the heavy chains of the IgM immunoglobulin.",
    "vicuna-7b_fact": [
      "There are five different human immunoglobulin heavy chains: alpha, delta, epsilon, gamma, and mu.",
      "Alpha heavy chains are encoded by the IGH gene and are expressed in both the heavy and light chains of the IgA, IgD, and IgE immunoglobulins.",
      "Delta heavy chains are encoded by the IGHD gene and are expressed in the heavy chains of the IgD immunoglobulin.",
      "Epsilon heavy chains are encoded by the IGHV gene and are expressed in the heavy chains of the IgG, IgA, and IgE immunoglobulins.",
      "Mu heavy chains are encoded by the IGHJ gene and are expressed in the heavy chains of the IgM immunoglobulin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Alpha heavy chains are encoded by the IGH gene and are expressed in heavy chains of the IgA immunoglobulin.\n3. TRUE\n4. FALSE [correction]: Epsilon heavy chains are encoded by the IGH gene and are expressed in the heavy chains of the IgE immunoglobulin.\n5. FALSE [correction]: Mu heavy chains are encoded by the IGHM gene and are expressed in the heavy chains of the IgM immunoglobulin.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-7b_response": "The BLISS technique is based on the principles of behaviorism, specifically on the idea that behavior is acquired through learning and can be shaped and changed through reinforcement and punishment. The BLISS technique is a type of behavioral therapy that aims to help individuals with substance use disorders by teaching them new behaviors and skills that can replace their substance-using behaviors.\nThe BLISS technique stands for Brief Life-Space Intervention Supporting Sobriety, and it was developed by Dr. Mark Willenbring, a psychiatrist and addiction specialist. The technique is based on the idea that addiction is a chronic disease that requires ongoing management and support.\nThe BLISS technique involves a brief intervention that is delivered in a single session, usually in a primary care setting. The intervention is designed to help individuals identify and change their substance-using behaviors by teaching them new coping skills and strategies.\nThe BLISS technique is based on the principles of motivational interviewing, which is a counseling style that focuses on helping individuals identify their own motivation for change and developing a plan for achieving their goals. The technique also incorporates elements of cognitive-behavioral therapy, which aims to help individuals identify and change negative thoughts and beliefs that may be contributing to their substance use.\nOverall, the BLISS technique is a brief, evidence-based intervention that can be effective in helping individuals with substance use disorders achieve and maintain sobriety.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The BLISS technique is based on the principles of behaviorism.\n2. The BLISS technique is a type of therapy that aims to replace substance-using behaviors with new behaviors and skills.\n3. Brief Life-Space Intervention Supporting Sobriety, or the BLISS technique, was developed by Dr. Mark Willenbring.\n4. The BLISS technique involves a brief intervention that is delivered in a single session, usually in a primary care setting.\n5. The BLISS technique is based on the principles of motivational interviewing and incorporates elements of cognitive-behavioral therapy.",
    "vicuna-7b_fact": [
      "The BLISS technique is based on the principles of behaviorism.",
      "The BLISS technique is a type of therapy that aims to replace substance-using behaviors with new behaviors and skills.",
      "Brief Life-Space Intervention Supporting Sobriety, or the BLISS technique, was developed by Dr. Mark Willenbring.",
      "The BLISS technique involves a brief intervention that is delivered in a single session, usually in a primary care setting.",
      "The BLISS technique is based on the principles of motivational interviewing and incorporates elements of cognitive-behavioral therapy."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The BLISS technique is based on principles of motivational interviewing and cognitive-behavioral therapy, not behaviorism.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The BLISS technique is delivered over multiple sessions, not in a single session.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-7b_response": "NK3R antagonists are drugs that block the action of the NK3 receptor, which is a type of receptor found on cells in the nervous system. Here are three examples of NK3R antagonists:\n1. APD334: APD334 is a selective NK3R antagonist that is being developed for the treatment of pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.\n2. Tegoprazan: Tegoprazan is another selective NK3R antagonist that is used to treat acute and chronic pain. It has been shown to be effective in reducing pain in animal models and has been approved for use in several countries for the treatment of acute pain.\n3. SB-277011: SB-277011 is a selective NK3R antagonist that is being developed for the treatment of chronic pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. NK3R antagonists are drugs that block the action of the NK3 receptor.\n2. The NK3 receptor is a type of receptor found on cells in the nervous system.\n3. APD334 is a selective NK3R antagonist.\n4. Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.\n5. SB-277011 is a selective NK3R antagonist.",
    "vicuna-7b_fact": [
      "NK3R antagonists are drugs that block the action of the NK3 receptor.",
      "The NK3 receptor is a type of receptor found on cells in the nervous system.",
      "APD334 is a selective NK3R antagonist.",
      "Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.",
      "SB-277011 is a selective NK3R antagonist."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: APD334 is a selective sphingosine-1-phosphate receptor modulator, not an NK3R antagonist.\n4. FALSE [correction]: Tegoprazan is a potent and selective potassium-competitive acid blocker, not an NK3R antagonist.\n5. FALSE [correction]: SB-277011 is a selective dopamine D3 receptor antagonist, not an NK3R antagonist.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3682,
    "user_query": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Indinavir is a medication that is primarily used to treat HIV/AIDS. It is not approved for the treatment of amyotrophic lateral sclerosis (ALS).\nALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. It is also known as Lou Gehrig's disease, after the famous baseball player who died from the condition. There is currently no cure for ALS, and treatment options are limited.\nThere are a few medications that have been studied for the treatment of ALS, but they have not been proven to be effective. Some of these medications include riluzole, edaravone, and rasagiline.\nIt is important to note that while there are no FDA-approved treatments for ALS, there are ongoing clinical trials for new treatments. If you are interested in participating in a clinical trial, you should speak with your healthcare provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Indinavir is primarily used to treat HIV/AIDS.\n2. Indinavir is not approved for the treatment of amyotrophic lateral sclerosis (ALS).\n3. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n4. ALS is also known as Lou Gehrig's disease.\n5. There is no cure for ALS and treatment options are limited.",
    "vicuna-7b_fact": [
      "Indinavir is primarily used to treat HIV/AIDS.",
      "Indinavir is not approved for the treatment of amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "ALS is also known as Lou Gehrig's disease.",
      "There is no cure for ALS and treatment options are limited."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3685,
    "user_query": "What is ORMD-0801?",
    "vicuna-7b_response": "ORMD-0801 is a standardized test used to assess the knowledge and skills of individuals in the field of pharmacy. It is designed to evaluate the candidate's ability to apply their knowledge of pharmacy principles and practices to real-world scenarios. The test is administered by the National Association of Boards of Pharmacy (NABP) and is typically taken by individuals who are seeking licensure to practice pharmacy. The test covers a wide range of topics, including medication safety, pharmacology, pharmacy practice, and pharmacy law. It is important to note that the specific content and format of the ORMD-0801 test may vary depending on the jurisdiction in which it is administered.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ORMD-0801 is a standardized test used to assess knowledge and skills in the field of pharmacy.\n2. The National Association of Boards of Pharmacy (NABP) administers the ORMD-0801 test.\n3. The test is typically taken by individuals seeking licensure to practice pharmacy.\n4. The ORMD-0801 test covers topics including medication safety, pharmacology, pharmacy practice, and pharmacy law.\n5. The specific content and format of the ORMD-0801 test may vary depending on the jurisdiction in which it is administered.",
    "vicuna-7b_fact": [
      "ORMD-0801 is a standardized test used to assess knowledge and skills in the field of pharmacy.",
      "The National Association of Boards of Pharmacy (NABP) administers the ORMD-0801 test.",
      "The test is typically taken by individuals seeking licensure to practice pharmacy.",
      "The ORMD-0801 test covers topics including medication safety, pharmacology, pharmacy practice, and pharmacy law.",
      "The specific content and format of the ORMD-0801 test may vary depending on the jurisdiction in which it is administered."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3686,
    "user_query": "Does saracatinib promote oncogenesis?",
    "vicuna-7b_response": "Saracatinib is a small molecule inhibitor of the protein kinase C (PKC) family, specifically PKCα, PKCε, and PKCζ. It has been shown to have anti-proliferative and anti-angiogenic effects in various cancer models, including breast, ovarian, and colon cancer. However, the exact mechanism of action of saracatinib and its potential to promote oncogenesis is not well understood.\nSaracatinib has been shown to inhibit the growth and survival of cancer cells by blocking the activation of PKC family members, which are known to play a role in cell proliferation, survival, and angiogenesis. In addition, saracatinib has been shown to induce apoptosis (programmed cell death) in cancer cells.\nWhile saracatinib has shown promise in preclinical studies, its potential to promote oncogenesis has not been extensively studied. Some studies have suggested that saracatinib may have a limited therapeutic window and may cause adverse effects such as myelosuppression, diarrhea, and nausea.\nOverall, more research is needed to fully understand the potential of saracatinib as a cancer therapeutic and to determine its safety and efficacy in clinical settings.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Saracatinib is a small molecule inhibitor of the protein kinase C (PKC) family, specifically PKCα, PKCε, and PKCζ.\n2. Saracatinib has been shown to have anti-proliferative and anti-angiogenic effects in various cancer models.\n3. Saracatinib inhibits the growth and survival of cancer cells by blocking the activation of PKC family members.\n4. Saracatinib has been shown to induce apoptosis (programmed cell death) in cancer cells.\n5. Some studies have suggested that saracatinib may cause adverse effects such as myelosuppression, diarrhea, and nausea.",
    "vicuna-7b_fact": [
      "Saracatinib is a small molecule inhibitor of the protein kinase C (PKC) family, specifically PKCα, PKCε, and PKCζ.",
      "Saracatinib has been shown to have anti-proliferative and anti-angiogenic effects in various cancer models.",
      "Saracatinib inhibits the growth and survival of cancer cells by blocking the activation of PKC family members.",
      "Saracatinib has been shown to induce apoptosis (programmed cell death) in cancer cells.",
      "Some studies have suggested that saracatinib may cause adverse effects such as myelosuppression, diarrhea, and nausea."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Saracatinib is a small molecule inhibitor of the Src family kinases.\n2. TRUE\n3. FALSE [correction]: Saracatinib inhibits the growth and survival of cancer cells by blocking the functioning of src-family protein tyrosine kinases.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3687,
    "user_query": "Is BCL11B involved in schizophrenia?",
    "vicuna-7b_response": "BCL11B is a gene that has been implicated in the development of schizophrenia. Studies have shown that variations in the BCL11B gene can increase the risk of developing schizophrenia. Specifically, a variant of the BCL11B gene has been found to be associated with an increased risk of developing negative symptoms of schizophrenia, such as apathy and social withdrawal.\nAdditionally, research has shown that BCL11B plays a role in the development of the brain and the regulation of neurotransmitters, which are chemicals that allow nerve cells to communicate with each other. This suggests that changes in the BCL11B gene may affect the development of the brain and contribute to the symptoms of schizophrenia.\nOverall, while more research is needed to fully understand the role of BCL11B in schizophrenia, it is clear that this gene plays a significant role in the development of the disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The BCL11B gene has been implicated in the development of schizophrenia.\n2. Studies have found that variations in the BCL11B gene can increase the risk of schizophrenia.\n3. A variant of the BCL11B gene is associated with an increased risk of developing negative symptoms of schizophrenia, such as apathy and social withdrawal.\n4. BCL11B has a role in the development of the brain and the regulation of neurotransmitters.\n5. Changes in the BCL11B gene may affect the development of the brain and contribute to the symptoms of schizophrenia.",
    "vicuna-7b_fact": [
      "The BCL11B gene has been implicated in the development of schizophrenia.",
      "Studies have found that variations in the BCL11B gene can increase the risk of schizophrenia.",
      "A variant of the BCL11B gene is associated with an increased risk of developing negative symptoms of schizophrenia, such as apathy and social withdrawal.",
      "BCL11B has a role in the development of the brain and the regulation of neurotransmitters.",
      "Changes in the BCL11B gene may affect the development of the brain and contribute to the symptoms of schizophrenia."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3690,
    "user_query": "What is a zoonotic virus?",
    "vicuna-7b_response": "A zoonotic virus is a virus that can be transmitted from animals to humans. These viruses can cause a range of diseases, from mild to severe, and can have significant impacts on both human and animal health.\nZoonotic viruses can be transmitted through various routes, including direct contact with infected animals or their bodily fluids, consumption of contaminated food or water, or inhalation of contaminated air. Some examples of zoonotic viruses include the influenza virus, SARS coronavirus, and Ebola virus.\nIt is important to note that many viruses that can infect humans can also infect animals, and vice versa. This is why it is important to practice good hygiene and avoid close contact with animals, especially during outbreaks of infectious diseases.\nIn addition, it is also important to report any suspected cases of zoonotic viruses to public health authorities, as early detection and response can help to prevent the spread of the virus and minimize the impact on both human and animal health.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A zoonotic virus is a virus that can be transmitted from animals to humans.\n2. Zoonotic viruses can cause a range of diseases, from mild to severe.\n3. These viruses can be transmitted through direct contact with infected animals or their bodily fluids, consumption of contaminated food or water, or inhalation of contaminated air.\n4. Examples of zoonotic viruses include the influenza virus, SARS coronavirus, and Ebola virus.\n5. Many viruses that can infect humans can also infect animals, and vice versa.",
    "vicuna-7b_fact": [
      "A zoonotic virus is a virus that can be transmitted from animals to humans.",
      "Zoonotic viruses can cause a range of diseases, from mild to severe.",
      "These viruses can be transmitted through direct contact with infected animals or their bodily fluids, consumption of contaminated food or water, or inhalation of contaminated air.",
      "Examples of zoonotic viruses include the influenza virus, SARS coronavirus, and Ebola virus.",
      "Many viruses that can infect humans can also infect animals, and vice versa."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as Liraglutide. Liraglutide is a GLP-1 receptor agonist that also acts as a ghrelin receptor inverse agonist. It is used in the treatment of type 2 diabetes and obesity. Liraglutide is marketed under the brand name Victoza by Novo Nordisk.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. Liraglutide is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Liraglutide is a GLP-1 receptor agonist.\n3. Liraglutide acts as a ghrelin receptor inverse agonist.\n4. Liraglutide is used in the treatment of type 2 diabetes and obesity.\n5. Liraglutide is marketed under the brand name Victoza by Novo Nordisk.",
    "vicuna-7b_fact": [
      "Liraglutide is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Liraglutide is a GLP-1 receptor agonist.",
      "Liraglutide acts as a ghrelin receptor inverse agonist.",
      "Liraglutide is used in the treatment of type 2 diabetes and obesity.",
      "Liraglutide is marketed under the brand name Victoza by Novo Nordisk."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Liraglutide is not a ghrelin receptor inverse agonist, it's a GLP-1 receptor agonist.\n2. TRUE\n3. FALSE [correction]: Liraglutide does not act as a ghrelin receptor inverse agonist, it's a GLP-1 receptor agonist.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-7b_response": "Vaxchora is a vaccine that is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older. The vaccine is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.\nStudies have shown that Vaxchora is effective in preventing cholera caused by the serogroup Ogawa. In a clinical trial, the vaccine was found to be 77% effective in preventing symptomatic cholera and 87% effective in preventing severe cholera.\nIt is important to note that Vaxchora is not approved for use in individuals under the age of 18, and its effectiveness may vary in individuals with underlying health conditions. It is also important to follow the recommended dosing schedule and to consult with a healthcare provider before receiving the vaccine.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Vaxchora is a vaccine approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.\n2. Vaxchora is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.\n3. Studies have found that Vaxchora is 77% effective in preventing symptomatic cholera.\n4. Vaxchora is 87% effective in preventing severe cholera as per clinical trials.\n5. Vaxchora is not approved for use in individuals under the age of 18.",
    "vicuna-7b_fact": [
      "Vaxchora is a vaccine approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.",
      "Vaxchora is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.",
      "Studies have found that Vaxchora is 77% effective in preventing symptomatic cholera.",
      "Vaxchora is 87% effective in preventing severe cholera as per clinical trials.",
      "Vaxchora is not approved for use in individuals under the age of 18."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Vaxchora is a vaccine approved for the prevention of cholera caused by the serogroup O1 in individuals aged 18 years or older.\n2. TRUE\n3. FALSE [correction]: Studies have found that Vaxchora is around 90% effective in preventing symptomatic cholera.\n4. FALSE [correction]: Vaxchora is around 90% effective in preventing severe cholera as per clinical trials.\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3694,
    "user_query": "What is minodixil approved for?",
    "vicuna-7b_response": "Minodixil is a medication that is approved for the treatment of androgenetic alopecia, also known as male-pattern baldness. It is a topical solution that is applied to the scalp and works by inhibiting the production of dihydrotestosterone (DHT), a hormone that is responsible for hair loss. Minodixil is generally well-tolerated and has been shown to be effective in clinical trials for the treatment of male pattern baldness. It is important to note that Minodixil is not approved for use in women and should not be used by women or children.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Minodixil is a medication approved for the treatment of androgenetic alopecia.\n2. Androgenetic alopecia is also known as male-pattern baldness.\n3. Minodixil works by inhibiting the production of dihydrotestosterone (DHT).\n4. Dihydrotestosterone (DHT) is a hormone responsible for hair loss.\n5. Minodixil is not approved for use in women or children.",
    "vicuna-7b_fact": [
      "Minodixil is a medication approved for the treatment of androgenetic alopecia.",
      "Androgenetic alopecia is also known as male-pattern baldness.",
      "Minodixil works by inhibiting the production of dihydrotestosterone (DHT).",
      "Dihydrotestosterone (DHT) is a hormone responsible for hair loss.",
      "Minodixil is not approved for use in women or children."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Minoxidil is a medication approved for the treatment of androgenetic alopecia.\n2. TRUE\n3. FALSE [correction]: Minoxidil does not inhibit the production of dihydrotestosterone (DHT). It works by helping the blood flow to the hair follicles.\n4. TRUE\n5. FALSE [correction]: Minoxidil is approved for use in both men and women, however, it is not recommended for children.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3697,
    "user_query": "Is SATB1 necessary for T-cell maturation?",
    "vicuna-7b_response": "SATB1 (Sperm-associated antigen 1) is a protein that plays a role in the maturation of T-cells. SATB1 is expressed in the thymus, where T-cells mature and is thought to be involved in the process of positive and negative selection, which helps to ensure that T-cells are functional and do not attack the body's own cells.\nSATB1 has also been shown to be important for the maturation of T-cells in the periphery, where they are produced in the bone marrow and migrate to the lymphoid organs. In these organs, T-cells continue to mature and become functional.\nIn summary, SATB1 is necessary for T-cell maturation, as it plays a role in the maturation process in the thymus and in the periphery.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. SATB1 is a protein that plays a role in the maturation of T-cells.\n2. SATB1 is expressed in the thymus, where T-cells mature.\n3. SATB1 is thought to be involved in the process of positive and negative selection, which helps to ensure that T-cells are functional and do not attack the body's own cells.\n4. SATB1 is also important for the maturation of T-cells in the periphery.\n5. T-cells are produced in the bone marrow and migrate to the lymphoid organs to continue to mature and become functional.",
    "vicuna-7b_fact": [
      "SATB1 is a protein that plays a role in the maturation of T-cells.",
      "SATB1 is expressed in the thymus, where T-cells mature.",
      "SATB1 is thought to be involved in the process of positive and negative selection, which helps to ensure that T-cells are functional and do not attack the body's own cells.",
      "SATB1 is also important for the maturation of T-cells in the periphery.",
      "T-cells are produced in the bone marrow and migrate to the lymphoid organs to continue to mature and become functional."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3700,
    "user_query": "What is the function of a viral peplomer?",
    "vicuna-7b_response": "A viral peplomer is a protein found on the surface of certain viruses, such as the human immunodeficiency virus (HIV). Its function is to help the virus attach to and enter target cells.\nThe viral peplomer is a large, multi-domain protein that contains multiple copies of a small, repeating motif called the heptad repeat. This motif is responsible for the specific recognition of certain cell surface receptors, allowing the virus to bind to and infect specific cells.\nOnce the virus has attached to a cell, it can then use other viral proteins to enter the cell and replicate its genetic material. The viral peplomer plays a crucial role in this process by helping the virus to recognize and bind to its target cells.\nInhibitors of viral peplomers are being developed as potential treatments for viral infections, as they can block the ability of the virus to attach to and infect cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. A viral peplomer is a protein found on the surface of certain viruses, such as the human immunodeficiency virus (HIV).\n2. The function of a viral peplomer is to help the virus attach to and enter target cells.\n3. The viral peplomer is a large, multi-domain protein that contains multiple copies of a small, repeating motif called the heptad repeat.\n4. Once the virus has attached to a cell, the viral peplomer helps the virus to recognize and bind to its target cells.\n5. Inhibitors of viral peplomers are being developed as potential treatments for viral infections.",
    "vicuna-7b_fact": [
      "A viral peplomer is a protein found on the surface of certain viruses, such as the human immunodeficiency virus (HIV).",
      "The function of a viral peplomer is to help the virus attach to and enter target cells.",
      "The viral peplomer is a large, multi-domain protein that contains multiple copies of a small, repeating motif called the heptad repeat.",
      "Once the virus has attached to a cell, the viral peplomer helps the virus to recognize and bind to its target cells.",
      "Inhibitors of viral peplomers are being developed as potential treatments for viral infections."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Once the virus has attached to a cell, the viral peplomer helps the virus to fuse with the cell membrane.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3704,
    "user_query": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "vicuna-7b_response": "Radiotherapy for prostate cancer can increase the risk of bladder cancer. This is because radiotherapy can damage the cells in the bladder, which can lead to the development of cancer. However, the risk of bladder cancer after radiotherapy for prostate cancer is relatively low, and most men do not go on to develop bladder cancer.\nIt is important to note that the risk of bladder cancer after radiotherapy for prostate cancer depends on several factors, including the dose and duration of radiotherapy, as well as the patient's age and overall health. Men who have had radiotherapy for prostate cancer should be aware of the potential risks and should report any symptoms of bladder cancer to their healthcare provider immediately.\nIn general, the benefits of radiotherapy for prostate cancer outweigh the risks for most men. Radiotherapy is an effective treatment for prostate cancer and can help to improve survival rates and quality of life. However, it is important for men to discuss the potential risks and benefits of radiotherapy with their healthcare provider before making a decision about treatment.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Radiotherapy for prostate cancer can increase the risk of bladder cancer.\n2. Radiotherapy works by damaging cells, which can lead to cancer development.\n3. The risk of bladder cancer after radiotherapy for prostate cancer is relatively low.\n4. The benefits of radiotherapy for prostate cancer generally outweigh the risks for most men.\n5. Radiotherapy is an effective treatment for prostate cancer and can help to improve survival rates and quality of life.",
    "vicuna-7b_fact": [
      "Radiotherapy for prostate cancer can increase the risk of bladder cancer.",
      "Radiotherapy works by damaging cells, which can lead to cancer development.",
      "The risk of bladder cancer after radiotherapy for prostate cancer is relatively low.",
      "The benefits of radiotherapy for prostate cancer generally outweigh the risks for most men.",
      "Radiotherapy is an effective treatment for prostate cancer and can help to improve survival rates and quality of life."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3705,
    "user_query": "What is ESN364?",
    "vicuna-7b_response": "ESN364 is a unique identifier assigned to a specific electronic device. It is commonly used in the telecommunications industry to identify mobile phones and other wireless devices. The ESN (Electronic Serial Number) is a 32-digit number that is stored in the device's memory and is used to identify the device on a network. The first 8 digits of the ESN are known as the manufacturer code and are used to identify the manufacturer of the device. The remaining 24 digits are unique to the device and are used to identify it on a network.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. ESN364 is a unique identifier assigned to a specific electronic device.\n2. ESN (Electronic Serial Number) is commonly used in the telecommunications industry.\n3. An ESN is a 32-digit number stored in a device's memory.\n4. The first 8 digits of the ESN are known as the manufacturer code.\n5. The manufacturer code in an ESN is used to identify the manufacturer of the device.",
    "vicuna-7b_fact": [
      "ESN364 is a unique identifier assigned to a specific electronic device.",
      "ESN (Electronic Serial Number) is commonly used in the telecommunications industry.",
      "An ESN is a 32-digit number stored in a device's memory.",
      "The first 8 digits of the ESN are known as the manufacturer code.",
      "The manufacturer code in an ESN is used to identify the manufacturer of the device."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: An ESN is typically an 8-digit number stored in a device's memory.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3707,
    "user_query": "Has MLE4901 been tested in phase III clinical trials?",
    "vicuna-7b_response": "MLE4901 is a medical device used in the treatment of atrial fibrillation, a common heart rhythm disorder. The device is a radiofrequency ablation system that uses electrical energy to create scar tissue in the heart tissue that is causing the abnormal heart rhythm.\nThere have been clinical trials conducted on MLE4901, but it is not clear if it has been tested in phase III clinical trials. Phase III clinical trials are the largest and most complex clinical trials conducted on a medical device or drug. They are designed to evaluate the safety and efficacy of the device or drug in a large population of patients and are typically conducted after the device or drug has been tested in phase I and phase II clinical trials.\nIt is possible that MLE4901 has been tested in phase III clinical trials, but the results have not been published or made publicly available. Alternatively, it is possible that MLE4901 has not been tested in phase III clinical trials at all.\nIt is important to note that clinical trials are conducted to evaluate the safety and efficacy of medical devices and drugs, and the results of these trials can help healthcare professionals and patients make informed decisions about the use of these products.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. MLE4901 is a medical device used in the treatment of atrial fibrillation.\n2. The MLE4901 device is a radiofrequency ablation system that uses electrical energy to create scar tissue in heart tissue.\n3. Clinical trials have been conducted on MLE4901.\n4. Phase III clinical trials are the largest and most complex clinical trials conducted on a medical device or drug.\n5. Phase III clinical trials evaluate the safety and efficacy of a device or drug in a large population of patients and typically occur after phase I and phase II trials.",
    "vicuna-7b_fact": [
      "MLE4901 is a medical device used in the treatment of atrial fibrillation.",
      "The MLE4901 device is a radiofrequency ablation system that uses electrical energy to create scar tissue in heart tissue.",
      "Clinical trials have been conducted on MLE4901.",
      "Phase III clinical trials are the largest and most complex clinical trials conducted on a medical device or drug.",
      "Phase III clinical trials evaluate the safety and efficacy of a device or drug in a large population of patients and typically occur after phase I and phase II trials."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MLE4901 is not a medical device, but a compound which is used for the treatment of polycystic ovary syndrome (PCOS) and menopausal hot flushes.\n2. FALSE [correction]: MLE4901 is not a device but a compound, so it does not use electrical energy to create scar tissue in heart tissue.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3713,
    "user_query": "What is the interaction between WAPL and PDS5 proteins?",
    "vicuna-7b_response": "The WAPL and PDS5 proteins are involved in the regulation of the actin cytoskeleton in cells.\nWAPL (Wiskott-Aldrich syndrome protein-like) is a protein that is involved in the regulation of the actin cytoskeleton and cell adhesion. It is also involved in the regulation of the immune system and the development of autoimmune diseases.\nPDS5 (Pleckstrin domain containing protein 5) is a protein that is involved in the regulation of the actin cytoskeleton and cell adhesion. It is also involved in the regulation of the immune system and the development of autoimmune diseases.\nBoth WAPL and PDS5 proteins are involved in the regulation of the actin cytoskeleton and cell adhesion, and they are also involved in the regulation of the immune system and the development of autoimmune diseases. However, the exact mechanism of their interaction is not well understood.\nIt is important to note that the interaction between WAPL and PDS5 proteins may vary depending on the specific context and the cell type in question. Further research is needed to fully understand the interaction between these proteins.",
    "vicuna-7b_fact_raw": "Here are all the factual statements: \n1. WAPL and PDS5 proteins are involved in the regulation of the actin cytoskeleton in cells.\n2. The WAPL protein is involved in the regulation of cell adhesion.\n3. The PDS5 protein is involved in the regulation of cell adhesion.\n4. Both WAPL and PDS5 proteins are involved in the regulation of the immune system and the development of autoimmune diseases.\n5. The interaction between WAPL and PDS5 proteins may vary depending on the specific context and the cell type.",
    "vicuna-7b_fact": [
      "WAPL and PDS5 proteins are involved in the regulation of the actin cytoskeleton in cells.",
      "The WAPL protein is involved in the regulation of cell adhesion.",
      "The PDS5 protein is involved in the regulation of cell adhesion.",
      "Both WAPL and PDS5 proteins are involved in the regulation of the immune system and the development of autoimmune diseases.",
      "The interaction between WAPL and PDS5 proteins may vary depending on the specific context and the cell type."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-7b_response": "The first cholera vaccine approved in the US was the killed whole-cell cholera vaccine, also known as the Dukor-Smith vaccine. It was licensed for use in 1914 and was the first cholera vaccine to be widely used in the United States. The vaccine was developed by Dr. Paul Dukor and Dr. Charles Smith and was made from a killed preparation of the bacteria that causes cholera. It was administered orally and was effective against both classical and El Tor strains of cholera. The vaccine was later replaced by more effective vaccines, but it played an important role in the control of cholera in the United States.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The first cholera vaccine approved in the US was the killed whole-cell cholera vaccine, also known as the Dukor-Smith vaccine.\n2. The Dukor-Smith vaccine was licensed for use in 1914.\n3. Dr. Paul Dukor and Dr. Charles Smith developed the first cholera vaccine in the US.\n4. The vaccine was administered orally and was effective against both classical and El Tor strains of cholera.\n5. The vaccine was later replaced by more effective vaccines.",
    "vicuna-7b_fact": [
      "The first cholera vaccine approved in the US was the killed whole-cell cholera vaccine, also known as the Dukor-Smith vaccine.",
      "The Dukor-Smith vaccine was licensed for use in 1914.",
      "Dr. Paul Dukor and Dr. Charles Smith developed the first cholera vaccine in the US.",
      "The vaccine was administered orally and was effective against both classical and El Tor strains of cholera.",
      "The vaccine was later replaced by more effective vaccines."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Dukor-Smith vaccine was licensed for use in 1964.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3718,
    "user_query": "Are there negative enhancers?",
    "vicuna-7b_response": "Yes, there are negative enhancers. A negative enhancer is a type of enhancer that suppresses the expression of a gene. These enhancers do not increase gene expression, but rather decrease it.\nNegative enhancers are typically found in regions of the genome that are far away from the gene they regulate. They can be found in non-coding regions, such as intergenic regions or introns, or in regulatory regions, such as promoters or enhancers.\nNegative enhancers work by binding to the promoter region of a gene and blocking the binding of transcription factors that would otherwise increase gene expression. This can lead to decreased expression of the gene, even in the presence of positive enhancers.\nNegative enhancers have been shown to play a role in a variety of biological processes, including development, differentiation, and cellular proliferation. They have also been implicated in the regulation of gene expression in response to environmental cues, such as light or temperature.\nOverall, negative enhancers are an important part of the regulatory landscape of the genome, and their function is critical for the proper regulation of gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Negative enhancers are a type of enhancer that suppresses the expression of a gene.\n2. Negative enhancers are typically found in regions of the genome that are far away from the gene they regulate.\n3. Negative enhancers can be found in non-coding regions, such as intergenic regions or introns, or in regulatory regions, such as promoters or enhancers.\n4. Negative enhancers work by blocking the binding of transcription factors that would otherwise increase gene expression, hence leading to decreased expression of the gene.\n5. Negative enhancers play a role in a variety of biological processes, including development, differentiation, cellular proliferation, and the regulation of gene expression in response to environmental cues.",
    "vicuna-7b_fact": [
      "Negative enhancers are a type of enhancer that suppresses the expression of a gene.",
      "Negative enhancers are typically found in regions of the genome that are far away from the gene they regulate.",
      "Negative enhancers can be found in non-coding regions, such as intergenic regions or introns, or in regulatory regions, such as promoters or enhancers.",
      "Negative enhancers work by blocking the binding of transcription factors that would otherwise increase gene expression, hence leading to decreased expression of the gene.",
      "Negative enhancers play a role in a variety of biological processes, including development, differentiation, cellular proliferation, and the regulation of gene expression in response to environmental cues."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3719,
    "user_query": "What is the function of WAPL protein on cohesin?",
    "vicuna-7b_response": "WAPL (Whipped cream, Anchor, Plakophilin-related protein) is a protein that plays a crucial role in regulating the function of cohesin, a complex that is responsible for maintaining the integrity of chromosomes during cell division.\nCohesin is composed of three subunits: SMC1, SMC3, and SMC4. These subunits form a ring-like structure that surrounds the DNA and holds the sister chromatids together. WAPL interacts with the SMC1 subunit of cohesin and helps to anchor it to the inner nuclear membrane.\nWAPL also interacts with other proteins, such as Plakophilin-related protein 2 (PKP2) and Plakophilin-related protein 3 (PKP3), which are involved in the regulation of cell adhesion and cytoskeletal organization.\nThe function of WAPL in regulating cohesin is important for maintaining the integrity of chromosomes during cell division. Mutations in the WAPL gene have been associated with several human diseases, including Cornelia de Lange syndrome and Wolf-Hirschhorn syndrome.\nIn summary, WAPL is a protein that plays a crucial role in regulating the function of cohesin, a complex that is responsible for maintaining the integrity of chromosomes during cell division. WAPL interacts with the SMC1 subunit of cohesin and helps to anchor it to the inner nuclear membrane. WAPL also interacts with other proteins involved in cell adhesion and cytoskeletal organization. Mutations in the WAPL gene have been associated with several human diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. WAPL (Whipped cream, Anchor, Plakophilin-related protein) is a protein that regulates the function of cohesin.\n2. Cohesin is responsible for maintaining the integrity of chromosomes during cell division.\n3. WAPL interacts with the SMC1 subunit of cohesin and helps to anchor it to the inner nuclear membrane.\n4. WAPL also interacts with Plakophilin-related protein 2 (PKP2) and Plakophilin-related protein 3 (PKP3), which are involved in the regulation of cell adhesion and cytoskeletal organization.\n5. Mutations in the WAPL gene have been associated with several human diseases, including Cornelia de Lange syndrome and Wolf-Hirschhorn syndrome.",
    "vicuna-7b_fact": [
      "WAPL (Whipped cream, Anchor, Plakophilin-related protein) is a protein that regulates the function of cohesin.",
      "Cohesin is responsible for maintaining the integrity of chromosomes during cell division.",
      "WAPL interacts with the SMC1 subunit of cohesin and helps to anchor it to the inner nuclear membrane.",
      "WAPL also interacts with Plakophilin-related protein 2 (PKP2) and Plakophilin-related protein 3 (PKP3), which are involved in the regulation of cell adhesion and cytoskeletal organization.",
      "Mutations in the WAPL gene have been associated with several human diseases, including Cornelia de Lange syndrome and Wolf-Hirschhorn syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: WAPL helps remove cohesin off of the chromosome arms, not anchor it to the inner nuclear membrane.\n4. TRUE\n5. FALSE [correction]: Mutations in the cohesin complex, not WAPL, have been associated with Cornelia de Lange syndrome and Wolf-Hirschhorn syndrome.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3728,
    "user_query": "Which cells mature in the human thymus?",
    "vicuna-7b_response": "The human thymus is a gland located in the chest, just behind the sternum. It is responsible for the development and maturation of T cells, a type of immune cell that plays a crucial role in the immune system.\nThe thymus is made up of two lobes, each of which is divided into lobules. The lobes and lobules of the thymus contain a number of different types of cells, including epithelial cells, stromal cells, and immune cells.\nT cells, also known as T lymphocytes, are produced in the thymus through a process called positive and negative selection. During this process, T cells undergo a series of maturation stages in which they become specialized to recognize and respond to specific types of antigens.\nThe maturation of T cells in the thymus is a complex process that involves the interaction of T cells with thymic epithelial cells and stromal cells. During this process, T cells undergo a series of genetic and functional changes that allow them to become functional immune cells.\nIn summary, the cells that mature in the human thymus are T cells, which are a type of immune cell that plays a crucial role in the immune system. T cells are produced in the thymus through a process of positive and negative selection, during which they undergo a series of maturation stages and become specialized to recognize and respond to specific types of antigens.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The human thymus is a gland located in the chest, just behind the sternum.\n2. T cells, a type of immune cell, mature in the human thymus.\n3. The thymus is made up of two lobes, each divided into lobules.\n4. T cells are produced in the thymus through a process called positive and negative selection.\n5. During the maturation process, T cells undergo a series of genetic and functional changes that allow them to become functional immune cells.",
    "vicuna-7b_fact": [
      "The human thymus is a gland located in the chest, just behind the sternum.",
      "T cells, a type of immune cell, mature in the human thymus.",
      "The thymus is made up of two lobes, each divided into lobules.",
      "T cells are produced in the thymus through a process called positive and negative selection.",
      "During the maturation process, T cells undergo a series of genetic and functional changes that allow them to become functional immune cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3729,
    "user_query": "What are the eRNA-producing centers (EPCs)?",
    "vicuna-7b_response": "eRNA-producing centers (EPCs) are specialized cellular structures that are responsible for the production of endogenous retroviruses (ERVs) in the human body. ERVs are a type of retrovirus that is integrated into the host genome and can be transcribed into RNA.\nThere are several types of EPCs, including germ cells, spermatozoa, and some types of cancer cells. Germ cells are responsible for producing sperm and eggs, and they are the primary site of ERV production in the human body. Spermatozoa also contain ERVs, which can be transmitted to the offspring.\nCancer cells can also produce ERVs, which can contribute to the development and progression of cancer. Some studies have suggested that ERVs may play a role in the development of certain types of cancer, such as leukemia and lymphoma.\nOverall, EPCs are important for the normal functioning of the human body, but they can also contribute to the development of certain diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. eRNA-producing centers (EPCs) are responsible for the production of endogenous retroviruses (ERVs) in the human body.\n2. ERVs are a type of retrovirus that is integrated into the host genome and can be transcribed into RNA.\n3. There are several types of EPCs, including germ cells, spermatozoa, and some types of cancer cells.\n4. Germ cells are the primary site of ERV production in the human body.\n5. ERVs can be produced by cancer cells, potentially contributing to the development and progression of cancer.",
    "vicuna-7b_fact": [
      "eRNA-producing centers (EPCs) are responsible for the production of endogenous retroviruses (ERVs) in the human body.",
      "ERVs are a type of retrovirus that is integrated into the host genome and can be transcribed into RNA.",
      "There are several types of EPCs, including germ cells, spermatozoa, and some types of cancer cells.",
      "Germ cells are the primary site of ERV production in the human body.",
      "ERVs can be produced by cancer cells, potentially contributing to the development and progression of cancer."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: eRNA-producing centers (EPCs) are not responsible for the production of endogenous retroviruses (ERVs) in the human body. ERVs are relics of ancient retroviral infections that have been integrated into the genome.\n2. TRUE\n3. FALSE [correction]: There aren't several types of EPCs as such. Germ cells, spermatozoa, and some types of cancer cells can be sites of ERV expression, not EPCs.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3731,
    "user_query": "When was vivotif first licenced in Europe?",
    "vicuna-7b_response": "ViviTech's Vivotif technology was first licensed in Europe in 2019.",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. ViviTech's Vivotif technology was first licensed in Europe in 2019.",
    "vicuna-7b_fact": [
      "ViviTech's Vivotif technology was first licensed in Europe in 2019."
    ],
    "vicuna-7b_judge_raw": "UNKNOWN",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3735,
    "user_query": "Which molecules are inhibited by Gilteritinib?",
    "vicuna-7b_response": "Gilteritinib is a medication that is used to treat certain types of blood cancer, such as acute myeloid leukemia (AML) and follicular lymphoma. It works by inhibiting the activity of a protein called FLT3, which is involved in the growth and survival of cancer cells.\nGilteritinib is specifically designed to inhibit the activity of FLT3-ITD and FLT3-TKD mutations, which are common mutations found in AML and follicular lymphoma. These mutations can cause the FLT3 protein to become constitutively active and promote the proliferation and survival of cancer cells. By inhibiting the activity of FLT3, gilteritinib can help to slow down or stop the growth of cancer cells and improve the response to treatment.\nIn addition to inhibiting the activity of FLT3, gilteritinib may also inhibit the activity of other proteins involved in the growth and survival of cancer cells. However, the specific molecules that are inhibited by gilteritinib are not fully understood and continue to be the subject of ongoing research.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Gilteritinib is used to treat certain types of blood cancer, such as acute myeloid leukemia (AML) and follicular lymphoma.\n2. Gilteritinib functions by inhibiting the activity of a protein called FLT3, which is involved in the growth and survival of cancer cells.\n3. Gilteritinib is designed specifically to inhibit the activity of FLT3-ITD and FLT3-TKD mutations, which are common mutations found in AML and follicular lymphoma.\n4. FLT3 mutations can cause the FLT3 protein to become constitutively active and promote the proliferation and survival of cancer cells.\n5. Other than FLT3, gilteritinib may also inhibit the activity of other proteins involved in the growth and survival of cancer cells.",
    "vicuna-7b_fact": [
      "Gilteritinib is used to treat certain types of blood cancer, such as acute myeloid leukemia (AML) and follicular lymphoma.",
      "Gilteritinib functions by inhibiting the activity of a protein called FLT3, which is involved in the growth and survival of cancer cells.",
      "Gilteritinib is designed specifically to inhibit the activity of FLT3-ITD and FLT3-TKD mutations, which are common mutations found in AML and follicular lymphoma.",
      "FLT3 mutations can cause the FLT3 protein to become constitutively active and promote the proliferation and survival of cancer cells.",
      "Other than FLT3, gilteritinib may also inhibit the activity of other proteins involved in the growth and survival of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Gilteritinib is used to treat certain types of blood cancer, such as acute myeloid leukemia (AML). It is not indicated for follicular lymphoma.\n2. TRUE\n3. FALSE [correction]: Gilteritinib is designed specifically to inhibit the activity of FLT3-ITD and FLT3-TKD mutations, which are common mutations found in AML, not follicular lymphoma.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the Fc receptor 3B (FcR3B) gene.\nCVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections. CVID can be caused by both genetic and environmental factors. Monogenic causes of CVID are rare, but they account for about 10-15% of all cases.\nThe FcR3B gene provides instructions for making a protein called Fc receptor 3B, which is involved in the clearance of immune complexes from the blood. Mutations in the FcR3B gene can lead to reduced levels of Fc receptor 3B protein, which can result in the accumulation of immune complexes in the blood and a reduced ability to clear them. This can lead to the symptoms of CVID, including recurrent infections, low levels of immunoglobulins, and autoimmune disorders.\nThe FcR3B gene is located on chromosome 11q23.3 and is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene (one from each parent) to develop CVID caused by FcR3B mutations.\nIt is important to note that there are other genetic and environmental factors that can cause CVID, and the diagnosis of CVID should be made by a qualified healthcare professional based on a thorough clinical evaluation and laboratory testing.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the Fc receptor 3B (FcR3B) gene.\n2. CVID is characterized by reduced levels of immunoglobulins and an increased susceptibility to infections.\n3. Monogenic causes of CVID account for about 10-15% of all cases.\n4. The FcR3B gene is located on chromosome 11q23.3.\n5. CVID caused by FcR3B mutations is inherited in an autosomal recessive manner.",
    "vicuna-7b_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the Fc receptor 3B (FcR3B) gene.",
      "CVID is characterized by reduced levels of immunoglobulins and an increased susceptibility to infections.",
      "Monogenic causes of CVID account for about 10-15% of all cases.",
      "The FcR3B gene is located on chromosome 11q23.3.",
      "CVID caused by FcR3B mutations is inherited in an autosomal recessive manner."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3738,
    "user_query": "List 3 human diseases caused by  viruses in the family Paramyxoviridae.",
    "vicuna-7b_response": "1. Measles (Rubeola)\n2. Mumps\n3. Respiratory Syncytial Virus (RSV)",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Measles is caused by a virus in the family Paramyxoviridae.\n2. Mumps is caused by a virus in the family Paramyxoviridae.\n3. Respiratory Syncytial Virus is caused by a virus in the family Paramyxoviridae.",
    "vicuna-7b_fact": [
      "Measles is caused by a virus in the family Paramyxoviridae.",
      "Mumps is caused by a virus in the family Paramyxoviridae.",
      "Respiratory Syncytial Virus is caused by a virus in the family Paramyxoviridae."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3740,
    "user_query": "What is the target of a drug pidilizumab?",
    "vicuna-7b_response": "Pidilizumab is a monoclonal antibody that is used as a therapeutic agent for the treatment of certain autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. The target of pidilizumab is the CD4+ T cells, which are a type of immune cell that plays a key role in the development of autoimmune diseases.\nPidilizumab works by binding to the CD4+ T cells and blocking the interaction between these cells and the antigens that they recognize. This reduces the activation and proliferation of the CD4+ T cells, which helps to reduce the inflammation and autoimmune response in the body.\nOverall, the target of pidilizumab is to reduce the activity of the immune system and prevent or treat the symptoms of autoimmune diseases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pidilizumab is a monoclonal antibody used for the treatment of certain autoimmune diseases.\n2. Autoimmune diseases that pidilizumab can treat include rheumatoid arthritis, systemic lupus erythematosus, and vasculitis.\n3. The target of pidilizumab is the CD4+ T cells.\n4. Pidilizumab binds to CD4+ T cells and blocks the interaction with antigens.\n5. The function of pidilizumab is to reduce the activity of the immune system and treat or prevent symptoms of autoimmune diseases.",
    "vicuna-7b_fact": [
      "Pidilizumab is a monoclonal antibody used for the treatment of certain autoimmune diseases.",
      "Autoimmune diseases that pidilizumab can treat include rheumatoid arthritis, systemic lupus erythematosus, and vasculitis.",
      "The target of pidilizumab is the CD4+ T cells.",
      "Pidilizumab binds to CD4+ T cells and blocks the interaction with antigens.",
      "The function of pidilizumab is to reduce the activity of the immune system and treat or prevent symptoms of autoimmune diseases."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3742,
    "user_query": "Han Wistar and Sprague Dawley are breeds of what laboratory animal?",
    "vicuna-7b_response": "Han Wistar and Sprague Dawley are breeds of laboratory animals that are commonly used in scientific research. They are both strains of rats, and are widely used in research due to their genetic stability, ease of maintenance, and availability.\nHan Wistar rats are a strain of albino rats that were first developed in the 1920s by the Wistar Institute in Philadelphia, Pennsylvania. They are known for their docile temperament and are widely used in research for their genetic stability and ease of maintenance.\nSprague Dawley rats, on the other hand, are a strain of laboratory rats that were first developed in the 1920s by Dr. Sprague Dawley at the University of Wisconsin. They are also known for their docile temperament and are widely used in research due to their genetic stability and ease of maintenance.\nBoth Han Wistar and Sprague Dawley rats are commonly used in research in a variety of fields, including medicine, toxicology, and pharmacology. They are often used in studies to test the safety and efficacy of new drugs, as well as to study the effects of various environmental factors on human health.\nOverall, Han Wistar and Sprague Dawley rats are two of the most commonly used laboratory animals in scientific research due to their genetic stability, ease of maintenance, and availability.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Han Wistar and Sprague Dawley are breeds of laboratory rats.\n2. Han Wistar rats were first developed in the 1920s by the Wistar Institute in Philadelphia, Pennsylvania.\n3. Han Wistar rats are known for their genetic stability and ease of maintenance.\n4. Sprague Dawley rats were first developed in the 1920s by Dr. Sprague Dawley at the University of Wisconsin.\n5. Both Han Wistar and Sprague Dawley rats are commonly used in scientific research in a variety of fields including medicine, toxicology, and pharmacology.",
    "vicuna-7b_fact": [
      "Han Wistar and Sprague Dawley are breeds of laboratory rats.",
      "Han Wistar rats were first developed in the 1920s by the Wistar Institute in Philadelphia, Pennsylvania.",
      "Han Wistar rats are known for their genetic stability and ease of maintenance.",
      "Sprague Dawley rats were first developed in the 1920s by Dr. Sprague Dawley at the University of Wisconsin.",
      "Both Han Wistar and Sprague Dawley rats are commonly used in scientific research in a variety of fields including medicine, toxicology, and pharmacology."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Sprague Dawley rats were first developed in the 20th century by Dr. Sprague Dawley.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "vicuna-7b_response": "The IFIT1 gene, also known as interferon, alpha-2, is a gene that encodes for a protein called interferon-alpha-2. Interferon-alpha-2 is a type of interferon, which is a group of signaling proteins that are produced by cells in response to viral infections or other harmful stimuli.\nIn the context of Systemic Lupus Erythematosus (SLE), the role of IFIT1 gene is not well understood. However, some studies have suggested that IFIT1 gene may play a role in the development of SLE.\nOne study published in the journal Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls. Additionally, another study published in the journal Rheumatology in 2019 found that IFIT1 gene may be associated with the development of lupus nephritis, a complication of SLE that affects the kidneys.\nHowever, more research is needed to fully understand the role of IFIT1 gene in the development and progression of SLE.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The IFIT1 gene also known as interferon, alpha-2, encodes for a protein called interferon-alpha-2.\n2. Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.\n3. Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).\n4. A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.\n5. A study in the journal Rheumatology in 2019 found that the IFIT1 gene may be associated with the development of lupus nephritis, a complication of SLE that affects the kidneys.",
    "vicuna-7b_fact": [
      "The IFIT1 gene also known as interferon, alpha-2, encodes for a protein called interferon-alpha-2.",
      "Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.",
      "Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).",
      "A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.",
      "A study in the journal Rheumatology in 2019 found that the IFIT1 gene may be associated with the development of lupus nephritis, a complication of SLE that affects the kidneys."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The IFIT1 gene encodes for the Interferon Induced Protein With Tetratricopeptide Repeats 1, not interferon-alpha-2.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3744,
    "user_query": "Has tocilizumab been assessed against Covid-19?",
    "vicuna-7b_response": "Tocilizumab is a medication that is primarily used to treat autoimmune diseases such as rheumatoid arthritis and juvenile idiopathic arthritis. It is not specifically approved or studied for the treatment of Covid-19.\nHowever, there have been some studies and reports of patients with autoimmune diseases who have developed Covid-19 while taking tocilizumab. These cases suggest that tocilizumab may have some potential to prevent or reduce the severity of Covid-19 in certain patients. However, more research is needed to fully understand the relationship between tocilizumab and Covid-19.\nIt is important to note that tocilizumab is not a substitute for proven treatments for Covid-19, such as vaccines and antiviral medications. If you have been prescribed tocilizumab and develop symptoms of Covid-19, it is important to seek medical attention immediately.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tocilizumab is primarily used to treat autoimmune diseases such as rheumatoid arthritis and juvenile idiopathic arthritis.\n2. Tocilizumab has not been specifically approved or studied for the treatment of Covid-19.\n3. Some patients with autoimmune diseases who have developed Covid-19 were taking tocilizumab.\n4. Tocilizumab is not a substitute for proven treatments for Covid-19, such as vaccines and antiviral medications.\n5. If a person has been prescribed tocilizumab and develops symptoms of Covid-19, they should seek medical attention immediately.",
    "vicuna-7b_fact": [
      "Tocilizumab is primarily used to treat autoimmune diseases such as rheumatoid arthritis and juvenile idiopathic arthritis.",
      "Tocilizumab has not been specifically approved or studied for the treatment of Covid-19.",
      "Some patients with autoimmune diseases who have developed Covid-19 were taking tocilizumab.",
      "Tocilizumab is not a substitute for proven treatments for Covid-19, such as vaccines and antiviral medications.",
      "If a person has been prescribed tocilizumab and develops symptoms of Covid-19, they should seek medical attention immediately."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tocilizumab has been approved in some countries and studied for the treatment of severe Covid-19 cases.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3745,
    "user_query": "Variants in which genes cause nonsyndromic retinal degeneration?",
    "vicuna-7b_response": "Nonsyndromic retinal degeneration is a group of inherited eye disorders that affect the retina, the light-sensitive layer of tissue at the back of the eye. These disorders can be caused by mutations in many different genes. Here are some examples of genes that have been identified to cause nonsyndromic retinal degeneration:\n1. RPE65: This gene provides instructions for making an enzyme called retinoid-specific protein 65 kDa (RPE65). Mutations in the RPE65 gene have been linked to a form of retinal degeneration called Leber congenital amaurosis (LCA).\n2. CRB1: This gene provides instructions for making a protein called cryptochrome-1. Mutations in the CRB1 gene have been linked to a form of retinal degeneration called autosomal recessive retinitis pigmentosa (RP).\n3. GUCY2D: This gene provides instructions for making an enzyme called guanylate cyclase-coupled receptor 2D (GUCY2D). Mutations in the GUCY2D gene have been linked to a form of retinal degeneration called cone-rod dystrophy (CRD).\n4. NPHP6: This gene provides instructions for making a protein called nephrocystin-6. Mutations in the NPHP6 gene have been linked to a form of retinal degeneration called Joubert syndrome.\n5. USH2A: This gene provides instructions for making an enzyme called uromodulin-specific protease 2A (USH2A). Mutations in the USH2A gene have been linked to a form of retinal degeneration called Usher syndrome type 2A.\nThese are just a few examples of genes that have been linked to nonsyndromic retinal degeneration. There are many other genes that can cause this condition, and the specific gene that is responsible for a person's retinal degeneration can vary depending on the specific type of retinal degeneration they have.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nonsyndromic retinal degeneration is a group of inherited eye disorders that affect the retina.\n2. Mutations in the RPE65 gene cause a form of retinal degeneration called Leber congenital amaurosis (LCA).\n3. The CRB1 gene, when mutated, is linked to a form of retinal degeneration called autosomal recessive retinitis pigmentosa (RP).\n4. Mutations in the GUCY2D gene cause a form of retinal degeneration called cone-rod dystrophy (CRD).\n5. A form of retinal degeneration called Joubert syndrome is associated with mutations in the NPHP6 gene.",
    "vicuna-7b_fact": [
      "Nonsyndromic retinal degeneration is a group of inherited eye disorders that affect the retina.",
      "Mutations in the RPE65 gene cause a form of retinal degeneration called Leber congenital amaurosis (LCA).",
      "The CRB1 gene, when mutated, is linked to a form of retinal degeneration called autosomal recessive retinitis pigmentosa (RP).",
      "Mutations in the GUCY2D gene cause a form of retinal degeneration called cone-rod dystrophy (CRD).",
      "A form of retinal degeneration called Joubert syndrome is associated with mutations in the NPHP6 gene."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Joubert syndrome is a disorder that affects many parts of the body. Its association with retinal degeneration can be due to mutations in several different genes, not just the NPHP6 gene.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "vicuna-7b_response": "The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is a simple, reliable, and valid tool that can be used in clinical practice to assess the functional status of patients with elbow osteoarthritis.\nThe LES is based on the patient's ability to perform five tasks with their affected elbow:\n1. Flexion: The patient is asked to bend their elbow to 90 degrees.\n2. Extension: The patient is asked to straighten their elbow.\n3. Internal rotation: The patient is asked to rotate their forearm so that their little finger faces forward.\n4. External rotation: The patient is asked to rotate their forearm so that their little finger faces backward.\n5. Pronation: The patient is asked to bend and straighten their wrist.\nEach task is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function. The scores for each task are then added together to give a total LES score, which ranges from 0 to 15.\nThe LES has been shown to be a reliable and valid tool for assessing the functional status of patients with elbow osteoarthritis. It can be used to monitor the progress of patients over time and to guide treatment decisions, such as the need for surgical intervention.\nIn summary, the Liverpool Elbow Score is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is based on the patient's ability to perform five tasks with their affected elbow and provides a simple, reliable, and valid tool for assessing the functional status of patients with elbow osteoarthritis.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis.\n2. The LES is based on the patient's ability to perform five tasks with their affected elbow.\n3. Each task in the LES is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function.\n4. The total LES score ranges from 0 to 15.\n5. The LES can be used to monitor the progress of patients over time and to guide treatment decisions, such as the need for surgical intervention.",
    "vicuna-7b_fact": [
      "The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis.",
      "The LES is based on the patient's ability to perform five tasks with their affected elbow.",
      "Each task in the LES is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function.",
      "The total LES score ranges from 0 to 15.",
      "The LES can be used to monitor the progress of patients over time and to guide treatment decisions, such as the need for surgical intervention."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3755,
    "user_query": "What is the function of the zelda transcription factor in D. melanogaster?",
    "vicuna-7b_response": "The zelda transcription factor is a key regulator of cellular processes in Drosophila melanogaster. It plays a crucial role in the development of various tissues, including the nervous system, and is also involved in the regulation of stress responses.\nZelda is a DNA-binding transcription factor that regulates the expression of downstream genes involved in a variety of cellular processes, including cell growth, differentiation, and survival. In the nervous system, Zelda is required for the proper development of neurons and their synapses, and is also involved in the regulation of stress responses.\nIn addition to its role in development and stress responses, Zelda has also been implicated in the regulation of metabolism and energy homeostasis. Studies have shown that Zelda can regulate the expression of genes involved in glucose metabolism and energy production, suggesting that it may play a role in the adaptation of cells to changing energy demands.\nOverall, the function of the zelda transcription factor in Drosophila melanogaster is complex and multifaceted, and its regulation of various cellular processes is critical for the proper development and function of the organism.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The zelda transcription factor is a key regulator of cellular processes in Drosophila melanogaster.\n2. Zelda plays a crucial role in the development of various tissues, including the nervous system in Drosophila melanogaster.\n3. Zelda is a DNA-binding transcription factor that regulates the expression of downstream genes involved in cellular processes like cell growth, differentiation, survival, and stress responses.\n4. In the nervous system of Drosophila melanogaster, Zelda is required for the proper development of neurons and their synapses.\n5. Zelda has been implicated in the regulation of metabolism and energy homeostasis in Drosophila melanogaster.",
    "vicuna-7b_fact": [
      "The zelda transcription factor is a key regulator of cellular processes in Drosophila melanogaster.",
      "Zelda plays a crucial role in the development of various tissues, including the nervous system in Drosophila melanogaster.",
      "Zelda is a DNA-binding transcription factor that regulates the expression of downstream genes involved in cellular processes like cell growth, differentiation, survival, and stress responses.",
      "In the nervous system of Drosophila melanogaster, Zelda is required for the proper development of neurons and their synapses.",
      "Zelda has been implicated in the regulation of metabolism and energy homeostasis in Drosophila melanogaster."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3757,
    "user_query": "Which conditions are manifested by TRIM8 mutations?",
    "vicuna-7b_response": "TRIM8 is a protein that is involved in the regulation of RNA splicing. Mutations in the TRIM8 gene can lead to a variety of conditions, including:\n1. Spinal muscular atrophy (SMA): TRIM8 mutations have been identified as a cause of SMA, which is a genetic disorder that affects the nervous system and results in muscle weakness and wasting.\n2. Charcot-Marie-Tooth disease (CMT): TRIM8 mutations have also been linked to CMT, which is a group of inherited nerve disorders that can cause weakness, muscle wasting, and sensory problems.\n3. Cancer: TRIM8 mutations have been found in some types of cancer, including breast cancer and colorectal cancer. These mutations can affect the regulation of gene expression and contribute to the development and progression of cancer.\n4. Other conditions: TRIM8 mutations have also been associated with other conditions, including intellectual disability, autism, and autoimmune disorders.\nOverall, TRIM8 mutations can lead to a wide range of conditions, depending on the specific mutation and the individual affected.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. TRIM8 is a protein that is involved in the regulation of RNA splicing.\n2. Mutations in the TRIM8 gene have been identified as a cause of Spinal muscular atrophy (SMA).\n3. TRIM8 mutations have been linked to Charcot-Marie-Tooth disease (CMT).\n4. Some types of cancer, including breast cancer and colorectal cancer, have been found to have TRIM8 mutations.\n5. TRIM8 mutations have been associated with conditions including intellectual disability, autism, and autoimmune disorders.",
    "vicuna-7b_fact": [
      "TRIM8 is a protein that is involved in the regulation of RNA splicing.",
      "Mutations in the TRIM8 gene have been identified as a cause of Spinal muscular atrophy (SMA).",
      "TRIM8 mutations have been linked to Charcot-Marie-Tooth disease (CMT).",
      "Some types of cancer, including breast cancer and colorectal cancer, have been found to have TRIM8 mutations.",
      "TRIM8 mutations have been associated with conditions including intellectual disability, autism, and autoimmune disorders."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the SMN1 and SMN2 genes, not TRIM8, are a cause of Spinal muscular atrophy (SMA).\n3. UNKNOWN \n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3758,
    "user_query": "What is LY-CoV555?",
    "vicuna-7b_response": "LY-CoV555 is a variant of the SARS-CoV-2 virus that was first detected in the city of Lyon, France in December 2020. It is a highly pathogenic strain of the virus that has been associated with severe illness and death, particularly in older adults and those with underlying health conditions.\nLY-CoV555 is considered to be a \"drifted\" variant, meaning that it has undergone genetic changes that have allowed it to evade the body's immune system and persist in the body for longer periods of time. These changes can make it more difficult to diagnose and treat, and can also contribute to the spread of the virus.\nLY-CoV555 has been detected in a number of countries around the world, and has been associated with outbreaks of COVID-19 in various settings, including hospitals, long-term care facilities, and the community at large.\nIt is important for individuals to be aware of the signs and symptoms of COVID-19 and to seek medical attention if they suspect they may have been exposed to the virus. Healthcare workers and those in close contact with high-risk individuals should also be vigilant in monitoring their health and seeking medical attention if they develop symptoms.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. LY-CoV555 is a variant of the SARS-CoV-2 virus.\n2. The virus was first detected in Lyon, France in December 2020.\n3. LY-CoV555 has been associated with severe illness and death, particularly in older adults and those with underlying health conditions.\n4. It is a \"drifted\" variant, meaning that it has undergone genetic changes that have allowed it to evade the body's immune system.\n5. LY-CoV555 has been detected in a number of countries around the world.",
    "vicuna-7b_fact": [
      "LY-CoV555 is a variant of the SARS-CoV-2 virus.",
      "The virus was first detected in Lyon, France in December 2020.",
      "LY-CoV555 has been associated with severe illness and death, particularly in older adults and those with underlying health conditions.",
      "It is a \"drifted\" variant, meaning that it has undergone genetic changes that have allowed it to evade the body's immune system.",
      "LY-CoV555 has been detected in a number of countries around the world."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: LY-CoV555 is not a variant of the SARS-CoV-2 virus, but a monoclonal antibody treatment for COVID-19 developed by Eli Lilly.\n2. FALSE [correction]: LY-CoV555 is not a virus, but a treatment for COVID-19, and was not first detected in Lyon, France in December 2020. \n3. FALSE [correction]: LY-CoV555 is not a virus and therefore has not been associated with severe illness and death. However, it has been used in the treatment of COVID-19, which can cause severe illness or death.\n4. FALSE [correction]: LY-CoV555 is not a \"drifted\" variant of a virus. It is a monoclonal antibody treatment for COVID-19.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3760,
    "user_query": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "vicuna-7b_response": "Yes, bacteria in the genus Clostridium are facultative anaerobes. This means that they can grow in the presence or absence of oxygen. Clostridium bacteria are known for their ability to produce spores, which can survive in a dormant state for long periods of time, and can cause a variety of diseases in humans and animals, including tetanus, botulism, and gas gangrene. Some species of Clostridium are also used in industrial applications, such as the production of enzymes and antibiotics.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Bacteria in the genus Clostridium are facultative anaerobes.\n2. Facultative anaerobes can grow in the presence or absence of oxygen.\n3. Clostridium bacteria can produce spores, which can survive in a dormant state for long periods.\n4. Clostridium bacteria can cause diseases in humans and animals, including tetanus, botulism, and gas gangrene.\n5. Some species of Clostridium are used in industrial applications, including the production of enzymes and antibiotics.",
    "vicuna-7b_fact": [
      "Bacteria in the genus Clostridium are facultative anaerobes.",
      "Facultative anaerobes can grow in the presence or absence of oxygen.",
      "Clostridium bacteria can produce spores, which can survive in a dormant state for long periods.",
      "Clostridium bacteria can cause diseases in humans and animals, including tetanus, botulism, and gas gangrene.",
      "Some species of Clostridium are used in industrial applications, including the production of enzymes and antibiotics."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Bacteria in the genus Clostridium are obligate anaerobes.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "vicuna-7b_response": "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases. The project was launched in 2012 and is expected to be completed by 2021.\nIn terms of sarcoma, the 100,000 Genomes Project has made significant efforts to sequence sarcoma patients' genomes. The project has identified several genetic mutations that are specific to sarcoma, including those that are associated with poor prognosis.\nOne of the key findings from the 100,000 Genomes Project is that sarcoma is a highly genetically diverse disease, with many different genetic mutations present in different patients. This diversity makes it difficult to develop targeted therapies for sarcoma, but it also presents an opportunity to identify new therapeutic targets.\nThe 100,000 Genomes Project has also identified several genetic subtypes of sarcoma, each with its own unique set of genetic mutations. This has allowed researchers to develop more personalized treatment plans for patients based on their specific genetic profile.\nOverall, the 100,000 Genomes Project has made significant progress in understanding the genetic basis of sarcoma and has paved the way for the development of new and more effective treatments for this disease.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The 100,000 Genomes Project is a UK-based initiative.\n2. The aim of the 100,000 Genomes Project is to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.\n3. The 100,000 Genomes Project was launched in 2012 and is expected to be completed by 2021.\n4. The 100,000 Genomes Project has identified several genetic mutations that are specific to sarcoma.\n5. The 100,000 Genomes Project has identified several genetic subtypes of sarcoma.",
    "vicuna-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative.",
      "The aim of the 100,000 Genomes Project is to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.",
      "The 100,000 Genomes Project was launched in 2012 and is expected to be completed by 2021.",
      "The 100,000 Genomes Project has identified several genetic mutations that are specific to sarcoma.",
      "The 100,000 Genomes Project has identified several genetic subtypes of sarcoma."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3770,
    "user_query": "Describe the mechanism of action of pitolisant.",
    "vicuna-7b_response": "Pitolisant is a medication that is used to treat narcolepsy, a neurological disorder that affects the regulation of sleep-wake cycles. It works by increasing the levels of a chemical called orexin in the brain. Orexin is also known as hypocretin and is produced by neurons in the hypothalamus.\nOrexin plays an important role in regulating wakefulness and arousal, and it is deficient in narcolepsy. Pitolisant mimics the action of orexin and helps to restore normal levels of wakefulness and reduce excessive daytime sleepiness.\nThe medication is taken orally and is available in the form of a tablet. It is usually taken once daily in the evening, and the dosage may be adjusted based on the individual's response to the medication.\nIt is important to note that pitolisant should only be used under the supervision of a healthcare professional, as it can cause side effects such as dizziness, drowsiness, and nausea. It is also contraindicated in certain medical conditions, such as liver disease, and pregnancy.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pitolisant is a medication used to treat narcolepsy.\n2. Pitolisant works by increasing the levels of a chemical called orexin in the brain.\n3. Orexin regulates wakefulness and arousal and is deficient in people with narcolepsy.\n4. Pitolisant is taken orally and is usually taken once daily in the evening.\n5. Pitolisant can cause side effects such as dizziness, drowsiness, and nausea, and is contraindicated in certain conditions, such as liver disease and pregnancy.",
    "vicuna-7b_fact": [
      "Pitolisant is a medication used to treat narcolepsy.",
      "Pitolisant works by increasing the levels of a chemical called orexin in the brain.",
      "Orexin regulates wakefulness and arousal and is deficient in people with narcolepsy.",
      "Pitolisant is taken orally and is usually taken once daily in the evening.",
      "Pitolisant can cause side effects such as dizziness, drowsiness, and nausea, and is contraindicated in certain conditions, such as liver disease and pregnancy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Pitolisant works by blocking the histamine H3 receptor in the brain, thereby increasing the levels of histamine, not orexin.\n3. TRUE\n4. FALSE [correction]: Pitolisant is usually taken orally once daily in the morning, not in the evening.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3773,
    "user_query": "Do circular exons increase gene expression?",
    "vicuna-7b_response": "Circular exons are a type of non-canonical exon that can be found in some eukaryotic genes. These exons are formed when a gene is circularized, meaning that the gene is repeated in a circular form rather than in a linear form.\nThe effect of circular exons on gene expression can vary depending on the specific gene and the context in which it is found. In some cases, circular exons may not have any effect on gene expression, while in other cases they may increase or decrease gene expression.\nOne study found that circular exons can increase gene expression in some cases. For example, in a study of the mouse gene Slc22a1, it was found that circular exons increased the expression of the gene in certain cell types. However, it is important to note that this was a specific case and the effect of circular exons on gene expression can vary widely.\nIn general, the effect of circular exons on gene expression is not well understood and more research is needed to fully understand this phenomenon. However, it is clear that circular exons can have a significant impact on gene expression and can play a role in regulating gene expression in some cases.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Circular exons are a type of non-canonical exon found in some eukaryotic genes.\n2. Circular exons are formed when a gene is circularized.\n3. The effect of circular exons on gene expression can vary depending on the specific gene and the context.\n4. One study found that circular exons can increase gene expression in some cases, such as the mouse gene Slc22a1 in certain cell types.\n5. The effect of circular exons on gene expression is not well understood and requires more research.",
    "vicuna-7b_fact": [
      "Circular exons are a type of non-canonical exon found in some eukaryotic genes.",
      "Circular exons are formed when a gene is circularized.",
      "The effect of circular exons on gene expression can vary depending on the specific gene and the context.",
      "One study found that circular exons can increase gene expression in some cases, such as the mouse gene Slc22a1 in certain cell types.",
      "The effect of circular exons on gene expression is not well understood and requires more research."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "vicuna-7b_response": "Protein ALEX1 is a protein that is involved in various cellular processes, including DNA repair, transcriptional regulation, and cell cycle progression. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nArmadillo repeats are a type of protein domain that is composed of a series of repeating units of approximately 60 amino acids. They are named after the armadillo, which has a similar structure. Armadillo repeats are found in a variety of proteins, including some that are involved in cellular processes such as DNA repair and transcriptional regulation. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nIf you have any additional information about protein ALEX1, such as its amino acid sequence or the experimental techniques used to study it, I may be able to provide more information.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.\n2. Armadillo repeats are a type of protein domain that is composed of a series of repeating units of approximately 60 amino acids.\n3. Armadillo repeats get their name from the armadillo, which has a similar structure.\n4. Armadillo repeats are found in a variety of proteins.\n5. Some proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation.",
    "vicuna-7b_fact": [
      "Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.",
      "Armadillo repeats are a type of protein domain that is composed of a series of repeating units of approximately 60 amino acids.",
      "Armadillo repeats get their name from the armadillo, which has a similar structure.",
      "Armadillo repeats are found in a variety of proteins.",
      "Some proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Armadillo repeats are named so because of the multilayered, or \"armadillo-like\", structure of these proteins, not because they are similar to the structure of the armadillo animal.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3782,
    "user_query": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "vicuna-7b_response": "Radiotherapy for cervical cancer can increase the risk of developing colon cancer. This is because radiotherapy can damage the cells in the colon and increase the risk of mutations that can lead to the development of cancer.\nStudies have shown that women who have received radiotherapy for cervical cancer have a higher risk of developing colon cancer compared to the general population. This risk appears to increase with the dose and duration of radiotherapy.\nIt is important to note that the risk of colon cancer after radiotherapy for cervical cancer is still relatively low, and the majority of women do not go on to develop colon cancer. However, it is important for women who have received radiotherapy for cervical cancer to be screened for colon cancer regularly, as they are at increased risk.\nAdditionally, it is important to maintain a healthy lifestyle, including a balanced diet, regular exercise, and not smoking, as these can all help to reduce the risk of developing colon cancer.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Radiotherapy for cervical cancer can increase the risk of colon cancer.\n2. Radiotherapy can potentially damage cells in the colon and lead to the development of cancer.\n3. Some studies suggest women who have received radiotherapy for cervical cancer have a higher risk of developing colon cancer compared to the general population.\n4. The risk of colon cancer after radiotherapy for cervical cancer is still relatively low.\n5. Lifestyle choices such as a balanced diet, regular exercise, and not smoking can help reduce the risk of developing colon cancer.",
    "vicuna-7b_fact": [
      "Radiotherapy for cervical cancer can increase the risk of colon cancer.",
      "Radiotherapy can potentially damage cells in the colon and lead to the development of cancer.",
      "Some studies suggest women who have received radiotherapy for cervical cancer have a higher risk of developing colon cancer compared to the general population.",
      "The risk of colon cancer after radiotherapy for cervical cancer is still relatively low.",
      "Lifestyle choices such as a balanced diet, regular exercise, and not smoking can help reduce the risk of developing colon cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3785,
    "user_query": "Is yeast fbp1 affected by glucose starvation stress?",
    "vicuna-7b_response": "Yes, glucose starvation stress can affect the Fbp1 gene in yeast. Fbp1, also known as Fructose-1,6-bisphosphate aldolase, is an enzyme that catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. This enzyme is involved in the glycolytic pathway, which is responsible for generating energy in the form of ATP from glucose.\nGlucose starvation stress occurs when the concentration of glucose in the environment is low, and the yeast cells are unable to obtain sufficient glucose for energy production. In response to this stress, the yeast cells activate various stress response pathways, including the Hog1 pathway, which is involved in regulating cellular responses to various stresses, including osmotic stress, heat stress, and oxidative stress.\nStudies have shown that glucose starvation stress can affect the expression of the Fbp1 gene in yeast. Specifically, glucose starvation can lead to a decrease in the expression of the Fbp1 gene, which can result in a decrease in the activity of the Fbp1 enzyme. This decrease in Fbp1 activity can lead to a buildup of fructose-1,6-bisphosphate, which can inhibit the glycolytic pathway and reduce the energy production of the yeast cells.\nIn summary, glucose starvation stress can affect the Fbp1 gene in yeast by decreasing its expression and activity, which can lead to a decrease in energy production and a buildup of fructose-1,6-bisphosphate.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fbp1, or Fructose-1,6-bisphosphate aldolase, is an enzyme that catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate in yeast.\n2. This enzyme is involved in the glycolytic pathway, which generates energy in the form of ATP from glucose.\n3. Glucose starvation, when the concentration of glucose in the environment is low, can lead to the yeast cells' inability to obtain sufficient glucose for energy production.\n4. Glucose starvation stress can lead to a decrease in the expression of the Fbp1 gene in yeast and thus a decrease in the activity of the Fbp1 enzyme.\n5. The decrease in Fbp1 activity can cause a buildup of fructose-1,6-bisphosphate, inhibiting the glycolytic pathway and reducing the yeast cells' energy production.",
    "vicuna-7b_fact": [
      "Fbp1, or Fructose-1,6-bisphosphate aldolase, is an enzyme that catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate in yeast.",
      "This enzyme is involved in the glycolytic pathway, which generates energy in the form of ATP from glucose.",
      "Glucose starvation, when the concentration of glucose in the environment is low, can lead to the yeast cells' inability to obtain sufficient glucose for energy production.",
      "Glucose starvation stress can lead to a decrease in the expression of the Fbp1 gene in yeast and thus a decrease in the activity of the Fbp1 enzyme.",
      "The decrease in Fbp1 activity can cause a buildup of fructose-1,6-bisphosphate, inhibiting the glycolytic pathway and reducing the yeast cells' energy production."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Glucose starvation stress can lead to an increase in the expression of the Fbp1 gene in yeast, thus an increase in the activity of the Fbp1 enzyme. \n5. FALSE [correction]: The increase in Fbp1 activity splits fructose-1,6-bisphosphate into two three-carbon sugars, glyceraldehyde 3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP), helping the glycolytic pathway to continue and ensuring the yeast cells' energy production.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3786,
    "user_query": "What does csDMARD stand for?",
    "vicuna-7b_response": "csDMARD stands for \"cumulative standard deviation of the modified Ashman score.\"",
    "vicuna-7b_fact_raw": "The factual statement is:\n1. csDMARD stands for \"cumulative standard deviation of the modified Ashman score.\"",
    "vicuna-7b_fact": [
      "csDMARD stands for \"cumulative standard deviation of the modified Ashman score.\""
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: csDMARD stands for \"conventional synthetic Disease-Modifying Anti-Rheumatic Drug.\"",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3788,
    "user_query": "Is Semagacestat effective for Alzheimer's Disease?",
    "vicuna-7b_response": "Semagacestat is a drug that has been studied for its potential to treat Alzheimer's disease. It is a selective modulator of amyloid beta (Aβ) peptide clearance, which means that it is designed to help remove the harmful Aβ protein that accumulates in the brains of people with Alzheimer's disease.\nSeveral clinical trials have been conducted to evaluate the effectiveness of semagacestat for the treatment of Alzheimer's disease. The results of these trials have been mixed, with some studies showing that the drug may be effective in slowing the progression of the disease, while others have not found a significant benefit.\nIt is important to note that the development of semagacestat as a treatment for Alzheimer's disease is ongoing, and more research is needed to fully understand its potential benefits and risks. While semagacestat may show promise as a treatment for Alzheimer's disease, it is not yet approved by regulatory authorities for this use.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Semagacestat is a drug that has been studied for its potential to treat Alzheimer's disease.\n2. Semagacestat is a selective modulator of amyloid beta (Aβ) peptide clearance.\n3. Several clinical trials have been conducted to evaluate the effectiveness of semagacestat for the treatment of Alzheimer's disease.\n4. The results of these trials have been mixed, with some studies showing that the drug may be effective in slowing the progression of the disease, while others have not found a significant benefit.\n5. Semagacestat is not yet approved by regulatory authorities for the treatment of Alzheimer's disease.",
    "vicuna-7b_fact": [
      "Semagacestat is a drug that has been studied for its potential to treat Alzheimer's disease.",
      "Semagacestat is a selective modulator of amyloid beta (Aβ) peptide clearance.",
      "Several clinical trials have been conducted to evaluate the effectiveness of semagacestat for the treatment of Alzheimer's disease.",
      "The results of these trials have been mixed, with some studies showing that the drug may be effective in slowing the progression of the disease, while others have not found a significant benefit.",
      "Semagacestat is not yet approved by regulatory authorities for the treatment of Alzheimer's disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Semagacestat is a gamma-secretase inhibitor, and it has been studied for its potential to decrease the production of amyloid beta (Aβ) peptides.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "vicuna-7b_response": "There are several enzymes that remove histone modifications from chromatin. Here are some examples:\n1. Histone deacetylases (HDACs): HDACs remove acetyl groups from histone tails, leading to a more compact chromatin structure. Some examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n2. Histone demethylases: Histone demethylases remove methyl groups from histone tails, leading to a more open chromatin structure. Some examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n3. Histone methyltransferases: Histone methyltransferases add methyl groups to histone tails, leading to a more compact chromatin structure. Some examples of histone methyltransferases include SETDB1, SET7, and KMT2A (also known as MLL).\n4. Chromatin remodeling complexes: Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications by altering the structure of chromatin.\nOverall, the removal of histone modifications by enzymes is an important process in regulating chromatin structure and gene expression.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Histone deacetylases (HDACs) remove acetyl groups from histone tails, leading to a more compact chromatin structure.\n2. Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n3. Histone demethylases remove methyl groups from histone tails, leading to a more open chromatin structure.\n4. Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n5. Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications by altering the structure of chromatin.",
    "vicuna-7b_fact": [
      "Histone deacetylases (HDACs) remove acetyl groups from histone tails, leading to a more compact chromatin structure.",
      "Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.",
      "Histone demethylases remove methyl groups from histone tails, leading to a more open chromatin structure.",
      "Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.",
      "Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications by altering the structure of chromatin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, alter the structure of chromatin which can impact histone modifications, but they do not directly remove histone modifications.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3790,
    "user_query": "Roughly how many base pairs are in the human mitochondrial genome or mtDNA?",
    "vicuna-7b_response": "The human mitochondrial genome, also known as mtDNA, contains around 16,569 base pairs. This is the DNA sequence that is found in the mitochondria of cells, which are organelles responsible for generating energy for the cell. Mitochondria have their own DNA separate from the nuclear DNA in the cell nucleus.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The human mitochondrial genome contains around 16,569 base pairs.\n2. mtDNA is the DNA sequence found in the mitochondria of cells.\n3. Mitochondria are organelles responsible for generating energy for the cell.\n4. Mitochondria have their own DNA separate from the nuclear DNA in the cell nucleus.",
    "vicuna-7b_fact": [
      "The human mitochondrial genome contains around 16,569 base pairs.",
      "mtDNA is the DNA sequence found in the mitochondria of cells.",
      "Mitochondria are organelles responsible for generating energy for the cell.",
      "Mitochondria have their own DNA separate from the nuclear DNA in the cell nucleus."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3791,
    "user_query": "Do nematodes contain a CTCF gene?",
    "vicuna-7b_response": "Yes, nematodes, including the species Caenorhabditis elegans and Pristionchus pacificus, do contain a CTCF gene.\nCTCF (CCCTC-binding factor) is a transcriptional regulator that plays a crucial role in the regulation of gene expression during development and in response to environmental cues. CTCF is found in many organisms, including nematodes, and is involved in the formation of chromatin structures, such as insulators and enhancer-promoter interactions.\nIn nematodes, CTCF has been shown to play a role in the regulation of gene expression during development, as well as in response to environmental stimuli. For example, in C. elegans, CTCF has been shown to be involved in the regulation of the insulin/IGF-1 signaling pathway, which is important for the development and survival of the animal. Additionally, CTCF has been shown to be involved in the regulation of stress response genes in P. pacificus.\nOverall, CTCF is an important gene in nematodes, and its function has been studied extensively in both C. elegans and P. pacificus.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Nematodes, including the species Caenorhabditis elegans and Pristionchus pacificus, contain a CTCF gene.\n2. CCCTC-binding factor (CTCF) is a transcriptional regulator.\n3. CTCF plays a role in the regulation of gene expression during development and in response to environmental cues.\n4. In the nematode species C. elegans, CTCF is involved in the regulation of the insulin/IGF-1 signaling pathway.\n5. CTCF is involved in the regulation of stress response genes in P. pacificus.",
    "vicuna-7b_fact": [
      "Nematodes, including the species Caenorhabditis elegans and Pristionchus pacificus, contain a CTCF gene.",
      "CCCTC-binding factor (CTCF) is a transcriptional regulator.",
      "CTCF plays a role in the regulation of gene expression during development and in response to environmental cues.",
      "In the nematode species C. elegans, CTCF is involved in the regulation of the insulin/IGF-1 signaling pathway.",
      "CTCF is involved in the regulation of stress response genes in P. pacificus."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Nematodes, including the species Caenorhabditis elegans and Pristionchus pacificus, do not contain a CTCF gene. It is observed primarily in mammals.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the nematode species C. elegans, DAF-16/FOXO, not CTCF, regulates the insulin/IGF-1 signaling pathway.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3796,
    "user_query": "What does Retapamulin treat?",
    "vicuna-7b_response": "Retapamulin is an antibiotic medication that is used to treat a variety of bacterial infections, including skin infections such as impetigo and cutaneous bacterial infections, respiratory tract infections such as community-acquired pneumonia, and urinary tract infections. It works by inhibiting the synthesis of bacterial cell wall, thereby preventing the growth and reproduction of bacteria. Retapamulin is a topical antibiotic, which means it is applied to the skin or mucous membranes to treat infections. It is usually applied twice daily, and the treatment course may vary depending on the type and severity of the infection. It is important to follow the instructions provided by your healthcare provider and complete the full course of treatment to ensure the best possible outcome.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Retapamulin is an antibiotic medication.\n2. Retapamulin is used to treat bacterial infections including skin infections like impetigo and cutaneous bacterial infections.\n3. It is also used in treating respiratory tract infections such as community-acquired pneumonia, and urinary tract infections.\n4. Retapamulin works by inhibiting the synthesis of the bacterial cell wall, which prevents the growth and reproduction of bacteria.\n5. Retapamulin is a topical antibiotic, which means it is applied to the skin or mucous membranes to treat infections.",
    "vicuna-7b_fact": [
      "Retapamulin is an antibiotic medication.",
      "Retapamulin is used to treat bacterial infections including skin infections like impetigo and cutaneous bacterial infections.",
      "It is also used in treating respiratory tract infections such as community-acquired pneumonia, and urinary tract infections.",
      "Retapamulin works by inhibiting the synthesis of the bacterial cell wall, which prevents the growth and reproduction of bacteria.",
      "Retapamulin is a topical antibiotic, which means it is applied to the skin or mucous membranes to treat infections."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Retapamulin is not used to treat respiratory tract infections such as community-acquired pneumonia, and urinary tract infections.\n4. FALSE [correction]: Retapamulin works by inhibiting the synthesis of bacterial protein, not the bacterial cell wall.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3797,
    "user_query": "Which histone mark distinguishes active from inactive enhancers?",
    "vicuna-7b_response": "The histone mark that distinguishes active from inactive enhancers is the acetylation of histone H3 lysine 27 (H3K27ac).\nEnhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes. Active enhancers are regions of the genome that are actively being transcribed into RNA, while inactive enhancers are regions that are not being transcribed.\nAcetylation of H3K27 is a mark that is associated with active enhancers. This mark is added by enzymes such as p300 and CBP, which are histone acetyltransferases (HATs). The addition of H3K27ac to the DNA surrounding an enhancer promoter allows for the recruitment of transcriptional machinery, including RNA polymerase II, which is necessary for the initiation of transcription.\nIn contrast, the methylation of H3K27, particularly H3K27me1 and H3K27me2, is associated with inactive enhancers. These marks are added by enzymes such as SETDB1 and KDM6A, which are histone demethylases (HDACs). The removal of H3K27me1 and H3K27me2 from the DNA surrounding an enhancer promoter prevents the recruitment of transcriptional machinery and inhibits transcription.\nOverall, the acetylation of H3K27 is a key histone mark that distinguishes active from inactive enhancers, and it plays a crucial role in regulating the expression of genes.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The acetylation of histone H3 lysine 27 (H3K27ac) is the histone mark that distinguishes active from inactive enhancers.\n2. Enhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes.\n3. Active enhancers are regions of the genome that are actively being transcribed into RNA.\n4. Inactive enhancers are regions of the genome that are not being transcribed into RNA.\n5. The enzymes p300 and CBP, which are histone acetyltransferases (HATs), add the mark of H3K27ac to the DNA surrounding an enhancer promoter, facilitating the recruitment of transcription machinery and initiation of transcription.",
    "vicuna-7b_fact": [
      "The acetylation of histone H3 lysine 27 (H3K27ac) is the histone mark that distinguishes active from inactive enhancers.",
      "Enhancers are regions of DNA that act as binding sites for transcription factors, which regulate the expression of genes.",
      "Active enhancers are regions of the genome that are actively being transcribed into RNA.",
      "Inactive enhancers are regions of the genome that are not being transcribed into RNA.",
      "The enzymes p300 and CBP, which are histone acetyltransferases (HATs), add the mark of H3K27ac to the DNA surrounding an enhancer promoter, facilitating the recruitment of transcription machinery and initiation of transcription."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Active enhancers are regions of the genome that are actively facilitating the transcription of their target genes.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3800,
    "user_query": "What is targeted by Pexidartinib?",
    "vicuna-7b_response": "Pexidartinib is a drug that is being developed to treat a rare genetic disorder called focal segmental glomerulosclerosis (FSGS). FSGS is a type of kidney disease that causes scarring in the kidneys and can lead to kidney failure if left untreated.\nPexidartinib works by inhibiting the activity of a protein called TGF-beta, which is thought to play a role in the development of FSGS. By inhibiting TGF-beta, pexidartinib may help to slow the progression of kidney disease and potentially even reverse the damage caused by FSGS.\nIn clinical trials, pexidartinib has shown promise in reducing proteinuria (protein in the urine) and improving kidney function in patients with FSGS. However, more research is needed to fully understand the potential benefits and risks of this drug.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Pexidartinib is being developed to treat a genetic disorder called focal segmental glomerulosclerosis (FSGS).\n2. FSGS is a type of kidney disease that causes scarring in the kidneys.\n3. Pexidartinib works by inhibiting the activity of a protein called TGF-beta.\n4. In clinical trials, pexidartinib has shown potential in reducing proteinuria and improving kidney function in patients with FSGS.\n5. FSGS can potentially lead to kidney failure if left untreated.",
    "vicuna-7b_fact": [
      "Pexidartinib is being developed to treat a genetic disorder called focal segmental glomerulosclerosis (FSGS).",
      "FSGS is a type of kidney disease that causes scarring in the kidneys.",
      "Pexidartinib works by inhibiting the activity of a protein called TGF-beta.",
      "In clinical trials, pexidartinib has shown potential in reducing proteinuria and improving kidney function in patients with FSGS.",
      "FSGS can potentially lead to kidney failure if left untreated."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Pexidartinib works by inhibiting the activity of a protein called colony-stimulating factor 1 (CSF1).\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "vicuna-7b_response": "Head CT scans are a type of medical imaging test that uses X-rays to create detailed images of the brain and surrounding structures. While head CT scans are generally considered safe, they do have some risks associated with them.\nOne potential risk of head CT scans is the possibility of developing a brain tumor as a result of exposure to radiation. However, the risk of developing a brain tumor from a head CT scan is relatively low, and the benefits of the test typically outweigh the risks in most cases.\nThe risk of developing a brain tumor from a head CT scan is generally considered to be low, especially when compared to the risks associated with other medical procedures. However, the risk increases with the number of CT scans a person has undergone, and with the use of other radiation-based medical procedures.\nIt is important to note that head CT scans are typically only recommended when medically necessary, and that other diagnostic tests may be used in some cases to diagnose and treat brain conditions. If you are concerned about the risks associated with head CT scans, it is important to discuss your concerns with your healthcare provider. They can help you determine the best course of action for your individual situation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Head CT scans use X-rays to create detailed images of the brain and surrounding structures.\n2. A potential risk of head CT scans is developing a brain tumor due to radiation exposure.\n3. The risk of developing a brain tumor from a head CT scan is generally low.\n4. The risk increases with the number of CT scans a person has undergone and with the use of other radiation-based medical procedures.\n5. Head CT scans are typically only recommended when medically necessary.",
    "vicuna-7b_fact": [
      "Head CT scans use X-rays to create detailed images of the brain and surrounding structures.",
      "A potential risk of head CT scans is developing a brain tumor due to radiation exposure.",
      "The risk of developing a brain tumor from a head CT scan is generally low.",
      "The risk increases with the number of CT scans a person has undergone and with the use of other radiation-based medical procedures.",
      "Head CT scans are typically only recommended when medically necessary."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3807,
    "user_query": "Which main viral protein is targeted by the drug remdesivir?",
    "vicuna-7b_response": "The main viral protein targeted by the drug remdesivir is the viral RNA polymerase.\nRemdesivir is a direct-acting antiviral drug that inhibits the replication of the SARS-CoV-2 virus, the causative agent of the COVID-19 disease. It specifically targets the viral RNA polymerase, which is responsible for synthesizing new viral RNA from the genetic material of the virus. By inhibiting the activity of the RNA polymerase, remdesivir prevents the virus from producing new copies of itself, thereby reducing the spread of the infection.\nIn addition to targeting the RNA polymerase, remdesivir has also been shown to have some effect on other viral proteins, such as the helicase and nucleoside triphosphate hydrolase. However, its primary mechanism of action is inhibiting the activity of the RNA polymerase, which is essential for the replication of the SARS-CoV-2 virus.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The main viral protein targeted by the drug remdesivir is the viral RNA polymerase.\n2. Remdesivir is an antiviral drug that inhibits the replication of the SARS-CoV-2 virus.\n3. Remdesivir targets the viral RNA polymerase, which is responsible for synthesizing new viral RNA from the genetic material of the virus.\n4. By inhibiting the activity of the RNA polymerase, remdesivir prevents the virus from producing new copies of itself.\n5. Remdesivir has also been shown to have some effect on other viral proteins, such as the helicase and nucleoside triphosphate hydrolase.",
    "vicuna-7b_fact": [
      "The main viral protein targeted by the drug remdesivir is the viral RNA polymerase.",
      "Remdesivir is an antiviral drug that inhibits the replication of the SARS-CoV-2 virus.",
      "Remdesivir targets the viral RNA polymerase, which is responsible for synthesizing new viral RNA from the genetic material of the virus.",
      "By inhibiting the activity of the RNA polymerase, remdesivir prevents the virus from producing new copies of itself.",
      "Remdesivir has also been shown to have some effect on other viral proteins, such as the helicase and nucleoside triphosphate hydrolase."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "vicuna-7b_response": "Otx2 is associated with the pluripotent state of embryonic stem cells. Otx2 is a transcription factor that plays a crucial role in the regulation of embryonic stem cell self-renewal and differentiation. It has been shown to be essential for the maintenance of pluripotency in embryonic stem cells and for the generation of differentiated cell types. Otx2 is also involved in the regulation of gene expression in the developing nervous system, and it has been shown to be expressed in a variety of cell types, including neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Otx2 is associated with the pluripotent state of embryonic stem cells.\n2. Otx2 is a transcription factor that plays a role in the regulation of embryonic stem cell self-renewal and differentiation.\n3. Otx2 is essential for the maintenance of pluripotency in embryonic stem cells and for the generation of differentiated cell types.\n4. Otx2 is involved in the regulation of gene expression in the developing nervous system.\n5. Otx2 is expressed in a variety of cell types, including neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact": [
      "Otx2 is associated with the pluripotent state of embryonic stem cells.",
      "Otx2 is a transcription factor that plays a role in the regulation of embryonic stem cell self-renewal and differentiation.",
      "Otx2 is essential for the maintenance of pluripotency in embryonic stem cells and for the generation of differentiated cell types.",
      "Otx2 is involved in the regulation of gene expression in the developing nervous system.",
      "Otx2 is expressed in a variety of cell types, including neural stem cells, germ cells, and cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3813,
    "user_query": "Is aggrephagy a variant of autophagy?",
    "vicuna-7b_response": "Aggrephagy is not a variant of autophagy. Autophagy is a process by which cells break down and recycle their own damaged or unnecessary organelles and proteins. Aggrephagy, on the other hand, is a process by which cells engulf and digest large, external particles such as bacteria or dead cells. While both processes involve the uptake and degradation of material within the cell, they are distinct and serve different functions.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process by which cells break down and recycle their own damaged or unnecessary organelles and proteins.\n2. Aggrephagy is a process by which cells engulf and digest large, external particles such as bacteria or dead cells.\n3. Aggrephagy is not a variant of autophagy.\n4. Both autophagy and aggrephagy involve the uptake and degradation of material within the cell.\n5. Autophagy and aggrephagy serve different functions.",
    "vicuna-7b_fact": [
      "Autophagy is a process by which cells break down and recycle their own damaged or unnecessary organelles and proteins.",
      "Aggrephagy is a process by which cells engulf and digest large, external particles such as bacteria or dead cells.",
      "Aggrephagy is not a variant of autophagy.",
      "Both autophagy and aggrephagy involve the uptake and degradation of material within the cell.",
      "Autophagy and aggrephagy serve different functions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Phagocytosis is a process by which cells engulf and digest large, external particles such as bacteria or dead cells. Aggrephagy is a subtype of autophagy that targets aggregated proteins.\n3. FALSE [correction]: Aggrephagy is a variant of autophagy.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "vicuna-7b_response": "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS). The exact number of DHS in the murine beta globin locus region can vary depending on the study and the method used to identify DHS.\nOne study using chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS in the murine beta globin locus region reported the presence of over 100 DHS in this region [1]. Another study using a similar approach reported the presence of over 50 DHS in the murine beta globin locus region [2].\nIt is worth noting that the number of DHS in the murine beta globin locus region may be different in other studies, as different methods and conditions can lead to different results.\nReferences:\n1. Liu JS, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.\n2. Zhang Y, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).\n2. The exact number of DHS in the murine beta globin locus region can vary depending on the study and the method used to identify DHS.\n3. One study using chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS reported the presence of over 100 DHS in the murine beta globin locus region.\n4. Another study using a similar approach reported the presence of over 50 DHS in the murine beta globin locus region.\n5. Different methods and conditions can lead to different results in the number of DHS in the murine beta globin locus region.",
    "vicuna-7b_fact": [
      "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).",
      "The exact number of DHS in the murine beta globin locus region can vary depending on the study and the method used to identify DHS.",
      "One study using chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS reported the presence of over 100 DHS in the murine beta globin locus region.",
      "Another study using a similar approach reported the presence of over 50 DHS in the murine beta globin locus region.",
      "Different methods and conditions can lead to different results in the number of DHS in the murine beta globin locus region."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3817,
    "user_query": "Which loss-of-function ABCC8 mutation is associated with Pulmonary Arterial Hypertension (PAH)?",
    "vicuna-7b_response": "The loss-of-function ABCC8 mutation that is associated with Pulmonary Arterial Hypertension (PAH) is c.2877C>T. This mutation results in a premature stop codon and is predicted to result in a non-functional protein. This mutation has been identified in several families with a history of PAH, and it is estimated to account for approximately 2-5% of all cases of PAH. Other loss-of-function mutations in ABCC8 have also been identified in patients with PAH, including c.2979C>T and c.3084C>T.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The loss-of-function ABCC8 mutation associated with Pulmonary Arterial Hypertension (PAH) is c.2877C>T.\n2. The mutation c.2877C>T results in a premature stop codon and is predicted to result in a non-functional protein.\n3. The c.2877C>T mutation has been identified in several families with a history of PAH.\n4. It is estimated that the c.2877C>T mutation accounts for approximately 2-5% of all cases of PAH.\n5. Other loss-of-function mutations in ABCC8 have been identified in patients with PAH, including c.2979C>T and c.3084C>T.",
    "vicuna-7b_fact": [
      "The loss-of-function ABCC8 mutation associated with Pulmonary Arterial Hypertension (PAH) is c.2877C>T.",
      "The mutation c.2877C>T results in a premature stop codon and is predicted to result in a non-functional protein.",
      "The c.2877C>T mutation has been identified in several families with a history of PAH.",
      "It is estimated that the c.2877C>T mutation accounts for approximately 2-5% of all cases of PAH.",
      "Other loss-of-function mutations in ABCC8 have been identified in patients with PAH, including c.2979C>T and c.3084C>T."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3819,
    "user_query": "List the core SNARE complex proteins.",
    "vicuna-7b_response": "The SNARE complex is a group of proteins that are involved in the transport of secretory vesicles across the cell membrane. The core SNARE complex proteins are:\n1. SNAP-25 (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor)\n2. VAMP (Vesicle-associated membrane protein)\n3. Syntaxin\n4. Sec1p (Sec1, a component of the endoplasmic reticulum)\nThese proteins work together to form a channel through the cell membrane, allowing secretory vesicles to fuse with the plasma membrane and release their contents.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The SNARE complex is a group of proteins that are involved in the transport of secretory vesicles across the cell membrane.\n2. SNAP-25 is one of the core SNARE complex proteins.\n3. VAMP is one of the core SNARE complex proteins.\n4. Syntaxin is classified as a core SNARE complex protein.\n5. Sec1p is a component of the SNARE complex and of the endoplasmic reticulum.",
    "vicuna-7b_fact": [
      "The SNARE complex is a group of proteins that are involved in the transport of secretory vesicles across the cell membrane.",
      "SNAP-25 is one of the core SNARE complex proteins.",
      "VAMP is one of the core SNARE complex proteins.",
      "Syntaxin is classified as a core SNARE complex protein.",
      "Sec1p is a component of the SNARE complex and of the endoplasmic reticulum."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE \n5. FALSE [correction]: Sec1p is associated with the SNARE complex and functions in the regulation of vesicle fusion, but it is not a component of the endoplasmic reticulum.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "vicuna-7b_response": "Sure, here are some European influenza vaccines:\n1. Fluarix: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). Fluarix is manufactured by GlaxoSmithKline.\n2. Fluzone: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix. Fluzone is also manufactured by GlaxoSmithKline.\n3. Fluvirin: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix and Fluzone. Fluvirin is manufactured by Seqirus.\n4. Fluad: This is a quadrivalent influenza vaccine that protects against four strains of influenza virus: two A strains (an A/H3N2 strain and an A/H1N1 strain) and two B strains (a B/Victoria strain and a B/Yamagata strain). Fluad is manufactured by Novartis.\n5. FluLaval: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). FluLaval is manufactured by Sanofi Pasteur.\n6. FluMist: This is a live attenuated influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Victoria strain). FluMist is manufactured by MedImm",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Fluarix is a trivalent influenza vaccine that protects against an A/H1N1 strain, an A/H3N2 strain, and a B strain (either a B/Yamagata or B/Victoria strain), and is manufactured by GlaxoSmithKline.\n2. Fluzone is also a trivalent influenza vaccine, produced by GlaxoSmithKline, protecting against the same three strains as Fluarix.\n3. Fluvirin is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix and Fluzone, and is manufactured by Seqirus.\n4. Fluad is a quadrivalent influenza vaccine that protects against two A strains and two B strains, and is made by Novartis.\n5. FluLaval is a trivalent influenza vaccine that is manufactured by Sanofi Pasteur and covers the same three strains as Fluarix.\n6. FluMist is a live attenuated influenza vaccine protecting against the same three strains and is produced by MedImm.",
    "vicuna-7b_fact": [
      "Fluarix is a trivalent influenza vaccine that protects against an A/H1N1 strain, an A/H3N2 strain, and a B strain (either a B/Yamagata or B/Victoria strain), and is manufactured by GlaxoSmithKline.",
      "Fluzone is also a trivalent influenza vaccine, produced by GlaxoSmithKline, protecting against the same three strains as Fluarix.",
      "Fluvirin is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix and Fluzone, and is manufactured by Seqirus.",
      "Fluad is a quadrivalent influenza vaccine that protects against two A strains and two B strains, and is made by Novartis.",
      "FluLaval is a trivalent influenza vaccine that is manufactured by Sanofi Pasteur and covers the same three strains as Fluarix.",
      "FluMist is a live attenuated influenza vaccine protecting against the same three strains and is produced by MedImm."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Fluarix is a quadrivalent influenza vaccine that protects against an A/H1N1 strain, an A/H3N2 strain, and two B strains (either a B/Yamagata or B/Victoria strain), and is manufactured by GlaxoSmithKline.\n2. FALSE [correction]: Fluzone is also a trivalent influenza vaccine, but it's produced by Sanofi Pasteur, not GlaxoSmithKline, and it protects against the same three strains as Fluarix.\n3. TRUE\n4. FALSE [correction]: Fluad is a trivalent influenza vaccine that protects against two A strains and one B strain, and is made by Seqirus, not Novartis.\n5. TRUE\n6. FALSE [correction]: FluMist is a live attenuated quadrivalent influenza vaccine, not trivalent, protecting against the same four strains as Fluarix and is produced by MedImmune/AstraZeneca.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3823,
    "user_query": "What is canSAR?",
    "vicuna-7b_response": "canSAR is a machine learning model developed by researchers at the Allen Institute for Artificial Intelligence (AI2). It stands for \"Cancer Subtype Analysis by Recurrent Neural Networks\" and is designed to classify cancer subtypes based on gene expression data.\nThe canSAR model is trained on a large dataset of gene expression profiles from over 1000 breast cancer patients. It uses a recurrent neural network architecture to learn the underlying patterns in the data and can accurately classify cancer subtypes with high accuracy.\ncanSAR has been used in several studies to investigate the molecular mechanisms underlying breast cancer and to identify potential therapeutic targets. It has also been used to develop a web-based tool called the Cancer Subtype Analysis Tool (cSAT) which allows researchers to easily analyze and compare their own gene expression data with the canSAR model.\nOverall, canSAR is a powerful tool for cancer research and has the potential to improve our understanding of the molecular mechanisms underlying breast cancer and to aid in the development of new treatments.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. canSAR is a machine learning model developed by the Allen Institute for Artificial Intelligence (AI2).\n2. The canSAR model is designed to classify cancer subtypes based on gene expression data.\n3. The canSAR model was trained on a large dataset of gene expression profiles from over 1000 breast cancer patients.\n4. The canSAR model has been used in several studies to investigate the molecular mechanisms underlying breast cancer.\n5. CanSAR has been used to develop a web-based tool called the Cancer Subtype Analysis Tool (cSAT).",
    "vicuna-7b_fact": [
      "canSAR is a machine learning model developed by the Allen Institute for Artificial Intelligence (AI2).",
      "The canSAR model is designed to classify cancer subtypes based on gene expression data.",
      "The canSAR model was trained on a large dataset of gene expression profiles from over 1000 breast cancer patients.",
      "The canSAR model has been used in several studies to investigate the molecular mechanisms underlying breast cancer.",
      "CanSAR has been used to develop a web-based tool called the Cancer Subtype Analysis Tool (cSAT)."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: canSAR is a publicely available cancer bioinformatics resource developed by the Inistitute of Cancer Research not, Allen Institute for Artificial Intelligence (AI2).\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3824,
    "user_query": "What is the mechanism of action of magrolimab?",
    "vicuna-7b_response": "Magrolimab is a monoclonal antibody therapy that targets the interleukin-2 receptor alpha (IL-2Rα) on T cells. It works by binding to IL-2Rα and blocking the signaling of IL-2, a cytokine that plays a crucial role in T cell activation and proliferation. By inhibiting IL-2 signaling, magrolimab reduces the activation and proliferation of T cells, leading to a decrease in the immune response and the suppression of autoimmune diseases.\nIn specific, magrolimab is used to treat certain types of cancer, such as melanoma, kidney cancer, and lung cancer. It is also being studied for the treatment of other autoimmune diseases, such as multiple sclerosis and psoriasis.\nIt's important to note that Magrolimab is a investigational drug, and its mechanism of action is still under investigation.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Magrolimab is a monoclonal antibody therapy that targets the interleukin-2 receptor alpha (IL-2Rα) on T cells.\n2. Magrolimab works by blocking the signaling of IL-2, a cytokine that plays a role in T cell activation and proliferation.\n3. By inhibiting IL-2 signaling, magrolimab reduces the activation and proliferation of T cells.\n4. Magrolimab is used in the treatment of cancers such as melanoma, kidney cancer, and lung cancer.\n5. Magrolimab is an investigational drug and is being studied for the treatment of other autoimmune diseases such as multiple sclerosis and psoriasis.",
    "vicuna-7b_fact": [
      "Magrolimab is a monoclonal antibody therapy that targets the interleukin-2 receptor alpha (IL-2Rα) on T cells.",
      "Magrolimab works by blocking the signaling of IL-2, a cytokine that plays a role in T cell activation and proliferation.",
      "By inhibiting IL-2 signaling, magrolimab reduces the activation and proliferation of T cells.",
      "Magrolimab is used in the treatment of cancers such as melanoma, kidney cancer, and lung cancer.",
      "Magrolimab is an investigational drug and is being studied for the treatment of other autoimmune diseases such as multiple sclerosis and psoriasis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Magrolimab is a monoclonal antibody therapy that targets the CD47 molecule on cancer cells.\n2. FALSE [correction]: Magrolimab works by blocking the signal of CD47, a molecule that tells the immune system not to attack the cell.\n3. FALSE [correction]: By inhibiting the signal of CD47, magrolimab allows the immune system to recognize and attack the cancer cells.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3830,
    "user_query": "Should tirilazad be used for treatment of ischemic stroke?",
    "vicuna-7b_response": "Tirilazad is a drug that has been studied for its potential to treat ischemic stroke, which is the most common type of stroke. Ischemic stroke occurs when there is a blockage in an artery that supplies blood to the brain, which can cause brain cells to die.\nTirilazad is a selective inhibitor of matrix metalloproteinase (MMP)-9, which is an enzyme that plays a role in the breakdown of blood vessels and the development of blood clots. By inhibiting MMP-9, tirilazad may help to prevent the formation of blood clots that can cause ischemic stroke.\nThere have been several clinical trials that have investigated the use of tirilazad for the treatment of ischemic stroke. These studies have shown that tirilazad can significantly reduce the risk of death and disability in patients who have experienced an ischemic stroke.\nHowever, it is important to note that tirilazad has not been approved by the FDA for the treatment of ischemic stroke. Further research is needed to fully understand the safety and efficacy of tirilazad for this indication.\nIn summary, tirilazad is a promising drug for the treatment of ischemic stroke, but more research is needed to fully understand its potential benefits and risks.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Tirilazad is a drug that has been studied for its potential to treat ischemic stroke.\n2. Ischemic stroke occurs when there is a blockage in an artery that supplies blood to the brain.\n3. Tirilazad is a selective inhibitor of matrix metalloproteinase (MMP)-9, an enzyme that plays a role in the breakdown of blood vessels and the development of blood clots.\n4. Clinical trials have shown that tirilazad can significantly reduce the risk of death and disability in patients who have experienced an ischemic stroke.\n5. Tirilazad has not been approved by the FDA for the treatment of ischemic stroke.",
    "vicuna-7b_fact": [
      "Tirilazad is a drug that has been studied for its potential to treat ischemic stroke.",
      "Ischemic stroke occurs when there is a blockage in an artery that supplies blood to the brain.",
      "Tirilazad is a selective inhibitor of matrix metalloproteinase (MMP)-9, an enzyme that plays a role in the breakdown of blood vessels and the development of blood clots.",
      "Clinical trials have shown that tirilazad can significantly reduce the risk of death and disability in patients who have experienced an ischemic stroke.",
      "Tirilazad has not been approved by the FDA for the treatment of ischemic stroke."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tirilazad is not a selective inhibitor of matrix metalloproteinase (MMP)-9, it is a type of steroid that has a neuroprotective effect.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3831,
    "user_query": "List the major families of Histones.",
    "vicuna-7b_response": "There are five major families of histones: H1, H2A, H2B, H3, and H4.\nHistones are proteins that are responsible for the organization and regulation of DNA within the nucleus of a cell. They are involved in the compaction of DNA into chromatin, which is a more compact form of DNA that is better suited for gene regulation.\nEach of the five major families of histones has a specific function in the regulation of gene expression. For example, H1 histones are involved in the stability of chromatin structure, while H3 and H4 histones are involved in the regulation of transcription.\nIt is important to note that histones are not only involved in the regulation of gene expression, but they also play a role in the repair of DNA damage and the maintenance of chromosome structure.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. There are five major families of histones: H1, H2A, H2B, H3, and H4.\n2. Histones are proteins that are responsible for the organization and regulation of DNA within the nucleus of a cell.\n3. Histones are involved in the compaction of DNA into chromatin.\n4. Each of the five major families of histones has a specific function in the regulation of gene expression.\n5. Histones also play a role in the repair of DNA damage and the maintenance of chromosome structure.",
    "vicuna-7b_fact": [
      "There are five major families of histones: H1, H2A, H2B, H3, and H4.",
      "Histones are proteins that are responsible for the organization and regulation of DNA within the nucleus of a cell.",
      "Histones are involved in the compaction of DNA into chromatin.",
      "Each of the five major families of histones has a specific function in the regulation of gene expression.",
      "Histones also play a role in the repair of DNA damage and the maintenance of chromosome structure."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "vicuna-7b_response": "Yes, the Paramyxovirus geneome is segmented and negative-sense RNA.\nParamyxoviruses are a type of virus that infects mammals and birds. They have a single-stranded, negative-sense RNA genome, which means that the nucleotide sequence of the RNA is complementary to that of the virus's mRNA. The negative-sense RNA is synthesized in the nucleus of the infected cell and is then transported to the cytoplasm, where it is translated into proteins by the ribosomes.\nParamyxoviruses are further classified into two genera: Pneumovirinae and Rubulavirinae. Pneumovirinae includes the respiratory syncytial virus (RSV), which is a major cause of respiratory illness in children, and the metapneumovirus, which causes respiratory disease in pigs. Rubulavirinae includes the measles virus, which is a highly contagious disease that causes fever, cough, and rash.\nThe Paramyxovirus genome is segmented, meaning that it is composed of several smaller RNA segments that are produced by the viral RNA-dependent RNA polymerase. These segments are then assembled into a single genome during the replication process. The segmented nature of the Paramyxovirus genome allows the virus to evolve and adapt to new hosts and environments more quickly than a single, continuous genome would.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Paramyxovirus geneome is segmented and negative-sense RNA.\n2. The nucleotide sequence of the RNA of Paramyxoviruses is complementary to that of the virus's mRNA.\n3. Paramyxoviruses are further classified into two genera: Pneumovirinae and Rubulavirinae.\n4. The respiratory syncytial virus (RSV) is a major cause of respiratory illness in children.\n5. Rubulavirinae includes the measles virus which causes fever, cough, and rash.",
    "vicuna-7b_fact": [
      "Paramyxovirus geneome is segmented and negative-sense RNA.",
      "The nucleotide sequence of the RNA of Paramyxoviruses is complementary to that of the virus's mRNA.",
      "Paramyxoviruses are further classified into two genera: Pneumovirinae and Rubulavirinae.",
      "The respiratory syncytial virus (RSV) is a major cause of respiratory illness in children.",
      "Rubulavirinae includes the measles virus which causes fever, cough, and rash."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Paramyxovirus genome is non-segmented and negative-sense RNA.\n2. TRUE\n3. FALSE [correction]: Paramyxoviruses are classified into two subfamilies: Pneumovirinae and Paramyxovirinae.\n4. TRUE\n5. FALSE [correction]: Morbillivirus, a genus within the subfamily Paramyxovirinae, includes the measles virus which causes fever, cough, and rash.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3835,
    "user_query": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "vicuna-7b_response": "Yes, exon 38 or 39 missense variants in the KMT2D gene can cause Kabuki syndrome type 1 (KS1).\nKabuki syndrome is a rare genetic disorder characterized by a wide range of physical and developmental abnormalities. KS1 is caused by mutations in the KMT2D gene, which encodes a histone methyltransferase called KMT2D (also known as MLL2).\nExon 38 and 39 missense variants in the KMT2D gene have been identified as causative mutations for KS1. These variants can lead to the production of non-functional or misfolded proteins, which can disrupt the normal function of KMT2D and cause the various symptoms of KS1.\nIndividuals with KS1 may have a range of physical and developmental abnormalities, including growth and developmental delays, distinctive facial features, and intellectual disability. Other symptoms can include heart defects, hearing loss, and kidney abnormalities.\nKS1 is a genetically heterogeneous disorder, and the severity of symptoms can vary widely among affected individuals. Genetic testing can help identify individuals with KS1 and provide information for genetic counseling and management of the condition.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Exon 38 or 39 missense variants in the KMT2D gene can cause Kabuki syndrome type 1 (KS1).\n2. Kabuki syndrome is a rare genetic disorder characterized by a wide range of physical and developmental abnormalities.\n3. Exon 38 and 39 missense variants in the KMT2D gene have been identified as causative mutations for KS1.\n4. Individuals with KS1 may have a range of physical and developmental abnormalities, including growth and developmental delays, distinctive facial features, and intellectual disability.\n5. KS1 is a genetically heterogeneous disorder, and the severity of symptoms can vary widely among affected individuals.",
    "vicuna-7b_fact": [
      "Exon 38 or 39 missense variants in the KMT2D gene can cause Kabuki syndrome type 1 (KS1).",
      "Kabuki syndrome is a rare genetic disorder characterized by a wide range of physical and developmental abnormalities.",
      "Exon 38 and 39 missense variants in the KMT2D gene have been identified as causative mutations for KS1.",
      "Individuals with KS1 may have a range of physical and developmental abnormalities, including growth and developmental delays, distinctive facial features, and intellectual disability.",
      "KS1 is a genetically heterogeneous disorder, and the severity of symptoms can vary widely among affected individuals."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3836,
    "user_query": "The NoSAS Score can be used for screening of which disorders?",
    "vicuna-7b_response": "The NoSAS (Non-Specific Anxiety and Stress) score is a tool used to assess the severity of non-specific anxiety and stress in individuals. It is commonly used in research studies and clinical settings to screen for a variety of disorders related to anxiety and stress.\nThe NoSAS score can be used to screen for the following disorders:\n1. Generalized Anxiety Disorder (GAD): GAD is characterized by excessive anxiety and worry about a variety of events and activities. The NoSAS score can be used to screen for GAD by assessing symptoms such as restlessness, fatigue, and difficulty concentrating.\n2. Post-Traumatic Stress Disorder (PTSD): PTSD is a disorder that develops in response to a traumatic event, such as military combat, natural disasters, or sexual assault. The NoSAS score can be used to screen for PTSD by assessing symptoms such as re-experiencing the traumatic event, avoidance of reminders of the event, and hyperarousal.\n3. Social Anxiety Disorder (SAD): SAD is characterized by excessive anxiety and fear of social or performance situations. The NoSAS score can be used to screen for SAD by assessing symptoms such as blushing, sweating, and difficulty speaking in front of others.\n4. Panic Disorder: Panic disorder is a disorder characterized by recurrent and unexpected panic attacks. The NoSAS score can be used to screen for panic disorder by assessing symptoms such as palpitations, shortness of breath, and fear of having another panic attack.\nIt is important to note that the NoSAS score should not be used to diagnose a disorder, but rather to screen for the presence of symptoms related to anxiety and stress. If a person scores high on the NoSAS score, it is recommended that they seek professional help from a mental health provider.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. The NoSAS (Non-Specific Anxiety and Stress) score is used to assess the severity of non-specific anxiety and stress.\n2. The NoSAS score is used to screen for disorders like Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Panic Disorder.\n3. Generalized Anxiety Disorder is characterized by excessive anxiety about a variety of events and activities.\n4. Post-Traumatic Stress Disorder develops in response to a traumatic event.\n5. The NoSAS score is not used to diagnose a disorder, but to screen for the presence of symptoms related to anxiety and stress.",
    "vicuna-7b_fact": [
      "The NoSAS (Non-Specific Anxiety and Stress) score is used to assess the severity of non-specific anxiety and stress.",
      "The NoSAS score is used to screen for disorders like Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Panic Disorder.",
      "Generalized Anxiety Disorder is characterized by excessive anxiety about a variety of events and activities.",
      "Post-Traumatic Stress Disorder develops in response to a traumatic event.",
      "The NoSAS score is not used to diagnose a disorder, but to screen for the presence of symptoms related to anxiety and stress."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3837,
    "user_query": "What is the chromosomal abnormality associated with Klinefelter Syndrome",
    "vicuna-7b_response": "Klinefelter Syndrome is a chromosomal abnormality that occurs when a person has an extra X chromosome in their genetic makeup. Specifically, it is caused by an additional X chromosome in each cell, resulting in a total of four X chromosomes instead of the typical two in males. This extra X chromosome results in the development of male reproductive structures, but the individual has a Y chromosome and testes instead of ovaries and ovarian tissue.\nThe most common symptoms of Klinefelter Syndrome include tall stature, breast development, and small testes. Other symptoms may include learning difficulties, speech and language delays, and behavioral problems. The severity of symptoms can vary widely among individuals with Klinefelter Syndrome.\nKlinefelter Syndrome is the most common chromosomal abnormality in males, occurring in approximately 1 in every 5,000 to 6,000 male births. It is typically diagnosed in early childhood or adolescence, although some individuals may not be diagnosed until later in life.\nTreatment for Klinefelter Syndrome typically focuses on managing symptoms and promoting health and well-being. This may include hormone therapy to promote growth and development, speech and language therapy, and educational support to address learning difficulties. In some cases, surgery may be necessary to address reproductive or other physical issues.",
    "vicuna-7b_fact_raw": "Here are all the factual statements:\n1. Klinefelter Syndrome is a chromosomal abnormality caused by an extra X chromosome in each cell.\n2. The most common symptoms of Klinefelter Syndrome include tall stature, breast development, and small testes.\n3. Klinefelter Syndrome is found in approximately 1 in every 5,000 to 6,000 male births.\n4. The disorder is typically diagnosed in early childhood or adolescence.\n5. Treatment for Klinefelter Syndrome may include hormone therapy, speech and language therapy, and educational support.",
    "vicuna-7b_fact": [
      "Klinefelter Syndrome is a chromosomal abnormality caused by an extra X chromosome in each cell.",
      "The most common symptoms of Klinefelter Syndrome include tall stature, breast development, and small testes.",
      "Klinefelter Syndrome is found in approximately 1 in every 5,000 to 6,000 male births.",
      "The disorder is typically diagnosed in early childhood or adolescence.",
      "Treatment for Klinefelter Syndrome may include hormone therapy, speech and language therapy, and educational support."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Klinefelter Syndrome is found in approximately 1 in every 500 to 1,000 male births.\n4. FALSE [correction]: The disorder is often not diagnosed until adulthood, although some symptoms may be noticeable in adolescence.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  }
]